PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Surmeier, DJ; Schumacker, PT				Surmeier, D. James; Schumacker, Paul T.			Calcium, Bioenergetics, and Neuronal Vulnerability in Parkinson's Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SUBSTANTIA-NIGRA NEURONS; MIDBRAIN DOPAMINERGIC-NEURONS; MITOCHONDRIAL-DNA DELETIONS; DORSAL RAPHE NEURONS; CHANNEL BLOCKERS; TUBEROMAMMILLARY NEURONS; PACEMAKER ACTIVITY; OXIDATIVE STRESS; OLFACTORY-BULB; OXIDANT STRESS	The most distinguishing feature of neurons is their capacity for regenerative electrical activity. This activity imposes a significant mitochondrial burden, especially in neurons that are autonomously active, have broad action potentials, and exhibit prominent Ca2+ entry. Many of the genetic mutations and toxins associated with Parkinson's disease compromise mitochondrial function, providing a mechanistic explanation for the pattern of neuronal pathology in this disease. Because much of the neuronal mitochondrial burden can be traced to L-type voltage-dependent channels (channels for which there are brain-penetrant antagonists approved for human use), a neuroprotective strategy to reduce this burden is available.	[Surmeier, D. James] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Schumacker, Paul T.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Surmeier, DJ (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu		Schumacker, Paul T/0000-0001-9591-2034	National Institutes of Health [NS047085, RR025355, HL35440]; Hartman Foundation; United States Army Medical Research and Materiel Command; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025355] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS047085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartman Foundation; United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS047085, RR025355, and HL35440. This work was also supported by grants from the Hartman Foundation and the United States Army Medical Research and Materiel Command. This article is part of the Thematic Minireview Series on Calcium Function and Disease.	ALREJA M, 1991, BRAIN RES, V556, P339, DOI 10.1016/0006-8993(91)90327-R; Atherton JF, 2005, J NEUROSCI, V25, P8272, DOI 10.1523/JNEUROSCI.1475-05.2005; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Becker C, 2008, NEUROLOGY, V70, P1438, DOI 10.1212/01.wnl.0000303818.38960.44; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bonci A, 1998, J NEUROSCI, V18, P6693; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; BURLHIS TM, 1987, SYNAPSE, V1, P582, DOI 10.1002/syn.890010611; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chan CS, 2011, NAT NEUROSCI, V14, P85, DOI 10.1038/nn.2692; CHAN JYH, 1989, NEUROSCI LETT, V97, P169, DOI 10.1016/0304-3940(89)90158-4; Choi SW, 2011, J NEUROSCI, V31, P4524, DOI 10.1523/JNEUROSCI.5817-10.2011; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Decuypere JP, 2011, CELL CALCIUM, V50, P242, DOI 10.1016/j.ceca.2011.04.001; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Fahn S, 2005, J NEUROL, V252, P37, DOI 10.1007/s00415-005-4008-5; Foehring RC, 2009, J NEUROPHYSIOL, V102, P2326, DOI 10.1152/jn.00038.2009; GERMAN DC, 1992, ANN NEUROL, V32, P667, DOI 10.1002/ana.410320510; GERMAN DC, 1992, ANN NY ACAD SCI, V648, P42, DOI 10.1111/j.1749-6632.1992.tb24523.x; Goldberg JA, 2012, NAT NEUROSCI, V15, P1414, DOI 10.1038/nn.3209; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; GRIFFITH WH, 1991, ADV EXP MED BIOL, V295, P143; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; HORNYKIEWICZ O, 1966, PHARMACOL REV, V18, P925; ITO H, 1992, ANN NEUROL, V32, P543, DOI 10.1002/ana.410320410; JENSEN PK, 1966, BIOCHIM BIOPHYS ACTA, V122, P167, DOI 10.1016/0926-6593(66)90058-0; Khaliq ZM, 2010, J NEUROSCI, V30, P7401, DOI 10.1523/JNEUROSCI.0143-10.2010; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Lee CR, 2007, J COMP NEUROL, V500, P958, DOI 10.1002/cne.21220; Lee I, 2001, BIOL CHEM, V382, P1629, DOI 10.1515/BC.2001.198; Lloyd-Evans E, 2011, CELL CALCIUM, V50, P200, DOI 10.1016/j.ceca.2011.03.010; Marras C, 2012, ANN NEUROL, V71, P362, DOI 10.1002/ana.22616; MATZUK MM, 1985, ANN NEUROL, V18, P552, DOI 10.1002/ana.410180507; MCCANN MJ, 1990, J PHYSIOL-LONDON, V428, P95, DOI 10.1113/jphysiol.1990.sp018202; MERCURI NB, 1994, BRIT J PHARMACOL, V113, P831, DOI 10.1111/j.1476-5381.1994.tb17068.x; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Murchison D, 2007, AGING CELL, V6, P297, DOI 10.1111/j.1474-9726.2007.00293.x; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NEDERGAARD S, 1993, J PHYSIOL-LONDON, V466, P727; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Pasternak B, 2012, AM J EPIDEMIOL, V175, P627, DOI 10.1093/aje/kwr362; Pignatelli A, 2005, J PHYSIOL-LONDON, V564, P501, DOI 10.1113/jphysiol.2005.084632; Ping HX, 1996, NEUROREPORT, V7, P809, DOI 10.1097/00001756-199602290-00031; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; Puopolo M, 2005, J NEUROPHYSIOL, V94, P3618, DOI 10.1152/jn.00225.2005; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; SAPER CB, 1991, ANN NEUROL, V29, P577, DOI 10.1002/ana.410290602; SERAFIN M, 1990, NEUROSCI LETT, V120, P5, DOI 10.1016/0304-3940(90)90154-2; Stevens DR, 1996, J PHYSIOL-LONDON, V493, P747, DOI 10.1113/jphysiol.1996.sp021419; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; VANDERMAELEN CP, 1983, BRAIN RES, V289, P109, DOI 10.1016/0006-8993(83)90011-2; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; WILLIAMS JT, 1984, NEUROSCIENCE, V13, P137, DOI 10.1016/0306-4522(84)90265-3; Wilson CJ, 2000, J NEUROPHYSIOL, V83, P3084, DOI 10.1152/jn.2000.83.5.3084; Zara V, 2007, FEBS J, V274, P4526, DOI 10.1111/j.1742-4658.2007.05982.x	69	146	147	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10736	10741		10.1074/jbc.R112.410530	http://dx.doi.org/10.1074/jbc.R112.410530			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23086948	hybrid, Green Published			2022-12-28	WOS:000317565000051
J	Dexter, JP; Gunawardena, J				Dexter, Joseph P.; Gunawardena, Jeremy			Dimerization and Bifunctionality Confer Robustness to the Isocitrate Dehydrogenase Regulatory System in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-BINDING-SITE; X-RAY ANALYSIS; KINASE PHOSPHATASE; MULTISITE PHOSPHORYLATION; KINASE/PHOSPHATASE; ENZYME; CYCLE; PURIFICATION; PROTEIN; CRYSTALLIZATION	An important goal of systems biology is to develop quantitative models that explain how specific molecular features give rise to systems-level properties. Metabolic and regulatory pathways that contain multifunctional proteins are especially interesting to study from this perspective because they have frequently been observed to exhibit robustness: the ability for a system to perform its proper function even as levels of its components change. In this study, we use extensive biochemical data and algebraic modeling to develop and analyze a model that shows how robust behavior arises in the isocitrate dehydrogenase (IDH) regulatory system of Escherichia coli, which was shown in 1985 to experimentally exhibit robustness. E. coli IDH is regulated by reversible phosphorylation catalyzed by the bifunctional isocitrate dehydrogenase kinase/phosphatase (IDHKP), and the level of IDH activity determines whether carbon flux is directed through the glyoxylate bypass (for growth on two-carbon substrates) or the full tricarboxylic acid cycle. Our model, which incorporates recent structural data on IDHKP, identifies several specific biochemical features of the system (including homodimerization of IDH and bifunctionality of IDHKP) that provide a potential explanation for robustness. Using algebraic techniques, we derive an invariant that summarizes the steady-state relationship between the phospho-forms of IDH. We use the invariant in combination with kinetic data on IDHKP to calculate IDH activity at a range of total IDH levels and find that our model predicts robustness. Our work unifies much of the known biochemistry of the IDH regulatory system into a single quantitative framework and highlights the importance of constructing biochemically realistic models in systems biology.	[Dexter, Joseph P.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Dexter, Joseph P.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Gunawardena, Jeremy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Princeton University; Princeton University; Harvard University; Harvard Medical School	Dexter, JP (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, 1566 1st Ctr, Princeton, NJ 08544 USA.	jdexter@princeton.edu			National Science Foundation [0856285]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant 0856285 (to J. G.)	Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; BORTHWICK AC, 1984, EUR J BIOCHEM, V141, P393, DOI 10.1111/j.1432-1033.1984.tb08204.x; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; Cozzone AJ, 2005, J MOL MICROB BIOTECH, V9, P132, DOI 10.1159/000089642; DEAN AM, 1989, J BIOL CHEM, V264, P20482; GARNAK M, 1979, SCIENCE, V203, P1111, DOI 10.1126/science.34215; Gunawardena J., 2009, ELEMENTS COMPUTATION, P21; Gunawardena J, 2010, SCIENCE, V328, P581, DOI 10.1126/science.1188974; Hart Y, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-171; Hart Y, 2011, MOL CELL, V41, P117, DOI 10.1016/j.molcel.2010.12.023; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; KORNBERG HL, 1966, BIOCHEM J, V99, P1; LAPORTE DC, 1983, NATURE, V305, P286, DOI 10.1038/305286a0; LAPORTE DC, 1993, J CELL BIOCHEM, V51, P14, DOI 10.1002/jcb.240510104; LAPORTE DC, 1985, J BIOL CHEM, V260, P563; LAPORTE DC, 1989, BIOCHIMIE, V71, P1051, DOI 10.1016/0300-9084(89)90110-7; LAPORTE DC, 1982, NATURE, V300, P458, DOI 10.1038/300458a0; Manrai AK, 2008, BIOPHYS J, V95, P5533, DOI 10.1529/biophysj.108.140632; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; MCKEE JS, 1989, BIOCHIMIE, V71, P1059, DOI 10.1016/0300-9084(89)90111-9; Miller SP, 1996, J BIOL CHEM, V271, P19124, DOI 10.1074/jbc.271.32.19124; NIMMO GA, 1984, EUR J BIOCHEM, V141, P401, DOI 10.1111/j.1432-1033.1984.tb08205.x; Ohta S, 2006, MOL BREEDING, V18, P29, DOI 10.1007/s11032-006-9011-8; Oudot C, 1999, EUR J BIOCHEM, V262, P224, DOI 10.1046/j.1432-1327.1999.00395.x; Prabakaran S, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.15; Russo F D, 1993, Trends Microbiol, V1, P306, DOI 10.1016/0966-842X(93)90007-E; SENIOR PJ, 1975, J BACTERIOL, V123, P407, DOI 10.1128/JB.123.2.407-418.1975; Shinar G, 2007, P NATL ACAD SCI USA, V104, P19931, DOI 10.1073/pnas.0706792104; Shinar G, 2011, MATH BIOSCI, V231, P39, DOI 10.1016/j.mbs.2011.02.012; Shinar G, 2010, SCIENCE, V327, P1389, DOI 10.1126/science.1183372; Shinar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000297; Singh SK, 2002, J BIOL CHEM, V277, P7567, DOI 10.1074/jbc.M107908200; Strogatz S. H., 2001, NONLINEAR DYNAMICS C; STUELAND CS, 1989, J BIOL CHEM, V264, P13775; Thomson M, 2009, NATURE, V460, P274, DOI 10.1038/nature08102; VARELA I, 1988, FEBS LETT, V231, P361, DOI 10.1016/0014-5793(88)80850-0; WAMPLER DE, 1985, P NATL ACAD SCI USA, V82, P6830, DOI 10.1073/pnas.82.20.6830; Xu YQ, 2012, J THEOR BIOL, V311, P139, DOI 10.1016/j.jtbi.2012.07.012; Yates SP, 2011, BIOCHEMISTRY-US, V50, P8103, DOI 10.1021/bi200809p; Zheng JM, 2010, NATURE, V465, P961, DOI 10.1038/nature09088; Zheng JM, 2009, ACTA CRYSTALLOGR F, V65, P1153, DOI 10.1107/S1744309109038718; Zheng JM, 2009, ACTA CRYSTALLOGR F, V65, P536, DOI 10.1107/S1744309109014729	45	20	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5770	5778		10.1074/jbc.M112.339226	http://dx.doi.org/10.1074/jbc.M112.339226			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23192354	Green Published, hybrid			2022-12-28	WOS:000315342500048
J	Berim, A; Gang, DR				Berim, Anna; Gang, David R.			The Roles of a Flavone-6-Hydroxylase and 7-O-Demethylation in the Flavone Biosynthetic Network of Sweet Basil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; OCIMUM-BASILICUM; GLANDULAR HAIRS; O-DEMETHYLATION; ESSENTIAL OIL; CYTOCHROME-P450; AGLYCONES; EXPRESSION; P450S	Lipophilic flavonoids found in the Lamiaceae exhibit unusual 6- and 8-hydroxylations whose enzymatic basis is unknown. We show that crude protein extracts from peltate trichomes of sweet basil (Ocimum basilicum L.) cultivars readily hydroxylate position 6 of 7-O-methylated apigenin but not apigenin itself. The responsible protein was identified as a P450 monooxygenase from the CYP82 family, a family not previously reported to be involved in flavonoid metabolism. This enzyme prefers flavones but also accepts flavanones in vitro and requires a 5-hydroxyl in addition to a 7-methoxyl residue on the substrate. A peppermint (Mentha x piperita L.) homolog displayed identical substrate requirements, suggesting that early 7-O-methylation of flavones might be common in the Lamiaceae. This hypothesis is further substantiated by the pioneering discovery of 2-oxoglutarate-dependent flavone demethylase activity in basil, which explains the accumulation of 7-O-demethylated flavone nevadensin.	[Berim, Anna; Gang, David R.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Washington State University	Gang, DR (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	gangd@wsu.edu			Department of Energy Biological and Environmental Research Program [DE-SC0001728]	Department of Energy Biological and Environmental Research Program(United States Department of Energy (DOE))	This work was supported by Department of Energy Biological and Environmental Research Program Grant DE-SC0001728 (to D. R. G.).	Anzellotti D, 2000, ARCH BIOCHEM BIOPHYS, V382, P161, DOI 10.1006/abbi.2000.2002; Anzellotti Dominique, 2004, BMC Plant Biology, V4, P20, DOI 10.1186/1471-2229-4-20; Berim A, 2012, PLANT PHYSIOL, V160, P1052, DOI 10.1104/pp.112.204164; Bosabalidis A, 1998, PHYTOCHEMISTRY, V49, P1549, DOI 10.1016/S0031-9422(98)00186-1; Bui ML, 2004, BIOCHEM SYST ECOL, V32, P943, DOI 10.1016/j.bse.2004.03.001; Chemler JA, 2008, CURR OPIN BIOTECH, V19, P597, DOI 10.1016/j.copbio.2008.10.011; Facchini PJ, 2012, TRENDS BIOTECHNOL, V30, P127, DOI 10.1016/j.tibtech.2011.10.001; FERRERES F, 1985, PHYTOCHEMISTRY, V24, P1869, DOI 10.1016/S0031-9422(00)82579-0; Fliegmann J, 2010, PHYTOCHEMISTRY, V71, P508, DOI 10.1016/j.phytochem.2010.01.007; Gang DR, 2005, ANNU REV PLANT BIOL, V56, P301, DOI 10.1146/annurev.arplant.56.032604.144128; Gang DR, 2001, PLANT PHYSIOL, V125, P539, DOI 10.1104/pp.125.2.539; GERSHENZON J, 1992, ANAL BIOCHEM, V200, P130, DOI 10.1016/0003-2697(92)90288-I; Grayer RJ, 1996, PHYTOCHEMISTRY, V43, P1041, DOI 10.1016/S0031-9422(96)00430-X; Grayer RJ, 2001, PHYTOCHEMISTRY, V56, P559, DOI 10.1016/S0031-9422(00)00439-8; Greenham J, 2001, PHYTOCHEMISTRY, V56, P87, DOI 10.1016/S0031-9422(00)00355-1; Hagel JM, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00014; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Halbwirth H, 2004, PLANT SCI, V167, P129, DOI 10.1016/j.plantsci.2004.03.007; Halbwirth H, 2010, INT J MOL SCI, V11, P595, DOI 10.3390/ijms11020595; Ibrahim RK, 2005, CAN J BOT, V83, P433, DOI [10.1139/b05-030, 10.1139/B05-030]; Ikezawa N, 2008, J BIOL CHEM, V283, P8810, DOI 10.1074/jbc.M705082200; Kitada C, 2001, PLANT CELL PHYSIOL, V42, P1338, DOI 10.1093/pcp/pce169; Kruse T, 2008, CHEM BIOL, V15, P149, DOI 10.1016/j.chembiol.2008.01.008; Lange BM, 2000, P NATL ACAD SCI USA, V97, P2934, DOI 10.1073/pnas.97.6.2934; Larbat R, 2007, J BIOL CHEM, V282, P542, DOI 10.1074/jbc.M604762200; Latunde-Dada AO, 2001, J BIOL CHEM, V276, P1688, DOI 10.1074/jbc.M006277200; Lee S, 2010, P NATL ACAD SCI USA, V107, P21205, DOI 10.1073/pnas.1009975107; Liu Y, 1998, PHYTOCHEMISTRY, V48, P339, DOI 10.1016/S0031-9422(97)01129-1; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Matsuba Y, 2010, PLANT CELL, V22, P3374, DOI 10.1105/tpc.110.077487; Mau Christopher J. D., 2006, Phytochemistry Reviews, V5, P373, DOI 10.1007/s11101-006-9008-2; OMURA T, 1964, J BIOL CHEM, V239, P2370; PARMAR VS, 1994, PHYTOCHEMISTRY, V36, P507, DOI 10.1016/S0031-9422(00)97104-8; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Pollastri S, 2011, ANN BOT-LONDON, V108, P1225, DOI 10.1093/aob/mcr234; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Ralston L, 2001, ARCH BIOCHEM BIOPHYS, V393, P222, DOI 10.1006/abbi.2001.2483; RIESEBERG LH, 1987, AM J BOT, V74, P224, DOI 10.2307/2444024; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroder G, 1999, FEBS LETT, V458, P97, DOI 10.1016/S0014-5793(99)01138-2; Siminszky B, 2005, P NATL ACAD SCI USA, V102, P14919, DOI 10.1073/pnas.0506581102; Takemura T, 2012, PHYTOCHEMIS IN PRESS; TALAPATR.SK, 1974, PHYTOCHEMISTRY, V13, P284, DOI 10.1016/S0031-9422(00)91316-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; Tezuka Y, 2000, CHEM PHARM BULL, V48, P1711, DOI 10.1248/cpb.48.1711; Valant-Vetschera KM, 2003, BIOCHEM SYST ECOL, V31, P1279, DOI 10.1016/S0305-1978(03)00037-1; VANDENBROUCKE CO, 1982, PHYTOCHEMISTRY, V21, P2581, DOI 10.1016/0031-9422(82)85261-8; Veitch NC, 2011, NAT PROD REP, V28, P1626, DOI 10.1039/c1np00044f; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; VOIRIN B, 1992, PHYTOCHEMISTRY, V31, P2299, DOI 10.1016/0031-9422(92)83268-4; Wang YC, 2011, APPL MICROBIOL BIOT, V91, P949, DOI 10.1007/s00253-011-3449-2; WERKER E, 1993, ANN BOT-LONDON, V71, P43, DOI 10.1006/anbo.1993.1005; WOLLENWEBER E, 1981, PHYTOCHEMISTRY, V20, P869, DOI 10.1016/0031-9422(81)83001-4; Wollenweber E, 2003, Z NATURFORSCH C, V58, P771; WOLLENWEBER E, 1972, TETRAHEDRON LETT, P797, DOI 10.1016/S0040-4039(01)84442-7; Wollenweber E, 2008, BIOCHEM SYST ECOL, V36, P481, DOI 10.1016/j.bse.2007.12.004; Yuk HJ, 2011, J AGR FOOD CHEM, V59, P12683, DOI 10.1021/jf203326c; Zhang JA, 2007, PLANT PHYSIOL, V144, P741, DOI 10.1104/pp.106.095018	59	43	45	3	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1795	1805		10.1074/jbc.M112.420448	http://dx.doi.org/10.1074/jbc.M112.420448			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184958	Green Published, hybrid			2022-12-28	WOS:000313751400035
J	Bunker, RD; Bulloch, EMM; Dickson, JMJ; Loomes, KM; Baker, EN				Bunker, Richard D.; Bulloch, Esther M. M.; Dickson, James M. J.; Loomes, Kerry M.; Baker, Edward N.			Structure and Function of Human Xylulokinase, an Enzyme with Important Roles in Carbohydrate Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; RESPONSE ELEMENT; GLYCEROL KINASE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; ESSENTIAL PENTOSURIA; CRYSTAL-STRUCTURES; DATA QUALITY; GLUCOSE; LIVER	D-Xylulokinase (XK; EC 2.7.1.17) catalyzes the ATP-dependent phosphorylation of D-xylulose (Xu) to produce xylulose 5-phosphate (Xu5P). In mammals, XK is the last enzyme in the glucuronate-xylulose pathway, active in the liver and kidneys, and is linked through its product Xu5P to the pentose-phosphate pathway. XK may play an important role in metabolic disease, given that Xu5P is a key regulator of glucose metabolism and lipogenesis. We have expressed the product of a putative human XK gene and identified it as the authentic human D-xylulokinase (hXK). NMR studies with a variety of sugars showed that hXK acts only on D-xylulose, and a coupled photometric assay established its key kinetic parameters as K-m(Xu) = 24 +/- 3 mu M and k(cat) = 35 +/- 5 s(-1). Crystal structures were determined for hXK, on its own and in complexes with Xu, ADP, and a fluorinated inhibitor. These reveal that hXK has a two-domain fold characteristic of the sugar kinase/hsp70/actin superfamily, with glycerol kinase as its closest relative. Xu binds to domain-I and ADP to domain-II, but in this open form of hXK they are 10 angstrom apart, implying that a large scale conformational change is required for catalysis. Xu binds in its linear keto-form, sandwiched between a Trp side chain and polar side chains that provide exquisite hydrogen bonding recognition. The hXK structure provides a basis for the design of specific inhibitors with which to probe its roles in sugar metabolism and metabolic disease.	[Loomes, Kerry M.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand; Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand	University of Auckland; University of Auckland	Loomes, KM (corresponding author), Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Private Bag 92019, Auckland 1142, New Zealand.	k.loomes@auckland.ac.nz; ted.baker@auckland.ac.nz		Baker, Edward/0000-0003-2456-7661; Bulloch, Esther/0000-0002-4262-1791; Bunker, Richard/0000-0001-8866-5290	Tertiary Education Commission of New Zealand through Maurice Wilkins Centre for Molecular Biodiscovery; University of Auckland; Maurice Wilkins Centre for Molecular Biodiscovery	Tertiary Education Commission of New Zealand through Maurice Wilkins Centre for Molecular Biodiscovery; University of Auckland; Maurice Wilkins Centre for Molecular Biodiscovery	This work was supported by the Tertiary Education Commission of New Zealand through funding of the Maurice Wilkins Centre for Molecular Biodiscovery.; Supported by a Doctorate Scholarship from the University of Auckland and by the Maurice Wilkins Centre for Molecular Biodiscovery.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; BAIS R, 1985, BIOCHEM J, V230, P53, DOI 10.1042/bj2300053; Blanc E., 2011, BUSTER VERSION 2 11; BOZIAN RC, 1959, NATURE, V184, P463, DOI 10.1038/184463a0; Bunker RD, 2012, ACTA CRYSTALLOGR F, V68, P1259, DOI 10.1107/S1744309112031181; Bystrom CE, 1999, BIOCHEMISTRY-US, V38, P3508, DOI 10.1021/bi982460z; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CONYERS RAJ, 1990, CLIN CHEM, V36, P1717; Di Luccio E, 2007, J MOL BIOL, V365, P783, DOI 10.1016/j.jmb.2006.10.068; DILLS WL, 1994, PROTEIN EXPRES PURIF, V5, P259, DOI 10.1006/prep.1994.1039; Doiron B, 1996, J BIOL CHEM, V271, P5321, DOI 10.1074/jbc.271.10.5321; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engh RA, 2006, INT TABLES CRYSTALLO, VF, P382; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feese MD, 1998, STRUCTURE, V6, P1407, DOI 10.1016/S0969-2126(98)00140-3; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Hadwiger P, 2000, TETRAHEDRON-ASYMMETR, V11, P607, DOI 10.1016/S0957-4166(99)00526-1; Hahn-Hagerdal B, 2001, Adv Biochem Eng Biotechnol, V73, P53; HICKMAN J, 1958, J BIOL CHEM, V232, P737; Holmes RP, 1998, J UROLOGY, V160, P1617, DOI 10.1016/S0022-5347(01)62363-2; Home PD, 2008, DIABETES OBES METAB, V10, P699, DOI 10.1111/j.1463-1326.2007.00761.x; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Mao C, 1999, BIOCHEM BIOPH RES CO, V259, P640, DOI 10.1006/bbrc.1999.0816; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MORAVCOVA J, 1994, CARBOHYD RES, V263, P61, DOI 10.1016/0008-6215(94)00165-0; Moreland N, 2005, ACTA CRYSTALLOGR D, V61, P1378, DOI 10.1107/S090744905023590; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Richard P, 2000, FEMS MICROBIOL LETT, V190, P39, DOI 10.1016/S0378-1097(00)00312-8; Schnick C, 2009, MOL MICROBIOL, V71, P533, DOI 10.1111/j.1365-2958.2008.06544.x; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; STEITZ TA, 1981, PHILOS T ROY SOC B, V293, P43, DOI 10.1098/rstb.1981.0058; Stutz A. E., 1976, J MAGN RESON, V21, P337; Tamari M, 1998, CYTOGENET CELL GENET, V82, P101, DOI 10.1159/000015076; TOUSTER O, 1960, FED PROC, V19, P977; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Veech RL, 2003, P NATL ACAD SCI USA, V100, P5578, DOI 10.1073/pnas.1132039100; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; VUORINEN T, 1991, CARBOHYD RES, V209, P13, DOI 10.1016/0008-6215(91)80142-A; WU J, 1990, CARBOHYD RES, V206, P1, DOI 10.1016/0008-6215(90)84001-B; Yew WS, 2004, BIOCHEMISTRY-US, V43, P6427, DOI 10.1021/bi049741t	52	18	19	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1643	1652		10.1074/jbc.M112.427997	http://dx.doi.org/10.1074/jbc.M112.427997			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23179721	Green Published, hybrid			2022-12-28	WOS:000313751400020
J	Jaramillo-Lambert, A; Hao, J; Xiao, HJ; Li, YM; Han, ZY; Zhu, WG				Jaramillo-Lambert, Aimee; Hao, Jing; Xiao, Haijie; Li, Yongming; Han, Zhiyong; Zhu, Wenge			Acidic Nucleoplasmic DNA-binding Protein (And-1) Controls Chromosome Congression by Regulating the Assembly of Centromere Protein A (CENP-A) at Centromeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-ALPHA; SACCHAROMYCES-CEREVISIAE; HUMAN-CELLS; CHROMATIN; REPLICATION; MAINTENANCE; CHECKPOINT; COMPLEX; DOMAIN; HJURP	The centromere is an epigenetically designated chromatin domain that is essential for the accurate segregation of chromosomes during mitosis. The incorporation of centromere protein A (CENP-A) into chromatin is fundamental in defining the centromeric loci. Newly synthesized CENP-A is loaded at centromeres in early G(1) phase by the CENP-A-specific histone chaperone Holliday junction recognition protein (HJURP) coupled with other chromatin assembly factors. However, it is unknown whether there are additional HJURP-interacting factor(s) involving in this process. Here we identify acidic nucleoplasmic DNA-binding protein 1 (And-1) as a new factor that is required for the assembly of CENP-A nucleosomes. And-1 interacts with both CENP-A and HJURP in a prenucleosomal complex, and the association of And-1 with CENP-A is increased during the cell cycle transition from mitosis to G(1) phase. And-1 down-regulation significantly compromises chromosome congression and the deposition of HJURP-CENP-A complexes at centromeres. Consistently, overexpression of And-1 enhances the assembly of CENP-A at centromeres. We conclude that And-1 is an important factor that functions together with HJURP to facilitate the cell cycle-specific recruitment of CENP-A to centromeres.	[Jaramillo-Lambert, Aimee; Hao, Jing; Xiao, Haijie; Li, Yongming; Han, Zhiyong; Zhu, Wenge] George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20037 USA	George Washington University	Zhu, WG (corresponding author), George Washington Univ, Sch Med, Dept Biochem & Mol Biol, 2300 Eye St NW, Washington, DC 20037 USA.	wz6812@gwu.edu	li, yong/HDN-3885-2022	Jaramillo-Lambert, Aimee/0000-0001-7697-8580	National Institutes of Health [CA136555]; National Center for Research Resources [S10RR025565-01]; NATIONAL CANCER INSTITUTE [R00CA136555] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant CA136555 (to W. Z).; We thank Dr. Daniel Foltz for CENP-A, HJURP, H3.1, and H4 plasmids. Images collected with the Zeiss 710 microscope were supported by National Center for Research Resources Grant S10RR025565-01.	Ahmad K, 2001, J CELL BIOL, V153, P101, DOI 10.1083/jcb.153.1.101; Alexiadis V, 2007, BBA-GENE STRUCT EXPR, V1769, P29, DOI 10.1016/j.bbaexp.2006.11.006; Bermudez VP, 2010, J BIOL CHEM, V285, P9493, DOI 10.1074/jbc.M109.093609; Black BE, 2010, COLD SH Q B, V75, P403, DOI 10.1101/sqb.2010.75.038; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; KOUPRINA N, 1992, MOL CELL BIOL, V12, P5736, DOI 10.1128/MCB.12.12.5736; Lagana A, 2010, NAT CELL BIOL, V12, P1186, DOI 10.1038/ncb2129; LALANDE M, 1990, EXP CELL RES, V186, P332, DOI 10.1016/0014-4827(90)90313-Y; Li Y, 2012, ONCOGENE, V31, P643, DOI 10.1038/onc.2011.261; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Mamnun YM, 2006, BIOCHEM BIOPH RES CO, V350, P125, DOI 10.1016/j.bbrc.2006.09.024; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Perpelescu M, 2009, J CELL BIOL, V185, P397, DOI 10.1083/jcb.200903088; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Sibani S, 2005, BIOCHEMISTRY-US, V44, P7885, DOI 10.1021/bi047327n; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	36	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1480	1488		10.1074/jbc.M112.429266	http://dx.doi.org/10.1074/jbc.M112.429266			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184928	Green Published, hybrid			2022-12-28	WOS:000313751400006
J	Blanchevoye, C; Floquet, N; Scandolera, A; Baud, S; Maurice, P; Bocquet, O; Blaise, S; Ghoneim, C; Cantarelli, B; Delacoux, F; Dauchez, M; Efremov, RG; Martiny, L; Duca, L; Debelle, L				Blanchevoye, Charlotte; Floquet, Nicolas; Scandolera, Amandine; Baud, Stephanie; Maurice, Pascal; Bocquet, Olivier; Blaise, Sebastien; Ghoneim, Christelle; Cantarelli, Benoit; Delacoux, Frederic; Dauchez, Manuel; Efremov, Roman G.; Martiny, Laurent; Duca, Laurent; Debelle, Laurent			Interaction between the Elastin Peptide VGVAPG and Human Elastin Binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; BETA-GALACTOSIDASE; LAMININ RECEPTOR; MATRIX METALLOPROTEINASE-1; UP-REGULATION; TROPOELASTIN; FIBROBLASTS; COMPLEX; SURFACE; FIBERS	The elastin binding protein (EBP), a spliced variant of lysosomal beta-galactosidase, is the primary receptor of elastin peptides that have been linked to emphysema, aneurysm and cancer progression. The sequences recognized by EBP share the XGXXPG consensus pattern found in numerous matrix proteins, notably in elastin where the VGVAPG motif is repeated. To delineate the elastin binding site of human EBP, we built a homology model of this protein and docked VGVAPG on its surface. Analysis of this model suggested that Gln-97 and Asp-98 were required for interaction with VGVAPG because they contribute to the definition of a pocket thought to represent the elastin binding site of EBP. Additionally, we proposed that Leu-103, Arg-107, and Glu-137 were essential residues because they could interact with VGVAPG itself. Site-directed mutagenesis experiments at these key positions validated our model. This work therefore provides the first structural data concerning the interaction of the VGVAPG with its cognate receptor. The present structural data should now allow the development of EBP-specific antagonists.	[Blanchevoye, Charlotte; Floquet, Nicolas; Scandolera, Amandine; Baud, Stephanie; Maurice, Pascal; Bocquet, Olivier; Blaise, Sebastien; Ghoneim, Christelle; Cantarelli, Benoit; Delacoux, Frederic; Dauchez, Manuel; Martiny, Laurent; Duca, Laurent; Debelle, Laurent] Univ Reims, UFR Sci Exactes & Nat, FRE CNRS 3184, Lab Signalisat & Recepteurs Matriciels, F-51687 Reims 2, France; [Efremov, Roman G.] Russian Acad Sci, Lab Biomol Modeling, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, GSP, Russia	Universite de Reims Champagne-Ardenne; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Debelle, L (corresponding author), UFR Sci Exactes & Nat, FRE CNRS MEDyC 3184, Lab Signalisat & Recepteurs Matriciels, BP 1039, F-51687 Reims 2, France.	laurent.debelle@univ-reims.fr	Baud, Stephanie/AAR-8256-2020; BLAISE, Sebastien/AAS-1022-2020; Roman, Efremov/A-7460-2014; MARTINY, Laurent/ABI-5531-2020; Maurice, Pascal/AAM-9126-2021	Baud, Stephanie/0000-0002-4436-0652; BLAISE, Sebastien/0000-0003-3012-1500; Roman, Efremov/0000-0002-5474-4721; DUCA, Laurent/0000-0002-6035-4906; MAURICE, Pascal/0000-0003-2167-4808; SCANDOLERA, Amandine/0000-0001-6403-1664	Fond National pour la Sante [ACI 2004, ACI 2007]; CNRS; Region Champagne Ardenne (CPER Reparation)	Fond National pour la Sante; CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Champagne Ardenne (CPER Reparation)(Region Grand-Est)	This work was supported by Fond National pour la Sante Grants ACI 2004 and ACI 2007 (Canceropole Grand-Est project), CNRS and Region Champagne Ardenne (CPER 2007 Reparation).	Booms P, 2006, J MOL CELL CARDIOL, V40, P234, DOI 10.1016/j.yjmcc.2005.11.009; Brassart B, 2001, J BIOL CHEM, V276, P5222, DOI 10.1074/jbc.M003642200; Duca L, 2004, CRIT REV ONCOL HEMAT, V49, P235, DOI 10.1016/j.critrevonc.2003.09.007; Duca L, 2007, J BIOL CHEM, V282, P12484, DOI 10.1074/jbc.M609505200; Fahem A, 2008, INT J BIOCHEM CELL B, V40, P1581, DOI 10.1016/j.biocel.2007.11.022; Faury G, 1997, MECH AGEING DEV, V95, P31, DOI 10.1016/S0047-6374(96)01842-8; Floquet N, 2004, BIOPOLYMERS, V76, P266, DOI 10.1002/bip.20029; Heinz A, 2012, BIOCHIMIE, V94, P192, DOI 10.1016/j.biochi.2011.10.006; HINEK A, 1994, CELL ADHES COMMUN, V2, P185, DOI 10.3109/15419069409004436; HINEK A, 1992, EXP CELL RES, V203, P344, DOI 10.1016/0014-4827(92)90008-V; HINEK A, 1995, EXP CELL RES, V220, P312, DOI 10.1006/excr.1995.1321; Hinek A, 2006, J BIOL CHEM, V281, P3698, DOI 10.1074/jbc.M508736200; HINEK A, 1994, J CELL BIOL, V126, P563, DOI 10.1083/jcb.126.2.563; HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941; HINEK A, 1993, J CLIN INVEST, V91, P1198, DOI 10.1172/JCI116280; Hornebeck W, 2005, ANTICANCER RES, V25, P2617; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; JACOB MP, 1987, P NATL ACAD SCI USA, V84, P995, DOI 10.1073/pnas.84.4.995; Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X; Kunecki M, 2001, PATHOL BIOL, V49, P333, DOI 10.1016/S0369-8114(01)00142-0; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; MECHAM RP, 1991, J CELL BIOL, V113, P187, DOI 10.1083/jcb.113.1.187; MECHAM RP, 1989, J BIOL CHEM, V264, P16652; Mochizuki S, 2002, J BIOL CHEM, V277, P44854, DOI 10.1074/jbc.M205630200; Moroy G, 2009, PROTEINS, V76, P461, DOI 10.1002/prot.22361; MORREAU H, 1989, J BIOL CHEM, V264, P20655; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Ohto U, 2012, J BIOL CHEM, V287, P1801, DOI 10.1074/jbc.M111.293795; Pocza P, 2008, INT J CANCER, V122, P1972, DOI 10.1002/ijc.23296; Privitera S, 1998, J BIOL CHEM, V273, P6319, DOI 10.1074/jbc.273.11.6319; Robert L, 1999, EXP GERONTOL, V34, P491, DOI 10.1016/S0531-5565(99)00030-3; Rojas AL, 2004, J MOL BIOL, V343, P1281, DOI 10.1016/j.jmb.2004.09.012; Rutter JL, 1997, J CELL BIOCHEM, V66, P322, DOI 10.1002/(SICI)1097-4644(19970901)66:3<322::AID-JCB5>3.3.CO;2-D; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SENIOR RM, 1980, J CLIN INVEST, V66, P859, DOI 10.1172/JCI109926; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x	38	36	45	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1317	1328		10.1074/jbc.M112.419929	http://dx.doi.org/10.1074/jbc.M112.419929			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23166321	hybrid, Green Published			2022-12-28	WOS:000313570300053
J	Bazan, S; Mileykovskaya, E; Mallampalli, VKPS; Heacock, P; Sparagna, GC; Dowhan, W				Bazan, Soledad; Mileykovskaya, Eugenia; Mallampalli, Venkata K. P. S.; Heacock, Philip; Sparagna, Genevieve C.; Dowhan, William			Cardiolipin-dependent Reconstitution of Respiratory Supercomplexes from Purified Saccharomyces cerevisiae Complexes III and IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; CHAIN COMPLEXES; SUPRAMOLECULAR ORGANIZATION; YEAST; LIPIDS; PURIFICATION; RESPIRASOME; ARRANGEMENT; COMPONENTS; ENZYMES	Here, we report for the first time in vitro reconstitution of the respiratory supercomplexes from individual complexes III and IV. Complexes III and IV were purified from Saccharomyces cerevisiae mitochondria. Complex III contained eight molecules of cardiolipin, and complex IV contained two molecules of cardiolipin, as determined by electrospray ionization-mass spectrometry. Complex IV also contained Rcf1p. No supercomplexes were formed upon mixing of the purified complexes, and low amounts of the supercomplex trimer III2IV1 were formed after reconstitution into proteoliposomes containing only phosphatidylcholine and phosphatidylethanolamine. Further addition of cardiolipin to the proteoliposome reconstitution mixture resulted in distinct formation of both the III2IV1 supercomplex trimer and III2IV2 supercomplex tetramer. No other anionic phospholipid was as effective as cardiolipin in supporting tetramer formation. Phospholipase treatment of complex IV prevented trimer formation in the absence of cardio-lipin. Both trimer and tetramer formations were restored by cardiolipin. Analysis of the reconstituted tetramer by single particle electron microscopy confirmed native organization of individual complexes within the supercomplex. In conclusion, although some trimerformation ocurred dependent only on tightly bound cardio-lipin, tetramer formation required additional cardiolipin. This is consistent with the high cardiolipin content in the native tetramer. The dependence on cardiolipin for supercomplex formation suggests that changes in cardiolipin levels resulting from changes in physiological conditions may control the equilibrium between individual respiratory complexes and supercomplexes in vivo.	[Bazan, Soledad; Mileykovskaya, Eugenia; Mallampalli, Venkata K. P. S.; Heacock, Philip; Dowhan, William] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Dowhan, William] Univ Texas Houston, Sch Med, Struct Biol Imaging Ctr, Houston, TX 77030 USA; [Dowhan, William] Univ Texas Houston, Sch Med, Ctr Membrane Biol, Houston, TX 77030 USA; [Sparagna, Genevieve C.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Colorado System; University of Colorado Boulder	Mileykovskaya, E (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, 6431 Fannin St,Ste 6-200, Houston, TX 77030 USA.	Eugenia.Mileykovskaya@uth.tmc.edu; William.Dowhan@uth.tmc.edu	Mallampalli, Venkata KPS/I-3208-2019	Mileykovskaya, Eugenia/0000-0002-8775-4467	National Institutes of Health [GM-069338, GM R01 56389]; John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338, R01GM056389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Irina Serysheva for use of the Odyssey Infrared Imaging System. We also acknowledge the generous gift of antibodies by Drs. Rosemary Stuart and Bernard Trumpower. We thank Dr. Robert Murphy for the use of the LIPID MAPS mass spectrometry facility at the University of Colorado at Denver, which is supported by National Institutes of Health Large Scale Collaborative Grant GM-069338.; This work was supported, in whole or in part, by National Institutes of Health Grant GM R01 56389 (to W. D.). This work was also supported by the John Dunn Research Foundation (to W.D.).	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Bogdanov Mikhail, 2008, V49, P197, DOI 10.1007/978-1-4020-8831-5_8; Boumans H, 1998, J BIOL CHEM, V273, P4872, DOI 10.1074/jbc.273.9.4872; CHANCE B, 1955, NATURE, V176, P250, DOI 10.1038/176250a0; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; DOWHAN W, 1985, EMBO J, V4, P179, DOI 10.1002/j.1460-2075.1985.tb02334.x; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Dumas J. F., 2012, BIOCHIMIE IN PRESS; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Gomez LA, 2012, SEMIN CELL DEV BIOL, V23, P758, DOI 10.1016/j.semcdb.2012.04.002; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Huang ZT, 2008, FREE RADICAL BIO MED, V44, P1935, DOI 10.1016/j.freeradbiomed.2008.02.016; Hunte C, 2005, BIOCHEM SOC T, V33, P938, DOI 10.1042/BST0330938; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; Lenaz G, 2012, ADV EXP MED BIOL, V748, P107, DOI 10.1007/978-1-4614-3573-0_5; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; McMillin J. B., 2002, BIOCHIM BIOPHYS ACTA, V1585, P95; Meunier B, 2012, BIOCHEM J, V444, P199, DOI 10.1042/BJ20120116; Mileykovskaya E, 2012, J BIOL CHEM, V287, P23095, DOI 10.1074/jbc.M112.367888; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Musatov A, 2000, BIOCHEMISTRY-US, V39, P12996, DOI 10.1021/bi000884z; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Palsdottir H., 2003, MEMBRANE PROTEIN PUR, P191; Paradies G, 2011, NEUROCHEM INT, V58, P447, DOI 10.1016/j.neuint.2010.12.016; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Piccoli C, 2006, BIOCHEM J, V396, P573, DOI 10.1042/BJ20060077; Sabar M, 2005, PLANT J, V44, P893, DOI 10.1111/j.1365-313X.2005.02577.x; Saini-Chohan HK, 2009, J LIPID RES, V50, P1600, DOI 10.1194/jlr.M800561-JLR200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Sedlak E, 2006, BIOCHEMISTRY-US, V45, P746, DOI 10.1021/bi050870z; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Sparagna GC, 2005, J LIPID RES, V46, P1196, DOI 10.1194/jlr.M500031-JLR200; Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Stuart RA, 2009, METHOD ENZYMOL, V456, P191, DOI 10.1016/S0076-6879(08)04411-X; Stuart RA, 2008, J BIOENERG BIOMEMBR, V40, P411, DOI 10.1007/s10863-008-9168-4; TAANMAN JW, 1992, J BIOL CHEM, V267, P22481; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2009, BBA-BIOENERGETICS, V1787, P672, DOI 10.1016/j.bbabio.2008.12.016; Yamashita T, 2007, J BIOL CHEM, V282, P6012, DOI 10.1074/jbc.M610646200; Yoshikawa S, 1998, J BIOENERG BIOMEMBR, V30, P7, DOI 10.1023/A:1020595108560; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2003, J BIOL CHEM, V278, P35204, DOI 10.1074/jbc.M306729200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	54	106	106	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					401	411		10.1074/jbc.M112.425876	http://dx.doi.org/10.1074/jbc.M112.425876			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23172229	Green Published, hybrid			2022-12-28	WOS:000313197200041
J	Ghasriani, H; Belcourt, PJF; Sauve, S; Hodgson, DJ; Brochu, D; Gilbert, M; Aubin, Y				Ghasriani, Houman; Belcourt, Pascal J. F.; Sauve, Simon; Hodgson, Derek J.; Brochu, Denis; Gilbert, Michel; Aubin, Yves			A Single N-Acetylgalactosamine Residue at Threonine 106 Modifies the Dynamics and Structure of Interferon alpha 2a around the Glycosylation Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; VISUALIZATION; SPECTROSCOPY; SYSTEM	Enzymatic addition of GalNAc to isotopically labeled IFN alpha 2a produced in Escherichia coli yielded the O-linked glycoprotein GalNAc alpha-[C-13,N-15]IFN alpha 2a. The three-dimensional structure of GalNAc alpha-IFN alpha 2a has been determined in solution by NMR spectroscopy at high resolution. Proton-nitrogen heteronuclear Overhauser enhancement measurements revealed that the addition of a single monosaccharide unit at Thr-106 significantly slowed motions of the glycosylation loop on the nanosecond time scale. Subsequent addition of a Gal unit produced Gal(beta 1,3) GalNAc alpha-[C-13,N-15]IFN alpha 2a. This extension resulted in a further decrease in the dynamics of this loop. The methodology used here allowed the first such description of the structure and dynamics of an O-glycoprotein and opens the way to the study of this class of proteins.	[Ghasriani, Houman; Belcourt, Pascal J. F.; Sauve, Simon; Hodgson, Derek J.; Aubin, Yves] Hlth Canada, Biol & Genet Therapies Directorate, Ctr Vaccine Evaluat, Ottawa, ON K1A 0K9, Canada; [Ghasriani, Houman; Aubin, Yves] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Belcourt, Pascal J. F.; Aubin, Yves] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Brochu, Denis; Gilbert, Michel] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	Health Canada; University of Ottawa; Carleton University; National Research Council Canada	Aubin, Y (corresponding author), Hlth Canada, Biol & Genet Therapies Directorate, Ctr Vaccine Evaluat, 251 Sir Frederick Banting Drwy, Ottawa, ON K1A 0K9, Canada.	yves.aubin@hc-sc.gc.ca		Gilbert, Michel/0000-0002-0204-4408; Ghasriani, Houman/0000-0002-9646-0006	Faculty of Graduate and Postdoctoral Affairs M.S. scholarship; National Science and Engineering Research Council	Faculty of Graduate and Postdoctoral Affairs M.S. scholarship; National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Faculty of Graduate and Postdoctoral Affairs M.S. scholarship (to P. J. F. B.) and a National Science and Engineering Research Council Discovery Grant (to Y. A.).	ADOLF GR, 1991, BIOCHEM J, V276, P511, DOI 10.1042/bj2760511; Bernatchez S, 2007, GLYCOBIOLOGY, V17, P1333, DOI 10.1093/glycob/cwm090; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brik A, 2006, CURR OPIN CHEM BIOL, V10, P638, DOI 10.1016/j.cbpa.2006.10.003; Brockausen I., 1999, ESSENTIALS GLYCOBIOL, P115; Coltart DM, 2002, J AM CHEM SOC, V124, P9833, DOI 10.1021/ja020208f; DeFrees S, 2006, GLYCOBIOLOGY, V16, P833, DOI 10.1093/glycob/cwl004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1995, BIOCHEMISTRY-US, V34, P868, DOI 10.1021/bi00003a021; Glue P, 2000, CLIN PHARMACOL THER, V68, P556, DOI 10.1067/mcp.2000.110973; Goddard D., 2008, SPARKY 3; Guntert Peter, 2004, Methods Mol Biol, V278, P353; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnston MJW, 2011, PHARM RES-DORDR, V28, P1661, DOI 10.1007/s11095-011-0402-0; Klaus W, 1997, J MOL BIOL, V274, P661, DOI 10.1006/jmbi.1997.1396; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2007, BIOINFORMATICS, V23, P1824, DOI 10.1093/bioinformatics/btm085; Loignon M, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-65; Loris R, 2000, J MOL BIOL, V301, P987, DOI 10.1006/jmbi.2000.4016; Nudelman I, 2011, J AM CHEM SOC, V133, P14755, DOI 10.1021/ja205480v; OHEDA M, 1990, J BIOL CHEM, V265, P11432; Panjwani N, 2010, J PHARM SCI-US, V99, P3334, DOI 10.1002/jps.22105; Parham P, 2005, IMMUNE SYSTEM, P250; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; YAMAMOTO K, 1981, APPL ENVIRON MICROB, V41, P392, DOI 10.1128/AEM.41.2.392-395.1981; Youngster S, 2002, CURR PHARM DESIGN, V8, P2139, DOI 10.2174/1381612023393242; Zhao GH, 2010, NAT PROTOC, V5, P636, DOI 10.1038/nprot.2010.3	30	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					247	254		10.1074/jbc.M112.413252	http://dx.doi.org/10.1074/jbc.M112.413252			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23184955	hybrid, Green Published			2022-12-28	WOS:000313197200024
J	Pohar, J; Pirher, N; Bencina, M; Mancek-Keber, M; Jerala, R				Pohar, Jelka; Pirher, Nina; Bencina, Mojca; Mancek-Keber, Mateja; Jerala, Roman			The Role of UNC93B1 Protein in Surface Localization of TLR3 Receptor and in Cell Priming to Nucleic Acid Agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; NF-KAPPA-B; EPITHELIAL-CELLS; DENDRITIC CELLS; VIRUS COUNTERMEASURES; TRANSCRIPTION FACTOR; ANTIVIRAL RESPONSES; HUMAN UNC-93B; UP-REGULATION	Translocation of nucleic acid-sensing (NAS) Toll-like receptors (TLRs) to endosomes is essential for response to microbial nucleic acids as well as for prevention of the autoimmune response. The accessory protein UNC93B1 is indispensable for activation of NAS TLRs because it regulates their response through trafficking to endosomes. We observed that poly(I: C) up-regulates transcription of UNC93B1 and promotes trafficking of TLR3 to the plasma membrane in human epithelial cell line. Up-regulation of UNC93B1 is triggered through TLR3 activation by poly(I: C). Further studies revealed that expression of UNC93B1 promotes trafficking of differentially glycosylated TLR3, but not other NAS TLRs, to the plasma membrane. UNC93B1 promoter region contains binding sites for poly(I: C)and type I interferon-inducible regulatory elements. UNC93B1 also increases the protein lifetime of TLR3 and TLR9 and augments signaling of all NAS TLRs. Furthermore, we discovered that poly(I: C) pretreatment primes B-cells to the activation by ssDNA via up-regulation of UNC93B1. Our findings identified TLR3 as the important regulator of UNC93B1 that in turn governs the responsiveness of all NAS TLRs.	[Jerala, Roman] Univ Ljubljana, Natl Inst Chem, Dept Biotechnol, Ljubljana 1000, Slovenia; [Bencina, Mojca; Jerala, Roman] Univ Ljubljana, EN FIST Ctr Excellence, Ljubljana 1000, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia	National Institute of Chemistry - Slovenia; University of Ljubljana; University of Ljubljana; University of Ljubljana	Jerala, R (corresponding author), Univ Ljubljana, Natl Inst Chem, Dept Biotechnol, Hajdrihova 19,POB 660, Ljubljana 1000, Slovenia.	roman.jerala@ki.si		Pohar, Jelka/0000-0002-7616-164X	Slovenian Research Agency; International Centre for Genetic Engineering and Biotechnology (CRP-ICGEB Research Grant Project) [CRP/SLO08-01]; EN-FIST Centre of Excellence.	Slovenian Research Agency(Slovenian Research Agency - Slovenia); International Centre for Genetic Engineering and Biotechnology (CRP-ICGEB Research Grant Project); EN-FIST Centre of Excellence.	This work was supported by the Slovenian Research Agency, International Centre for Genetic Engineering and Biotechnology (CRP-ICGEB Research Grant Project CRP/SLO08-01) and EN-FIST Centre of Excellence.	Agarwal SK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3221; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bhatia Prakash K., 1999, V64, P155; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Chuang TH, 2001, BBA-GENE STRUCT EXPR, V1518, P157, DOI 10.1016/S0167-4781(00)00289-X; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005; Jelinek I, 2011, J IMMUNOL, V186, P2422, DOI 10.4049/jimmunol.1002845; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Johnson TR, 2009, VACCINE, V27, P3045, DOI 10.1016/j.vaccine.2009.03.026; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Koehn J, 2007, HUM IMMUNOL, V68, P871, DOI 10.1016/j.humimm.2007.07.007; Kono DH, 2009, P NATL ACAD SCI USA, V106, P12061, DOI 10.1073/pnas.0905441106; KRAMEROV DA, 1979, NUCLEIC ACIDS RES, V6, P697, DOI 10.1093/nar/6.2.697; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leifer CA, 2006, J BIOL CHEM, V281, P35585, DOI 10.1074/jbc.M607511200; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Mouchess ML, 2011, IMMUNITY, V35, P721, DOI 10.1016/j.immuni.2011.10.009; Nakano S, 2010, RHEUMATOLOGY, V49, P876, DOI 10.1093/rheumatology/keq001; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; Pegu A, 2008, J IMMUNOL, V180, P3399, DOI 10.4049/jimmunol.180.5.3399; Pirher N, 2008, NAT STRUCT MOL BIOL, V15, P761, DOI 10.1038/nsmb.1453; Qi RS, 2012, J BIOL CHEM, V287, P32617, DOI 10.1074/jbc.M112.387803; Qi RS, 2010, J BIOL CHEM, V285, P36635, DOI 10.1074/jbc.M110.144402; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Rudd BD, 2005, J VIROL, V79, P3350, DOI 10.1128/JVI.79.6.3350-3357.2005; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Ueta M, 2005, BIOCHEM BIOPH RES CO, V331, P285, DOI 10.1016/j.bbrc.2005.02.196; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	58	52	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					442	454		10.1074/jbc.M112.413922	http://dx.doi.org/10.1074/jbc.M112.413922			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23166319	Green Published, hybrid			2022-12-28	WOS:000313197200045
J	Sun, YY; Selvaraj, S; Varma, A; Derry, S; Sahmoun, AE; Singh, BB				Sun, Yuyang; Selvaraj, Senthil; Varma, Archana; Derry, Susan; Sahmoun, Abe E.; Singh, Brij B.			Increase in Serum Ca2+/Mg2+ Ratio Promotes Proliferation of Prostate Cancer Cells by Activating TRPM7 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DETERMINANTS; EPITHELIAL-CELLS; CALCIUM; CA2+; MAGNESIUM; MG2+; EXPRESSION; HOMEOSTASIS; RECEPTOR; PROTEIN	TRPM7 is a novel magnesium-nucleotide-regulated metal current (MagNuM) channel that is regulated by serum Mg2+ concentrations. Changes in Mg2+ concentration have been shown to alter cell proliferation in various cells; however, the mechanism and the ion channel(s) involved have not yet been identified. Here we demonstrate that TRPM7 is expressed in control and prostate cancer cells. Supplementation of intracellular Mg-ATP or addition of external 2-aminoethoxydiphenyl borate inhibited MagNuM currents. Furthermore, silencing of TRPM7 inhibited whereas overexpression of TRPM7 increased endogenous MagNuM currents, suggesting that these currents are dependent on TRPM7. Importantly, although an increase in the serum Ca2+/Mg2+ ratio facilitated Ca2+ influx in both control and prostate cancer cells, a significantly higher Ca2+ influx was observed in prostate cancer cells. TRPM7 expression was also increased in cancer cells, but its expression was not dependent on the Ca2+/Mg2+ ratio per se. Additionally, an increase in the extracellular Ca2+/Mg2+ ratio led to a significant increase in cell proliferation of prostate cancer cells when compared with control cells. Consistent with these results, age-matched prostate cancer patients also showed a subsequent increase in the Ca2+/Mg2+ ratio and TRPM7 expression. Altogether, we provide evidence that the TRPM7 channel has an important role in prostate cancer and have identified that the Ca2+/Mg2+ ratio could be essential for the initiation/progression of prostate cancer.	[Sun, Yuyang; Selvaraj, Senthil; Singh, Brij B.] Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA; [Varma, Archana; Derry, Susan; Sahmoun, Abe E.] Univ N Dakota, Sch Med & Hlth Sci, Dept Internal Med, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks; University of North Dakota Grand Forks	Singh, BB (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA.	brij.singh@med.und.edu	Selvaraj, Senthil/P-5766-2019	Selvaraj, Senthil/0000-0002-0185-6033; Singh, Brij/0000-0003-0535-5997	National Institutes of Health [RO1 DE017102, 5P20RR017699, P20RR017699]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DE017102 and 5P20RR017699 (to B. B. S.).; We acknowledge The Edward C. Carlson Imaging and Image Analysis core facility (supported in part by National Institutes of Health Grant P20RR017699) and thank Sarah Abrahamson for technical advice. We also thank Dr. Loren Runnels for providing the HA-TRPM7 construct.	Alexander RT, 2008, J AM SOC NEPHROL, V19, P1451, DOI 10.1681/ASN.2008010098; Anghileri LJ, 2009, MAGNESIUM RES, V22, P247, DOI 10.1684/mrh.2009.0173; BERRIDGE MJ, 1985, J CELL SCI, P187; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Dai Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018237; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Dimke H, 2011, J PHYSIOL-LONDON, V589, P1535, DOI 10.1113/jphysiol.2010.199869; Flourakis M, 2009, BBA-MOL CELL RES, V1793, P1105, DOI 10.1016/j.bbamcr.2009.01.009; GONG YW, 1995, ENDOCRINOLOGY, V136, P2172, DOI 10.1210/en.136.5.2172; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; HAZELTON B, 1979, J CELL BIOL, V83, P487, DOI 10.1083/jcb.83.2.487; Ikari A, 2008, BIOCHEM BIOPH RES CO, V369, P1129, DOI 10.1016/j.bbrc.2008.03.002; Jiang XP, 2003, J BIOL CHEM, V278, P42867, DOI 10.1074/jbc.M304487200; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Matsushita M, 2005, J BIOL CHEM, V280, P20793, DOI 10.1074/jbc.M413671200; Mishra R, 2009, AM J PHYSIOL-GASTR L, V297, pG687, DOI 10.1152/ajpgi.90683.2008; Montell C, 2003, CURR BIOL, V13, pR799, DOI 10.1016/j.cub.2003.09.048; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Pani B, 2006, MOL BIOL CELL, V17, P4446, DOI 10.1091/mbc.E06-03-0251; Pani B, 2009, P NATL ACAD SCI USA, V106, P20087, DOI 10.1073/pnas.0905002106; Prevarskaya N, 2004, BIOCHEM BIOPH RES CO, V322, P1326, DOI 10.1016/j.bbrc.2004.08.037; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Rubin H, 2005, ADV CANCER RES, V93, P1, DOI 10.1016/S0065-230X(05)93001-7; Runnels LW, 2011, CURR PHARM BIOTECHNO, V12, P42; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sahmoun AE, 2010, MED HYPOTHESES, V75, P315, DOI 10.1016/j.mehy.2010.02.037; Schmitz C, 2007, MAGNESIUM RES, V20, P6; Selvaraj S, 2009, CELL CALCIUM, V46, P209, DOI 10.1016/j.ceca.2009.07.008; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Sun YH, 2006, J ANDROL, V27, P671, DOI 10.2164/jandrol.106.000554; Thebault S, 2009, J AM SOC NEPHROL, V20, P78, DOI 10.1681/ASN.2008030327; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Wang HP, 2007, ASIAN J ANDROL, V9, P634, DOI 10.1111/j.1745-7262.2007.00291.x; WHITFIELD JF, 1979, MOL CELL BIOCHEM, V27, P155, DOI 10.1007/BF00215364; Wissenbach U, 2004, BIOCHEM BIOPH RES CO, V322, P1359, DOI 10.1016/j.bbrc.2004.08.042; Wolf FI, 2004, FRONT BIOSCI-LANDMRK, V9, P2056, DOI 10.2741/1389; Zhang L, 2006, ENDOCR-RELAT CANCER, V13, P27, DOI 10.1677/erc.1.01093	40	85	86	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					255	263		10.1074/jbc.M112.393918	http://dx.doi.org/10.1074/jbc.M112.393918			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23168410	Green Published, hybrid			2022-12-28	WOS:000313197200025
J	Biswas-Fiss, EE; Affet, S; Ha, M; Biswas, SB				Biswas-Fiss, Esther E.; Affet, Stephanie; Ha, Malissa; Biswas, Subhasis B.			Retinoid Binding Properties of Nucleotide Binding Domain 1 of the Stargardt Disease-associated ATP Binding Cassette (ABC) Transporter, ABCA4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONE-ROD DYSTROPHY; MACULAR DEGENERATION; RETINITIS-PIGMENTOSA; ALTERNATING ACCESS; FUNDUS FLAVIMACULATUS; BIOCHEMICAL DEFECTS; NONSENSE MUTATION; A2E ACCUMULATE; P-GLYCOPROTEIN; GENE ABCR	The retina-specific ATP binding cassette transporter, ABCA4 protein, is associated with a broad range of inherited macular degenerations, including Stargardt disease, autosomal recessive cone rod dystrophy, and fundus flavimaculatus. In order to understand its role in retinal transport in rod out segment discs, we have investigated the interactions of the soluble domains of ABCA4 with both 11-cis- and all-trans-retinal. Using fluorescence anisotropy-based binding analysis and recombinant polypeptides derived from the amino acid sequences of the four soluble domains of ABCA4, we demonstrated that the nucleotide binding domain 1 (NBD1) specifically bound 11-cis-retinal. Its affinity for all-trans-retinal was markedly reduced. Stargardt disease-associated mutations in this domain resulted in attenuation of 11-cis-retinal binding. Significant differences in 11-cis-retinal binding affinities were observed between NBD1 and other cytoplasmic and lumenal domains of ABCA4. The results suggest a possible role of ABCA4 and, in particular, the NBD1 domain in 11-cis-retinal binding. These results also correlate well with a recent report on the in vivo role of ABCA4 in 11-cis-retinal transport.	[Biswas-Fiss, Esther E.; Affet, Stephanie; Ha, Malissa] Thomas Jefferson Univ, Jefferson Sch Hlth Profess, Program Biotechnol, Dept Biosci Technol, Philadelphia, PA 19107 USA; [Biswas-Fiss, Esther E.; Biswas, Subhasis B.] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Mol Biol, Stratford, NJ 08084 USA	Jefferson University; Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Biswas-Fiss, EE (corresponding author), Thomas Jefferson Univ, Jefferson Sch Hlth Profess, Program Biotechnol, Dept Biosci Technol, Edison Bldg,Suite 2124,130 S 9th St, Philadelphia, PA 19107 USA.	Esther.Biswas@jefferson.edu			National Institutes of Health, NEI [EY 013113]; NATIONAL EYE INSTITUTE [R15EY013113] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health, NEI, Grant EY 013113 and a National Institutes of Health administrative supplement, Quantitative Physical Measurements at the Nanaoscale (to E.E.B.-F.).	Ahn J, 2000, METHOD ENZYMOL, V315, P864; Ahn JH, 2003, J BIOL CHEM, V278, P39600, DOI 10.1074/jbc.M304236200; Allikmets R, 2000, AM J HUM GENET, V67, P793, DOI 10.1086/303100; Azarian SM, 1997, FEBS LETT, V409, P247, DOI 10.1016/S0014-5793(97)00517-6; Balan A, 2008, GENET MOL RES, V7, P117, DOI 10.4238/vol7-1gmr392; Bennett J, 2012, METHOD ENZYMOL, V507, P255, DOI 10.1016/B978-0-12-386509-0.00013-2; Birch DG, 2001, EXP EYE RES, V73, P877, DOI 10.1006/exer.2001.1093; Biswas EE, 2001, BIOCHEMISTRY-US, V40, P8181, DOI 10.1021/bi0106686; Biswas EE, 2000, BIOCHEMISTRY-US, V39, P15879, DOI 10.1021/bi0015966; Biswas-Fiss E. E., 2011, INVEST OPHTHALMOL VI, V52; Biswas-Fiss EE, 2006, BIOCHEMISTRY-US, V45, P3813, DOI 10.1021/bi052059u; Biswas-Fiss EE, 2003, BIOCHEMISTRY-US, V42, P10683, DOI 10.1021/bi034481l; Biswas-Fiss EE, 2010, J BIOL CHEM, V285, P19372, DOI 10.1074/jbc.M110.112896; Booth CL, 2000, BIOCHEMISTRY-US, V39, P5518, DOI 10.1021/bi992931x; Boyer NP, 2012, PHOTOCHEM PHOTOBIOL, V88, P1373, DOI 10.1111/j.1751-1097.2012.01127.x; Boyer NP, 2012, J BIOL CHEM, V287, P22276, DOI 10.1074/jbc.M111.329235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briggs CE, 2001, INVEST OPHTH VIS SCI, V42, P2229; Brunkhorst C, 2005, RES MICROBIOL, V156, P322, DOI 10.1016/j.resmic.2004.10.016; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; Cremers F P M, 2002, Ned Tijdschr Geneeskd, V146, P1581; De La Paz MA, 1999, OPHTHALMOLOGY, V106, P1531, DOI 10.1016/S0161-6420(99)90449-9; Di Pietro A, 2002, CELL MOL LIFE SCI, V59, P307, DOI 10.1007/s00018-002-8424-8; Fishman GA, 2004, ARCH OPHTHALMOL-CHIC, V122, P70, DOI 10.1001/archopht.122.1.70; Fishman GA, 2003, ARCH OPHTHALMOL-CHIC, V121, P851, DOI 10.1001/archopht.121.6.851; Fukui T, 2002, INVEST OPHTH VIS SCI, V43, P2819; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Ito YA, 2007, ARCH OPHTHALMOL-CHIC, V125, P128, DOI 10.1001/archopht.125.1.128; Jaakson K, 2003, HUM MUTAT, V22, P395, DOI 10.1002/humu.10263; Jones PM, 2002, P NATL ACAD SCI USA, V99, P12639, DOI 10.1073/pnas.152439599; Katz ML, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/198042; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Klevering BJ, 2004, EUR J HUM GENET, V12, P1024, DOI 10.1038/sj.ejhg.5201258; Klevering BJ, 1999, BRIT J OPHTHALMOL, V83, P914, DOI 10.1136/bjo.83.8.914; Klevering BJ, 2005, GRAEF ARCH CLIN EXP, V243, P90, DOI 10.1007/s00417-004-1079-4; Klevering BJ, 2002, INVEST OPHTH VIS SCI, V43, P1980; Koenekoop Robert K, 2003, Ophthalmic Genet, V24, P75, DOI 10.1076/opge.24.2.75.13996; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Lois N, 1999, INVEST OPHTH VIS SCI, V40, P2668; Mace PD, 2007, PROTEIN EXPRES PURIF, V52, P40, DOI 10.1016/j.pep.2006.07.025; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; Molday, 2000, Am J Ophthalmol, V130, P689, DOI 10.1016/S0002-9394(00)00756-X; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Papaioannou M, 2000, INVEST OPHTH VIS SCI, V41, P16; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Sambrook J., 2002, MOL CLONING LAB MANU; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Simonelli F, 2004, OPHTHALMIC RES, V36, P82, DOI 10.1159/000076886; Souied EH, 1999, INVEST OPHTH VIS SCI, V40, P2740; Stankiewicz P, 2006, GENOME DYN, V1, P1, DOI 10.1159/000092496; Suarez T, 2002, J BIOL CHEM, V277, P21759, DOI 10.1074/jbc.M202053200; Sun H, 2000, NAT GENET, V26, P242, DOI 10.1038/79994; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Tsybovsky Y, 2010, ADV EXP MED BIOL, V703, P105, DOI 10.1007/978-1-4419-5635-4_8; van Driel MA, 1998, OPHTHALMIC GENET, V19, P117, DOI 10.1076/opge.19.3.117.2187; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang J, 2011, J BIOL CHEM, V286, P7308, DOI 10.1074/jbc.M110.210880; Wang WY, 2012, J BIOL CHEM, V287, P10156, DOI 10.1074/jbc.M112.342972; Webster AR, 2001, INVEST OPHTH VIS SCI, V42, P1179; Wen PC, 2011, BIOPHYS J, V101, P680, DOI 10.1016/j.bpj.2011.06.031; Winterfeld S, 2009, BIOCHEMISTRY-US, V48, P6684, DOI 10.1021/bi9003809; Yates JRW, 2000, J MED GENET, V37, P83, DOI 10.1136/jmg.37.2.83; Zernant J, 2011, INVEST OPHTH VIS SCI, V52, P8479, DOI 10.1167/iovs.11-8182; Zhang K, 1999, GENOMICS, V60, P234, DOI 10.1006/geno.1999.5896; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051	70	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44097	44107		10.1074/jbc.M112.409623	http://dx.doi.org/10.1074/jbc.M112.409623			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144455	Green Published, hybrid			2022-12-28	WOS:000312938600008
J	Engel, J; Schmalhorst, PS; Routier, FH				Engel, Jakob; Schmalhorst, Philipp S.; Routier, Francoise H.			Biosynthesis of the Fungal Cell Wall Polysaccharide Galactomannan Requires Intraluminal GDP-mannose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL MEMBRANE ANCHORS; NUCLEOTIDE-SUGAR TRANSPORTERS; ASPERGILLUS-FUMIGATUS; YEAST; GOLGI; GENE; GALACTOFURANOSE; IDENTIFICATION; MORPHOGENESIS; GLYCOSYLATION	Fungal cell walls frequently contain a polymer of mannose and galactose called galactomannan. In the pathogenic filamentous fungus Aspergillus fumigatus, this polysaccharide is made of a linear mannan backbone with side chains of galactofuran and is anchored to the plasma membrane via a glycosylphosphatidylinositol or is covalently linked to the cell wall. To date, the biosynthesis and significance of this polysaccharide are unknown. The present data demonstrate that deletion of the Golgi UDP-galactofuranose transporter GlfB or the GDP-mannose transporter GmtA leads to the absence of galactofuran or galactomannan, respectively. This indicates that the biosynthesis of galactomannan probably occurs in the lumen of the Golgi apparatus and thus contrasts with the biosynthesis of other fungal cell wall polysaccharides studied to date that takes place at the plasma membrane. Transglycosylation of galactomannan from the membrane to the cell wall is hypothesized because both the cell wall-bound and membrane-bound polysaccharide forms are affected in the generated mutants. Considering the severe growth defect of the A. fumigatus GmtA-deficient mutant, proving this paradigm might provide new targets for antifungal therapy.	[Engel, Jakob; Schmalhorst, Philipp S.; Routier, Francoise H.] Hannover Med Sch, Dept Cellular Chem, D-30625 Hannover, Germany	Hannover Medical School	Routier, FH (corresponding author), Hannover Med Sch, Dept Cellular Chem, OE 4330,Carl Neuberg Str 1, D-30625 Hannover, Germany.	Routier.Francoise@mh-hannover.de	Routier, Francoise/O-1611-2019	Schmalhorst, Philipp/0000-0002-5795-0133; Routier, Francoise/0000-0002-7163-0590	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	Afroz S, 2011, FUNGAL GENET BIOL, V48, P896, DOI 10.1016/j.fgb.2011.06.001; Arakawa K, 2006, J GEN APPL MICROBIOL, V52, P137, DOI 10.2323/jgam.52.137; Atmodjo MA, 2011, P NATL ACAD SCI USA, V108, P20225, DOI 10.1073/pnas.1112816108; Baldwin TC, 2001, PLANT CELL, V13, P2283, DOI 10.1105/tpc.13.10.2283; Beauvais A, 2001, J BACTERIOL, V183, P2273, DOI 10.1128/JB.183.7.2273-2279.2001; Bernard M, 2001, MED MYCOL, V39, P9, DOI 10.1080/mmy.39.1.9.17; Carvalho NDSP, 2011, FUNGAL BIOL-UK, V115, P253, DOI 10.1016/j.funbio.2010.12.010; Costachel C, 2005, J BIOL CHEM, V280, P39835, DOI 10.1074/jbc.M510163200; Cottrell TR, 2007, EUKARYOT CELL, V6, P776, DOI 10.1128/EC.00015-07; De Groot PWJ, 2005, FUNGAL GENET BIOL, V42, P657, DOI 10.1016/j.fgb.2005.04.002; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; Dean N, 1999, BBA-GEN SUBJECTS, V1426, P309, DOI 10.1016/S0304-4165(98)00132-9; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Douglas CM, 1997, ANTIMICROB AGENTS CH, V41, P2471, DOI 10.1128/AAC.41.11.2471; Douglas CM, 2001, MED MYCOL, V39, P55, DOI 10.1080/mmy.39.1.55.66; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Ecker M, 2006, J BIOL CHEM, V281, P11523, DOI 10.1074/jbc.M600314200; Engel J, 2009, J BIOL CHEM, V284, P33859, DOI 10.1074/jbc.M109.070219; FANKHAUSER C, 1993, J BIOL CHEM, V268, P26365; Fontaine T, 2003, GLYCOBIOLOGY, V13, P169, DOI 10.1093/glycob/cwg004; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Francois JM, 2006, NAT PROTOC, V1, P2995, DOI 10.1038/nprot.2006.457; Gastebois A, 2010, J BIOL CHEM, V285, P2386, DOI 10.1074/jbc.M109.077545; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Handford M, 2006, BRAZ J MED BIOL RES, V39, P1149, DOI 10.1590/S0100-879X2006000900002; Jackson-Hayes L, 2008, MICROBIOL-SGM, V154, P2037, DOI 10.1099/mic.0.2008/017483-0; KOLLAR R, 1995, J BIOL CHEM, V270, P1170, DOI 10.1074/jbc.270.3.1170; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Kotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015729; Kotz A, 2010, FUNGAL GENET BIOL, V47, P169, DOI 10.1016/j.fgb.2009.10.001; KRAKOW JL, 1986, J BIOL CHEM, V261, P2147; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Krappmann S, 2005, EUKARYOT CELL, V4, P1298, DOI 10.1128/EC.4.7.1298-1307.2005; LATGE JP, 1994, INFECT IMMUN, V62, P5424; Lussier M, 1997, J BIOL CHEM, V272, P15527, DOI 10.1074/jbc.272.24.15527; Ma DQ, 1997, J BIOL CHEM, V272, P3799, DOI 10.1074/jbc.272.6.3799; Maertens J, 2001, BLOOD, V97, P1604, DOI 10.1182/blood.V97.6.1604; McConville MJ, 2002, MICROBIOL MOL BIOL R, V66, P122, DOI 10.1128/MMBR.66.1.122-154.2002; Morelle W, 2005, EUKARYOT CELL, V4, P1308, DOI 10.1128/EC.4.7.1308-1316.2005; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Mouyna I, 2010, MOL MICROBIOL, V76, P1205, DOI 10.1111/j.1365-2958.2010.07164.x; Nishikawa A, 2002, J BACTERIOL, V184, P29, DOI 10.1128/JB.184.1.29-42.2002; Popolo L, 1999, BBA-GEN SUBJECTS, V1426, P385, DOI 10.1016/S0304-4165(98)00138-X; Roncero C, 2002, CURR GENET, V41, P367, DOI 10.1007/s00294-002-0318-7; Sandhu APS, 2009, MOL PLANT, V2, P840, DOI 10.1093/mp/ssp056; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Schneider P, 1996, BIOCHEM J, V313, P963, DOI 10.1042/bj3130963; SHEMATEK EM, 1980, J BIOL CHEM, V255, P888; Simenel C, 2008, GLYCOBIOLOGY, V18, P84, DOI 10.1093/glycob/cwm122; Stepan H, 2011, ANAL BIOCHEM, V418, P24, DOI 10.1016/j.ab.2011.07.005; STYNEN D, 1995, J CLIN MICROBIOL, V33, P497, DOI 10.1128/JCM.33.2.497-500.1995; Takahashi HK, 2009, AN ACAD BRAS CIENC, V81, P477, DOI 10.1590/S0001-37652009000300012; Tefsen B, 2012, GLYCOBIOLOGY, V22, P456, DOI 10.1093/glycob/cwr144; Toledo MS, 2007, J LIPID RES, V48, P1801, DOI 10.1194/jlr.M700149-JLR200; Wallis GLF, 2001, EUR J BIOCHEM, V268, P4134, DOI 10.1046/j.1432-1327.2001.02322.x; Weidner G, 1998, CURR GENET, V33, P378, DOI 10.1007/s002940050350; Yoneda A, 2006, MOL BIOL CELL, V17, P5131, DOI 10.1091/mbc.E06-08-0701	60	36	39	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44418	44424		10.1074/jbc.M112.398321	http://dx.doi.org/10.1074/jbc.M112.398321			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23139423	Green Published, hybrid			2022-12-28	WOS:000312938600038
J	Han, KJ; Foster, DG; Zhang, NY; Kanisha, K; Dzieciatkowska, M; Sclafani, RA; Hansen, KC; Peng, JM; Liu, CW				Han, Ke-Jun; Foster, Daniel G.; Zhang, Nan-Yan; Kanisha, Kavdia; Dzieciatkowska, Monika; Sclafani, Robert A.; Hansen, Kirk C.; Peng, Junmin; Liu, Chang-Wei			Ubiquitin-specific Protease 9x Deubiquitinates and Stabilizes the Spinal Muscular Atrophy Protein-Survival Motor Neuron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE GENE-PRODUCT; COILED BODIES; SMN PROTEIN; MASS-SPECTROMETRY; SNRNP BIOGENESIS; DEGRADATION; COMPLEX; SEVERITY; DEFECTS; ENZYME	Spinal muscular atrophy (SMA), the leading genetic disorder of infant mortality, is caused by low levels of survival motor neuron (SMN) protein. Currently it is not clear how the SMN protein levels are regulated at the post-transcriptional level. In this report, we find that Usp9x, a deubiquitinating enzyme, stably associates with the SMN complex via directly interacting with SMN. Usp9x deubiquitinates SMN that is mostly mono-and di-ubiquitinated. Knockdown of Usp9x promotes SMN degradation and reduces the protein levels of SMN and the SMN complex in cultured mammalian cells. Interestingly, Usp9x does not deubiquitinate nuclear SMN Delta 7, the main protein product of the SMN2 gene, which is polyubiquitinated and rapidly degraded by the proteasome. Together, our results indicate that SMN and SMN Delta 7 are differently ubiquitinated; Usp9x plays an important role in stabilizing SMN and the SMN complex, likely via antagonizing Ub-dependent SMN degradation.	[Han, Ke-Jun; Foster, Daniel G.; Zhang, Nan-Yan; Dzieciatkowska, Monika; Sclafani, Robert A.; Hansen, Kirk C.; Liu, Chang-Wei] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Kanisha, Kavdia; Peng, Junmin] St Jude Childrens Res Hosp, St Jude Prote Facil, Struct Biol & Dev Neurobiol, Memphis, TN 38105 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; St Jude Children's Research Hospital	Liu, CW (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	changwei.liu@ucdenver.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; Sclafani, Robert/0000-0002-1100-6489	National Institutes of Health [5RO1NS72397]; American-Syrian-Lebanese Associated Charities; Cancer League of Colorado; NIH/NCRR Colorado CTSI Grant [UL1 RR025780]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American-Syrian-Lebanese Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Cancer League of Colorado; NIH/NCRR Colorado CTSI Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5RO1NS72397 (to C. W. L.) and grants from the American-Syrian-Lebanese Associated Charities (to J. P.) and the Cancer League of Colorado (to K. J. H.).; We are grateful to D. R. Alessi for providing the Usp9x and Usp9x(C1566A) plasmids, L. G. Xu for providing a 293T cDNA library, and B. Chong for initial Usp9x purification. We thank the members of the Liu lab for insightful discussion and reading of the manuscript. Imaging experiments were performed in the University of Colorado Anschutz Medical Campus Advance Light Microscopy Core supported in part by NIH/NCRR Colorado CTSI Grant UL1 RR025780.	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Baumer D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000773; Boulisfane N, 2011, HUM MOL GENET, V20, P641, DOI 10.1093/hmg/ddq508; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Carvalho T, 1999, J CELL BIOL, V147, P715, DOI 10.1083/jcb.147.4.715; Carvallo L, 2010, J BIOL CHEM, V285, P29546, DOI 10.1074/jbc.M110.155812; Chang HC, 2004, NEUROCHEM INT, V45, P1107, DOI 10.1016/j.neuint.2004.04.005; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Danielsen JMR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003590; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Eggert C, 2006, TRENDS MOL MED, V12, P113, DOI 10.1016/j.molmed.2006.01.005; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Han KJ, 2010, J BIOL CHEM, V285, P12543, DOI 10.1074/jbc.M109.072231; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; HIRAKATA M, 1993, J IMMUNOL, V150, P3592; HOVLAND P, 1989, GENE, V83, P57, DOI 10.1016/0378-1119(89)90403-4; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Mailman MD, 2002, GENET MED, V4, P20, DOI 10.1097/00125817-200201000-00004; Marx C, 2010, CANCER RES, V70, P3709, DOI 10.1158/0008-5472.CAN-09-3768; Matera AG, 1998, AM J HUM GENET, V63, P317, DOI 10.1086/301992; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; Melcher K, 2000, ANAL BIOCHEM, V277, P109, DOI 10.1006/abio.1999.4383; Melki J, 1997, CURR OPIN NEUROL, V10, P381, DOI 10.1097/00019052-199710000-00005; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Nagai H, 2009, MOL CELL, V36, P805, DOI 10.1016/j.molcel.2009.10.016; Narayanan U, 2004, MOL CELL, V16, P223, DOI 10.1016/j.molcel.2004.09.024; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Pantaleon M, 2001, MECH DEVELOP, V109, P151, DOI 10.1016/S0925-4773(01)00551-2; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Povlsen LK, 2012, NAT CELL BIOL, V14, P1089, DOI 10.1038/ncb2579; Praveen K, 2012, CELL REPORTS, V1, P624, DOI 10.1016/j.celrep.2012.05.014; Raasi Shahri, 2005, V301, P47; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Rossoll W, 2009, RESULTS PROBL CELL D, V48, P289, DOI 10.1007/400_2009_4; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Sleeman JE, 1999, CURR BIOL, V9, P1065, DOI 10.1016/S0960-9822(99)80475-8; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Taya S, 1998, J CELL BIOL, V142, P1053, DOI 10.1083/jcb.142.4.1053; Theard D, 2010, EMBO J, V29, P1499, DOI 10.1038/emboj.2010.46; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Xu P, 2009, J PROTEOME RES, V8, P3944, DOI 10.1021/pr900251d; Yin H, 2010, J BIOL CHEM, V285, P13580, DOI 10.1074/jbc.M109.046359; Young PJ, 2000, HUM MOL GENET, V9, P2869, DOI 10.1093/hmg/9.19.2869; Young PJ, 2001, EXP CELL RES, V265, P252, DOI 10.1006/excr.2001.5186; Young PJ, 2000, EXP CELL RES, V256, P365, DOI 10.1006/excr.2000.4858; Zhang HLL, 2003, J NEUROSCI, V23, P6627; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zhu X, 2007, PROTEINS, V69, P1, DOI 10.1002/prot.21546	77	42	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43741	43752		10.1074/jbc.M112.372318	http://dx.doi.org/10.1074/jbc.M112.372318			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23112048	Green Published, hybrid			2022-12-28	WOS:000312940800053
J	Kitamura, A; Nishimoto, M; Sengoku, T; Shibata, R; Jager, G; Bjork, GR; Grosjean, H; Yokoyama, S; Bessho, Y				Kitamura, Aya; Nishimoto, Madoka; Sengoku, Toru; Shibata, Rie; Jager, Gunilla; Bjork, Glenn R.; Grosjean, Henri; Yokoyama, Shigeyuki; Bessho, Yoshitaka			Characterization and Structure of the Aquifex aeolicus Protein DUF752 A BACTERIAL tRNA-METHYLTRANSFERASE (MnmC2) FUNCTIONING WITHOUT THE USUALLY FUSED OXIDASE DOMAIN (MnmC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL TRANSFER-RNAS; BIFUNCTIONAL ENZYME MNMC; BIOSYNTHESIS; SEQUENCE; GIDA; IDENTIFICATION; TRANSLATION; BIOGENESIS; MODOMICS; INSIGHTS	Post-transcriptional modifications of the wobble uridine (U34) of tRNAs play a critical role in reading NNA/G codons belonging to split codon boxes. In a subset of Escherichia coli tRNA, this wobble uridine is modified to 5-methylaminomethyluridine (mnm(5)U34) through sequential enzymatic reactions. Uridine 34 is first converted to 5-carboxymethylaminomethyluridine (cmnm(5)U34) by the MnmE-Mnm Genzyme complex. The cmnm(5)U34 is further modified to mnm(5)U by the bifunctional MnmC protein. In the first reaction, the FAD-dependent oxidase domain (MnmC1) converts cmnm(5)U into 5-aminomethyluridine (nm(5)U34), and this reaction is immediately followed by the methylation of the free amino group into mnm(5)U34 by the S-adenosylmethionine-dependent domain (MnmC2). Aquifex aeolicus lacks a bifunctional MnmC protein fusion and instead encodes the Rossmann-fold protein DUF752, which is homologous to the methyltransferase MnmC2 domain of Escherichia coli MnmC (26% identity). Here, we determined the crystal structure of the A. aeolicus DUF752 protein at 2.5 angstrom resolution, which revealed that it catalyzes the S-adenosylmethionine-dependent methylation of nm(5)U in vitro, to form mnm(5)U34 in tRNA. We also showed that naturally occurring tRNA from A. aeolicus contains the 5-mnm group attached to the C5 atom of U34. Taken together, these results support the recent proposal of an alternative MnmC1-independent shortcut pathway for producing mnm(5)U34 in tRNAs.	[Nishimoto, Madoka; Sengoku, Toru; Shibata, Rie; Yokoyama, Shigeyuki; Bessho, Yoshitaka] RIKEN Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kitamura, Aya; Bessho, Yoshitaka] RIKEN SPring 8 Ctr, Harima Inst, Sayo, Hyogo 6795148, Japan; [Jager, Gunilla; Bjork, Glenn R.] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Grosjean, Henri] Univ Paris 11, Ctr Genet Mol, UPR 3404, CNRS,FRC 3115, F-91190 Gif Sur Yvette, France; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Struct Biol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; RIKEN; Umea University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Tokyo; University of Tokyo	Yokoyama, S (corresponding author), RIKEN Syst & Struct Biol Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	yokoyama@riken.jp; bessho@spring8.or.jp	Yokoyama, Shigeyuki/N-6911-2015; Bessho, Yoshitaka/K-7702-2012; Sengoku, Toru/E-4304-2013; Björk, Glenn/AAE-8219-2022	Yokoyama, Shigeyuki/0000-0003-3133-7338; Bessho, Yoshitaka/0000-0001-9297-7473; Sengoku, Toru/0000-0001-9461-8714; 	RIKEN Structural Genomics/Proteomics Initiative; National Project on Protein Structural and Functional Analyses; Targeted Proteins Research Program; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Naito Foundation [2011-164]; Swedish Science Research Council [BU-2930]; Carl Tryggers Foundation	RIKEN Structural Genomics/Proteomics Initiative; National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Swedish Science Research Council; Carl Tryggers Foundation	This work was supported in part by the RIKEN Structural Genomics/Proteomics Initiative, the National Project on Protein Structural and Functional Analyses, the Targeted Proteins Research Program, the X-ray Free Electron Laser Priority Strategy Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Naito Foundation Grant 2011-164 (to Y.B.), Swedish Science Research Council Project Grant BU-2930, and the Carl Tryggers Foundation (to G.R.B.).	Agris PF, 2008, EMBO REP, V9, P629, DOI 10.1038/embor.2008.104; ANDACHI Y, 1989, J MOL BIOL, V209, P37, DOI 10.1016/0022-2836(89)90168-X; Armengod ME, 2012, BIOCHIMIE, V94, P1510, DOI 10.1016/j.biochi.2012.02.019; Awai T, 2011, J BIOL CHEM, V286, P35236, DOI 10.1074/jbc.M111.253641; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbe V, 2009, MICROBIOL-SGM, V155, P1758, DOI 10.1099/mic.0.027839-0; Bessho Y., 2009, DNA RNA MODIFICATION, P409; Bjork GR, 2005, ECOSAL ESCHERICHIA C; Bujnicki JM, 2004, RNA, V10, P1236, DOI 10.1261/rna.7470904; Chen P, 2005, EMBO J, V24, P1842, DOI 10.1038/sj.emboj.7600666; Constantinesco F, 1999, J MOL BIOL, V291, P375, DOI 10.1006/jmbi.1999.2976; Czerwoniec A, 2009, NUCLEIC ACIDS RES, V37, pD118, DOI 10.1093/nar/gkn710; de Crecy-Lagard V, 2007, IUBMB LIFE, V59, P634, DOI 10.1080/15216540701604632; EDQVIST J, 1992, NUCLEIC ACIDS RES, V20, P6575, DOI 10.1093/nar/20.24.6575; ELLIS SR, 1986, J BIOL CHEM, V261, P9703; ELSEVIERS D, 1984, NUCLEIC ACIDS RES, V12, P3521, DOI 10.1093/nar/12.8.3521; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GEHRKE CW, 1989, J CHROMATOGR, V471, P3, DOI 10.1016/S0021-9673(00)94152-9; GEHRKE CW, 1982, J CHROMATOGR, V230, P297, DOI 10.1016/S0378-4347(00)80479-X; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grosjean H., 2009, DNA RNA MODIFICATION, P1; Grosjean H, 2010, FEBS LETT, V584, P252, DOI 10.1016/j.febslet.2009.11.052; HAGERVALL TG, 1987, J BIOL CHEM, V262, P8488; Ihsanawati, 2008, J MOL BIOL, V383, P871, DOI 10.1016/j.jmb.2008.08.068; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kitamura A, 2011, PROTEIN SCI, V20, P1105, DOI 10.1002/pro.659; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; KOWALAK JA, 1994, BIOCHEMISTRY-US, V33, P7869, DOI 10.1021/bi00191a014; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Meyer S, 2009, J MOL BIOL, V392, P910, DOI 10.1016/j.jmb.2009.07.004; Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762; Newby ZER, 2002, P NATL ACAD SCI USA, V99, P7922, DOI 10.1073/pnas.122231499; Osawa T, 2009, STRUCTURE, V17, P713, DOI 10.1016/j.str.2009.03.013; Pearson D, 2011, NUCLEIC ACIDS RES, V39, P4818, DOI 10.1093/nar/gkr071; REINHART MP, 1986, NUCLEIC ACIDS RES, V14, P1131, DOI 10.1093/nar/14.3.1131; Roovers M, 2008, PROTEINS, V71, P2076, DOI 10.1002/prot.21918; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Schubert HL, 2003, BIOCHEMISTRY-US, V42, P5592, DOI 10.1021/bi034026p; Shi R, 2009, J BACTERIOL, V191, P7614, DOI 10.1128/JB.00650-09; Shigi N, 2006, J BIOL CHEM, V281, P14296, DOI 10.1074/jbc.M511675200; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Takeda Hiroshi, 2002, Nucleic Acids Res Suppl, P229; TAYA Y, 1973, BIOCHEM BIOPH RES CO, V51, P1062, DOI 10.1016/0006-291X(73)90035-1; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Tucker J, 1996, BIOCHEM J, V317, P891, DOI 10.1042/bj3170891; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Urbonavicius J, 2007, METHOD ENZYMOL, V425, P103; WATANABE K, 1974, FEBS LETT, V43, P59, DOI 10.1016/0014-5793(74)81105-1; Watanabe K, 2010, P JPN ACAD B-PHYS, V86, P11, DOI 10.2183/pjab.86.11; YAMADA Y, 1981, NUCLEIC ACIDS RES, V9, P1933, DOI 10.1093/nar/9.8.1933; Yim L, 2006, NUCLEIC ACIDS RES, V34, P5892, DOI 10.1093/nar/gkl752	52	9	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43950	43960		10.1074/jbc.M112.409300	http://dx.doi.org/10.1074/jbc.M112.409300			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23091054	Green Published, hybrid			2022-12-28	WOS:000312940800070
J	Schiller, B; Makrypidi, G; Razzazi-Fazeli, E; Paschinger, K; Walochnik, J; Wilson, IBH				Schiller, Birgit; Makrypidi, Georgia; Razzazi-Fazeli, Ebrahim; Paschinger, Katharina; Walochnik, Julia; Wilson, Iain B. H.			Exploring the Unique N-Glycome of the Opportunistic Human Pathogen Acanthamoeba	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCEIN-CONJUGATED LECTINS; FREE-LIVING AMEBAS; LINKED OLIGOSACCHARIDES; GLYCOPROTEIN N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; TRICHOMONAS-VAGINALIS; ENTAMOEBA-HISTOLYTICA; PLASMA-MEMBRANE; SEQUENCE TYPES; GLYCANS; CASTELLANII	Glycans play key roles in host-pathogen interactions; thus, knowing the N-glycomic repertoire of a pathogen can be helpful in deciphering its methods of establishing and sustaining a disease. Therefore, we sought to elucidate the glycomic potential of the facultative amoebal parasite Acanthamoeba. This is the first study of its asparagine-linked glycans, for which we applied biochemical tools and various approaches of mass spectrometry. An initial glycomic screen of eight strains from five genotypes of this human pathogen suggested, in addition to the common eukaryotic oligomannose structures, the presence of pentose and deoxyhexose residues on their N-glycans. A more detailed analysis was performed on the N-glycans of a genotype T11 strain (4RE); fractionation by HPLC and tandem mass spectrometric analyses indicated the presence of a novel mannosylfucosyl modification of the reducing terminal core as well as phosphorylation of mannose residues, methylation of hexose and various forms of pentosylation. The largest N-glycan in the 4RE strain contained two N-acetylhexosamine, thirteen hexose, one fucose, one methyl, and two pentose residues; however, in this and most other strains analyzed, glycans with compositions of Hex(8-9)HexNAc(2)Pnt(0-1) tended to dominate in terms of abundance. Although no correlation between pathogenicity and N-glycan structure can be proposed, highly unusual structures in this facultative parasite can be found which are potential virulence factors or therapeutic targets.	[Schiller, Birgit; Paschinger, Katharina; Wilson, Iain B. H.] Univ Nat Resources & Life Sci, Univ Bodenkultur, Dept Chem, A-1190 Vienna, Austria; [Makrypidi, Georgia] Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Dept Biochem, D-20246 Hamburg, Germany; [Razzazi-Fazeli, Ebrahim] Univ Vet Med, Vetom Core Facil Res, A-1210 Vienna, Austria; [Walochnik, Julia] Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, A-1090 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Veterinary Medicine Vienna; Medical University of Vienna	Wilson, IBH (corresponding author), Univ Nat Resources & Life Sci, Univ Bodenkultur, Dept Chem, A-1190 Vienna, Austria.	iain.wilson@boku.ac.at	Walochnik, Julia/AAM-8963-2020; Wilson, Iain/B-3326-2009	Walochnik, Julia/0000-0003-0356-2853; Wilson, Iain/0000-0001-8996-1518; Paschinger, Katharina/0000-0002-3594-7136; Razzazi-Fazeli, Ebrahim/0000-0002-3343-0301	Austrian Fonds zur Forderung der wissenschaftlichen Forschung Grant [P20565]	Austrian Fonds zur Forderung der wissenschaftlichen Forschung Grant(Austrian Science Fund (FWF))	This work was supported in part by Austrian Fonds zur Forderung der wissenschaftlichen Forschung Grant P20565 (to I. B. H. W.).	Bleuler-Martinez S, 2011, MOL ECOL, V20, P3056, DOI 10.1111/j.1365-294X.2011.05093.x; BOSE K, 1989, INT J PARASITOL, V19, P737, DOI 10.1016/0020-7519(89)90060-X; Butschi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000717; Ciucanu I, 2003, J AM CHEM SOC, V125, P16213, DOI 10.1021/ja035660t; Corsaro D, 2010, PARASITOL RES, V107, P233, DOI 10.1007/s00436-010-1870-6; Dudley R, 2009, EXP PARASITOL, V122, P338, DOI 10.1016/j.exppara.2009.04.009; Elloway EAG, 2004, J APPL MICROBIOL, V97, P1319, DOI 10.1111/j.1365-2672.2004.02430.x; Garate M, 2005, INFECT IMMUN, V73, P5775, DOI 10.1128/IAI.73.9.5775-5781.2005; Gast RJ, 1996, J EUKARYOT MICROBIOL, V43, P498, DOI 10.1111/j.1550-7408.1996.tb04510.x; ISHIHARA H, 1979, J BIOL CHEM, V254, P715; KETCHAM CM, 1992, J BIOL CHEM, V267, P11654; Khan NA, 2002, CURR MICROBIOL, V45, P197, DOI 10.1007/s00284-001-0108-3; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; Kong HH, 2009, KOREAN J PARASITOL, V47, pS21, DOI 10.3347/kjp.2009.47.S.S21; KORN ED, 1974, J BIOL CHEM, V249, P3335; KUROSAKA A, 1991, J BIOL CHEM, V266, P4168; LANG L, 1986, J BIOL CHEM, V261, P6320; Lehr T, 2007, GLYCOBIOLOGY, V17, P82, DOI 10.1093/glycob/cwl048; Leitsch D, 2010, EUKARYOT CELL, V9, P611, DOI 10.1128/EC.00300-09; Levy-Ontman O, 2011, J BIOL CHEM, V286, P21340, DOI 10.1074/jbc.M110.175042; Magliano ACM, 2012, PARASITOLOGY, V139, P45, DOI 10.1017/S0031182011001648; Magnelli P, 2008, J BIOL CHEM, V283, P18355, DOI 10.1074/jbc.M800725200; Makrypidi G, 2012, MOL CELL BIOL, V32, P774, DOI 10.1128/MCB.06195-11; Michel R, 2004, ACTA PROTOZOOL, V43, P37; Mullerr-Loennies S, 2010, AM J PATHOL, V177, P240, DOI 10.2353/ajpath.2010.090954; NEFF RJ, 1957, J PROTOZOOL, V4, P176, DOI 10.1111/j.1550-7408.1957.tb02505.x; Okumura CYM, 2008, CELL MICROBIOL, V10, P2078, DOI 10.1111/j.1462-5822.2008.01190.x; PAATERO GIL, 1988, EXP CELL RES, V179, P253, DOI 10.1016/0014-4827(88)90364-3; Park JN, 2012, J BIOL CHEM, V287, P19501, DOI 10.1074/jbc.M112.354209; Paschinger K, 2012, GLYCOBIOLOGY, V22, P300, DOI 10.1093/glycob/cwr149; Paschinger K, 2011, J MASS SPECTROM, V46, P561, DOI 10.1002/jms.1925; Paschinger K, 2009, GLYCOCONJUGATE J, V26, P385, DOI 10.1007/s10719-008-9155-3; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; PUANGLARP N, 1995, EUR J BIOCHEM, V232, P873; Pumidonming W, 2010, PARASITOL RES, V106, P553, DOI 10.1007/s00436-009-1694-4; ROBIN JB, 1988, ARCH OPHTHALMOL-CHIC, V106, P1273, DOI 10.1001/archopht.1988.01060140433047; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Schachter H, 2000, GLYCOCONJUGATE J, V17, P465; Schiller B, 2012, BIOL CHEM, V393, P661, DOI 10.1515/hsz-2012-0150; Schiller B, 2009, BIOCHEM J, V423, P41, DOI 10.1042/BJ20090786; Schuster FL, 2004, INT J PARASITOL, V34, P1001, DOI 10.1016/j.ijpara.2004.06.004; Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6; Stothard DR, 1998, J EUKARYOT MICROBIOL, V45, P45, DOI 10.1111/j.1550-7408.1998.tb05068.x; TOMIYA N, 1991, ANAL BIOCHEM, V193, P90, DOI 10.1016/0003-2697(91)90047-W; VANKUIK JA, 1987, EUR J BIOCHEM, V169, P399; VISVESVARA GS, 1975, J PROTOZOOL, V22, P245, DOI 10.1111/j.1550-7408.1975.tb05860.x; Walochnik J, 2000, APPL ENVIRON MICROB, V66, P4408, DOI 10.1128/AEM.66.10.4408-4413.2000; Walochnik J, 2000, J CLIN MICROBIOL, V38, P3932, DOI 10.1128/JCM.38.11.3932-3936.2000; Wilson IBH, 2012, GLYCOCONJUGATE J, V29, P173, DOI 10.1007/s10719-012-9378-1; Wuhrer M, 2004, BIOCHEM J, V378, P625, DOI 10.1042/BJ20031380; Wuhrer M, 2011, MASS SPECTROM REV, V30, P664, DOI 10.1002/mas.20337; Yan S, 2012, J BIOL CHEM, V287, P28276, DOI 10.1074/jbc.M112.353128; Zhang Y, 1997, GLYCOBIOLOGY, V7, P1153, DOI 10.1093/glycob/7.8.1153	53	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43191	43204		10.1074/jbc.M112.418095	http://dx.doi.org/10.1074/jbc.M112.418095			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23139421	Green Published, hybrid			2022-12-28	WOS:000312940800001
J	Hatanaka, T; Ohzono, S; Park, M; Sakamoto, K; Tsukamoto, S; Sugita, R; Ishitobi, H; Mori, T; Ito, O; Sorajo, K; Sugimura, K; Ham, S; Ito, Y				Hatanaka, Takaaki; Ohzono, Shinji; Park, Mirae; Sakamoto, Kotaro; Tsukamoto, Shogo; Sugita, Ryohei; Ishitobi, Hiroyuki; Mori, Toshiyuki; Ito, Osamu; Sorajo, Koichi; Sugimura, Kazuhisa; Ham, Sihyun; Ito, Yuji			Human IgA-binding Peptides Selected from Random Peptide Libraries AFFINITY MATURATION AND APPLICATION IN IGA PURIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCI; FC-ALPHA-RI; EFFECTOR MECHANISMS; MUCOSAL IMMUNITY; SURFACE PROTEIN; RECEPTOR; ANTIBODIES; CHROMATOGRAPHY; PYOGENES; COMPLEX	Phage display system is a powerful tool to design specific ligands for target molecules. Here, we used disulfide-constrained random peptide libraries constructed with the T7 phage display system to isolate peptides specific to human IgA. The binding clones (A1-A4) isolated by biopanning exhibited clear specificity to human IgA, but the synthetic peptide derived from the A2 clone exhibited a low specificity/affinity (K-d = 1.3 mu M). Therefore, we tried to improve the peptide using a partial randomized phage display library and mutational studies on the synthetic peptides. The designed Opt-1 peptide exhibited a 39-fold higher affinity (K-d = 33 nM) than the A2 peptide. An Opt-1 peptide-conjugated column was used to purify IgA from human plasma. However, the recovered IgA fraction was contaminated with other proteins, indicating nonspecific binding. To design a peptide with increased binding specificity, we examined the structural features of Opt-1 and the Opt-1-IgA complex using all-atom molecular dynamics simulations with explicit water. The simulation results revealed that the Opt-1 peptide displayed partial helicity in the N-terminal region and possessed a hydrophobic cluster that played a significant role in tight binding with IgA-Fc. However, these hydrophobic residues of Opt-1 may contribute to nonspecific binding with other proteins. To increase binding specificity, we introduced several mutations in the hydrophobic residues of Opt-1. The resultant Opt-3 peptide exhibited high specificity and high binding affinity for IgA, leading to successful isolation of IgA without contamination.	[Park, Mirae; Ham, Sihyun] Sookmyung Womens Univ, Dept Chem, Seoul 140742, South Korea; [Sugimura, Kazuhisa; Ito, Yuji] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan; [Ohzono, Shinji; Ishitobi, Hiroyuki; Ito, Osamu; Sorajo, Koichi] Otsuka Chem Co Ltd, Gen Res Lab, Tokyo 7710193, Japan; [Mori, Toshiyuki] NCI, Mol Targets Lab, Ctr Canc Res, Frederick, MD 21702 USA	Sookmyung Women's University; Kagoshima University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ham, S (corresponding author), Sookmyung Womens Univ, Dept Chem, Hyochangwon Gil 52, Seoul 140742, South Korea.	sihyun@sookmyung.ac.kr; k2174603@kadai.jp		Hatanaka, Takaaki/0000-0002-1154-6004	Japan Science and Technology Agency; Basic Science Research Program of the National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-0012096]; Japan Society for the Promotion of Science [238036]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Basic Science Research Program of the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by funds from the Japan Science and Technology Agency. This work was also supported by the Basic Science Research Program of the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grant 2011-0012096 and by Japan Society for the Promotion of Science Grant-in-Aid 238036 (to T. H.).	ALBRECHTSEN M, 1988, IMMUNOLOGY, V64, P201; Beyer T, 2009, J IMMUNOL METHODS, V346, P26, DOI 10.1016/j.jim.2009.05.002; Carlsson F, 2003, J EXP MED, V198, P1057, DOI 10.1084/jem.20030543; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Dechant M, 2007, J IMMUNOL, V179, P2936, DOI 10.4049/jimmunol.179.5.2936; Durrer P, 2003, VACCINE, V21, P4328, DOI 10.1016/S0264-410X(03)00457-2; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; FRITHZ E, 1989, MOL MICROBIOL, V3, P1111, DOI 10.1111/j.1365-2958.1989.tb00261.x; Herr AB, 2003, NATURE, V423, P614, DOI 10.1038/nature01685; HOLMGREN J, 1991, FEMS MICROBIOL IMMUN, V89, P1, DOI 10.1016/0378-1097(91)90057-H; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Huls G, 1999, CANCER RES, V59, P5778; KERR MA, 1990, BIOCHEM J, V271, P285, DOI 10.1042/bj2710285; KONDOH H, 1987, MOL IMMUNOL, V24, P1219; Krumpe LRH, 2006, PROTEOMICS, V6, P4210, DOI 10.1002/pmic.200500606; Langley R, 2005, J IMMUNOL, V174, P2926, DOI 10.4049/jimmunol.174.5.2926; Li RX, 1998, NAT BIOTECHNOL, V16, P190, DOI 10.1038/nbt0298-190; LINDAHL G, 1990, EUR J IMMUNOL, V20, P2241, DOI 10.1002/eji.1830201013; MONTEIRO RC, 1990, J EXP MED, V171, P597, DOI 10.1084/jem.171.3.597; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Morton HC, 1996, CRIT REV IMMUNOL, V16, P423; Pack T. D., 2001, CURRENT PROTOCOLS IM; Palombo G, 1998, J MOL RECOGNIT, V11, P243, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<243::AID-JMR431>3.0.CO;2-#; Persson J, 2005, J IMMUNOL METHODS, V297, P83, DOI 10.1016/j.jim.2004.11.024; PLAUT AG, 1974, J CLIN INVEST, V54, P1295, DOI 10.1172/JCI107875; Pleass RJ, 2001, J BIOL CHEM, V276, P8197, DOI 10.1074/jbc.M009396200; Ramsland PA, 2007, P NATL ACAD SCI USA, V104, P15051, DOI 10.1073/pnas.0706028104; RUSSELLJONES GJ, 1984, J EXP MED, V160, P1467, DOI 10.1084/jem.160.5.1467; Sandin C, 2002, J IMMUNOL, V169, P1357, DOI 10.4049/jimmunol.169.3.1357; SCOTT JK, 1992, TRENDS BIOCHEM SCI, V17, P241, DOI 10.1016/0968-0004(92)90401-T; STENBERG L, 1994, J BIOL CHEM, V269, P13458; Zhao J, 2008, ONCOL RES, V17, P217, DOI 10.3727/096504008786111374	33	28	31	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43126	43136		10.1074/jbc.M112.389742	http://dx.doi.org/10.1074/jbc.M112.389742			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23076147	Green Published, hybrid			2022-12-28	WOS:000312501600068
J	Gao, JL; Lu, YL; Browne, G; Yap, BCM; Trewhella, J; Hunter, N; Nguyen, KA				Gao, Jin-Long; Lu, Yanling; Browne, Gina; Yap, Benjamin C. -M.; Trewhella, Jill; Hunter, Neil; Ky-Anh Nguyen			The Role of Heme Binding by DNA-protective Protein from Starved Cells (Dps) in the Tolerance of Porphyromonas gingivalis to Heme Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE BETA-SYNTHASE; GRAM-NEGATIVE BACTERIA; HYDROGEN-PEROXIDE; THIOLATE LIGATION; BIOLOGICAL MACROMOLECULES; STAPHYLOCOCCUS-AUREUS; STRESS RESISTANCE; ESCHERICHIA-COLI; IRON; GENE	The widely expressed DNA-protective protein from starved-cells (Dps) family proteins are considered major contributors to prokaryotic resistance to stress. We show here that Porphyromonas gingivalis Dps (PgDps), previously described as an iron-storage and DNA-binding protein, also mediates heme sequestration. We determined that heme binds strongly to PgDps with an apparent K-d of 3.7 x 10(-8) M and is coordinated by a single surface-located cysteine at the fifth axial ligand position. Heme and iron sequestered in separate sites by PgDps provide protection of DNA from H2O2-mediated free radical damage and were found to be important for growth of P. gingivalis under excess heme as the only iron source. Conservation of the heme-coordinating cysteine among Dps isoforms from the Bacteroidales order suggests that this function may be a common feature within these anaerobic bacteria.	[Gao, Jin-Long; Hunter, Neil; Ky-Anh Nguyen] Univ Sydney, Fac Dent, Sydney, NSW 2006, Australia; [Lu, Yanling; Trewhella, Jill] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Gao, Jin-Long; Browne, Gina; Yap, Benjamin C. -M.; Hunter, Neil; Ky-Anh Nguyen] Westmead Hosp, Westmead Millennium Inst, Inst Dent Res, Westmead, NSW 2145, Australia; [Gao, Jin-Long; Browne, Gina; Yap, Benjamin C. -M.; Hunter, Neil; Ky-Anh Nguyen] Westmead Hosp, Westmead Ctr Oral Hlth, Westmead, NSW 2145, Australia	University of Sydney; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney	Nguyen, KA (corresponding author), Inst Dent Res, POB 533, Wentworthville, NSW 2145, Australia.	kyanhn@gmail.com	; Nguyen, Ky-Anh/A-4971-2010	Trewhella, Jill/0000-0002-8555-6766; Nguyen, Ky-Anh/0000-0002-1643-6576; Gao, Jinlong/0000-0002-5153-5393	National Institutes of Health [DE 09761]; Australian Research Council [LP0562660]; Ramaciotti Foundation, Australia [RN38/08]; Bela Schwartz Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); Ramaciotti Foundation, Australia; Bela Schwartz Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE 09761 (to Jan Potempa and subcontracted to K.-A.N.). This work was also supported in part by Grant LP0562660 from the Australian Research Council (to N. H.) and Establishment Grant RN38/08 from the Ramaciotti Foundation, Australia (to K.-A.N.).; Recipient of fellowship support from The Bela Schwartz Foundation.	AFT RL, 1983, J BIOL CHEM, V258, P2069; ANDREWS SC, 1995, J BIOL CHEM, V270, P23268, DOI 10.1074/jbc.270.40.23268; Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; Asher C, 2009, INORG CHEM, V48, P7994, DOI 10.1021/ic900647y; Bagshaw C. R., 1987, SPECTROPHOTOMETRY SP, P91; Barnard JP, 1999, INFECT IMMUN, V67, P6558; BULLEN JJ, 1981, REV INFECT DIS, V3, P1127; Calhoun LN, 2011, J APPL MICROBIOL, V110, P375, DOI 10.1111/j.1365-2672.2010.04890.x; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Ceci P, 2003, J BIOL CHEM, V278, P20319, DOI 10.1074/jbc.M302114200; Chapple ILC, 1996, J CLIN PATHOL-CL MOL, V49, pM247; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Chowdhury RP, 2008, BIOCHEMISTRY-US, V47, P11110, DOI 10.1021/bi801158e; Dashper SG, 2000, J BACTERIOL, V182, P6456, DOI 10.1128/JB.182.22.6456-6462.2000; Dashper SG, 2009, J BACTERIOL, V191, P1044, DOI 10.1128/JB.01270-08; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; Ezzo PJ, 2003, PERIODONTOL 2000, V32, P24, DOI 10.1046/j.0906-6713.2003.03203.x; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gao JL, 2010, J BIOL CHEM, V285, P40028, DOI 10.1074/jbc.M110.163535; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Haikarainen T, 2010, CELL MOL LIFE SCI, V67, P341, DOI 10.1007/s00018-009-0168-2; Huang TJ, 2001, ANTIOXID REDOX SIGN, V3, P685, DOI 10.1089/15230860152543023; Ishikawa T, 2003, J BACTERIOL, V185, P1010, DOI 10.1128/JB.185.3.1010-1017.2003; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; Jeffries CM, 2011, J MOL BIOL, V414, P735, DOI 10.1016/j.jmb.2011.10.029; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KERY V, 1994, J BIOL CHEM, V269, P25283; Knight DA, 2008, POLYHEDRON, V27, P1795, DOI 10.1016/j.poly.2008.02.013; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; LADAN H, 1993, FEMS MICROBIOL LETT, V112, P173; Lewis JP, 2006, MICROBIOL-SGM, V152, P3367, DOI 10.1099/mic.0.29011-0; Lewis JP, 2010, PERIODONTOL 2000, V52, P94, DOI 10.1111/j.1600-0757.2009.00329.x; Liu XF, 2006, J BIOL CHEM, V281, P27827, DOI 10.1074/jbc.M601398200; LU Y, 1993, P NATL ACAD SCI USA, V90, P11456, DOI 10.1073/pnas.90.24.11456; Lynch MC, 1999, INFECT IMMUN, V67, P3367, DOI 10.1128/IAI.67.7.3367-3375.1999; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Nguyen KA, 2009, MICROBIOL-SGM, V155, P328, DOI 10.1099/mic.0.024323-0; NIKOLICH MP, 1992, ANTIMICROB AGENTS CH, V36, P1005, DOI 10.1128/AAC.36.5.1005; NITZAN Y, 1994, CURR MICROBIOL, V29, P125, DOI 10.1007/BF01570752; Omura T, 2005, BIOCHEM BIOPH RES CO, V338, P404, DOI 10.1016/j.bbrc.2005.08.267; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; PENA MMO, 1995, J BIOL CHEM, V270, P22478, DOI 10.1074/jbc.270.38.22478; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; RIVERA M, 1995, ANAL BIOCHEM, V230, P295, DOI 10.1006/abio.1995.1477; Roper JM, 2000, J BIOL CHEM, V275, P40316, DOI 10.1074/jbc.M007146200; RUF HH, 1979, J INORG BIOCHEM, V11, P189, DOI 10.1016/S0162-0134(00)80017-3; Seymour GJ, 2007, CLIN MICROBIOL INFEC, V13, P3, DOI 10.1111/j.1469-0691.2007.01798.x; Shepherd M, 2007, BIOCHEMISTRY-US, V46, P5030, DOI 10.1021/bi700183u; Sigman JA, 1999, BIOCHEMISTRY-US, V38, P11122, DOI 10.1021/bi990815o; Simpson W, 2000, J BACTERIOL, V182, P5737, DOI 10.1128/JB.182.20.5737-5748.2000; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Slakeski N, 2000, ORAL MICROBIOL IMMUN, V15, P388, DOI 10.1034/j.1399-302x.2000.150609.x; Smalley JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017182; Smith JL, 2004, CRIT REV MICROBIOL, V30, P173, DOI 10.1080/10408410490435151; SONO M, 1985, INORG CHEM, V24, P4339, DOI 10.1021/ic00219a028; Su MH, 2005, BIOCHEMISTRY-US, V44, P5572, DOI 10.1021/bi0472705; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svistunenko DA, 2005, BBA-BIOENERGETICS, V1707, P127, DOI 10.1016/j.bbabio.2005.01.004; Ueshima J, 2003, INFECT IMMUN, V71, P1170, DOI 10.1128/IAI.71.3.1170-1178.2003; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	67	15	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42243	42258		10.1074/jbc.M112.392787	http://dx.doi.org/10.1074/jbc.M112.392787			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086936	Green Published, hybrid			2022-12-28	WOS:000312103000060
J	Kaplan, FM; Kugel, CH; Dadpey, N; Shao, YP; Abel, EV; Aplin, AE				Kaplan, Fred M.; Kugel, Curtis H., III; Dadpey, Neda; Shao, Yongping; Abel, Ethan V.; Aplin, Andrew E.			SHOC2 and CRAF Mediate ERK1/2 Reactivation in Mutant NRAS-mediated Resistance to RAF Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-RAF; MELANOMA-CELLS; MAP KINASE; SIGNALING PATHWAY; PROTEIN; BRAF; ACTIVATION; PHOSPHATASE; MECHANISM; PHOSPHORYLATION	ERK1/2 signaling is frequently dysregulated in tumors through BRAF mutation. Targeting mutant BRAF with vemurafenib frequently elicits therapeutic responses; however, durable effects are often limited by ERK1/2 pathway reactivation via poorly defined mechanisms. We generated mutant BRAF(V600E) melanoma cells that exhibit resistance to PLX4720, the tool compound for vemurafenib, that co-expressed mutant (Q61K) NRAS. In these BRAF(V600E)/NRAS(Q61K) co-expressing cells, reactivation of the ERK1/2 pathway during PLX4720 treatment was dependent on NRAS. Expression of mutant NRAS in parental BRAF(V600) cells was sufficient to by-pass PLX4720 effects on ERK1/2 signaling, entry into S phase and susceptibility to apoptosis in a manner dependent on the RAF binding site in NRAS. ERK1/2 activation in BRAF(V600E)/NRAS(Q61K) cells required CRAF only in the presence of PLX4720, indicating a switch in RAF isoform requirement. Both ERK1/2 activation and resistance to apoptosis of BRAF(V600E)/NRAS(Q61K) cells in the presence of PLX4720 was modulated by SHOC-2/Sur-8 expression, a RAS-RAF scaffold protein. These data show that NRAS mutations confer resistance to RAF inhibitors in mutant BRAF cells and alter RAF isoform and scaffold molecule requirements to re-activate the ERK1/2 pathway.	[Kaplan, Fred M.; Kugel, Curtis H., III; Dadpey, Neda; Shao, Yongping; Abel, Ethan V.; Aplin, Andrew E.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Aplin, Andrew E.] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Aplin, AE (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, 233 S 10th St, Philadelphia, PA 19107 USA.	Andrew.Aplin@KimmelCancerCenter.Org	Shao, Yongping/D-9966-2011		National Institutes of Health [GM067893, CA125103]; Pennsylvania Commonwealth Universal Research Enhancement [AF0301]; Department of Defense Grant [CA101019]; Outrun the Sun; Joanna M. Nicolay Melanoma Research Foundation; National Cancer Institute [1P30CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036, R01CA125103, R01CA101019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Commonwealth Universal Research Enhancement; Department of Defense Grant(United States Department of Defense); Outrun the Sun; Joanna M. Nicolay Melanoma Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM067893 and CA125103, Pennsylvania Commonwealth Universal Research Enhancement Grant AF0301, and Department of Defense Grant CA101019. This work was also supported by fellowships from Outrun the Sun (to Y.S.) and the Joanna M. Nicolay Melanoma Research Foundation (to E.A.), respectively.; We thank Dr. Gideon Bollag and Plexxikon Inc. for providing PLX4720, and Dr. Meenhard Herlyn (Wistar Institute, Philadelphia, PA) for supplying the WM melanoma cell lines. The Kimmel Cancer Center is funded by National Cancer Institute Support Grant 1P30CA56036.	Abel EV, 2010, CANCER RES, V70, P2891, DOI 10.1158/0008-5472.CAN-09-3139; Aebersold DM, 2004, MOL CELL BIOL, V24, P10000, DOI 10.1128/MCB.24.22.10000-10015.2004; Aplin AE, 2011, J INVEST DERMATOL, V131, P1817, DOI 10.1038/jid.2011.147; Boisvert-Adamo K, 2006, ONCOGENE, V25, P4848, DOI 10.1038/sj.onc.1209493; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hingorani SR, 2003, CANCER RES, V63, P5198; Hu R, 2010, PIGM CELL MELANOMA R, V23, P201, DOI 10.1111/j.1755-148X.2010.00668.x; Hunger-Glaser I, 2004, J CELL PHYSIOL, V200, P213, DOI 10.1002/jcp.20018; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kaplan FM, 2011, ONCOGENE, V30, P366, DOI 10.1038/onc.2010.408; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Li WQ, 2000, GENE DEV, V14, P895; Muda M, 1996, J BIOL CHEM, V271, P4319; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Papin C, 1998, J BIOL CHEM, V273, P24939, DOI 10.1074/jbc.273.38.24939; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Shao YP, 2010, CANCER RES, V70, P6670, DOI 10.1158/0008-5472.CAN-09-4471; Shaul YD, 2009, GENE DEV, V23, P1779, DOI 10.1101/gad.523909; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Stinchcombe TE, 2011, LANCET ONCOL, V12, P717, DOI 10.1016/S1470-2045(11)70200-5; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3	42	40	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41797	41807		10.1074/jbc.M112.390906	http://dx.doi.org/10.1074/jbc.M112.390906			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23076151	hybrid, Green Published			2022-12-28	WOS:000312103000021
J	Oeemig, JS; Lynggaard, C; Knudsen, DH; Hansen, FT; Norgaard, KD; Schneider, T; Vad, BS; Sandvang, DH; Nielsen, LA; Neve, S; Kristensen, HH; Sahl, HG; Otzen, DE; Wimmer, R				Oeemig, Jesper S.; Lynggaard, Carina; Knudsen, Daniel H.; Hansen, Frederik T.; Norgaard, Kent D.; Schneider, Tanja; Vad, Brian S.; Sandvang, Dorthe H.; Nielsen, Line A.; Neve, Soren; Kristensen, Hans-Henrik; Sahl, Hans-Georg; Otzen, Daniel E.; Wimmer, Reinhard			Eurocin, a New Fungal Defensin STRUCTURE, LIPID BINDING, AND ITS MODE OF ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; ARTHROPOD DEFENSIN; PROTEIN STRUCTURES; ANTIBACTERIAL; CATHELICIDINS; CONFORMATION; LEUKOCYTES; INHIBITION; PLECTASIN; MECHANISM	Antimicrobial peptides are a new class of antibiotics that are promising for pharmaceutical applications because they have retained efficacy throughout evolution. One class of antimicrobial peptides are the defensins, which have been found in different species. Here we describe a new fungal defensin, eurocin. Eurocin acts against a range of Gram-positive human pathogens but not against Gram-negative bacteria. Eurocin consists of 42 amino acids, forming a cysteine-stabilized alpha/beta-fold. The thermal denaturation data point shows the disulfide bridges being responsible for the stability of the fold. Eurocin does not form pores in cell membranes at physiologically relevant concentrations; it does, however, lead to limited leakage of a fluorophore from small unilamellar vesicles. Eurocin interacts with detergent micelles, and it inhibits the synthesis of cell walls by binding equimolarly to the cell wall precursor lipid II.	[Oeemig, Jesper S.; Lynggaard, Carina; Knudsen, Daniel H.; Hansen, Frederik T.; Norgaard, Kent D.; Wimmer, Reinhard] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, DK-9000 Aalborg, Denmark; [Schneider, Tanja; Sahl, Hans-Georg] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Sect, D-53115 Bonn, Germany; [Vad, Brian S.; Otzen, Daniel E.] Univ Aarhus, Dept Mol Biol, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark; [Sandvang, Dorthe H.; Nielsen, Line A.; Neve, Soren; Kristensen, Hans-Henrik] Novozymes AS, DK-2880 Bagsvaerd, Denmark	Aalborg University; University of Bonn; Aarhus University; Novozymes	Wimmer, R (corresponding author), Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Sohngaardsholmsvej 49, DK-9000 Aalborg, Denmark.	rw@bio.aau.dk	Schneider, Tanja/L-8049-2013; Wimmer, Reinhard/M-2346-2019; Wimmer, Reinhard/A-7901-2012	Wimmer, Reinhard/0000-0001-6942-5056; Otzen, Daniel/0000-0002-2918-8989; Teilfeldt Hansen, Frederik/0000-0003-2500-2072; Schneider, Tanja/0000-0001-7269-4716	Obel Foundation; SparNord Foundation; Lundbeck Foundation; Danish Research Foundation	Obel Foundation; SparNord Foundation; Lundbeck Foundation(Lundbeckfonden); Danish Research Foundation	This work was supported by the Obel and SparNord Foundations.; Supported by the Lundbeck Foundation and the Danish Research Foundation.	Brotz H, 1998, ANTIMICROB AGENTS CH, V42, P154, DOI 10.1128/AAC.42.1.154; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0; Da Silva P, 2003, PROTEIN SCI, V12, P438, DOI 10.1110/ps.0228303; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Delepierre M, 1999, BIOCHEMISTRY-US, V38, P16756, DOI 10.1021/bi991685m; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garcia-Olmedo F, 1998, BIOPOLYMERS, V47, P479, DOI 10.1002/(SICI)1097-0282(1998)47:6<479::AID-BIP6>3.0.CO;2-K; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Guntert P, 1998, J BIOMOL NMR, V12, P543, DOI 10.1023/A:1008391403193; Hancock RD, 2001, COORDIN CHEM REV, V212, P1, DOI 10.1016/S0010-8545(00)00418-5; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HANZAWA H, 1990, FEBS LETT, V269, P413, DOI 10.1016/0014-5793(90)81206-4; Hubert F, 1996, EUR J BIOCHEM, V240, P302, DOI 10.1111/j.1432-1033.1996.0302h.x; Izadpanah A, 2005, J AM ACAD DERMATOL, V52, P381, DOI 10.1016/j.jaad.2004.08.026; Jing W, 2003, J PEPT RES, V61, P219, DOI 10.1034/j.1399-3011.2003.00050.x; Katsu T, 2007, ANAL SCI, V23, P517, DOI 10.2116/analsci.23.517; Keller R., 2004, COMPUTER AIDED RESON, V1; KOHLRAUSCH U, 1991, J BACTERIOL, V173, P3425, DOI 10.1128/jb.173.11.3425-3431.1991; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Krzeminski M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-51; Lamberty M, 2001, BIOCHEMISTRY-US, V40, P11995, DOI 10.1021/bi0103563; Landon C, 1997, PROTEIN SCI, V6, P1878, DOI 10.1002/pro.5560060908; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lowenberger C, 2001, INSECT BIOCHEM MOLEC, V31, P219, DOI 10.1016/S0965-1748(00)00141-7; Melo FR, 2002, PROTEINS, V48, P311, DOI 10.1002/prot.10142; MENDEZ E, 1990, EUR J BIOCHEM, V194, P533, DOI 10.1111/j.1432-1033.1990.tb15649.x; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Nygaard MKE, 2012, J BIOMOL NMR, V52, P277, DOI 10.1007/s10858-012-9608-7; Pal D, 1999, J MOL BIOL, V294, P271, DOI 10.1006/jmbi.1999.3217; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pelegrini PB, 2005, INT J BIOCHEM CELL B, V37, P2239, DOI 10.1016/j.biocel.2005.06.011; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Popplewell JF, 2007, BBA-BIOMEMBRANES, V1768, P13, DOI 10.1016/j.bbamem.2006.05.016; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Savarin P, 1999, PROTEIN SCI, V8, P2672; Sawai MV, 2002, PROTEIN ENG, V15, P225, DOI 10.1093/protein/15.3.225; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Seo JK, 2005, BIOCHEM BIOPH RES CO, V338, P1998, DOI 10.1016/j.bbrc.2005.11.013; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Todd SM, 2007, MED VET ENTOMOL, V21, P141, DOI 10.1111/j.1365-2915.2007.00682.x; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Vad B, 2010, BBA-PROTEINS PROTEOM, V1804, P806, DOI 10.1016/j.bbapap.2009.12.006; van Heijenoort J, 2007, MICROBIOL MOL BIOL R, V71, P620, DOI 10.1128/MMBR.00016-07; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902; Wimmer R, 2006, BIOCHEMISTRY-US, V45, P481, DOI 10.1021/bi051876r; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yang YS, 2000, BIOCHEMISTRY-US, V39, P14436, DOI 10.1021/bi0011835; ZANETTI M, 1995, FEBS LETT, V374, P1, DOI 10.1016/0014-5793(95)01050-O; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhu S., 2012, P NATL ACAD SCI USA, V109, P1; Zhu SY, 2008, MOL IMMUNOL, V45, P828, DOI 10.1016/j.molimm.2007.06.354	68	64	66	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42361	42372		10.1074/jbc.M112.382028	http://dx.doi.org/10.1074/jbc.M112.382028			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23093408	hybrid, Green Published			2022-12-28	WOS:000312103000071
J	Liu, T; Li, Y; Gu, H; Zhu, G; Li, JB; Cao, L; Li, F				Liu, Tong; Li, Yang; Gu, Hui; Zhu, Ge; Li, Jiabin; Cao, Liu; Li, Feng			p21-activated Kinase 6 (PAK6) Inhibits Prostate Cancer Growth via Phosphorylation of Androgen Receptor and Tumorigenic E3 Ligase Murine Double Minute-2 (Mdm2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE; UBIQUITYLATION; DEGRADATION; PROGRESSION; EXPRESSION; METASTASES; CELLS	The androgen receptor (AR) signaling pathway plays a crucial role in the development and growth of prostate malignancies. Regulation of AR homeostasis in prostate tumorigenesis has not yet been fully characterized. In this study, we demonstrate that p21-activated kinase 6 (PAK6) inhibits prostate tumorigenesis by regulating AR homeostasis. First, we demonstrated that in normal prostate epithelium, AR co-localizes with PAK6 in the cytoplasm and translocates into the nucleus in malignant prostate. Furthermore, AR phosphorylation at Ser-578 by PAK6 promotes AR-E3 ligase murine double minute-2 (Mdm2) association, causing AR degradation upon androgen stimuli. We also showed that PAK6 phosphorylates Mdm2 on Thr-158 and Ser-186, which is critical for AR ubiquitin-mediated degradation. Moreover, we found that Thr-158 collaborates with Ser-186 for AR-Mdm2 association and AR ubiquitin-mediated degradation as it facilitates PAK6-mediated AR homeostasis. PAK6 knockdown promotes prostate tumor growth in vivo. Interestingly, we found a strong inverse correlation between PAK6 and AR expression in the cytoplasm of prostate cancer cells. These observations indicate that PAK6 may be important for the maintenance of androgen-induced AR signaling homeostasis and in prostate malignancy, as well as being a possible new therapeutic target for AR-positive and hormone-sensitive prostate cancer.	[Li, Feng] China Med Univ, Minist Publ Hlth, Dept Cell Biol, Key Lab Cell Biol, Shenyang 110001, Peoples R China; [Li, Feng] China Med Univ, Key Lab Med Cell Biol, Minist Educ, Shenyang 110001, Peoples R China	China Medical University; China Medical University	Li, F (corresponding author), China Med Univ, Minist Publ Hlth, Dept Cell Biol, Key Lab Cell Biol, Shenyang 110001, Peoples R China.	fli@mail.cmu.edu.cn		Li, Feng/0000-0001-5868-7456	National Natural Science Foundation of China [30771128, 90813038, 31171360]; Ministry of Education of China Doctoral Fund [20102104110016]; Education Department of Liaoning Province Grant [LT2011011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China Doctoral Fund; Education Department of Liaoning Province Grant	This work was supported by National Natural Science Foundation of China Grants 30771128, 90813038, and 31171360, Ministry of Education of China Doctoral Fund 20102104110016, and Education Department of Liaoning Province Grant LT2011011.	Agoulnik IU, 2008, ADV EXP MED BIOL, V617, P245, DOI 10.1007/978-0-387-69080-3_23; Buchanan G, 2001, CANCER METAST REV, V20, P207, DOI 10.1023/A:1015531326689; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; DEWINTER JAR, 1994, AM J PATHOL, V144, P735; Faus H, 2006, BIOMED PHARMACOTHER, V60, P520, DOI 10.1016/j.biopha.2006.07.082; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Ha S, 2011, ENDOCR-RELAT CANCER, V18, P245, DOI 10.1530/ERC-10-0204; Hartel A, 2003, J STEROID BIOCHEM, V84, P231, DOI 10.1016/S0960-0760(03)00033-5; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Higano CS, 2011, UROL ONCOL-SEMIN ORI, V29, pS1, DOI 10.1016/j.urolonc.2011.08.013; Hobisch A, 1996, PROSTATE, V28, P129; HOBISCH A, 1995, CANCER RES, V55, P3068; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Kaur R, 2008, PROSTATE, V68, P1510, DOI 10.1002/pros.20787; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee SR, 2002, MOL ENDOCRINOL, V16, P85, DOI 10.1210/me.16.1.85; Li XD, 2010, EXPERT OPIN THER TAR, V14, P419, DOI 10.1517/14728221003642019; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Ponguta LA, 2008, J BIOL CHEM, V283, P20989, DOI 10.1074/jbc.M802392200; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Rees I, 2006, BBA-PROTEINS PROTEOM, V1764, P1073, DOI 10.1016/j.bbapap.2006.03.013; Saraon P, 2011, CLIN CHEM, V57, P1366, DOI 10.1373/clinchem.2011.165977; Schrantz N, 2004, J BIOL CHEM, V279, P1922, DOI 10.1074/jbc.M311145200; Shu SK, 2010, J BIOL CHEM, V285, P33045, DOI 10.1074/jbc.M110.121129; Wang LG, 2006, CARCINOGENESIS, V27, P2124, DOI 10.1093/carcin/bgl075; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wen XQ, 2009, UROLOGY, V73, P1407, DOI 10.1016/j.urology.2008.09.041; Whale A, 2011, FRONT BIOSCI-LANDMRK, V16, P849, DOI 10.2741/3724; Yang F, 2001, J BIOL CHEM, V276, P15345, DOI 10.1074/jbc.M010311200; Zhou H, 2005, J BIOL CHEM, V280, P10624, DOI 10.1074/jbc.M411900200; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	36	37	39	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3359	3369		10.1074/jbc.M112.384289	http://dx.doi.org/10.1074/jbc.M112.384289			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23132866	hybrid, Green Published			2022-12-28	WOS:000314397900041
J	Biswas, K; Yoshioka, K; Asanuma, K; Okamoto, Y; Takuwa, N; Sasaki, T; Takuwa, Y				Biswas, Kuntal; Yoshioka, Kazuaki; Asanuma, Ken; Okamoto, Yasuo; Takuwa, Noriko; Sasaki, Takehiko; Takuwa, Yoh			Essential Role of Class II Phosphatidylinositol-3-kinase-C2 alpha in Sphingosine 1-Phosphate Receptor-1-mediated Signaling and Migration in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; RHO GTPASES; SPHINGOSINE-1-PHOSPHATE; RAC; ACTIVATION; ANGIOGENESIS; MEMBRANE; CLATHRIN; MOTILITY; KINASE	The phosphatidylinositol (PtdIns) 3-kinase (PI3K) family regulates diverse cellular processes, including cell proliferation, migration, and vesicular trafficking, through catalyzing 3'-phosphorylation of phosphoinositides. In contrast to class I PI3Ks, including p110 alpha and p110 beta, functional roles of class II PI3Ks, comprising PI3K-C2 alpha, PI3K-C2 beta, and PI3K-C2 gamma, are little understood. The lysophospholipid mediator sphingosine 1-phosphate (S1P) plays the important roles in regulating vascular functions, including vascular formation and barrier integrity, via the G-protein-coupled receptors S1P(1-3). We studied the roles of PI3K-C2 alpha in S1P-induced endothelial cell (EC) migration and tube formation. S1P stimulated cell migration and activation of Akt, ERK, and Rac1, the latter of which acts as a signaling molecule essential for cell migration and tube formation, via S1P(1) in ECs. Knockdown of either PI3K-C2 alpha or class I p110 beta markedly inhibited S1P-induced migration, lamellipodium formation, and tube formation, whereas that of p110 alpha or Vps34 did not. Only p110 beta was necessary for S1P-iduced Akt activation, but both PI3K-C2 alpha and p110 beta were required for Rac1 activation. FRET imaging showed that S1P induced Rac1 activation in both the plasma membrane and PtdIns 3-phosphate (PtdIns(3) P)-enriched endosomes. Knockdown of PI3K-C2 alpha but not p110 beta markedly reduced PtdIns(3) P-enriched endosomes and suppressed endosomal Rac1 activation. Also, knockdown of PI3K-C2 alpha but not p110 beta suppressed S1P-induced S1P(1) internalization into PtdIns(3) P-enriched endosomes. Finally, pharmacological inhibition of endocytosis suppressed S1P-induced S1P(1) internalization, Rac1 activation, migration, and tube formation. These observations indicate that PI3K-C2 alpha plays the crucial role in S1P(1) internalization into the intracellular vesicular compartment, Rac1 activation on endosomes, and thereby migration through regulating vesicular trafficking in ECs.	[Biswas, Kuntal; Yoshioka, Kazuaki; Okamoto, Yasuo; Takuwa, Noriko; Takuwa, Yoh] Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa 9208640, Japan; [Asanuma, Ken; Sasaki, Takehiko] Akita Univ, Grad Sch Med, Dept Med Biol, Akita 0108543, Japan; [Asanuma, Ken; Sasaki, Takehiko] Akita Univ, Biosignal Res Ctr, Akita 0108543, Japan; [Takuwa, Noriko] Ishikawa Prefectural Nursing Univ, Dept Hlth & Med Sci, Kahoku, Ishikawa 9291210, Japan	Kanazawa University; Akita University; Akita University	Yoshioka, K (corresponding author), Kanazawa Univ, Sch Med, Dept Physiol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	yoshioka@med.kanazawa-u.ac.jp; ytakuwa@med.kanazawa-u.ac.jp	OKAMOTO, Yasuo/J-8438-2015; Yoshioka, Kazuaki/G-1038-2013	Yoshioka, Kazuaki/0000-0002-8631-3846; TAKUWA, Noriko/0000-0002-4278-2704; Sasaki, Takehiko/0000-0003-1837-3748	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science; Honjin Foundation; Mitsubishi Pharma Research Foundation; SENSIN Medical Research Foundation; Grants-in-Aid for Scientific Research [23590257] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Honjin Foundation; Mitsubishi Pharma Research Foundation; SENSIN Medical Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; the Japan Society for the Promotion of Science; the Honjin Foundation; the Mitsubishi Pharma Research Foundation; and the SENSIN Medical Research Foundation.	Beningo KA, 2006, ARCH BIOCHEM BIOPHYS, V456, P224, DOI 10.1016/j.abb.2006.09.025; Blaho VA, 2011, CHEM REV, V111, P6299, DOI 10.1021/cr200273u; Broussard JA, 2012, MOL BIOL CELL, V23, P1486, DOI 10.1091/mbc.E11-02-0124; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Dobrowolski R, 2012, NAT REV MOL CELL BIO, V13, P53, DOI 10.1038/nrm3244; Domin J, 2005, J CELL PHYSIOL, V205, P452, DOI 10.1002/jcp.20478; Domin J, 2000, J BIOL CHEM, V275, P11943, DOI 10.1074/jbc.275.16.11943; Du W, 2010, CANCER RES, V70, P772, DOI 10.1158/0008-5472.CAN-09-2722; Eccles Suzanne A., 2009, V467, P159, DOI 10.1007/978-1-59745-241-0_9; El Sheikh Soha Salama, 2003, BMC Clin Pathol, V3, P4, DOI 10.1186/1472-6890-3-4; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Falasca M, 2012, BIOCHEM J, V443, P587, DOI 10.1042/BJ20120008; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Gaidarov I, 2005, J BIOL CHEM, V280, P40766, DOI 10.1074/jbc.M507731200; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Igarashi J, 2001, J BIOL CHEM, V276, P36281, DOI 10.1074/jbc.M105628200; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015; Katso RM, 2006, MOL BIOL CELL, V17, P3729, DOI 10.1091/mbc.E05-11-1083; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Lee JF, 2009, AM J PHYSIOL-HEART C, V296, pH33, DOI 10.1152/ajpheart.00097.2008; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Mazza Simona, 2011, Int J Biochem Mol Biol, V2, P168; Means CK, 2009, CARDIOVASC RES, V82, P193, DOI 10.1093/cvr/cvp086; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Okamoto H, 2000, MOL CELL BIOL, V20, P9247, DOI 10.1128/MCB.20.24.9247-9261.2000; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Ryu Y, 2002, CIRC RES, V90, P325, DOI 10.1161/hh0302.104455; Sakurada S, 2001, AM J PHYSIOL-CELL PH, V281, pC571, DOI 10.1152/ajpcell.2001.281.2.C571; Sasaki J, 2005, J EXP MED, V201, P859, DOI 10.1084/jem.20041891; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Sasaki T, 2009, PROG LIPID RES, V48, P307, DOI 10.1016/j.plipres.2009.06.001; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Sugimoto N, 2003, MOL CELL BIOL, V23, P1534, DOI 10.1128/MCB.23.5.1534-1545.2003; Takuwa Y, 2012, BIOFACTORS, V38, P329, DOI 10.1002/biof.1030; Usui S, 2004, J BIOL CHEM, V279, P12300, DOI 10.1074/jbc.M305025200; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Wang Y, 2006, BIOCHEM J, V394, P581, DOI 10.1042/BJ20051471; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yoshioka K, 2012, NAT MED, V18, P1560, DOI 10.1038/nm.2928; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	64	41	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2325	2339		10.1074/jbc.M112.409656	http://dx.doi.org/10.1074/jbc.M112.409656			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23192342	Green Published, hybrid			2022-12-28	WOS:000314211500022
J	Bruns, AM; Pollpeter, D; Hadizadeh, N; Myong, S; Marko, JF; Horvath, CM				Bruns, Annie M.; Pollpeter, Darja; Hadizadeh, Nastaran; Myong, Sua; Marko, John F.; Horvath, Curt M.			ATP Hydrolysis Enhances RNA Recognition and Antiviral Signal Transduction by the Innate Immune Sensor, Laboratory of Genetics and Physiology 2 (LGP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIG-I; STRUCTURAL BASIS; HELICASE; ACTIVATION; MDA5	Laboratory of genetics and physiology 2 (LGP2) is a member of the RIG-I-like receptor family of cytoplasmic pattern recognition receptors that detect molecular signatures of virus infection and initiate antiviral signal transduction cascades. The ATP hydrolysis activity of LGP2 is essential for antiviral signaling, but it has been unclear how the enzymatic properties of LGP2 regulate its biological response. Quantitative analysis of the dsRNA binding and enzymatic activities of LGP2 revealed high dsRNA-independent ATP hydrolysis activity. Biochemical assays and single-molecule analysis of LGP2 and mutant variants that dissociate basal from dsRNA-stimulated ATP hydrolysis demonstrate that LGP2 utilizes basal ATP hydrolysis to enhance and diversify its RNA recognition capacity, enabling the protein to associate with intrinsically poor substrates. This property is required for LGP2 to synergize with another RIG-I-like receptor, MDA5, to potentiate IFN beta transcription in vivo during infection with encephalomyocarditis virus or transfection with poly(I: C). These results demonstrate previously unrecognized properties of LGP2 ATP hydrolysis and RNA interaction and provide a mechanistic basis for a positive regulatory role for LGP2 in antiviral signaling.	[Bruns, Annie M.; Pollpeter, Darja; Marko, John F.; Horvath, Curt M.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Hadizadeh, Nastaran; Marko, John F.] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA; [Myong, Sua] Univ Illinois, Inst Genom Biol, Champaign, IL 61801 USA	Northwestern University; Northwestern University; University of Illinois System; University of Illinois Urbana-Champaign	Horvath, CM (corresponding author), Pancoe Pavil,Rm 4401,2200 Campus Dr, Evanston, IL 60208 USA.	horvath@northwestern.edu	Marko, John F./AAY-7111-2021	Marko, John F./0000-0003-4151-9530; Horvath, Curt/0000-0003-2449-225X	National Institutes of Health [R01AI073919, U01AI082984]; NU-PS-OC [1U54CA143869-01]; National Science Foundation [MCB-1022117]; Immune Mechanisms of Virus Control Pilot Award; National Institutes of Health Cellular and Molecular Basis of Disease Training Grant [T32GM008061]; Div Of Molecular and Cellular Bioscience [1022117] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [U54CA143869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073919, U01AI082984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NU-PS-OC; National Science Foundation(National Science Foundation (NSF)); Immune Mechanisms of Virus Control Pilot Award; National Institutes of Health Cellular and Molecular Basis of Disease Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI073919 and U01AI082984 (to C. M. H.) and 1U54CA143869-01 (NU-PS-OC) and National Science Foundation Grant MCB-1022117 (to J. M.), and an Immune Mechanisms of Virus Control Pilot Award (to C. M. H. and S. M.).; Supported in part by a predoctoral fellowship from the National Institutes of Health Cellular and Molecular Basis of Disease Training Grant T32GM008061.	Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruns AM, 2012, CRIT REV BIOCHEM MOL, V47, P194, DOI 10.3109/10409238.2011.630974; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Gitlin L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000734; Hwang H, 2011, P NATL ACAD SCI USA, V108, P7414, DOI 10.1073/pnas.1017672108; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Moresco EMY, 2010, P NATL ACAD SCI USA, V107, P1261, DOI 10.1073/pnas.0914011107; Myong S, 2010, CURR OPIN STRUC BIOL, V20, P121, DOI 10.1016/j.sbi.2009.12.008; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Parisien JP, 2009, J VIROL, V83, P7252, DOI 10.1128/JVI.00153-09; Pollpeter D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018842; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schmidt A, 2012, EUR J CELL BIOL, V91, P78, DOI 10.1016/j.ejcb.2011.01.015; Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	27	66	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					938	946		10.1074/jbc.M112.424416	http://dx.doi.org/10.1074/jbc.M112.424416			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184951	Green Published, hybrid			2022-12-28	WOS:000313570300018
J	Chandrashekarappa, DG; McCartney, RR; Schmidt, MC				Chandrashekarappa, Dakshayini G.; McCartney, Rhonda R.; Schmidt, Martin C.			Ligand Binding to the AMP-activated Protein Kinase Active Site Mediates Protection of the Activation Loop from Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SNF1 KINASE; REGULATES TRANSCRIPTION; CONFORMATIONAL-CHANGES; STRUCTURAL INSIGHT; CRYSTAL-STRUCTURE; SUBUNIT; YEAST; PHOSPHORYLATION; GLUCOSE	The AMP-activated protein kinase (AMPK) is a conserved signaling molecule in a pathway that maintains adenosine triphosphate homeostasis. Recent studies have suggested that low energy adenylate ligands bound to one or more sites in the gamma subunit of AMPK promote the formation of an active, phosphatase-resistant conformation. We propose an alternative model in which the kinase domain association with the heterotrimer core results in activation of the kinase catalytic activity, whereas low energy adenylate ligands bound in the kinase active site promote phosphatase resistance. Purified Snf1 alpha subunit with a conservative, single amino acid substitution in the kinase domain is protected from dephosphorylation by adenosine diphosphate in the complete absence of the beta and gamma subunits. Staurosporine, a compound known to bind to the active site of many protein kinases, mediates strong protection from dephosphorylation to yeast and mammalian AMPK enzymes. The analog-sensitive Snf1-I132G protein but not wild type Snf1 exhibits protection from dephosphorylation when bound by the adenosine analog 2NM-PP1 in vitro and in vivo. These data demonstrate that ligand binding to the Snf1 active site can mediate phosphatase resistance. Finally, Snf1 kinase with an amino acid substitution at the interface of the kinase domain and the heterotrimer core exhibits normal regulation of phosphorylation in vivo but greatly reduced Snf1 kinase activity, supporting a model in which kinase domain association with the heterotrimer core is needed for kinase activation.	[Chandrashekarappa, Dakshayini G.; McCartney, Rhonda R.; Schmidt, Martin C.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schmidt, MC (corresponding author), Dept Microbiol & Mol Genet, 450 Technol Dr, Pittsburgh, PA 15219 USA.	mcs2@pitt.edu			National Institutes of Health [GM46443]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046443, R01GM046443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46443.	Alepuz PM, 1997, MOL MICROBIOL, V26, P91, DOI 10.1046/j.1365-2958.1997.5531917.x; Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Barrett L, 2012, EUKARYOT CELL, V11, P119, DOI 10.1128/EC.05061-11; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Castermans D, 2012, CELL RES, V22, P1058, DOI 10.1038/cr.2012.20; Chan TO, 2011, P NATL ACAD SCI USA, V108, pE1120, DOI 10.1073/pnas.1109879108; Chandrashekarappa DG, 2011, J BIOL CHEM, V286, P44532, DOI 10.1074/jbc.M111.315895; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; DAVIES SP, 1994, EUR J BIOCHEM, V223, P351, DOI 10.1111/j.1432-1033.1994.tb19001.x; Elbing K, 2006, J BIOL CHEM, V281, P26170, DOI 10.1074/jbc.M603811200; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Jin XS, 2007, STRUCTURE, V15, P1285, DOI 10.1016/j.str.2007.07.017; Kemp BE, 2007, STRUCTURE, V15, P1161, DOI 10.1016/j.str.2007.09.006; Keshwani MM, 2008, J BIOL CHEM, V283, P11972, DOI 10.1074/jbc.M800114200; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; Leech A, 2003, EUKARYOT CELL, V2, P265, DOI 10.1128/EC.2.2.265-273.2003; Lin K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002618; Littler DR, 2010, ACTA CRYSTALLOGR F, V66, P143, DOI 10.1107/S1744309109052543; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; MEGGIO F, 1995, EUR J BIOCHEM, V234, P317, DOI 10.1111/j.1432-1033.1995.317_c.x; Momcilovic M, 2011, J BIOL CHEM, V286, P23544, DOI 10.1074/jbc.M111.244111; Murray BW, 2001, BIOCHEMISTRY-US, V40, P10243, DOI 10.1021/bi010959e; Nath N, 2002, J BIOL CHEM, V277, P50403, DOI 10.1074/jbc.M207058200; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Oakhill JS, 2009, ACTA PHYSIOL, V196, P3, DOI 10.1111/j.1748-1716.2009.01977.x; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Orlova M, 2008, YEAST, V25, P745, DOI 10.1002/yea.1628; Prade L, 1997, STRUCTURE, V5, P1627, DOI 10.1016/S0969-2126(97)00310-9; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rubenstein EM, 2008, J BIOL CHEM, V283, P222, DOI 10.1074/jbc.M707957200; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Ruiz A, 2012, P NATL ACAD SCI USA, V109, P8652, DOI 10.1073/pnas.1206280109; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shaffer J, 2001, BIOCHEMISTRY-US, V40, P11149, DOI 10.1021/bi011029y; Shirra MK, 2008, J BIOL CHEM, V283, P35889, DOI 10.1074/jbc.M805325200; Smith FC, 1999, FEBS LETT, V453, P219, DOI 10.1016/S0014-5793(99)00725-5; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; WOODS A, 1994, J BIOL CHEM, V269, P19509; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Young ET, 2012, J BIOL CHEM, V287, P29021, DOI 10.1074/jbc.M112.380147; Zaman S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.2; Zhou J, 1997, BIOCHEMISTRY-US, V36, P15733, DOI 10.1021/bi971438n; [No title captured]	51	25	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					89	98		10.1074/jbc.M112.422659	http://dx.doi.org/10.1074/jbc.M112.422659			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23184934	hybrid, Green Published			2022-12-28	WOS:000313197200009
J	Lauer, ME; Cheng, G; Swaidani, S; Aronica, MA; Weigel, PH; Hascall, VC				Lauer, Mark E.; Cheng, Georgiana; Swaidani, Shadi; Aronica, Mark A.; Weigel, Paul H.; Hascall, Vincent C.			Tumor Necrosis Factor-stimulated Gene-6 (TSG-6) Amplifies Hyaluronan Synthesis by Airway Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TRYPSIN INHIBITOR; HEAVY-CHAIN; PROTEIN; SHAP; COMPLEX; SERUM; INFLAMMATION; ARTHRITIS; MATRIX; MODEL	We tested the hypothesis that the artificial addition of heavy chains from inter-alpha-inhibitor to hyaluronan (HA), by adding recombinant TSG-6 (TNF-stimulated gene-6) to the culture medium of murine airway smooth muscle (MASM) cells, would enhance leukocyte binding to HA cables produced in response to poly(I: C). As predicted, the addition of heavy chains to HA cables enhanced leukocyte adhesion to these cables, but it also had several unexpected effects. (i) It produced thicker, more pronounced HA cables. (ii) It increased the accumulation of HA in the cell-associated matrix. (iii) It decreased the amount of HA in the conditioned medium. Importantly, these effects were observed only when TSG-6 was administered in the presence of poly(I: C), and TSG-6 did not exert any effect on its own. Increased HA synthesis occurred during active, poly(I:C)-induced HA synthesis and did not occur when TSG-6 was added after poly(I:C)-induced HA synthesis was complete. MASM cells derived from TSG-6(-/-), HAS1/3(-/-), and CD44(-/-) mice amplified HA synthesis in response to poly(I: C) + TSG-6 in a manner similar to WT MASM cells, demonstrating that they are expendable in this process. We conclude that TSG-6 increases the accumulation of HA in the cell-associated matrix, partially by preventing its dissolution from the cell-associated matrix into the conditioned medium, but primarily by inducing HA synthesis.	[Lauer, Mark E.; Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Cheng, Georgiana; Swaidani, Shadi; Aronica, Mark A.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA; [Swaidani, Shadi] Cleveland Clin, Dept Immunol, Cleveland, OH 44195 USA; [Aronica, Mark A.] Cleveland Clin, Resp Inst, Cleveland, OH 44195 USA; [Weigel, Paul H.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Lauer, ME (corresponding author), Cleveland Clin, Dept Biomed Engn, ND20, Cleveland, OH 44195 USA.	lauerm1@ccf.org			National Institutes of Health from NHLBI [P11 HL081064, P01 HL107147]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147, P01HL103453, P01HL081064] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P11 HL081064 and P01 HL107147 from NHLBI.	Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139; Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Cheng G, 2011, MATRIX BIOL, V30, P126, DOI 10.1016/j.matbio.2010.12.003; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fries E, 2003, ACTA BIOCHIM POL, V50, P735; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; HUANG L, 1993, J BIOL CHEM, V268, P26725; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kida D, 1999, J RHEUMATOL, V26, P1230; Kishida T, 2008, CONNECT TISSUE RES, V49, P105, DOI 10.1080/03008200701818629; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; Lauer ME, 2008, J BIOL CHEM, V283, P26283, DOI 10.1074/jbc.M803350200; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; Leigh DR, 2012, J ORTHOP RES, V30, P1725, DOI 10.1002/jor.22149; Mack JA, 2012, J INVEST DERMATOL, V132, P198, DOI 10.1038/jid.2011.248; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Obayashi Y, 2008, ONCOL REP, V19, P1245; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; Shen L, 2006, HEPATOL RES, V34, P178, DOI 10.1016/j.hepres.2005.12.008; Stoop R, 2001, ARTHRITIS RHEUM, V44, P2922, DOI 10.1002/1529-0131(200112)44:12<2922::AID-ART480>3.0.CO;2-7; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	31	35	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					423	431		10.1074/jbc.M112.389882	http://dx.doi.org/10.1074/jbc.M112.389882			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23129777	Green Published, hybrid			2022-12-28	WOS:000313197200043
J	Andre, P; Wang, QY; Wang, N; Gao, B; Schilit, A; Halford, MM; Stacker, SA; Zhang, XM; Yang, YZ				Andre, Philipp; Wang, Qianyi; Wang, Na; Gao, Bo; Schilit, Arielle; Halford, Michael M.; Stacker, Steven A.; Zhang, Xuemin; Yang, Yingzi			The Wnt Coreceptor Ryk Regulates Wnt/Planar Cell Polarity by Modulating the Degradation of the Core Planar Cell Polarity Component Vangl2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; NEURAL-TUBE DEFECTS; CONVERGENT EXTENSION MOVEMENTS; RECESSIVE ROBINOW-SYNDROME; BRACHYDACTYLY TYPE-B; ZEBRAFISH GASTRULATION; AXON GUIDANCE; HAIR-CELLS; PATHWAY; ROR2	The Wnt signaling pathways control many critical developmental and adult physiological processes. In vertebrates, one fundamentally important function of Wnts is to provide directional information by regulating the evolutionarily conserved planar cell polarity (PCP) pathway during embryonic morphogenesis. However, despite the critical roles of Wnts and PCP in vertebrate development and disease, little is known about the molecular mechanisms underlying Wnt regulation of PCP. Here, we have found that the receptor-like tyrosine kinase (Ryk), a Wnt5a-binding protein required in axon guidance, regulates PCP signaling. We show that Ryk interacts with Vangl2 genetically and biochemically, and such interaction is potentiated by Wnt5a. Loss of Ryk in a Vangl2(+/-) background results in classic PCP defects, including open neural tube, misalignment of sensory hair cells in the inner ear, and shortened long bones in the limbs. Complete loss of both Ryk and Vangl2 results in more severe phenotypes that resemble the Wnt5a(-/-) mutant in many aspects such as shortened anterior-posterior body axis, limb, and frontonasal process. Our data identify the Wnt5a-binding protein Ryk as a general regulator of the mammalian Wnt/PCP signaling pathway. We show that Ryk transduces Wnt5a signaling by forming a complex with Vangl2 and that Ryk regulates PCP by at least in part promoting Vangl2 stability. As human mutations in WNT5A and VANGL2 are found to cause Robinow syndrome and neural tube defects, respectively, our results further suggest that human mutations in RYK may also be involved in these diseases.	[Andre, Philipp; Gao, Bo; Schilit, Arielle; Yang, Yingzi] NHGRI, Genet Dis Res Branch, Bethesda, MD 20892 USA; [Wang, Qianyi; Wang, Na; Zhang, Xuemin] China Natl Ctr Biomed Anal, Inst Basic Med Sci, State Key Lab Prote, Beijing 100850, Peoples R China; [Halford, Michael M.; Stacker, Steven A.] Peter MacCallum Canc Ctr, Tumour Angiogenesis Program, Melbourne, Vic 3002, Australia; [Stacker, Steven A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne	Yang, YZ (corresponding author), NHGRI, Genet Dis Res Branch, 49 Convent Dr,MSC 4472, Bethesda, MD 20892 USA.	yingzi@mail.nih.gov		Stacker, Steven/0000-0003-4096-9273; Gao, Bo/0000-0002-8684-5199	intramural research program of National Human Genome Research Institute; National Health and Medical Research Council of Australia; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000187] Funding Source: NIH RePORTER	intramural research program of National Human Genome Research Institute; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the intramural research program of National Human Genome Research Institute and by the National Health and Medical Research Council of Australia.	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; DURA JM, 1995, FEBS LETT, V370, P250, DOI 10.1016/0014-5793(95)00847-3; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; Hashimoto M, 2010, NAT CELL BIOL, V12, P170, DOI 10.1038/ncb2020; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Lei Y, 2010, NEW ENGL J MED, V362, P2232, DOI 10.1056/NEJMc0910820; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Macheda ML, 2012, J BIOL CHEM, V287, P29312, DOI 10.1074/jbc.M112.362681; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; McNeill H, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003376; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Schwabe GC, 2000, AM J HUM GENET, V67, P822, DOI 10.1086/303084; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shafer B, 2011, DEV CELL, V20, P177, DOI 10.1016/j.devcel.2011.01.002; Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129; Tada M, 2000, DEVELOPMENT, V127, P2227; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	45	83	85	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44518	44525		10.1074/jbc.M112.414441	http://dx.doi.org/10.1074/jbc.M112.414441			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144463	Green Published, hybrid			2022-12-28	WOS:000312938600048
J	Elantak, L; Espeli, M; Boned, A; Bornet, O; Bonzi, J; Gauthier, L; Feracci, M; Roche, P; Guerlesquin, F; Schiff, C				Elantak, Latifa; Espeli, Marion; Boned, Annie; Bornet, Olivier; Bonzi, Jeremy; Gauthier, Laurent; Feracci, Mikael; Roche, Philippe; Guerlesquin, Francoise; Schiff, Claudine			Structural Basis for Galectin-1-dependent Pre-B Cell Receptor (Pre-BCR) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE BONE-MARROW; STROMAL CELLS; PROTEIN; BINDING; LAMBDA-5; ANGIOGENESIS; REPERTOIRE; REVEALS; ANGINEX; PEPTIDE	During B cell differentiation in the bone marrow, the expression and activation of the pre-B cell receptor (pre-BCR) constitute crucial checkpoints for B cell development. Both constitutive and ligand-dependent pre-BCR activation modes have been described. The pre-BCR constitutes an immunoglobulin heavy chain (Ig mu) and a surrogate light chain composed of the invariant lambda 5 and VpreB proteins. We previously showed that galectin-1 (GAL1), produced by bone marrow stromal cells, is a pre-BCR ligand that induces receptor clustering, leading to efficient pre-BII cell proliferation and differentiation. GAL1 interacts with the pre-BCR via the unique region of lambda 5 (lambda 5-UR). Here, we investigated the solution structure of a minimal lambda 5-UR motif that interacts with GAL1. This motif adopts a stable helical conformation that docks onto a GAL1 hydrophobic surface adjacent to its carbohydrate binding site. We identified key hydrophobic residues from the lambda 5-UR as crucial for the interaction with GAL1 and for pre-BCR clustering. These residues involved in GAL1-induced pre-BCR activation are different from those essential for autonomous receptor activation. Overall, our results indicate that constitutive and ligand-induced pre-BCR activation could occur in a complementary manner.	[Elantak, Latifa; Bonzi, Jeremy; Guerlesquin, Francoise] Aix Marseille Univ, CNRS UMR7255, Lab Ingn Syst Macromol, F-13402 Marseille 20, France; [Espeli, Marion; Boned, Annie; Schiff, Claudine] Aix Marseille Univ, UM2, INSERM U1104, Ctr Immunol Marseille Luminy,CNRS UMR7280, F-13288 Marseille 09, France; [Bornet, Olivier] Inst Microbiol Mediterranee, FR 3479, F-13402 Marseille 20, France; [Gauthier, Laurent] Innate Pharma, F-13276 Marseille, France; [Feracci, Mikael] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Roche, Philippe] Aix Marseille Univ, Inst J Paoli I Calmettes, CNRS UMR7258, Lab Integrat Struct & Chem Biol,INSERM U1068, F-13273 Marseille 09, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; University of Leicester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Guerlesquin, F (corresponding author), Aix Marseille Univ, CNRS UMR7255, Lab Ingn Syst Macromol, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	guerlesquin@imm.cnrs.fr; schiff@ciml.univ-mrs.fr	Espeli, Marion/AAH-4483-2021; ELANTAK, Latifa/S-7004-2019; ROCHE, Philippe/E-5661-2010	Espeli, Marion/0000-0001-5005-1664; ROCHE, Philippe/0000-0002-5580-0588	Agence Nationale de la Recherche [ANR-05-BLAN-0035-01]; ARC; INSERM; CNRS; Fondation pour la Recherche Medicale; WeNMR Project European FP7 e-Infrastructure grant [261572]	Agence Nationale de la Recherche(French National Research Agency (ANR)); ARC(Australian Research Council); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); WeNMR Project European FP7 e-Infrastructure grant	This work was supported by grants from the Agence Nationale de la Recherche (ANR-05-BLAN-0035-01), ARC (to M. E.), INSERM, and CNRS and the Fondation pour la Recherche Medicale (to L. E.), the WeNMR Project European FP7 e-Infrastructure grant, Contract 261572, for the use of Web portals, computing, and storage facilities.	Bankovich AJ, 2007, SCIENCE, V316, P291, DOI 10.1126/science.1139412; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Bradl H, 2003, J IMMUNOL, V171, P2338, DOI 10.4049/jimmunol.171.5.2338; Camby I, 2002, J NEUROPATH EXP NEUR, V61, P585, DOI 10.1093/jnen/61.7.585; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Dings RPM, 2012, J MED CHEM, V55, P5121, DOI 10.1021/jm300014q; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Espeli M, 2009, BLOOD, V113, P5878, DOI 10.1182/blood-2009-01-198465; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; Griffioen AW, 2001, BIOCHEM J, V354, P233, DOI 10.1042/0264-6021:3540233; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; JOUBERT R, 1992, J NEUROCHEM, V58, P200, DOI 10.1111/j.1471-4159.1992.tb09296.x; Keenan RA, 2008, SCIENCE, V321, P696, DOI 10.1126/science.1157533; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Knoll M, 2012, J IMMUNOL, V188, P6010, DOI 10.4049/jimmunol.1200071; Lanig H, 2004, MOL IMMUNOL, V40, P1263, DOI 10.1016/j.molimm.2003.11.030; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lopez-Lucendo MF, 2004, J MOL BIOL, V343, P957, DOI 10.1016/j.jmb.2004.08.078; Meixlsperger S, 2007, IMMUNITY, V26, P323, DOI 10.1016/j.immuni.2007.01.012; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Mourcin F, 2011, BLOOD, V117, P6552, DOI 10.1182/blood-2010-12-323113; Nesmelova IV, 2010, J MOL BIOL, V397, P1209, DOI 10.1016/j.jmb.2010.02.033; Nesmelova IV, 2008, BIOMOL NMR ASSIGN, V2, P203, DOI 10.1007/s12104-008-9121-9; Ohnishi K, 2003, NAT IMMUNOL, V4, P849, DOI 10.1038/ni959; Pace KE, 2003, METHOD ENZYMOL, V363, P499; Park JW, 2001, NUCLEIC ACIDS RES, V29, P3595, DOI 10.1093/nar/29.17.3595; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; PEARLMAN DA, 1995, J MOL BIOL, V248, P696, DOI 10.1006/jmbi.1995.0252; Rossi B, 2006, J IMMUNOL, V177, P796, DOI 10.4049/jimmunol.177.2.796; Rotblat B, 2004, CANCER RES, V64, P3112, DOI 10.1158/0008-5472.CAN-04-0026; tenBoekel E, 1997, IMMUNITY, V7, P357; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; van der Schaft DWJ, 2002, FASEB J, V16, P1991, DOI 10.1096/fj.02-0509fje; Vyakarnam A, 1997, MOL CELL BIOL, V17, P4730, DOI 10.1128/MCB.17.8.4730	35	37	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44703	44713		10.1074/jbc.M112.395152	http://dx.doi.org/10.1074/jbc.M112.395152			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23124203	Green Published, hybrid			2022-12-28	WOS:000312938600066
J	Trujillo, CA; Negraes, PD; Schwindt, TT; Lameu, C; Carromeu, C; Muotri, AR; Pesquero, JB; Cerqueira, DM; Pillat, MM; de Souza, HDN; Turaca, LT; Abreu, JG; Ulrich, H				Trujillo, Cleber A.; Negraes, Priscilla D.; Schwindt, Telma T.; Lameu, Claudiana; Carromeu, Cassiano; Muotri, Alysson R.; Pesquero, Joao B.; Cerqueira, Debora M.; Pillat, Micheli M.; de Souza, Hellio D. N.; Turaca, Lauro T.; Abreu, Jose G.; Ulrich, Henning			Kinin-B2 Receptor Activity Determines the Differentiation Fate of Neural Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; NEURONAL DIFFERENTIATION; SUBVENTRICULAR ZONE; ISCHEMIC-STROKE; MESSENGER-RNA; BRADYKININ; ADULT; NEUROGENESIS; EXPRESSION; MIGRATION	Bradykinin is not only important for inflammation and blood pressure regulation, but also involved in neuromodulation and neuroprotection. Here we describe novel functions for bradykinin and the kinin-B2 receptor (B2BkR) in differentiation of neural stem cells. In the presence of the B2BkR antagonist HOE-140 during rat neurosphere differentiation, neuron-specific beta 3-tubulin and enolase expression was reduced together with an increase in glial protein expression, indicating that bradykinin- induced receptor activity contributes to neurogenesis. In agreement, HOE-140 affected in the same way expression levels of neural markers during neural differentiation of murine P19 and human iPS cells. Kinin-B1 receptor agonists and antagonists did not affect expression levels of neural markers, suggesting that bradykinin-mediated effects are exclusively mediated via B2BkR. Neurogenesis was augmented by bradykinin in the middle and late stages of the differentiation process. Chronic treatment with HOE-140 diminished eNOS and nNOS as well as M1-M4 muscarinic receptor expression and also affected purinergic receptor expression and activity. Neurogenesis, gliogenesis, and neural migration were altered during differentiation of neurospheres isolated from B2BkR knock-out mice. Whole mount in situ hybridization revealed the presence of B2BkR mRNA throughout the nervous system in mouse embryos, and less beta 3-tubulin and more glial proteins were expressed in developing and adult B2BkR knock-out mice brains. As a underlying transcriptional mechanism for neural fate determination, HOE-140 induced up-regulation of Notch1 and Stat3 gene expression. Because pharmacological treatments did not affect cell viability and proliferation, we conclude that bradykinin-induced signaling provides a switch for neural fate determination and specification of neurotransmitter receptor expression.	[Trujillo, Cleber A.; Negraes, Priscilla D.; Schwindt, Telma T.; Lameu, Claudiana; Pillat, Micheli M.; de Souza, Hellio D. N.; Ulrich, Henning] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508000 Sao Paulo, Brazil; [Carromeu, Cassiano; Muotri, Alysson R.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92093 USA; [Carromeu, Cassiano; Muotri, Alysson R.] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92093 USA; [Pesquero, Joao B.; Turaca, Lauro T.] Univ Fed Sao Paulo, Dept Biofis, BR-04023062 Sao Paulo, Brazil; [Cerqueira, Debora M.; Abreu, Jose G.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, Brazil	Universidade de Sao Paulo; University of California System; University of California San Diego; University of California System; University of California San Diego; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro	Ulrich, H (corresponding author), Av Prof Lineu Prestes 748, BR-05508900 Sao Paulo, Brazil.	henning@iq.usp.br	Pillat, Micheli/AAW-3423-2020; Ulrich, Henning/C-5245-2013; Cerqueira, Debora Malta/CAF-4323-2022; Neurociencia, Inct/I-1011-2013; Cerqueira, Debora Malta/AAB-6204-2020; Abreu, Jose G/ABB-1199-2021; Ulrich, Henning/AAX-8586-2021; Carromeu, Cassiano/B-1487-2014; Lameu, Claudiana/B-9089-2012; Abreu, Jose G/G-6159-2010	Pillat, Micheli/0000-0002-6753-6083; Ulrich, Henning/0000-0002-2114-3815; Abreu, Jose G/0000-0002-1363-1755; Ulrich, Henning/0000-0002-2114-3815; Lameu, Claudiana/0000-0002-6874-5864; Abreu, Jose G/0000-0002-9875-7786; Carromeu, Cassiano/0000-0002-7570-2213; Turaca, Lauro/0000-0001-6001-4306; Malta Cerqueira Sant'Anna Santos, Debora/0000-0001-9773-4606	National Institutes of Health [1-DP2-OD006495-01]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/61285-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Provost's Office for Research of the University of Sao Paulo Programa de Incentivo a Pesquisa [2011.1.9333.1.3]; NAPNA-USP, Brazil; International Rett Syndrome Foundation [2517]; Emerald Foundation; California Institute for Regenerative Medicine Grant [TR2-01814]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Provost's Office for Research of the University of Sao Paulo Programa de Incentivo a Pesquisa; NAPNA-USP, Brazil; International Rett Syndrome Foundation; Emerald Foundation; California Institute for Regenerative Medicine Grant(California Institute for Regenerative Medicine); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Director's New Innovator Award Program Grant 1-DP2-OD006495-01 (to A. R. M.), research grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (number 2006/61285-9), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and the Provost's Office for Research of the University of Sao Paulo Programa de Incentivo a Pesquisa, Project numbers 2011.1.9333.1.3 and NAPNA-USP, Brazil (to H. U.).; Supported by a fellowship from the International Rett Syndrome Foundation, 2517.; Supported by the Emerald Foundation and the California Institute for Regenerative Medicine Grant TR2-01814.; Supported by a fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).; Supported by a fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	Bayer S.A., 1991, NEOCORTICAL DEV; Bertram CM, 2007, J LEUKOCYTE BIOL, V81, P1445, DOI 10.1189/jlb.0106055; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; BORKOWSKI JA, 1995, J BIOL CHEM, V270, P13706, DOI 10.1074/jbc.270.23.13706; Bortone F, 2008, INT IMMUNOPHARMACOL, V8, P206, DOI 10.1016/j.intimp.2007.09.004; Burnstock G, 2011, CELL MOL LIFE SCI, V68, P1369, DOI 10.1007/s00018-010-0614-1; BUSH AB, 1991, J NEUROCHEM, V57, P562, DOI 10.1111/j.1471-4159.1991.tb03787.x; Buznikov GA, 1996, CELL MOL NEUROBIOL, V16, P533, DOI 10.1007/BF02152056; Calixto JB, 2000, PAIN, V87, P1, DOI 10.1016/S0304-3959(00)00335-3; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.3.CO;2-E; Campbell K, 2005, NEURON, V46, P373, DOI 10.1016/j.neuron.2005.04.014; Cardenas A, 2005, BRAIN RES REV, V50, P1, DOI 10.1016/j.brainresrev.2005.03.006; Covacu R, 2006, STEM CELLS, V24, P2792, DOI 10.1634/stemcells.2005-0640; Estrada C, 2005, NEUROSCIENTIST, V11, P294, DOI 10.1177/1073858404273850; Eurin J, 2002, NEUROPEPTIDES, V36, P257, DOI 10.1016/S0143-4179(02)00025-2; Foshay KM, 2008, STEM CELLS DEV, V17, P269, DOI 10.1089/scd.2007.0098; Franca CE, 2010, GENET MOL RES, V9, P215, DOI 10.4238/vol9-1gmr681; Gallego MJ, 2009, STEM CELLS DEV, V18, P737, DOI 10.1089/scd.2008.0190; Ghashghaei HT, 2007, NAT REV NEUROSCI, V8, P141, DOI 10.1038/nrn2074; Gibbs SM, 2003, MOL NEUROBIOL, V27, P107, DOI 10.1385/MN:27:2:107; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Hagg T, 2005, TRENDS NEUROSCI, V28, P589, DOI 10.1016/j.tins.2005.08.009; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Kansui Y, 2002, HYPERTENSION, V39, P29, DOI 10.1161/hy0102.098309; KOZLOWSKI MR, 1989, PEPTIDES, V10, P1121, DOI 10.1016/0196-9781(89)90002-8; Lakner AM, 2010, WORLD J GASTROENTERO, V16, P5047, DOI 10.3748/wjg.v16.i40.5047; Lameu C, 2012, J BIOL CHEM, V287, P29690, DOI 10.1074/jbc.M111.338095; Lin JHC, 2007, DEV BIOL, V302, P356, DOI 10.1016/j.ydbio.2006.09.017; Ling L, 2008, BRAIN RES, V1206, P89, DOI 10.1016/j.brainres.2008.01.099; LORENZON P, 1995, J CELL BIOL, V129, P797, DOI 10.1083/jcb.129.3.797; Lu DY, 2010, J CELL BIOCHEM, V110, P141, DOI 10.1002/jcb.22520; Lugo-Garcia L, 2007, EUR J PHARMACOL, V568, P54, DOI 10.1016/j.ejphar.2007.04.012; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Madeddu P, 2007, NAT CLIN PRACT NEPHR, V3, P208, DOI 10.1038/ncpneph0444; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Martins AHB, 2005, J BIOL CHEM, V280, P19576, DOI 10.1074/jbc.M502513200; Martins AH, 2008, CYTOM PART A, V73A, P361, DOI 10.1002/cyto.a.20519; Martins AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030755; McLaren FH, 2001, J NEUROIMMUNOL, V112, P35, DOI 10.1016/S0165-5728(00)00410-0; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nitsch RM, 1998, NEUROCHEM RES, V23, P807, DOI 10.1023/A:1022423813362; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328; PURKISS J, 1991, J NEUROCHEM, V57, P1084, DOI 10.1111/j.1471-4159.1991.tb08262.x; Racchi M, 1998, BIOCHEM J, V330, P1271, DOI 10.1042/bj3301271; Raidoo DM, 1998, PHARMACOL THERAPEUT, V79, P105, DOI 10.1016/S0163-7258(98)00011-4; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Reber BFX, 1996, PFLUG ARCH EUR J PHY, V432, P893, DOI 10.1007/s004240050213; Resende RR, 2008, INT J DEV NEUROSCI, V26, P763, DOI 10.1016/j.ijdevneu.2008.07.008; Resende RR, 2008, EXP CELL RES, V314, P1429, DOI 10.1016/j.yexcr.2008.01.003; Sainz IM, 2007, THROMB HAEMOSTASIS, V98, P77, DOI 10.1160/Th07-04-0250; Scemes E, 2003, J NEUROSCI, V23, P11444; Schwindt TT, 2011, J MOL NEUROSCI, V44, P141, DOI 10.1007/s12031-010-9417-y; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Ueno S, 2002, BRAIN RES PROTOC, V10, P95, DOI 10.1016/S1385-299X(02)00187-3; Ulrich H., 2011, CURR PROTOC STEM CEL, V2, p2D9; Ulrich H, 2012, STEM CELL REV REP, V8, P755, DOI 10.1007/s12015-012-9372-9; WALKER K, 1995, NEUROCHEM INT, V26, P1, DOI 10.1016/0197-0186(94)00114-A; Wang HB, 2005, J NEUROSCI, V25, P7986, DOI 10.1523/JNEUROSCI.2393-05.2005; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Xia CF, 2006, HUM GENE THER, V17, P206, DOI 10.1089/hum.2006.17.206; Xia CF, 2004, HYPERTENSION, V43, P452, DOI 10.1161/01.HYP.0000110905.29389.e5; Yang WH, 2010, J CELL BIOCHEM, V109, P82, DOI 10.1002/jcb.22383; Zheng H, 2010, J NEUROSCI, V30, P8102, DOI 10.1523/JNEUROSCI.6069-09.2010	71	35	35	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44046	44061		10.1074/jbc.M112.407197	http://dx.doi.org/10.1074/jbc.M112.407197			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23132855	hybrid, Green Published			2022-12-28	WOS:000312938600004
J	Davalos, V; Suarez-Lopez, L; Castano, J; Messent, A; Abasolo, I; Fernandez, Y; Guerra-Moreno, A; Espin, E; Armengol, M; Musulen, E; Ariza, A; Sayos, J; Arango, D; Schwartz, S				Davalos, Veronica; Suarez-Lopez, Lucia; Castano, Julio; Messent, Anthea; Abasolo, Ibane; Fernandez, Yolanda; Guerra-Moreno, Angel; Espin, Eloy; Armengol, Manel; Musulen, Eva; Ariza, Aurelio; Sayos, Joan; Arango, Diego; Schwartz, Simo, Jr.			Human SMC2 Protein, a Core Subunit of Human Condensin Complex, Is a Novel Transcriptional Target of the WNT Signaling Pathway and a New Therapeutic Target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CHROMOSOME CONDENSATION; BETA-CATENIN; CELL-DIVISION; CANCER CELLS; C-MYC; ACTIVATION; PHOSPHORYLATION; OVEREXPRESSION; IDENTIFICATION; INHIBITION	Human SMC2 is part of the condensin complex, which is responsible for tightly packaging replicated genomic DNA prior to segregation into daughter cells. Engagement of the WNT signaling pathway is known to have a mitogenic effect on cells, but relatively little is known about WNT interaction with mitotic structural organizer proteins. In this work, we described the novel transcriptional regulation of SMC2 protein by direct binding of the beta-catenin.TCF4 transcription factor to the SMC2 promoter. Furthermore, we identified the precise region in the SMC2 promoter that is required for beta-catenin-mediated promoter activation. Finally, we explored the functional significance of down-regulating SMC2 protein in vivo. Treatment of WNT-activated intestinal tumor cells with SMC2 siRNA significantly reduced cell proliferation in nude mice, compared with untreated controls (p = 0.02). Therefore, we propose that WNT signaling can directly activate SMC2 transcription as a key player in the mitotic cell division machinery. Furthermore, SMC2 represents a new target for oncological therapeutic intervention.	[Davalos, Veronica; Suarez-Lopez, Lucia; Castano, Julio; Messent, Anthea; Abasolo, Ibane; Fernandez, Yolanda; Guerra-Moreno, Angel; Espin, Eloy; Armengol, Manel; Schwartz, Simo, Jr.] Univ Autonoma Barcelona, Vall Hebron Inst Recerca, Drug Delivery & Targeting Grp, Mol Biol & Biochem Res Ctr Nano Med CIBBIM Nanome, Barcelona 08035, Spain; [Messent, Anthea; Abasolo, Ibane; Fernandez, Yolanda; Guerra-Moreno, Angel; Espin, Eloy; Armengol, Manel; Sayos, Joan; Schwartz, Simo, Jr.] Inst Salud Carlos III, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Zaragoza 50018, Spain; [Espin, Eloy; Armengol, Manel] Univ Hosp Vall Hebron, Dept Gen Surg, Barcelona 08035, Spain; [Musulen, Eva; Ariza, Aurelio] Hosp Trias & Pujol, Dept Pathol, Badalona 08916, Spain; [Sayos, Joan] Univ Autonoma Barcelona, Univ Hosp Vall Hebron, Vall Hebron Inst Recerca, CIBBIM Nanomed,Immunobiol Grp, Barcelona 08035, Spain; [Arango, Diego] Univ Autonoma Barcelona, Univ Hosp Vall Hebron, Vall Hebron Inst Recerca, CIBBIM Nanomed,Mol Oncol Grp, Barcelona 08035, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Instituto de Salud Carlos III; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Schwartz, S (corresponding author), Univ Autonoma Barcelona, Univ Hosp Vall Hebron, Vall Hebron Inst Recerca,Drug Delivery & Targeti, Mol Biol & Biochem Res Ctr Nanomed CIBBIM Nanomed, Barcelona 08035, Spain.	simo.schwartz@vhir.org	Abasolo, Ibane/H-7741-2012; Sayos, Joan/B-6119-2009; Guerra-Moreno, Angel/K-6258-2015; Musulen, Eva/AAI-9169-2020; Arango, Diego/AFW-0125-2022; Davalos, Veronica/AAR-8547-2020; Arango, Diego/M-5667-2016; Angel, Guerra-Moreno/AAF-7135-2021; Cardoso, Julio Castaño/AAB-5820-2019; Davalos, Veronica/S-1668-2016	Abasolo, Ibane/0000-0001-5970-6276; Sayos, Joan/0000-0002-4664-3461; Guerra-Moreno, Angel/0000-0003-2321-1129; Musulen, Eva/0000-0002-9667-6464; Arango, Diego/0000-0003-2953-3284; Arango, Diego/0000-0003-2953-3284; Angel, Guerra-Moreno/0000-0003-2321-1129; Davalos, Veronica/0000-0003-4077-5137; Armengol, Manuel/0000-0002-3211-3195; Schwartz, Simo/0000-0001-8297-7971; Suarez Lopez, Lucia/0000-0002-3719-0536; Castano Cardoso, Julio/0000-0002-0712-5856; Espin-Basany, Eloy/0000-0002-9139-4548	Spanish Ministry of Science and Innovation [EU2008-0170]; "Fondo de Investigaciones Sanitarias" [PI080771]; Spanish Ministry of Science and Innovation; Networking Centre on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN); Instituto de Salud Carlos III	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); "Fondo de Investigaciones Sanitarias"(Instituto de Salud Carlos III); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Networking Centre on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported in part by Grants EU2008-0170 from the Spanish Ministry of Science and Innovation, PI080771 from the "Fondo de Investigaciones Sanitarias," and grants from the Spanish Ministry of Science and Innovation, the Networking Centre on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, and Spanish Ministry of Science and Innovation.	Arango D, 2003, BRIT J CANCER, V89, P1757, DOI 10.1038/sj.bjc.6601338; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Banks JD, 2004, CURR BIOL, V14, P2033, DOI 10.1016/j.cub.2004.10.049; Bazile F, 2010, CELL CYCLE, V9, P3243, DOI 10.4161/cc.9.16.12620; Bex A, 2001, CANCER GENET CYTOGEN, V124, P98, DOI 10.1016/S0165-4608(00)00332-0; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Davidson G, 2010, TRENDS CELL BIOL, V20, P453, DOI 10.1016/j.tcb.2010.05.002; Dikovskaya D, 2004, MOL BIOL CELL, V15, P2978, DOI 10.1091/mbc.E03-08-0613; Ghiselli G, 2003, J BIOL CHEM, V278, P20259, DOI 10.1074/jbc.M209511200; Ghiselli G, 2000, J BIOL CHEM, V275, P20235, DOI 10.1074/jbc.C000213200; Ham MF, 2007, CANCER SCI, V98, P1041, DOI 10.1111/j.1349-7006.2007.00500.x; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hudson DF, 2009, CHROMOSOME RES, V17, P131, DOI 10.1007/s10577-008-9009-7; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee G, 2009, P NATL ACAD SCI USA, V106, P4701, DOI 10.1073/pnas.0900751106; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Oliveira RA, 2010, BIOCHEM SOC T, V38, P1639, DOI 10.1042/BST0381639; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Paliulis LV, 2004, CURR BIOL, V14, P2124, DOI 10.1016/j.cub.2004.11.052; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; St-Pierre J, 2009, MOL CELL, V34, P416, DOI 10.1016/j.molcel.2009.04.013; Strunnikov AV, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-15; Takemoto A, 2004, J BIOL CHEM, V279, P4551, DOI 10.1074/jbc.M310925200; Takemoto A, 2007, NUCLEIC ACIDS RES, V35, P2403, DOI 10.1093/nar/gkm157; Takemoto A, 2006, EMBO J, V25, P5339, DOI 10.1038/sj.emboj.7601394; Takemoto A, 2009, NAT STRUCT MOL BIOL, V16, P1302, DOI 10.1038/nsmb.1708; Thomson Scientific, SCI; Tone SO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014345; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865	35	33	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43472	43481		10.1074/jbc.M112.428466	http://dx.doi.org/10.1074/jbc.M112.428466			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23095742	Green Published, hybrid			2022-12-28	WOS:000312940800028
J	Ramaswamy, S; Cooper, D; Poddar, N; MacLean, DM; Rambhadran, A; Taylor, JN; Uhm, H; Landes, CF; Jayaraman, V				Ramaswamy, Swarna; Cooper, David; Poddar, Nitesh; MacLean, David M.; Rambhadran, Anu; Taylor, J. Nick; Uhm, Heui; Landes, Christy F.; Jayaraman, Vasanthi			Role of Conformational Dynamics in alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid (AMPA) Receptor Partial Agonism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; IONOTROPIC GLUTAMATE-RECEPTOR; RESONANCE ENERGY-TRANSFER; SINGLE-MOLECULE; PROTEIN INTERACTIONS; SYNAPTIC PLASTICITY; NMR-SPECTROSCOPY; GLUR2; ACTIVATION; MECHANISM	We have investigated the range of cleft closure conformational states that the agonist-binding domains of the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors occupy when bound to a series of willardiine derivatives using single-molecule FRET. These studies show that the agonist-binding domain exhibits varying degrees of dynamics when bound to the different willardiines with differing efficacies. The chlorowillardiine- and nitrowillardiine-bound form of the agonist-binding domain probes a narrower range of cleft closure states relative to the iodowillardiine bound form of the protein, with the antagonist (alpha S)-alpha-amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinepropanoic acid (UBP-282)-bound form exhibiting the widest range of cleft closure states. Additionally, the average cleft closure follows the order UBP-282 > iodowillardiine > chlorowillardiine > nitrowillardiine-bound forms of agonist-binding domain. These single-molecule FRET data, along with our previously reported data for the glutamate-bound forms of wild type and T686S mutant proteins, show that the mean currents under nondesensitizing conditions can be directly correlated to the fraction of the agonist-binding domains in the "closed" cleft conformation. These results indicate that channel opening in the AMPA receptors is controlled by both the ability of the agonist to induce cleft closure and the dynamics of the agonist-binding domain when bound to the agonist.	[Cooper, David; Poddar, Nitesh; Taylor, J. Nick; Uhm, Heui; Landes, Christy F.] Rice Univ, Dept Chem, Houston, TX 77251 USA; [Ramaswamy, Swarna; MacLean, David M.; Rambhadran, Anu; Jayaraman, Vasanthi] Univ Texas Houston, Hlth Sci Ctr, Grad Sch Biomed Sci, Ctr Membrane Biol,Dept Biochem & Mol Biol, Houston, TX 77030 USA	Rice University; University of Texas System; University of Texas Health Science Center Houston	Landes, CF (corresponding author), Rice Univ, Dept Chem, MS 60, Houston, TX 77251 USA.	cflandes@rice.edu; vasanthi.jayaraman@uth.tmc.edu	Landes, Christy/I-5501-2014; poddar, nitesh/AAD-9130-2022	MacLean, David/0000-0001-8294-6075; PODDAR, NITESH/0000-0002-2162-9110	National Institutes of Health [GM094246]; Gulf Coast Consortia Grant/Welch Foundation [H-E-0035/R-11-0055]; American Heart Association [11GRNT7890004]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gulf Coast Consortia Grant/Welch Foundation; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM094246. This work was also supported by Gulf Coast Consortia Grant/Welch Foundation Grant H-E-0035/R-11-0055 and American Heart Association Grant 11GRNT7890004.	Ahmed AH, 2011, J BIOL CHEM, V286, P35257, DOI 10.1074/jbc.M111.269001; Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Ahmed AH, 2009, BIOCHEMISTRY-US, V48, P3894, DOI 10.1021/bi900107m; Ahmed AH, 2007, J BIOL CHEM, V282, P12773, DOI 10.1074/jbc.M610077200; Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Birdsey-Benson A, 2010, J NEUROSCI, V30, P1463, DOI 10.1523/JNEUROSCI.4558-09.2010; Cheng Q, 2005, NAT CHEM BIOL, V1, P329, DOI 10.1038/nchembio738; Darugar Q, 2008, J VIROL, V82, P12164, DOI 10.1128/JVI.01158-08; Du M, 2005, J BIOL CHEM, V280, P8633, DOI 10.1074/jbc.C400590200; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; Gonzalez J, 2008, BIOCHEMISTRY-US, V47, P10027, DOI 10.1021/bi800690b; Gonzalez J, 2010, P NATL ACAD SCI USA, V107, P9891, DOI 10.1073/pnas.0911854107; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; Jayaraman V, 2000, BIOCHEMISTRY-US, V39, P8693, DOI 10.1021/bi000892f; Jayaraman V, 2004, METHOD ENZYMOL, V380, P170; Jayaraman V, 2000, FEBS LETT, V475, P278, DOI 10.1016/S0014-5793(00)01690-2; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; JOHNSON KR, 2009, NATL GEOGR, V215, P8; Karam P, 2010, P NATL ACAD SCI USA, V107, P17480, DOI 10.1073/pnas.1008068107; Keifer J, 2010, EUR J NEUROSCI, V32, P269, DOI 10.1111/j.1460-9568.2010.07339.x; Kwak S, 2005, J MOL MED, V83, P110, DOI 10.1007/s00109-004-0599-z; Landes CF, 2011, NAT CHEM BIOL, V7, P168, DOI 10.1038/NCHEMBIO.523; MacLean DM, 2011, J NEUROSCI, V31, P2136, DOI 10.1523/JNEUROSCI.4314-10.2011; Madden DR, 2004, BIOCHEMISTRY-US, V43, P15838, DOI 10.1021/bi048447y; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Madden DR, 2001, J BIOL CHEM, V276, P37821; MADSEN U, 1994, BIOMED PHARMACOTHER, V48, P305, DOI 10.1016/0753-3322(94)90176-7; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Maltsev AS, 2010, J BIOL CHEM, V285, P10154, DOI 10.1074/jbc.M109.088641; Mankiewicz KA, 2007, BRAZ J MED BIOL RES, V40, P1419, DOI 10.1590/S0100-879X2007001100001; Mankiewicz KA, 2008, BIOCHEMISTRY-US, V47, P398, DOI 10.1021/bi702004b; McFeeters RL, 2004, FASEB J, V18, P428, DOI 10.1096/fj.03-0873rev; McFeeters RL, 2002, BIOCHEMISTRY-US, V41, P10472, DOI 10.1021/bi026010p; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; O'Neill MJ, 2007, CURR DRUG TARGETS, V8, P603, DOI 10.2174/138945007780618517; Oswald RE, 2007, CURR DRUG TARGETS, V8, P573, DOI 10.2174/138945007780618526; Poon K, 2011, MOL PHARMACOL, V80, P49, DOI 10.1124/mol.111.071688; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P291, DOI 10.1016/0165-6147(92)90088-N; Taylor JN, 2008, BIOCHEM BIOPH RES CO, V373, P213, DOI 10.1016/j.bbrc.2008.05.191; Taylor JN, 2011, J PHYS CHEM B, V115, P1105, DOI 10.1021/jp1050707; Taylor JN, 2010, BIOPHYS J, V98, P164, DOI 10.1016/j.bpj.2009.09.047; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Valentine ER, 2005, BIOCHEMISTRY-US, V44, P3410, DOI 10.1021/bi047984f; Vogelsang J, 2007, ANAL CHEM, V79, P7367, DOI 10.1021/ac071176n; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhang W, 2008, J NEUROSCI, V28, P932, DOI 10.1523/JNEUROSCI.3309-07.2008	53	35	35	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43557	43564		10.1074/jbc.M112.371815	http://dx.doi.org/10.1074/jbc.M112.371815			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115239	Green Published, hybrid			2022-12-28	WOS:000312940800036
J	Hardy, RY; Resh, MD				Hardy, Rayshonda Y.; Resh, Marilyn D.			Identification of N-terminal Residues of Sonic Hedgehog Important for Palmitoylation by Hedgehog Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL MODIFICATION; ANIMAL DEVELOPMENT; PROTEIN; RANGE; GENE; FORM; MUTATIONS; CANCER	Sonic Hedgehog (Shh) is a secreted morphogen that regulates embryonic development. After removal of the signal peptide, Shh is processed to the mature, active form through autocleavage and a series of lipid modifications, including the attachment of palmitate. Covalent attachment of palmitate to the N-terminal cysteine of Shh is catalyzed by Hedgehog acyltransferase (Hhat) and is critical for proper signaling. The sequences within Shh that are responsible for palmitoylation by Hhat are not known. Here we show that the first six amino acids of mature Shh (CGPGRG) are sufficient for Hhat-mediated palmitoylation. Alanine scanning mutagenesis was used to determine the role of each amino acid and the positional sequence requirement in a cell-based Shh palmitoylation assay. Mutation of residues in the GPGR sequence to Ala had no effect on palmitoylation, provided that a positively charged residue was present within the first seven residues. The N-terminal position exhibited a strong but not exclusive requirement for Cys. Constructs with an N-terminal Ala were not palmitoylated. However, an N-terminal Ser served as a substrate for Hhat, but not the Drosophila melanogaster ortholog Rasp, highlighting a critical difference between the mammalian and fly enzymes. These findings define residues and regions within Shh that are necessary for its recognition as a substrate for Hhat-mediated palmitoylation. Finally, we report the results of a bioinformatics screen to identify other potential Hhat substrates encoded in the human genome.	[Resh, Marilyn D.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; Cornell Univ, Weill Grad Sch Med Sci, Grad Program Biochem Cell & Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Resh, MD (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave,Box 143, New York, NY 10065 USA.	m-resh@ski.mskcc.org		Resh, Marilyn/0000-0001-6118-9466	National Institutes of Health [GM57966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM57966.	ALLAND L, 1994, J BIOL CHEM, V269, P16701; Balan L, 2009, P NATL ACAD SCI USA, V106, P7589, DOI 10.1073/pnas.0809442106; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; BERTHIAUME L, 1995, METHOD ENZYMOL, V250, P454; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Buglino JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011195; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dawber RJ, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-21; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Hehr U, 2004, EUR J PEDIATR, V163, P347, DOI 10.1007/s00431-004-1459-0; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Lee JD, 2001, DEV BIOL, V233, P122, DOI 10.1006/dbio.2001.0218; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Li YN, 2006, P NATL ACAD SCI USA, V103, P6548, DOI 10.1073/pnas.0600124103; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Maurer-Stroh S, 2002, J MOL BIOL, V317, P523, DOI 10.1006/jmbi.2002.5425; Miura GI, 2006, DEV CELL, V10, P167, DOI 10.1016/j.devcel.2005.11.017; Odent S, 1999, HUM MOL GENET, V8, P1683, DOI 10.1093/hmg/8.9.1683; Pathi S, 2001, MECH DEVELOP, V106, P107, DOI 10.1016/S0925-4773(01)00427-0; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PESECKIS SM, 1993, J BIOL CHEM, V268, P5107; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Roessler E, 2009, HUM MUTAT, V30, pE921, DOI 10.1002/humu.21090; Singh S, 2009, HUM GENET, V125, P95, DOI 10.1007/s00439-008-0599-0; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Taylor FR, 2001, BIOCHEMISTRY-US, V40, P4359, DOI 10.1021/bi002487u; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648	35	33	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42881	42889		10.1074/jbc.M112.426833	http://dx.doi.org/10.1074/jbc.M112.426833			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23112049	Green Published, hybrid			2022-12-28	WOS:000312501600046
J	Vitashenkova, N; Moeller, JB; Leth-Larsen, R; Schlosser, A; Lund, KP; Tornoe, I; Vitved, L; Hansen, S; Willis, A; Kharazova, AD; Skjodt, K; Sorensen, GL; Holmskov, U				Vitashenkova, Nina; Moeller, Jesper Bonnet; Leth-Larsen, Rikke; Schlosser, Anders; Lund, Kit Peiter; Tornoe, Ida; Vitved, Lars; Hansen, Soren; Willis, Anthony; Kharazova, Alexandra D.; Skjodt, Karsten; Sorensen, Grith Lykke; Holmskov, Uffe			Identification and Characterization of a Chitin-binding Protein Purified from Coelomic Fluid of the Lugworm Arenicola marina Defining a Novel Protein Sequence Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; POLYANDROCARPA-MISAKIENSIS; ANTIMICROBIAL PEPTIDE; INNATE IMMUNITY; CDNA CLONING; PURIFICATION; INVERTEBRATE; SPECIFICITY; DIVERSITY; MOLECULES	We have isolated a novel type of lectin named Arenicola marina lectin-1 (AML-1) from the lugworm A. marina. The lectin was purified from the coelomic fluid by affinity chromatography on a GlcNAc-derivatized column and eluted with GlcNAc. On SDS-PAGE, AML-1 showed an apparent molecular mass of 27 and 31 kDa in the reduced state. The N-terminal amino acid sequences were identical in these two bands. In the unreduced state, a complex band pattern was observed with bands from 35 kDa to more than 200 kDa. Two different full-length clones encoding polypeptides of 241 and 243 amino acids, respectively, were isolated from a coelomocyte cDNA library. The two clones, designated AML-1a and AML-1b, were 92% identical at the protein level and represent a novel type of protein sequence family. Purified AML-1 induced agglutination of rabbit erythrocytes, which could be inhibited by N-acetylated saccharides. Recombinant AML-1b showed the same band pattern as the native protein, whereas recombinant AML-1a in the reduced state lacked a 27 kDa band. AML-1b bound GlcNAc-derivatized columns and chitin, whereas AML-1a did not bind to these matrices. Immunohistochemical analysis revealed that AML-1 is expressed by coelomocytes in the nephridium and in round cells in the epidermis and in eggs. Moreover, AML-1 expression was up-regulated in response to a parasitic infection. We conclude that AML-1 purified from coelomic fluid is encoded by AML-1b and represents a novel type of protein family that binds acetylated components.	[Vitashenkova, Nina; Moeller, Jesper Bonnet; Schlosser, Anders; Lund, Kit Peiter; Tornoe, Ida; Sorensen, Grith Lykke; Holmskov, Uffe] Univ So Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, DK-5000 Odense C, Denmark; [Leth-Larsen, Rikke; Vitved, Lars; Hansen, Soren; Skjodt, Karsten] Univ So Denmark, Inst Mol Med, Dept Canc & Inflammat, DK-5000 Odense C, Denmark; [Willis, Anthony] Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England; [Vitashenkova, Nina; Kharazova, Alexandra D.] St Petersburg State Univ, Fac Biol, Dept Cytol & Histol, St Petersburg 199034, Russia	University of Southern Denmark; University of Southern Denmark; University of Oxford; Saint Petersburg State University	Holmskov, U (corresponding author), Univ So Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, JP Winsloews Vej 25-3, DK-5000 Odense C, Denmark.	uholmskov@health.sdu.dk	Kharazova, Alexandra/I-6876-2015; Holmskov, Uffe/AAA-3056-2022; Moeller, Jesper B/E-6377-2015	Kharazova, Alexandra/0000-0001-9149-9633; Holmskov, Uffe/0000-0002-2391-9445; Moeller, Jesper B/0000-0001-8786-8037; Sorensen, Grith Lykke/0000-0002-5273-1097; Leth-Larsen, Rikke/0000-0002-1612-4089; Skjodt, Karsten/0000-0002-9161-8185; Hansen, Soren/0000-0002-8186-4630	Benzon Foundation	Benzon Foundation	This research work was supported by the Benzon Foundation.	Abe Y, 1999, EUR J BIOCHEM, V261, P33, DOI 10.1046/j.1432-1327.1999.00238.x; Adema CM, 1999, PARASITOLOGY, V119, P395, DOI 10.1017/S0031182099004850; Adema CM, 1997, P NATL ACAD SCI USA, V94, P8691, DOI 10.1073/pnas.94.16.8691; Andra J, 2008, BIOCHEM J, V410, P113, DOI 10.1042/BJ20071051; Azumi Kaoru, 1996, P43; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cooper DNW, 1997, J BIOL CHEM, V272, P1514, DOI 10.1074/jbc.272.3.1514; COOPER EL, 1985, DEV COMP IMMUNOL, V9, P577, DOI 10.1016/0145-305X(85)90021-7; DALES RP, 1982, COMP BIOCHEM PHYS A, V73, P663, DOI 10.1016/0300-9629(82)90272-9; DAM TK, 1994, BIOCHEM BIOPH RES CO, V203, P36, DOI 10.1006/bbrc.1994.2145; Davidson CR, 2008, DEV COMP IMMUNOL, V32, P608, DOI 10.1016/j.dci.2007.11.004; DRICKAMER K, 1995, CURR OPIN STRUC BIOL, V5, P612, DOI 10.1016/0959-440X(95)80052-2; FITZGERALD SW, 1989, J EXP ZOOL, V249, P293, DOI 10.1002/jez.1402490308; FITZGERALD SW, 1982, DEV COMP IMMUNOL, V6, P23, DOI 10.1016/0145-305X(82)90004-0; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; GARTE SJ, 1976, BIOCHIM BIOPHYS ACTA, V439, P368, DOI 10.1016/0005-2795(76)90073-8; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451; Hirabayashi J, 1998, J BIOL CHEM, V273, P14450, DOI 10.1074/jbc.273.23.14450; HIRABAYASHI J, 1992, J BIOL CHEM, V267, P15485; Hirabayashi J, 1996, J BIOL CHEM, V271, P2497, DOI 10.1074/jbc.271.5.2497; HIRABAYASHI J, 1993, GLYCOBIOLOGY, V3, P297, DOI 10.1093/glycob/3.4.297; HIRABAYASHI J, 1992, J BIOCHEM-TOKYO, V111, P553, DOI 10.1093/oxfordjournals.jbchem.a123794; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Loker ES, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00025; Loker ES, 2010, ADV EXP MED BIOL, V708, P17; Lu JH, 1998, IMMUNOBIOLOGY, V199, P190, DOI 10.1016/S0171-2985(98)80026-0; Messier-Solek C, 2010, SEMIN IMMUNOL, V22, P39, DOI 10.1016/j.smim.2009.11.007; Nair SV, 2000, COMP BIOCHEM PHYS B, V125, P279, DOI 10.1016/S0305-0491(99)00180-7; Ovchinnikova TV, 2004, FEBS LETT, V577, P209, DOI 10.1016/j.febslet.2004.10.012; Ozeki Y, 1997, COMP BIOCHEM PHYS B, V118, P1, DOI 10.1016/S0305-0491(97)00014-X; Poget SF, 1999, J MOL BIOL, V290, P867, DOI 10.1006/jmbi.1999.2910; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Saito T, 1997, J BIOL CHEM, V272, P30703, DOI 10.1074/jbc.272.49.30703; SAITO T, 1995, J BIOL CHEM, V270, P14493, DOI 10.1074/jbc.270.24.14493; Schlosser A, 2006, SCAND J IMMUNOL, V64, P104, DOI 10.1111/j.1365-3083.2006.01778.x; Schlosser A, 2009, J IMMUNOL, V183, P3800, DOI 10.4049/jimmunol.0901526; Soderhall K, 2010, ADV EXP MED BIOL, V708, P1, DOI 10.1007/978-1-4419-8059-5; SUZUKI T, 1990, J BIOL CHEM, V265, P1274; Thomsen T, 2011, MOL IMMUNOL, V48, P369, DOI 10.1016/j.molimm.2010.09.019; Thomsen T, 2010, J BIOL CHEM, V285, P1229, DOI 10.1074/jbc.M109.061523; TSUJI T, 1986, CARBOHYD RES, V151, P391, DOI 10.1016/S0008-6215(00)90358-6; Tunkijjanukij S, 1998, DEV COMP IMMUNOL, V22, P139, DOI 10.1016/S0145-305X(98)00017-2; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Vasta GR, 2004, CURR OPIN STRUC BIOL, V14, P617, DOI 10.1016/j.sbi.2004.09.008; VASTA GR, 1994, ANN NY ACAD SCI, V712, P55, DOI 10.1111/j.1749-6632.1994.tb33562.x; Vetvicka V., 1994, IMMUNOLOGY ANNELIDS; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x	49	3	3	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42846	42855		10.1074/jbc.M112.420976	http://dx.doi.org/10.1074/jbc.M112.420976			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23115230	Green Published, hybrid			2022-12-28	WOS:000312501600043
J	Solinski, HJ; Zierler, S; Gudermann, T; Breit, A				Solinski, Hans Juergen; Zierler, Susanna; Gudermann, Thomas; Breit, Andreas			Human Sensory Neuron-specific Mas-related G Protein-coupled Receptors-X1 Sensitize and Directly Activate Transient Receptor Potential Cation Channel V1 via Distinct Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT K+ CURRENTS; KINASE-C-EPSILON; CAPSAICIN RECEPTOR; CELL-LINE; VANILLOID RECEPTOR-1; POSSIBLE MECHANISM; PROTON ACTIVATION; HYBRID-CELLS; GENE FAMILY; TRPV1	Sensory neuron-specific Mas-related G protein-coupled receptors-X1 (MRGPR-X1) are primate-specific proteins that are exclusively expressed in primary sensory neurons and provoke pain in humans. Hence, MRGPR-X1 represent promising targets for future pain therapy, but signaling pathways activated by MRGPR-X1 are poorly understood. The transient receptor potential cation channel V1 (TRPV1) is also expressed in primary sensory neurons and detects painful stimuli such as protons and heat. G(q)-promoted signaling has been shown to sensitize TRPV1 via protein kinase C (PKC)-dependent phosphorylation. In addition, recent studies suggested TRPV1 activation via a G(q)-mediated mechanism involving diacylglycerol (DAG) or phosphatidylinositol-4,5-bisphosphate (PIP2). However, it is not clear if DAG-promoted TRPV1 activation occurs independently from classic TRPV1 activation modes induced by heat and protons. Herein, we analyzed putative functional interactions between MRGPR-X1 and TRPV1 in a previously reported F11 cell line stably over-expressing MRGPR-X1. First, we found that MRGPR-X1 sensitized TRPV1 to heat and protons in a PKC-dependent manner. Second, we observed direct MRGPR-X1-mediated TRPV1 activation independent of MRGPR-X1-induced Ca2+-release and PKC activity or other TRPV1 affecting enzymes such as lipoxygenase, extracellular signal-regulated kinases-1/2, sarcoma, or phosphoinositide 3-kinase. Investigating several TRPV1 mutants, we observed that removal of the TRPV1 binding site for DAG and of the putative PIP2 sensor decreased MRGPR-X1-induced TRPV1 activation by 71 and 43%, respectively. Therefore, we demonstrate dual functional interactions between MRGPR-X1 and TRPV1, resulting in PKC-dependent TRPV1 sensitization and DAG/PIP2-mediated activation. The molecular discrimination between TRPV1 sensitization and activation may help improve the specificity of current pain therapies.	[Solinski, Hans Juergen; Zierler, Susanna; Gudermann, Thomas; Breit, Andreas] Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-80336 Munich, Germany	University of Munich	Breit, A (corresponding author), Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-80336 Munich, Germany.	andreas.breit@lrz.uni-muenchen.de	Zierler, Susanna/E-2070-2012	Zierler, Susanna/0000-0002-4684-0385	Deutsche Forschungsgemeinschaft [BR 3346/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant BR 3346/3-1.	Amadesi S, 2006, J PHYSIOL-LONDON, V575, P555, DOI 10.1113/jphysiol.2006.111534; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; BOLAND LM, 1991, J NEUROSCI, V11, P1140; Breit A, 2006, MOL PHARMACOL, V70, P686, DOI 10.1124/mol.106.022897; Burstein ES, 2006, BRIT J PHARMACOL, V147, P73, DOI 10.1038/sj.bjp.0706448; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Chen HM, 2004, J NEUROSCI, V24, P5044, DOI 10.1523/JNEUROSCI.0990-04.2004; Choi SS, 2003, GENOME RES, V13, P2252, DOI 10.1101/gr.1431603; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Eijkelkamp N, 2010, J NEUROSCI, V30, P2138, DOI 10.1523/JNEUROSCI.5752-09.2010; FAN SF, 1992, BRAIN RES, V590, P329, DOI 10.1016/0006-8993(92)91116-V; FAN SF, 1993, BRAIN RES, V605, P214, DOI 10.1016/0006-8993(93)91743-C; Fioravanti B, 2008, J NEUROSCI, V28, P11593, DOI 10.1523/JNEUROSCI.3322-08.2008; FRANCEL PC, 1987, J NEUROCHEM, V48, P1624, DOI 10.1111/j.1471-4159.1987.tb05711.x; Garami A, 2010, J NEUROSCI, V30, P1435, DOI 10.1523/JNEUROSCI.5150-09.2010; Gaudioso C, 2012, PAIN, V153, P473, DOI 10.1016/j.pain.2011.11.014; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Gavva NR, 2005, MOL PHARMACOL, V68, P1524, DOI 10.1124/mol.105.015727; Grazzini E, 2004, P NATL ACAD SCI USA, V101, P7175, DOI 10.1073/pnas.0307185101; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; Hao LL, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-316; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang JH, 2006, CURR NEUROPHARMACOL, V4, P197, DOI 10.2174/157015906778019554; Jow F, 2006, ASSAY DRUG DEV TECHN, V4, P49, DOI 10.1089/adt.2006.4.49; Jung HT, 2008, MOL CELL NEUROSCI, V37, P170, DOI 10.1016/j.mcn.2007.09.004; Kim YH, 2009, J NEUROSCI, V29, P10000, DOI 10.1523/JNEUROSCI.5030-08.2009; Kleibeuker W, 2007, EUR J NEUROSCI, V25, P1696, DOI 10.1111/j.1460-9568.2007.05423.x; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Li YZ, 2004, J NEUROSCI, V24, P9623, DOI 10.1523/JNEUROSCI.2392-04.2004; Mandadi S, 2004, CELL CALCIUM, V35, P471, DOI 10.1016/j.ceca.2003.11.003; McIlvain HB, 2006, BRAIN RES, V1077, P16, DOI 10.1016/j.brainres.2005.12.130; Mizumura K, 2009, EXP BRAIN RES, V196, P53, DOI 10.1007/s00221-009-1814-5; Moriyama T, 2003, J NEUROSCI, V23, P6058, DOI 10.1523/JNEUROSCI.23-14-06058.2003; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Plant TD, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-35; Poole AAW, 2004, TRENDS PHARMACOL SCI, V25, P528, DOI 10.1016/j.tips.2004.08.006; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Puttfarcken PS, 1997, J NEUROCHEM, V69, P930; Rothe K, 2012, J PHARMACOL EXP THER, V342, P41, DOI 10.1124/jpet.112.192757; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Sikand P, 2011, J NEUROSCI, V31, P7563, DOI 10.1523/JNEUROSCI.1192-11.2011; Solinski HJ, 2010, MOL PHARMACOL, V78, P249, DOI 10.1124/mol.110.063867; Sowa NA, 2010, J NEUROSCI, V30, P10282, DOI 10.1523/JNEUROSCI.2162-10.2010; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Tay SK, 2009, P NATL ACAD SCI USA, V106, P12019, DOI 10.1073/pnas.0904569106; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Turner H, 2003, BIOCHEM J, V371, P341, DOI 10.1042/BJ20021381; Valenzano KJ, 2003, J PHARMACOL EXP THER, V306, P377, DOI 10.1124/jpet.102.045674; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Walker KM, 2003, J PHARMACOL EXP THER, V304, P56, DOI 10.1124/jpet.102.042010; Woo DH, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-42; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	59	15	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40956	40971		10.1074/jbc.M112.408617	http://dx.doi.org/10.1074/jbc.M112.408617			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23074220	hybrid, Green Published			2022-12-28	WOS:000311887600014
J	Margariti, A; Li, HL; Chen, T; Martin, D; Vizcay-Barrena, G; Alam, S; Karamariti, E; Xiao, QZ; Zampetaki, A; Zhang, ZY; Wang, W; Jiang, ZX; Gao, C; Ma, BY; Chen, YG; Cockerill, G; Hu, YH; Xu, QB; Zeng, LF				Margariti, Andriana; Li, Hongling; Chen, Ting; Martin, Daniel; Vizcay-Barrena, Gema; Alam, Saydul; Karamariti, Eirini; Xiao, Qingzhong; Zampetaki, Anna; Zhang, Zhongyi; Wang, Wen; Jiang, Zhixin; Gao, Chan; Ma, Benyu; Chen, Ye-Guang; Cockerill, Gillian; Hu, Yanhua; Xu, Qingbo; Zeng, Lingfang			XBP1 mRNA Splicing Triggers an Autophagic Response in Endothelial Cells through BECLIN-1 Transcriptional Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; SMOOTH-MUSCLE-CELLS; ER STRESS; DEATH; ATHEROSCLEROSIS; APOPTOSIS; PATHWAY; ANGIOGENESIS; DEACETYLATION	Sustained activation of X-box-binding protein 1 (XBP1) results in endothelial cell (EC) apoptosis and atherosclerosis development. The present study provides evidence that XBP1 mRNA splicing triggered an autophagic response in ECs by inducing autophagic vesicle formation and markers of autophagy BECLIN-1 and microtubule-associated protein 1 light chain 3 beta (LC3-beta II). Endostatin activated autophagic gene expression through XBP1 mRNA splicing in an inositol-requiring enzyme 1 alpha (IRE1 alpha)-dependent manner. Knockdown of XBP1 or IRE1 alpha by shRNA in ECs ablated endostatin-induced autophagosome formation. Importantly, data from arterial vessels from XBP1 EC conditional knock-out (XBP1eko) mice demonstrated that XBP1 deficiency in ECs reduced the basal level of LC3 beta expression and ablated response to endostatin. Chromatin immunoprecipitation assays further revealed that the spliced XBP1 isoform bound directly to the BECLIN-1 promoter at the region from nt -537 to -755. BECLIN-1 deficiency in ECs abolished the XBP1-induced autophagy response, whereas spliced XBP1 did not induce transcriptional activation of a truncated BECLIN-1 promoter. These results suggest that XBP1 mRNA splicing triggers an autophagic signal pathway through transcriptional regulation of BECLIN-1.	[Margariti, Andriana; Li, Hongling; Martin, Daniel; Alam, Saydul; Karamariti, Eirini; Zampetaki, Anna; Zhang, Zhongyi; Hu, Yanhua; Xu, Qingbo; Zeng, Lingfang] Kings Coll London BHF Ctr, Div Cardiovasc, London SE5 9NU, England; [Chen, Ting] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China; [Vizcay-Barrena, Gema] Kings Coll London, Ctr Ultrastruct Imaging, London WC2R 2LS, England; [Xiao, Qingzhong] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Clin Pharmacol, London EC1M 6BQ, England; [Wang, Wen] Queen Mary Univ London, Sch Engn & Mat Sci, London E1 4NS, England; [Jiang, Zhixin] 305th Hosp Peoples Liberat Army, Ctr Lab, Beijing 100017, Peoples R China; [Gao, Chan; Ma, Benyu; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Cockerill, Gillian] St Georges Univ London, Dept Cardiovasc Sci, London SW17 0RE, England	University of London; King's College London; Zhejiang University; University of London; King's College London; University of London; Queen Mary University London; University of London; Queen Mary University London; Tsinghua University; St Georges University London	Margariti, A (corresponding author), Kings Coll London BHF Ctr, Div Cardiovasc, 125 Coldharbour Lane, London SE5 9NU, England.	andriani.margariti@kcl.ac.uk; lingfang.zeng@kcl.ac.uk	Margariti, Andriana/AAH-5318-2019; Chen, Ye-Guang/L-6998-2019; Gao, Chan/D-7964-2013	Zeng, Lingfang/0000-0002-0390-4561; Zampetaki, Anna/0000-0002-7257-8624	British Heart Foundation; Oak Foundation; British Heart Foundation [FS/09/044/28007, PG/11/40/28891, PG/12/11/29408, FS/13/18/30207] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Oak Foundation; British Heart Foundation(British Heart Foundation)	This work was supported by Grants from the British Heart Foundation and the Oak Foundation.	Chau YP, 2003, HISTOL HISTOPATHOL, V18, P715, DOI 10.14670/HH-18.715; CLAUSS IM, 1993, DEV DYNAM, V197, P146, DOI 10.1002/aja.1001970207; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Du JH, 2012, AM J PHYSIOL-CELL PH, V302, pC383, DOI 10.1152/ajpcell.00164.2011; Fouillet A, 2012, AUTOPHAGY, V8, P915, DOI 10.4161/auto.19716; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Ghavami S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.61; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Han Qiao, 2011, Zhonghua Yi Xue Za Zhi, V91, P2216; Hetz C, 2008, P NATL ACAD SCI USA, V105, P757, DOI 10.1073/pnas.0711094105; Hu PF, 2012, INT J MOL MED, V29, P613, DOI 10.3892/ijmm.2012.891; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P422, DOI 10.1111/j.1440-1711.2006.01449.x; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liao XH, 2012, CELL METAB, V15, P545, DOI 10.1016/j.cmet.2012.01.022; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Margariti A, 2012, P NATL ACAD SCI USA, V109, P13793, DOI 10.1073/pnas.1205526109; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; Margariti A, 2009, J CELL SCI, V122, P460, DOI 10.1242/jcs.034850; Martinet W, 2008, CURR ATHEROSCLER REP, V10, P216, DOI 10.1007/s11883-008-0034-y; Martinet W, 2009, CIRC RES, V104, P304, DOI 10.1161/CIRCRESAHA.108.188318; Mitra AK, 2004, CAN J PHYSIOL PHARM, V82, P860, DOI 10.1139/Y04-095; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; Nguyen TMB, 2009, J CELL MOL MED, V13, P3687, DOI 10.1111/j.1582-4934.2009.00722.x; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Pehar M, 2012, J BIOL CHEM, V287, P29921, DOI 10.1074/jbc.M112.363911; Razani B, 2012, CELL METAB, V15, P534, DOI 10.1016/j.cmet.2012.02.011; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rovetta F, 2012, EXP CELL RES, V318, P238, DOI 10.1016/j.yexcr.2011.11.008; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Schrijvers DM, 2011, ARTERIOSCL THROM VAS, V31, P2787, DOI 10.1161/ATVBAHA.111.224899; Sirois I, 2012, AUTOPHAGY, V8, P927, DOI 10.4161/auto.19768; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Tao R, 2011, CELL RES, V21, P1619, DOI 10.1038/cr.2011.58; Valenzuela V, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.8; Vidal RL, 2012, AUTOPHAGY, V8, P970, DOI 10.4161/auto.20139; Vidal RL, 2012, HUM MOL GENET, V21, P2245, DOI 10.1093/hmg/dds040; Wang B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010409; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshimori T, 2007, CELL, V128, P833, DOI 10.1016/j.cell.2007.02.023; Yoshimori Tamotsu, 2004, Tanpakushitsu Kakusan Koso, V49, P1029; Younce C, 2012, CELL PHYSIOL BIOCHEM, V30, P307, DOI 10.1159/000339066; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106; Zhang YL, 2010, BIOCHEM BIOPH RES CO, V394, P377, DOI 10.1016/j.bbrc.2010.03.026	58	183	195	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					859	872		10.1074/jbc.M112.412783	http://dx.doi.org/10.1074/jbc.M112.412783			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184933	hybrid, Green Published			2022-12-28	WOS:000313570300011
J	Margaron, Y; Fradet, N; Cote, JF				Margaron, Yoran; Fradet, Nadine; Cote, Jean-Francois			ELMO Recruits Actin Cross-linking Family 7 (ACF7) at the Cell Membrane for Microtubule Capture and Stabilization of Cellular Protrusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; INTEGRIN-LINKED KINASE; RAC ACTIVATOR; MYOBLAST CITY; RHO GTPASES; CRKII/DOCK180/RAC PATHWAY; NEUTROPHIL CHEMOTAXIS; COLLECTIVE MIGRATION; SIGNALING PATHWAY; EXCHANGE FACTORS	ELMO and DOCK180 proteins form an evolutionarily conserved module controlling Rac GTPase signaling during cell migration, phagocytosis, and myoblast fusion. Here, we identified the microtubule and actin-binding spectraplakin ACF7 as a novel ELMO-interacting partner. AC-terminal polyproline segment in ELMO and the last spectrin repeat of ACF7 mediate a direct interaction between these proteins. Co-expression of ELMO1 with ACF7 promoted the formation of long membrane protrusions during integrin-mediated cell spreading. Quantification of membrane dynamics established that coupling of ELMO and ACF7 increases the persistence of the protruding activity. Mechanistically, we uncovered a role for ELMO in the recruitment of ACF7 to the membrane to promote microtubule capture and stability. Functionally, these effects of ELMO and ACF7 on cytoskeletal dynamics required the Rac GEF DOCK180. In conclusion, our findings support a role for ELMO in protrusion stability by acting at the interface between the actin cytoskeleton and the microtubule network.	[Margaron, Yoran; Fradet, Nadine; Cote, Jean-Francois] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Cote, Jean-Francois] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Cote, Jean-Francois] McGill Univ, Div Expt Med, Montreal, PQ H3A 1A3, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University	Cote, JF (corresponding author), Inst Rech Clin Montreal, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada.	jean-francois.cote@ircm.qc.ca			Canadian Cancer Society [019104]; Canadian Institute of Health Research [MOP 77591]; Fonds de Recherche en Sante du Quebec post-doctoral fellowship; Fonds de Recherche en Sante du Quebec Junior 2 career award	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec post-doctoral fellowship; Fonds de Recherche en Sante du Quebec Junior 2 career award	This work was supported by Operating Grant 019104 from the Canadian Cancer Society and Canadian Institute of Health Research Grant MOP 77591 (to J.-F. C.).; Recipient of a Fonds de Recherche en Sante du Quebec post-doctoral fellowship.; Recipient of a Fonds de Recherche en Sante du Quebec Junior 2 career award. To whom correspondence should be addressed: IRCM, 110 Avenue des Pins Ouest, Montreal, PQ H2W 1R7, Canada. Tel.: 514-987-5647; Fax: 514-987-5624; E-mail: jean-francois.cote@ircm.qc.ca.	Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2009, SCIENCE, V324, P346, DOI 10.1126/science.1173646; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Dubin-Thaler BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003735; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Geisbrecht ER, 2008, DEV BIOL, V314, P137, DOI 10.1016/j.ydbio.2007.11.022; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hanawa-Suetsugu K, 2012, P NATL ACAD SCI USA, V109, P3305, DOI 10.1073/pnas.1113512109; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ho E, 2012, MOL BIOL CELL, V23, P492, DOI 10.1091/mbc.E11-07-0596; Ho E, 2009, MOL BIOL CELL, V20, P3033, DOI 10.1091/mbc.E09-01-0050; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Mitra RD, 1996, GENE, V173, P13, DOI 10.1016/0378-1119(95)00768-7; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Namekata K, 2012, J NEUROSCI, V32, P264, DOI 10.1523/JNEUROSCI.4884-11.2012; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Parrini MC, 2011, MOL CELL, V42, P650, DOI 10.1016/j.molcel.2011.03.032; Patel M, 2011, J BIOL CHEM, V286, P38969, DOI 10.1074/jbc.M111.274191; Patel M, 2010, CURR BIOL, V20, P2021, DOI 10.1016/j.cub.2010.10.028; Poukkula M, 2011, J CELL BIOL, V192, P513, DOI 10.1083/jcb.201010003; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Rorth P, 2011, DEV CELL, V20, P9, DOI 10.1016/j.devcel.2010.12.014; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Sanchez-Soriano N, 2009, J CELL SCI, V122, P2534, DOI 10.1242/jcs.046268; Sanematsu F, 2010, CIRC RES, V107, P1102, DOI 10.1161/CIRCRESAHA.110.223388; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; Sun YP, 1999, J BIOL CHEM, V274, P33522, DOI 10.1074/jbc.274.47.33522; Takaya A, 2004, MOL BIOL CELL, V15, P2549, DOI 10.1091/mbc.E03-11-0857; Upadhyay G, 2008, ONCOGENE, V27, P5845, DOI 10.1038/onc.2008.202; Vives V, 2011, J BONE MINER RES, V26, P1099, DOI 10.1002/jbmr.282; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107; Zaoui K, 2010, P NATL ACAD SCI USA, V107, P18517, DOI 10.1073/pnas.1000975107; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	65	34	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1184	1199		10.1074/jbc.M112.431825	http://dx.doi.org/10.1074/jbc.M112.431825			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184944	Green Published, hybrid			2022-12-28	WOS:000313570300040
J	Tang, J; Majeti, JW; Sudom, A; Xiong, YM; Lu, M; Liu, Q; Higbee, J; Zhang, Y; Wang, Y; Wang, W; Cao, P; Xia, Z; Johnstone, S; Min, XS; Yang, XP; Shao, H; Yu, T; Sharkov, N; Walker, N; Tu, H; Shen, WY; Wang, ZL				Tang, Jie; Majeti, Jiangwen; Sudom, Athena; Xiong, Yumei; Lu, Mei; Liu, Qiang; Higbee, Jared; Zhang, Yi; Wang, Yan; Wang, Wei; Cao, Ping; Xia, Zhen; Johnstone, Sheree; Min, Xiaoshan; Yang, Xiaoping; Shao, Hui; Yu, Timothy; Sharkov, Nik; Walker, Nigel; Tu, Hua; Shen, Wenyan; Wang, Zhulun			An Inhibitory Antibody against Dipeptidyl Peptidase IV Improves Glucose Tolerance in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ADENOSINE-DEAMINASE; PROTEASE INHIBITION; 7-36 AMIDE; COMPLEX; POTENT; CD26; VILDAGLIPTIN; MEMBRANE; MOLECULE	Dipeptidyl peptidase IV (DPP-IV) degrades the incretin hormone glucagon-like peptide 1 (GLP-1). Small molecule DPP-IV inhibitors have been used as treatments for type 2 diabetes to improve glucose tolerance. However, each of the marketed small molecule drugs has its own limitation in terms of efficacy and side effects. To search for an alternative strategy of inhibiting DPP-IV activity, we generated a panel of tight binding inhibitory mouse monoclonal antibodies (mAbs) against rat DPP-IV. When tested in vitro, these mAbs partially inhibited the GLP-1 cleavage activity of purified enzyme and rat plasma. To understand the partial inhibition, we solved the co-crystal structure of one of the mAb Fabs (Ab1) in complex with rat DPP-IV. Although Ab1 does not bind at the active site, it partially blocks the side opening, which prevents the large substrates such as GLP-1 from accessing the active site, but not small molecules such as sitagliptin. When Ab1 was tested in vivo, it reduced plasma glucose and increased plasma GLP-1 concentration during an oral glucose tolerance test in rats. Together, we demonstrated the feasibility of using mAbs to inhibit DPP-IV activity and to improve glucose tolerance in a diabetic rat model.	[Tang, Jie; Lu, Mei; Liu, Qiang; Higbee, Jared; Zhang, Yi; Wang, Yan; Wang, Wei; Cao, Ping; Xia, Zhen; Yang, Xiaoping; Shao, Hui; Yu, Timothy; Sharkov, Nik; Shen, Wenyan] Amgen Inc, Dept Biol, 1120 Vet Blvd, San Francisco, CA 94080 USA; [Majeti, Jiangwen; Xiong, Yumei; Tu, Hua] Amgen Inc, Dept Metab Disorders, San Francisco, CA 94080 USA; [Sudom, Athena; Johnstone, Sheree; Min, Xiaoshan; Walker, Nigel; Wang, Zhulun] Amgen Inc, Dept Mol Struct, San Francisco, CA 94080 USA	Amgen; Amgen; Amgen	Tang, J (corresponding author), Amgen Inc, Dept Biol, 1120 Vet Blvd, San Francisco, CA 94080 USA.	jiet@amgen.com; zwang@amgen.com			United States Department of Energy at the Lawrence Berkeley National Laboratory [DE-AC03-76SF00098]	United States Department of Energy at the Lawrence Berkeley National Laboratory(United States Department of Energy (DOE))	The ALS is supported by the United States Department of Energy under Contract DE-AC03-76SF00098 at the Lawrence Berkeley National Laboratory.	Aertgeerts K, 2004, PROTEIN SCI, V13, P412, DOI 10.1110/ps.03460604; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Balkan B, 1999, DIABETOLOGIA, V42, P1324, DOI 10.1007/s001250051445; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chahal H, 2007, QJM-INT J MED, V100, P671, DOI 10.1093/qjmed/hcm081; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Che ZW, 1998, J VIROL, V72, P4610, DOI 10.1128/JVI.72.6.4610-4622.1998; Davidson Jaime A, 2009, Cleve Clin J Med, V76 Suppl 5, pS28, DOI 10.3949/ccjm.76.s5.05; Deacon CF, 2011, DIABETES OBES METAB, V13, P7, DOI 10.1111/j.1463-1326.2010.01306.x; Deacon CF, 2004, DIABETES, V53, P2181, DOI 10.2337/diabetes.53.9.2181; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel SS, 2010, INT J CLIN PRACT, V64, P984, DOI 10.1111/j.1742-1241.2010.02382.x; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gallwitz B, 2011, EXPERT OPIN INV DRUG, V20, P723, DOI 10.1517/13543784.2011.576667; Ganesan R, 2009, STRUCTURE, V17, P1614, DOI 10.1016/j.str.2009.09.014; Garber AJ, 2010, AM J MANAG CARE, V16, pS187; Gorrell MD, 2005, CLIN SCI, V108, P277, DOI 10.1042/CS20040302; Gorrell MD, 2001, SCAND J IMMUNOL, V54, P249, DOI 10.1046/j.1365-3083.2001.00984.x; Gupta R, 2009, CURR DRUG TARGETS, V10, P71, DOI 10.2174/138945009787122860; KAMEOKA J, 1993, SCIENCE, V261, P466, DOI 10.1126/science.8101391; Keating GM, 2010, DRUGS, V70, P2089, DOI 10.2165/11206370-000000000-00000; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; Kirby M, 2010, CLIN SCI, V118, P31, DOI 10.1042/CS20090047; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Ligueros-Saylan M, 2010, DIABETES OBES METAB, V12, P495, DOI 10.1111/j.1463-1326.2010.01214.x; Longenecker KL, 2006, BIOCHEMISTRY-US, V45, P7474, DOI 10.1021/bi060184f; MARGUET D, 1992, J BIOL CHEM, V267, P2200; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; MISUMI Y, 1992, BIOCHIM BIOPHYS ACTA, V1131, P333, DOI 10.1016/0167-4781(92)90036-Y; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Pederson RA, 1998, DIABETES, V47, P1253, DOI 10.2337/diabetes.47.8.1253; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Richter B, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006739.pub2; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Sheehan SM, 2007, BIOORG MED CHEM LETT, V17, P1765, DOI 10.1016/j.bmcl.2006.12.074; Sun J, 2003, BIOCHEMISTRY-US, V42, P892, DOI 10.1021/bi026878f; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vilsboll T, 2002, DIABETOLOGIA, V45, P1111, DOI 10.1007/s00125-002-0878-6; Weihofen WA, 2005, J BIOL CHEM, V280, P14911, DOI 10.1074/jbc.M413400200; Weihofen WA, 2004, J BIOL CHEM, V279, P43330, DOI 10.1074/jbc.M405001200; Williams-Herman D, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-7; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104	46	5	6	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1307	1316		10.1074/jbc.M112.396317	http://dx.doi.org/10.1074/jbc.M112.396317			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184939	hybrid, Green Published			2022-12-28	WOS:000313570300052
J	Lee, JO; Lee, SK; Kim, JH; Kim, N; You, GY; Moon, JW; Kim, SJ; Park, SH; Kim, HS				Lee, Jung Ok; Lee, Soo Kyung; Kim, Ji Hae; Kim, Nami; You, Ga Young; Moon, Ji Wook; Kim, Su Jin; Park, Sun Hwa; Kim, Hyeon Soo			Metformin Regulates Glucose Transporter 4 (GLUT4) Translocation through AMP-activated Protein Kinase (AMPK)-mediated Cbl/CAP Signaling in 3T3-L1 Preadipocyte Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUCOSE-TRANSPORT; SKELETAL-MUSCLE; C-CBL; POTENTIAL ROLE; FATTY-ACID; INSULIN; ADIPOCYTES; CAP; CONTRACTION; DOMAIN	Metformin is a leading oral anti-diabetes mellitus medication and is known to stimulate GLUT4 translocation. However, the mechanism by which metformin acts is still largely unknown. Here, we showed that short time treatment with metformin rapidly increased phosphorylation of Cbl in an AMP-activated protein kinase (AMPK)-dependent fashion in 3T3-L1 preadipocytes. Metformin also increased phosphorylation of Src in an AMPK-dependent manner. Src inhibition blocked metformin-mediated Cbl phosphorylation, suggesting that metformin stimulates AMPK-Src-Cbl axis pathway. In addition, long term treatment with metformin stimulated the expression of Cbl-associated protein (CAP) mRNA and protein. Long term treatment with metformin stimulated phosphorylation of c-Jun N-terminal kinase (JNK) and its downstream molecule c-Jun, which is a critical molecule for CAP transcription. Knockdown of AMPK and JNK blocked metformin-induced expression of CAP, implying that metformin stimulates AMPK-JNK-CAP axis pathway. Moreover, AMPK knockdown attenuated metformin-induced Cbl/CAP multicomplex formation, which is critical for GLUT4 translocation. A colorimetric absorbance assay demonstrated that metformin-induced translocation of GLUT4 was suppressed in CAP or Cbl knockdown cells. Furthermore, the promoter activity of CAP was increased by metformin in an AMPK/JNK-dependent fashion. In summary, these results demonstrate that metformin modulates GLUT4 translocation by regulating Cbl and CAP signals via AMPK.	[Lee, Jung Ok; Lee, Soo Kyung; Kim, Ji Hae; Kim, Nami; You, Ga Young; Moon, Ji Wook; Kim, Su Jin; Park, Sun Hwa; Kim, Hyeon Soo] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine)	Kim, HS (corresponding author), 126-1 Anam Dong 5-Ga, Seoul 136705, South Korea.	anatomykim@korea.ac.kr			National Research Foundation of Korea; Korean Government [2010-0011053]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government)	This work was supported by the National Research Foundation of Korea funded by Korean Government Grant 2010-0011053.	Ai H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1291, DOI 10.1152/ajpendo.00167.2001; Alcazar O, 2004, BIOCHEM BIOPH RES CO, V317, P285, DOI 10.1016/j.bbrc.2004.03.038; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Barnes BR, 2005, CURR MOL MED, V5, P341, DOI 10.2174/1566524053766103; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Baumann CA, 2000, J BIOL CHEM, V275, P9131, DOI 10.1074/jbc.275.13.9131; BLAKE TJ, 1991, ONCOGENE, V6, P653; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; FISCHER Y, 1995, ENDOCRINOLOGY, V136, P412, DOI 10.1210/en.136.2.412; Gunton JE, 2003, J CLIN ENDOCR METAB, V88, P1323, DOI 10.1210/jc.2002-021394; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jessen N, 2003, J APPL PHYSIOL, V94, P1373, DOI 10.1152/japplphysiol.00250.2002; Kimura A, 2001, P NATL ACAD SCI USA, V98, P9098, DOI 10.1073/pnas.151252898; Kumar N, 2002, BRIT J PHARMACOL, V137, P329, DOI 10.1038/sj.bjp.0704878; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Liu J, 2003, J BIOL CHEM, V278, P36754, DOI 10.1074/jbc.M300664200; Liu J, 2002, MOL CELL BIOL, V22, P3599, DOI 10.1128/MCB.22.11.3599-3609.2002; Longnus SL, 2005, DIABETOLOGIA, V48, P2591, DOI 10.1007/s00125-005-0016-3; Makinde AO, 1997, CIRC RES, V80, P482, DOI 10.1161/01.RES.80.4.482; Meuillet EJ, 1999, EUR J PHARMACOL, V377, P241, DOI 10.1016/S0014-2999(99)00386-6; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Ribon V, 1998, MOL CELL BIOL, V18, P872, DOI 10.1128/MCB.18.2.872; Ribon V, 1998, J BIOL CHEM, V273, P4073, DOI 10.1074/jbc.273.7.4073; SARABIA V, 1992, J CLIN INVEST, V90, P1386, DOI 10.1172/JCI116005; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Tanti JF, 1997, ENDOCRINOLOGY, V138, P2005, DOI 10.1210/en.138.5.2005; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; Wijesekara N, 2006, AM J PHYSIOL-ENDOC M, V290, pE1276, DOI 10.1152/ajpendo.00573.2005; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI200114178; Yamaguchi S, 2005, AM J PHYSIOL-ENDOC M, V289, pE643, DOI 10.1152/ajpendo.00456.2004; Yang J, 2006, ENDOCRINOLOGY, V147, P2728, DOI 10.1210/en.2005-1433; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	37	77	83	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44121	44129		10.1074/jbc.M112.361386	http://dx.doi.org/10.1074/jbc.M112.361386			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23135276	hybrid, Green Published			2022-12-28	WOS:000312938600011
J	Tian, N; Leshchyns'ka, I; Welch, JH; Diakowski, W; Yang, HY; Schachner, M; Sytnyk, V				Tian, Nan; Leshchyns'ka, Iryna; Welch, Jeffrey H.; Diakowski, Witold; Yang, Hongyuan; Schachner, Melitta; Sytnyk, Vladimir			Lipid Raft-dependent Endocytosis of Close Homolog of Adhesion Molecule L1 (CHL1) Promotes Neuritogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CELL-SURFACE; DENDRITE ORIENTATION; NEURITE OUTGROWTH; MICE DEFICIENT; RPTP-ALPHA; SPECTRIN; NCAM; ASSOCIATION; COMPLEX; PHOSPHORYLATION	CHL1 plays a dual role by either promoting or inhibiting neuritogenesis. We report here that neuritogenesis-promoting ligand-dependent cell surface clustering of CHL1 induces palmitoylation and lipid raft-dependent endocytosis of CHL1. We identify beta II spectrin as a binding partner of CHL1, and we show that partial disruption of the complex between CHL1 and beta II spectrin accompanies CHL1 endocytosis. Inhibition of the association of CHL1 with lipid rafts by pharmacological disruption of lipid rafts or by mutation of cysteine 1102 within the intracellular domain of CHL1 reduces endocytosis of CHL1. Endocytosis of CHL1 is also reduced by nifedipine, an inhibitor of the L-type voltage-dependent Ca2+ channels. CHL1-dependent neurite outgrowth is reduced by inhibitors of lipid raft assembly, inhibitors of voltage-dependent Ca2+ channels, and overexpression of CHL1 with mutated cysteine Cys-1102. Our results suggest that ligand-induced and lipid raft-dependent regulation of CHL1 adhesion via Ca2+-dependent remodeling of the CHL1-beta II spectrin complex and CHL1 endocytosis are required for CHL1- dependent neurite outgrowth.	[Tian, Nan; Leshchyns'ka, Iryna; Schachner, Melitta; Sytnyk, Vladimir] Univ Krankenhaus Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Tian, Nan] Dalian Med Univ, Dept Physiol, Dalian 116044, Peoples R China; [Diakowski, Witold] Univ Wroclaw, Biotechnol Fac, Lab Cytobiochem, PL-51148 Wroclaw, Poland; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Leshchyns'ka, Iryna; Welch, Jeffrey H.; Yang, Hongyuan; Sytnyk, Vladimir] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	University of Hamburg; University Medical Center Hamburg-Eppendorf; Dalian Medical University; University of Wroclaw; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of New South Wales Sydney	Sytnyk, V (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	v.sytnyk@unsw.edu.au	Sytnyk, Vladimir/A-3878-2010; TIan, nan/GQP-1717-2022; Yang, Hongyuan/AAR-1326-2020	Yang, Hongyuan/0000-0002-8482-6031; Sytnyk, Vladimir/0000-0003-1927-2199; Leshchyns'ka, Iryna/0000-0002-2025-5831	Deutsche Forschungsgemeinschaft; Rebecca L. Cooper Medical Research Foundation; National Health and Medical Research Council; New Jersey Commission for Spinal Cord Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rebecca L. Cooper Medical Research Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); New Jersey Commission for Spinal Cord Research	This work was supported by Deutsche Forschungsgemeinschaft (to M. S., I. L., and V. S.), The Rebecca L. Cooper Medical Research Foundation (to V. S. and I. L.), National Health and Medical Research Council (to V. S.), and the New Jersey Commission for Spinal Cord Research (to M. S.).	Andreyeva A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012018; Ango F, 2008, PLOS BIOL, V6, P739, DOI 10.1371/journal.pbio.0060103; BENNETT V, 1986, METHOD ENZYMOL, V134, P55; Bennett V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003012; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Bodrikov V, 2008, J CELL BIOL, V182, P1185, DOI 10.1083/jcb.200803045; Buhusi M, 2003, J BIOL CHEM, V278, P25024, DOI 10.1074/jbc.M303084200; Chen QY, 2005, SCHIZOPHR RES, V73, P269, DOI 10.1016/j.schres.2004.06.001; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Chernyshova Y, 2011, J NEUROSCI, V31, P3522, DOI 10.1523/JNEUROSCI.3109-10.2011; De Matteis MA, 2000, J CELL SCI, V113, P2331; Demyanenko GP, 2011, CEREB CORTEX, V21, P401, DOI 10.1093/cercor/bhq115; Demyanenko GP, 2004, NEURON, V44, P423, DOI 10.1016/j.neuron.2004.10.016; Dequidt C, 2007, MOL BIOL CELL, V18, P3131, DOI 10.1091/mbc.E06-12-1101; Devanathan V, 2010, J NEUROSCI, V30, P9292, DOI 10.1523/JNEUROSCI.5657-09.2010; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; HARDY B, 1979, J CELL BIOL, V82, P654, DOI 10.1083/jcb.82.3.654; Hillenbrand R, 1999, EUR J NEUROSCI, V11, P813, DOI 10.1046/j.1460-9568.1999.00496.x; HINSSEN H, 1987, J CELL BIOL, V105, P1425, DOI 10.1083/jcb.105.3.1425; Jakovcevski I, 2007, J NEUROSCI, V27, P7222, DOI 10.1523/JNEUROSCI.0739-07.2007; Jakovcevski I, 2009, J COMP NEUROL, V513, P496, DOI 10.1002/cne.21981; Kamal A, 1998, J CELL BIOL, V142, P937, DOI 10.1083/jcb.142.4.937; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kolata S, 2008, J NEUROSCI, V28, P13505, DOI 10.1523/JNEUROSCI.2127-08.2008; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; Leshchyns'ka I, 2006, NEURON, V52, P1011, DOI 10.1016/j.neuron.2006.10.020; Michaely P, 1999, J BIOL CHEM, V274, P35908, DOI 10.1074/jbc.274.50.35908; Molitoris BA, 1996, AM J PHYSIOL-RENAL, V271, pF790, DOI 10.1152/ajprenal.1996.271.4.F790; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Morellini F, 2007, MOL CELL NEUROSCI, V34, P121, DOI 10.1016/j.mcn.2006.10.006; Nakai Y, 2002, J CELL BIOL, V159, P1097, DOI 10.1083/jcb.200209077; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Nishimune H, 2005, J NEUROSCI RES, V80, P593, DOI 10.1002/jnr.20517; Ponimaskin E, 2008, J NEUROSCI, V28, P8897, DOI 10.1523/JNEUROSCI.2171-08.2008; Pratte M, 2009, PHYSIOL BEHAV, V97, P394, DOI 10.1016/j.physbeh.2009.03.009; Puchkov D, 2011, CEREB CORTEX, V21, P2217, DOI 10.1093/cercor/bhq283; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Schlatter MC, 2008, J NEUROCHEM, V104, P731, DOI 10.1111/j.1471-4159.2007.05013.x; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Schrier S L, 1979, Prog Clin Biol Res, V30, P437; Simonovic M, 2006, J BIOL CHEM, V281, P34333, DOI 10.1074/jbc.M604613200; Spira ME, 2001, CELL MOL NEUROBIOL, V21, P591, DOI 10.1023/A:1015135617557; Stuermer CAO, 2011, J NEUROCHEM, V116, P708, DOI 10.1111/j.1471-4159.2010.07007.x; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; TRAVE G, 1995, EUR J BIOCHEM, V227, P35, DOI 10.1111/j.1432-1033.1995.tb20357.x; Westphal D, 2010, J BIOL CHEM, V285, P42046, DOI 10.1074/jbc.M110.177147; Wright AG, 2007, J NEUROSCI, V27, P13667, DOI 10.1523/JNEUROSCI.2888-07.2007; Ye H, 2008, EMBO J, V27, P188, DOI 10.1038/sj.emboj.7601939	52	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44447	44463		10.1074/jbc.M112.394973	http://dx.doi.org/10.1074/jbc.M112.394973			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144456	hybrid, Green Published			2022-12-28	WOS:000312938600041
J	Szpyt, J; Lorenzon, N; Perez, CF; Norris, E; Allen, PD; Beam, KG; Samso, M				Szpyt, John; Lorenzon, Nancy; Perez, Claudio F.; Norris, Ethan; Allen, Paul D.; Beam, Kurt G.; Samso, Montserrat			Three-Dimensional Localization of the alpha and beta Subunits and of the II-III Loop in the Skeletal Muscle L-type Ca2+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNELS; DIHYDROPYRIDINE RECEPTOR; RYANODINE RECEPTOR; ELECTRON CRYOMICROSCOPY; CRYSTAL-STRUCTURE; CYTOPLASMIC LOOP; RELEASE CHANNEL; SODIUM-CHANNEL; ACTIN GENE; DOMAINS II	The L-type Ca2+ channel (dihydropyridine receptor (DHPR) in skeletal muscle acts as the voltage sensor for excitation-contraction coupling. To better resolve the spatial organization of the DHPR subunits (alpha(1s) or Ca(V)1.1, alpha(2), beta(1a), delta 1, and gamma), we created transgenic mice expressing a recombinant beta(1a) subunit with YFP and a biotin acceptor domain attached to its N- and C-termini, respectively. DHPR complexes were purified from skeletal muscle, negatively stained, imaged by electron microscopy, and subjected to single-particle image analysis. The resulting 19.1-A resolution, three-dimensional reconstruction shows a main body of 17 x 11 x 8 nm with five corners along its perimeter. Two protrusions emerge from either face of the main body: the larger one attributed to the alpha(2)-delta 1 subunit that forms a flexible hook-shaped feature and a smaller protrusion on the opposite side that corresponds to the II-III loop of Ca(V)1.1 as revealed by antibody labeling. Novel features discernible in the electron density accommodate the atomic coordinates of a voltage-gated sodium channel and of the beta subunit in a single docking possibility that defines the alpha 1-beta interaction. The beta subunit appears more closely associated to the membrane than expected, which may better account for both its role in localizing the alpha(1s) subunit to the membrane and its suggested role in excitation-contraction coupling.	[Samso, Montserrat] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Szpyt, John; Perez, Claudio F.; Allen, Paul D.; Samso, Montserrat] Brigham & Womens Hosp, Dept Anesthesia, Boston, MA 02115 USA; [Szpyt, John; Perez, Claudio F.; Allen, Paul D.; Samso, Montserrat] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lorenzon, Nancy] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Norris, Ethan; Beam, Kurt G.] Univ Colorado Denver, Dept Physiol & Biophys, Aurora, CO 80045 USA	Virginia Commonwealth University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Samso, M (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Med Coll Virginia Campus, Richmond, VA 23298 USA.	msamso@vcu.edu		Samso, Montserrat/0000-0002-2788-3283	National Institutes of Health Grant [5K01AR054818, 1R01GM081819, 2R01AR05510]; Brigham and Women's Hospital Biomedical Research Institute Fund; Virginia Commonwealth University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR054818, R01AR055104, P01AR052354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081819] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brigham and Women's Hospital Biomedical Research Institute Fund; Virginia Commonwealth University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5K01AR054818 (to C. F. P.), 1R01GM081819 (to P. D. A. and M. S.), and 2R01AR05510 (to K. G. B. and P. D. A.). This work was also supported by the Brigham and Women's Hospital Biomedical Research Institute Fund to sustain Research Excellence (to M. S.) and by Virginia Commonwealth University startup funds (to M. S.).	Altafaj X, 2005, J BIOL CHEM, V280, P4013, DOI 10.1074/jbc.C400433200; Andronache Z, 2007, P NATL ACAD SCI USA, V104, P17885, DOI 10.1073/pnas.0704340104; Arikkath J, 2003, J BIOL CHEM, V278, P1212, DOI 10.1074/jbc.M208689200; Bannister RA, 2008, J BIOL CHEM, V283, P23217, DOI 10.1074/jbc.M804312200; Beurg M, 1999, BIOPHYS J, V76, P1744, DOI 10.1016/S0006-3495(99)77336-4; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Carbonneau L, 2005, BIOPHYS J, V89, P243, DOI 10.1529/biophysj.104.056218; Casarotto MG, 2006, CLIN EXP PHARMACOL P, V33, P1114, DOI 10.1111/j.1440-1681.2006.04501.x; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Cheng WJ, 2005, P NATL ACAD SCI USA, V102, P19225, DOI 10.1073/pnas.0504334102; CONSLER TG, 1993, P NATL ACAD SCI USA, V90, P6934, DOI 10.1073/pnas.90.15.6934; Conway JF, 2010, J MOL BIOL, V397, P575, DOI 10.1016/j.jmb.2010.01.043; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dulhunty AF, 2006, CLIN EXP PHARMACOL P, V33, P763, DOI 10.1111/j.1440-1681.2006.04441.x; Dulhunty AF, 1999, BIOPHYS J, V77, P189, DOI 10.1016/S0006-3495(99)76881-5; ELHAYEK R, 1995, J BIOL CHEM, V270, P22116, DOI 10.1074/jbc.270.38.22116; FLORIO V, 1992, METHOD ENZYMOL, V207, P529; Frank J, 2009, Q REV BIOPHYS, V42, P139, DOI 10.1017/S0033583509990059; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; GLAESER RM, 1989, ULTRAMICROSCOPY, V27, P307, DOI 10.1016/0304-3991(89)90021-1; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; HAASE H, 1991, EUR J PHARM-MOLEC PH, V207, P51, DOI 10.1016/S0922-4106(05)80037-9; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; He LL, 2007, BIOPHYS J, V93, P834, DOI 10.1529/biophysj.106.101691; Kobrinsky E, 2004, BIOPHYS J, V87, P844, DOI 10.1529/biophysj.104.041152; Kugler G, 2004, J BIOL CHEM, V279, P4721, DOI 10.1074/jbc.M307538200; Leong P, 1998, J BIOL CHEM, V273, P7791, DOI 10.1074/jbc.273.14.7791; Leong P, 1998, J BIOL CHEM, V273, P29958, DOI 10.1074/jbc.273.45.29958; Li RA, 2001, J BIOL CHEM, V276, P11072, DOI 10.1074/jbc.M010862200; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lorenzon NM, 2007, J GEN PHYSIOL, V130, P379, DOI 10.1085/jgp.200609730; Lorenzon NM, 2004, J BIOL CHEM, V279, P44057, DOI 10.1074/jbc.M405318200; LU XY, 1995, J BIOL CHEM, V270, P18459, DOI 10.1074/jbc.270.31.18459; LU XY, 1994, J BIOL CHEM, V269, P6511; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Meng X, 2007, J BIOL CHEM, V282, P25929, DOI 10.1074/jbc.M704474200; Murata K, 2010, J ELECTRON MICROSC, V59, P215, DOI 10.1093/jmicro/dfp059; MUSCAT GEO, 1987, MOL CELL BIOL, V7, P4089, DOI 10.1128/MCB.7.11.4089; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; Nakai J, 1997, P NATL ACAD SCI USA, V94, P1019, DOI 10.1073/pnas.94.3.1019; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; Paolini C, 2004, J MOL BIOL, V342, P145, DOI 10.1016/j.jmb.2004.07.035; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Proenza C, 2002, J BIOL CHEM, V277, P6530, DOI 10.1074/jbc.M106471200; Quillin ML, 2000, ACTA CRYSTALLOGR D, V56, P791, DOI 10.1107/S090744490000679X; Richards MW, 2007, CHANNELS, V1, P92, DOI 10.4161/chan.4145; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Schredelseker J, 2009, J BIOL CHEM, V284, P1242, DOI 10.1074/jbc.M807767200; Serysheva II, 2002, P NATL ACAD SCI USA, V99, P10370, DOI 10.1073/pnas.162363499; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Sheridan DC, 2012, CHANNELS, V6, P26, DOI 10.4161/chan.18916; Sheridan DC, 2003, BIOPHYS J, V84, P220, DOI 10.1016/S0006-3495(03)74844-9; Tae HS, 2011, J BIOL CHEM, V286, P22589, DOI 10.1074/jbc.M110.205476; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Vendel AC, 2006, PROTEIN SCI, V15, P378, DOI 10.1110/ps.051894506; Walsh CP, 2009, J BIOL CHEM, V284, P22310, DOI 10.1074/jbc.M109.017152; Wang MC, 2002, J MOL BIOL, V323, P85, DOI 10.1016/S0022-2836(02)00890-2; Wolf M, 2003, J MOL BIOL, V332, P171, DOI 10.1016/S0022-2836(03)00899-4; Yang L, 2011, FASEB J, V25, P928, DOI 10.1096/fj.10-172353; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13	70	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43853	43861		10.1074/jbc.M112.419283	http://dx.doi.org/10.1074/jbc.M112.419283			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118233	Green Published, hybrid			2022-12-28	WOS:000312940800062
J	Hagel, JM; Beaudoin, GAW; Fossati, E; Ekins, A; Martin, VJJ; Facchini, PJ				Hagel, Jillian M.; Beaudoin, Guillaume A. W.; Fossati, Elena; Ekins, Andrew; Martin, Vincent J. J.; Facchini, Peter J.			Characterization of a Flavoprotein Oxidase from Opium Poppy Catalyzing the Final Steps in Sanguinarine and Papaverine Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BERBERINE BRIDGE ENZYME; BRANCH-POINT ENZYME; CELL-CULTURES; DIHYDROBENZOPHENANTHRIDINE OXIDASE; ALKALOID BIOSYNTHESIS; MOLECULAR-CLONING; (S)-TETRAHYDROPROTOBERBERINE OXIDASE; BENZYLISOQUINOLINE ALKALOIDS; CANNABIS-SATIVA; ACID SYNTHASE	Benzylisoquinoline alkaloids are a diverse class of plant specialized metabolites that includes the analgesic morphine, the antimicrobials sanguinarine and berberine, and the vasodilator papaverine. The two-electron oxidation of dihydrosanguinarine catalyzed by dihydrobenzophenanthridine oxidase (DBOX) is the final step in sanguinarine biosynthesis. The formation of the fully conjugated ring system in sanguinarine is similar to the four-electron oxidations of (S)-canadine to berberine and (S)-tetrahydropapaverine to papaverine. We report the isolation and functional characterization of an opium poppy (Papaver somniferum) cDNA encoding DBOX, a flavoprotein oxidase with homology to (S)-tetrahydroprotoberberine oxidase and the berberine bridge enzyme. A query of translated opium poppy stem transcriptome databases using berberine bridge enzyme yielded several candidate genes, including an (S)-tetrahydroprotoberberine oxidase-like sequence selected for heterologous expression in Pichia pastoris. The recombinant enzyme preferentially catalyzed the oxidation of dihydrosanguinarine to sanguinarine but also converted (RS)-tetrahydropapaverine to papaverine and several protoberberine alkaloids to oxidized forms, including (RS)-canadine to berberine. The Km values of 201 and 146 mu M for dihydrosanguinarine and the protoberberine alkaloid (S)-scoulerine, respectively, suggested high concentrations of these substrates in the plant. Virus-induced gene silencing to reduce DBOX transcript levels resulted in a corresponding reduction in sanguinarine, dihydrosanguinarine, and papaverine accumulation in opium poppy roots in sup-port of DBOX as a multifunctional oxidative enzyme in BIA metabolism.	[Hagel, Jillian M.; Beaudoin, Guillaume A. W.; Facchini, Peter J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Fossati, Elena; Ekins, Andrew; Martin, Vincent J. J.] Concordia Univ, Dept Biol, Montreal, PQ H4B 1R6, Canada	University of Calgary; Concordia University - Canada	Facchini, PJ (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	pfacchin@ucalgary.ca		Facchini, Peter/0000-0002-7693-290X	Genome Canada; Genome Alberta; Genome Quebec; Government of Alberta; Canada Foundation for Innovation-Leaders Opportunity Fund; Natural Sciences and Engineering Research Council of Canada; Fonds Quebecois de la Recherche sur la Nature et les Technologies	Genome Canada(Genome Canada); Genome Alberta; Genome Quebec; Government of Alberta; Canada Foundation for Innovation-Leaders Opportunity Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT)	This work was supported by Genome Canada, Genome Alberta, Genome Quebec, the Government of Alberta, and the Canada Foundation for Innovation-Leaders Opportunity Fund.; Recipient of scholarships from the Natural Sciences and Engineering Research Council of Canada and Fonds Quebecois de la Recherche sur la Nature et les Technologies.	AMANN M, 1984, TETRAHEDRON LETT, V25, P953, DOI 10.1016/S0040-4039(01)80071-X; AMANN M, 1988, EUR J BIOCHEM, V175, P17, DOI 10.1111/j.1432-1033.1988.tb14160.x; ARAKAWA H, 1992, ARCH BIOCHEM BIOPHYS, V299, P1, DOI 10.1016/0003-9861(92)90236-P; Barken I, 2008, ANTICANCER RES, V28, P3701; BATTERSBY AR, 1977, BIOORG CHEM, V6, P43, DOI 10.1016/0045-2068(77)90006-2; Bird DA, 2001, PLANTA, V213, P888, DOI 10.1007/s004250100582; BROCHMANNHANSSEN E, 1975, J CHEM SOC PERK T 1, P1531, DOI 10.1039/p19750001531; Chavez MLD, 2011, ARCH BIOCHEM BIOPHYS, V507, P186, DOI 10.1016/j.abb.2010.11.016; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chou WM, 1998, PLANT J, V15, P289, DOI 10.1046/j.1365-313X.1998.00220.x; Custers JHHV, 2004, PLANT J, V39, P147, DOI 10.1111/j.1365-313X.2004.02117.x; Dang TTT, 2012, PLANT PHYSIOL, V159, P618, DOI 10.1104/pp.112.194886; Desgagne-Penix I, 2012, PLANT J, V72, P331, DOI 10.1111/j.1365-313X.2012.05084.x; Desgagne-Penix I, 2012, PLANT MOL BIOL, V79, P295, DOI 10.1007/s11103-012-9913-2; Desgagne-Penix I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-252; DITTRICH H, 1991, P NATL ACAD SCI USA, V88, P9969, DOI 10.1073/pnas.88.22.9969; Facchini PJ, 1996, PLANT PHYSIOL, V112, P1669, DOI 10.1104/pp.112.4.1669; Farrow SC, 2012, PHYTOCHEMISTRY, V77, P79, DOI 10.1016/j.phytochem.2012.02.014; Frick S, 2005, J NAT PROD, V68, P666, DOI 10.1021/np0496643; Gesell A, 2011, PLANTA, V233, P1185, DOI 10.1007/s00425-011-1357-4; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Hagel JM, 2008, TRENDS PLANT SCI, V13, P631, DOI 10.1016/j.tplants.2008.09.005; Han X, 2010, PHYTOCHEMISTRY, V71, P1305, DOI 10.1016/j.phytochem.2010.04.022; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Hirata K, 2004, PHYTOCHEMISTRY, V65, P1039, DOI 10.1016/j.phytochem.2004.02.015; Ignatov A, 1997, ARCH BIOCHEM BIOPHYS, V347, P208, DOI 10.1006/abbi.1997.0336; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Leferink NGH, 2008, ARCH BIOCHEM BIOPHYS, V474, P292, DOI 10.1016/j.abb.2008.01.027; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; ONeil M.J., 2006, MERCK INDEX ENCY CHE, V14th; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; SCHUMACHER HM, 1988, PLANT CELL REP, V7, P43, DOI 10.1007/BF00272975; Sirikantaramas S, 2004, J BIOL CHEM, V279, P39767, DOI 10.1074/jbc.M403693200; Takemura T, 2013, PHYTOCHEMISTRY, V91, P100, DOI 10.1016/j.phytochem.2012.02.013; Taura F, 2007, FEBS LETT, V581, P2929, DOI 10.1016/j.febslet.2007.05.043; UPRETY H, 1975, PHYTOCHEMISTRY, V14, P1535, DOI 10.1016/0031-9422(75)85346-5; Wijekoon CP, 2012, PLANT J, V69, P1052, DOI 10.1111/j.1365-313X.2011.04855.x; Winkler A, 2008, NAT CHEM BIOL, V4, P739, DOI 10.1038/nchembio.123; Winkler A, 2006, J BIOL CHEM, V281, P21276, DOI 10.1074/jbc.M603267200; Winkler A, 2009, PHYTOCHEMISTRY, V70, P1092, DOI 10.1016/j.phytochem.2009.06.005; Winzer T, 2012, SCIENCE, V336, P1704, DOI 10.1126/science.1220757; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730; Zulak KG, 2007, PLANTA, V225, P1085, DOI 10.1007/s00425-006-0419-5	48	39	49	1	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42972	42983		10.1074/jbc.M112.420414	http://dx.doi.org/10.1074/jbc.M112.420414			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23118227	Green Published, hybrid			2022-12-28	WOS:000312501600054
J	Kang, EL; Biscaro, B; Piazza, F; Tesco, G				Kang, Eugene L.; Biscaro, Barbara; Piazza, Fabrizio; Tesco, Giuseppina			BACE1 Protein Endocytosis and Trafficking Are Differentially Regulated by Ubiquitination at Lysine 501 and the Di-leucine Motif in the Carboxyl Terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE ACTIVITY; TRANS-GOLGI NETWORK; MULTIVESICULAR BODY PATHWAY; ALZHEIMERS-DISEASE; GGA PROTEINS; A-BETA; MEMORY DEFICITS; SORTING SIGNAL; EGF RECEPTOR	beta-Site amyloid precursor protein-cleaving enzyme (BACE1) is a membrane-tethered member of the aspartyl proteases that has been identified as beta-secretase. BACE1 is targeted through the secretory pathway to the plasma membrane and then is internalized to endosomes. Sorting of membrane proteins to the endosomes and lysosomes is regulated by the interaction of signals present in their carboxyl-terminal fragment with specific trafficking molecules. The BACE1 carboxyl-terminal fragment contains a di-leucine sorting signal ((DDISLL500)-D-495) and a ubiquitination site at Lys-501. Here, we report that lack of ubiquitination at Lys-501 (BACE1K501R) does not affect the rate of endocytosis but produces BACE1 stabilization and accumulation of BACE1 in early and late endosomes/lysosomes as well as at the cell membrane. In contrast, the disruption of the di-leucine motif (BACE1LLAA) greatly impairs BACE1 endocytosis and produces a delayed retrograde transport of BACE1 to the trans-Golgi network (TGN) and a delayed delivery of BACE1 to the lysosomes, thus decreasing its degradation. Moreover, the combination of the lack of ubiquitination at Lys-501 and the disruption of the di-leucine motif (BACE1LLAA/KR) produces additive effects on BACE1 stabilization and defective internalization. Finally, BACE1LLAA/KR accumulates in the TGN, while its levels are decreased in EEA1-positive compartments indicating that both ubiquitination at Lys-501 and the di-leucine motif are necessary for the trafficking of BACE1 from the TGN to early endosomes. Our studies have elucidated a differential role for the di-leucine motif and ubiquitination at Lys-501 in BACE1 endocytosis, trafficking, and degradation and suggest the involvement of multiple adaptor molecules.	[Kang, Eugene L.; Biscaro, Barbara; Piazza, Fabrizio; Tesco, Giuseppina] Tufts Univ, Sch Med, Dept Neurosci, Alzheimer Dis Res Lab, Boston, MA 02111 USA	Tufts University	Tesco, G (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Alzheimer Dis Res Lab, 136 Harrison Ave,Ste 328A, Boston, MA 02111 USA.	Giuseppina.Tesco@Tufts.edu	Piazza, Fabrizio/L-2094-2016	Piazza, Fabrizio/0000-0002-3385-3224	National Institutes of Health [5R01AG025952-07, P30 NS047243]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01AG025952-07 (to G. T.).; We thank Dr. Kendall Walker for the useful comments in the preparation and editing of this manuscript. We thank Dr. Alenka Lovy-Wheeler of the Tufts Imaging Facility for help with confocal microscopy (Tufts Center for Neuroscience Research, supported by National Institutes of Health Grant P30 NS047243).	Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bilodeau PS, 2004, J BIOL CHEM, V279, P54808, DOI 10.1074/jbc.M406654200; Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Cuartero Y, 2012, TRAFFIC, V13, P1393, DOI 10.1111/j.1600-0854.2012.01392.x; Davies BA, 2009, CHEM REV, V109, P1575, DOI 10.1021/cr800473s; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Deng Y, 2009, J BIOL CHEM, V284, P23830, DOI 10.1074/jbc.M109.030015; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; He XY, 2003, BIOCHEMISTRY-US, V42, P12174, DOI 10.1021/bi035199h; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kawasaki M, 2005, GENES CELLS, V10, P639, DOI 10.1111/j.1365-2443.2005.00865.x; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Pastorino L, 2002, MOL CELL NEUROSCI, V19, P175, DOI 10.1006/mcne.2001.1065; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Prabhu Y, 2012, MOL BIOL CELL, V23, P2339, DOI 10.1091/mbc.E11-11-0944; Prag G, 2005, P NATL ACAD SCI USA, V102, P2334, DOI 10.1073/pnas.0500118102; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Sankaranarayanan S, 2008, J PHARMACOL EXP THER, V324, P957, DOI 10.1124/jpet.107.130039; Sannerud R, 2011, P NATL ACAD SCI USA, V108, pE559, DOI 10.1073/pnas.1100745108; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Shiba T, 2004, TRAFFIC, V5, P437, DOI 10.1111/j.1600-0854.2004.00188.x; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; von Arnim CAF, 2004, J CELL SCI, V117, P5437, DOI 10.1242/jcs.01422; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	57	38	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42867	42880		10.1074/jbc.M112.407072	http://dx.doi.org/10.1074/jbc.M112.407072			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23109336	Green Published, hybrid			2022-12-28	WOS:000312501600045
J	Oku, T; Nakano, M; Kaneko, Y; Ando, Y; Kenmotsu, H; Itoh, S; Tsuiji, M; Seyama, Y; Toyoshima, S; Tsuji, T				Oku, Teruaki; Nakano, Mai; Kaneko, Yutaka; Ando, Yusuke; Kenmotsu, Hiroki; Itoh, Saotomo; Tsuiji, Makoto; Seyama, Yoshiyuki; Toyoshima, Satoshi; Tsuji, Tsutomu			Constitutive Turnover of Phosphorylation at Thr-412 of Human p57/Coronin-1 Regulates the Interaction with Actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; LEUCINE-ZIPPER MOTIF; T-CELL-ACTIVATION; PROTEIN-KINASE-C; BINDING-PROTEIN; CORONIN FAMILY; TRANSIENT ASSOCIATION; DICTYOSTELIUM CELLS; CYTOSKELETON; NEUTROPHILS	The actin-binding protein p57/coronin-1, a member of the coronin protein family, is selectively expressed in hematopoietic cells and plays crucial roles in the immune response through reorganization of the actin cytoskeleton. We previously reported that p57/coronin-1 is phosphorylated by protein kinase C, and the phosphorylation down-regulates the association of this protein with actin. In this study we analyzed the phosphorylation sites of p57/coronin-1 derived from HL60 human leukemic cells by MALDI-TOF-MS, two-dimensional gel electrophoresis, and Phos-tag (R) acrylamide gel electrophoresis in combination with site-directed mutagenesis and identified Ser-2 and Thr-412 as major phosphorylation sites. A major part of p57/coronin-1 was found as an unphosphorylated form in HL60 cells, but phosphorylation at Thr-412 of p57/coronin-1 was detected after the cells were treated with calyculin A, a Ser/Thr phosphatase inhibitor, suggesting that p57/coronin-1 undergoes constitutive turnover of phosphorylation/dephosphorylation at Thr-412. A diphosphorylated form of p57/coronin-1 was detected after the cells were treated with phorbol 12-myristate 13-acetate plus calyculin A. We then assessed the effects of phosphorylation at Thr-412 on the association of p57/coronin-1 with actin. A co-immunoprecipitation experiment with anti-p57/coronin-1 antibodies and HL60 cell lysates revealed that beta-actin was co-precipitated with the unphosphorylated form but not with the phosphorylated form at Thr-412 of p57/coronin-1. Furthermore, the phosphorylation mimic (T412D) of p57/coronin-1 expressed in HEK293T cells exhibited lower affinity for actin than the wild-type or the unphosphorylation mimic (T412A) did. These results indicate that the constitutive turnover of phosphorylation at Thr-412 of p57/coronin-1 regulates its interaction with actin.	[Tsuji, Tsutomu] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Microbiol, Shinagawa Ku, Tokyo 1428501, Japan; [Seyama, Yoshiyuki] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Clin Chem, Tokyo 1428501, Japan; [Toyoshima, Satoshi] Japan Pharmacists Educ Ctr, Tokyo 1070052, Japan	Hoshi University; Hoshi University	Tsuji, T (corresponding author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Microbiol, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	tsuji@hoshi.ac.jp		Tsuiji, Makoto/0000-0002-5607-4880; Ando, Yukio/0000-0001-7115-9105	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Open Research Center Project; Hoshi University Otani Research Grants; Araki Medical and Biochemical Research Memorial Fund	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Open Research Center Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hoshi University Otani Research Grants; Araki Medical and Biochemical Research Memorial Fund	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by the Open Research Center Project, by Hoshi University Otani Research Grants, and by the Araki Medical and Biochemical Research Memorial Fund.	Allen LAH, 1999, BLOOD, V93, P3521, DOI 10.1182/blood.V93.10.3521.410k21_3521_3530; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Combaluzier B, 2009, J IMMUNOL, V182, P1954, DOI 10.4049/jimmunol.0801811; Das V, 2002, IMMUNOL REV, V189, P123, DOI 10.1034/j.1600-065X.2002.18911.x; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Foger N, 2011, J EXP MED, V208, P1777, DOI 10.1084/jem.20101757; GAMBLE JR, 1988, J IMMUNOL METHODS, V109, P175, DOI 10.1016/0022-1759(88)90240-2; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; GERISCH G, 1995, CURR BIOL, V5, P1280, DOI 10.1016/S0960-9822(95)00254-5; GERISCH G, 1993, SYM SOC EXP BIOL, V47, P297; Hacker U, 1997, J CELL SCI, V110, P105; Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023; Hogquist KA, 2008, NAT IMMUNOL, V9, P1207, DOI 10.1038/ni1108-1207; Itoh S, 2006, J BIOMED MATER RES A, V77A, P294, DOI 10.1002/jbm.a.30608; Itoh S, 2002, BIOL PHARM BULL, V25, P837, DOI 10.1248/bpb.25.837; Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Kaminski S, 2011, J AUTOIMMUN, V37, P198, DOI 10.1016/j.jaut.2011.05.018; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Liu CZ, 2006, CELL RES, V16, P106, DOI 10.1038/sj.cr.7310014; MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Mueller P, 2011, J IMMUNOL, V186, P4039, DOI 10.4049/jimmunol.1003352; Mugnier B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003467; Nal B, 2004, INT IMMUNOL, V16, P231, DOI 10.1093/intimm/dxh022; Oku T, 2005, BIOCHEM J, V387, P325, DOI 10.1042/BJ20041020; Oku T, 2003, BIOL PHARM BULL, V26, P409; Oku T, 2008, J BIOL CHEM, V283, P28918, DOI 10.1074/jbc.M709990200; Pareek TK, 2010, J EXP MED, V207, P2507, DOI 10.1084/jem.20100876; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Shiow LR, 2009, CLIN IMMUNOL, V131, P24, DOI 10.1016/j.clim.2008.11.002; Siegmund K, 2011, J IMMUNOL, V186, P3452, DOI 10.4049/jimmunol.1003491; SUZUKI K, 1995, FEBS LETT, V364, P283, DOI 10.1016/0014-5793(95)00393-N; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Yan M, 2005, MOL BIOL CELL, V16, P3077, DOI 10.1091/mbc.E04-11-0989; Yan M, 2007, J IMMUNOL, V178, P5769, DOI 10.4049/jimmunol.178.9.5769	40	7	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42910	42920		10.1074/jbc.M112.349829	http://dx.doi.org/10.1074/jbc.M112.349829			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23100250	hybrid, Green Published			2022-12-28	WOS:000312501600049
J	Manna, P; Jain, SK				Manna, Prasenjit; Jain, Sushil K.			Vitamin D Up-regulates Glucose Transporter 4 (GLUT4) Translocation and Glucose Utilization Mediated by Cystathionine-gamma-lyase (CSE) Activation and H2S Formation in 3T3L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-SULFIDE; KNOCKOUT MICE; 1,25-DIHYDROXYVITAMIN D-3; 25-HYDROXYVITAMIN D; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; CELLS; RATS; ISCHEMIA; PROTEIN	A scientific explanation for the beneficial role of vitamin D supplementation in the lowering of glycemia in diabetes remains to be determined. This study examined the biochemical mechanism by which vitamin D supplementation regulates glucose metabolism in diabetes. 3T3L1 adipocytes were treated with high glucose (HG, 25 mM) in the presence or absence of 1,25-dihydroxyvitamin D-3(1,25(OH)(2)D-3) (25, 50 nM), the active form of vitamin D. 1,25(OH)(2)D-3 treatment caused significant up-regulation of GLUT4 total protein expression and its trans-location to cell surface, and an increase in glucose uptake as well as glucose utilization in HG-treated cells. 1,25(OH)(2)D-3 also caused cystathionine-gamma-lyase (CSE) activation and H2S formation in HG-treated adipocytes. The effect of 1,25(OH)(2)D-3 on GLUT4 translocation, glucose utilization, and H2S formation was prevented by propargylglycine, an inhibitor of CSE that catalyzes H2S formation. Studies using antisense CSE also demonstrated the inhibition of GLUT4 translocation as well as glucose uptake and utilization in 1,25(OH)(2)D-3-supplemented CSE-siRNA-transfected adipocytes compared with controls. 1,25(OH)(2)D-3 treatment along with insulin enhanced GLUT4 translocation and glucose utilization compared with either insulin or 1,25(OH)(2)D-3 alone in HG-treated adipocytes. 1,25(OH)(2)D-3 supplementation also inhibited monocyte chemoattractant protein-1 and stimulated adiponectin secretion in HG-treated adipocytes, and this positive effect was prevented in propargylglycine-treated or CSE-knockdown adipocytes. This is the first report to demonstrate that 1,25(OH)(2)D-3 up-regulates GLUT4 translocation and glucose utilization and decreases inflammatory markers, which is mediated by CSE activation and H2S formation in adipocytes. This study provides evidence for a novel molecular mechanism by which 1,25(OH)(2)D-3 can up-regulate the GLUT4 translocation essential for maintenance of glucose metabolism.	[Manna, Prasenjit; Jain, Sushil K.] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, Shreveport, LA 71103 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Jain, SK (corresponding author), Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, 1501 Kings Hwy, Shreveport, LA 71103 USA.	sjain@lsuhsc.edu		Jain, Sushil/0000-0002-9574-0436; Manna, Prasenjit/0000-0003-1952-6531	National Institutes of Health Grant through the NIDDK and the Office of Dietary Supplements [R01 DK072433]; Malcolm Feist Chair in Diabetes; Malcolm Feist Cardiovascular research fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072433] Funding Source: NIH RePORTER	National Institutes of Health Grant through the NIDDK and the Office of Dietary Supplements; Malcolm Feist Chair in Diabetes; Malcolm Feist Cardiovascular research fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01 DK072433 through the NIDDK and the Office of Dietary Supplements. This work was also supported by the Malcolm Feist Chair in Diabetes and the Malcolm Feist Cardiovascular research fellowship.	Aljabri KS, 2010, ANN SAUDI MED, V30, P454, DOI 10.4103/0256-4947.72265; CANDILOROS H, 1995, DIABETES CARE, V18, P549, DOI 10.2337/diacare.18.4.549; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; Foran PGP, 1999, J BIOL CHEM, V274, P28087, DOI 10.1074/jbc.274.40.28087; Grant WB, 2010, J AM MED DIR ASSOC, V11, P617, DOI 10.1016/j.jamda.2010.03.013; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jain SK, 2010, ANTIOXID REDOX SIGN, V12, P1333, DOI 10.1089/ars.2009.2956; Jung DW, 2011, MOL BIOSYST, V7, P346, DOI 10.1039/c0mb00089b; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Koshy S., 2010, JOVE-J VIS EXP, V45, pe2429; Lamendola CA, 2012, AM J CLIN NUTR, V95, P1055, DOI 10.3945/ajcn.111.032060; Li J, 2000, FASEB J, V14, P1117, DOI 10.1096/fasebj.14.9.1117; Liao W, 2006, ENDOCRINOLOGY, V147, P2245, DOI 10.1210/en.2005-1638; Liu YH, 2012, ANTIOXID REDOX SIGN, V17, P141, DOI 10.1089/ars.2011.4005; Maestro B, 2000, ENDOCR J, V47, P383, DOI 10.1507/endocrj.47.383; Manna P, 2011, J BIOL CHEM, V286, P39848, DOI 10.1074/jbc.M111.270884; Pittas AG, 2010, J STEROID BIOCHEM, V121, P425, DOI 10.1016/j.jsbmb.2010.03.042; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Rudich A, 2003, DIABETOLOGIA, V46, P649, DOI 10.1007/s00125-003-1080-1; Schwalfenberg G, 2008, CAN FAM PHYSICIAN, V54, P864; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; Suzuki K, 2011, P NATL ACAD SCI USA, V108, P13829, DOI 10.1073/pnas.1105121108; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Whiteman M, 2010, DIABETOLOGIA, V53, P1722, DOI 10.1007/s00125-010-1761-5; Willheim M, 1999, J CLIN ENDOCR METAB, V84, P3739, DOI 10.1210/jc.84.10.3739; Xu ZB, 2009, AM J PHYSIOL-RENAL, V297, pF27, DOI 10.1152/ajprenal.00096.2009; Yan H, 2004, BIOCHEM BIOPH RES CO, V313, P22, DOI 10.1016/j.bbrc.2003.11.081; YANG J, 1993, J BIOL CHEM, V268, P4600; Yaturu S., 2011, ISRN ENDOCRINOL, V2011; Zhu YZ, 2007, J APPL PHYSIOL, V102, P261, DOI 10.1152/japplphysiol.00096.2006	31	108	114	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42324	42332		10.1074/jbc.M112.407833	http://dx.doi.org/10.1074/jbc.M112.407833			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23074218	hybrid, Green Published			2022-12-28	WOS:000312103000067
J	Yurtsever, Z; Sala-Rabanal, M; Randolph, DT; Scheaffer, SM; Roswit, WT; Alevy, YG; Patel, AC; Heier, RF; Romero, AG; Nichols, CG; Holtzman, MJ; Brett, TJ				Yurtsever, Zeynep; Sala-Rabanal, Monica; Randolph, David T.; Scheaffer, Suzanne M.; Roswit, William T.; Alevy, Yael G.; Patel, Anand C.; Heier, Richard F.; Romero, Arthur G.; Nichols, Colin G.; Holtzman, Michael J.; Brett, Tom J.			Self-cleavage of Human CLCA1 Protein by a Novel Internal Metalloprotease Domain Controls Calcium-activated Chloride Channel Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECURRENT AIRWAY-OBSTRUCTION; CYSTIC-FIBROSIS; MEMBRANE-PROTEIN; CATALYTIC DOMAIN; FAMILY-MEMBERS; DISEASE; MCLCA3; CLONING; HCLCA2; GENE	The chloride channel calcium-activated (CLCA) family are secreted proteins that regulate both chloride transport and mucin expression, thus controlling the production of mucus in respiratory and other systems. Accordingly, human CLCA1 is a critical mediator of hypersecretory lung diseases, such as asthma, chronic obstructive pulmonary disease, and cystic fibrosis, that manifest mucus obstruction. Despite relevance to homeostasis and disease, the mechanism of CLCA1 function remains largely undefined. We address this void by showing that CLCA proteins contain a consensus proteolytic cleavage site recognized by a novel zincin metalloprotease domain located within the N terminus of CLCA itself. CLCA1 mutations that inhibit self-cleavage prevent activation of calcium-activated chloride channel (CaCC)-mediated chloride transport. CaCC activation requires cleavage to unmask the N-terminal fragment of CLCA1, which can independently gate CaCCs. Gating of CaCCs mediated by CLCA1 does not appear to involve proteolytic cleavage of the channel because a mutant N-terminal fragment deficient in proteolytic activity is able to induce currents comparable with that of the native fragment. These data provide both a mechanistic basis for CLCA1 self-cleavage and a novel mechanism for regulation of chloride channel activity specific to the mucosal interface.	[Yurtsever, Zeynep] Washington Univ, Sch Med, Biochem Program, St Louis, MO 63110 USA; [Yurtsever, Zeynep; Randolph, David T.; Roswit, William T.; Alevy, Yael G.; Heier, Richard F.; Romero, Arthur G.; Holtzman, Michael J.; Brett, Tom J.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Sala-Rabanal, Monica; Nichols, Colin G.; Holtzman, Michael J.; Brett, Tom J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Sala-Rabanal, Monica; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA; [Alevy, Yael G.; Patel, Anand C.; Romero, Arthur G.; Holtzman, Michael J.; Brett, Tom J.] Washington Univ, Sch Med, Drug Discovery Program, St Louis, MO 63110 USA; [Patel, Anand C.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Brett, Tom J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Brett, TJ (corresponding author), Campus Box 8052,660 S Euclid, St Louis, MO 63110 USA.	tbrett@wustl.edu	Brett, Thomas/AAC-9147-2019; Sala-Rabanal, Monica/AAU-2383-2021; Nichols, Colin/D-6336-2012; Patel, Anand/B-1441-2009	Brett, Thomas/0000-0002-6871-6676; Yurtsever, Zeynep/0000-0001-6848-8602; Patel, Anand/0000-0002-6570-8582	National Institutes of Health [RO1-HL073159, P50-HL107183, RO1-HL54171]; American Heart Association [0730336N]; American Cancer Society Grant [IRG-58-010-52]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171, K08HL083095, R01HL073159, P50HL107183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Cancer Society Grant(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL073159 and P50-HL107183 (to M. J. H.) and RO1-HL54171 (to C. G. N.). This work was also supported in part by funding from the American Heart Association (Grant 0730336N) and American Cancer Society Grant IRG-58-010-52 (to T. J. B).	Alevy Y. G., 2012, J CLIN INVE IN PRESS; Andrade A, 2007, EUR J NEUROSCI, V25, P1705, DOI 10.1111/j.1460-9568.2007.05454.x; Anton F, 2005, J HISTOCHEM CYTOCHEM, V53, P1011, DOI 10.1369/jhc.4A6599.2005; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bauer CS, 2010, CURR OPIN NEUROBIOL, V20, P563, DOI 10.1016/j.conb.2010.05.007; Bothe MK, 2008, J HISTOCHEM CYTOCHEM, V56, P495, DOI 10.1369/jhc.2008.950592; Bothe MK, 2012, MOL CELLS, V33, P251, DOI 10.1007/s10059-012-2217-1; Bothe M, 2011, MOL CELLS, V32, P535, DOI 10.1007/s10059-011-0158-8; Braun J, 2010, HISTOCHEM CELL BIOL, V133, P285, DOI 10.1007/s00418-009-0667-0; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; Devel L, 2010, BIOCHIMIE, V92, P1501, DOI 10.1016/j.biochi.2010.07.017; Duran C, 2012, AM J PHYSIOL-CELL PH, V302, pC482, DOI 10.1152/ajpcell.00140.2011; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Evans SR, 2004, J BIOL CHEM, V279, P41792, DOI 10.1074/jbc.M408354200; Galietta LJV, 2009, BIOPHYS J, V97, P3047, DOI 10.1016/j.bpj.2009.09.024; Gerhardt S, 2007, J MOL BIOL, V373, P891, DOI 10.1016/j.jmb.2007.07.047; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; Gruber AD, 1999, AM J PHYSIOL-CELL PH, V276, pC1261; Hamann M, 2009, J PHYSIOL-LONDON, V587, P2255, DOI 10.1113/jphysiol.2009.170159; Hegab AE, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012484; Huan CL, 2008, AM J PHYSIOL-CELL PH, V295, pC279, DOI 10.1152/ajpcell.00060.2008; Jeong SM, 2005, BIOCHEM BIOPH RES CO, V334, P569, DOI 10.1016/j.bbrc.2005.06.122; Kamada F, 2004, GENES IMMUN, V5, P540, DOI 10.1038/sj.gene.6364124; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Loewen ME, 2005, PHYSIOL REV, V85, P1061, DOI 10.1152/physrev.00016.2004; Mundhenk L, 2006, J BIOL CHEM, V281, P30072, DOI 10.1074/jbc.M606489200; Nakanishi A, 2001, P NATL ACAD SCI USA, V98, P5175, DOI 10.1073/pnas.081510898; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Patel AC, 2006, PHYSIOL GENOMICS, V25, P502, DOI 10.1152/physiolgenomics.00321.2005; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Range F, 2007, VET PATHOL, V44, P901, DOI 10.1354/vp.44-6-901; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Ritzka M, 2004, HUM GENET, V115, P483, DOI 10.1007/s00439-004-1190-y; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Tortorella MD, 2009, CURR PHARM DESIGN, V15, P2359, DOI 10.2174/138161209788682433; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; van der Doef HPJ, 2010, J PEDIATR GASTR NUTR, V50, P347, DOI 10.1097/MPG.0b013e3181afce6c; Walia V, 2012, ONCOGENE, V31, P2237, DOI 10.1038/onc.2011.392; Walia V, 2009, CANCER RES, V69, P6624, DOI 10.1158/0008-5472.CAN-08-4101; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Yamamura Aya, 2011, Pulm Circ, V1, P269, DOI 10.4103/2045-8932.83447; Yamazaki J, 2005, BBA-BIOMEMBRANES, V1715, P132, DOI 10.1016/j.bbamem.2005.08.001; Young FD, 2007, GASTROENTEROLOGY, V133, P1928, DOI 10.1053/j.gastro.2007.10.007	50	50	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42138	42149		10.1074/jbc.M112.410282	http://dx.doi.org/10.1074/jbc.M112.410282			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23112050	Green Published, hybrid			2022-12-28	WOS:000312103000052
J	Williams, RAM; Mottram, JC; Coombs, GH				Williams, Roderick A. M.; Mottram, Jeremy C.; Coombs, Graham H.			Distinct Roles in Autophagy and Importance in Infectivity of the Two ATG4 Cysteine Peptidases of Leishmania major	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLE TARGETING PATHWAY; APOPTOSIS; MITOCHONDRIA; DIFFERENTIATION; PROTEINS; MEXICANA; MICE; DEGRADATION; DYSFUNCTION; ACTIVATION	Macroautophagy in Leishmania, which is important for the cellular remodeling required during differentiation, relies upon the hydrolytic activity of two ATG4 cysteine peptidases (ATG4.1 and ATG4.2). We have investigated the individual contributions of each ATG4 to Leishmania major by generating individual gene deletion mutants (Delta atg4.1 and Delta atg4.2); double mutants could not be generated, indicating that ATG4 activity is required for parasite viability. Both mutants were viable as promastigotes and infected macrophages in vitro and mice, but Delta atg4.2 survived poorly irrespective of infection with promastigotes or amastigotes, whereas this was the case only when promastigotes of Delta atg4.1 were used. Promastigotes of Delta atg4.2 but not Delta atg4.1 were more susceptible than wild type promastigotes to starvation and oxidative stresses, which correlated with increased reactive oxygen species levels and oxidatively damaged proteins in the cells as well as impaired mitochondrial function. The antioxidant N-acetylcysteine reversed this phenotype, reducing both basal and induced autophagy and restoring mitochondrial function, indicating a relationship between reactive oxygen species levels and autophagy. Deletion of ATG4.2 had a more dramatic effect upon autophagy than did deletion of ATG4.1. This phenotype is consistent with a reduced efficiency in the autophagic process in Delta atg4.2, possibly due to ATG4.2 having a key role in removal of ATG8 from mature autophagosomes and thus facilitating delivery to the lysosomal network. These findings show that there is a level of functional redundancy between the two ATG4s, and that ATG4.2 appears to be the more important. Moreover, the low infectivity of Delta atg4.2 demonstrates that autophagy is important for the virulence of the parasite.	[Williams, Roderick A. M.; Coombs, Graham H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland; [Mottram, Jeremy C.] Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland	University of Strathclyde; University of Glasgow	Coombs, GH (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland.	graham.coombs@strath.ac.uk	Williams, Roderick/V-4317-2019	Williams, Roderick/0000-0001-5065-9768; Mottram, Jeremy/0000-0001-5574-3766	Medical Research Council [G0700127]; Wellcome Trust [085349]; MRC [G0700127, G0000508] Funding Source: UKRI; Medical Research Council [G0000508] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported Medical Research Council Grant G0700127 and core funding from Wellcome Trust Grant 085349.	AFONSO LCC, 1993, INFECT IMMUN, V61, P2952, DOI 10.1128/IAI.61.7.2952-2959.1993; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; Betin VMS, 2009, AUTOPHAGY, V5, P1057, DOI 10.4161/auto.5.7.9684; Betin VMS, 2009, J CELL SCI, V122, P2554, DOI 10.1242/jcs.046250; Bhattacharya A, 2008, FREE RADICAL BIO MED, V44, P779, DOI 10.1016/j.freeradbiomed.2007.10.059; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cabrera S, 2010, AUTOPHAGY, V6, P961, DOI 10.4161/auto.6.7.13065; Dalle-Donne I, 2002, FREE RADICAL BIO MED, V32, P927, DOI 10.1016/S0891-5849(02)00799-2; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Dolai S, 2011, J BIOL CHEM, V286, P13638, DOI 10.1074/jbc.M110.201889; Dolai S, 2009, EUKARYOT CELL, V8, P1721, DOI 10.1128/EC.00198-09; Garami A, 2001, EMBO J, V20, P3657, DOI 10.1093/emboj/20.14.3657; Geng JF, 2010, MOL BIOL CELL, V21, P2257, DOI 10.1091/mbc.E09-11-0969; Goldman SJ, 2011, ANTIOXID REDOX SIGN, V14, P1971, DOI 10.1089/ars.2010.3777; Graef M, 2011, AUTOPHAGY, V7, P1245, DOI 10.4161/auto.7.10.16508; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Krebiehl G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009367; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Li YC, 2012, TOXICOL APPL PHARM, V263, P21, DOI 10.1016/j.taap.2012.05.018; Manjithaya R, 2011, TRENDS CELL BIOL, V21, P67, DOI 10.1016/j.tcb.2010.09.009; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Marino G, 2010, J CLIN INVEST, V120, P2331, DOI 10.1172/JCI42601; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Misslitz A, 2000, MOL BIOCHEM PARASIT, V107, P251, DOI 10.1016/S0166-6851(00)00195-X; Morck C, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-39; Morck C, 2007, AUTOPHAGY, V3, P51; Mortensen M, 2011, AUTOPHAGY, V7, P1069, DOI 10.4161/auto.7.9.15886; Mottram JC, 1996, MOL MICROBIOL, V22, P573, DOI 10.1046/j.1365-2958.1996.00136.x; Nair U, 2010, J BIOL CHEM, V285, P11476, DOI 10.1074/jbc.M109.080374; Okamoto K, 2012, BBA-GEN SUBJECTS, V1820, P595, DOI 10.1016/j.bbagen.2011.08.001; Read R, 2011, VET PATHOL, V48, P486, DOI 10.1177/0300985810375810; SACKS DL, 1985, J IMMUNOL, V135, P564; Schapira AHV, 2008, NEUROCHEM RES, V33, P2502, DOI 10.1007/s11064-008-9855-x; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2007, AUTOPHAGY, V3, P371, DOI 10.4161/auto.4214; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Williams RAM, 2003, J BIOL CHEM, V278, P1480, DOI 10.1074/jbc.M209395200; Williams RA, 2006, MOL MICROBIOL, V61, P655, DOI 10.1111/j.1365-2958.2006.05274.x; Williams RAM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002695; Williams RAM, 2009, AUTOPHAGY, V5, P159, DOI 10.4161/auto.5.2.7328; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	56	24	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3678	3690		10.1074/jbc.M112.415372	http://dx.doi.org/10.1074/jbc.M112.415372			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23166325	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000314397900071
J	Zhang, SM; Wang, X; Iqbal, S; Wang, YR; Osunkoya, AO; Chen, ZJ; Chen, Z; Shin, DM; Yuan, HW; Wang, YQA; Zhau, HYE; Chung, LWK; Ritenour, C; Kucuk, O; Wu, DQ				Zhang, Shumin; Wang, Xu; Iqbal, Shareen; Wang, Yanru; Osunkoya, Adeboye O.; Chen, Zhengjia; Chen, Zhuo; Shin, Dong M.; Yuan, Hongwei; Wang, Yongqiang A.; Zhau, Haiyen E.; Chung, Leland W. K.; Ritenour, Chad; Kucuk, Omer; Wu, Daqing			Epidermal Growth Factor Promotes Protein Degradation of Epithelial Protein Lost in Neoplasm (EPLIN), a Putative Metastasis Suppressor, during Epithelial-mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PROSTATE-CANCER; TUMOR-CELL INVASION; ANDROGEN-INDEPENDENCE; GENE-EXPRESSION; BONE METASTASIS; DOWN-REGULATION; ENDOTHELIAL-CELLS; ALPHA EXPRESSION; REACTIVE STROMA; CROSS-LINKING	Aberrant expression of EGF receptors has been associated with hormone-refractory and metastatic prostate cancer (PCa). However, the molecular mechanism for EGF signaling in promoting PCa metastasis remains elusive. Using experimental models of PCa metastasis, we demonstrated that EGF could induce robust epithelial-mesenchymal transition (EMT) and increase invasiveness. Interestingly, EGF was found to be capable of promoting protein turnover of epithelial protein lost in neoplasm (EPLIN), a putative suppressor of EMT and tumor metastasis. Mechanistic study revealed that EGF could activate the phosphorylation, ubiquitination, and degradation of EPLIN through an extracellular signal-regulated kinase 1/2 (ERK1/2)-dependent signaling cascade. Pharmacological inhibition of the ERK1/2 pathway effectively antagonized EGF-induced EPLIN degradation. Two serine residues, i.e. serine 362 and serine 604, were identified as putative ERK1/2 phosphorylation sites in human EPLIN, whose point mutation rendered resistance to EGF-induced protein turnover. This study elucidated a novel molecular mechanism for EGF regulation of EMT and invasiveness in PCa cells, indicating that blockade of EGF signaling could be beneficial in preventing and retarding PCa metastasis at early stages.	[Zhang, Shumin; Iqbal, Shareen; Wang, Yanru; Osunkoya, Adeboye O.; Ritenour, Chad; Kucuk, Omer; Wu, Daqing] Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA; [Wang, Xu; Chen, Zhuo; Shin, Dong M.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA; [Osunkoya, Adeboye O.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Chen, Zhengjia] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Yuan, Hongwei] Inner Mongolia Med Coll, Dept Pathol, Affiliated Hosp, Hohhot 10050, Inner Mongolia, Peoples R China; [Wang, Yongqiang A.] Ocean NanoTech LLC, Springdale, AR 72764 USA; [Zhau, Haiyen E.; Chung, Leland W. K.] Cedars Sinai Med Ctr, Urooncol Res Program, Los Angeles, CA 90048 USA	Emory University; Emory University; Emory University; Emory University; Rollins School Public Health; Inner Mongolia Medical University; Cedars Sinai Medical Center	Wu, DQ (corresponding author), Emory Univ, Sch Med, Dept Urol, 1365 Clifton Rd NE,Clin B,B5107, Atlanta, GA 30322 USA.	dwu2@emory.edu	Ray, Dana M/C-3470-2013; Shin, Dong Moon/G-9649-2013	Shin, Dong Moon/0000-0002-8245-4174; , Shareen/0000-0002-9489-7781	NCI, National Institutes of Health [1R21CA164612-01A1, 1R43CA141870, P01 CA098912, R01 CA122602]; Georgia Cancer Coalition Distinguished Scholar Grant; American Cancer Society [RSG-10-140-01]; NATIONAL CANCER INSTITUTE [R43CA141870, P01CA098912, R01CA122602, R21CA164612] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition Distinguished Scholar Grant; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants 1R21CA164612-01A1 (to D. W), 1R43CA141870 (to Y. A. W), P01 CA098912 and R01 CA122602 (to L. W. K. C), and Georgia Cancer Coalition Distinguished Scholar Grant (to O. K). This work was also supported by American Cancer Society Grant RSG-10-140-01 (to D. W.).	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Angelucci A, 2006, ENDOCR-RELAT CANCER, V13, P197, DOI 10.1677/erc.1.01100; Ayala G, 2003, CLIN CANCER RES, V9, P4792; Bailey JM, 2007, J CELL BIOCHEM, V102, P829, DOI 10.1002/jcb.21509; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Chen SX, 2000, GENE, V248, P69, DOI 10.1016/S0378-1119(00)00144-X; Chervin-Petinot A, 2012, J BIOL CHEM, V287, P7556, DOI 10.1074/jbc.M111.328682; CHUNG LWK, 1991, CANCER METAST REV, V10, P263, DOI 10.1007/BF00050797; Dakhova O, 2009, CLIN CANCER RES, V15, P3979, DOI 10.1158/1078-0432.CCR-08-1899; DeHaan AM, 2009, PROSTATE, V69, P528, DOI 10.1002/pros.20903; Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; GLEAVE M, 1991, CANCER RES, V51, P3753; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Han MY, 2007, MOL CELL BIOL, V27, P8190, DOI 10.1128/MCB.00661-07; Hardy KM, 2010, J MAMMARY GLAND BIOL, V15, P191, DOI 10.1007/s10911-010-9172-2; Hernes E, 2004, BRIT J CANCER, V90, P449, DOI 10.1038/sj.bjc.6601536; Jiang WG, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-71; Josson S, 2011, CANCER RES, V71, P2600, DOI 10.1158/0008-5472.CAN-10-3382; Leitner L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-60; Liu YN, 2012, ANTICANCER RES, V32, P1283; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Maul RS, 1999, ONCOGENE, V18, P7838, DOI 10.1038/sj.onc.1203206; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Mimeault M, 2003, GROWTH FACTORS, V21, P1, DOI 10.1080/0897719031000094921; Mundy GR, 1997, CANCER-AM CANCER SOC, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.3.CO;2-R; Peraldo-Neia C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-31; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Sanders AJ, 2011, J UROLOGY, V186, P295, DOI 10.1016/j.juro.2011.03.038; Sanders AJ, 2010, ANGIOGENESIS, V13, P317, DOI 10.1007/s10456-010-9188-7; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Shah RB, 2006, PROSTATE, V66, P1437, DOI 10.1002/pros.20460; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Small EJ, 2007, BJU INT, V100, P765, DOI 10.1111/j.1464-410X.2007.07121.x; Song YH, 2002, MOL BIOL CELL, V13, P1408, DOI 10.1091/mbc.01-08-0414; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; Teixeira AL, 2008, CLIN CANCER RES, V14, P3367, DOI 10.1158/1078-0432.CCR-07-5119; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Xu ZH, 2010, BIOCHEM BIOPH RES CO, V401, P376, DOI 10.1016/j.bbrc.2010.09.059; Yanagisawa N, 2008, HUM PATHOL, V39, P282, DOI 10.1016/j.humpath.2007.04.025; Zellweger T, 2005, INT J CANCER, V113, P619, DOI 10.1002/ijc.20615; Zhang S, 2011, ONCOGENE, V30, P4941, DOI 10.1038/onc.2011.199; Zhang X, 2006, CLIN EXP METASTAS, V23, P209, DOI 10.1007/s10585-006-9031-0; Zhau HE, 2008, CLIN EXP METASTAS, V25, P601, DOI 10.1007/s10585-008-9183-1; Zhau HYE, 1996, P NATL ACAD SCI USA, V93, P15152, DOI 10.1073/pnas.93.26.15152; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	50	29	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1469	1479		10.1074/jbc.M112.438341	http://dx.doi.org/10.1074/jbc.M112.438341			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23188829	Green Published, hybrid			2022-12-28	WOS:000313751400005
J	Avrahami, L; Farfara, D; Shaham-Kol, M; Vassar, R; Frenkel, D; Eldar-Finkelman, H				Avrahami, Limor; Farfara, Dorit; Shaham-Kol, Maya; Vassar, Robert; Frenkel, Dan; Eldar-Finkelman, Hagit			Inhibition of Glycogen Synthase Kinase-3 Ameliorates beta-Amyloid Pathology and Restores Lysosomal Acidification and Mammalian Target of Rapamycin Activity in the Alzheimer Disease Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATHEPSIN-D; SYNAPTIC PLASTICITY; SIGNALING PATHWAY; AUTOPHAGY; CATENIN; GSK-3-BETA; PEPTIDE; COMPLEX; MEMORY; PHOSPHORYLATION	Accumulation of beta-amyloid (A beta) deposits is a primary pathological feature of Alzheimer disease that is correlated with neurotoxicity and cognitive decline. The role of glycogen synthase kinase-3 (GSK-3) in Alzheimer disease pathogenesis has been debated. To study the role of GSK-3 in A beta pathology, we used 5XFAD mice co-expressing mutated amyloid precursor protein and presenilin-1 that develop massive cerebral A beta loads. Both GSK-3 isozymes (alpha/beta) were hyperactive in this model. Nasal treatment of 5XFAD mice with a novel substrate competitive GSK-3 inhibitor, L803-mts, reduced A beta deposits and ameliorated cognitive deficits. Analyses of 5XFAD hemi-brain samples indicated that L803-mts restored the activity of mammalian target of rapamycin (mTOR) and inhibited autophagy. Lysosomal acidification was impaired in the 5XFAD brains as indicated by reduced cathepsin D activity and decreased N-glycoyslation of the vacuolar ATPase subunit V0a1, a modification required for lysosomal acidification. Treatment with L803-mts restored lysosomal acidification in 5XFAD brains. Studies in SH-SY5Y cells confirmed that GSK-3 beta and GSK-3 beta impair lysosomal acidification and that treatment with L803-mts enhanced the acidic lysosomal pool as demonstrated in LysoTracker Red-stained cells. Furthermore, L803-mts restored impaired lysosomal acidification caused by dysfunctional presenilin-1. We provide evidence that mTOR is a target activated by GSK-3 but inhibited by impaired lysosomal acidification and elevation in amyloid precursor protein/A beta loads. Taken together, our data indicate that GSK-3 is a player in A beta pathology. Inhibition of GSK-3 restores lysosomal acidification that in turn enables clearance of A beta burdens and reactivation of mTOR. These changes facilitate amelioration in cognitive function.	[Avrahami, Limor; Shaham-Kol, Maya; Eldar-Finkelman, Hagit] Tel Aviv Univ, George S Wise Fac Life Sci, Sackler Sch Med, Dept Human Mol Genet, IL-69978 Tel Aviv, Israel; [Avrahami, Limor; Shaham-Kol, Maya; Eldar-Finkelman, Hagit] Tel Aviv Univ, George S Wise Fac Life Sci, Sackler Sch Med, Dept Biochem, IL-69978 Tel Aviv, Israel; [Farfara, Dorit; Frenkel, Dan] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Vassar, Robert] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Northwestern University	Frenkel, D (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	dfrenkel@post.tau.ac.il; heldar@post.tau.ac.il	Eldar-Finkelman, Hagit/AAF-8329-2019	Eldar-Finkelman, Hagit/0000-0002-8460-9686	Israel Science Foundation [341/10]; Seventh Framework Program European Union [223276]; Alzheimer's Association [NIRG-11-205535]	Israel Science Foundation(Israel Science Foundation); Seventh Framework Program European Union; Alzheimer's Association(Alzheimer's Association)	This work was supported by Israel Science Foundation Grant 341/10 and Seventh Framework Program European Union Grant 223276 "NeuroGSK3" (to H. E.-F.) and by Alzheimer's Association Grant NIRG-11-205535 (to D. F.).	Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boland B, 2010, J BIOL CHEM, V285, P37415, DOI 10.1074/jbc.M110.186411; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Butler D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020501; Cataldo AM, 2004, J NEUROPATH EXP NEUR, V63, P821, DOI 10.1093/jnen/63.8.821; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cuervo AM, 2000, EXP GERONTOL, V35, P119, DOI 10.1016/S0531-5565(00)00075-9; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Eldar-Finkelman H, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00032; ELDARFINKELMAN H, 1995, J BIOL CHEM, V270, P987, DOI 10.1074/jbc.270.3.987; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Frydman-Marom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016564; Gasparini L, 2002, TRENDS PHARMACOL SCI, V23, P288, DOI 10.1016/S0165-6147(02)02037-0; GIESELMANN V, 1985, J BIOL CHEM, V260, P3215; Gomez-Sintes R, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00045; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hernandez F, 2010, MOL CELL BIOCHEM, V344, P211, DOI 10.1007/s11010-010-0544-0; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Huang HC, 2006, CURR DRUG TARGETS, V7, P1389, DOI 10.2174/1389450110607011389; Hurtado DE, 2012, J NEUROSCI, V32, P7392, DOI 10.1523/JNEUROSCI.0889-12.2012; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Illum L, 2000, EUR J PHARM SCI, V11, P1, DOI 10.1016/S0928-0987(00)00087-7; Jaworski T, 2011, NATURE, V480, pE4, DOI 10.1038/nature10615; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaidanovich-Beilin O, 2006, J PHARMACOL EXP THER, V316, P17, DOI 10.1124/jpet.105.090266; Kaidanovich-Beilin O, 2004, BIOL PSYCHIAT, V55, P781, DOI 10.1016/j.biopsych.2004.01.008; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Karyo R, 2010, MOL CELL NEUROSCI, V45, P449, DOI 10.1016/j.mcn.2010.08.004; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Lafay-Chebassier C, 2005, J NEUROCHEM, V94, P215, DOI 10.1111/j.1471-4159.2005.03187.x; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li BL, 2003, FEBS LETT, V553, P347, DOI 10.1016/S0014-5793(03)01042-1; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Ma T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012845; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Neely KM, 2011, J NEUROSCI, V31, P2781, DOI 10.1523/JNEUROSCI.5156-10.2010; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Plotkin B, 2003, J PHARMACOL EXP THER, V305, P974, DOI 10.1124/jpet.102.047381; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Rao R, 2007, DIABETOLOGIA, V50, P452, DOI 10.1007/s00125-006-0552-5; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Saura CA, 2005, J NEUROSCI, V25, P6755, DOI 10.1523/JNEUROSCI.1247-05.2005; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sereno L, 2009, NEUROBIOL DIS, V35, P359, DOI 10.1016/j.nbd.2009.05.025; Shin S, 2011, P NATL ACAD SCI USA, V108, pE1204, DOI 10.1073/pnas.1110195108; Song B, 2010, J BIOL CHEM, V285, P41122, DOI 10.1074/jbc.M110.130351; Steinfeld R, 2006, AM J HUM GENET, V78, P988, DOI 10.1086/504159; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Sun X, 2002, NEUROSCI LETT, V321, P61, DOI 10.1016/S0304-3940(01)02583-6; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Vila M, 2011, AUTOPHAGY, V7, P98, DOI 10.4161/auto.7.1.13933; Williamson W Ryan, 2010, Commun Integr Biol, V3, P604, DOI 10.4161/cib.3.6.13364; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yang DS, 2011, AUTOPHAGY, V7, P788, DOI 10.4161/auto.7.7.15596; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	83	161	167	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1295	1306		10.1074/jbc.M112.409250	http://dx.doi.org/10.1074/jbc.M112.409250			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23155049	Green Published, hybrid			2022-12-28	WOS:000313570300051
J	Mazor, R; Alsaigh, T; Shaked, H; Altshuler, AE; Pocock, ES; Kistler, EB; Karin, M; Schmid-Schonbein, GW				Mazor, Rafi; Alsaigh, Tom; Shaked, Helena; Altshuler, Angelina E.; Pocock, Elizabeth S.; Kistler, Erik B.; Karin, Michael; Schmid-Schoenbein, Geert W.			Matrix Metalloproteinase-1-mediated Up-regulation of Vascular Endothelial Growth Factor-2 in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; BREAST-CANCER; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; POOR-PROGNOSIS; PROMOTES; ANGIOGENESIS; PERMEABILITY; RECEPTOR; SURVIVAL	Matrix metalloproteinase-1 (MMP-1) is a collagenase that is highly active in extracellular matrix and vascular remodeling, angiogenesis, and tumor progression. Vascular endothelial growth factor receptor-2 (VEGFR2), the main receptor for VEGF-A, is expressed on endothelial cells and promotes cell survival, proliferation, and other functions. Although MMP-1 and VEGFR2 co-exist in many normal and pathophysiological conditions, the effect of MMP-1 on cellular VEGFR2 that can promote the above processes is unknown. In this study we test the hypothesis that stimulation of endothelial cells with MMP-1 increases their levels of VEGFR2. The increased VEGFR2 is then available to bind VEGF-A, resulting in increased response. Indeed we found that endothelial cells incubated with active MMP-1 had higher mRNA and protein levels of VEGFR2. Furthermore, VEGF-A-dependent phosphorylation of intracellular signaling molecules and endothelial proliferation were elevated after MMP-1 treatment. MMP-1 caused activation of the nuclear factor-kappa B (NF-kappa B) pathway (p65/RelA) in endothelial cells, and this response was dependent upon activation of protease activated receptor-1 (PAR-1). Chromatin immunoprecipitation was used to confirm NF-kappa B-mediated active transcription of the VEGFR2 (KDR) gene. Elevation in VEGFR2 after MMP-1 stimulation was inhibited by PAR-1 knockdown and NF-kappa B specific inhibition. We conclude that MMP-1 promotes VEGFR2 expression and proliferation of endothelial cells through stimulation of PAR-1 and activation of NF-kappa B. These results suggest a mechanism by which MMP-1 may prime or sensitize endothelial cell functions.	[Mazor, Rafi; Alsaigh, Tom; Altshuler, Angelina E.; Kistler, Erik B.; Schmid-Schoenbein, Geert W.] Vet Affairs Med Ctr, Inst Engn Med, Dept Bioengn, San Diego, CA 92161 USA; [Pocock, Elizabeth S.] Vet Affairs Med Ctr, Dept Surg, San Diego, CA 92161 USA; [Kistler, Erik B.] Vet Affairs Med Ctr, Anesthesiol Serv, San Diego, CA 92161 USA; [Kistler, Erik B.] Univ Calif San Diego, Dept Anesthesiol & Crit Care, La Jolla, CA 92093 USA; [Shaked, Helena; Karin, Michael] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Diego; University of California System; University of California San Diego	Mazor, R (corresponding author), Vet Affairs Med Ctr, Inst Engn Med, Dept Bioengn, San Diego, CA 92161 USA.	rmazor@eng.ucsd.edu; tom.alsaigh@gmail.com	Shaked, Helena/M-9682-2014	Mazor, Rafi/0000-0002-1382-1401; Kistler, Erik/0000-0002-6512-4798	National Institutes of Health [HL 10881]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development [1lK2BX001277-01A1]; Foundation for Anesthesia Education and Research; American Society of Critical Care Anesthesiologists; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL010881, T32HL105373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); Foundation for Anesthesia Education and Research; American Society of Critical Care Anesthesiologists; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 10881 (to G. W. S. S.) and by Career Development Award (CDA2) 1lK2BX001277-01A1(to E. K.) from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, and the Foundation for Anesthesia Education and Research and the American Society of Critical Care Anesthesiologists.	Agarwal A, 2008, MOL CANCER THER, V7, P2746, DOI 10.1158/1535-7163.MCT-08-0177; Alexander JS, 2002, J ANAT, V200, P561, DOI 10.1046/j.1469-7580.2002.00057.x; Alsaigh T, 2011, MICROVASC RES, V81, P108, DOI 10.1016/j.mvr.2010.09.010; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Blackburn JS, 2009, ONCOGENE, V28, P4237, DOI 10.1038/onc.2009.272; Blackburn JS, 2007, CANCER RES, V67, P10849, DOI 10.1158/0008-5472.CAN-07-1791; Blackburn JS, 2008, AM J PATHOL, V173, P1736, DOI 10.2353/ajpath.2008.080512; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Breslin JW, 2003, AM J PHYSIOL-HEART C, V284, pH92, DOI 10.1152/ajpheart.00330.2002; Bujan J, 2000, PHLEBOLOGY, V15, P64, DOI 10.1007/s005230070024; Carden D, 1998, AM J PHYSIOL-HEART C, V275, pH385, DOI 10.1152/ajpheart.1998.275.2.H385; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Giraudo E, 1998, J BIOL CHEM, V273, P22128, DOI 10.1074/jbc.273.34.22128; Goerge T, 2006, CANCER RES, V66, P7766, DOI 10.1158/0008-5472.CAN-05-3897; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsieh HL, 2009, ARTERIOSCL THROM VAS, V29, P1594, DOI 10.1161/ATVBAHA.109.185801; Illi B, 2000, CIRC RES, V86, pE110; Inoue T, 1999, INT J MOL MED, V4, P73; Ito T, 1999, MODERN PATHOL, V12, P669; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim Sangsoo, 2011, Genomics & Informatics, V9, P1; Klarenbach SW, 2003, CIRC RES, V92, P272, DOI 10.1161/01.RES.0000057386.15390.A3; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Murray GI, 1996, NAT MED, V2, P461, DOI 10.1038/nm0496461; Murray GI, 1998, J PATHOL, V185, P256; Nakopoulou L, 1999, HUM PATHOL, V30, P436, DOI 10.1016/S0046-8177(99)90120-X; Nesi A, 2007, CHEMBIOCHEM, V8, P1367, DOI 10.1002/cbic.200700055; Nikkola J, 2005, CLIN CANCER RES, V11, P5158, DOI 10.1158/1078-0432.CCR-04-2478; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Poola I, 2005, NAT MED, V11, P481, DOI 10.1038/nm1243; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Tantivejkul K, 2005, J CELL BIOCHEM, V96, P641, DOI 10.1002/jcb.20533; Tsopanoglou NE, 1999, J BIOL CHEM, V274, P23969, DOI 10.1074/jbc.274.34.23969; Uchida C, 2008, CELL BIOL INT, V32, P769, DOI 10.1016/j.cellbi.2008.03.005; Veikkola T, 2000, CANCER RES, V60, P203; Wachtel M, 1999, J CELL SCI, V112, P4347; Woodside KJ, 2003, J VASC SURG, V38, P162, DOI 10.1016/S0741-5214(03)00134-4	43	46	48	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					598	607		10.1074/jbc.M112.417451	http://dx.doi.org/10.1074/jbc.M112.417451			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23155052	Green Published, hybrid			2022-12-28	WOS:000313197200060
J	de Kreuk, BJ; Anthony, EC; Geerts, D; Hordijk, PL				de Kreuk, Bart-Jan; Anthony, Eloise C.; Geerts, Dirk; Hordijk, Peter L.			The F-BAR Protein PACSIN2 Regulates Epidermal Growth Factor Receptor Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; EGF RECEPTOR; DOWN-REGULATION; QUANTITATIVE-ANALYSIS; MEDIATED ENDOCYTOSIS; PCH PROTEINS; HER2 LEVELS; TRAFFICKING; DEGRADATION; SYNDAPIN	Signaling via growth factor receptors, including the epidermal growth factor (EGF) receptor, is key to various cellular processes, such as proliferation, cell survival, and cell migration. In a variety of human diseases such as cancer, aberrant expression and activation of growth factor receptors can lead to disturbed signaling. Intracellular trafficking is crucial for proper signaling of growth factor receptors. As a result, the level of cell surface expression of growth factor receptors is an important determinant for the outcome of downstream signaling. BAR domain-containing proteins represent an important family of proteins that regulate membrane dynamics. In this study, we identify a novel role for the F-BAR protein PACSIN2 in the regulation of EGF receptor signaling. We show that internalized EGF as well as the (activated) EGF receptor translocated to PACSIN2-positive endosomes. Furthermore, loss of PACSIN2 increased plasma membrane expression of the EGF receptor in resting cells and increased EGF-induced phosphorylation of the EGF receptor. As a consequence, EGF-induced activation of Erk and Akt as well as cell proliferation were enhanced in PACSIN2-depleted cells. In conclusion, this study identifies a novel role for the F-BAR-domain protein PACSIN2 in regulating EGF receptor surface levels and EGF-induced downstream signaling.	[Hordijk, Peter L.] Univ Amsterdam, Swammerdam Inst Life Sci, Acad Med Ctr, Dept Mol Cell Biol,Sanquin Res & Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands; [Geerts, Dirk] Erasmus Univ, Med Ctr, Dept Pediat Oncol Hematol, NL-3015 GE Rotterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC	Hordijk, PL (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Acad Med Ctr, Dept Mol Cell Biol,Sanquin Res & Landsteiner Lab, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	p.hordijk@sanquin.nl	Geerts, Dirk/K-8260-2015	Geerts, Dirk/0000-0002-6386-8187; Hordijk, Peter/0000-0002-3348-078X	Landsteiner Stichting voor Bloedtransfusie Research (LSBR) [0731]; Netherlands Organization for Scientific Research [40-00506-98-10013]	Landsteiner Stichting voor Bloedtransfusie Research (LSBR); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Supported by an Landsteiner Stichting voor Bloedtransfusie Research (LSBR) Grant 0731.; The NanoPro 1000 System (ProteinSimple) in the Hordijk laboratory was enabled through a "middelgroot" investment grant (40-00506-98-10013) from the Netherlands Organization for Scientific Research. We thank Dr. M. Fernandez-Borja for stimulating discussions.	Bao J, 2000, J BIOL CHEM, V275, P26178, DOI 10.1074/jbc.M002367200; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; de Kreu BJ, 2011, J CELL SCI, V124, P2375, DOI 10.1242/jcs.080630; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Grant SL, 2002, ONCOGENE, V21, P460, DOI 10.1038/sj.onc.1205100; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hanafusa H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1161; Hendriks BS, 2003, CANCER RES, V63, P1130; Hendriks BS, 2003, J BIOL CHEM, V278, P23343, DOI 10.1074/jbc.M300477200; HERBST JJ, 1994, J BIOL CHEM, V269, P12865; Hu JH, 2009, CELL SIGNAL, V21, P1686, DOI 10.1016/j.cellsig.2009.07.007; Huang Y, 2006, ONCOGENE, V25, P7565, DOI 10.1038/sj.onc.1209740; Kessels MM, 2006, J BIOL CHEM, V281, P13285, DOI 10.1074/jbc.M510226200; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Kim SH, 2006, GENES CELLS, V11, P1197, DOI 10.1111/j.1365-2443.2006.01008.x; KING AC, 1984, BIOCHEM BIOPH RES CO, V124, P585, DOI 10.1016/0006-291X(84)91594-8; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Liu H, 2006, BIOCHEM BIOPH RES CO, V342, P537, DOI 10.1016/j.bbrc.2006.01.179; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Mechtcheriakova D, 2001, FASEB J, V15, P230, DOI 10.1096/fj.00-0247com; Modregger J, 2000, J CELL SCI, V113, P4511; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Prasad NK, 2008, CARCINOGENESIS, V29, P25, DOI 10.1093/carcin/bgm213; Prasad NK, 2005, J BIOL CHEM, V280, P13129, DOI 10.1074/jbc.M410289200; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Razi M, 2006, MOL BIOL CELL, V17, P3469, DOI 10.1091/mbc.E05-11-1054; Rush JS, 2012, J BIOL CHEM, V287, P712, DOI 10.1074/jbc.M111.294470; Schmidt MHH, 2004, MOL CELL BIOL, V24, P8981, DOI 10.1128/MCB.24.20.8981-8993.2004; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Shimada A, 2010, FEBS LETT, V584, P1111, DOI 10.1016/j.febslet.2010.02.058; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; van Weering JRT, 2010, SEMIN CELL DEV BIOL, V21, P371, DOI 10.1016/j.semcdb.2009.11.009; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang Q, 2009, P NATL ACAD SCI USA, V106, P12700, DOI 10.1073/pnas.0902974106; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974	47	24	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43438	43453		10.1074/jbc.M112.391078	http://dx.doi.org/10.1074/jbc.M112.391078			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129763	Green Published, hybrid			2022-12-28	WOS:000312940800025
J	Machado, CF; Beraldo, FH; Santos, TG; Bourgeon, D; Landemberger, MC; Roffe, M; Martins, VR				Machado, Cleiton F.; Beraldo, Flavio H.; Santos, Tiago G.; Bourgeon, Dominique; Landemberger, Michele C.; Roffe, Martin; Martins, Vilma R.			Disease-associated Mutations in the Prion Protein Impair Laminin-induced Process Outgrowth and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCIBLE PROTEIN-1; CREUTZFELDT-JAKOB-DISEASE; FATAL FAMILIAL INSOMNIA; ANTI-BAX FUNCTION; CELLULAR PRION; PATHOGENIC MUTATIONS; NEURONAL APOPTOSIS; MITOMYCIN-C; THERMODYNAMIC STABILITY; HYDROPHOBIC CORE	Prions, the agents of transmissible spongiform encephalopathies, require the expression of prion protein (PrPC) to propagate disease. PrPC is converted into an abnormal insoluble form, PrPSc, that gains neurotoxic activity. Conversely, clinical manifestations of prion disease may occur either before or in the absence of PrPSc deposits, but the loss of normal PrPC function contribution for the etiology of these diseases is still debatable. Prion disease-associated mutations in PrPC represent one of the best models to understand the impact of PrPC loss-of-function. PrPC associates with various molecules and, in particular, the interaction of PrPC with laminin (Ln) modulates neuronal plasticity and memory formation. To assess the functional alterations associated with PrPC mutations, wild-type and mutated PrPC proteins were expressed in a neural cell line derived from a PrPC-null mouse. Treatment with the laminin gamma 1 chain peptide (Ln gamma 1), which mimics the Ln binding site for PrPC, increased intracellular calcium in cells expressing wild-type PrPC, whereas a significantly lower response was observed in cells expressing mutated PrPC molecules. The Ln gamma 1 did not promote process outgrowth or protect against staurosporine-induced cell death in cells expressing mutated PrPC molecules in contrast to cells expressing wild-type PrPC. The co-expression of wild-type PrPC with mutated PrPC molecules was able to rescue the Ln protective effects, indicating the lack of negative dominance of PrPC mutated molecules. These results indicate that PrPC mutations impair process outgrowth and survival mediated by Ln gamma 1 peptide in neural cells, which may contribute to the pathogenesis of genetic prion diseases.	[Machado, Cleiton F.; Santos, Tiago G.; Bourgeon, Dominique; Landemberger, Michele C.; Roffe, Martin; Martins, Vilma R.] AC Camargo Hosp, Int Res Ctr, BR-01508010 Sao Paulo, Brazil; [Machado, Cleiton F.; Santos, Tiago G.; Bourgeon, Dominique; Landemberger, Michele C.; Roffe, Martin; Martins, Vilma R.] CNPq MCT FAPESP, Natl Inst Translat Neurosci, BR-01508010 Sao Paulo, Brazil; [Beraldo, Flavio H.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada; [Beraldo, Flavio H.] Univ Western Ontario, Robarts Res Inst, J Allyn Taylor Ctr Cell Biol, Mol Brain Res Grp, London, ON N6A 5K8, Canada	A.C.Camargo Cancer Center; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Western University (University of Western Ontario); Western University (University of Western Ontario)	Martins, VR (corresponding author), AC Camargo Hosp, Int Res Ctr, Rua Tagua 440, BR-01508010 Sao Paulo, Brazil.	vmartins@cipe.accamargo.org.br	Martins, Vilma R/E-2547-2012; Martins, Vilma/N-5446-2019; Santos, Tiago/F-2387-2012; Roffe, Martin/S-1124-2019; Neurociencia, Inct/I-1011-2013; dos Santos, Tiago Goss/A-1538-2019; Roffé, Martín/I-1864-2013; Machado, Cleiton/I-5907-2014; Santos, Tiago Goss/AAQ-4272-2020; Landemberger, Michele Christine/P-3014-2014	Martins, Vilma R/0000-0002-2909-8502; Santos, Tiago/0000-0001-6641-7413; Roffe, Martin/0000-0001-7247-3067; dos Santos, Tiago Goss/0000-0001-6641-7413; Roffé, Martín/0000-0001-7247-3067; Machado, Cleiton/0000-0002-3313-3868; Santos, Tiago Goss/0000-0001-6641-7413; Landemberger, Michele Christine/0000-0002-3513-3554	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/01427-2]; Howard Hughes Medical Institute; National Institute of Tanslational Neuroscience-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Ministerio da Ciencia e Tecnologia (INNT-CNPq/MCT); Ludwig Institute for Cancer Research; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [06/61251-7, 09/51653-9, 08/04776-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Tanslational Neuroscience-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Ministerio da Ciencia e Tecnologia (INNT-CNPq/MCT); Ludwig Institute for Cancer Research; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2009/01427-2), the Howard Hughes Medical Institute, and the National Institute of Tanslational Neuroscience-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Ministerio da Ciencia e Tecnologia (INNT-CNPq/MCT) and Ludwig Institute for Cancer Research. This work was also supported by the following fellowships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: 06/61251-7 (to C. F. M.); 09/51653-9 (T. G. S.); 08/04776-5 (to D. B.).	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Ali SH, 2001, SEMIN CANCER BIOL, V11, P15, DOI 10.1006/scbi.2000.0342; Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Baumann F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006707; Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653; BLACKER KL, 1987, J INVEST DERMATOL, V89, P536, DOI 10.1111/1523-1747.ep12461169; Blake DA, 2006, J GLAUCOMA, V15, P291, DOI 10.1097/01.ijg.0000212236.96039.9c; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Campana V, 2006, J CELL SCI, V119, P433, DOI 10.1242/jcs.02768; Coitinho AS, 2006, EUR J NEUROSCI, V24, P3255, DOI 10.1111/j.1460-9568.2006.05156.x; Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005; Diarra-Mehrpour M, 2004, CANCER RES, V64, P719, DOI 10.1158/0008-5472.CAN-03-1735; Dorandeu A, 1998, BRAIN PATHOL, V8, P531; Esch T, 1999, J NEUROSCI, V19, P6417; Faucheux BA, 2011, NEUROPATH APPL NEURO, V37, P500, DOI 10.1111/j.1365-2990.2011.01179.x; Fioriti L, 2005, J BIOL CHEM, V280, P11320, DOI 10.1074/jbc.M412441200; Flechsig E, 2003, EMBO J, V22, P3095, DOI 10.1093/emboj/cdg285; Galderisi U, 2003, ONCOGENE, V22, P5208, DOI 10.1038/sj.onc.1206558; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Gray F, 1999, B ACAD NAT MED PARIS, V183, P305; Gray F, 1999, J NEUROPATH EXP NEUR, V58, P321, DOI 10.1097/00005072-199904000-00002; Greil CS, 2008, VIROLOGY, V379, P284, DOI 10.1016/j.virol.2008.07.006; Hetz C, 2003, TRENDS MOL MED, V9, P237, DOI 10.1016/S1471-4914(03)00069-8; Jodoin J, 2007, J NEUROSCI, V27, P5081, DOI 10.1523/JNEUROSCI.0957-07.2007; Jodoin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006647; Kiachopoulos S, 2005, J BIOL CHEM, V280, P9320, DOI 10.1074/jbc.M412525200; Kim C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002835; KRISTENSSON K, 1993, NEUROLOGY, V43, P2335, DOI 10.1212/WNL.43.11.2335; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Lima FRS, 2007, J NEUROCHEM, V103, P2164, DOI 10.1111/j.1471-4159.2007.04904.x; Linden R., 2011, UCSD NATURE MOL 0729, DOI [10.1038/mp.a003935.01, DOI 10.1038/MP.A003935.01]; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Linden R, 2012, CELL MOL LIFE SCI, V69, P1105, DOI 10.1007/s00018-011-0847-7; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Parchi P, 1998, BRAIN PATHOL, V8, P539; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; PAULSSON M, 1987, EUR J BIOCHEM, V166, P11, DOI 10.1111/j.1432-1033.1987.tb13476.x; Petersen RB, 1996, J BIOL CHEM, V271, P12661, DOI 10.1074/jbc.271.21.12661; Ponchio L, 2000, CYTOTHERAPY, V2, P281, DOI 10.1080/146532400539215; Prusiner SB, 1997, ANNU REV GENET, V31, P139, DOI 10.1146/annurev.genet.31.1.139; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Rodriguez A, 2005, NEUROSCIENCE, V131, P825, DOI 10.1016/j.neuroscience.2004.12.023; Rodriguez A, 2006, NEUROSCI LETT, V410, P115, DOI 10.1016/j.neulet.2006.09.084; Roffe M, 2010, P NATL ACAD SCI USA, V107, P13147, DOI 10.1073/pnas.1000784107; Romano SA, 2009, FASEB J, V23, P4308, DOI 10.1096/fj.09-138974; Rossetti G, 2011, J MOL BIOL, V411, P700, DOI 10.1016/j.jmb.2011.06.008; Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; Sakudo A, 2005, BIOCHEM BIOPH RES CO, V328, P14, DOI 10.1016/j.bbrc.2004.12.132; Sakurai-Yamashita Y, 2005, NEUROSCIENCE, V136, P281, DOI 10.1016/j.neuroscience.2005.06.095; Schiff E, 2008, TRAFFIC, V9, P1101, DOI 10.1111/j.1600-0854.2008.00746.x; Shyu WC, 2005, J NEUROSCI, V25, P8967, DOI 10.1523/JNEUROSCI.1115-05.2005; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; Thackray AM, 2007, BIOCHEM J, V401, P475, DOI 10.1042/BJ20061264; van der Kamp MW, 2010, J MOL BIOL, V404, P732, DOI 10.1016/j.jmb.2010.09.060; van der Kamp MW, 2009, PROTEIN ENG DES SEL, V22, P461, DOI 10.1093/protein/gzp039; Watanabe Y, 2008, BIOCHEM BIOPH RES CO, V366, P244, DOI 10.1016/j.bbrc.2007.11.145; Weise J, 2006, STROKE, V37, P1296, DOI 10.1161/01.STR.0000217262.03192.d4; Weise J, 2004, NEUROSCI LETT, V372, P146, DOI 10.1016/j.neulet.2004.09.030; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325	78	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43777	43788		10.1074/jbc.M112.428235	http://dx.doi.org/10.1074/jbc.M112.428235			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23132868	Green Published, hybrid			2022-12-28	WOS:000312940800056
J	Sahu, BS; Obbineni, JM; Sahu, G; Allu, PKR; Subramanian, L; Sonawane, PJ; Singh, PK; Sasi, BK; Senapati, S; Maji, SK; Bera, AK; Gomathi, BS; Mullasari, AS; Mahapatra, NR				Sahu, Bhavani S.; Obbineni, Jagan M.; Sahu, Giriraj; Allu, Prasanna K. R.; Subramanian, Lakshmi; Sonawane, Parshuram J.; Singh, Pradeep K.; Sasi, Binu K.; Senapati, Sanjib; Maji, Samir K.; Bera, Amal K.; Gomathi, Balashankar S.; Mullasari, Ajit S.; Mahapatra, Nitish R.			Functional Genetic Variants of the Catecholamine-Release-Inhibitory Peptide Catestatin in an Indian Population ALLELE-SPECIFIC EFFECTS ON METABOLIC TRAITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOGRANIN-A FRAGMENT; NICOTINIC ACETYLCHOLINE-RECEPTOR; ENDOGENOUS PEPTIDE; MECHANISM; A(352-372); COMMON; RISK; ACTS	Catestatin (CST), a chromogranin A (CHGA)-derived peptide, is a potent inhibitor of catecholamine release from adrenal chromaffin cells and postganglionic sympathetic axons. We re-sequenced the CST region of CHGA in an Indian population (n = 1010) and detected two amino acid substitution variants: G364S and G367V. Synthesized CST variant peptides (viz. CST-Ser-364 and CST-Val-367) were significantly less potent than the wild type peptide (CST-WT) to inhibit nicotine-stimulated catecholamine secretion from PC12 cells. Consistently, the rank-order of blockade of nicotinic acetylcholine receptor (nAChR)-stimulated inward current and intracellular Ca2+ rise by these peptides in PC12 cells was: CST-WT > CST-Ser-364 > CST-Val-367. Structural analysis by CD spectroscopy coupled with molecular dynamics simulations revealed the following order of alpha-helical content: CST-WT > CST-Ser-364 > CST-Val-367; docking of CST peptides onto a major human nAChR subtype and molecular dynamics simulations also predicted the above rank order for their binding affinity with nAChR and the extent of occlusion of the receptor pore, providing a mechanistic basis for differential potencies. The G364S polymorphism was in strong linkage disequilibrium with several common CHGA genetic variations. Interestingly, the Ser-364 allele (detected in similar to 15% subjects) was strongly associated with profound reduction (up to similar to 2.1-fold) in plasma norepinephrine/epinephrine levels consistent with the diminished nAChR desensitization-blocking effect of CST-Ser-364 as compared with CST-WT. Additionally, the Ser-364 allele showed strong associations with elevated levels of plasma triglyceride and glucose levels. In conclusion, a common CHGA variant in an Indian population influences several biochemical parameters relevant to cardiovascular/metabolic disorders.	[Sonawane, Parshuram J.; Sasi, Binu K.; Senapati, Sanjib; Bera, Amal K.; Mahapatra, Nitish R.] Indian Inst Technol Madras, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Singh, Pradeep K.; Maji, Samir K.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Gomathi, Balashankar S.; Mullasari, Ajit S.] Madras Med Mission, Inst Cardiovasc Dis, Madras 600037, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Mahapatra, NR (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	nmahapatra@iitm.ac.in	Mahapatra, Nitish R/D-4123-2014; SONAWANE, PARSHURAM/CAF-3202-2022; Sahu, Giriraj/GXF-2849-2022; Maji, Samir K. K./B-9640-2019; Obbineni, Jagan Mohan/C-9195-2017; SASI, BINU K/B-3770-2008	Mahapatra, Nitish R/0000-0002-0695-3510; Sahu, Giriraj/0000-0001-6566-9563; Maji, Samir K. K./0000-0002-9110-1565; Obbineni, Jagan Mohan/0000-0001-7716-2778; SASI, BINU K/0000-0002-3325-9874; Bera, Amal Kanti/0000-0003-0362-5578; Singh, Pradeep/0000-0002-4625-9873	Department of Biotechnology, Government of India [BT/PR9546/MED/12/349/2007]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by a grant (BT/PR9546/MED/12/349/2007) from the Department of Biotechnology, Government of India (to N. R. M., A. S. M., and B. S. G.).	ANGELETTI RH, 1994, ACTA PHYSIOL SCAND, V152, P11, DOI 10.1111/j.1748-1716.1994.tb09780.x; Angelone T, 2008, ENDOCRINOLOGY, V149, P4780, DOI 10.1210/en.2008-0318; Bandyopadhyay GK, 2012, J BIOL CHEM, V287, P23141, DOI 10.1074/jbc.M111.335877; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Bartolomucci A, 2011, ENDOCR REV, V32, P755, DOI 10.1210/er.2010-0027; Belloni D, 2007, FASEB J, V21, P3052, DOI 10.1096/fj.06-6829com; BENEDUM UM, 1986, EMBO J, V5, P1495, DOI 10.1002/j.1460-2075.1986.tb04388.x; Brar BK, 2010, REGUL PEPTIDES, V165, P63, DOI 10.1016/j.regpep.2010.07.153; Cui JSS, 2003, HYPERTENSION, V41, P207, DOI 10.1161/01.HYP.0000044938.94050.E3; Helle KB, 2010, CELL MOL NEUROBIOL, V30, P1145, DOI 10.1007/s10571-010-9552-6; Herrero CJ, 2002, J NEUROSCI, V22, P377, DOI 10.1523/JNEUROSCI.22-02-00377.2002; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IACANGELO A, 1986, NATURE, V323, P82, DOI 10.1038/323082a0; Kim T, 2005, J CLIN INVEST, V115, P1711, DOI 10.1172/JCI25706; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Loh YP, 2012, J MOL NEUROSCI, V48, P347, DOI 10.1007/s12031-012-9728-2; Mahapatra NR, 2008, CARDIOVASC RES, V80, P330, DOI 10.1093/cvr/cvn155; Mahapatra NR, 2006, J HYPERTENS, V24, P895, DOI 10.1097/01.hjh.0000222760.99852.e0; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Mahata SK, 2000, MOL ENDOCRINOL, V14, P1525, DOI 10.1210/me.14.10.1525; Mahata SK, 2004, MOL PHARMACOL, V66, P1180, DOI 10.1124/mol.104.002139; Mahata SK, 1999, J BIOL CHEM, V274, P2920, DOI 10.1074/jbc.274.5.2920; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; Mahata SK, 2010, REGUL PEPTIDES, V165, P52, DOI 10.1016/j.regpep.2010.09.007; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; O'Connor DT, 2002, J HYPERTENS, V20, P1335, DOI 10.1097/00004872-200207000-00020; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Preece NE, 2004, REGUL PEPTIDES, V118, P75, DOI 10.1016/j.regpep.2003.10.035; Rao F, 2007, CIRCULATION, V115, P2271, DOI 10.1161/CIRCULATIONAHA.106.628859; Sahu BS, 2012, J CELL SCI, V125, P2323, DOI 10.1242/jcs.103176; Sanchez-Margalet V, 2010, REGUL PEPTIDES, V161, P8, DOI 10.1016/j.regpep.2010.02.005; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tota B, 2008, CURR MED CHEM, V15, P1444, DOI 10.2174/092986708784567662; Tota B, 2012, FASEB J, V26, P2888, DOI 10.1096/fj.11-201111; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wen G, 2004, AM J HUM GENET, V74, P197, DOI 10.1086/381399; Wightman R. M., 1995, 8 INT S CHROM CELL B, V66, pS; WINKLER H, 1986, NEUROSCIENCE, V18, P261, DOI 10.1016/0306-4522(86)90154-5; Zhang KX, 2006, DIABETES OBES METAB, V8, P621, DOI 10.1111/j.1463-1326.2006.00575.x	43	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43840	43852		10.1074/jbc.M112.407916	http://dx.doi.org/10.1074/jbc.M112.407916			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23105094	Green Published, hybrid			2022-12-28	WOS:000312940800061
J	Rauen, T; Grammatikos, AP; Hedrich, CM; Floege, J; Tenbrock, K; Ohl, K; Kyttaris, VC; Tsokos, GC				Rauen, Thomas; Grammatikos, Alexandros P.; Hedrich, Christian M.; Floege, Juergen; Tenbrock, Klaus; Ohl, Kim; Kyttaris, Vasileios C.; Tsokos, George C.			cAMP-responsive Element Modulator alpha (CREM alpha) Contributes to Decreased Notch-1 Expression in T Cells from Patients with Active Systemic Lupus Erythematosus (SLE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; IL-2 PRODUCTION; AUTOIMMUNE; DISEASE; GENE; METHYLATION; LYMPHOCYTES; BINDING; DIFFERENTIATION; MECHANISMS	Notch signaling constitutes an evolutionarily conserved pathway that transduces signals between neighboring cells and determines major decisions in cell proliferation, survival, and differentiation. Notch signaling has been shown to play a pivotal role during T cell lineage determination. T lymphocytes from patients with systemic lupus erythematosus (SLE) display a severely altered phenotype with several molecular and functional aberrations, including defective capacities to up-regulate Notch-1 receptor expression upon T cell receptor activation. Here, we demonstrate that basal Notch-1 expression is decreased in T cells from active SLE patients at the mRNA and protein levels in various T cell subpopulations. Notch-1 transcript numbers inversely correlate with disease activity in SLE patients. We provide evidence that both enhanced histone H3 methylation and CpG DNA methylation of the human Notch-1 promoter contribute to decreased Notch-1 expression in SLE T cells. Previous data from our group identified cAMP-responsive element modulator alpha (CREM alpha), which is up-regulated in SLE T cells, as a key regulator of epigenetic patterns and gene transcription, e. g. that of IL2 and IL17 genes. In this study, we observed increased CREM alpha binding to the Notch-1 promoter, which eventually resulted in significantly reduced Notch-1 promoter activity and gene transcription. Notably, decreased Notch-1 levels were associated with elevated IL-17A levels. Our data suggest a role for Notch-1 in SLE immunopathogenesis, and for the first time, we present molecular mechanisms that mediate dysregulated Notch-1 expression in SLE T cells.	[Rauen, Thomas; Grammatikos, Alexandros P.; Hedrich, Christian M.; Kyttaris, Vasileios C.; Tsokos, George C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol,Dept Med, Boston, MA 02115 USA; [Rauen, Thomas; Floege, Juergen] Rhein Westfal TH Aachen, Dept Nephrol & Clin Immunol, D-52074 Aachen, Germany; [Tenbrock, Klaus; Ohl, Kim] Rhein Westfal TH Aachen, Dept Pediat, Div Allergol & Immunol, D-52074 Aachen, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; RWTH Aachen University; RWTH Aachen University	Tsokos, GC (corresponding author), Beth Israel Deaconess Med Ctr CLS 937, Div Rheumatol, Dept Med, 330 Brookline Ave, Boston, MA 02115 USA.	gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013; Grammatikos, Alexandros/B-2804-2008; Hedrich, Christian/AAW-3958-2020; Hedrich, Christian/AAD-6855-2019; Rauen, Thomas/GLR-8682-2022	tsokos, george C/0000-0001-9589-2360; Grammatikos, Alexandros/0000-0001-6544-8218; Hedrich, Christian/0000-0002-1295-6179	National Institutes of Health [R01 AI42269, R01 AI49954, R01 AI85567]; Deutsche Forschungsgemeinschaft [RA1927-1/1]; START Grant for Young Researchers of the Medical Faculty of RWTH University of Aachen; Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Aachen [E6-6]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042269, R01AI049954, R01AI085567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); START Grant for Young Researchers of the Medical Faculty of RWTH University of Aachen; Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Aachen; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI42269, R01 AI49954, and R01 AI85567 (to G. C. T.). This work was also supported by Deutsche Forschungsgemeinschaft Grant RA1927-1/1 and a START Grant for Young Researchers of the Medical Faculty of RWTH University of Aachen (to T. R.) and Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Aachen Grant E6-6 (to K. T.).	Ahlmann M, 2009, J IMMUNOL, V182, P4167, DOI 10.4049/jimmunol.0802976; Bailey J, 2005, J MOL ENDOCRINOL, V34, P1, DOI 10.1677/jme.1.01594; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brenner C, 2007, DEV CELL, V12, P843, DOI 10.1016/j.devcel.2007.05.011; Chatterjee M, 2012, J IMMUNOL, V188, P1206, DOI 10.4049/jimmunol.1102773; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Ghosh D, 2012, ARTHRITIS RHEUM-US, V64, P799, DOI 10.1002/art.33375; Grammatikos AP, 2012, TRENDS MOL MED, V18, P101, DOI 10.1016/j.molmed.2011.10.005; Hedrich CM, 2012, J BIOL CHEM, V287, P4715, DOI 10.1074/jbc.M111.323261; Hedrich CM, 2011, J BIOL CHEM, V286, P43429, DOI 10.1074/jbc.M111.299339; Hedrich CM, 2011, TRENDS MOL MED, V17, P714, DOI 10.1016/j.molmed.2011.07.005; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Janson PCJ, 2008, J IMMUNOL, V181, P2878, DOI 10.4049/jimmunol.181.4.2878; Juang YT, 2011, J BIOL CHEM, V286, P1795, DOI 10.1074/jbc.M110.166785; Jurynczyk M, 2008, J IMMUNOL, V180, P2634, DOI 10.4049/jimmunol.180.4.2634; Kyttaris VC, 2004, J IMMUNOL, V173, P3557, DOI 10.4049/jimmunol.173.5.3557; Lippe R, 2012, J MOL CELL BIOL, V4, P121, DOI 10.1093/jmcb/mjs004; Liu ZL, 2009, CANCER BIOL THER, V8, P1840, DOI 10.4161/cbt.8.19.9440; Mi XB, 2008, ACTA PHARMACOL SIN, V29, P105, DOI 10.1111/j.1745-7254.2008.00739.x; Rauen T, 2011, J BIOL CHEM, V286, P43437, DOI 10.1074/jbc.M111.299313; Rauen T, 2009, J BIOL CHEM, V284, P26928, DOI 10.1074/jbc.M109.046599; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; Scalapino KJ, 2008, IMMUNOL REV, V223, P143, DOI 10.1111/j.1600-065X.2008.00639.x; Sodsal P, 2008, LUPUS, V17, P645, DOI 10.1177/0961203308089406; Solomou EE, 2001, J IMMUNOL, V166, P4216, DOI 10.4049/jimmunol.166.6.4216; Sunahori K, 2009, J IMMUNOL, V182, P1500, DOI 10.4049/jimmunol.182.3.1500; Teachey DT, 2008, BLOOD, V111, P705, DOI 10.1182/blood-2007-05-087353; Tenbrock K, 2007, RHEUMATOLOGY, V46, P1525, DOI 10.1093/rheumatology/kem154; Tenbrock K, 2004, INT REV IMMUNOL, V23, P333, DOI 10.1080/08830180490452558; Tenbrock K, 2006, J IMMUNOL, V177, P6159, DOI 10.4049/jimmunol.177.9.6159; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Zhao M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/931018	40	31	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42525	42532		10.1074/jbc.M112.425371	http://dx.doi.org/10.1074/jbc.M112.425371			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23124208	Green Published, hybrid			2022-12-28	WOS:000312501600014
J	Sparks, JL; Kumar, R; Singh, M; Wold, MS; Pandita, TK; Burgers, PM				Sparks, Justin L.; Kumar, Rakesh; Singh, Mayank; Wold, Marc S.; Pandita, Tej K.; Burgers, Peter M.			Human Exonuclease 5 Is a Novel Sliding Exonuclease Required for Genome Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUMERMYCIN-INDUCED DIMERIZATION; IRON-SULFUR CLUSTER; CROSS-LINK REPAIR; BREAK REPAIR; DNA-DAMAGE; PROTEIN; NUCLEASES; CELLS; END; MECHANISM	Previously, we characterized Saccharomyces cerevisiae exonuclease 5 (EXO5), which is required for mitochondrial genome maintenance. Here, we identify the human homolog (C1orf176; EXO5) that functions in the repair of nuclear DNA damage. Human EXO5 (hEXO5) contains an iron-sulfur cluster. It is a single-stranded DNA (ssDNA)-specific bidirectional exonuclease with a strong preference for 5'-ends. After loading at an ssDNA end, hEXO5 slides extensively along the ssDNA prior to cutting, hence the designation sliding exonuclease. However, the single-stranded binding protein human replication protein A (hRPA) restricts sliding and enforces a unique, species-specific 5'-directionality onto hEXO5. This specificity is lost with a mutant form of hRPA (hRPA-t11) that fails to interact with hEXO5. hEXO5 localizes to nuclear repair foci in response to DNA damage, and its depletion in human cells leads to an increased sensitivity to DNA-damaging agents, in particular interstrand cross-linking-inducing agents. Depletion of hEXO5 also results in an increase in spontaneous and damage-induced chromosome abnormalities including the frequency of triradial chromosomes, suggesting an additional defect in the resolution of stalled DNA replication forks in hEXO5-depleted cells.	[Kumar, Rakesh; Singh, Mayank; Pandita, Tej K.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Sparks, Justin L.; Burgers, Peter M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Wold, Marc S.] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL); University of Iowa	Pandita, TK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	tej.pandita@utsouthwestern.edu; burgers@biochem.wustl.edu	Burgers, Peter M/AAW-6621-2021; Singh, Mayank/ABE-5733-2021; singh, mayank/N-6931-2014; Pandita, Tej K/AAM-9188-2020	Singh, Mayank/0000-0003-0728-1936; Wold, Marc/0000-0002-4580-1624; kumar, rakesh/0000-0002-0741-3663	National Institutes of Health [GM032431, GM083970, CA123232, CA129537, CA154320, U19A1091175, GM44721]; NATIONAL CANCER INSTITUTE [R01CA129537, R01CA123232, R01CA154320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044721, R01GM032431, R01GM083970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM032431 and GM083970 (to P. M. B.); CA123232, CA129537, CA154320, and U19A1091175 (to T. K. P.); and GM44721 (to M. S. W.).	Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Burgers PM, 2010, MOL CELL BIOL, V30, P1457, DOI 10.1128/MCB.01321-09; Bylund GO, 2006, METHOD ENZYMOL, V409, P1, DOI 10.1016/S0076-6879(05)09001-4; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; Farrar MA, 2000, METHOD ENZYMOL, V327, P421, DOI 10.1016/S0076-6879(00)27293-5; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Gupta A, 2005, MOL CELL BIOL, V25, P5292, DOI 10.1128/MCB.25.12.5292-5305.2005; Gupta A, 2009, CELL CYCLE, V8, P2198, DOI 10.4161/cc.8.14.8947; Hunt CR, 2007, CANCER RES, V67, P3010, DOI 10.1158/0008-5472.CAN-06-4328; Kantake N, 2003, J BIOL CHEM, V278, P23410, DOI 10.1074/jbc.M302995200; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Pandita TK, 1996, RADIAT RES, V145, P730, DOI 10.2307/3579364; Pandita TK, 1996, ONCOGENE, V13, P1423; Pandita TK, 1999, MOL CELL BIOL, V19, P5096; PLOOY ACM, 1985, CARCINOGENESIS, V6, P561, DOI 10.1093/carcin/6.4.561; Pokharel S, 2012, NUCLEIC ACIDS RES, V40, P7821, DOI 10.1093/nar/gks534; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Saikrishnan K, 2012, EMBO J, V31, P1568, DOI 10.1038/emboj.2012.9; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Umezu K, 1998, GENETICS, V148, P989; WALKER J, 1993, MOL BIOCHEM PARASIT, V61, P255, DOI 10.1016/0166-6851(93)90071-5; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200	32	18	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42773	42783		10.1074/jbc.M112.422444	http://dx.doi.org/10.1074/jbc.M112.422444			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095756	Green Published, hybrid			2022-12-28	WOS:000312501600036
J	Westphal, K; Langklotz, S; Thomanek, N; Narberhaus, F				Westphal, Kai; Langklotz, Sina; Thomanek, Nikolas; Narberhaus, Franz			A Trapping Approach Reveals Novel Substrates and Physiological Functions of the Essential Protease FtsH in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; TRANSCRIPTION FACTOR SIGMA(32); AMINO-ACID DEHYDROGENASE; IN-VITRO DEGRADATION; AAA PROTEASE; FORMATE DEHYDROGENASE; TURNOVER ELEMENT; REGULATED DEGRADATION; PHOSPHORELAY SYSTEM; NITRATE REDUCTASE	Proteolysis is a universal strategy to rapidly adjust the amount of regulatory and metabolic proteins to cellular demand. FtsH is the only membrane-anchored and essential ATP-dependent protease in Escherichia coli. Among the known functions of FtsH are the control of the heat shock response by proteolysis of the transcription factor RpoH (sigma(32)) and its essential role in lipopolysaccharide biosynthesis by degradation of the two key enzymes LpxC and KdtA. Here, we identified new FtsH substrates by using a proteomic-based substrate trapping approach. AnFtsH variant (FtsH(trap)) carrying a single amino acid exchange in the proteolytic center was expressed and purified in E. coli. FtsH(trap) is devoid of its proteolytic activity but fully retains ATPase activity allowing for unfolding and translocation of substrates into the inactivated proteolytic chamber. Proteins associated with FtsH(trap) and wild-type FtsH (FtsH(WT)) were purified, separated by two-dimensional PAGE, and subjected to mass spectrometry. Over-representation of LpxC in the FtsHtrap preparation validated the trapping strategy. Four novel FtsH substrates were identified. The sulfur delivery protein IscS and the D-amino acid dehydrogenase DadA were degraded under all tested conditions. The formate dehydrogenase subunit FdoH and the yet uncharacterized YfgM protein were subject to growth condition-dependent regulated proteolysis. Several lines of evidence suggest that YfgM serves as negative regulator of the RcsB-dependent stress response pathway, which must be degraded under stress conditions. The proteins captured by FtsH(trap) revealed previously unknown biological functions of the physiologically most important AAA(+) protease in E. coli.	[Narberhaus, Franz] Ruhr Univ Bochum, Fak Biol & Biotechnol, Inst Biol Mikroorganismen, D-44801 Bochum, Germany	Ruhr University Bochum	Narberhaus, F (corresponding author), Ruhr Univ Bochum, Fak Biol & Biotechnol, Inst Biol Mikroorganismen, Univ Str 150, D-44801 Bochum, Germany.	franz.narberhaus@rub.de	Schäkermann, Sina/HCI-7539-2022	Schäkermann, Sina/0000-0001-7969-0005; Narberhaus, Franz/0000-0002-8552-5310	German Research Foundation [SFB 642]	German Research Foundation(German Research Foundation (DFG))	This work was supported by German Research Foundation Grant SFB 642 for GTP- and ATP-dependent membrane processes (to F. N.).	ABAIBOU H, 1995, J BACTERIOL, V177, P7141, DOI 10.1128/jb.177.24.7141-7149.1995; Akiyama Y, 1996, FEBS LETT, V399, P26, DOI 10.1016/S0014-5793(96)01283-5; Akiyama Y, 1996, J BIOL CHEM, V271, P31196, DOI 10.1074/jbc.271.49.31196; Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Bandow JE, 2008, PROTEOMICS, V8, P3030, DOI 10.1002/pmic.200701184; Benoit S, 1998, J BACTERIOL, V180, P6625, DOI 10.1128/JB.180.24.6625-6634.1998; Bieniossek C, 2006, P NATL ACAD SCI USA, V103, P3066, DOI 10.1073/pnas.0600031103; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chiba S, 2002, J BACTERIOL, V184, P4775, DOI 10.1128/JB.184.17.4775-4782.2002; ENOCH HG, 1975, J BIOL CHEM, V250, P6693; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Fuhrer F, 2007, J MOL BIOL, V372, P485, DOI 10.1016/j.jmb.2007.06.083; Fuhrer F, 2006, MOL MICROBIOL, V59, P1025, DOI 10.1111/j.1365-2958.2005.04994.x; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Gonzalez M, 1998, GENE DEV, V12, P3889, DOI 10.1101/gad.12.24.3889; Griffith KL, 2004, MOL MICROBIOL, V51, P1801, DOI 10.1046/j.1365-2958.2003.03952.x; Guisbert E, 2004, GENE DEV, V18, P2812, DOI 10.1101/gad.1219204; Gur E, 2011, NAT REV MICROBIOL, V9, P839, DOI 10.1038/nrmicro2669; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Herman C, 1997, J BACTERIOL, V179, P358, DOI 10.1128/jb.179.2.358-363.1997; HERMAN C, 1995, P NATL ACAD SCI USA, V92, P3516, DOI 10.1073/pnas.92.8.3516; Horikoshi M, 2004, J BACTERIOL, V186, P7474, DOI 10.1128/JB.186.22.7474-7480.2004; IOBBINIVOL C, 1990, EUR J BIOCHEM, V188, P679, DOI 10.1111/j.1432-1033.1990.tb15450.x; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Johnson MD, 2011, J BACTERIOL, V193, P3653, DOI 10.1128/JB.05040-11; Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x; Katz C, 2008, J BACTERIOL, V190, P7117, DOI 10.1128/JB.00871-08; Kihara A, 1997, P NATL ACAD SCI USA, V94, P5544, DOI 10.1073/pnas.94.11.5544; Klusener S, 2010, MOL GENET GENOMICS, V283, P575, DOI 10.1007/s00438-010-0542-7; Krzywda S, 2002, STRUCTURE, V10, P1073, DOI 10.1016/S0969-2126(02)00806-7; Kuroda A, 1999, P NATL ACAD SCI USA, V96, P14264, DOI 10.1073/pnas.96.25.14264; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Langklotz S, 2012, BBA-MOL CELL RES, V1823, P40, DOI 10.1016/j.bbamcr.2011.08.015; Langklotz S, 2011, MOL MICROBIOL, V80, P1313, DOI 10.1111/j.1365-2958.2011.07646.x; Lasserre JP, 2006, ELECTROPHORESIS, V27, P3306, DOI 10.1002/elps.200500912; Leffers GG, 1998, J BACTERIOL, V180, P1573, DOI 10.1128/JB.180.6.1573-1577.1998; LOBOCKA M, 1994, J BACTERIOL, V176, P1500, DOI 10.1128/jb.176.5.1500-1510.1994; Maddalo G, 2011, J PROTEOME RES, V10, P1848, DOI 10.1021/pr101105c; Majdalani N, 2002, MOL MICROBIOL, V46, P813, DOI 10.1046/j.1365-2958.2002.03203.x; Matern Y, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-251; Narberhaus F, 2009, RES MICROBIOL, V160, P652, DOI 10.1016/j.resmic.2009.08.011; Obrist M, 2005, J BACTERIOL, V187, P3807, DOI 10.1128/JB.187.11.3807-3813.2005; Obrist M, 2009, FEMS MICROBIOL LETT, V290, P199, DOI 10.1111/j.1574-6968.2008.01423.x; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Okuno T, 2006, J STRUCT BIOL, V156, P109, DOI 10.1016/j.jsb.2006.02.003; OLSIEWSKI PJ, 1980, J BIOL CHEM, V255, P4487; Peterson CN, 2006, J BACTERIOL, V188, P3175, DOI 10.1128/JB.188.9.3175-3181.2006; PLUNKETT G, 1993, NUCLEIC ACIDS RES, V21, P3391, DOI 10.1093/nar/21.15.3391; POMMIER J, 1992, BIOCHIM BIOPHYS ACTA, V1107, P305, DOI 10.1016/0005-2736(92)90417-K; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Saikawa N, 2002, BIOCHEMISTRY-US, V41, P1861, DOI 10.1021/bi015748o; Sambrook J., 2001, MOL CLONING LAB MANU; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Shah IM, 2006, J MOL BIOL, V357, P718, DOI 10.1016/j.jmb.2005.12.088; Singh S, 2011, J BACTERIOL, V193, P6436, DOI 10.1128/JB.05942-11; Sledjeski DD, 1996, J BACTERIOL, V178, P1204, DOI 10.1128/jb.178.4.1204-1206.1996; Srinivasan R, 2007, J BASIC MICROB, V47, P251, DOI 10.1002/jobm.200610236; TOMOYASU T, 1993, J BACTERIOL, V175, P1352, DOI 10.1128/JB.175.5.1352-1357.1993; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; Van Melderen L, 2009, RES MICROBIOL, V160, P645, DOI 10.1016/j.resmic.2009.08.021; WEINER L, 1991, GENE DEV, V5, P1912, DOI 10.1101/gad.5.10.1912; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wu GF, 2008, BIOCHEM BIOPH RES CO, V374, P399, DOI 10.1016/j.bbrc.2008.07.050; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200	70	46	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42962	42971		10.1074/jbc.M112.388470	http://dx.doi.org/10.1074/jbc.M112.388470			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23091052	Green Published, hybrid			2022-12-28	WOS:000312501600053
J	Schattauer, SS; Miyatake, M; Shankar, H; Zietz, C; Levin, JR; Liu-Chen, LY; Gurevich, VV; Rieder, MJ; Chavkin, C				Schattauer, Selena S.; Miyatake, Mayumi; Shankar, Haripriya; Zietz, Chad; Levin, Jamie R.; Liu-Chen, Lee-Yuan; Gurevich, Vsevolod V.; Rieder, Mark J.; Chavkin, Charles			Ligand Directed Signaling Differences between Rodent and Human kappa-Opioid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NARCOTIC ANTAGONIST; KNOCKOUT MICE; PENTAZOCINE; ACTIVATION; STRESS; ANALGESIA; PHOSPHORYLATION; (-)-PENTAZOCINE; ADDICTION; LINE	KOR activation of G beta gamma dependent signaling results in analgesia, whereas the dysphoric effects of KOR agonists are mediated by a different pathway involving G protein receptor kinase and non-visual arrestin. Based on this distinction, a partial KOR agonist that does not efficiently activate arrestin-dependent biased signaling may produce analgesia without dysphoria. No KOR-selective partial agonists are currently available, and preclinical assessment is complicated by sequence differences between rodent (r) and human (h) KOR. In this study, we compared the signaling initiated by the available partial agonists. Pentazocine was significantly more potent at activating p38 MAPK in hKOR than rKOR expressed in HEK293 cells but equally potent at arrestin-independent activation of ERK1/2 in hKOR and rKOR. Similarly, butorphanol increased phospho-p38-ir in hKOR-expressing cells but did not activate p38 in rKOR-HEK293. Like pentazocine, butorphanol was equally efficacious at activating ERK1/2 in rKOR and hKOR. In contrast, levorphanol, nalorphine, and U50,488 did not distinguish between hKOR and rKOR in p38 MAPK activation. Consistent with its low potency at p38 activation, pentazocine did not produce conditioned place aversion in mice. hKOR lacks the Ser-369 phosphorylation site in rKOR required for G protein receptor kinase/arrestin-dependent p38 activation, but mutation of the Ser-358 to asparagine in hKOR blocked p38 activation without affecting the acute arrestin-independent activation of ERK1/2. This study shows that hKOR activates p38 MAPK through a phosphorylation and arrestin-dependent mechanism; however, activation differs between hKOR and rKOR for some ligands. These functional selectivity differences have important implications for preclinical screening of partial KOR agonists.	[Schattauer, Selena S.; Miyatake, Mayumi; Shankar, Haripriya; Zietz, Chad; Levin, Jamie R.; Chavkin, Charles] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Rieder, Mark J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Liu-Chen, Lee-Yuan] Temple Univ, Dept Pharmacol, Philadelphia, PA 19140 USA; [Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Vanderbilt University	Chavkin, C (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	cchavkin@u.washington.edu	Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	National Institutes of Health [T32DA07278, KO5 DA020570, RO1DA030074]; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA020570, R01DA030074, T32DA007278, R01DA017302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants T32DA07278 (to H.S., J.R.L., and S.S.S.), KO5 DA020570 (to C. C.), and RO1DA030074 (to C. C.).	BEAVER WT, 1966, CLIN PHARMACOL THER, V7, P740; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Bruchas MR, 2011, NEURON, V71, P498, DOI 10.1016/j.neuron.2011.06.011; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Chavkin C, 2011, NEUROPSYCHOPHARMACOL, V36, P369, DOI 10.1038/npp.2010.137; Chien CC, 1995, EUR J PHARMACOL, V294, P303, DOI 10.1016/0014-2999(95)00552-8; Clarke S, 2002, EUR J NEUROSCI, V16, P1705, DOI 10.1046/j.1460-9568.2002.02239.x; Emmerson PJ, 1996, J PHARMACOL EXP THER, V278, P1121; FRASER HF, 1964, J PHARMACOL EXP THER, V143, P149; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; HAMILTON RC, 1967, BRIT J ANAESTH, V39, P647, DOI 10.1093/bja/39.8.647; Hiramatsu M, 2005, BRAIN RES, V1057, P72, DOI 10.1016/j.brainres.2005.07.028; Ide S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-23; JASINSKI DR, 1970, CLIN PHARMACOL THER, V11, P385; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; Land BB, 2009, P NATL ACAD SCI USA, V106, P19168, DOI 10.1073/pnas.0910705106; LEVINE JD, 1988, J CLIN INVEST, V82, P1574, DOI 10.1172/JCI113768; Li J, 2002, MOL PHARMACOL, V61, P73, DOI 10.1124/mol.61.1.73; Livingston RJ, 2004, GENOME RES, V14, P1821, DOI 10.1101/gr.2730004; Mague SD, 2003, J PHARMACOL EXP THER, V305, P323, DOI 10.1124/jpet.102.046433; MARTIN WR, 1983, PHARMACOL REV, V35, P283; MARTIN WR, 1965, J PHARMACOL EXP THER, V150, P426; McLaughlin JP, 2003, J BIOL CHEM, V278, P34631, DOI 10.1074/jbc.M304022200; McLaughlin JP, 2003, J NEUROSCI, V23, P5674, DOI 10.1523/jneurosci.23-13-05674.2003; McLennan GP, 2008, J NEUROCHEM, V107, P1753, DOI 10.1111/j.1471-4159.2008.05745.x; Mori T, 2012, ADDICT BIOL, V17, P717, DOI 10.1111/j.1369-1600.2010.00306.x; MUCHA RF, 1985, PSYCHOPHARMACOLOGY, V86, P274, DOI 10.1007/BF00432213; PFEIFFER A, 1986, SCIENCE, V233, P774, DOI 10.1126/science.3016896; PRESTON KL, 1993, J PHARMACOL EXP THER, V264, P813; Remmers AE, 1999, J PHARMACOL EXP THER, V288, P827; Schuller AGP, 1999, NAT NEUROSCI, V2, P151, DOI 10.1038/5706; Shu HH, 2011, J PHARMACOL EXP THER, V338, P579, DOI 10.1124/jpet.111.179879; Stephens M, 2006, NAT GENET, V38, P375, DOI 10.1038/ng1746; SUZUKI T, 1991, LIFE SCI, V48, P1827, DOI 10.1016/0024-3205(91)90238-7; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; von Zastrow M, 2003, CURR OPIN NEUROBIOL, V13, P348, DOI 10.1016/S0959-4388(03)00069-2; Wadenberg MLG, 2003, CNS DRUG REV, V9, P187; Walther C, 2010, J BIOL CHEM, V285, P41578, DOI 10.1074/jbc.M110.162156; Zacny JP, 1998, J PHARMACOL EXP THER, V286, P1197; Zhu JM, 1997, J PHARMACOL EXP THER, V282, P676	43	31	31	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41595	41607		10.1074/jbc.M112.381368	http://dx.doi.org/10.1074/jbc.M112.381368			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086943	Green Published, hybrid			2022-12-28	WOS:000312103000004
J	Braun, DA; Fribourg, M; Sealfon, SC				Braun, David A.; Fribourg, Miguel; Sealfon, Stuart C.			Cytokine Response Is Determined by Duration of Receptor and Signal Transducers and Activators of Transcription 3 (STAT3) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-6; CELLS; IDENTIFICATION; SURVIVAL; IMMUNITY; INNATE	Paradoxically, the pro-inflammatory cytokine IL-6 and the anti-inflammatory cytokine IL-10 both activate STAT3, yet generate nearly opposing cellular responses. Here, we show that the temporal pattern of STAT3 activation codes for the specific cytokine response. A computational model of IL-6 and IL-10 signaling predicted that IL-6 stimulation results in transient activation of STAT3, with a rapid decline in phosphorylation and nuclear localization. In contrast, simulated IL-10 signaling resulted in sustained STAT3 activation. The predicted STAT3 patterns produced by each cytokine were confirmed experimentally in human dendritic cells. Time course microarray studies further showed that the dynamic genome-wide transcriptional responses were nearly identical at early time points following stimulation (when STAT3 is active in response to both IL-6 and IL-10) but divergent at later times (when STAT3 is active only in response to IL-10). Truncating STAT3 activation after IL-10 stimulation caused IL-10 to elicit an IL-6-like transcriptional and secretory response. That the duration of IL-10 receptor and STAT3 activation can direct distinct responses reveals a complex cellular information-coding mechanism that may be relevant to improving the prediction of the effects of drug candidates using this mechanism.	[Braun, David A.; Fribourg, Miguel; Sealfon, Stuart C.] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Braun, David A.; Fribourg, Miguel; Sealfon, Stuart C.] Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY 10029 USA; [Braun, David A.] NYU, Computat Biol Program, New York, NY 10012 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University	Sealfon, SC (corresponding author), Mt Sinai Sch Med, Dept Neurol, 1 Gustave Levy Pl, New York, NY 10029 USA.	stuart.sealfon@mssm.edu	Fribourg, Miguel/AAO-2186-2020	Fribourg, Miguel/0000-0003-1804-8136; SEALFON, Stuart/0000-0001-5791-1217	National Institutes of Health [HHSN272201000054C]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported, in whole or in part, by National Institutes of Health Contract HHSN272201000054C.	Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Borderia AV, 2008, J IMMUNOL, V181, P6872, DOI 10.4049/jimmunol.181.10.6872; Butler D, 2008, NATURE, V453, P840, DOI 10.1038/453840a; Coller BS, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000265; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Levy DE, 2006, P NATL ACAD SCI USA, V103, P10151, DOI 10.1073/pnas.0604042103; Lio D, 2003, GENES IMMUN, V4, P234, DOI 10.1038/sj.gene.6363964; Mahdavi A, 2007, PLOS COMPUT BIOL, V3, P1257, DOI 10.1371/journal.pcbi.0030130; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Nishimoto N, 2004, CURR OPIN PHARMACOL, V4, P386, DOI 10.1016/j.coph.2004.03.005; Qiao L, 2010, BIOPHYS J, V98, P505, DOI 10.1016/j.bpj.2009.10.049; Tagore A, 1999, TISSUE ANTIGENS, V54, P386, DOI 10.1034/j.1399-0039.1999.540408.x; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wehinger J, 1996, FEBS LETT, V394, P365, DOI 10.1016/0014-5793(96)00990-8; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zi ZK, 2005, FEBS LETT, V579, P1101, DOI 10.1016/j.febslet.2005.01.009	32	108	110	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2986	2993		10.1074/jbc.M112.386573	http://dx.doi.org/10.1074/jbc.M112.386573			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23166328	hybrid, Green Published			2022-12-28	WOS:000314397900009
J	Banfic, H; Bedalov, A; York, JD; Visnjic, D				Banfic, Hrvoje; Bedalov, Antonio; York, John D.; Visnjic, Dora			Inositol Pyrophosphates Modulate S Phase Progression after Pheromone-induced Arrest in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPENSATORY LIVER GROWTH; PHOSPHOLIPASE-C; CELL-CYCLE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PHOSPHOINOSITIDE 3-KINASE; SWISS 3T3-CELLS; TELOMERE LENGTH; PLASMA-MEMBRANE; PROTEIN-KINASE; HL-60 CELLS	Several studies have demonstrated the activation of phosphoinositide-specific phospholipase C (Plc) in nuclei of mammalian cells during synchronous progression through the cell cycle, but the downstream targets of Plc-generated inositol 1,4,5-trisphosphate are poorly described. Phospholipid signaling in the budding yeast Saccharomyces cerevisiae shares similarities with endonuclear phospholipid signaling in mammals, and many recent studies point to a role for inositol phosphates, including InsP(5), InsP(6), and inositol pyrophosphates, in mediating the action of Plc. In this study, we investigated the changes in inositol phosphate levels in alpha-factor-treated S. cerevisiae, which allows cells to progress synchronously through the cell cycle after release from a G(1) block. We found an increase in the activity of Plc1 early after release from the block with a concomitant increase in the levels of InsP(7) and InsP(8). Treatment of cells with the Plc inhibitor U73122 prevented increases in inositol phosphate levels and blocked progression of cells through S phase after pheromone arrest. The enzymatic activity of Kcs1 in vitro and HPLC analysis of [H-3] inositol-labeled kcs1 Delta cells confirmed that Kcs1 is the principal kinase responsible for generation of pyrophosphates in synchronously progressing cells. Analysis of plc1 Delta, kcs1 Delta, and ddp1 Delta yeast mutants further confirmed the role that a Plc1- and Kcs1-mediated increase in pyrophosphates may have in progression through S phase. Our data provide genetic, metabolic, and biochemical evidence that synthesis of inositol pyrophosphates through activation of Plc1 and Kcs1 plays an important role in the signaling response required for cell cycle progression after mating pheromone arrest.	[Banfic, Hrvoje; Visnjic, Dora] Univ Zagreb, Sch Med, Dept Physiol, Zagreb 10000, Croatia; [Banfic, Hrvoje; Visnjic, Dora] Univ Zagreb, Sch Med, Croatian Inst Brain Res, Zagreb 10000, Croatia; [Bedalov, Antonio] Fred Hutchinson Canc Reaserch Ctr, Seattle, WA 98109 USA; [York, John D.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA	University of Zagreb; University of Zagreb; Fred Hutchinson Cancer Center; Vanderbilt University	Banfic, H (corresponding author), Univ Zagreb, Sch Med, Dept Physiol, Salata 3, Zagreb 10000, Croatia.	hrvoje.banfic@zg.t-com.hr			National Institutes of Health [R01-HL55672-15, R01-CA129132]; Ministry of Science, Education, and Sport of the Republic of Croatia [108-1081347-0173, 108-1081347-1448]; Unity through Knowledge Fund [02/07]; University of Zagreb Development Fund [380-181/102-12-21]; NATIONAL CANCER INSTITUTE [R21CA164545, R01CA129132] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science, Education, and Sport of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Unity through Knowledge Fund; University of Zagreb Development Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL55672-15 and R01-CA129132 (to J. Y. and A. B., respectively). This work was also supported by Ministry of Science, Education, and Sport of the Republic of Croatia Grants 108-1081347-0173 (to H. B.) and 108-1081347-1448 (to D. V.); Unity through Knowledge Fund Grant 02/07 (to H. B. and A. B.); and University of Zagreb Development Fund Grant 380-181/102-12-21 (to H. B.).	Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Barker CJ, 2004, BIOCHEM J, V380, P465, DOI 10.1042/BJ20031872; Crljen V, 2004, FEBS LETT, V571, P35, DOI 10.1016/j.febslet.2004.06.051; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; Dubois E, 2002, J BIOL CHEM, V277, P23755, DOI 10.1074/jbc.M202206200; Faenza I, 2000, J BIOL CHEM, V275, P30520, DOI 10.1074/jbc.M004630200; Garrenton LS, 2010, P NATL ACAD SCI USA, V107, P11805, DOI 10.1073/pnas.1005817107; GUSE AH, 1993, J BIOL CHEM, V268, P7129; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; HUANG KN, 1995, GENETICS, V141, P1275; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lin HY, 2000, MOL CELL BIOL, V20, P3597, DOI 10.1128/MCB.20.10.3597-3607.2000; Lukinovic-Skudar V, 2005, BBA-MOL CELL BIOL L, V1733, P148, DOI 10.1016/j.bbalip.2004.12.009; Lukinovic-Skudar V, 2007, BBA-MOL CELL BIOL L, V1771, P514, DOI 10.1016/j.bbalip.2007.02.002; Luo HBR, 2002, BIOCHEMISTRY-US, V41, P2509, DOI 10.1021/bi0118153; MARTELLI AM, 1992, NATURE, V358, P242, DOI 10.1038/358242a0; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Onnebo SMN, 2009, BIOCHEM J, V423, P109, DOI 10.1042/BJ20090241; Perera NM, 2004, J BIOL CHEM, V279, P5216, DOI 10.1074/jbc.M305068200; Pesesse X, 2004, J BIOL CHEM, V279, P43378, DOI 10.1074/jbc.C400286200; Safrany ST, 1999, J BIOL CHEM, V274, P21735, DOI 10.1074/jbc.274.31.21735; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Saiardi A., 2012, SUBCELL BIOCH, V59, P413; Sindic A, 2001, J BIOL CHEM, V276, P17754, DOI 10.1074/jbc.M006533200; Stallings JD, 2005, J BIOL CHEM, V280, P22060, DOI 10.1074/jbc.M413813200; Stallings JD, 2008, J BIOL CHEM, V283, P13992, DOI 10.1074/jbc.M800752200; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Sun B, 1997, J BIOL CHEM, V272, P26313, DOI 10.1074/jbc.272.42.26313; Tsui MM, 2010, ADV ENZYME REGUL, V50, P324, DOI 10.1016/j.advenzreg.2009.12.002; Visnjic D, 2007, PFLUG ARCH EUR J PHY, V455, P19, DOI 10.1007/s00424-007-0288-1; Yang L, 2008, J BIOL CHEM, V283, P11823, DOI 10.1074/jbc.M800308200; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	40	14	15	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1717	1725		10.1074/jbc.M112.412288	http://dx.doi.org/10.1074/jbc.M112.412288			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23179856	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000313751400028
J	Kanuru, M; Raman, R; Aradhyam, GK				Kanuru, Madhavi; Raman, Rajeev; Aradhyam, Gopala Krishna			Serine Protease Activity of Calnuc REGULATION BY Zn2+ AND G PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; NUCLEOBINDIN 1; CALCIUM; YEAST; PURIFICATION; HYDROLYSIS; ACTIVATION; EVOLUTION; DISEASE; SITES	The functions of calnuc, a novel Ca2+-binding protein with multiple structural domains and diverse interacting partners, are yet unknown. We demonstrate unknown facets of calnuc, which is a serine protease in which Ser-378 of GXSXG motif, Asp-328 of DTG motif, and His-339 form the "catalytic triad," locating the enzyme active site in the C-terminal region. Analogous to the active site of Zn2+ carboxypeptidases, calnuc has two high affinity (K-d similar to 20 nM), well conserved Zn2+-binding sites near its N terminus, although it is inactive as a peptidase. Zn2+ binding allosterically and negatively regulates the serine protease activity of calnuc, inhibition being caused by an "open to close" change in its conformation not seen upon Ca2+ binding. Most strikingly, interaction with G protein alpha subunit completely inhibits the enzymatic activity of calnuc. We thus illustrate that G proteins and Zn2+ act as two "keys" that control enzymatic activity of calnuc, arresting it in "locked" state. Calnuc, therefore, exists dynamically in two different forms, (i) as a Ca2+-binding protein in Zn2+-bound form and (ii) as a protease in Zn2+-free form, commissioning it to perform multiple functions.	[Kanuru, Madhavi; Aradhyam, Gopala Krishna] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Raman, Rajeev] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Aradhyam, GK (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	agk@iitm.ac.in		Aradhyam, Gopala Krishna/0000-0001-8232-3935	Indian Institute of Technology Madras (IITM); Council of Scientific and Industrial Research (India); Department of Science and Technology (DST); Department of Biotechnology (DBT)	Indian Institute of Technology Madras (IITM); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	This work was supported by Indian Institute of Technology Madras (IITM), Council of Scientific and Industrial Research (India), Department of Science and Technology (DST) and Department of Biotechnology (DBT).	Abian O, 2009, PROTEINS, V77, P624, DOI 10.1002/prot.22475; Aradhyam GK, 2010, IUBMB LIFE, V62, P436, DOI 10.1002/iub.341; Bauer MC, 2008, PROTEIN SCI, V17, P760, DOI 10.1110/ps.073381108; Bergmeyer H. U., 1974, METHOD ENZYMAT AN, P436; Bleackley MR, 2011, BIOMETALS, V24, P785, DOI 10.1007/s10534-011-9451-4; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Cuajungco MP, 2000, ANN NY ACAD SCI, V920, P292; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Garcia-Marcos M, 2011, J BIOL CHEM, V286, P28138, DOI 10.1074/jbc.M110.204099; Geiger SR, 2011, ANGEW CHEM INT EDIT, V50, P5748, DOI 10.1002/anie.201100666; Guntas G, 2005, P NATL ACAD SCI USA, V102, P11224, DOI 10.1073/pnas.0502673102; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; KANAI Y, 1992, IMMUNOL LETT, V32, P43; KANAI Y, 1993, BIOCHEM BIOPH RES CO, V196, P729, DOI 10.1006/bbrc.1993.2310; Kanuru M, 2009, FEBS J, V276, P2529, DOI 10.1111/j.1742-4658.2009.06977.x; Kapoor N, 2010, J BIOL CHEM, V285, P31647, DOI 10.1074/jbc.M110.148429; Karabinos A, 1998, J MOL EVOL, V46, P327, DOI 10.1007/PL00006309; Karabinos A, 1996, MOL BIOL EVOL, V13, P990, DOI 10.1093/oxfordjournals.molbev.a025667; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; Leclerc P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002229; Liang J, 2007, PROTEIN SCI, V16, P929, DOI 10.1110/ps.062706007; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; Lin P, 2007, J NEUROCHEM, V100, P1505, DOI 10.1111/j.1471-4159.2006.07336.x; Lin P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-15; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; MCDONALD JK, 1966, J BIOL CHEM, V241, P1494; MIURA K, 1992, BIOCHEM BIOPH RES CO, V187, P375, DOI 10.1016/S0006-291X(05)81503-7; MIURA K, 1994, BIOCHEM BIOPH RES CO, V199, P1388, DOI 10.1006/bbrc.1994.1384; MOCHIZUKI N, 1995, FEBS LETT, V373, P155, DOI 10.1016/0014-5793(95)01031-9; Ostermeier M, 2009, CURR OPIN STRUC BIOL, V19, P442, DOI 10.1016/j.sbi.2009.04.007; SARATH G., 1989, PROTEOLYTIC ENZYMES, P22; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Schaub MC, 2008, BIOCHEM BIOPH RES CO, V369, P247, DOI 10.1016/j.bbrc.2007.10.082; TAYLOR EL, 1963, J BIOL CHEM, V238, P734; Tsukumo Y, 2007, J BIOL CHEM, V282, P29264, DOI 10.1074/jbc.M705038200; TUNLID A, 1994, MICROBIOL-UK, V140, P1687, DOI 10.1099/13500872-140-7-1687; TWINING SS, 1984, ANAL BIOCHEM, V143, P30, DOI 10.1016/0003-2697(84)90553-0; Valencia CA, 2008, FEBS LETT, V582, P286, DOI 10.1016/j.febslet.2007.12.019; Weiss TS, 2001, P NATL ACAD SCI USA, V98, P14961, DOI 10.1073/pnas.261572098	41	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1762	1773		10.1074/jbc.M112.382846	http://dx.doi.org/10.1074/jbc.M112.382846			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23195954	Green Published, hybrid			2022-12-28	WOS:000313751400032
J	Mogilenko, DA; Kudriavtsev, IV; Shavva, VS; Dizhe, EB; Vilenskaya, EG; Efremov, AM; Perevozchikov, AP; Orlov, SV				Mogilenko, Denis A.; Kudriavtsev, Igor V.; Shavva, Vladimir S.; Dizhe, Ella B.; Vilenskaya, Ekaterina G.; Efremov, Alexander M.; Perevozchikov, Andrej P.; Orlov, Sergey V.			Peroxisome Proliferator-activated Receptor alpha Positively Regulates Complement C3 Expression but Inhibits Tumor Necrosis Factor alpha-mediated Activation of C3 Gene in Mammalian Hepatic-derived Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYLATION-STIMULATING PROTEIN; PPAR-ALPHA; NUCLEAR RECEPTORS; 3RD COMPONENT; X-RECEPTOR; FACTOR-B; FATTY-ACIDS; KAPPA-B; INFLAMMATION; PATHWAY	Complement C3 is a pivotal component of three cascades of complement activation. The liver is the main source of C3 in circulation and expression and secretion of C3 by hepatocytes is increased during acute inflammation. However, the mechanism of the regulation of the C3 gene in hepatocytes is not well elucidated. We showed that the C3 gene is the direct target for peroxisome proliferator-activated receptor alpha (PPAR alpha) in human hepatoma HepG2 cells and mouse liver. Using PPAR alpha siRNA and synthetic PPAR alpha agonist WY-14643 and antagonist MK886 we showed that activation of PPAR alpha results in up-regulation of C3 gene expression and protein secretion by HepG2 cells. The PPAR response element (PPRE), which is able to bind PPAR alpha in vitro and in vivo, was found in the human C3 promoter. PPRE is conserved between human and mouse, and WY-14643 stimulates mouse C3 expression in the liver. TNF alpha increases C3 gene via NF-kappa B and, to a lesser extent, MEK1/2 signaling pathways, whereas TNF alpha-mediated stimulation of C3 protein secretion depends on activation of MEK1/2, p38, and JNK in HepG2 cells. Activation of PPAR alpha abolishes TNF alpha-mediated up-regulation of C3 gene expression and protein secretion due to interference with NF-kappa B via PPRE-dependent mechanism in HepG2 cells. TNF alpha decreases PPAR alpha protein content via NF-kappa B and MEK1/2 signaling pathways and inhibits PPAR alpha binding with the human C3 promoter in HepG2 cells. These results suggest novel mechanism controlling C3 expression in hepatocytes during acute phase inflammation and demonstrate a crosstalk between PPAR alpha and TNF alpha in the regulation of complement system.	[Mogilenko, Denis A.; Shavva, Vladimir S.; Dizhe, Ella B.; Vilenskaya, Ekaterina G.; Efremov, Alexander M.; Perevozchikov, Andrej P.; Orlov, Sergey V.] Russian Acad Med Sci, Inst Expt Med, Dept Biochem, St Petersburg 197376, Russia; [Kudriavtsev, Igor V.] Russian Acad Med Sci, Inst Expt Med, Dept Immunol, St Petersburg 197376, Russia; [Mogilenko, Denis A.; Shavva, Vladimir S.; Vilenskaya, Ekaterina G.; Perevozchikov, Andrej P.; Orlov, Sergey V.] St Petersburg State Univ, Dept Embryol, St Petersburg 199034, Russia; [Kudriavtsev, Igor V.; Efremov, Alexander M.] St Petersburg State Univ, Dept Cytol & Histol, St Petersburg 199034, Russia	Institute of Experimental Medicine; Russian Academy of Medical Sciences; Institute of Experimental Medicine; Russian Academy of Medical Sciences; Saint Petersburg State University; Saint Petersburg State University	Mogilenko, DA (corresponding author), Russian Acad Med Sci, Inst Expt Med, Dept Biochem, Acad Pavlov Str 12, St Petersburg 197376, Russia.	denis@iem.sp.ru; serge@iem.sp.ru	Orlov, Sergey V./N-6823-2014; Mogilenko, Denis/H-4436-2013; Dizhe, Ella B./N-6842-2014; Perevozchikov, Andrej/M-9744-2015; Mogilenko, Denis/ABE-9454-2021; Kudryavtsev, Igor/D-2124-2013	Orlov, Sergey V./0000-0002-3134-1989; Mogilenko, Denis/0000-0001-5427-5243; Perevozchikov, Andrej/0000-0001-7049-3224; Kudryavtsev, Igor/0000-0001-7204-7850; Dizhe, Ella/0000-0001-5147-4749; Shavva, Vladimir S./0000-0002-5080-8636	Russian Fund of Basic Research [11-04-02012-a, 12-04-00858-a]	Russian Fund of Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Russian Fund of Basic Research Grants 11-04-02012-a and 12-04-00858-a.	Ajjan R, 2005, THROMB HAEMOSTASIS, V94, P1048, DOI 10.1160/TH05-06-0384; ALPER CA, 1969, SCIENCE, V163, P286, DOI 10.1126/science.163.3864.286; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BALDO A, 1993, J CLIN INVEST, V92, P1543, DOI 10.1172/JCI116733; Beigneux AP, 2000, J BIOL CHEM, V275, P16390, DOI 10.1074/jbc.M000953200; Charney DS, 2004, AM J PSYCHIAT, V161, P1, DOI 10.1176/appi.ajp.161.1.1; CHOY LN, 1992, J BIOL CHEM, V267, P12736; Cianflone K, 2003, BBA-BIOMEMBRANES, V1609, P127, DOI 10.1016/S0005-2736(02)00686-7; Cope Nathan F, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5137; Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; EINSTEIN LP, 1977, J CLIN INVEST, V60, P963, DOI 10.1172/JCI108876; FALUS A, 1987, J IMMUNOL, V138, P856; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Gervois P, 2001, J BIOL CHEM, V276, P33471, DOI 10.1074/jbc.M102839200; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Huang W, 2010, ARTERIOSCL THROM VAS, V30, P1542, DOI 10.1161/ATVBAHA.109.191189; ISSEMANN I, 1993, BIOCHIMIE, V75, P251, DOI 10.1016/0300-9084(93)90084-6; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; LEVISTRAUSS M, 1987, J IMMUNOL, V139, P2361; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Li JL, 2005, J BIOL CHEM, V280, P7427, DOI 10.1074/jbc.M411473200; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Mogilenko DA, 2012, J BIOL CHEM, V287, P5954, DOI 10.1074/jbc.M111.289322; Mogilenko DA, 2009, BIOCHEMISTRY-US, V48, P11950, DOI 10.1021/bi9015742; Muscari A, 2000, EUR HEART J, V21, P1081, DOI 10.1053/euhj.1999.2013; Orlov SV, 2007, FEBS J, V274, P4848, DOI 10.1111/j.1742-4658.2007.06006.x; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; PERLMUTTER DH, 1986, MOL IMMUNOL, V23, P1263, DOI 10.1016/0161-5890(86)90162-8; PERLMUTTER DH, 1986, SCIENCE, V232, P850, DOI 10.1126/science.3010455; Persson L, 2004, ARTERIOSCL THROM VAS, V24, P1062, DOI 10.1161/01.ATV.0000127302.24266.40; Rigamonti E, 2008, ARTERIOSCL THROM VAS, V28, P1050, DOI 10.1161/ATVBAHA.107.158998; Rodgers JT, 2000, ANAL BIOCHEM, V277, P254, DOI 10.1006/abio.1999.4394; RUDDY S, 1974, NEW ENGL J MED, V290, P1284, DOI 10.1056/NEJM197406062902304; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; Shoda J, 2004, J LIPID RES, V45, P1813, DOI 10.1194/jlr.M400132-JLR200; STRUNK RC, 1985, J CLIN INVEST, V76, P985, DOI 10.1172/JCI112099; Van Hermelen V, 1999, J BIOL CHEM, V274, P18243, DOI 10.1074/jbc.274.26.18243; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; VOLANAKIS JE, 1995, ANNU REV IMMUNOL, V13, P277, DOI 10.1146/annurev.immunol.13.1.277; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WARREN HB, 1987, AM J PATHOL, V129, P9; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975	51	33	38	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1726	1738		10.1074/jbc.M112.437525	http://dx.doi.org/10.1074/jbc.M112.437525			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23168409	Green Published, hybrid			2022-12-28	WOS:000313751400029
J	Fjellstrom, O; Deinum, J; Sjogren, T; Johansson, C; Geschwindner, S; Nerme, V; Legnehed, A; McPheat, J; Olsson, K; Bodin, C; Paunovic, A; Gustafsson, D				Fjellstrom, Ola; Deinum, Johanna; Sjogren, Tove; Johansson, Carina; Geschwindner, Stefan; Nerme, Viveca; Legnehed, Anne; McPheat, Jane; Olsson, Karolina; Bodin, Cristian; Paunovic, Amalia; Gustafsson, David			Characterization of a Small Molecule Inhibitor of Plasminogen Activator Inhibitor Type 1 That Accelerates the Transition into the Latent Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; COMPLEX-FORMATION; PAI-1; VITRONECTIN; SERPIN; FIBRINOLYSIS; MECHANISM; ANTIBODY; CONVERSION; MODEL	A novel class of small molecule inhibitors for plasminogen activator inhibitor type 1 (PAI-1), represented by AZ3976, was identified in a high throughput screening campaign. AZ3976 displayed an IC50 value of 26 mu M in an enzymatic chromogenic assay. In a plasma clot lysis assay, the compound was active with an IC50 of 16 mu M. Surprisingly, AZ3976 did not bind to active PAI-1 but bound to latent PAI-1 with a K-D of 0.29 mu M at 35 degrees C and a binding stoichiometry of 0.94, as measured by isothermal calorimetry. Reversible binding was confirmed by surface plasmon resonance direct binding experiments. The x-ray structure of AZ3976 in complex with latent PAI-1 was determined at 2.4 angstrom resolution. The inhibitor was bound in the flexible joint region with the entrance to the cavity located between alpha-helix D and beta-strand 2A. A set of surface plasmon resonance experiments revealed that AZ3976 inhibited PAI-1 by enhancing the latency transition of active PAI-1. Because AZ3976 only had measurable affinity for latent PAI-1, we propose that its mechanism of inhibition is based on binding to a small fraction in equilibrium with active PAI-1, a latent-like prelatent form, from which latent PAI-1 is then generated more rapidly. This mode of action, with induced accelerated latency transition of active PAI-1 may, together with supporting x-ray data, provide improved opportunities for small molecule drug design in the hunt for therapeutically useful PAI-1 inhibitors.	[Fjellstrom, Ola] AstraZeneca R&D, Dept Med Chem, S-43183 Molndal, Sweden; [Deinum, Johanna; Nerme, Viveca; Legnehed, Anne; Gustafsson, David] AstraZeneca R&D, Dept Biosci, S-43183 Molndal, Sweden; [Sjogren, Tove; Johansson, Carina; Geschwindner, Stefan; McPheat, Jane; Olsson, Karolina; Bodin, Cristian; Paunovic, Amalia] AstraZeneca R&D, Dept Discovery Sci, S-43183 Molndal, Sweden	AstraZeneca; AstraZeneca; AstraZeneca	Fjellstrom, O (corresponding author), AstraZeneca R&D, Dept Med Chem, S-43183 Molndal, Sweden.	ola.fjellstrom@astrazeneca.com						Bjorquist P, 1999, BBA-PROTEIN STRUCT M, V1431, P24, DOI 10.1016/S0167-4838(99)00031-X; BJORQUIST P, 1994, BBA-PROTEIN STRUCT M, V1209, P191, DOI 10.1016/0167-4838(94)90184-8; Bjorquist P, 1998, BIOCHEMISTRY-US, V37, P1227, DOI 10.1021/bi971554q; Blouse GE, 2009, BIOCHEMISTRY-US, V48, P1723, DOI 10.1021/bi8017015; BOOTH NA, 1992, ANN NY ACAD SCI, V667, P70, DOI 10.1111/j.1749-6632.1992.tb51599.x; Brogren H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026762; Cale JM, 2010, J BIOL CHEM, V285, P7892, DOI 10.1074/jbc.M109.067967; Cesari M, 2010, CARDIOVASC THER, V28, pe72, DOI 10.1111/j.1755-5922.2010.00171.x; Crandall DL, 2006, ARTERIOSCL THROM VAS, V26, P2209, DOI 10.1161/01.ATV.0000235605.51400.9d; Dupont DM, 2006, J BIOL CHEM, V281, P36071, DOI 10.1074/jbc.M606851200; Dupont DM, 2009, FRONT BIOSCI-LANDMRK, V14, P1337, DOI 10.2741/3312; Egelund R, 2001, J BIOL CHEM, V276, P13077, DOI 10.1074/jbc.M009024200; Ehnebom J, 1997, FIBRINOLYSIS PROTEOL, V11, P287, DOI 10.1016/S0268-9499(97)80114-2; Ehnebom J, 2000, FIBRINOLYSIS PROTEOL, V14, P47, DOI 10.1054/fipr.2000.0052; Ehnebom J, 1997, FIBRINOLYSIS PROTEOL, V11, P165, DOI 10.1016/S0268-9499(97)80061-6; Elokdah H, 2004, J MED CHEM, V47, P3491, DOI 10.1021/jm049766q; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falk K, 2001, BRIT J SURG, V88, P286, DOI 10.1046/j.1365-2168.2001.01647.x; Gardell SJ, 2007, MOL PHARMACOL, V72, P897, DOI 10.1124/mol.107.037010; Gorlatova NV, 2007, J BIOL CHEM, V282, P9288, DOI 10.1074/jbc.M611642200; Gorlatova NV, 2003, J BIOL CHEM, V278, P16329, DOI 10.1074/jbc.M208420200; Hrafnkelsdottir T, 2004, J THROMB HAEMOST, V2, P1960, DOI 10.1111/j.1538-7836.2004.00948.x; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Izuhara Y, 2008, ARTERIOSCL THROM VAS, V28, P672, DOI 10.1161/ATVBAHA.107.157479; Izuhara Y, 2010, J CEREBR BLOOD F MET, V30, P904, DOI 10.1038/jcbfm.2009.272; Jensen JK, 2011, J BIOL CHEM, V286, P29709, DOI 10.1074/jbc.M111.236554; KLUFT C, 1990, FIBRINOLYSIS, V4, P155, DOI 10.1016/0268-9499(90)90397-3; Lang IM, 1996, J BIOL CHEM, V271, P2754, DOI 10.1074/jbc.271.5.2754; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; LEVI M, 1992, CIRCULATION, V85, P305, DOI 10.1161/01.CIR.85.1.305; LEVIN EG, 1987, BLOOD, V70, P1090; Lin ZH, 2011, J BIOL CHEM, V286, P7027, DOI 10.1074/jbc.M110.204537; LINDAHL TL, 1989, THROMB HAEMOSTASIS, V62, P748; Lucking AJ, 2010, J THROMB HAEMOST, V8, P1333, DOI 10.1111/j.1538-7836.2010.03872.x; Lucking AJ, 2010, THROMB RES, V126, P431, DOI 10.1016/j.thromres.2010.06.030; Maksimenko A. V., 2002, PHARM CHEM J, V36, P348; Mathiasen L, 2008, MOL PHARMACOL, V74, P641, DOI 10.1124/mol.108.046417; Montes R, 2000, THROMB HAEMOSTASIS, V84, P65, DOI 10.1055/s-0037-1613969; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Naessens D, 2003, THROMB HAEMOSTASIS, V90, P52, DOI 10.1055/s-0037-1613598; Nar H, 2000, J MOL BIOL, V297, P683, DOI 10.1006/jmbi.2000.3604; Ngo TH, 2002, THROMB HAEMOSTASIS, V88, P288; Nordenhem A, 1997, SCAND J CLIN LAB INV, V57, P453, DOI 10.3109/00365519709084594; Pandya V, 2011, BIOORG MED CHEM LETT, V21, P5701, DOI 10.1016/j.bmcl.2011.08.031; Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x; Robbie LA, 1996, ARTERIOSCL THROM VAS, V16, P539, DOI 10.1161/01.ATV.16.4.539; Roessler FC, 2011, BLOOD COAGUL FIBRIN, V22, P407, DOI 10.1097/MBC.0b013e3283468a60; Schar CR, 2008, J BIOL CHEM, V283, P28487, DOI 10.1074/jbc.M804257200; Schar CR, 2008, J BIOL CHEM, V283, P10297, DOI 10.1074/jbc.M708017200; SIGURDARDOTTIR O, 1990, BIOCHIM BIOPHYS ACTA, V1035, P56, DOI 10.1016/0304-4165(90)90173-T; STEIN P, 1991, J MOL BIOL, V221, P615, DOI 10.1016/0022-2836(91)80076-7; Stout TJ, 2000, BIOCHEMISTRY-US, V39, P8460, DOI 10.1021/bi000290w; STROMQVIST M, 1994, PROTEIN EXPRES PURIF, V5, P309, DOI 10.1006/prep.1994.1046; vanGiezen JJJ, 1997, THROMB HAEMOSTASIS, V77, P964; VANLOON BJP, 1992, THROMB HAEMOSTASIS, V67, P101; Verhamme I, 1999, J BIOL CHEM, V274, P17511, DOI 10.1074/jbc.274.25.17511; Whisstock JC, 2010, J BIOL CHEM, V285, P24307, DOI 10.1074/jbc.R110.141408; Willems PKA, 1999, ACTA CRYSTALLOGR D, V55, P574, DOI 10.1107/S0907444998013511; Xue YF, 1998, STRUCT FOLD DES, V6, P627, DOI 10.1016/S0969-2126(98)00064-1; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943	61	22	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					873	885		10.1074/jbc.M112.371732	http://dx.doi.org/10.1074/jbc.M112.371732			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23155046	Green Published, hybrid			2022-12-28	WOS:000313570300012
J	Franke, M; Braulke, T; Storch, S				Franke, Mine; Braulke, Thomas; Storch, Stephan			Transport of the GlcNAc-1-phosphotransferase alpha/beta-Subunit Precursor Protein to the Golgi Apparatus Requires a Combinatorial Sorting Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDO-HURLER POLYDYSTROPHY; COPII-DEPENDENT EXPORT; MUCOLIPIDOSIS-II; VESICLE FORMATION; MECHANISMS; MUTATIONS; ENZYME; ER; N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; PHOSPHOTRANSFERASE	The Golgi-resident N-acetylglucosamine-1-phosphotransferase (PT) complex is composed of two alpha-, beta-, and gamma-subunits and represents the key enzyme for the biosynthesis of mannose 6-phosphate recognition marker on soluble lysosomal proteins. Mutations in the PT complex cause the lysosomal storage diseases mucolipidosis II and III. A prerequisite for the enzymatic activity is the site-1 protease-mediated cleavage of the PT alpha/beta-subunit precursor protein in the Golgi apparatus. Here, we have investigated structural requirements of the PT alpha/beta-subunit precursor protein for its efficient export from the endoplasmic reticulum (ER). Both wild-type and a cleavage-resistant type III membrane PT alpha/beta-subunit precursor protein are exported whereas coexpressed separate alpha- and beta-subunits failed to reach the cis-Golgi compartment. Mutational analyses revealed combinatorial, non-exchangeable dileucine and dibasic motifs located in a defined sequence context in the cytosolic N- and C-terminal domains that are required for efficient ER exit and subsequent proteolytic activation of the alpha/beta-subunit precursor protein in the Golgi. In the presence of a dominant negative Sar1 mutant the ER exit of the PT alpha/beta-subunit precursor protein is inhibited indicating its transport in coat protein complex II-coated vesicles. Expression studies of missense mutations identified in mucolipidosis III patients that alter amino acids in the N- and C-terminal domains demonstrated that the substitution of a lysine residue in close proximity to the dileucine sorting motif impaired ER-Golgi transport and subsequent activation of the PT alpha/beta-subunit precursor protein. The data suggest that the oligomeric type III membrane protein PT complex requires a combinatorial sorting motif that forms a tertiary epitope to be recognized by distinct sites within the coat protein complex II machinery.	[Franke, Mine; Braulke, Thomas; Storch, Stephan] Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Childrens Hosp, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Storch, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Childrens Hosp, Martinistr 52,Bldg N27, D-20246 Hamburg, Germany.	storch@uke.uni-hamburg.de	Braulke, Thomas/AAV-9121-2020	Braulke, Thomas/0000-0002-2336-8532; Storch, Stephan/0000-0002-8807-5917	Deutsche Forschungsgemeinschaft [STO 761/2-1, GRK1459]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants STO 761/2-1 and GRK1459.	Bao M, 1996, J BIOL CHEM, V271, P31446, DOI 10.1074/jbc.271.49.31446; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Braulke T, 2008, J INHERIT METAB DIS, V31, P253, DOI 10.1007/s10545-008-0862-5; Encarnacao M, 2011, J BIOL CHEM, V286, P5311, DOI 10.1074/jbc.M110.202382; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Jensen D, 2011, J CELL SCI, V124, P1, DOI 10.1242/jcs.069773; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; Kudo M, 2006, AM J HUM GENET, V78, P451, DOI 10.1086/500849; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Otte S, 2002, EMBO J, V21, P6095, DOI 10.1093/emboj/cdf598; Qian Y, 2010, FRONT ENVIRON SCI EN, V4, P1, DOI 10.1007/s11783-010-1000-9; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Storch S, 2007, TRAFFIC, V8, P431, DOI 10.1111/j.1600-0854.2007.00537.x; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Tiede S, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9443; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797	31	23	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1238	1249		10.1074/jbc.M112.407676	http://dx.doi.org/10.1074/jbc.M112.407676			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23192343	Green Published, hybrid			2022-12-28	WOS:000313570300044
J	Weiser, BP; Kelz, MB; Eckenhoff, RG				Weiser, Brian P.; Kelz, Max B.; Eckenhoff, Roderic G.			In Vivo Activation of Azipropofol Prolongs Anesthesia and Reveals Synaptic Targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(A) RECEPTOR; BINDING-SITE; TRANSMEMBRANE DOMAIN; GEL-ELECTROPHORESIS; CALCIUM-CHANNELS; ANALOG; MODULATION; ETOMIDATE; SNAP-25; RAT	General anesthetic photolabels have been instrumental in discovering and confirming protein binding partners and binding sites of these promiscuous ligands. We report the in vivo photoactivation of meta-azipropofol, a potent analog of propofol, in Xenopus laevis tadpoles. Covalent adduction of meta-azipropofol in vivo prolongs the primary pharmacologic effect of general anesthetics in a behavioral phenotype we termed "optoanesthesia." Coupling this behavior with a tritiated probe, we performed unbiased, time-resolved gel proteomics to identify neuronal targets of meta-azipropofol in vivo. We have identified synaptic binding partners, such as synaptosomal-associated protein 25, as well as voltage-dependent anion channels as potential facilitators of the general anesthetic state. Pairing behavioral phenotypes elicited by the activation of efficacious photolabels in vivo with time-resolved proteomics provides a novel approach to investigate molecular mechanisms of general anesthetics.	[Weiser, Brian P.; Kelz, Max B.; Eckenhoff, Roderic G.] Univ Penn, Dept Anesthesia & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Weiser, Brian P.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kelz, Max B.] Univ Penn, Ctr Sleep & Circadian Neurobiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kelz, Max B.] Univ Penn, David Mahoney Inst Neurol Sci, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Eckenhoff, RG (corresponding author), Univ Penn, Dept Anesthesia & Crit Care, Perelman Sch Med, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	roderic.eckenhoff@uphs.upenn.edu	Kelz, Max/E-4054-2010	Kelz, Max/0000-0002-2803-6078; Eckenhoff, Roderic/0000-0002-5581-746X	National Institutes of Health [GM055876, NS080519, GM088156]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088156, P01GM055876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS080519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM055876 (to R. G. E.), NS080519 (to B. P. W.), and GM088156 (to M. B. K.).	Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; Bunai K, 2005, J CHROMATOGR B, V815, P227, DOI 10.1016/j.jchromb.2004.08.030; BUREAU MH, 1992, J BIOL CHEM, V267, P8679; Chen ZW, 2012, MOL PHARMACOL, V82, P408, DOI 10.1124/mol.112.078410; Chen ZW, 2012, ELECTROPHORESIS, V33, P666, DOI 10.1002/elps.201100434; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Condliffe SB, 2010, J BIOL CHEM, V285, P24968, DOI 10.1074/jbc.M110.145813; Cui TX, 2012, BBA-BIOMEMBRANES, V1818, P617, DOI 10.1016/j.bbamem.2011.11.021; Darbandi-Tonkabon R, 2003, J BIOL CHEM, V278, P13196, DOI 10.1074/jbc.M213168200; Darbandi-Tonkabon R, 2004, J PHARMACOL EXP THER, V308, P502, DOI 10.1124/jpet.103.058123; Das J, 2004, J BIOL CHEM, V279, P37964, DOI 10.1074/jbc.M405137200; Downes H, 1996, J PHARMACOL EXP THER, V278, P284; ECKENHOFF RG, 1993, ANESTHESIOLOGY, V79, P96, DOI 10.1097/00000542-199307000-00015; Eckenhoff RG, 2010, ACS CHEM NEUROSCI, V1, P139, DOI 10.1021/cn900014m; Friedman EB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011903; Garbelli R, 2008, J COMP NEUROL, V506, P373, DOI 10.1002/cne.21505; Gerachshenko T, 2005, NAT NEUROSCI, V8, P597, DOI 10.1038/nn1439; Hall MA, 2010, J MED CHEM, V53, P5667, DOI 10.1021/jm1004072; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Herring BE, 2011, J PHYSIOL-LONDON, V589, P1103, DOI 10.1113/jphysiol.2010.200964; Herring BE, 2009, J NEUROPHYSIOL, V102, P1265, DOI 10.1152/jn.00252.2009; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Issaq HJ, 2008, BIOTECHNIQUES, V44, P697, DOI 10.2144/000112823; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Krasowski MD, 2001, J PHARMACOL EXP THER, V297, P338; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Nagele P, 2005, ANESTHESIOLOGY, V103, P768, DOI 10.1097/00000542-200510000-00015; Nguyen HT, 2009, ANESTHESIOLOGY, V110, P326, DOI 10.1097/ALN.0b013e3181942b5b; Stewart DS, 2011, J MED CHEM, V54, P8124, DOI 10.1021/jm200943f; van Swinderen B, 1999, P NATL ACAD SCI USA, V96, P2479, DOI 10.1073/pnas.96.5.2479; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Xi J, 2004, J BIOL CHEM, V279, P19628, DOI 10.1074/jbc.M313864200; Yuki K, 2012, FASEB J, V26, P4408, DOI 10.1096/fj.12-212746; Zhong HJ, 2008, ANESTHESIOLOGY, V108, P103, DOI 10.1097/01.anes.0000296074.33999.52; Ziebell MR, 2004, J BIOL CHEM, V279, P17640, DOI 10.1074/jbc.M313886200	37	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1279	1285		10.1074/jbc.M112.413989	http://dx.doi.org/10.1074/jbc.M112.413989			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184948	Green Published, hybrid			2022-12-28	WOS:000313570300049
J	Wu, D; Ozaki, T; Yoshihara, Y; Kubo, N; Nakagawara, A				Wu, Dan; Ozaki, Toshinori; Yoshihara, Yukari; Kubo, Natsumi; Nakagawara, Akira			Runt-related Transcription Factor 1 (RUNX1) Stimulates Tumor Suppressor p53 Protein in Response to DNA Damage through Complex Formation and Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; MULTIPLE CHROMOSOMAL TRANSLOCATIONS; ACTIVATES P53; AML1 GENE; GROWTH; APOPTOSIS; P300; MDM2; BETA; EXPRESSION	Representative tumor suppressor p53 plays a critical role in the regulation of proper DNA damage response. In this study, we have found for the first time that Runt-related transcription factor 1 (RUNX1) contributes to p53-dependent DNA damage response. Upon adriamycin (ADR) exposure, p53 as well as RUNX1 were strongly induced in p53-proficient HCT116 and U2OS cells, which were closely associated with significant transactivation of p53 target genes, such as p21(WAF1), BAX, NOXA, and PUMA. RUNX1 was exclusively expressed in the cell nucleus and formed a complex with p53 in response to ADR. Chromatin immunoprecipitation assay demonstrated that p53 together with RUNX1 are efficiently recruited onto p53 target gene promoters following ADR exposure, indicating that RUNX1 is involved in p53-mediated transcriptional regulation. Indeed, forced expression of RUNX1 stimulated the transcriptional activity of p53 in response to ADR. Consistent with these observations, knockdown of RUNX1 attenuated ADR-mediated induction of p53 target genes and suppressed ADR-dependent apoptosis. Furthermore, RUNX1 was associated with p300 histone acetyltransferase, and ADR-dependent acetylation of p53 at Lys-373/382 was markedly inhibited in RUNX1 knockdown cells. In addition, knockdown of RUNX1 resulted in a significant decrease in the amount of p53-p300 complex following ADR exposure. Taken together, our present results strongly suggest that RUNX1 is required for the stimulation of p53 in response to DNA damage and also provide novel insight into understanding the molecular mechanisms behind p53-dependent DNA damage response.	[Wu, Dan; Nakagawara, Akira] Chiba Canc Ctr, Res Inst, Lab Innovat Canc Therapeut, Chuoh Ku, Chiba 2608717, Japan; [Wu, Dan; Ozaki, Toshinori; Yoshihara, Yukari; Kubo, Natsumi] Chiba Canc Ctr, Res Inst, Lab DNA Damage Signaling, Chuoh Ku, Chiba 2608717, Japan	Chiba Cancer Center; Chiba Cancer Center	Ozaki, T (corresponding author), Chiba Canc Ctr, Res Inst, Lab DNA Damage Signaling, Chuoh Ku, 666-2 Nitona, Chiba 2608717, Japan.	tozaki@chiba-cc.jp; akiranak@chiba-cc.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Hamaguchi Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hamaguchi Foundation(Hamaguchi Foundation for the Advancement of Biochemistry)	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Hamaguchi Foundation.	D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Guo H, 2011, J BIOL CHEM, V286, P208, DOI 10.1074/jbc.M110.149013; Hanamoto T, 2005, J BIOL CHEM, V280, P16665, DOI 10.1074/jbc.M414323200; HARRIS CC, 1993, SCIENCE, V262, P1980, DOI 10.1126/science.8266092; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Kawai H, 2001, J BIOL CHEM, V276, P45928, DOI 10.1074/jbc.M107770200; Kim WJ, 2012, MOL CELL, V45, P587, DOI 10.1016/j.molcel.2011.12.025; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Li XL, 2007, ONCOGENE, V26, P7231, DOI 10.1038/sj.onc.1210523; Li Y, 2008, ONCOGENE, V27, P3700, DOI 10.1038/sj.onc.1211032; Linggi B, 2002, NAT MED, V8, P743, DOI 10.1038/nm726; Lutterbach B, 2000, J BIOL CHEM, V275, P651, DOI 10.1074/jbc.275.1.651; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; Piette J, 1997, ONCOGENE, V15, P1001, DOI 10.1038/sj.onc.1201432; Prives C, 1999, J PATHOL, V187, P112; Roumier C, 2003, LEUKEMIA, V17, P9, DOI 10.1038/sj.leu.2402766; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Silva FPG, 2003, ONCOGENE, V22, P538, DOI 10.1038/sj.onc.1206141; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; TAKAHASHI A, 1995, BLOOD, V86, P607, DOI 10.1182/blood.V86.2.607.bloodjournal862607; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Velculescu VE, 1996, CLIN CHEM, V42, P858; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wen Z, 2012, MOL CELL BIOL, V32, P26, DOI 10.1128/MCB.05513-11; Wildey GM, 2009, J BIOL CHEM, V284, P20227, DOI 10.1074/jbc.M109.027201; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Wotton SF, 2004, ONCOGENE, V23, P5476, DOI 10.1038/sj.onc.1207729; Yamada C, 2010, J BIOL CHEM, V285, P16693, DOI 10.1074/jbc.M109.055525; Yamaguchi Y, 2004, J BIOL CHEM, V279, P15630, DOI 10.1074/jbc.M400355200; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200; Yoshihara Y, 2012, BIOCHEM BIOPH RES CO, V421, P57, DOI 10.1016/j.bbrc.2012.03.108; Yuan ZM, 1999, J BIOL CHEM, V274, P1883, DOI 10.1074/jbc.274.4.1883; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	56	36	38	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1353	1364		10.1074/jbc.M112.402594	http://dx.doi.org/10.1074/jbc.M112.402594			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23148227	hybrid, Green Published			2022-12-28	WOS:000313570300056
J	Dennis, MD; Kimball, SR; Jefferson, LS				Dennis, Michael D.; Kimball, Scot R.; Jefferson, Leonard S.			Mechanistic Target of Rapamycin Complex 1 (mTORC1)-mediated Phosphorylation Is Governed by Competition between Substrates for Interaction with Raptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; MAMMALIAN TARGET; SIGNALING PATHWAY; PROTEIN-SYNTHESIS; MTOR; BINDING; 4E-BP1; TRANSLATION; AKT; TOR	In this study, the interaction of mTORC1 with its downstream targets p70S6K1 and 4E-BP1 was evaluated in both mouse liver and mouse embryonic fibroblasts following combined disruption of the genes encoding 4E-BP1 and 4E-BP2. Phosphorylation of p70S6K1 was dramatically elevated in the livers of mice lacking 4E-BP1 and 4E-BP2 following feeding-induced activation of mTORC1. Immunoprecipitation of mTORC1 suggested that elevated phosphorylation was the result of enhanced interaction of p70S6K1 with raptor. These findings were extended to a cell culture system wherein loss of 4E-BP1 and 4E-BP2 resulted in elevated interaction of p70S6K1 with IGF1-induced activation of mTORC1 in conjunction with an enhanced rate of p70S6K1 phosphorylation at Thr-389. Furthermore, co-transfecting HA-p70S6K1 with 4E-BP1, but not 4E-BP1(F114A), reduced recovery of mTORC1 in HA-p70S6K1 immunoprecipitates. Together, these findings support the conclusion that, in the absence of 4E-BP proteins, mTORC1-mediated phosphorylation of p70S6K1 is elevated by a reduction in competition between the two substrates for interaction with raptor.	[Dennis, Michael D.; Kimball, Scot R.; Jefferson, Leonard S.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kimball, SR (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, H166,500 Univ Dr, Hershey, PA 17033 USA.	skimball@psu.edu		Dennis, Michael/0000-0002-0645-6864	National Institutes of Health [DK13499, DK088416]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK088416, R37DK013499, R01DK013499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK13499 (to L. S. J.) and DK088416 (to M. D. D.).	Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Dennis MD, 2011, J BIOL CHEM, V286, P34286, DOI 10.1074/jbc.M111.259457; Dennis MD, 2011, J BIOL CHEM, V286, P8287, DOI 10.1074/jbc.M110.209171; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Kimball SR, 1997, AM J PHYSIOL-CELL PH, V272, pC754, DOI 10.1152/ajpcell.1997.272.2.C754; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Rapley J, 2011, J BIOL CHEM, V286, P38043, DOI 10.1074/jbc.M111.245449; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Winter JN, 2011, AM J PHYSIOL-CELL PH, V300, pC1172, DOI 10.1152/ajpcell.00504.2010; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017	26	25	26	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					10	19		10.1074/jbc.M112.402461	http://dx.doi.org/10.1074/jbc.M112.402461			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23184952	Green Published, hybrid			2022-12-28	WOS:000313197200002
J	Moritz, AE; Foster, JD; Gorentla, BK; Mazei-Robison, MS; Yang, JW; Sitte, HH; Blakely, RD; Vaughan, RA				Moritz, Amy E.; Foster, James D.; Gorentla, Balachandra K.; Mazei-Robison, Michelle S.; Yang, Jae-Won; Sitte, Harald H.; Blakely, Randy D.; Vaughan, Roxanne A.			Phosphorylation of Dopamine Transporter Serine 7 Modulates Cocaine Analog Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; OUTWARD-FACING CONFORMATION; INDUCED REVERSE TRANSPORT; NEUROTRANSMITTER TRANSPORTERS; FUNCTIONAL REGULATION; MONOAMINE TRANSPORTERS; DEPENDENT MECHANISM; UPTAKE INHIBITORS; SYNTAXIN 1A; AMPHETAMINE	As an approach to elucidating dopamine transporter (DAT) phosphorylation characteristics, we examined in vitro phosphorylation of a recombinant rat DAT N-terminal peptide (NDAT) using purified protein kinases. We found that NDAT becomes phosphorylated at single distinct sites by protein kinase A (Ser-7) and calcium-calmodulin-dependent protein kinase II (Ser-13) and at multiple sites (Ser-4, Ser-7, and Ser-13) by protein kinase C (PKC), implicating these residues as potential sites of DAT phosphorylation by these kinases. Mapping of rat striatal DAT phosphopeptides by two-dimensional thin layer chromatography revealed basal and PKC-stimulated phosphorylation of the same peptide fragments and comigration of PKC-stimulated phosphopeptide fragments with NDAT Ser-7 phosphopeptide markers. We further confirmed by site-directed mutagenesis and mass spectrometry that Ser-7 is a site for PKC-stimulated phosphorylation in heterologously expressed rat and human DATs. Mutation of Ser-7 and nearby residues strongly reduced the affinity of rat DAT for the cocaine analog (-)-2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (CFT), whereas in rat striatal tissue, conditions that promote DAT phosphorylation caused increased CFT affinity. Ser-7 mutation also affected zinc modulation of CFT binding, with Ala and Asp substitutions inducing opposing effects. These results identify Ser-7 as a major site for basal and PKC-stimulated phosphorylation of native and expressed DAT and suggest that Ser-7 phosphorylation modulates transporter conformational equilibria, shifting the transporter between high and low affinity cocaine binding states.	[Moritz, Amy E.; Foster, James D.; Gorentla, Balachandra K.; Vaughan, Roxanne A.] Univ N Dakota, Dept Biochem & Mol Biol, Sch Med & Hlth Sci, Grand Forks, ND 58203 USA; [Mazei-Robison, Michelle S.; Blakely, Randy D.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Mazei-Robison, Michelle S.; Blakely, Randy D.] Vanderbilt Univ, Dept Psychiat, Nashville, TN 37232 USA; [Yang, Jae-Won; Sitte, Harald H.] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	University of North Dakota Grand Forks; Vanderbilt University; Vanderbilt University; Medical University of Vienna	Vaughan, RA (corresponding author), Univ N Dakota, Dept Biochem & Mol Biol, Sch Med & Hlth Sci, Grand Forks, ND 58202 USA.	roxanne.vaughan@med.und.edu	Sitte, Harald/O-7025-2019; Mazei-Robison, Michelle/I-4304-2017; Sitte, Harald/N-2681-2013	Sitte, Harald/0000-0002-1339-7444; Mazei-Robison, Michelle/0000-0002-2372-1420; Sitte, Harald/0000-0002-1339-7444; Yang, Jae-Won/0000-0001-8928-0130	National Institutes of Health [DA13147, P20 RR01769, MH067472, DA07390]; North Dakota EPSCoR IIG; North Dakota EPSCOR; Austrian Science Fund [SFB3506, P23670-B09]; National Institutes of Health COBRE Program from NCRR [P20 RR017699]; Austrian Science Fund (FWF) [P 23670] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017699, R24RR001769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH067472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007390, R01DA013147] Funding Source: NIH RePORTER; EPSCoR [0814442] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Dakota EPSCoR IIG; North Dakota EPSCOR; Austrian Science Fund(Austrian Science Fund (FWF)); National Institutes of Health COBRE Program from NCRR; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported, in whole or in part, by National Institutes of Health Grants DA13147 (to R. A. V.) and P20 RR01769 (to U. N. D.), Predoctoral Fellowship MH067472 (to M. S. M.-R.), and Grant DA07390 (to R. D. B.). This work was also supported by North Dakota EPSCoR IIG (to R. A. V. and J. D. F.), North Dakota EPSCOR Doctoral Dissertation Fellowship (to B. K. G.), and the Austrian Science Fund SFB3506 (to H. H. S.) and P23670-B09 (to J. W. Y.); We thank Steven Adkins and Qiao Han for excellent technical assistance and Drs. Gert Lubec and Wei-Qiang Chen for generous support with mass spectrometry. The University of North Dakota was recipient of National Institutes of Health COBRE Program Grant P20 RR017699 from NCRR.	AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Batchelor M, 1998, J NEUROSCI, V18, P10304; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; Cervinski MA, 2010, NEUROSCIENCE, V170, P408, DOI 10.1016/j.neuroscience.2010.07.025; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; Chang MY, 2001, J NEUROCHEM, V77, P754, DOI 10.1046/j.1471-4159.2001.00284.x; Chen NH, 2004, J NEUROCHEM, V89, P853, DOI 10.1111/j.1471-4159.2004.02386.x; Chen NH, 2004, J BIOL CHEM, V279, P5508, DOI 10.1074/jbc.M306294200; Chen NH, 1998, J NEUROSCI, V18, P10257; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Foster JD, 2006, HANDB EXP PHARM, V175, P197; Foster J. D., 2010, ABSTRACT VIEWER ITIN, V546.8; Foster J. D., 2003, ABSTRACT VIEWER ITIN, V167.12; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Foster JD, 2012, J BIOL CHEM, V287, P29702, DOI 10.1074/jbc.M112.367706; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Gaffaney JD, 2004, MOL PHARMACOL, V65, P692, DOI 10.1124/mol.65.3.692; Gnegy ME, 2003, EUR J PHARMACOL, V479, P83, DOI 10.1016/j.ejphar.2003.08.059; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; Gorentla BK, 2009, BIOCHEMISTRY-US, V48, P1067, DOI 10.1021/bi801696n; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Guptaroy B, 2011, MOL PHARMACOL, V79, P520, DOI 10.1124/mol.110.069039; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Huff RA, 1997, J NEUROCHEM, V68, P225; Jayanthi LD, 2005, AAPS J, V7, pE728, DOI 10.1208/aapsj070373; Johnson LA, 2005, J BIOL CHEM, V280, P10914, DOI 10.1074/jbc.M413887200; Kahlig KM, 2003, EUR J PHARMACOL, V479, P153, DOI 10.1016/j.ejphar.2003.08.065; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Khoshbouei H, 2003, J BIOL CHEM, V278, P12070, DOI 10.1074/jbc.M212815200; KITAYAMA S, 1994, EUR J PHARM-MOLEC PH, V268, P115, DOI 10.1016/0922-4106(94)90180-5; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Lee KH, 2004, NEUROCHEM RES, V29, P1405, DOI 10.1023/B:NERE.0000026404.08779.43; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Loland CJ, 2008, MOL PHARMACOL, V73, P813, DOI 10.1124/mol.107.039800; Meisenhelder J., 2001, CURR PROTOC PROTEIN; Miller GW, 1999, TRENDS PHARMACOL SCI, V20, P424, DOI 10.1016/S0165-6147(99)01379-6; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; Page G, 2004, NEUROCHEM INT, V45, P627, DOI 10.1016/j.neuint.2004.04.002; Park YH, 2003, J NEUROCHEM, V87, P1546, DOI 10.1046/j.1471-4159.2003.02127.x; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pristupa ZB, 1998, SYNAPSE, V30, P79, DOI 10.1002/(SICI)1098-2396(199809)30:1<79::AID-SYN10>3.3.CO;2-I; Ramamoorthy S, 2011, PHARMACOL THERAPEUT, V129, P220, DOI 10.1016/j.pharmthera.2010.09.009; RICHFIELD EK, 1993, MOL PHARMACOL, V43, P100; Robertson SD, 2009, MOL NEUROBIOL, V39, P73, DOI 10.1007/s12035-009-8053-4; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Schmitt KC, 2010, ANN NY ACAD SCI, V1187, P316, DOI 10.1111/j.1749-6632.2009.05148.x; Sitte HH, 2010, J NEUROCHEM, V112, P340, DOI 10.1111/j.1471-4159.2009.06474.x; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Steinkellner T, 2012, J BIOL CHEM, V287, P29627, DOI 10.1074/jbc.M112.367219; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Vaughan RA, 1996, J BIOL CHEM, V271, P21672, DOI 10.1074/jbc.271.35.21672; Vaughan RA, 2004, J PHARMACOL EXP THER, V310, P1, DOI 10.1124/jpet.103.052423; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yang JW, 2007, P NATL ACAD SCI USA, V104, P20055, DOI 10.1073/pnas.0708574104; Zhang L, 1997, BIOCHEM PHARMACOL, V53, P677, DOI 10.1016/S0006-2952(96)00898-2; Zheng JF, 2009, J PROTEOME RES, V8, P4479, DOI 10.1021/pr9002596	63	42	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					20	32		10.1074/jbc.M112.407874	http://dx.doi.org/10.1074/jbc.M112.407874			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23161550	Green Published, hybrid			2022-12-28	WOS:000313197200003
J	Ruiz, JC; Walker, SD; Anderson, SA; Eisenstein, RS; Bruick, RK				Ruiz, Julio C.; Walker, Scott D.; Anderson, Sheila A.; Eisenstein, Richard S.; Bruick, Richard K.			F-box and Leucine-rich Repeat Protein 5 (FBXL5) Is Required for Maintenance of Cellular and Systemic Iron Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMERYTHRIN-LIKE DOMAIN; REGULATORY PROTEINS; MAMMALIAN IRON; TRANSFERRIN RECEPTOR; RAT-LIVER; MITOCHONDRIAL ACONITASE; MESSENGER-RNA; IN-VIVO; METABOLISM; DEGRADATION	Maintenance of cellular iron homeostasis requires post-transcriptional regulation of iron metabolism genes by iron regulatory protein 2 (IRP2). The hemerythrin-like domain of F-box and leucine-rich repeat protein 5 (FBXL5), an E3 ubiquitin ligase subunit, senses iron and oxygen availability and facilitates IRP2 degradation in iron replete cells. Disruption of the ubiquitously expressed murine Fbxl5 gene results in a failure to sense increased cellular iron availability, accompanied by constitutive IRP2 accumulation and misexpression of IRP2 target genes. FBXL5-null mice die during embryogenesis, although viability is restored by simultaneous deletion of the IRP2, but not IRP1, gene. Mice containing a single functional Fbxl5 allele behave like their wild type littermates when fed an iron-sufficient diet. However, unlike wild type mice that manifest decreased hematocrit and hemoglobin levels when fed a low-iron diet, Fbxl5 heterozygotes maintain normal hematologic values due to increased iron absorption. The responsiveness of IRP2 to low iron is specifically enhanced in the duodena of the heterozygotes and is accompanied by increased expression of the divalent metal transporter-1. These results confirm the role of FBXL5 in the in vivo maintenance of cellular and systemic iron homeostasis and reveal a privileged role for the intestine in their regulation by virtue of its unique FBXL5 iron sensitivity.	[Ruiz, Julio C.; Walker, Scott D.; Bruick, Richard K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Anderson, Sheila A.; Eisenstein, Richard S.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Wisconsin System; University of Wisconsin Madison	Bruick, RK (corresponding author), 5323 Harry Hines Blvd,K3-112, Dallas, TX 75390 USA.	richard.bruick@utsouthwestern.edu			National Center for Research Resources [C06 RR 15437-01]; National Institutes of Health [HL102481, DK66600, GM084266]; Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund; Robert A. Welch Foundation [I-1568]; Sara and Frank McKnight Graduate Student Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015437] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK066600, R01DK066600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084266] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); Robert A. Welch Foundation(The Welch Foundation); Sara and Frank McKnight Graduate Student Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Sean McCormick and Paul A. Lindahl for inductively coupled plasma mass spectrometry analysis, Sandi Jo Estill, James Richardson, and the UTSW Molecular Pathology Core for assistance with the animal studies, C. Nizzi and N. Keuler for statistical analysis, and members of the Bruick lab for helpful advice. This investigation was conducted in a facility constructed with support from the Research Facilities Improvement Program Grant C06 RR 15437-01 from the National Center for Research Resources.; This work was supported, in whole or in part, by National Institutes of Health Grants HL102481 (to R. K. B.), DK66600 (to R. S. E.), and GM084266 (to P. A. L.), a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund (to R. K. B.), and Robert A. Welch Foundation Grant I-1568 (to R. K. B.).; HHMI Scholar and supported by a Sara and Frank McKnight Graduate Student Fellowship.	Butt J, 1996, P NATL ACAD SCI USA, V93, P4345, DOI 10.1073/pnas.93.9.4345; Camaschella C, 2011, CURR OPIN PEDIATR, V23, P14, DOI 10.1097/MOP.0b013e3283425591; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Chollangi S, 2012, J BIOL CHEM, V287, P23710, DOI 10.1074/jbc.M112.360404; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; De Domenico I, 2011, SEMIN LIVER DIS, V31, P272, DOI 10.1055/s-0031-1286058; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Galy B, 2005, GENESIS, V43, P181, DOI 10.1002/gene.20169; Galy B, 2004, RNA, V10, P1019, DOI 10.1261/rna.7220704; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Galy B, 2008, CELL METAB, V7, P79, DOI 10.1016/j.cmet.2007.10.006; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Grosbois B, 2005, B ACAD NAT MED PARIS, V189, P1649, DOI 10.1016/S0001-4079(19)33422-3; GUO B, 1995, J BIOL CHEM, V270, P16529, DOI 10.1074/jbc.270.28.16529; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; KOELLER DM, 1989, P NATL ACAD SCI USA, V86, P3574, DOI 10.1073/pnas.86.10.3574; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; LEIBOLD EA, 1992, ANNU REV NUTR, V12, P345, DOI 10.1146/annurev.nu.12.070192.002021; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Moroishi T, 2011, CELL METAB, V14, P339, DOI 10.1016/j.cmet.2011.07.011; Mueller S, 2001, J BIOL CHEM, V276, P23192, DOI 10.1074/jbc.M100654200; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; PANTOPOULOS K, 1995, RNA, V1, P155; Ponka P, 1999, INT J BIOCHEM CELL B, V31, P1111, DOI 10.1016/S1357-2725(99)00070-9; Popescu BFG, 2009, CEREBELLUM, V8, P74, DOI 10.1007/s12311-008-0091-3; Ross KL, 2002, J NUTR, V132, P643, DOI 10.1093/jn/132.4.643; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Salahudeen AA, 2009, ANN NY ACAD SCI, V1177, P30, DOI 10.1111/j.1749-6632.2009.05038.x; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Schneider BD, 2003, BLOOD, V102, P3404, DOI 10.1182/blood-2003-02-0433; Shu C, 2012, CHEMBIOCHEM, V13, P788, DOI 10.1002/cbic.201200043; Smith SR, 2006, BLOOD CELL MOL DIS, V36, P283, DOI 10.1016/j.bcmd.2005.12.006; Thompson JW, 2012, BBA-MOL CELL RES, V1823, P1484, DOI 10.1016/j.bbamcr.2012.02.003; Thompson JW, 2012, J BIOL CHEM, V287, P7357, DOI 10.1074/jbc.M111.308684; Thomson AM, 1999, INT J BIOCHEM CELL B, V31, P1139, DOI 10.1016/S1357-2725(99)00080-1; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Wang J, 2007, MOL CELL BIOL, V27, P2423, DOI 10.1128/MCB.01111-06	41	30	32	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					552	560		10.1074/jbc.M112.426171	http://dx.doi.org/10.1074/jbc.M112.426171			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23135277	hybrid, Green Published			2022-12-28	WOS:000313197200055
J	Zhao, JG; Sun, W; Cho, HM; Ouyang, H; Li, WL; Lin, Y; Do, J; Zhang, LF; Ding, S; Liu, YZ; Lu, P; Zhang, K				Zhao, Jiagang; Sun, Woong; Cho, Hyo Min; Ouyang, Hong; Li, Wenlin; Lin, Ying; Do, Jiun; Zhang, Liangfang; Ding, Sheng; Liu, Yizhi; Lu, Paul; Zhang, Kang			Integration and Long Distance Axonal Regeneration in the Central Nervous System from Transplanted Primitive Neural Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; DIRECTED DIFFERENTIATION; AUTONOMIC DYSREFLEXIA; ADULT CNS; RECOVERY; STAGE; MODULATION; INHIBITORS; INDUCTION; NEURONS	Spinal cord injury (SCI) results in devastating motor and sensory deficits secondary to disrupted neuronal circuits and poor regenerative potential. Efforts to promote regeneration through cell extrinsic and intrinsic manipulations have met with limited success. Stem cells represent an as yet unrealized therapy in SCI. Recently, we identified novel culture methods to induce and maintain primitive neural stem cells (pNSCs) from human embryonic stem cells. We tested whether transplanted human pNSCs can integrate into the CNS of the developing chick neural tube and injured adult rat spinal cord. Following injection of pNSCs into the developing chick CNS, pNSCs integrated into the dorsal aspects of the neural tube, forming cell clusters that spontaneously differentiated into neurons. Furthermore, following transplantation of pNSCs into the lesioned rat spinal cord, grafted pNSCs survived, differentiated into neurons, and extended long distance axons through the scar tissue at the graft-host interface and into the host spinal cord to form terminal-like structures near host spinal neurons. Together, these findings suggest that pNSCs derived from human embryonic stem cells differentiate into neuronal cell types with the potential to extend axons that associate with circuits of the CNS and, more importantly, provide new insights into CNS integration and axonal regeneration, offering hope for repair in SCI.	[Zhao, Jiagang; Lin, Ying; Liu, Yizhi; Zhang, Kang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Jiagang; Sun, Woong; Ouyang, Hong; Do, Jiun; Zhang, Kang] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Zhao, Jiagang; Sun, Woong; Ouyang, Hong; Do, Jiun; Zhang, Kang] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA; [Zhang, Liangfang] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA; [Lu, Paul] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Sun, Woong; Cho, Hyo Min] Korea Univ, Coll Med, Dept Anat, Brain Korea Program 21, Seoul 151742, South Korea; [Li, Wenlin] Second Mil Med Univ, Dept Cell Biol, Shanghai 200433, Peoples R China; [Ding, Sheng] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Lu, Paul; Zhang, Kang] Vet Adm Healthcare Syst, San Diego, CA 92161 USA	Sun Yat Sen University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Korea University; Korea University Medicine (KU Medicine); Naval Medical University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Zhang, K (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	kang.zhang@ucsd.edu	Zhang, Kang/Y-2740-2019; liu, yi/GXE-9662-2022	Zhang, Kang/0000-0002-4549-1697; li, wenlin/0000-0002-0842-222X; Ouyang, Hong/0000-0002-7622-7733; sun, woong/0000-0003-1792-4894; Do, Jiun/0000-0003-4768-0624	973 Program [2013CB967504]; NSFC [81130017]; National Institutes of Health [RO1 EY021374]; National Eye Institute [RO1 EY018660]; King Abdulazz City for Science and Technology-University of California San Diego Center of Excellence in Nanomedicine; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, Korea Ministry of Education and Science [20110019409, 20110019212]; Veterans Administration; NATIONAL EYE INSTITUTE [R01EY021374, R01EY018660] Funding Source: NIH RePORTER	973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); King Abdulazz City for Science and Technology-University of California San Diego Center of Excellence in Nanomedicine; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, Korea Ministry of Education and Science; Veterans Administration(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by grants from the 973 Program (2013CB967504), NSFC (grant 81130017), National Institutes of Health Director's Transformative RO1 Program (Grant RO1 EY021374), National Eye Institute (Grant RO1 EY018660), a grant from the King Abdulazz City for Science and Technology-University of California San Diego Center of Excellence in Nanomedicine, the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, Korea Ministry of Education and Science (Grants 20110019409 and 20110019212), and the Veterans Administration.	Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Audero E, 2008, SCIENCE, V321, P130, DOI 10.1126/science.1157871; Boulland Jean-Luc, 2010, J Vis Exp, DOI 10.3791/2071; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; HAMBURGER V, 1992, DEV DYNAM, V195, P273, DOI 10.1002/dvdy.1001950405; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Hitoshi S, 2004, GENE DEV, V18, P1806, DOI 10.1101/gad.1208404; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hollis ER, 2009, P NATL ACAD SCI USA, V106, P7215, DOI 10.1073/pnas.0810624106; Kubasak MD, 2008, BRAIN, V131, P264, DOI 10.1093/brain/awm267; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Mason P, 1999, CURR OPIN NEUROBIOL, V9, P436, DOI 10.1016/S0959-4388(99)80065-8; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pochampally RR, 2004, P NATL ACAD SCI USA, V101, P9282, DOI 10.1073/pnas.0401558101; Rabchevsky AG, 2006, PROG BRAIN RES, V152, P265, DOI 10.1016/S0079-6123(05)52017-X; Schottler J, 2009, SPINAL CORD, V47, P681, DOI 10.1038/sc.2009.12; SENUT MC, 1995, EXP NEUROL, V135, P36, DOI 10.1006/exnr.1995.1064; Sigurjonsson OE, 2005, P NATL ACAD SCI USA, V102, P5227, DOI 10.1073/pnas.0501029102; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8	29	18	19	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					164	168		10.1074/jbc.M112.433607	http://dx.doi.org/10.1074/jbc.M112.433607			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23155053	Green Published, hybrid			2022-12-28	WOS:000313197200016
J	Basu, R; Fan, D; Kandalam, V; Lee, J; Das, SK; Wang, XH; Baldwin, TA; Oudit, GY; Kassiri, Z				Basu, Ratnadeep; Fan, Dong; Kandalam, Vijay; Lee, Jiwon; Das, Subhash K.; Wang, Xiuhua; Baldwin, Troy A.; Oudit, Gavin Y.; Kassiri, Zamaneh			Loss of Timp3 Gene Leads to Abdominal Aortic Aneurysm Formation in Response to Angiotensin II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; EXTRACELLULAR-MATRIX; CARDIOVASCULAR MORTALITY; RECEPTOR BLOCKERS; HEART-FAILURE; DOXYCYCLINE; EXPRESSION; GELATINASE; PROTEIN	Aortic aneurysm is dilation of the aorta primarily due to degradation of the aortic wall extracellular matrix (ECM). Tissue inhibitors of metalloproteinases (TIMPs) inhibit matrix metalloproteinases (MMPs), the proteases that degrade the ECM. Timp3 is the only ECM-bound Timp, and its levels are altered in the aorta from patients with abdominal aortic aneurysm (AAA). We investigated the causal role of Timp3 in AAA formation. Infusion of angiotensin II (Ang II) using micro-osmotic (Alzet) pumps in Timp3(-/-) male mice, but not in wild type control mice, led to adverse remodeling of the abdominal aorta, reduced collagen and elastin proteins but not mRNA, and elevated proteolytic activities, suggesting excess protein degradation within 2 weeks that led to formation of AAA by 4 weeks. Intriguingly, despite early up-regulation of MMP2 in Timp3(-/-)Ang II aortas, additional deletion of Mmp2 in these mice (Timp3(-/-)/Mmp2(-/-)) resulted in exacerbated AAA, compromised survival due to aortic rupture, and inflammation in the abdominal aorta. Reconstitution of WT bone marrow in Timp3(-/-)/Mmp2(-/-) mice reduced inflammation and prevented AAA in these animals following Ang II infusion. Treatment with a broad spectrum MMP inhibitor (PD166793) prevented the Ang II-induced AAA in Timp3(-/-) and Timp3(-/-)/Mmp2(-/-) mice. Our study demonstrates that the regulatory function of TIMP3 is critical in preventing adverse vascular remodeling and AAA. Hence, replenishing TIMP3, a physiological inhibitor of a number of metalloproteinases, could serve as a therapeutic approach in limiting AAA development or expansion.	[Basu, Ratnadeep; Fan, Dong; Kandalam, Vijay; Lee, Jiwon; Wang, Xiuhua; Kassiri, Zamaneh] Univ Alberta, Dept Physiol, Div Cardiol, Edmonton, AB T6G 2S2, Canada; [Baldwin, Troy A.] Univ Alberta, Dept Med Microbiol & Immunol, Div Cardiol, Edmonton, AB T6G 2S2, Canada; [Das, Subhash K.; Oudit, Gavin Y.] Univ Alberta, Dept Med, Div Cardiol, Edmonton, AB T6G 2S2, Canada; [Basu, Ratnadeep; Fan, Dong; Kandalam, Vijay; Lee, Jiwon; Das, Subhash K.; Wang, Xiuhua; Oudit, Gavin Y.; Kassiri, Zamaneh] Mazankowski Alberta Heart Inst, Cardiovasc Res Ctr, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; University of Alberta	Kassiri, Z (corresponding author), Univ Alberta, Dept Physiol, Div Cardiol, 474 HMRC, Edmonton, AB T6G 2S2, Canada.	z.kassiri@ualberta.ca	Fan, Dong/AFM-6258-2022	Fan, Dong/0000-0001-6730-0612	Canadian Institute of Health [84279]; Heart and Stroke Foundation of Canada; Alberta Innovates-Health Solutions (AI-HS) studentship	Canadian Institute of Health(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Alberta Innovates-Health Solutions (AI-HS) studentship	This work was supported by Canadian Institute of Health Research Grant 84279 and a Heart and Stroke Foundation of Canada grant (to Z.K.).; Supported by an Alberta Innovates-Health Solutions (AI-HS) studentship.	AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Allaire E, 1998, J CLIN INVEST, V102, P1413, DOI 10.1172/JCI2909; Barisione C, 2006, J VASC SURG, V44, P372, DOI 10.1016/j.jvs.2006.04.047; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Baxter BT, 2002, J VASC SURG, V36, P1, DOI 10.1067/mva.2002.125018; Bohm M, 2007, AM J CARDIOL, V100, p38J, DOI 10.1016/j.amjcard.2007.05.013; Brands MW, 2010, HYPERTENSION, V56, P879, DOI 10.1161/HYPERTENSIONAHA.110.158071; Crowther M, 2000, BRIT J SURG, V87, P1391, DOI 10.1046/j.1365-2168.2000.01554.x; Cuadrado E, 2008, J LEUKOCYTE BIOL, V84, P207, DOI 10.1189/jlb.0907606; Cummins PM, 2007, AM J PHYSIOL-HEART C, V292, pH28, DOI 10.1152/ajpheart.00304.2006; Danyi P, 2011, CIRCULATION, V124, P1469, DOI 10.1161/CIRCULATIONAHA.110.006486; Davis V, 1998, ARTERIOSCL THROM VAS, V18, P1625, DOI 10.1161/01.ATV.18.10.1625; English JL, 2006, J BIOL CHEM, V281, P10337, DOI 10.1074/jbc.M512009200; Eskandari MK, 2005, J SURG RES, V123, P289, DOI 10.1016/j.jss.2004.07.247; Ferguson CD, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.016; Flamant M, 2007, HYPERTENSION, V50, P212, DOI 10.1161/HYPERTENSIONAHA.107.089631; Forsdahl SH, 2010, INT J EPIDEMIOL, V39, P225, DOI 10.1093/ije/dyp320; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Golledge J, 2011, ATHEROSCLEROSIS, V217, P57, DOI 10.1016/j.atherosclerosis.2011.03.006; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Goodall S, 2001, CIRCULATION, V104, P304, DOI 10.1161/01.CIR.104.3.304; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1872, DOI 10.1056/NEJMoa0911056; Hackmann AE, 2008, J VASC SURG, V48, P519, DOI 10.1016/j.jvs.2008.03.064; Hance KA, 2002, J VASC SURG, V35, P254, DOI 10.1067/mva.2002.120382; Ikonomidis JS, 2006, CIRCULATION, V114, pI365, DOI 10.1161/CIRCULATIONAHA.105.000810; Ikonomidis JS, 2004, CIRCULATION, V110, pII268, DOI 10.1161/01.CIR.0000138384.68947.20; Isselbacher EM, 2005, CIRCULATION, V111, P816, DOI 10.1161/01.CIR.0000154569.08857.7A; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Javed U, 2008, CARDIOL CLIN, V26, P507, DOI 10.1016/j.ccl.2008.07.001; Kandalam V, 2011, CIRCULATION, V124, P2094, DOI 10.1161/CIRCULATIONAHA.111.030338; Kandalam V, 2010, AM J PHYSIOL-HEART C, V299, pH1012, DOI 10.1152/ajpheart.00246.2010; Kandalam V, 2010, CIRC RES, V106, P796, DOI 10.1161/CIRCRESAHA.109.209189; Kassiri Z, 2005, CIRC RES, V97, P380, DOI 10.1161/01.RES.0000178789.16929.cf; Kassiri Z, 2009, J BIOL CHEM, V284, P29893, DOI 10.1074/jbc.M109.028449; Kassiri Z, 2009, J AM SOC NEPHROL, V20, P1223, DOI 10.1681/ASN.2008050492; Knox JB, 1997, CIRCULATION, V95, P205, DOI 10.1161/01.CIR.95.1.205; Lambert JM, 2008, INT J CARDIOL, V130, P147, DOI 10.1016/j.ijcard.2008.04.059; LECO KJ, 1994, J BIOL CHEM, V269, P9352; Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Lira EB, 2006, J AM SOC ECHOCARDIOG, V19, P829, DOI 10.1016/j.echo.2005.12.023; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; Moore L, 2012, HEART FAIL REV, V17, P693, DOI 10.1007/s10741-011-9266-y; Mori S, 2006, J CARD FAIL, V12, P314, DOI 10.1016/j.cardfail.2006.01.009; Mosorin M, 2001, J VASC SURG, V34, P606, DOI 10.1067/mva.2001.117891; MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277; Ogata T, 2005, J VASC SURG, V41, P1036, DOI 10.1016/j.jvs.2005.02.020; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Ruddy JM, 2008, J THORAC CARDIOV SUR, V136, P1123, DOI 10.1016/j.jtcvs.2008.06.027; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; SHAPIRO SD, 1991, J RHEUMATOL, V18, P95; SHAPIRO SD, 1991, ANN NY ACAD SCI, V624, P69, DOI 10.1111/j.1749-6632.1991.tb17007.x; Singh K, 2001, AM J EPIDEMIOL, V154, P236, DOI 10.1093/aje/154.3.236; Suen AYW, 2012, P NATL ACAD SCI USA, V109, P893, DOI 10.1073/pnas.1114834109; THOMPSON RW, 1995, J CLIN INVEST, V96, P318, DOI 10.1172/JCI118037; Tomaschitz A, 2011, EUR HEART J, V32, P2642, DOI 10.1093/eurheartj/ehr150; Tsarouhas K, 2010, THROMB RES, V126, P399, DOI 10.1016/j.thromres.2010.08.015; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; Xiong WF, 2006, J VASC SURG, V44, P1061, DOI 10.1016/j.jvs.2006.06.036; Xiong WF, 2012, CIRC RES, V110, pE92, DOI 10.1161/CIRCRESAHA.112.268268; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200; Zhang X, 2012, CIRC RES, V110, pE73, DOI 10.1161/CIRCRESAHA.111.253880	64	53	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44083	44096		10.1074/jbc.M112.425652	http://dx.doi.org/10.1074/jbc.M112.425652			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144462	Green Published, hybrid			2022-12-28	WOS:000312938600007
J	Chen, CY; Abell, AM; Moon, YS; Kim, KH				Chen, Chih-Yu; Abell, Allison Martorano; Moon, Yang Soo; Kim, Kee-Hong			An Advanced Glycation End Product (AGE)-Receptor for AGEs (RAGE) Axis Restores Adipogenic Potential of Senescent Preadipocytes through Modulation of p53 Protein Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; LIFE-SPAN; OXIDANT STRESS; GLYOXALASE-I; RECEPTOR; INFLAMMATION; DIFFERENTIATION; ATHEROSCLEROSIS; EXPRESSION	The impaired adipogenic potential of senescent preadipocytes is a hallmark of adipose aging and aging-related adipose dysfunction. Although advanced glycation end products (AGEs) derived from both foods and endogenous nonenzymatic glycation and AGE-associated signaling pathways are known to play a key role in aging and its related diseases, the role of AGEs in adipose aging remains elusive. We show a novel pro-adipogenic function of AGEs in replicative senescent preadipocytes and mouse embryonic fibroblasts, as well as primary preadipocytes isolated from aged mice. Using glycated bovine serum albumin (BSA) as a model protein of AGEs, we found that glycated BSA restores the impaired adipogenic potential of senescent preadipocytes in vitro and ex vivo. However, glycated BSA showed no effect on adipogenesis in nonsenescent preadipocytes. The AGE-induced receptor for AGE (RAGE) expression is required for the pro-adipogenic function of AGEs in senescent preadipocytes. RAGEis required for impairment of p53 expression and p53 function in regulating p21 expression in senescent preadipocytes. We also observed a direct binding between RAGE and p53 in senescent preadipocytes. Taken together, our findings reveal a novel pro-adipogenic function of the AGE-RAGE axis in p53-regulated adipogenesis of senescent preadipocytes, providing new insights into aging-dependent adiposity by diet-driven and/or endogenous glycated proteins.	[Chen, Chih-Yu; Abell, Allison Martorano; Kim, Kee-Hong] Purdue Univ, Dept Food Sci, W Lafayette, IN 47906 USA; [Moon, Yang Soo] Gyeongnam Natl Univ Sci & Technol, Dept Anim Sci & Biotechnol, Jinju 660758, South Korea	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Gyeongnam National University of Science and Technology	Kim, KH (corresponding author), Purdue Univ, Dept Food Sci, W Lafayette, IN 47906 USA.	keehong@purdue.edu			Taiwan Government; Ralph W. and Grace M. Showalter Trust Award from Purdue University; Technology Development Program for Agriculture and Forestry, Korea [PJ007981]	Taiwan Government; Ralph W. and Grace M. Showalter Trust Award from Purdue University; Technology Development Program for Agriculture and Forestry, Korea	This work was supported in part by a study abroad scholarship from the Taiwan Government (to C. Y. C.), a start-up fund and a Ralph W. and Grace M. Showalter Trust Award from Purdue University (to K. H. K.), and Next-Generation BioGreen 21 Grant PJ007981 from Technology Development Program for Agriculture and Forestry, Korea (to Y. S. M.).	Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996; Ahmed N, 2002, BIOCHEM J, V364, P15, DOI 10.1042/bj3640015; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Beccafico S, 2011, AGE, V33, P523, DOI 10.1007/s11357-010-9197-x; Brune M, 2013, ONCOGENE, V32, P1460, DOI 10.1038/onc.2012.150; Cai WJ, 2007, AM J PATHOL, V170, P1893, DOI 10.2353/ajpath.2007.061281; Cai WJ, 2012, P NATL ACAD SCI USA, V109, P15888, DOI 10.1073/pnas.1205847109; Cai WJ, 2010, AM J PHYSIOL-CELL PH, V298, pC624, DOI 10.1152/ajpcell.00463.2009; Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003; CHUMLEA WC, 1992, INT J OBESITY, V16, P125; Constance CM, 1996, MOL CELL BIOL, V16, P3878; Cui M, 2009, J CELL PHYSIOL, V219, P132, DOI 10.1002/jcp.21657; Cui S, 2011, J BONE MINER RES, V26, P1084, DOI 10.1002/jbmr.299; Dumble M, 2004, ANN NY ACAD SCI, V1019, P171, DOI 10.1196/annals.1297.027; Gustafson B, 2009, AM J PHYSIOL-ENDOC M, V297, pE999, DOI 10.1152/ajpendo.00377.2009; Hallenborg P, 2009, EXPERT OPIN THER TAR, V13, P235, DOI [10.1517/14712590802680141 , 10.1517/14712590802680141]; Harcourt BE, 2011, KIDNEY INT, V80, P191, DOI 10.1038/ki.2011.57; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Kang R, 2010, CELL DEATH DIFFER, V17, P666, DOI 10.1038/cdd.2009.149; Kang R, 2012, P NATL ACAD SCI USA, V109, P7031, DOI 10.1073/pnas.1113865109; Kang R, 2011, AUTOPHAGY, V7, P442, DOI 10.4161/auto.7.4.14681; Kawabata K, 2011, BBA-PROTEINS PROTEOM, V1814, P1246, DOI 10.1016/j.bbapap.2011.06.006; Kim CY, 2011, J NUTR BIOCHEM, V22, P910, DOI 10.1016/j.jnutbio.2010.08.003; Kim J, 2012, J NEUROSCI RES, V90, P1136, DOI 10.1002/jnr.23014; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474; Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60; Li CH, 2005, J BIOL CHEM, V280, P26193, DOI 10.1074/jbc.M501371200; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Liu WY, 2012, DEV BIOL, V361, P27, DOI 10.1016/j.ydbio.2011.10.011; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Luevano-Contreras C, 2010, NUTRIENTS, V2, P1247, DOI 10.3390/nu2121247; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Monden M, 2013, DIABETES, V62, P478, DOI 10.2337/db11-1116; Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x; Nagai R, 2000, DIABETES, V49, P1714, DOI 10.2337/diabetes.49.10.1714; Noer A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-18; Peppa M, 2008, HORM-INT J ENDOCRINO, V7, P123, DOI 10.1007/BF03401503; Ponath G, 2007, J NEUROIMMUNOL, V184, P214, DOI 10.1016/j.jneuroim.2006.12.011; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Riuzzi F, 2006, J BIOL CHEM, V281, P8242, DOI 10.1074/jbc.M509436200; Sandu O, 2005, DIABETES, V54, P2314, DOI 10.2337/diabetes.54.8.2314; Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567; Sebekova K, 2005, ANN NY ACAD SCI, V1043, P482, DOI 10.1196/annals.1333.055; Sebekova K, 2003, AM J KIDNEY DIS, V41, pS48, DOI 10.1053/ajkd.2003.50084; Sell DR, 2000, FASEB J, V14, P145, DOI 10.1096/fasebj.14.1.145; Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074; Shimizu I, 2012, CELL METAB, V15, P51, DOI 10.1016/j.cmet.2011.12.006; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016; Starr ME, 2009, J GERONTOL A-BIOL, V64, P723, DOI 10.1093/gerona/glp046; Sun L, 2009, CARDIOVASC RES, V82, P371, DOI 10.1093/cvr/cvp036; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Tang DL, 2010, AUTOPHAGY, V6, P1181, DOI 10.4161/auto.6.8.13367; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Tikellis C, 2008, AM J PHYSIOL-ENDOC M, V295, pE323, DOI 10.1152/ajpendo.00024.2008; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Ueno H, 2010, ATHEROSCLEROSIS, V211, P431, DOI 10.1016/j.atherosclerosis.2010.04.006; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; WEISSMANSHOMER P, 1975, MECH AGEING DEV, V4, P159, DOI 10.1016/0047-6374(75)90017-2; Yanagisawa K, 1998, METABOLISM, V47, P1348, DOI 10.1016/S0026-0495(98)90303-1; Zhang L, 2009, CELL MOL LIFE SCI, V66, P3923, DOI 10.1007/s00018-009-0121-4	66	32	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44498	44507		10.1074/jbc.M112.399790	http://dx.doi.org/10.1074/jbc.M112.399790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23150674	Green Published, hybrid			2022-12-28	WOS:000312938600046
J	Fujii, Y; Dohmae, N; Takio, K; Kawsar, SMA; Matsumoto, R; Hasan, I; Koide, Y; Kanaly, RA; Yasumitsu, H; Ogawa, Y; Sugawara, S; Hosono, M; Nitta, K; Hamako, J; Matsui, T; Ozeki, Y				Fujii, Yuki; Dohmae, Naoshi; Takio, Koji; Kawsar, Sarkar M. A.; Matsumoto, Ryo; Hasan, Imtiaj; Koide, Yasuhiro; Kanaly, Robert A.; Yasumitsu, Hidetaro; Ogawa, Yukiko; Sugawara, Shigeki; Hosono, Masahiro; Nitta, Kazuo; Hamako, Jiharu; Matsui, Taei; Ozeki, Yasuhiro			A Lectin from the Mussel Mytilus galloprovincialis Has a Highly Novel Primary Structure and Induces Glycan-mediated Cytotoxicity of Globotriaosylceramide-expressing Lymphoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTOSIDE-SPECIFIC LECTIN; SILURUS-ASOTUS LECTIN; C-TYPE LECTIN; BINDING PROFILE; MOLECULAR CHARACTERIZATION; AFFINITY-CHROMATOGRAPHY; MARINE SPONGE; OLIGOSACCHARIDE; IDENTIFICATION; PURIFICATION	A novel lectin structure was found for a 17-kDa alpha-D-galactose-binding lectin (termed "MytiLec") isolated from the Mediterranean mussel, Mytilus galloprovincialis. The complete primary structure of the lectin was determined by Edman degradation and mass spectrometric analysis. MytiLec was found to consist of 149 amino acids with a total molecular mass of 16,812.59 Da by Fourier transform-ion cyclotron resonance mass spectrometry, in good agreement with the calculated value of 16,823.22 Da. MytiLec had an N terminus of acetylthreonine and a primary structure that was highly novel in comparison with those of all known lectins in the structure database. The polypeptide structure consisted of three tandem-repeat domains of similar to 50 amino acids each having 45-52% homology with each other. Frontal affinity chromatography technology indicated that MytiLec bound specifically to globotriose (Gb3; Gal alpha 1-4Gal beta 1-4Glc), the epitope of globotriaosylceramide. MytiLec showed a dose-dependent cytotoxic effect on human Burkitt lymphoma Raji cells (which have high surface expression of Gb3) but had no such effect on erythroleukemia K562 cells (which do not express Gb3). The cytotoxic effect of MytiLec was specifically blocked by the co-presence of an alpha-galactoside. MytiLec treatment of Raji cells caused increased binding of anti-annexin V antibody and incorporation of propidium iodide, which are indicators of cell membrane inversion and perforation. MytiLec is the first reported lectin having a primary structure with the highly novel triple tandem-repeat domain and showing transduction of apoptotic signaling against Burkitt lymphoma cells by interaction with a glycosphingolipid-enriched microdomain containing Gb3.	[Fujii, Yuki; Kawsar, Sarkar M. A.; Matsumoto, Ryo; Hasan, Imtiaj; Koide, Yasuhiro; Kanaly, Robert A.; Yasumitsu, Hidetaro; Ozeki, Yasuhiro] Yokohama City Univ, Grad Sch NanoBio Sci, Dept Life & Environm Syst Sci, Lab Glycobiol & Marine Biochem,Kanazawa Ku, Yokohama, Kanagawa 2360027, Japan; [Dohmae, Naoshi; Takio, Koji] RIKEN Adv Sci Inst, Biomol Characterizat Team, Wako, Saitama 3510198, Japan; [Fujii, Yuki; Ogawa, Yukiko] Nagasaki Int Univ, Fac Pharmaceut Sci, Dept Pharm, Div Funct Morphol, Sasebo, Nagasaki 8593298, Japan; [Fujii, Yuki; Ogawa, Yukiko] Nagasaki Int Univ, Fac Pharmaceut Sci, Dept Pharm, Div Microbiol, Sasebo, Nagasaki 8593298, Japan; [Kawsar, Sarkar M. A.] Univ Chittagong, Fac Sci, Dept Chem, Lab Carbohydrate & Prot Chem, Chittagong 4331, Bangladesh; [Hasan, Imtiaj] Rajshahi Univ, Fac Sci, Dept Biochem & Mol Biol, Rajshahi 6205, Bangladesh; [Sugawara, Shigeki; Hosono, Masahiro; Nitta, Kazuo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Cell Recognit Study, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Hamako, Jiharu; Matsui, Taei] Fujita Hlth Univ, Dept Biol, Toyoake, Aichi 4701192, Japan	Yokohama City University; RIKEN; Nagasaki International University; Nagasaki International University; University of Chittagong; University of Rajshahi; Tohoku Medical & Pharmaceutical University; Fujita Health University	Ozeki, Y (corresponding author), Yokohama City Univ, Grad Sch NanoBio Sci, Dept Life & Environm Syst Sci, Lab Glycobiol & Marine Biochem,Kanazawa Ku, 22-2 Seto, Yokohama, Kanagawa 2360027, Japan.	ozeki@yokohama-cu.ac.jp	Kawsar, Prof. Dr. S. M. Abe/AAF-5893-2022; Dohmae, Naoshi/C-2040-2011; Ozeki, Yasuhiro/O-8493-2015; Sugawara, Shigeki/AAB-2757-2021; Hasan, Imtiaj/O-8298-2017; Kawsar, Prof. Dr. S. M. Abe/ABC-9066-2022	Kawsar, Prof. Dr. S. M. Abe/0000-0001-7964-9117; Dohmae, Naoshi/0000-0002-5242-9410; Ozeki, Yasuhiro/0000-0002-2782-6158; Hasan, Imtiaj/0000-0002-4715-9022; Kawsar, Prof. Dr. S. M. Abe/0000-0001-7964-9117	Japan Society for the Promotion of Science; Japanese Association for Marine Biology from the Ministry of Education, Culture, Sports, Science, and Technology Japan; City of Yokohama "Blue Carbon Project"; Yachiyo Engineering Co., Ltd.,	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Association for Marine Biology from the Ministry of Education, Culture, Sports, Science, and Technology Japan; City of Yokohama "Blue Carbon Project"; Yachiyo Engineering Co., Ltd.,	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science and Japanese Association for Marine Biology from the Ministry of Education, Culture, Sports, Science, and Technology Japan.; We thank the City of Yokohama "Blue Carbon Project" and Yachiyo Engineering Co., Ltd., for their support. Naoko Masuda and Chihiro Iwahara are specially thanked for assistance with experiments. We thank Dr. Stephen Anderson for the English editing of the manuscript.	ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angeloni S, 2005, GLYCOBIOLOGY, V15, P31, DOI 10.1093/glycob/cwh143; Belogortseva NI, 1998, COMP BIOCHEM PHYS C, V119, P45, DOI 10.1016/S0742-8413(97)00180-1; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Chen JH, 2011, FISH SHELLFISH IMMUN, V30, P750, DOI 10.1016/j.fsi.2010.12.025; Espinosa EP, 2010, COMP BIOCHEM PHYS A, V156, P495, DOI 10.1016/j.cbpa.2010.04.004; Fujii Y, 2012, PROTEIN J, V31, P15, DOI 10.1007/s10930-011-9369-2; Gorbushin AM, 2011, FISH SHELLFISH IMMUN, V30, P434, DOI 10.1016/j.fsi.2010.10.002; Gourdine JP, 2008, J BIOL CHEM, V283, P30112, DOI 10.1074/jbc.M804353200; Gros E., 1967, METHOD ENZYMOL, V11, P238; Gutternigg M, 2007, GLYCOCONJUGATE J, V24, P475, DOI 10.1007/s10719-007-9040-5; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hirabayashi J, 2003, METHOD ENZYMOL, V362, P353; Hirabayashi J, 2008, J BIOCHEM, V144, P139, DOI 10.1093/jb/mvn043; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Kasai K, 1996, J BIOCHEM-TOKYO, V119, P1; KASAI KI, 1978, J BIOCHEM, V84, P1061, DOI 10.1093/oxfordjournals.jbchem.a132220; KASAI KI, 1978, J BIOCHEM-TOKYO, V84, P1051, DOI 10.1093/oxfordjournals.jbchem.a132219; Kawano T, 2008, BIOL PHARM BULL, V31, P998, DOI 10.1248/bpb.31.998; Kawano T, 2009, BIOL PHARM BULL, V32, P345, DOI 10.1248/bpb.32.345; Kawsar SMA, 2008, COMP BIOCHEM PHYS B, V150, P349, DOI 10.1016/j.cbpb.2008.04.004; Kawsar SMA, 2011, PROTEIN J, V30, P509, DOI 10.1007/s10930-011-9356-7; Kawsar SMA, 2009, COMP BIOCHEM PHYS B, V152, P382, DOI 10.1016/j.cbpb.2009.01.009; Kim YM, 2006, J BIOL CHEM, V281, P26854, DOI 10.1074/jbc.M601251200; Kinoshita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021238; Kotake T, 2005, PLANT PHYSIOL, V138, P1563, DOI 10.1104/pp.105.062562; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li CH, 2011, FISH SHELLFISH IMMUN, V30, P1202, DOI 10.1016/j.fsi.2011.02.022; MASAKI T, 1981, BIOCHIM BIOPHYS ACTA, V660, P44, DOI 10.1016/0005-2744(81)90106-6; Matsumoto R, 2012, TOXINS, V4, P323, DOI 10.3390/toxins4050323; Matsumoto R, 2011, COMP BIOCHEM PHYS B, V158, P266, DOI 10.1016/j.cbpb.2010.12.004; Naganuma T, 2006, MOL DIVERS, V10, P607, DOI 10.1007/s11030-006-9051-3; Naismith JH, 1996, J BIOL CHEM, V271, P972, DOI 10.1074/jbc.271.2.972; Ogawa Tomohisa, 2011, J Amino Acids, V2011, P838914, DOI 10.4061/2011/838914; OZEKI Y, 1991, BIOCHEMISTRY-US, V30, P2391, DOI 10.1021/bi00223a014; Pepper C, 1998, LEUKEMIA RES, V22, P439, DOI 10.1016/S0145-2126(98)00013-7; SHINOHARA Y, 1994, EUR J BIOCHEM, V223, P189, DOI 10.1111/j.1432-1033.1994.tb18982.x; SIMPSON RJ, 1976, J BIOL CHEM, V251, P1936; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stepan H, 2012, GLYCOCONJUGATE J, V29, P189, DOI 10.1007/s10719-012-9391-4; Sugawara S, 2005, YAKUGAKU ZASSHI, V125, P327, DOI 10.1248/yakushi.125.327; Sugawara S, 2005, BIOL PHARM BULL, V28, P434, DOI 10.1248/bpb.28.434; Tahirov TH, 1998, J MOL BIOL, V284, P101, DOI 10.1006/jmbi.1998.2146; Tasumi S, 2007, J IMMUNOL, V179, P3086, DOI 10.4049/jimmunol.179.5.3086; Tateno H, 2007, GLYCOBIOLOGY, V17, P1138, DOI 10.1093/glycob/cwm084; TENNANT JR, 1964, TRANSPLANTATION, V2, P685, DOI 10.1097/00007890-196411000-00001; TITANI K, 1964, J BIOCHEM-TOKYO, V56, P241, DOI 10.1093/oxfordjournals.jbchem.a127986; Transue TR, 1997, NAT STRUCT BIOL, V4, P779, DOI 10.1038/nsb1097-779; Vakonakis I, 2008, STRUCTURE, V16, P944, DOI 10.1016/j.str.2008.02.020; Velkova L, 2011, GLYCOCONJUGATE J, V28, P385, DOI 10.1007/s10719-011-9337-2; Venier P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-69; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Vukelic Z, 2005, J AM SOC MASS SPECTR, V16, P571, DOI 10.1016/j.jasms.2005.01.013; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1; Xu NX, 1997, J AM SOC MASS SPECTR, V8, P116, DOI 10.1016/S1044-0305(96)00233-4	58	64	66	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44772	44783		10.1074/jbc.M112.418012	http://dx.doi.org/10.1074/jbc.M112.418012			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23093409	Green Published, hybrid			2022-12-28	WOS:000312938600071
J	Kakuta, S; Yamamoto, H; Negishi, L; Kondo-Kakuta, C; Hayashi, N; Ohsumi, Y				Kakuta, Soichiro; Yamamoto, Hayashi; Negishi, Lumi; Kondo-Kakuta, Chika; Hayashi, Nobuhiro; Ohsumi, Yoshinori			Atg9 Vesicles Recruit Vesicle-tethering Proteins Trs85 and Ypt1 to the Autophagosome Formation Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; SELECTIVE AUTOPHAGY; TRAPP COMPLEXES; RAB GTPASES; EARLY STEPS; ORGANIZATION; CVT; CYTOPLASM; PATHWAY	Atg9 is a transmembrane protein that is essential for autophagy. In the budding yeast Saccharomyces cerevisiae, it has recently been revealed that Atg9 exists on cytoplasmic small vesicles termed Atg9 vesicles. To identify the components of Atg9 vesicles, we purified the Atg9 vesicles and subjected them to mass spectrometry. We found that their protein composition was distinct from other organellar membranes and that Atg9 and Atg27 in particular are major components of Atg9 vesicles. In addition to these two components, Trs85, a specific subunit of the transport protein particle III (TRAPPIII) complex, and the Rab GTPase Ypt1 were also identified. Trs85 directly interacts with Atg9, and the Trs85-containing TRAPPIII complex facilitates the association of Ypt1 onto Atg9 vesicles. We also showed that Trs85 and Ypt1 are localized to the preautophagosomal structure in an Atg9-dependent manner. Our data suggest that Atg9 vesicles recruit the TRAPPIII complex and Ypt1 to the preautophagosomal structure. The vesicle-tethering machinery consequently acts in the process of autophagosome formation.	[Kakuta, Soichiro; Yamamoto, Hayashi; Kondo-Kakuta, Chika; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan; [Negishi, Lumi; Hayashi, Nobuhiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Ohsumi, Y (corresponding author), Tokyo Inst Technol, Frontier Res Ctr S2 12, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	yohsumi@iri.titech.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Hayashi, Nobuhiro/F-6088-2011	Ohsumi, Yoshinori/0000-0003-2384-2166; Hayashi, Nobuhiro/0000-0002-9950-094X; Negishi, Lumi/0000-0002-7297-0634	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Calero M, 2002, FEBS LETT, V515, P89, DOI 10.1016/S0014-5793(02)02442-0; Choi C, 2011, TRAFFIC, V12, P715, DOI 10.1111/j.1600-0854.2011.01181.x; De Antoni A, 2002, J BIOL CHEM, V277, P41023, DOI 10.1074/jbc.M205783200; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Huang J, 2011, AUTOPHAGY, V7, P17, DOI 10.4161/auto.7.1.13840; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kurosawa G, 2009, J IMMUNOL METHODS, V351, P1, DOI 10.1016/j.jim.2009.09.003; Lang T, 2000, J BACTERIOL, V182, P2125, DOI 10.1128/JB.182.8.2125-2133.2000; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lipatova Z, 2012, P NATL ACAD SCI USA, V109, P6981, DOI 10.1073/pnas.1121299109; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Zoppino FCM, 2010, TRAFFIC, V11, P1246, DOI 10.1111/j.1600-0854.2010.01086.x; Meiling-Wesse K, 2005, J BIOL CHEM, V280, P33669, DOI 10.1074/jbc.M501701200; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nazarko TY, 2005, AUTOPHAGY, V1, P37, DOI 10.4161/auto.1.1.1512; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Scrivens PJ, 2011, MOL BIOL CELL, V22, P2083, DOI 10.1091/mbc.E10-11-0873; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Tucker KA, 2003, J BIOL CHEM, V278, P48445, DOI 10.1074/jbc.M309238200; van Werven FJ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl003; Wang K, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371591; Wu YW, 2010, NAT CHEM BIOL, V6, P534, DOI [10.1038/NCHEMBIO.386, 10.1038/nchembio.386]; Yamada T, 2005, J BIOL CHEM, V280, P18283, DOI 10.1074/jbc.M413957200; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061; Yen WL, 2007, MOL BIOL CELL, V18, P581, DOI 10.1091/mbc.E06-07-0612; Young AJ, 2006, MED SCI SPORT EXER, V38, P1, DOI 10.1249/01.mss.0000196708.08925.8b; Zong M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023350	45	78	85	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44261	44269		10.1074/jbc.M112.411454	http://dx.doi.org/10.1074/jbc.M112.411454			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23129774	Green Published, hybrid			2022-12-28	WOS:000312938600024
J	Ramadoss, S; Chen, XH; Wang, CY				Ramadoss, Sivakumar; Chen, Xiaohong; Wang, Cun-Yu			Histone Demethylase KDM6B Promotes Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; JMJD3 CONTRIBUTES; GENE-EXPRESSION; H3K27ME3 DEMETHYLASE; STEM-CELLS; PROGRESSION; SNAIL; EZH2; TRANSCRIPTION; UTX	Epithelial-mesenchymal transition (EMT) is a critical event that occurs in embryonic development, tissue repair control, organ fibrosis, and carcinoma invasion and metastasis. Although significant progress has been made in understanding the molecular regulation of EMT, little is known about how chromatin is modified in EMT. Chromatin modifications through histone acetylation and methylation determine the precise control of gene expression. Recently, histone demethylases were found to play important roles in gene expression through demethylating mono-, di-, or trimethylated lysines. KDM6B (also known as JMJD3) is a histone demethylase that might activate gene expression by removing repressive histone H3 lysine 27 trimethylation marks from chromatin. Here we report that KDM6B played a permissive role in TGF-beta-induced EMT in mammary epithelial cells by stimulating SNAI1 expression. KDM6B was induced by TGF-beta, and the knockdown of KDM6B inhibited EMT induced by TGF-beta. Conversely, overexpression of KDM6B induced the expression of mesenchymal genes and promoted EMT. Chromatin immunoprecipitation (ChIP) assays revealed that KDM6B promoted SNAI1 expression by removing histone H3 lysine trimethylation marks. Consistently, our analysis of the Oncomine database found that KDM6B expression was significantly increased in invasive breast carcinoma compared with normal breast tissues. The knockdown of KDM6B significantly inhibited breast cancer cell invasion. Collectively, our study uncovers a novel epigenetic mechanism regulating EMT and tumor cell invasion, and has important implication in targeting cancer metastasis.	[Ramadoss, Sivakumar; Chen, Xiaohong; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Wang, CY (corresponding author), Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, 33-030A CHS,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	cwang@dentistry.ucla.edu		Ramadoss, Sivakumar/0000-0001-7943-7501	National Institutes of Health [CA132134, R3713848, DE15964]; NATIONAL CANCER INSTITUTE [R01CA132134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132134, R3713848, and DE15964.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Anderton JA, 2011, ONCOGENE, V30, P2037, DOI 10.1038/onc.2010.579; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Dahle O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000841; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Ding L, 2006, CANCER RES, V66, P4095, DOI 10.1158/0008-5472.CAN-05-4300; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gong Y, 2011, CANCER-AM CANCER SOC, V117, P5476, DOI 10.1002/cncr.26179; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Hubner MR, 2010, COLD SH Q B, V75, P43, DOI 10.1101/sqb.2010.75.020; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Kunju LP, 2011, MODERN PATHOL, V24, P786, DOI 10.1038/modpathol.2011.8; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Pereira F, 2011, HUM MOL GENET, V20, P4655, DOI 10.1093/hmg/ddr399; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Ramadoss S, 2011, MOL CELL BIOL, V31, P924, DOI 10.1128/MCB.00576-10; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Smith AP, 2009, ONCOGENE, V28, P422, DOI 10.1038/onc.2008.395; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Wendt MK, 2012, CELL TISSUE RES, V347, P85, DOI 10.1007/s00441-011-1199-1; Xiang Y, 2007, CELL RES, V17, P850, DOI 10.1038/cr.2007.83; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	47	123	127	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44508	44517		10.1074/jbc.M112.424903	http://dx.doi.org/10.1074/jbc.M112.424903			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23152497	hybrid, Green Published			2022-12-28	WOS:000312938600047
J	Schepers, W; Van Zeebroeck, G; Pinkse, M; Verhaert, P; Thevelein, JM				Schepers, Wim; Van Zeebroeck, Griet; Pinkse, Martijn; Verhaert, Peter; Thevelein, Johan M.			In Vivo Phosphorylation of Ser(21) and Ser(83) during Nutrient-induced Activation of the Yeast Protein Kinase A (PKA) Target Trehalase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; NEUTRAL TREHALASE; CYCLIC-AMP; SIGNALING PATHWAYS; NITROGEN-SOURCES; BINDING-SITE; GLUCOSE; GENE; CAMP; PURIFICATION	The readdition of an essential nutrient to starved, fermenting cells of the yeast Saccharomyces cerevisiae triggers rapid activation of the protein kinase A (PKA) pathway. Trehalase is activated 5-10-fold within minutes and has been used as a convenient reporter for rapid activation of PKA in vivo. Although trehalase can be phosphorylated and activated by PKA in vitro, demonstration of phosphorylation during nutrient activation in vivo has been lacking. We now show, using phosphospecific antibodies, that glucose and nitrogen activation of trehalase in vivo is associated with phosphorylation of Ser(21) and Ser(83). Unexpectedly, mutants with reduced PKA activity show constitutive phosphorylation despite reduced trehalase activation. The same phenotype was observed upon deletion of the catalytic subunits of yeast protein phosphatase 2A, suggesting that lower PKA activity causes reduced trehalase dephosphorylation. Hence, phosphorylation of trehalase in vivo is not sufficient for activation. Deletion of the inhibitor Dcs1 causes constitutive trehalase activation and phosphorylation. It also enhances binding of trehalase to the 14-3-3 proteins Bmh1 and Bmh2, suggesting that Dcs1 inhibits by preventing 14-3-3 binding. Deletion of Bmh1 and Bmh2 eliminates both trehalase activation and phosphorylation. Our results reveal that trehalase activation in vivo is associated with phosphorylation of typical PKA sites and thus establish the enzyme as a reliable read-out for nutrient activation of PKA in vivo.	[Schepers, Wim; Van Zeebroeck, Griet; Verhaert, Peter; Thevelein, Johan M.] Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, B-3001 Louvain, Flanders, Belgium; [Schepers, Wim; Van Zeebroeck, Griet; Verhaert, Peter; Thevelein, Johan M.] VIB, Dept Mol Microbiol, B-3001 Louvain, Flanders, Belgium; [Pinkse, Martijn; Verhaert, Peter] Delft Univ Technol, Netherlands Prote Ctr, Dept Biotechnol, NL-2628 BC Delft, Netherlands	KU Leuven; Flanders Institute for Biotechnology (VIB); Delft University of Technology	Thevelein, JM (corresponding author), Kasteelpk Arenberg 31, B-3001 Louvain, Belgium.	johan.thevelein@mmbio.vib-kuleuven.be	Thevelein, Johan M./AAK-4203-2021	Thevelein, Johan/0000-0002-2626-0180; Verhaert, Peter/0000-0002-6921-087X	Agency for Innovation by Science and Technology (IWT-Flanders); Fonds Wetenschappelijk Onderzoek; Fund for Scientific Research-Flanders, Interuniversity Attraction Poles Networks [P6/14, P7/40]; Research Fund of the KU Leuven (Concerted Research Actions)	Agency for Innovation by Science and Technology (IWT-Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fonds Wetenschappelijk Onderzoek(FWO); Fund for Scientific Research-Flanders, Interuniversity Attraction Poles Networks; Research Fund of the KU Leuven (Concerted Research Actions)	This work was supported by a Ph.D. fellowship from the Agency for Innovation by Science and Technology (IWT-Flanders) (to W.S.); a postdoctoral fellowship from the Fonds Wetenschappelijk Onderzoek (to G.V.Z.); and grants from the Fund for Scientific Research-Flanders, Interuniversity Attraction Poles Networks (P6/14 and P7/40) and the Research Fund of the KU Leuven (Concerted Research Actions) (to J.M.T.).	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Alizadeh P, 1996, FEBS LETT, V391, P273, DOI 10.1016/0014-5793(96)00751-X; APP H, 1989, J BIOL CHEM, V264, P17583; Brachmann CB, 1998, YEAST, V14, P115; Broach J R, 1990, Adv Cancer Res, V54, P79, DOI 10.1016/S0065-230X(08)60809-X; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; CARRILLO D, 1995, MICROBIOL-UK, V141, P679, DOI 10.1099/13500872-141-3-679; Castermans D, 2012, CELL RES, V22, P1058, DOI 10.1038/cr.2012.20; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Crauwels M, 1997, MICROBIOL-UK, V143, P2627, DOI 10.1099/00221287-143-8-2627; d'Enfert C, 1999, MOL MICROBIOL, V32, P471, DOI 10.1046/j.1365-2958.1999.01327.x; De Mesquita JF, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-45; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; DURNEZ P, 1994, YEAST, V10, P1049, DOI 10.1002/yea.320100807; Franco A, 2005, ARCH MICROBIOL, V183, P394, DOI 10.1007/s00203-005-0005-4; Franco A, 2003, BIOCHEM J, V376, P209, DOI 10.1042/BJ20030825; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GELPERIN D, 1995, P NATL ACAD SCI USA, V92, P11539, DOI 10.1073/pnas.92.25.11539; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Griffioen G, 2000, J BIOL CHEM, V275, P1449, DOI 10.1074/jbc.275.2.1449; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; HIRIMBUREGAMA K, 1992, J GEN MICROBIOL, V138, P2035, DOI 10.1099/00221287-138-10-2035; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; James P, 1996, GENETICS, V144, P1425; JONES EW, 1991, METHOD ENZYMOL, V194, P428; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KOPP M, 1993, J BIOL CHEM, V268, P4766; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Liu HD, 2002, EMBO J, V21, P4699, DOI 10.1093/emboj/cdf448; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Matsumoto K, 1985, Yeast, V1, P15, DOI 10.1002/yea.320010103; MBONYI K, 1990, MOL CELL BIOL, V10, P4518, DOI 10.1128/MCB.10.9.4518; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; ORITZ CH, 1983, J BACTERIOL, V153, P644, DOI 10.1128/JB.153.2.644-651.1983; Panni S, 2008, FEMS YEAST RES, V8, P53, DOI 10.1111/j.1567-1364.2007.00312.x; Paul G, 2009, GENOMICS, V94, P287, DOI 10.1016/j.ygeno.2009.07.004; Pernambuco MB, 1996, MICROBIOL-SGM, V142, P1775, DOI 10.1099/13500872-142-7-1775; Popova Y, 2010, P NATL ACAD SCI USA, V107, P2890, DOI 10.1073/pnas.0906546107; Roberts RL, 1997, CELL, V89, P1055, DOI 10.1016/S0092-8674(00)80293-7; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Rubio-Texeira M, 2012, NAT CHEM BIOL, V8, P400, DOI [10.1038/NCHEMBIO.910, 10.1038/nchembio.910]; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Soto T, 1997, MICROBIOL-UK, V143, P2457, DOI 10.1099/00221287-143-7-2457; Souza AC, 2002, BRAZ J MED BIOL RES, V35, P11, DOI 10.1590/S0100-879X2002000100002; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; THEVELEIN JM, 1984, MICROBIOL REV, V48, P42, DOI 10.1128/MMBR.48.1.42-59.1984; THEVELEIN JM, 1985, J GEN MICROBIOL, V131, P3199; Thevelein JM, 2008, ACTA MICROBIOL IMM H, V55, P75, DOI 10.1556/AMicr.55.2008.2.1; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Van Zeebroeck G, 2009, NAT CHEM BIOL, V5, P45, DOI 10.1038/nchembio.132; VANDERPL.JB, 1974, BIOCHEM BIOPH RES CO, V56, P580, DOI 10.1016/0006-291X(74)90643-3; VANSOLINGEN P, 1975, BIOCHEM BIOPH RES CO, V62, P553, DOI 10.1016/0006-291X(75)90434-9; Veisova D, 2012, BIOCHEM J, V443, P663, DOI 10.1042/BJ20111615; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Wang C, 2009, GENETICS, V183, P1373, DOI 10.1534/genetics.109.107797; Wera S, 1999, BIOCHEM J, V343, P621, DOI 10.1042/0264-6021:3430621; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4	62	47	48	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44130	44142		10.1074/jbc.M112.421503	http://dx.doi.org/10.1074/jbc.M112.421503			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23155055	hybrid, Green Published			2022-12-28	WOS:000312938600012
J	Sykes, AM; Palstra, N; Abankwa, D; Hill, JM; Skeldal, S; Matusica, D; Venkatraman, P; Hancock, JF; Coulson, EJ				Sykes, Alex M.; Palstra, Nickless; Abankwa, Daniel; Hill, Justine M.; Skeldal, Sune; Matusica, Dusan; Venkatraman, Prahatha; Hancock, John F.; Coulson, Elizabeth J.			The Effects of Transmembrane Sequence and Dimerization on Cleavage of the p75 Neurotrophin Receptor by gamma-Secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; NERVE GROWTH-FACTOR; NUCLEAR TRANSLOCATION; DEPENDENT CLEAVAGE; DOMAIN; GXXXG; DIMER; DEATH; NOTCH; FRET	Cleavage of transmembrane receptors by gamma-secretase is the final step in the process of regulated intramembrane proteolysis (RIP) and has a significant impact on receptor function. Although relatively little is known about the molecular mechanism of gamma-secretase enzymatic activity, it is becoming clear that substrate dimerization and/or the alpha-helical structure of the substrate can regulate the site and rate of gamma-secretase activity. Here we show that the transmembrane domain of the pan-neurotrophin receptor p75(NTR), best known for regulating neuronal death, is sufficient for its homodimerization. Although the p75(NTR) ligands NGF and pro-NGF do not induce homerdimerization or RIP, homodimers of p75(NTR) are gamma-secretase substrates. However, dimerization is not a requirement for p75(NTR) cleavage, suggesting that gamma-secretase has the ability to recognize and cleave each receptor molecule independently. The transmembrane cysteine 257, which mediates covalent p75(NTR) interactions, is not crucial for homodimerization, but this residue is required for normal rates of gamma-secretase cleavage. Similarly, mutation of the residues alanine 262 and glycine 266 of an AXXXG dimerization motif flanking the gamma-secretase cleavage site within the p75(NTR) transmembrane domain alters the orientation of the domain and inhibits gamma-secretase cleavage of p75(NTR). Nonetheless, heteromer interactions of p75(NTR) with TrkA increase full-length p75(NTR) homodimerization, which in turn potentiates the rate of gamma-cleavage following TrkA activation independently of rates of alpha-cleavage. These results provide support for the idea that the helical structure of the p75(NTR) transmembrane domain, which may be affected by co-receptor interactions, is a key element in gamma-secretase-catalyzed cleavage.	[Sykes, Alex M.; Palstra, Nickless; Skeldal, Sune; Matusica, Dusan; Coulson, Elizabeth J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Abankwa, Daniel; Venkatraman, Prahatha; Hancock, John F.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Hill, Justine M.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Hill, Justine M.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland	Coulson, EJ (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	e.coulson@uq.edu.au	Hill, Justine M/C-5781-2009; Coulson, Elizabeth J./C-8766-2009; Matusica, Dusan/G-8138-2011	Coulson, Elizabeth J./0000-0003-3783-6197; Matusica, Dusan/0000-0001-6472-7653; Abankwa, Daniel/0000-0003-2769-0745; Hancock, John/0000-0003-0542-4710; Sykes, Alex/0000-0001-8981-6652	National Health and Medical Research Council of Australia (NHMRC) [569507, 10012610]; NHMRC [401748, 569601]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council of Australia (NHMRC) project Grants 569507 and 10012610.; Supported by NHMRC Career Development (RD Wright) Fellowship 401748.; Supported by NHMRC Career Development (RD Wright) Fellowship 569601.	Abad C, 2009, BBA-BIOMEMBRANES, V1788, P2132, DOI 10.1016/j.bbamem.2009.07.008; Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2007, J CELL SCI, V120, P2953, DOI 10.1242/jcs.001404; Aurikko JP, 2005, J BIOL CHEM, V280, P33453, DOI 10.1074/jbc.M503189200; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Ceni C, 2010, J CELL SCI, V123, P2299, DOI 10.1242/jcs.062612; Chakravarthy B, 2010, J ALZHEIMERS DIS, V19, P915, DOI 10.3233/JAD-2010-1288; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Coulson EJ, 2000, J BIOL CHEM, V275, P30537, DOI 10.1074/jbc.M005214200; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; del Valle J, 2010, J ALZHEIMERS DIS, V19, P1303, DOI 10.3233/JAD-2010-1321; DeLano W.L, PYMOL MOL GRAPHICS S; Dews IC, 2007, P NATL ACAD SCI USA, V104, P20782, DOI 10.1073/pnas.0708909105; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Feng D, 2010, J MOL BIOL, V396, P967, DOI 10.1016/j.jmb.2009.12.030; Fombonne J, 2009, ANN NEUROL, V65, P294, DOI 10.1002/ana.21578; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Gong Y, 2008, NATURE, V454, P789, DOI 10.1038/nature07089; Gorman PM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-17; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kleiger G, 2002, BIOCHEMISTRY-US, V41, P5990, DOI 10.1021/bi0200763; Kommaddi RP, 2011, FASEB J, V25, P2061, DOI 10.1096/fj.10-173740; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee SF, 2004, J BIOL CHEM, V279, P4144, DOI 10.1074/jbc.M309745200; LI SC, 1992, FEBS LETT, V311, P217, DOI 10.1016/0014-5793(92)81106-V; Liu W, 2005, BIOCHEMISTRY-US, V44, P3591, DOI 10.1021/bi047827g; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Miyashita N, 2009, J AM CHEM SOC, V131, P3438, DOI 10.1021/ja809227c; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Munter LM, 2010, J BIOL CHEM, V285, P21636, DOI 10.1074/jbc.M109.088005; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Sakamoto K, 2005, EXP CELL RES, V302, P281, DOI 10.1016/j.yexcr.2004.09.016; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Skeldal S, 2012, J BIOL CHEM, V287, P43798, DOI 10.1074/jbc.M112.374710; Skeldal S, 2011, BIOESSAYS, V33, P614, DOI 10.1002/bies.201100036; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Underwood CK, 2008, MOL CELL NEUROSCI, V37, P346, DOI 10.1016/j.mcn.2007.10.005; Vilar M, 2009, J CELL SCI, V122, P3351, DOI 10.1242/jcs.055061; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Ye J, 2000, P NATL ACAD SCI USA, V97, P5123, DOI 10.1073/pnas.97.10.5123; Zhang JM, 2002, J BIOL CHEM, V277, P15069, DOI 10.1074/jbc.M105375200	54	32	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43810	43824		10.1074/jbc.M112.382903	http://dx.doi.org/10.1074/jbc.M112.382903			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23105112	Green Published, hybrid			2022-12-28	WOS:000312940800059
J	Haga, CL; Phinney, DG				Haga, Christopher L.; Phinney, Donald G.			MicroRNAs in the Imprinted DLK1-DIO3 Region Repress the Epithelial-to-Mesenchymal Transition by Targeting the TWIST1 Protein Signaling Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIR-200 FAMILY; CANCER; ZEB1; HYPOXIA; GENES; ATM; PHOSPHORYLATION; ACTIVATION; EXPRESSION; REGULATORS	Development of metastatic disease accounts for the vast majority of cancer-related deaths. Nevertheless, few treatments exist that are designed to specifically inhibit processes that drive tumor metastasis. The imprinted DLK1-DIO3 region contains tumor-suppressing miRNAs, but their identity and function remain indeterminate. In this study we identify seven miRNAs in the imprinted DLK1-DIO3 region that function cooperatively to repress the epithelial-to-mesenchymal transition, a critical step that drives tumor metastasis, as well as proliferation of carcinoma cells. These seven miRNAs (miRs 300, 382, 494, 495, 539, 543, and 544) repress a signaling network comprising TWIST1, BMI1, ZEB1/2, and miR-200 family miRNAs and silencing of the cluster, which occurs via hypermethylation of upstream CpG islands in human ductal carcinomas, confers morphological, molecular, and function changes consistent with an epithelial-to-mesenchymal transition. Moreover, ectopic expression of miR-544 independently inhibited proliferation of numerous tumor cell lines by inducing the ATM cell cycle checkpoint pathway. These results establish the DLKI-DIO3 miRNA cluster as a critical checkpoint regulating tumor growth and metastasis and implicate epigenetic modification of the cluster in driving tumor progression. These results also suggest that promoter methylation status and miRNA expression levels represent new diagnostic tools and therapeutic targets to predict and inhibit, respectively, tumor metastasis in carcinoma patients.	[Haga, Christopher L.; Phinney, Donald G.] Scripps Res Inst Florida, Dept Mol Therapeut, Jupiter, FL 33458 USA	Scripps Research Institute	Phinney, DG (corresponding author), Scripps Res Inst Florida, Dept Mol Therapeut, A213,130 Scripps Way, Jupiter, FL 33458 USA.	dphinney@scripps.edu	Phinney, Donald G/D-2155-2014	Phinney, Donald/0000-0002-8688-2619	National Institutes of Health [R01 NS052301-01A2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported, in whole or in part, by National Institutes of Health Grant R01 NS052301-01A2 (to D. G. P.).	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Cui J, 2012, J MOL CELL BIOL, V4, P174, DOI 10.1093/jmcb/mjs017; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Hu HL, 2010, P NATL ACAD SCI USA, V107, P1506, DOI 10.1073/pnas.0907763107; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Le QT, 2004, CANCER METAST REV, V23, P293, DOI 10.1023/B:CANC.0000031768.89246.d7; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Li W, 2011, CELL RES, V21, P550, DOI 10.1038/cr.2011.25; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Zhang H, 2010, ONCOGENE, V29, P937, DOI 10.1038/onc.2009.406	36	105	110	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42695	42707		10.1074/jbc.M112.387761	http://dx.doi.org/10.1074/jbc.M112.387761			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105110	Green Published, hybrid			2022-12-28	WOS:000312501600030
J	Truong, K; Lee, TD; Li, BZ; Chen, Y				Khue Truong; Lee, Terry D.; Li, Baozong; Chen, Yuan			Sumoylation of SAE2 C Terminus Regulates SAE Nuclear Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODIFIER SUMO RECOGNITION; LEPTOMYCIN B; ACTIVATING ENZYME; UBIQUITIN LIGASE; BINDING MOTIF; SR PROTEINS; IMPORT; E1; IDENTIFICATION; ACCUMULATION	SUMOylation occurs predominantly in the nucleus, but nonnuclear proteins can also be SUMOylated. It is unclear how intracellular trafficking of the SUMOylation enzymes is regulated to catalyze SUMOylation in different cellular compartments. Here we report that the SAE2 subunit of human SUMO activation enzyme (SAE) underwent rapid nucleocytoplasmic shuttling and its nuclear accumulation depended on SUMO modification at the C terminus. The SUMOylation sites included three Lys residues on the bipartite nuclear localization sequence (NLS) and two Lys residues outside of but adjacent to the NLS, and their SUMOylation was catalyzed by Ubc9. Because SAE2 forms a tight heterodimer with SAE1 and it controls the trafficking of the heterodimer, this study has identified the mechanism used to localize SAE to the nucleus. Similar mechanisms are likely to exist for other proteins that depend on SUMOylation for nuclear localization.	[Khue Truong; Li, Baozong; Chen, Yuan] City Hope Natl Med Ctr, Dept Mol Med, Duarte, CA 91010 USA; [Lee, Terry D.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA	City of Hope; City of Hope; Beckman Research Institute of City of Hope	Chen, Y (corresponding author), City Hope Natl Med Ctr, Dept Mol Med, Duarte, CA 91010 USA.	ychen@coh.org	Li, Baozong/ABD-4742-2020		NIGMS, National Institutes of Health [R01 GM086171, R01 GM102538]; NCI, National Institutes of Health [P30 CA033572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102538, R01GM086171] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant R01 GM086171 and R01 GM102538 (to Y. C.) from the NIGMS, National Institutes of Health and Grant P30 CA033572 from the NCI, National Institutes of Health.	ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gong LM, 1999, FEBS LETT, V448, P185, DOI 10.1016/S0014-5793(99)00367-1; Hay RT, 2004, NAT CELL BIOL, V6, P89, DOI 10.1038/ncb0204-89; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hofmann WA, 2009, J CELL BIOL, V186, P193, DOI 10.1083/jcb.200905016; Itahana Y, 2006, MOL CELL BIOL, V26, P4675, DOI 10.1128/MCB.01830-05; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kaikkonen S, 2009, MOL ENDOCRINOL, V23, P292, DOI 10.1210/me.2008-0219; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Truong K, 2012, J BIOL CHEM, V287, P15154, DOI 10.1074/jbc.M112.353789; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Li X, 2008, CELL DEATH DIFFER, V15, P739, DOI 10.1038/sj.cdd.4402303; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P6532, DOI 10.1073/pnas.92.14.6532; Moutty MC, 2011, MOL BIOL CELL, V22, P652, DOI 10.1091/mbc.E10-05-0461; Namanja AT, 2012, J BIOL CHEM, V287, P3231, DOI 10.1074/jbc.M111.293118; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Rangasamy D, 2000, J BIOL CHEM, V275, P37999, DOI 10.1074/jbc.M007777200; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saito K, 2010, J BIOCHEM, V147, P833, DOI 10.1093/jb/mvq020; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stade K, 2002, J BIOL CHEM, V277, P49554, DOI 10.1074/jbc.M207991200; Subramaniam S, 2010, J BIOL CHEM, V285, P20428, DOI 10.1074/jbc.C110.127191; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Sundvall M, 2012, J BIOL CHEM, V287, P23216, DOI 10.1074/jbc.M111.335927; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Vethantham V, 2008, GENE DEV, V22, P499, DOI 10.1101/gad.1628208; Wang JH, 2009, J BIOL CHEM, V284, P20340, DOI 10.1074/jbc.M109.000257; WEIS K, 1995, SCIENCE, V268, P1049, DOI 10.1126/science.7754385; Weisshaar SR, 2008, FEBS LETT, V582, P3174, DOI 10.1016/j.febslet.2008.08.008; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yao Z, 2001, ONCOGENE, V20, P7588, DOI 10.1038/sj.onc.1204963; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200	47	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42611	42619		10.1074/jbc.M112.420877	http://dx.doi.org/10.1074/jbc.M112.420877			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095757	hybrid, Green Published			2022-12-28	WOS:000312501600022
J	Xiao, CY; Wang, RH; Lahusen, TJ; Park, O; Bertola, A; Maruyama, T; Reynolds, D; Chen, Q; Xu, XL; Young, HA; Chen, WJ; Gao, B; Deng, CX				Xiao, Cuiying; Wang, Rui-Hong; Lahusen, Tyler J.; Park, Ogyi; Bertola, Adeline; Maruyama, Takashi; Reynolds, Della; Chen, Qiang; Xu, Xiaoling; Young, Howard A.; Chen, Wan-Jun; Gao, Bin; Deng, Chu-Xia			Progression of Chronic Liver Inflammation and Fibrosis Driven by Activation of c-JUN Signaling in Sirt6 Mutant Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPMENTAL DEFECTS; MAMMALIAN SIRTUINS; TUMOR-SUPPRESSOR; TRANSCRIPTION 3; EFFECTOR-CELLS; CANCER; METABOLISM; EXPRESSION; ABSENCE; TUMORIGENESIS	The human body has a remarkable ability to regulate inflammation, a biophysical response triggered by virus infection and tissue damage. Sirt6 is critical for metabolism and lifespan; however, its role in inflammation is unknown. Here we show that Sirt6-null (Sirt6(-/-)) mice developed chronic liver inflammation starting at similar to 2 months of age, and all animals were affected by 7-8 months of age. Deletion of Sirt6 in T cells or myeloid-derived cells was sufficient to induce liver inflammation and fibrosis, albeit to a lesser degree than that in the global Sirt6(-/-) mice, suggesting that Sirt6 deficiency in the immune cells is the cause. Consistently, macrophages derived from the bone marrow of Sirt6(-/-) mice showed increased MCP-1, IL-6, and TNF alpha expression levels and were hypersensitive to LPS stimulation. Mechanistically, SIRT6 interacts with c-JUN and deacetylates histone H3 lysine 9 (H3K9) at the promoter of proinflammatory genes whose expression involves the c-JUN signaling pathway. Sirt6-deficient macrophages displayed hyperacetylation of H3K9 and increased occupancy of c-JUN in the promoter of these genes, leading to their elevated expression. These data suggest that Sirt6 plays an anti-inflammatory role in mice by inhibiting c-JUN-dependent expression of proinflammatory genes.	[Xiao, Cuiying; Wang, Rui-Hong; Lahusen, Tyler J.; Chen, Qiang; Xu, Xiaoling; Deng, Chu-Xia] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Xiao, Cuiying; Park, Ogyi; Bertola, Adeline; Gao, Bin] NIAAA, Lab Liver Dis, NIH, Bethesda, MD 20892 USA; [Maruyama, Takashi; Chen, Wan-Jun] Natl Inst Dent & Craniofacial Res, Mucosal Immunol Sect, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA; [Reynolds, Della; Young, Howard A.] Frederick Natl Lab Canc Res, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Deng, CX (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA.	chuxiad@bdg10.niddk.nih.gov	deng, chuxia/N-6713-2016; chen, qiang/HGU-5418-2022; Young, Howard/R-5140-2019; chen, qiang/GWZ-7308-2022; MaruYama, Takashi/N-5994-2014; Young, Howard/A-6350-2008	MaruYama, Takashi/0000-0003-0820-3219; Bertola, Adeline/0000-0002-4885-8423; Young, Howard/0000-0002-3118-5111	National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056010, ZIADK056009, ZIADK056011] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; BLASI E, 1989, CANCER BIOCHEM BIOPH, V10, P303; Calderon B, 2006, AM J PATHOL, V169, P2137, DOI 10.2353/ajpath.2006.060539; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Clemmesen O, 2002, DAN MED BULL, V49, P177; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Farrell GC, 2012, GUT LIVER, V6, P149, DOI 10.5009/gnl.2012.6.2.149; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Gao B, 2012, J GASTROEN HEPATOL, V27, P89, DOI 10.1111/j.1440-1746.2011.07003.x; Graziadei Ivo W, 2011, Liver Int, V31 Suppl 3, P24, DOI 10.1111/j.1478-3231.2011.02585.x; Grimley R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039847; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Haigis MC, 2012, CANCER RES, V72, P2468, DOI 10.1158/0008-5472.CAN-11-3633; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Horiguchi N, 2008, GASTROENTEROLOGY, V134, P1148, DOI 10.1053/j.gastro.2008.01.016; Jacobs KM, 2008, INT J BIOL SCI, V4, P291; Jagger AL, 2012, J AUTOIMMUN, V38, P29, DOI 10.1016/j.jaut.2011.11.015; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Li XL, 2011, INT J BIOL SCI, V7, P575, DOI 10.7150/ijbs.7.575; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; McBurney MW, 2003, MOL CANCER RES, V1, P402; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nikolaou K, 2012, CANCER CELL, V21, P738, DOI 10.1016/j.ccr.2012.04.026; Oo YH, 2010, DIGEST DIS, V28, P31, DOI 10.1159/000282062; Pan K, 2010, INT J BIOL SCI, V6, P639; Peng H, 2012, CURR OPIN PHARMACOL, V12, P491, DOI 10.1016/j.coph.2012.03.002; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Schwer B, 2010, P NATL ACAD SCI USA, V107, P21790, DOI 10.1073/pnas.1016306107; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Van Meter M, 2011, AGING-US, V3, P829, DOI 10.18632/aging.100389; Wagner EF, 2010, ANN RHEUM DIS, V69, P86, DOI 10.1136/ard.2009.119396; Wang H, 2011, INT J BIOL SCI, V7, P536, DOI 10.7150/ijbs.7.536; Wang RH, 2004, P NATL ACAD SCI USA, V101, P17108, DOI 10.1073/pnas.0407585101; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wang RH, 2010, INT J BIOL SCI, V6, P682; Weber A, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13197; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Zamarron BF, 2011, INT J BIOL SCI, V7, P651, DOI 10.7150/ijbs.7.651; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604	56	120	126	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41903	41913		10.1074/jbc.M112.415182	http://dx.doi.org/10.1074/jbc.M112.415182			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23076146	Green Published, hybrid			2022-12-28	WOS:000312103000030
J	Hwang, I; Kim, J; Jeong, S				Hwang, Injoo; Kim, Jeeho; Jeong, Sunjoo			beta-Catenin and Peroxisome Proliferator-activated Receptor-delta Coordinate Dynamic Chromatin Loops for the Transcription of Vascular Endothelial Growth Factor A Gene in Colon Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Vascular endothelial growth factor A (VEGFA) mRNA is regulated by beta-catenin and peroxisome proliferator activated receptor delta (PPAR-delta) activation in colon cancer cells, but the detailed mechanism remains to be elucidated. As chromatin loops are generally hubs for transcription factors, we tested here whether beta-catenin could modulate chromatin looping near the VEGFA gene and play any important role for PPAR-delta activated VEGFA transcription. First, we identified the far upstream site as an important site for VEGFA transcription by luciferase assay and chromatin immunoprecipitation in colorectal carcinoma HCT116 cells. Chromatin conformation capture analysis also revealed the chromatin loops formed by the beta-catenin bindings on these sites near the VEGFA gene. Dynamic association and dissociation of beta-catenin/TCF-4/PPAR-delta on the far upstream site and beta-catenin/NF-kappa B p65 on the downstream site were also detected depending on PPAR-delta activation. Interestingly, beta-catenin-mediated chromatin loops were relieved by PPAR-delta activation, suggesting a regulatory role of beta-catenin for VEGFA transcription. Based on these data, we propose a model for PPAR-delta-activated VEGFA transcription that relies on beta-catenin-mediated chromatin looping as a prerequisite for the activation. Our findings could extend to other beta-catenin regulated target genes and could provide a general mechanism and novel paradigm for beta-catenin-mediated oncogenesis.	Dankook Univ, Natl Res Lab RNA Cell Biol, Grad Program RNA Biol BK21, Inst Nanosensor & Biotechnol, Gyeonggi Do 448701, South Korea; [Jeong, Sunjoo] Dankook Univ, Dept Mol Biol, Gyeonggi Do 448701, South Korea	Dankook University; Dankook University	Jeong, S (corresponding author), Dankook Univ, Dept Mol Biol, Gyeonggi Do 448701, South Korea.	sjsj@dankook.ac.kr		Kim, Jeeho/0000-0001-6869-3606				Aarenstrup L, 2008, J INVEST DERMATOL, V128, P1095, DOI 10.1038/sj.jid.5701146; Allred CD, 2008, J NUTR, V138, P250, DOI 10.1093/jn/138.2.250; Babbar N, 2003, J BIOL CHEM, V278, P47762, DOI 10.1074/jbc.M307265200; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Choi YS, 2007, NUCLEIC ACIDS RES, V35, P5511, DOI 10.1093/nar/gkm547; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Easwaran V, 2003, CANCER RES, V63, P3145; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fauconnet S, 2002, J BIOL CHEM, V277, P23534, DOI 10.1074/jbc.M200172200; Foreman JE, 2011, MOL CARCINOGEN, V50, P884, DOI 10.1002/mc.20757; Goodwin A. M., 2002, Angiogenesis, V5, P1, DOI 10.1023/A:1021563510866; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Gupta RA, 2000, P NATL ACAD SCI USA, V97, P13275, DOI 10.1073/pnas.97.24.13275; Hampsey M, 2011, ADV ENZYME REGUL, V51, P118, DOI 10.1016/j.advenzreg.2010.10.001; Han C, 2008, J CELL BIOCHEM, V105, P534, DOI 10.1002/jcb.21852; Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063; Hao CY, 2005, CLIN CANCER RES, V11, P1400, DOI 10.1158/1078-0432.CCR-04-1942; Harman FS, 2004, NAT MED, V10, P481, DOI 10.1038/nm1026; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hollingshead HE, 2007, CARCINOGENESIS, V28, P2641, DOI 10.1093/carcin/bgm183; Hsu PY, 2010, GENOME RES, V20, P733, DOI 10.1101/gr.101923.109; Hwang I, 2010, BIOCHEM BIOPH RES CO, V403, P79, DOI 10.1016/j.bbrc.2010.10.118; Ignatenko NA, 2004, MOL CARCINOGEN, V39, P91, DOI 10.1002/mc.10166; Kim DJ, 2006, CELL DEATH DIFFER, V13, P53, DOI 10.1038/sj.cdd.4401713; Kim YJ, 2011, P NATL ACAD SCI USA, V108, P7391, DOI 10.1073/pnas.1018279108; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kwak H, 2009, MOL CANCER THER, V8, P2664, DOI 10.1158/1535-7163.MCT-09-0214; Li QL, 2006, TRENDS GENET, V22, P197, DOI 10.1016/j.tig.2006.02.004; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; Moraes LA, 2006, PHARMACOL THERAPEUT, V110, P371, DOI 10.1016/j.pharmthera.2005.08.007; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Muller R, 2004, J CANCER RES CLIN, V130, P429, DOI 10.1007/s00432-004-0570-y; Notterman DA, 2001, CANCER RES, V61, P3124; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Peeters Louis L. H., 2005, Angiogenesis, V8, P373; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Reed KR, 2004, ONCOGENE, V23, P8992, DOI 10.1038/sj.onc.1208143; Rohrl C, 2011, J CANCER RES CLIN, V137, P29, DOI 10.1007/s00432-010-0856-1; Saif MW, 2010, CANCER J, V16, P196, DOI 10.1097/PPO.0b013e3181e076af; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Stephen RL, 2004, CANCER RES, V64, P3162, DOI 10.1158/0008-5472.CAN-03-2760; Takayama O, 2006, BRIT J CANCER, V95, P889, DOI 10.1038/sj.bjc.6603343; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wagner N, 2009, CARDIOVASC RES, V83, P61, DOI 10.1093/cvr/cvp106; Wang DZ, 2007, CELL CYCLE, V6, P682, DOI 10.4161/cc.6.6.4030; Wang DZ, 2006, P NATL ACAD SCI USA, V103, P19069, DOI 10.1073/pnas.0607948103; Wang DZ, 2008, PPAR RES, V2008, DOI 10.1155/2008/931074; Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wu CW, 2009, ONCOL REP, V22, P451, DOI 10.3892/or_00000456; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Yochum GS, 2010, P NATL ACAD SCI USA, V107, P145, DOI 10.1073/pnas.0912294107; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08; Zhang XB, 2001, CANCER RES, V61, P6050; Zuo XS, 2009, JNCI-J NATL CANCER I, V101, P762, DOI 10.1093/jnci/djp078	65	21	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41364	41373		10.1074/jbc.M112.377739	http://dx.doi.org/10.1074/jbc.M112.377739			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	V34EZ	23086933	hybrid, Green Published			2022-12-28	WOS:000209071000001
J	LeGendre, JB; Campbell, ZT; Kroll-Conner, P; Anderson, P; Kimble, J; Wickens, M				LeGendre, Jacqueline Baca; Campbell, Zachary T.; Kroll-Conner, Peggy; Anderson, Phil; Kimble, Judith; Wickens, Marvin			RNA Targets and Specificity of Staufen, a Double-stranded RNA-binding Protein in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BICOID MESSENGER-RNA; C-ELEGANS; SOMATODENDRITIC DOMAIN; GENETIC INTERFERENCE; MAMMALIAN STAUFEN; DISTINCT ROLES; LOCALIZATION; TRANSPORT; INTERACT; PATHWAYS	The Staufen family consists of proteins that possess double-stranded RNA-binding domains (dsRBDs). Staufen proteins of Drosophila and mammals regulate mRNA localization, translation, and decay. We report analysis of Staufen in Caenorhabditis elegans, which we have designated STAU-1. We focus on its biochemical properties, mRNA targets, and possible role in RNAi. We show that STAU-1 is expressed as mRNA and protein at all stages of C. elegans development. The wild-type, full-length protein, purified from bacteria, binds duplex RNA with high affinity in vitro. Purified, mutant proteins lacking single dsRBDs still bind RNA efficiently, demonstrating that no single domain is required for binding to duplex RNA (although dsRBD2 could not be tested). STAU-1 mRNA targets were identified via immunoprecipitation with specific anti-STAU-1 antibodies, followed by microarray analysis (RIP-Chip). These studies define a set of 418 likely STAU-1 mRNA targets. Finally, we demonstrate that stau-1 mutants enhance exogenous RNAi and that stau-1; eri-1 double mutants exhibit sterility and synthetic germ line defects.	[LeGendre, Jacqueline Baca] Univ Wisconsin, Grad Program Cellular & Mol Biol, Madison, WI 53706 USA; [Anderson, Phil; Kimble, Judith] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Campbell, Zachary T.; Kimble, Judith; Wickens, Marvin] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Kroll-Conner, Peggy; Kimble, Judith] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Wickens, M (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	wickens@biochem.wisc.edu		Campbell, Zachary/0000-0002-3768-6996; Baca LeGendre, Jacqueline/0000-0003-4889-857X	National Institutes of Health [F31 GM084683, GM095169, GM50933, R01GM069454, GM031892, GM050942]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050942, F32GM095169, F31GM084683, R01GM031892, R01GM069454, R01GM050933, R37GM031892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Predoctoral Fellowship F31 GM084683 (to J. B. L.) and Grants GM095169 (to Z. T. C.), GM50933 (to P. A.), R01GM069454 (to J. K.), and GM031892 and GM050942 (to M. W.).	Bernstein D, 2005, RNA, V11, P447, DOI 10.1261/rna.7255805; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blaszczyk J, 2004, STRUCTURE, V12, P457, DOI 10.1016/j.str.2004.02.004; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; Buchon N, 2006, HEREDITY, V96, P195, DOI 10.1038/sj.hdy.6800789; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Campbell ZT, 2012, CELL REP, V1, P570, DOI 10.1016/j.celrep.2012.04.003; Chang KY, 2005, FEBS J, V272, P2109, DOI 10.1111/j.1742-4658.2005.04652.x; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Cui MX, 2006, PLOS GENET, V2, P719, DOI 10.1371/journal.pgen.0020074; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Duchaine TF, 2002, J CELL SCI, V115, P3285; Ferrandon D, 1997, EMBO J, V16, P1751, DOI 10.1093/emboj/16.7.1751; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; Fierro-Monti I, 2000, TRENDS BIOCHEM SCI, V25, P241, DOI 10.1016/S0968-0004(00)01580-2; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Furic L, 2008, RNA, V14, P324, DOI 10.1261/rna.720308; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hogg M, 2011, ADV GENET, V73, P87, DOI 10.1016/B978-0-12-380860-8.00003-3; Hook B, 2005, RNA, V11, P227, DOI 10.1261/rna.7202705; Hundley HA, 2010, TRENDS BIOCHEM SCI, V35, P377, DOI 10.1016/j.tibs.2010.02.008; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; LEHMANN R, 1991, DEVELOPMENT, V112, P679; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; Mueller Geoffrey A, 2010, Silence, V1, P2, DOI 10.1186/1758-907X-1-2; Nakahara KS, 2012, P NATL ACAD SCI USA, V109, P10113, DOI 10.1073/pnas.1201628109; Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002; Pavelec DM, 2009, GENETICS, V183, P1283, DOI 10.1534/genetics.109.108134; Pohludka M, 2008, BIOCHEM BIOPH RES CO, V374, P49, DOI 10.1016/j.bbrc.2008.06.115; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Roegiers F, 2000, TRENDS CELL BIOL, V10, P220, DOI 10.1016/S0962-8924(00)01767-0; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; SCHUPBACH T, 1986, DEV BIOL, V113, P443, DOI 10.1016/0012-1606(86)90179-X; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Eeden F, 1999, CURR OPIN GENET DEV, V9, P396, DOI 10.1016/S0959-437X(99)80060-4; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Welker NC, 2010, RNA, V16, P893, DOI 10.1261/rna.2122010; Wickham L, 1999, MOL CELL BIOL, V19, P2220; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wu D, 2011, NAT STRUCT MOL BIOL, V18, P1094, DOI 10.1038/nsmb.2129; Zhang C, 2011, P NATL ACAD SCI USA, V108, P1201, DOI 10.1073/pnas.1018695108; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	72	40	303	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2532	2545		10.1074/jbc.M112.397349	http://dx.doi.org/10.1074/jbc.M112.397349			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23195953	Green Published, hybrid			2022-12-28	WOS:000314211500039
J	Buffone, A; Mondal, N; Gupta, R; McHugh, KP; Lau, JTY; Neelamegham, S				Buffone, Alexander, Jr.; Mondal, Nandini; Gupta, Rohitesh; McHugh, Kyle P.; Lau, Joseph T. Y.; Neelamegham, Sriram			Silencing alpha 1,3-Fucosyltransferases in Human Leukocytes Reveals a Role for FUT9 Enzyme during E-selectin-mediated Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALYL-LEWIS-X; P-SELECTIN; GLYCOPROTEIN LIGAND-1; FUCOSYL-TRANSFERASE; FUCT-VII; ACCEPTOR-SPECIFICITY; EXPRESSION CLONING; HYDRODYNAMIC SHEAR; MOLECULAR-CLONING; BINDING	Leukocyte adhesion during inflammation is initiated by the binding of sialofucosylated carbohydrates expressed on leukocytes to endothelial E/P-selectin. Although the glycosyltransferases (glycoTs) constructing selectin-ligands have largely been identified using knock-out mice, important differences may exist between humans and mice. To address this, we developed a systematic lentivirus-based shRNA delivery workflow to create human leukocytic HL-60 cell lines that lack up to three glycoTs. Using this, the contributions of all three myeloid alpha 1,3-fucosyltransferases (FUT4, FUT7, and FUT9) to selectin-ligand biosynthesis were evaluated. The cell adhesion properties of these modified cells to L-, E-, and P-selectin under hydrodynamic shear were compared with bone marrow-derived neutrophils from Fut4(-/-)Fut7(-/-) dual knock-out mice. Results demonstrate that predominantly FUT7, and to a lesser extent FUT4, forms the selectin-ligand at the N terminus of leukocyte P-selectin glycoprotein ligand-1 (PSGL-1) in humans and mice. Here, 85% reduction in leukocyte interaction was observed in human FUT4(-)7(-) dual knockdowns on P/L-selectin substrates. Unlike Fut4(-/-)Fut7(-/-) mouse neutrophils, however, human knockdowns lacking FUT4 and FUT7 only exhibited partial reduction in rolling interaction on E-selectin. In this case, the third alpha 1,3-fucosyltransferase FUT9 played an important role because leukocyte adhesion was reduced by 50-60% in FUT9-HL-60, 70-80% in dual knockdown FUT7(-)9(-) cells, and similar to 85% in FUT4(-)7(-)9(-) triple knockdowns. Gene silencing results are in agreement with gain-of-function experiments where all three fucosyltransferases conferred E-selectin-mediated rolling in HEK293T cells. This study advances new tools to study human glycoT function. It suggests a species-specific role for FUT9 during the biosynthesis of human E-selectin ligands.	[Buffone, Alexander, Jr.; Mondal, Nandini; Gupta, Rohitesh; McHugh, Kyle P.; Neelamegham, Sriram] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA; [Neelamegham, Sriram] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA; [Lau, Joseph T. Y.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Neelamegham, S (corresponding author), SUNY Buffalo, Dept Chem & Biol Engn, 906 Furnas Hall, Buffalo, NY 14260 USA.	neel@buffalo.edu		Mondal, Nandini/0000-0001-9508-3280; Neelamegham, Sriram/0000-0002-1371-8500; gupta, rohitesh/0000-0001-8515-5869	National Institutes of Health [HL63014, HL103411, HL107146]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107146, R01HL063014, R01HL103411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL63014 (to S. N.), HL103411 (to S. N.), and HL107146 (to J. T. Y. L.).	Aeed PA, 1998, GLYCOCONJUGATE J, V15, P975, DOI 10.1023/A:1006985825141; Beauharnois ME, 2005, BIOCHEMISTRY-US, V44, P9507, DOI 10.1021/bi0507130; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brito C, 2008, BIOCHIMIE, V90, P1279, DOI 10.1016/j.biochi.2008.03.002; Britten CJ, 1998, GLYCOBIOLOGY, V8, P321, DOI 10.1093/glycob/8.4.321; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Huang MC, 2002, J BIOL CHEM, V277, P47786, DOI 10.1074/jbc.M208283200; Jayakumar D, 2009, CYTOM PART A, V75A, P866, DOI 10.1002/cyto.a.20773; Kobzdej MMA, 2002, BLOOD, V100, P4485, DOI 10.1182/blood-2002-06-1799; Konstantopoulos K, 1998, CIRCULATION, V98, P873, DOI 10.1161/01.CIR.98.9.873; LARSEN GR, 1992, J BIOL CHEM, V267, P11104; Liu ZH, 2010, J EXP MED, V207, P2975, DOI 10.1084/jem.20101545; LOWE JB, 1991, J BIOL CHEM, V266, P17467; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; M'Rini C, 2003, J EXP MED, V198, P1301, DOI 10.1084/jem.20030182; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Marathe DD, 2010, BLOOD, V115, P1303, DOI 10.1182/blood-2009-07-231480; Marathe DD, 2008, FASEB J, V22, P4154, DOI 10.1096/fj.07-104257; Martinez M, 2005, J BIOL CHEM, V280, P5378, DOI 10.1074/jbc.M410899200; Merzaban JS, 2011, BLOOD, V118, P1774, DOI 10.1182/blood-2010-11-320705; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; NATSUKA S, 1994, J BIOL CHEM, V269, P16789; Niemela R, 1998, J BIOL CHEM, V273, P4021, DOI 10.1074/jbc.273.7.4021; Nimrichter L, 2008, BLOOD, V112, P3744, DOI 10.1182/blood-2008-04-149641; Nishihara S, 2003, GLYCOBIOLOGY, V13, P445, DOI 10.1093/glycob/cwg048; Nishihara S, 1999, FEBS LETT, V462, P289, DOI 10.1016/S0014-5793(99)01549-5; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Pan JL, 1998, J BIOL CHEM, V273, P10058, DOI 10.1074/jbc.273.16.10058; Patil SA, 2012, ANAL BIOCHEM, V425, P135, DOI 10.1016/j.ab.2012.03.009; Patnaik SK, 2004, J BIOL CHEM, V279, P49716, DOI 10.1074/jbc.M408755200; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sackstein R, 2009, IMMUNOL REV, V230, P51, DOI 10.1111/j.1600-065X.2009.00792.x; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; SASAKI K, 1994, J BIOL CHEM, V269, P14730; Schaff UY, 2010, BLOOD, V115, P657, DOI 10.1182/blood-2009-05-224659; Snapp KR, 1997, BLOOD, V89, P896, DOI 10.1182/blood.V89.3.896; Taniguchi N., 2002, HDB GLYCOSYLTRANSFER; Taylor AD, 1996, BIOPHYS J, V71, P3488, DOI 10.1016/S0006-3495(96)79544-9; Toivonen S, 2002, GLYCOBIOLOGY, V12, P361, DOI 10.1093/glycob/12.6.361; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Wagers AJ, 1997, J IMMUNOL, V159, P1917; Walcheck B, 1996, J CLIN INVEST, V98, P1081, DOI 10.1172/JCI118888; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; Wilkins PP, 1996, J BIOL CHEM, V271, P18732, DOI 10.1074/jbc.271.31.18732; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zhang Y, 2002, BIOPHYS J, V83, P1934, DOI 10.1016/S0006-3495(02)73956-8	48	57	58	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1620	1633		10.1074/jbc.M112.400929	http://dx.doi.org/10.1074/jbc.M112.400929			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23192350	Green Published, hybrid			2022-12-28	WOS:000313751400018
J	Wu, JW; Herman, M; Liu, L; Simoes, S; Acker, CM; Figueroa, H; Steinberg, JI; Margittai, M; Kayed, R; Zurzolo, C; Di Paolo, G; Duff, KE				Wu, Jessica W.; Herman, Mathieu; Liu, Li; Simoes, Sabrina; Acker, Christopher M.; Figueroa, Helen; Steinberg, Joshua I.; Margittai, Martin; Kayed, Rakez; Zurzolo, Chiara; Di Paolo, Gilbert; Duff, Karen E.			Small Misfolded Tau Species Are Internalized via Bulk Endocytosis and Anterogradely and Retrogradely Transported in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; PAIRED HELICAL FILAMENTS; ALPHA-SYNUCLEIN OLIGOMERS; IN-VITRO; ALZHEIMERS-DISEASE; AMYLOID-BETA; PROPAGATION; MUTATIONS; MECHANISM; PATHOLOGY	The accumulation of Tau into aggregates is associated with key pathological events in frontotemporal lobe degeneration (FTD-Tau) and Alzheimer disease (AD). Recent data have shown that misfolded Tau can be internalized by cells in vitro (Frost, B., Jacks, R. L., and Diamond, M. I. (2009) J. Biol. Chem. 284, 12845-12852) and propagate pathology in vivo (Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., Jucker, M., Goedert, M., and Tolnay, M. (2009) Nat. Cell Biol. 11, 909-913; Lasagna-Reeves, C. A., Castillo-Carranza, D. L., Sengupta, U., Guerrero-Munoz, M. J., Kiritoshi, T., Neugebauer, V., Jackson, G. R., and Kayed, R. (2012) Sci. Rep. 2, 700). Here we show that recombinant Tau misfolds into low molecular weight (LMW) aggregates prior to assembly into fibrils, and both extracellular LMW Tau aggregates and short fibrils, but not monomers, long fibrils, nor long filaments purified from brain extract are taken up by neurons. Remarkably, misfolded Tau can be internalized at the somatodendritic compartment, or the axon terminals and it can be transported anterogradely, retrogradely, and can enhance tauopathy in vivo. The internalized Tau aggregates co-localize with dextran, a bulk-endocytosis marker, and with the endolysosomal compartments. Our findings demonstrate that exogenous Tau can be taken up by cells, uptake depends on both the conformation and size of the Tau aggregates and once inside cells, Tau can be transported. These data provide support for observations that tauopathy can spread trans-synaptically in vivo, via cell-to-cell transfer.	[Wu, Jessica W.; Herman, Mathieu; Liu, Li; Simoes, Sabrina; Figueroa, Helen; Steinberg, Joshua I.; Di Paolo, Gilbert; Duff, Karen E.] Columbia Univ, Dept Pathol & Cell Biol, Taub Inst Alzheimers Dis Res, New York, NY 10032 USA; [Acker, Christopher M.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Margittai, Martin] Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA; [Kayed, Rakez] Univ Texas Med Branch, George P & Cynthia Woods Mitchell Ctr Neurodegene, Dept Neurol, Galveston, TX 77555 USA; [Zurzolo, Chiara] Inst Pasteur, Unite Traff Membranaire & Pathogenese, Paris, France; [Duff, Karen E.] New York State Psychiat Inst & Hosp, Dept Psychiat, New York, NY 10032 USA	Columbia University; Yeshiva University; Albert Einstein College of Medicine; University of Denver; University of Texas System; University of Texas Medical Branch Galveston; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; New York State Psychiatry Institute	Duff, KE (corresponding author), Columbia Univ, Med Ctr, Taub Inst Alzheimers Dis Res, Dept Pathol, P&S 12-461,630 W 168th St, New York, NY 10032 USA.	ked2115@columbia.edu	Margittai, Martin/D-5039-2014; Zurzolo, Chiara/AAH-5225-2019	Margittai, Martin/0000-0003-1903-5927; ZURZOLO, Chiara/0000-0001-6048-6602; Duff, Karen/0000-0002-6177-868X	National Institutes of Health from the NINDS [NS074874, NS076619, NS056049]; American Health Assistance Foundation AHAF fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056049, R01NS076619, R01NS081555, R01NS074874] Funding Source: NIH RePORTER	National Institutes of Health from the NINDS; American Health Assistance Foundation AHAF fellowship(BrightFocus Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS074874 (to K. D.), NS076619 (to M. M.), and NS056049 (to G. D. P.) from the NINDS and an American Health Assistance Foundation AHAF fellowship (to J. W. W.).	Acker CM, 2013, NEUROBIOL AGING, V34, P338, DOI 10.1016/j.neurobiolaging.2012.05.010; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Barghorn Stefan, 2004, V299, P35; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, J NEURAL TRANSM, V118, P809, DOI 10.1007/s00702-010-0508-2; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Congdon EE, 2012, AUTOPHAGY, V8, P609, DOI 10.4161/auto.19048; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; D'Souza I, 2005, BBA-MOL BASIS DIS, V1739, P104, DOI 10.1016/j.bbadis.2004.08.009; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Danzer KM, 2009, J NEUROCHEM, V111, P192, DOI 10.1111/j.1471-4159.2009.06324.x; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gerdes HH, 2009, NAT CELL BIOL, V11, P235, DOI 10.1038/ncb0309-235; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Narayanan S, 2003, P NATL ACAD SCI USA, V100, P9286, DOI 10.1073/pnas.1233535100; OLIVER JM, 1984, METHOD ENZYMOL, V108, P336; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; POLLOCK NJ, 1986, LANCET, V2, P1211; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Raposo G, 1997, HDB EXPT IMMUNOLOGY, V4, P1; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; Siddiqua A, 2010, J BIOL CHEM, V285, P37920, DOI 10.1074/jbc.M110.185728; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Thompson HM, 2006, NAT CHEM BIOL, V2, P355, DOI 10.1038/nchembio0706-355; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Voss EW, 1996, BIOTECHNIQUES, V20, P286; Wilson DM, 1997, AM J PATHOL, V150, P2181; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011	76	332	338	1	67	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1856	1870		10.1074/jbc.M112.394528	http://dx.doi.org/10.1074/jbc.M112.394528			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23188818	Green Published, hybrid			2022-12-28	WOS:000313751400040
J	Puchulu-Campanella, E; Chu, HY; Anstee, DJ; Galan, JA; Tao, WA; Low, PS				Puchulu-Campanella, Estela; Chu, Haiyan; Anstee, David J.; Galan, Jacob A.; Tao, W. Andy; Low, Philip S.			Identification of the Components of a Glycolytic Enzyme Metabolon on the Human Red Blood Cell Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBONIC-ANHYDRASE-II; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ERYTHROCYTE-MEMBRANE; MULTIPROTEIN COMPLEX; TRANSPORT METABOLON; CYTOPLASMIC DOMAIN; STATISTICAL-MODEL; PROTEIN COMPLEXES; BAND-3; ALDOLASE	Glycolytic enzymes (GEs) have been shown to exist in multienzyme complexes on the inner surface of the human erythrocyte membrane. Because no protein other than band 3 has been found to interact with GEs, and because several GEs do not bind band 3, we decided to identify the additional membrane proteins that serve as docking sites for GE on the membrane. For this purpose, a method known as "label transfer" that employs a photoactivatable trifunctional cross-linking reagent to deliver a biotin from a derivatized GE to its binding partner on the membrane was used. Mass spectrometry analysis of membrane proteins that were biotinylated following rebinding and photoactivation of labeled GAPDH, aldolase, lactate dehydrogenase, and pyruvate kinase revealed not only the anticipated binding partner, band 3, but also the association of GEs with specific peptides in alpha- and beta-spectrin, ankyrin, actin, p55, and protein 4.2. More importantly, the labeled GEs were also found to transfer biotin to other GEs in the complex, demonstrating for the first time that GEs also associate with each other in their membrane complexes. Surprisingly, a new GE binding site was repeatedly identified near the junction of the membrane-spanning and cytoplasmic domains of band 3, and this binding site was confirmed by direct binding studies. These results not only identify new components of the membrane-associated GE complexes but also provide molecular details on the specific peptides that form the interfacial contacts within each interaction.	[Puchulu-Campanella, Estela; Chu, Haiyan; Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Galan, Jacob A.; Tao, W. Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Anstee, David J.] Natl Hlth Serv Blood & Transplant, Bristol Inst Transfus Sci, Bristol BS34 7QG, Avon, England	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; NHS Blood & Transplant (NHSBT)	Low, PS (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	plow@purdue.edu	Tao, Weiguo/AAL-2777-2020; Anstee, David/AAE-9231-2020; Tao, Andy/N-1290-2019	Tao, Weiguo/0000-0002-5535-5517; Galan, Jacob/0000-0003-3304-0474; Low, Philip/0000-0001-9042-5528; Puchulu-Campanella, Estela/0000-0002-3951-3925	National Institutes of Health [R01GM24417-33, R01GM088317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088317, R01GM024417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM24417-33 and R01GM088317.	Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; BENNETT V, 1983, METHOD ENZYMOL, V96, P313; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Campanella ME, 2008, BLOOD, V112, P3900, DOI 10.1182/blood-2008-03-146159; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Chu HY, 2006, BIOCHEM J, V400, P143, DOI 10.1042/BJ20060792; Chu HY, 2012, P NATL ACAD SCI USA, V109, P12794, DOI 10.1073/pnas.1209014109; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Dhar-Chowdhury P, 2005, J BIOL CHEM, V280, P38464, DOI 10.1074/jbc.M508744200; Emara M, 2012, J BIOL CHEM, V287, P5756, DOI 10.1074/jbc.M111.312520; Endeward V, 2008, FASEB J, V22, P64, DOI 10.1096/fj.07-9097com; ERCOLANI L, 1992, AM J PHYSIOL, V262, pF892, DOI 10.1152/ajprenal.1992.262.5.F892; Franco T, 2010, TRANSFUS CLIN BIOL, V17, P87, DOI 10.1016/j.tracli.2010.05.008; Gallagher P., 2003, HEMATOLOGY INFANCY C, P560; Harper SL, 2010, J BIOL CHEM, V285, P11003, DOI 10.1074/jbc.M109.083048; HARRISON ML, 1991, J BIOL CHEM, V266, P4106; Hassoun H, 1998, BLOOD, V92, P1785, DOI 10.1182/blood.V92.5.1785.417k17_1785_1792; Hoffman JF, 2009, J GEN PHYSIOL, V134, P351, DOI 10.1085/jgp.200910270; Hurst GB, 2004, J AM SOC MASS SPECTR, V15, P832, DOI 10.1016/S1044-0305(04)00154-0; KANT JA, 1973, J BIOL CHEM, V248, P8457; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KELLEY GE, 1984, BIOCHIM BIOPHYS ACTA, V778, P67, DOI 10.1016/0005-2736(84)90448-6; Kim S, 2011, J BIOL CHEM, V286, P20746, DOI 10.1074/jbc.M111.230326; Kim YH, 2007, DEV BIOL, V302, P463, DOI 10.1016/j.ydbio.2006.10.004; Kovacic L, 2007, BIOORG CHEM, V35, P295, DOI 10.1016/j.bioorg.2006.12.002; Lewis IA, 2009, P NATL ACAD SCI USA, V106, P18515, DOI 10.1073/pnas.0905999106; Li B., 2009, THESIS CONCORDIA U M; LOW PS, 1990, BIOMED BIOCHIM ACTA, V49, pS135; Mankelow TJ, 2012, BLOOD CELL MOL DIS, V49, P1, DOI 10.1016/j.bcmd.2012.03.001; MARFATIA SM, 1995, J BIOL CHEM, V270, P715, DOI 10.1074/jbc.270.2.715; MCDANIEL CF, 1974, J BIOL CHEM, V249, P6478; Mitola S, 2010, BLOOD, V116, P3677, DOI 10.1182/blood-2010-06-291930; Murphy SC, 2006, PLOS MED, V3, P2403, DOI 10.1371/journal.pmed.0030528; MURTHY SNP, 1981, J BIOL CHEM, V256, P1203; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; OVADI J, 1978, EUR J BIOCHEM, V90, P499, DOI 10.1111/j.1432-1033.1978.tb12629.x; OVADI J, 1988, TRENDS BIOCHEM SCI, V13, P486, DOI 10.1016/0968-0004(88)90237-X; Pomel S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000188; Raikar LS, 2006, J CELL BIOCHEM, V98, P861, DOI 10.1002/jcb.20732; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Satchwell TJ, 2011, BLOOD, V118, P182, DOI 10.1182/blood-2010-10-314187; Satchwell TJ, 2009, BLOOD CELL MOL DIS, V42, P201, DOI 10.1016/j.bcmd.2009.01.005; Simpson R. J., 2003, PROTEINS PROTEOMICS, P529; Sowah D, 2011, AM J PHYSIOL-CELL PH, V301, pC336, DOI 10.1152/ajpcell.00005.2011; Sprague RS, 2007, TRENDS ENDOCRIN MET, V18, P350, DOI 10.1016/j.tem.2007.08.008; Sprague RS, 2001, AM J PHYSIOL-CELL PH, V281, pC1158, DOI 10.1152/ajpcell.2001.281.4.C1158; SRERE PA, 1990, FEBS LETT, V268, P360, DOI 10.1016/0014-5793(90)81286-W; STECK TL, 1976, BIOCHEMISTRY-US, V15, P1154, DOI 10.1021/bi00650a030; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Stochaj Wayne R, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4543; STRAPAZON E, 1977, BIOCHEMISTRY-US, V16, P2966, DOI 10.1021/bi00632a025; Su Y, 2011, AM J PHYSIOL-RENAL, V300, pF157, DOI 10.1152/ajprenal.00228.2010; Su Y, 2006, MOL CELL BIOCHEM, V289, P159, DOI 10.1007/s11010-006-9159-x; Tiffert T, 2011, J GEN PHYSIOL, V138, P381, DOI 10.1085/jgp.201110660; TSAI IH, 1982, J BIOL CHEM, V257, P1438; van den Akker E, 2010, BLOOD CELL MOL DIS, V45, P1, DOI 10.1016/j.bcmd.2010.02.019; Vonck J, 2009, BBA-MOL CELL RES, V1793, P117, DOI 10.1016/j.bbamcr.2008.05.019; Wang QY, 2010, J BIOL CHEM, V285, P10408, DOI 10.1074/jbc.M109.085787; Zhang DC, 2000, BLOOD, V96, P2925	60	77	82	0	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					848	858		10.1074/jbc.M112.428573	http://dx.doi.org/10.1074/jbc.M112.428573			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23150667	Green Published, hybrid			2022-12-28	WOS:000313570300010
J	Zhong, XT; Kieras, E; Sousa, E; D'Antona, A; Baber, JC; He, T; Desharnais, J; Wood, L; Luxenberg, D; Stahl, M; Kriz, R; Lin, L; Somers, W; Fitz, LJ; Wright, JF				Zhong, Xiaotian; Kieras, Elizabeth; Sousa, Eric; D'Antona, Aaron; Baber, J. Christian; He, Tao; Desharnais, Joel; Wood, Lauren; Luxenberg, Deborah; Stahl, Mark; Kriz, Ronald; Lin, Laura; Somers, Will; Fitz, Lori J.; Wright, Jill F.			Pyroglutamate and O-Linked Glycan Determine Functional Production of Anti-IL17A and Anti-IL22 Peptide-Antibody Bispecific Genetic Fusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO SELECTION; TH17 CELLS; PROTEIN THERAPEUTICS; DISPLAY; LIBRARIES; INFLAMMATION; EXPRESSION; DISEASE; POTENT; IL-22	Protein biosynthesis and extracellular secretion are essential biological processes for therapeutic protein production in mammalian cells, which offer the capacity for correct folding and proper post-translational modifications. In this study, we have generated bispecific therapeutic fusion proteins in mammalian cells by combining a peptide and an antibody into a single open reading frame. A neutralizing peptide directed against interleukin-17A (IL17A) was genetically fused to the N termini of an anti-IL22 antibody, through either the light chain, the heavy chain, or both chains. Although the resulting fusion proteins bound and inhibited IL22 with the same affinity and potency as the unmodified anti-IL22 antibody, the peptide modality in the fusion scaffold was not active in the cell-based assay due to the N-terminal degradation. When a glutamine residue was introduced at the N terminus, which can be cyclized to form pyroglutamate in mammalian cells, the IL17A neutralization activity of the fusion protein was restored. Interestingly, the mass spectroscopic analysis of the purified fusion protein revealed an unexpected O-linked glycosylation modification at threonine 5 of the anti-IL17A peptide. The subsequent removal of this post-translational modification by site-directed mutagenesis drastically enhanced the IL17A binding affinity and neutralization potency for the resulting fusion protein. These results provide direct experimental evidence that post-translational modifications during protein biosynthesis along secretory pathways play critical roles in determining the structure and function of therapeutic proteins produced by mammalian cells. The newly engineered peptide-antibody genetic fusion is promising for therapeutically targeting multiple antigens in a single antibody like molecule.	[Zhong, Xiaotian; Kieras, Elizabeth; Sousa, Eric; D'Antona, Aaron; Baber, J. Christian; He, Tao; Luxenberg, Deborah; Stahl, Mark; Kriz, Ronald; Lin, Laura; Somers, Will; Fitz, Lori J.; Wright, Jill F.] Pfizer BioTherapeut Res & Dev, Cambridge, MA 02140 USA; [Desharnais, Joel; Wood, Lauren] Pfizer CovX Res, San Diego, CA 92121 USA	Pfizer; Pfizer	Zhong, XT (corresponding author), Pfizer BioTherapeut Res & Dev, 87 Cambridge Pk Dr, Cambridge, MA 02140 USA.	Xiaotian.Zhong@pfizer.com; Lori.Fitz@pfizer.com						Bendele A, 1998, TOXICOL SCI, V42, P152, DOI 10.1093/toxsci/42.2.152; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Bray BL, 2003, NAT REV DRUG DISCOV, V2, P587, DOI 10.1038/nrd1133; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Cohn CS, 2009, DRUG TODAY, V45, P175, DOI 10.1358/dot.2009.45.3.1343793; CULL MG, 1992, P NATL ACAD SCI USA, V89, P1865, DOI 10.1073/pnas.89.5.1865; Dick LW, 2007, BIOTECHNOL BIOENG, V97, P544, DOI 10.1002/bit.21260; Doppalapudi VR, 2010, P NATL ACAD SCI USA, V107, P22611, DOI 10.1073/pnas.1016478108; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Ebbinghaus S, 2007, P NATL ACAD SCI USA, V104, P20749, DOI 10.1073/pnas.0709207104; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; Fouser LA, 2008, IMMUNOL REV, V226, P87, DOI 10.1111/j.1600-065X.2008.00712.x; Gerhardt S, 2009, J MOL BIOL, V394, P905, DOI 10.1016/j.jmb.2009.10.008; Hagemeyer CE, 2009, THROMB HAEMOSTASIS, V101, P1012, DOI 10.1160/TH08-12-0816; Hanisch FG, 2001, ANAL BIOCHEM, V290, P47, DOI 10.1006/abio.2000.4955; Huang BC, 2007, BIOCHEMISTRY-US, V46, P10102, DOI 10.1021/bi700220x; Huang CC, 2009, CURR OPIN BIOTECH, V20, P692, DOI 10.1016/j.copbio.2009.10.010; Hudson PJ, 1999, J IMMUNOL METHODS, V231, P177, DOI 10.1016/S0022-1759(99)00157-X; Kelley WS, 1996, BIO-TECHNOL, V14, P28, DOI 10.1038/nbt0196-28; Kipriyanov SM, 2009, METHODS MOL BIOL, V562, P177, DOI 10.1007/978-1-60327-302-2_14; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Leavy O, 2010, NAT REV IMMUNOL, V10, P297, DOI 10.1038/nri2763; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liang SC, 2010, J IMMUNOL, V185, P5531, DOI 10.4049/jimmunol.0904091; Liu YD, 2011, J BIOL CHEM, V286, P11211, DOI 10.1074/jbc.M110.185041; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Macdougall IC, 2009, NEW ENGL J MED, V361, P1848, DOI 10.1056/NEJMoa074037; MATTHEAKIS LC, 1994, P NATL ACAD SCI USA, V91, P9022, DOI 10.1073/pnas.91.19.9022; McGregor DP, 2008, CURR OPIN PHARMACOL, V8, P616, DOI 10.1016/j.coph.2008.06.002; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Odegrip R, 2004, P NATL ACAD SCI USA, V101, P2806, DOI 10.1073/pnas.0400219101; Omasa T, 2010, CURR PHARM BIOTECHNO, V11, P233, DOI 10.2174/138920110791111960; Peschen D, 2004, NAT BIOTECHNOL, V22, P732, DOI 10.1038/nbt970; Rader C, 2003, J MOL BIOL, V332, P889, DOI 10.1016/S0022-2836(03)00992-6; Rink R, 2010, J PHARMACOL TOX MET, V61, P210, DOI 10.1016/j.vascn.2010.02.010; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Sonnenberg GF, 2010, ADV IMMUNOL, V107, P1, DOI [10.1016/S0065-2776(10)07008-2, 10.1016/B978-0-12-381300-8.00001-0]; Sroda K, 2005, CELL MOL BIOL LETT, V10, P37; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Subramanian GM, 2007, NAT BIOTECHNOL, V25, P1411, DOI 10.1038/nbt1364; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yonezawa M, 2004, J BIOCHEM, V135, P285, DOI 10.1093/jb/mvh034; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003; Zuraw B, 2010, NAT REV DRUG DISCOV, V9, P189, DOI 10.1038/nrd3125	54	16	19	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1409	1419		10.1074/jbc.M112.417717	http://dx.doi.org/10.1074/jbc.M112.417717			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184956	Green Published, hybrid			2022-12-28	WOS:000313570300061
J	Ji, FL; Jung, J; Koharudin, LMI; Gronenborn, AM				Ji, Fangling; Jung, Jinwon; Koharudin, Leonardus M. I.; Gronenborn, Angela M.			The Human W42R gamma D-Crystallin Mutant Structure Provides a Link between Congenital and Age-related Cataracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPTOPHAN FLUORESCENCE; DOMINANT CATARACT; S-CRYSTALLIN; PROTEIN; MUTATION; IDENTIFICATION; PHOTOLYSIS; MECHANISM; MOUSE; STATE	Some mutants of human gamma D-crystallin are closely linked to congenital cataracts, although the detailed molecular mechanisms of mutant-associated cataract formation are generally not known. Here we report on a recently discovered gamma D-crystallin mutant (W42R) that has been linked to autosomal dominant, congenital cataracts in a Chinese family. The mutant protein is much less soluble and stable than wild-type gamma D-crystallin. We solved the crystal structure of W42R at 1.7 angstrom resolution, which revealed only minor differences from the wild-type structure. Interestingly, the W42R variant is highly susceptible to protease digestion, suggesting the presence of a small population of partially unfolded protein. This partially unfolded species was confirmed and quantified by NMR spectroscopy. Hydrogen/deuterium exchange experiments revealed chemical exchange between the folded and unfolded species. Exposure of wild-type gamma D-crystallin to UV caused damage to the N-terminal domain of the protein, resulting in very similar proteolytic susceptibility as observed for the W42R mutant. Altogether, our combined data allowed us to propose a model for W42R pathogenesis, with the W42R mutant serving as a mimic for photodamaged gamma D-crystallin involved in age-related cataract.	[Ji, Fangling] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian 116024, Peoples R China; [Ji, Fangling; Jung, Jinwon; Koharudin, Leonardus M. I.; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA	Dalian University of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gronenborn, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, 3501 5th Ave, Pittsburgh, PA 15261 USA.	amg100@pitt.edu		Jung, Jinwon/0000-0002-7981-3316; Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [EY021193]; China Scholarship Council; NATIONAL EYE INSTITUTE [R01EY021193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY021193 (to A. M. G). This work was also supported by a scholarship from the China Scholarship Council (to F. J.).	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; BENT DV, 1975, J AM CHEM SOC, V97, P2612, DOI 10.1021/ja00843a004; BRYANT FD, 1975, J PHYS CHEM-US, V79, P2711, DOI 10.1021/j100592a002; Chen JJ, 2008, BIOCHEMISTRY-US, V47, P10705, DOI 10.1021/bi800499k; Chen JJ, 2006, BIOCHEMISTRY-US, V45, P11552, DOI 10.1021/bi060988v; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVERETT CA, 1994, GENOMICS, V20, P429, DOI 10.1006/geno.1994.1197; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Fu L, 2002, FEBS LETT, V513, P213, DOI 10.1016/S0014-5793(02)02313-X; Goddard T.D., 2004, SPARKY 3; Graw J, 2002, MAMM GENOME, V13, P452, DOI 10.1007/s00335-002-3021-6; Graw JC, 2004, INVEST OPHTH VIS SCI, V45, P1202, DOI 10.1167/iovs.03-0811; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Hubbard S. J., 1993, NACCESS; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ji FL, 2012, BIOCHEMISTRY-US, V51, P2588, DOI 10.1021/bi300199d; Jung J, 2009, BIOCHEMISTRY-US, V48, P2597, DOI 10.1021/bi802292q; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Keller B, 2007, J BIOMOL NMR, V37, P1, DOI 10.1007/s10858-006-9081-2; Kmoch S, 2000, HUM MOL GENET, V9, P1779, DOI 10.1093/hmg/9.12.1779; Kosinski-Collins MS, 2004, PROTEIN SCI, V13, P2223, DOI 10.1110/ps.04627004; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Lee S, 2010, J MOL BIOL, V399, P320, DOI 10.1016/j.jmb.2010.04.003; Mahler B, 2011, J MOL BIOL, V405, P840, DOI 10.1016/j.jmb.2010.11.005; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MITRAKI A, 1989, BIO-TECHNOL, V7, P690, DOI 10.1038/nbt0789-690; Moreau KL, 2009, J BIOL CHEM, V284, P33285, DOI 10.1074/jbc.M109.031344; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholson EM, 2002, J MOL BIOL, V316, P807, DOI 10.1006/jmbi.2001.5347; Oyster CW., 1999, HUMAN EYE STRUCTURE; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rahi JS, 2000, INVEST OPHTH VIS SCI, V41, P2108; Reddy MA, 2004, HUM MOL GENET, V13, P945, DOI 10.1093/hmg/ddh110; Robman L, 2005, EYE, V19, P1074, DOI 10.1038/sj.eye.6701964; Searle BC, 2005, J PROTEOME RES, V4, P546, DOI 10.1021/pr049781j; Shiels A, 2010, MOL VIS, V16, P2007; Sinha D, 1998, Mol Vis, V4, P8; Sinha D, 2001, J BIOL CHEM, V276, P9308, DOI 10.1074/jbc.M010583200; TALLMADGE DH, 1990, PHOTOCHEM PHOTOBIOL, V51, P363, DOI 10.1111/j.1751-1097.1990.tb01723.x; Vijaya R, 1997, CLIN GENET, V52, P427; Wang BB, 2011, HUM MUTAT, V32, pE1939, DOI 10.1002/humu.21386; Wang SSS, 2010, MOL VIS, V16, P2777; WUTHRICH K, 1979, J MOL BIOL, V130, P1, DOI 10.1016/0022-2836(79)90548-5	52	37	38	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					99	109		10.1074/jbc.M112.416354	http://dx.doi.org/10.1074/jbc.M112.416354			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23124202	Green Published, hybrid			2022-12-28	WOS:000313197200010
J	Scilabra, SD; Troeberg, L; Yamamoto, K; Emonard, H; Thogersen, I; Enghild, JJ; Strickland, DK; Nagase, H				Scilabra, Simone D.; Troeberg, Linda; Yamamoto, Kazuhiro; Emonard, Herve; Thogersen, Ida; Enghild, Jan J.; Strickland, Dudley K.; Nagase, Hideaki			Differential Regulation of Extracellular Tissue Inhibitor of Metalloproteinases-3 Levels by Cell Membrane-bound and Shed Low Density Lipoprotein Receptor-related Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; PLASMINOGEN-ACTIVATOR; BINDING-SITE; ARTICULAR CHONDROCYTES; ENDOCYTIC CLEARANCE; COMPLEX-FORMATION; GENE-EXPRESSION; TIMP3(-/-) MICE; MATRIX; LRP	Tissue inhibitor of metalloproteinases-3 (TIMP-3) plays a key role in regulating extracellular matrix turnover by inhibiting matrix metalloproteinases (MMPs), adamalysins (ADAMs), and adamalysins with thrombospondin motifs (ADAMTSs). We demonstrate that levels of this physiologically important inhibitor can be regulated post-translationally by endocytosis. TIMP-3 was endocytosed and degraded by a number of cell types including chondrocytes, fibroblasts, and monocytes, and we found that the endocytic receptor low density lipoprotein receptor-related protein-1 (LRP-1) plays a major role in TIMP-3 internalization. However, the cellular uptake of TIMP-3 significantly slowed down after 10 h due to shedding of LRP-1 from the cell surface and formation of soluble LRP-1 (sLRP-1)-TIMP-3 complexes. Addition of TIMP-3 to HTB94 human chondrosarcoma cells increased the release of sLRP-1 fragments of 500, 215, 160, and 110 kDa into the medium in a concentration-dependent manner, and all of these fragments were able to bind to TIMP-3. TIMP-3 bound to sLRP-1, which was resistant to endocytosis, retained its inhibitory activity against metalloproteinases. Extracellular levels of sLRP-1 can thus increase the half-life of TIMP-3 in the extracellular space, controlling the bioavailability of TIMP-3 to inhibit metalloproteinases.	[Scilabra, Simone D.; Troeberg, Linda; Nagase, Hideaki] Univ London Imperial Coll Sci Technol & Med, Dept Med, London SW7 2AZ, England; [Scilabra, Simone D.; Troeberg, Linda; Yamamoto, Kazuhiro; Nagase, Hideaki] Univ Oxford, Kennedy Inst Rheumatol, London W6 8LH, England; [Emonard, Herve] Univ Reims, CNRS, FRE 3481, F-51100 Reims, France; [Thogersen, Ida; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Strickland, Dudley K.] Univ Maryland, Dept Surg, Baltimore, MD 21201 USA	Imperial College London; University of Oxford; Centre National de la Recherche Scientifique (CNRS); Universite de Reims Champagne-Ardenne; Aarhus University; University System of Maryland; University of Maryland Baltimore	Nagase, H (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, 65 Aspenlea Rd, London W6 8LH, England.	hideaki.nagase@kennedy.ox.ac.uk	scilabra, simone/AAT-4753-2021; Emonard, Hervé/AAD-5432-2019; Emonard, Herve/R-9718-2019; Yamamoto, Kazuhiro/AAD-9650-2019	Scilabra, Simone Dario/0000-0001-7300-6153; Enghild, Jan Johannes/0000-0001-9292-9172; /0000-0003-0939-4651	Arthritis Research United Kingdom Career Development Fellowship Grant [19466]; National Institutes of Health through NIAMS [AR40994]; Arthritis Research United Kingdom Core Grant; Versus Arthritis [19466] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	Arthritis Research United Kingdom Career Development Fellowship Grant(Versus Arthritis); National Institutes of Health through NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Research United Kingdom Core Grant(Versus Arthritis); Versus Arthritis(Versus Arthritis); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Recipient of Arthritis Research United Kingdom Career Development Fellowship Grant 19466.; Supported by National Institutes of Health Grant AR40994 through NIAMS and by a Arthritis Research United Kingdom Core Grant to the Kennedy Institute of Rheumatology. To whom correspondence should be addressed: Kennedy Institute of Rheumatology, University of Oxford, 65 Aspenlea Rd., London W6 8LH, United Kingdom. Tel.: 44-0-20-8383-4488; E-mail: hideaki.nagase@kennedy.ox.ac.uk.	Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Cardellini M, 2009, DIABETES, V58, P2396, DOI 10.2337/db09-0280; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Darnton SJ, 2005, INT J CANCER, V115, P351, DOI 10.1002/ijc.20830; Echtermeyer F, 1999, J CELL SCI, V112, P3433; Emonard H, 2004, J BIOL CHEM, V279, P54944, DOI 10.1074/jbc.M406792200; Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Fata JE, 2001, J CLIN INVEST, V108, P831, DOI 10.1172/JCI13171; Fedak PWM, 2004, CIRCULATION, V110, P2401, DOI 10.1161/01.CIR.0000134959.83967.2D; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gendron C, 2003, FEBS LETT, V555, P431, DOI 10.1016/S0014-5793(03)01295-X; Gorovoy M, 2010, J LEUKOCYTE BIOL, V88, P769, DOI 10.1189/jlb.0410220; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Horn IR, 1998, THROMB HAEMOSTASIS, V80, P822; Ishiguro K, 2000, J BIOL CHEM, V275, P5249, DOI 10.1074/jbc.275.8.5249; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kjoller L, 2004, EXP CELL RES, V293, P106, DOI 10.1016/j.yexcr.2003.10.008; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; Li WQ, 1998, J IMMUNOL, V161, P5000; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; Limana F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019845; Liu Q, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-17; Martin EL, 2003, AM J PHYSIOL-LUNG C, V285, pL1222, DOI 10.1152/ajplung.00141.2003; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Neels JG, 2000, BLOOD, V96, P3459, DOI 10.1182/blood.V96.10.3459.h8003459_3459_3465; NIELSEN MS, 1995, J BIOL CHEM, V270, P23713, DOI 10.1074/jbc.270.40.23713; Nilsson SK, 2007, BIOCHEMISTRY-US, V46, P3896, DOI 10.1021/bi7000533; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Quinn KA, 1997, J BIOL CHEM, V272, P23946, DOI 10.1074/jbc.272.38.23946; Quinn KA, 1999, EXP CELL RES, V251, P433, DOI 10.1006/excr.1999.4590; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Sahebjam S, 2007, ARTHRITIS RHEUM, V56, P905, DOI 10.1002/art.22427; Sarafanov AG, 2001, J BIOL CHEM, V276, P11970, DOI 10.1074/jbc.M008046200; Schwartz AL, 1997, TRENDS CARDIOVAS MED, V7, P234, DOI 10.1016/S1050-1738(97)00083-2; Selvais C, 2011, FASEB J, V25, P2770, DOI 10.1096/fj.10-169508; Selvais C, 2009, ENDOCRINOLOGY, V150, P3792, DOI 10.1210/en.2009-0015; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; STASKUS PW, 1991, J BIOL CHEM, V266, P449; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Su SM, 1998, J CELL BIOCHEM, V70, P517, DOI 10.1002/(SICI)1097-4644(19980915)70:4<517::AID-JCB8>3.0.CO;2-M; Troeberg L, 2008, FASEB J, V22, P3515, DOI 10.1096/fj.08-112680; Troeberg L, 2009, MATRIX BIOL, V28, P463, DOI 10.1016/j.matbio.2009.07.005; van den Biggelaar M, 2011, INT J BIOCHEM CELL B, V43, P431, DOI 10.1016/j.biocel.2010.11.017; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang SX, 2004, J CELL BIOCHEM, V91, P766, DOI 10.1002/jcb.10781; Westein E, 2002, J BIOL CHEM, V277, P2511, DOI 10.1074/jbc.M102293200; WILLNOW TE, 1994, J CELL SCI, V107, P719; Wygrecka M, 2011, AM J RESP CRIT CARE, V184, P438, DOI 10.1164/rccm.201009-1422OC; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200	58	53	54	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					332	342		10.1074/jbc.M112.393322	http://dx.doi.org/10.1074/jbc.M112.393322			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23166318	hybrid, Green Published			2022-12-28	WOS:000313197200035
J	Arai, R; Fukui, S; Kobayashi, N; Sekiguchi, J				Arai, Ryoichi; Fukui, Sadaharu; Kobayashi, Naoya; Sekiguchi, Junichi			Solution Structure of IseA, an Inhibitor Protein of DL-Endopeptidases from Bacillus subtilis, Reveals a Novel Fold with a Characteristic Inhibitory Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SEPARATION; ESCHERICHIA-COLI; HYDROLASE GENE; NMR; RECOGNITION; ENZYMES; COMPLEX; BINDING; DOMAIN; METABOLISM	In Bacillus subtilis, LytE, LytF, CwlS, and CwlO are vegetative autolysins, DL-endopeptidases in the NlpC/P60 family, and play essential roles in cell growth and separation. IseA (YoeB) is a proteinaceous inhibitor against the DL-endopeptidases, peptidoglycan hydrolases. Overexpression of IseA caused significantly long chained cell morphology, because IseA inhibits the cell separation DL-endopeptidases post-translationally. Here, we report the first three-dimensional structure of IseA, determined by NMR spectroscopy. The structure includes a single domain consisting of three alpha-helices, one 3(10)-helix, and eight beta-strands, which is a novel fold like a "hacksaw." Noteworthy is a dynamic loop between beta 4 and the 3(10)-helix, which resembles a "blade." The electrostatic potential distribution shows that most of the surface is positively charged, but the region around the loop is negatively charged. In contrast, the LytF active-site cleft is expected to be positively charged. NMR chemical shift perturbation of IseA interacting with LytF indicated that potential interaction sites are located around the loop. Furthermore, the IseA mutants D100K/D102K and G99P/G101P at the loop showed dramatic loss of inhibition activity against LytF, compared with wild-type IseA, indicating that the beta 4-3(10) loop plays an important role in inhibition. Moreover, we built a complex structure model of IseA-LytF by docking simulation, suggesting that the beta 4-3(10) loop of IseA gets stuck deep in the cleft of LytF, and the active site is occluded. These results suggest a novel inhibition mechanism of the hacksaw-like structure, which is different from known inhibitor proteins, through interactions around the characteristic loop regions with the active-site cleft of enzymes.	[Arai, Ryoichi; Fukui, Sadaharu; Kobayashi, Naoya; Sekiguchi, Junichi] Shinshu Univ, Fac Text Sci & Technol, Div Appl Biol, Ueda, Nagano 3868567, Japan; [Arai, Ryoichi] Shinshu Univ, Int Young Researchers Empowerment Ctr, Ueda, Nagano 3868567, Japan	Shinshu University; Shinshu University	Arai, R (corresponding author), Shinshu Univ, Fac Text Sci & Technol, Div Appl Biol, Ueda, Nagano 3868567, Japan.	rarai@shinshu-u.ac.jp; jsekigu@shinshu-u.ac.jp	Arai, Ryoichi/M-7804-2019	Kobayashi, Naoya/0000-0002-6599-1680; Arai, Ryoichi/0000-0001-5606-8483	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan;  [19380047];  [22248008];  [22113508];  [24113707];  [24780097]; Grants-in-Aid for Scientific Research [24780097] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research (KAKENHI) (B) 19380047 and (A) 22248008 (to J. S.), Grants-in-aid for Scientific Research on Innovative Areas 22113508 and 24113707 and for Young Scientists (B) 24780097, and Program for Dissemination of Tenure-Track System (to R. A.), funded by Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abergel C, 2007, P NATL ACAD SCI USA, V104, P6394, DOI 10.1073/pnas.0611019104; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; Bisicchia P, 2010, MOL MICROBIOL, V75, P972, DOI 10.1111/j.1365-2958.2009.07036.x; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Clarke CA, 2010, J BIOL CHEM, V285, P14843, DOI 10.1074/jbc.C110.120931; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Cushman I, 2004, J MOL BIOL, V344, P303, DOI 10.1016/j.jmb.2004.09.043; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Drenth J, 1971, Adv Protein Chem, V25, P79, DOI 10.1016/S0065-3233(08)60279-X; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fukushima T, 2006, J BACTERIOL, V188, P5541, DOI 10.1128/JB.00188-06; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hashimoto M, 2012, J BACTERIOL, V194, P796, DOI 10.1128/JB.05569-11; Hoelz A, 2003, MOL CELL, V11, P1241, DOI 10.1016/S1097-2765(03)00171-0; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ishikawa S, 1998, J BACTERIOL, V180, P2549, DOI 10.1128/JB.180.9.2549-2555.1998; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson ET, 2009, J BIOL CHEM, V284, P26839, DOI 10.1074/jbc.M109.003780; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Matsuda Takayoshi, 2006, Journal of Structural and Functional Genomics, V7, P93, DOI 10.1007/s10969-006-9012-1; Matsuda T, 2007, J BIOMOL NMR, V37, P225, DOI 10.1007/s10858-006-9127-5; Monchois V, 2001, J BIOL CHEM, V276, P18437, DOI 10.1074/jbc.M010297200; Motoyama T, 2002, ACTA CRYSTALLOGR D, V58, P148, DOI 10.1107/S0907444901017371; Ohnishi R, 1999, J BACTERIOL, V181, P3178, DOI 10.1128/JB.181.10.3178-3184.1999; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfeffer JM, 2012, BACTERIAL GLYCOMICS: CURRENT RESEARCH, TECHNOLOGY AND APPLICATIONS, P55; Pilgrim S, 2003, INFECT IMMUN, V71, P3473, DOI 10.1128/IAI.71.6.3473-3484.2003; Salzberg LI, 2007, J BACTERIOL, V189, P4671, DOI 10.1128/JB.00403-07; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Suzuki T, 2003, J BACTERIOL, V185, P2379, DOI 10.1128/JB.185.7.2379-2382.2003; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; VAKSER IA, 1994, PROTEINS, V20, P320, DOI 10.1002/prot.340200405; VAKSER IA, 1995, PROTEIN ENG, V8, P371, DOI 10.1093/protein/8.4.371; Wang SX, 2007, STRUCTURE, V15, P535, DOI 10.1016/j.str.2007.03.012; Wang SX, 2006, P NATL ACAD SCI USA, V103, P11503, DOI 10.1073/pnas.0600489103; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Xu QP, 2009, STRUCTURE, V17, P303, DOI 10.1016/j.str.2008.12.008; Yamaguchi H, 2004, J BIOSCI BIOENG, V98, P174, DOI 10.1263/jbb.98.174; Yamamoto H, 2008, MOL MICROBIOL, V70, P168, DOI 10.1111/j.1365-2958.2008.06398.x	61	10	10	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44736	44748		10.1074/jbc.M112.414763	http://dx.doi.org/10.1074/jbc.M112.414763			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23091053	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000312938600068
J	Khan, SH; Awasthi, S; Guo, CH; Goswami, D; Ling, J; Griffin, PR; Simons, SS; Kumar, R				Khan, Shagufta H.; Awasthi, Smita; Guo, Chunhua; Goswami, Devrishi; Ling, Jun; Griffin, Patrick R.; Simons, S. Stoney, Jr.; Kumar, Raj			Binding of the N-terminal Region of Coactivator TIF2 to theIntrinsically Disordered AF1 Domain of the Glucocorticoid Receptor Is Accompanied by Conformational Reorganizations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALF THYMUS DNA; TRANSCRIPTIONAL ACTIVITY; COREPRESSOR BINDING; HORMONE RECEPTORS; CHROMATIN ACCESSIBILITY; PROGESTERONE-RECEPTOR; ANTAGONIST COMPLEXES; INDUCTION PROPERTIES; SECONDARY STRUCTURE; INTRINSIC DISORDER	Control of gene transcription by glucocorticoid receptors (GRs) is important for many physiological processes. Like other steroid hormone receptors, the regulation of target genes by GR is mediated by two transactivation domains: activation function 1 (AF1) in the N-terminal domain and AF2 in the C-terminal ligand-binding domain (LBD). Full receptor activity requires both AF1 and -2 plus assorted coregulatory proteins. Crystal structures of the ligand-bound LBD have provided insight regarding how AF2 interacts with specific coactivators. However, despite its being the major activation domain of GRs, knowledge of AF1 structure/function has languished. This is mainly because of the highly disorganized structure of the GR N-terminal domain. This lack of AF1 structure is shared by all members of the steroid/nuclear receptor superfamily for which it has been examined and AF1 is thought to allow productive interactions with assorted cofactors via protein-induced changes in secondary/tertiary structures. To date, there are no reports of a classical coactivator altering the secondary/tertiary structure of the GR AF1 domain. Earlier, we reported an N-terminal fragment of the p160 coactivator TIF2, called TIF2.0, that binds the GR N-terminal domain and alters GR transcriptional activity. We therefore proposed that TIF2.0 binding to AF1 changes both its conformation and transcriptional activity. We now report that TIF2.0 interacts with the GR AF1 domain to increase the amount of alpha-helical structure in the complex. Furthermore, TIF2 coactivator activity is observed in the absence of the GR LBD in a manner that requires the AF1 domain. This contrasts with previous models where TIF2 receptor interaction domains binding to GR LBD somehow alter AF1 conformation. Our results establish for the first time that coactivators can modify the structure of the AF1 domain directly via the binding of a second region of the coactivator and suggest a molecular explanation for how coactivators increase the transcriptional activity of GR-agonist complexes.	[Khan, Shagufta H.; Ling, Jun; Kumar, Raj] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA 18509 USA; [Simons, S. Stoney, Jr.] NIDDK, Steroid Hormones Sect, LERB, NIH,CEB, Bethesda, MD 20892 USA; [Goswami, Devrishi; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	Geisinger Commonwealth School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Scripps Research Institute	Simons, SS (corresponding author), NIDDK, Steroid Hormones Sect, LERB, NIH,CEB, Bldg 10,Rm 8N-307B, Bethesda, MD 20892 USA.	stoneys@helix.nih.gov; rkumar@tcmedc.org	Guo, Chunhua/N-2586-2014	Awasthi, Smita/0000-0002-2065-5800	National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK047041, ZIADK057800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health Intramural Research Program of the NIDDK (to S. S. S., Jr.).	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Babu MM, 2012, SCIENCE, V337, P1460, DOI 10.1126/science.1228775; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Baskakov IV, 1999, J BIOL CHEM, V274, P10693, DOI 10.1074/jbc.274.16.10693; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Busby SA, 2007, INT J MASS SPECTROM, V259, P130, DOI 10.1016/j.ijms.2006.08.006; CAVANAUGH AH, 1990, BIOCHEMISTRY-US, V29, P989, DOI 10.1021/bi00456a022; CAVANAUGH AH, 1990, BIOCHEMISTRY-US, V29, P996, DOI 10.1021/bi00456a023; Chalmers Michael J, 2007, J Biomol Tech, V18, P194; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Cho SY, 2005, MOL ENDOCRINOL, V19, P290, DOI 10.1210/me.2004-0134; Chrousos George P, 2005, Sci STKE, V2005, ppe48, DOI 10.1126/stke.3042005pe48; Copik AJ, 2006, MOL ENDOCRINOL, V20, P1218, DOI 10.1210/me.2005-0257; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2010, CURR OPIN PHARMACOL, V10, P782, DOI 10.1016/j.coph.2010.09.005; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Garza AMS, 2010, MOL CELL BIOL, V30, P220, DOI 10.1128/MCB.00552-09; Garza AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025875; He YZ, 2002, J BIOL CHEM, V277, P49256, DOI 10.1074/jbc.M205536200; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hill KK, 2009, J BIOL CHEM, V284, P24415, DOI 10.1074/jbc.M109.003244; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; KHAN SH, 2009, J BIOPHYS; Khan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021939; Kino T, 2007, MOL ENDOCRINOL, V21, P1552, DOI 10.1210/me.2006-0345; Kumar R, 2007, ARCH BIOCHEM BIOPHYS, V465, P452, DOI 10.1016/j.abb.2007.06.019; Kumar R, 1999, J BIOL CHEM, V274, P24737, DOI 10.1074/jbc.274.35.24737; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101; Kumar R, 2001, J BIOL CHEM, V276, P18146, DOI 10.1074/jbc.M100825200; Kumar R, 2012, ENDOCR REV, V33, P271, DOI 10.1210/er.2011-1033; Kumar R, 2009, STEROIDS, V74, P877, DOI 10.1016/j.steroids.2009.07.012; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; LEACH KL, 1979, J BIOL CHEM, V254, P1884; Lee GS, 2011, BIOCHEMISTRY-US, V50, P356, DOI 10.1021/bi101792d; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Minezaki Y, 2006, J MOL BIOL, V359, P1137, DOI 10.1016/j.jmb.2006.04.016; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Nilsson J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r65; Norris JD, 1998, J BIOL CHEM, V273, P6679, DOI 10.1074/jbc.273.12.6679; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; PRATT WB, 1993, J BIOL CHEM, V268, P21455; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Simons SS, 2010, CURR OPIN PHARMACOL, V10, P613, DOI 10.1016/j.coph.2010.08.001; Tao YG, 2008, BIOCHEMISTRY-US, V47, P7648, DOI 10.1021/bi800472w; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Walsh I, 2011, NUCLEIC ACIDS RES, V39, pW190, DOI 10.1093/nar/gkr411; Wang DQ, 2007, BIOCHEMISTRY-US, V46, P8036, DOI 10.1021/bi7004575; Wang DQ, 2005, MOL ENDOCRINOL, V19, P1483, DOI 10.1210/me.2005-0012; Wang Q, 2004, MOL ENDOCRINOL, V18, P1376, DOI 10.1210/me.2003-0421; Wardell SE, 2005, MOL CELL BIOL, V25, P8792, DOI 10.1128/MCB.25.20.8792-8808.2005; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; York B, 2010, J BIOL CHEM, V285, P38743, DOI 10.1074/jbc.R110.193367	71	33	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44546	44560		10.1074/jbc.M112.411330	http://dx.doi.org/10.1074/jbc.M112.411330			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23132854	Green Published, hybrid			2022-12-28	WOS:000312938600051
J	Miller, C; Matic, I; Maier, KC; Schwalb, B; Roether, S; Strasser, K; Tresch, A; Mann, M; Cramer, P				Miller, Christian; Matic, Ivan; Maier, Kerstin C.; Schwalb, Bjoern; Roether, Susanne; Straesser, Katja; Tresch, Achim; Mann, Matthias; Cramer, Patrick			Mediator Phosphorylation Prevents Stress Response Transcription During Non-stress Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II TRANSCRIPTION; MESSENGER-RNA STABILITY; GENE-EXPRESSION; IN-VIVO; MULTISTRESS RESPONSE; FUNCTIONAL-ANALYSIS; GLOBAL ANALYSIS; OSMOTIC-STRESS; CELL-CULTURE; AMINO-ACIDS	The multiprotein complex Mediator is a coactivator of RNA polymerase (Pol) II transcription that is required for the regulated expression of protein-coding genes. Mediator serves as an end point of signaling pathways and regulates Pol II transcription, but the mechanisms it uses are not well understood. Here, we used mass spectrometry and dynamic transcriptome analysis to investigate a functional role of Mediator phosphorylation in gene expression. Affinity purification and mass spectrometry revealed that Mediator from the yeast Saccharomyces cerevisiae is phosphorylated at multiple sites of 17 of its 25 subunits. Mediator phosphorylation levels change upon an external stimulus set by exposure of cells to high salt concentrations. Phosphorylated sites in the Mediator tail subunit Med15 are required for suppression of stress-induced changes in gene expression under non-stress conditions. Thus dynamic and differential Mediator phosphorylation contributes to gene regulation in eukaryotic cells.	[Miller, Christian; Maier, Kerstin C.; Schwalb, Bjoern; Roether, Susanne; Straesser, Katja; Tresch, Achim; Cramer, Patrick] Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; [Miller, Christian; Maier, Kerstin C.; Schwalb, Bjoern; Roether, Susanne; Straesser, Katja; Tresch, Achim; Cramer, Patrick] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biochem, D-81377 Munich, Germany; [Matic, Ivan; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany	University of Munich; University of Munich; Max Planck Society	Mann, M (corresponding author), Max Planck Inst Biochem, Dept Prote & Signal Transduct, Klopferspitz 18, D-82152 Martinsried, Germany.	mmann@biochem.mpg.de	Matic, Ivan/HFZ-7772-2022; Matic, Ivan/F-7284-2010; Mann, Matthias/A-3454-2013	Matic, Ivan/0000-0003-0170-7991; Matic, Ivan/0000-0003-0170-7991; Mann, Matthias/0000-0003-1292-4799; Strasser, Katja/0000-0003-3533-5516; Miller, Christian/0000-0002-7918-6869; Schwalb, Bjorn/0000-0003-2987-2622	Mann and Cramer laboratories; Center for Integrated Protein Science Munich; LMUexcellent; European Research Council; Deutsche Forschungsgemeinschaft [SFB646, TR5, FOR1068]; Nanosystems Initiative Munich; Jung-Stiftung; Vallee Foundation	Mann and Cramer laboratories; Center for Integrated Protein Science Munich; LMUexcellent; European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Nanosystems Initiative Munich; Jung-Stiftung; Vallee Foundation	This work was supported in part by the Mann and Cramer laboratories, which are supported by the Center for Integrated Protein Science Munich.; Supported by an LMUexcellent research professorship.; Supported by SFB646 and European Research Council.; Supported by the Deutsche Forschungsgemeinschaft, SFB646, TR5, FOR1068, Nanosystems Initiative Munich, the Jung-Stiftung, and the Vallee Foundation. To whom correspondence may be addressed.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Alexander MR, 2001, MOL BIOL CELL, V12, P53, DOI 10.1091/mbc.12.1.53; Ansari SA, 2012, EMBO J, V31, P44, DOI 10.1038/emboj.2011.362; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Backstrom S, 2007, MOL CELL, V26, P717, DOI 10.1016/j.molcel.2007.05.007; Barik D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.55; Bauer S, 2011, BIOINFORMATICS, V27, P1882, DOI 10.1093/bioinformatics/btr296; Belakavadi M, 2008, MOL CELL BIOL, V28, P3932, DOI 10.1128/MCB.02191-07; Berti L, 2001, GENOMICS, V74, P320, DOI 10.1006/geno.2001.6566; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Brzovic PS, 2011, MOL CELL, V44, P942, DOI 10.1016/j.molcel.2011.11.008; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chang YW, 2004, MOL CELL, V15, P107, DOI 10.1016/j.molcel.2004.05.021; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Enjalbert B, 2004, MOL GENET GENOMICS, V271, P697, DOI 10.1007/s00438-004-1014-8; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Guidi BW, 2004, J BIOL CHEM, V279, P29114, DOI 10.1074/jbc.M404426200; Hallberg M, 2004, P NATL ACAD SCI USA, V101, P3370, DOI 10.1073/pnas.0400221101; Herbig E, 2010, MOL CELL BIOL, V30, P2376, DOI 10.1128/MCB.01046-09; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Hirata Y, 2003, MOL BIOL CELL, V14, P302, DOI 10.1091/mbc.E02-05-0247; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jedidi I, 2010, J BIOL CHEM, V285, P2438, DOI 10.1074/jbc.M109.071589; Jeong CJ, 2001, BIOCHEMISTRY-US, V40, P9421, DOI 10.1021/bi010011k; KELLEHER RJ, 1990, CELL, V61, P1209, DOI 10.1016/0092-8674(90)90685-8; Kobayashi N, 1996, BIOCHEM BIOPH RES CO, V229, P540, DOI 10.1006/bbrc.1996.1840; Koivomagi M, 2011, NATURE, V480, P128, DOI 10.1038/nature10560; Lallet S, 2006, MOL MICROBIOL, V62, P438, DOI 10.1111/j.1365-2958.2006.05363.x; Lariviere L, 2008, GENE DEV, V22, P872, DOI 10.1101/gad.465108; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Macek B, 2009, ANNU REV PHARMACOL, V49, P199, DOI 10.1146/annurev.pharmtox.011008.145606; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Melamed D, 2008, RNA, V14, P1337, DOI 10.1261/rna.864908; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Molin C, 2009, RNA, V15, P600, DOI 10.1261/rna.1403509; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Murray DB, 2011, BBA-GEN SUBJECTS, V1810, P945, DOI 10.1016/j.bbagen.2011.04.005; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Park JM, 2000, MOL CELL BIOL, V20, P8709, DOI 10.1128/MCB.20.23.8709-8719.2000; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sadeh A, 2012, J CELL SCI, V125, P3333, DOI 10.1242/jcs.096446; Seizl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027595; SIKORSKI RS, 1989, GENETICS, V122, P19; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Spaeth JM, 2011, SEMIN CELL DEV BIOL, V22, P776, DOI 10.1016/j.semcdb.2011.07.024; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Thakur JK, 2009, J BIOL CHEM, V284, P4422, DOI 10.1074/jbc.M808263200; Thomson M, 2009, NATURE, V460, P274, DOI 10.1038/nature08102; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; Treger JM, 1998, BIOCHEM BIOPH RES CO, V243, P13, DOI 10.1006/bbrc.1997.8061; Unnikrishnan I, 2003, J BIOL CHEM, V278, P26450, DOI 10.1074/jbc.M211808200; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Wang W, 2009, DEV CELL, V16, P764, DOI 10.1016/j.devcel.2009.04.006; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Zahringer H, 2000, MOL MICROBIOL, V35, P397, DOI 10.1046/j.1365-2958.2000.01706.x	85	26	26	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44017	44026		10.1074/jbc.M112.430140	http://dx.doi.org/10.1074/jbc.M112.430140			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23135281	hybrid, Green Published			2022-12-28	WOS:000312938600001
J	Garnier, D; Magnus, N; Lee, TH; Bentley, V; Meehan, B; Milsom, C; Montermini, L; Kislinger, T; Rak, J				Garnier, Delphine; Magnus, Nathalie; Lee, Tae Hoon; Bentley, Victoria; Meehan, Brian; Milsom, Chloe; Montermini, Laura; Kislinger, Thomas; Rak, Janusz			Cancer Cells Induced to Express Mesenchymal Phenotype Release Exosome-like Extracellular Vesicles Carrying Tissue Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR-BEARING MICROPARTICLES; E-CADHERIN; TUMOR PROGRESSION; MICROVESICLES; GLIOBLASTOMA; ANGIOGENESIS; COAGULATION; THROMBOSIS; DISEASE	Aggressive epithelial cancer cells frequently adopt mesenchymal characteristics and exhibit aberrant interactions with their surroundings, including the vasculature. Whether the release/uptake of extracellular vesicles (EVs) plays a role during these processes has not been studied. EVs are heterogeneous membrane structures that originate either at the surface (microparticles), or within (exosomes) activated or transformed cells, and are involved in intercellular trafficking of bioactive molecules. Here, we show that epithelial cancer cells (A431, DLD-1) adopt mesenchymal features (epithelial-to-mesenchymal transition-like state) upon activation of epidermal growth factor receptor (EGFR) coupled with blockade of E-cadherin. This treatment leads to a coordinated loss of EGFR and tissue factor (TF) from the plasma membrane and coincides with a surge in emission of small, exosome-like EVs containing both receptors. TF (but not EGFR) is selectively up-regulated in EVs produced by mesenchymal-like cancer cells and can be transferred to cultured endothelial cells rendering them highly procoagulant. We postulate that epithelial-to-mesenchymal transition-like changes may alter cancer cell interactions with the vascular systems through altered vesiculation and TF shedding.	[Rak, Janusz] McGill Univ, Montreal Childrens Hosp, Res Inst, RI MUHC, Montreal, PQ H3Z 2Z3, Canada; [Milsom, Chloe] Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Kislinger, Thomas] Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	McGill University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Rak, J (corresponding author), McGill Univ, Montreal Childrens Hosp, Res Inst, RI MUHC, Pl Toulon,4060 Ste,PT 232, Montreal, PQ H3Z 2Z3, Canada.	janusz.rak@mcgill.ca	Kislinger, Thomas/A-5934-2008	Lee, Tae Hoon/0000-0002-4195-1174; Garnier, Delphine/0000-0002-5744-5612; Kislinger, Thomas/0000-0003-3525-5540	Canadian Institutes of Health Research [MOP-102736, MOP 111119]; Foundation of Stars/Montreal Children's Hospital Foundation (MCHF); Fonds de recherche en sante du Quebec (FRSQ); Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Foundation of Stars/Montreal Children's Hospital Foundation (MCHF); Fonds de recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Operating Grants MOP-102736 and MOP 111119 (to J.R.). Infrastructure support was provided by Fonds de recherche en sante du Quebec. Postdoctoral awards were funded by Thelma Adams Award Program from the Foundation of Stars/Montreal Children's Hospital Foundation (MCHF) and Canadian Institutes of Health Research (to D. G. and C. M., respectively).; Recipient of a doctoral studentship from Fonds de recherche en sante du Quebec (FRSQ).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Bogdanov VY, 2003, NAT MED, V9, P458, DOI 10.1038/nm841; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Contrino J, 1996, NAT MED, V2, P209, DOI 10.1038/nm0296-209; Dahl KDC, 2008, CANCER RES, V68, P4606, DOI 10.1158/0008-5472.CAN-07-5046; Davila M, 2008, J THROMB HAEMOST, V6, P1517, DOI 10.1111/j.1538-7836.2008.02987.x; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Falanga A, 2005, SEMIN THROMB HEMOST, V31, P104, DOI 10.1055/s-2005-863812; Hansen CB, 2001, BLOOD, V97, P1712, DOI 10.1182/blood.V97.6.1712; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Horowitz NA, 2011, BLOOD, V118, P2889, DOI 10.1182/blood-2011-03-341222; Lacroix R, 2012, J THROMB HAEMOST, V10, P437, DOI 10.1111/j.1538-7836.2011.04610.x; Magnus N, 2010, BLOOD, V116, P815, DOI 10.1182/blood-2009-10-250639; Mandal SK, 2007, BLOOD, V110, P161, DOI 10.1182/blood-2006-10-050476; Mandal SK, 2006, BLOOD, V107, P4746, DOI 10.1182/blood-2005-11-4674; Milsom CC, 2008, CANCER RES, V68, P10068, DOI 10.1158/0008-5472.CAN-08-2067; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Rak J., 2009, CANC GENOME TUMOR MI, P150; Rak J, 2012, BIOESSAYS, V34, P489, DOI 10.1002/bies.201100169; Rickles FR, 2006, PATHOPHYSIOL HAEMO T, V35, P103, DOI 10.1159/000093551; Rong Y, 2009, CANCER RES, V69, P2540, DOI 10.1158/0008-5472.CAN-08-1547; Ruf W, 2011, J THROMB HAEMOST, V9, P306, DOI 10.1111/j.1538-7836.2011.04318.x; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Taylor P, 2009, J PROTEOME RES, V8, P1610, DOI 10.1021/pr800986c; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Hinsbergh VWM, 2012, SEMIN IMMUNOPATHOL, V34, P93, DOI 10.1007/s00281-011-0285-5; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Wang JG, 2012, BLOOD, V119, P5543, DOI 10.1182/blood-2012-01-402156; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Yu JL, 2005, BLOOD, V105, P1734, DOI 10.1182/blood-2004-05-2042; Yu J, 2008, ARTERIOSCL THROM VAS, V28, P1975, DOI 10.1161/ATVBAHA.108.175083; Zuo JH, 2011, J CELL BIOCHEM, V112, P2508, DOI 10.1002/jcb.23175; Zwicker JI, 2011, ARTERIOSCL THROM VAS, V31, P728, DOI 10.1161/ATVBAHA.109.200964; Zwicker JI, 2010, THROMB RES, V125, pS89, DOI 10.1016/S0049-3848(10)70022-0	45	112	113	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43565	43572		10.1074/jbc.M112.401760	http://dx.doi.org/10.1074/jbc.M112.401760			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118232	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000312940800037
J	Valentine, CD; Lukacs, GL; Verkman, AS; Haggie, PM				Valentine, Cathleen D.; Lukacs, Gergely L.; Verkman, Alan S.; Haggie, Peter M.			Reduced PDZ Interactions of Rescued Delta F508CFTR Increases Its Cell Surface Mobility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE-CONDUCTANCE-REGULATOR; PROTEIN-QUALITY CONTROL; CYSTIC-FIBROSIS; PLASMA-MEMBRANE; CFTR; EXPRESSION; DEGRADATION; DIFFUSION; DOMAIN; RECEPTORS	Deletion of phenylalanine 508 (Delta F508) in the cystic fibrosis transmembrane conductance regulator (CFTR) plasma membrane chloride channel is the most common cause of cystic fibrosis (CF). Though several maneuvers can rescue endoplasmic reticulum-retained Delta F508CFTR and promote its trafficking to the plasma membrane, rescued Delta F508CFTR remains susceptible to quality control mechanisms that lead to accelerated endocytosis, ubiquitination, and lysosomal degradation. To investigate the role of scaffold protein interactions in rescued Delta F508CFTR surface instability, the plasma membrane mobility of Delta F508CFTR was measured in live cells by quantum dot single particle tracking. Following rescue by low temperature, chemical correctors, thapsigargin, or overexpression of GRASP55, Delta F508CFTR diffusion was more rapid than that of wild-type CFTR because of reduced interactions with PDZ domain-containing scaffold proteins. Knock-down of the plasma membrane quality control proteins CHIP and Hsc70 partially restored Delta F508CFTR-scaffold association. Quantitative comparisons of CFTR cell surface diffusion and endocytosis kinetics suggested an association between reduced scaffold binding and CFTR internalization. Our surface diffusion measurements in live cells indicate defective scaffold interactions of rescued Delta F508CFTR at the cell surface, which may contribute to its defective peripheral processing.	[Valentine, Cathleen D.; Verkman, Alan S.; Haggie, Peter M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Lukacs, Gergely L.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Lukacs, Gergely L.] McGill Univ, GRASP, Montreal, PQ H3G 1Y6, Canada	University of California System; University of California San Francisco; McGill University; McGill University	Haggie, PM (corresponding author), Univ Calif San Francisco, Dept Med, 1246 HSE,513 Parnassus Ave, San Francisco, CA 94143 USA.	peter.haggie@ucsf.edu		Lukacs, Gergely/0000-0003-0900-0675	National Institutes of Health [DK081355, DK075302, EB000415]; Cystic Fibrosis Foundation; Canadian Institute of Health Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072517, R01DK081355, R01DK075302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported, in whole or in part, by National Institutes of Health Grants DK081355 (to P. M. H.), DK075302 (to G. L. L.), EB000415 (to A. S. V.), a Research Development Program grant from the Cystic Fibrosis Foundation (to P. M. H. and A. S. V.), and a grant from the Canadian Institute of Health Research (to G. L. L.).	Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Benharouga M, 2001, J CELL BIOL, V153, P957, DOI 10.1083/jcb.153.5.957; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Crane JM, 2008, BIOPHYS J, V94, P702, DOI 10.1529/biophysj.107.115121; Cushing PR, 2010, ANGEW CHEM INT EDIT, V49, P9907, DOI 10.1002/anie.201005585; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; Favia M, 2010, MOL BIOL CELL, V21, P73, DOI 10.1091/mbc.E09-03-0185; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Guerra L, 2005, J BIOL CHEM, V280, P40925, DOI 10.1074/jbc.M505103200; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Haardt M, 1999, J BIOL CHEM, V274, P21873, DOI 10.1074/jbc.274.31.21873; Haggie PM, 2008, J BIOL CHEM, V283, P23510, DOI 10.1074/jbc.C800100200; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Jin S, 2007, BIOPHYS J, V93, P1079, DOI 10.1529/biophysj.106.102244; Kwon SH, 2007, CELL PHYSIOL BIOCHEM, V20, P763, DOI 10.1159/000110436; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Okiyoneda T, 2011, CURR OPIN CELL BIOL, V23, P483, DOI 10.1016/j.ceb.2011.04.012; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Owen DM, 2009, TRAFFIC, V10, P962, DOI 10.1111/j.1600-0854.2009.00908.x; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Phuan PW, 2011, MOL PHARMACOL, V80, P683, DOI 10.1124/mol.111.073056; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sainlos M, 2011, NAT CHEM BIOL, V7, P81, DOI 10.1038/NCHEMBIO.498; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Valentine CD, 2011, MOL BIOL CELL, V22, P2970, DOI 10.1091/mbc.E11-01-0034; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Varga K., 2008, BIOCHEM J, V15, P555; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wolde M, 2007, J BIOL CHEM, V282, P8099, DOI 10.1074/jbc.M611049200; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	43	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43630	43638		10.1074/jbc.M112.421172	http://dx.doi.org/10.1074/jbc.M112.421172			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115232	Green Published, hybrid			2022-12-28	WOS:000312940800043
J	Saikia, M; Krokowski, D; Guan, BJ; Ivanov, P; Parisien, M; Hu, GF; Anderson, P; Pan, T; Hatzoglou, M				Saikia, Mridusmita; Krokowski, Dawid; Guan, Bo-Jhih; Ivanov, Pavel; Parisien, Marc; Hu, Guo-fu; Anderson, Paul; Pan, Tao; Hatzoglou, Maria			Genome-wide Identification and Quantitative Analysis of Cleaved tRNA Fragments Induced by Cellular Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; TRANSLATION INITIATION; OSMOTIC-STRESS; ANGIOGENIN; KINASE; STARVATION; INHIBITOR; SURVIVAL; PHOSPHORYLATION; RIBONUCLEASE	Certain stress conditions can induce cleavage of tRNAs around the anticodon loop via the use of the ribonuclease angiogenin. The cellular factors that regulate tRNA cleavage are not well known. In this study we used normal and eIF2 alpha phosphorylation-deficient mouse embryonic fibroblasts and applied a microarray-based methodology to identify and compare tRNA cleavage patterns in response to hypertonic stress, oxidative stress (arsenite), and treatment with recombinant angiogenin. In all three scenarios mouse embryonic fibroblasts deficient in eIF2 alpha phosphorylation showed a higher accumulation of tRNA fragments including those derived from initiator-tRNA(Met). We have shown that tRNA cleavage is regulated by the availability of angiogenin, its substrate (tRNA), the levels of the angiogenin inhibitor RNH1, and the rates of protein synthesis. These conclusions are supported by the following findings: (i) exogenous treatment with angiogenin or knockdown of RNH1 increased tRNA cleavage; (ii) tRNA fragment accumulation was higher during oxidative stress than hypertonic stress, in agreement with a dramatic decrease of RNH1 levels during oxidative stress; and (iii) a positive correlation was observed between angiogenin-mediated tRNA cleavage and global protein synthesis rates. Identification of the stress-specific tRNA cleavage mechanisms and patterns will provide insights into the role of tRNA fragments in signaling pathways and stress-related disorders.	[Saikia, Mridusmita; Krokowski, Dawid; Guan, Bo-Jhih; Hatzoglou, Maria] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Ivanov, Pavel; Anderson, Paul] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Parisien, Marc; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Hu, Guo-fu] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Chicago; Tufts Medical Center	Saikia, M (corresponding author), Case Western Reserve Univ, Dept Nutr, 10900 Euclid Ave,RT 600H, Cleveland, OH 44106 USA.	mxs945@case.edu; mxh8@case.edu	Ivanov, Pavel/F-3339-2016	Ivanov, Pavel/0000-0002-7986-7760; Parisien, Marc/0000-0003-2924-5960; Saikia, Mridusmita/0000-0002-5848-3303	National Institutes of Health [DK060596, DK053307, DP1OD008169]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053307, R37DK060596, R01DK060596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065237] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD008169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants DK060596 and DK053307 (to M. H.) and DP1OD008169 (to T. P.).	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Bjork GR, 1995, TRNA STRUCTURE BIOSY, P165; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Chen JJ, 2000, COLD SPRING HARBOR M, V39, P529; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Dittmar KA, 2004, J MOL BIOL, V337, P31, DOI 10.1016/j.jmb.2004.01.024; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Giege R, 2008, NAT STRUCT MOL BIOL, V15, P1007, DOI 10.1038/nsmb.1498; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; HIGA T, 1981, TETRAHEDRON LETT, V22, P2777, DOI 10.1016/S0040-4039(01)90550-7; HIGA T, 1981, CHEM LETT, P1647, DOI 10.1246/cl.1981.1647; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jochl C, 2008, NUCLEIC ACIDS RES, V36, P2677, DOI 10.1093/nar/gkn123; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kishikawa H, 2008, EXPERT OPIN THER TAR, V12, P1229, DOI 10.1517/14728222.12.10.1229 ; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Krokowski D, 2011, CELL CYCLE, V10, P2691, DOI 10.4161/cc.10.16.16844; Kwon MS, 2009, PHYSIOLOGY, V24, P186, DOI 10.1152/physiol.00005.2009; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee SH, 2010, J BIOL CHEM, V285, P41280, DOI 10.1074/jbc.M110.182188; Lee SR, 2005, J BIOL CHEM, V280, P42744, DOI 10.1074/jbc.M510356200; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; LEVITZ R, 1990, EMBO J, V9, P1383, DOI 10.1002/j.1460-2075.1990.tb08253.x; Li SP, 2012, J CELL PHYSIOL, V227, P2822, DOI 10.1002/jcp.23051; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Luo Lihui, 2005, Eye Contact Lens, V31, P186, DOI 10.1097/01.ICL.0000162759.79740.46; Majumder M, 2012, MOL CELL BIOL, V32, P992, DOI 10.1128/MCB.06665-11; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Naddeo N, 2005, FEBS LETT, V579, P2663, DOI 10.1016/j.febslet.2005.03.087; NEGRUTSKII BS, 1991, P NATL ACAD SCI USA, V88, P4991, DOI 10.1073/pnas.88.11.4991; NEGRUTSKII BS, 1994, P NATL ACAD SCI USA, V91, P964, DOI 10.1073/pnas.91.3.964; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Ron D, 2000, COLD SPRING HARBOR M, V39, P547; Saikia M, 2010, RNA, V16, P1317, DOI 10.1261/rna.2057810; SAXENA SK, 1992, J BIOL CHEM, V267, P21982; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schwartz L, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-21; SHAPIRO R, 1987, P NATL ACAD SCI USA, V84, P2238, DOI 10.1073/pnas.84.8.2238; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; STAPULIONIS R, 1995, P NATL ACAD SCI USA, V92, P7158, DOI 10.1073/pnas.92.16.7158; Stohrer M, 2000, CANCER RES, V60, P4251; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; van Es MA, 2011, ANN NEUROL, V70, P964, DOI 10.1002/ana.22611; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877; Zhang SD, 2009, PLANT PHYSIOL, V150, P378, DOI 10.1104/pp.108.134767	70	143	149	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42708	42725		10.1074/jbc.M112.371799	http://dx.doi.org/10.1074/jbc.M112.371799			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23086926	Green Published, hybrid			2022-12-28	WOS:000312501600031
J	Ding, WX; Guo, FL; Ni, HM; Bockus, A; Manley, S; Stolz, DB; Eskelinen, EL; Jaeschke, H; Yin, XM				Ding, Wen-Xing; Guo, Fengli; Ni, Hong-Min; Bockus, Abigail; Manley, Sharon; Stolz, Donna B.; Eskelinen, Eeva-Liisa; Jaeschke, Hartmut; Yin, Xiao-Ming			Parkin and Mitofusins Reciprocally Regulate Mitophagy and Mitochondrial Spheroid Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; CELL-DEATH; CASPASE ACTIVATION; OXIDATIVE STRESS; AUTOPHAGY; DISEASE; FUSION; LIVER; FRAGMENTATION; DEGRADATION	Mitochondrial homeostasis via mitochondrial dynamics and quality control is crucial to normal cellular functions. Mitophagy (mitochondria removed by autophagy) stimulated by a mitochondrial uncoupler, carbonyl cyanide m-chlorophenylhydrazone (CCCP), requires Parkin, but it is not clear why Parkin is crucial to this process. We found that in the absence of Parkin, carbonyl cyanide m-chlorophenylhydrazone induced the formation of mitochondrial spheroids. Mitochondrial spheroid formation is also induced in vivo in the liver by acetaminophen overdose, a condition causing severe oxidative mitochondrial damages and liver injury. Mitochondrial spheroids could undergo a maturation process by interactions with acidic compartments. The formation of this new structure required reactive oxygen species and mitofusins. Parkin suppressed these mitochondrial dynamics by promoting mitofusin degradation. Consistently, genetic deletion of mitofusins without concomitant expression of Parkin was sufficient to prevent mitochondrial spheroid formation and resumed mitophagy. Mitochondrial spheroid formation and mitophagy could represent different strategies of mitochondrial homeostatic response to oxidative stress and are reciprocally regulated by mitofusins and Parkin.	[Ding, Wen-Xing; Ni, Hong-Min; Bockus, Abigail; Manley, Sharon; Jaeschke, Hartmut] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Guo, Fengli] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Stolz, Donna B.] Univ Pittsburgh, Dept Cell Biol & Physiol, Sch Med, Pittsburgh, PA 15261 USA; [Eskelinen, Eeva-Liisa] Univ Helsinki, Div Biochem & Biotechnol, Dept Biosci, FIN-00014 Helsinki, Finland; [Yin, Xiao-Ming] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA	University of Kansas; University of Kansas Medical Center; Stowers Institute for Medical Research; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Helsinki; Indiana University System; Indiana University Bloomington	Ding, WX (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, MS 1018,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	wxding@kumc.edu; xmyin@iupui.edu	Jaeschke, Hartmut/J-6285-2013; Eskelinen, Eeva-Liisa/AAF-3496-2019	Eskelinen, Eeva-Liisa/0000-0003-0006-7785; Manley, Sharon/0000-0002-2411-9706	National Institutes of Health [R01 AA020518-01, R21AA017421, P20 RR021940, P20 RR016475, R01CA111456, R01CA83817]; NATIONAL CANCER INSTITUTE [R01CA083817, R01CA111456] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940, P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103529, P20GM103418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA020518, R01AA020518, R21AA017421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AA020518-01, R21AA017421, P20 RR021940, and P20 RR016475 (to W.X.D.) and R01CA111456 and R01CA83817 (to X.M.Y.).	Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; CHRISTENSEN AK, 1959, EXP CELL RES, V18, P576, DOI 10.1016/0014-4827(59)90323-4; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Ding WX, 2012, J BIOL CHEM, V287, P42373, DOI 10.1074/jbc.M112.413674; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Izeradjene K, 2005, CANCER RES, V65, P7436, DOI 10.1158/0008-5472.CAN-04-2628; Jaeschke H, 2011, LIFE SCI, V88, P737, DOI 10.1016/j.lfs.2011.01.025; Kanki T, 2010, MOL MICROBIOL, V75, P795, DOI 10.1111/j.1365-2958.2009.07035.x; KIESSLING KH, 1964, EXP CELL RES, V33, P350, DOI 10.1016/S0014-4827(64)81040-5; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; LAUBER JK, 1983, CURR EYE RES, V2, P855, DOI 10.3109/02713688209020022; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Liot G, 2009, CELL DEATH DIFFER, V16, P899, DOI 10.1038/cdd.2009.22; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Pletjushkina OY, 2006, BBA-BIOENERGETICS, V1757, P518, DOI 10.1016/j.bbabio.2006.03.018; Ricci JE, 2003, CELL DEATH DIFFER, V10, P488, DOI 10.1038/sj.cdd.4401225; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Scheffler I.E., 1999, MITOCHONDRIA, p[15, 145]; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; STEPHENS RJ, 1965, J CELL BIOL, V24, P500, DOI 10.1083/jcb.24.3.500; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tian CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005546; Tolkovsky AM, 2009, BBA-MOL CELL RES, V1793, P1508, DOI 10.1016/j.bbamcr.2009.03.002; Tujios S, 2011, NAT REV GASTRO HEPAT, V8, P202, DOI 10.1038/nrgastro.2011.22; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	41	94	97	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42379	42388		10.1074/jbc.M112.413682	http://dx.doi.org/10.1074/jbc.M112.413682			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23095748	Green Published, hybrid			2022-12-28	WOS:000312103000073
J	Kotiguda, GG; Weinberg, D; Dessau, M; Salvi, C; Serino, G; Chamovitz, DA; Hirsch, JA				Kotiguda, Giri Gowda; Weinberg, Dahlia; Dessau, Moshe; Salvi, Chiara; Serino, Giovanna; Chamovitz, Daniel A.; Hirsch, Joel A.			The Organization of a CSN5-containing Subcomplex of the COP9 Signalosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS COP9; CELL-CYCLE; SUBUNIT INTERACTION; 26S PROTEASOME; LIGHT CONTROL; PCI DOMAIN; COMPLEX; ARCHITECTURE; PROTEIN; GENE	The COP9 signalosome (CSN) is an evolutionarily conserved multi-protein complex that interfaces with the ubiquitin-proteasome pathway and plays critical developmental roles in both animals and plants. Although some subunits are present only in an similar to 320-kDa complex-dependent form, other subunits are also detected in configurations distinct from the 8-subunit holocomplex. To date, the only known biochemical activity intrinsic to the complex, deneddylation of the Cullin subunits from Cullin-RING ubiquitin ligases, is assigned to CSN5. As an essential step to understanding the structure and assembly of a CSN5-containing subcomplex of the CSN, we reconstituted a CSN4-5-6-7 subcomplex. The core of the subcomplex is based on a stable heterotrimeric association of CSN7, CSN4, and CSN6, requiring coexpression in a bacterial reconstitution system. To this heterotrimer, we could then add CSN5 in vitro to reconstitute a quaternary complex. Using biochemical and biophysical methods, we identified pairwise and combinatorial interactions necessary for the formation of the CSN4-5-6-7 subcomplex. The subcomplex is stabilized by three types of interactions: MPN-MPN between CSN5 and CSN6, PCI-PCI between CSN4 and CSN7, and interactions mediated through the CSN6 C terminus with CSN4 and CSN7. CSN8 was also found to interact with the CSN4-6-7 core. These data provide a strong framework for further investigation of the organization and assembly of this pivotal regulatory complex.	[Kotiguda, Giri Gowda; Weinberg, Dahlia; Chamovitz, Daniel A.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Biol & Ecol Plants, IL-69978 Ramat Aviv, Israel; [Dessau, Moshe; Hirsch, Joel A.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Ramat Aviv, Israel; [Kotiguda, Giri Gowda; Dessau, Moshe; Hirsch, Joel A.] Tel Aviv Univ, George S Wise Fac Life Sci, Inst Biol Struct, IL-69978 Ramat Aviv, Israel; [Salvi, Chiara; Serino, Giovanna] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol, Rome, Italy; [Serino, Giovanna] New York Bot Garden, Bronx, NY 10458 USA	Tel Aviv University; Tel Aviv University; Tel Aviv University; Sapienza University Rome; New York Botanical Garden	Chamovitz, DA (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Biol & Ecol Plants, IL-69978 Ramat Aviv, Israel.	dannyc@tauex.tau.ac.il; jhirsch@post.tau.ac.il	Chamovitz, Daniel/S-5021-2019; Serino, Giovanna/W-4683-2019; Hirsch, Joel/AAC-8000-2021	Chamovitz, Daniel/0000-0002-2815-2909; Serino, Giovanna/0000-0001-8689-6132; Hirsch, Joel/0000-0001-7544-8668	Israel Science Foundation [145/09]; Sapienza University [C26F09JTKN]; Manna Center for Plant Biosciences (Tel Aviv University)	Israel Science Foundation(Israel Science Foundation); Sapienza University; Manna Center for Plant Biosciences (Tel Aviv University)	This work was funded by a grant (145/09) from the Israel Science Foundation (to D. A. C.) and a 2009 Research Grant (Project C26F09JTKN) from Sapienza University (to G. S.).; Recipient of a George S. Wise post-doctoral fellowship and support from the Manna Center for Plant Biosciences (Tel Aviv University).	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Deng XW, 2000, TRENDS GENET, V16, P202, DOI 10.1016/S0168-9525(00)01982-X; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Dessau M, 2008, PLANT CELL, V20, P2815, DOI 10.1105/tpc.107.053801; Dohmann EMN, 2005, PLANT CELL, V17, P1967, DOI 10.1105/tpc.105.032870; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fu HY, 2001, EMBO J, V20, P7096, DOI 10.1093/emboj/20.24.7096; Fukumoto A, 2005, FEBS LETT, V579, P1047, DOI 10.1016/j.febslet.2004.12.076; Golemis E A, 1997, Methods Mol Biol, V63, P197; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; Halimi Y, 2011, PLANT MOL BIOL, V77, P77, DOI 10.1007/s11103-011-9795-8; Harari-Steinberg O, 2004, CURR PROTEIN PEPT SC, V5, P185, DOI 10.2174/1389203043379792; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Kapelari B, 2000, J MOL BIOL, V300, P1169, DOI 10.1006/jmbi.2000.3912; Karniol B, 1999, PLANT CELL, V11, P839, DOI 10.1105/tpc.11.5.839; Kwok SF, 1998, PLANT CELL, V10, P1779, DOI 10.1105/tpc.10.11.1779; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Mundt KE, 2002, MOL BIOL CELL, V13, P493, DOI 10.1091/mbc.01-10-0521; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; Oron E, 2002, DEVELOPMENT, V129, P4399; Oron E, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100150; Peng ZH, 2001, DEVELOPMENT, V128, P4277; Pick E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043980; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; Scheel H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-71; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Serino G, 1999, PLANT CELL, V11, P1967, DOI 10.1105/tpc.11.10.1967; Serino G, 2003, PLANT CELL, V15, P719, DOI 10.1105/tpc.009092; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Tomoda K, 2005, BLOOD, V105, P775, DOI 10.1182/blood-2004-04-1242; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; Tsuge T, 2001, J MOL BIOL, V305, P1, DOI 10.1006/jmbi.2000.4288; Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004	45	24	28	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42031	42041		10.1074/jbc.M112.387977	http://dx.doi.org/10.1074/jbc.M112.387977			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086934	Green Published, hybrid			2022-12-28	WOS:000312103000042
J	Thompson, CH; Porter, JC; Kahlig, KM; Daniels, MA; George, AL				Thompson, Christopher H.; Porter, J. Christopher; Kahlig, Kristopher M.; Daniels, Melissa A.; George, Alfred L., Jr.			Nontruncating SCN1A Mutations Associated with Severe Myoclonic Epilepsy of Infancy Impair Cell Surface Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED SODIUM-CHANNELS; LONG QT SYNDROME; CYSTIC-FIBROSIS; MOLECULAR-BASIS; SEIZURES; TRAFFICKING; RESCUE; INTERNEURONS; DYSFUNCTION; DISORDERS	Mutations in SCN1A, encoding the voltage-gated sodium channel Na(V)1.1, are the most common cause of severe myoclonic epilepsy of infancy (SMEI) or Dravet syndrome. SMEI is most often associated with premature truncations of Na(V)1.1 that cause loss of function, but nontruncating mutations also occur. We hypothesized that some nontruncating mutations might impair trafficking of NaV1.1 to the plasma membrane. Here we demonstrated that seven nontruncating missense or in-frame deletion mutations (L986F, delF1289, R1648C, F1661S, G1674R, and G1979E) exhibited reduced cell surface expression relative to wild type (WT) Na(V)1.1 consistent with impaired trafficking. We tested whether two commonly prescribed antiepileptic drugs (phenytoin, lamotrigine), as well as the cystic fibrosis transmembrane conductance regulator (CFTR) trafficking corrector VRT-325, could rescue cell surface and functional expression of two representative Na(V)1.1 mutants (R1648C, G1674R). Treatment of cells with phenytoin increased cell surface expression of WT-Na(V)1.1 and both mutant channels, whereas lamotrigine only increased surface expression of R1648C. VRT-325 did not alter surface expression of WT-Na(V)1.1 or mutant channels. Although phenytoin increased surface expression of G1674R, channel function was not restored, suggesting that this mutation also causes an intrinsic loss of function. Both phenytoin and lamotrigine increased functional expression of R1648C, but lamotrigine also increased persistent sodium current evoked by this mutation. Our findings indicate that certain nontruncating SCN1A mutations associated with SMEI have impaired cell surface expression and that some alleles may be amenable to pharmacological rescue of this defect. However, rescue of dysfunctional Na(V)1.1 channels to the plasma membrane could contribute to exacerbating rather than ameliorating the disease.	[Thompson, Christopher H.; Porter, J. Christopher; Daniels, Melissa A.; George, Alfred L., Jr.] Vanderbilt Univ, Div Genet Med, Dept Med, Nashville, TN 37232 USA; [Kahlig, Kristopher M.; George, Alfred L., Jr.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	George, AL (corresponding author), Vanderbilt Univ, Div Genet Med, Dept Med, 2215 Garland Ave,529 Light Hall, Nashville, TN 37232 USA.	al.george@vanderbilt.edu	Porter, Joanna/C-7162-2009	Porter, Joanna/0000-0002-7307-169X	National Institutes of Health [NS032387]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032387, R37NS032387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS032387 (to A. L. G.).	Becq F, 2011, J CYST FIBROS, V10, pS129, DOI 10.1016/S1569-1993(11)60018-0; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Ficker E, 2002, J BIOL CHEM, V277, P4989, DOI 10.1074/jbc.M107345200; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Guerrini R, 1998, EPILEPSIA, V39, P508, DOI 10.1111/j.1528-1157.1998.tb01413.x; Guerrini R, 1998, EPILEPSIA, V39, pS2, DOI 10.1111/j.1528-1157.1998.tb05118.x; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; Kahlig KM, 2008, P NATL ACAD SCI USA, V105, P9799, DOI 10.1073/pnas.0711717105; Kahlig KM, 2010, P NATL ACAD SCI USA, V107, P1343, DOI 10.1073/pnas.0910383107; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Lossin C, 2009, BRAIN DEV-JPN, V31, P114, DOI 10.1016/j.braindev.2008.07.011; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Meisler MH, 2010, J PHYSIOL-LONDON, V588, P1841, DOI 10.1113/jphysiol.2010.188482; Mulley JC, 2005, HUM MUTAT, V25, P535, DOI 10.1002/humu.20178; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Ohmori I, 2006, EPILEPSIA, V47, P1636, DOI 10.1111/j.1528-1167.2006.00643.x; Rhodes TH, 2005, J PHYSIOL-LONDON, V569, P433, DOI 10.1113/jphysiol.2005.094326; Rhodes TH, 2004, P NATL ACAD SCI USA, V101, P11147, DOI 10.1073/pnas.0402482101; Rusconi R, 2007, J NEUROSCI, V27, P11037, DOI 10.1523/JNEUROSCI.3515-07.2007; Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348; Thompson CH, 2011, EPILEPSIA, V52, P1000, DOI 10.1111/j.1528-1167.2011.03040.x; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Volkers L, 2011, EUR J NEUROSCI, V34, P1268, DOI 10.1111/j.1460-9568.2011.07826.x; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	27	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42001	42008		10.1074/jbc.M112.421883	http://dx.doi.org/10.1074/jbc.M112.421883			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086956	Green Published, hybrid			2022-12-28	WOS:000312103000039
J	Tundo, GR; Sbardella, D; Ciaccio, C; Bianculli, A; Orlandi, A; Desimio, MG; Arcuri, G; Coletta, M; Marini, S				Tundo, Grazia Raffaella; Sbardella, Diego; Ciaccio, Chiara; Bianculli, Antonio; Orlandi, Augusto; Desimio, Maria Giovanna; Arcuri, Gaetano; Coletta, Massimiliano; Marini, Stefano			Insulin-degrading Enzyme (IDE) A NOVEL HEAT SHOCK-LIKE PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEGRADATION; UBIQUITIN; BINDING; CANCER; METALLOENDOPROTEASE; CHAPERONES; EXPRESSION; INHIBITORS; SECRETION; INFECTION	Insulin-degrading enzyme (IDE) is a highly conserved zinc metallopeptidase that is ubiquitously distributed in human tissues, and particularly abundant in the brain, liver, and muscles. IDE activity has been historically associated with insulin and beta-amyloid catabolism. However, over the last decade, several experimental findings have established that IDE is also involved in a wide variety of physiopathological processes, including ubiquitin clearance and Varicella Zoster Virus infection. In this study, we demonstrate that normal and malignant cells exposed to different stresses markedly up-regulate IDE in a heat shock protein (HSP)-like fashion. Additionally, we focused our attention on tumor cells and report that (i) IDE is overexpressed in vivo in tumors of the central nervous system (CNS); (ii) IDE-silencing inhibits neuroblastoma (SHSY5Y) cell proliferation and triggers cell death; (iii) IDE inhibition is accompanied by a decrease of the poly-ubiquitinated protein content and co-immunoprecipitates with proteasome and ubiquitin in SHSY5Y cells. In this work, we propose a novel role for IDE as a heat shock protein with implications in cell growth regulation and cancer progression, thus opening up an intriguing hypothesis of IDE as an anticancer target.	[Tundo, Grazia Raffaella; Sbardella, Diego; Ciaccio, Chiara; Bianculli, Antonio; Coletta, Massimiliano; Marini, Stefano] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, I-00133 Rome, Italy; [Tundo, Grazia Raffaella; Sbardella, Diego; Ciaccio, Chiara; Coletta, Massimiliano; Marini, Stefano] CIRCMSB, I-70125 Bari, Italy; [Orlandi, Augusto; Desimio, Maria Giovanna; Arcuri, Gaetano] Univ Roma Tor Vergata, Dept Biomed & Prevent, I-00133 Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata	Marini, S (corresponding author), Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Via Montpellier 1, I-00133 Rome, Italy.	stefano.marini@uniroma2.it	Coletta, Massimo/N-9049-2015; Sbardella, Diego/N-9187-2015; Desimio, Maria Giovanna/AAA-7541-2020; Marini, Stefano/B-1161-2012; Orlandi, Augusto/AHE-8753-2022; Coletta, Massimiliano/GSN-5927-2022; Sbardella, Diego/K-7519-2016	Marini, Stefano/0000-0003-1299-6696; Sbardella, Diego/0000-0002-9924-7761; Desimio, Maria Giovanna/0000-0002-6353-7935; TUNDO, Grazia Raffaella/0000-0002-3866-3171; orlandi, augusto/0000-0001-7202-5854; COLETTA, Massimiliano/0000-0002-5489-9467	Italian Ministry for the University and Research [MiUR PRIN 2008L57JXW 002, FIRB RBNE03PX83]	Italian Ministry for the University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by the Italian Ministry for the University and Research (MiUR PRIN 2008L57JXW 002 (to S. M.) and FIRB RBNE03PX83 (to M. C.).	Abdul-Hay SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020818; Bennett RG, 2000, ENDOCRINOLOGY, V141, P2508, DOI 10.1210/en.141.7.2508; Bennett RG, 2003, J ENDOCRINOL, V177, P399, DOI 10.1677/joe.0.1770399; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Ciaccio C, 2009, J MOL BIOL, V385, P1556, DOI 10.1016/j.jmb.2008.11.025; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; De Maio A, 2011, CELL STRESS CHAPERON, V16, P235, DOI 10.1007/s12192-010-0236-4; de Tullio MB, 2008, PRION, V2, P51, DOI 10.4161/pri.2.2.6710; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Fernandez-Gamba A, 2009, CURR PHARM DESIGN, V15, P3644, DOI 10.2174/138161209789271799; Garrido C, 2003, CELL DEATH DIFFER, V10, P619, DOI 10.1038/sj.cdd.4401229; Glebov K, 2011, J BIOL CHEM, V286, P22711, DOI 10.1074/jbc.C110.217893; Grasso G, 2008, BBA-PROTEINS PROTEOM, V1784, P1122, DOI 10.1016/j.bbapap.2008.04.011; Hersh LB, 2006, CELL MOL LIFE SCI, V63, P2432, DOI 10.1007/s00018-006-6238-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x; Karapanagiotou EM, 2009, EXPERT OPIN INV DRUG, V18, P161, DOI [10.1517/13543780802715792, 10.1517/13543780802715792 ]; KAYALAR C, 1989, J BIOL CHEM, V264, P8928; Khalil AA, 2011, BBA-REV CANCER, V1816, P89, DOI 10.1016/j.bbcan.2011.05.001; KIRSCHNER RJ, 1983, J BIOL CHEM, V258, P967; KUO WL, 1993, ENDOCRINOLOGY, V132, P604, DOI 10.1210/en.132.2.604; KUPFER SR, 1994, J BIOL CHEM, V269, P20622; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; Li QX, 2006, CELL, V127, P305, DOI 10.1016/j.cell.2006.08.046; Lopes FM, 2010, BRAIN RES, V1337, P85, DOI 10.1016/j.brainres.2010.03.102; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Orlandi A, 2006, MODERN PATHOL, V19, P797, DOI 10.1038/modpathol.3800586; Parmentier N, 2010, NAT IMMUNOL, V11, P449, DOI 10.1038/ni.1862; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Ralat LA, 2011, J MOL BIOL, V406, P454, DOI 10.1016/j.jmb.2010.12.026; Rudovich N, 2009, J MOL MED, V87, P1145, DOI 10.1007/s00109-009-0540-6; Simbulan-Rosenthal CM, 1999, MOL CELL BIOCHEM, V193, P137, DOI 10.1023/A:1006988832729; Thomas SK, 2004, J BIOL CHEM, V279, P27994, DOI 10.1074/jbc.M312663200; Tundo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034376; Udrisar DP, 2005, EXP BIOL MED, V230, P479; Wu G, 1998, J NEUROCYTOL, V27, P1, DOI 10.1023/A:1006910001869; Yfanti C, 2008, INT J MOL MED, V22, P421, DOI 10.3892/ijmm_00000038; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4	40	50	52	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2281	2289		10.1074/jbc.M112.393108	http://dx.doi.org/10.1074/jbc.M112.393108			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23188819	Green Published, hybrid			2022-12-28	WOS:000314211500018
J	Kober, FX; Koelmel, W; Kuper, J; Drechsler, J; Mais, C; Hermanns, HM; Schindelin, H				Kober, Franz-Xaver; Koelmel, Wolfgang; Kuper, Jochen; Drechsler, Johannes; Mais, Christine; Hermanns, Heike M.; Schindelin, Hermann			The Crystal Structure of the Protein-Disulfide Isomerase Family Member ERp27 Provides Insights into Its Substrate Binding Capabilities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYSIS; ERP57; CALRETICULIN; EXPRESSION; CHAPERONE; CALNEXIN; DOMAINS; ENZYME; MODEL	About one-third of all cellular proteins pass through the secretory pathway and hence undergo oxidative folding in the endoplasmic reticulum (ER). Protein-disulfide isomerase (PDI) and related members of the PDI family assist in the folding of substrates by catalyzing the oxidation of two cysteines and isomerization of disulfide bonds as well as by acting as chaperones. In this study, we present the crystal structure of ERp27, a redox-inactive member of the PDI family. The structure reveals its substrate-binding cleft, which is homologous to PDI, but is able to adapt in size and hydrophobicity. Isothermal titration calorimetry experiments demonstrate that ERp27 is able to distinguish between folded and unfolded substrates, only interacting with the latter. ERp27 is up-regulated during ER stress, thus presumably allowing it to bind accumulating misfolded substrates and present them to ERp57 for catalysis.	[Kober, Franz-Xaver; Koelmel, Wolfgang; Kuper, Jochen; Drechsler, Johannes; Mais, Christine; Hermanns, Heike M.; Schindelin, Hermann] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany	University of Wurzburg	Schindelin, H (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	hermann.schindelin@virchow.uni-wuerzburg.de	Schindelin, Hermann/Q-2697-2019		Deutsche Forschungsgemeinschaft (Rudolf Virchow Center for Experimental Biomedicine) [FZ 82, Schi 425/3-1]	Deutsche Forschungsgemeinschaft (Rudolf Virchow Center for Experimental Biomedicine)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Rudolf Virchow Center for Experimental Biomedicine FZ 82 and Schi 425/3-1).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alanen HI, 2006, J BIOL CHEM, V281, P33727, DOI 10.1074/jbc.M604314200; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; CAI H, 1994, J BIOL CHEM, V269, P24550; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; CREIGHTON TE, 1980, J MOL BIOL, V142, P43, DOI 10.1016/0022-2836(80)90205-3; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; Dixon DP, 2003, ANTIOXID REDOX SIGN, V5, P389, DOI 10.1089/152308603768295122; Dobson Christopher M., 1999, Current Opinion in Structural Biology, V9, P92, DOI 10.1016/S0959-440X(99)80012-8; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gulow K, 2002, J CELL SCI, V115, P2443; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kemmink J, 1997, CURR BIOL, V7, P239, DOI 10.1016/S0960-9822(06)00119-9; Kerbiriou M, 2007, BBA-MOL BASIS DIS, V1772, P1236, DOI 10.1016/j.bbadis.2007.10.004; Klappa P, 1997, EUR J BIOCHEM, V248, P37, DOI 10.1111/j.1432-1033.1997.t01-1-00037.x; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Kozlov G, 2009, STRUCTURE, V17, P651, DOI 10.1016/j.str.2009.02.016; Lash AE, 2000, GENOME RES, V10, P1051, DOI 10.1101/gr.10.7.1051; Low LK, 2000, FEBS LETT, V472, P67, DOI 10.1016/S0014-5793(00)01432-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRUSINER SB, 1987, NEW ENGL J MED, V317, P1571, DOI 10.1056/NEJM198712173172505; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WANG CC, 1993, FASEB J, V7, P1515, DOI 10.1096/fasebj.7.15.7903263; Wang LK, 2008, EMBO REP, V9, P642, DOI 10.1038/embor.2008.88; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	47	16	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2029	2039		10.1074/jbc.M112.410522	http://dx.doi.org/10.1074/jbc.M112.410522			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23192347	hybrid, Green Published			2022-12-28	WOS:000313751400054
J	Boundy, S; Safo, MK; Wang, L; Musayev, FN; O'Farrell, HC; Rife, JP; Archer, GL				Boundy, Sam; Safo, Martin K.; Wang, Lei; Musayev, Faik N.; O'Farrell, Heather C.; Rife, Jason P.; Archer, Gordon L.			Characterization of the Staphylococcus aureus rRNA Methyltransferase Encoded by orfX, the Gene Containing the Staphylococcal Chromosome Cassette mec (SCCmec) Insertion Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHICILLIN RESISTANCE; CRYSTAL-STRUCTURE; CALORIMETRY; PROTEINS; YBEA	The gene orfX is conserved among all staphylococci, and its complete sequence is maintained upon insertion of the staphylococcal chromosome cassette mec (SCCmec) genomic island, containing the gene encoding resistance to beta-lactam antibiotics (mecA), into its C terminus. The function of OrfX has not been determined. We show that OrfX was constitutively produced during growth, that orfX could be inactivated without altering bacterial growth, and that insertion of SCCmec did not alter gene expression. We solved the crystal structure of OrfX at 1.7 angstrom and found that it belongs to the S-adenosyl-L-methionine (AdoMet)-dependent alpha/beta-knot superfamily of SPOUT methyltransferases (MTases), with a high structural homology to YbeA, the gene product of the Escherichia coli 70 S ribosomal MTase RlmH. MTase activity was confirmed by demonstrating the OrfX-dependent methylation of the Staphylococcus aureus 70 S ribosome. When OrfX was crystallized in the presence of its AdoMet substrate, we found that each monomer of the homodimeric structure bound AdoMet in its active site. Solution studies using isothermal titration calorimetry confirmed that each monomer bound AdoMet but with different binding affinities (K-d = 52 +/- 0.4 and 606 +/- 2 mu M). In addition, the structure shows that the AdoMet-binding pocket, formed by a deep trefoil knot, contains a bound phosphate molecule, which is the likely nucleotide methylation site. This study represents the first characterization of a staphylococcal ribosomal MTase and provides the first crystal structure of a member of the alpha/beta-knot superfamily of SPOUT MTases in the RlmH or COG1576 family with bound AdoMet.	[Boundy, Sam; Wang, Lei; Archer, Gordon L.] Virginia Commonwealth Univ, Div Infect Dis, Dept Med, Richmond, VA 23298 USA; [O'Farrell, Heather C.; Rife, Jason P.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA; [Safo, Martin K.; Musayev, Faik N.] Virginia Commonwealth Univ, Dept Med Chem, Sch Pharm, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Archer, GL (corresponding author), Virginia Commonwealth Univ, Div Infect Dis, Dept Med, Sanger Hall,Rm 1-018,POB 980565,1101 E Marshall S, Richmond, VA 23298 USA.	garcher@vcu.edu	Wang, Lei/F-4512-2012; Safo, Martin/AAJ-9833-2020; Musayev, Faik/AAY-2010-2020	Boundy, Sam/0000-0003-0541-1776	National Institutes of Health from NIAID [2R01 AI035705]; National Institutes of Health from NCI [CA 16059-28]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035705] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01 AI035705 from NIAID (to G. L. A.).; The structural biology resources were supported in part by National Institutes of Health Grant CA 16059-28 from NCI to the Virginia Commonwealth University Massey Cancer Center.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahn HJ, 2003, EMBO J, V22, P2593, DOI 10.1093/emboj/cdg269; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Bergman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000573; Chen HY, 2010, J MOL CELL BIOL, V2, P366, DOI 10.1093/jmcb/mjq034; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ero R, 2008, RNA, V14, P2223, DOI 10.1261/rna.1186608; Farrar CE, 2005, J NUTR BIOCHEM, V16, P554, DOI 10.1016/j.jnutbio.2005.02.004; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Li JN, 1999, RNA, V5, P395, DOI 10.1017/S1355838299980834; Mallam AL, 2007, J MOL BIOL, V366, P650, DOI 10.1016/j.jmb.2006.11.014; McGhee GC, 2011, PHYTOPATHOLOGY, V101, P192, DOI 10.1094/PHYTO-04-10-0128; Niemeyer DM, 1996, J BACTERIOL, V178, P5464, DOI 10.1128/jb.178.18.5464-5471.1996; Noto MJ, 2008, J BACTERIOL, V190, P1276, DOI 10.1128/JB.01128-07; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Persson BC, 1997, NUCLEIC ACIDS RES, V25, P4093, DOI 10.1093/nar/25.20.4093; Purta E, 2008, RNA, V14, P2234, DOI 10.1261/rna.1198108; Sass P, 2012, J BACTERIOL, V194, P2107, DOI 10.1128/JB.06631-11; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; Wang L, 2012, J BACTERIOL, V194, P486, DOI 10.1128/JB.05047-11	24	44	45	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					132	140		10.1074/jbc.M112.385138	http://dx.doi.org/10.1074/jbc.M112.385138			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23150671	Green Published, hybrid			2022-12-28	WOS:000313197200013
J	Greenall, SA; Bentley, JD; Pearce, LA; Scoble, JA; Sparrow, LG; Bartone, NA; Xiao, XW; Baxter, RC; Cosgrove, LJ; Adams, TE				Greenall, Sameer A.; Bentley, John D.; Pearce, Lesley A.; Scoble, Judith A.; Sparrow, Lindsay G.; Bartone, Nicola A.; Xiao, Xiaowen; Baxter, Robert C.; Cosgrove, Leah J.; Adams, Timothy E.			Biochemical Characterization of Individual Human Glycosylated pro-Insulin-like Growth Factor (IGF)-II and big-IGF-II Isoforms Associated with Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; CELL TUMOR HYPOGLYCEMIA; FACTOR BINDING-PROTEINS; STRUCTURAL DETERMINANTS; MONOCLONAL-ANTIBODIES; RECEPTOR; SERUM; ACTIVATION; PRECURSOR; LIGAND	Insulin-like growth factor II (IGF-II) is a major embryonic growth factor belonging to the insulin-like growth factor family, which includes insulin and IGF-I. Its expression in humans is tightly controlled by maternal imprinting, a genetic restraint that is lost in many cancers, resulting in up-regulation of both mature IGF-II mRNA and protein expression. Additionally, increased expression of several longer isoforms of IGF-II, termed "pro" and "big" IGF-II, has been observed. To date, it is ambiguous as to what role these IGF-II isoforms have in initiating and sustaining tumorigenesis and whether they are bioavailable. We have expressed each individual IGF-II isoform in their proper O-glycosylated format and established that all bind to the IGF-I receptor and both insulin receptors A and B, resulting in their activation and subsequent stimulation of fibroblast proliferation. We also confirmed that all isoforms are able to be sequestered into binary complexes with several IGF-binding proteins (IGFBP-2, IGFBP-3, and IGFBP-5). In contrast to this, ternary complex formation with IGFBP-3 or IGFBP-5 and the auxillary protein, acid labile subunit, was severely diminished. Furthermore, big-IGF-II isoforms bound much more weakly to purified ectodomain of the natural IGF-II scavenging receptor, IGF-IIR. IGF-II isoforms thus possess unique biological properties that may enable them to escape normal sequestration avenues and remain bioavailable in vivo to sustain oncogenic signaling.	[Greenall, Sameer A.; Bentley, John D.; Pearce, Lesley A.; Scoble, Judith A.; Sparrow, Lindsay G.; Bartone, Nicola A.; Xiao, Xiaowen; Adams, Timothy E.] CSIRO, Div Mat Sci & Engn, Parkville, Vic 3052, Australia; [Baxter, Robert C.] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, St Leonards, NSW 2065, Australia; [Cosgrove, Leah J.] CSIRO, Div Food Anim & Nutrit Sci, Adelaide, SA 5000, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Adams, TE (corresponding author), CSIRO, Div Mat Sci & Engn, 343 Royal Parade, Parkville, Vic 3052, Australia.	tim.adams@csiro.au	Scoble, Judith A/B-4919-2016; Cosgrove, Leah J/A-7764-2010; Baxter, Robert C/F-3927-2012; Adams, Timothy E/I-6231-2012	Scoble, Judith A/0000-0002-6652-0717; Cosgrove, Leah J/0000-0002-8340-4291; Baxter, Robert C/0000-0001-5061-2142; Adams, Timothy E/0000-0003-3436-0066; Greenall, Sameer/0000-0002-1461-7111				Bond JJ, 2000, J ENDOCRINOL, V165, P253, DOI 10.1677/joe.0.1650253; Breuhahn K, 2008, WORLD J GASTROENTERO, V14, P1690, DOI 10.3748/wjg.14.1690; Brierley GV, 2010, ENDOCRINOLOGY, V151, P1418, DOI 10.1210/en.2009-1006; Brown J, 2008, EMBO J, V27, P265, DOI 10.1038/sj.emboj.7601938; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Cosgrove L, 1995, PROTEIN EXPRES PURIF, V6, P789, DOI 10.1006/prep.1995.0010; DAUGHADAY WH, 1993, P NATL ACAD SCI USA, V90, P5823, DOI 10.1073/pnas.90.12.5823; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Denley A, 2006, ENDOCRINOLOGY, V147, P1029, DOI 10.1210/en.2005-0736; Dransfield DT, 2010, MOL CANCER THER, V9, P1809, DOI 10.1158/1535-7163.MCT-09-1134; Duguay SJ, 1998, J BIOL CHEM, V273, P18443, DOI 10.1074/jbc.273.29.18443; EASTMAN RC, 1992, J CLIN INVEST, V89, P1958, DOI 10.1172/JCI115803; El-Shewy HM, 2011, MOL ENDOCRINOL, V25, P2144, DOI 10.1210/me.2011-0101; Elmlinger MW, 1999, HORM RES, V52, P178, DOI 10.1159/000023458; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Firth SM, 1998, J BIOL CHEM, V273, P2631, DOI 10.1074/jbc.273.5.2631; Firth SM, 2001, ENDOCRINOLOGY, V142, P2147, DOI 10.1210/en.142.5.2147; Fukuda I, 2006, GROWTH HORM IGF RES, V16, P211, DOI 10.1016/j.ghir.2006.05.003; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Hizuka N, 1998, J CLIN ENDOCR METAB, V83, P2875, DOI 10.1210/jc.83.8.2875; Hoekman K, 1999, CLIN ENDOCRINOL, V51, P247, DOI 10.1046/j.1365-2265.1999.00833.x; Holly J, 2006, NEUROENDOCRINOLOGY, V83, P154, DOI 10.1159/000095523; Ishikura K., 2010, BMJ CASE REP, V2010, pbcr07; Jespersen S, 1996, J MASS SPECTROM, V31, P893, DOI 10.1002/(SICI)1096-9888(199608)31:8<893::AID-JMS374>3.0.CO;2-S; Marks AG, 2011, ENDOCRINOLOGY, V152, P922, DOI 10.1210/en.2010-0784; McKern NM, 1997, PROTEIN SCI, V6, P2663; Nakamura M, 2005, BIOCHEM BIOPH RES CO, V333, P1011, DOI 10.1016/j.bbrc.2005.06.010; Qiu Q, 2010, GROWTH HORM IGF RES, V20, P110, DOI 10.1016/j.ghir.2009.11.001; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; Singh SK, 2008, GROWTH FACTORS, V26, P92, DOI 10.1080/08977190802057258; SOOS MA, 1992, J BIOL CHEM, V267, P12955; SOOS MA, 1989, P NATL ACAD SCI USA, V86, P5217, DOI 10.1073/pnas.86.14.5217; Valenzano KJ, 1997, J BIOL CHEM, V272, P4804, DOI 10.1074/jbc.272.8.4804; Van Doorn J, 2002, CLIN CHEM, V48, P1739; ZAPF J, 1992, J CLIN INVEST, V90, P2574, DOI 10.1172/JCI116152	36	31	31	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					59	68		10.1074/jbc.M112.432013	http://dx.doi.org/10.1074/jbc.M112.432013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23166326	Green Published, hybrid			2022-12-28	WOS:000313197200006
J	Koutsioumpa, M; Polytarchou, C; Courty, J; Zhang, Y; Kieffer, N; Mikelis, C; Skandalis, SS; Hellman, U; Iliopoulos, D; Papadimitriou, E				Koutsioumpa, Marina; Polytarchou, Christos; Courty, Jose; Zhang, Yue; Kieffer, Nelly; Mikelis, Constantinos; Skandalis, Spyros S.; Hellman, Ulf; Iliopoulos, Dimitrios; Papadimitriou, Evangelia			Interplay between alpha(v)beta(3) Integrin and Nucleolin Regulates Human Endothelial and Glioma Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-EXPRESSED NUCLEOLIN; GROWTH-FACTOR; IN-VITRO; ANGIOGENIC FUNCTION; TUMOR VASCULATURE; BETA(3) INTEGRIN; RECEPTOR; PROTEIN; ACTIVATION; BINDS	The multifunctional protein nucleolin (NCL) is overexpressed on the surface of activated endothelial and tumor cells and mediates the stimulatory actions of several angiogenic growth factors, such as pleiotrophin (PTN). Because alpha(v)beta(3) integrin is also required for PTN-induced cell migration, the aim of the present work was to study the interplay between NCL and alpha(v)beta(3) by using biochemical, immunofluorescence, and proximity ligation assays in cells with genetically altered expression of the studied molecules. Interestingly, cell surface NCL localization was detected only in cells expressing alpha(v)beta(3) and depended on the phosphorylation of beta(3) at Tyr(773) through receptor protein-tyrosine phosphatase beta/zeta (RPTP beta/zeta) and c-Src activation. Downstream of alpha(v)beta(3), PI3K activity mediated this phenomenon and cell surface NCL was found to interact with both alpha(v)beta(3) and RPTP beta/zeta. Positive correlation of cell surface NCL and alpha(v)beta(3) expression was also observed in human glioblastoma tissue arrays, and inhibition of cell migration by cell surface NCL antagonists was observed only in cells expressing alpha(v)beta(3). Collectively, these data suggest that both expression and beta(3) integrin phosphorylation at Tyr(773) determine the cell surface localization of NCL downstream of the RPTP beta/zeta/c-Src signaling cascade and can be used as a biomarker for the use of cell surface NCL antagonists as anticancer agents.	[Koutsioumpa, Marina; Mikelis, Constantinos; Papadimitriou, Evangelia] Univ Patras, Dept Pharm, Mol Pharmacol Lab, GR-26504 Patras, Greece; [Polytarchou, Christos; Iliopoulos, Dimitrios] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; [Polytarchou, Christos; Iliopoulos, Dimitrios] Harvard Univ, Dept Immunobiol & Microbiol, Sch Med, Boston, MA 02115 USA; [Courty, Jose] Univ Paris 12, Lab CRRET, F-94010 Creteil, France; [Zhang, Yue; Kieffer, Nelly] Jiao Tong Univ, CNRS LIA 124, Sinofrench Res Ctr Life Sci & Genom, Rui Jin Hosp,Med Sch, Shanghai 200025, Peoples R China; [Skandalis, Spyros S.; Hellman, Ulf] Uppsala Univ, Ludwig Inst Canc Res, SE-75105 Uppsala, Sweden	University of Patras; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Shanghai Jiao Tong University; Ludwig Institute for Cancer Research; Uppsala University	Papadimitriou, E (corresponding author), Univ Patras, Dept Pharm, Mol Pharmacol Lab, GR-26504 Patras, Greece.	epapad@upatras.gr	KOUTSIOUMPA, MARINA/CAI-1960-2022; Skandalis, Spyros/F-6815-2010; Courty, Jose/Q-3702-2018; Papadimitriou, Evangelia/ABG-1356-2020; Iliopoulos, Dimitrios/AAE-9106-2019; Mikelis, Constantinos/AGF-9423-2022; KOUTSIOUMPA, MARINA/CAF-5457-2022	KOUTSIOUMPA, MARINA/0000-0002-6359-573X; Papadimitriou, Evangelia/0000-0001-6429-4325; KOUTSIOUMPA, MARINA/0000-0002-6359-573X; Skandalis, Spyros/0000-0003-1156-2896	European Union (European Social Fund); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: "Heracleitus II, and Investing in Knowledge Society through the European Social Fund"	European Union (European Social Fund)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: "Heracleitus II, and Investing in Knowledge Society through the European Social Fund"	This work was supported by the European Union (European Social Fund) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: "Heracleitus II, and Investing in Knowledge Society through the European Social Fund."	Barel M, 2003, EUR J IMMUNOL, V33, P2557, DOI 10.1002/eji.200324059; Borges E, 2000, J BIOL CHEM, V275, P39867, DOI 10.1074/jbc.M007040200; Burks DJ, 1998, J BIOL CHEM, V273, P31061, DOI 10.1074/jbc.273.47.31061; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Chen YQ, 1997, INT J CANCER, V72, P642, DOI 10.1002/(SICI)1097-0215(19970807)72:4<642::AID-IJC16>3.0.CO;2-D; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; De Donatis A, 2008, J BIOL CHEM, V283, P19948, DOI 10.1074/jbc.M709428200; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Destouches D, 2011, CANCER RES, V71, P3296, DOI 10.1158/0008-5472.CAN-10-3459; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Di Segni A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002310; Ding YP, 2012, ARTERIOSCL THROM VAS, V32, pE126, DOI 10.1161/ATVBAHA.112.247502; Dumler I, 1999, CURR BIOL, V9, P1468, DOI 10.1016/S0960-9822(00)80116-5; El Khoury D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-325; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Fogal V, 2009, ANGIOGENESIS, V12, P91, DOI 10.1007/s10456-009-9137-5; Garcia MC, 2011, FEBS LETT, V585, P618, DOI 10.1016/j.febslet.2011.01.035; Ginisty H, 1999, J CELL SCI, V112, P761; Guerrero CA, 2012, ACTA VIROL, V56, P63, DOI 10.4149/av_2012_01_63; Hellman U, 2002, MASS SPECTROMETRY AND HYPHENATED TECHNIQUES IN NEUROPEPTIDE RESEARCH, P259; Heroult M, 2004, ONCOGENE, V23, P1745, DOI 10.1038/sj.onc.1206879; Hoja-Lukowicz D, 2009, CANCER IMMUNOL IMMUN, V58, P1471, DOI 10.1007/s00262-009-0705-8; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Huang Y, 2006, BLOOD, V107, P3564, DOI 10.1182/blood-2005-07-2961; Huddleson JP, 2006, J BIOL CHEM, V281, P15121, DOI 10.1074/jbc.M513406200; Inder Kerry L, 2010, Commun Integr Biol, V3, P188; KIBBEY MC, 1995, J NEUROSCI RES, V42, P314, DOI 10.1002/jnr.490420305; Ko MH, 2009, SMALL, V5, P1207, DOI 10.1002/smll.200801580; Koutsioumpa M, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-4; Krust B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-333; LAPEYRE B, 1986, J BIOL CHEM, V261, P9167; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lian JQ, 2006, BIOCHEM BIOPH RES CO, V347, P248, DOI 10.1016/j.bbrc.2006.06.069; Losfeld ME, 2009, EXP CELL RES, V315, P357, DOI 10.1016/j.yexcr.2008.10.039; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Mercurio AM, 2001, SEMIN CANCER BIOL, V11, P129, DOI 10.1006/scbi.2000.0364; Mikelis C, 2009, FASEB J, V23, P1459, DOI 10.1096/fj.08-117564; Oikawa Y, 2011, EXP CELL RES, V317, P1119, DOI 10.1016/j.yexcr.2010.12.019; Papadimitriou E, 2001, BIOCHEM BIOPH RES CO, V282, P306, DOI 10.1006/bbrc.2001.4574; Papadimitriou E, 2009, EUR CYTOKINE NETW, V20, P180, DOI 10.1684/ecn.2009.0172; Patsenker E, 2007, J HEPATOL, V46, P878, DOI 10.1016/j.jhep.2006.11.011; Polykratis A, 2005, J BIOL CHEM, V280, P22454, DOI 10.1074/jbc.M414407200; Rahman S, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-8; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; Reyes-Reyes EM, 2008, EXP CELL RES, V314, P2212, DOI 10.1016/j.yexcr.2008.03.016; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Said EA, 2002, J BIOL CHEM, V277, P37492, DOI 10.1074/jbc.M201194200; Schaffner-Reckinger E, 1998, J BIOL CHEM, V273, P12623, DOI 10.1074/jbc.273.20.12623; Schnell O, 2008, BRAIN PATHOL, V18, P378, DOI 10.1111/j.1750-3639.2008.00137.x; Senger DR, 1996, AM J PATHOL, V149, P293; Shi HB, 2007, BLOOD, V110, P2899, DOI 10.1182/blood-2007-01-064428; Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9; Soundararajan S, 2009, MOL PHARMACOL, V76, P984, DOI 10.1124/mol.109.055947; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Tate A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-197; Turck N, 2006, J CELL PHYSIOL, V206, P545, DOI 10.1002/jcp.20501; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7	62	49	49	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					343	354		10.1074/jbc.M112.387076	http://dx.doi.org/10.1074/jbc.M112.387076			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23161541	Green Published, hybrid			2022-12-28	WOS:000313197200036
J	Makarava, N; Savtchenko, R; Baskakov, IV				Makarava, Natallia; Savtchenko, Regina; Baskakov, Ilia V.			Selective Amplification of Classical and Atypical Prions Using Modified Protein Misfolding Cyclic Amplification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO GENERATION; AMYLOID FIBRILS; HETEROGENEITY; PRPSC; CONFORMATION; PROPAGATION; ADAPTATION; GLYCOFORMS; MOLECULES; COFACTOR	With the development of protein misfolding cyclic amplification (PMCA), the topic of faithful propagation of prion strain-specific structures has been constantly debated. Here we show that by subjecting brain material of a synthetic strain consisting of a mixture of self-replicating states to PMCAb, selective amplification of PrPSc could be achieved, and that PMCAb mimicked the evolutionary trend observed during serial transmission in animals. On the other hand, using modified PMCAb conditions that employ partially deglycosylated PrPC (dgPMCAb), an alternative transmissible state referred to as atypical protease-resistant form of the prion protein (atypical PrPres) was selectively amplified from a mixture. Surprisingly, when hamster-adapted strains (263K and Hyper) were subjected to dgPMCAb, their proteinase K digestion profile underwent a dramatic transformation, suggesting that a mixture of atypical PrPres and PrPSc might be present in brain-derived materials. However, detailed analysis revealed that the proteinase K-resistant profile of PrPSc changed in response to dgPMCAb. Despite these changes, the 263K strain-specific disease phenotype was preserved after passage through dgPMCAb. This study revealed that the change in PrPSc biochemical phenotype does not always represent an irreversible transformation of a strain, but rather demonstrated the existence of a wide range of variation for strain-specific physical features in response to a change in prion replication environment. The current work introduced a new PMCA technique for amplification of atypical PrPres and raised a number of questions about the need for a clever distinction between actual strain mutation and variation of strain-specific features in response to a change in the replication environment.	Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Baskakov, IV (corresponding author), 725 W Lombard St, Baltimore, MD 21201 USA.	Baskakov@umaryland.edu			National Institutes of Health [NS045585, NS074998]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074998, R56NS074998, R01NS045585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS045585 and NS074998 (to I. V. B.).	Anderson M, 2006, J MOL BIOL, V358, P580, DOI 10.1016/j.jmb.2006.02.007; Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Baron T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000137; Bartz JC, 2000, J VIROL, V74, P5542, DOI 10.1128/JVI.74.12.5542-5547.2000; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; Bett C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002522; Biacabe AG, 2007, PRION, V1, P61, DOI 10.4161/pri.1.1.3828; Bieschke J, 2004, P NATL ACAD SCI USA, V101, P12207, DOI 10.1073/pnas.0404650101; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; DeArmond SJ, 1999, J NEUROPATH EXP NEUR, V58, P1000, DOI 10.1097/00005072-199909000-00010; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Ghaemmaghami S, 2011, J MOL BIOL, V413, P527, DOI 10.1016/j.jmb.2011.07.021; Ghaemmaghami S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000673; Gong BB, 2011, BIOCHEMISTRY-US, V50, P4963, DOI 10.1021/bi102073j; Gonzalez-Montalban N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041210; Gonzalez-Montalban N, 2011, BIOCHEMISTRY-US, V50, P7933, DOI 10.1021/bi200950v; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Klingeborn M, 2011, P NATL ACAD SCI USA, V108, pE1244, DOI 10.1073/pnas.1111255108; Li JL, 2011, EMBO REP, V12, P1243, DOI 10.1038/embor.2011.191; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Makarava N, 2012, J NEUROSCI, V32, P7345, DOI 10.1523/JNEUROSCI.6351-11.2012; Makarava N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002419; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Meyerett C, 2008, VIROLOGY, V382, P267, DOI 10.1016/j.virol.2008.09.023; Monnet C, 2003, EUR J NEUROSCI, V18, P542, DOI 10.1046/j.1460-9568.2003.02777.x; Nishina KA, 2006, BIOCHEMISTRY-US, V45, P14129, DOI 10.1021/bi061526k; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Piro JR, 2009, J VIROL, V83, P5321, DOI 10.1128/JVI.02502-08; Pritzkow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020384; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sajnani G, 2008, J MOL BIOL, V382, P88, DOI 10.1016/j.jmb.2008.06.070; Shashilov V, 2012, J PHYS CHEM B, V116, P7926, DOI 10.1021/jp2122455; Shikiya RA, 2011, J VIROL, V85, P13439, DOI 10.1128/JVI.06134-11; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	45	41	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					33	41		10.1074/jbc.M112.419531	http://dx.doi.org/10.1074/jbc.M112.419531			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23168413	Green Published, hybrid			2022-12-28	WOS:000313197200004
J	Mou, LY; Kang, YW; Zhou, Y; Zeng, Q; Song, HJ; Wang, R				Mou, Lingyun; Kang, Yawei; Zhou, Ying; Zeng, Qian; Song, Hongjing; Wang, Rui			Neurokinin-1 Receptor Directly Mediates Glioma Cell Migration by Up-regulation of Matrix Metalloproteinase-2 (MMP-2) and Membrane Type 1-Matrix Metalloproteinase (MT1-MMP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTANCE-P; ASTROCYTOMA-CELLS; HEMOKININ-1; TACHYKININS; SURVIVAL; BIOLOGY; PROLIFERATION; ANGIOGENESIS; STIMULATION; ACTIVATION	Neurokinin-1 receptor (NK1R) occurs naturally on human glioblastomas. Its activation mediates glioma cell proliferation. However, it is unknown whether NK1R is directly involved in tumor cell migration. In this study, we found human hemokinin-1 (hHK-1), via NK1R, dose-dependently promoted the migration of U-251 and U-87 cells. In addition, we showed that hHK-1 enhanced the activity of MMP-2 and the expression of MMP-2 and MT1-matrix metalloproteinase (MMP), which were responsible for cell migration, because neutralizing the MMPs with antibodies decreased cell migration. The involved mechanisms were then investigated. In U-251, hHK-1 induced significant calcium efflux; phospholipase C inhibitor U-73122 reduced the calcium mobilization, the up-regulation of MMP-2 and MT1-MMP, and the cell migration induced by hHK-1, which meant the migration effect of NK1R was mainly mediated through the G(q)-PLC pathway. We further demonstrated that hHK-1 boosted rapid phosphorylation of ERK, JNK, and Akt; inhibition of ERK and Akt effectively reduced MMP-2 induction by hHK-1. Meanwhile, inhibition of ERK, JNK, and Akt reduced the MT1-MMP induction. hHK-1 stimulated significant phosphorylation of p65 and c-JUN in U-251. Reporter gene assays indicated hHK-1 enhanced both AP-1 and NF-kappa B activity; inhibition of ERK, JNK, and Akt dose-dependently suppressed the NF-kappa B activity; only the inhibition of ERK significantly suppressed the AP-1 activity. Treatment with specific inhibitors for AP-1 or NF-kappa B strongly blocked the MMP up-regulation by hHK-1. Taken together, our data suggested NK1R was a potential regulator of human glioma cell migration by the up-regulation of MMP-2 and MT1-MMP.	[Mou, Lingyun; Kang, Yawei; Zhou, Ying; Zeng, Qian; Song, Hongjing; Wang, Rui] Lanzhou Univ, Sch Life Sci, Inst Biochem & Mol Biol,Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China	Lanzhou University	Wang, R (corresponding author), Lanzhou Univ, Sch Life Sci, Inst Biochem & Mol Biol,Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, 222 Tian Shui S Rd, Lanzhou 730000, Peoples R China.	wangrui@lzu.edu.cn			National Nature Science Foundation of China [91213302, 20932003, 21272102]; Key National S & T Major Project and Major New Drugs Development of China [2012ZX09504-001-003]; Fundamental Research Funds for the Central Universities [lzujbky-2012-117]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National S & T Major Project and Major New Drugs Development of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by National Nature Science Foundation of China Grants 91213302, 20932003, and 21272102, Key National S & T Major Project and Major New Drugs Development of China Grant 2012ZX09504-001-003, and Fundamental Research Funds for the Central Universities Grant lzujbky-2012-117.	Akazawa T, 2009, J NEUROCHEM, V109, P1079, DOI 10.1111/j.1471-4159.2009.06032.x; Berger A, 2005, J NEUROIMMUNOL, V164, P48, DOI 10.1016/j.jneuroim.2005.03.016; Christian Christine, 1994, Neuroimmunomodulation, V1, P159, DOI 10.1159/000097156; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Davis FG, 1998, J NEUROSURG, V88, P1, DOI 10.3171/jns.1998.88.1.0001; Dzwonek J, 2004, FEBS LETT, V567, P129, DOI 10.1016/j.febslet.2004.03.070; EISTETTER HR, 1992, GLIA, V6, P89, DOI 10.1002/glia.440060203; Feistritzer C, 2003, REGUL PEPTIDES, V116, P119, DOI 10.1016/S0167-0115(03)00193-9; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Guha A, 2004, CURR OPIN NEUROL, V17, P655, DOI 10.1097/00019052-200412000-00004; Guha S, 2005, CANCER RES, V65, P2738, DOI 10.1158/0008-5472.CAN-04-3197; HENNIG IM, 1995, INT J CANCER, V61, P786, DOI 10.1002/ijc.2910610608; Janelsins BM, 2009, BLOOD, V113, P3017, DOI 10.1182/blood-2008-06-163121; Koon HW, 2007, P NATL ACAD SCI USA, V104, P2013, DOI 10.1073/pnas.0610664104; Koul D, 2006, MOL CANCER THER, V5, P637, DOI 10.1158/1535-7163.MCT-05-0453; Kurtz MM, 2002, GENE, V296, P205, DOI 10.1016/S0378-1119(02)00861-2; Kwiatkowska A., 2011, BIOCHIM BIOPHYS ACTA, V1813, P665; Lazarczyk M, 2007, FOLIA NEUROPATHOL, V45, P99; Lieb K, 1997, J IMMUNOL, V159, P4952; Lohi J, 2000, GENE, V242, P75, DOI 10.1016/S0378-1119(99)00549-1; Lu DY, 2010, BIOCHEM PHARMACOL, V80, P1201, DOI 10.1016/j.bcp.2010.06.046; Luo WH, 1996, CANCER RES, V56, P4983; Matsumura T, 2008, BRIT J PHARMACOL, V155, P767, DOI 10.1038/bjp.2008.301; Meshki J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025332; Meshki J, 2009, J BIOL CHEM, V284, P9280, DOI 10.1074/jbc.M808825200; MITSUHASHI M, 1992, J NEUROSCI RES, V32, P437, DOI 10.1002/jnr.490320315; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Mou LY, 2011, BIOCHEM PHARMACOL, V81, P661, DOI 10.1016/j.bcp.2010.12.007; Munoz M, 2011, CURR DRUG TARGETS, V12, P909, DOI 10.2174/138945011795528796; Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5; NAKAJIMA Y, 1992, J BIOL CHEM, V267, P2437; Nishida Y, 2008, CANCER RES, V68, P9096, DOI 10.1158/0008-5472.CAN-08-2522; Ogo H, 1996, J NEUROCHEM, V67, P1813; Page NM, 2005, PEPTIDES, V26, P1356, DOI 10.1016/j.peptides.2005.03.030; Page NM, 2003, P NATL ACAD SCI USA, V100, P6245, DOI 10.1073/pnas.0931458100; Palma C, 1999, BRIT J CANCER, V79, P236, DOI 10.1038/sj.bjc.6690039; Palma C, 2006, CURR DRUG TARGETS, V7, P1043, DOI 10.2174/138945006778019282; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Reddy Bobby Y, 2008, Curr Drug Discov Technol, V5, P15; Reubi JC, 2005, J NUCL MED, V46, p67S; RUFF MR, 1985, PEPTIDES, V6, P107, DOI 10.1016/0196-9781(85)90142-1; Sagan S, 1996, J PHARMACOL EXP THER, V276, P1039; Sakai A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032268; Schratzberger P, 1997, J IMMUNOL, V158, P3895; Song HJ, 2012, INT J BIOCHEM CELL B, V44, P1410, DOI 10.1016/j.biocel.2012.04.014; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; VanMeter TE, 2001, J NEURO-ONCOL, V53, P213, DOI 10.1023/A:1012280925031; Wang W, 2010, J IMMUNOL, V184, P3590, DOI 10.4049/jimmunol.0901278; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; ZICHE M, 1990, MICROVASC RES, V40, P264, DOI 10.1016/0026-2862(90)90024-L	52	35	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					306	318		10.1074/jbc.M112.389783	http://dx.doi.org/10.1074/jbc.M112.389783			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23166329	hybrid, Green Published			2022-12-28	WOS:000313197200033
J	Steen, HC; Nogusa, S; Thapa, RJ; Basagoudanavar, SH; Gill, AL; Merali, S; Barrero, CA; Balachandran, S; Gamero, AM				Steen, Hakan C.; Nogusa, Shoko; Thapa, Roshan J.; Basagoudanavar, Suresh H.; Gill, Amanda L.; Merali, Salim; Barrero, Carlos A.; Balachandran, Siddharth; Gamero, Ana M.			Identification of STAT2 Serine 287 as a Novel Regulatory Phosphorylation Site in Type I Interferon-induced Cellular Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; TRANSCRIPTION FACTOR; TYROSINE PHOSPHORYLATION; DNA-BINDING; STIMULATED GENES; IFN-ALPHA; ACTIVATION; PROTEIN; REQUIRES; RECEPTOR	STAT2 is a positive modulator of the transcriptional response to type I interferons (IFNs). STAT2 acquires transcriptional function by becoming tyrosine phosphorylated and imported to the nucleus following type I IFN receptor activation. Although most STAT proteins become dually phosphorylated on specific tyrosine and serine residues to acquire full transcriptional activity, no serine phosphorylation site in STAT2 has been reported. To find novel phosphorylation sites, mass spectrometry of immunoprecipitated STAT2 was used to identify several phosphorylated residues. Of these, substitution of serine 287 with alanine (S287A) generated a gain-of-function mutant that enhanced the biological effects of IFN-alpha. S287A-STAT2 increased cell growth inhibition, prolonged protection against vesicular stomatitis virus infection and enhanced transcriptional responses following exposure of cells to IFN-alpha. In contrast, a phosphomimetic STAT2 mutant (S287D) produced a loss-of-function protein that weakly activated IFN-induced ISGs. Our mechanistic studies suggest that S287A-STAT2 likely mediates its gain-of-function effects by prolonging STAT2/STAT1 dimer activation and retaining it in transcriptionally active complexes with chromatin. Altogether, we have uncovered that in response to type I IFN, STAT2 is serine phosphorylated in the coiled-coil domain that when phosphorylated can negatively regulate the biological activities of type I IFNs.	[Steen, Hakan C.; Gill, Amanda L.; Merali, Salim; Barrero, Carlos A.; Gamero, Ana M.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Nogusa, Shoko; Thapa, Roshan J.; Basagoudanavar, Suresh H.; Balachandran, Siddharth] Fox Chase Canc Ctr, Immune Cell Dev & Host Def Program, Philadelphia, PA 19111 USA; [Basagoudanavar, Suresh H.] Indian Vet Res Inst, Bangalore 560024, Karnataka, India	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Fox Chase Cancer Center; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Gamero, AM (corresponding author), 3400 N Broad St,Kresge Hall, Philadelphia, PA 19140 USA.	gameroa@temple.edu	Basagoudanavar, Suresh/AAG-4317-2019	Basagoudanavar, Suresh/0000-0001-7714-3120; Barrero, Carlos/0000-0001-5779-6642	National Cancer Institute [RO1CA140499, K22CA095326]; ACS Research Scholar Grant [RSG-09-195-01-MPC]; Fox Chase Cancer Center institutional support via the Kidney Cancer Keystone Program; NATIONAL CANCER INSTITUTE [R01CA140499, K22CA095326] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ACS Research Scholar Grant; Fox Chase Cancer Center institutional support via the Kidney Cancer Keystone Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Grants RO1CA140499 and K22CA095326 (to A. M. G.). This work was also supported by an ACS Research Scholar Grant (RSG-09-195-01-MPC) with additional funding provided by the Fox Chase Cancer Center institutional support via the Kidney Cancer Keystone Program.	Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bluyssen HAR, 1997, J BIOL CHEM, V272, P4600, DOI 10.1074/jbc.272.7.4600; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Cho SS, 1996, J IMMUNOL, V157, P4781; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002; Friedbichler K, 2010, BLOOD, V116, P1548, DOI 10.1182/blood-2009-12-258913; FU XY, 1992, CELL, V70, P323, DOI 10.1016/0092-8674(92)90106-M; Gamero AM, 2004, J BIOL CHEM, V279, P12379, DOI 10.1074/jbc.M310787200; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Hasham MG, 2004, VIROLOGY, V320, P313, DOI 10.1016/j.virol.2003.11.032; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; IMPROTA T, 1994, P NATL ACAD SCI USA, V91, P4776, DOI 10.1073/pnas.91.11.4776; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Kadota S, 2011, J CELL SCI, V124, P892, DOI 10.1242/jcs.078253; KESSLER DS, 1990, GENE DEV, V4, P1753, DOI 10.1101/gad.4.10.1753; LARNER AC, 1986, J BIOL CHEM, V261, P453; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Maher SG, 2007, CURR MED CHEM, V14, P1279, DOI 10.2174/092986707780597907; Maiti NR, 2005, J INTERF CYTOK RES, V25, P553, DOI 10.1089/jir.2005.25.553; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; MartinezMoczygemba M, 1997, J BIOL CHEM, V272, P20070, DOI 10.1074/jbc.272.32.20070; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Sakamoto S, 2004, J BIOL CHEM, V279, P3245, DOI 10.1074/jbc.M309631200; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Scarzello AJ, 2007, MOL BIOL CELL, V18, P2455, DOI 10.1091/mbc.E06-09-0843; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Shirakawa T, 2011, J BIOL CHEM, V286, P4003, DOI 10.1074/jbc.M110.168435; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; Tamura T, 2009, J BIOL CHEM, V284, P12217, DOI 10.1074/jbc.M805651200; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Testoni B, 2011, J BIOL CHEM, V286, P20217, DOI 10.1074/jbc.M111.231068; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; VEALS SA, 1993, MOL CELL BIOL, V13, P196, DOI 10.1128/MCB.13.1.196; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yamashita H, 1998, J BIOL CHEM, V273, P30218, DOI 10.1074/jbc.273.46.30218; Yan H, 1996, EMBO J, V15, P1064, DOI 10.1002/j.1460-2075.1996.tb00444.x; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	40	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					747	758		10.1074/jbc.M112.402529	http://dx.doi.org/10.1074/jbc.M112.402529			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23139419	Green Published, hybrid			2022-12-28	WOS:000313197200074
J	Cooper, I; Sasson, K; Teichberg, VI; Schnaider-Beeri, M; Fridkin, M; Shechter, Y				Cooper, Itzik; Sasson, Keren; Teichberg, Vivian I.; Schnaider-Beeri, Michal; Fridkin, Mati; Shechter, Yoram			Peptide Derived from HIV-1 TAT Protein Destabilizes a Monolayer of Endothelial Cells in an in Vitro Model of the Blood-Brain Barrier and Allows Permeation of High Molecular Weight Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL CHARACTERIZATION; TIGHT JUNCTIONS; DELIVERY; PERMEABILITY; TRANSDUCTION; EXPRESSION; ASSIGNMENT; DOMAIN; VIVO	Most chemotherapeutic agents are blood-brain barrier (BBB) impermeants. HIV-1-derived TAT protein variants contain a transmembrane domain, which may enable them to cross the BBB and reach the brain. Here we synthesized CAYGRK-KRRQRRR, a peptide containing a cysteine moiety attached to the N terminus of the transmembrane domain (C-TAT peptide), and studied its effects in an in vitro BBB model, which we found to reflect penetration by a receptor-independent pathway. Incubation of the brain capillary endothelial cell monolayer with 0.3-0.6 mu mol/ml of this C-TAT peptide, for a period of 1-2 h, destabilizes brain capillary endothelial cell monolayer and introduces the ability of impermeant therapeutic agents including high molecular weight proteins to penetrate it substantially. The cysteinyl moiety at position 1 of the C-TAT peptide contributes largely to the destabilizing potency and the penetration efficacy of impermeant substances. The destabilizing effect was reversed using heparin. In summary, experimental conditions allowing a significant increase in entry of impermeant low and high molecular weight substances from the luminal (blood) to the abluminal side (brain) were found in an in vitro BBB model reflecting in vivo protein penetrability by a receptor-independent pathway.	[Cooper, Itzik; Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Sasson, Keren; Shechter, Yoram] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Fridkin, Mati] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; [Cooper, Itzik; Schnaider-Beeri, Michal] Sheba Med Ctr, Sagol Neurosci Ctr, IL-52621 Ramat Gan, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Chaim Sheba Medical Center	Cooper, I (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	itzik.cooper@sheba.health.gov.il; mati.fridkin@weizmann.ac.il; yoram.shechter@weizmann.ac.il		cooper, itzik/0000-0003-0723-5542	Weizmann Institute of Science-Sheba Medical Center grant for Biomedical Research	Weizmann Institute of Science-Sheba Medical Center grant for Biomedical Research	This work was supported by a joint Weizmann Institute of Science-Sheba Medical Center grant for Biomedical Research.	Abbott NJ, 2008, CURR DRUG METAB, V9, P901, DOI 10.2174/138920008786485182; Andras IE, 2005, J CEREBR BLOOD F MET, V25, P1159, DOI 10.1038/sj.jcbfm.9600115; Banks WA, 2005, EXP NEUROL, V193, P218, DOI 10.1016/j.expneurol.2004.11.019; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Brown RC, 2004, BRAIN RES, V1014, P221, DOI 10.1016/j.brainres.2004.04.034; Campbell GR, 2005, J BIOL CHEM, V280, P38376, DOI 10.1074/jbc.M506630200; Cooper I, 2011, J NEUROCHEM, V116, P467, DOI 10.1111/j.1471-4159.2010.06934.x; Dakwar GR, 2012, J CONTROL RELEASE, V160, P315, DOI 10.1016/j.jconrel.2011.12.042; DEHOUCK MP, 1990, J NEUROCHEM, V54, P1798, DOI 10.1111/j.1471-4159.1990.tb01236.x; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Doolittle N D, 1998, J Neurosci Nurs, V30, P81; Doolittle ND, 2007, J NEURO-ONCOL, V81, P81, DOI 10.1007/s11060-006-9209-y; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; Gregoire C, 2001, BIOPOLYMERS, V62, P324, DOI 10.1002/bip.10000; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Huber JD, 2002, AM J PHYSIOL-HEART C, V283, pH1531, DOI 10.1152/ajpheart.00027.2002; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; Jarajapu YPR, 2005, J GENE MED, V7, P908, DOI 10.1002/jgm.738; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Malina KCK, 2009, BRAIN RES, V1284, P12, DOI 10.1016/j.brainres.2009.05.072; MOORADIAN AD, 1988, NEUROBIOL AGING, V9, P31, DOI 10.1016/S0197-4580(88)80013-7; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Pardridge WM, 2008, BIOCONJUGATE CHEM, V19, P1327, DOI 10.1021/bc800148t; Pardridge WM, 2010, J DRUG TARGET, V18, P157, DOI 10.3109/10611860903548354; Peloponese JM, 2000, CR ACAD SCI III-VIE, V323, P883, DOI 10.1016/S0764-4469(00)01228-2; RUTTEN MJ, 1987, BRAIN RES, V425, P301, DOI 10.1016/0006-8993(87)90513-0; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Shechter Y, 2002, J MED CHEM, V45, P4264, DOI 10.1021/jm020042t; STONE LA, 1995, NEUROLOGY, V45, P1122, DOI 10.1212/WNL.45.6.1122; van de Waterbeemd H, 1998, J DRUG TARGET, V6, P151, DOI 10.3109/10611869808997889; Xu RF, 2012, BRAIN RES, V1436, P13, DOI 10.1016/j.brainres.2011.11.052; YANG GY, 1994, STROKE, V25, P1658, DOI 10.1161/01.STR.25.8.1658; Zhong Y, 2012, J NEUROSCI, V32, P143, DOI 10.1523/JNEUROSCI.4266-11.2012; Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6	36	19	25	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44676	44683		10.1074/jbc.M112.395384	http://dx.doi.org/10.1074/jbc.M112.395384			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23150670	hybrid, Green Published			2022-12-28	WOS:000312938600063
J	Nissinen, L; Koivunen, J; Kapyla, J; Salmela, M; Nieminen, J; Jokinen, J; Sipila, K; Pihlavisto, M; Pentikainen, OT; Marjamaki, A; Heino, J				Nissinen, Liisa; Koivunen, Jarkko; Kapyla, Jarmo; Salmela, Maria; Nieminen, Jonna; Jokinen, Johanna; Sipila, Kalle; Pihlavisto, Marjo; Pentikainen, Olli T.; Marjamaki, Anne; Heino, Jyrki			Novel alpha 2 beta 1 Integrin Inhibitors Reveal That Integrin Binding to Collagen under Shear Stress Conditions Does Not Require Receptor Preactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; I-DOMAIN; CRYSTAL-STRUCTURE; ALPHA-I-2 DOMAIN; CELL-ADHESION; FIRM ADHESION; A-DOMAIN; ACTIVATION; ALPHA(2)BETA(1); SUBTYPES	The interaction between alpha 2 beta 1 integrin (GPIa/IIa, VLA-2) and vascular collagen is one of the initiating events in thrombus formation. Here, we describe two structurally similar sulfonamide derivatives, BTT-3033 and BTT-3034, and show that, under static conditions, they have an almost identical effect on alpha 2-expressing CHO cell adhesion to collagen I, but only BTT-3033 blocks platelet attachment under flow (90 dynes/cm(2)). Differential scanning fluorimetry showed that both molecules bind to the alpha 2I domain of the recombinant alpha 2 subunit. To further study integrin binding mechanism(s) of the two sulfonamides, we created an alpha 2 Y285F mutant containing a substitution near the metal ion-dependent adhesion site motif in the alpha 2I domain. The action of BTT-3033, unlike that of BTT-3034, was dependent on Tyr-285. In static conditions BTT-3034, but not BTT3033, inhibited collagen binding by an alpha 2 variant carrying a conformationally activating E318W mutation. Conversely, in under flow conditions (90 dynes/cm(2)) BTT-3033, but not BTT-3034, inhibited collagen binding by an alpha 2 variant expressing E336A loss-of-function mutation. Thus, the binding sites for BTT-3033 and BTT-3034 are differentially available in distinct integrin conformations. Therefore, these sulfonamides can be used to study the biological role of different functional stages of alpha 2 beta 1. Furthermore, only the inhibitor that recognized the nonactivated conformation of alpha 2 beta 1 integrin under shear stress conditions effectively blocked platelet adhesion, suggesting that the initial interaction between integrin and collagen takes place prior to receptor activation.	[Nissinen, Liisa; Nieminen, Jonna; Pihlavisto, Marjo; Marjamaki, Anne] BioTie Therapies, FI-20520 Turku, Finland; [Koivunen, Jarkko; Pentikainen, Olli T.] Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland; [Kapyla, Jarmo; Salmela, Maria; Jokinen, Johanna; Sipila, Kalle; Heino, Jyrki] Univ Turku, Dept Biochem & Food Chem, FI-20014 Turku, Finland	University of Jyvaskyla; University of Turku	Heino, J (corresponding author), Univ Turku, Dept Biochem & Food Chem, FI-20014 Turku, Finland.	jyrki.heino@utu.fi	Pentikäinen, Olli T/E-1980-2012; Koivunen, Jarkko/AAF-8012-2020	Pentikäinen, Olli T/0000-0001-7188-4016; Koivunen, Jarkko/0000-0001-8060-555X; Kapyla, Jarmo/0000-0003-3036-713X; Nissinen, Liisa/0000-0002-6743-6736; Salmela, Maria/0000-0003-1949-7101	Academy of Finland; Sigrid Juselius Foundation; Finnish Cancer Association	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Association	This work was supported by grants from the Academy of Finland, the Sigrid Juselius Foundation, and the Finnish Cancer Association. L.N., J.N.,M.P., and A.M. are/have been employees of BioTie Therapies Corp., a biotechnology company that has developed sulfonamide compounds.	Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; Aquilina A, 2002, EUR J BIOCHEM, V269, P1136, DOI 10.1046/j.0014-2956.2001.02740.x; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; Carlsson LE, 1999, BLOOD, V93, P3583, DOI 10.1182/blood.V93.11.3583.410k34_3583_3586; Choi S, 2007, J MED CHEM, V50, P5457, DOI 10.1021/jm070252b; Connors WL, 2007, J BIOL CHEM, V282, P14675, DOI 10.1074/jbc.M700759200; Dunne JL, 2002, BLOOD, V99, P336, DOI 10.1182/blood.V99.1.336; Ivaska J, 1999, J BIOL CHEM, V274, P3513, DOI 10.1074/jbc.274.6.3513; Jokinen J, 2010, EMBO J, V29, P196, DOI 10.1038/emboj.2009.326; Jung SM, 2000, J BIOL CHEM, V275, P8016, DOI 10.1074/jbc.275.11.8016; Jung SM, 2001, EUR J BIOCHEM, V268, P3513, DOI 10.1046/j.1432-1327.2001.02252.x; KAMATA T, 1994, J BIOL CHEM, V269, P26006; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; Kapyla J, 2007, J MED CHEM, V50, P2742, DOI 10.1021/jm070063t; Koivunen JT, 2011, J AM CHEM SOC, V133, P14558, DOI 10.1021/ja206086c; Koivunen JT, 2011, MEDCHEMCOMM, V2, P764, DOI 10.1039/c1md00089f; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Miller MW, 2009, P NATL ACAD SCI USA, V106, P719, DOI 10.1073/pnas.0811622106; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; NIEUWENHUIS HK, 1985, NATURE, V318, P470, DOI 10.1038/318470a0; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Nissinen L, 2010, THROMB HAEMOSTASIS, V103, P387, DOI 10.1160/TH09-06-0358; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pentikainen O, 1999, J BIOL CHEM, V274, P31493, DOI 10.1074/jbc.274.44.31493; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; Salas A, 2006, J BIOL CHEM, V281, P10876, DOI 10.1074/jbc.M512472200; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Salas A, 2002, J BIOL CHEM, V277, P50255, DOI 10.1074/jbc.M209822200; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Tulla M, 2008, EXP CELL RES, V314, P1734, DOI 10.1016/j.yexcr.2008.01.025; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	41	25	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44694	44702		10.1074/jbc.M111.309450	http://dx.doi.org/10.1074/jbc.M111.309450			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23132859	Green Published, hybrid			2022-12-28	WOS:000312938600065
J	Salas, M				Salas, Margarita			My Life with Bacteriophage phi 29	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL-DNA REPLICATION; TERMINAL PROTEIN; GENETIC MESSAGE; BACILLUS-SUBTILIS; TRANSCRIPTION ACTIVATION; STRAND-DISPLACEMENT; RNA-POLYMERASE; CIRCULAR DNA; PHAGE; INITIATION	This article is a survey of my scientific work over 52 years. During my postdoctoral stay in Severo Ochoa's laboratory, I determined the direction of reading of the genetic message, and I discovered two proteins that I showed to be involved in the initiation of protein synthesis. The work I have done in Spain with bacteriophage phi 29 for 45 years has been very rewarding. I can say that I was lucky because I did not expect that phi 29 would give so many interesting results, but I worked hard, with a lot of dedication and enthusiasm, and I was there when the luck arrived. I would like to emphasize our work on the control of phi 29 DNA transcription and, in particular, the finding for the first time of a protein covalently linked to the 5'- ends of phi 29 DNA that we later showed to be the primer for the initiation of phage DNA replication. Very relevant was the discovery of the phi 29 DNA polymerase, with its properties of extremely high processivity and strand displacement capacity, together with its high fidelity. The phi 29 DNA polymerase has become an ideal enzyme for DNA amplification, both rolling- circle and whole- genome linear amplification. I am also very proud of the many brilliant students and collaborators with whom I have worked over the years and who have become excellent scientists. This Reflections article is not intended to be the end ofmy scientific career. I expect to work for many years to come.	Univ Autonoma Madrid, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Salas, M (corresponding author), Univ Autonoma Madrid, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain.	msalas@cbm.uam.es	Salas, Margarita/J-9873-2014	Salas, Margarita/0000-0001-5939-3441	Jane Coffin Childs Memorial Fund for Medical Research, Spain	Jane Coffin Childs Memorial Fund for Medical Research, Spain	I also would like to thank the funding agencies that have supported my work: the Jane Coffin Childs Memorial Fund for Medical Research, which provided the financial support that enabled us to begin our work in Spain; the National Institutes of Health; the European Community; the Spanish Ministry of Education and Science; the Spanish Ministry of Science and Innovation; the Madrid Autonomous Community; and the Fundacion Ramon Areces, which supplied an institutional grant to the CBMSO.	ANDERSON DL, 1966, J BACTERIOL, V91, P2081, DOI 10.1128/JB.91.5.2081-2089.1966; Avila J, 1970, Nature, V226, P1244, DOI 10.1038/2261244a0; Badia D, 2006, MOL CELL, V22, P73, DOI 10.1016/j.molcel.2006.02.019; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BLANCO L, 1985, P NATL ACAD SCI USA, V82, P6404, DOI 10.1073/pnas.82.19.6404; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Blanco L, 1996, J BIOL CHEM, V271, P8509, DOI 10.1074/jbc.271.15.8509; BLANCO L, 1994, P NATL ACAD SCI USA, V91, P12198, DOI 10.1073/pnas.91.25.12198; de Vega M, 2010, P NATL ACAD SCI USA, V107, P16506, DOI 10.1073/pnas.1011428107; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Elias-Arnanz M, 1999, GENE DEV, V13, P2502, DOI 10.1101/gad.13.19.2502; Kamtekar S, 2006, EMBO J, V25, P1335, DOI 10.1038/sj.emboj.7601027; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; LAST JA, 1967, P NATL ACAD SCI USA, V57, P1062, DOI 10.1073/pnas.57.4.1062; MELLADO RP, 1976, J VIROL, V19, P495, DOI 10.1128/JVI.19.2.495-500.1976; Mencia M, 2011, P NATL ACAD SCI USA, V108, P18655, DOI 10.1073/pnas.1114397108; Mendez J, 1997, EMBO J, V16, P2519, DOI 10.1093/emboj/16.9.2519; MENDEZ J, 1992, P NATL ACAD SCI USA, V89, P9579, DOI 10.1073/pnas.89.20.9579; Monsalve M, 1997, MOL CELL, V1, P99, DOI 10.1016/S1097-2765(00)80011-8; Munoz-Espin D, 2010, P NATL ACAD SCI USA, V107, P16548, DOI 10.1073/pnas.1010530107; Munoz-Espin D, 2009, P NATL ACAD SCI USA, V106, P13347, DOI 10.1073/pnas.0906465106; ORTIN J, 1971, NATURE-NEW BIOL, V234, P275, DOI 10.1038/newbio234275a0; PENALVA MA, 1982, P NATL ACAD SCI-BIOL, V79, P5522, DOI 10.1073/pnas.79.18.5522; Redrejo-Rodriguez M, 2012, P NATL ACAD SCI USA, V109, P18482, DOI 10.1073/pnas.1216635109; REKOSH DMK, 1977, CELL, V11, P283, DOI 10.1016/0092-8674(77)90045-9; ROBINSON AJ, 1973, VIROLOGY, V56, P54, DOI 10.1016/0042-6822(73)90287-0; Rodriguez I, 2005, P NATL ACAD SCI USA, V102, P6407, DOI 10.1073/pnas.0500597102; Rojo F, 1998, PROG NUCLEIC ACID RE, V60, P29, DOI 10.1016/S0079-6603(08)60888-0; SALAS M, 1963, J BIOL CHEM, V238, P3535; SALAS M, 1965, J BIOL CHEM, V240, P3988; SALAS M, 1965, J BIOL CHEM, V240, P561; SALAS M, 1978, J MOL BIOL, V119, P269, DOI 10.1016/0022-2836(78)90438-2; SALAS M, 1967, P NATL ACAD SCI USA, V57, P387, DOI 10.1073/pnas.57.2.387; SALAS M, 1996, DNA REPLICATION EUKA, P131; SERRANO M, 1990, SCIENCE, V248, P1012, DOI 10.1126/science.2111580; Serrano-Heras G, 2008, P NATL ACAD SCI USA, V105, P19044, DOI 10.1073/pnas.0808797105; SHAPIRO AL, 1967, BIOCHEM BIOPH RES CO, V28, P815, DOI 10.1016/0006-291X(67)90391-9; SMITH MA, 1966, P NATL ACAD SCI USA, V55, P141, DOI 10.1073/pnas.55.1.141; STANLEY WM, 1966, P NATL ACAD SCI USA, V56, P290, DOI 10.1073/pnas.56.1.290; VINUELA E, 1963, J BIOL CHEM, V238, P1175; VINUELA E, 1967, P NATL ACAD SCI USA, V57, P729, DOI 10.1073/pnas.57.3.729	42	11	11	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44568	44579		10.1074/jbc.X112.433458	http://dx.doi.org/10.1074/jbc.X112.433458			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23124207	hybrid, Green Published			2022-12-28	WOS:000312938600053
J	Ganner, T; Bubner, P; Eibinger, M; Mayrhofer, C; Plank, H; Nidetzky, B				Ganner, Thomas; Bubner, Patricia; Eibinger, Manuel; Mayrhofer, Claudia; Plank, Harald; Nidetzky, Bernd			Dissecting and Reconstructing Synergism IN SITU VISUALIZATION OF COOPERATIVITY AMONG CELLULASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI; CRYSTALLINE CELLULOSE; ENZYMATIC-HYDROLYSIS; CELLOBIOHYDROLASE-I; ENDOGLUCANASE-I; CATALYTIC CORE; ENZYMES; SUBSTRATE; BIOFUELS; LONGIBRACHIATUM	Cellulose is the most abundant biopolymer and a major reservoir of fixed carbon on earth. Comprehension of the elusive mechanism of its enzymatic degradation represents a fundamental problem at the interface of biology, biotechnology, and materials science. The interdependence of cellulose disintegration and hydrolysis and the synergistic interplay among cellulases is yet poorly understood. Here we report evidence from in situ atomic force microscopy (AFM) that delineates degradation of a polymorphic cellulose substrate as a dynamic cycle of alternating exposure and removal of crystalline fibers. Direct observation shows that chain-end-cleaving cellobiohydrolases (CBH I, CBH II) and an internally chain-cleaving endoglucanase (EG), the major components of cellulase systems, take on distinct roles: EG and CBH II make the cellulose surface accessible for CBH I by removing amorphous-unordered substrate areas, thus exposing otherwise embedded crystalline-ordered nanofibrils of the cellulose. Subsequently, these fibrils are degraded efficiently by CBH I, thereby uncovering new amorphous areas. Without prior action of EG and CBH II, CBH I was poorly active on the cellulosic substrate. This leads to the conclusion that synergism among cellulases is morphology-dependent and governed by the cooperativity between enzymes degrading amorphous regions and those targeting primarily crystalline regions. The surface-disrupting activity of cellulases therefore strongly depends on mesoscopic structural features of the substrate: size and packing of crystalline fibers are key determinants of the overall efficiency of cellulose degradation.	[Ganner, Thomas; Plank, Harald] Graz Univ Technol, Inst Electron Microscopy & Fine Struct Res, A-8010 Graz, Austria; [Ganner, Thomas; Mayrhofer, Claudia; Plank, Harald] Ctr Electron Microscopy, A-8010 Graz, Austria; [Bubner, Patricia; Eibinger, Manuel; Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria	Graz University of Technology; Graz University of Technology	Plank, H (corresponding author), Graz Univ Technol, Inst Electron Microscopy & Fine Struct Res, Steyrergasse 17, A-8010 Graz, Austria.	harald.plank@felmi-zfe.at; bernd.nidetzky@tugraz.at		Nidetzky, Bernd/0000-0002-5030-2643	Austrian Science Fund FWF [P 24156-B21]	Austrian Science Fund FWF(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund FWF (Grant P 24156-B21, to B. N.).	Bansal P, 2012, BIORESOURCE TECHNOL, V107, P243, DOI 10.1016/j.biortech.2011.12.063; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Becker D, 2001, BIOCHEM J, V356, P19, DOI 10.1042/0264-6021:3560019; Blanch HW, 2011, BIOTECHNOL J, V6, P1086, DOI 10.1002/biot.201000180; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bubner P, 2012, J BIOL CHEM, V287, P2759, DOI 10.1074/jbc.M111.257717; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Druzhinina IS, 2012, FUNGAL GENET BIOL, V49, P358, DOI 10.1016/j.fgb.2012.02.004; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; GOYAL A, 1991, BIORESOURCE TECHNOL, V36, P37, DOI 10.1016/0960-8524(91)90098-5; Graham-Rowe D, 2011, NATURE, V474, pS6, DOI 10.1038/474S06a; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; Hill J, 2009, P NATL ACAD SCI USA, V106, P2077, DOI 10.1073/pnas.0812835106; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hu JG, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-36; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jarvis M, 2003, NATURE, V426, P611, DOI 10.1038/426611a; Josefsson P, 2008, BIOMACROMOLECULES, V9, P249, DOI 10.1021/bm700980b; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Koivula A, 1996, PROTEIN ENG, V9, P691, DOI 10.1093/protein/9.8.691; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; Kubicek CP, 1996, FUNGAL GENET BIOL, V20, P105, DOI 10.1006/fgbi.1996.0025; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8; Levine SE, 2010, BIOTECHNOL BIOENG, V107, P37, DOI 10.1002/bit.22789; Liu YS, 2011, J BIOL CHEM, V286, P11195, DOI 10.1074/jbc.M110.216556; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mansfield SD, 1999, BIOTECHNOL PROGR, V15, P804, DOI 10.1021/bp9900864; Marx MC, 2001, SOIL BIOL BIOCHEM, V33, P1633, DOI 10.1016/S0038-0717(01)00079-7; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; NIDETZKY B, 1994, BIOCHEM J, V298, P705, DOI 10.1042/bj2980705; NIEVES RA, 1991, APPL ENVIRON MICROB, V57, P3163, DOI 10.1128/AEM.57.11.3163-3170.1991; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Sturcova A, 2004, BIOMACROMOLECULES, V5, P1333, DOI 10.1021/bm034517p; Valjamae P, 1999, EUR J BIOCHEM, V266, P327, DOI 10.1046/j.1432-1327.1999.00853.x; Wang JP, 2012, LANGMUIR, V28, P9664, DOI 10.1021/la301030f; Yang B, 2006, BIOTECHNOL BIOENG, V94, P1122, DOI 10.1002/bit.20942; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; Zhou W, 2010, BIOTECHNOL BIOENG, V107, P224, DOI 10.1002/bit.22814	48	58	59	2	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43215	43222		10.1074/jbc.M112.419952	http://dx.doi.org/10.1074/jbc.M112.419952			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118223	Green Published, hybrid			2022-12-28	WOS:000312940800003
J	He, M; Jenkins, P; Bennett, V				He, Meng; Jenkins, Paul; Bennett, Vann			Cysteine 70 of Ankyrin-G Is S-Palmitoylated and Is Required for Function of Ankyrin-G in Membrane Domain Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXON INITIAL SEGMENT; BRONCHIAL EPITHELIAL-CELLS; PROTEIN PALMITOYLATION; ADHESION MOLECULE; LATERAL MEMBRANE; E-CADHERIN; L1 FAMILY; IN-VIVO; ASSOCIATION; NEUROFASCIN	Ankyrin-G (AnkG) coordinates protein composition of diverse membrane domains, including epithelial lateral membranes and neuronal axon initial segments. However, how AnkG itself localizes to these membrane domains is not understood. We report that AnkG remains on the plasma membrane in Madin-Darby canine kidney (MDCK) cells grown in low calcium, although these cells lack apical-basal polarity and exhibit loss of plasma membrane association of AnkG partners, E-cadherin and beta(2)-spectrin. We subsequently demonstrate using mutagenesis and mass spectrometry that AnkG is S-palmitoylated exclusively at Cys-70, which is located in a loop of the first ankyrin repeat and is conserved in the vertebrate ankyrin family. Moreover, C70A mutation abolishes membrane association of 190-kDa AnkG in MDCK cells grown in low calcium. C70A 190-kDa AnkG fails to restore biogenesis of epithelial lateral membranes in MDCK cells depleted of endogenous AnkG. In addition, C70A 270-kDa AnkG fails to cluster at the axon initial segment of AnkG-depleted cultured hippocampal neurons and fails to recruit neurofascin as well as voltage-gated sodium channels. These effects of C70A mutation combined with evidence for its S-palmitoylation are consistent with a requirement of palmitoylation for targeting and function of AnkG in membrane domain biogenesis at epithelial lateral membranes and neuronal axon initial segments.	[Jenkins, Paul; Bennett, Vann] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [He, Meng] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Jenkins, Paul; Bennett, Vann] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Jenkins, Paul; Bennett, Vann] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Jenkins, Paul; Bennett, Vann] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University; Duke University	Bennett, V (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	vann.bennett@duke.edu	Jenkins, Paul/C-9098-2015	Jenkins, Paul/0000-0002-4207-5823	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018; BENNETT V, 1980, J BIOL CHEM, V255, P2540; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Boiko T, 2007, J NEUROSCI, V27, P590, DOI 10.1523/JNEUROSCI.4302-06.2007; Busche S, 2010, J CELL SCI, V123, P2803, DOI 10.1242/jcs.061887; Delint-Ramirez I, 2011, J BIOL CHEM, V286, P32962, DOI 10.1074/jbc.M111.243899; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Fragoso R, 2003, J IMMUNOL, V170, P913, DOI 10.4049/jimmunol.170.2.913; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Greaves J, 2010, BIOCHEM SOC T, V38, P522, DOI 10.1042/BST0380522; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Henis YI, 2006, METHODS, V40, P183, DOI 10.1016/j.ymeth.2006.02.003; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Jennings BC, 2012, J BIOL CHEM, V287, P7236, DOI 10.1074/jbc.M111.337246; KAISER HW, 1989, J CELL BIOL, V109, P557, DOI 10.1083/jcb.109.2.557; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Kizhatil K, 2009, SCIENCE, V323, P1614, DOI 10.1126/science.1169789; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; MARTINEZPALOMO A, 1980, J CELL BIOL, V87, P736, DOI 10.1083/jcb.87.3.736; MATTEY DL, 1986, J CELL SCI, V85, P95; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; PETERS LL, 1995, J CELL BIOL, V130, P313, DOI 10.1083/jcb.130.2.313; Ren Q, 1998, J NEUROCHEM, V70, P1839; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; SILICIANO JD, 1988, J CELL BIOL, V107, P2389, DOI 10.1083/jcb.107.6.2389; Sobotzik JM, 2009, P NATL ACAD SCI USA, V106, P17564, DOI 10.1073/pnas.0909267106; STAUFENBIEL M, 1988, J BIOL CHEM, V263, P13615; STAUFENBIEL M, 1987, MOL CELL BIOL, V7, P2981, DOI 10.1128/MCB.7.8.2981; Zhang X, 1998, J CELL BIOL, V142, P1571, DOI 10.1083/jcb.142.6.1571; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	43	44	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43995	44005		10.1074/jbc.M112.417501	http://dx.doi.org/10.1074/jbc.M112.417501			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129772	Green Published, hybrid			2022-12-28	WOS:000312940800074
J	Iwasa, M; Aihara, T; Maeda, K; Narita, A; Maeda, Y; Oda, T				Iwasa, Mitsusada; Aihara, Tomoki; Maeda, Kayo; Narita, Akihiro; Maeda, Yuichiro; Oda, Toshiro			Role of the Actin Ala-108-Pro-112 Loop in Actin Polymerization and ATPase Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; F-ACTIN; FILAMENT; COMPLEX; MACROMOLECULES; HYDROLYSIS; ELONGATION; KINETICS; RELEASE; MYOSIN	Actin plays fundamental roles in a variety of cell functions in eukaryotic cells. The polymerization-depolymerization cycle, between monomeric G-actin and fibrous F-actin, drives essential cell processes. Recently, we proposed the atomic model for the F-actin structure and found that actin was in the twisted form in the monomer and in the untwisted form in the filament. To understand how the polymerization process is regulated (Caspar, D. L. (1991) Curr. Biol. 1, 30-32), we need to know further details about the transition from the twisted to the untwisted form. For this purpose, we focused our attention on the Ala-108-Pro-112 loop, which must play crucial roles in the transition, and analyzed the consequences of the amino acid replacements on the polymerization process. As compared with the wild type, the polymerization of P109A was accelerated in both the nucleation and the elongation steps, and this was attributed to an increase in the frequency factor of the Arrhenius equation. The multiple conformations allowed by the substitution presumably resulted in the effective formation of the collision complex, thus accelerating polymerization. On the other hand, the A108G mutation reduced the rates of both nucleation and elongation due to an increase in the activation energy. In the cases of polymerization acceleration and deceleration, each functional aberration is attributed to a distinct elementary process. The rigidity of the loop, which mediates neither too strong nor too weak interactions between subdomains 1 and 3, might play crucial roles in actin polymerization.	[Aihara, Tomoki; Oda, Toshiro] RIKEN SPring 8 Ctr, Xray Struct Anal Team, Sayo, Hyogo 6795148, Japan; [Maeda, Kayo; Narita, Akihiro; Maeda, Yuichiro] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Nagoya, Aichi 4648602, Japan; [Maeda, Kayo; Narita, Akihiro; Maeda, Yuichiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; [Iwasa, Mitsusada; Aihara, Tomoki; Maeda, Kayo; Narita, Akihiro; Maeda, Yuichiro; Oda, Toshiro] Japan Sci & Technol Agcy, RIKEN SPring Ctr 8, ERATO Actin Filament Dynam Project, Sayo, Hyogo 6795148, Japan; [Narita, Akihiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	RIKEN; Nagoya University; Nagoya University; Japan Science & Technology Agency (JST); RIKEN; Japan Science & Technology Agency (JST)	Oda, T (corresponding author), RIKEN SPring 8 Ctr, Xray Struct Anal Team, Kouto 1-1, Sayo, Hyogo 6795148, Japan.	toda@spring8.or.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [23570200]; JSPS [20227008]; Takeda Science Foundation	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 23570200 (to T. O.), JSPS Grant-in-aid for Scientific Research (S) 20227008 (to Y. M. and A. N.), and a special fund from the Takeda Science Foundation (to Y. M.).	Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; CASPAR D L D, 1991, Current Biology, V1, P30, DOI 10.1016/0960-9822(91)90119-H; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W., 2006, PYMOL MOL GRAPHICS S; DRENCKHAHN D, 1986, J BIOL CHEM, V261, P2754; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; Iwasa M, 2008, J BIOL CHEM, V283, P21045, DOI 10.1074/jbc.M800570200; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KASAI M, 1969, BIOCHIM BIOPHYS ACTA, V180, P399, DOI 10.1016/0005-2728(69)90124-8; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Matsuura Y, 2000, J MOL BIOL, V296, P579, DOI 10.1006/jmbi.1999.3467; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; NISHIDA E, 1983, J BIOCHEM-TOKYO, V93, P1011, DOI 10.1093/oxfordjournals.jbchem.a134224; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Oosawa F., 1961, PROG THEOR PHYS SUPP, V17, P14; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pavlicek J, 2008, J BIOL CHEM, V283, P14552, DOI 10.1074/jbc.M800593200; POLLARD TD, 1983, ANAL BIOCHEM, V134, P406, DOI 10.1016/0003-2697(83)90316-0; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Sano KI, 2002, FEBS LETT, V532, P143, DOI 10.1016/S0014-5793(02)03659-1; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Truhlar DG, 2001, P NATL ACAD SCI USA, V98, P848, DOI 10.1073/pnas.98.3.848; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100	29	2	2	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43270	43276		10.1074/jbc.M112.392019	http://dx.doi.org/10.1074/jbc.M112.392019			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23135274	Green Published, hybrid			2022-12-28	WOS:000312940800008
J	Dennis, MD; Jefferson, LS; Kimball, SR				Dennis, Michael D.; Jefferson, Leonard S.; Kimball, Scot R.			Role of p70S6K1-mediated Phosphorylation of eIF4B and PDCD4 Proteins in the Regulation of Protein Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 4E; RAT SKELETAL-MUSCLE; TRANSLATION INITIATION; EUKARYOTIC TRANSLATION; BINDING-PROTEIN; INHIBITS TRANSLATION; MAMMALIAN TARGET; SUPPRESSOR PDCD4; FACTOR 4A; RAPAMYCIN	Modulation of mRNA binding to the 40 S ribosomal subunit during translation initiation controls not only global rates of protein synthesis but also regulates the pattern of protein expression by allowing for selective inclusion, or exclusion, of mRNAs encoding particular proteins from polysomes. The mRNA binding step is modulated by signaling through a protein kinase known as the mechanistic target of rapamycin complex 1 (mTORC1). mTORC1 directly phosphorylates the translational repressors eIF4E binding proteins (4E-BP) 1 and 2, releasing them from the mRNA cap binding protein eIF4E, thereby promoting assembly of the eIF4E.eIF4G complex. mTORC1 also phosphorylates the 70-kDa ribosomal protein S6 kinase 1 (p70S6K1), which subsequently phosphorylates eIF4B, and programmed cell death 4 (PDCD4), which sequesters eIF4A from the eIF4E.eIF4G complex, resulting in repressed translation of mRNAs with highly structured 5'-untranslated regions. In the present study, we compared the role of the 4E-BPs in the regulation of global rates of protein synthesis to that of eIF4B and PDCD4. We found that maintenance of eIF4E interaction with eIF4G was not by itself sufficient to sustain global rates of protein synthesis in the absence of mTORC1 signaling to p70S6K1; phosphorylation of both eIF4B and PDCD4 was additionally required. We also found that the interaction of eIF4E with eIF4G was maintained in the liver of fasted rats as well as in serum-deprived mouse embryo fibroblasts lacking both 4E-BP1 and 4E-BP2, suggesting that the interaction of eIF4G with eIF4E is controlled primarily through the 4E-BPs.	[Dennis, Michael D.; Jefferson, Leonard S.; Kimball, Scot R.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kimball, SR (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, H166,500 Univ Dr, Hershey, PA 17033 USA.	skimball@psu.edu		Dennis, Michael/0000-0002-0645-6864	National Institutes of Health [DK13499, DK088416]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013499, R37DK013499, F32DK088416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK13499 (to L. S. J.) and DK088416 (to M. D. D.).	Bolster DR, 2004, J NUTR, V134, P1704, DOI 10.1093/jn/134.7.1704; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Huang BPH, 2009, AM J PHYSIOL-HEART C, V296, pH505, DOI 10.1152/ajpheart.01105.2008; Huo YL, 2012, BIOCHEM J, V444, P141, DOI 10.1042/BJ20112107; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Kimball SR, 1997, AM J PHYSIOL-CELL PH, V272, pC754, DOI 10.1152/ajpcell.1997.272.2.C754; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Luo J, 2005, J CELL BIOL, V170, P455, DOI 10.1083/jcb.200503088; Miyazaki M, 2010, FEBS J, V277, P2180, DOI 10.1111/j.1742-4658.2010.07635.x; Nielsen KH, 2011, NUCLEIC ACIDS RES, V39, P2678, DOI 10.1093/nar/gkq1206; Ozes AR, 2011, J MOL BIOL, V412, P674, DOI 10.1016/j.jmb.2011.08.004; Olanich ME, 2011, ONCOGENE, V30, P77, DOI 10.1038/onc.2010.404; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Poulin F, 1998, J BIOL CHEM, V273, P14002, DOI 10.1074/jbc.273.22.14002; Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Sans MD, 2004, BIOCHEM BIOPH RES CO, V319, P144, DOI 10.1016/j.bbrc.2004.04.164; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tuckow AP, 2011, AM J PHYSIOL-ENDOC M, V300, pE564, DOI 10.1152/ajpendo.00383.2010; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Winter JN, 2011, AM J PHYSIOL-CELL PH, V300, pC1172, DOI 10.1152/ajpcell.00504.2010; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yoshizawa F, 1998, AM J PHYSIOL-ENDOC M, V275, pE814, DOI 10.1152/ajpendo.1998.275.5.E814	35	90	92	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42890	42899		10.1074/jbc.M112.404822	http://dx.doi.org/10.1074/jbc.M112.404822			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105104	Green Published, hybrid			2022-12-28	WOS:000312501600047
J	Gabrielli, N; Ayte, J; Hidalgo, E				Gabrielli, Natalia; Ayte, Jose; Hidalgo, Elena			Cells Lacking Pfh1, a Fission Yeast Homolog of Mammalian Frataxin Protein, Display Constitutive Activation of the Iron Starvation Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING FACTOR PHP4; FRIEDREICHS-ATAXIA; OXIDATIVE STRESS; GENE-EXPRESSION; DEFICIENCY; PAP1; ACCUMULATION; ACONITASE; FEP1; CARDIOMYOPATHY	Friedreich ataxia is a genetic disease caused by deficiencies in frataxin. This protein has homologs not only in higher eukaryotes but also in bacteria, fungi, and plants. The function of this protein is still controversial. We have identified a frataxin homolog in fission yeast, and we have analyzed whether its depletion leads to any of the phenotypes observed in other organisms. Cells deleted in pfh1 are sensitive to growth under aerobic conditions, display increased levels of total iron, hallmarks of oxidative stress such as protein carbonylation, decreased aconitase activity, and lower levels of oxygen consumption compared with wild-type cells. This mitochondrial protein seems to be important for iron and/or reactive oxygen species homeostasis. We have analyzed the proteome of cells devoid of Pfh1, and we determined that gene products up-and down-regulated upon iron depletion in wild-type cells are constitutively misregulated in this mutant. Because of the particular signaling pathway components governing the iron starvation response in fission yeast, our experiments suggest that cells lacking Pfh1 display a decrease of cytosolic available iron that triggers activation of Grx4, the common regulator of the iron starvation gene expression program. Our Schizosaccharomyces pombe Delta pfh1 strain constitutes a new and useful model system to study Friedreich ataxia.	[Gabrielli, Natalia; Ayte, Jose; Hidalgo, Elena] Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, Dept Ciencies Expt & Salut, Barcelona 08003, Spain	Pompeu Fabra University	Hidalgo, E (corresponding author), Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, Dept Ciencies Expt & Salut, C Dr Aiguader 88, Barcelona 08003, Spain.	elena.hidalgo@upf.edu	Hidalgo, Elena/K-2919-2014; Ayte, Jose/L-5217-2014	Hidalgo, Elena/0000-0002-3768-6785; Ayte, Jose/0000-0002-6354-0536	Spanish Ministry of Science and Innovation [BFU2009-06933, BFU2012-32045]; PLAN E; FEDER; Spanish Program Consolider-Ingenio [CSD 2007-0020]; Generalitat de Catalunya (Spain) [SGR2009-196]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); PLAN E; FEDER(European Commission); Spanish Program Consolider-Ingenio; Generalitat de Catalunya (Spain)(Generalitat de Catalunya)	This work was supported in part by Spanish Ministry of Science and Innovation Grants BFU2009-06933 and BFU2012-32045, PLAN E, FEDER, by Spanish Program Consolider-Ingenio 2010 Grant CSD 2007-0020, and by Generalitat de Catalunya (Spain) Grant SGR2009-196 (to E. H.).	Alfa C, 1993, EXPT FISSION YEAST L; Armstrong JS, 2010, FASEB J, V24, P2152, DOI 10.1096/fj.09-143222; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Calvo IA, 2012, NUCLEIC ACIDS RES, V40, P4816, DOI 10.1093/nar/gks141; Calvo IA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006619; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Castillo EA, 2003, J BIOL CHEM, V278, P40565, DOI 10.1074/jbc.M305859200; Castillo EA, 2002, MOL MICROBIOL, V45, P243, DOI 10.1046/j.1365-2958.2002.03020.x; Chaudhuri AR, 2006, MECH AGEING DEV, V127, P849, DOI 10.1016/j.mad.2006.08.006; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Foury F, 1999, FEBS LETT, V456, P281, DOI 10.1016/S0014-5793(99)00961-8; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; Garcia-Santamarina S, 2011, J PROTEOMICS, V74, P2476, DOI 10.1016/j.jprot.2011.05.030; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Hausse AO, 2002, HEART, V87, P346, DOI 10.1136/heart.87.4.346; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; Huang MLH, 2009, P NATL ACAD SCI USA, V106, P16381, DOI 10.1073/pnas.0906784106; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; LAMARCHE JB, 1980, CAN J NEUROL SCI, V7, P389, DOI 10.1017/S0317167100022927; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Leupold U., 1970, METHODS CELL PHYSL, V4, P169; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Mercier A, 2009, J BIOL CHEM, V284, P20249, DOI 10.1074/jbc.M109.009563; Moreno-Cermeno A, 2010, J BIOL CHEM, V285, P41653, DOI 10.1074/jbc.M110.149443; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Puccio H, 2000, HUM MOL GENET, V9, P887, DOI 10.1093/hmg/9.6.887; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Sanso M, 2008, EUKARYOT CELL, V7, P826, DOI 10.1128/EC.00465-07; Tamarit J, 2006, ANAL BIOCHEM, V351, P149, DOI 10.1016/j.ab.2005.12.001; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Zuin A, 2005, J BIOL CHEM, V280, P36708, DOI 10.1074/jbc.M508400200; Zuin A, 2010, EMBO J, V29, P981, DOI 10.1038/emboj.2009.407	52	15	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43042	43051		10.1074/jbc.M112.421735	http://dx.doi.org/10.1074/jbc.M112.421735			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23115244	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000312501600060
J	Yuan, H; Marmorstein, R				Yuan, Hua; Marmorstein, Ronen			Structural Basis for Sirtuin Activity and Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SMALL-MOLECULE ACTIVATORS; PROTEIN DEACETYLASE; NICOTINAMIDE INHIBITION; CRYSTAL-STRUCTURE; SIR2 FAMILY; ADP-RIBOSE; MECHANISM; HOMOLOG; RESVERATROL; SPECIFICITY	Sir2 proteins, or sirtuins, are a family of enzymes that catalyze NAD(+)-dependent deacetylation reactions and can also process ribosyltransferase, demalonylase, and desuccinylase activities. More than 40 crystal structures of sirtuins have been determined, alone or in various liganded forms. These high-resolution architectural details lay the foundation for understanding the molecular mechanisms of catalysis, regulation, substrate specificity, and inhibition of sirtuins. In this minireview, we summarize these structural features and discuss their implications for understanding sirtuin function.	[Yuan, Hua; Marmorstein, Ronen] Wistar Inst Anat & Biol, Program Gene Express & Regulat, Philadelphia, PA 19104 USA; [Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania	Marmorstein, R (corresponding author), Wistar Inst Anat & Biol, Program Gene Express & Regulat, Philadelphia, PA 19104 USA.	marmor@wistar.org			NIA NIH HHS [P01 AG031862] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Avalos JL, 2004, MOL CELL, V13, P639, DOI 10.1016/S1097-2765(04)00082-6; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Bheda P, 2011, PROTEIN SCI, V20, P131, DOI 10.1002/pro.544; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Chakrabarty SP, 2010, BBA-PROTEINS PROTEOM, V1804, P1743, DOI 10.1016/j.bbapap.2010.06.010; Chang JH, 2002, J BIOL CHEM, V277, P34489, DOI 10.1074/jbc.M205460200; Cosgrove MS, 2006, BIOCHEMISTRY-US, V45, P7511, DOI 10.1021/bi0526332; Dai H, 2010, J BIOL CHEM, V285, P32695, DOI 10.1074/jbc.M110.133892; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Garske AL, 2006, BIOCHEMISTRY-US, V45, P94, DOI 10.1021/bi052015l; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Hawse WF, 2008, STRUCTURE, V16, P1368, DOI 10.1016/j.str.2008.05.015; Hirsch BM, 2011, MOL BIOSYST, V7, P16, DOI 10.1039/c0mb00033g; Hoff KG, 2006, STRUCTURE, V14, P1231, DOI 10.1016/j.str.2006.06.006; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Jin L, 2009, J BIOL CHEM, V284, P24394, DOI 10.1074/jbc.M109.014928; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Khan AN, 2005, J BIOL CHEM, V280, P36073, DOI 10.1074/jbc.M508247200; Kim EJ, 2008, BMB REP, V41, P751, DOI 10.5483/BMBRep.2008.41.11.751; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Mahajan S. S., 2011, HDB EXPT PHARM HISTO, P241; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pan M, 2012, J BIOL CHEM, V287, P2468, DOI 10.1074/jbc.M111.285031; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Prasad GS, 1999, NAT STRUCT BIOL, V6, P1126; Sanders BD, 2007, MOL CELL, V25, P463, DOI 10.1016/j.molcel.2006.12.022; Sanders BD, 2010, BBA-PROTEINS PROTEOM, V1804, P1604, DOI 10.1016/j.bbapap.2009.09.009; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Schuetz A, 2007, STRUCTURE, V15, P377, DOI 10.1016/j.str.2007.02.002; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Wolberger C, 2007, MOL CELL, V28, P1102, DOI 10.1016/j.molcel.2007.12.006; Zhao KH, 2003, NAT STRUCT BIOL, V10, P864, DOI 10.1038/nsb978; Zhao KH, 2004, J MOL BIOL, V337, P731, DOI 10.1016/j.jmb.2004.01.060; Zhao KH, 2003, STRUCTURE, V11, P1403, DOI 10.1016/j.str.2003.09.016; Zhao KH, 2004, P NATL ACAD SCI USA, V101, P8563, DOI 10.1073/pnas.0401057101	53	88	88	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42428	42435		10.1074/jbc.R112.372300	http://dx.doi.org/10.1074/jbc.R112.372300			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23086949	Green Published, hybrid			2022-12-28	WOS:000312501600003
J	Zaarour, N; Demaretz, S; Defontaine, N; Zhu, YY; Laghmani, K				Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Zhu, Yingying; Laghmani, Kamel			Multiple Evolutionarily Conserved Di-leucine Like Motifs in the Carboxyl Terminus Control the Anterograde Trafficking of NKCC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-CHLORIDE COTRANSPORTERS; CELL-SURFACE EXPRESSION; K-CL COTRANSPORTER; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; ER EXPORT; SECRETORY PATHWAY; ENDOCYTIC PATHWAY; CYTOPLASMIC TAIL; BARTTER-SYNDROME	Mutations in the apical Na-K-2Cl co-transporter, NKCC2, cause type I Bartter syndrome, a life-threatening kidney disease. Yet the mechanisms underlying the regulation of NKCC2 trafficking in renal cells are scarcely known. We previously showed that naturally occurring mutations depriving NKCC2 of its distal COOH-terminal tail and interfering with the (LLV1083)-L-1081 motif result in defects in the ER exit of the co-transporter. Here we show that this motif is necessary but not sufficient for anterograde trafficking of NKCC2. Indeed, we have identified two additional hydrophobic motifs, (LL1039)-L-1038 and (LI1049)-L-1048, that are required for ER exit and surface expression of the co-transporter. Double mutations of (LL1039)-L-1038 or (LI1049)-L-1048 to di-alanines disrupted glycosylation and cell surface expression of NKCC2, independently of the expression system. Pulse-chase analysis demonstrated that the absence of the terminally glycosylated form of NKCC2 was not due to reduced synthesis or increased rates of degradation of mutant co-transporters, but was instead caused by defects in maturation. Co-immunolocalization experiments revealed that (1038)AA(1039) and (1048)AA(1049) were trapped mainly in the ER as indicated by extensive co-localization with the ER marker calnexin. Remarkably, among several analyzed motifs present in the NKCC2 COOH terminus, only those required for ER exit and surface expression of NKCC2 are evolutionarily conserved in all members of the SLC12A family, a group of cation-chloride co-transporters that are targets of therapeutic drugs and mutated in several human diseases. Based upon these data, we propose abnormal anterograde trafficking as a common mechanism associated with mutations depriving NKCC2, and also all other members of the SLC12A family, of their COOH terminus.	[Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Zhu, Yingying; Laghmani, Kamel] INSERM, Ctr Rech Cordeliers, UMRS872, Paris, France; [Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Zhu, Yingying; Laghmani, Kamel] CNRS, ERL7226, F-75006 Paris, France; [Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Zhu, Yingying; Laghmani, Kamel] Univ Paris 06, F-75006 Paris, France; [Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Zhu, Yingying; Laghmani, Kamel] Univ Paris 05, Fac Med, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Laghmani, K (corresponding author), UMRS 872 Equipe 3 ERL7226, 15 Rue Ecole Med, F-75270 Paris 06, France.	Kamel.Laghmani@crc.jussieu.fr	Laghmani, Kamel/AIE-9621-2022	Laghmani, Kamel/0000-0002-2167-5766	INSERM, Paris, France; Fondation pour la Recherche Medicale (FRM); la Societe de Neprologie	INSERM, Paris, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); la Societe de Neprologie	This work was supported by grants from INSERM, Paris, France.; Recipient of a thesis fellowship from Fondation pour la Recherche Medicale (FRM) and from la Societe de Neprologie.	Acuna R, 2011, J HYPERTENS, V29, P475, DOI 10.1097/HJH.0b013e328341d0fd; Adachi M, 2007, ENDOCR J, V54, P1003, DOI 10.1507/endocrj.K06-204; Ares GR, 2011, AM J PHYSIOL-RENAL, V301, pF1143, DOI 10.1152/ajprenal.00396.2011; Bello V, 2001, MOL BIOL CELL, V12, P3004, DOI 10.1091/mbc.12.10.3004; Benziane B, 2007, J BIOL CHEM, V282, P33817, DOI 10.1074/jbc.M700195200; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Caplan MJ, 1997, AM J PHYSIOL-RENAL, V272, pF425, DOI 10.1152/ajprenal.1997.272.4.F425; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Delpire E, 2000, NEWS PHYSIOL SCI, V15, P309, DOI 10.1152/physiologyonline.2000.15.6.309; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gassmann M, 2005, MOL PHARMACOL, V68, P137, DOI 10.1124/mol.104.010256; Gavrikov KE, 2006, P NATL ACAD SCI USA, V103, P18793, DOI 10.1073/pnas.0604551103; Hasdemir B, 2005, J CELL BIOL, V171, P459, DOI 10.1083/jcb.200506005; Howell GJ, 2006, INT REV CYTOL, V252, P1, DOI 10.1016/S0074-7696(06)52005-4; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Isenring P, 1998, J BIOL CHEM, V273, P11295, DOI 10.1074/jbc.273.18.11295; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Kalandadze A, 2004, J NEUROSCI, V24, P5183, DOI 10.1523/JNEUROSCI.0839-04.2004; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; Kasai K, 2008, CELL MOL BIOL LETT, V13, P144, DOI 10.2478/s11658-007-0043-9; Kupershmidt S, 2002, J BIOL CHEM, V277, P27442, DOI 10.1074/jbc.M112375200; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Li PL, 2011, CIRC RES, V108, P458, DOI 10.1161/CIRCRESAHA.110.227835; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Monette MY, 2011, AM J PHYSIOL-RENAL, V300, pF840, DOI 10.1152/ajprenal.00552.2010; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Mount DB, 2006, AM J PHYSIOL-RENAL, V290, pF606, DOI 10.1152/ajprenal.00410.2005; Muth TR, 2003, ANNU REV CELL DEV BI, V19, P333, DOI 10.1146/annurev.cellbio.19.110701.161425; Nezu A, 2009, J BIOL CHEM, V284, P6869, DOI 10.1074/jbc.M804302200; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nufer O, 2002, J CELL SCI, V115, P619; Parvin MN, 2007, BIOCHEMISTRY-US, V46, P9630, DOI 10.1021/bi700881a; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Pietila EM, 2005, J BIOL CHEM, V280, P26622, DOI 10.1074/jbc.M413815200; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; Reiterer V, 2008, J NEUROSCI, V28, P12453, DOI 10.1523/JNEUROSCI.3451-08.2008; Ren XQ, 2005, J NEUROSCI, V25, P6676, DOI 10.1523/JNEUROSCI.1079-05.2005; Roy G, 2010, MOL BIOL CELL, V21, P597, DOI 10.1091/mbc.E09-05-0427; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Sabath E, 2004, AM J PHYSIOL-RENAL, V287, pF195, DOI 10.1152/ajprenal.00044.2004; SANDOVAL IV, 1994, J BIOL CHEM, V269, P6622; Schepetilnikov MV, 2005, J GEN VIROL, V86, P2379, DOI 10.1099/vir.0.80865-0; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; SHIN J, 1991, P NATL ACAD SCI USA, V88, P1918, DOI 10.1073/pnas.88.5.1918; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Valdenaire O, 1999, J CELL SCI, V112, P3115; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Vargas-Poussou R, 1998, AM J HUM GENET, V62, P1332, DOI 10.1086/301872; Vincent MJ, 1998, J BIOL CHEM, V273, P950, DOI 10.1074/jbc.273.2.950; Vitale A, 1999, PLANT CELL, V11, P615, DOI 10.1105/tpc.11.4.615; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; Zaarour N, 2011, J BIOL CHEM, V286, P9489, DOI 10.1074/jbc.M110.166546; Zaarour N, 2009, J BIOL CHEM, V284, P21752, DOI 10.1074/jbc.M109.000679; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034	71	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42642	42653		10.1074/jbc.M112.399162	http://dx.doi.org/10.1074/jbc.M112.399162			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105100	Green Published, hybrid			2022-12-28	WOS:000312501600025
J	Ahrens, S; Geissler, B; Satchell, KJF				Ahrens, Sebastian; Geissler, Brett; Satchell, Karla J. F.			Identification of a His-Asp-Cys Catalytic Triad Essential for Function of the Rho Inactivation Domain (RID) of Vibrio cholerae MARTX Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING DOMAIN; RTX TOXIN; GENE-CLUSTER; ACTIN; INTESTINE; RESIDUES; DELIVERY	Vibrio cholerae is the causative agent of the severe diarrheal disease cholera. For V. cholerae to colonize the intestinal epithelium, accessory toxins such as the multifunctional autoprocessing repeats-in-toxin (MARTX(Vc)) toxin are required. MARTX toxins are composite toxins comprised of arrayed effector domains that carry out distinct functions inside the host cell. Among the three effector domains of MARTX(Vc) is the Rho inactivation domain (RIDVc) known to cause cell rounding through inactivation of small RhoGTPases. Using alanine scanning mutagenesis in the activity subdomain of RIDVc, four residues, His-2782, Leu-2851, Asp-2854, and Cys-3022, were identified as impacting RIDVc function in depolymerization of the actin cytoskeleton and inactivation of RhoA. Tyr-2807 and Tyr-3015 were identified as important potentially for forming the active structure for substrate contact but are not involved in catalysis or post translational modifications. Finally, V. cholerae strains modified to carry a catalytically inactive RIDVc show that the rate and efficiency of MARTX(Vc) actin cross-linking activity does not depend on a functional RIDVc, demonstrating that these domains function independently in actin depolymerization. Overall, our results indicate a His-Asp-Cys catalytic triad is essential for function of the RID effector domain family shared by MARTX toxins produced by many Gram-negative bacteria.	[Ahrens, Sebastian; Geissler, Brett; Satchell, Karla J. F.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Satchell, KJF (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, 320 E Super Ave,Searle 3-525, Chicago, IL 60611 USA.	k-satchell@northwestern.edu	Satchell, Karla/GSN-3100-2022		National Institutes of Health [RO1 AI051490]; Burroughs Wellcome Investigators in Pathogenesis of Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Investigators in Pathogenesis of Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI051490 (to K. J. F. S.). This work was also supported by Burroughs Wellcome Investigators in Pathogenesis of Infectious Diseases (to K. J. F. S.).	Ballard JD, 1996, P NATL ACAD SCI USA, V93, P12531, DOI 10.1073/pnas.93.22.12531; Barrett AJ, 2001, BIOL CHEM, V382, P727, DOI 10.1515/BC.2001.088; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Boardman Bethany Kay, 2009, P433; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Cullinane M, 2008, AUTOPHAGY, V4, P744, DOI 10.4161/auto.6246; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Egerer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000942; Fullner KJ, 1999, INFECT IMMUN, V67, P1393, DOI 10.1128/IAI.67.3.1393-1404.1999; Geissler B, 2012, CELL MICROBIOL, V14, P286, DOI 10.1111/j.1462-5822.2011.01718.x; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; Geissler B, 2009, MOL MICROBIOL, V73, P858, DOI 10.1111/j.1365-2958.2009.06810.x; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; Kim YR, 2008, CELL MICROBIOL, V10, P848, DOI 10.1111/j.1462-5822.2007.01088.x; Kudryashov DS, 2008, P NATL ACAD SCI USA, V105, P18537, DOI 10.1073/pnas.0808082105; Kwak JS, 2011, P NATL ACAD SCI USA, V108, P1645, DOI 10.1073/pnas.1014339108; Le Roux F, 2011, ENVIRON MICROBIOL, V13, P296, DOI 10.1111/j.1462-2920.2010.02329.x; Li L, 2008, INFECT IMMUN, V76, P2620, DOI 10.1128/IAI.01308-07; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Olivier V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007352; Pei JM, 2009, PROTEINS, V77, P413, DOI 10.1002/prot.22447; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Prochazkova K, 2009, J BIOL CHEM, V284, P26557, DOI 10.1074/jbc.M109.025510; Queen J, 2012, INFECT IMMUN, V80, P2905, DOI 10.1128/IAI.00356-12; Rasband W., 2006, IMAGEJ; Roig FJ, 2011, APPL ENVIRON MICROB, V77, P657, DOI 10.1128/AEM.01806-10; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Satchell KJF, 2009, TOXINS, V1, P123, DOI 10.3390/toxins1020123; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Sheahan KL, 2007, CELL MICROBIOL, V9, P1324, DOI 10.1111/j.1462-5822.2006.00876.x; Sheahan KL, 2004, P NATL ACAD SCI USA, V101, P9798, DOI 10.1073/pnas.0401104101; Shen A, 2009, NAT CHEM BIOL, V5, P469, DOI 10.1038/nchembio.178; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Spyres LM, 2001, INFECT IMMUN, V69, P599, DOI 10.1128/IAI.69.1.599-601.2001	39	27	28	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1397	1408		10.1074/jbc.M112.396309	http://dx.doi.org/10.1074/jbc.M112.396309			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184949	Green Published, hybrid			2022-12-28	WOS:000313570300060
J	Chaurasia, P; Sen, R; Bhaumik, SR				Chaurasia, Priyasri; Sen, Rwik; Bhaumik, Sukesh R.			Functional Analysis of Rad14p, a DNA Damage Recognition Factor in Nucleotide Excision Repair, in Regulation of Transcription in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PIGMENTOSUM GROUP-A; TERMINAL DOMAIN KINASE; XERODERMA-PIGMENTOSUM; SACCHAROMYCES-CEREVISIAE; CANCER RISK; XPA A23G; POLYMORPHISMS; GENE; YEAST	Rad14p is a DNA damage recognition factor in nucleotide excision repair. Intriguingly, we show here that Rad14p associates with the promoter of a galactose-inducible GAL1 gene after transcriptional induction in the absence of DNA lesion. Such an association of Rad14p facilitates the recruitment of TBP, TFIIH, and RNA polymerase II to the GAL1 promoter. Furthermore, the association of RNA polymerase II with the GAL1 promoter is significantly decreased in the absence of Rad14p, when the coding sequence was deleted. These results support the role of Rad14p in transcriptional initiation. Consistently, the level of GAL1 mRNA is significantly decreased in the absence of Rad14p. Similar results are also obtained at other galactose-inducible GAL genes such as GAL7 and GAL10. Likewise, Rad14p promotes transcription of other non-GAL genes such as CUP1, CTT1, and STL1 after transcriptional induction. However, the effect of Rad14p on the steady-state levels of transcription of GAL genes or constitutively active genes such as ADH1, PGK1, PYK1, and RPS5 is not observed. Thus, Rad14p promotes initial transcription but does not appear to regulate the steady-state level. Collectively, our results unveil a new role of Rad14p in stimulating transcription in addition to its well-known function in nucleotide excision repair.	[Chaurasia, Priyasri; Sen, Rwik; Bhaumik, Sukesh R.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Bhaumik, SR (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	sbhaumik@siumed.edu		Sen, Rwik/0000-0003-2853-2378	National Institutes of Health [1R15GM088798-01]; American Heart Association (Greater Midwest Affiliate) [10GRNT4300059]; Mallinckrodt Foundation grant; Excellence in Academic Medicine (EAM) grants from Southern Illinois University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM088798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (Greater Midwest Affiliate)(American Heart Association); Mallinckrodt Foundation grant; Excellence in Academic Medicine (EAM) grants from Southern Illinois University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R15GM088798-01. This work was also supported by American Heart Association (Greater Midwest Affiliate) Grant-in-aid 10GRNT4300059, a Mallinckrodt Foundation grant, and Excellence in Academic Medicine (EAM) grants from Southern Illinois University School of Medicine.	Abbasi R, 2009, INT J CANCER, V125, P1431, DOI 10.1002/ijc.24442; ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Andressoo JO, 2006, CELL CYCLE, V5, P2886, DOI 10.4161/cc.5.24.3565; Ausubel F. M., 2001, CURRENT PROTOCOLS MO; BANKMANN M, 1992, NATURE, V355, P555, DOI 10.1038/355555a0; Bau DT, 2007, CHINESE J PHYSIOL, V50, P294; Bergoglio V, 2006, GENOME DYN, V1, P35, DOI 10.1159/000092499; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Bhaumik SR, 2003, METHOD ENZYMOL, V370, P445; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Bhaumik SR, 2011, BBA-GENE REGUL MECH, V1809, P97, DOI 10.1016/j.bbagrm.2010.08.009; Bhaumik SR, 2008, CRIT REV BIOCHEM MOL, V43, P419, DOI 10.1080/10409230802605914 ; Butkiewicz D, 2004, CANCER EPIDEM BIOMAR, V13, P2242; CISMOWSKI MJ, 1995, MOL CELL BIOL, V15, P2983; Costa RMA, 2003, BIOCHIMIE, V85, P1083, DOI 10.1016/j.biochi.2003.10.017; Crew KD, 2007, CANCER EPIDEM BIOMAR, V16, P2033, DOI 10.1158/1055-9965.EPI-07-0096; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; De Ruyck K, 2007, MUTAT RES-GEN TOX EN, V631, P101, DOI 10.1016/j.mrgentox.2007.03.010; Dong ZM, 2008, J CLIN GASTROENTEROL, V42, P910, DOI 10.1097/MCG.0b013e3180f6262c; Guo W, 2008, J CANCER RES CLIN, V134, P263, DOI 10.1007/s00432-007-0283-0; Guzder SN, 1996, J BIOL CHEM, V271, P8903, DOI 10.1074/jbc.271.15.8903; Guzder SN, 2006, MOL CELL BIOL, V26, P1135, DOI 10.1128/MCB.26.3.1135-1141.2006; GUZDER SN, 1993, P NATL ACAD SCI USA, V90, P5433, DOI 10.1073/pnas.90.12.5433; GUZDER SN, 1995, J BIOL CHEM, V270, P12973, DOI 10.1074/jbc.270.22.12973; Habraken Y, 1996, P NATL ACAD SCI USA, V93, P10718, DOI 10.1073/pnas.93.20.10718; HABRAKEN Y, 1993, NATURE, V366, P365, DOI 10.1038/366365a0; Hall J, 2007, CARCINOGENESIS, V28, P665, DOI 10.1093/carcin/bgl160; Hansen RD, 2007, MUTAT RES-FUND MOL M, V619, P68, DOI 10.1016/j.mrfmmm.2007.02.002; Jelonek K, 2010, J APPL GENET, V51, P343, DOI 10.1007/BF03208865; Keogh MC, 2002, MOL CELL BIOL, V22, P1288, DOI 10.1128/MCB.22.5.1288-1297.2002; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lee SK, 2002, MOL CELL BIOL, V22, P4383, DOI 10.1128/MCB.22.12.4383-4389.2002; Lee SK, 2002, CELL, V109, P823, DOI 10.1016/S0092-8674(02)00795-X; Leibeling D, 2006, J MOL HISTOL, V37, P225, DOI 10.1007/s10735-006-9041-x; Lichon Vanessa, 2007, J Drugs Dermatol, V6, P281; Lin J, 2008, CARCINOGENESIS, V29, P2112, DOI 10.1093/carcin/bgn189; Liu J, 2012, MOL BIOL REP, V39, P6791, DOI 10.1007/s11033-012-1504-4; Lockett KL, 2005, CANCER LETT, V220, P125, DOI 10.1016/j.canlet.2004.08.019; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Magnaldo T, 2004, CELLS TISSUES ORGANS, V177, P189, DOI 10.1159/000079993; Malik S, 2012, NUCLEIC ACIDS RES, V40, P3348, DOI 10.1093/nar/gkr1244; Malik S, 2010, NUCLEIC ACIDS RES, V38, P1461, DOI 10.1093/nar/gkp1147; Mardiros A, 2011, ACTA HISTOCHEM, V113, P409, DOI 10.1016/j.acthis.2010.03.005; Miller KL, 2006, CARCINOGENESIS, V27, P1670, DOI 10.1093/carcin/bgi376; Nouspikel T, 2008, DNA REPAIR, V7, P1155, DOI 10.1016/j.dnarep.2008.03.015; Palli D, 2010, MUTAGENESIS, V25, P569, DOI 10.1093/mutage/geq042; Pan J, 2009, CARCINOGENESIS, V30, P785, DOI 10.1093/carcin/bgp058; Park JY, 2002, CANCER EPIDEM BIOMAR, V11, P993; PETERSON CL, 1991, CELL, V64, P1135, DOI 10.1016/0092-8674(91)90268-4; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Qian BY, 2011, LUNG CANCER, V73, P138, DOI 10.1016/j.lungcan.2010.11.018; Raaschou-Nielsen O, 2008, LUNG CANCER, V59, P171, DOI 10.1016/j.lungcan.2007.08.018; Rademakers S, 2003, MOL CELL BIOL, V23, P5755, DOI 10.1128/MCB.23.16.5755-5767.2003; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; Reardon JT, 2002, MOL CELL BIOL, V22, P5938, DOI 10.1128/MCB.22.16.5938-5945.2002; Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000; Rodriguez K, 1998, J BIOL CHEM, V273, P34180, DOI 10.1074/jbc.273.51.34180; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; SIKORSKI RS, 1989, GENETICS, V122, P19; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Sugimura T, 2006, J ORAL PATHOL MED, V35, P11, DOI 10.1111/j.1600-0714.2005.00364.x; SUNG P, 1993, J BIOL CHEM, V268, P26391; VALAY JG, 1995, J MOL BIOL, V249, P535, DOI 10.1006/jmbi.1995.0316; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; Vermeulen W, 2011, DNA REPAIR, V10, P760, DOI 10.1016/j.dnarep.2011.04.015; Vogel U, 2005, CANCER LETT, V222, P67, DOI 10.1016/j.canlet.2004.11.016; Weiss JM, 2005, CANCER EPIDEM BIOMAR, V14, P2524, DOI 10.1158/1055-9965.EPI-05-0414; Wu XF, 2003, CARCINOGENESIS, V24, P505, DOI 10.1093/carcin/24.3.505; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	74	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					793	806		10.1074/jbc.M112.413716	http://dx.doi.org/10.1074/jbc.M112.413716			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23188830	hybrid, Green Published			2022-12-28	WOS:000313570300005
J	Alfadhli, A; McNett, H; Eccles, J; Tsagli, S; Noviello, C; Sloan, R; Lopez, CS; Peyton, DH; Barklis, E				Alfadhli, Ayna; McNett, Henry; Eccles, Jacob; Tsagli, Seyram; Noviello, Colleen; Sloan, Rachel; Lopez, Claudia S.; Peyton, David H.; Barklis, Eric			Analysis of Small Molecule Ligands Targeting the HIV-1 Matrix Protein-RNA Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEAR-LOCALIZATION SIGNAL; MEMBRANE-BINDING; ENVELOPE PROTEIN; PLASMA-MEMBRANE; BASIC DOMAIN; GAG PROTEINS; REPLICATION; ASSOCIATION; MUTATIONS	The matrix domain (MA) of the HIV-1 precursor Gag (PrGag) protein directs PrGag proteins to assembly sites at the plasma membrane by virtue of its affinity to the phospholipid, phosphatidylinositol-4,5-bisphosphate (PI(4,5)P-2). MA also binds to RNA at a site that overlaps its PI(4,5)P-2 site, suggesting that RNA binding may protect MA from associating with inappropriate cellular membranes prior to PrGag delivery to the PM. Based on this, we have developed an assay in which small molecule competitors to MA-RNA binding can be characterized, with the assumption that such compounds might interfere with essential MA functions and help elucidate additional features of MA binding. Following this approach, we have identified four compounds, including three thiadiazolanes, that compete with RNA for MA binding. We also have identified MA residues involved in thiadiazolane binding and found that they overlap the MA PI(4,5)P-2 and RNA sites. Cell culture studies demonstrated that thiadiazolanes inhibit HIV-1 replication but are associated with significant levels of toxicity. Nevertheless, these observations provide new insights into MA binding and pave the way for the development of antivirals that target the HIV-1 matrix domain.	[Alfadhli, Ayna; McNett, Henry; Eccles, Jacob; Tsagli, Seyram; Noviello, Colleen; Sloan, Rachel; Lopez, Claudia S.; Barklis, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Alfadhli, Ayna; McNett, Henry; Eccles, Jacob; Tsagli, Seyram; Noviello, Colleen; Sloan, Rachel; Lopez, Claudia S.; Barklis, Eric] Oregon Hlth & Sci Univ, Dept Microbiol, Portland, OR 97201 USA; [Peyton, David H.] Portland State Univ, Dept Chem, Portland, OR 97207 USA	Oregon Health & Science University; Oregon Health & Science University; Portland State University	Alfadhli, A (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	alfadhli@ohsu.edu; barklis@ohsu.edu	Lopez, Claudia/GXN-1686-2022	ECCLES, Jacob/0000-0002-4202-0355; Peyton, David/0000-0001-5828-055X	National Institutes of Health [GM060170, GM101983, AI071798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101983, R01GM060170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM060170, GM101983, and AI071798 (to E. B.).	Alfadhi A, 2009, VIROLOGY, V387, P466, DOI 10.1016/j.virol.2009.02.048; Alfadhli A, 2005, J VIROL, V79, P14498, DOI 10.1128/JVI.79.23.14498-14506.2005; Alfadhli A, 2007, J VIROL, V81, P1472, DOI 10.1128/JVI.02122-06; Alfadhli A, 2011, J MOL BIOL, V410, P653, DOI 10.1016/j.jmb.2011.04.063; Alfadhli A, 2009, J VIROL, V83, P12196, DOI 10.1128/JVI.01197-09; Barklis E, 2009, J MOL BIOL, V387, P376, DOI 10.1016/j.jmb.2009.01.058; Bhatia AK, 2007, VIROLOGY, V369, P47, DOI 10.1016/j.virol.2007.06.046; Bouamr F, 2003, BIOCHEMISTRY-US, V42, P6408, DOI 10.1021/bi020692z; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; Burniston MT, 1999, J VIROL, V73, P8527, DOI 10.1128/JVI.73.10.8527-8540.1999; Cai ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015675; Chang CY, 2008, VIROLOGY, V378, P97, DOI 10.1016/j.virol.2008.05.010; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen ZJ, 2012, J BIOL CHEM, V287, P23537, DOI 10.1074/jbc.M112.363960; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2011, J MOL BIOL, V410, P512, DOI 10.1016/j.jmb.2011.04.015; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Coffin J. M., 1997, P335; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Dalton AK, 2007, J VIROL, V81, P6434, DOI 10.1128/JVI.02757-06; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; DORFMAN T, 1994, J VIROL, V68, P8180, DOI 10.1128/JVI.68.12.8180-8187.1994; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Ehrlich LS, 1996, BIOCHEMISTRY-US, V35, P3933, DOI 10.1021/bi952337x; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Ghanam RH, 2010, J BIOL CHEM, V285, P41911, DOI 10.1074/jbc.M110.179093; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; Haffar OK, 2000, J MOL BIOL, V299, P359, DOI 10.1006/jmbi.2000.3768; Hearps AC, 2008, BIOCHEMISTRY-US, V47, P2199, DOI 10.1021/bi701360j; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Jones CP, 2011, J VIROL, V85, P1594, DOI 10.1128/JVI.01809-10; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; Lochrie MA, 1997, NUCLEIC ACIDS RES, V25, P2902, DOI 10.1093/nar/25.14.2902; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; MERVIS RJ, 1988, J VIROL, V62, P3993, DOI 10.1128/JVI.62.11.3993-4002.1988; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; MOLDT P, 1988, AGENTS ACTIONS, V24, P35, DOI 10.1007/BF01968077; Monde K, 2011, J VIROL, V85, P3584, DOI 10.1128/JVI.02266-10; Moreno S, 2010, J ANTIMICROB CHEMOTH, V65, P827, DOI 10.1093/jac/dkq061; Murray PS, 2005, STRUCTURE, V13, P1521, DOI 10.1016/j.str.2005.07.010; Noviello CM, 2011, J VIROL, V85, P4730, DOI 10.1128/JVI.00099-11; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ott DE, 2005, J VIROL, V79, P13839, DOI 10.1128/JVI.79.22.13839-13847.2005; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Purohit P, 2001, RNA, V7, P576, DOI 10.1017/S1355838201002023; Reil H, 1998, EMBO J, V17, P2699, DOI 10.1093/emboj/17.9.2699; Resh MD, 2004, P NATL ACAD SCI USA, V101, P417, DOI 10.1073/pnas.0308043101; RICHMAN D, 1991, P NATL ACAD SCI USA, V88, P11241, DOI 10.1073/pnas.88.24.11241; Saad JS, 2007, J MOL BIOL, V366, P574, DOI 10.1016/j.jmb.2006.11.068; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Scarlata S, 1998, J MOL BIOL, V277, P161, DOI 10.1006/jmbi.1997.1615; Scholz I, 2008, VIROLOGY, V371, P322, DOI 10.1016/j.virol.2007.10.010; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Smith U, 2001, INT J CLIN PRACT, P13; SPEARMAN P, 1994, J VIROL, V68, P3232, DOI 10.1128/JVI.68.5.3232-3242.1994; Swanstrom R., 1997, P263; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Tang C, 2003, J MOL BIOL, V327, P1013, DOI 10.1016/S0022-2836(03)00289-4; Tritel M, 2000, J VIROL, V74, P5845, DOI 10.1128/JVI.74.13.5845-5855.2000; VONSCHWEDLER U, 1994, P NATL ACAD SCI USA, V91, P6992, DOI 10.1073/pnas.91.15.6992; WANG CT, 1993, J VIROL, V67, P7067, DOI 10.1128/JVI.67.12.7067-7076.1993; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wyma DJ, 2000, J VIROL, V74, P9381, DOI 10.1128/JVI.74.20.9381-9387.2000; YU XF, 1992, J VIROL, V66, P4966, DOI 10.1128/JVI.66.8.4966-4971.1992; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhou J, 2005, J MOL BIOL, V349, P976, DOI 10.1016/j.jmb.2005.04.046; Zuber G, 2000, J VIROL, V74, P7431, DOI 10.1128/JVI.74.16.7431-7441.2000	73	17	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					666	676		10.1074/jbc.M112.399865	http://dx.doi.org/10.1074/jbc.M112.399865			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23135280	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000313197200067
J	Gao, GF; Wieczorek, L; Peachman, KK; Polonis, VR; Alving, CR; Rao, M; Rao, VB				Gao, Guofen; Wieczorek, Lindsay; Peachman, Kristina K.; Polonis, Victoria R.; Alving, Carl R.; Rao, Mangala; Rao, Venigalla B.			Designing a Soluble Near Full-length HIV-1 gp41 Trimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROXIMAL EXTERNAL REGION; BROADLY NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODY; TYPE-1 ENVELOPE; INTEGRIN ALPHA(4)BETA(7); CONFORMATIONAL-CHANGES; IMMUNODOMINANT DOMAIN; MEMBRANE-FUSION	The HIV-1 envelope spike is a trimer of heterodimers composed of an external glycoprotein gp120 and a transmembrane glycoprotein gp41. gp120 initiates virus entry by binding to host receptors, whereas gp41 mediates fusion between viral and host membranes. Although the basic pathway of HIV-1 entry has been extensively studied, the detailed mechanism is still poorly understood. Design of gp41 recombinants that mimic key intermediates is essential to elucidate the mechanism as well as to develop potent therapeutics and vaccines. Here, using molecular genetics and biochemical approaches, a series of hypotheses was tested to overcome the extreme hydrophobicity of HIV-1 gp41 and design a soluble near full-length gp41 trimer. The two long heptad repeat helices HR1 and HR2 of gp41 ectodomain were mutated to disrupt intramolecular HR1-HR2 interactions but not intermolecular HR1-HR1 interactions. This resulted in reduced aggregation and improved solubility. Attachment of a 27-amino acid foldon at the C terminus and slow refolding channeled gp41 into trimers. The trimers appear to be stabilized in a prehairpin-like structure, as evident from binding of a HR2 peptide to exposed HR1 grooves, lack of binding to hexa-helical bundle specific NC-1 mAb, and inhibition of virus neutralization by broadly neutralizing antibodies 2F5 and 4E10. Fusion to T4 small outer capsid protein, Soc, allowed display of gp41 trimers on the phage nanoparticle. These approaches for the first time led to the design of a soluble gp41 trimer containing both the fusion peptide and the cytoplasmic domain, providing insights into the mechanism of entry and development of gp41-based HIV-1 vaccines.	[Gao, Guofen; Rao, Venigalla B.] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA; [Wieczorek, Lindsay; Peachman, Kristina K.] Henry M Jackson Fdn Adv Mil Med, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Polonis, Victoria R.; Alving, Carl R.; Rao, Mangala] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA	Catholic University of America; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Rao, VB (corresponding author), Catholic Univ Amer, Dept Biol, 620 Michigan Ave NE, Washington, DC 20064 USA.	rao@cua.edu		Rao, Venigalla/0000-0002-0777-6587	National Institutes of Health [R01AI02725 (NIAID)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102725] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant R01AI02725 (NIAID).	Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bianchi E, 2010, P NATL ACAD SCI USA, V107, P10655, DOI 10.1073/pnas.1004261107; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Chakrabarti BK, 2011, J VIROL, V85, P8217, DOI 10.1128/JVI.00756-11; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; de Rosny E, 2004, J VIROL, V78, P2627, DOI 10.1128/JVI.78.5.2627-2631.2004; Dimitrov AS, 2005, BIOCHEMISTRY-US, V44, P12471, DOI 10.1021/bi051092d; Fokine A, 2004, P NATL ACAD SCI USA, V101, P6003, DOI 10.1073/pnas.0400444101; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Frey G, 2010, NAT STRUCT MOL BIOL, V17, P1486, DOI 10.1038/nsmb.1950; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; GNANN JW, 1987, J VIROL, V61, P2639, DOI 10.1128/JVI.61.8.2639-2641.1987; Greenberg M, 2004, REV MED VIROL, V14, P321, DOI 10.1002/rmv.440; Hager-Braun C, 2006, J IMMUNOL, V176, P7471, DOI 10.4049/jimmunol.176.12.7471; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; Kim M, 2007, VACCINE, V25, P5102, DOI 10.1016/j.vaccine.2006.09.071; Kwong P. D., 2012, COLD SPRING HARB PER, V4; Li Q, 2007, J MOL BIOL, V370, P1006, DOI 10.1016/j.jmb.2007.05.008; Li Q, 2006, J MOL BIOL, V363, P577, DOI 10.1016/j.jmb.2006.08.049; Lorizate M, 2006, J MOL BIOL, V360, P45, DOI 10.1016/j.jmb.2006.04.056; Maltez Fernando, 2011, Curr Opin HIV AIDS, V6 Suppl 1, pS21, DOI 10.1097/01.COH.0000410238.80894.81; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; MATHIESEN T, 1989, IMMUNOLOGY, V67, P1; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Meadows DC, 2006, CHEMMEDCHEM, V1, P16, DOI 10.1002/cmdc.200500026; Melchers M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-48; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nelson JK, 2008, IEEE T DIELECT EL IN, V15, P1, DOI 10.1109/T-DEI.2008.4446730; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Peachman KK, 2012, CLIN VACCINE IMMUNOL, V19, P11, DOI 10.1128/CVI.05376-11; Pejchal R, 2010, CURR PHARM DESIGN, V16, P3744, DOI 10.2174/138161210794079173; Phogat S, 2007, CURR PHARM DESIGN, V13, P213, DOI 10.2174/138161207779313632; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; Qin L, 2010, J MOL BIOL, V395, P728, DOI 10.1016/j.jmb.2009.10.007; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; ROBINSON WE, 1990, J VIROL, V64, P5301, DOI 10.1128/JVI.64.11.5301-5305.1990; ROBINSON WE, 1991, J VIROL, V65, P4169, DOI 10.1128/JVI.65.8.4169-4176.1991; Sathaliyawala T, 2006, J VIROL, V80, P7688, DOI 10.1128/JVI.00235-06; Scholz C, 2005, J MOL BIOL, V345, P1229, DOI 10.1016/j.jmb.2004.10.091; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018233; WANG JJG, 1986, P NATL ACAD SCI USA, V83, P6159, DOI 10.1073/pnas.83.16.6159; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	69	17	24	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					234	246		10.1074/jbc.M112.424432	http://dx.doi.org/10.1074/jbc.M112.424432			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23184960	Green Published, hybrid			2022-12-28	WOS:000313197200023
J	Nagy, A; Takagi, Y; Billington, N; Sun, SA; Hong, DKT; Homsher, E; Wang, AB; Sellers, JR				Nagy, Attila; Takagi, Yasuharu; Billington, Neil; Sun, Sara A.; Hong, Davin K. T.; Homsher, Earl; Wang, Aibing; Sellers, James R.			Kinetic Characterization of Nonmuscle Myosin IIB at the Single Molecule Level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOAD-DEPENDENT KINETICS; NATIVE THICK FILAMENTS; MUSCLE-CONTRACTION; OPTICAL TWEEZERS; ACTIN-FILAMENTS; CELL-ADHESION; LIGHT-CHAIN; IN-VITRO; MECHANISM; MOTOR	Nonmuscle myosin IIB (NMIIB) is a cytoplasmic myosin, which plays an important role in cell motility by maintaining cortical tension. It forms bipolar thick filaments with similar to 14 myosin molecule dimers on each side of the bare zone. Our previous studies showed that the NMIIB is a moderately high duty ratio (similar to 20-25%) motor. The ADP release step (similar to 0.35 s(-1)) of NMIIB is only similar to 3 times faster than the rate-limiting phosphate release (0.13 +/- 0.01 s(-1)). The aim of this study was to relate the known in vitro kinetic parameters to the results of single molecule experiments and to compare the kinetic and mechanical properties of single-and double-headed myosin fragments and nonmuscle IIB thick filaments. Examination of the kinetics of NMIIB interaction with actin at the single molecule level was accomplished using total internal reflection fluorescence (TIRF) with fluorescence imaging with 1-nm accuracy (FIONA) and dual-beam optical trapping. At a physiological ATP concentration (1 mM), the rate of detachment of the single-headed and double-headed molecules was similar (similar to 0.4 s(-1)). Using optical tweezers we found that the power stroke sizes of single-and double-headed heavy meromyosin (HMM) were each similar to 6 nm. No signs of processive stepping at the single molecule level were observed in the case of NMIIB-HMM in optical tweezers or TIRF/in vitro motility experiments. In contrast, robust motility of individual fluorescently labeled thick filaments of full-length NMIIB was observed on actin filaments. Our results are in good agreement with the previous steady-state and transient kinetic studies and show that the individual nonprocessive nonmuscle myosin IIB molecules form a highly processive unit when polymerized into filaments.	[Nagy, Attila; Takagi, Yasuharu; Billington, Neil; Sun, Sara A.; Hong, Davin K. T.; Homsher, Earl; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Wang, Aibing] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA; [Homsher, Earl] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sellers, JR (corresponding author), NHLBI, Lab Mol Physiol, NIH, 50 South Dr,B50-3523, Bethesda, MD 20892 USA.	sellersj@nhlbi.nih.gov	Sun, Sara A./T-4334-2019	Billington, Neil/0000-0003-2306-0228; Sun, Sara/0000-0002-1456-2528	National Institutes of Health intramural funds from the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004216, ZIAHL001786] Funding Source: NIH RePORTER	National Institutes of Health intramural funds from the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or part, by National Institutes of Health intramural funds from the NHLBI.	Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Batters C, 2004, PHILOS T R SOC B, V359, P1895, DOI 10.1098/rstb.2004.1559; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; BRENNER B, 1982, P NATL ACAD SCI-BIOL, V79, P7288, DOI 10.1073/pnas.79.23.7288; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Cuda G, 1997, BIOPHYS J, V72, P1767, DOI 10.1016/S0006-3495(97)78823-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; de la Fuente H, 2005, MOL BIOL CELL, V16, P3314, DOI 10.1091/mbc.E05-01-0005; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Furch M, 2000, BIOCHEMISTRY-US, V39, P11602, DOI 10.1021/bi000985x; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Greenberg MJ, 2012, P NATL ACAD SCI USA, V109, pE2433, DOI 10.1073/pnas.1207811109; GREENE LE, 1987, J BIOL CHEM, V262, P4177; GREENE LE, 1981, BIOCHEMISTRY-US, V20, P2120, DOI 10.1021/bi00511a008; Guzik-Lendrum S, 2011, J BIOL CHEM, V286, P21755, DOI 10.1074/jbc.M111.218669; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; HARRIS DE, 1993, J BIOL CHEM, V268, P14764; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Heissler SM, 2011, J BIOL CHEM, V286, P21191, DOI 10.1074/jbc.M110.212290; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; Ivanov AI, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-36; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; Kelley CA, 1996, J CELL BIOL, V134, P675, DOI 10.1083/jcb.134.3.675; Kengyel A, 2010, J MUSCLE RES CELL M, V31, P163, DOI 10.1007/s10974-010-9220-y; Knight AE, 2001, PROG BIOPHYS MOL BIO, V77, P45, DOI 10.1016/S0079-6107(01)00010-4; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Kural C, 2005, J PHYS-CONDENS MAT, V17, pS3979, DOI 10.1088/0953-8984/17/47/023; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; MARGOSSIAN SS, 1973, J MOL BIOL, V74, P301, DOI 10.1016/0022-2836(73)90375-6; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; MAUPIN P, 1994, J CELL SCI, V107, P3077; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; NIEDERMAN R, 1975, J CELL BIOL, V67, P72, DOI 10.1083/jcb.67.1.72; Norstrom MF, 2010, J BIOL CHEM, V285, P26326, DOI 10.1074/jbc.M110.123851; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; Rosenfeld SS, 2003, J BIOL CHEM, V278, P27449, DOI 10.1074/jbc.M302555200; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; SELLERS JR, 1990, SCIENCE, V249, P406, DOI 10.1126/science.2377894; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Smith DA, 2004, J MUSCLE RES CELL M, V25, P215, DOI 10.1023/B:JURE.0000038171.22680.2e; Snyder GE, 2004, BIOPHYS J, V87, P1776, DOI 10.1529/biophysj.103.036897; Takagi Y, 2006, BIOPHYS J, V90, P1295, DOI 10.1529/biophysj.105.068429; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Tyska MJ, 2002, CELL MOTIL CYTOSKEL, V51, P1, DOI 10.1002/cm.10014; Vanzi F, 2005, BIOPHYS J, V89, P1909, DOI 10.1529/biophysj.104.056283; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; Vicente-Manzanares M, 2003, J IMMUNOL, V171, P1023, DOI 10.4049/jimmunol.171.2.1023; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang F, 2000, BIOCHEMISTRY-US, V39, P5555, DOI 10.1021/bi000133x; West JM, 1996, J MUSCLE RES CELL M, V17, P637, DOI 10.1007/BF00154058; Yanagida T, 2000, CURR OPIN CELL BIOL, V12, P20, DOI 10.1016/S0955-0674(99)00052-6; Yildiz A, 2005, ACCOUNTS CHEM RES, V38, P574, DOI 10.1021/ar040136s	67	51	51	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					709	722		10.1074/jbc.M112.424671	http://dx.doi.org/10.1074/jbc.M112.424671			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23148220	hybrid, Green Published			2022-12-28	WOS:000313197200071
J	Valdes, R; Shinde, U; Landfear, SM				Valdes, Raquel; Shinde, Ujwal; Landfear, Scott M.			Cysteine Cross-linking Defines the Extracellular Gate for the Leishmania donovani Nucleoside Transporter 1.1 (LdNT1.1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE-GUANOSINE TRANSPORTER; NUCLEOBASE TRANSPORTER; GLUTAMATE TRANSPORTER; CHIMERIC CONSTRUCTS; MUTATIONAL ANALYSIS; P-GLYCOPROTEIN; ENT FAMILY; SENSITIVITY; GENE; NITROBENZYLTHIOINOSINE	Equilibrative nucleoside transporters are a unique family of proteins that enable uptake of nucleosides-nucleobases into a wide range of eukaryotes and internalize a myriad of drugs used in the treatment of cancer, heart disease, AIDs, and parasitic infections. In previous work we generated a structural model for such a transporter, the LdNT1.1 nucleoside permease from the parasitic protozoan Leishmania donovani, using ab initio computation. The model suggested that aromatic residues present in transmembrane helices 1, 2, and 7 interact to form an extracellular gate that closes the permeation pathway in the inward-open conformation. Mutation of residues Phe-48(TM1) and Trp-75(TM2) abrogated transport activity, consistent with such prediction. In this study cysteine mutagenesis and oxidative cross-linking were combined to analyze proximity relationships of helices 1, 2, and 7 in LdNT1.1. Disulfide bond formation between introduced paired cysteines at the interface of such helices (A61C(TM1)/F74C(TM2), A61C(TM1)/G350C(TM7), and F74C(TM2)/ G350C(TM7)) was analyzed by transport measurement and gel mobility shifts upon oxidation with Cu (II)-(1,10-phenanthroline)(3). In all cases cross-linking inhibited transport. However, if LdNT1.1 ligands were included during cross-linking, inhibition of transport was reduced, suggesting that ligands moved the three gating helices apart. Moreover, all paired cysteine mutants exhibited a mobility shift upon oxidation, corroborating the formation of a disulfide bond. These data support the notion that helices 1, 2, and 7 constitute the extracellular gate of LdNT1.1, thus further validating the computational model and the previously demonstrated importance of F48(TM1) and Trp-75(TM2) in tethering together helices that are part of the gate.	[Valdes, Raquel; Landfear, Scott M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Shinde, Ujwal] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Landfear, SM (corresponding author), OR Hlth & Sci Univ, Dept Mol Microbiol & Immunol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	landfear@ohsu.edu		Landfear, Scott/0000-0002-1643-6664	National Institutes of Health [AI44138]; National Science Foundation [0746589]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI44138 (to S. M. L.). This work was also supported by National Science Foundation Grant 0746589 (to U. S.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Arastu-Kapur S, 2005, J BIOL CHEM, V280, P2213, DOI 10.1074/jbc.M408224200; Arastu-Kapur S, 2003, J BIOL CHEM, V278, P33327, DOI 10.1074/jbc.M305141200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Baldwin SA, 2007, CURR PHARM DESIGN, V13, P569, DOI 10.2174/138161207780162845; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Carter NS, 2000, J BIOL CHEM, V275, P20935, DOI 10.1074/jbc.M002418200; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Detke S, 2007, EXP CELL RES, V313, P1963, DOI 10.1016/j.yexcr.2007.02.027; GRAY WR, 1993, PROTEIN SCI, V2, P1732, DOI 10.1002/pro.5560021017; HAMMOND DJ, 1984, MOL BIOCHEM PARASIT, V13, P243, DOI 10.1016/0166-6851(84)90117-8; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hyde RJ, 2001, MOL MEMBR BIOL, V18, P53, DOI 10.1080/09687680110033765; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; Kaback HR, 2011, J MEMBRANE BIOL, V239, P85, DOI 10.1007/s00232-010-9327-5; Kavanaugh MP, 1998, P NATL ACAD SCI USA, V95, P12737, DOI 10.1073/pnas.95.22.12737; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Kong W, 2004, CURR DRUG METAB, V5, P63, DOI 10.2174/1389200043489162; Krovetz HS, 1997, BIOPHYS J, V72, P117, DOI 10.1016/S0006-3495(97)78651-X; Kubo Y, 2000, J BIOL CHEM, V275, P5270, DOI 10.1074/jbc.275.8.5270; LEBOWITZ JH, 1994, METHOD CELL BIOL, V45, P65; LEBOWITZ JH, 1990, P NATL ACAD SCI USA, V87, P9736, DOI 10.1073/pnas.87.24.9736; Leighton BH, 2006, J BIOL CHEM, V281, P29788, DOI 10.1074/jbc.M604991200; Liu W, 2006, MOL BIOCHEM PARASIT, V150, P300, DOI 10.1016/j.molbiopara.2006.09.002; Loo TW, 2004, J BIOL CHEM, V279, P7692, DOI 10.1074/jbc.M311825200; Loo TW, 2000, J BIOL CHEM, V275, P5253, DOI 10.1074/jbc.275.8.5253; Opella SJ, 2004, CHEM REV, V104, P3587, DOI 10.1021/cr0304121; Ortiz D, 2010, MOL MICROBIOL, V78, P108, DOI 10.1111/j.1365-2958.2010.07328.x; Ortiz D, 2009, J BIOL CHEM, V284, P16164, DOI 10.1074/jbc.M109.006718; Papageorgiou I, 2008, INT J PARASITOL, V38, P641, DOI 10.1016/j.ijpara.2007.10.005; Paproski RJ, 2008, BIOCHEM J, V414, P291, DOI 10.1042/BJ20080074; Qiu ZY, 2001, J BIOL CHEM, V276, P194, DOI 10.1074/jbc.M005571200; Rose JB, 2008, PHYSIOLOGY, V23, P41, DOI 10.1152/physiol.00036.2007; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; SenGupta DJ, 2004, BIOCHEM PHARMACOL, V67, P453, DOI 10.1016/j.bcp.2003.09.018; SenGupta DJ, 2002, BIOCHEMISTRY-US, V41, P1512, DOI 10.1021/bi015833w; Smirnova I, 2011, BIOCHEMISTRY-US, V50, P9684, DOI 10.1021/bi2014294; Stein A, 2003, J BIOL CHEM, V278, P35127, DOI 10.1074/jbc.M306188200; Stroud RM, 2007, P NATL ACAD SCI USA, V104, P1445, DOI 10.1073/pnas.0610349104; Sundaram M, 1998, J BIOL CHEM, V273, P21519, DOI 10.1074/jbc.273.34.21519; Sundaram M, 2001, BIOCHEMISTRY-US, V40, P8146, DOI 10.1021/bi0101805; Tao Z, 2009, J BIOL CHEM, V284, P33807, DOI 10.1074/jbc.M109.071977; Valdes R, 2004, BIOCHEMISTRY-US, V43, P6793, DOI 10.1021/bi049873m; Valdes R, 2006, J BIOL CHEM, V281, P22647, DOI 10.1074/jbc.M602366200; Valdes R, 2009, J BIOL CHEM, V284, P19067, DOI 10.1074/jbc.M109.017947; Vasudevan G, 1998, P NATL ACAD SCI USA, V95, P9873, DOI 10.1073/pnas.95.17.9873; Vasudevan G, 2001, P NATL ACAD SCI USA, V98, P6092, DOI 10.1073/pnas.101537298; Visser F, 2005, J BIOL CHEM, V280, P11025, DOI 10.1074/jbc.M410348200; Visser F, 2005, MOL PHARMACOL, V67, P1291, DOI 10.1124/mol.104.005884; Visser F, 2002, J BIOL CHEM, V277, P395, DOI 10.1074/jbc.M105324200; Visser F, 2007, J BIOL CHEM, V282, P14148, DOI 10.1074/jbc.M701735200; White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Yao SYM, 2001, BIOCHEM J, V353, P387, DOI 10.1042/0264-6021:3530387; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Zhang XP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021288; Zomot E, 2005, J BIOL CHEM, V280, P25512, DOI 10.1074/jbc.M503864200	59	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44036	44045		10.1074/jbc.M112.414433	http://dx.doi.org/10.1074/jbc.M112.414433			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23150661	hybrid, Green Published			2022-12-28	WOS:000312938600003
J	Chu, PC; Chuang, HC; Kulp, SK; Chen, CS				Chu, Po-Chen; Chuang, Hsiao-Ching; Kulp, Samuel K.; Chen, Ching-Shih			The mRNA-stabilizing Factor HuR Protein Is Targeted by beta-TrCP Protein for Degradation in Response to Glycolysis Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENT; CASPASE-MEDIATED CLEAVAGE; POSTTRANSCRIPTIONAL REGULATION; COLON-CANCER; KAPPA-B; EXPRESSION; BINDING; ALPHA; PHOSPHORYLATION; CYCLOOXYGENASE-2	The mRNA-stabilizing protein HuR acts a stress response protein whose function and/or protein stability are modulated by diverse stress stimuli through posttranslational modifications. Here, we report a novel mechanism by which metabolic stress facilitates proteasomal degradation of HuR in cancer cells. In response to the glucose transporter inhibitor CG-5, HuR translocates to the cytoplasm, where it is targeted by the ubiquitin E3 ligase beta-TrCP1 for degradation. The cytoplasmic localization of HuR is facilitated by PKC alpha-mediated phosphorylation at Ser-318 as the Ser-318 -> alanine substitution abolishes the ability of the resulting HuR to bind PKC alpha and to undergo nuclear export. The mechanistic link between beta-TrCP1 and HuR degradation was supported by the ability of ectopically expressed beta-TrCP1 to mimic CG-5 to promote HuR degradation and by the protective effect of dominant negative inhibition of beta-TrCP1 on HuR ubiquitination and degradation. Substrate targeting of HuR by beta-TrCP1 was further verified by coimmunoprecipitation and in vitro GST pull-down assays and by the identification of a beta-TrCP1 recognition site. Although HuR does not contain a DSG destruction motif, we obtained evidence that beta-TrCP1 recognizes an unconventional motif, (296)EEAMAIAS(304), in the RNA recognition motif 3. Furthermore, mutational analysis indicates that IKK alpha-dependent phosphorylation at Ser-304 is crucial to the binding of HuR to beta-TrCP1. Mechanistically, this HuR degradation pathway differs from that reported for heat shock and hypoxia, which underlies the complexity in the regulation of HuR turnover under different stress stimuli. The ability of glycolysis inhibitors to target the expression of oncogenic proteins through HuR degradation might foster novel strategies for cancer therapy.	[Chu, Po-Chen; Chuang, Hsiao-Ching; Kulp, Samuel K.; Chen, Ching-Shih] Ohio State Univ, Div Med Chem, Coll Pharm, Columbus, OH 43210 USA; [Chu, Po-Chen; Chuang, Hsiao-Ching; Kulp, Samuel K.; Chen, Ching-Shih] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Chen, Ching-Shih] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; National Cheng Kung University	Chen, CS (corresponding author), Ohio State Univ, Div Med Chem, Coll Pharm, 500 W 12th Ave, Columbus, OH 43210 USA.	chen.844@osu.edu			National Cancer Institute Public Health Service [R01CA112250]; NATIONAL CANCER INSTITUTE [R01CA112250] Funding Source: NIH RePORTER	National Cancer Institute Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Public Health Service Grant R01CA112250.	Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4; Abdelmohsen K, 2009, EMBO J, V28, P1271, DOI 10.1038/emboj.2009.67; Abdelmohsen K, 2008, P NATL ACAD SCI USA, V105, P20297, DOI 10.1073/pnas.0809376106; Chae MJ, 2009, EXP MOL MED, V41, P824, DOI 10.3858/emm.2009.41.11.088; Chen CYA, 2002, MOL CELL BIOL, V22, P7268, DOI 10.1128/MCB.22.20.7268-7278.2002; Davis M, 2002, GENE DEV, V16, P439, DOI 10.1101/gad.218702; Denkert C, 2006, MODERN PATHOL, V19, P1261, DOI 10.1038/modpathol.3800645; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Embade N, 2012, HEPATOLOGY, V55, P1237, DOI 10.1002/hep.24795; Erkinheimo TL, 2003, CANCER RES, V63, P7591; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Guo X, 2009, RNA BIOL, V6, P575, DOI 10.4161/rna.6.5.10079; Heinonen M, 2005, CANCER RES, V65, P2157, DOI 10.1158/0008-5472.CAN-04-3765; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Kim HH, 2008, CELL CYCLE, V7, P3371; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Kim HH, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/981487; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Niesporek S, 2008, INT J ONCOL, V32, P341; Song IS, 2005, J BIOL CHEM, V280, P28230, DOI 10.1074/jbc.M413103200; Srikantan S, 2012, FRONT BIOSCI-LANDMRK, V17, P189, DOI 10.2741/3921; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Talwar S, 2011, J BIOL CHEM, V286, P32333, DOI 10.1074/jbc.M111.255927; Wang DS, 2012, J MED CHEM, V55, P3827, DOI 10.1021/jm300015m; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wei S, 2008, J BIOL CHEM, V283, P26759, DOI 10.1074/jbc.M802160200; Wei SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047298; Wei SO, 2010, J BIOL CHEM, V285, P9780, DOI 10.1074/jbc.M109.065466; Yoshida K, 2008, ONCOGENE, V27, P1183, DOI 10.1038/sj.onc.1210722; Zou TT, 2006, J BIOL CHEM, V281, P19387, DOI 10.1074/jbc.M602344200	36	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43639	43650		10.1074/jbc.M112.393678	http://dx.doi.org/10.1074/jbc.M112.393678			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115237	Green Published, hybrid			2022-12-28	WOS:000312940800044
J	Destouches, D; Huet, E; Sader, M; Frechault, S; Carpentier, G; Ayoul, F; Briand, JP; Menashi, S; Courty, J				Destouches, Damien; Huet, Eric; Sader, Maha; Frechault, Sophie; Carpentier, Gilles; Ayoul, Florie; Briand, Jean-Paul; Menashi, Suzanne; Courty, Jose			Multivalent Pseudopeptides Targeting Cell Surface Nucleoproteins Inhibit Cancer Cell Invasion through Tissue Inhibitor of Metalloproteinases 3 (TIMP-3) Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-GROWTH; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; MELANOMA-CELLS; BREAST-CANCER; EXPRESSION; PROTEIN; ANGIOGENESIS; NUCLEOLIN; NEUROBLASTOMA	Blockage of the metastasis process remains a significant clinical challenge, requiring innovative therapeutic approaches. For this purpose, molecules that inhibit matrix metalloproteinases activity or induce the expression of their natural inhibitor, the tissue inhibitor of metalloproteinases (TIMPs), are potentially interesting. In a previous study, we have shown that synthetic ligands binding to cell surface nucleolin/nucleophosmin and known as HB 19 for the lead compound and NucAnt 6L (N6L) for the most potent analog, inhibit both tumor growth and angiogenesis. Furthermore, they prevent metastasis in a RET transgenic mice model which develops melanoma. Here, we investigated the effect of N6L on the invasion capacity of MDA-MB-435 melanoma cells. Our results show that the multivalent pseudopeptide N6L inhibited Matrigel invasion of MDA-MB-435 cells in a modified Boyden chamber model. This was associated with an increase in TIMP-3 in the cell culture medium without a change in TIMP-3 mRNA expression suggesting its release from cell surface and/or extracellular matrix. This may be explained by our demonstrated N6L interaction with sulfated glycosaminoglycans and consequently the controlled bioavailability of glycosaminoglycan-bound TIMP-3. The implication of TIMP-3 in N6L-induced inhibition of cell invasion was evidenced by siRNA silencing experiments showing that the loss of TIMP-3 expression abrogated the effect of N6L. The inhibition of tumor cell invasion by N6L demonstrated in this study, in addition to its previously established inhibitory effect on tumor growth and angiogenesis, suggests that N6L represents a promising anticancer drug candidate warranting further investigation.	[Destouches, Damien; Huet, Eric; Sader, Maha; Frechault, Sophie; Carpentier, Gilles; Ayoul, Florie; Menashi, Suzanne; Courty, Jose] Univ Paris Est, Lab Rech Croissance Cellulaire Reparat & Regenera, CNRS, F-94010 Creteil, France; [Briand, Jean-Paul] CNRS, Inst Biol Mol & Cellulaire, Lab Immunol & Chim Therapeut, UPR 9021, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Courty, J (corresponding author), Univ Paris Est, Lab Rech Croissance Cellulaire Reparat & Regenera, CNRS, 61 Ave Gen De Gaulle, F-94010 Creteil, France.	courty@u-pec.fr	Destouches, Damien/R-2430-2018; HUET, Eric/R-3178-2018; Courty, Jose/Q-3702-2018	Destouches, Damien/0000-0003-4959-2580; HUET, Eric/0000-0002-5541-5954; Carpentier, Gilles/0000-0002-3730-7263	Multifunctional Nanotechnology for Selective Detection and Treatment of Cancer (MULTIFUN) program	Multifunctional Nanotechnology for Selective Detection and Treatment of Cancer (MULTIFUN) program	This work has been funded in part by the Multifunctional Nanotechnology for Selective Detection and Treatment of Cancer (MULTIFUN) program.	Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Ara T, 1998, J PEDIATR SURG, V33, P1272, DOI 10.1016/S0022-3468(98)90167-1; Bachman KE, 1999, CANCER RES, V59, P798; Bemis LT, 2000, CANCER RES, V60, P3414; Bian JH, 1996, CARCINOGENESIS, V17, P1805, DOI 10.1093/carcin/17.9.1805; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Deng XY, 2006, EUR J CANCER, V42, P3267, DOI 10.1016/j.ejca.2006.07.003; Destouches D, 2011, CANCER RES, V71, P3296, DOI 10.1158/0008-5472.CAN-10-3459; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; El Khoury D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-325; Fariss RN, 1997, AM J PATHOL, V150, P323; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hoe HS, 2007, J NEUROSCI, V27, P10895, DOI 10.1523/JNEUROSCI.3135-07.2007; Huet E, 2002, CLIN EXP METASTAS, V19, P107, DOI 10.1023/A:1014547324918; Joo EJ, 2005, GLYCOBIOLOGY, V15, P1, DOI 10.1093/glycob/cwh132; Kang KH, 2008, CARDIOVASC RES, V79, P150, DOI 10.1093/cvr/cvn072; Krust B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-333; LECO KJ, 1994, J BIOL CHEM, V269, P9352; Loging WT, 1999, ONCOGENE, V18, P7608, DOI 10.1038/sj.onc.1203135; Ma DHK, 2003, J BIOMED SCI, V10, P526, DOI 10.1159/000072380; Mahller YY, 2008, CANCER RES, V68, P1170, DOI 10.1158/0008-5472.CAN-07-2734; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; PAVLOFF N, 1992, J BIOL CHEM, V267, P17321; Pennie WD, 1999, CELL GROWTH DIFFER, V10, P279; Plumb J, 2005, J NEUROIMMUNOL, V164, P1, DOI 10.1016/j.jneuroim.2005.02.021; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Ribatti D, 2001, LIFE SCI, V68, P1161, DOI 10.1016/S0024-3205(00)01030-4; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Sakakibara M, 1999, CANCER, V85, P231, DOI 10.1002/(SICI)1097-0142(19990101)85:1<231::AID-CNCR31>3.0.CO;2-3; Smith MR, 1997, CYTOKINE, V9, P770, DOI 10.1006/cyto.1997.0233; Soulie P, 2002, J IMMUNOASS IMMUNOCH, V23, P33, DOI 10.1081/IAS-120002273; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Ueki T, 2000, CANCER RES, V60, P1835; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200	40	36	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43685	43693		10.1074/jbc.M112.380402	http://dx.doi.org/10.1074/jbc.M112.380402			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23109338	Green Published, hybrid			2022-12-28	WOS:000312940800048
J	Jung, JH; Seo, PJ; Park, CM				Jung, Jae-Hoon; Seo, Pil Joon; Park, Chung-Mo			The E3 Ubiquitin Ligase HOS1 Regulates Arabidopsis Flowering by Mediating CONSTANS Degradation Under Cold Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLORAL INDUCTION; FT PROTEIN; TEMPERATURE PERCEPTION; AMBIENT-TEMPERATURE; SIGNAL-TRANSDUCTION; NEGATIVE REGULATOR; GENE-EXPRESSION; DISTINCT ROLES; LOCUS-T; TIME	The timing of flowering is coordinated by a web of gene regulatory networks that integrates developmental and environmental cues in plants. Light and temperature are two major environmental determinants that regulate flowering time. Although prolonged treatment with low nonfreezing temperatures accelerates flowering by stable repression of FLOWERING LOCUS C (FLC), repeated brief cold treatments delay flowering. Here, we report that intermittent cold treatments trigger the degradation of CONSTANS (CO), a central activator of photoperiodic flowering; daily treatments caused suppression of the floral integrator FLOWERING LOCUS T (FT) and delayed flowering. Cold-induced CO degradation is mediated via a ubiquitin/proteasome pathway that involves the E3 ubiquitin ligase HIGH EXPRESSION OF OSMOTICALLY RESPONSIVE GENE 1 (HOS1). HOS1-mediated CO degradation occurs independently of the well established cold response pathways. It is also independent of the light signaling repressor CONSTITUTIVE PHOTOMORPHOGENIC 1 (COP1) E3 ligase and light wavelengths. CO has been shown to play a key role in photoperiodic flowering. Here, we demonstrated that CO served as a molecular hub, integrating photoperiodic and cold stress signals into the flowering genetic pathways. We propose that the HOS1-CO module contributes to the fine-tuning of photoperiodic flowering under short term temperature fluctuations, which often occur during local weather disturbances.	[Jung, Jae-Hoon; Park, Chung-Mo] Seoul Natl Univ, Dept Chem, Seoul 151742, South Korea; [Seo, Pil Joon] Chonbuk Natl Univ, Dept Chem, Jeonju 561756, South Korea; [Park, Chung-Mo] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul 151742, South Korea	Seoul National University (SNU); Jeonbuk National University; Seoul National University (SNU)	Park, CM (corresponding author), Seoul Natl Univ, Dept Chem, Seoul 151742, South Korea.	cmpark@snu.ac.kr	Seo, Pil Joon/AAR-9426-2020; Park, Chung-Mo/B-6175-2012		National Research Foundation of Korea [20120005600]; Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center) from the Rural Development Administration [201203013055290010200]; Agricultural R & D Promotion Center from the Korea Ministry for Food, Agriculture, Forestry and Fisheries [309017-05-4-HD140]	National Research Foundation of Korea(National Research Foundation of Korea); Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center) from the Rural Development Administration; Agricultural R & D Promotion Center from the Korea Ministry for Food, Agriculture, Forestry and Fisheries	This work was supported by Leaping Research Program Grant 20120005600 from the National Research Foundation of Korea, the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center Grant 201203013055290010200) from the Rural Development Administration, and Agricultural R & D Promotion Center Grant 309017-05-4-HD140 from the Korea Ministry for Food, Agriculture, Forestry and Fisheries.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Davis SJ, 2002, CURR BIOL, V12, pR841, DOI 10.1016/S0960-9822(02)01348-9; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Dong CH, 2006, P NATL ACAD SCI USA, V103, P8281, DOI 10.1073/pnas.0602874103; Foreman J, 2011, PLANT J, V65, P441, DOI 10.1111/j.1365-313X.2010.04434.x; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Gilmour SJ, 2004, PLANT MOL BIOL, V54, P767, DOI 10.1023/B:PLAN.0000040902.06881.d4; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Hong SY, 2011, J BIOL CHEM, V286, P1659, DOI 10.1074/jbc.M110.167692; Ishitani M, 1998, PLANT CELL, V10, P1151, DOI 10.1105/tpc.10.7.1151; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; Kim YS, 2006, PLANT CELL, V18, P3132, DOI 10.1105/tpc.106.043018; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Laubinger S, 2006, DEVELOPMENT, V133, P3213, DOI 10.1242/dev.02481; Lazaro A, 2012, PLANT CELL, V24, P982, DOI 10.1105/tpc.110.081885; Lee HJ, 2001, GENE DEV, V15, P912, DOI 10.1101/gad.866801; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Liu LJ, 2008, PLANT CELL, V20, P292, DOI 10.1105/tpc.107.057281; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Miura K, 2011, PLANT J, V67, P269, DOI 10.1111/j.1365-313X.2011.04589.x; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Samach A, 2005, CURR OPIN PLANT BIOL, V8, P483, DOI 10.1016/j.pbi.2005.07.011; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Seo E, 2009, PLANT CELL, V21, P3185, DOI 10.1105/tpc.108.063883; Seo PJ, 2010, PLANT J, V61, P661, DOI 10.1111/j.1365-313X.2009.04091.x; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010; Zuo ZC, 2011, CURR BIOL, V21, P841, DOI 10.1016/j.cub.2011.03.048	51	65	75	3	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43277	43287		10.1074/jbc.M112.394338	http://dx.doi.org/10.1074/jbc.M112.394338			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23135282	hybrid, Green Published			2022-12-28	WOS:000312940800009
J	Aragao, AZB; Nogueira, MLC; Granato, DC; Simabuco, FM; Honorato, RV; Hoffman, Z; Yokoo, S; Laurindo, FRM; Squina, FM; Zeri, ACM; Oliveira, PSL; Sherman, NE; Leme, AFP				Aragao, Annelize Z. B.; Nogueira, Maria Luiza C.; Granato, Daniela C.; Simabuco, Fernando M.; Honorato, Rodrigo V.; Hoffman, Zaira; Yokoo, Sami; Laurindo, Francisco R. M.; Squina, Fabio M.; Zeri, Ana Carolina M.; Oliveira, Paulo S. L.; Sherman, Nicholas E.; Paes Leme, Adriana F.			Identification of Novel Interaction between ADAM17 (a Disintegrin and Metalloprotease 17) and Thioredoxin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE-C; TYROSINE KINASE; SHEDDING ACTIVITY; C2C12 CELLS; LIPID RAFTS; RECEPTOR; ACTIVATION; NMR	ADAM17, which is also known as TNF alpha-converting enzyme, is the major sheddase for the EGF receptor ligands and is considered to be one of the main proteases responsible for the ectodomain shedding of surface proteins. How a membrane-anchored proteinase with an extracellular catalytic domain can be activated by inside-out regulation is not completely understood. We characterized thioredoxin-1 (Trx-1) as a partner of the ADAM17 cytoplasmic domain that could be involved in the regulation of ADAM17 activity. We induced the overexpression of the ADAM17 cytoplasmic domain in HEK293 cells, and ligands able to bind this domain were identified by MS after protein immunoprecipitation. Trx-1 was also validated as a ligand of the ADAM17 cytoplasmic domain and full-length ADAM17 recombinant proteins by immunoblotting, immunolocalization, and solid phase binding assay. In addition, using nuclear magnetic resonance, it was shown in vitro that the titration of the ADAM17 cytoplasmic domain promotes changes in the conformation of Trx-1. The MS analysis of the cross-linked complexes showed cross-linking between the two proteins by lysine residues. To further evaluate the functional role of Trx-1, we used a heparin-binding EGF shedding cell model and observed that the overexpression of Trx-1 in HEK293 cells could decrease the activity of ADAM17, activated by either phorbol 12-myristate 13-acetate or EGF. This study identifies Trx-1 as a novel interaction partner of the ADAM17 cytoplasmic domain and suggests that Trx-1 is a potential candidate that could be involved in ADAM17 activity regulation.	[Aragao, Annelize Z. B.; Nogueira, Maria Luiza C.; Granato, Daniela C.; Simabuco, Fernando M.; Honorato, Rodrigo V.; Yokoo, Sami; Zeri, Ana Carolina M.; Oliveira, Paulo S. L.; Paes Leme, Adriana F.] CNPEM, Lab Espectrometria Massas, Lab Nacl Biociencias, LNBio, BR-13083970 Campinas, SP, Brazil; [Hoffman, Zaira; Squina, Fabio M.] CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol, CTBE, BR-13083970 Campinas, SP, Brazil; [Laurindo, Francisco R. M.] Univ Sao Paulo, Inst Coracao, BR-05403000 Sao Paulo, Brazil; [Sherman, Nicholas E.] Univ Virginia, WM Keck Biomed Mass Spectrometry Lab, Charlottesville, VA 22908 USA	Universidade de Sao Paulo; University of Virginia	Leme, AFP (corresponding author), CNPEM, Lab Espectrometria Massas, Lab Nacl Biociencias, LNBio, BR-13083970 Campinas, SP, Brazil.	adriana.paesleme@lnbio.org.br	Oliveira, Paulo/D-5463-2011; Zeri, Ana/AAY-4799-2021; Honorato, Rodrigo/H-9773-2013; Oliveira, Paulo S/K-5588-2013; NOGUEIRA, MARIA LUIZA CALDAS/ABD-4713-2020; Aragão, Annelize Z B/I-6535-2012; Simabuco, Fernando M/GQA-4176-2022; Simabuco, Fernando M/G-8421-2017; Leme, Adriana F Paes/C-9679-2012; Squina, Fabio/J-8130-2012; Honorato, Rodrigo Vargas/AAY-9375-2020	Oliveira, Paulo/0000-0002-1287-8019; Zeri, Ana/0000-0003-4169-4523; Honorato, Rodrigo/0000-0001-5267-3002; NOGUEIRA, MARIA LUIZA CALDAS/0000-0003-2548-6564; Simabuco, Fernando M/0000-0002-1672-9686; Simabuco, Fernando M/0000-0002-1672-9686; Leme, Adriana F Paes/0000-0001-7959-147X; Squina, Fabio/0000-0002-8154-7459; Honorato, Rodrigo Vargas/0000-0001-5267-3002; Yokoo, Sami/0000-0003-4658-9319; Sherman, Nicholas/0000-0003-3206-3113	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/54067-3, 2009/18301-1, 2010/15675-5, 2010/19278-0, 2011/02267-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [470567/2009-0, 470549/2011-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grants 2009/54067-3, 2009/18301-1, 2010/15675-5, 2010/19278-0, and 2011/02267-9 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grants 470567/2009-0 and 470549/2011-4.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Bass Rosemary, 2010, Biochem J, V428, pe3, DOI 10.1042/BJ20100568; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Butler Georgina S., 2009, V528, P159, DOI 10.1007/978-1-60327-310-7_12; Canault M, 2006, J CELL PHYSIOL, V208, P363, DOI 10.1002/jcp.20671; Cao Y, 2001, BIOCHEM J, V357, P353, DOI 10.1042/0264-6021:3570353; Chen K, 2004, J BIOL CHEM, V279, P35079, DOI 10.1074/jbc.M404859200; CHEN XR, 1995, J BIOL CHEM, V270, P18285, DOI 10.1074/jbc.270.31.18285; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Dethlefsen SM, 1998, J CELL BIOCHEM, V69, P143, DOI 10.1002/(SICI)1097-4644(19980501)69:2<143::AID-JCB5>3.0.CO;2-S; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Fan HZ, 2003, J BIOL CHEM, V278, P18617, DOI 10.1074/jbc.M300331200; Fischer OM, 2004, MOL CELL BIOL, V24, P5172, DOI 10.1128/MCB.24.12.5172-5183.2004; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hara T, 2007, ANTIOXID REDOX SIGN, V9, P1427, DOI 10.1089/ars.2007.1661; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kang Q, 2001, J BIOL CHEM, V276, P24466, DOI 10.1074/jbc.M101162200; Kang Q, 2000, BIOCHEM J, V352, P883, DOI 10.1042/0264-6021:3520883; Kim J, 2005, J CELL BIOCHEM, V94, P39, DOI 10.1002/jcb.20276; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Li Monica X, 2002, Methods Mol Biol, V173, P255; Mori S, 2003, J BIOL CHEM, V278, P46029, DOI 10.1074/jbc.M306393200; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Nelson KK, 1999, BIOCHEM J, V343, P673, DOI 10.1042/0264-6021:3430673; Oliveira AK, 2010, THROMB HAEMOSTASIS, V104, P485, DOI 10.1160/TH09-12-0855; Pearson KM, 2002, RAPID COMMUN MASS SP, V16, P149, DOI 10.1002/rcm.554; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Scott AJ, 2011, J BIOL CHEM, V286, P35466, DOI 10.1074/jbc.M111.277434; Sundberg C, 2004, J BIOL CHEM, V279, P51601, DOI 10.1074/jbc.M403753200; Suzuki A, 2000, ONCOGENE, V19, P5842, DOI 10.1038/sj.onc.1203986; Tanaka M, 2004, J BIOL CHEM, V279, P41950, DOI 10.1074/jbc.M400086200; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Watanabe R, 2010, PHARMACOL THERAPEUT, V127, P261, DOI 10.1016/j.pharmthera.2010.04.004; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang ZL, 2001, FASEB J, V15, P303; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	50	30	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43071	43082		10.1074/jbc.M112.364513	http://dx.doi.org/10.1074/jbc.M112.364513			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105116	Green Published, hybrid			2022-12-28	WOS:000312501600063
J	Clapp, KM; Peng, HM; Jenkins, GJ; Ford, MJ; Morishima, Y; Lau, M; Osawa, Y				Clapp, Kelly M.; Peng, Hwei-Ming; Jenkins, Gary J.; Ford, Michael J.; Morishima, Yoshihiro; Lau, Miranda; Osawa, Yoichi			Ubiquitination of Neuronal Nitric-oxide Synthase in the Calmodulin-binding Site Triggers Proteasomal Degradation of the Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; IN-VITRO; PROTEOLYTIC DEGRADATION; CHAPERONE MACHINERY; MASS-SPECTROMETRY; STATISTICAL-MODEL; ELECTRON-TRANSFER; TRIAGE DECISIONS; CHIP; SYSTEM	Nitric-oxide synthase, a cytochrome P450-like hemoprotein enzyme, catalyzes the synthesis of nitric oxide, a critical signaling molecule in a variety of physiological processes. Our laboratory has discovered that certain drugs suicide-inactivate neuronal nitric-oxide synthase (nNOS) and lead to the preferential ubiquitination of the inactivated nNOS by an Hsp70- and CHIP (C terminus of Hsc70-interacting protein)-dependent process. To further understand the process by which altered nNOS is recognized, ubiquitinated, and proteasomally degraded, we examined the sites of ubiquitination on nNOS. We utilized an in vitro ubiquitination system containing purified E1, E2 (UbcH5a), Hsp70, and CHIP that recapitulates the ability of the cells to selectively recognize and ubiquitinate the altered forms of nNOS. LC-MS/MS analysis of the tryptic peptides obtained from the in vitro ubiquitinated nNOS identified 12 ubiquitination sites. Nine of the sites were within the oxygenase domain and two were in the calmodulin-binding site, which links the oxygenase and reductase domains, and one site was in the reductase domain. Mutational analysis of the lysines in the calmodulin-binding site revealed that Lys-739 is a major site for poly-ubiquitination of nNOS in vitro and regulates, in large part, the CHIP-dependent degradation of nNOS in HEK293 cells, as well as in in vitro studies with fraction II. Elucidating the exact site of ubiquitination is an important step in understanding how chaperones recognize and trigger degradation of nNOS.	[Clapp, Kelly M.; Peng, Hwei-Ming; Jenkins, Gary J.; Morishima, Yoshihiro; Lau, Miranda; Osawa, Yoichi] Univ Michigan, Dept Pharmacol, Sch Med, Ann Arbor, MI 48109 USA; [Ford, Michael J.] MS Bioworks, Ann Arbor, MI 48108 USA	University of Michigan System; University of Michigan	Osawa, Y (corresponding author), Univ Michigan, Dept Pharmacol, Sch Med, 1301 Med Sci Res Bldg 3, Ann Arbor, MI 48109 USA.	osawa@umich.edu			National Institutes of Health [GM077430]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077430.	Ausubel F. M., 1993, CURRENT PROTOCOLS MO, P911; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Banerjee A, 2000, DRUG METAB DISPOS, V28, P118; Bender AT, 2000, J BIOL CHEM, V275, P17407, DOI 10.1074/jbc.M000155200; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Clapp KM, 2010, J BIOL CHEM, V285, P33642, DOI 10.1074/jbc.M110.159178; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Dunbar AY, 2006, DRUG METAB DISPOS, V34, P1448, DOI 10.1124/dmd.106.009951; Dunbar AY, 2004, MOL PHARMACOL, V66, P964, DOI 10.1124/mol.104.000125; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jiang JH, 2003, J BIOL CHEM, V278, P49332, DOI 10.1074/jbc.M304738200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kolodziejski PJ, 2002, P NATL ACAD SCI USA, V99, P12315, DOI 10.1073/pnas.192345199; Korsmeyer KK, 1999, ARCH BIOCHEM BIOPHYS, V365, P31, DOI 10.1006/abbi.1999.1138; Kuang ZH, 2010, J CELL BIOL, V190, P129, DOI 10.1083/jcb.200912087; Li RF, 2007, J MOL BIOL, V374, P777, DOI 10.1016/j.jmb.2007.09.082; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; Matter H, 2005, J MED CHEM, V48, P4783, DOI 10.1021/jm050007x; Morishima Y, 2005, BIOCHEMISTRY-US, V44, P16333, DOI 10.1021/bi0515570; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Nakatsuka M, 1998, DRUG METAB DISPOS, V26, P497; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Osawa Y, 2003, J PHARMACOL EXP THER, V304, P493, DOI 10.1124/jpet.102.035055; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Peng HM, 2012, J BIOL CHEM, V287, P1556, DOI 10.1074/jbc.M111.323295; Peng HM, 2009, BIOCHEMISTRY-US, V48, P8483, DOI 10.1021/bi901058g; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Song Y, 2001, BIOCHEM J, V355, P357, DOI 10.1042/0264-6021:3550357; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Wang DX, 2005, J PROTEOME RES, V4, P1554, DOI 10.1021/pr050104e; Wang Y., 2012, MOL CELL PROTEOMICS, V11, P1; Wang YQ, 2011, J BIOL CHEM, V286, P9443, DOI 10.1074/jbc.M110.176685; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200	39	10	10	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42601	42610		10.1074/jbc.M112.412494	http://dx.doi.org/10.1074/jbc.M112.412494			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23109339	hybrid, Green Published			2022-12-28	WOS:000312501600021
J	Newman, JC; He, WJ; Verdin, E				Newman, John C.; He, Wenjuan; Verdin, Eric			Mitochondrial Protein Acylation and Intermediary Metabolism: Regulation by Sirtuins and Implications for Metabolic Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FATTY-ACID OXIDATION; DIET-INDUCED OBESITY; INDUCED INSULIN-RESISTANCE; COENZYME-A DECARBOXYLASE; ACETYL-COA CARBOXYLASE-2; LIFE-SPAN EXTENSION; CHAIN AMINO-ACIDS; CALORIE RESTRICTION; LYSINE ACETYLATION; SKELETAL-MUSCLE	The sirtuins are a family of NAD(+)-dependent protein deacetylases that regulate cell survival, metabolism, and longevity. Three sirtuins, SIRT3-5, localize to mitochondria. Expression of SIRT3 is selectively activated during fasting and calorie restriction. SIRT3 regulates the acetylation level and enzymatic activity of key metabolic enzymes, such as acetyl-CoA synthetase, long-chain acyl-CoA dehydrogenase, and 3-hydroxy-3-methylglutaryl-CoA synthase 2, and enhances fat metabolism during fasting. SIRT5 exhibits demalonylase/desuccinylase activity, and lysine succinylation and malonylation are abundant mitochondrial protein modifications. No convincing enzymatic activity has been reported for SIRT4. Here, we review the emerging role of mitochondrial sirtuins as metabolic sensors that respond to changes in the energy status of the cell and modulate the activities of key metabolic enzymes via protein deacylation.	[Newman, John C.; He, Wenjuan; Verdin, Eric] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Newman, John C.] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA; [Verdin, Eric] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verdin, E (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA.	everdin@gladstone.ucsf.edu	Verdin, Eric/AAB-7999-2019; Newman, John C/L-8112-2013	Verdin, Eric/0000-0003-3703-3183	National Institutes of Health from NIDDK [P30 DK026743, R24 DK085610]; Ellison Medical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK085610, P30DK026743] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 DK026743 (to the UCSF Liver Center) and R24 DK085610 from NIDDK. This work was also supported by a Senior Scholarship in Aging from the Ellison Medical Foundation and institutional support from the J. David Gladstone Institutes. Eric Verdin is a member of the Scientific Advisory Board of Sirtris/GSK, a company involved in the commercialization of sirtuin-related discoveries. This is the third article in the Thematic Minireview Series on Sirtuins: From Biochemistry to Health and Disease.	Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Alhazzazi TY, 2011, CANCER-AM CANCER SOC, V117, P1670, DOI 10.1002/cncr.25676; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bao JJ, 2010, FREE RADICAL BIO MED, V49, P1230, DOI 10.1016/j.freeradbiomed.2010.07.009; Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; Berg JM, 2012, BIOCHEMISTRY; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blomstrand E, 2006, J NUTR, V136, p269S, DOI 10.1093/jn/136.1.269S; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Cooper HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004986; Cordente AG, 2004, J BIOL CHEM, V279, P33899, DOI 10.1074/jbc.M402685200; Crunkhorn S, 2007, J BIOL CHEM, V282, P15439, DOI 10.1074/jbc.M611214200; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Dyck JRB, 2006, CIRCULATION, V114, P1721, DOI 10.1161/CIRCULATIONAHA.106.642009; Dyck JRB, 2004, CIRC RES, V94, pE78, DOI 10.1161/01.RES.0000129255.19569.8f; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Fritz KS, 2012, J PROTEOME RES, V11, P1633, DOI 10.1021/pr2008384; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; GARLAND PB, 1965, BIOCHEM J, V97, P587, DOI 10.1042/bj0970587; Groop L, 2000, BRIT J NUTR, V83, pS39; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang JS, 2012, FASEB J, V26, P628, DOI 10.1096/fj.11-194019; Ji H, 2008, INT J OBESITY, V32, P1331, DOI 10.1038/ijo.2008.71; Ji H, 2007, METABOLISM, V56, P1124, DOI 10.1016/j.metabol.2007.04.006; Jin L, 2009, PROTEIN SCI, V18, P514, DOI 10.1002/pro.50; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nasrin N, 2010, J BIOL CHEM, V285, P31995, DOI 10.1074/jbc.M110.124164; PAIK WK, 1970, BIOCHIM BIOPHYS ACTA, V213, P513, DOI 10.1016/0005-2787(70)90058-4; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Pedersen PL, 2002, BBA-BIOENERGETICS, V1555, P14, DOI 10.1016/S0005-2728(02)00248-7; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Petro AE, 2004, METABOLISM, V53, P454, DOI 10.1016/j.metabol.2003.11.018; Picklo MJ, 2008, BIOCHEM BIOPH RES CO, V376, P615, DOI 10.1016/j.bbrc.2008.09.039; Pollex RL, 2006, NAT CLIN PRACT CARD, V3, P482, DOI 10.1038/ncpcardio0638; Poulsen P, 2001, DIABETOLOGIA, V44, P537, DOI 10.1007/s001250051659; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; RANDLE PJ, 1963, LANCET, V1, P785; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Shimomura Y, 2001, CURR OPIN CLIN NUTR, V4, P419, DOI 10.1097/00075197-200109000-00013; Shulga N, 2010, J CELL SCI, V123, P894, DOI 10.1242/jcs.061846; Siegel AB, 2009, CANCER-AM CANCER SOC, V115, P5651, DOI 10.1002/cncr.24687; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tauriainen E, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/525094; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	93	166	170	4	67	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42436	42443		10.1074/jbc.R112.404863	http://dx.doi.org/10.1074/jbc.R112.404863			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23086951	hybrid, Green Published			2022-12-28	WOS:000312501600004
J	Orr, AL; Quinlan, CL; Perevoshchikova, IV; Brand, MD				Orr, Adam L.; Quinlan, Casey L.; Perevoshchikova, Irina V.; Brand, Martin D.			A Refined Analysis of Superoxide Production by Mitochondrial sn-Glycerol 3-Phosphate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED GLYCEROL-3-PHOSPHATE DEHYDROGENASE; PIG BRAIN MITOCHONDRIA; GLYCEROPHOSPHATE DEHYDROGENASE; PHOSPHATE DEHYDROGENASE; ALPHA-GLYCEROPHOSPHATE; MAMMALIAN-CELLS; SKELETAL-MUSCLE; L-3-GLYCEROPHOSPHATE DEHYDROGENASE; DROSOPHILA MITOCHONDRIA; ELECTRON-TRANSPORT	The oxidation of sn-glycerol 3-phosphate by mitochondrial sn-glycerol 3-phosphate dehydrogenase (mGPDH) is a major pathway for transfer of cytosolic reducing equivalents to the mitochondrial electron transport chain. It is known to generate H2O2 at a range of rates and from multiple sites within the chain. The rates and sites depend upon tissue source, concentrations of glycerol 3-phosphate and calcium, and the presence of different electron transport chain inhibitors. We report a detailed examination of H2O2 production during glycerol 3-phosphate oxidation by skeletal muscle, brown fat, brain, and heart mitochondria with an emphasis on conditions under which mGPDH itself is the source of superoxide and H2O2. Importantly, we demonstrate that a substantial portion of H2O2 production commonly attributed to mGPDH originates instead from electron flow through the ubiquinone pool into complex II. When complex II is inhibited and mGPDH is the sole superoxide producer, the rate of superoxide production depends on the concentrations of glycerol 3-phosphate and calcium and correlates positively with the predicted reduction state of the ubiquinone pool. mGPDH-specific superoxide production plateaus at a rate comparable with the other major sites of superoxide production in mitochondria, the superoxide-producing center shows no sign of being overreducible, and the maximum superoxide production rate correlates with mGPDH activity in four different tissues. mGPDH produces superoxide approximately equally toward each side of the mitochondrial inner membrane, suggesting that the Q-binding pocket of mGPDH is the major site of superoxide generation. These results clarify the maximum rate and mechanism of superoxide production by mGPDH.	[Orr, Adam L.; Quinlan, Casey L.; Perevoshchikova, Irina V.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Orr, AL (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	aorr@buckinstitute.org	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153	National Institutes of Health [R01 AG033542, TL1 AG032116]; Ellison Medical Foundation [AG-SS-2288-09]; NATIONAL INSTITUTE ON AGING [TL1AG032116, R01AG033542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG033542 and TL1 AG032116 (to C. L. Q.). This work was also supported by Ellison Medical Foundation Grant AG-SS-2288-09.	Affourtit C, 2012, METHODS MOL BIOL, V810, P165, DOI 10.1007/978-1-61779-382-0_11; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; BROWN LJ, 1994, J BIOL CHEM, V269, P14363; Bruneau JM, 1998, BIOCHEM J, V336, P299, DOI 10.1042/bj3360299; Chowdhury SKR, 2007, FREE RADICAL RES, V41, P1116, DOI 10.1080/10715760701579314; COLE ES, 1978, J BIOL CHEM, V253, P7952; COTTINGHAM IR, 1980, BIOCHEM J, V192, P9, DOI 10.1042/bj1920009; Daoud H, 2009, HUM GENET, V124, P649, DOI 10.1007/s00439-008-0588-3; DAWSON AP, 1969, BIOCHEM J, V111, P27, DOI 10.1042/bj1110027; Dummler K, 1996, BIOCHEM J, V317, P913; FELLENIU.E, 1973, ACTA CHEM SCAND, V27, P2361, DOI 10.3891/acta.chem.scand.27-2361; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; GARRIB A, 1986, J BIOL CHEM, V261, P8042; Gudayol M, 2001, ENDOCRINE, V16, P39, DOI 10.1385/ENDO:16:1:39; Halliwell B., 2007, FREE RADICAL BIO MED, P241; Hu CAA, 2007, MOL CELL BIOCHEM, V295, P85, DOI 10.1007/s11010-006-9276-6; HUNT SM, 1970, CANCER RES, V30, P1764; Jackman MR, 1996, AM J PHYSIOL-CELL PH, V270, pC673, DOI 10.1152/ajpcell.1996.270.2.C673; JOHNSON MA, 1984, Q J EXP PHYSIOL CMS, V69, P257, DOI 10.1113/expphysiol.1984.sp002804; Kempf L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000252; KLINGENBERG M, 1970, EUR J BIOCHEM, V13, P247, DOI 10.1111/j.1432-1033.1970.tb00924.x; KOPP SJ, 1984, J NEUROCHEM, V43, P1716, DOI 10.1111/j.1471-4159.1984.tb06100.x; Koza RA, 1996, ARCH BIOCHEM BIOPHYS, V336, P97, DOI 10.1006/abbi.1996.0536; Lagoutte E, 2010, BBA-BIOENERGETICS, V1797, P1500, DOI 10.1016/j.bbabio.2010.04.004; Lambert AJ, 2008, BBA-BIOENERGETICS, V1777, P397, DOI 10.1016/j.bbabio.2008.03.005; Linden DR, 2012, BRIT J PHARMACOL, V165, P2178, DOI 10.1111/j.1476-5381.2011.01681.x; MacDonald MJ, 1996, ARCH BIOCHEM BIOPHYS, V326, P79, DOI 10.1006/abbi.1996.0049; MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287; MACDONALD MJ, 1990, CANCER RES, V50, P7203; MacDonald MJ, 2000, ARCH BIOCHEM BIOPHYS, V384, P143, DOI 10.1006/abbi.2000.2107; MEINHARDT SW, 1983, BIOCHIM BIOPHYS ACTA, V723, P219, DOI 10.1016/0005-2728(83)90121-4; Miwa S, 2005, BBA-BIOENERGETICS, V1709, P214, DOI 10.1016/j.bbabio.2005.08.003; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Mookerjee SA, 2011, BBA-BIOENERGETICS, V1807, P1474, DOI 10.1016/j.bbabio.2011.07.011; Mracek T, 2009, ARCH BIOCHEM BIOPHYS, V481, P30, DOI 10.1016/j.abb.2008.10.011; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Nguyen NHT, 2007, J NEUROCHEM, V101, P1694, DOI 10.1111/j.1471-4159.2006.04433.x; Novials A, 1997, BIOCHEM BIOPH RES CO, V231, P570, DOI 10.1006/bbrc.1997.6147; Oelkrug R, 2010, J BIOL CHEM, V285, P21961, DOI 10.1074/jbc.M110.122861; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; PERON FG, 1974, CANCER RES, V34, P2711; Quinlan CL, 2008, AM J PHYSIOL-HEART C, V295, pH953, DOI 10.1152/ajpheart.00520.2008; Quinlan CL, 2012, FREE RADICAL BIO MED, V53, P1807, DOI 10.1016/j.freeradbiomed.2012.08.015; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; St-Pierre J, 2001, MOL GENET METAB, V72, P209, DOI 10.1006/mgme.2000.3144; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; Treberg JR, 2010, FEBS J, V277, P2766, DOI 10.1111/j.1742-4658.2010.07693.x; Tretter L, 2007, J NEUROSCI RES, V85, P3471, DOI 10.1002/jnr.21405; Tretter L, 2007, J NEUROCHEM, V100, P650, DOI 10.1111/j.1471-4159.2006.04223.x; URBAN PF, 1969, EUR J BIOCHEM, V9, P519, DOI 10.1111/j.1432-1033.1969.tb00640.x; Weitzel JM, 2000, BIOL CHEM, V381, P611, DOI 10.1515/BC.2000.078; Weitzel JM, 2003, BIOL REPROD, V68, P699, DOI 10.1095/biolreprod.102.008540; Weitzel JM, 2001, EUR J BIOCHEM, V268, P4095, DOI 10.1046/j.1432-1327.2001.02332.x; WERNETTE ME, 1981, J BIOL CHEM, V256, P2767; Yeh JI, 2008, P NATL ACAD SCI USA, V105, P3280, DOI 10.1073/pnas.0712331105; Zundorf G, 2011, ANTIOXID REDOX SIGN, V14, P1275, DOI 10.1089/ars.2010.3359	60	116	118	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42921	42935		10.1074/jbc.M112.397828	http://dx.doi.org/10.1074/jbc.M112.397828			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23124204	hybrid, Green Published			2022-12-28	WOS:000312501600050
J	Peng, GQ; Xu, LQ; Lin, YL; Chen, L; Pasquarella, JR; Holmes, KV; Li, F				Peng, Guiqing; Xu, Liqing; Lin, Yi-Lun; Chen, Lang; Pasquarella, Joseph R.; Holmes, Kathryn V.; Li, Fang			Crystal Structure of Bovine Coronavirus Spike Protein Lectin Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE HEPATITIS-VIRUS; RESPIRATORY SYNDROME CORONAVIRUS; CARCINOEMBRYONIC ANTIGEN FAMILY; SIALIC-ACID; AMINOPEPTIDASE-N; BINDING DOMAIN; HEMAGGLUTININ-ESTERASE; SARS CORONAVIRUS; S-PROTEIN; RECEPTOR	The spike protein N-terminal domains (NTDs) of bovine coronavirus (BCoV) and mouse hepatitis coronavirus (MHV) recognize sugar and protein receptors, respectively, despite their significant sequence homology. We recently determined the crystal structure of MHV NTD complexed with its protein receptor murine carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), which surprisingly revealed a human galectin (galactose-binding lectin) fold in MHV NTD. Here, we have determined at 1.55 angstrom resolution the crystal structure of BCoV NTD, which also has the human galectin fold. Using mutagenesis, we have located the sugar-binding site in BCoV NTD, which overlaps with the galactose-binding site in human galectins. Using a glycan array screen, we have identified 5-N-acetyl-9-O-acetylneuraminic acid as the preferred sugar substrate for BCoV NTD. Subtle structural differences between BCoV and MHV NTDs, primarily involving different conformations of receptor-binding loops, explain why BCoV NTD does not bind CEACAM1 and why MHV NTD does not bind sugar. These results suggest a successful viral evolution strategy in which coronaviruses stole a galectin from hosts, incorporated it into their spike protein, and evolved it into viral receptor-binding domains with altered sugar specificity in contemporary BCoV or novel protein specificity in contemporary MHV.	[Peng, Guiqing; Xu, Liqing; Lin, Yi-Lun; Chen, Lang; Pasquarella, Joseph R.; Li, Fang] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Holmes, Kathryn V.] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO 80045 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Colorado System; University of Colorado Anschutz Medical Campus	Li, F (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	lifang@umn.edu			National Institutes of Health [R01AI089728]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI089728 (to F. L.).	Beauchemin N, 1999, EXP CELL RES, V252, P243; CAVANAGH D, 1986, J GEN VIROL, V67, P1443, DOI 10.1099/0022-1317-67-7-1443; Chen L, 2012, P NATL ACAD SCI USA, V109, P17966, DOI 10.1073/pnas.1210123109; COMPTON SR, 1992, J VIROL, V66, P7420, DOI 10.1128/JVI.66.12.7420-7428.1992; DELMAS B, 1993, ADV EXP MED BIOL, V342, P293; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Dormitzer PR, 2002, EMBO J, V21, P885, DOI 10.1093/emboj/21.5.885; DVEKSLER GS, 1991, J VIROL, V65, P6881, DOI 10.1128/JVI.65.12.6881-6891.1991; Haselhorst T, 2007, GLYCOBIOLOGY, V17, P68, DOI 10.1093/glycob/cwl051; Hofmann H, 2006, J VIROL, V80, P8639, DOI 10.1128/JVI.00560-06; Kammerer R, 2004, GENE, V339, P99, DOI 10.1016/j.gene.2004.06.023; Krempl C, 1997, J VIROL, V71, P3285, DOI 10.1128/JVI.71.4.3285-3287.1997; KUNKEL F, 1993, VIROLOGY, V195, P195, DOI 10.1006/viro.1993.1360; Langereis MA, 2010, J VIROL, V84, P8970, DOI 10.1128/JVI.00566-10; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li F, 2006, J VIROL, V80, P6794, DOI 10.1128/JVI.02744-05; Li F, 2012, J VIROL, V86, P2856, DOI 10.1128/JVI.06882-11; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohtsuka N, 1996, J GEN VIROL, V77, P1683, DOI 10.1099/0022-1317-77-8-1683; Peng GQ, 2011, P NATL ACAD SCI USA, V108, P10696, DOI 10.1073/pnas.1104306108; Reguera J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002859; SCHULTZE B, 1992, VIROLOGY, V189, P792, DOI 10.1016/0042-6822(92)90608-R; SCHULTZE B, 1991, J VIROL, V65, P6232, DOI 10.1128/JVI.65.11.6232-6237.1991; Vijgen L, 2005, J VIROL, V79, P1595, DOI 10.1128/JVI.79.3.1595-1604.2005; Vijgen L, 2006, J VIROL, V80, P7270, DOI 10.1128/JVI.02675-05; Wessner DR, 1998, J VIROL, V72, P1941, DOI 10.1128/JVI.72.3.1941-1948.1998; WILLIAMS RK, 1991, P NATL ACAD SCI USA, V88, P5533, DOI 10.1073/pnas.88.13.5533; Wu KL, 2009, P NATL ACAD SCI USA, V106, P19970, DOI 10.1073/pnas.0908837106; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; YEATES TO, 1988, ACTA CRYSTALLOGR A, V44, P142, DOI 10.1107/S0108767387009632; YOKOMORI K, 1991, VIROLOGY, V183, P647, DOI 10.1016/0042-6822(91)90994-M; Zeng QH, 2008, P NATL ACAD SCI USA, V105, P9065, DOI 10.1073/pnas.0800502105; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	36	103	110	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41931	41938		10.1074/jbc.M112.418210	http://dx.doi.org/10.1074/jbc.M112.418210			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23091051	Green Published, hybrid			2022-12-28	WOS:000312103000033
J	Barbolina, MV; Liu, YY; Gurler, H; Kim, M; Kajdacsy-Balla, AA; Rooper, L; Shepard, J; Weiss, M; Shea, LD; Penzes, P; Ravosa, MJ; Stack, MS				Barbolina, Maria V.; Liu, Yiuying; Gurler, Hilal; Kim, Mijung; Kajdacsy-Balla, Andre A.; Rooper, Lisa; Shepard, Jaclyn; Weiss, Michael; Shea, Lonnie D.; Penzes, Peter; Ravosa, Matthew J.; Stack, M. Sharon			Matrix Rigidity Activates Wnt Signaling through Down-regulation of Dickkopf-1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARIAN-CANCER METASTASIS; BETA-CATENIN EXPRESSION; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; CELL INVASION; MICROENVIRONMENTAL REGULATION; CLINICOPATHOLOGICAL FEATURES; METALLOPROTEINASE EXPRESSION; AMINOTERMINAL PROPEPTIDE; PERICELLULAR PROTEOLYSIS	Cells respond to changes in the physical properties of the extracellular matrix with altered behavior and gene expression, highlighting the important role of the microenvironment in the regulation of cell function. In the current study, culture of epithelial ovarian cancer cells on three-dimensional collagen I gels led to a dramatic down-regulation of the Wnt signaling inhibitor dickkopf-1 with a concomitant increase in nuclear beta-catenin and enhanced beta-catenin/Tcf/Lef transcriptional activity. Increased three-dimensional collagen gel invasion was accompanied by transcriptional up-regulation of the membrane-tethered collagenase membrane type 1 matrix metalloproteinase, and an inverse relationship between dickkopf-1 and membrane type 1 matrix metalloproteinase was observed in human epithelial ovarian cancer specimens. Similar results were obtained in other tissue-invasive cells such as vascular endothelial cells, suggesting a novel mechanism for functional coupling of matrix adhesion with Wnt signaling.	[Barbolina, Maria V.; Gurler, Hilal; Kim, Mijung] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL 60622 USA; [Kajdacsy-Balla, Andre A.; Rooper, Lisa] Univ Illinois, Dept Pathol, Chicago, IL 60622 USA; [Ravosa, Matthew J.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Liu, Yiuying; Stack, M. Sharon] Univ Notre Dame, Dept Chem & Biochem, Harper Canc Res Inst, Notre Dame, IN 46556 USA; [Shepard, Jaclyn; Weiss, Michael; Shea, Lonnie D.; Penzes, Peter] Northwestern Univ, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Notre Dame; University of Notre Dame; Northwestern University	Barbolina, MV (corresponding author), Univ Illinois, Dept Biopharmaceut Sci, PHARM 453, 833 S Wood St, Chicago, IL 60612 USA.	mvb@uic.edu	Penzes, Peter/L-3987-2016; Shea, Lonnie D/B-7615-2009	Penzes, Peter/0000-0001-5449-1640; Rooper, Lisa/0000-0001-5636-9753	National Institutes of Health [CA086984, CA109545]; Ovarian Cancer Research Foundation Program of Excellence; Illinois Department of Public Health; NATIONAL CANCER INSTITUTE [R01CA109545, R01CA086984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Foundation Program of Excellence; Illinois Department of Public Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA086984 and CA109545 (to M. S. S.). This work was also supported by the Ovarian Cancer Research Foundation Program of Excellence (to M. V. B.) and the Illinois Department of Public Health (to M. V. B.).	Barbolina MV, 2008, LAB INVEST, V88, P602, DOI 10.1038/labinvest.2008.25; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Barbolina MV, 2007, J BIOL CHEM, V282, P4924, DOI 10.1074/jbc.M608428200; Barbolina MV, 2011, BIOCHEM J, V437, P1, DOI 10.1042/BJ20110112; Barbolina MV, 2009, CANCER TREAT RES, V149, P319, DOI 10.1007/978-0-387-98094-2_15; Barbolina MV, 2009, INT J CANCER, V125, P816, DOI 10.1002/ijc.24347; Barbolina MV, 2008, CANCER-AM CANCER SOC, V112, P1632, DOI 10.1002/cncr.23341; Beck L, 1997, FASEB J, V11, P365, DOI 10.1096/fasebj.11.5.9141503; BISSELL MJ, 1987, J CELL SCI, P327; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Brown XQ, 2010, J CELL PHYSIOL, V225, P115, DOI 10.1002/jcp.22202; Burkhalter RJ, 2011, J BIOL CHEM, V286, P23467, DOI 10.1074/jbc.M110.199539; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Ellerbroek SM, 1999, CANCER RES, V59, P1635; Engler AJ, 2009, SCIENCE, V324, P208, DOI 10.1126/science.1170107; Fishman DA, 1997, GYNECOL ONCOL, V67, P193, DOI 10.1006/gyno.1997.4850; Gamallo C, 1999, AM J PATHOL, V155, P527, DOI 10.1016/S0002-9440(10)65148-6; Gatcliffe TA, 2008, INT J GYNECOL CANCER, V18, P954, DOI 10.1111/j.1525-1438.2007.01127.x; Gehler S, 2009, MOL BIOL CELL, V20, P3224, DOI 10.1091/mbc.E08-12-1186; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hlubek F, 2004, INT J CANCER, V108, P321, DOI 10.1002/ijc.11522; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Kildal W, 2005, EUR J CANCER, V41, P1127, DOI 10.1016/j.ejca.2005.01.022; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Koh W, 2009, J CELL SCI, V122, P1812, DOI 10.1242/jcs.045799; LABATROBERT J, 1990, FEBS LETT, V268, P386, DOI 10.1016/0014-5793(90)81291-U; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CM, 2003, GYNECOL ONCOL, V88, P363, DOI 10.1016/S0090-8258(02)00015-X; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liu P, 2010, J CELL PHYSIOL, V225, P810, DOI 10.1002/jcp.22292; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Marchenko GN, 2002, BIOCHEM J, V363, P253, DOI 10.1042/0264-6021:3630253; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Moon Randall T, 2005, Sci STKE, V2005, pcm1; Moser TL, 1996, INT J CANCER, V67, P695, DOI 10.1002/(SICI)1097-0215(19960904)67:5<695::AID-IJC18>3.3.CO;2-2; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Paszek MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000604; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; PUISTOLA U, 1990, AM J OBSTET GYNECOL, V163, P1276, DOI 10.1016/0002-9378(90)90707-E; Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682; RISTELI L, 1988, INT J CANCER, V41, P409, DOI 10.1002/ijc.2910410316; RISTELI L, 1992, ACTA OBSTET GYN SCAN, V71, P99, DOI 10.1111/j.1600-0412.1992.tb00014.x; Roskelley CD, 2002, SEMIN CANCER BIOL, V12, P97, DOI 10.1006/scbi.2001.0417; ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0; Schambony A, 2004, DIFFERENTIATION, V72, P307, DOI 10.1111/j.1432-0436.2004.07207002.x; Shedden KA, 2005, CLIN CANCER RES, V11, P2123, DOI 10.1158/1078-0432.CCR-04-2061; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Tsukatani T, 2003, NEUROREPORT, V14, P1135, DOI 10.1097/00001756-200306110-00007; Velegol D, 2001, BIOPHYS J, V81, P1786, DOI 10.1016/S0006-3495(01)75829-8; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wright K, 1999, INT J CANCER, V82, P625, DOI 10.1002/(SICI)1097-0215(19990827)82:5<625::AID-IJC1>3.0.CO;2-2; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; ZHU GG, 1993, CANCER RES, V53, P5028; Zirn B, 2006, INT J CANCER, V118, P1954, DOI 10.1002/ijc.21564	64	38	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					141	151		10.1074/jbc.M112.431411	http://dx.doi.org/10.1074/jbc.M112.431411			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23152495	hybrid, Green Published			2022-12-28	WOS:000313197200014
J	Bristow, JM; Reno, TA; Jo, M; Gonias, SL; Klemke, RL				Bristow, Jeanne M.; Reno, Theresa A.; Jo, Minji; Gonias, Steven L.; Klemke, Richard L.			Dynamic Phosphorylation of Tyrosine 665 in Pseudopodium-enriched Atypical Kinase 1 (PEAK1) Is Essential for the Regulation of Cell Migration and Focal Adhesion Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; INTEGRIN ADHESOME; MATRIX ADHESIONS; SRC; PAXILLIN; RECEPTOR; PROTEIN; REVEALS; IDENTIFICATION; CYTOSKELETON	Pseudopodium-enriched atypical kinase 1 (PEAK1) is a recently described tyrosine kinase that associates with the actin cytoskeleton and focal adhesion (FA) in migrating cells. PEAK1 is known to promote cell migration, but the responsible mechanisms remain unclear. Here, we show that PEAK1 controls FA assembly and disassembly in a dynamic pathway controlled by PEAK1 phosphorylation at Tyr-665. Knockdown of endogenous PEAK1 inhibits random cell migration. In PEAK1-deficient cells, FA lifetimes are decreased, FA assembly times are shortened, and FA disassembly times are extended. Phosphorylation of Tyr-665 in PEAK1 is essential for normal PEAK1 localization and its function in the regulation of FAs; however, constitutive phosphorylation of PEAK1 Tyr-665 is also disruptive of its function, indicating a requirement for precise spatiotemporal regulation of PEAK1. Src family kinases are required for normal PEAK1 localization and function. Finally, we provide evidence that PEAK1 promotes cancer cell invasion through Matrigel by a mechanism that requires dynamic regulation of Tyr-665 phosphorylation.	[Klemke, Richard L.] Univ Calif San Diego, Dept Pathol, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Klemke, RL (corresponding author), Univ Calif San Diego, Dept Pathol, Moores Canc Ctr, 9500 Gilman Dr,0612, La Jolla, CA 92093 USA.	rklemke@ucsd.edu			National Institutes of Health [CA097022, HL060551]; American Cancer Society [121437-PF-11-276-01-CSM]; NATIONAL CANCER INSTITUTE [R01CA097022] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA097022 (to R. L. K.) and HL060551 (to S. L. G.).; Supported by American Cancer Society Postdoctoral Fellowship 121437-PF-11-276-01-CSM.	Bach CTT, 2010, CELL ADHES MIGR, V4, P226, DOI 10.4161/cam.4.2.10888; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Bristow JM, 2009, J CELL SCI, V122, P4535, DOI 10.1242/jcs.053728; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Burridge K, 2006, J BIOL CHEM, V281, P15593, DOI 10.1074/jbc.R500030200; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Choi CK, 2011, BIOPHYS J, V100, P583, DOI 10.1016/j.bpj.2010.12.3719; Donato DM, 2010, J BIOL CHEM, V285, P20769, DOI 10.1074/jbc.M109.091207; Feigin ME, 2009, EXP CELL RES, V315, P707, DOI 10.1016/j.yexcr.2008.10.034; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Goetz JG, 2009, CELL ADHES MIGR, V3, P185, DOI 10.4161/cam.3.2.7295; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Holcomb M, 2006, J BIOL CHEM, V281, P2430, DOI 10.1074/jbc.M508454200; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Kelber JA, 2012, CANCER RES, V72, P2554, DOI 10.1158/0008-5472.CAN-11-3552; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leroy C, 2009, CANCER RES, V69, P2279, DOI 10.1158/0008-5472.CAN-08-2354; Lock JG, 2008, SEMIN CANCER BIOL, V18, P65, DOI 10.1016/j.semcancer.2007.10.001; McEwen DP, 2004, J BIOL CHEM, V279, P16044, DOI 10.1074/jbc.M400856200; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Nagaraj NS, 2011, CLIN CANCER RES, V17, P483, DOI 10.1158/1078-0432.CCR-10-1670; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; RESZKA AA, 1992, J CELL BIOL, V117, P1321, DOI 10.1083/jcb.117.6.1321; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Valles AM, 2004, J BIOL CHEM, V279, P44490, DOI 10.1074/jbc.M405144200; Wang YC, 2010, P NATL ACAD SCI USA, V107, P10920, DOI 10.1073/pnas.0914776107; Webb DJ, 2000, J CELL SCI, V113, P123; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wu Y, 1998, J BIOL CHEM, V273, P5765, DOI 10.1074/jbc.273.10.5765; Xu Y, 2009, BRIT J CANCER, V100, P633, DOI 10.1038/sj.bjc.6604901; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183	41	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					123	131		10.1074/jbc.M112.410910	http://dx.doi.org/10.1074/jbc.M112.410910			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23105102	Green Published, hybrid			2022-12-28	WOS:000313197200012
J	Chang, CWJ; Lee, LD; Yu, D; Dao, K; Bossuyt, J; Bers, DM				Chang, Chia-Wei Jenny; Lee, Linda; Yu, David; Dao, Khanha; Bossuyt, Julie; Bers, Donald M.			Acute beta-Adrenergic Activation Triggers Nuclear Import of Histone Deacetylase 5 and Delays G(q)-induced Transcriptional Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CARDIAC-HYPERTROPHY; II-DELTA; HEART; EXPORT; PHOSPHORYLATION; DYNAMICS; MYOCYTES; RABBIT; MUSCLE	During hemodynamic stress, catecholamines and neurohumoral stimuli may induce co-activation of G(q)-coupled receptors and beta-adrenergic receptors (beta-AR), leading to cardiac remodeling. Dynamic regulation of histone deacetylase 5 (HDAC5), a transcriptional repressor, is crucial during stress signaling due to its role in epigenetic control of fetal gene markers. Little is known about its regulation during acute and chronic beta-AR stimulation and its cross-interaction with G(q) signaling in adult cardiac myocytes. Here, we evaluate the potential cross-talk between G(q)-driven and beta-AR mediated signaling at the level of nucleocytoplasmic shuttling of HDAC5. We show the translocation of GFP-tagged wild type HDAC5 or mutants (S279A and S279D) in response to beta-AR or G(q) agonists. Isoproterenol (ISO) or PKA activation results in strong nuclear accumulation of HDAC5 in contrast to nuclear export driven by Ca2+-calmodulin protein kinase II and protein kinase D. Moreover, nuclear accumulation of HDAC5 under acute ISO/PKA signaling is dependent on phosphorylation of Ser-279 and can block subsequent G(q)-mediated nuclear HDAC5 export. Intriguingly, the attenuation of G(q)-induced export is abolished after chronic PKA activation, yet nuclear HDAC5 remains elevated. Last, the effect of chronic beta-AR signaling on HDAC5 translocation was examined in adult myocytes from a rabbit model of heart failure, where ISO-induced nuclear import is ablated, but G(q)-agonist mediated export is preserved. Acute beta-AR/PKA activation protects against hypertrophic signaling by delaying G(q)-mediated transcriptional activation. This serves as a key physiological control switch before allowing genetic reprogramming via HDAC5 nuclear export during more severe stress, such as heart failure.	[Chang, Chia-Wei Jenny; Lee, Linda; Yu, David; Dao, Khanha; Bossuyt, Julie; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Chang, Chia-Wei Jenny] Loyola Univ, Dept Cell & Mol Physiol, Maywood, IL 60153 USA	University of California System; University of California Davis; Loyola University Chicago	Bers, DM (corresponding author), Univ Calif Davis, Dept Pharmacol, Genome Bldg,Rm 3503,1 Shields Ave, Davis, CA 95616 USA.	dmbers@ucdavis.edu		Bossuyt, Julie/0000-0001-8874-4765; Bers, Donald/0000-0002-2237-9483	National Institutes of Health [P01-HL80101, R01HL103933]; American Heart Association [0835312N, 09PRE2260256]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080101, R01HL103933] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health examined the functional role of HDAC5 in the heart and its Grant P01-HL80101 (to D. M. B.) and R01HL103933 (to J. B.). This work was also supported by American Heart Association Scientist Development Grant 0835312N (to J. B.) and American Heart Association Predoctoral Fellowship 09PRE2260256 (to C. W. C.).	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Backs J, 2011, J CELL BIOL, V195, P403, DOI 10.1083/jcb.201105063; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; BASSANI JWM, 1995, BIOPHYS J, V68, P1453, DOI 10.1016/S0006-3495(95)80318-8; Berthouze Magali, 2011, Curr Heart Fail Rep, V8, P159, DOI 10.1007/s11897-011-0062-8; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; Bossuyt J, 2011, J BIOL CHEM, V286, P33390, DOI 10.1074/jbc.M111.246447; Bush EW, 2009, EXPERT OPIN THER TAR, V13, P767, DOI 10.1517/14728220902939161; Calalb MB, 2009, CTS-CLIN TRANSL SCI, V2, P325, DOI 10.1111/j.1752-8062.2009.00141.x; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; CHIDSEY CA, 1963, NEW ENGL J MED, V269, P653, DOI 10.1056/NEJM196309262691302; Diviani D, 2011, AM J PHYSIOL-HEART C, V301, pH1742, DOI 10.1152/ajpheart.00569.2011; Dodge-Kafka KL, 2010, J BIOL CHEM, V285, P11078, DOI 10.1074/jbc.M109.034868; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dodge-Kafka KL, 2006, CIRC RES, V98, P993, DOI 10.1161/01.RES.0000218273.91741.30; Ellis JJ, 2003, MOL CELL BIOCHEM, V242, P153, DOI 10.1023/A:1021158216582; Faul C, 2007, MOL CELL BIOL, V27, P8215, DOI 10.1128/MCB.00950-07; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; Greco TM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004317; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Ha CH, 2010, P NATL ACAD SCI USA, V107, P15467, DOI 10.1073/pnas.1000462107; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Harrison BC, 2004, MOL CELL BIOL, V24, P10636, DOI 10.1128/MCB.24.24.10636-10649.2004; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Haworth RS, 2012, CIRC RES, V110, P1585, DOI 10.1161/CIRCRESAHA.111.263665; Johnson CA, 1999, SEMIN CELL DEV BIOL, V10, P179, DOI 10.1006/scdb.1999.0299; Kee HJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/928326; Leroy J, 2008, CIRC RES, V102, P1091, DOI 10.1161/CIRCRESAHA.107.167817; Liu SB, 2011, BIOCHEM BIOPH RES CO, V404, P581, DOI 10.1016/j.bbrc.2010.11.116; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Martin M, 2009, INT J DEV BIOL, V53, P291, DOI 10.1387/ijdb.082698mm; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; McKinsey TA, 2012, ANNU REV PHARMACOL, V52, P303, DOI 10.1146/annurev-pharmtox-010611-134712; Mika D, 2012, J MOL CELL CARDIOL, V52, P323, DOI 10.1016/j.yjmcc.2011.08.016; Mongillo M, 2006, BIOCHEM SOC T, V34, P510, DOI 10.1042/BST0340510; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; Movsesian MA, 2005, CURR TOP DEV BIOL, V68, P25, DOI 10.1016/S0070-2153(05)68002-7; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Pogwizd SM, 1999, CIRC RES, V85, P1009; Port JD, 2001, J MOL CELL CARDIOL, V33, P887, DOI 10.1006/jmcc.2001.1358; Redden JM, 2011, J CARDIOVASC PHARM, V58, P354, DOI 10.1097/FJC.0b013e31821e5649; Sucharov CC, 2011, J CARD FAIL, V17, P592, DOI 10.1016/j.cardfail.2011.03.006; Taniguchi M, 2012, NEURON, V73, P108, DOI 10.1016/j.neuron.2011.10.032; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005	59	42	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					192	204		10.1074/jbc.M112.382358	http://dx.doi.org/10.1074/jbc.M112.382358			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23161540	Green Published, hybrid			2022-12-28	WOS:000313197200019
J	Houben, AJS; van Wijk, XMR; van Meeteren, LA; van Zeijl, L; van de Westerlo, EMA; Hausmann, J; Fish, A; Perrakis, A; van Kuppevelt, TH; Moolenaar, WH				Houben, Anna J. S.; van Wijk, Xander M. R.; van Meeteren, Laurens A.; van Zeijl, Leonie; van de Westerlo, Els M. A.; Hausmann, Jens; Fish, Alexander; Perrakis, Anastassis; van Kuppevelt, Toin H.; Moolenaar, Wouter H.			The Polybasic Insertion in Autotaxin alpha Confers Specific Binding to Heparin and Cell Surface Heparan Sulfate Proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID PRODUCTION; MOTILITY-STIMULATING PROTEIN; GROWTH-FACTOR BINDING; LYSOPHOSPHOLIPASE-D; BIOCHEMICAL-CHARACTERIZATION; EXPRESSION; CANCER; FURIN; LPA; IDENTIFICATION	Autotaxin (ATX) is a secreted lysophospholipase D that generates the lipid mediator lysophosphatidic acid (LPA), playing a key role in diverse physiological and pathological processes. ATX exists in distinct splice variants, but isoform-specific functions remain elusive. Here we characterize the ATX alpha isoform, which differs from the canonical form (ATX beta) in having a 52-residue polybasic insertion of unknown function in the catalytic domain. We find that the ATX alpha insertion is susceptible to cleavage by extracellular furin-like endoproteases, but cleaved ATX alpha remains structurally and functionally intact due to strong interactions within the catalytic domain. Through ELISA and surface plasmon resonance assays, we show that ATX alpha binds specifically to heparin with high affinity (K-d similar to 10(-8) M), whereas ATX beta does not; furthermore, heparin moderately enhanced the lysophospholipase D activity of ATX alpha. We further show that ATX alpha, but not ATX beta, binds abundantly to SKOV3 carcinoma cells. ATX alpha binding was abolished after treating the cells with heparinase III, but not after chondroitinase treatment. Thus, the ATX alpha insertion constitutes a cleavable heparin-binding domain that mediates interaction with heparan sulfate proteoglycans, thereby targeting LPA production to the plasma membrane.	[Houben, Anna J. S.; van Meeteren, Laurens A.; Moolenaar, Wouter H.] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [van Wijk, Xander M. R.; van de Westerlo, Els M. A.; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6525 GA Nijmegen, Netherlands; [van Zeijl, Leonie; Hausmann, Jens; Fish, Alexander; Perrakis, Anastassis] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Radboud University Nijmegen; Netherlands Cancer Institute	van Kuppevelt, TH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, Geert Grootepl 28, NL-6525 GA Nijmegen, Netherlands.	a.vankuppevelt@ncmls.ru.nl; w.moolenaar@nki.nl	Van Meeteren, Laurens A./AGQ-6139-2022; Perrakis, Anastassis/E-8704-2013; van Kuppevelt, A.H.M.S.M./L-4463-2015; van Meeteren, Laurens/A-9890-2008	Perrakis, Anastassis/0000-0002-1151-6227; van Meeteren, Laurens/0000-0001-9885-0668; Hausmann, Jens/0000-0001-8960-6225	Dutch Cancer Society; Netherlands Organisation for Scientific Research	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Dutch Cancer Society and The Netherlands Organisation for Scientific Research.	Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Choi JW, 2013, BBA-MOL CELL BIOL L, V1831, P20, DOI 10.1016/j.bbalip.2012.07.015; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Clair T, 2003, CANCER RES, V63, P5446; David M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009741; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Fuss B, 1997, J NEUROSCI, V17, P9095; Giganti A, 2008, J BIOL CHEM, V283, P7776, DOI 10.1074/jbc.M708705200; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Hashimoto T, 2012, J BIOCHEM, V151, P89, DOI 10.1093/jb/mvr126; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Hausmann J, 2010, ACTA CRYSTALLOGR F, V66, P1130, DOI 10.1107/S1744309110032938; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Jansen S, 2005, J CELL SCI, V118, P3081, DOI 10.1242/jcs.02438; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Kawagoe H, 1997, CANCER RES, V57, P2516; Koike S, 2006, GENES CELLS, V11, P133, DOI 10.1111/j.1365-2443.2006.00924.x; Koo BH, 2006, J BIOL CHEM, V281, P12485, DOI 10.1074/jbc.M511083200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lai SL, 2012, DEVELOPMENT, V139, P4439, DOI 10.1242/dev.081745; Lee HY, 1996, BIOCHEM BIOPH RES CO, V218, P714, DOI 10.1006/bbrc.1996.0127; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Matas-Rico E, 2008, MOL CELL NEUROSCI, V39, P342, DOI 10.1016/j.mcn.2008.07.014; Mesnard D, 2011, GENE DEV, V25, P1871, DOI 10.1101/gad.16738711; Moolenaar WH, 2013, BBA-MOL CELL BIOL L, V1831, P13, DOI 10.1016/j.bbalip.2012.09.013; Moolenaar WH, 2011, NAT REV MOL CELL BIO, V12, P674, DOI 10.1038/nrm3188; Munoz EM, 2004, ARTERIOSCL THROM VAS, V24, P1549, DOI 10.1161/01.ATV.0000137189.22999.3f; MURATA J, 1994, J BIOL CHEM, V269, P30479; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Sun T, 2010, INT J BIOL SCI, V6, P89; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tanaka M, 2004, FEBS LETT, V571, P197, DOI 10.1016/j.febslet.2004.06.083; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; ten Dam GB, 2009, HISTOCHEM CELL BIOL, V132, P117, DOI 10.1007/s00418-009-0592-2; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; van Meeteren LA, 2005, J BIOL CHEM, V280, P21155, DOI 10.1074/jbc.M413183200; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; van Wijk XMR, 2010, EXP CELL RES, V316, P2504, DOI 10.1016/j.yexcr.2010.04.025; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yang Y, 1999, AM J RESP CELL MOL, V21, P216, DOI 10.1165/ajrcmb.21.2.3667; Zhang YF, 2012, J IMMUNOL, V189, P3914, DOI 10.4049/jimmunol.1201604	51	40	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					510	519		10.1074/jbc.M112.358416	http://dx.doi.org/10.1074/jbc.M112.358416			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23150666	hybrid, Green Published			2022-12-28	WOS:000313197200051
J	Hung, HI; Schwartz, JM; Maldonado, EN; Lemasters, JJ; Nieminen, AL				Hung, Hsin-I; Schwartz, Justin M.; Maldonado, Eduardo N.; Lemasters, John J.; Nieminen, Anna-Liisa			Mitoferrin-2-dependent Mitochondrial Iron Uptake Sensitizes Human Head and Neck Squamous Carcinoma Cells to Photodynamic Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER MEMBRANE; PHTHALOCYANINE PHOTOSENSITIZERS; CALCIUM UNIPORTER; OXIDATIVE STRESS; CANCER; LYSOSOMES; TRANSPORT; FUSION; AUTOPHAGOSOMES; REQUIREMENT	Photodynamic therapy (PDT) is a promising approach to treat head and neck cancer cells. Here, we investigated whether mitochondrial iron uptake through mitoferrin-2 (Mfrn2) enhanced PDT-induced cell killing. Three human head and neck squamous carcinoma cell lines (UMSCC1, UMSCC14A, and UMSCC22A) were exposed to light and Pc 4, a mitochondria-targeted photosensitizer. The three cell lines responded differently: UMSCC1 and UMSCC14A cells were more resistant, whereas UMSCC22A cells were more sensitive to Pc 4-PDT-induced cell death. In non-erythroid cells, Mfrn2 is an iron transporter in the mitochondrial inner membrane. PDT-sensitive cells expressed higher Mfrn2 mRNA and protein levels compared with PDT-resistant cells. High Mfrn2-expressing cells showed higher rates of mitochondrial Fe2+ uptake compared with low Mfrn2-expressing cells. Bafilomycin, an inhibitor of the vacuolar proton pump of lysosomes and endosomes that causes lysosomal iron release to the cytosol, enhanced PDT-induced cell killing of both resistant and sensitive cells. Iron chelators and the inhibitor of the mitochondrial Ca2+ (and Fe2+) uniporter, Ru360, protected against PDT plus bafilomycin toxicity. Knockdown of Mfrn2 in UMSCC22A cells decreased the rate of mitochondrial Fe2+ uptake and delayed PDT plus bafilomycin-induced mitochondrial depolarization and cell killing. Taken together, the data suggest that lysosomal iron release and Mfrn2-dependent mitochondrial iron uptake act synergistically to induce PDT-mediated and iron-dependent mitochondrial dysfunction and subsequent cell killing. Furthermore, Mfrn2 represents a possible biomarker of sensitivity of head and neck cancers to cell killing after PDT.	[Hung, Hsin-I; Schwartz, Justin M.; Maldonado, Eduardo N.; Lemasters, John J.; Nieminen, Anna-Liisa] Med Univ S Carolina, Ctr Cell Death Injury & Regenerat, Charleston, SC 29425 USA; [Hung, Hsin-I; Schwartz, Justin M.; Maldonado, Eduardo N.; Lemasters, John J.; Nieminen, Anna-Liisa] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Lemasters, John J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Maldonado, Eduardo N.; Lemasters, John J.; Nieminen, Anna-Liisa] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Nieminen, AL (corresponding author), Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, DD505 Drug Discovery Bldg,70 President St, Charleston, SC 29425 USA.	nieminen@musc.edu		Maldonado, Eduardo/0000-0002-5285-3027	U.S. National Cancer Institute [R01 CA119079, P30 CA138313]; Abney Cancer Foundation; government of Taiwan; NATIONAL CANCER INSTITUTE [P30CA138313, R01CA119079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073336, R56DK037034] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Abney Cancer Foundation; government of Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by grants from the U.S. National Cancer Institute R01 CA119079 (A.-L. N.), P30 CA138313 (Hollings Cancer Center Cell and Molecular Imaging Shared Resource), Abney Cancer Foundation (H.-I. H.), and a scholarship from the government of Taiwan (H.-I. H.).	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Amigo JD, 2011, MOL CELL BIOL, V31, P1344, DOI 10.1128/MCB.01010-10; Baron ED, 2010, LASER SURG MED, V42, P728, DOI 10.1002/lsm.20984; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Bihan H, 2012, HEAD NECK-J SCI SPEC, V34, P493, DOI 10.1002/hed.21763; BREUER W, 1995, AM J PHYSIOL-CELL PH, V268, pC1354, DOI 10.1152/ajpcell.1995.268.6.C1354; Carroll CB, 2011, NEUROCHEM INT, V59, P73, DOI 10.1016/j.neuint.2011.05.006; Chiu SM, 2010, PHOTOCHEM PHOTOBIOL, V86, P1161, DOI 10.1111/j.1751-1097.2010.00766.x; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Duvvuri U, 2009, CURR PROB SURG, V46, P114, DOI [10.1067/j.cpsurg.2008.10.002, 10.1067/j.cpsurg.2008.10.001]; FLATMARK T, 1975, J BIOL CHEM, V250, P6433; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; Jerjes W, 2011, LASER SURG MED, V43, P463, DOI 10.1002/lsm.21071; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Kon K, 2010, TOXICOL SCI, V117, P101, DOI 10.1093/toxsci/kfq175; Kurz T, 2011, FREE RADICAL BIO MED, V50, P1647, DOI 10.1016/j.freeradbiomed.2011.03.014; Lam M, 2001, J BIOL CHEM, V276, P47379, DOI 10.1074/jbc.M107678200; Li Z, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-34; Liu L, 2011, FREE RADICAL BIO MED, V51, P53, DOI 10.1016/j.freeradbiomed.2011.03.042; Messner DJ, 2009, LIVER INT, V29, P63, DOI 10.1111/j.1478-3231.2008.01793.x; NIEMINEN AL, 1992, TOXICOL APPL PHARM, V115, P147, DOI 10.1016/0041-008X(92)90317-L; OLEINICK NL, 1993, PHOTOCHEM PHOTOBIOL, V57, P242, DOI 10.1111/j.1751-1097.1993.tb02282.x; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Ren YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029666; Rodriguez ME, 2009, PHOTOCHEM PHOTOBIOL, V85, P1189, DOI 10.1111/j.1751-1097.2009.00558.x; Saggu S, 2012, PHOTOCHEM PHOTOBIOL, V88, P461, DOI 10.1111/j.1751-1097.2012.01081.x; Satre M, 2007, BIOCHIMIE, V89, P1058, DOI 10.1016/j.biochi.2007.03.004; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Tan IB, 2010, HEAD NECK-J SCI SPEC, V32, P1597, DOI 10.1002/hed.21368; Troadec MB, 2011, BLOOD, V117, P5494, DOI 10.1182/blood-2010-11-319483; Uchiyama A, 2008, HEPATOLOGY, V48, P1644, DOI 10.1002/hep.22498; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; YING WL, 1991, BIOCHEMISTRY-US, V30, P4949, DOI 10.1021/bi00234a016	36	43	44	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					677	686		10.1074/jbc.M112.422667	http://dx.doi.org/10.1074/jbc.M112.422667			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23135267	Green Published, hybrid			2022-12-28	WOS:000313197200068
J	Zanotti, S; Smerdel-Ramoya, A; Canalis, E				Zanotti, Stefano; Smerdel-Ramoya, Anna; Canalis, Ernesto			Nuclear Factor of Activated T-cells (NFAT)c2 Inhibits Notch Receptor Signaling in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-FORMATION; TRANSCRIPTIONAL REGULATION; PRIMARY TARGET; DIFFERENTIATION; EXPRESSION; PATHWAY; BINDING; PROTEINS; GENES; NFAT	Notch receptors regulate osteoblastogenesis, and Notch activation induces cleavage and nuclear translocation of the Notch intracellular domain (NICD), which associates with Epstein-Barr virus latency C-promoter binding factor-1/suppressor of hairless/lag-1 (CSL) and induces transcription of Notch target genes, such as hairy enhancer of split-related with YRPW motif (Hey)1 and Hey2. Nuclear factors of activated T-cells (NFAT) are transcription factors that regulate osteoclastogenesis, but their function in osteoblasts is not clear. Notch inhibits NFATc1 transcription, but interactions between Notch and NFAT are understood poorly. To determine the regulation of NFAT expression by Notch, osteoblasts from Rosa(Notch) mice, where NICD is transcribed following excision of a loxP flanked STOP cassette, were used. Alternatively, wild-type C57BL/6 osteoblasts were exposed to the Notch ligand Delta-like (Dll)1 to induce Notch signaling or to bovine serum albumin as control. In Rosa(Notch) osteoblasts, Notch suppressed NFATc1 expression, increased Nfatc2 mRNA by post-transcriptional mechanisms, and had no effect on NFATc3 and NFATc4 transcripts. Induction of Nfatc2 transcripts by Notch was confirmed in C57BL/6 osteoblasts exposed to Dll1. To investigate NFATc2 function in osteoblasts, constitutively active NFATc2 was overexpressed in Rosa(Notch) osteoblasts. NFATc2 suppressed Notch transactivation and expression of Hey genes. Electrophoretic mobility shift assays revealed that NFATc2 and CSL bind to similar DNA sequences, and chromatin immunoprecipitation indicated that NFATc2 displaced CSL from the Hey2 promoter. The effects of NICD and NFATc2 in Rosa(Notch) osteoblasts were assessed, and both proteins inhibited osteoblast function. In conclusion, Notch stabilizes Nfatc2 transcripts, NFATc2 suppresses Notch signaling, and both proteins inhibit osteoblast function.	[Zanotti, Stefano; Smerdel-Ramoya, Anna; Canalis, Ernesto] St Francis Hosp & Med Ctr, Dept Res, Hartford, CT 06105 USA; [Zanotti, Stefano; Canalis, Ernesto] Univ Connecticut, Sch Med, Farmington, CT 06030 USA	Saint Francis Hospital & Medical Center; University of Connecticut	Canalis, E (corresponding author), St Francis Hosp & Med Ctr, Dept Res, 114 Woodland St, Hartford, CT 06105 USA.	ecanalis@stfranciscare.org			National Institutes of Health through the NIDDK [DK045227]; Arthritis Foundation [5371]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; Arthritis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK045227 through the NIDDK (to E. C.). This work was also supported by Research Fellowship 5371 from the Arthritis Foundation (to S. Z.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Canalis E, 2005, J Endocrinol Invest, V28, P3; Choo MK, 2009, BONE, V45, P579, DOI 10.1016/j.bone.2009.05.009; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; DAHL LK, 1952, P SOC EXP BIOL MED, V80, P474, DOI 10.3181/00379727-80-19661; EHEBAUER M, 2006, SCI STKE, pCM7, DOI DOI 10.1126/STKE.3642006CM7; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iso T, 2002, J BIOL CHEM, V277, P6598, DOI 10.1074/jbc.M110495200; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; MCCARTHY TL, 1990, J BIOL CHEM, V265, P15353; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; Nobta M, 2005, J BIOL CHEM, V280, P15842, DOI 10.1074/jbc.M412891200; Pereira RC, 2004, ENDOCRINOLOGY, V145, P1952, DOI 10.1210/en.2003-0868; Pereira RMR, 2002, J CELL BIOCHEM, V85, P252, DOI 10.1002/jcb.10125; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; Rydziel S, 2004, J BIOL CHEM, V279, P5397, DOI 10.1074/jbc.M311984200; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Sitara D, 2010, IMMUNOL REV, V233, P286, DOI 10.1111/j.0105-2896.2009.00849.x; Sokal R. R, 1981, BIOMETRY; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; Sun L, 2005, P NATL ACAD SCI USA, V102, P17130, DOI 10.1073/pnas.0508480102; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yeo HJ, 2007, J BIOL CHEM, V282, P35318, DOI 10.1074/jbc.M702435200; Yeo H, 2007, BONE, V40, P1502, DOI 10.1016/j.bone.2007.02.017; Zanotti S, 2011, J BIOL CHEM, V286, P4576, DOI 10.1074/jbc.M110.161893; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09; Zhou SF, 2001, MOL CELL BIOL, V21, P6222, DOI 10.1128/MCB.21.18.6222-6232.2001	50	24	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					624	632		10.1074/jbc.M112.340455	http://dx.doi.org/10.1074/jbc.M112.340455			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23166323	Green Published, hybrid			2022-12-28	WOS:000313197200063
J	Boudko, SP; Bachinger, HP				Boudko, Sergei P.; Baechinger, Hans Peter			The NC2 Domain of Type IX Collagen Determines the Chain Register of the Triple Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; CRYSTAL-STRUCTURE; CYSTINE-KNOT; BINDING; TRIMERIZATION; IDENTIFICATION; PEPTIDES; SEGMENT; MOTIFS; SITES	Precise mapping and unraveling the mechanism of interaction or degradation of a certain type of collagen triple helix requires the generation of short and stable collagenous fragments. This is a great challenge especially for hetero-trimeric collagens, where chain composition and register (stagger) are important factors. No system has been reported that can be efficiently used to generate a natural collagenous fragment with exact chain composition and desired chain register. The NC2 domain (only 35-50 residues) of FACIT collagens is a potent trimerization domain. In the case of type IX collagen it provides the efficient selection and hetero-trimerization of three distinct chains. The ability of the NC2 domain to determine the chain register of the triple helix is studied. We generated three possible sequence combinations (alpha 1 alpha 1 alpha 2, alpha 1 alpha 2 alpha 1, alpha 2 alpha 1 alpha 1) of a type I collagen fragment (the binding region for the von Willebrand factor A3 domain) attached to the NC2 domain. In addition, two control combinations were produced that constitute homo-trimers of (alpha 1)(3) or (alpha 2)(3). For the hetero-trimeric constructs, alpha 1 alpha 1 alpha 2 demonstrated a higher melting temperature than the other two. Binding experiments with the von Willebrand factor A3 domain revealed the homo-trimer of (alpha 1)(3) as the strongest binding construct, whereas the homo-trimer of (alpha 2)(3) showed no binding. For hetero-trimers, alpha 1 alpha 1 alpha 2 was found to be the strongest binding construct. Differences in thermal stability and binding to the A3 domain unambiguously demonstrate that the NC2 domain of type IX collagen determines not only the chain composition but also the chain register of the adjacent triple helix.	[Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Bachinger, HP (corresponding author), Oregon Hlth & Sci Univ, Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org		Boudko, Sergei/0000-0003-3856-4859	Shriners Hospitals for Children	Shriners Hospitals for Children	The work was supported by a grant from Shriners Hospitals for Children.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bachinger HP, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 5: AMINO ACIDS, PEPTIDES AND PROTEINS, P469; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BENDER E, 1982, J BIOL CHEM, V257, P9653; Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200; Boudko SP, 2012, INT J BIOCHEM CELL B, V44, P21, DOI 10.1016/j.biocel.2011.09.009; Boudko SP, 2010, J BIOL CHEM, V285, P23721, DOI 10.1074/jbc.M110.128405; Boudko SP, 2009, J MOL BIOL, V392, P787, DOI 10.1016/j.jmb.2009.07.057; Boudko SP, 2008, J BIOL CHEM, V283, P34345, DOI 10.1074/jbc.M806352200; Boudko SP, 2004, J MOL BIOL, V335, P1289, DOI 10.1016/j.jmb.2003.11.054; Brondijk THC, 2012, P NATL ACAD SCI USA, V109, P5253, DOI 10.1073/pnas.1112388109; BRUCKNER P, 1978, EUR J BIOCHEM, V90, P595, DOI 10.1111/j.1432-1033.1978.tb12640.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CRUZ MA, 1995, J BIOL CHEM, V270, P19668; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fallas JA, 2009, J BIOL CHEM, V284, P26851, DOI 10.1074/jbc.M109.014753; Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640; Giudici C, 2008, J BIOL CHEM, V283, P19551, DOI 10.1074/jbc.M710001200; HOFMANN H, 1978, J MOL BIOL, V125, P137, DOI 10.1016/0022-2836(78)90342-X; Jarvis GE, 2008, BLOOD, V111, P4986, DOI 10.1182/blood-2007-08-108472; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Lebbink RJ, 2009, MATRIX BIOL, V28, P202, DOI 10.1016/j.matbio.2009.03.005; Leo JC, 2010, INFECT IMMUN, V78, P3226, DOI 10.1128/IAI.01057-09; Li F, 2002, ANN BIOMED ENG, V30, P1107, DOI 10.1114/1.1521931; Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532; Mizuno K, 2010, BIOPHYS J, V98, P3004, DOI 10.1016/j.bpj.2010.03.019; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Ottl J, 1996, FEBS LETT, V398, P31, DOI 10.1016/S0014-5793(96)01212-4; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Trapani S, 2008, ACTA CRYSTALLOGR D, V64, P11, DOI 10.1107/S0907444907044460; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wirz JA, 2011, MATRIX BIOL, V30, P9, DOI 10.1016/j.matbio.2010.09.005	35	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44536	44545		10.1074/jbc.M112.417543	http://dx.doi.org/10.1074/jbc.M112.417543			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23132862	hybrid, Green Published			2022-12-28	WOS:000312938600050
J	Madenspacher, JH; Azzam, KM; Gong, WH; Gowdy, KM; Vitek, MP; Laskowitz, DT; Remaley, AT; Wang, JM; Fessler, MB				Madenspacher, Jennifer H.; Azzam, Kathleen M.; Gong, Wanghua; Gowdy, Kymberly M.; Vitek, Michael P.; Laskowitz, Daniel T.; Remaley, Alan T.; Wang, Ji Ming; Fessler, Michael B.			Apolipoproteins and Apolipoprotein Mimetic Peptides Modulate Phagocyte Trafficking through Chemotactic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; A-I; BIOLOGICAL-PROPERTIES; DENSITY-LIPOPROTEIN; IMMUNE-RESPONSES; HUMAN MONOCYTES; MURINE MODEL; LUNG INJURY; APOA-I; INFLAMMATION	The plasma lipoprotein-associated apolipoproteins (apo) A-I and apoE have well described anti-inflammatory actions in the cardiovascular system, and mimetic peptides that retain these properties have been designed as therapeutics. The anti-inflammatory mechanisms of apolipoprotein mimetics, however, are incompletely defined. Whether circulating apolipoproteins and their mimetics regulate innate immune responses at mucosal surfaces, sites where transvascular emigration of leukocytes is required during inflammation, remains unclear. Herein, we report that Apoai(-/-) and Apoe(-/-) mice display enhanced recruitment of neutrophils to the airspace in response to both inhaled lipopolysaccharide and direct airway inoculation with CXCL1. Conversely, treatment with apoA-I (L-4F) or apoE (COG1410) mimetic peptides reduces airway neutrophilia. We identify suppression of CXCR2-directed chemotaxis as a mechanism underlying the apolipoprotein effect. Pursuing the possibility that L-4F might suppress chemotaxis through heterologous desensitization, we confirmed that L-4F itself induces chemotaxis of human PMNs and monocytes. L-4F, however, fails to induce a calcium flux. Further exploring structure-function relationships, we studied the alternate apoA-I mimetic L-37pA, a bihelical analog of L-4F with two Leu-Phe substitutions. We find that L-37pA induces calcium and chemotaxis through formyl peptide receptor (FPR) 2/ALX, whereas its D-stereoisomer (i.e. D-37pA) blocks L-37pA signaling and induces chemotaxis but not calcium flux through an unidentified receptor. Taken together, apolipoprotein mimetic peptides are novel chemotactic agents that possess complex structure-activity relationships to multiple receptors, displaying anti-inflammatory efficacy against innate immune responses in the airway.	[Madenspacher, Jennifer H.; Azzam, Kathleen M.; Gowdy, Kymberly M.; Fessler, Michael B.] NIEHS, Lab Resp Biol, NIH, Res Triangle Pk, NC 27709 USA; [Wang, Ji Ming] NCI, Mol Immunoregulat Lab, Canc & Inflammat Program, NIH, Frederick, MD 21702 USA; [Vitek, Michael P.; Laskowitz, Daniel T.] Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA; [Vitek, Michael P.] Cognosci Inc, Res Triangle Pk, NC 27709 USA; [Remaley, Alan T.] NHLBI, Pulm & Vasc Med Branch, NIH, Bethesda, MD 20892 USA; [Gong, Wanghua] SAIC Frederick, Basic Res Program, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Science Applications International Corporation (SAIC); SAIC-Frederick	Fessler, MB (corresponding author), 111 TW Alexander Dr,POB 12233,MD D2-01, Res Triangle Pk, NC 27709 USA.	fesslerm@niehs.nih.gov	Fessler, Michael B/C-6323-2019	Fessler, Michael B/0000-0002-8262-8613; Vitek, Michael/0000-0001-8140-8048	National Institutes of Health Intramural Research Program NIEHS [Z01 ES102005]; NCI, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of the NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010015, ZIABC010725] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102005, ZICES102546] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program NIEHS; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program NIEHS Grant Z01 ES102005.; Supported in part by funds from the NCI, National Institutes of Health, under Contract HHSN261200800001E and the Intramural Research Program of the NCI, National Institutes of Health.	Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Bae YS, 2003, J IMMUNOL, V171, P6807, DOI 10.4049/jimmunol.171.12.6807; BLACKBURN WD, 1991, J LIPID RES, V32, P1911; Bloedon LT, 2008, J LIPID RES, V49, P1344, DOI 10.1194/jlr.P800003-JLR200; Bocharov AV, 2004, J BIOL CHEM, V279, P36072, DOI 10.1074/jbc.M314264200; BREWER HB, 1986, METHOD ENZYMOL, V128, P223; Burli RW, 2006, BIOORG MED CHEM LETT, V16, P3713, DOI 10.1016/j.bmcl.2006.04.068; Bursill CA, 2010, ARTERIOSCL THROM VAS, V30, P1773, DOI 10.1161/ATVBAHA.110.211342; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Christensen DJ, 2011, J IMMUNOL, V186, P2535, DOI 10.4049/jimmunol.1002847; Dai LJ, 2010, J LIPID RES, V51, P2695, DOI 10.1194/jlr.M008086; Datta G, 2001, J LIPID RES, V42, P1096; Deng XY, 1999, BLOOD, V94, P1165, DOI 10.1182/blood.V94.4.1165.416k23_1165_1173; Diederich W, 2001, ATHEROSCLEROSIS, V159, P313, DOI 10.1016/S0021-9150(01)00518-4; Filep JG, 2009, J CELL BIOCHEM, V108, P1039, DOI 10.1002/jcb.22351; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Gao J, 2006, NEUROCRIT CARE, V4, P25, DOI 10.1385/NCC:4:1:025; Getz GS, 2010, CURR ATHEROSCLER REP, V12, P96, DOI 10.1007/s11883-010-0097-4; Hu JY, 2001, J LEUKOCYTE BIOL, V70, P155; Kim TH, 2010, AM J RESP CRIT CARE, V182, P633, DOI 10.1164/rccm.200905-0659OC; Klein C, 1998, NAT BIOTECHNOL, V16, P1334, DOI 10.1038/4310; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Le YY, 2001, CYTOKINE GROWTH F R, V12, P91, DOI 10.1016/S1359-6101(01)00003-X; Le YY, 2000, CLIN IMMUNOL, V96, P236, DOI 10.1006/clim.2000.4896; Le YY, 1999, J IMMUNOL, V163, P6777; Lee HY, 2008, J IMMUNOL, V181, P4332, DOI 10.4049/jimmunol.181.6.4332; LIN CT, 1986, J CLIN INVEST, V78, P947, DOI 10.1172/JCI112685; MARSHALL GR, 1990, P NATL ACAD SCI USA, V87, P487, DOI 10.1073/pnas.87.1.487; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Murphy AJ, 2010, CLIN EXP PHARMACOL P, V37, P710, DOI 10.1111/j.1440-1681.2009.05338.x; MURPHY PM, 1992, J BIOL CHEM, V267, P7637; Navab M, 2010, ARTERIOSCL THROM VAS, V30, P164, DOI 10.1161/ATVBAHA.109.187518; Remaley AT, 2003, J LIPID RES, V44, P828, DOI 10.1194/jlr.M200475-JLR200; Shen WP, 2000, BIOCHEM BIOPH RES CO, V272, P276, DOI 10.1006/bbrc.2000.2770; Smoak K, 2008, J IMMUNOL, V180, P3305, DOI 10.4049/jimmunol.180.5.3305; Sogawa Y, 2011, IMMUNOLOGY, V132, P441, DOI 10.1111/j.1365-2567.2010.03367.x; Sogawa Y, 2011, J PHARMACOL SCI, V115, P63, DOI 10.1254/jphs.10194FP; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Tabet F, 2010, ARTERIOSCL THROM VAS, V30, P246, DOI 10.1161/ATVBAHA.109.200196; Wang WL, 2010, J LIPID RES, V51, P2560, DOI 10.1194/jlr.M004549; Yan YJ, 2006, LIFE SCI, V79, P210, DOI 10.1016/j.lfs.2006.02.011; Yao XL, 2011, J IMMUNOL, V186, P576, DOI 10.4049/jimmunol.1001534; Yao XL, 2010, AM J RESP CRIT CARE, V182, P1228, DOI 10.1164/rccm.201002-0308OC; YE RD, 1992, BIOCHEM BIOPH RES CO, V184, P582, DOI 10.1016/0006-291X(92)90629-Y; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Ying GG, 2004, J IMMUNOL, V172, P7078, DOI 10.4049/jimmunol.172.11.7078; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhang ZF, 2009, EUR J IMMUNOL, V39, P3181, DOI 10.1002/eji.200939496	50	29	30	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43730	43740		10.1074/jbc.M112.377192	http://dx.doi.org/10.1074/jbc.M112.377192			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118226	hybrid, Green Published			2022-12-28	WOS:000312940800052
J	Bang, YJ; Oh, MH; Choi, SH				Bang, Ye-Ji; Oh, Man Hwan; Choi, Sang Ho			Distinct Characteristics of Two 2-Cys Peroxiredoxins of Vibrio vulnificus Suggesting Differential Roles in Detoxifying Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE CYSTEINE; ALKYLHYDROPEROXIDE REDUCTASE; IDENTIFICATION; PROTEIN; AHPC; OVEROXIDATION; SPECIFICITY; PEROXIDASE; OXIDANTS; SYSTEM	Peroxiredoxins (Prxs) are ubiquitous antioxidant enzymes reducing toxic peroxides. Two distinct 2-Cys Prxs, Prx1 and Prx2, were identified in Vibrio vulnificus, a facultative aerobic pathogen. Both Prxs have two conserved catalytic cysteines, C-P and C-R, but Prx2 is more homologous in amino acid sequences to eukaryotic Prx than to Prx1. Prx2 utilized thioredoxin A as a reductant, whereas Prx1 required AhpF. Prx2 contained GGIG and FL motifs similar to the motifs conserved in sensitive Prxs and exhibited sensitivity to overoxidation. MS analysis and C-P-SO3H specific immunoblotting demonstrated overoxidation of C-P to C-P-SO2H (or C-P-SO3H) in vitro and in vivo, respectively. In contrast, Prx1 was robust and C-P was not overoxidized. Discrete expression of the Prxs implied that Prx2 is induced by trace amounts of H2O2 and thereby residential in cells grown aerobically. In contrast, Prx1 was occasionally expressed only in cells exposed to high levels of H2O2. A mutagenesis study indicated that lack of Prx2 accumulated sufficient H2O2 to induce Prx1. Kinetic properties indicated that Prx2 effectively scavenges low levels of peroxides because of its high affinity to H2O2, whereas Prx1 quickly degrades higher levels of peroxides because of its high turnover rate and more efficient reactivation. This study revealed that the two Prxs are differentially optimized for detoxifying distinct ranges of H2O2, and proposed that Prx2 is a residential scavenger of peroxides endogenously generated, whereas Prx1 is an occasional scavenger of peroxides exogenously encountered. Furthermore, genome sequence database search predicted widespread coexistence of the two Prxs among bacteria.	[Choi, Sang Ho] Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Dept Agr Biotechnol, Ctr Food Safety & Toxicol, Seoul 151921, South Korea; Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul 151921, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Choi, SH (corresponding author), Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Dept Agr Biotechnol, Ctr Food Safety & Toxicol, Seoul 151921, South Korea.	choish@snu.ac.kr		Bang, Ye-Ji/0000-0003-4009-0824; Choi, Sang Ho/0000-0003-3865-1039	National Research Foundation [2009-0092822, 2012R1A2A1A03009679]; Ministry of Education, Science and Technology; Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	National Research Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	This work was supported by Mid-career Researcher Program Grants 2009-0092822 and 2012R1A2A1A03009679 through the National Research Foundation funded by Ministry of Education, Science and Technology and the Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea (to S. H. C.).	Baek WK, 2009, J MICROBIOL, V47, P624, DOI 10.1007/s12275-009-0130-x; Chuang MH, 2006, P NATL ACAD SCI USA, V103, P2552, DOI 10.1073/pnas.0510770103; Cox AG, 2010, METHOD ENZYMOL, V474, P51, DOI 10.1016/S0076-6879(10)74004-0; DALZIEL K, 1957, ACTA CHEM SCAND, V11, P1706, DOI 10.3891/acta.chem.scand.11-1706; Dietz KJ, 2002, J EXP BOT, V53, P1321, DOI 10.1093/jexbot/53.372.1321; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Huang CH, 2010, J BIOCHEM, V147, P661, DOI 10.1093/jb/mvp209; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jeong W, 2000, J BIOL CHEM, V275, P2924, DOI 10.1074/jbc.275.4.2924; Kim Y, 2010, J BIOL CHEM, V285, P14020, DOI 10.1074/jbc.M109.100248; Lim MS, 2011, J BACTERIOL, V193, P3722, DOI 10.1128/JB.00314-11; Link AJ, 1997, ELECTROPHORESIS, V18, P1259, DOI 10.1002/elps.1150180807; MILLER PH, 1995, J CLIN MICROBIOL, V33, P2388, DOI 10.1128/JCM.33.9.2388-2391.1995; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Nelson KJ, 2011, PROTEINS, V79, P947, DOI 10.1002/prot.22936; Oh MH, 2008, J MICROBIOL BIOTECHN, V18, P968; Oh MH, 2009, INFECT IMMUN, V77, P1208, DOI 10.1128/IAI.01006-08; Parsonage D, 2008, P NATL ACAD SCI USA, V105, P8209, DOI 10.1073/pnas.0708308105; Parsonage D, 2010, P NATL ACAD SCI USA, V107, P6240, DOI 10.1073/pnas.0910057107; Pascual MB, 2010, J BIOL CHEM, V285, P34485, DOI 10.1074/jbc.M110.160465; Poole LB, 2000, BIOCHEMISTRY-US, V39, P6602, DOI 10.1021/bi000405w; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Poole Leslie B., 2007, V44, P61; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Riddell JR, 2010, J IMMUNOL, V184, P1022, DOI 10.4049/jimmunol.0901945; Sambrook J., 2001, MOL CLONING LAB MANU; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Trujillo Madia, 2007, V44, P83; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405	34	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42516	42524		10.1074/jbc.M112.421214	http://dx.doi.org/10.1074/jbc.M112.421214			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095744	hybrid, Green Published			2022-12-28	WOS:000312501600013
J	Klein, JM; Busch, JD; Potting, C; Baker, MJ; Langer, T; Schwarz, G				Klein, Julian M.; Busch, Jakob D.; Potting, Christoph; Baker, Michael J.; Langer, Thomas; Schwarz, Guenter			The Mitochondrial Amidoxime-reducing Component (mARC1) Is a Novel Signal-anchored Protein of the Outer Mitochondrial Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-B5-LIKE HEMOPROTEIN; LIVER-MITOCHONDRIA; REDUCTASE; TRANSLOCATION; IMPORT; SYSTEM	The mitochondrial amidoxime-reducing component (mARC) was recently discovered as the fifth eukaryotic molybdenum cofactor-containing enzyme. The human genome encodes two mARC proteins, mARC1 and mARC2, sharing significant homologies with respect to sequence and function. Whereas mARC2 was identified as a mitochondrial enzyme, the subcellular localization of mARC1 has remained uncharacterized, although the similarity of both proteins suggested identical subcellular localizations. In addition, neither mARC1 nor mARC2 could be attributed unambiguously to one of the four mitochondrial subcompartments. Accordingly, mechanisms triggering the subcellular distribution of both enzymes have been unexplored so far. Here, we shed light on the subcellular localization of mARC1 and demonstrate that it is integrated into the outer mitochondrial membrane. The C-terminal catalytic domain of the protein remains exposed to the cytosol and confers an N-(in)-C-(out) membrane orientation of mARC1. This localization is triggered by the N terminus of the enzyme, being composed of a weak N-terminal mitochondrial targeting signal and a downstream transmembrane helix. We demonstrate the transmembrane domain of mARC1 to be sufficient for mitochondrial targeting and the N-terminal targeting signal to function as a supportive receptor for the outer mitochondrial membrane. According to its localization and targeting mechanism, we classify mARC1 as a novel signal-anchored mitochondrial protein. During mitochondrial import, mARC1 is not processed, and membrane integration proceeds membrane potential independently but requires external ATP, which finally results in the assembly of mARC1 into high oligomeric protein complexes.	[Klein, Julian M.; Busch, Jakob D.; Schwarz, Guenter] Univ Cologne, Dept Chem, Inst Biochem, D-50674 Cologne, Germany; [Potting, Christoph; Baker, Michael J.; Langer, Thomas] Univ Cologne, Ctr Mol Med, Inst Genet, D-50674 Cologne, Germany	University of Cologne; University of Cologne	Schwarz, G (corresponding author), Zuelpicher Str 47, D-50674 Cologne, Germany.	gschwarz@uni-koeln.de	Schwarz, Guenter/ABE-9643-2021; Schwarz, Guenter/F-2217-2013	Schwarz, Guenter/0000-0002-2118-9338; Langer, Thomas/0000-0003-1250-1462	Studienstiftung des Deutschen Volkes; German Science Foundation; Fonds der Chemischen Industrie	Studienstiftung des Deutschen Volkes; German Science Foundation(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by a grant from the Studienstiftung des Deutschen Volkes (to J. M. K.), the German Science Foundation (to G. S.), and the Fonds der Chemischen Industrie (to G. S.).	Bittner F, 2010, PLANT CELL MONOGR, V17, P119, DOI [10.1016/j.bbamcr.2006.03.013, 10.1007/978-3-642-10613-2_6]; BORGESE N, 1986, BIOCHEM J, V239, P393, DOI 10.1042/bj2390393; Borgese N, 1996, J CELL BIOL, V135, P1501, DOI 10.1083/jcb.135.6.1501; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; COHEN HJ, 1972, J BIOL CHEM, V247, P7759; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FUKUSHIMA K, 1972, J BIOCHEM, V71, P447; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gruenewald S, 2008, J MED CHEM, V51, P8173, DOI 10.1021/jm8010417; HAHNE K, 1994, CELL, V79, P829, DOI 10.1016/0092-8674(94)90072-8; Havemeyer A, 2006, J BIOL CHEM, V281, P34796, DOI 10.1074/jbc.M607697200; ITO A, 1980, J BIOCHEM, V87, P63, DOI 10.1093/oxfordjournals.jbchem.a132753; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Klein J. M., 2012, J CELL SCI, DOI 10.1242; Kotthaus J, 2011, BIOCHEM J, V433, P383, DOI 10.1042/BJ20100960; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MCBRIDE HM, 1992, J CELL BIOL, V119, P1451, DOI 10.1083/jcb.119.6.1451; NASON A, 1971, P NATL ACAD SCI USA, V68, P3242, DOI 10.1073/pnas.68.12.3242; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Neve EPA, 2012, J BIOL CHEM, V287, P6307, DOI 10.1074/jbc.M111.328237; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; SHORE GC, 1995, EUR J BIOCHEM, V227, P9, DOI 10.1111/j.1432-1033.1995.tb20354.x; Suzuki H, 2002, J CELL SCI, V115, P1895; WACHTER C, 1994, MOL BIOL CELL, V5, P465, DOI 10.1091/mbc.5.4.465; Wahl B, 2010, J BIOL CHEM, V285, P37847, DOI 10.1074/jbc.M110.169532; Walther DM, 2009, BBA-MOL CELL RES, V1793, P42, DOI 10.1016/j.bbamcr.2008.04.013; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200	32	40	43	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42795	42803		10.1074/jbc.M112.419424	http://dx.doi.org/10.1074/jbc.M112.419424			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23086957	Green Published, hybrid			2022-12-28	WOS:000312501600038
J	Park, HR; Kong, KH; Yu, BP; Mattson, MP; Lee, J				Park, Hee Ra; Kong, Kyoung Hye; Yu, Byung Pal; Mattson, Mark P.; Lee, Jaewon			Resveratrol Inhibits the Proliferation of Neural Progenitor Cells and Hippocampal Neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; DIETARY RESTRICTION; DENTATE GYRUS; STEM-CELLS; ADULT MICE; LIFE-SPAN; NEURODEGENERATIVE DISORDERS; STIMULATES PROLIFERATION; MAMMALIAN BRAIN; RED WINE	Resveratrol is a phytoalexin and natural phenol that is present at relatively high concentrations in peanuts and red grapes and wine. Based upon studies of yeast and invertebrate models, it has been proposed that ingestion of resveratrol may also have anti-aging actions in mammals including humans. It has been suggested that resveratrol exerts its beneficial effects on health by activating the same cellular signaling pathways that are activated by dietary energy restriction (DR). Some studies have reported therapeutic actions of resveratrol in animal models of metabolic and neurodegenerative disorders. However, the effects of resveratrol on cell, tissue and organ function in healthy subjects are largely unknown. In the present study, we evaluated the potential effects of resveratrol on the proliferation and survival of neural progenitor cells (NPCs) in culture, and in the hippocampus of healthy young adult mice. Resveratrol reduced the proliferation of cultured mouse multi-potent NPCs, and activated AMP-activated protein kinase (AMPK), in a concentration-dependent manner. Administration of resveratrol to mice (1-10 mg/kg) resulted in activation of AMPK, and reduced the proliferation and survival of NPCs in the dentate gyrus of the hippocampus. Resveratrol down-regulated the levels of the phosphorylated form of cyclic AMP response element-binding protein (pCREB) and brain-derived neurotrophic factor (BDNF) in the hippocampus. Finally, resveratrol-treated mice exhibited deficits in hippocampus-dependent spatial learning and memory. Our findings suggest that resveratrol, unlike DR, adversely affects hippocampal neurogenesis and cognitive function by a mechanism involving activation of AMPK and suppression of CREB and BDNF signaling.	[Park, Hee Ra; Kong, Kyoung Hye; Lee, Jaewon] Pusan Natl Univ, Dept Pharm, Coll Pharm, Pusan 609735, South Korea; [Park, Hee Ra; Kong, Kyoung Hye; Lee, Jaewon] Pusan Natl Univ, Mol Inflammat Res Ctr Aging Intervent, Pusan 609735, South Korea; [Yu, Byung Pal] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA	Pusan National University; Pusan National University; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Lee, J (corresponding author), Pusan Natl Univ, Dept Pharm, Coll Pharm, Pusan 609735, South Korea.	neuron@pusan.ac.kr	Lee, Jaewon/N-9064-2013	Lee, Jaewon/0000-0003-3203-2130	Intramural Research Program of the NIA, National Institutes of Health; National Research Foundation of Korea (NRF); Korea government (MEST) [2009-0083538]; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A084225]	Intramural Research Program of the NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This work was supported, in part, by the Intramural Research Program of the NIA, National Institutes of Health. This research was supported by the National Research Foundation of Korea (NRF) funded by the Korea government (MEST) (Grant no. 2009-0083538). This research was also supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (No. A084225).	Albani D, 2010, BIOFACTORS, V36, P370, DOI 10.1002/biof.118; Anderson MF, 2002, DEV BRAIN RES, V134, P115; Athar M, 2007, TOXICOL APPL PHARM, V224, P274, DOI 10.1016/j.taap.2006.12.025; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Bastianetto S, 2000, BRIT J PHARMACOL, V131, P711, DOI 10.1038/sj.bjp.0703626; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Blander G, 2005, J BIOL CHEM, V280, P9780, DOI 10.1074/jbc.M414080200; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Briand LA, 2010, BRAIN RES, V1314, P219, DOI 10.1016/j.brainres.2009.11.002; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P980, DOI 10.1177/0960327110383625; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Choi SH, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-52; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Fusco S, 2012, P NATL ACAD SCI USA, V109, P621, DOI 10.1073/pnas.1109237109; Harada N, 2011, J NUTR BIOCHEM, V22, P1150, DOI 10.1016/j.jnutbio.2010.09.016; Hirsch C, 2007, EXP CELL RES, V313, P572, DOI 10.1016/j.yexcr.2006.11.002; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang HM, 2005, ANN NY ACAD SCI, V1042, P349, DOI 10.1196/annals.1338.032; Joe AK, 2002, CLIN CANCER RES, V8, P893; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kang OH, 2009, PHARMACOL RES, V59, P330, DOI 10.1016/j.phrs.2009.01.009; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Kim WR, 2012, BEHAV BRAIN RES, V227, P470, DOI 10.1016/j.bbr.2011.07.012; Kim Young-Ae, 2003, Journal of Medicinal Food, V6, P273; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Le Corre L, 2005, MOL NUTR FOOD RES, V49, P462, DOI 10.1002/mnfr.200400094; Learish RD, 2000, DEV BRAIN RES, V122, P97; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lee J, 2002, J NEUROCHEM, V80, P539, DOI 10.1046/j.0022-3042.2001.00747.x; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Leong CW, 2007, BIOCHEM BIOPH RES CO, V360, P173, DOI 10.1016/j.bbrc.2007.06.025; Liu ML, 2010, J BIOL CHEM, V285, P36387, DOI 10.1074/jbc.M110.169284; Lu KT, 2008, J AGR FOOD CHEM, V56, P6910, DOI 10.1021/jf8007212; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Markus MA, 2008, CLIN INTERV AGING, V3, P331; Moriya J, 2011, BIOL PHARM BULL, V34, P354, DOI 10.1248/bpb.34.354; Niles LP, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-41; Oh YC, 2009, AM J CHINESE MED, V37, P1203, DOI 10.1142/S0192415X09007600; Orallo F, 2008, CURR MED CHEM, V15, P1887, DOI 10.2174/092986708785132951; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Palazuelos J, 2012, J BIOL CHEM, V287, P1198, DOI 10.1074/jbc.M111.291294; Park M, 2009, NEUROSCI LETT, V449, P201, DOI 10.1016/j.neulet.2008.11.007; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Ramprasath VR, 2010, EUR J CLIN NUTR, V64, P660, DOI 10.1038/ejcn.2010.77; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Shukitt-Hale B, 2007, NEUROBIOL AGING, V28, P1187, DOI 10.1016/j.neurobiolaging.2006.05.031; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Wang QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017234; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Yang Y, 2006, NEUROREPORT, V17, P235, DOI 10.1097/01.wnr.0000199470.29357.8f; Zang Y, 2008, J BIOL CHEM, V283, P6201, DOI 10.1074/jbc.M708619200; Zang Y, 2009, J BIOL CHEM, V284, P6175, DOI 10.1074/jbc.M806887200; Zhang F, 2013, PHYTOTHER RES, V27, P344, DOI 10.1002/ptr.4734; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhou R, 2009, BRIT J PHARMACOL, V158, P462, DOI 10.1111/j.1476-5381.2009.00268.x	70	71	77	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42588	42600		10.1074/jbc.M112.406413	http://dx.doi.org/10.1074/jbc.M112.406413			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105098	Green Published, hybrid			2022-12-28	WOS:000312501600020
J	Wier, EM; Neighoff, J; Sun, X; Fu, K; Wan, FY				Wier, Eric M.; Neighoff, Jordan; Sun, Xin; Fu, Kai; Wan, Fengyi			Identification of an N-terminal Truncation of the NF-kappa B p65 Subunit That Specifically Modulates Ribosomal Protein S3-dependent NF-kappa B Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENIC ESCHERICHIA-COLI; CASPASE-3-MEDIATED CLEAVAGE; SIGNALING PATHWAYS; INDUCED APOPTOSIS; CELL-DEATH; ACTIVATION; PHOSPHORYLATION; INFECTION; ALPHA; INFLAMMATION	NF-kappa B is a pleiotrophic transcription factor that plays a prominent regulatory role in various cellular processes. Although previous efforts have focused on its activation, how NF-kappa B selects specific target genes in response to discrete signals remains puzzling. In addition to the well defined Rel protein components of NF-kappa B, the ribosomal protein S3 (RPS3) was identified to be an essential component of specific NF-kappa B complexes. RPS3 synergistically interacts with the NF-kappa B p65 subunit to achieve optimal binding and transactivation of a subset of NF-kappa B target genes, thus providing regulatory specificity. Emerging evidence suggests an important role for the RPS3-p65 interaction in context-specific NF-kappa B gene transcription. The food-borne pathogen Escherichia coli O157:H7 impacts the transcription of a subset of NF-kappa B target genes encoding proinflammatory cytokines and chemokines in host cells by preventing the nuclear translocation of RPS3, but not p65. The N terminus of p65 is crucial for RPS3 binding. Although several p65 N-terminal fragments are generated by either protease cleavage or alternative mRNA splicing under certain pathophysiological conditions, the role of these fragments in modulating NF-kappa B signaling, in particular RPS3-dependent selective gene transcription, has not been fully characterized. Here we report that an N-terminal fragment of p65 (amino acids 21-186) can selectively modulate NF-kappa B gene transcription by competing for RPS3 binding to p65. This 21-186 fragment preferentially localizes in the cytoplasm where it delays stimuli-induced RPS3 nuclear translocation, without affecting the nuclear translocation of p65. Our findings thus uncover a new cytoplasmic function for the N-terminal domain of p65 and provide a novel strategy for selective inhibition of NF-kappa B gene transcription.	[Wier, Eric M.; Neighoff, Jordan; Sun, Xin; Fu, Kai; Wan, Fengyi] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wan, FY (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, 615 N Wolfe St,W8041, Baltimore, MD 21205 USA.	fwan@jhsph.edu		Sun, Xin/0000-0003-2424-8011; Wier, Eric/0000-0003-3824-410X	National Institutes of Health [R00CA137171]; National Cancer Institute [T32CA009110]; NATIONAL CANCER INSTITUTE [R00CA137171, T32CA009110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R00CA137171 (to F. W.). This work was also supported by National Cancer Institute Training Grant T32CA009110 (to E. M. W.).	Barnitz RA, 2010, J VIROL, V84, P6410, DOI 10.1128/JVI.02273-09; Baruch K, 2011, EMBO J, V30, P221, DOI 10.1038/emboj.2010.297; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Cadera EJ, 2009, J EXP MED, V206, P1803, DOI 10.1084/jem.20082815; Christian J, 2010, J BIOL CHEM, V285, P41320, DOI 10.1074/jbc.M110.152280; Coiras M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-109; DELOUKAS P, 1993, HUM MOL GENET, V2, P1895, DOI 10.1093/hmg/2.11.1895; Gao XF, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00137; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Gregory DJ, 2008, EUR J IMMUNOL, V38, P1071, DOI 10.1002/eji.200737586; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Kang KH, 2001, J BIOL CHEM, V276, P24638, DOI 10.1074/jbc.M101291200; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; Lad SP, 2007, P NATL ACAD SCI USA, V104, P2933, DOI 10.1073/pnas.0608393104; Lee RM, 1999, GENE DEV, V13, P718, DOI 10.1101/gad.13.6.718; Leeman JR, 2008, GENE, V423, P97, DOI 10.1016/j.gene.2008.07.015; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lu T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001966; Lukong KE, 2005, J BIOL CHEM, V280, P38639, DOI 10.1074/jbc.M505802200; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Mokhtari D, 2009, AM J PHYSIOL-ENDOC M, V297, pE1067, DOI 10.1152/ajpendo.00212.2009; Muhlen S, 2011, J BIOL CHEM, V286, P5100, DOI 10.1074/jbc.M110.172254; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; Neuzil J, 2001, BIOCHEMISTRY-US, V40, P4686, DOI 10.1021/bi002498n; Neves BM, 2010, AM J PATHOL, V177, P2898, DOI 10.2353/ajpath.2010.100367; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Pearson JS, 2011, MOL MICROBIOL, V80, P219, DOI 10.1111/j.1365-2958.2011.07568.x; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Perkins ND, 2012, MOL CELL, V45, P1, DOI 10.1016/j.molcel.2011.12.023; Pham TH, 2012, INFECT IMMUN, V80, P2133, DOI 10.1128/IAI.06358-11; POGUEGEILE K, 1991, MOL CELL BIOL, V11, P3842, DOI 10.1128/MCB.11.8.3842; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Sen R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000257; Shames SR, 2011, CELL MICROBIOL, V13, P1542, DOI 10.1111/j.1462-5822.2011.01640.x; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Turner DJ, 2007, ANN SURG, V245, P415, DOI 10.1097/01.sla.0000236631.72698.99; UEDA A, 1994, J IMMUNOL, V153, P2052; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan FY, 2011, NAT IMMUNOL, V12, P335, DOI 10.1038/ni.2007; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; YAO KS, 1995, BIOCHEM PHARMACOL, V49, P275, DOI 10.1016/0006-2952(94)00544-V; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231; Zhu Ning-xi, 2003, Zhonghua Xue Ye Xue Za Zhi, V24, P14	51	25	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43019	43029		10.1074/jbc.M112.388694	http://dx.doi.org/10.1074/jbc.M112.388694			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23115242	Green Published, hybrid			2022-12-28	WOS:000312501600058
J	Dong, Q; Ji, YS; Cai, C; Chen, ZY				Dong, Qing; Ji, Yun-Song; Cai, Chang; Chen, Zhe-Yu			LIM Kinase 1 (LIMK1) Interacts with Tropomyosin-related Kinase B (TrkB) and Mediates Brain-derived Neurotrophic Factor (BDNF)-induced Axonal Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; HIPPOCAMPAL-NEURONS; NEURITE EXTENSION; BDNF; RECEPTORS; PHOSPHORYLATION; MORPHOLOGY; SLINGSHOT; OUTGROWTH; DYNAMICS	BDNF/TrkB signaling plays critical roles in axonal outgrowth of neurons, the process of which requires the remodeling of the cytoskeleton structure, including microtubules and filamentous actin. However, the mechanism by which BDNF/TrkB signaling regulates cytoskeleton reorganization is still unclear. Here, we identified a novel interaction between LIMK1 and TrkB, which is required for the BDNF-induced axonal elongation. We demonstrated that BDNF-induced TrkB dimerization led to LIMK1 dimerization and transphosphorylation independent of TrkB kinase activity, which could further enhance the activation and stabilization of LIMK1. Moreover, activated LIMK1 translocated to the membrane fraction and phosphorylated its substrate cofilin, thus promoting actin polymerization and axonal elongation. Our findings provided evidence of a novel mechanism for the BDNF-mediated signal transduction leading to axonal elongation.	[Dong, Qing; Ji, Yun-Song; Cai, Chang; Chen, Zhe-Yu] Shandong Univ, Dept Neurobiol, Sch Med, Shandong Prov Key Lab Mental Disorders, Jinan 250012, Shandong, Peoples R China	Shandong University	Chen, ZY (corresponding author), Shandong Univ, Dept Neurobiol, Sch Med, Shandong Prov Key Lab Mental Disorders, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	zheyuchen@sdu.edu.cn			National Natural Science Foundation of China [31071254, 31130026]; National 973 Basic Research Program of China [2012CB911000, 2009CB941403]; State Program of National Natural Science Foundation of China for Innovative Research Group [81021001]; Independent Innovation Foundation of Shandong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University	This work was supported by National Natural Science Foundation of China Grants 31071254 and 31130026, National 973 Basic Research Program of China Grants 2012CB911000 and 2009CB941403, State Program of National Natural Science Foundation of China for Innovative Research Group Grant 81021001, and the Independent Innovation Foundation of Shandong University.	Bagheri-Yarmand R, 2006, INT J CANCER, V118, P2703, DOI 10.1002/ijc.21650; Bartkowska K, 2010, ACTA NEUROBIOL EXP, V70, P454; BERNARD O, 1994, CELL GROWTH DIFFER, V5, P1159; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Birkenfeld J, 2001, J NEUROCHEM, V78, P924, DOI 10.1046/j.1471-4159.2001.00500.x; Buchan AMJ, 2002, J BIOL CHEM, V277, P28431, DOI 10.1074/jbc.M201261200; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; Claus C, 2011, J VIROL, V85, P3881, DOI 10.1128/JVI.02492-10; Cosker KE, 2008, J CELL SCI, V121, P796, DOI 10.1242/jcs.019166; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Danzer SC, 2002, J NEUROSCI, V22, P9754; Endo M, 2003, J NEUROSCI, V23, P2527; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Gehler S, 2004, J NEUROSCI, V24, P4363, DOI 10.1523/JNEUROSCI.0404-04.2004; Goldberg JL, 2003, GENE DEV, V17, P941, DOI 10.1101/gad.1062303; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Horita Y, 2008, J BIOL CHEM, V283, P6013, DOI 10.1074/jbc.M706538200; Huang SH, 2011, J NEUROSCI, V31, P10602, DOI 10.1523/JNEUROSCI.0436-11.2011; Labelle C, 2000, DEV BRAIN RES, V123, P1, DOI 10.1016/S0165-3806(00)00069-9; Li R, 2006, FASEB J, V20, P1218, DOI 10.1096/fj.05-5258fje; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Luikart BW, 2005, J NEUROSCI, V25, P3774, DOI 10.1523/JNEUROSCI.0041-05.2005; Matsui S, 2002, J BIOL CHEM, V277, P544, DOI 10.1074/jbc.M110153200; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Namekata K, 2010, P NATL ACAD SCI USA, V107, P7586, DOI 10.1073/pnas.0914514107; Nishimura Y, 2006, HISTOCHEM CELL BIOL, V126, P627, DOI 10.1007/s00418-006-0198-x; Ohira K, 2009, CURR NEUROPHARMACOL, V7, P276, DOI 10.2174/157015909790031210; PROSCHEL C, 1995, ONCOGENE, V11, P1271; Purcell AL, 2003, TRENDS NEUROSCI, V26, P625, DOI 10.1016/j.tins.2003.09.005; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Santos AR, 2010, PROG NEUROBIOL, V92, P505, DOI 10.1016/j.pneurobio.2010.08.004; Schecterson LC, 2010, DEV NEUROBIOL, V70, P332, DOI 10.1002/dneu.20767; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Shen K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001842; Tahirovic S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001644; Takahashi H, 1998, BIOCHEM BIOPH RES CO, V249, P138, DOI 10.1006/bbrc.1998.9094; Toda S, 2006, J NEUROSCI, V26, P1579, DOI 10.1523/JNEUROSCI.4132-05.2006; Tucker KL, 2002, PANMINERVA MED, V44, P325; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Yin YX, 2010, J NEUROCHEM, V114, P110, DOI 10.1111/j.1471-4159.2010.06745.x; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhao L, 2009, J CELL SCI, V122, P3123, DOI 10.1242/jcs.047712	50	24	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41720	41731		10.1074/jbc.M112.405415	http://dx.doi.org/10.1074/jbc.M112.405415			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086941	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000312103000014
J	Kaneiwa, T; Miyazaki, A; Kogawa, R; Mizumoto, S; Sugahara, K; Yamada, S				Kaneiwa, Tomoyuki; Miyazaki, Anzu; Kogawa, Ryo; Mizumoto, Shuji; Sugahara, Kazuyuki; Yamada, Shuhei			Identification of Amino Acid Residues Required for the Substrate Specificity of Human and Mouse Chondroitin Sulfate Hydrolase (Conventional Hyaluronidase-4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; DERMATAN SULFATE; PROTEOGLYCANS; EXPRESSION; GENES; FRAGMENTS; ENZYMES; BIOLOGY; PROTEIN; SYSTEM	Human hyaluronidase-4 (hHYAL4), a member of the hyaluronidase family, has no hyaluronidase activity, but is a chondroitin sulfate (CS)-specific endo-beta-N-acetylgalactosaminidase. The expression of hHYAL4 is not ubiquitous but restricted to placenta, skeletal muscle, and testis, suggesting that hHYAL4 is not involved in the systemic catabolism of CS, but rather has specific functions in particular organs or tissues. To elucidate the function of hyaluronidase-4 in vivo, mouse hyaluronidase-4 (mHyal4) was characterized. mHyal4 was also demonstrated to be a CS-specific endo-beta-N-acetylgalactosaminidase. However, mHyal4 and hHYAL4 differed in the sulfate groups they recognized. Although hHYAL4 strongly preferred GlcUA(2-O-sulfate)- GalNAc(6-O-sulfate)-containing sequences typical in CSD, where GlcUA represents D-glucuronic acid, mHyal4 depolymerized various CS isoforms to a similar extent, suggesting broad substrate specificity. To identify the amino acid residues responsible for this difference, a series of human/mouse HYAL4 chimeric proteins and HYAL4 point mutants were generated, and their preference for substrates was investigated. A combination of the amino acid residues at 261-265 and glutamine at 305 was demonstrated to be essential for the enzymatic activity as well as substrate specificity of mHyal4.	[Yamada, Shuhei] Meijo Univ, Fac Pharm, Dept Pathobiochem, Tempaku Ku, Nagoya, Aichi 4688503, Japan; [Kaneiwa, Tomoyuki; Miyazaki, Anzu; Kogawa, Ryo; Mizumoto, Shuji; Sugahara, Kazuyuki; Yamada, Shuhei] Hokkaido Univ, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut, Sapporo, Hokkaido 0010021, Japan	Meijo University; Hokkaido University	Yamada, S (corresponding author), Meijo Univ, Fac Pharm, Dept Pathobiochem, Tempaku Ku, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.	shuheiy@meijo-u.ac.jp	Mizumoto, Shuji/F-8313-2018	Mizumoto, Shuji/0000-0002-4641-1505	Matching Program for Innovations in Future Drug Discovery and Medical Care from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Mizutani Foundation for Glycoscience Tokyo, Japan;  [C-24590071]	Matching Program for Innovations in Future Drug Discovery and Medical Care from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Mizutani Foundation for Glycoscience Tokyo, Japan; 	This work was supported in part by Grant-in-aid for Scientific Research C-24590071 (to S.Y.) and the Matching Program for Innovations in Future Drug Discovery and Medical Care (to K.S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT), and the Mizutani Foundation for Glycoscience (to S.Y.), Tokyo, Japan.	Achur RN, 2000, J BIOL CHEM, V275, P40344, DOI 10.1074/jbc.M006398200; Akatsu C, 2011, GLYCOBIOLOGY, V21, P565, DOI 10.1093/glycob/cwq208; Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Csoka AB, 1999, GENOMICS, V60, P356, DOI 10.1006/geno.1999.5876; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Kaneiwa T, 2008, J BIOL CHEM, V283, P14971, DOI 10.1074/jbc.M709236200; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kim E, 2005, P NATL ACAD SCI USA, V102, P18028, DOI 10.1073/pnas.0506825102; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; LIN Y, 1994, J CELL BIOL, V125, P1157, DOI 10.1083/jcb.125.5.1157; Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Rauch U, 2006, ADV PHARMACOL, V53, P337, DOI 10.1016/S1054-3589(05)53016-3; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Stern R, 2008, SEMIN CANCER BIOL, V18, P275, DOI 10.1016/j.semcancer.2008.03.017; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2000, TRENDS GLYCOSCI GLYC, V12, P321, DOI 10.4052/tigg.12.321; Sugahara KN, 2008, CANCER RES, V68, P7191, DOI 10.1158/0008-5472.CAN-07-6198; Uyama T., 2007, COMPR GLYCOSCI, V3, P79; VLODAVSKY I, 1990, CANCER METAST REV, V9, P203, DOI 10.1007/BF00046361; Yamada Shuhei, 2008, Curr Drug Discov Technol, V5, P289; Zhang L, 2009, J BIOL CHEM, V284, P9433, DOI 10.1074/jbc.M900210200	33	23	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42119	42128		10.1074/jbc.M112.360693	http://dx.doi.org/10.1074/jbc.M112.360693			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086929	Green Published, hybrid			2022-12-28	WOS:000312103000050
J	Liu, Z; Tian, YJ; Machida, K; Lai, MMC; Luo, GX; Foung, SKH; Ou, JHJ				Liu, Zhe; Tian, Yongjun; Machida, Keigo; Lai, Michael M. C.; Luo, Guangxiang; Foung, Steven K. H.; Ou, Jing-Hsiung James			Transient Activation of the PI3K-AKT Pathway by Hepatitis C Virus to Enhance Viral Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR CLASS-B; HIGH-DENSITY-LIPOPROTEIN; MICROVILLAR CHANNEL FORMATION; I SR-BI; SCAVENGER RECEPTOR; SIGNALING PATHWAY; INSULIN-RESISTANCE; PI3K/AKT PATHWAY; PLASMA-MEMBRANE; CELL-CULTURE	The PI3K-AKT signaling pathway plays an important role in cell growth and metabolism. Here we report that hepatitis C virus (HCV) transiently activates the PI3K-AKT pathway. This activation was observed as early as 15 min postinfection, peaked by 30 min, and became undetectable at 24 h postinfection. The activation of AKT could also be mediated by UV-inactivated HCV, HCV pseudoparticle, and the ectodomain of the HCV E2 envelope protein. Because antibodies directed against CD81 and claudin-1, but not antibodies directed against scavenger receptor class B type I or occludin, could also activate AKT, the interaction between HCV E2 and its two co-receptors CD81 and claudin-1 probably triggered the activation of AKT. This activation of AKT by HCV was important for HCV infectivity, because the silencing of AKT by siRNA or the treatment of cells with its inhibitors or with the inhibitor of its upstream regulator PI3K significantly inhibited HCV infection, whereas the expression of constitutively active AKT enhanced HCV infection. The PI3K-AKT pathway is probably involved in HCV entry, because the inhibition of this pathway could inhibit the entry of HCV pseudoparticle but not the VSV pseudoparticle into cells. Furthermore, the treatment of cells with the AKT inhibitor AKT-V prior to HCV infection inhibited HCV infection, whereas the treatment after HCV infection had no obvious effect. Taken together, our studies indicated that HCV transiently activates the PI3K-AKT pathway to facilitate its entry. These results provide important information for understanding HCV replication and pathogenesis and raised the possibility of targeting this cellular pathway to treat HCV patients.	[Liu, Zhe; Tian, Yongjun; Machida, Keigo; Lai, Michael M. C.; Ou, Jing-Hsiung James] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Luo, Guangxiang] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40506 USA; [Foung, Steven K. H.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	University of Southern California; University of Kentucky; Stanford University	Ou, JHJ (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, 2011 Zonal Ave,HMR-401, Los Angeles, CA 90033 USA.	jamesou@hsc.usc.edu	Tian, Yongjun/F-8007-2011; Lai, Michael M. C./I-7001-2012	Foung, Steven/0000-0001-7149-6160	National Institutes of Health [DK094652, AI083025]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091953, R01AI097318, U19AI083025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK094652 and AI083025.	Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; Banerjee S, 2008, J VIROL, V82, P2606, DOI 10.1128/JVI.01672-07; Bartenschlager R, 2004, ADV VIRUS RES, V63, P71, DOI 10.1016/S0065-3527(04)63002-8; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Benedicto I, 2009, J VIROL, V83, P8012, DOI 10.1128/JVI.00038-09; Bertaux C, 2006, J VIROL, V80, P4940, DOI 10.1128/JVI.80.10.4940-4948.2006; Bose SK, 2012, J VIROL, V86, P6315, DOI 10.1128/JVI.00050-12; Brass Volker, 2006, Int J Med Sci, V3, P29; COORAY S, 2007, APOPTOSIS CELL SIGNA, P57; Esfandiarei M, 2004, J VIROL, V78, P4289, DOI 10.1128/JVI.78.8.4289-4298.2004; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Farquhar MJ, 2008, J VIROL, V82, P8797, DOI 10.1128/JVI.00592-08; Feng SZ, 2011, J GEN VIROL, V92, P1688, DOI 10.1099/vir.0.030866-0; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Guo HT, 2007, J VIROL, V81, P10072, DOI 10.1128/JVI.00541-07; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Huang ZH, 2003, BIOCHEMISTRY-US, V42, P3949, DOI 10.1021/bi0269207; Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12; Jiang JY, 2012, J VIROL, V86, P7256, DOI 10.1128/JVI.07222-11; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Keck ZY, 2007, J VIROL, V81, P1043, DOI 10.1128/JVI.01710-06; Keck ZY, 2011, J VIROL, V85, P10451, DOI 10.1128/JVI.05259-11; Kellner-Weibel G, 2000, BIOCHEMISTRY-US, V39, P221, DOI 10.1021/bi991666c; Kohaar I, 2010, J VIROL, V84, P6987, DOI 10.1128/JVI.00196-10; Lin KYK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001148; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; LO SY, 1995, VIROLOGY, V213, P455, DOI 10.1006/viro.1995.0018; Patel RK, 2012, J VIROL, V86, P3595, DOI 10.1128/JVI.06625-11; Peng Y, 2004, MOL BIOL CELL, V15, P384, DOI 10.1091/mbc.e03-06-0445; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Rahaus M, 2007, CELL SIGNAL, V19, P312, DOI 10.1016/j.cellsig.2006.07.003; Reaven E, 1998, ENDOCRINOLOGY, V139, P2847, DOI 10.1210/en.139.6.2847; Reaven E, 2001, P NATL ACAD SCI USA, V98, P1613, DOI 10.1073/pnas.98.4.1613; Reaven E, 2000, J LIPID RES, V41, P343; Rigotti A, 1996, J BIOL CHEM, V271, P33545, DOI 10.1074/jbc.271.52.33545; Saeed MF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000141; Sanchez EG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002754; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shin YK, 2007, J GEN VIROL, V88, P942, DOI 10.1099/vir.0.82483-0; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Street A, 2005, J VIROL, V79, P5006, DOI 10.1128/JVI.79.8.5006-5016.2005; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Urata S, 2012, J VIROL, V86, P4578, DOI 10.1128/JVI.06604-11; Williams DL, 2002, J LIPID RES, V43, P544; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Ye J, 2007, PLOS PATHOG, V3, P1017, DOI 10.1371/journal.ppat.0030108; Yu YJ, 2002, J VIROL, V76, P3731, DOI 10.1128/JVI.76.8.3731-3738.2002; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zhang C, 2005, MOL CELL BIOL, V25, P6899, DOI 10.1128/MCB.25.16.6899-6911.2005	55	69	69	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41922	41930		10.1074/jbc.M112.414789	http://dx.doi.org/10.1074/jbc.M112.414789			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23095753	hybrid, Green Published			2022-12-28	WOS:000312103000032
J	Pena-Diaz, P; Pelosi, L; Ebikeme, C; Colasante, C; Gao, F; Bringaud, F; Voncken, F				Pena-Diaz, Priscila; Pelosi, Ludovic; Ebikeme, Charles; Colasante, Claudia; Gao, Fei; Bringaud, Frederic; Voncken, Frank			Functional Characterization of TbMCP5, a Conserved and Essential ADP/ATP Carrier Present in the Mitochondrion of the Human Pathogen Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE LEVEL PHOSPHORYLATION; SUCCINATE COA-TRANSFERASE; BLOOD-STREAM; INDUCIBLE EXPRESSION; ENERGY-METABOLISM; PROTEIN; PROLINE; ACETATE; GENE; TRANSPORT	Trypanosoma brucei is a kinetoplastid parasite of medical and veterinary importance. Its digenetic life cycle alternates between the bloodstream form in the mammalian host and the procyclic form (PCF) in the bloodsucking insect vector, the tsetse fly. PCF trypanosomes rely in the glucose-depleted environment of the insect vector primarily on the mitochondrial oxidative phosphorylation of proline for their cellular ATP provision. We previously identified two T. brucei mitochondrial carrier family proteins, TbMCP5 and TbMCP15, with significant sequence similarity to functionally characterized ADP/ATP carriers from other eukaryotes. Comprehensive sequence analysis confirmed that TbMCP5 contains canonical ADP/ATP carrier sequence features, whereas they are not conserved in TbMCP15. Heterologous expression in the ANC-deficient yeast strain JL1 Delta 2 Delta 3u(-) revealed that only TbMCP5 was able to restore its growth on the non-fermentable carbon source lactate. Transport studies in yeast mitochondria showed that TbMCP5 has biochemical properties and ADP/ATP exchange kinetics similar to those of Anc2p, the prototypical ADP/ATP carrier of S. cerevisiae. Immunofluorescence microscopy and Western blot analysis confirmed that TbMCP5 is exclusively mitochondrial and is differentially expressed with 4.5-fold more TbMCP5 in the procyclic form of the parasite. Silencing of TbMCP5 expression in PCF T. brucei revealed that this ADP/ATP carrier is essential for parasite growth, particularly when depending on proline for energy generation. Moreover, ADP/ATP exchange in isolated T. brucei mitochondria was eliminated upon TbMCP5 depletion. These results confirmed that TbMCP5 functions as the main ADP/ATP carrier in the trypanosome mitochondrion. The important role of TbMCP5 in the T. brucei energy metabolism is further discussed.	[Pena-Diaz, Priscila; Gao, Fei; Voncken, Frank] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Pena-Diaz, Priscila; Gao, Fei; Voncken, Frank] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Pelosi, Ludovic] Univ Grenoble 1, Lab Biol Grande Echelle, iRTSV CEA Grenoble, Equipe Dynam Organelles & Plasticite Cellulaire, F-38054 Grenoble 9, France; [Ebikeme, Charles; Bringaud, Frederic] Univ Bordeaux Segalen, Ctr Resonance Magnet Syst Biol, CNRS UMR 5536, F-33076 Bordeaux, France; [Colasante, Claudia] Univ Giessen, Inst Anat & Zellbiol 2, D-35385 Giessen, Germany	University of Hull; University of Hull; University of York - UK; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Justus Liebig University Giessen	Voncken, F (corresponding author), Univ Hull, Dept Biol Sci, Cottingham Rd, Kingston Upon Hull HU6 7RX, N Humberside, England.	F.Voncken@hull.ac.uk	Colasante, Claudia/AAO-1230-2021; Pelosi, Ludovic/M-6406-2014; Pelosi, Ludovic/AAB-9832-2020; Peña-Diaz, Priscila/AAI-1209-2020; Pena-Diaz, Priscila/G-9503-2014	Pelosi, Ludovic/0000-0002-4198-5681; Peña-Diaz, Priscila/0000-0002-9428-6737; Ebikeme, Charles/0000-0002-9989-6489; Voncken, Frank/0000-0002-2929-276X; Colasante, Claudia/0000-0002-5760-4919	BBSRC [BB/G00448X/1]; University Joseph Fourier; CNRS [ANR-MIME2007, ANR-BLANC-2010]; Commissariat a l'Energie Atomique et aux Energies Alternatives (programme Signalisation et Transport Membranaire); Universite Bordeaux Segalen; Conseil Regional d'Aquitaine; Agence Nationale de la Recherche (ANR) programs; Biotechnology and Biological Sciences Research Council [BB/G00448X/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University Joseph Fourier; CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique et aux Energies Alternatives (programme Signalisation et Transport Membranaire); Universite Bordeaux Segalen; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Agence Nationale de la Recherche (ANR) programs(French National Research Agency (ANR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC Grant BB/G00448X/1 (to F. V.); by grants from the University Joseph Fourier, CNRS, and the Commissariat a l'Energie Atomique et aux Energies Alternatives (programme Signalisation et Transport Membranaire) (to L. P.); and by grants METABOTRYP of the ANR-MIME2007 call and ACETOTRYP of the ANR-BLANC-2010 call from CNRS, the Universite Bordeaux Segalen, the Conseil Regional d'Aquitaine, and the Agence Nationale de la Recherche (ANR) programs (to F. B.).	ADRIAN GS, 1986, MOL CELL BIOL, V6, P626, DOI 10.1128/MCB.6.2.626; Allemann N, 2000, MOL BIOCHEM PARASIT, V111, P87, DOI 10.1016/S0166-6851(00)00303-0; Babot M, 2012, J BIOL CHEM, V287, P10368, DOI 10.1074/jbc.M111.320697; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bellofatto Vivian, 2008, V442, P83, DOI 10.1007/978-1-59745-191-8_7; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; BLOCK MR, 1982, BIOCHEMISTRY-US, V21, P5451, DOI 10.1021/bi00265a011; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; BOULAY F, 1983, ANAL BIOCHEM, V128, P323, DOI 10.1016/0003-2697(83)90382-2; BRANDOLIN G, 1993, BIOCHEM BIOPH RES CO, V192, P143, DOI 10.1006/bbrc.1993.1393; Bringaud F, 1995, MOL BIOCHEM PARASIT, V74, P119, DOI 10.1016/0166-6851(95)02486-7; Bringaud F, 2010, PARASITOLOGY, V137, P1315, DOI 10.1017/S0031182009991843; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Bringaud F, 2012, FRONT BIOSCI-LANDMRK, V17, P349, DOI 10.2741/3931; Brown SV, 2006, EUKARYOT CELL, V5, P45, DOI 10.1128/EC.5.1.45-53.2006; BRUN R, 1979, ACTA TROP, V36, P289; Chaudhuri M, 2006, TRENDS PARASITOL, V22, P484, DOI 10.1016/j.pt.2006.08.007; Clayton CE, 1999, PARASITOL TODAY, V15, P372, DOI 10.1016/S0169-4758(99)01498-2; Clemencon B, 2008, J BIOL CHEM, V283, P11218, DOI 10.1074/jbc.M709565200; Clemencon B, 2011, J BIOL CHEM, V286, P36119, DOI 10.1074/jbc.M111.277376; Colasante C, 2006, EUKARYOT CELL, V5, P1194, DOI 10.1128/EC.00096-06; Colasante C, 2009, MOL BIOCHEM PARASIT, V167, P104, DOI 10.1016/j.molbiopara.2009.05.004; Coustou V, 2005, J BIOL CHEM, V280, P16559, DOI 10.1074/jbc.M500343200; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006; Dassa EP, 2005, PROTEIN EXPRES PURIF, V40, P358, DOI 10.1016/j.pep.2004.12.019; DAUM G, 1982, J BIOL CHEM, V257, P3028; David C, 2008, BIOCHEMISTRY-US, V47, P13223, DOI 10.1021/bi8012565; Ebikeme C, 2010, J BIOL CHEM, V285, P32312, DOI 10.1074/jbc.M110.124917; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Gualdron-Lopez M, 2012, INT J PARASITOL, V42, P1, DOI 10.1016/j.ijpara.2011.10.007; Hashimoto M, 1999, BBA-BIOENERGETICS, V1409, P113, DOI 10.1016/S0005-2728(98)00155-8; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Millerioux Y, 2012, J BIOL CHEM, V287, P17186, DOI 10.1074/jbc.M112.355404; Nury H, 2006, ANNU REV BIOCHEM, V75, P713, DOI 10.1146/annurev.biochem.75.103004.142747; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; PRIEST JW, 1994, J BIOENERG BIOMEMBR, V26, P179, DOI 10.1007/BF00763067; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Riviere L, 2009, P NATL ACAD SCI USA, V106, P12694, DOI 10.1073/pnas.0903355106; Roux P, 1996, ANAL BIOCHEM, V234, P31, DOI 10.1006/abio.1996.0046; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schneider Andre, 2007, Methods Mol Biol, V372, P379, DOI 10.1007/978-1-59745-365-3_27; Trezeguet V, 2008, J BIOENERG BIOMEMBR, V40, P435, DOI 10.1007/s10863-008-9178-2; van Hellemond JJ, 2005, BIOCHEM SOC T, V33, P967, DOI 10.1042/BST20050967; Van Hellemond JJ, 1998, P NATL ACAD SCI USA, V95, P3036, DOI 10.1073/pnas.95.6.3036; van Weelden SWH, 2003, J BIOL CHEM, V278, P12854, DOI 10.1074/jbc.M213190200; van Wilpe S, 1999, EUR J BIOCHEM, V264, P825, DOI 10.1046/j.1432-1327.1999.00673.x; Vassella E, 1997, MOL BIOCHEM PARASIT, V90, P381, DOI 10.1016/S0166-6851(97)00171-0; Voncken F, 2003, J BIOL CHEM, V278, P35299, DOI 10.1074/jbc.M301811200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436	58	20	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41861	41874		10.1074/jbc.M112.404699	http://dx.doi.org/10.1074/jbc.M112.404699			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23074217	Green Published, hybrid			2022-12-28	WOS:000312103000027
J	Crotty, TM; Nakano, T; Stafforini, DM; Topham, MK				Crotty, Tracy M.; Nakano, Tomoyuki; Stafforini, Diana M.; Topham, Matthew K.			Diacylglycerol Kinase delta Modulates Akt Phosphorylation through Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase 2 (PHLPP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; PROSTATE-CANCER; C-ALPHA; PROMOTES APOPTOSIS; INSULIN-RESISTANCE; IN-VITRO; ACTIVATION; PATHWAY; PKC	Discovering proteins that modulate Akt signaling has become a critical task, given the oncogenic role of Akt in a wide variety of cancers. We have discovered a novel diacylglycerol signaling pathway that promotes dephosphorylation of Akt. This pathway is regulated by diacylglycerol kinase delta (DGK delta). In DGK delta-deficient cells, we found reduced Akt phosphorylation downstream of three receptor tyrosine kinases. Phosphorylation upstream of Akt was not affected. Our data indicate that PKC alpha, which is excessively active in DGK delta-deficient cells, promotes dephosphorylation of Akt through pleckstrin homology domain leucine-rich repeats protein phosphatase (PHLPP) 2. Depletion of either PKC alpha or PHLPP2 rescued Akt phosphorylation in DGK delta-deficient cells. In contrast, depletion of PHLPP1, another Akt phosphatase, failed to rescue Akt phosphorylation. Other PHLPP substrates were not affected by DGK delta deficiency, suggesting mechanisms allowing specific modulation of Akt dephosphorylation. We found that beta-arrestin 1 acted as a scaffold for PHLPP2 and Akt1, providing a mechanism for specificity. Because of its ability to reduce Akt phosphorylation, we tested whether depletion of DGK delta could attenuate tumorigenic properties of cultured cells and found that DGK delta deficiency reduced cell proliferation and migration and enhanced apoptosis. We have, thus, discovered a novel pathway in which diacylglycerol signaling negatively regulates Akt activity. Our collective data indicate that DGK delta is a pertinent cancer target, and our studies could lay the groundwork for development of novel cancer therapeutics.	[Crotty, Tracy M.; Nakano, Tomoyuki; Stafforini, Diana M.; Topham, Matthew K.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Topham, Matthew K.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Stafforini, Diana M.; Topham, Matthew K.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Topham, MK (corresponding author), 2000 E Circle Hope, Salt Lake City, UT 84112 USA.	matt.topham@hci.utah.edu			National Institutes of Health [R01-CA95463]; Huntsman Cancer Foundation; R. Harold Burton Foundation; Cancer Center Support Grant [P30-CA042014]; NATIONAL CANCER INSTITUTE [R01CA095463, P30CA042014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntsman Cancer Foundation; R. Harold Burton Foundation; Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA95463 (to M. K. T.). This work was also supported by the Huntsman Cancer Foundation, the R. Harold Burton Foundation, and by Cancer Center Support Grant P30-CA042014 for support of core facilities.	Al-Salihi MA, 2007, CELL SIGNAL, V19, P1956, DOI 10.1016/j.cellsig.2007.05.003; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bacchiocchi R, 2005, BLOOD, V106, P2175, DOI 10.1182/blood-2005-01-0316; BAIRD WM, 1971, CANCER RES, V31, P1074; Baldanzi G, 2004, ONCOGENE, V23, P4828, DOI 10.1038/sj.onc.1207633; BLUMBERG PM, 1983, ANN NY ACAD SCI, V407, P303, DOI 10.1111/j.1749-6632.1983.tb47836.x; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cai JJ, 2010, J BIOL CHEM, V285, P6952, DOI 10.1074/jbc.M109.055731; Caino MC, 2012, ONCOGENE, V31, P2593, DOI 10.1038/onc.2011.428; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Crotty T, 2006, P NATL ACAD SCI USA, V103, P15485, DOI 10.1073/pnas.0604104103; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hellwinkel OJC, 2008, BJU INT, V101, P1454, DOI 10.1111/j.1464-410X.2008.07540.x; Kakefuda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013447; Leitges M, 2002, MOL ENDOCRINOL, V16, P1203; Li X, 2011, EMBO REP, V12, P818, DOI 10.1038/embor.2011.106; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Liu JY, 2011, J BIOL CHEM, V286, P6510, DOI 10.1074/jbc.M110.183087; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Luo B, 2003, J CELL BIOL, V160, P929, DOI 10.1083/jcb.200208120; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; Nelson CD, 2007, SCIENCE, V315, P663, DOI 10.1126/science.1134562; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Oliva JL, 2008, J BIOL CHEM, V283, P5466, DOI 10.1074/jbc.M707576200; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Regier DS, 2005, P NATL ACAD SCI USA, V102, P7595, DOI 10.1073/pnas.0500663102; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Shulga YV, 2011, CHEM REV, V111, P6186, DOI 10.1021/cr1004106; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Yasuda S, 2009, J BIOL CHEM, V284, P29559, DOI 10.1074/jbc.M109.043604; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958	46	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1439	1447		10.1074/jbc.M112.407379	http://dx.doi.org/10.1074/jbc.M112.407379			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184957	hybrid, Green Published			2022-12-28	WOS:000313751400002
J	Dai, BB; Gong, AH; Jing, ZT; Aldape, KD; Kang, SH; Sawaya, R; Huang, SY				Dai, Bingbing; Gong, Aihua; Jing, Zhitao; Aldape, Kenneth D.; Kang, Shin-Hyuk; Sawaya, Raymond; Huang, Suyun			Forkhead Box M1 Is Regulated by Heat Shock Factor 1 and Promotes Glioma Cells Survival under Heat Shock Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR HSF1; MITOTIC PROGRESSION; TARGETED DISRUPTION; OXIDATIVE STRESS; GENE-EXPRESSION; S-PHASE; FOXM1; CANCER; THERMOTOLERANCE; PHOSPHORYLATION	The forkhead box M1 (FoxM1) is a key transcription factor regulating multiple aspects of cell biology. Prior studies have shown that FoxM1 is overexpressed in a variety of human tumors, including brain tumor, and plays a critical role in cancer development and progression. In this study we found that FoxM1 was up-regulated by heat shock factor 1 (HSF1) under heat shock stress condition in multiple cell lines. Knockdown of HSF1 with HSF1 siRNA or inhibition of HSF1 with a HSF1 inhibitor abrogated heat shock-induced expression of FoxM1. Genetic deletion of HSF1 in mouse embryo fibroblast cells also abolished heat shock stress-induced FoxM1 expression. Moreover, we showed that HSF1 directly bound to FoxM1 promoter and increased FoxM1 promoter activity. Furthermore, we demonstrated that FoxM1 was required for the G(2)-M phase progression through regulating Cdc2, Cdc20, and Cdc25B under a mild heat shock stress but enhanced cell survival under lethal heat shock stress condition. Finally, in human glioblastoma specimens, FoxM1 overexpression correlated with elevated HSF1 expression. Our results indicate that FoxM1 is regulated by HSF1 and is critical for HSF1-mediated heat shock response. We demonstrated a novel mechanism of stress resistance controlled by HSF1 and a new HSF-FoxM1 connection that mediates cellular thermotolerance.	[Dai, Bingbing; Gong, Aihua; Jing, Zhitao; Kang, Shin-Hyuk; Sawaya, Raymond; Huang, Suyun] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Aldape, Kenneth D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Huang, Suyun] Univ Texas Grad Sch Biomed Sci Houston, Program Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Dai, BB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Unit 0023, 1515 Holcombe Blvd, Houston, TX 77030 USA.	bdai@mdanderson.org; suhuang@mdanderson.org		gang, sinhyeog/0000-0002-8912-7985	National Institutes of Health [R01CA157933, R21CA152623, P50CA127001, CA-16672 (NCI)]; Center for Targeted Therapy; Multidisciplinary Research Program at M.D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P50CA127001, R21CA152623, R01CA157933, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Targeted Therapy; Multidisciplinary Research Program at M.D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA157933, R21CA152623, P50CA127001, and CA-16672 (NCI). This work was also supported by research grants from the Center for Targeted Therapy and the Multidisciplinary Research Program at M.D. Anderson Cancer Center.	Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Behren A, 2010, ONCOGENE, V29, P1519, DOI 10.1038/onc.2009.436; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; Dai BB, 2010, CANCER RES, V70, P2951, DOI 10.1158/0008-5472.CAN-09-3909; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Jones TJ, 2004, MOL ENDOCRINOL, V18, P509, DOI 10.1210/me.2003-0366; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Karapanagiotou EM, 2009, EXPERT OPIN INV DRUG, V18, P161, DOI [10.1517/13543780802715792, 10.1517/13543780802715792 ]; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; Komarova EA, 2003, J BIOL CHEM, V278, P15465, DOI 10.1074/jbc.C300011200; Korver W, 1997, GENOMICS, V46, P435, DOI 10.1006/geno.1997.5065; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Lee YJ, 2008, CANCER RES, V68, P7550, DOI 10.1158/0008-5472.CAN-08-0129; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045; Li SKM, 2008, J BIOL CHEM, V283, P16545, DOI 10.1074/jbc.M709604200; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Luft JC, 2001, CELL STRESS CHAPERON, V6, P326, DOI 10.1379/1466-1268(2001)006<0326:HSFMTP>2.0.CO;2; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Millour J, 2010, ONCOGENE, V29, P2983, DOI 10.1038/onc.2010.47; Neckers Len, 2002, Expert Opin Emerg Drugs, V7, P277, DOI 10.1517/14728214.7.2.277; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; Park HJ, 2008, MOL CELL BIOL, V28, P5162, DOI 10.1128/MCB.00387-08; Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Sherman M, 2007, ANN NY ACAD SCI, V1113, P192, DOI 10.1196/annals.1391.030; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang JD, 2006, J BIOL CHEM, V281, P2451, DOI 10.1074/jbc.M505890200; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Whitesell L, 2009, EXPERT OPIN THER TAR, V13, P469, DOI [10.1517/14728220902832697, 10.1517/14728220902832697 ]; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154	48	39	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1634	1642		10.1074/jbc.M112.379362	http://dx.doi.org/10.1074/jbc.M112.379362			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23192351	hybrid, Green Published			2022-12-28	WOS:000313751400019
J	Herbst, DA; Boll, B; Zocher, G; Stehle, T; Heide, L				Herbst, Dominik A.; Boll, Bjoern; Zocher, Georg; Stehle, Thilo; Heide, Lutz			Structural Basis of the Interaction of MbtH-like Proteins, Putative Regulators of Nonribosomal Peptide Biosynthesis, with Adenylating Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE INHIBITOR STREPTOLYDIGIN; CRYSTAL-STRUCTURE; NRPS ADENYLATION; DOMAIN; ACTIVATION; INSIGHTS; SYNTHETASE; REFINEMENT; ALLOSTERY; CLUSTER	The biosynthesis of nonribosomally formed peptides (NRPs), which include important antibiotics such as vancomycin, requires the activation of amino acids through adenylate formation. The biosynthetic gene clusters of NRPs frequently contain genes for small, so-called MbtH-like proteins. Recently, it was discovered that these MbtH-like proteins are required for some of the adenylation reactions in NRP biosynthesis, but the mechanism of their interaction with the adenylating enzymes has remained unknown. In this study, we determined the structure of SlgN1, a 3-methylaspartate-adenylating enzyme involved in the biosynthesis of the hybrid polyketide/NRP antibiotic streptolydigin. SlgN1 contains an MbtH-like domain at its N terminus, and our analysis defines the parameters required for an interaction between MbtH-like domains and an adenylating enzyme. Highly conserved tryptophan residues of the MbtH-like domain critically contribute to this interaction. Trp-25 and Trp-35 form a cleft on the surface of the MbtH-like domain, which accommodates the alanine side chain of Ala-433 of the adenylating domain. Mutation of Ala-433 to glutamate abolished the activity of SlgN1. Mutation of Ser-23 of the MbtH-like domain to tyrosine resulted in strongly reduced activity. However, the activity of this S23Y mutant could be completely restored by addition of the intact MbtH-like protein CloY from another organism. This suggests that the interface found in the structure of SlgN1 is the genuine interface between MbtH-like proteins and adenylating enzymes.	[Herbst, Dominik A.; Zocher, Georg; Stehle, Thilo] Univ Tubingen, Interfak Inst Biochem, D-72076 Tubingen, Germany; [Boll, Bjoern; Heide, Lutz] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Vanderbilt University	Stehle, T (corresponding author), Univ Tubingen, Interfak Inst Biochem, Hoppe Seyler Str 4, D-72076 Tubingen, Germany.	thilo.stehle@uni-tuebingen.de	Boll, Björn/AAJ-2892-2020	Heide, Lutz/0000-0001-7809-7453; Herbst, Dominik A./0000-0003-4671-5493	Deutsche Forschungsgemeinschaft [SFB 766]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 766 (to L. H. and T. S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Baltz RH, 2011, J IND MICROBIOL BIOT, V38, P1747, DOI 10.1007/s10295-011-1022-8; Boll B, 2011, J BIOL CHEM, V286, P36281, DOI 10.1074/jbc.M111.288092; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Buchko GW, 2010, TUBERCULOSIS, V90, P245, DOI 10.1016/j.tube.2010.04.002; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Drake EJ, 2007, J BIOL CHEM, V282, P20425, DOI 10.1074/jbc.M611833200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Felnagle EA, 2010, BIOCHEMISTRY-US, V49, P8815, DOI 10.1021/bi1012854; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Gomez C, 2012, J ANTIBIOT, V65, P341, DOI 10.1038/ja.2012.37; Gomez C, 2011, J BACTERIOL, V193, P4214, DOI 10.1128/JB.05062-11; Goyal A, 2006, ACTA CRYSTALLOGR F, V62, P350, DOI 10.1107/S1744309106005938; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Horna DH, 2011, J BACTERIOL, V193, P2647, DOI 10.1128/JB.00108-11; Imker HJ, 2010, CHEM BIOL, V17, P1077, DOI 10.1016/j.chembiol.2010.08.007; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lautru S, 2007, MICROBIOL-SGM, V153, P1405, DOI 10.1099/mic.0.2006/003145-0; Marsh ENG, 2009, BIOCHEM SOC T, V37, P336, DOI 10.1042/BST0370336; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon MD, 2012, J BACTERIOL, V194, P2809, DOI 10.1128/JB.00088-12; Mitchell CA, 2012, BIOCHEMISTRY-US, V51, P3252, DOI 10.1021/bi300112e; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Olano C, 2009, CHEM BIOL, V16, P1031, DOI 10.1016/j.chembiol.2009.09.015; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Siddiqui N, 2012, J MOL BIOL, V415, P781, DOI 10.1016/j.jmb.2011.12.002; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stanger K, 2012, NAT CHEM BIOL, V8, P655, DOI [10.1038/nchembio.967, 10.1038/NCHEMBIO.967]; Stegmann E, 2006, FEMS MICROBIOL LETT, V262, P85, DOI 10.1111/j.1574-6968.2006.00368.x; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Sundlov JA, 2012, CHEM BIOL, V19, P188, DOI 10.1016/j.chembiol.2011.11.013; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Tatham E, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-118; Ten L., 1973, ACTA CRYSTALLOGR A, V29, P183; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wolpert M, 2007, MICROBIOL-SGM, V153, P1413, DOI 10.1099/mic.0.2006/002998-0; Zhang WJ, 2010, BIOCHEMISTRY-US, V49, P9946, DOI 10.1021/bi101539b	52	69	71	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1991	2003		10.1074/jbc.M112.420182	http://dx.doi.org/10.1074/jbc.M112.420182			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23192349	Green Published, hybrid			2022-12-28	WOS:000313751400051
J	Bugatti, A; Giagulli, C; Urbinati, C; Caccuri, F; Chiodelli, P; Oreste, P; Fiorentini, S; Orro, A; Milanesi, L; D'Ursi, P; Caruso, A; Rusnati, M				Bugatti, Antonella; Giagulli, Cinzia; Urbinati, Chiara; Caccuri, Francesca; Chiodelli, Paola; Oreste, Pasqua; Fiorentini, Simona; Orro, Alessandro; Milanesi, Luciano; D'Ursi, Pasqualina; Caruso, Arnaldo; Rusnati, Marco			Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; COLI POLYSACCHARIDE DERIVATIVES; CHEMICALLY-MODIFIED HEPARINS; TAT PROTEIN; SULFATE PROTEOGLYCANS; BINDING; GP120; GLYCOPROTEIN; INFECTION; ENVELOPE	Once released by HIV+ cells, p17 binds heparan sulfate proteoglycans (HSPGs) and CXCR1 on leukocytes causing their dysfunction. By exploiting an approach integrating computational modeling, site-directed mutagenesis of p17, chemical desulfation of heparin, and surface plasmon resonance, we characterized the interaction of p17 with heparin, a HSPG structural analog, and CXCR1. p17 binds to heparin with an affinity (K-d = 190 nM) that is similar to those of other heparin-binding viral proteins. Two stretches of basic amino acids (basic motifs) are present in p17 N and C termini. Neutralization (Arg3 -> Ala substitution) of the N-terminal, but not of the C-terminal basic motif, causes the loss of p17 heparin-binding capacity. The N-terminal heparin-binding motif of p17 partially overlaps the CXCR1-binding domain. Accordingly, its neutralization prevents also p17 binding to the chemochine receptor. Competition experiments demonstrated that free heparin and heparan sulfate (HS), but not selectively 2-O-, 6-O-, and N-O desulfated heparins, prevent p17 binding to substrate-immobilized heparin, indicating that the sulfate groups of the glycosaminoglycan mediate p17 interaction. Evaluation of the p17 antagonist activity of a panel of biotechnological heparins derived by chemical sulfation of the Escherichia coli K5 polysaccharide revealed that the highly N,O-sulfated derivative prevents the binding of p17 to both heparin and CXCR1, thus inhibiting p17-driven chemotactic migration of human monocytes with an efficiency that is higher than those of heparin and HS. Here, we characterized at a molecular level the interaction of p17 with its cellular receptors, laying the basis for the development of heparin-mimicking p17 antagonists.	[Bugatti, Antonella; Urbinati, Chiara; Chiodelli, Paola; Rusnati, Marco] Univ Brescia, Dept Mol & Translat Med, Sect Expt Oncol & Immunol, Sch Med, I-25123 Brescia, Italy; [Giagulli, Cinzia; Caccuri, Francesca; Fiorentini, Simona; Caruso, Arnaldo] Univ Brescia, Dept Mol & Translat Med, Microbiol Sect, Sch Med, I-25123 Brescia, Italy; [Oreste, Pasqua] Glycores 2000A, I-20155 Milan, Italy; [Orro, Alessandro; Milanesi, Luciano; D'Ursi, Pasqualina] CNR, Inst Biomed Technol, I-20090 Segrate, Italy	University of Brescia; University of Brescia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Rusnati, M (corresponding author), Univ Brescia, Dept Mol & Translat Med, Sect Expt Oncol & Immunol, Sch Med, Viale Europa 11, I-25123 Brescia, Italy.	rusnati@med.unibs.it	Caccuri, Francesca/AAC-1281-2022; Orro, Alessandro/ABA-3542-2020; Caruso, Arnaldo/H-7818-2014; Milanesi, Luciano/AAE-7230-2019; Rusnati, Marco/F-1168-2010; Chiodelli, Paola/K-1418-2016	Caccuri, Francesca/0000-0002-1923-9033; Milanesi, Luciano/0000-0002-1201-3939; Rusnati, Marco/0000-0001-9968-5908; Chiodelli, Paola/0000-0002-8702-0623; FIORENTINI, SIMONA/0000-0002-1866-314X; Urbinati, Chiara Eva/0000-0002-0138-7871; CARUSO, Arnaldo/0000-0001-5178-566X	Istituto Superiore di Sanita (AIDS) [40H.51, 40G.16]; Italian Ministry of University and Scientific Research; Bonino-Pulejo Foundation (Messina, Italy); Accordo Quadro RL-CNR "Nanoscienze per materiali e applicazioni biomediche"; Interomics Flagship Project; Italian Ministry of University and Scientific Research Fondo per gli Investimenti della Ricerca di Base-Protocollo HIRMA [RBAP11YS7K]	Istituto Superiore di Sanita (AIDS); Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Bonino-Pulejo Foundation (Messina, Italy); Accordo Quadro RL-CNR "Nanoscienze per materiali e applicazioni biomediche"; Interomics Flagship Project; Italian Ministry of University and Scientific Research Fondo per gli Investimenti della Ricerca di Base-Protocollo HIRMA	This work was supported by the Istituto Superiore di Sanita (AIDS Grants 40H.51 (to M. R.) and 40G.16 (to A. C.)), the Italian Ministry of University and Scientific Research (to M. R. and A. C.), the Bonino-Pulejo Foundation (Messina, Italy; to A. C.), the Accordo Quadro RL-CNR "Nanoscienze per materiali e applicazioni biomediche," the Interomics Flagship Project, and Italian Ministry of University and Scientific Research Fondo per gli Investimenti della Ricerca di Base-Protocollo HIRMA Grant RBAP11YS7K (to L. M.).	Ai J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002662; Ben Khalifa M, 2001, ANAL BIOCHEM, V293, P194, DOI 10.1006/abio.2001.5119; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; BUDKA H, 1990, ACTA NEUROPATHOL, V79, P611, DOI 10.1007/BF00294238; Bugatti A, 2007, ANTIMICROB AGENTS CH, V51, P2337, DOI 10.1128/AAC.01362-06; Caccuri F, 2012, P NATL ACAD SCI USA, V109, P14580, DOI 10.1073/pnas.1206605109; Cannon PM, 1997, J VIROL, V71, P3474, DOI 10.1128/JVI.71.5.3474-3483.1997; CASU B, 1994, CARBOHYD RES, V263, P271, DOI 10.1016/0008-6215(94)00172-3; Chauhan A, 2003, J BIOL CHEM, V278, P13512, DOI 10.1074/jbc.M209381200; COLTRINI D, 1993, EUR J BIOCHEM, V214, P51, DOI 10.1111/j.1432-1033.1993.tb17895.x; COLTRINI D, 1994, BIOCHEM J, V303, P583, DOI 10.1042/bj3030583; Corasaniti MT, 2001, J NEUROCHEM, V79, P1; Crublet E, 2008, J BIOL CHEM, V283, P15193, DOI 10.1074/jbc.M800066200; De Francesco MA, 2006, VIRUS RES, V118, P170, DOI 10.1016/j.virusres.2005.12.008; De Francesco MA, 1998, AIDS, V12, P245, DOI 10.1097/00002030-199803000-00001; De Francesco MA, 2002, P NATL ACAD SCI USA, V99, P9972, DOI 10.1073/pnas.142274699; De Francesco MA, 2011, J BIOL CHEM, V286, P19541, DOI 10.1074/jbc.M110.191270; Fernando H, 2007, FEBS J, V274, P241, DOI 10.1111/j.1742-4658.2006.05579.x; Fiorentini S, 2006, NEW MICROBIOL, V29, P1; Fiorentini S, 2004, BIOPOLYMERS, V76, P334, DOI 10.1002/bip.20130; Fiorentini S, 2008, P NATL ACAD SCI USA, V105, P3867, DOI 10.1073/pnas.0800370105; Fiorentini S, 2010, PHARMACOL THERAPEUT, V128, P433, DOI 10.1016/j.pharmthera.2010.08.005; Fontana L, 2001, ARTERIOSCL THROM VAS, V21, P55, DOI 10.1161/01.ATV.21.1.55; Giagulli C, 2012, BLOOD, V119, P2274, DOI 10.1182/blood-2011-06-364083; Giagulli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017831; Goldstein G, 1996, NAT MED, V2, P960, DOI 10.1038/nm0996-960; Hearps AC, 2007, AIDS RES HUM RETROV, V23, P341, DOI 10.1089/aid.2006.0108; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Hetenyi C, 2006, FEBS LETT, V580, P1447, DOI 10.1016/j.febslet.2006.01.074; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; INOUE Y, 1976, CARBOHYD RES, V46, P87, DOI 10.1016/S0008-6215(00)83533-8; ISACCHI A, 1991, P NATL ACAD SCI USA, V88, P2628, DOI 10.1073/pnas.88.7.2628; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leali D, 2001, J BIOL CHEM, V276, P37900; Lembo D, 2008, ANTIMICROB AGENTS CH, V52, P1374, DOI 10.1128/AAC.01467-07; LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8; LOPALCO L, 1994, AIDS RES HUM RETROV, V10, P787, DOI 10.1089/aid.1994.10.787; Massiah MA, 1996, PROTEIN SCI, V5, P2391, DOI 10.1002/pro.5560051202; Matthews S, 1995, BIOCHEM SOC T, V23, P725, DOI 10.1042/bst0230725; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Ping LH, 1999, J VIROL, V73, P6271, DOI 10.1128/JVI.73.8.6271-6281.1999; Poiesi C, 2008, VIRUS RES, V132, P25, DOI 10.1016/j.virusres.2007.10.006; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; RIDER CC, 1994, BIOCHEMISTRY-US, V33, P6974, DOI 10.1021/bi00188a029; Rusnati M, 1998, J BIOL CHEM, V273, P16027, DOI 10.1074/jbc.273.26.16027; Rusnati M, 1999, J BIOL CHEM, V274, P28198, DOI 10.1074/jbc.274.40.28198; Rusnati M, 1996, INT J CLIN LAB RES, V26, P15, DOI 10.1007/BF02644769; Rusnati M, 1997, J BIOL CHEM, V272, P11313, DOI 10.1074/jbc.272.17.11313; Rusnati M, 2001, J BIOL CHEM, V276, P22420, DOI 10.1074/jbc.M010779200; Rusnati Marco, 2002, Angiogenesis, V5, P141, DOI 10.1023/A:1023892223074; Rusnati M, 2009, PHARMACOL THERAPEUT, V123, P310, DOI 10.1016/j.pharmthera.2009.05.001; Rusnati M, 2009, CURR PHARM DESIGN, V15, P2946, DOI 10.2174/138161209789058156; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Singh IN, 2004, J NEUROVIROL, V10, P141, DOI 10.1080/13550280490441103; Spillmann D, 2001, BIOCHIMIE, V83, P811, DOI 10.1016/S0300-9084(01)01290-1; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Urbinati C, 2004, FEBS LETT, V568, P171, DOI 10.1016/j.febslet.2004.05.033; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vicenzi E, 2003, AIDS, V17, P177, DOI 10.1097/00002030-200301240-00006; Vitale M, 2003, BRIT J HAEMATOL, V120, P337, DOI 10.1046/j.1365-2141.2003.04053.x; Vives RR, 2005, J BIOL CHEM, V280, P21353, DOI 10.1074/jbc.M500911200	65	30	30	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1150	1161		10.1074/jbc.M112.400077	http://dx.doi.org/10.1074/jbc.M112.400077			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23166320	hybrid, Green Published			2022-12-28	WOS:000313570300037
J	Chambers, JW; Howard, S; LoGrasso, PV				Chambers, Jeremy W.; Howard, Shannon; LoGrasso, Philip V.			Blocking c-Jun N-terminal Kinase (JNK) Translocation to the Mitochondria Prevents 6-Hydroxydopamine-induced Toxicity in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE ACTIVITY; PARKINSONS-DISEASE; PEPTIDE INHIBITOR; CRITICAL FEATURES; COMPLEX-I; ACTIVATION; NEURONS; MODEL; BIOENERGETICS; EXPRESSION	Because oxidative stress and mitochondrial dysfunction are well known contributors to Parkinson disease (PD), we set out to investigate the role mitochondrial JNK plays in the etiology of 6-hydroxydopamine-induced (6-OHDA) oxidative stress, mitochondrial dysfunction, and neurotoxicity in SHSY5Y cells and neuroprotection and motor behavioral protection in vivo. To do this, we utilized a cell-permeable peptide of the outer mitochondrial membrane protein, Sab (SH3BP5), as an inhibitor of JNK mitochondrial translocation. In vitro studies showed that 6-OHDA induced JNK translocation to the mitochondria and that inhibition of mitochondrial JNK signaling by Tat-Sab(KIM1) protected against 6-OHDA-induced oxidative stress, mitochondrial dysfunction, and neurotoxicity. Administration of Tat-Sab(KIM1) via an intracerebral injection into the mid-forebrain bundle increased the number of tyrosine hydroxylase immunoreactive neurons in the substantia nigra pars compacta by 2-fold (p < 0.05) in animals lesioned with 6-OHDA, compared with animals treated only with 6-OHDA into the nigrostriatal pathway. In addition, Tat-Sab(KIM1) decreased the D-amphetamine-induced unilateral rotations associated with the lesion by 30% (p < 0.05). Steady-state brain levels of Tat-Sab(KIM1) at day 7 were 750 nM, which was similar to 3.4-fold higher than the IC50 for this peptide versus Sab protein. Collectively, these data suggest that 6-OHDA induced JNK translocation to the mitochondria and that blocking this translocation reduced oxidative stress, mitochondrial dysfunction, and neurotoxicity both in vitro and in vivo. Moreover, the data suggest that inhibitors that block association of JNKs with the mitochondria may be useful neuroprotective agents for the treatment of Parkinson disease.	[LoGrasso, Philip V.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute	LoGrasso, PV (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA.	lograsso@scripps.edu		Chambers, Jeremy/0000-0002-6143-3091	National Institutes of Health [U01NS057153-04]; Saul and Theresa Esman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS057153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saul and Theresa Esman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant U01NS057153-04 (to P. L.). This work was also supported by The Saul and Theresa Esman Foundation. Philip LoGrasso serves as a consultant for OPKO Health.	Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Barr RK, 2004, J BIOL CHEM, V279, P36327, DOI 10.1074/jbc.M402181200; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Chambers JW, 2011, ACS CHEM BIOL, V6, P808, DOI 10.1021/cb200062a; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Chambers JW, 2011, ACS CHEM NEUROSCI, V2, P198, DOI 10.1021/cn100109k; Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Ho DT, 2006, J BIOL CHEM, V281, P13169, DOI 10.1074/jbc.M601010200; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Pan J, 2007, NEUROSCI LETT, V428, P82, DOI 10.1016/j.neulet.2007.09.032; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Vaudano E, 2001, EUR J NEUROSCI, V13, P1, DOI 10.1046/j.1460-9568.2001.01356.x; Wiltshire C, 2002, BIOCHEM J, V367, P577, DOI 10.1042/BJ20020553; Xia XG, 2001, P NATL ACAD SCI USA, V98, P10433, DOI 10.1073/pnas.181182298; Zhao Y, 2009, MOL CELL NEUROSCI, V41, P186, DOI 10.1016/j.mcn.2009.02.012; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x; Zhou QQ, 2009, FEBS LETT, V583, P1132, DOI 10.1016/j.febslet.2009.02.043	21	56	59	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1079	1087		10.1074/jbc.M112.421354	http://dx.doi.org/10.1074/jbc.M112.421354			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184940	Green Published, hybrid			2022-12-28	WOS:000313570300031
J	Deole, R; Challacombe, J; Raiford, DW; Hoff, WD				Deole, Ratnakar; Challacombe, Jean; Raiford, Douglas W.; Hoff, Wouter D.			An Extremely Halophilic Proteobacterium Combines a Highly Acidic Proteome with a Low Cytoplasmic Potassium Content	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM SALINIBACTER-RUBER; ECTOTHIORHODOSPIRA-HALOCHLORIS; HALOBACTERIUM-SALINARUM; PHOTOTROPIC BACTERIUM; CRYSTAL-STRUCTURE; ADAPTATION; PROTEINS; SALT; DEHYDROGENASE; GENOME	Halophilic archaea accumulate molar concentrations of KCl in their cytoplasm as an osmoprotectant and have evolved highly acidic proteomes that function only at high salinity. We examined osmoprotection in the photosynthetic Proteobacteria Halorhodospira halophila and Halorhodospira halochloris. Genome sequencing and isoelectric focusing gel electrophoresis showed that the proteome of H. halophila is acidic. In line with this finding, H. halophila accumulated molar concentrations of KCl when grown in high salt medium as detected by x-ray microanalysis and plasma emission spectrometry. This result extends the taxonomic range of organisms using KCl as a main osmoprotectant to the Proteobacteria. The closely related organism H. halochloris does not exhibit an acidic proteome, matching its inability to accumulate K+. This observation indicates recent evolutionary changes in the osmoprotection strategy of these organisms. Upon growth of H. halophila in low salt medium, its cytoplasmic K+ content matches that of Escherichia coli, revealing an acidic proteome that can function in the absence of high cytoplasmic salt concentrations. These findings necessitate a reassessment of two central aspects of theories for understanding extreme halophiles. First, we conclude that proteome acidity is not driven by stabilizing interactions between K+ ions and acidic side chains but by the need for maintaining sufficient solvation and hydration of the protein surface at high salinity through strongly hydrated carboxylates. Second, we propose that obligate protein halophilicity is a non-adaptive property resulting from genetic drift in which constructive neutral evolution progressively incorporates weakly stabilizing K+-binding sites on an increasingly acidic protein surface.	[Deole, Ratnakar; Hoff, Wouter D.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA; [Hoff, Wouter D.] Oklahoma State Univ, Dept Chem, Stillwater, OK 74078 USA; [Challacombe, Jean] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Raiford, Douglas W.] Univ Montana, Dept Comp Sci, Missoula, MT 59812 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Montana System; University of Montana	Hoff, WD (corresponding author), Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA.	wouter.hoff@okstate.edu	Deole, Ratnakar/AFA-6902-2022		National Science Foundation [0722410]; Office of Science of the United States Department of Energy [DE-AC02-05CH11231]; Oklahoma State University; Direct For Biological Sciences [1051590] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); Oklahoma State University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Michael Kress and Terry Colberg for expert technical assistance with the plasma emission spectrometry and electron microscopy measurements. We thank all of the Joint Genome Institute personnel who participated in the sequencing, assembly, and automation of the H. halophila genome. The purchase of the FEI Quanta 600 environmental scanning electron microscope used in this work was supported by National Science Foundation Grant 0722410 to Oklahoma State University. The work conducted by the United States Department of Energy Joint Genome Institute is supported by the Office of Science of the United States Department of Energy under Contract DE-AC02-05CH11231.; This work was supported by Oklahoma State University startup funds (to W. D. H.).	Anton J, 2002, INT J SYST EVOL MICR, V52, P485, DOI 10.1099/00207713-52-2-485; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Bonete MJ, 2003, FEMS MICROBIOL LETT, V226, P181, DOI 10.1016/S0378-1097(03)00592-5; Britton KL, 2006, P NATL ACAD SCI USA, V103, P4846, DOI 10.1073/pnas.0508854103; Collins KD, 1997, BIOPHYS J, V72, P65, DOI 10.1016/S0006-3495(97)78647-8; Coquelle N, 2010, J MOL BIOL, V404, P493, DOI 10.1016/j.jmb.2010.09.055; Elcock AH, 1998, J MOL BIOL, V280, P731, DOI 10.1006/jmbi.1998.1904; Engel MB, 2005, CELL BIOL INT, V29, P616, DOI 10.1016/j.cellbi.2005.03.024; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; Frolow F, 1996, NAT STRUCT BIOL, V3, P452, DOI 10.1038/nsb0596-452; Fukuchi S, 2003, J MOL BIOL, V327, P347, DOI 10.1016/S0022-2836(03)00150-5; GALINSKI EA, 1982, FEMS MICROBIOL LETT, V13, P357, DOI 10.1016/0378-1097(82)90191-4; IMHOFF JF, 1977, ARCH MICROBIOL, V114, P115, DOI 10.1007/BF00410772; Jackson RB, 2001, ECOL APPL, V11, P1027, DOI 10.1890/1051-0761(2001)011[1027:WIACW]2.0.CO;2; Kennedy SP, 2001, GENOME RES, V11, P1641, DOI 10.1101/gr.190201; Kramer RM, 2012, BIOPHYS J, V102, P1907, DOI 10.1016/j.bpj.2012.01.060; LANYI JK, 1974, BACTERIOL REV, V38, P272, DOI 10.1128/MMBR.38.3.272-290.1974; Lim WK, 2009, P NATL ACAD SCI USA, V106, P2595, DOI 10.1073/pnas.0812588106; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Lukes J, 2011, IUBMB LIFE, V63, P528, DOI 10.1002/iub.489; Madern D, 2004, BIOCHIMIE, V86, P295, DOI 10.1016/j.biochi.2004.04.004; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Mavromatis K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004192; McGenity TJ, 2000, ENVIRON MICROBIOL, V2, P243, DOI 10.1046/j.1462-2920.2000.00105.x; Mevarech M, 2000, BIOPHYS CHEM, V86, P155, DOI 10.1016/S0301-4622(00)00126-5; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Oren A, 2002, EXTREMOPHILES, V6, P491, DOI 10.1007/s00792-002-0286-3; Oren A, 1999, MICROBIOL MOL BIOL R, V63, P334, DOI 10.1128/MMBR.63.2.334-348.1999; Oren A, 1997, CAN J MICROBIOL, V43, P588, DOI 10.1139/m97-083; Ortega G, 2011, SCI REP-UK, V1, DOI 10.1038/srep00006; RAYMOND JC, 1969, ARCH MIKROBIOL, V69, P121, DOI 10.1007/BF00409756; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Strahl H, 2008, EXTREMOPHILES, V12, P741, DOI 10.1007/s00792-008-0177-3; Tadeo X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000257; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Trevino SR, 2007, J MOL BIOL, V366, P449, DOI 10.1016/j.jmb.2006.10.026; Ventosa A, 1998, MICROBIOL MOL BIOL R, V62, P504, DOI 10.1128/MMBR.62.2.504-544.1998; Winter JA, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-55; ZIMMERMANN U, 1973, BIOCHIM BIOPHYS ACTA, V311, P442, DOI 10.1016/0005-2736(73)90324-6	40	45	47	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					581	588		10.1074/jbc.M112.420505	http://dx.doi.org/10.1074/jbc.M112.420505			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23144460	Green Published, hybrid			2022-12-28	WOS:000313197200058
J	Shi, ZC; Cai, ZY; Yu, JC; Zhang, TT; Zhao, S; Smeds, E; Zhang, QY; Wang, F; Zhao, CH; Fu, SB; Ghosh, S; Zhang, DK				Shi, Zhongcheng; Cai, Zhenyu; Yu, Jingcui; Zhang, Tingting; Zhao, Shu; Smeds, Emanuel; Zhang, Qingyuan; Wang, Fen; Zhao, Changhong; Fu, Songbin; Ghosh, Sankar; Zhang, Dekai			Toll-like Receptor 11 (TLR11) Prevents Salmonella Penetration into the Murine Peyer Patches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-INFECTIONS; EPITHELIAL-CELLS; INNATE IMMUNITY; III SECRETION; MOUSE MODEL; RECOGNITION; TYPHIMURIUM; HOMEOSTASIS; COMPONENTS; DEFENSE	Toll-like receptors (TLRs) are key molecular sensors used by the mammalian innate immune system to detect microorganisms. Although TLR functions in colonic immune homeostasis and tolerance to commensal bacteria have been intensively researched, the precise roles of different TLRs in response to pathogen infection in the gut remain elusive. Peyer patches are the major entrance of Salmonella infection and antigen transportation in intestine. Here, we report that, in contrast to TLR5 as a "carrier of Salmonella," TLR11 works as a "blocker of Salmonella" to prevent highly invasive Salmonella from penetrating into the murine Peyer patches and spreading systemically. TLR11 plays an important role in mediating TNF-alpha induction and systemic inflammation in response to Salmonella infection. Remarkably, in mice lacking TLR11, apparent hemorrhages at Peyer patches are induced by highly invasive Salmonella, a phenotype resembling human Salmonella infection. Therefore, our results indicate a potentially important role for TLR11 in preventing murine intestinal infection and modulating antigen transportation in the gut and imply an important role for various TLRs in cooperation with tight control of pathogens penetrating into Peyer patches. The TLR11 knock-out mouse can serve as a good animal model to study Salmonella infection.	[Shi, Zhongcheng; Cai, Zhenyu; Zhang, Tingting; Zhao, Shu; Smeds, Emanuel; Zhang, Dekai] Texas A&M Univ, Hlth Sci Ctr, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA; [Wang, Fen] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA; [Zhao, Shu; Zhang, Qingyuan; Zhao, Changhong] Harbin Med Univ, Affiliated Hosp 3, Dept Med Oncol, Harbin 150081, Peoples R China; [Shi, Zhongcheng; Yu, Jingcui; Fu, Songbin] Harbin Med Univ, Med Genet Lab, Harbin 150081, Peoples R China; [Ghosh, Sankar] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Harbin Medical University; Harbin Medical University; Columbia University	Zhang, DK (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA.	dzhang@ibt.tamhsc.edu			National Institutes of Health [1R56AI085164]; Texas A&M University Health Science Center; NATIONAL CANCER INSTITUTE [P50CA140388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas A&M University Health Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R56AI085164. This work was also supported by the Texas A&M University Health Science Center.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Chabot S, 2006, J IMMUNOL, V176, P4275, DOI 10.4049/jimmunol.176.7.4275; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; Eckmann L, 2006, CURR OPIN GASTROEN, V22, P95, DOI 10.1097/01.mog.0000208458.38772.2a; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Gerold G, 2007, SEMIN IMMUNOL, V19, P41, DOI 10.1016/j.smim.2006.12.003; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tukel C, 2005, MOL MICROBIOL, V58, P289, DOI 10.1111/j.1365-2958.2005.04825.x; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhao L, 2001, MICROBIOL IMMUNOL, V45, P149, DOI 10.1111/j.1348-0421.2001.tb01283.x	30	16	18	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43417	43423		10.1074/jbc.M112.411009	http://dx.doi.org/10.1074/jbc.M112.411009			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23135279	Green Published, hybrid			2022-12-28	WOS:000312940800023
J	Fernhoff, NB; Derbyshire, ER; Underbakke, ES; Marletta, MA				Fernhoff, Nathaniel B.; Derbyshire, Emily R.; Underbakke, Eric S.; Marletta, Michael A.			Heme-assisted S-Nitrosation Desensitizes Ferric Soluble Guanylate Cyclase to Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-BASIS; L-ARGININE; NO; ACTIVATION; MECHANISM; OXIDATION; BINDING; HYPERTENSION; INHIBITION; REACTIVITY	Nitric oxide (NO) signaling regulates key processes in cardiovascular physiology, specifically vasodilation, platelet aggregation, and leukocyte rolling. Soluble guanylate cyclase (sGC), the mammalian NO sensor, transduces an NO signal into the classical second messenger cyclic GMP (cGMP). NO binds to the ferrous (Fe2+) oxidation state of the sGC heme cofactor and stimulates formation of cGMP several hundred-fold. Oxidation of the sGC heme to the ferric (Fe3+) state desensitizes the enzyme to NO. The heme-oxidized state of sGC has emerged as a potential therapeutic target in the treatment of cardiovascular disease. Here, we investigate the molecular mechanism of NO desensitization and find that sGC undergoes a reductive nitrosylation reaction that is coupled to the S-nitrosation of sGC cysteines. We further characterize the kinetics of NO desensitization and find that heme-assisted nitrosothiol formation of beta 1Cys-78 and beta 1Cys-122 causes the NO desensitization of ferric sGC. Finally, we provide evidence that the mechanism of reductive nitrosylation is gated by a conformational change of the protein. These results yield insights into the function and dysfunction of sGC in cardiovascular disease.	[Marletta, Michael A.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Fernhoff, Nathaniel B.; Derbyshire, Emily R.; Marletta, Michael A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Underbakke, Eric S.; Marletta, Michael A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Scripps Research Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Marletta, MA (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	marletta@scripps.edu		Underbakke, Eric/0000-0003-4269-7339	National Institutes of Health [GM077365]; Bayer Healthcare (Wuppertal, Germany); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698, R01GM077365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bayer Healthcare (Wuppertal, Germany)(Bayer AGBayer Healthcare Pharmaceuticals); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077365. This work was also supported by Bayer Healthcare (Wuppertal, Germany).	Basu S, 2010, FREE RADICAL BIO MED, V48, P255, DOI 10.1016/j.freeradbiomed.2009.10.049; Boerrigter G, 2007, HYPERTENSION, V49, P1128, DOI 10.1161/HYPERTENSIONAHA.106.083832; BRANDWEIN HJ, 1981, J BIOL CHEM, V256, P2958; BRAUGHLER JM, 1983, BIOCHEM PHARMACOL, V32, P811, DOI 10.1016/0006-2952(83)90581-6; BULT H, 1990, NATURE, V345, P346, DOI 10.1038/345346a0; Cary SPL, 2005, P NATL ACAD SCI USA, V102, P13064, DOI 10.1073/pnas.0506289102; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Derbyshire ER, 2008, BIOCHEMISTRY-US, V47, P3892, DOI 10.1021/bi7022943; Derbyshire ER, 2007, J BIOL CHEM, V282, P35741, DOI 10.1074/jbc.M705557200; Derbyshire ER, 2011, BIOCHEMISTRY-US, V50, P4281, DOI 10.1021/bi200341b; Derbyshire ER, 2010, J BIOL CHEM, V285, P17471, DOI 10.1074/jbc.M109.098269; Derbyshire ER, 2009, BIOCHEMISTRY-US, V48, P7519, DOI 10.1021/bi900696x; Derbyshire ER, 2005, BIOCHEMISTRY-US, V44, P16257, DOI 10.1021/bi0515671; Erbil WK, 2009, P NATL ACAD SCI USA, V106, P19753, DOI 10.1073/pnas.0911645106; Fernhoff NB, 2009, P NATL ACAD SCI USA, V106, P21602, DOI 10.1073/pnas.0911083106; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; Gibb BJ, 2003, BRIT J PHARMACOL, V139, P1032, DOI 10.1038/sj.bjp.0705318; Harrison DG, 1997, CLIN CARDIOL, V20, P11; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; Hoshino M, 1999, COORDIN CHEM REV, V187, P75, DOI 10.1016/S0010-8545(98)00228-8; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Karow DS, 2005, BIOCHEMISTRY-US, V44, P16266, DOI 10.1021/bi051601b; Keilin D., 1937, NATURE, V139, P548; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; Kojda G, 1999, CARDIOVASC RES, V43, P562, DOI 10.1016/S0008-6363(99)00169-8; Lapp H, 2009, CIRCULATION, V119, P2781, DOI 10.1161/CIRCULATIONAHA.108.800292; Luchsinger BP, 2003, P NATL ACAD SCI USA, V100, P461, DOI 10.1073/pnas.0233287100; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; Maron BA, 2009, J BIOL CHEM, V284, P7665, DOI 10.1074/jbc.M809460200; Miersch S, 2005, CLIN BIOCHEM, V38, P777, DOI 10.1016/j.clinbiochem.2005.05.014; Mitchell DA, 2007, P NATL ACAD SCI USA, V104, P11609, DOI 10.1073/pnas.0704898104; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Priestley Joseph, 1775, EXPT OBSERVATIONS DI, V2nd; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Ruetten H, 1999, CIRC RES, V85, P534, DOI 10.1161/01.RES.85.6.534; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; SANCIER KM, 1962, SCIENCE, V137, P752, DOI 10.1126/science.137.3532.752; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Schrammel A, 1996, MOL PHARMACOL, V50, P1; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; STONE JR, 1995, BIOCHEM BIOPH RES CO, V207, P572, DOI 10.1006/bbrc.1995.1226; Stone JR, 1996, BIOCHEMISTRY-US, V35, P1093, DOI 10.1021/bi9519718; Tschudi MR, 1996, HYPERTENSION, V27, P32, DOI 10.1161/01.HYP.27.1.32; Weichsel A, 2005, P NATL ACAD SCI USA, V102, P594, DOI 10.1073/pnas.0406549102; Winger JA, 2007, J BIOL CHEM, V282, P897, DOI 10.1074/jbc.M606327200; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753; Zhao YD, 2000, BIOCHEMISTRY-US, V39, P10848, DOI 10.1021/bi9929296	54	44	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43053	43062		10.1074/jbc.M112.393892	http://dx.doi.org/10.1074/jbc.M112.393892			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23093402	hybrid, Green Published			2022-12-28	WOS:000312501600061
J	Nelson, AD; Hoffmann, MM; Parks, CA; Dasari, S; Schrum, AG; Gil, D				Nelson, Alfreda D.; Hoffmann, Michele M.; Parks, Christopher A.; Dasari, Surendra; Schrum, Adam G.; Gil, Diana			IgG Fab Fragments Forming Bivalent Complexes by a Conformational Mechanism That Is Reversible by Osmolytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-RECEPTOR ENGAGEMENT; RABBIT GAMMA-GLOBULIN; TUMOR-NECROSIS-FACTOR; PROTEIN AGGREGATION; IN-VIVO; ANTIGEN RECOGNITION; CERTOLIZUMAB PEGOL; ANTIBODY STRUCTURE; T-LYMPHOCYTES; FACTOR-ALPHA	Generated by proteolytic cleavage of immunoglobulin, Fab fragments possess great promise as blocking reagents, able to bind receptors or other targets without inducing cross-linking. However, aggregation of Fab preparations is a common occurrence, which generates intrinsic stimulatory capacity and thwarts signal blockade strategies. Using a panel of biochemical approaches, including size exclusion chromatography, SDS-PAGE, mass spectrometry, and cell stimulation followed by flow cytometry, we have measured the oligomerization and acquisition of stimulatory capacity that occurs in four monoclonal IgG Fabs specific for TCR/CD3. Unexpectedly, we observed that all Fabs spontaneously formed complexes that were precisely bivalent, and these bivalent complexes possessed most of the stimulatory activity of each Fab preparation. Fabs composing bivalent complexes were more susceptible to proteolysis than monovalent Fabs, indicating a difference in conformation between the Fabs involved in these two different states of valency. Because osmolytes represent a class of compounds that stabilize protein folding and conformation, we sought to determine the extent to which the amino acid osmolyte L-proline might impact bivalent Fab complexation. We found that L-proline (i) inhibited the adoption of the conformation associated with bivalent complexation, (ii) preserved Fab monovalency, (iii) reversed the conformation of preformed bivalent Fabs to that of monovalent Fabs, and (iv) separated a significant percentage of preformed bivalent complexes into monovalent species. Thus, Fab fragments can adopt a conformation that is compatible with folding or packing of a bivalent complex in a process that can be inhibited by osmolytes.	[Nelson, Alfreda D.; Hoffmann, Michele M.; Parks, Christopher A.; Schrum, Adam G.; Gil, Diana] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Nelson, Alfreda D.; Hoffmann, Michele M.] Mayo Clin, Coll Med, Initiat Maximize Student Divers, Rochester, MN 55905 USA; [Parks, Christopher A.] Mayo Clin, Coll Med, Summer Undergrad Res Fellowship Program, Rochester, MN 55905 USA; [Dasari, Surendra] Mayo Clin, Coll Med, Div Biomed Stat & Informat, Ctr Individualized Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Gil, D (corresponding author), Mayo Clin, Coll Med, Dept Immunol, 200 1st St SW,321 Guggenheim Bldg, Rochester, MN 55905 USA.	gilpages.diana@mayo.edu		Parks, Christopher/0000-0002-2772-2965; Schrum, Adam/0000-0001-9276-1859	National Institutes of Health [1R56AI097187-01]; Mayo Foundation; Mayo Clinic Summer Undergraduate Research Fellowship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI097187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474, R25GM055252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Mayo Clinic Summer Undergraduate Research Fellowship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R56AI097187-01 (to D. G. and A. G. S.). This work was also supported by the Mayo Foundation (to D. G. and A. G. S.) and the Mayo Clinic Summer Undergraduate Research Fellowship Program (to C. A. P.).	Anderson DE, 2000, NAT MED, V6, P211, DOI 10.1038/72323; Andrew S M, 2001, Curr Protoc Immunol, VChapter 2, DOI [10.1002/0471142735.im0208s21, 10.1002/0471142735.im0209s21, 10.1002/0471142735.im0207s21]; Arakawa T, 2007, AMINO ACIDS, V33, P587, DOI 10.1007/s00726-007-0506-3; AUGENER W, 1970, J IMMUNOL, V105, P1024; Baden EM, 2009, CURR PROTEIN PEPT SC, V10, P500, DOI 10.2174/138920309789351949; Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819; Bolen DW, 2004, METHODS, V34, P312, DOI 10.1016/j.ymeth.2004.03.022; BUCHNER J, 1991, BIO-TECHNOL, V9, P157, DOI 10.1038/nbt0291-157; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P6922, DOI 10.1021/bi00242a016; Chapman AP, 1999, NAT BIOTECHNOL, V17, P780, DOI 10.1038/11717; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; CYSTER JG, 1992, EUR J IMMUNOL, V22, P2565, DOI 10.1002/eji.1830221015; DAMLE NK, 1988, J IMMUNOL, V140, P1753; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Fekade D, 1996, NEW ENGL J MED, V335, P311, DOI 10.1056/NEJM199608013350503; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Gil D, 2005, J EXP MED, V201, P517, DOI 10.1084/jem.20042036; Gil D, 2008, J IMMUNOL, V180, P3900, DOI 10.4049/jimmunol.180.6.3900; Hamidi M, 2006, DRUG DELIV, V13, P399, DOI 10.1080/10717540600814402; Horton S, 2012, EXPERT OPIN BIOL TH, V12, P235, DOI 10.1517/14712598.2012.645533; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Kashanian S, 2008, HYBRIDOMA, V27, P99, DOI 10.1089/hyb.2007.0554; Kashanian S, 2008, HYBRIDOMA, V27, P48, DOI 10.1089/hyb.2007.0547; KAYE J, 1984, J EXP MED, V159, P1397, DOI 10.1084/jem.159.5.1397; KAYE J, 1992, J IMMUNOL, V148, P3342; Keane PA, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/483034; KEARNEY ER, 1995, J IMMUNOL, V155, P1032; KIEFHABER T, 1991, BIO-TECHNOL, V9, P825, DOI 10.1038/nbt0991-825; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Looareesuwan S, 1999, AM J TROP MED HYG, V61, P26, DOI 10.4269/ajtmh.1999.61.26; Makowski L, 2008, J MOL BIOL, V375, P529, DOI 10.1016/j.jmb.2007.07.075; Marshall H, 2012, ACTA CRYSTALLOGR D, V68, P69, DOI 10.1107/S0907444911050360; Meng FG, 2001, INT J BIOCHEM CELL B, V33, P701, DOI 10.1016/S1357-2725(01)00048-6; Miao HQ, 2006, BIOCHEM BIOPH RES CO, V345, P438, DOI 10.1016/j.bbrc.2006.04.119; Narciso JET, 2011, NEW BIOTECHNOL, V28, P435, DOI 10.1016/j.nbt.2011.03.012; Paul S, 2006, IMMUNOL LETT, V103, P8, DOI 10.1016/j.imlet.2005.10.003; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; PORTER RR, 1958, NATURE, V182, P670, DOI 10.1038/182670a0; POTTER TA, 1989, NATURE, V337, P73, DOI 10.1038/337073a0; Risueno RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001747; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Samuel D, 2000, PROTEIN SCI, V9, P344; Sandborn WJ, 2003, BEST PRACT RES CL GA, V17, P105, DOI 10.1053/bega.2002.0345; Sapparapu G, 2009, J BIOL CHEM, V284, P24622, DOI 10.1074/jbc.M109.011858; SCHODIN BA, 1993, J BIOL CHEM, V268, P25722; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Sharma V, 2009, J BIOL CHEM, V284, P33079, DOI 10.1074/jbc.M109.036087; Smith LS, 2010, ANN PHARMACOTHER, V44, P333, DOI 10.1345/aph.1M314; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Vanhove B, 2003, BLOOD, V102, P564, DOI 10.1182/blood-2002-08-2480; Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004; WALDMANN TA, 1969, PROG ALLERGY, V13, P1, DOI 10.1159/000287491; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727; Wang XL, 2010, PHARM RES-DORDR, V27, P1512, DOI 10.1007/s11095-010-0143-5; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	59	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42936	42950		10.1074/jbc.M112.410217	http://dx.doi.org/10.1074/jbc.M112.410217			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23109335	Green Published, hybrid			2022-12-28	WOS:000312501600051
J	Sakane, A; Abdallah, AAM; Nakano, K; Honda, K; Ikeda, W; Nishikawa, Y; Matsumoto, M; Matsushita, N; Kitamura, T; Sasaki, T				Sakane, Ayuko; Abdallah, Ahmed Alamir Mahmoud; Nakano, Kiyoshi; Honda, Kazufumi; Ikeda, Wataru; Nishikawa, Yumiko; Matsumoto, Mitsuru; Matsushita, Natsuki; Kitamura, Toshio; Sasaki, Takuya			Rab13 Small G Protein and Junctional Rab13-binding Protein (JRAB) Orchestrate Actin Cytoskeletal Organization during Epithelial Junctional Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL TIGHT JUNCTIONS; CELL-CELL JUNCTIONS; MYOSIN-II MOTOR; APICAL JUNCTIONS; RHO-GTPASES; JRAB/MICAL-L2; ADHESION; POLYMERIZATION; MORPHOGENESIS; EFFICIENT	During epithelial junctional development, both vesicle transport and reorganization of the actin cytoskeleton must be spatiotemporally regulated. Coordination of these cellular functions is especially important, but the precise mechanism remains elusive. Previously, we identified junctional Rab13-binding protein (JRAB)/molecules interacting with CasL-like 2 (MICAL-L2) as an effector of the Rab13 small G protein, and we found that the Rab13-JRAB system may be involved in the formation of cell-cell adhesions via transport of adhesion molecules. Here, we showed that JRAB interacts with two actin-binding proteins, actinin-1 and -4, and filamentous actin via different domains and regulates actin cross-linking and stabilization through these interactions. During epithelial junctional development, JRAB is prominently enriched in the actin bundle at the free border; subsequently, JRAB undergoes a Rab13-dependent conformational change that is required for maturation of cell-cell adhesion sites. These results suggest that Rab13 and JRAB regulate reorganization of the actin cytoskeleton throughout epithelial junctional development from establishment to maturation of cell-cell adhesion.	[Sakane, Ayuko; Abdallah, Ahmed Alamir Mahmoud; Nakano, Kiyoshi; Sasaki, Takuya] Univ Tokushima, Grad Sch, Dept Biochem, Inst Hlth Biosci, Tokushima 7708503, Japan; [Nakano, Kiyoshi] Univ Tokushima, Fac Med, Student Lab, Tokushima 7708503, Japan; [Honda, Kazufumi] Natl Canc Ctr, Res Inst, Div Chemotherapy & Clin Res, Tokyo 1040045, Japan; [Ikeda, Wataru] KAN Res Inst Inc, Kobe, Hyogo 6500047, Japan; [Nishikawa, Yumiko; Matsumoto, Mitsuru] Univ Tokushima, Inst Enzyme Res, Div Mol Immunol, Tokushima 7708503, Japan; [Matsushita, Natsuki] Ehime Univ, Funct Genom Core Lab, Proteomed Res Ctr, Ehime 7910295, Japan; [Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Dept Hematopoiet Factor, Tokyo 1088639, Japan	Tokushima University; Tokushima University; National Cancer Center - Japan; KAN Research Institute; Tokushima University; Ehime University; University of Tokyo	Sasaki, T (corresponding author), Univ Tokushima, Grad Sch, Dept Biochem, Inst Hlth Biosci, Tokushima 7708503, Japan.	sasaki@basic.med.tokushima-u.ac.jp	Abdallah, Ahmed Alamir Mahmoud/ABG-4989-2021; Kitamura, Toshio/AAA-2071-2021; Ikeda, Wataru/V-8531-2019	Ikeda, Wataru/0000-0002-6907-9058	Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas 2008-2012 from the Ministry of Education, Culture, Sports, Science and Technology (to T. S.), Grant-in-aid for Scientific Research 2009-2012 (to T. S.), and Grant-in-aid for Young Scientists 2008-2012 from the Japan Society for the Promotion of Science (to A. S.).	Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gov N, 2011, NAT MATER, V10, P412, DOI 10.1038/nmat3036; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Ivanov AI, 2004, MOL BIOL CELL, V15, P2639, DOI 10.1091/mbc.E04-02-0163; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; James P, 1996, GENETICS, V144, P1425; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Krendel MF, 1999, CELL MOTIL CYTOSKEL, V43, P296, DOI 10.1002/(SICI)1097-0169(1999)43:4<296::AID-CM3>3.0.CO;2-U; Marzesco AM, 2002, MOL BIOL CELL, V13, P1819, DOI 10.1091/mbc.02-02-0029; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakatsuji H, 2008, MOL CELL BIOL, V28, P3324, DOI 10.1128/MCB.00144-08; Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513; Nishimura N, 2009, FRONT BIOSCI-LANDMRK, V14, P2115, DOI 10.2741/3366; Oikonomou KG, 2011, AUTOIMMUN REV, V10, P389, DOI 10.1016/j.autrev.2010.12.009; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Rahajeng Juliati, 2010, World J Biol Chem, V1, P254, DOI 10.4331/wjbc.v1.i8.254; Sakane A, 2010, MOL CELL BIOL, V30, P1077, DOI 10.1128/MCB.01067-09; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Terai T, 2006, MOL BIOL CELL, V17, P2465, DOI 10.1091/mbc.E05-09-0826; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita Shoichiro, 1992, Current Opinion in Cell Biology, V4, P834, DOI 10.1016/0955-0674(92)90108-O; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Yamamura R, 2008, MOL BIOL CELL, V19, P971, DOI 10.1091/mbc.E07-06-0551; YONEMURA S, 1995, J CELL SCI, V108, P127; ZAHRAOUI A, 1994, J CELL BIOL, V124, P101, DOI 10.1083/jcb.124.1.101; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang JK, 2005, J CELL SCI, V118, P5549, DOI 10.1242/jcs.02639	39	34	36	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42455	42468		10.1074/jbc.M112.383653	http://dx.doi.org/10.1074/jbc.M112.383653			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23100251	Green Published, hybrid			2022-12-28	WOS:000312501600008
J	Vollers, SS; Carruthers, A				Vollers, Sabrina S.; Carruthers, Anthony			Sequence Determinants of GLUT1-mediated Accelerated-exchange Transport ANALYSIS BY HOMOLOGY-SCANNING MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUT1 GLUCOSE-TRANSPORTER; SUBSTITUTED CYSTEINE ACCESSIBILITY; SELECTIVE BIOLOGICAL TRANSPORT; MAJOR FACILITATOR SUPERFAMILY; ERYTHROCYTE SUGAR-TRANSPORT; CYTOCHALASIN-B; 3-ORTHO-METHYL-D-GLUCOSE TRANSPORT; 3-O-METHYLGLUCOSE TRANSPORT; 2-DEOXYGLUCOSE TRANSPORT; OLIGOMERIC STRUCTURE	The class 1 equilibrative glucose transporters GLUT1 and GLUT4 are structurally similar but catalyze distinct modes of transport. GLUT1 exhibits trans-acceleration, in which the presence of intracellular sugar stimulates the rate of unidirectional sugar uptake. GLUT4-mediated uptake is unaffected by intracellular sugar. Using homology-scanning mutagenesis in which domains of GLUT1 are substituted with equivalent domains from GLUT4 and vice versa, we show that GLUT1 transmembrane domain 6 is both necessary and sufficient for trans-acceleration. This region is not directly involved in GLUT1 binding of substrate or inhibitors. Rather, transmembrane domain 6 is part of two putative scaffold domains, which coordinate membrane-spanning amphipathic helices that form the sugar translocation pore. We propose that GLUT1 transmembrane domain 6 restrains import when intracellular sugar is absent by slowing transport-associated conformational changes.	[Vollers, Sabrina S.; Carruthers, Anthony] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Carruthers, A (corresponding author), 364 Plantat St,LRB Room 926, Worcester, MA 01605 USA.	anthony.carruthers@umassmed.edu		Vollers, Sabrina/0000-0002-6772-0155	National Institutes of Health [DK 36081, DK 44888]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK036081, R01DK036081, R01DK044888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 36081 and DK 44888.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Al-Hasani H, 2002, J CELL SCI, V115, P131; BACHELARD HS, 1972, BIOCHEM J, V127, pP83; BAKER GF, 1973, J PHYSIOL-LONDON, V231, P143, DOI 10.1113/jphysiol.1973.sp010225; BAKER GF, 1979, BIOCHIM BIOPHYS ACTA, V550, P474, DOI 10.1016/0005-2736(79)90150-0; BAKER PF, 1981, J PHYSIOL-LONDON, V316, P503, DOI 10.1113/jphysiol.1981.sp013803; BALDWIN SA, 1979, BIOCHIM BIOPHYS ACTA, V552, P183, DOI 10.1016/0005-2736(79)90257-8; Bissonnette P, 1996, AM J PHYSIOL-GASTR L, V270, pG153, DOI 10.1152/ajpgi.1996.270.1.G153; Blodgett DM, 2007, J GEN PHYSIOL, V130, P157, DOI 10.1085/jgp.200709818; CARRUTHERS A, 1989, BIOCHEMISTRY-US, V28, P8337, DOI 10.1021/bi00447a011; Cloherty EK, 2001, BIOCHEMISTRY-US, V40, P15549, DOI 10.1021/bi015586w; Cloherty EK, 1996, BIOCHEMISTRY-US, V35, P10411, DOI 10.1021/bi953077m; CORVERA S, 1994, J CELL BIOL, V126, P979, DOI 10.1083/jcb.126.4.979; CRAIK JD, 1979, BIOCHEM J, V182, P503, DOI 10.1042/bj1820503; Craik JD, 1998, AM J PHYSIOL-REG I, V274, pR112, DOI 10.1152/ajpregu.1998.274.1.R112; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; Cura AJ, 2010, J BIOL CHEM, V285, P15430, DOI 10.1074/jbc.M110.110593; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; GORGA FR, 1982, BIOCHEMISTRY-US, V21, P1905, DOI 10.1021/bi00537a031; HANSEN P, 1995, AM J PHYSIOL-CELL PH, V268, pC30, DOI 10.1152/ajpcell.1995.268.1.C30; HARIK SI, 1990, J NEUROSCI, V10, P3862, DOI 10.1523/JNEUROSCI.10-12-03862.1990; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; HELGERSON AL, 1989, BIOCHEMISTRY-US, V28, P6410, DOI 10.1021/bi00441a038; HELGERSON AL, 1989, BIOCHEMISTRY-US, V28, P4580, DOI 10.1021/bi00437a012; HELLWIG B, 1991, MOL PHARMACOL, V40, P383; Holyoake J, 2006, BIOPHYS J, V91, pL84, DOI 10.1529/biophysj.106.093971; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JAY TM, 1990, J NEUROCHEM, V55, P989, DOI 10.1111/j.1471-4159.1990.tb04588.x; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; KRUPKA RM, 1981, J BIOL CHEM, V256, P5410; Lemieux MJ, 2007, MOL MEMBR BIOL, V24, P333, DOI 10.1080/09687680701496507; Levine KB, 2005, BIOCHEMISTRY-US, V44, P5606, DOI 10.1021/bi0477541; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; LIEB WR, 1974, BIOCHIM BIOPHYS ACTA, V373, P178, DOI 10.1016/0005-2736(74)90144-8; LIEB WR, 1974, BIOCHIM BIOPHYS ACTA, V373, P165, DOI 10.1016/0005-2736(74)90143-6; Liu Q, 2001, BIOCHEMISTRY-US, V40, P7874, DOI 10.1021/bi002850x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maher F, 1996, BIOCHEM J, V315, P827, DOI 10.1042/bj3150827; Mann GE, 2003, PHYSIOL REV, V83, P183, DOI 10.1152/physrev.00022.2002; MILLER DM, 1968, BIOPHYS J, V8, P1339, DOI 10.1016/S0006-3495(68)86560-9; MILLER DM, 1968, BIOPHYS J, V8, P1329, DOI 10.1016/S0006-3495(68)86559-2; Mueckler M, 2002, J BIOL CHEM, V277, P3498, DOI 10.1074/jbc.M109157200; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2005, J BIOL CHEM, V280, P39562, DOI 10.1074/jbc.M509050200; Mueckler M, 2008, J BIOL CHEM, V283, P11550, DOI 10.1074/jbc.M708896200; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; Naftalin RJ, 2008, BIOPHYS J, V95, P4300, DOI 10.1529/biophysj.108.136366; NAFTALIN RJ, 1988, BIOCHIM BIOPHYS ACTA, V946, P431, DOI 10.1016/0005-2736(88)90420-8; NAFTALIN RJ, 1991, BIOCHIM BIOPHYS ACTA, V1064, P37, DOI 10.1016/0005-2736(91)90409-2; NAFTALIN RJ, 1977, MEMBRANE TRANSPORT R, P257; NISHIMURA H, 1993, J BIOL CHEM, V268, P8514; PIPER RC, 1993, J CELL BIOL, V121, P1221, DOI 10.1083/jcb.121.6.1221; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; Seatter MJ, 1998, BIOCHEMISTRY-US, V37, P1322, DOI 10.1021/bi972322u; SOGIN DC, 1980, BIOCHEMISTRY-US, V19, P5417, DOI 10.1021/bi00564a041; Stein W., 2012, TRANSPORT DIFFUSION; TAYLOR LP, 1981, BIOCHIM BIOPHYS ACTA, V642, P325, DOI 10.1016/0005-2736(81)90449-1; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; TOYODA N, 1987, J BIOL CHEM, V262, P2737; VERHEY KJ, 1994, J BIOL CHEM, V269, P2353; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	65	16	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42533	42544		10.1074/jbc.M112.369587	http://dx.doi.org/10.1074/jbc.M112.369587			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23093404	Green Published, hybrid			2022-12-28	WOS:000312501600015
J	Arat, NO; Griffith, JD				Arat, N. Oezlem; Griffith, Jack D.			Human Rap1 Interacts Directly with Telomeric DNA and Regulates TRF2 Localization at the Telomere	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR BRCA1; MAMMALIAN TELOMERE; HOLLIDAY JUNCTIONS; REPLICATION FORK; STRAND BREAKS; BINDING; END; PROTECTION; COMPLEX; PROTEINS	The TRF2-Rap1 complex suppresses non-homologous end joining and interacts with DNAPK-C to prevent end joining. We previously demonstrated that hTRF2 is a double strand telomere binding protein that forms t-loops in vitro and recognizes three- and four-way junctions independent of DNA sequence. How the DNA binding characteristics of hTRF2 to DNA is altered in the presence of hRap1 however is not known. Here we utilized EM and quantitative gel retardation to characterize the DNA binding properties of hRap1 and the TRF2-Rap1 complex. Both gel filtration chromatography and mass analysis from two-dimensional projections showed that the TRF2-Rap1 complex exists in solution and binds to DNA as a complex consisting of four monomers each of hRap1 and hTRF2. EM revealed for the first time that hRap1 binds to DNA templates in the absence of hTRF2 with a preference for double strand-single strand junctions in a sequence independent manner. When hTRF2 and hRap1 are in a complex, its affinity for ds telomeric sequences is 2-fold higher than TRF2 alone and more than 10-fold higher for telomeric 3' ends. This suggests that as hTRF2 recruits hRap1 to telomeric sequences, hRap1 alters the affinity of hTRF2 and its binding preference on telomeric DNA. Moreover, the TRF2-Rap1 complex has higher ability to re-model telomeric DNA than either component alone. This finding underlies the importance of complex formation between hRap1 and hTRF2 for telomere function and end protection.	[Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem, Chapel Hill, NC 27599 USA; [Arat, N. Oezlem; Griffith, Jack D.] Univ N Carolina, Dept Biophys, Chapel Hill, NC 27599 USA; [Griffith, Jack D.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Griffith, JD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem, 450 W Dr, Chapel Hill, NC 27599 USA.	jdg@med.unc.edu			National Institutes of Health [GM31819, ES3773]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM31819 and ES3773 (to J. D. G.).	Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bombarde O, 2010, EMBO J, V29, P1573, DOI 10.1038/emboj.2010.49; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chen Y, 2011, NAT STRUCT MOL BIOL, V18, P213, DOI 10.1038/nsmb.1974; Chow TT, 2012, GENE DEV, V26, P1167, DOI 10.1101/gad.187211.112; Compton SA, 2010, J BIOL CHEM, V285, P13349, DOI 10.1074/jbc.M109.074286; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Fouche N, 2006, J BIOL CHEM, V281, P37486, DOI 10.1074/jbc.M608778200; GRIFFITH JD, 1995, J MOL BIOL, V246, P576, DOI 10.1016/S0022-2836(05)80107-X; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hanaoka S, 2005, PROTEIN SCI, V14, P119, DOI 10.1110/ps.04983705; Hanaoka S, 2001, J MOL BIOL, V312, P167, DOI 10.1006/jmbi.2001.4924; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kobayashi M, 2006, J BIOL CHEM, V281, P4308, DOI 10.1074/jbc.M511090200; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Lee SM, 1997, J BIOL CHEM, V272, P7532, DOI 10.1074/jbc.272.11.7532; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Li BB, 2003, MOL BIOL CELL, V14, P5060, DOI 10.1091/mbc.e03-06-0403; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; O'Connor MS, 2004, J BIOL CHEM, V279, P28585, DOI 10.1074/jbc.M312913200; Oganesian L, 2011, MOL CELL, V42, P224, DOI 10.1016/j.molcel.2011.03.015; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Sarthy J, 2009, EMBO J, V28, P3390, DOI 10.1038/emboj.2009.275; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Stansel RM, 2001, EMBO J, V20, P5532; Subramanian D, 2005, J BIOL CHEM, V280, P42568, DOI 10.1074/jbc.M506348200; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Tarsounas M, 2004, CELL, V117, P337, DOI 10.1016/S0092-8674(04)00337-X; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Xu L, 2007, MOL CELL, V28, P315, DOI 10.1016/j.molcel.2007.10.005; Yamane K, 1999, ONCOGENE, V18, P5194, DOI 10.1038/sj.onc.1202922; Yamane K, 2000, BIOCHEM BIOPH RES CO, V279, P678, DOI 10.1006/bbrc.2000.3983; Yang D, 2011, CELL RES, V21, P1013, DOI 10.1038/cr.2011.39; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	48	49	49	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41583	41594		10.1074/jbc.M112.415984	http://dx.doi.org/10.1074/jbc.M112.415984			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086976	Green Published, hybrid			2022-12-28	WOS:000312103000003
J	Cohen, SP; Buckley, BK; Kosloff, M; Garland, AL; Bosch, DE; Cheng, JG; Radhakrishna, H; Brown, MD; Willard, FS; Arshavsky, VY; Tarran, R; Siderovski, DP; Kimple, AJ				Cohen, Staci P.; Buckley, Brian K.; Kosloff, Mickey; Garland, Alaina L.; Bosch, Dustin E.; Cheng, JrGang; Radhakrishna, Harish; Brown, Michael D.; Willard, Francis S.; Arshavsky, Vadim Y.; Tarran, Robert; Siderovski, David P.; Kimple, Adam J.			Regulator of G-protein Signaling-21 (RGS21) Is an Inhibitor of Bitter Gustatory Signaling Found in Lingual and Airway Epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; HETEROTRIMERIC G-PROTEINS; G-ALPHA-INTERACTION; TASTE BUD CELLS; STRUCTURAL DETERMINANTS; HIGH-THROUGHPUT; RECEPTOR-CELLS; ACESULFAME-K; P115 RHOGEF; UMAMI TASTE	The gustatory system detects tastants and transmits signals to the brain regarding ingested substances and nutrients. Although tastant receptors and taste signaling pathways have been identified, little is known about their regulation. Because bitter, sweet, and umami taste receptors are G protein-coupled receptors (GPCRs), we hypothesized that regulators of G protein signaling (RGS) proteins may be involved. The recent cloning of RGS21 from taste bud cells has implicated this protein in the regulation of taste signaling; however, the exact role of RGS21 has not been precisely defined. Here, we sought to determine the role of RGS21 in tastant responsiveness. Biochemical analyses confirmed in silico predictions that RGS21 acts as a GTPase-accelerating protein (GAP) for multiple G protein alpha subunits, including adenylyl cyclase-inhibitory (G alpha(i)) subunits and those thought to be involved in tastant signal transduction. Using a combination of in situ hybridization, RT-PCR, immunohistochemistry, and immunofluorescence, we demonstrate that RGS21 is not only endogenously expressed in mouse taste buds but also in lung airway epithelial cells, which have previously been shown to express components of the taste signaling cascade. Furthermore, as shown by reverse transcription-PCR, the immortalized human airway cell line 16HBE was found to express transcripts for tastant receptors, RGS21, and down-stream taste signaling components. Over- and underexpression of RGS21 in 16HBE cells confirmed that RGS21 acts to oppose bitter tastant signaling to cAMP and calcium second messenger changes. Our data collectively suggests that RGS21 modulates bitter taste signal transduction.	[Cohen, Staci P.; Buckley, Brian K.; Bosch, Dustin E.; Willard, Francis S.; Siderovski, David P.; Kimple, Adam J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Garland, Alaina L.; Tarran, Robert] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Tarran, Robert] Univ N Carolina, CF Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Cheng, JrGang] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Kosloff, Mickey; Arshavsky, Vadim Y.] Duke Univ, Duke Eye Ctr, Med Ctr, Durham, NC 27710 USA; [Kosloff, Mickey] Univ Haifa, Dept Biol, Fac Nat Sci, IL-31905 Haifa, Israel; [Radhakrishna, Harish; Brown, Michael D.] Coca Cola Co, Dept Biosci, Atlanta, GA 30313 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of Haifa; The Coca-Cola Company	Siderovski, DP (corresponding author), Robert C Byrd Hlth Sci Ctr, 3051A Hlth Sci N,1 Med Ctr Dr, Morgantown, WV 26506 USA.	dpsiderovski@hsc.wvu.edu	Siderovski, David Peter/AAA-9603-2019; Kosloff, Mickey/B-5962-2008	Siderovski, David Peter/0000-0002-0688-8210; Kosloff, Mickey/0000-0003-1807-4000; Bosch, Dustin/0000-0002-7430-2939; Kimple, Adam/0000-0003-1670-8401	National Institutes of Health [R01 GM082892, R01 HL108927, R01 EY012859]; National Institutes of Health/NIDCD Ruth L. Kirschstein NRSA Fellowship [F32 DC011670]; NATIONAL EYE INSTITUTE [R01EY012859, P30EY005722] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK091978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC011670] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/NIDCD Ruth L. Kirschstein NRSA Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM082892 (to D. P. S.), R01 HL108927 (to R. T.), R01 EY012859 (to V. Y. A.), and National Institutes of Health/NIDCD Ruth L. Kirschstein NRSA Fellowship F32 DC011670 (to S. P. C.).	Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Arshavsky VY, 1998, NEURON, V20, P11, DOI 10.1016/S0896-6273(00)80430-4; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Behrens M, 2006, J BIOL CHEM, V281, P20650, DOI 10.1074/jbc.M513637200; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bosch D. E., 2012, CURR PROTOC PHARM, V56; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Fenech C, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.011.2009; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; He W, 2004, J NEUROSCI, V24, P7674, DOI 10.1523/JNEUROSCI.2441-04.2004; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Horne J, 2002, CHEM SENSES, V27, P31, DOI 10.1093/chemse/27.1.31; Hutsell SQ, 2010, METHODS MOL BIOL, V627, P75, DOI 10.1007/978-1-60761-670-2_4; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Johnston CA, 2006, BIOCHEMISTRY-US, V45, P11390, DOI 10.1021/bi0613832; Kimple AJ, 2008, COMB CHEM HIGH T SCR, V11, P396, DOI 10.2174/138620708784534770; Kimple AJ, 2007, BBA-PROTEINS PROTEOM, V1774, P1213, DOI 10.1016/j.bbapap.2007.06.002; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kimple AJ, 2010, METHODS MOL BIOL, V627, P91, DOI 10.1007/978-1-60761-670-2_5; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; Kinnamon SC, 2012, ACTA PHYSIOL, V204, P158, DOI 10.1111/j.1748-1716.2011.02308.x; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Kosloff M, 2011, NAT STRUCT MOL BIOL, V18, P846, DOI 10.1038/nsmb.2068; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Kusakabe Y, 2000, CHEM SENSES, V25, P525, DOI 10.1093/chemse/25.5.525; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Li X, 2005, ACTA BIOCHIM POL, V52, P943; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockhart IA, 2009, DEMENT GERIATR COGN, V28, P389, DOI 10.1159/000255578; Mall MA, 2010, J BIOL CHEM, V285, P26945, DOI 10.1074/jbc.M110.151803; Matsui Doreen, 2007, Paediatr Drugs, V9, P283; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Mennella JA, 2008, CLIN THER, V30, P2120, DOI 10.1016/j.clinthera.2008.11.018; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nishiyama M, 2011, ZOOL SCI, V28, P623, DOI 10.2108/zsj.28.623; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Renwick W, 2009, BIODRUGS, V23, P175, DOI 10.2165/00063030-200923030-00004; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Saito M, 1999, BIOL PHARM BULL, V22, P997; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shah PP, 2010, PHARM DEV TECHNOL, V15, P276, DOI 10.3109/10837450903188485; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Sobolev V, 2005, NUCLEIC ACIDS RES, V33, pW39, DOI 10.1093/nar/gki398; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Strachan RT, 2009, J BIOL CHEM, V284, P5557, DOI 10.1074/jbc.M805705200; Ueda T, 2003, J NEUROSCI, V23, P7376; von Buchholtz L, 2004, EUR J NEUROSCI, V19, P1535, DOI 10.1111/j.1460-9568.2004.03257.x; Willard FS, 2005, ANAL BIOCHEM, V340, P341, DOI 10.1016/j.ab.2005.02.015; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Worthington EN, 2011, METHODS MOL BIOL, V742, P77, DOI 10.1007/978-1-61779-120-8_5; Wu SV, 2005, PHYSIOL GENOMICS, V22, P139, DOI 10.1152/physiolgenomics.00030.2005; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; YAMANAKA G, 1985, BIOCHEMISTRY-US, V24, P8094, DOI 10.1021/bi00348a039; Yan WT, 2001, AM J PHYSIOL-CELL PH, V280, pC742, DOI 10.1152/ajpcell.2001.280.4.C742; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757	82	24	24	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41706	41719		10.1074/jbc.M112.423806	http://dx.doi.org/10.1074/jbc.M112.423806			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23095746	Green Published, hybrid			2022-12-28	WOS:000312103000013
J	Golubkov, VS; Strongin, AY				Golubkov, Vladislav S.; Strongin, Alex Y.			Insights into Ectodomain Shedding and Processing of Protein-tyrosine Pseudokinase 7 (PTK7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; ALPHA-CONVERTING-ENZYME; EXTRACELLULAR-MATRIX; TISSUE INHIBITOR; CELL POLARITY; KINASE FAMILY; CANCER-CELLS; OFF-TRACK; MT1-MMP; PROTEOLYSIS	The membrane PTK7 pseudokinase, a component of both the canonical and noncanonical/planar cell polarity Wnt pathways, modulates cell polarity and motility in biological processes as diverse as embryo development and cancer cell invasion. To determine the individual proteolytic events and biological significance of the ectodomain shedding in the PTK7 function, we used highly invasive fibrosarcoma HT1080 cells as a model system. Current evidence suggested a likely link between PTK7 shedding and cell invasion in our HT1080 cell model system. We also demonstrated that in HT1080 cells the cleavage of the PTK7 ectodomain by an ADAM proteinase was coupled with the membrane type-1 matrix metalloproteinase (MT1-MMP) cleavage of the PKP621 down arrow LI site in the seventh Ig-like domain of PTK7. Proteolytic cleavages led to the generation of two soluble, N-terminal and two matching C-terminal, cell-associated fragments of PTK7. This proteolysis was a prerequisite for the intramembrane cleavage of the C-terminal fragments of PTK7 by gamma-secretase. gamma-Secretase cleavage was predominantly followed by the efficient decay of the resulting C-terminal PTK7 fragment via the proteasome. In contrast, in HT1080 cells, which overexpressed the C-terminal PTK7 fragment, the latter readily entered the nucleus. Our data imply that therapeutic inhibition of PTK7 shedding may be used to slow cancer progression.	[Golubkov, Vladislav S.; Strongin, Alex Y.] Sanford Burnham Inst Med Res, Canc Res Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Golubkov, VS (corresponding author), Sanford Burnham Inst Med Res, Canc Res Ctr, La Jolla, CA 92037 USA.	vgolubkov@sanfordburnham.org; strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019; Golubkov, Vladislav/L-6828-2017	Strongin, Alex/0000-0003-3765-3016; 	National Institutes of Health [CA77470, CA83017, CA157328]; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470, R01CA157328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77470, CA83017, and CA157328 (to A. Y. S.).	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 2002, FEBS LETT, V524, P154, DOI 10.1016/S0014-5793(02)03047-8; Baudrier-Regnier A, 2000, CANCER GENET CYTOGEN, V119, P80, DOI 10.1016/S0165-4608(99)00215-0; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Bigg HF, 2001, CANCER RES, V61, P3610; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Duffy Michael J, 2011, Clin Proteomics, V8, P9, DOI 10.1186/1559-0275-8-9; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Fridman JS, 2007, CLIN CANCER RES, V13, P1892, DOI 10.1158/1078-0432.CCR-06-2116; Golubkov VS, 2006, CANCER RES, V66, P10460, DOI 10.1158/0008-5472.CAN-06-2997; Golubkov VS, 2011, J BIOL CHEM, V286, P20970, DOI 10.1074/jbc.M111.237669; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jones GC, 2005, ARTHRITIS RES THER, V7, P160, DOI 10.1186/ar1783; Jung JW, 2002, BBA-GENE STRUCT EXPR, V1579, P153, DOI 10.1016/S0167-4781(02)00536-5; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Killar L, 1999, ANN NY ACAD SCI, V878, P442, DOI 10.1111/j.1749-6632.1999.tb07701.x; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Kveiborg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017168; Kwak HI, 2009, MATRIX BIOL, V28, P470, DOI 10.1016/j.matbio.2009.07.007; Le Gall SM, 2003, J BIOL CHEM, V278, P45255, DOI 10.1074/jbc.M307745200; Lee MH, 2005, J BIOL CHEM, V280, P15967, DOI 10.1074/jbc.M500897200; Lhoumeau AC, 2011, CELL CYCLE, V10, P1233, DOI 10.4161/cc.10.8.15368; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Lim NH, 2010, BIOCHEM J, V431, P113, DOI 10.1042/BJ20100725; Lin EA, 2010, PROTEIN CELL, V1, P33, DOI 10.1007/s13238-010-0002-5; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Montes de Oca-B Pavel, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P337; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; MOSSIE K, 1995, ONCOGENE, V11, P2179; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; Na HW, 2012, J BIOL CHEM, V287, P25001, DOI 10.1074/jbc.M112.348904; Peradziryi H, 2011, EMBO J, V30, P3729, DOI 10.1038/emboj.2011.236; Piao Z, 2001, GENE CHROMOSOME CANC, V30, P113, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1069>3.3.CO;2-Y; Puppo F, 2011, EMBO REP, V12, P43, DOI 10.1038/embor.2010.185; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rowe RG, 2009, J CELL BIOL, V184, P399, DOI 10.1083/jcb.200810113; Rozanov DV, 2008, CANCER RES, V68, P4086, DOI 10.1158/0008-5472.CAN-07-6458; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Seiki M, 2003, CANCER METAST REV, V22, P129, DOI 10.1023/A:1023087113214; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; Sounnil NE, 2010, INT J CANCER, V126, P1067, DOI 10.1002/ijc.24690; STOCKER W, 1995, PROTEIN SCI, V4, P823; Su YA, 2010, J CANCER, V1, P38; Sundberg C, 2004, J BIOL CHEM, V279, P51601, DOI 10.1074/jbc.M403753200; Szabova L, 2008, ONCOGENE, V27, P3274, DOI 10.1038/sj.onc.1210982; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Wehner P, 2011, DEVELOPMENT, V138, P1321, DOI 10.1242/dev.056291; Whitford KL, 2001, NEURON, V32, P1, DOI 10.1016/S0896-6273(01)00459-7; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Yanez-Mo M, 2011, BIOCHEM SOC T, V39, P541, DOI 10.1042/BST0390541; Yen WW, 2009, DEVELOPMENT, V136, P2039, DOI 10.1242/dev.030601; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024; Zolkiewska A, 2008, CELL MOL LIFE SCI, V65, P2056, DOI 10.1007/s00018-008-7586-4	70	23	25	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42009	42018		10.1074/jbc.M112.371153	http://dx.doi.org/10.1074/jbc.M112.371153			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23095747	Green Published, hybrid			2022-12-28	WOS:000312103000040
J	Ryall, KA; Holland, DO; Delaney, KA; Kraeutler, MJ; Parker, AJ; Saucerman, JJ				Ryall, Karen A.; Holland, David O.; Delaney, Kyle A.; Kraeutler, Matthew J.; Parker, Audrey J.; Saucerman, Jeffrey J.			Network Reconstruction and Systems Analysis of Cardiac Myocyte Hypertrophy Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; KINASE; ACTIVATION; ENDOTHELIN-1; MECHANISMS; INHIBITORS; APOPTOSIS; PATHWAY; MODELS; GROWTH	Cardiac hypertrophy is managed by a dense web of signaling pathways with many pathways influencing myocyte growth. A quantitative understanding of the contributions of individual pathways and their interactions is needed to better understand hypertrophy signaling and to develop more effective therapies for heart failure. We developed a computational model of the cardiac myocyte hypertrophy signaling network to determine how the components and network topology lead to differential regulation of transcription factors, gene expression, and myocyte size. Our computational model of the hypertrophy signaling network contains 106 species and 193 reactions, integrating 14 established pathways regulating cardiac myocyte growth. 109 of 114 model predictions were validated using published experimental data testing the effects of receptor activation on transcription factors and myocyte phenotypic outputs. Network motif analysis revealed an enrichment of bifan and biparallel cross-talk motifs. Sensitivity analysis was used to inform clustering of the network into modules and to identify species with the greatest effects on cell growth. Many species influenced hypertrophy, but only a few nodes had large positive or negative influences. Ras, a network hub, had the greatest effect on cell area and influenced more species than any other protein in the network. We validated this model prediction in cultured cardiac myocytes. With this integrative computational model, we identified the most influential species in the cardiac hypertrophy signaling network and demonstrate how different levels of network organization affect myocyte size, transcription factors, and gene expression.	[Ryall, Karen A.; Holland, David O.; Delaney, Kyle A.; Kraeutler, Matthew J.; Parker, Audrey J.; Saucerman, Jeffrey J.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA	University of Virginia	Saucerman, JJ (corresponding author), Univ Virginia, Dept Biomed Engn, POB 800759, Charlottesville, VA 22908 USA.	jsaucerman@virginia.edu		Saucerman, Jeffrey/0000-0001-9464-8374	National Institutes of Health [HL094476]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094476, R01HL105242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL094476 (to J.S.) and a National Science Foundation graduate fellowship (to K.R.).	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Chavali AK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.15; Cooling M, 2007, BIOPHYS J, V93, P3421, DOI 10.1529/biophysj.107.110031; Ferro A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-58; Fuller SJ, 1998, J BIOL CHEM, V273, P18146, DOI 10.1074/jbc.273.29.18146; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hung WC, 1998, INT J ONCOL, V12, P137; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kalir S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100010; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kraeutler MJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-157; Lusis AJ, 2010, CIRCULATION, V121, P157, DOI 10.1161/CIRCULATIONAHA.108.847699; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Morgan MA, 2001, BLOOD, V97, P1823, DOI 10.1182/blood.V97.6.1823; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Omura T, 2002, HYPERTENSION, V39, P81, DOI 10.1161/hy0102.100783; Prasad KMR, 2011, GENE THER, V18, P43, DOI 10.1038/gt.2010.105; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Ryall KA, 2012, J MOL CELL CARDIOL, V53, P282, DOI 10.1016/j.yjmcc.2012.04.016; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Saucerman JJ, 2004, CIRC RES, V95, P1216, DOI 10.1161/01.RES.0000150055.06226.4e; Saucerman JJ, 2003, J BIOL CHEM, V278, P47997, DOI 10.1074/jbc.M308362200; Schaub MC, 1997, J MOL MED, V75, P901, DOI 10.1007/s001090050182; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin SY, 2006, FEBS LETT, V580, P5965, DOI 10.1016/j.febslet.2006.09.064; Ueyama T, 2000, J MOL CELL CARDIOL, V32, P947, DOI 10.1006/jmcc.2000.1135; Wang YB, 1998, J BIOL CHEM, V273, P5423, DOI 10.1074/jbc.273.10.5423; Yue TL, 2000, J BIOL CHEM, V275, P37895, DOI 10.1074/jbc.M007037200; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115	37	50	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42259	42268		10.1074/jbc.M112.382937	http://dx.doi.org/10.1074/jbc.M112.382937			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23091058	hybrid, Green Published			2022-12-28	WOS:000312103000061
J	Ahmed, AH; Hamada, M; Shinada, T; Ohfune, Y; Weerasinghe, L; Garner, PP; Oswald, RE				Ahmed, H. Ahmed; Hamada, Makoto; Shinada, Tetsuro; Ohfune, Yasufumi; Weerasinghe, Laksiri; Garner, Philip P.; Oswald, Robert E.			The Structure of (-)-Kaitocephalin Bound to the Ligand Binding Domain of the (S)-alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA)/Glutamate Receptor, GluA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC PLASTICITY; GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURES; PARTIAL AGONISTS; AMPA RECEPTORS; ION CHANNELS; TERMINAL DOMAIN; MECHANISMS; ANTAGONISM; ACTIVATION	Glutamate receptors mediate the majority of excitatory synaptic transmission in the central nervous system, and excessive stimulation of these receptors is involved in a variety of neurological disorders and neuronal damage from stroke. The development of new subtype-specific antagonists would be of considerable therapeutic interest. Natural products can provide important new lead compounds for drug discovery. The only natural product known to inhibit glutamate receptors competitively is (-)-kaitocephalin, which was isolated from the fungus Eupenicillium shearii and found to protect CNS neurons from excitotoxicity. Previous work has shown that it is a potent antagonist of some subtypes of glutamate receptors (AMPA and NMDA, but not kainate). The structure of kaitocephalin bound to the ligand binding domain of the AMPA receptor subtype, GluA2, is reported here. The structure suggests how kaitocephalin can be used as a scaffold to develop more selective and high affinity antagonists for glutamate receptors.	[Ahmed, H. Ahmed; Oswald, Robert E.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Hamada, Makoto; Shinada, Tetsuro; Ohfune, Yasufumi] Osaka City Univ, Grad Sch Sci, Osaka 5588585, Japan; [Weerasinghe, Laksiri; Garner, Philip P.] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	Cornell University; Osaka Metropolitan University; Washington State University	Oswald, RE (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	reo1@cornell.edu	; Weerasinghe, Laksiri/H-4185-2018	Garner, Philip/0000-0002-6503-9550; Weerasinghe, Laksiri/0000-0003-1255-1101	National Institutes of Health [R01-GM068935]; National Science Foundation; National Institutes of Health/NIGMS under National Science Foundation [DMR-0936384]; National Institutes of Health through the NIGMS [GM103485]; Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) [19201045, 23102009]; Yamada Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068935, P41GM103485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/NIGMS under National Science Foundation; National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, National Institutes of Health Grant R01-GM068935 (to R. E. O.). This work is based on research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation and the National Institutes of Health/NIGMS under National Science Foundation award DMR-0936384, using the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by National Institutes of Health Award GM103485 through the NIGMS.; Supported by the Japan Society for the Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) Grants-in-aid for Scientific Research 19201045 and 23102009 and the Yamada Science Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahmed AH, 2011, J BIOL CHEM, V286, P35257, DOI 10.1074/jbc.M111.269001; Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Ahmed AH, 2009, BIOCHEMISTRY-US, V48, P3894, DOI 10.1021/bi900107m; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Case D. A., 2012, AMBER 12; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Cokic B, 2008, NEUROPHARMACOLOGY, V54, P1062, DOI 10.1016/j.neuropharm.2008.02.012; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dingledine R, 1999, PHARMACOL REV, V51, P7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gill A, 2008, BIOCHEMISTRY-US, V47, P13831, DOI 10.1021/bi8013196; Hamada M, 2009, ORG LETT, V11, P4664, DOI 10.1021/ol9019343; Heath PR, 2002, MUSCLE NERVE, V26, P438, DOI 10.1002/mus.10186; Hogner A, 2003, J MED CHEM, V46, P214, DOI 10.1021/jm020989v; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Kasper C, 2006, J MOL BIOL, V357, P1184, DOI 10.1016/j.jmb.2006.01.024; Kawasaki M, 2005, ORG LETT, V7, P4165, DOI 10.1021/ol0515154; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Limon A, 2010, ACS CHEM NEUROSCI, V1, P175, DOI 10.1021/cn900037c; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Nelson JK, 2009, ANGEW CHEM INT EDIT, V48, P3087, DOI 10.1002/anie.200805426; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; ShinYa K, 1997, TETRAHEDRON LETT, V38, P7079, DOI 10.1016/S0040-4039(97)01653-5; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Steenland HW, 2008, EUR J NEUROSCI, V27, P1166, DOI 10.1111/j.1460-9568.2008.06078.x; Takahashi K, 2012, ORG LETT, V14, P1644, DOI 10.1021/ol300431n; Taverna F, 2000, J BIOL CHEM, V275, P8475, DOI 10.1074/jbc.275.12.8475; Ueda M, 2012, CHEM LETT, V41, P658, DOI 10.1246/cl.2012.658; Vaswani RG, 2008, J ORG CHEM, V73, P1661, DOI 10.1021/jo702329z; Vaswani RG, 2009, BIOORG MED CHEM LETT, V19, P132, DOI 10.1016/j.bmcl.2008.11.004; Watanabe H, 2002, TETRAHEDRON LETT, V43, P861, DOI 10.1016/S0040-4039(01)02255-9; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Yu SY, 2011, TETRAHEDRON, V67, P1673, DOI 10.1016/j.tet.2010.12.068	42	12	13	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41007	41013		10.1074/jbc.M112.416362	http://dx.doi.org/10.1074/jbc.M112.416362			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23076153	Green Published, hybrid			2022-12-28	WOS:000311887600018
J	Zhang, S; Li, W; Zhu, CC; Wang, XH; Li, Z; Zhang, JS; Zhao, J; Hu, J; Li, T; Zhang, YQ				Zhang, Shun; Li, Wei; Zhu, Chuchao; Wang, Xiaohong; Li, Zhen; Zhang, Jinshan; Zhao, Jie; Hu, Jing; Li, Teng; Zhang, Yuanqiang			Sertoli Cell-specific Expression of Metastasis-associated Protein 2 (MTA2) Is Required for Transcriptional Regulation of the Follicle-stimulating Hormone Receptor (FSHR) Gene during Spermatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITOR TRICHOSTATIN-A; HISTONE-DEACETYLASE; ANDROGEN RECEPTOR; ESTROGEN-RECEPTOR; MALE-INFERTILITY; MOUSE TESTIS; LEYDIG; CANCER; RAT; ACETYLATION	The effect of follicle-stimulating hormone (FSH) on spermatogenesis is modulated at a fundamental level by controlling the number of competent receptors present at the surface of Sertoli cells (SCs). One underlying mechanism is the down-regulation of the expression levels of the FSH receptor (FSHR) gene after exposure to FSH. Here we report that metastasis-associated protein 2 (MTA2), a component of histone deacetylase and nucleosome-remodeling complexes, as a gene product induced directly by testosterone or indirectly by FSH, is exclusively expressed in SCs. Stimulation of SCs with FSH is accompanied by up-regulation of MTA2 expression and enhancement of deacetylase activity. This effect requires the integrity of functional androgen receptor. Furthermore, MTA2 is a potent corepressor of FSHR transcription, because it can recruit histone deacetylase-1 onto the FSHR promoter and participates in the down-regulation of FSHR expression upon FSH treatment. Abolishment of endogenous MTA2 by siRNA treatment disrupted the desensitization of the FSH response and thereafter impaired the FSH-dependent secretory function of SCs. From a clinical standpoint, deregulated expression of MTA2 in SCs of human pathological testes negatively correlates to the deregulated level of serum FSH. Overall, our present results provide the first evidence that the FSH/androgen receptor/MTA2 cascade may serve as an indispensable negative feedback mechanism to modulate the transduction events of SCs in response to FSH. These data also underscore an unexpected reproductive facet of MTA2,	[Zhang, Shun; Li, Wei; Zhu, Chuchao; Li, Zhen; Zhang, Jinshan; Zhao, Jie; Hu, Jing; Li, Teng; Zhang, Yuanqiang] Fourth Mil Med Univ, Dept Human Anat Histol & Embryol, Xian 710032, Peoples R China; [Zhang, Shun; Wang, Xiaohong] Fourth Mil Med Univ, Reprod Med Ctr, Dept Gynecol & Obstet, Tangdu Hosp, Xian 710038, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Li, W (corresponding author), Fourth Mil Med Univ, Dept Human Anat Histol & Embryol, Xian 710032, Peoples R China.	liweipepeyato@yahoo.com.cn; zhangyq@fmmu.edu.cn			National Natural Science Foundation of China [31271248, 30800395, 31171154]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31271248, 30800395, and 31171154.	Chamkhia N, 2006, TOXICOL IND HEALTH, V22, P349, DOI 10.1177/0748233706071739; Chang YF, 2011, BIOTECHNIQUES, V51, P341, DOI 10.2144/000113764; Cheng J, 2007, ENDOCRINOLOGY, V148, P2066, DOI 10.1210/en.2006-1465; Chuang CK, 2007, BIOSCIENCE REP, V27, P403, DOI 10.1007/s10540-007-9063-y; Cui YK, 2006, MOL ENDOCRINOL, V20, P2020, DOI 10.1210/me.2005-0063; Devi YS, 2006, J CLIN ENDOCR METAB, V91, P1062, DOI 10.1210/jc.2005-2072; Faure AK, 2003, MOL HUM REPROD, V9, P757, DOI 10.1093/molehr/gag101; Fenic I, 2004, J ANDROL, V25, P811; Fenic I, 2008, J ANDROL, V29, P172, DOI 10.2164/jandrol.107.003848; Foxley GL, 2001, ENDOCRINE, V15, P193, DOI 10.1385/ENDO:15:2:193; George JW, 2011, BIOL REPROD, V84, P7, DOI 10.1095/biolreprod.110.085043; Grinspon RP, 2010, HORM RES PAEDIAT, V73, P81, DOI 10.1159/000277140; Griswold MD, 2001, MOL CELL ENDOCRINOL, V173, P95, DOI 10.1016/S0303-7207(00)00412-3; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; Heckert LL, 1998, MOL ENDOCRINOL, V12, P1499, DOI 10.1210/me.12.10.1499; Hermann BP, 2008, ENDOCRINOLOGY, V149, P5297, DOI 10.1210/en.2007-1199; Hou W., 2012, J ANDROL IN PRESS; Huang WQ, 2004, J MOL HISTOL, V35, P47, DOI 10.1023/B:HIJO.0000021063.86024.48; Kim DH, 2005, EXP MOL MED, V37, P492, DOI 10.1038/emm.2005.61; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Lardone MC, 2011, MOL HUM REPROD, V17, P739, DOI 10.1093/molehr/gar051; Li WB, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026013, 10.1371/journal.pone.0021082]; Loss ES, 2007, HORM METAB RES, V39, P806, DOI 10.1055/s-2007-991167; Lu XD, 2008, J BIOL CHEM, V283, P13825, DOI 10.1074/jbc.M801275200; Ma L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015439; Ma PP, 2010, BIOL REPROD, V83, P1027, DOI 10.1095/biolreprod.110.086397; Maguire SM, 1997, BIOL REPROD, V56, P1106, DOI 10.1095/biolreprod56.5.1106; Manavathi Bramanandam, 2007, Nucl Recept Signal, V5, pe010, DOI 10.1621/nrs.05010; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Mendis SHS, 2011, BIOL REPROD, V84, P379, DOI 10.1095/biolreprod.110.086231; O'Shaughnessy PJ, 2008, REPRODUCTION, V135, P851, DOI 10.1530/REP-07-0529; Petersen C, 2006, HORM RES, V66, P153, DOI 10.1159/000094142; Popov VM, 2007, STEROIDS, V72, P221, DOI 10.1016/j.steroids.2006.12.001; Saito M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015541; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Wu XF, 2010, REPRODUCTION, V140, P113, DOI 10.1530/REP-09-0349; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200; Yong EL, 2003, HUM REPROD UPDATE, V9, P1, DOI 10.1093/humupd/dmg003	40	57	59	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40471	40483		10.1074/jbc.M112.383802	http://dx.doi.org/10.1074/jbc.M112.383802			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23086931	hybrid, Green Published			2022-12-28	WOS:000311448800038
J	Brown, BL; Lord, DM; Grigoriu, S; Peti, W; Page, R				Brown, Breann L.; Lord, Dana M.; Grigoriu, Simina; Peti, Wolfgang; Page, Rebecca			The Escherichia coli Toxin MqsR Destabilizes the Transcriptional Repression Complex Formed between the Antitoxin MqsA and the mqsRA Operon Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; MULTIDRUG TOLERANCE; CRYSTAL-STRUCTURE; BIOFILM FORMATION; STRUCTURAL BASIS; PERSISTER CELLS; ANTIDOTE; RELE; CCDA; DNA	Bacterial biofilms are complex communities of cells containing an increased prevalence of dormant cells known as persisters, which are characterized by an up-regulation of genes known as toxin-antitoxin (TA) modules. The association of toxins with their cognate antitoxins neutralizes toxin activity, allowing for normal cell growth. Additionally, protein antitoxins bind their own promoters and repress transcription, whereas the toxins serve as co-repressors. Recently, TA pairs have been shown to regulate their own transcription through a phenomenon known as conditional cooperativity, where the TA complexes bind operator DNA and repress transcription only when present in the proper stoichiometric amounts. The most differentially up-regulated gene in persister cells is mqsR, a gene that, with the antitoxin mqsA, constitutes a TA module. Here, we reveal that, unlike other TA systems, MqsR is not a transcription co-repressor but instead functions to destabilize the MqsA-DNA complex. We further show that DNA binding is not regulated by conditional cooperativity. Finally, using biophysical studies, we show that complex formation between MqsR and MqsA results in an exceptionally stable interaction, resulting in a subnanomolar dissociation constant that is similar to that observed between MqsA and DNA. In combination with crystallographic studies, this work reveals that MqsA binding to DNA and MqsR is mutually exclusive. To our knowledge, this is the first TA system in which the toxin does not function as a transcriptional co-repressor, but instead functions to destabilize the antitoxin-operator complex under all conditions, and thus defines another unique feature of the mqsRA TA module.	[Brown, Breann L.; Lord, Dana M.; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Grigoriu, Simina; Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Peti, Wolfgang] Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Page, R (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Box GE 4, Providence, RI 02912 USA.	rebecca_page@brown.edu	Peti, Wolfgang/L-3492-2014		National Science Foundation-CAREER Award [MCB-0952550]; National Institutes of Health-NINDS Predoctoral Fellowship Award [F31NS062630]; National Science Foundation-Experimental Program to Stimulate Competitive Research (EPSCoR) graduate fellowship; National Science Foundation-EPSCoR [1004057, 0554548]; National Institutes of Health [1S10RR020923]; Rhode Island Science and Technology Advisory Council grant; Division of Biology and Medicine, Brown University; National Institutes of Health (NCRR) [P30RR031153, P20RR018728, S10RR02763]; Lifespan Rhode Island Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031153, S10RR020923, P20RR018728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103410, T32GM007601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS062630] Funding Source: NIH RePORTER; Direct For Biological Sciences [0952550] Funding Source: National Science Foundation; Office of Integrative Activities [1004057] Funding Source: National Science Foundation	National Science Foundation-CAREER Award(National Science Foundation (NSF)); National Institutes of Health-NINDS Predoctoral Fellowship Award; National Science Foundation-Experimental Program to Stimulate Competitive Research (EPSCoR) graduate fellowship; National Science Foundation-EPSCoR(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhode Island Science and Technology Advisory Council grant; Division of Biology and Medicine, Brown University; National Institutes of Health (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Lifespan Rhode Island Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by National Science Foundation-CAREER Award MCB-0952550 (to R. P.), National Institutes of Health-NINDS Predoctoral Fellowship Award F31NS062630 (to B. L. B.), and a National Science Foundation-Experimental Program to Stimulate Competitive Research (EPSCoR) graduate fellowship (to D. M. L.). This research is based in part upon work conducted using the Rhode Island National Science Foundation-EPSCoR Proteomics Shared Resource Facility, which is supported in part by the National Science Foundation-EPSCoR Grant 1004057, National Institutes of Health Grant 1S10RR020923, a Rhode Island Science and Technology Advisory Council grant, and the Division of Biology and Medicine, Brown University. This research is based in part upon work conducted in the Center for Genomics and Proteomics Core Facility with partial support from the National Institutes of Health (NCRR Grants P30RR031153, P20RR018728, and S10RR02763), National Science Foundation-EPSCoR Grant 0554548, Lifespan Rhode Island Hospital, and the Division of Biology and Medicine, Brown University.	Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Bigger JW, 1944, LANCET, V2, P497; Blower TR, 2009, J BACTERIOL, V191, P6029, DOI 10.1128/JB.00720-09; Blower TR, 2011, CURR OPIN STRUC BIOL, V21, P109, DOI 10.1016/j.sbi.2010.10.009; Brown BL, 2011, J BIOL CHEM, V286, P2285, DOI 10.1074/jbc.M110.172643; Brown BL, 2010, ACTA CRYSTALLOGR F, V66, P1060, DOI 10.1107/S1744309110028617; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Cherny I, 2004, J BIOL CHEM, V279, P8252, DOI 10.1074/jbc.M308263200; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cvitkovitch DG, 2003, J CLIN INVEST, V112, P1626, DOI 10.1172/JCI200320430; Dao-Thi MH, 2005, J MOL BIOL, V348, P1091, DOI 10.1016/j.jmb.2005.03.049; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Falla TJ, 1998, ANTIMICROB AGENTS CH, V42, P3282, DOI 10.1128/AAC.42.12.3282; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Loris R, 2003, J BIOL CHEM, V278, P28252, DOI 10.1074/jbc.M302336200; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; Magnuson R, 1998, J BACTERIOL, V180, P6342; Marianovsky I, 2001, J BIOL CHEM, V276, P5975, DOI 10.1074/jbc.M008832200; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Oberer M, 2007, PROTEIN SCI, V16, P1676, DOI 10.1110/ps.062680707; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Overgaard M, 2009, J MOL BIOL, V394, P183, DOI 10.1016/j.jmb.2009.09.006; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; TAM JE, 1989, MOL GEN GENET, V219, P26, DOI 10.1007/BF00261153; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Wang XX, 2011, NAT CHEM BIOL, V7, P359, DOI [10.1038/NCHEMBIO.560, 10.1038/nchembio.560]; Wilbur JS, 2005, BIOCHEMISTRY-US, V44, P12515, DOI 10.1021/bi0511080; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Yamaguchi Y, 2009, J BIOL CHEM, V284, P28746, DOI 10.1074/jbc.M109.032904; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	50	59	63	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1286	1294		10.1074/jbc.M112.421008	http://dx.doi.org/10.1074/jbc.M112.421008			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23172222	Green Published, hybrid			2022-12-28	WOS:000313570300050
J	Helwig, M; Hoshino, A; Berridge, C; Lee, SN; Lorenzen, N; Otzen, DE; Eriksen, JL; Lindberg, I				Helwig, Michael; Hoshino, Akina; Berridge, Casey; Lee, Sang-Nam; Lorenzen, Nikolai; Otzen, Daniel E.; Eriksen, Jason L.; Lindberg, Iris			The Neuroendocrine Protein 7B2 Suppresses the Aggregation of Neurodegenerative Disease-related Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PEPTIDE; HEAT-SHOCK PROTEINS; ALPHA-SYNUCLEIN; CONVERTASE PC2; A-BETA; CHAPERONE; BIOMARKERS; TAU; IDENTIFICATION; MODULATION	Neurodegenerative diseases such as Alzheimer (AD) and Parkinson (PD) are characterized by abnormal aggregation of misfolded beta-sheet-rich proteins, including amyloid-beta (A beta)-derived peptides and tau in AD and alpha-synuclein in PD. Correct folding and assembly of these proteins are controlled by ubiquitously expressed molecular chaperones; however, our understanding of neuron-specific chaperones and their involvement in the pathogenesis of neurodegenerative diseases is limited. We here describe novel chaperone-like functions for the secretory protein 7B2, which is widely expressed in neuronal and endocrine tissues. In in vitro experiments, 7B2 efficiently prevented fibrillation and formation of A beta(1-42), A beta(1-40), and alpha-synuclein aggregates at a molar ratio of 1:10. In cell culture experiments, inclusion of recombinant 7B2, either in the medium of Neuro-2A cells or intracellularly via adenoviral 7B2 overexpression, blocked the neurocytotoxic effect of A beta(1-42) and significantly increased cell viability. Conversely, knockdown of 7B2 by RNAi increased A beta(1-42)-induced cytotoxicity. In the brains of APP/PSEN1 mice, a model of AD amyloidosis, immunoreactive 7B2 co-localized with aggregation-prone proteins and their respective aggregates. Furthermore, in the hippocampus and substantia nigra of human AD-and PD-affected brains, 7B2 was highly co-localized with A beta plaques and alpha-synuclein deposits, strongly suggesting physiological association. Our data provide insight into novel functions of 7B2 and establish this neural protein as an anti-aggregation chaperone associated with neurodegenerative disease.	[Helwig, Michael; Hoshino, Akina; Lindberg, Iris] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Berridge, Casey; Eriksen, Jason L.] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Coll Pharm, Houston, TX 77204 USA; [Lee, Sang-Nam] Yonsei Univ, Res Ctr Nat Human Def Syst, Coll Med, Seoul 120752, South Korea; [Lorenzen, Nikolai; Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol & Genet, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark	University System of Maryland; University of Maryland Baltimore; University of Houston System; University of Houston; Yonsei University; Yonsei University Health System; Aarhus University	Lindberg, I (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, HSF 2,Rm S251,20 Penn St, Baltimore, MD 21201 USA.	ilind001@umaryland.edu	Lindberg, Iris/Q-3825-2019; Eriksen, Jason/A-8054-2008	Eriksen, Jason/0000-0003-1549-4165; Otzen, Daniel/0000-0002-2918-8989	National Institutes of Health [1R01DK49703, 1R15AG039008]; Alzheimer's Association [NIRG-08-92033]; Michael J. Fox Foundation for Parkinson's Research; German Academy of Sciences Leopoldina Foundation Post-doctoral Grant [LPDS 2009-33]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R15AG039008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Michael J. Fox Foundation for Parkinson's Research; German Academy of Sciences Leopoldina Foundation Post-doctoral Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01DK49703 (to I. L.) and 1R15AG039008 (to J. L. E.). This work was also supported by Alzheimer's Association Grant NIRG-08-92033 (to J. L. E.), the Michael J. Fox Foundation for Parkinson's Research (to N. L. and D. E. O.), and German Academy of Sciences Leopoldina Foundation Post-doctoral Grant LPDS 2009-33 (to M. H.).	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Bayes A, 2009, NAT REV NEUROSCI, V10, P635, DOI 10.1038/nrn2701; Bianchi FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022370; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; BRAKS JAM, 1994, CELL, V78, P263, DOI 10.1016/0092-8674(94)90296-8; CHAUDHURI B, 1995, BIOCHEM BIOPH RES CO, V211, P417, DOI 10.1006/bbrc.1995.1830; Clemente C, 1985, GRAYS ANATOMY HUMAN, V30th; Croisier E, 2006, NEUROPATH APPL NEURO, V32, P351, DOI 10.1111/j.1365-2990.2006.00722.x; Dasgupta I, 2012, BIOCHEMISTRY-US, V51, P7456, DOI 10.1021/bi300871k; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Finehout EJ, 2007, ANN NEUROL, V61, P120, DOI 10.1002/ana.21038; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Helwig M, 2011, J BIOL CHEM, V286, P42504, DOI 10.1074/jbc.M111.281980; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; IGUCHI H, 1984, NEUROENDOCRINOLOGY, V39, P453, DOI 10.1159/000124020; Jahn H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026540; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Kanekiyo T, 2009, J BIOL CHEM, V284, P33352, DOI 10.1074/jbc.M109.015032; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; KJAER A, 1995, NEUROENDOCRINOLOGY, V61, P167, DOI 10.1159/000126837; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee SN, 2008, ENDOCRINOLOGY, V149, P4116, DOI 10.1210/en.2008-0064; Lee SN, 2006, J BIOL CHEM, V281, P3312, DOI 10.1074/jbc.M506635200; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Mbikay M, 2001, BIOCHEM J, V357, P329, DOI 10.1042/0264-6021:3570329; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Muller L, 1999, J BIOL CHEM, V274, P21471, DOI 10.1074/jbc.274.30.21471; Muller L, 2000, PROG NUCLEIC ACID RE, V63, P69, DOI 10.1016/S0079-6603(08)60720-5; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; Nemes Z, 2004, FASEB J, V18, P1135, DOI 10.1096/fj.04-1493fje; PAQUET L, 1994, J BIOL CHEM, V269, P19279; Pasinetti GM, 2006, NEUROLOGY, V66, P1218, DOI 10.1212/01.wnl.0000203129.82104.07; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; Ranganathan S, 2005, J NEUROCHEM, V95, P1461, DOI 10.1111/j.1471-4159.2005.03478.x; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P511; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sasaki K, 2009, MOL CELL PROTEOMICS, V8, P1638, DOI 10.1074/mcp.M900044-MCP200; Seidel B, 1998, DNA CELL BIOL, V17, P1017, DOI 10.1089/dna.1998.17.1017; SIGAFOOS J, 1993, CELL MOL NEUROBIOL, V13, P271, DOI 10.1007/BF00733755; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Tanaka N, 2008, BIOCHEMISTRY-US, V47, P2961, DOI 10.1021/bi701823g; Winsky-Sommerer R, 2003, NEUROSCIENCE, V122, P437, DOI 10.1016/S0306-4522(03)00560-8; Wu ZC, 2012, ADV CLIN CHEM, V56, P155, DOI 10.1016/B978-0-12-394317-0.00011-X; Zhu XR, 1996, J BIOL CHEM, V271, P23582, DOI 10.1074/jbc.271.38.23582	54	30	35	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1114	1124		10.1074/jbc.M112.417071	http://dx.doi.org/10.1074/jbc.M112.417071			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23172224	hybrid, Green Published			2022-12-28	WOS:000313570300034
J	Spirig, T; Malmirchegini, GR; Zhang, J; Robson, SA; Sjodt, M; Liu, MY; Kumar, KK; Dickson, CF; Gell, DA; Lei, BF; Loo, JA; Clubb, RT				Spirig, Thomas; Malmirchegini, G. Reza; Zhang, Jiang; Robson, Scott A.; Sjodt, Megan; Liu, Mengyao; Kumar, Kaavya Krishna; Dickson, Claire F.; Gell, David A.; Lei, Benfang; Loo, Joseph A.; Clubb, Robert T.			Staphylococcus aureus Uses a Novel Multidomain Receptor to Break Apart Human Hemoglobin and Steal Its Heme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE PROTEIN; STRUCTURAL BASIS; GLOBIN CHAINS; NEAT DOMAIN; IRON; BINDING; SYSTEM; ISDB; WALL; IDENTIFICATION	Staphylococcus aureus is a leading cause of life-threatening infections in the United States. It requires iron to grow, which must be actively procured from its host to successfully mount an infection. Heme-iron within hemoglobin (Hb) is the most abundant source of iron in the human body and is captured by S. aureus using two closely related receptors, IsdH and IsdB. Here we demonstrate that each receptor captures heme using two conserved near iron transporter (NEAT) domains that function synergistically. NMR studies of the 39-kDa conserved unit from IsdH (IsdH(N2N3), Ala(326)-Asp(660)) reveals that it adopts an elongated dumbbell-shaped structure in which its NEAT domains are properly positioned by a helical linker domain, whose three-dimensional structure is determined here in detail. Electrospray ionization mass spectrometry and heme transfer measurements indicate that IsdH(N2N3) extracts heme from Hb via an ordered process in which the receptor promotes heme release by inducing steric strain that dissociates the Hb tetramer. Other clinically significant Gram-positive pathogens capture Hb using receptors that contain multiple NEAT domains, suggesting that they use a conserved mechanism.	[Spirig, Thomas; Malmirchegini, G. Reza; Zhang, Jiang; Robson, Scott A.; Sjodt, Megan; Loo, Joseph A.; Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Spirig, Thomas; Malmirchegini, G. Reza; Zhang, Jiang; Robson, Scott A.; Sjodt, Megan; Loo, Joseph A.; Clubb, Robert T.] Univ Calif Los Angeles, UCLA Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Loo, Joseph A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Kumar, Kaavya Krishna; Dickson, Claire F.; Gell, David A.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia; [Liu, Mengyao; Lei, Benfang] Montana State Univ, Dept Vet Biol, Bozeman, MT USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Tasmania; Menzies Institute for Medical Research; Montana State University System; Montana State University Bozeman	Clubb, RT (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 602 Boyer Hall, Los Angeles, CA 90095 USA.	rclubb@mbi.ucla.edu	Zhang, Jiang/D-1136-2015	Robson, Scott/0000-0002-0529-0399; Spirig, Thomas/0000-0001-8936-238X; Sjodt, Megan/0000-0003-0234-4336; Gell, David/0000-0003-0382-1181; Lei, Benfang Lei/0000-0001-8133-6021	National Institutes of Health [AI52217, GM103479, RR020004]; National Center for Research Resources for purchase of the Fourier transform ion cyclotron resonance mass spectrometer [S10RR028893]; Swiss National Science Foundation Fellowship [PBEZP3-124281]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028893, R01RR020004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM101931, R01GM103479] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources for purchase of the Fourier transform ion cyclotron resonance mass spectrometer; Swiss National Science Foundation Fellowship(Swiss National Science Foundation (SNSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI52217 (to R. T. C.), RR020004 (now reassigned as GM103479) (to J. A. L.), and S10RR028893 from the National Center for Research Resources for purchase of the Fourier transform ion cyclotron resonance mass spectrometer. This work was also supported by Swiss National Science Foundation Fellowship PBEZP3-124281 (to T. S.).	Abe R, 2012, J BIOL CHEM, V287, P16477, DOI 10.1074/jbc.M112.346700; Andrade MA, 2002, GENOME BIOL, V3; Ascoli F, 1981, Methods Enzymol, V76, P72; BENESCH RE, 1995, J BIOL CHEM, V270, P13785, DOI 10.1074/jbc.270.23.13785; BRUNGER AT, 1993, SCIENCE, V261, P328, DOI 10.1126/science.8332897; Bunn F. H., 1986, HEMOGLOBIN MOL GENET, P21; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Clarke SR, 2004, MOL MICROBIOL, V51, P1509, DOI 10.1111/j.1365-2958.2003.03938.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W., 2006, PYMOL MOL GRAPHICS S; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Garrett Daniel S, 2011, J Magn Reson, V213, P357, DOI 10.1016/j.jmr.2011.09.007; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Goddard T. D., 2001, SPARKY NMR ANAL SOFT; GOUDA H, 1992, BIOCHEMISTRY-US, V31, P9665, DOI 10.1021/bi00155a020; Griffith WP, 2003, BIOCHEMISTRY-US, V42, P10024, DOI 10.1021/bi034035y; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Honsa ES, 2011, J BIOL CHEM, V286, P33652, DOI 10.1074/jbc.M111.241687; Honsa ES, 2011, BIOMETALS, V24, P533, DOI 10.1007/s10534-011-9413-x; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu JJ, 2011, J AM SOC MASS SPECTR, V22, P408, DOI 10.1007/s13361-010-0052-1; Liu MY, 2005, INFECT IMMUN, V73, P5086, DOI 10.1128/IAI.73.8.5086-5092.2005; Loo JA, 2000, INT J MASS SPECTROM, V200, P175, DOI 10.1016/S1387-3806(00)00298-0; Lu CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037556; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Moriwaki Y, 2011, BIOCHEMISTRY-US, V50, P7311, DOI 10.1021/bi200493h; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Pishchany G, 2009, INFECT IMMUN, V77, P2624, DOI 10.1128/IAI.01531-08; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Schneider JP, 1998, FOLD DES, V3, pR29, DOI 10.1016/S1359-0278(98)00011-X; Senturia R, 2010, PROTEIN SCI, V19, P1354, DOI 10.1002/pro.414; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Spirig T, 2012, BIOMOL NMR ASSIGN, V6, P169, DOI 10.1007/s12104-011-9348-8; SUGITA Y, 1975, J BIOL CHEM, V250, P1251; Taylor JM, 2002, MOL MICROBIOL, V43, P1603, DOI 10.1046/j.1365-2958.2002.02850.x; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Visai L, 2009, MICROBIOL-SGM, V155, P667, DOI 10.1099/mic.0.025684-0; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; WAKS M, 1973, J BIOL CHEM, V248, P6462; Ward PP, 2004, BIOMETALS, V17, P203, DOI 10.1023/B:BIOM.0000027693.60932.26; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Xiao QB, 2011, MOL MICROBIOL, V80, P1581, DOI 10.1111/j.1365-2958.2011.07667.x; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15	70	43	43	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1065	1078		10.1074/jbc.M112.419119	http://dx.doi.org/10.1074/jbc.M112.419119			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23132864	hybrid, Green Published			2022-12-28	WOS:000313570300030
J	Crabtree, MJ; Brixey, R; Batchelor, H; Hale, AB; Channon, KM				Crabtree, Mark J.; Brixey, Rachel; Batchelor, Helen; Hale, Ashley B.; Channon, Keith M.			Integrated Redox Sensor and Effector Functions for Tetrahydrobiopterin- and Glutathionylation-dependent Endothelial Nitric-oxide Synthase Uncoupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-GLUTATHIONYLATION; INTRACELLULAR SUPEROXIDE; CELLS; ENOS; HPLC; EXPRESSION; OXIDATION; RATIO	Endothelial nitric-oxide synthase (eNOS) is a critical regulator of vascular homeostasis by generation of NO that is dependent on the cofactor tetrahydrobiopterin (BH4). When BH4 availability is limiting, eNOS becomes "uncoupled," resulting in superoxide production in place of NO. Recent evidence suggests that eNOS uncoupling can also be induced by S-glutathionylation, although the functional relationships between BH4 and S-glutathionylation remain unknown. To address a possible role for BH4 in S-glutathionylation-induced eNOS uncoupling, we expressed either WT or mutant eNOS rendered resistant to S-glutathionylation in cells with Tet-regulated expression of human GTP cyclohydrolase I to regulate intracellular BH4 availability. We reveal that S-glutathionylation of eNOS, by exposure to either 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) or glutathione reductase-specific siRNA, results in diminished NO production and elevated eNOS-derived superoxide production, along with a concomitant reduction in BH4 levels and BH4:7,8-dihydrobiopterin ratio. In eNOS uncoupling induced by BH4 deficiency, BCNU exposure further exacerbates superoxide production, BH4 oxidation, and eNOS activity. Following mutation of C908S, BCNU-induced eNOS uncoupling and BH4 oxidation are abolished, whereas uncoupling induced by BH4 deficiency was preserved. Furthermore, BH4 deficiency alone is alone sufficient to reduce intracellular GSH:GSSG ratio and cause eNOS S-glutathionylation. These data provide the first evidence that BH4 deficiency-and S-glutathionylation-induced mechanisms of eNOS uncoupling, although mechanistically distinct, are functionally related. We propose that uncoupling of eNOS by S-glutathionylation- or by BH4-dependent mechanisms exemplifies eNOS as an integrated redox "hub" linking upstream redox-sensitive effects of BH4 and glutathione with redox-dependent targets and pathways that lie downstream of eNOS.	[Crabtree, Mark J.; Brixey, Rachel; Batchelor, Helen; Hale, Ashley B.; Channon, Keith M.] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England	University of Oxford	Crabtree, MJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England.	mark.crabtree@well.ox.ac.uk		Crabtree, Mark/0000-0003-3298-2697; channon, keith/0000-0002-1043-4342	British Heart Foundation Centre of Research Excellence [RE/08/004]; British Heart Foundation [RG/07/003/23133]; British Heart Foundation [RG/12/5/29576] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10247] Funding Source: researchfish	British Heart Foundation Centre of Research Excellence(British Heart Foundation); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by British Heart Foundation Centre of Research Excellence Intermediate Fellowship Award RE/08/004 (to M. J. C.) and British Heart Foundation Programme Grant RG/07/003/23133.	Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Crabtree MJ, 2008, AM J PHYSIOL-HEART C, V294, pH1530, DOI 10.1152/ajpheart.00823.2007; Crabtree MJ, 2009, J BIOL CHEM, V284, P28128, DOI 10.1074/jbc.M109.041483; Crabtree MJ, 2009, J BIOL CHEM, V284, P1136, DOI 10.1074/jbc.M805403200; Cunnington C, 2012, CIRCULATION, V125, P1356, DOI 10.1161/CIRCULATIONAHA.111.038919; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; de Bono JP, 2007, NITRIC OXIDE-BIOL CH, V16, P1, DOI 10.1016/j.niox.2006.03.008; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; HEALES S, 1989, J CHROMATOGR-BIOMED, V494, P77, DOI 10.1016/S0378-4347(00)82658-4; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; McDonald DM, 2004, PHARMACOGENETICS, V14, P831, DOI 10.1097/00008571-200412000-00006; OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; PANZA JA, 1995, CIRCULATION, V91, P1732, DOI 10.1161/01.CIR.91.6.1732; Sen CK, 1998, BIOCHEM PHARMACOL, V55, P1747, DOI 10.1016/S0006-2952(97)00672-2; Stroes E, 1998, FEBS LETT, V438, P161, DOI 10.1016/S0014-5793(98)01292-7; Sugiyama T, 2010, AM J PHYSIOL-HEART C, V298, pH194, DOI 10.1152/ajpheart.00767.2009; Townsend DM, 2007, MOL INTERV, V7, P313, DOI 10.1124/mi.7.6.7; TZENG E, 1995, P NATL ACAD SCI USA, V92, P11771, DOI 10.1073/pnas.92.25.11771; Vasquez-Vivar J, 2002, BIOCHEM J, V362, P733, DOI 10.1042/0264-6021:3620733; WHITE CR, 1994, P NATL ACAD SCI USA, V91, P1044, DOI 10.1073/pnas.91.3.1044; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	24	63	66	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					561	569		10.1074/jbc.M112.415992	http://dx.doi.org/10.1074/jbc.M112.415992			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23139420	Green Published, hybrid			2022-12-28	WOS:000313197200056
J	Unal, H; Jagannathan, R; Bhatnagar, A; Tirupula, K; Desnoyer, R; Karnik, SS				Unal, Hamiyet; Jagannathan, Rajaganapathi; Bhatnagar, Anushree; Tirupula, Kalyan; Desnoyer, Russell; Karnik, Sadashiva S.			Long Range Effect of Mutations on Specific Conformational Changes in the Extracellular Loop 2 of Angiotensin II Type 1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; CYSTEINE-SCANNING MUTAGENESIS; BLOOD-PRESSURE REGULATION; 3RD TRANSMEMBRANE DOMAIN; CONSTITUTIVE ACTIVATION; AT(1) RECEPTOR; LIGAND-BINDING; ACTIVE-STATE; ACCESSIBILITY METHOD; HELIX MOVEMENT	The topology of the second extracellular loop (ECL2) and its interaction with ligands is unique in each G protein-coupled receptor. When the orthosteric ligand pocket located in the transmembrane (TM) domain is occupied, ligand-specific conformational changes occur in the ECL2. In more than 90% of G protein-coupled receptors, ECL2 is tethered to the third TM helix via a disulfide bond. Therefore, understanding the extent to which the TM domain and ECL2 conformations are coupled is useful. To investigate this, we examined conformational changes in ECL2 of the angiotensin II type 1 receptor (AT1R) by introducing mutations in distant sites that alter the activation state equilibrium of the AT1R. Differential accessibility of reporter cysteines introduced at four conformation-sensitive sites in ECL2 of these mutants was measured. Binding of the agonist angiotensin II (AngII) and inverse agonist losartan in wild-type AT1R changed the accessibility of reporter cysteines, and the pattern was consistent with ligand-specific "lid" conformations of ECL2. Without agonist stimulation, the ECL2 in the gain of function mutant N111G assumed a lid conformation similar to AngII-bound wild-type AT1R. In the presence of inverse agonists, the conformation of ECL2 in the N111G mutant was similar to the inactive state of wild-type AT1R. In contrast, AngII did not induce a lid conformation in ECL2 in the loss of function D281A mutant, which is consistent with the reduced AngII binding affinity in this mutant. However, a lid conformation was induced by [Sar(1), Gln(2), Ile(8)] AngII, a specific analog that binds to the D281A mutant with better affinity than AngII. These results provide evidence for the emerging paradigm of domain coupling facilitated by long range interactions at distant sites on the same receptor.	[Unal, Hamiyet; Jagannathan, Rajaganapathi; Bhatnagar, Anushree; Tirupula, Kalyan; Desnoyer, Russell; Karnik, Sadashiva S.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Karnik, SS (corresponding author), 9500 Euclid Ave, Cleveland, OH 44195 USA.	karniks@ccf.org	Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753	National Institutes of Health [RO1 HL57470]; National Research Service [HL007914]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007914, R01HL057470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL57470 (to S. K.). This work was also supported by National Research Service Award HL007914 (to H. U.).	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Baleanu-Gogonea C, 2006, J MOL MODEL, V12, P325, DOI 10.1007/s00894-005-0049-z; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bonde MM, 2010, BIOCHEM PHARMACOL, V80, P86, DOI 10.1016/j.bcp.2010.03.006; Boucard AA, 2003, J BIOL CHEM, V278, P36628, DOI 10.1074/jbc.M305952200; Clement M, 2009, J BIOL CHEM, V284, P26603, DOI 10.1074/jbc.M109.012922; Costa-Neto CM, 2000, BRIT J PHARMACOL, V130, P1263, DOI 10.1038/sj.bjp.0703430; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; Domazet I, 2009, J BIOL CHEM, V284, P31953, DOI 10.1074/jbc.M109.051839; Escano CS, 2008, J PHARMACOL EXP THER, V324, P34, DOI 10.1124/jpet.107.126300; FENG YH, 1995, J BIOL CHEM, V270, P12846, DOI 10.1074/jbc.270.21.12846; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; Groblewski T, 1997, J BIOL CHEM, V272, P1822, DOI 10.1074/jbc.272.3.1822; Hauser M, 2007, J BIOL CHEM, V282, P10387, DOI 10.1074/jbc.M608903200; HJORTH SA, 1994, J BIOL CHEM, V269, P30953; Hunyady L, 2003, TRENDS PHARMACOL SCI, V24, P81, DOI 10.1016/S0165-6147(02)00050-0; Hwa J, 2001, P NATL ACAD SCI USA, V98, P4872, DOI 10.1073/pnas.061632798; Javitch JA, 1997, J BIOL CHEM, V272, P18546, DOI 10.1074/jbc.272.30.18546; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lee C, 2007, FEBS LETT, V581, P2517, DOI 10.1016/j.febslet.2007.04.069; Li M, 2004, J CLIN INVEST, V114, P112, DOI 10.1172/JCI200420805; Lin JC, 2004, MOL CELL BIOL, V24, P2041, DOI 10.1128/MCB.24.5.2041-2051.2004; Martin SS, 2004, J BIOL CHEM, V279, P51415, DOI 10.1074/jbc.M407965200; Martin SS, 2007, MOL PHARMACOL, V72, P182, DOI 10.1124/mol.106.033670; Miura S, 1999, J BIOL CHEM, V274, P7103, DOI 10.1074/jbc.274.11.7103; Miura S, 2003, J BIOL CHEM, V278, P3720, DOI 10.1074/jbc.M211338200; Miura S, 2002, J BIOL CHEM, V277, P24299, DOI 10.1074/jbc.M202743200; Nikiforovich GV, 2005, J PEPT RES, V66, P236, DOI 10.1111/j.1399-3011.2005.00293.x; Noda K, 1996, BIOCHEMISTRY-US, V35, P16435, DOI 10.1021/bi961593m; Post CB, 1995, BIOCHEMISTRY-US, V34, P15881, DOI 10.1021/bi00049a001; Rakesh K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000769; Rana S, 2010, J BIOL CHEM, V285, P31472, DOI 10.1074/jbc.M110.129213; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Roberts DJ, 2011, PEPTIDES, V32, P1593, DOI 10.1016/j.peptides.2011.06.009; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Stojanovic A, 2003, J BIOL CHEM, V278, P39020, DOI 10.1074/jbc.M303625200; Uddin MS, 2012, J RECEPT SIG TRANSD, V32, P65, DOI 10.3109/10799893.2011.647352; Unal H, 2012, ADV EXP MED BIOL, V749, P187, DOI 10.1007/978-1-4614-3381-1_13; Unal H, 2012, TRENDS PHARMACOL SCI, V33, P79, DOI 10.1016/j.tips.2011.09.007; Unal H, 2010, J BIOL CHEM, V285, P16341, DOI 10.1074/jbc.M109.094870; Vaidehi N, 2010, CURR OPIN PHARMACOL, V10, P775, DOI 10.1016/j.coph.2010.09.004; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; West GM, 2011, STRUCTURE, V19, P1424, DOI 10.1016/j.str.2011.08.001; Yan ECY, 2003, P NATL ACAD SCI USA, V100, P9262, DOI 10.1073/pnas.1531970100; Yan LP, 2010, J BIOL CHEM, V285, P2227, DOI 10.1074/jbc.M109.077180	51	24	25	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					540	551		10.1074/jbc.M112.392514	http://dx.doi.org/10.1074/jbc.M112.392514			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23139413	hybrid, Green Published			2022-12-28	WOS:000313197200054
J	Banerjee, R; Nath, S; Ranjan, A; Khamrui, S; Pani, B; Sen, R; Sen, U				Banerjee, Ramanuj; Nath, Seema; Ranjan, Amitabh; Khamrui, Susmita; Pani, Bibhusita; Sen, Ranjan; Sen, Udayaditya			The First Structure of Polarity Suppression Protein, Psu from Enterobacteria Phage P4, Reveals a Novel Fold and a Knotted Dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-P4; INTERFACE; MECHANISM	Psu is a capsid decoration protein of bacteriophage P4 and acts as an antiterminator of Rho-dependent transcription termination in bacteria. So far, no structures have been reported for the Psu protein or its homologues. Here, we report the first structure of Psu solved by the Hg2+ single wavelength anomalous dispersion method, which reveals that Psu exists as a knotted homodimer and is first of its kind in nature. Each monomer of Psu attains a novel fold around a tight coiled-coil motif. CD spectroscopy and the structure of an engineered disulfide-bridged Psu derivative reveal that the protein folds reversibly and reassembles by itself into the knotted dimeric conformation without the requirement of any chaperone. This structure would help to explain the functional properties of the protein and can be used as a template to design a minimal peptide fragment that can be used as a drug against Rho-dependent transcription termination in bacteria.	[Banerjee, Ramanuj; Nath, Seema; Khamrui, Susmita; Sen, Udayaditya] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata 700064, India; [Ranjan, Amitabh; Pani, Bibhusita; Sen, Ranjan] Ctr DNA Fingerprinting & Diagnost, Lab Transcript Biol, Hyderabad 500001, Andhra Pradesh, India	Saha Institute of Nuclear Physics; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Sen, U (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, 1-AF, Kolkata 700064, India.	udayaditya.sen@saha.ac.in	RANJAN, AMITABH/AAB-9856-2022; Sen, Ranjan/AAP-7075-2021	Pani, Bibhusita/0000-0003-1513-5189; Sen, Udayaditya/0000-0001-5742-2907; Banerjee, Ramanuj/0000-0002-7751-2317	SPGHGD project, DAE, India, Saha Institute of Nuclear Physics; Department of Biotechnology, India	SPGHGD project, DAE, India, Saha Institute of Nuclear Physics; Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported in part by the SPGHGD project, DAE, India, Saha Institute of Nuclear Physics (to U. S.). This work was also supported by the Department of Biotechnology, India (to R. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DOKLAND T, 1993, VIROLOGY, V194, P682, DOI 10.1006/viro.1993.1308; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; ISAKSEN ML, 1992, VIROLOGY, V188, P831, DOI 10.1016/0042-6822(92)90538-Z; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; King NP, 2010, P NATL ACAD SCI USA, V107, P20732, DOI 10.1073/pnas.1007602107; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; LINDEROTH NA, 1991, J BACTERIOL, V173, P6722, DOI 10.1128/jb.173.21.6722-6731.1991; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pani B, 2006, J BIOL CHEM, V281, P26491, DOI 10.1074/jbc.M603982200; Pani B, 2009, J MOL BIOL, V389, P647, DOI 10.1016/j.jmb.2009.04.052; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; Saitta AM, 1999, NATURE, V399, P46, DOI 10.1038/19935	24	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44667	44675		10.1074/jbc.M112.423202	http://dx.doi.org/10.1074/jbc.M112.423202			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23150672	Green Published, hybrid			2022-12-28	WOS:000312938600062
J	Garcia-Huerta, P; Diaz-Hernandez, M; Delicado, EG; Pimentel-Santillana, M; Miras-Portugal, MT; Gomez-Villafuertes, R				Garcia-Huerta, Paula; Diaz-Hernandez, Miguel; Delicado, Esmerilda G.; Pimentel-Santillana, Maria; Teresa Miras-Portugal, Ma; Gomez-Villafuertes, Rosa			The Specificity Protein Factor Sp1 Mediates Transcriptional Regulation of P2X7 Receptors in the Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAIN-OF-FUNCTION; P2X(7) RECEPTOR; GENE-EXPRESSION; HUNTINGTON-DISEASE; POLYMORPHISM LEADS; ACTIVATION; ATP; BINDING; INHIBITION; CLONING	P2X7 receptors are involved not only in physiological functions but also in pathological brain processes. Although an increasing number of findings indicate that altered receptor expression has a causative role in neurodegenerative diseases and cancer, little is known about how expression of P2rx7 gene is controlled. Here we reported the first molecular and functional evidence that Specificity protein 1 (Sp1) transcription factor plays a pivotal role in the transcriptional regulation of P2X7 receptor. We delimited a minimal region in the murine P2rx7 promoter containing four SP1 sites, two of them being highly conserved in mammals. The functionality of these SP1 sites was confirmed by site-directed mutagenesis and Sp1 overexpression/down-regulation in neuroblastoma cells. Inhibition of Sp1-mediated transcriptional activation by mithramycin A reduced endogenous P2X7 receptor levels in primary cultures of cortical neurons and astrocytes. Using P2rx7-EGFP transgenic mice that express enhanced green fluorescent protein under the control of P2rx7 promoter, we found a high correlation between reporter expression and Sp1 levels in the brain, demonstrating that Sp1 is a key element in the transcriptional regulation of P2X7 receptor in the nervous system. Finally, we found that Sp1 mediates P2X7 receptor up-regulation in neuroblastoma cells cultured in the absence of serum, a condition that enhances chromatin accessibility and facilitates the exposure of SP1 binding sites.	[Garcia-Huerta, Paula; Diaz-Hernandez, Miguel; Delicado, Esmerilda G.; Teresa Miras-Portugal, Ma; Gomez-Villafuertes, Rosa] Univ Complutense Madrid, Fac Vet, Dept Bioquim & Biol Mol, E-28040 Madrid, Spain; [Garcia-Huerta, Paula; Diaz-Hernandez, Miguel; Delicado, Esmerilda G.; Teresa Miras-Portugal, Ma; Gomez-Villafuertes, Rosa] Univ Complutense Madrid, Inst Univ Invest Neuroquim, E-28040 Madrid, Spain; [Garcia-Huerta, Paula; Diaz-Hernandez, Miguel; Delicado, Esmerilda G.; Teresa Miras-Portugal, Ma; Gomez-Villafuertes, Rosa] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid 28040, Spain; [Pimentel-Santillana, Maria] Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, E-28049 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Hospital Clinico San Carlos; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Gomez-Villafuertes, R (corresponding author), Univ Complutense Madrid, Fac Vet, Dept Bioquim & Biol Mol, Avda Puerta de Hierro S-N, E-28040 Madrid, Spain.	marosa@vet.ucm.es	Gomez-Villafuertes, Rosa/L-7181-2014; Miras-Portugal, Maria Teresa/L-7137-2014; Pimentel-Santillana, Maria/L-9437-2014; Delicado, Esmerilda G./L-6992-2014	Gomez-Villafuertes, Rosa/0000-0002-7064-0906; Pimentel-Santillana, Maria/0000-0003-1179-4259; Diaz-Hernandez, Miguel/0000-0002-1952-4600	Ministry of Science and Innovation [BFU2008-02699, BFU2011-24743]; Spanish Ion Channel Initiative [CSD2008-00005]; Marcelino Botin Foundation; Spanish Education Ministry; Spanish Ion Channel Initiative	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ion Channel Initiative; Marcelino Botin Foundation; Spanish Education Ministry(Spanish Government); Spanish Ion Channel Initiative	This work was supported by the Ministry of Science and Innovation (BFU2008-02699 and BFU2011-24743), the Spanish Ion Channel Initiative (CSD2008-00005), and the Marcelino Botin Foundation.; Supported by a fellowship from Spanish Education Ministry.; Supported by Spanish Ion Channel Initiative. To whom correspondence should be addressed: Departamento de Bioquimica y Biologia Molecular, Facultad de Veterinaria, Universidad Complutense de Madrid, Avda. Puerta de Hierro s/n, 28040 Madrid, Spain. Tel.: 34-913943890; Fax: 34-913943909; E-mail: marosa@vet.ucm.es.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Adinolfi E, 2012, CANCER RES, V72, P2957, DOI 10.1158/0008-5472.CAN-11-1947; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Buell GN, 1998, RECEPTOR CHANNEL, V5, P347; Burnstock G, 2011, PROG NEUROBIOL, V95, P229, DOI 10.1016/j.pneurobio.2011.08.006; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Carrasquero LMG, 2010, GLIA, V58, P984, DOI 10.1002/glia.20980; Chatterjee S, 2001, ANN NEUROL, V49, P345, DOI 10.1002/ana.71.abs; Chessell IP, 1998, FEBS LETT, V439, P26, DOI 10.1016/S0014-5793(98)01332-5; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; Clark SJ, 1997, GENE, V195, P67, DOI 10.1016/S0378-1119(97)00164-9; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Di Virgilio F, 2009, PURINERG SIGNAL, V5, P251, DOI 10.1007/s11302-009-9145-3; Diaz-Hernandez M, 2008, J CELL SCI, V121, P3717, DOI 10.1242/jcs.034082; Diaz-Hernandez M, 2009, FASEB J, V23, P1893, DOI 10.1096/fj.08-122275; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; EMILI A, 1994, MOL CELL BIOL, V14, P1582, DOI 10.1128/MCB.14.3.1582; Engel T, 2012, FASEB J, V26, P1616, DOI 10.1096/fj.11-196089; Eslick GD, 2009, INT J CARDIOL, V137, P81, DOI 10.1016/j.ijcard.2008.05.017; Ferrante RJ, 2004, J NEUROSCI, V24, P10335, DOI 10.1523/JNEUROSCI.2599-04.2004; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fuller SJ, 2009, PURINERG SIGNAL, V5, P257, DOI 10.1007/s11302-009-9136-4; Gomez-Villafuertes R, 2009, FEBS J, V276, P5307, DOI 10.1111/j.1742-4658.2009.07228.x; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gu BJ, 2004, J BIOL CHEM, V279, P31287, DOI 10.1074/jbc.M313902200; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Gutierrez-Martin Y, 2011, J BIOL CHEM, V286, P11370, DOI 10.1074/jbc.M110.139410; Hagiwara H, 2009, BRAIN RES, V1301, P189, DOI 10.1016/j.brainres.2009.09.010; Diaz-Hernandez JI, 2012, NEUROBIOL AGING, V33, P1816, DOI 10.1016/j.neurobiolaging.2011.09.040; Jia ZL, 2007, CANCER RES, V67, P4878, DOI 10.1158/0008-5472.CAN-06-3494; Jorgensen NR, 2012, EUR J HUM GENET, V20, P675, DOI 10.1038/ejhg.2011.253; KOLLER CA, 1986, NEW ENGL J MED, V315, P1433, DOI 10.1056/NEJM198612043152301; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Leon D, 2006, EUR J NEUROSCI, V23, P2999, DOI 10.1111/j.1460-9568.2006.04832.x; Leon-Otegui M, 2011, FEBS LETT, V585, P2255, DOI 10.1016/j.febslet.2011.05.048; Li CM, 2002, J INFECT DIS, V186, P1458, DOI 10.1086/344351; Li CM, 2002, FEBS LETT, V531, P127, DOI 10.1016/S0014-5793(02)03424-5; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Liu YY, 2004, GENOME RES, V14, P451, DOI 10.1101/gr.1327604; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; Nicolas M, 2001, J BIOL CHEM, V276, P22126, DOI 10.1074/jbc.M010740200; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ortega F, 2011, NEUROPHARMACOLOGY, V61, P1210, DOI 10.1016/j.neuropharm.2011.07.010; Ortega F, 2010, CELL MOL LIFE SCI, V67, P1723, DOI 10.1007/s00018-010-0278-x; Ortega F, 2009, NEUROTOX RES, V15, P193, DOI 10.1007/s12640-009-9020-6; Pan QH, 2010, BIOCHEM BIOPH RES CO, V401, P306, DOI 10.1016/j.bbrc.2010.09.058; Pankratov Y, 2009, NEUROSCIENCE, V158, P137, DOI 10.1016/j.neuroscience.2008.03.076; Qiu ZH, 2006, J BIOL CHEM, V281, P16672, DOI 10.1074/jbc.M511648200; Raffaghello L, 2006, CANCER RES, V66, P907, DOI 10.1158/0008-5472.CAN-05-3185; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; Ryu H, 2006, P NATL ACAD SCI USA, V103, P19176, DOI 10.1073/pnas.0606373103; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Seznec J, 2011, J NEURO-ONCOL, V101, P365, DOI 10.1007/s11060-010-0266-x; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Skarratt KK, 2005, FEBS LETT, V579, P2675, DOI 10.1016/j.febslet.2005.03.091; Sperlagh B, 2007, PURINERG SIGNAL, V3, P269, DOI 10.1007/s11302-007-9080-0; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Stack EC, 2007, HUM MOL GENET, V16, P1164, DOI 10.1093/hmg/ddm064; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Sun CQ, 2010, PURINERG SIGNAL, V6, P31, DOI 10.1007/s11302-009-9168-9; Sun SH, 2010, MOL NEUROBIOL, V41, P351, DOI 10.1007/s12035-010-8120-x; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tapias A, 2004, J BIOL CHEM, V279, P19074, DOI 10.1074/jbc.M312611200; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Tsuda M, 2010, BRAIN RES REV, V63, P222, DOI 10.1016/j.brainresrev.2009.11.003; Velasco M, 1997, J IMMUNOL, V158, P4437; Wang RT, 2012, J MOL NEUROSCI, V47, P311, DOI 10.1007/s12031-012-9739-z; Wiley JS, 2003, J BIOL CHEM, V278, P17108, DOI 10.1074/jbc.M212759200; Yoo J, 2002, J BIOL CHEM, V277, P11904, DOI 10.1074/jbc.M111788200; Zhou LY, 2009, PURINERG SIGNAL, V5, P409, DOI 10.1007/s11302-009-9167-x	82	47	47	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44628	44644		10.1074/jbc.M112.390971	http://dx.doi.org/10.1074/jbc.M112.390971			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23139414	Green Published, hybrid			2022-12-28	WOS:000312938600059
J	Kargl, J; Balenga, N; Parzmair, GP; Brown, AJ; Heinemann, A; Waldhoer, M				Kargl, Julia; Balenga, Nariman; Parzmair, Gerald P.; Brown, Andrew J.; Heinemann, Akos; Waldhoer, Maria			The Cannabinoid Receptor CB1 Modulates the Signaling Properties of the Lysophosphatidylinositol Receptor GPR55	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; DELTA-OPIOID RECEPTORS; L-ALPHA-LYSOPHOSPHATIDYLINOSITOL; HETERODIMERIZATION; IDENTIFICATION; MU; PHARMACOLOGY; DOPAMINE; OLIGOMERIZATION; TRAFFICKING	The G protein-coupled receptor (GPCR) 55 (GPR55) and the cannabinoid receptor 1 (CB1R) are co-expressed in many tissues, predominantly in the central nervous system. Seven transmembrane spanning (7TM) receptors/GPCRs can form homo-and heteromers and initiate distinct signaling pathways. Recently, several synthetic CB1 receptor inverse agonists/antagonists, such as SR141716A, AM251, and AM281, were reported to activate GPR55. Of these, SR141716A was marketed as a promising anti-obesity drug, but was withdrawn from the market because of severe side effects. Here, we tested whether GPR55 and CB1 receptors are capable of (i) forming heteromers and (ii) whether such heteromers could exhibit novel signaling patterns. We show that GPR55 and CB1 receptors alter each others signaling properties in human embryonic kidney (HEK293) cells. We demonstrate that the co-expression of FLAG-CB1 receptors in cells stably expressing HA-GPR55 specifically inhibits GPR55-mediated transcription factor activation, such as nuclear factor of activated T-cells and serum response element, as well as extracellular signal-regulated kinases (ERK1/2) activation. GPR55 and CB1 receptors can form heteromers, but the internalization of both receptors is not affected. In addition, we observe that the presence of GPR55 enhances CB1R-mediated ERK1/2 and nuclear factor of activated T-cell activation. Our data provide the first evidence that GPR55 can form heteromers with another 7TM/GPCR and that this interaction with the CB1 receptor has functional consequences in vitro. The GPR55-CB1R heteromer may play an important physiological and/or pathophysiological role in tissues endogenously co-expressing both receptors.	[Kargl, Julia; Balenga, Nariman; Parzmair, Gerald P.; Heinemann, Akos; Waldhoer, Maria] Med Univ Graz, Inst Expt & Clin Pharmacol, A-8010 Graz, Austria; [Brown, Andrew J.] GlaxoSmithKline, Med Res Ctr, Dept Screening & Compound Profiling, Stevenage SG1 2NY, Herts, England; [Balenga, Nariman] NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA	Medical University of Graz; GlaxoSmithKline; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kargl, J (corresponding author), Med Univ Graz, Inst Expt & Clin Pharmacol, A-8010 Graz, Austria.	julia.kargl@medunigraz.at; mriw@novonordisk.com	Aghaei Balenga, Nariman/A-5895-2011; Brown, Andrew J/G-6403-2013; Waldhoer, Maria/HDO-0619-2022	Aghaei Balenga, Nariman/0000-0002-2741-9595; Parzmair, Gerald/0000-0002-7915-6758; Brown, Andrew James/0000-0002-5616-3664; Heinemann, Akos/0000-0002-8554-2372; Waldhoer, Maria/0000-0003-3534-1959; Kargl, Julia/0000-0002-0870-0816	Austrian Science Fund [P18723, P22521]; Jubilaumsfonds of the Austrian National Bank Grant [12552]; Lanyar Stiftung; Medical University of Graz; Austrian Government; START-Funding Program (MUG); BA/CA visiting scientist program; Austrian Science Fund (FWF) [P 22521] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Jubilaumsfonds of the Austrian National Bank Grant; Lanyar Stiftung; Medical University of Graz; Austrian Government; START-Funding Program (MUG); BA/CA visiting scientist program; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund Grants P18723 (to M. W.) and P22521 (to A. H.), Jubilaumsfonds of the Austrian National Bank Grant 12552 (to M. W.), grants form the Lanyar Stiftung (to M. W.), and the Ph.D. program Molecular Medicine from the Medical University of Graz, a research fellowship from the Austrian Government, the START-Funding Program (MUG), and the BA/CA visiting scientist program (to J. K.).	AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Andradas C, 2011, ONCOGENE, V30, P245, DOI 10.1038/onc.2010.402; [Anonymous], 2010, PROBE REPORTS NIH MO; Balenga NAB, 2011, CELL RES, V21, P1452, DOI 10.1038/cr.2011.60; Balenga NAB, 2011, ADV PHARMACOL, V62, P251, DOI 10.1016/B978-0-12-385952-5.00004-X; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; BRADLEY DM, 2006, Patent No. 2006094843; Brown AJ, 2011, J PHARMACOL EXP THER, V337, P236, DOI 10.1124/jpet.110.172650; Buckley NE, 2008, BRIT J PHARMACOL, V153, P309, DOI 10.1038/sj.bjp.0707527; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Carriba P, 2007, NEUROPSYCHOPHARMACOL, V32, P2249, DOI 10.1038/sj.npp.1301375; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Ferre S, 2010, PROG MOL BIOL TRANSL, V91, P41, DOI 10.1016/S1877-1173(10)91002-8; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Ford LA, 2010, BRIT J PHARMACOL, V160, P762, DOI 10.1111/j.1476-5381.2010.00743.x; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Henstridge CM, 2011, MOL ENDOCRINOL, V25, P1835, DOI 10.1210/me.2011-1197; Henstridge CM, 2010, BRIT J PHARMACOL, V160, P604, DOI 10.1111/j.1476-5381.2009.00625.x; Henstridge CM, 2009, FASEB J, V23, P183, DOI 10.1096/fj.08-108670; Hinrichsen L, 2006, P NATL ACAD SCI USA, V103, P8715, DOI 10.1073/pnas.0600312103; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Huang L, 2011, LAB INVEST, V91, P1007, DOI 10.1038/labinvest.2011.62; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan BA, 2003, MOL PHARMACOL, V64, P1317, DOI 10.1124/mol.64.6.1317; Kapur A, 2009, J BIOL CHEM, V284, P29817, DOI 10.1074/jbc.M109.050187; Kargl J, 2012, BRIT J PHARMACOL, V165, P2611, DOI 10.1111/j.1476-5381.2011.01562.x; Kearn CS, 2005, MOL PHARMACOL, V67, P1697, DOI 10.1124/mol.104.006882; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kotsikorou E, 2011, BIOCHEMISTRY-US, V50, P5633, DOI 10.1021/bi200010k; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Martini L, 2010, NEUROPSYCHOPHARMACOL, V35, P1363, DOI 10.1038/npp.2010.6; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Milan-Lobo L, 2011, J PHARMACOL EXP THER, V337, P868, DOI 10.1124/jpet.111.179093; MILLIGAN G, 1995, TRENDS PHARMACOL SCI, V16, P10, DOI 10.1016/S0165-6147(00)88963-4; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Oka S, 2010, J BIOCHEM, V147, P671, DOI 10.1093/jb/mvp208; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pietr M, 2009, FEBS LETT, V583, P2071, DOI 10.1016/j.febslet.2009.05.028; Pineiro R, 2011, ONCOGENE, V30, P142, DOI 10.1038/onc.2010.417; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Rozenfeld R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029239; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sawzdargo M, 1999, MOL BRAIN RES, V64, P193, DOI 10.1016/S0169-328X(98)00277-0; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Sedej M, 2012, J ALLERGY CLIN IMMUN, V129, P492, DOI 10.1016/j.jaci.2011.08.015; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Sharir H, 2010, PHARMACOL THERAPEUT, V126, P301, DOI 10.1016/j.pharmthera.2010.02.004; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Tschische P, 2010, TRAFFIC, V11, P660, DOI 10.1111/j.1600-0854.2010.1045.x; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Wager-Miller J, 2002, CHEM PHYS LIPIDS, V121, P83, DOI 10.1016/S0009-3084(02)00151-2; Waldeck-Weiermair M, 2008, J CELL SCI, V121, P1704, DOI 10.1242/jcs.020958; Waldhoer M, 1998, MOL PHARMACOL, V53, P808; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x	66	68	70	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44234	44248		10.1074/jbc.M112.364109	http://dx.doi.org/10.1074/jbc.M112.364109			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23161546	Green Published, hybrid			2022-12-28	WOS:000312938600022
J	Li, J; Kanekiyo, T; Shinohara, M; Zhang, YW; LaDu, MJ; Xu, HX; Bu, GJ				Li, Jie; Kanekiyo, Takahisa; Shinohara, Mitsuru; Zhang, Yunwu; LaDu, Mary Jo; Xu, Huaxi; Bu, Guojun			Differential Regulation of Amyloid-beta Endocytic Trafficking and Lysosomal Degradation by Apolipoprotein E Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORADIC ALZHEIMERS-DISEASE; GENOME-WIDE ASSOCIATION; SOLUBLE A-BETA; IDENTIFIES VARIANTS; DEPOSITION; CLEARANCE; OLIGOMERS; LOCALIZATION; ACCUMULATION; AGGREGATION	Aggregation of amyloid-beta (A beta) peptides leads to synaptic disruption and neurodegeneration in Alzheimer disease (AD). A major A beta clearance pathway in the brain is cellular uptake and degradation. However, how A beta traffics through the endocytic pathway and how AD risk factors regulate this event is unclear. Here we show that the majority of endocytosed A beta in neurons traffics through early and late endosomes to the lysosomes for degradation. Overexpression of Rab5 or Rab7, small GTPases that function in vesicle fusion for early and late endosomes, respectively, significantly accelerates A beta endocytic trafficking to the lysosomes. We also found that a portion of endocytosed A beta traffics through Rab11-positive recycling vesicles. A blockage of this A beta recycling pathway with a constitutively active Rab11 mutant significantly accelerates cellular A beta accumulation. Inhibition of lysosomal enzymes results in A beta accumulation and aggregation. Importantly, apolipoprotein E (apoE) accelerates neuronal A beta uptake, lysosomal trafficking, and degradation in an isoform-dependent manner with apoE3 more efficiently facilitating A beta trafficking and degradation than apoE4, a risk factor for AD. Taken together, our results demonstrate that A beta endocytic trafficking to lysosomes for degradation is a major A beta clearance pathway that is differentially regulated by apoE isoforms. A disturbance of this pathway can lead to accumulation and aggregation of cellular A beta capable of causing neurotoxicity and seeding amyloid.	[Li, Jie; Zhang, Yunwu; Xu, Huaxi; Bu, Guojun] Xiamen Univ, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Inst Neurosci, Coll Med, Xiamen 361005, Fujian, Peoples R China; [Li, Jie] Xiamen Univ, Sch Pharmaceut Sci, Xiamen 361005, Fujian, Peoples R China; [Li, Jie; Kanekiyo, Takahisa; Shinohara, Mitsuru; Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [LaDu, Mary Jo] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA	Xiamen University; Xiamen University; Mayo Clinic; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bu, GJ (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	bu.guojun@mayo.edu	Zhang, YW/G-3999-2010; Xu, Huaxi/AAV-7177-2021	LaDu, Mary Jo/0000-0003-2141-1450	National Institutes of Health [R01AG027924, R01AG035355, P01AG030128, P01 NS074969]; National Institutes of Health Mayo Clinic Alzheimer's Disease Research Center (ADRC) Pilot Grant [P50AG16574]; Alzheimer's Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016574, R01AG027924, P01AG030128, R01AG038710, R01AG035355, R01AG021173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Mayo Clinic Alzheimer's Disease Research Center (ADRC) Pilot Grant; Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG027924, R01AG035355, P01AG030128, and P01 NS074969 (to G.B.) and National Institutes of Health Mayo Clinic Alzheimer's Disease Research Center (ADRC) Pilot Grant P50AG16574 (to T.K.). This work was also supported by a grant from the Alzheimer's Association (to G.B.).	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Chakrabarty P, 2010, J IMMUNOL, V184, P5333, DOI 10.4049/jimmunol.0903382; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Fuentealba RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011884; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; KNAUER MF, 1992, P NATL ACAD SCI USA, V89, P7437, DOI 10.1073/pnas.89.16.7437; Kok E, 2009, ANN NEUROL, V65, P650, DOI 10.1002/ana.21696; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; LADU MJ, 1994, J BIOL CHEM, V269, P23403; LADU MJ, 1995, J BIOL CHEM, V270, P9039, DOI 10.1074/jbc.270.16.9039; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Liu RQ, 2010, J BIOL CHEM, V285, P19986, DOI 10.1074/jbc.M109.036798; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Manelli AM, 2004, J MOL NEUROSCI, V23, P235, DOI 10.1385/JMN:23:3:235; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nixon RA, 2001, J ALZHEIMERS DIS, V3, P97, DOI 10.3233/JAD-2001-3114; Nixon RA, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P277; Peralvarez-Marin A, 2008, J MOL BIOL, V379, P589, DOI 10.1016/j.jmb.2008.04.014; POLVIKOSKI T, 1995, NEW ENGL J MED, V333, P1242, DOI 10.1056/NEJM199511093331902; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3	44	116	120	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44593	44601		10.1074/jbc.M112.420224	http://dx.doi.org/10.1074/jbc.M112.420224			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23132858	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000312938600056
J	Larsbrink, J; Izumi, A; Hemsworth, GR; Davies, GJ; Brumer, H				Larsbrink, Johan; Izumi, Atsushi; Hemsworth, Glyn R.; Davies, Gideon J.; Brumer, Harry			Structural Enzymology of Cellvibrio japonicus Agd31B Protein Reveals alpha-Transglucosylase Activity in Glycoside Hydrolase Family 31	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOTOGA-MARITIMA MALTOSYLTRANSFERASE; HUMAN MALTASE-GLUCOAMYLASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; THERMOSTABLE 4-ALPHA-GLUCANOTRANSFERASE; THERMUS-AQUATICUS; ACTION PATTERN; GLUCOSIDASE; METABOLISM; AMYLOMALTASE	The metabolism of the storage polysaccharides glycogen and starch is of vital importance to organisms from all domains of life. In bacteria, utilization of these alpha-glucans requires the concerted action of a variety of enzymes, including glycoside hydrolases, glycoside phosphorylases, and transglycosylases. In particular, transglycosylases from glycoside hydrolase family 13 (GH13) and GH77 play well established roles in alpha-glucan side chain (de) branching, regulation of oligo-and polysaccharide chain length, and formation of cyclic dextrans. Here, we present the biochemical and tertiary structural characterization of a new type of bacterial 1,4-alpha-glucan 4-alpha-glucosyltransferase from GH31. Distinct from 1,4-alpha-glucan 6-alpha-glucosyltransferases (EC 2.4.1.24) and 4-alpha-glucanotransferases (EC 2.4.1.25), this enzyme strictly transferred one glucosyl residue from alpha(1 -> 4)-glucans in disproportionation reactions. Substrate hydrolysis was undetectable for a series of malto-oligosaccharides except maltose for which transglycosylation nonetheless dominated across a range of substrate concentrations. Crystallographic analysis of the enzyme in free, acarbose-complexed, and trapped 5-fluoro-beta-glucosyl-enzyme intermediate forms revealed extended substrate interactions across one negative and up to three positive subsites, thus providing structural rationalization for the unique, single monosaccharide transferase activity of the enzyme.	[Izumi, Atsushi; Hemsworth, Glyn R.; Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Larsbrink, Johan; Brumer, Harry] AlbaNova Univ Ctr, Royal Inst Technol, Sch Biotechnol, Div Glycosci, S-10691 Stockholm, Sweden; [Brumer, Harry] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Brumer, Harry] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z4, Canada	University of York - UK; Royal Institute of Technology; University of British Columbia; University of British Columbia	Davies, GJ (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England.	gideon.davies@york.ac.uk; brumer@msl.ubc.ca	Larsbrink, Johan/A-3053-2013; Davies, Gideon J/A-9042-2011; Hemsworth, Glyn/AAS-5473-2021	Larsbrink, Johan/0000-0001-8386-2914; Davies, Gideon J/0000-0002-7343-776X; Hemsworth, Glyn/0000-0002-8226-1380	Mizutani Foundation for Glycoscience; Swedish Research Council Formas (via the European Union WoodWisdom-Net ERA-NET); Swedish Research Council Formas (via "Carbo-Mat-the KTH Advanced Carbohydrate Materials Centre"); Biotechnology and Biological Sciences Research Council [BB/I014802/1]; BBSRC [BB/I014802/1] Funding Source: UKRI	Mizutani Foundation for Glycoscience; Swedish Research Council Formas (via the European Union WoodWisdom-Net ERA-NET)(Swedish Research Council Formas); Swedish Research Council Formas (via "Carbo-Mat-the KTH Advanced Carbohydrate Materials Centre")(Swedish Research Council Formas); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work in Stockholm was supported by the Mizutani Foundation for Glycoscience and The Swedish Research Council Formas (via the European Union WoodWisdom-Net ERA-NET project "FiberSurf: New biotechnological tools for wood fiber surface modification and analysis" and via "Carbo-Mat-the KTH Advanced Carbohydrate Materials Centre"), and work in York was supported by Biotechnology and Biological Sciences Research Council Grant BB/I014802/1.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ball S, 2011, J EXP BOT, V62, P1775, DOI 10.1093/jxb/erq411; Barends TRM, 2007, J BIOL CHEM, V282, P17242, DOI 10.1074/jbc.M701444200; BECKER S, 1994, J BIOL CHEM, V269, P2485; Berezina OV, 1999, MOL BIOL+, V33, P801; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Burlingham BT, 2003, J CHEM EDUC, V80, P214, DOI 10.1021/ed080p214; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; Dippel R, 2005, J BACTERIOL, V187, P8322, DOI 10.1128/JB.187.24.8322-8331.2005; Elbein AD, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P185; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Hazlewood GP, 1998, PROG NUCLEIC ACID RE, V61, P211, DOI 10.1016/S0079-6603(08)60828-4; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Humphry DR, 2003, INT J SYST EVOL MICR, V53, P393, DOI 10.1099/ijs.0.02271-0; Janecek S, 2007, FEBS LETT, V581, P1261, DOI 10.1016/j.febslet.2007.02.036; JONES G, 1969, CARBOHYD RES, V9, P483, DOI 10.1016/S0008-6215(00)80033-6; Jung JH, 2011, PROTEINS, V79, P633, DOI 10.1002/prot.22911; Kato N, 2002, APPL ENVIRON MICROB, V68, P1250, DOI 10.1128/AEM.68.3.1250-1256.2002; Kim YK, 2003, CARBOHYD RES, V338, P2213, DOI 10.1016/S0008-6215(03)00375-6; Kim YM, 2012, FEBS J, V279, P3185, DOI 10.1111/j.1742-4658.2012.08698.x; Kim YM, 2012, J BIOL CHEM, V287, P19927, DOI 10.1074/jbc.M111.339036; Larsbrink J, 2011, BIOCHEM J, V436, P567, DOI 10.1042/BJ20110299; Lee SS, 2003, BIOCHEMISTRY-US, V42, P13081, DOI 10.1021/bi035189g; Lee SS, 2001, BIOCHEM J, V359, P381, DOI 10.1042/0264-6021:3590381; Leemhuis H, 2010, APPL MICROBIOL BIOT, V85, P823, DOI 10.1007/s00253-009-2221-3; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; LIEBL W, 1992, EUR J BIOCHEM, V207, P81, DOI 10.1111/j.1432-1033.1992.tb17023.x; Meissner H, 1998, EUR J BIOCHEM, V258, P1050, DOI 10.1046/j.1432-1327.1998.2581050.x; Mukai K, 2004, BIOSCI BIOTECH BIOCH, V68, P2529, DOI 10.1271/bbb.68.2529; Okuyama M, 2004, PROTEIN EXPRES PURIF, V37, P170, DOI 10.1016/j.pep.2004.05.008; PALMER TN, 1976, EUR J BIOCHEM, V69, P105, DOI 10.1111/j.1432-1033.1976.tb10863.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Przylas I, 2000, J MOL BIOL, V296, P873, DOI 10.1006/jmbi.1999.3503; Ren LM, 2011, CARBOHYD RES, V346, P2688, DOI 10.1016/j.carres.2011.09.012; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Rossi EJ, 2006, FEBS J, V273, P2673, DOI 10.1111/j.1742-4658.2006.05283.x; Roujeinikova A, 2002, J MOL BIOL, V321, P149, DOI 10.1016/S0022-2836(02)00570-3; Roujeinikova A, 2001, J MOL BIOL, V312, P119, DOI 10.1006/jmbi.2001.4944; SCHWARTZ M, 1967, EUR J BIOCHEM, V2, P132, DOI 10.1111/j.1432-1033.1967.tb00117.x; Seo SH, 2011, J MOL CATAL B-ENZYM, V72, P305, DOI 10.1016/j.molcatb.2011.07.006; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Stick RV, 2009, CARBOHYDRATES: THE ESSENTIAL MOLECULES OF LIFE, 2ND EDITION, P1; Sundqvist G, 2007, J CHROMATOGR B, V852, P188, DOI 10.1016/j.jchromb.2007.01.011; Suzuki R, 2012, BBA-PROTEINS PROTEOM, V1824, P919, DOI 10.1016/j.bbapap.2012.04.001; TAKAHA T, 1993, J BIOL CHEM, V268, P1391; Takaha T, 1999, BIOTECHNOL GENET ENG, V16, P257, DOI 10.1080/02648725.1999.10647978; Tan KM, 2010, FASEB J, V24, P3939, DOI 10.1096/fj.10-156257; Terada Y, 1999, APPL ENVIRON MICROB, V65, P910; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang YH, 2009, BIOLOGIA, V64, P1053, DOI 10.2478/s11756-009-0197-1; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WITHERS SG, 1990, J AM CHEM SOC, V112, P5887, DOI 10.1021/ja00171a043; Yamamoto T, 2004, BBA-PROTEINS PROTEOM, V1700, P189, DOI 10.1016/j.bbapap.2004.05.002; Zhou C, 2009, J MICROBIOL BIOTECHN, V19, P1547, DOI 10.4014/jmb.0905.05006	66	32	33	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43288	43299		10.1074/jbc.M112.416511	http://dx.doi.org/10.1074/jbc.M112.416511			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23132856	Green Published, hybrid			2022-12-28	WOS:000312940800010
J	Voss, M; Fukumori, A; Kuhn, PH; Kunzel, U; Klier, B; Grammer, G; Haug-Kroper, M; Kremmer, E; Lichtenthaler, SF; Steiner, H; Schroder, B; Haass, C; Fluhrer, R				Voss, Matthias; Fukumori, Akio; Kuhn, Peer-Hendrik; Kuenzel, Ulrike; Klier, Baerbel; Grammer, Gudula; Haug-Kroeper, Martina; Kremmer, Elisabeth; Lichtenthaler, Stefan F.; Steiner, Harald; Schroeder, Bernd; Haass, Christian; Fluhrer, Regina			Foamy Virus Envelope Protein Is a Substrate for Signal Peptide Peptidase-like 3 (SPPL3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; GAMMA-SECRETASE ACTIVITY; ENV LEADER PROTEIN; ASPARTIC PROTEASE; TNF-ALPHA; CLEAVAGE; PRESENILIN; GLYCOPROTEIN; DOMAIN; IDENTIFICATION	Signal peptide peptidase (SPP), its homologs, the SPP-like proteases SPPL2a/b/c and SPPL3, as well as presenilin, the catalytic subunit of the gamma-secretase complex, are intramembrane-cleaving aspartyl proteases of the GxGD type. In this study, we identified the 18-kDa leader peptide (LP18) of the foamy virus envelope protein (FVenv) as a new substrate for intramembrane proteolysis by human SPPL3 and SPPL2a/b. In contrast to SPPL2a/b and gamma-secretase, which require substrates with an ectodomain shorter than 60 amino acids for efficient intramembrane proteolysis, SPPL3 cleaves mutant FVenv lacking the proprotein convertase cleavage site necessary for the prior shedding. Moreover, the cleavage product of FVenv generated by SPPL3 serves as a new substrate for consecutive intramembrane cleavage by SPPL2a/b. Thus, human SPPL3 is the first GxGD-type aspartyl protease shown to be capable of acting like a sheddase, similar to members of the rhomboid family, which belong to the class of intramembrane-cleaving serine proteases.	[Voss, Matthias; Fukumori, Akio; Kuenzel, Ulrike; Klier, Baerbel; Grammer, Gudula; Haug-Kroeper, Martina; Steiner, Harald; Haass, Christian; Fluhrer, Regina] Univ Munich, Adolf Butenandt Inst Biochem, D-80336 Munich, Germany; [Kuhn, Peer-Hendrik; Kremmer, Elisabeth; Lichtenthaler, Stefan F.; Steiner, Harald; Haass, Christian; Fluhrer, Regina] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Lichtenthaler, Stefan F.; Haass, Christian] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany; [Kremmer, Elisabeth] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Lichtenthaler, Stefan F.] Tech Univ Munich, D-81377 Munich, Germany; [Schroeder, Bernd] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Kiel	Fluhrer, R (corresponding author), Univ Munich, Adolf Butenandt Inst Biochem, Schillerstr 44, D-80336 Munich, Germany.	regina.fluhrer@dzne.lmu.de	Schröder, Bernd/C-5504-2011; Lichtenthaler, Stefan F/B-6587-2016	Lichtenthaler, Stefan F/0000-0003-2211-2575; Voss, Matthias/0000-0002-4217-3175; Kuhn, Peer-Hendrik/0000-0001-7891-5102	Deutsche Forschungsgemeinschaft [HA 1737-11]; Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung; Hans und Ilse Breuer Stiftung; Elitenetwork of Bavaria within the Graduate Program "Protein Dynamics in Health and Disease"; "Forschungsprofessur" from the Ludwig-Maximilians University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung; Hans und Ilse Breuer Stiftung; Elitenetwork of Bavaria within the Graduate Program "Protein Dynamics in Health and Disease"; "Forschungsprofessur" from the Ludwig-Maximilians University	This work was supported in part by Deutsche Forschungsgemeinschaft Grant HA 1737-11 (to R. F. and C. H.) and the Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung.; Supported by a Ph.D. fellowship from the Hans und Ilse Breuer Stiftung and by the Elitenetwork of Bavaria within the Graduate Program "Protein Dynamics in Health and Disease."; Member of the Center for Integrated Protein Science Munich (CIPSM). Supported by a "Forschungsprofessur" from the Ludwig-Maximilians University.	Bansal A, 2000, J VIROL, V74, P2949, DOI 10.1128/JVI.74.6.2949-2954.2000; Chen G, 2010, PROTEIN SCI, V19, P2015, DOI 10.1002/pro.496; Duda A, 2004, J VIROL, V78, P13865, DOI 10.1128/JVI.78.24.13865-13870.2004; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fluhrer R, 2002, J NEUROCHEM, V81, P1011, DOI 10.1046/j.1471-4159.2002.00908.x; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fluhrer R, 2012, J BIOL CHEM, V287, P5156, DOI 10.1074/jbc.M111.328104; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Freeman M, 2009, SEMIN CELL DEV BIOL, V20, P231, DOI 10.1016/j.semcdb.2008.10.006; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Geiselhart V, 2004, J VIROL, V78, P13573, DOI 10.1128/JVI.78.24.13573-13581.2004; Geiselhart V, 2003, VIROLOGY, V310, P235, DOI 10.1016/S0042-6822(03)00125-9; GOEPFERT PA, 1995, CELL, V82, P543, DOI 10.1016/0092-8674(95)90026-8; Lemberg MK, 2007, MOL CELL, V28, P930, DOI 10.1016/j.molcel.2007.12.003; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Lindemann D, 2001, J VIROL, V75, P5762, DOI 10.1128/JVI.75.13.5762-5771.2001; Lindemann D, 2011, VIRUSES-BASEL, V3, P561, DOI 10.3390/v3050561; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; Meiering CD, 2001, CLIN MICROBIOL REV, V14, P165, DOI 10.1128/CMR.14.1.165-176.2001; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Nyborg AC, 2006, FASEB J, V20, P1671, DOI 10.1096/fj.06-5762com; Schrul B, 2010, BIOCHEM J, V427, P523, DOI 10.1042/BJ20091005; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Trobridge G, 2002, MOL THER, V6, P321, DOI 10.1006/mthe.2002.0672; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200	35	34	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43401	43409		10.1074/jbc.M112.371369	http://dx.doi.org/10.1074/jbc.M112.371369			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23132852	hybrid, Green Published			2022-12-28	WOS:000312940800021
J	Wang, CK; Wacklin, HP; Craik, DJ				Wang, Conan K.; Wacklin, Hanna P.; Craik, David J.			Cyclotides Insert into Lipid Bilayers to Form Membrane Pores and Destabilize the Membrane through Hydrophobic and Phosphoethanolamine-specific Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC CYSTINE KNOT; POLYPEPTIDE KALATA B1; ANTI-HIV CYCLOTIDES; PLANT CYCLOTIDES; CIRCULAR PROTEINS; ANTIMICROBIAL PEPTIDES; NEUTRON REFLECTIVITY; MACROCYCLIC PEPTIDES; OLDENLANDIA-AFFINIS; SPATIAL STRUCTURE	Cyclotides are a family of plant-derived circular proteins with potential therapeutic applications arising from their remarkable stability, broad sequence diversity, and range of bioactivities. Their membrane-binding activity is believed to be a critical component of their mechanism of action. Using isothermal titration calorimetry, we studied the binding of the prototypical cyclotides kalata B1 and kalata B2 (and various mutants) to dodecylphosphocholine micelles and phosphoethanolamine-containing lipid bilayers. Although binding is predominantly an entropy-driven process, suggesting that hydrophobic forces contribute significantly to cyclotide-lipid complex formation, specific binding to the phosphoethanolamine-lipid headgroup is also required, which is evident from the enthalpic changes in the free energy of binding. In addition, using a combination of dissipative quartz crystal microbalance measurements and neutron reflectometry, we elucidated the process by which cyclotides interact with bilayer membranes. Initially, a small number of cyclotides bind to the membrane surface and then insert first into the outer membrane leaflet followed by penetration through the membrane and pore formation. At higher concentrations of cyclotides, destabilization of membranes occurs. Our results provide significant mechanistic insight into how cyclotides exert their bioactivities.	[Wang, Conan K.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Wacklin, Hanna P.] Australian Nucl Sci & Technol Org, Natl Deuterat Facil, Sydney, NSW 2234, Australia	University of Queensland; Australian Nuclear Science & Technology Organisation	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Craik, David/B-1695-2010; Wang, Conan K/D-1481-2010	Craik, David/0000-0003-0007-6796; Wang, Conan K/0000-0002-7973-7632	Australian Research Council Grant [DP0984390]; Australian Nuclear Science and Technology Organisation [04/08-N-40]	Australian Research Council Grant(Australian Research Council); Australian Nuclear Science and Technology Organisation	This work was supported in part by Australian Research Council Grant DP0984390. Travel was supported by Australian Nuclear Science and Technology Organisation Grant 04/08-N-40 for neutron reflectometry.	Armen RS, 1998, BIOPHYS J, V75, P734, DOI 10.1016/S0006-3495(98)77563-0; Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; Colgrave ML, 2008, CHEMBIOCHEM, V9, P1939, DOI 10.1002/cbic.200800174; Colgrave ML, 2008, BIOCHEMISTRY-US, V47, P5581, DOI 10.1021/bi800223y; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2002, CURR OPIN DRUG DI DE, V5, P251; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Fernandez-Vidal M, 2011, J MEMBRANE BIOL, V239, P5, DOI 10.1007/s00232-010-9321-y; Goransson U, 2004, CURR PROTEIN PEPT SC, V5, P317, DOI 10.2174/1389203043379495; Goransson U, 2012, J BIOL CHEM, V287, P27001, DOI 10.1074/jbc.R111.300129; Gould A, 2011, CURR PHARM DESIGN, V17, P4294, DOI 10.2174/138161211798999438; GRAN L, 1973, LLOYDIA, V36, P174; Greenwood KP, 2007, INT J BIOCHEM CELL B, V39, P2252, DOI 10.1016/j.biocel.2007.06.016; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Gustafson KR, 2004, CURR PROTEIN PEPT SC, V5, P331, DOI 10.2174/1389203043379468; Heavens O.S, 1991, OPTICAL PROPERTIES T; Henriques ST, 2012, J BIOL CHEM, V287, P33629, DOI 10.1074/jbc.M112.372011; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; Kamimori H, 2005, ANAL BIOCHEM, V337, P149, DOI 10.1016/j.ab.2004.10.028; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; Mulvenna JP, 2006, PLANT CELL, V18, P2134, DOI 10.1105/tpc.106.042812; Mulvenna JP, 2006, NUCLEIC ACIDS RES, V34, pD192, DOI 10.1093/nar/gkj005; Nelson A, 2006, J APPL CRYSTALLOGR, V39, P273, DOI 10.1107/S0021889806005073; Nguyen GKT, 2012, J BIOL CHEM, V287, P17598, DOI 10.1074/jbc.M111.338970; Nourse A, 2004, J BIOL CHEM, V279, P562, DOI 10.1074/jbc.M306826200; Parisi Michael, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-198; PENFOLD J, 1991, PHYSICA B, V173, P1, DOI 10.1016/0921-4526(91)90028-D; Pinto MFS, 2012, J BIOL CHEM, V287, P134, DOI 10.1074/jbc.M111.294009; Plan MRR, 2008, J AGR FOOD CHEM, V56, P5237, DOI 10.1021/jf800302f; Poth AG, 2011, P NATL ACAD SCI USA, V108, P10127, DOI 10.1073/pnas.1103660108; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; Sando L, 2011, CHEMBIOCHEM, V12, P2456, DOI 10.1002/cbic.201100450; Schoepke T., 1993, SCI PHARM, V61, P145; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Shenkarev ZO, 2008, J INORG BIOCHEM, V102, P1246, DOI 10.1016/j.jinorgbio.2008.01.018; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; SILVIUS JR, 1986, BIOCHIM BIOPHYS ACTA, V857, P217, DOI 10.1016/0005-2736(86)90350-0; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; Simonsen SM, 2004, FEBS LETT, V577, P399, DOI 10.1016/j.febslet.2004.10.034; Skjeldal L, 2002, ARCH BIOCHEM BIOPHYS, V399, P142, DOI 10.1006/abbi.2002.2769; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tam JP, 1999, J AM CHEM SOC, V121, P4316, DOI 10.1021/ja984480u; Tang J, 2010, PEPTIDES, V31, P1434, DOI 10.1016/j.peptides.2010.05.004; Thongyoo P, 2009, J MED CHEM, V52, P6197, DOI 10.1021/jm901233u; Vacklin HP, 2005, LANGMUIR, V21, P2827, DOI 10.1021/la047389e; Vacklin HP, 2005, BIOCHEMISTRY-US, V44, P2811, DOI 10.1021/bi047727a; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wang CKL, 2008, J NAT PROD, V71, P47, DOI 10.1021/np070393g; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002; Wong CTT, 2012, ANGEW CHEM INT EDIT, V51, P5620, DOI 10.1002/anie.201200984; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	59	51	52	0	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43884	43898		10.1074/jbc.M112.421198	http://dx.doi.org/10.1074/jbc.M112.421198			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129773	Green Published, hybrid			2022-12-28	WOS:000312940800065
J	Dobruk-Serkowska, A; Caccamo, M; Rodriguez-Castaneda, F; Wu, MY; Bryce, K; Ng, I; Schumacher, MA; Barilla, D; Hayes, F				Dobruk-Serkowska, Aneta; Caccamo, Marisa; Rodriguez-Castaneda, Fernando; Wu, Meiyi; Bryce, Kerstyn; Ng, Irene; Schumacher, Maria A.; Barilla, Daniela; Hayes, Finbarr			Uncoupling of Nucleotide Hydrolysis and Polymerization in the ParA Protein Superfamily Disrupts DNA Segregation Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CHROMOSOME SEGREGATION; PLASMID-PARTITION; STRUCTURAL BIOLOGY; NONSPECIFIC DNA; ATP-BINDING; SOPA; SEGROSOME; MECHANISM; COMPLEX; MOTIF	DNA segregation in bacteria is mediated most frequently by proteins of the ParA superfamily that transport DNA molecules attached via the segrosome nucleoprotein complex. Segregation is governed by a cycle of ATP-induced polymerization and subsequent depolymerization of the ParA factor. Here, we establish that hyperactive ATPase variants of the ParA homolog ParF display altered segrosome dynamics that block accurate DNA segregation. An arginine finger-like motif in the ParG centromere-binding factor augments ParF ATPase activity but is ineffective in stimulating nucleotide hydrolysis by the hyperactive proteins. Moreover, whereas polymerization of wild-type ParF is accelerated by ATP and inhibited by ADP, filamentation of the mutated proteins is blocked indiscriminately by nucleotides. The mutations affect a triplet of conserved residues that are situated neither in canonical nucleotide binding and hydrolysis motifs in the ParF tertiary structure nor at interfaces implicated in ParF polymerization. Instead the residues are involved in shaping the contours of the binding pocket so that nucleotide binding locks the mutant proteins into a configuration that is refractory to polymerization. Thus, the architecture of the pocket not only is crucial for optimal ATPase kinetics but also plays a key role in the polymerization dynamics of ParA proteins that drive DNA segregation ubiquitously in procaryotes.	[Dobruk-Serkowska, Aneta; Caccamo, Marisa; Wu, Meiyi; Hayes, Finbarr] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; [Dobruk-Serkowska, Aneta; Caccamo, Marisa; Wu, Meiyi; Bryce, Kerstyn; Hayes, Finbarr] Univ Manchester, Fac Life Sci, Manchester M1 7DN, Lancs, England; [Rodriguez-Castaneda, Fernando; Ng, Irene; Barilla, Daniela] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Schumacher, Maria A.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	University of Manchester; University of Manchester; University of York - UK; Duke University	Hayes, F (corresponding author), Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.	finbarr.hayes@manchester.ac.uk		Barilla, Daniela/0000-0002-3486-7492	Biotechnology and Biological Sciences Research Council [G003114]; Medical Research Council [G0801162]; National Institutes of Health [GM074815]; M.D. Anderson Trust Fellowship; Burroughs Wellcome Career Development Award; Overseas Research Student Awards Scheme; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074815] Funding Source: NIH RePORTER; BBSRC [BB/G003114/1] Funding Source: UKRI; MRC [G0801162] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003114/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M.D. Anderson Trust Fellowship; Burroughs Wellcome Career Development Award(Burroughs Wellcome Fund); Overseas Research Student Awards Scheme; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by Biotechnology and Biological Sciences Research Council Grant G003114 (to F. H.). This work was also supported by Medical Research Council Grant G0801162 (to D. B.) and by National Institutes of Health Grant GM074815, an M.D. Anderson Trust Fellowship, and a Burroughs Wellcome Career Development Award (to M. A. S.).; Supported in part by a scholarship from the Overseas Research Student Awards Scheme.	Adachi S, 2006, J MOL BIOL, V356, P850, DOI 10.1016/j.jmb.2005.11.088; Anand SP, 2008, MOL MICROBIOL, V67, P881, DOI 10.1111/j.1365-2958.2007.06100.x; Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Barilla D, 2003, MOL MICROBIOL, V49, P487, DOI 10.1046/j.1365-2958.2003.03564.x; Barilla D, 2007, P NATL ACAD SCI USA, V104, P1811, DOI 10.1073/pnas.0607216104; Bloom K, 2010, NATURE, V463, P446, DOI 10.1038/nature08912; Bouet JY, 2007, MOL MICROBIOL, V63, P468, DOI 10.1111/j.1365-2958.2006.05537.x; Carmelo E, 2005, J BIOL CHEM, V280, P28683, DOI 10.1074/jbc.M501173200; Castaing JP, 2008, MOL MICROBIOL, V70, P1000, DOI 10.1111/j.1365-2958.2008.06465.x; Drew KRP, 2011, P NATL ACAD SCI USA, V108, P11075, DOI 10.1073/pnas.1018724108; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Golovanov AP, 2003, MOL MICROBIOL, V50, P1141, DOI 10.1046/j.1365-2958.2003.03750.x; Havey JC, 2012, NUCLEIC ACIDS RES, V40, P801, DOI 10.1093/nar/gkr747; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hayes F, 1998, J BACTERIOL, V180, P6415; Hayes F, 2000, MOL MICROBIOL, V37, P528, DOI 10.1046/j.1365-2958.2000.02030.x; Hayes F, 2006, TRENDS BIOCHEM SCI, V31, P247, DOI 10.1016/j.tibs.2006.03.002; Hayes F, 2010, BACTERIAL CHROMATIN, P49, DOI 10.1007/978-90-481-3473-1_4; HE L, 1993, MOL MICROBIOL, V9, P1131, DOI 10.1111/j.1365-2958.1993.tb01243.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kim KS, 2005, J BIOL CHEM, V280, P34667, DOI 10.1074/jbc.M505005200; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; LUDTKE DN, 1989, J MOL BIOL, V209, P393, DOI 10.1016/0022-2836(89)90005-3; Machon C, 2007, J MOL BIOL, V374, P1, DOI 10.1016/j.jmb.2007.09.025; MOTALLEBIVESHAREH M, 1990, MOL MICROBIOL, V4, P1455, DOI 10.1111/j.1365-2958.1990.tb02056.x; Ni LS, 2010, P NATL ACAD SCI USA, V107, P11763, DOI 10.1073/pnas.1003817107; Possoz C, 2012, FRONT BIOSCI-LANDMRK, V17, P1020, DOI 10.2741/3971; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schumacher MA, 2008, BIOCHEM J, V412, P1, DOI 10.1042/BJ20080359; Schumacher MA, 2007, CURR OPIN STRUC BIOL, V17, P103, DOI 10.1016/j.sbi.2006.11.005; Schumacher MA, 2012, J BIOL CHEM, V287, P26146, DOI 10.1074/jbc.M112.373696; Schumacher MA, 2012, CURR OPIN STRUC BIOL, V22, P72, DOI 10.1016/j.sbi.2011.11.001; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Wu MY, 2011, NUCLEIC ACIDS RES, V39, P5082, DOI 10.1093/nar/gkr115	42	8	8	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42545	42553		10.1074/jbc.M112.410324	http://dx.doi.org/10.1074/jbc.M112.410324			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23093445	Green Published, hybrid			2022-12-28	WOS:000312501600016
J	Sun, HY; Hunter, T				Sun, Huaiyu; Hunter, Tony			Poly-Small Ubiquitin-like Modifier (PolySUMO)-binding Proteins Identified through a String Search	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMINE-DNA GLYCOSYLASE; PROMYELOCYTIC LEUKEMIA PROTEIN; FAS-BINDING-PROTEIN; SUMO MODIFICATION; CRYSTAL-STRUCTURE; NUCLEAR-BODIES; C-MYB; FLASH; TRANSCRIPTION; MOTIF	Polysumoylation is a crucial cellular response to stresses against genomic integrity or proteostasis. Like the small ubiquitin-like modifier (SUMO)-targeted ubiquitin ligase RNF4, proteins with clustered SUMO-interacting motifs (SIMs) can be important signal transducers downstream of polysumoylation. To identify novel polySUMO-binding proteins, we conducted a computational string search with a custom Python script. We found clustered SIMs in another RING domain protein Arkadia/RNF111. Detailed biochemical analysis of the Arkadia SIMs revealed that dominant SIMs in a SIM cluster often contain a pentameric VIDLT ((V/I/L/F/Y)(V/I)DLT) core sequence that is also found in the SIMs in PIAS family E3s and is likely the best-fitted structure for SUMO recognition. This idea led to the identification of additional novel SIM clusters in FLASH/CASP8AP2, C5orf25, and SOBP/JXC1. We suggest that the clustered SIMs in these proteins form distinct SUMO binding domains to recognize diverse forms of protein sumoylation.	[Sun, Huaiyu; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Sun, HY (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hsun@salk.edu; hunter@salk.edu			National Institutes of Health [CA14195, CA80100, CA82683]; NATIONAL CANCER INSTITUTE [R01CA080100, R01CA082683, P30CA014195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA14195, CA80100, and CA82683 (to T.H.).	Alm-Kristiansen AH, 2008, ONCOGENE, V27, P4644, DOI 10.1038/onc.2008.105; Alm-Kristiansen AH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-21; Alm-Kristiansen AH, 2009, BIOCHEM BIOPH RES CO, V387, P494, DOI 10.1016/j.bbrc.2009.07.053; Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Armstrong AA, 2012, NATURE, V483, P59, DOI 10.1038/nature10883; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14802, DOI 10.1073/pnas.0604225103; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14808, DOI 10.1073/pnas.0604227103; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Birk E, 2010, AM J HUM GENET, V87, P694, DOI 10.1016/j.ajhg.2010.10.005; Boddy MN, 1996, ONCOGENE, V13, P971; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Chen Z, 2008, J NEUROSCI, V28, P6633, DOI 10.1523/JNEUROSCI.1280-08.2008; Cho G, 2009, J BIOL CHEM, V284, P19592, DOI 10.1074/jbc.M109.010181; Creton S, 2010, CELL, V143, P848, DOI 10.1016/j.cell.2010.11.026; Episkopou V, 2001, NATURE, V410, P825, DOI 10.1038/35071095; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Koonin EV, 1999, NATURE, V401, P662, DOI 10.1038/44317; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lee PSW, 2003, J BIOL CHEM, V278, P27853, DOI 10.1074/jbc.M301755200; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Li YJ, 2012, P NATL ACAD SCI USA, V109, P4092, DOI 10.1073/pnas.1109131109; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Lin X, 2003, J BIOL CHEM, V278, P18714, DOI 10.1074/jbc.M302243200; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Matunis MJ, 2006, DEV CELL, V11, P596, DOI 10.1016/j.devcel.2006.10.011; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Milovic-Holm K, 2007, EMBO J, V26, P391, DOI 10.1038/sj.emboj.7601504; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Miteva M, 2010, SUBCELL BIOCHEM, V54, P195, DOI 10.1007/978-1-4419-6676-6_16; Namanja AT, 2012, J BIOL CHEM, V287, P3231, DOI 10.1074/jbc.M111.293118; Niederlander C, 2001, NATURE, V410, P830, DOI 10.1038/35071103; Ogawa H, 2009, MOL BIOL CELL, V20, P4235, DOI 10.1091/mbc.E08-12-1247; Okura T, 1996, J IMMUNOL, V157, P4277; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Ryu SW, 2000, BIOCHEM BIOPH RES CO, V279, P6, DOI 10.1006/bbrc.2000.3882; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Shen ZY, 1996, GENOMICS, V37, P183, DOI 10.1006/geno.1996.0540; Shen ZY, 1996, GENOMICS, V36, P271, DOI 10.1006/geno.1996.0462; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Song AX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013202; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Street AG, 1999, P NATL ACAD SCI USA, V96, P9074, DOI 10.1073/pnas.96.16.9074; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Tanaka N, 2010, BIOSCI BIOTECH BIOCH, V74, P1302, DOI 10.1271/bbb.100082; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Uchimura Y, 2006, J BIOL CHEM, V281, P23180, DOI 10.1074/jbc.M602280200; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Uwada J, 2010, BIOCHEM BIOPH RES CO, V391, P407, DOI 10.1016/j.bbrc.2009.11.071; Vogt B, 2012, METHODS MOL BIOL, V832, P249, DOI 10.1007/978-1-61779-474-2_18; Weatheritt RJ, 2012, TRENDS BIOCHEM SCI, V37, P333, DOI 10.1016/j.tibs.2012.05.001; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yang SH, 2010, MOL CELL BIOL, V30, P2193, DOI 10.1128/MCB.01510-09; Yang XC, 2009, MOL CELL, V36, P267, DOI 10.1016/j.molcel.2009.08.016; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Yousef AF, 2010, ONCOGENE, V29, P4693, DOI 10.1038/onc.2010.226; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	78	71	77	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42071	42083		10.1074/jbc.M112.410985	http://dx.doi.org/10.1074/jbc.M112.410985			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086935	Green Published, hybrid			2022-12-28	WOS:000312103000046
J	Polster, A; Ohrtman, JD; Beam, KG; Papadopoulos, S				Polster, Alexander; Ohrtman, Joshua D.; Beam, Kurt G.; Papadopoulos, Symeon			Fluorescence Resonance Energy Transfer (FRET) Indicates That Association with the Type I Ryanodine Receptor (RyR1) Causes Reorientation of Multiple Cytoplasmic Domains of the Dihydropyridine Receptor (DHPR) alpha(1S) Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL BETA-SUBUNIT; SKELETAL-MUSCLE; III-LOOP; CALCIUM-CHANNEL; SARCOPLASMIC-RETICULUM; PROTEINS; JUNCTION; TRIAD; REGIONS; ARRAYS	The skeletal muscle dihydropyridine receptor (DHPR) in the t-tubular membrane serves as the Ca2+ channel and voltage sensor for excitation-contraction (EC) coupling, triggering Ca2+ release via the type 1 ryanodine receptor (RyR1) in the sarcoplasmic reticulum (SR). The two proteins appear to be physically linked, and both the alpha(1S) and beta(1a) subunits of the DHPR are essential for EC coupling. Within alpha(1S), cytoplasmic domains of importance include the I-II loop (to which beta(1a) binds), the II-III and III-IV loops, and the C terminus. However, the spatial relationship of these domains to one another has not been established. Here, we have taken the approach of measuring FRET between fluorescent proteins inserted into pairs of alpha(1S) cytoplasmic domains. Expression of these constructs in dyspedic (RyR1 null) and dysgenic (alpha(1S) null) myotubes was used to test for function and targeting to plasma membrane/SR junctions and to test whether the presence of RyR1 caused altered FRET. We found that in the absence of RyR1, measureable FRET occurred between the N terminus and C terminus (residue 1636), and between the II-III loop (residue 626) and both the N and C termini; the I-II loop (residue 406) showed weak FRET with the II-III loop but not with the N terminus. Association with RyR1 caused II-III loop FRET to decrease with the C terminus and increase with the N terminus and caused I-II loop FRET to increase with both the II-III loop and N terminus. Overall, RyR1 appears to cause a substantial reorientation of the cytoplasmic alpha(1S) domains consistent with their becoming more closely packed.	[Polster, Alexander; Papadopoulos, Symeon] Univ Cologne, Dept Vegetat Physiol, D-50931 Cologne, Germany; [Polster, Alexander; Ohrtman, Joshua D.; Beam, Kurt G.] Univ Colorado, Dept Physiol & Biophys, Aurora, CO 80045 USA	University of Cologne; University of Colorado System; University of Colorado Anschutz Medical Campus	Papadopoulos, S (corresponding author), Univ Cologne, Dept Vegetat Physiol, Robert Koch Str 39, D-50931 Cologne, Germany.	spapadop@uni-koeln.de			Deutsche Forschungsgemeinschaft [PA 801/6-1]; National Institutes of Health [AR055104, MDA 176448]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055104] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Deutsche Forschungsgemeinschaft Grant PA 801/6-1 (to S. P.) and by National Institutes of Health Grants AR055104 and MDA 176448 (to K. G. B.).	ARMSTRONG CM, 1972, BIOCHIM BIOPHYS ACTA, V267, P605, DOI 10.1016/0005-2728(72)90194-6; Bannister RA, 2005, BIOCHEM BIOPH RES CO, V336, P134, DOI 10.1016/j.bbrc.2005.08.047; Bannister RA, 2008, J BIOL CHEM, V283, P23217, DOI 10.1074/jbc.M804312200; Bannister RA, 2009, J GEN PHYSIOL, V134, P35, DOI 10.1085/jgp.200910241; Beam KG, 1997, METHOD CELL BIOL, V52, P283, DOI 10.1016/S0091-679X(08)60384-2; Beurg M, 1999, BIOPHYS J, V76, P1744, DOI 10.1016/S0006-3495(99)77336-4; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; Buck ED, 1997, J BIOL CHEM, V272, P7360, DOI 10.1074/jbc.272.11.7360; Cheng WJ, 2005, P NATL ACAD SCI USA, V102, P19225, DOI 10.1073/pnas.0504334102; Coronado R, 2004, BIOL RES, V37, P565; DEWAARD M, 1995, J BIOL CHEM, V270, P12056, DOI 10.1074/jbc.270.20.12056; Dirksen RT, 2002, FRONT BIOSCI-LANDMRK, V7, pD659, DOI 10.2741/dirksen; DOSREMEDIOS CG, 1995, J STRUCT BIOL, V115, P175, DOI 10.1006/jsbi.1995.1042; Flucher BE, 2000, J CELL BIOL, V151, P467, DOI 10.1083/jcb.151.2.467; FRANZINI.C, 1970, J CELL BIOL, V47, P488, DOI 10.1083/jcb.47.2.488; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; INUI M, 1987, J BIOL CHEM, V262, P1740; KNUDSON CM, 1989, J BIOL CHEM, V264, P1345; Kugler G, 2004, J BIOL CHEM, V279, P4721, DOI 10.1074/jbc.M307538200; Leuranguer V, 2006, J BIOL CHEM, V281, P3521, DOI 10.1074/jbc.M509566200; LU XY, 1994, J BIOL CHEM, V269, P6511; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; Neuhuber B, 1998, P NATL ACAD SCI USA, V95, P5015, DOI 10.1073/pnas.95.9.5015; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Paolini C, 2004, P NATL ACAD SCI USA, V101, P12748, DOI 10.1073/pnas.0404836101; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Proenza C, 2000, J BIOL CHEM, V275, P23169, DOI 10.1074/jbc.M003389200; Proenza C, 2002, J BIOL CHEM, V277, P6530, DOI 10.1074/jbc.M106471200; Protasi F, 1998, J CELL BIOL, V140, P831, DOI 10.1083/jcb.140.4.831; Protasi F, 2002, BIOPHYS J, V83, P3230, DOI 10.1016/S0006-3495(02)75325-3; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Schredelseker J, 2009, J BIOL CHEM, V284, P1242, DOI 10.1074/jbc.M807767200; Sencer S, 2001, J BIOL CHEM, V276, P38237; Sheridan DC, 2006, P NATL ACAD SCI USA, V103, P19760, DOI 10.1073/pnas.0609473103; Sheridan DC, 2012, CHANNELS, V6, P26, DOI 10.4161/chan.18916; SUN XH, 1995, J CELL BIOL, V129, P659, DOI 10.1083/jcb.129.3.659; Takekura H, 2004, MOL BIOL CELL, V15, P5408, DOI 10.1091/mbc.E04-05-0414; Takekura H, 1999, DEV DYNAM, V214, P372, DOI 10.1002/(SICI)1097-0177(199904)214:4<372::AID-AJA9>3.0.CO;2-Q; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Weiss RG, 2004, AM J PHYSIOL-CELL PH, V287, pC1094, DOI 10.1152/ajpcell.00173.2004; Wolf M, 2003, J MOL BIOL, V332, P171, DOI 10.1016/S0022-2836(03)00899-4	48	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41560	41568		10.1074/jbc.M112.404194	http://dx.doi.org/10.1074/jbc.M112.404194			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23071115	Green Published, hybrid			2022-12-28	WOS:000311887600065
J	Huang, H; Jin, T; Wang, L; Wang, FL; Zhang, R; Pan, Y; Wang, ZZ; Chen, Y				Huang, Heng; Jin, Ting; Wang, Lin; Wang, Fulong; Zhang, Rui; Pan, Yi; Wang, Zhenzhen; Chen, Yan			The RAS Guanyl Nucleotide-releasing Protein RasGRP1 Is Involved in Lymphatic Development in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-GROWTH-FACTOR; VASCULAR DEVELOPMENT; FACTOR-C; LYMPHANGIOGENESIS; DOWNSTREAM; ACTIVATION; MECHANISMS; SYSTEM; CELLS; CCBE1	The molecular basis of the lymphatic development remains largely unknown. Using zebrafish as a model, we discovered a novel role for the Ras guanine-releasing protein 1 (RasGRP1), a protein involved in Ras activation in lymphangiogenesis. Secondary lymphatic sprouts from the posterior cardinal vein give rise to thoracic duct which is the first lymphatic vessel in zebrafish. Knockdown of rasgrp1 by injecting morpholino in zebrafish embryos impaired formation of thoracic duct accompanied by pericardial and truck edema, whereas blood vessel development of the embryos was largely unaffected. In rasgrp1-knockdown embryos, the number of sprouts producing the string of parachordal lymphangioblast cells was reduced. Meanwhile the total number of the secondary sprouts was not changed. As a result, the number of venous intersegmental vessels was increased, whereas the number of lymphatic vessel was reduced at a later stage. The lymphatic developmental defects caused by rasgrp1 knockdown could be rescued by ectopic expression of a constitutively active HRas. Further analysis revealed that RasGRP1 knockdown could synergize with flt4/vegfr3 knockdown to induce defects in lymphangiogenesis. Taken together, this finding demonstrates a critical role for RasGRP1 in lymphatic development in zebrafish.	[Huang, Heng; Jin, Ting; Wang, Lin; Wang, Fulong; Zhang, Rui; Pan, Yi; Wang, Zhenzhen; Chen, Yan] Univ Chinese Acad Sci, Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Chen, Y (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Shanghai Inst Biol Sci, 294 Taiyuan Rd, Shanghai 200031, Peoples R China.	ychen3@sibs.ac.cn	Wang, Fulong/AAY-1178-2021	Wang, Fulong/0000-0002-7083-9675	Ministry of Science and Technology of China [2012CB524900, 2010CB529506]; National Natural Science Foundation of China [30830037, 81021002, 81130077, 30971660]; Chinese Academy of Sciences [KSCX2-EW-R-08]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Ministry of Science and Technology of China Research Grant 2012CB524900 (to Y. C.) and 2010CB529506 (to Y. P. and Z. W.); by National Natural Science Foundation of China Grants 30830037, 81021002, and 81130077 (to Y. C.) and 30971660 (to Y. P.); and by Chinese Academy of Sciences Grant KSCX2-EW-R-08 (to Y. C.).	Bos FL, 2011, CIRC RES, V109, P486, DOI 10.1161/CIRCRESAHA.111.250738; Bussmann J, 2010, DEVELOPMENT, V137, P2653, DOI 10.1242/dev.048207; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Cueni Leah N., 2008, Lymphatic Research and Biology, V6, P109, DOI 10.1089/lrb.2008.1008; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; Ehrhardt A, 2004, MOL CELL BIOL, V24, P6311, DOI 10.1128/MCB.24.14.6311-6323.2004; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; Geudens I, 2010, ARTERIOSCL THROM VAS, V30, P1695, DOI 10.1161/ATVBAHA.110.203034; Gomez GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004994; Hermans K, 2010, BLOOD, V116, P3356, DOI 10.1182/blood-2009-11-254557; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Hong CC, 2006, CURR BIOL, V16, P1366, DOI 10.1016/j.cub.2006.05.046; Huang H, 2012, ARTERIOSCL THROM VAS, V32, P2158, DOI 10.1161/ATVBAHA.112.252775; Ichise T, 2010, DEVELOPMENT, V137, P1003, DOI 10.1242/dev.043489; Jin T, 2012, CELL RES, V22, P661, DOI 10.1038/cr.2011.161; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Roberts DM, 2004, MOL CELL BIOL, V24, P10515, DOI 10.1128/MCB.24.24.10515-10528.2004; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Westerfield M., 1995, ZEBRAFISH BOOK, P144; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427	32	5	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2355	2364		10.1074/jbc.M112.418202	http://dx.doi.org/10.1074/jbc.M112.418202			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23184941	hybrid, Green Published			2022-12-28	WOS:000314211500024
J	Humphrey, RK; Yu, SMA; Bellary, A; Gonuguntla, S; Yebra, M; Jhala, US				Humphrey, Rohan K.; Yu, Shu Mei A.; Bellary, Aditi; Gonuguntla, Sumati; Yebra, Myra; Jhala, Ulupi S.			Lysine 63-linked Ubiquitination Modulates Mixed Lineage Kinase-3 Interaction with JIP1 Scaffold Protein in Cytokine-induced Pancreatic beta Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTOR; INDUCED APOPTOSIS; FACTORS TRAFS; IN-VIVO; ACTIVATION; A20; PHOSPHORYLATION; FAMILY; JNK	The mixed lineage kinase MLK3 plays a crucial role in compromising mitochondrial integrity and functions as a proapoptotic competence factor in the early stages of cytokine-induced pancreatic beta cell death. In an effort to identify mechanisms that regulate MLK3 activity in beta cells, we discovered that IL-1 beta stimulates Lys-63-linked ubiquitination of MLK3 via a conserved, TRAF6-binding peptapeptide motif in the catalytic domain of the kinase. TRAF6-mediated ubiquitination was required for dissociation of inactive monomeric MLK3 from the scaffold protein IB1/JIP1, facilitating the subsequent dimerization, autophosphorylation, and catalytic activation of MLK3. Inability to ubiquitinate MLK3, or the presence of A20, an upstream Lys-63-linked deubiquitinase, strongly curtailed the ability of MLK3 to affect the proapoptotic translocation of BAX in cytokine-stimulated pancreatic beta cells, an early step in the progression toward beta cell death. These studies suggest a novel mechanism for MLK3 activation and provide new clues for therapeutic intervention in promoting beta cell survival.	[Humphrey, Rohan K.; Yu, Shu Mei A.; Bellary, Aditi; Gonuguntla, Sumati; Yebra, Myra; Jhala, Ulupi S.] Univ Calif San Diego, Pediat Diabet Res Ctr, Sch Med, La Jolla, CA 92037 USA	University of California System; University of California San Diego	Jhala, US (corresponding author), Pediat Diabet Res Ctr, 3525 John Hopkins Court, San Diego, CA 92121 USA.	ujhala@ucsd.edu			National Institutes of Health Grant [R01DK080147]; Juvenile Diabetes Research Foundation Research Grant [40-2009-706]; Hillblom Foundation network grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080147] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation Research Grant(Juvenile Diabetes Research Foundation); Hillblom Foundation network grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK080147. This work was also supported by Juvenile Diabetes Research Foundation Research Grant 40-2009-706 and by a Hillblom Foundation network grant.	Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Arnush M, 1998, J CLIN INVEST, V102, P516, DOI 10.1172/JCI844; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Bock BC, 2000, J BIOL CHEM, V275, P14231, DOI 10.1074/jbc.275.19.14231; Bollyky PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005063; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Brancho D, 2005, MOL CELL BIOL, V25, P3670, DOI 10.1128/MCB.25.9.3670-3681.2005; Chang LK, 2002, BIOCHIMIE, V84, P223, DOI 10.1016/S0300-9084(02)01372-X; Chen J, 2012, CANCER RES, V72, P4130, DOI 10.1158/0008-5472.CAN-12-0655; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chung JY, 2007, ADV EXP MED BIOL, V597, P93; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Du Y, 2005, J BIOL CHEM, V280, P42984, DOI 10.1074/jbc.M502671200; Dupraz P, 2000, J BIOL CHEM, V275, P37672, DOI 10.1074/jbc.M005150200; Fan YH, 2011, CELL SIGNAL, V23, P660, DOI 10.1016/j.cellsig.2010.11.017; Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Grey ST, 1999, J EXP MED, V190, P1135, DOI 10.1084/jem.190.8.1135; Grey ST, 2003, J IMMUNOL, V170, P6250, DOI 10.4049/jimmunol.170.12.6250; Habelhah Hasem, 2010, Genes Cancer, V1, P735; Haefliger JA, 2003, J CELL SCI, V116, P1463, DOI 10.1242/jcs.00356; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Hudkins RL, 2008, J MED CHEM, V51, P5680, DOI 10.1021/jm8005838; Humphrey RK, 2010, J BIOL CHEM, V285, P22426, DOI 10.1074/jbc.M110.123786; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; Jadhav T, 2008, BIOCHEM BIOPH RES CO, V371, P521, DOI 10.1016/j.bbrc.2008.04.138; Jadhav Trafina S, 2011, BMC Proc, V5 Suppl 2, pS4, DOI 10.1186/1753-6561-5-S2-S4; Jaeschke A, 2007, MOL CELL, V27, P498, DOI 10.1016/j.molcel.2007.07.008; Korchnak AC, 2009, CELL SIGNAL, V21, P1620, DOI 10.1016/j.cellsig.2009.06.008; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Leung IWL, 1998, J BIOL CHEM, V273, P32408, DOI 10.1074/jbc.273.49.32408; Ling ZD, 2003, DIABETES, V52, P2497, DOI 10.2337/diabetes.52.10.2497; Martin F, 2011, NAT GENET, V43, P822, DOI 10.1038/ng.916; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nihalani D, 2000, J BIOL CHEM, V275, P7273, DOI 10.1074/jbc.275.10.7273; Nihalani D, 2001, EMBO J, V20, P3447, DOI 10.1093/emboj/20.13.3447; Nihalani D, 2003, J BIOL CHEM, V278, P28694, DOI 10.1074/jbc.M304212200; Nihalani D, 2007, MOL CELL BIOL, V27, P2431, DOI 10.1128/MCB.01479-06; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pineda G, 2007, ADV EXP MED BIOL, V597, P80; Pullen SS, 1999, BIOCHEMISTRY-US, V38, P10168, DOI 10.1021/bi9909905; Sathyanarayana P, 2002, MOL CELL, V10, P1527, DOI 10.1016/S1097-2765(02)00734-7; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Waeber G, 2000, NAT GENET, V24, P291, DOI 10.1038/73523; Wang LH, 2004, ANNU REV PHARMACOL, V44, P451, DOI 10.1146/annurev.pharmtox.44.101802.121840; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Whitmarsh AJ, 2006, BIOCHEM SOC T, V34, P828, DOI 10.1042/BST0340828; Xu ZH, 2005, MOL CELL BIOL, V25, P9949, DOI 10.1128/MCB.25.22.9949-9959.2005; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913; Zou WG, 2011, J CLIN INVEST, V121, P4383, DOI 10.1172/JCI59041	69	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2428	2440		10.1074/jbc.M112.425884	http://dx.doi.org/10.1074/jbc.M112.425884			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23172226	Green Published, hybrid			2022-12-28	WOS:000314211500030
J	Zhang, CC; Li, YL; Wu, YN; Wang, LY; Wang, XN; Du, J				Zhang, Congcong; Li, Yulin; Wu, Yina; Wang, Luya; Wang, Xiaonan; Du, Jie			Interleukin-6/Signal Transducer and Activator of Transcription 3 (STAT3) Pathway Is Essential for Macrophage Infiltration and Myoblast Proliferation during Muscle Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA INHIBITORY FACTOR; SKELETAL-MUSCLE; ALTERED INFLAMMATION; IL-6; PROTEIN; CELLS; DIFFERENTIATION; CYTOKINES; RECEPTOR; SIGNAL	Inflammation and microenvironment play a crucial role in muscle regeneration. IL (interleukin)-6, as a multifunctional cytokine is involved in the processes. However, the causative effect of IL-6 in muscle regeneration remains unclear. In a mouse model of cardiotoxin-induced muscle injury/regeneration, infiltrated monocytes/macrophages produce a high level of IL-6 started on 1 day (24 h) after injury. In IL-6 knock-out (-/-) mice, the muscle regeneration procedure was impaired along with decreased myogenic determination factor (MyoD) and myogenin mRNA level and increased interstitial fibrosis. The IL-6(-/-) mice exhibited less macrophage infiltration, lower inflammatory cytokine (IL-1 beta, inducible NO synthase, Transforming growth factor (TGF)-beta 1, and IL-10) and chemokine (CCL2, CCL3, and CCL5) expression, and inhibited myoblast proliferation. In vitro, IL-6 deficiency or Signal Transducer and Activator of Transcription 3 (STAT3) knockdown in activated macrophage attenuated the expression of CCL2, CCL3, but not CCL5, which resulted in less macrophage migration. Moreover, inflammatory macrophages promoted myoblast proliferation in an IL-6-dependent manner. Finally, adoptive transfer IL-6(+/+) BM cells into IL-6(-/-) mice rescued the impaired regeneration with improved MyoD and myogenin expression. Taken together, IL-6 expression and the activated STAT3 signaling pathway in monocytes/macrophages is a critical mediator of macrophage migration and myoblast proliferation during muscle regeneration.	[Zhang, Congcong; Li, Yulin; Wu, Yina; Wang, Luya; Wang, Xiaonan; Du, Jie] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing An Zhen Hosp, Beijing 100029, Peoples R China; [Du, Jie] Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing 100029, Peoples R China	Capital Medical University	Du, J (corresponding author), Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing An Zhen Hosp, 2 Anzhen Rd, Beijing 100029, Peoples R China.	jdu@bcm.edu	Li, yulin/AGZ-5611-2022		National Science Foundation of China [31090363, 81230006]; Chinese Ministry of Science and Technology [2009CB522205, 2012CB945104]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060268] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Science Foundation of China Grants 31090363 and 81230006 and Chinese Ministry of Science and Technology Grants 2009CB522205 and 2012CB945104.	Al-Shanti N, 2008, GROWTH FACTORS, V26, P61, DOI 10.1080/08977190802025024; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Boeynaems JM, 2006, J INVEST DERMATOL, V126, P943, DOI 10.1038/sj.jid.5700233; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; Gadient RA, 1999, STEM CELLS, V17, P127, DOI 10.1002/stem.170127; Hara M, 2011, J EXP MED, V208, P715, DOI 10.1084/jem.20101059; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hirano T, 2010, P JPN ACAD B-PHYS, V86, P717, DOI 10.2183/pjab.86.717; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Jougasaki M, 2010, BRIT J PHARMACOL, V159, P1294, DOI 10.1111/j.1476-5381.2009.00612.x; Kami K, 1998, MUSCLE NERVE, V21, P819, DOI 10.1002/(SICI)1097-4598(199806)21:6<819::AID-MUS20>3.0.CO;2-M; Kami K, 2000, J HISTOCHEM CYTOCHEM, V48, P1203, DOI 10.1177/002215540004800904; Li YL, 2012, ARTERIOSCL THROM VAS, V32, P1662, DOI 10.1161/ATVBAHA.112.249706; Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397; Luo Y., 2012, EUR J CANC; Panayi GS, 2004, CURR OPIN IMMUNOL, V16, P531, DOI 10.1016/j.coi.2004.05.017; Park EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027739; Ren JY, 2011, AM J HYPERTENS, V24, P701, DOI 10.1038/ajh.2011.42; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Toth KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017392; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Wang X, 2008, CELL MOL NEUROBIOL, V28, P113, DOI 10.1007/s10571-007-9247-9; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Zhang LP, 2009, AM J PATHOL, V175, P2518, DOI 10.2353/ajpath.2009.090275	36	186	192	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1489	1499		10.1074/jbc.M112.419788	http://dx.doi.org/10.1074/jbc.M112.419788			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184935	Green Published, hybrid			2022-12-28	WOS:000313751400007
J	Doppler, H; Bastea, LI; Eiseler, T; Storz, P				Doeppler, Heike; Bastea, Ligia I.; Eiseler, Tim; Storz, Peter			Neuregulin Mediates F-actin-driven Cell Migration through Inhibition of Protein Kinase D1 via Rac1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; COFILIN-PHOSPHATASE SLINGSHOT; NF-KAPPA-B; REGULATES COFILIN; SIGNALING PATHWAYS; ESTROGEN-RECEPTOR; MAMMARY-GLAND; TUMOR CELLS; HEREGULIN; ACTIVATION	Neuregulin (NRG; heregulin) is overexpressed in similar to 30% of breast cancers and mediates various processes involved in tumor progression, including tumor cell migration and invasion. Here, we show that NRG mediates its effects on tumor cell migration via PKD1. Downstream of RhoA, PKD1 can prevent directed cell migration through phosphorylation of its substrate SSH1L. NRG exerts its inhibitory effects on PKD1 through Rac1/NADPH oxidase, leading to decreased PKD1 activation loop phosphorylation and decreased activity toward SSH1L. The consequence of PKD1 inhibition by NRG is decreased binding of 14-3-3 to SSH1L, localization of SSH1L to F-actin at the leading edge, and increased cofilin activity, resulting in increased reorganization of the actin cytoskeleton and cell motility. Our data provide a mechanism through which the Rho GTPase Rac1 cross-talks with PKD1 signaling pathways to facilitate directed cell migration.	[Doeppler, Heike; Bastea, Ligia I.; Eiseler, Tim; Storz, Peter] Mayo Clin, Mayo Clin Comprehens Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Storz, P (corresponding author), Mayo Clin, Mayo Clin Comprehens Canc Ctr, Dept Canc Biol, Griffin Bldg,Rm 306,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	storz.peter@mayo.edu			National Institutes of Health [GM086435, CA140182]; Florida Department of Health [10BG11]; NATIONAL CANCER INSTITUTE [R01CA140182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM086435 and CA140182. This work was also supported by Bank-head-Coley Program Grant 10BG11 from the Florida Department of Health (to P.S.).	Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Atlas E, 2003, MOL CANCER RES, V1, P165; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bastea LI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030459; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Cowell CF, 2009, J CELL BIOCHEM, V106, P714, DOI 10.1002/jcb.22067; Daly JM, 1997, CANCER RES, V57, P3804; Dan C, 2001, J BIOL CHEM, V276, P32115, DOI 10.1074/jbc.M100871200; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; GRUNT TW, 1995, INT J CANCER, V63, P560, DOI 10.1002/ijc.2910630417; Guerra-Vladusic FK, 1999, INT J ONCOL, V15, P883; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P1217, DOI 10.1091/mbc.4.11.1217; Hijazi MM, 2000, INT J ONCOL, V17, P629; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Jaggi M, 2003, BIOCHEM BIOPH RES CO, V307, P254, DOI 10.1016/S0006-291X(03)01161-6; Karam M, 2012, EXP CELL RES, V318, P558, DOI 10.1016/j.yexcr.2012.01.001; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Kim M, 2008, CARCINOGENESIS, V29, P629, DOI 10.1093/carcin/bgm291; Kligys K, 2009, BIOCHEM BIOPH RES CO, V383, P450, DOI 10.1016/j.bbrc.2009.04.031; Krane IM, 1996, ONCOGENE, V12, P1781; Li L, 2002, ONCOGENE, V21, P4900, DOI 10.1038/sj.onc.1205634; Li QF, 2004, CANCER RES, V64, P7078, DOI 10.1158/0008-5472.CAN-04-1152; Marshall C, 2006, BREAST CANCER RES TR, V96, P163, DOI 10.1007/s10549-005-9073-z; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Schelfhout VRJ, 2000, JNCI-J NATL CANCER I, V92, P622, DOI 10.1093/jnci/92.8.622; Schmitt M, 2006, MOL CARCINOGEN, V45, P490, DOI 10.1002/mc.20180; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Spratley SJ, 2011, J BIOL CHEM, V286, P34254, DOI 10.1074/jbc.M111.259424; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Tan M, 1999, CANCER RES, V59, P1620; Tang CK, 1996, CANCER RES, V56, P3350; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; YANG YM, 1995, J CELL BIOL, V131, P215, DOI 10.1083/jcb.131.1.215; Yao J, 2001, ONCOGENE, V20, P8066, DOI 10.1038/sj.onc.1204944; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200	47	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					455	465		10.1074/jbc.M112.397448	http://dx.doi.org/10.1074/jbc.M112.397448			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23148218	Green Published, hybrid			2022-12-28	WOS:000313197200046
J	Marques, JV; Kim, KW; Lee, C; Costa, MA; May, GD; Crow, JA; Davin, LB; Lewis, NG				Marques, Joaquim V.; Kim, Kye-Won; Lee, Choonseok; Costa, Michael A.; May, Gregory D.; Crow, John A.; Davin, Laurence B.; Lewis, Norman G.			Next Generation Sequencing in Predicting Gene Function in Podophyllotoxin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINUM-USITATISSIMUM L.; DEOXYPODOPHYLLOTOXIN 6-HYDROXYLASE; ALKALOID BIOSYNTHESIS; DYSOSMA-VERSIPELLIS; SUSPENSION-CULTURES; MOLECULAR-CLONING; SESAMUM-INDICUM; LIGNANS; TRANSCRIPTOME; IDENTIFICATION	Podophyllum species are sources of (-)-podophyllotoxin, an aryltetralin lignan used for semi-synthesis of various powerful and extensively employed cancer-treating drugs. Its biosynthetic pathway, however, remains largely unknown, with the last unequivocally demonstrated intermediate being (-)-matairesinol. Herein, massively parallel sequencing of Podophyllum hexandrum and Podophyllum peltatum transcriptomes and subsequent bioinformatics analyses of the corresponding assemblies were carried out. Validation of the assembly process was first achieved through confirmation of assembled sequences with those of various genes previously established as involved in podophyllotoxin biosynthesis as well as other candidate biosynthetic pathway genes. This contribution describes characterization of two of the latter, namely the cytochrome P450s, CYP719A23 from P. hexandrum and CYP719A24 from P. peltatum. Both enzymes were capable of converting (-)-matairesinol into (-)-pluviatolide by catalyzing methylenedioxy bridge formation and did not act on other possible substrates tested. Interestingly, the enzymes described herein were highly similar to methylenedioxy bridge-forming enzymes from alkaloid biosynthesis, whereas candidates more similar to lignan biosynthetic enzymes were catalytically inactive with the substrates employed. This overall strategy has thus enabled facile further identification of enzymes putatively involved in (-)-podophyllotoxin biosynthesis and underscores the deductive power of next generation sequencing and bioinformatics to probe and deduce medicinal plant biosynthetic pathways.	[Marques, Joaquim V.; Kim, Kye-Won; Lee, Choonseok; Costa, Michael A.; Davin, Laurence B.; Lewis, Norman G.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [May, Gregory D.; Crow, John A.] Natl Ctr Genom Resources, Santa Fe, NM 87505 USA	Washington State University; National Center for Genome Resources (NCGR)	Lewis, NG (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	lewisn@wsu.edu		Davin, Laurence/0000-0002-3248-6485; Hwang, Julianne/0000-0002-9222-1729; Lewis, Norman/0000-0001-5742-032X	National Institutes of Health [1RC2GM092561]; National Science Foundation [MCB-1052557]; G. Thomas and Anita Hargrove Center for Plant Genomic Research; Direct For Biological Sciences [1229749] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [1052557] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); G. Thomas and Anita Hargrove Center for Plant Genomic Research; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RC2GM092561(NIGMS). This work was also supported by National Science Foundation Grant MCB-1052557 and by the G. Thomas and Anita Hargrove Center for Plant Genomic Research.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Bak Soren, 2011, Arabidopsis Book, V9, pe0144, DOI 10.1199/tab.0144; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; BROOMHEAD AJ, 1991, PHYTOCHEMISTRY, V30, P1489, DOI 10.1016/0031-9422(91)84194-W; BROOMHEAD AJ, 1990, PHYTOCHEMISTRY, V29, P3831, DOI 10.1016/0031-9422(90)85342-D; Canel C, 2000, PHYTOCHEMISTRY, V54, P115, DOI 10.1016/S0031-9422(00)00094-7; Chavez MLD, 2011, ARCH BIOCHEM BIOPHYS, V507, P186, DOI 10.1016/j.abb.2010.11.016; Chen S, 2011, PLANT CELL REP, V30, P1593, DOI 10.1007/s00299-011-1070-6; Chevreux B, 2005, THESIS GERMAN CANC R; Clemens S, 1996, PHYTOCHEMISTRY, V41, P457, DOI 10.1016/0031-9422(95)00618-4; Davin LB, 2000, PLANT PHYSIOL, V123, P453, DOI 10.1104/pp.123.2.453; Davin LB, 1997, SCIENCE, V275, P362, DOI 10.1126/science.275.5298.362; Desgagne-Penix I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-252; Ehlting Jurgen, 2006, Phytochemistry Reviews, V5, P239, DOI 10.1007/s11101-006-9025-1; Federolf K, 2007, PHYTOCHEMISTRY, V68, P1397, DOI 10.1016/j.phytochem.2007.02.031; Giddings LA, 2011, J BIOL CHEM, V286, P16751, DOI 10.1074/jbc.M111.225383; Gordaliza M, 2004, TOXICON, V44, P441, DOI 10.1016/j.toxicon.2004.05.008; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Hsiao YY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-360; Humphreys JM, 1999, P NATL ACAD SCI USA, V96, P10045, DOI 10.1073/pnas.96.18.10045; Ikezawa N, 2003, J BIOL CHEM, V278, P38557, DOI 10.1074/jbc.M302470200; Ikezawa N, 2007, FEBS J, V274, P1019, DOI 10.1111/j.1742-4658.2007.05652.x; Jiang RW, 2007, J NAT PROD, V70, P283, DOI 10.1021/np060430o; Jiao Y, 1998, PHYTOCHEMISTRY, V49, P387, DOI 10.1016/S0031-9422(98)00268-4; Kato MJ, 1998, PHYTOCHEMISTRY, V47, P583, DOI 10.1016/S0031-9422(97)00727-9; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Kranz K, 2003, PHYTOCHEMISTRY, V64, P453, DOI 10.1016/S0031-9422(03)00196-1; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lim CK, 1996, J CHROMATOGR A, V722, P267, DOI 10.1016/0021-9673(95)00433-5; Liscombe DK, 2005, PHYTOCHEMISTRY, V66, P1374, DOI 10.1016/j.phytochem.2005.04.029; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Molog GA, 2001, PLANTA, V214, P288, DOI 10.1007/s004250100617; Nadeem M, 2000, BIOL CONSERV, V92, P121, DOI 10.1016/S0006-3207(99)00059-2; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Nelson David R., 2006, Phytochemistry Reviews, V5, P193, DOI 10.1007/s11101-006-9015-3; OMURA T, 1964, J BIOL CHEM, V239, P2379; Ono E, 2006, P NATL ACAD SCI USA, V103, P10116, DOI 10.1073/pnas.0603865103; OZAWA S, 1993, PHYTOCHEMISTRY, V32, P643, DOI 10.1016/S0031-9422(00)95149-5; Pignatelli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019984; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Reynolds AJ, 2003, J AM CHEM SOC, V125, P12108, DOI 10.1021/ja0376588; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Samanani N, 2005, PLANT CELL, V17, P915, DOI 10.1105/tpc.104.028654; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; Schmidt TJ, 2006, PHYTOCHEM ANALYSIS, V17, P299, DOI 10.1002/pca.918; Schmidt TJ, 2008, RAPID COMMUN MASS SP, V22, P3642, DOI 10.1002/rcm.3783; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Seidel V, 2002, PLANTA, V215, P1031, DOI 10.1007/s00425-002-0834-1; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; STAHELIN HF, 1991, CANCER RES, V51, P5; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Subramaniyam S, 2011, PLANT CELL REP, V30, P2075, DOI 10.1007/s00299-011-1114-y; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Takaku N, 2001, J WOOD SCI, V47, P476, DOI 10.1007/BF00767901; UMEZAWA T, 1991, J BIOL CHEM, V266, P10210; Umezawa T, 2010, PHYTOCHEM REV, V9, P1, DOI 10.1007/s11101-009-9155-3; VANUDEN W, 1995, PLANT CELL TISS ORG, V42, P73, DOI 10.1007/BF00037684; VONWARTBURG A, 1957, HELV CHIM ACTA, V40, P1331, DOI 10.1002/hlca.19570400525; Wang W, 2007, SYST BOT, V32, P731, DOI 10.1600/036364407783390791; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wong MML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-342; Wu YM, 2007, ORG LETT, V9, P1199, DOI 10.1021/ol0630954; Xia ZQ, 2000, PHYTOCHEMISTRY, V55, P537, DOI 10.1016/S0031-9422(00)00242-9; Xia ZQ, 2001, J BIOL CHEM, V276, P12614, DOI 10.1074/jbc.M008622200; YU PZ, 1991, J NAT PROD, V54, P1422, DOI 10.1021/np50077a034; Zerbe P, 2012, J BIOL CHEM, V287, P12121, DOI 10.1074/jbc.M111.317669	69	83	88	1	74	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					466	479		10.1074/jbc.M112.400689	http://dx.doi.org/10.1074/jbc.M112.400689			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23161544	Green Published, hybrid			2022-12-28	WOS:000313197200047
J	Yang, Y; Wang, CJ; Zhang, PZ; Gao, K; Wang, DJ; Yu, HX; Zhang, T; Jiang, SR; Hexige, S; Hong, ZH; Yasui, A; Liu, JO; Huang, HJ; Yu, L				Yang, Yang; Wang, Chenji; Zhang, Pingzhao; Gao, Kun; Wang, Dejie; Yu, Hongxiu; Zhang, Ting; Jiang, Sirui; Hexige, Saiyin; Hong, Zehui; Yasui, Akira; Liu, Jun O.; Huang, Haojie; Yu, Long			Polycomb Group Protein PHF1 Regulates p53-dependent Cell Growth Arrest and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOMETRIAL STROMAL SARCOMA; P53; METHYLATION; DEGRADATION; JAZF1/PHF1	Polycomb group protein PHF1 is well known as a component of a novel EED-EZH2.Polycomb repressive complex 2 complex and plays important roles in H3K27 methylation and Hox gene silencing. PHF1 is also involved in the response to DNA double-strand breaks in human cells, promotes nonhomologous end-joining processes through interaction with Ku70/Ku80. Here, we identified another function of PHF1 as a potential p53 pathway activator in a pathway screen using luminescence reporter assay. Subsequent studies showed PHF1 directly interacts with p53 proteins both in vivo and in vitro and co-localized in nucleus. PHF1 binds to the C-terminal regulatory domain of p53. Overexpression of PHF1 elevated p53 protein level and prolonged its turnover. Knockdown of PHF1 reduced p53 protein level and its target gene expression both in normal state and DNA damage response. Mechanically, PHF1 protects p53 proteins from MDM2-mediated ubiquitination and degradation. Furthermore, we showed that PHF1 regulates cell growth arrest and etoposide-induced apoptosis in a p53-dependent manner. Finally, PHF1 expression was significantly down-regulated in human breast cancer samples. Taken together, we establish PHF1 as a novel positive regulator of the p53 pathway. These data shed light on the potential roles of PHF1 in tumorigenesis and/or tumor progression.	[Yang, Yang; Wang, Chenji; Zhang, Pingzhao; Gao, Kun; Wang, Dejie; Zhang, Ting; Jiang, Sirui; Hexige, Saiyin; Yu, Long] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Pingzhao; Yu, Hongxiu; Yu, Long] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Hong, Zehui] Southeast Univ, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing 210009, Jiangsu, Peoples R China; [Yasui, Akira] Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Genet, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Hong, Zehui] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Hong, Zehui] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Huang, Haojie] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Fudan University; Fudan University; Southeast University - China; Tohoku University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Mayo Clinic	Yu, L (corresponding author), Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, 220 Handan Rd, Shanghai 200433, Peoples R China.	longyu@fudan.edu.cn	Wang, Dejie/AAJ-9461-2020		National Key Sci-Tech Special Project of China [2008ZX10002-020]; National Natural Science Foundation of China [30872947, 31071193, 81171964]	National Key Sci-Tech Special Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Sci-Tech Special Project of China Grants 2008ZX10002-020) and National Natural Science Foundation of China Grants 30872947, 31071193, and 81171964.	Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Chiang S, 2011, AM J SURG PATHOL, V35, P1364, DOI 10.1097/PAS.0b013e3182262743; Hainaut P, 2000, ADV CANCER RES, V77, P81; Higashitsuji H, 2005, CANCER CELL, V8, P75, DOI 10.1016/j.ccr.2005.06.006; Hong ZH, 2008, NUCLEIC ACIDS RES, V36, P2939, DOI 10.1093/nar/gkn146; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Micci F, 2006, CANCER RES, V66, P107, DOI 10.1158/0008-5472.CAN-05-2485; O'Connell S, 2001, J BIOL CHEM, V276, P43065, DOI 10.1074/jbc.M104294200; Panagopoulos I, 2008, CANCER GENET CYTOGEN, V185, P74, DOI 10.1016/J.cancergencyto.2008.04.020; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004	19	25	29	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					529	539		10.1074/jbc.M111.338996	http://dx.doi.org/10.1074/jbc.M111.338996			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23150668	Green Published, hybrid			2022-12-28	WOS:000313197200053
J	De Leon, J; Jiang, GZ; Ma, Y; Rubin, E; Fortune, S; Sun, JJ				De Leon, Joaquin; Jiang, Guozhong; Ma, Yue; Rubin, Eric; Fortune, Sarah; Sun, Jianjun			Mycobacterium tuberculosis ESAT-6 Exhibits a Unique Membrane-interacting Activity That Is Not Found in Its Ortholog from Non-pathogenic Mycobacterium smegmatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTHRAX PROTECTIVE ANTIGEN; COMPLEX-FORMATION; CALMETTE-GUERIN; PORE FORMATION; SECRETION; VIRULENCE; CFP-10; BCG; DESTABILIZATION; ATTENUATION	Mycobacterium tuberculosis ESAT-6 (MtbESAT-6) reportedly shows membrane/cell-lysis activity, and recently its biological roles in pathogenesis have been implicated in rupture of the phagosomes for bacterial cytosolic translocation. However, molecular mechanism of MtbESAT-6-mediated membrane interaction, particularly in relation with its biological functions in pathogenesis, is poorly understood. In this study, we investigated the pH-dependent membrane interaction of MtbESAT-6, MtbCFP-10, and the MtbESAT-6/CFP-10 heterodimer, by using liposomal model membranes that mimic phagosomal compartments. MtbESAT-6, but neither MtbCFP-10 nor the heterodimer, interacted with the liposomal membranes at acidic conditions, which was evidenced by release of K+ ions from the liposomes. Most importantly, the orthologous ESAT-6 from non-pathogenic Mycobacterium smegmatis (MsESAT-6) was essentially inactive in release of K+. The differential membrane interactions between MtbESAT-6 and MsESAT-6 were further confirmed in an independent membrane leakage assay using the dye/quencher pair, 8-aminonapthalene-1,3,6 trisulfonic acid (ANTS)/p-xylene-bis-pyridinium bromide (DPX). Finally, using intrinsic and extrinsic fluorescence approaches, we probed the pH-dependent conformational changes of MtbESAT-6 and MsESAT-6. At acidic pH conditions, MtbESAT-6 underwent a significant conformational change, which was featured by an increased solvent-exposed hydrophobicity, while MsESAT-6 showed little conformational change in response to acidification. In conclusion, we have demonstrated that MtbESAT-6 possesses a unique membrane-interacting activity that is not found in MsESAT-6 and established the utility of rigorous biochemical approaches in dissecting the virulence of M. tuberculosis.	[De Leon, Joaquin; Jiang, Guozhong; Ma, Yue; Sun, Jianjun] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Rubin, Eric; Fortune, Sarah] Harvard Univ, Sch Publ Hlth, Dept Infect Dis & Immunol, Boston, MA 02115 USA	University of Texas System; University of Texas El Paso; Harvard University; Harvard T.H. Chan School of Public Health	De Leon, J (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.	jsun@utep.edu		Rubin, Eric/0000-0001-5120-962X; Fortune, Sarah/0000-0001-7565-9975	UTEP new faculty startup fund; National Center for Research Resources [5G12RR008124]; National Institute on Minority Health and Health Disparities [G12MD007592]; National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER	UTEP new faculty startup fund; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by UTEP new faculty startup fund, grants from the National Center for Research Resources (5G12RR008124), and the National Institute on Minority Health and Health Disparities (G12MD007592), National Institutes of Health.	Akopian T, 2012, EMBO J, V31, P1529, DOI 10.1038/emboj.2012.5; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Brodin P, 2005, J BIOL CHEM, V280, P33953, DOI 10.1074/jbc.M503515200; Callahan B, 2010, J BACTERIOL, V192, P326, DOI 10.1128/JB.01032-09; Converse SE, 2005, J BACTERIOL, V187, P1238, DOI 10.1128/JB.187.4.1238-1245.2005; Coros A, 2008, MOL MICROBIOL, V69, P794, DOI 10.1111/j.1365-2958.2008.06299.x; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; ELLENS H, 1984, BIOCHEMISTRY-US, V23, P1532, DOI 10.1021/bi00302a029; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Lightbody KL, 2008, J BIOL CHEM, V283, P17681, DOI 10.1074/jbc.M800123200; MacGurn JA, 2005, MOL MICROBIOL, V57, P1653, DOI 10.1111/j.1365-2958.2005.04800.x; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Okkels LM, 2004, PROTEOMICS, V4, P2954, DOI 10.1002/pmic.200400906; Orme I, 2004, CURR OPIN MICROBIOL, V7, P58, DOI 10.1016/j.mib.2003.11.002; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Raju RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002511; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Sun J, 2008, P NATL ACAD SCI USA, V105, P4346, DOI 10.1073/pnas.0800701105; Sun JJ, 2007, J BIOL CHEM, V282, P1059, DOI 10.1074/jbc.M609869200; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059	35	80	84	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44184	44191		10.1074/jbc.M112.420869	http://dx.doi.org/10.1074/jbc.M112.420869			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23150662	Green Published, hybrid			2022-12-28	WOS:000312938600017
J	Kim, KH; Song, K; Yoon, SH; Shehzad, O; Kim, YS; Son, JH				Kim, Kyung-Hee; Song, Karen; Yoon, Seung-Hee; Shehzad, Omer; Kim, Yeong-Shik; Son, Jin H.			Rescue of PINK1 Protein Null-specific Mitochondrial Complex IV Deficits by Ginsenoside Re Activation of Nitric Oxide Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; PARKINSONS-DISEASE; OXIDATIVE-PHOSPHORYLATION; MOLECULAR CHAPERONES; ALZHEIMERS-DISEASE; DOPAMINERGIC CELLS; LEIGH-SYNDROME; BIOGENESIS; MUTATIONS; GENE	PINK1, linked to familial Parkinson's disease, is known to affect mitochondrial function. Here we identified a novel regulatory role of PINK1 in the maintenance of complex IV activity and characterized a novel mechanism by which NO signaling restored complex IV deficiency in PINK1 null dopaminergic neuronal cells. In PINK1 null cells, levels of specific chaperones, including Hsp60, leucine-rich pentatricopeptide repeat-containing (LRPPRC), and Hsp90, were severely decreased. LRP-PRC and Hsp90 were found to act upstream of Hsp60 to regulate complex IV activity. Specifically, knockdown of Hsp60 resulted in a decrease in complex IV activity, whereas antagonistic inhibition of Hsp90 by 17-(allylamino) geldanamycin decreased both Hsp60 and complex IV activity. In contrast, overexpression of the PINK1-interacting factor LRPPRC augmented complex IV activity by up-regulating Hsp60. A similar recovery of complex IV activity was also induced by coexpression of Hsp90 and Hsp60. Drug screening identified ginsenoside Re as a compound capable of reversing the deficit in complex IV activity in PINK1 null cells through specific increases of LRPPRC, Hsp90, and Hsp60 levels. The pharmacological effects of ginsenoside Re could be reversed by treatment of the pan-NOS inhibitor L-NG-Nitroarginine Methyl Ester (L-NAME) and could also be reproduced by low-level NO treatment. These results suggest that PINK1 regulates complex IV activity via interactions with upstream regulators of Hsp60, such as LRPPRC and Hsp90. Furthermore, they demonstrate that treatment with ginsenoside Re enhances functioning of the defective PINK1-Hsp90/LRPPRC-Hsp60-complex IV signaling axis in PINK1 null neurons by restoring NO levels, providing potential for new therapeutics targeting mitochondrial dysfunction in Parkinson's disease.	[Kim, Kyung-Hee; Son, Jin H.] Ewha Womans Univ, Brain Dis Res Inst, Coll Pharm, Dept Brain & Cognit Sci, Seoul 120750, South Korea; [Song, Karen; Yoon, Seung-Hee; Son, Jin H.] Ewha Womans Univ, Brain Dis Res Inst, Coll Pharm, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Shehzad, Omer; Kim, Yeong-Shik] Seoul Natl Univ, Coll Pharm, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Seoul National University (SNU)	Son, JH (corresponding author), Ewha Womans Univ, Brain Dis Res Inst, Coll Pharm, Dept Brain & Cognit Sci, Sci Bldg C,Rm C307,11-1 Daehyun Dong, Seoul 120750, South Korea.	hjson@ewha.ac.kr	Kim, Hyung-Kwan/R-8375-2019		National Research Foundation [2010-0009233]; National Core Research Center, Republic of Korea [2012-0000952]	National Research Foundation; National Core Research Center, Republic of Korea	This work was supported in part by National Research Foundation Grant 2010-0009233 and National Core Research Center Program Grant 2012-0000952, Republic of Korea.	Atamna H, 2006, P NATL ACAD SCI USA, V103, P3381, DOI 10.1073/pnas.0600134103; Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003; Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje; BROWN GC, 1995, NEUROSCI LETT, V193, P201, DOI 10.1016/0304-3940(95)11703-Y; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Canevari L, 1999, FEBS LETT, V457, P131, DOI 10.1016/S0014-5793(99)01028-5; Chen X, 1997, CLIN EXP PHARMACOL P, V24, P958, DOI 10.1111/j.1440-1681.1997.tb02727.x; Coenen MJH, 2004, ANN NEUROL, V56, P560, DOI 10.1002/ana.20229; Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013; DRAPIER JC, 1988, J IMMUNOL, V140, P2829; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Hunot S, 1996, NEUROSCIENCE, V72, P355, DOI 10.1016/0306-4522(95)00578-1; KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; Leung KW, 2007, NEUROPHARMACOLOGY, V52, P827, DOI 10.1016/j.neuropharm.2006.10.001; Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; LUNDBERG JON, 1995, NAT MED, V1, P370, DOI 10.1038/nm0495-370; Meissner WG, 2011, NAT REV DRUG DISCOV, V10, P377, DOI 10.1038/nrd3430; Mohanakumar KP, 2002, ANN NY ACAD SCI, V962, P389, DOI 10.1111/j.1749-6632.2002.tb04083.x; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Nah SY, 2007, CNS DRUG REV, V13, P381; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Papadopoulou LC, 1999, NAT GENET, V23, P333; Pequignot MO, 2001, HUM MUTAT, V17, P374, DOI 10.1002/humu.1112.abs; Radi R, 2002, BIOL CHEM, V383, P401, DOI 10.1515/BC.2002.044; Rakovic A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/153979; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Schapira AHV, 2012, ANTIOXID REDOX SIGN, V16, P965, DOI 10.1089/ars.2011.4419; Shehzad O, 2011, J SEP SCI, V34, P1116, DOI 10.1002/jssc.201000932; SHEN WQ, 1995, CIRCULATION, V92, P3505, DOI 10.1161/01.CIR.92.12.3505; Shim JH, 2011, MITOCHONDRION, V11, P707, DOI 10.1016/j.mito.2011.05.013; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Stiburek L, 2010, BBA-BIOENERGETICS, V1797, P1149, DOI 10.1016/j.bbabio.2010.04.006; Stiburek L, 2009, AM J PHYSIOL-CELL PH, V296, pC1218, DOI 10.1152/ajpcell.00564.2008; Tian JW, 2009, PHYTOTHER RES, V23, P486, DOI 10.1002/ptr.2653; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Veereshwarayya V, 2006, J BIOL CHEM, V281, P29468, DOI 10.1074/jbc.M602533200; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Ye R, 2011, NEUROSCIENCE, V178, P169, DOI 10.1016/j.neuroscience.2011.01.007; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhang H, 2007, MOL REPROD DEV, V74, P497, DOI 10.1002/mrd.20583; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	48	28	31	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44109	44120		10.1074/jbc.M112.408146	http://dx.doi.org/10.1074/jbc.M112.408146			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144451	Green Published, hybrid			2022-12-28	WOS:000312938600010
J	Purvis, A; Hohenester, E				Purvis, Alan; Hohenester, Erhard			Laminin Network Formation Studied by Reconstitution of Ternary Nodes in Solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-EXCLUSION CHROMATOGRAPHY; N-TERMINAL DOMAINS; BINDING; ARM	The polymerization of laminins into a cell-associated network is a key process in basement membrane assembly. Network formation is mediated by the homologous short arm tips of the laminin heterotrimer, each consisting of a globular laminin N-terminal (LN) domain followed by a tandem of laminin-type epidermal growth factor-like (LEa) domains. How the short arms interact in the laminin network is unclear. Here, we have addressed this question by reconstituting laminin network nodes in solution and analyzing them by size exclusion chromatography and light scattering. Recombinant LN-LEa1-4 fragments of the laminin alpha 1, alpha 2, alpha 5, beta 1, and gamma 1 chains were monomeric in solution. The beta 1 and gamma 1 fragments formed the only detectable binary complex and ternary complexes of 1:1:1 stoichiometry with all alpha chain fragments. Ternary complex formation required calcium and did not occur at 4 degrees C, like the polymerization of full-length laminins. Experiments with chimeric short arm fragments demonstrated that the LEa2-4 regions of the beta 1 and gamma 1 fragments are dispensable for ternary complex formation, and an engineered glycan in the beta 1 LEa1 domain was also tolerated. In contrast, mutation of Ser-68 in the beta 1 LN domain (corresponding to a Pierson syndrome mutation in the closely related beta 2 chain) abolished ternary complex formation. We conclude that authentic ternary nodes of the laminin network can be reconstituted for structure-function studies.	[Purvis, Alan; Hohenester, Erhard] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	Imperial College London	Hohenester, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, 4th Floor,Sir Ernst Chain Bldg, London SW7 2AZ, England.	e.hohenester@imperial.ac.uk			Wellcome Trust Senior Research Fellowship in Basic Biomedical Science [083942/Z/07/Z]	Wellcome Trust Senior Research Fellowship in Basic Biomedical Science(Wellcome Trust)	This work was supported by Wellcome Trust Senior Research Fellowship in Basic Biomedical Science 083942/Z/07/Z (to E.H.).	Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; BRUCH M, 1989, EUR J BIOCHEM, V185, P271, DOI 10.1111/j.1432-1033.1989.tb15112.x; Carafoli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042473; Chen YM, 2011, J AM SOC NEPHROL, V22, P849, DOI 10.1681/ASN.2010060632; Cheng YS, 1997, J BIOL CHEM, V272, P31525, DOI 10.1074/jbc.272.50.31525; Garbe JHO, 2002, BIOCHEM J, V362, P213, DOI 10.1042/0264-6021:3620213; Hussain SA, 2011, EMBO REP, V12, P276, DOI 10.1038/embor.2011.3; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Lehnhardt A, 2012, PEDIATR NEPHROL, V27, P865, DOI 10.1007/s00467-011-2088-2; Matejas V, 2010, HUM MUTAT, V31, P992, DOI 10.1002/humu.21304; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Odenthal U, 2004, J BIOL CHEM, V279, P44504, DOI 10.1074/jbc.M402455200; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; PAULSSON M, 1988, J BIOL CHEM, V263, P5425; SCHITTNY JC, 1990, J CELL BIOL, V110, P825, DOI 10.1083/jcb.110.3.825; STEVENS FJ, 1989, BIOPHYS J, V55, P1155, DOI 10.1016/S0006-3495(89)82912-1; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286; YURCHENCO PD, 1992, J CELL BIOL, V117, P1119, DOI 10.1083/jcb.117.5.1119; YURCHENCO PD, 1985, J BIOL CHEM, V260, P7636; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	23	26	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44270	44277		10.1074/jbc.M112.418426	http://dx.doi.org/10.1074/jbc.M112.418426			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23166322	hybrid, Green Published			2022-12-28	WOS:000312938600025
J	Cho, KJ; Park, JH; Piggott, AM; Salim, AA; Gorfe, AA; Parton, RG; Capon, RJ; Lacey, E; Hancock, JF				Cho, Kwang-jin; Park, Jin-Hee; Piggott, Andrew M.; Salim, Angela A.; Gorfe, Alemaheyu A.; Parton, Robert G.; Capon, Robert J.; Lacey, Ernest; Hancock, John F.			Staurosporines Disrupt Phosphatidylserine Trafficking and Mislocalize Ras Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; K-RAS; H-RAS; KINASE-C; DEPENDENT ASSOCIATION; CELLULAR MEMBRANES; LOCALIZATION; ENDOSOMES; PHOSPHOLIPIDS; MICROTUBULES	Oncogenic mutant Ras is frequently expressed in human cancers, but no anti-Ras drugs have been developed. Since membrane association is essential for Ras biological activity, we developed a high content assay for inhibitors of Ras plasma membrane localization. We discovered that staurosporine and analogs potently inhibit Ras plasma membrane binding by blocking endosomal recycling of phosphatidylserine, resulting in redistribution of phosphatidylserine from plasma membrane to endomembrane. Staurosporines are more active against K-Ras than H-Ras. K-Ras is displaced to endosomes and undergoes proteasomal-independent degradation, whereas H-Ras redistributes to the Golgi and is not degraded. K-Ras nanoclustering on the plasma membrane is also inhibited. Ras mislocalization does not correlate with protein kinase C inhibition or induction of apoptosis. Staurosporines selectively abrogate K-Ras signaling and proliferation of K-Ras-transformed cells. These results identify staurosporines as novel inhibitors of phosphatidylserine trafficking, yield new insights into the role of phosphatidylserine and electrostatics in Ras plasma membrane targeting, and validate a new target for anti-Ras therapeutics.	[Cho, Kwang-jin; Park, Jin-Hee; Gorfe, Alemaheyu A.; Hancock, John F.] Univ Texas Houston, Med Sch Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, St Lucia, Qld 4072, Australia; [Piggott, Andrew M.; Salim, Angela A.; Capon, Robert J.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4072, Australia; [Lacey, Ernest] Microbial Screening Technol Pty Ltd, Smithfield, NSW 2164, Australia	University of Texas System; University of Texas Health Science Center Houston; University of Queensland; University of Queensland	Hancock, JF (corresponding author), Univ Texas Houston, Med Sch Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	john.f.hancock@uth.tmc.edu	Salim, Angela/J-4884-2014; Parton, Robert G/C-5673-2009; Capon, Robert/G-9238-2012; Piggott, Andrew M/G-9259-2012; Cho, Kwang-jin/AAI-4923-2020	Salim, Angela/0000-0002-8177-5689; Parton, Robert G/0000-0002-7494-5248; Capon, Robert/0000-0002-8341-7754; Piggott, Andrew M/0000-0002-5308-5314; Hancock, John/0000-0003-0542-4710	Cancer Prevention and Research Institute of Texas [RP100483]; Australian Research Council	Cancer Prevention and Research Institute of Texas; Australian Research Council(Australian Research Council)	This work was supported by the Cancer Prevention and Research Institute of Texas Grant RP100483 (to J.F.H.) and the Australian Research Council.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Ariotti N, 2010, MOL CELL BIOL, V30, P3795, DOI 10.1128/MCB.01615-09; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Bhagatji P, 2010, BIOPHYS J, V99, P3327, DOI 10.1016/j.bpj.2010.10.001; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Chen Z, 2000, J BIOL CHEM, V275, P41251, DOI 10.1074/jbc.M006687200; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; COURAGE C, 1995, BRIT J CANCER, V71, P697, DOI 10.1038/bjc.1995.137; COX AD, 1992, MOL CELL BIOL, V12, P2606, DOI 10.1128/MCB.12.6.2606; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Elad G, 1999, BBA-MOL CELL RES, V1452, P228, DOI 10.1016/S0167-4889(99)00144-5; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Fong-ngern K, 2009, ANAL BIOCHEM, V395, P25, DOI 10.1016/j.ab.2009.08.007; Gorfe AA, 2008, BIOPHYS J, V95, P3269, DOI 10.1529/biophysj.108.136481; Gorfe AA, 2007, J AM CHEM SOC, V129, P12280, DOI 10.1021/ja073949v; Hancock JF, 2005, METHODS, V37, P165, DOI 10.1016/j.ymeth.2005.05.018; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; HANCOCK JF, 1995, METHOD ENZYMOL, V255, P237; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Janosi L, 2010, BIOPHYS J, V99, P3666, DOI 10.1016/j.bpj.2010.10.031; Kay JG, 2012, MOL BIOL CELL, V23, P2198, DOI 10.1091/mbc.E11-11-0936; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Misaki R, 2010, J CELL BIOL, V191, P23, DOI 10.1083/jcb.200911143; Okeley NM, 2004, J BIOL CHEM, V279, P21833, DOI 10.1074/jbc.M313469200; OSADA H, 1992, J ANTIBIOT, V45, P189, DOI 10.7164/antibiotics.45.189; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rotblat B, 2004, MOL CELL BIOL, V24, P6799, DOI 10.1128/MCB.24.15.6799-6810.2004; Roy MO, 2000, BIOCHEMISTRY-US, V39, P8298, DOI 10.1021/bi000512q; SEYNAEVE CM, 1994, MOL PHARMACOL, V45, P1207; Thissen JA, 1997, J BIOL CHEM, V272, P30362, DOI 10.1074/jbc.272.48.30362; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; Wang G, 2006, MOL CELL BIOL, V26, P3243, DOI 10.1128/MCB.26.8.3243-3255.2006; Weise K, 2011, J AM CHEM SOC, V133, P880, DOI 10.1021/ja107532q; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200	50	65	65	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43573	43584		10.1074/jbc.M112.424457	http://dx.doi.org/10.1074/jbc.M112.424457			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23124205	Green Published, hybrid			2022-12-28	WOS:000312940800038
J	Lipari, MT; Li, W; Moran, P; Kong-Beltran, M; Sai, T; Lai, J; Lin, SJ; Kolumam, G; Zavala-Solorio, J; Izrael-Tomasevic, A; Arnott, D; Wang, JY; Peterson, AS; Kirchhofer, D				Lipari, Michael T.; Li, Wei; Moran, Paul; Kong-Beltran, Monica; Sai, Tao; Lai, Joyce; Lin, S. Jack; Kolumam, Ganesh; Zavala-Solorio, Jose; Izrael-Tomasevic, Anita; Arnott, David; Wang, Jianyong; Peterson, Andrew S.; Kirchhofer, Daniel			Furin-cleaved Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Is Active and Modulates Low Density Lipoprotein Receptor and Serum Cholesterol Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; LDL-CHOLESTEROL; NONHUMAN-PRIMATES; PROSTATE-CANCER; SECRETED PCSK9; DEGRADATION; ANTIBODY; HYPERCHOLESTEROLEMIA; MUTATIONS; BINDING	Proprotein convertase subtilisin/kexin 9 (PCSK9) regulates plasma LDL cholesterol levels by regulating the degradation of LDL receptors. Another proprotein convertase, furin, cleaves PCSK9 at Arg(218)-Gln(219) in the surface-exposed "218 loop." This cleaved form circulates in blood along with the intact form, albeit at lower concentrations. To gain a better understanding of how cleavage affects PCSK9 function, we produced recombinant furin-cleaved PCSK9 using antibody Ab-3D5, which binds the intact but not the cleaved 218 loop. Using Ab-3D5, we also produced highly purified hepsin-cleaved PCSK9. Hepsin cleaves PCSK9 at Arg(218)-Gln(219) more efficiently than furin but also cleaves at Arg(215)-Phe(216). Further analysis by size exclusion chromatography and mass spectrometry indicated that furin and hepsin produced an internal cleavage in the 218 loop without the loss of the N-terminal segment (Ser(153)-Arg(218)), which remained attached to the catalytic domain. Both furin-and hepsin-cleaved PCSK9 bound to LDL receptor with only 2-fold reduced affinity compared with intact PCSK9. Moreover, they reduced LDL receptor levels in HepG2 cells and in mouse liver with only moderately lower activity than intact PCSK9, consistent with the binding data. Single injection into mice of furin-cleaved PCSK9 resulted in significantly increased serum cholesterol levels, approaching the increase by intact PCSK9. These findings indicate that circulating furin-cleaved PCSK9 is able to regulate LDL receptor and serum cholesterol levels, although somewhat less efficiently than intact PCSK9. Therapeutic anti-PCSK9 approaches that neutralize both forms should be the most effective in preserving LDL receptors and in lowering plasma LDL cholesterol.	[Lipari, Michael T.; Li, Wei; Moran, Paul; Lin, S. Jack; Arnott, David; Kirchhofer, Daniel] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Kong-Beltran, Monica; Peterson, Andrew S.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Sai, Tao; Lai, Joyce] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Kolumam, Ganesh; Zavala-Solorio, Jose] Genentech Inc, Dept Biomed Imaging, San Francisco, CA 94080 USA; [Izrael-Tomasevic, Anita; Arnott, David] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Wang, Jianyong] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Kirchhofer, D (corresponding author), Genentech Inc, Dept Early Discovery Biochem, 1 DNA Way, San Francisco, CA 94080 USA.	dak@gene.com						Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Allard Delphine, 2005, Hum Mutat, V26, P497, DOI 10.1002/humu.9383; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Cameron J, 2008, J INTERN MED, V263, P420, DOI 10.1111/j.1365-2796.2007.01915.x; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Costet P, 2008, TRENDS BIOCHEM SCI, V33, P426, DOI 10.1016/j.tibs.2008.06.005; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Duff CJ, 2011, EXPERT OPIN THER TAR, V15, P157, DOI 10.1517/14728222.2011.547480; Duff CJ, 2009, BIOCHEM J, V419, P577, DOI 10.1042/BJ20082407; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Ganesan R, 2012, PROTEIN ENG DES SEL, V25, P127, DOI 10.1093/protein/gzr067; Guipponi M, 2007, AM J PATHOL, V171, P608, DOI 10.2353/ajpath.2007.070068; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Holla OL, 2011, J LIPID RES, V52, P1787, DOI 10.1194/jlr.M018093; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Klezovitch O, 2004, CANCER CELL, V6, P185, DOI 10.1016/j.ccr.2004.07.008; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Li W, 2009, CANCER RES, V69, P8395, DOI 10.1158/0008-5472.CAN-09-1995; Liang H, 2012, J PHARMACOL EXP THER, V340, P228, DOI 10.1124/jpet.111.187419; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Magee JA, 2001, CANCER RES, V61, P5692; Malby S, 2001, BIOCHEMISTRY-US, V40, P2555, DOI 10.1021/bi002322l; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Troutt JS, 2010, J LIPID RES, V51, P345, DOI 10.1194/jlr.M000620; Yamamoto T, 2011, J BIOL CHEM, V286, P5464, DOI 10.1074/jbc.M110.199042; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	39	65	85	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43482	43491		10.1074/jbc.M112.380618	http://dx.doi.org/10.1074/jbc.M112.380618			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23135270	hybrid, Green Published			2022-12-28	WOS:000312940800029
J	Feldman, JL; Dittenhafer-Reed, KE; Denu, JM				Feldman, Jessica L.; Dittenhafer-Reed, Kristin E.; Denu, John M.			Sirtuin Catalysis and Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FATTY-ACID OXIDATION; SMALL-MOLECULE ACTIVATORS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SUBSTRATE-SPECIFICITY; LYSINE PROPIONYLATION; CALORIE RESTRICTION; CELL-SURVIVAL; SIR2 PROTEIN; DEACETYLASE; MECHANISM	Sirtuins are a family of NAD(+)-dependent protein deacetylases/deacylases that dynamically regulate transcription, metabolism, and cellular stress response. Their general positive link with improved health span in mammals, potential regulation of pathways mediated by caloric restriction, and growing links to human disease have spurred interest in therapeutics that target their functions. Here, we review the current understanding of the chemistry of catalysis, biological targets, and endogenous regulation of sirtuin activity. We discuss recent efforts to generate small-molecule regulators of sirtuin activity.	[Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53715 USA; Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Denu, JM (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53715 USA.	jmdenu@wisc.edu		Dittenhafer-Reed, Kristin/0000-0001-7317-3912	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065386, R37GM059785] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM059785, R01 GM065386] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004; Anderson RM, 2012, AM J HUM BIOL, V24, P101, DOI 10.1002/ajhb.22243; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Blander G, 2005, J BIOL CHEM, V280, P9780, DOI 10.1074/jbc.M414080200; Blum CA, 2011, J MED CHEM, V54, P417, DOI 10.1021/jm100861p; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cen YN, 2011, ORG BIOMOL CHEM, V9, P987, DOI 10.1039/c0ob00774a; Cen Y, 2010, J AM CHEM SOC, V132, P12286, DOI 10.1021/ja910342d; Chakrabarty SP, 2010, BBA-PROTEINS PROTEOM, V1804, P1743, DOI 10.1016/j.bbapap.2010.06.010; Chakrabarty SP, 2009, BIOORGAN MED CHEM, V17, P8060, DOI 10.1016/j.bmc.2009.10.003; Chen D, 2011, J BIOL CHEM, V286, P13261, DOI 10.1074/jbc.M110.206771; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cosgrove MS, 2006, BIOCHEMISTRY-US, V45, P7511, DOI 10.1021/bi0526332; Dai H, 2010, J BIOL CHEM, V285, P32695, DOI 10.1074/jbc.M110.133892; Dan L, 2012, HAEMATOL-HEMATOL J, V97, P551, DOI 10.3324/haematol.2011.055236; Dancy BCR, 2012, J AM CHEM SOC, V134, P5138, DOI 10.1021/ja209574z; Dittenhafer-Reed KE, 2011, CHEMBIOCHEM, V12, P281, DOI 10.1002/cbic.201000434; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Fang YJ, 2011, CANCER LETT, V306, P10, DOI 10.1016/j.canlet.2011.02.019; Fritz KS, 2011, CHEM RES TOXICOL, V24, P651, DOI 10.1021/tx100355a; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Garske AL, 2006, BIOCHEMISTRY-US, V45, P94, DOI 10.1021/bi052015l; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Giralt A, 2011, J BIOL CHEM, V286, P16958, DOI 10.1074/jbc.M110.202390; Gurard-Levin ZA, 2010, ACS CHEM BIOL, V5, P863, DOI 10.1021/cb100088g; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hallows WC, 2012, J BIOL CHEM, V287, P3850, DOI 10.1074/jbc.M111.317404; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hawse WF, 2008, STRUCTURE, V16, P1368, DOI 10.1016/j.str.2008.05.015; He B, 2012, J AM CHEM SOC, V134, P1922, DOI 10.1021/ja2090417; Hebert A. S, 2012, MOL CELL IN PRESS; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huhtiniemi T, 2011, J MED CHEM, V54, P6456, DOI 10.1021/jm200590k; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Law IKM, 2009, PROTEOMICS, V9, P2444, DOI 10.1002/pmic.200800738; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Liu XY, 2011, P NATL ACAD SCI USA, V108, P1925, DOI 10.1073/pnas.1019619108; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Noriega LG, 2011, EMBO REP, V12, P1069, DOI 10.1038/embor.2011.151; Norvell A, 2010, SCIENCE, V327, P964, DOI 10.1126/science.1187159; Oliver SS, 2011, CHEMBIOCHEM, V12, P299, DOI 10.1002/cbic.201000474; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Sauve AA, 2010, BBA-PROTEINS PROTEOM, V1804, P1591, DOI 10.1016/j.bbapap.2010.01.021; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Schlicker C, 2011, AGING-US, V3, P852, DOI 10.18632/aging.100388; Sivaraman Padavattan, 2010, Syst Synth Biol, V4, P257, DOI 10.1007/s11693-011-9069-4; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Smith BC, 2007, J BIOL CHEM, V282, P37256, DOI 10.1074/jbc.M707878200; Smith BC, 2007, BIOCHEMISTRY-US, V46, P14478, DOI 10.1021/bi7013294; Smith BC, 2011, ACS CHEM BIOL, V6, P146, DOI 10.1021/cb100218d; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Suzuki T, 2009, BIOORG MED CHEM LETT, V19, P5670, DOI 10.1016/j.bmcl.2009.08.028; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tong L, 2010, BBA-PROTEINS PROTEOM, V1804, P1617, DOI 10.1016/j.bbapap.2010.02.007; Tsai YC, 2012, MOL CELL PROTEOMICS, V11, P60, DOI 10.1074/mcp.A111.015156; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Xie ZY, 2012, MOL CELL PROTEOMICS, V11, P100, DOI 10.1074/mcp.M111.015875; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	99	159	166	1	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42419	42427		10.1074/jbc.R112.378877	http://dx.doi.org/10.1074/jbc.R112.378877			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23086947	hybrid, Green Published			2022-12-28	WOS:000312501600002
J	Yu, SL; Levi, L; Siegel, R; Noy, N				Yu, Shuiliang; Levi, Liraz; Siegel, Ruth; Noy, Noa			Retinoic Acid Induces Neurogenesis by Activating Both Retinoic Acid Receptors (RARs) and Peroxisome Proliferator-activated Receptor beta/delta (PPAR beta/delta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REV-ERB-ALPHA; EMBRYONAL CARCINOMA; BINDING PROTEINS; NEURONAL DIFFERENTIATION; LIM PROTEIN; EXPRESSION; GENES; RESISTANCE; LIGAND; ROLES	Retinoic acid (RA) regulates gene transcription by activating the nuclear receptors retinoic acid receptor (RAR) and peroxisome proliferator-activated receptor (PPAR) beta/delta and their respective cognate lipid-binding proteins CRABP-II and FABP5. RA induces neuronal differentiation, but the contributions of the two transcriptional pathways of the hormone to the process are unknown. Here, we show that the RA-induced commitment of P19 stem cells to neuronal progenitors is mediated by the CRABP-II/RAR path and that the FABP5/PPAR beta/delta path can inhibit the process through induction of the RAR repressors SIRT1 and Ajuba. In contrast with its inhibitory activity in the early steps of neurogenesis, the FABP5/PPAR beta/delta path promotes differentiation of neuronal progenitors to mature neurons, an activity mediated in part by the PPAR beta/delta target gene PDK1. Hence, RA-induced neuronal differentiation is mediated through RAR in the early stages and through PPAR beta/delta in the late stages of the process. The switch in RA signaling is accomplished by a transient up-regulation of RAR beta concomitantly with a transient increase in the CRABP-II/FABP5 ratio at early stages of differentiation. In accordance with these conclusions, hippocampi of FABP5-null mice display excess accumulation of neuronal progenitor cells and a deficit in mature neurons versus wild-type animals.	[Yu, Shuiliang; Levi, Liraz; Siegel, Ruth; Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Noy, N (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave W333, Cleveland, OH 44106 USA.	noa.noy@case.edu		Levi, Liraz/0000-0001-7462-2396	National Institutes of Health [RO1 DK060684]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK060684 (to N. N.).	Berry DC, 2012, DIABETES, V61, P1112, DOI 10.2337/db11-1620; Berry DC, 2010, J BIOL CHEM, V285, P15324, DOI 10.1074/jbc.M110.110635; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Boneva NB, 2010, NEUROSCI RES, V68, P94, DOI 10.1016/j.neures.2010.07.2028; BOYLAN JF, 1991, J CELL BIOL, V112, P965, DOI 10.1083/jcb.112.5.965; BOYLAN JF, 1992, J BIOL CHEM, V267, P21486; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; D'Angelo B, 2011, J CELL PHYSIOL, V226, P2170, DOI 10.1002/jcp.22552; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Endo M, 2009, J BIOL CHEM, V284, P5107, DOI 10.1074/jbc.M807745200; Fishwick KJ, 2010, DEV BIOL, V338, P215, DOI 10.1016/j.ydbio.2009.12.001; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Gervois P, 1999, MOL ENDOCRINOL, V13, P400, DOI 10.1210/me.13.3.400; GILLESPIE MT, 1994, MOL CELL ENDOCRINOL, V100, P143, DOI 10.1016/0303-7207(94)90293-3; Goyal RK, 1999, MOL CELL BIOL, V19, P4379; Hall MG, 2008, PPAR RES, V2008, DOI 10.1155/2008/780452; Hou ZY, 2010, P NATL ACAD SCI USA, V107, P2938, DOI 10.1073/pnas.0908656107; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kang MR, 2010, NUCLEIC ACIDS RES, V38, P822, DOI 10.1093/nar/gkp1056; Kumar AP, 2004, J BIOL CHEM, V279, P8300, DOI 10.1074/jbc.M311625200; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Manor D, 2003, CANCER RES, V63, P4426; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; Means AL, 2000, CELL GROWTH DIFFER, V11, P71; Oishi K, 2009, P NATL ACAD SCI USA, V106, P13064, DOI 10.1073/pnas.0808400106; RINGOLD GM, 1984, P NATL ACAD SCI-BIOL, V81, P3964, DOI 10.1073/pnas.81.13.3964; Saluja I, 2001, GLIA, V33, P191, DOI 10.1002/1098-1136(200103)33:3<191::AID-GLIA1018>3.0.CO;2-M; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Stahel PF, 2008, PPAR RES, V2008, DOI 10.1155/2008/538141; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Venkatachalam G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S5	41	71	79	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42195	42205		10.1074/jbc.M112.410381	http://dx.doi.org/10.1074/jbc.M112.410381			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23105114	hybrid, Green Published			2022-12-28	WOS:000312103000056
J	Hahn, A; Stevanovic, M; Mirus, O; Schleiff, E				Hahn, Alexander; Stevanovic, Mara; Mirus, Oliver; Schleiff, Enrico			The TolC-like Protein HgdD of the Cyanobacterium Anabaena sp PCC 7120 Is Involved in Secondary Metabolite Export and Antibiotic Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP-STRAIN PCC-7120; GRAM-NEGATIVE BACTERIA; MULTIDRUG EFFLUX PUMPS; OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI; CELL-WALL; I SECRETION; TRANSPORT; PORE; GENE	The role of TolC has largely been explored in proteobacteria, where it functions as a metabolite and protein exporter. In contrast, little research has been carried out on the function of cyanobacterial homologues, and as a consequence, not much is known about the mechanism of cyanobacterial antibiotic uptake and metabolite secretion in general. It has been suggested that the TolC-like homologue of the filamentous, heterocyst-forming cyanobacterium Anabaena sp. PCC 7120, termed heterocyst glycolipid deposition protein D (HgdD), is involved in both protein and lipid secretion. To describe its function in secondary metabolite secretion, we established a system to measure the uptake of antibiotics based on the fluorescent molecule ethidium bromide. We analyzed the rate of porin-dependent metabolite uptake and confirmed the functional relation between detoxification and the action of HgdD. Moreover, we identified two major facilitator superfamily proteins that are involved in this process. It appears that anaOmp85 (Alr2269) is not required for insertion or assembly of HgdD, because an alr2269 mutant does not exhibit a phenotype similar to the hgdD mutant. Thus, we could assign components of the metabolite efflux system and describe parameters of detoxification by Anabaena sp. PCC 7120.	[Hahn, Alexander; Stevanovic, Mara; Mirus, Oliver; Schleiff, Enrico] Goethe Univ Frankfurt, Dept Biosci, Ctr Membrane Prote, D-60438 Frankfurt, Germany	Goethe University Frankfurt	Schleiff, E (corresponding author), Goethe Univ Frankfurt, Dept Biosci, Ctr Membrane Prote, Max von Laue Str 9, D-60438 Frankfurt, Germany.	schleiff@bio.uni-frankfurt.de	Schleiff, Enrico/C-5105-2017	Schleiff, Enrico/0000-0002-0518-3489; Hahn, Alexander/0000-0003-4118-5438	Center of Membrane Proteomics (Goethe University Frankfurt); Cluster of Excellence Frankfurt "Macro-molecular Complexes"; Deutsche Forschungsgemeinschaft [SCHL 585/2]	Center of Membrane Proteomics (Goethe University Frankfurt); Cluster of Excellence Frankfurt "Macro-molecular Complexes"; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Center of Membrane Proteomics (Goethe University Frankfurt) (to A. H.), the Cluster of Excellence Frankfurt "Macro-molecular Complexes" (to E. S.), and Deutsche Forschungsgemeinschaft Grant SCHL 585/2 (to E. S.).	APTE SK, 1986, EUR J BIOCHEM, V154, P395, DOI 10.1111/j.1432-1033.1986.tb09411.x; Awram P, 1998, J BACTERIOL, V180, P3062, DOI 10.1128/JB.180.12.3062-3069.1998; Baranovsky SF, 2009, J APPL SPECTROSC+, V76, P132, DOI 10.1007/s10812-009-9139-5; BENZ R, 1985, BIOCHIM BIOPHYS ACTA, V812, P286, DOI 10.1016/0005-2736(85)90550-4; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bleuel C, 2005, J BACTERIOL, V187, P6701, DOI 10.1128/JB.187.19.6701-6707.2005; Bolhuis H, 1997, FEMS MICROBIOL REV, V21, P55, DOI 10.1016/S0168-6445(97)00051-X; Bredemeier R, 2007, J BIOL CHEM, V282, P1882, DOI 10.1074/jbc.M609598200; CAI YP, 1990, J BACTERIOL, V172, P3138, DOI 10.1128/jb.172.6.3138-3145.1990; CHRASTIL J, 1993, COMPUT CHEM, V17, P103, DOI 10.1016/0097-8485(93)80035-C; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; ElhaI J, 1997, J BACTERIOL, V179, P1998, DOI 10.1128/jb.179.6.1998-2005.1997; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; Ertel F, 2005, J BIOL CHEM, V280, P28281, DOI 10.1074/jbc.M503035200; Fan Q, 2005, MOL MICROBIOL, V58, P227, DOI 10.1111/j.1365-2958.2005.04818.x; Flores E, 2006, TRENDS MICROBIOL, V14, P439, DOI 10.1016/j.tim.2006.08.007; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Furrer JL, 2002, MOL MICROBIOL, V44, P1225, DOI 10.1046/j.1365-2958.2002.02885.x; Goldberg M, 1999, J BIOL CHEM, V274, P26065, DOI 10.1074/jbc.274.37.26065; HANSEL A, 1994, ARCH MICROBIOL, V161, P163, DOI 10.1007/BF00276478; Hansel A, 1998, CURR MICROBIOL, V36, P321, DOI 10.1007/s002849900316; Hansel A, 1998, BBA-GENE STRUCT EXPR, V1399, P31, DOI 10.1016/S0167-4781(98)00090-6; Herzberg M, 2006, J BACTERIOL, V188, P587, DOI 10.1128/JB.188.2.587-598.2006; Hoiczyk E, 2000, J BACTERIOL, V182, P1191, DOI 10.1128/JB.182.5.1191-1199.2000; Huang F, 2004, MOL CELL PROTEOMICS, V3, P586, DOI 10.1074/mcp.M300137-MCP200; Iyer R, 1997, J BIOL CHEM, V272, P18595, DOI 10.1074/jbc.272.30.18595; Iyer R, 2000, J MOL BIOL, V297, P933, DOI 10.1006/jmbi.2000.3599; KASHIWAGI S, 1995, BBA-BIOMEMBRANES, V1237, P189, DOI 10.1016/0005-2736(95)00124-L; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Ladig R, 2011, PLANT J, V67, P181, DOI 10.1111/j.1365-313X.2011.04577.x; Lebel S, 2004, FEMS MICROBIOL LETT, V238, P93, DOI 10.1016/j.femsle.2004.07.022; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang WJ, 2005, J BACTERIOL, V187, P2377, DOI 10.1128/JB.187.7.2377-2385.2005; Mirus O, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P175, DOI 10.1007/978-3-642-05062-6_6; Moslavac S, 2005, J PROTEOME RES, V4, P1330, DOI 10.1021/pr050044c; Moslavac S, 2007, J BACTERIOL, V189, P7887, DOI 10.1128/JB.00750-07; Moslavac S, 2007, BIOL CHEM, V388, P823, DOI 10.1515/BC.2007.079; Nagano K, 2009, P NATL ACAD SCI USA, V106, P5854, DOI 10.1073/pnas.0901695106; Newton SM, 2010, J BIOL CHEM, V285, P17488, DOI 10.1074/jbc.M109.100206; Nicolaisen K, 2008, J BACTERIOL, V190, P7500, DOI 10.1128/JB.01062-08; Nicolaisen K, 2010, BBA-BIOMEMBRANES, V1798, P2131, DOI 10.1016/j.bbamem.2010.07.008; Nicolaisen K, 2009, MOL MICROBIOL, V74, P58, DOI 10.1111/j.1365-2958.2009.06850.x; Nicolalsen K, 2009, J BASIC MICROB, V49, P5, DOI 10.1002/jobm.200800300; NIKAIDO H, 1992, MOL MICROBIOL, V6, P435, DOI 10.1111/j.1365-2958.1992.tb01487.x; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; NITSCHMANN WH, 1986, J BACTERIOL, V168, P1205, DOI 10.1128/jb.168.3.1205-1211.1986; Olmedo-Verd E, 2006, J BACTERIOL, V188, P6694, DOI 10.1128/JB.00509-06; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Pernil R, 2008, MOL MICROBIOL, V67, P1067, DOI 10.1111/j.1365-2958.2008.06107.x; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; PLESIAT P, 1992, MOL MICROBIOL, V6, P1323, DOI 10.1111/j.1365-2958.1992.tb00853.x; Poolman B, 1996, MOL MICROBIOL, V19, P911, DOI 10.1046/j.1365-2958.1996.397949.x; Pos KM, 2009, BBA-PROTEINS PROTEOM, V1794, P782, DOI 10.1016/j.bbapap.2008.12.015; POURCHER T, 1990, PHILOS T ROY SOC B, V326, P411, DOI 10.1098/rstb.1990.0021; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; SAMBROOK J, 1989, MOL CLONING LAB MANU; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; SEN K, 1988, J BIOL CHEM, V263, P1182; Staron P, 2011, J BIOL CHEM, V286, P38202, DOI 10.1074/jbc.M111.269332; Tal N, 2009, P NATL ACAD SCI USA, V106, P9051, DOI 10.1073/pnas.0902400106; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Tripp J, 2012, J BIOL CHEM, V287, P24164, DOI 10.1074/jbc.M112.341644; Valladares A, 2011, J BACTERIOL, V193, P1172, DOI 10.1128/JB.01202-10; Werner J, 2005, MOL MICROBIOL, V57, P1450, DOI 10.1111/j.1365-2958.2005.04775.x; Wilk L, 2011, CELL MICROBIOL, V13, P1744, DOI 10.1111/j.1462-5822.2011.01655.x; WYMAN M, 1986, BRIT PHYCOL J, V21, P147, DOI 10.1080/00071618600650171; Zhang CC, 2006, MOL MICROBIOL, V59, P367, DOI 10.1111/j.1365-2958.2005.04979.x	72	30	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41126	41138		10.1074/jbc.M112.396010	http://dx.doi.org/10.1074/jbc.M112.396010			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23071120	Green Published, hybrid			2022-12-28	WOS:000311887600029
J	Dai, XH; Mashiguchi, K; Chen, QG; Kasahara, H; Kamiya, Y; Ojha, S; DuBois, J; Ballou, D; Zhao, YD				Dai, Xinhua; Mashiguchi, Kiyoshi; Chen, Qingguo; Kasahara, Hiroyuki; Kamiya, Yuji; Ojha, Sunil; DuBois, Jennifer; Ballou, David; Zhao, Yunde			The Biochemical Mechanism of Auxin Biosynthesis by an Arabidopsis YUCCA Flavin-containing Monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTAINING MONO-OXYGENASE; DEPENDENT MONOOXYGENASES; HALF-REACTION; TRYPTOPHAN; PATHWAY; CATALYSIS; PLANTS; FAD; MAIZE; RICE	Auxin regulates every aspect of plant growth and development. Previous genetic studies demonstrated that YUCCA (YUC) flavin-containing monooxygenases (FMOs) catalyze a rate-limiting step in auxin biosynthesis and that YUCs are essential for many developmental processes. We proposed that YUCs convert indole-3-pyruvate (IPA) to indole-3-acetate (IAA). However, the exact biochemical mechanism of YUCs has remained elusive. Here we present the biochemical characterization of recombinant Arabidopsis YUC6. Expressed in and purified from Escherichia coli, YUC6 contains FAD as a cofactor, which has peaks at 448 nm and 376 nm in the UV-visible spectrum. We show that YUC6 uses NADPH and oxygen to convert IPA to IAA. The first step of the YUC6-catalyzed reaction is the reduction of the FAD cofactor to FADH(-) by NADPH. Subsequently, FADH(-) reacts with oxygen to form a flavin-C4a-(hydro) peroxy intermediate, which we show has a maximum absorbance at 381 nm in its UV-visible spectrum. The final chemical step is the reaction of the C4a-intermediate with IPA to produce IAA. Although the sequences of the YUC enzymes are related to those of the mammalian FMOs, which oxygenate nucleophilic substrates, YUC6 oxygenates an electrophilic substrate (IPA). Nevertheless, both classes of enzymes form quasistable C4a-(hydro)peroxyl FAD intermediates. The YUC6 intermediate has a half-life of similar to 20 s whereas that of some FMOs is >30 min. This work reveals the catalytic mechanism of the first known plant flavin monooxygenase and provides a foundation for further investigating how YUC activities are regulated in plants.	[Dai, Xinhua; Mashiguchi, Kiyoshi; Chen, Qingguo; Zhao, Yunde] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Kasahara, Hiroyuki; Kamiya, Yuji] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Ojha, Sunil; DuBois, Jennifer] SRI Int, Harrisonburg, VA 22802 USA; [Ballou, David] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of California System; University of California San Diego; RIKEN; SRI International; University of Michigan System; University of Michigan	Zhao, YD (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yundezhao@ucsd.edu	Zhao, Yunde/AAC-5360-2019; Kasahara, Hiroyuki/F-6445-2012; Kamiya, Yuji/F-9420-2010; Chen, Qingguo/E-4346-2014; Mashiguchi, Kiyoshi/AAN-3854-2020	Kasahara, Hiroyuki/0000-0002-4858-0978; Kamiya, Yuji/0000-0003-4415-520X; Mashiguchi, Kiyoshi/0000-0002-7234-887X	National Institutes of Health [R01GM68631]; Japan Society for the Promotion of Science KAKENHI Grant [24370027]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090260, R01GM068631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM68631 (to Y.Z.). This work was also supported by Japan Society for the Promotion of Science KAKENHI Grant 24370027 (to H. K.).	Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; BEATY NB, 1981, J BIOL CHEM, V256, P4619; BEATY NB, 1981, J BIOL CHEM, V256, P4611; BENTLEY JA, 1956, BIOCHEM J, V64, P44, DOI 10.1042/bj0640044; BESSEY OA, 1949, J BIOL CHEM, V180, P755; Cashman JR, 2006, ANNU REV PHARMACOL, V46, P65, DOI 10.1146/annurev.pharmtox.46.120604.141043; Cheng YF, 2007, PLANT CELL, V19, P2430, DOI 10.1105/tpc.107.053009; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Exposito-Rodriguez M, 2007, J PLANT GROWTH REGUL, V26, P329, DOI 10.1007/s00344-007-9019-2; Gallavotti A, 2008, P NATL ACAD SCI USA, V105, P15196, DOI 10.1073/pnas.0805596105; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; JEAN M, 1968, CAN J MICROBIOL, V14, P429, DOI 10.1139/m68-068; Kim JI, 2007, PLANT PHYSIOL, V145, P722, DOI 10.1104/pp.107.104935; LeClere S, 2010, PLANT PHYSIOL, V153, P306, DOI 10.1104/pp.110.155226; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Mayfield JA, 2010, J BIOL CHEM, V285, P30375, DOI 10.1074/jbc.M110.157578; MUH U, 1994, J BIOL CHEM, V269, P7989; Ooi T, 2012, J MOL CATAL B-ENZYM, V74, P204, DOI 10.1016/j.molcatb.2011.10.006; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Pazmino DET, 2008, BIOCHEMISTRY-US, V47, P4082, DOI 10.1021/bi702296k; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Stepanova AN, 2011, PLANT CELL, V23, P3961, DOI 10.1105/tpc.111.088047; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; WALSH CT, 1988, ANGEW CHEM INT EDIT, V27, P333, DOI 10.1002/anie.198803331; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Woo YM, 2007, PLANT MOL BIOL, V65, P125, DOI 10.1007/s11103-007-9203-6; Yamamoto Y, 2007, PLANT PHYSIOL, V143, P1362, DOI 10.1104/pp.106.091561; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zhao YD, 2012, MOL PLANT, V5, P334, DOI 10.1093/mp/ssr104; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308; Ziegler DM, 2002, DRUG METAB REV, V34, P503, DOI 10.1081/DMR-120005650	34	131	141	1	83	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1448	1457		10.1074/jbc.M112.424077	http://dx.doi.org/10.1074/jbc.M112.424077			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23188833	Green Published, hybrid			2022-12-28	WOS:000313751400003
J	Li, JL; Li, P; Carr, A; Wang, XK; DeLaPaz, A; Sun, L; Lee, E; Tomei, E; Li, L				Li, Jingling; Li, Ping; Carr, Aprell; Wang, Xiaokai; DeLaPaz, April; Sun, Lei; Lee, Eric; Tomei, Erika; Li, Lei			Functional Expression of SCL/TAL1 interrupting locus (Stil) Protects Retinal Dopaminergic Cells from Neurotoxin-induced Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; ADULT ZEBRAFISH; TISSUE REGENERATION; MULLER GLIA; SIL GENE; NEURONS; INJURY; MODEL; NEURODEGENERATION; SENSITIVITY	We previously isolated a dominant mutation, night blindness b (nbb), which causes a late onset of retinal dopaminergic cell degeneration in zebrafish. In this study, we cloned the zebrafish nbb locus. Sequencing results revealed that nbb is a homolog of the vertebrate SCL/TAL1 interrupting locus (Stil). The Stil gene has been shown to play important roles in the regulation of vertebrate embryonic neural development and human cancer cell proliferation. In this study, we demonstrate that functional expression of Stil is also required for neural survival. In zebrafish, decreased expression of Stil resulted in increased toxic susceptibility of retinal dopaminergic cells to 6-hydroxydopamine. Increases in Stil-mediated Shh signaling transduction (i.e. by knocking down the Shh repressor Sufu) prevented dopaminergic cell death induced by neurotoxic insult. The data suggest that the oncogene Stil also plays important roles in neural protection.	[Li, Jingling; Li, Ping; Carr, Aprell; Wang, Xiaokai; DeLaPaz, April; Sun, Lei; Lee, Eric; Tomei, Erika; Li, Lei] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Li, L (corresponding author), Univ Notre Dame, Dept Biol Sci, 100 Galvin Life Sci Bldg, Notre Dame, IN 46556 USA.	Li.78@nd.edu	Li, Lei/F-5722-2015	Li, Lei/0000-0001-9703-2102; Lee, Eric/0000-0002-3659-1020	National Institutes of Health [R01EY013147]; National Natural Science Foundation of China [30970941, 81171066]; Tianjin Science and Technology Committee [12JCZDJC24000]; NATIONAL EYE INSTITUTE [R01EY013147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Science and Technology Committee; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grant R01EY013147, National Natural Science Foundation of China Grants 30970941 and 81171066, and Tianjin Science and Technology Committee Grant 12JCZDJC24000.	Anichtchik OV, 2004, J NEUROCHEM, V88, P443, DOI 10.1046/j.1471-4159.2003.02190.x; APLAN PD, 1990, SCIENCE, V250, P1426, DOI 10.1126/science.2255914; APLAN PD, 1991, MOL CELL BIOL, V11, P5462, DOI 10.1128/MCB.11.11.5462; Arbour N, 2008, J NEUROSCI, V28, P6068, DOI 10.1523/JNEUROSCI.4940-07.2008; Becker CG, 2004, J NEUROSCI, V24, P7837, DOI 10.1523/JNEUROSCI.2420-04.2004; Bezard E, 1997, BRAIN RES, V766, P107, DOI 10.1016/S0006-8993(97)00531-3; Bretaud S, 2004, NEUROTOXICOL TERATOL, V26, P857, DOI 10.1016/j.ntt.2004.06.014; Buttner A, 2012, REPROD TOXICOL, V33, P254, DOI 10.1016/j.reprotox.2011.12.010; Chablais F, 2012, DEVELOPMENT, V139, P1921, DOI 10.1242/dev.078543; Erez A, 2007, CANCER RES, V67, P4022, DOI 10.1158/0008-5472.CAN-07-0064; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Guo S, 1999, DEV BIOL, V208, P473, DOI 10.1006/dbio.1999.9204; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Izraeli S, 2001, GENESIS, V31, P72, DOI 10.1002/gene.10004; Izraeli S, 1999, NATURE, V399, P691, DOI 10.1038/21429; Kasai K, 2008, CANCER RES, V68, P7723, DOI 10.1158/0008-5472.CAN-07-6661; Kelly PD, 2000, GENOME RES, V10, P558, DOI 10.1101/gr.10.4.558; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Li L, 2000, J NEUROSCI, V20, P1883; Li L, 2000, J NEUROSCI, V20, P1893; LIN ZS, 1994, VISUAL NEUROSCI, V11, P683, DOI 10.1017/S0952523800002996; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Mizuno Y, 2001, CURR OPIN NEUROL, V14, P477, DOI 10.1097/00019052-200108000-00008; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; Pfaff KL, 2007, MOL CELL BIOL, V27, P5887, DOI 10.1128/MCB.00175-07; Powell C, 2012, J NEUROSCI, V32, P1096, DOI 10.1523/JNEUROSCI.5603-11.2012; Rink E, 2004, NEUROSCIENCE, V127, P147, DOI 10.1016/j.neuroscience.2004.05.004; Rosello A, 2012, CLIN EXP IMMUNOL, V168, P52, DOI 10.1111/j.1365-2249.2011.04544.x; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Shao JP, 2011, DEV DYNAM, V240, P1271, DOI 10.1002/dvdy.22603; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Thummel R, 2008, EXP EYE RES, V87, P433, DOI 10.1016/j.exer.2008.07.009; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Wang XK, 2011, J CELL PHYSIOL, V226, P608, DOI 10.1002/jcp.22369; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Zhou Y, 2011, METHOD CELL BIOL, V104, P287, DOI 10.1016/B978-0-12-374814-0.00016-1	39	8	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					886	893		10.1074/jbc.M112.417089	http://dx.doi.org/10.1074/jbc.M112.417089			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23166330	hybrid, Green Published			2022-12-28	WOS:000313570300013
J	Lin, QQ; London, E				Lin, Qingqing; London, Erwin			Altering Hydrophobic Sequence Lengths Shows That Hydrophobic Mismatch Controls Affinity for Ordered Lipid Domains (Rafts) in the Multitransmembrane Strand Protein Perfringolysin O	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; CALCIUM ADENOSINE-TRIPHOSPHATASE; INDEPENDENT-MUTAGENESIS SLIM; BILAYER THICKNESS; MODEL MEMBRANES; PORE FORMATION; PEPTIDES; BINDING; CHAIN; PENETRATION	The hypothesis that mismatch between transmembrane (TM) length and bilayer width controls TM protein affinity for ordered lipid domains (rafts) was tested using perfringolysin O (PFO), a pore-forming cholesterol-dependent cytolysin. PFO forms a multimeric barrel with many TM segments. The properties of PFO mutants with lengthened or shortened TM segments were compared with that of PFO with wild type TM sequences. Both mutant and wild type length PFO exhibited cholesterol-dependent membrane insertion. Maximal PFO-induced pore formation occurred in vesicles with wider bilayers for lengthened TM segments and in thinner bilayers for shortened TM segments. In diC(18:0) phosphatidylcholine (PC)/diC(14:1) PC/cholesterol vesicles, which form ordered domains with a relatively thick bilayer and disordered domains with a relatively thin bilayer, affinity for ordered domains was greatest with lengthened TM segments and least with shortened TM segments as judged by FRET. Similar results were observed by microscopy in giant vesicles containing sphingomyelin in place of diC(18:0) PC. In contrast, in diC(16:0) PC/diC(14:0) PC/diC(20:1) PC/cholesterol vesicles, which should form ordered domains with a relatively thin bilayer and disordered domains with a relatively thick bilayer, relative affinity for ordered domains was greatest with shortened TM segments and least with lengthened TM segments. The inability of multi-TM segment proteins (unlike single TM segment proteins) to adapt to mismatch by tilting may explain the sensitivity of raft affinity to mismatch. The difference in width sensitivity for single and multi-TM helix proteins may link raft affinity to multimeric state and thus control the assembly of multimeric TM complexes in rafts.	[Lin, Qingqing; London, Erwin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	London, E (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	Erwin.London@stonybrook.edu			National Science Foundation [MCB 1019986]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB 1019986.	Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Caffrey M, 1981, Biochem Soc Trans, V9, P155; CAFFREY M, 1981, BIOCHEMISTRY-US, V20, P1949, DOI 10.1021/bi00510a034; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; Chiantia S, 2007, LANGMUIR, V23, P7659, DOI 10.1021/la7010919; Chiantia S, 2011, BIOPHYS J, V100, pLO1, DOI 10.1016/j.bpj.2010.11.051; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Chiu J, 2008, J MICROBIOL METH, V73, P195, DOI 10.1016/j.mimet.2008.02.013; de Planque MRR, 2003, MOL MEMBR BIOL, V20, P271, DOI 10.1080/09687680310001605352; Dumas F, 2000, BIOCHEMISTRY-US, V39, P4846, DOI 10.1021/bi992634s; EAST JM, 1982, BIOCHEMISTRY-US, V21, P4144, DOI 10.1021/bi00260a035; Fastenberg ME, 2003, BIOCHEMISTRY-US, V42, P12376, DOI 10.1021/bi034718d; FLORINE KI, 1987, BIOCHEMISTRY-US, V26, P2978, DOI 10.1021/bi00385a004; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Heuck AP, 2007, J BIOL CHEM, V282, P22629, DOI 10.1074/jbc.M703207200; Hong HD, 2004, P NATL ACAD SCI USA, V101, P4065, DOI 10.1073/pnas.0400358101; Hotze EM, 2012, BBA-BIOMEMBRANES, V1818, P1028, DOI 10.1016/j.bbamem.2011.07.036; JOHANNSSON A, 1981, J BIOL CHEM, V256, P1643; JOHANNSSON A, 1981, BIOCHIM BIOPHYS ACTA, V641, P416, DOI 10.1016/0005-2736(81)90498-3; JOHNSON ID, 1991, ANAL BIOCHEM, V198, P228, DOI 10.1016/0003-2697(91)90418-S; Kucerka N, 2008, BIOPHYS J, V95, P2356, DOI 10.1529/biophysj.108.132662; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; LEWIS BA, 1983, J MOL BIOL, V166, P211, DOI 10.1016/S0022-2836(83)80007-2; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; LONDON E, 1981, BIOCHEMISTRY-US, V20, P1939, DOI 10.1021/bi00510a033; Marsh D, 2004, BBA-BIOMEMBRANES, V1666, P118, DOI 10.1016/j.bbamem.2004.08.006; MONTECUCCO C, 1982, FEBS LETT, V144, P145, DOI 10.1016/0014-5793(82)80588-7; Nelson LD, 2008, J BIOL CHEM, V283, P4632, DOI 10.1074/jbc.M709483200; Nelson LD, 2010, BIOPHYS J, V99, P3255, DOI 10.1016/j.bpj.2010.09.028; Nicol F, 1999, BIOPHYS J, V76, P2121, DOI 10.1016/S0006-3495(99)77368-6; Nir S, 1999, MOL MEMBR BIOL, V16, P95, DOI 10.1080/096876899294814; O'Keeffe AH, 2000, BIOPHYS J, V79, P2066, DOI 10.1016/S0006-3495(00)76454-X; Pathak P, 2011, BIOPHYS J, V101, P2417, DOI 10.1016/j.bpj.2011.08.059; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Ramachandran R, 2005, P NATL ACAD SCI USA, V102, P7139, DOI 10.1073/pnas.0500556102; Ren JH, 1999, BIOCHEMISTRY-US, V38, P5905, DOI 10.1021/bi982942a; Ridder ANJA, 2002, BIOCHEMISTRY-US, V41, P4946, DOI 10.1021/bi0158674; Sachs JN, 2006, ANNU REV BIOCHEM, V75, P707, DOI 10.1146/annurev.biochem.75.110105.142336; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Stopar D, 2009, BIOPHYS J, V96, P1408, DOI 10.1016/j.bpj.2008.11.029; Tweten RK, 2001, CURR TOP MICROBIOL, V257, P15; van Duyl BY, 2002, FEBS LETT, V523, P79, DOI 10.1016/S0014-5793(02)02939-3; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vidal A, 2005, BIOPHYS J, V89, P1102, DOI 10.1529/biophysj.105.062380; Wang J, 2006, BIOCHEMISTRY-US, V45, P8124, DOI 10.1021/bi060587f; Williamson IM, 2002, BIOPHYS J, V83, P2026, DOI 10.1016/S0006-3495(02)73964-7; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	54	49	49	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1340	1352		10.1074/jbc.M112.415596	http://dx.doi.org/10.1074/jbc.M112.415596			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23150664	hybrid, Green Published			2022-12-28	WOS:000313570300055
J	Swaidani, S; Cheng, G; Lauer, ME; Sharma, M; Mikecz, K; Hascall, VC; Aronica, MA				Swaidani, Shadi; Cheng, Georgiana; Lauer, Mark E.; Sharma, Manisha; Mikecz, Katalin; Hascall, Vincent C.; Aronica, Mark A.			TSG-6 Protein Is Crucial for the Development of Pulmonary Hyaluronan Deposition, Eosinophilia, and Airway Hyperresponsiveness in a Murine Model of Asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTER-ALPHA-INHIBITOR; FACTOR-STIMULATED GENE-6; EXTRACELLULAR-MATRIX; LINK MODULE; LUNG INJURY; INFLAMMATION; MOUSE; GLYCOSAMINOGLYCANS; EXPRESSION; CHALLENGE	Hyaluronan (HA) deposition is often correlated with mucosal inflammatory responses, where HA mediates both protective and pathological responses. By modifying the HA matrix, Tnfip6 (TNF-alpha-induced protein-6; also known as TSG-6 (TNF-stimulated gene-6)) is thought to potentiate anti-inflammatory and anti-plasmin effects that are inhibitory to leukocyte extravasation. In this study, we examined the role of endogenous TSG-6 in the pathophysiological responses associated with acute allergic pulmonary inflammation. Compared with wildtype littermate controls, TSG-6(-/-) mice exhibited attenuated inflammation marked by a significant decrease in pulmonary HA concentrations measured in the bronchoalveolar lavage and lung tissue. Interestingly, despite the equivalent induction of both humoral and cellular Th2 immunity and the comparable levels of cytokines and chemokines typically associated with eosinophilic pulmonary inflammation, airway eosinophilia was significantly decreased in TSG-6(-/-) mice. Most importantly, contrary to their counterpart wild-type littermates, TSG-6(-/-) mice were resistant to the induction of airway hyperresponsiveness and manifested improved lung mechanics in response to methacholine challenge. Our study demonstrates that endogenous TSG-6 is dispensable for the induction of Th2 immunity but is essential for the robust increase in pulmonary HA deposition, propagation of acute eosinophilic pulmonary inflammation, and development of airway hyperresponsiveness. Thus, TSG-6 is implicated in the experimental murine model of allergic pulmonary inflammation and is likely to contribute to the pathogenesis of asthma.	[Swaidani, Shadi; Cheng, Georgiana; Sharma, Manisha; Aronica, Mark A.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Swaidani, Shadi] Cleveland Clin, Dept Immunol, Lerner Res Inst, Cleveland, OH 44195 USA; [Lauer, Mark E.; Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA; [Aronica, Mark A.] Cleveland Clin, Resp Inst, Cleveland, OH 44195 USA; [Mikecz, Katalin] Rush Univ, Med Ctr, Sect Mol Med, Dept Orthoped Surg, Chicago, IL 60612 USA; [Mikecz, Katalin] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Rush University; Rush University	Aronica, MA (corresponding author), Cleveland Clin, Dept Pathobiol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	aronicm@ccf.org		Mikecz, Katalin/0000-0003-1506-4296; Swaidani, Shadi/0000-0003-1506-4472	National Institutes of Health from NIAID [AI067816]; National Institutes of Health from NHLBI [HL081064]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064, P01HL103453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067816] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI067816 from NIAID (to M. A. A.) and Grant HL081064 from NHLBI (to V. C. H. and M.A.A.).	Aronica MA, 1999, J IMMUNOL, V163, P5116; Blundell CD, 2005, J BIOL CHEM, V280, P18189, DOI 10.1074/jbc.M414343200; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; BOUSQUET J, 1991, J ALLERGY CLIN IMMUN, V88, P649, DOI 10.1016/0091-6749(91)90159-L; Burgess JK, 2009, PHARMACOL THERAPEUT, V122, P19, DOI 10.1016/j.pharmthera.2008.12.002; Cantor JO, 1999, CONNECT TISSUE RES, V40, P97, DOI 10.3109/03008209909029105; Cao TV, 2004, MICROCIRCULATION, V11, P615, DOI 10.1080/10739680490503438; Carrette O, 2001, BIOL REPROD, V65, P301, DOI 10.1095/biolreprod65.1.301; Cheng G, 2011, MATRIX BIOL, V30, P126, DOI 10.1016/j.matbio.2010.12.003; Culley FJ, 2003, EUR J IMMUNOL, V33, P1302, DOI 10.1002/eji.200323509; DARIUS H, 1994, EUR J PHARMACOL, V258, P207, DOI 10.1016/0014-2999(94)90482-0; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fuchs B, 2008, CURR DRUG TARGETS, V9, P495, DOI 10.2174/138945008784533589; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Garantziotis S, 2010, AM J RESP CRIT CARE, V181, P666, DOI 10.1164/rccm.200903-0381OC; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Herrerias A, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-30; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Holgate ST, 2009, IMMUNITY, V31, P362, DOI 10.1016/j.immuni.2009.08.013; Honda K, 2003, J EXP MED, V198, P533, DOI 10.1084/jem.20022218; Irvin CG, 2003, RESPIR RES, V4, DOI 10.1186/rr199; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang DH, 2010, ANAT REC, V293, P982, DOI 10.1002/ar.21102; Kahmann JD, 2000, STRUCTURE, V8, P763, DOI 10.1016/S0969-2126(00)00163-5; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Kumar RK, 2008, CURR DRUG TARGETS, V9, P485, DOI 10.2174/138945008784533561; LAITINEN A, 1994, ALLERGY PROC, V15, P323, DOI 10.2500/108854194778816436; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Lilly CM, 2005, AM J RESP CRIT CARE, V171, P579, DOI 10.1164/rccm.200404-532OC; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Mindrescu C, 2005, BIOCHEM BIOPH RES CO, V330, P737, DOI 10.1016/j.bbrc.2005.03.040; Monzon ME, 2006, AM J RESP CELL MOL, V34, P135, DOI 10.1165/rcmb.2005-0256OC; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Negrini D, 2008, INTENS CARE MED, V34, P610, DOI 10.1007/s00134-007-0962-y; NEY P, 1991, EICOSANOIDS, V4, P21; Noble Paul W, 2006, Proc Am Thorac Soc, V3, P401, DOI 10.1513/pats.200604-097AW; Papakonstantinou E, 2009, BRIT J PHARMACOL, V157, P1111, DOI 10.1111/j.1476-5381.2009.00279.x; Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; Pettipher R, 2008, BRIT J PHARMACOL, V153, pS191, DOI 10.1038/sj.bjp.0707488; Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x; SAHU S, 1978, BIOCHEM J, V173, P565, DOI 10.1042/bj1730565; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Spik I, 2005, J IMMUNOL, V174, P3703, DOI 10.4049/jimmunol.174.6.3703; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Vaday GG, 2000, J LEUKOCYTE BIOL, V67, P149, DOI 10.1002/jlb.67.2.149; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; Wisniewski HG, 1996, J IMMUNOL, V156, P1609	59	46	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					412	422		10.1074/jbc.M112.389874	http://dx.doi.org/10.1074/jbc.M112.389874			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23118230	hybrid, Green Published			2022-12-28	WOS:000313197200042
J	Andrew, AJ; Berndsen, CE; Kao, S; Strebel, K				Andrew, Amy J.; Berndsen, Christopher E.; Kao, Sandra; Strebel, Klaus			The Size and Conservation of a Coiled-coil Structure in the Ectodomain of Human BST-2/Tetherin Is Dispensable for Inhibition of HIV-1 Virion Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ANTI-TETHERIN ACTIVITIES; CELL-SURFACE; OLIGOMERIZATION STATE; MOLECULAR-CLONING; DOWN-MODULATION; VIRUS RELEASE; VPU; PROTEIN; BST-2	BST-2/CD317/tetherin is a host factor that inhibits HIV-1 release and is counteracted by HIV-1 Vpu. Structural studies indicate that the BST-2 ectodomain assumes a coiled-coil conformation. Here we studied the role of the BST-2 ectodomain for tethering function. First, we addressed the importance of the length and structure of the ectodomain by adding or substituting heterologous coiled-coil or non-coiled-coil sequences. We found that extending or replacing the BST-2 ectodomain using non-coiled-coil sequences resulted in loss of BST-2 function. Doubling the size of the BST-2 ectodomain by insertion of a heterologous coiled-coil motif or substituting the BST-2 coiled-coil domain with a heterologous coiled-coil motif maintained tethering function. Reductions in the size of the BST-2 coiled-coil domain were tolerated as well. In fact, deletion of the C-terminal half of the BST-2 ectodomain, including a series of seven consecutive heptad motifs did not abolish tethering function. However, slight changes in the positioning of deletions affecting the relative placing of charged or hydrophobic residues on the helix severely impacted the functional properties of BST-2. Overall, we conclude that the size of the BST-2 ectodomain is highly flexible and can be reduced or extended as long as the positioning of residues important for the stability of the dimer interface is maintained.	[Andrew, Amy J.; Kao, Sandra; Strebel, Klaus] NIAID, Viral Biochem Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Berndsen, Christopher E.] James Madison Univ, Dept Chem & Biochem, Harrisonburg, VA 22807 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); James Madison University	Strebel, K (corresponding author), NIAID, Viral Biochem Sect, Mol Microbiol Lab, NIH, Bldg 4,Rm 310,4 Ctr Dr MSC 0460, Bethesda, MD 20892 USA.	kstrebel@nih.gov		Berndsen, Christopher/0000-0002-4285-4341	Intramural Research Program of the NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000669] Funding Source: NIH RePORTER	Intramural Research Program of the NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the NIAID, National Institutes of Health.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Andrew A, 2011, J INTERF CYTOK RES, V31, P137, DOI 10.1089/jir.2010.0108; Andrew AJ, 2011, J BIOL CHEM, V286, P39967, DOI 10.1074/jbc.M111.287011; Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; Bartoli L, 2009, BIOINFORMATICS, V25, P2757, DOI 10.1093/bioinformatics/btp539; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; FISCHETTI VA, 1993, INFORM PROCESS LETT, V45, P11, DOI 10.1016/0020-0190(93)90245-5; Fitzpatrick K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000701; Fritz JV, 2012, VIROLOGY, V424, P33, DOI 10.1016/j.virol.2011.12.008; GOTO T, 1994, BLOOD, V84, P1922; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Habermann A, 2010, J VIROL, V84, P4646, DOI 10.1128/JVI.02421-09; Hammonds J, 2012, J VIROL, V86, P2259, DOI 10.1128/JVI.05906-11; Hammonds J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000749; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jones PH, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-10; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kobayashi T, 2011, J VIROL, V85, P932, DOI 10.1128/JVI.01668-10; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kueck T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002609; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Kwok SC, 2004, BIOPOLYMERS, V76, P378, DOI 10.1002/bip.20141; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Lopez LA, 2012, J VIROL, V86, P5467, DOI 10.1128/JVI.06280-11; Lu SM, 2004, PROTEIN SCI, V13, P714, DOI 10.1110/ps.03443204; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Miyagi E, 2011, J VIROL, V85, P11981, DOI 10.1128/JVI.05176-11; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rong LW, 2009, J VIROL, V83, P7536, DOI 10.1128/JVI.00620-09; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schubert HL, 2010, P NATL ACAD SCI USA, V107, P17951, DOI 10.1073/pnas.1008206107; Skasko M, 2012, J BIOL CHEM, V287, P58, DOI 10.1074/jbc.M111.296772; Swiecki M, 2011, J BIOL CHEM, V286, P2987, DOI 10.1074/jbc.M110.190538; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Vigan R, 2011, J VIROL, V85, P9737, DOI 10.1128/JVI.00479-11; Wagschal K, 1999, PROTEIN SCI, V8, P2312; Yang HT, 2010, P NATL ACAD SCI USA, V107, P18428, DOI 10.1073/pnas.1011485107; Yang SJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-13; Yoshida T, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00035; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008; Zhou JM, 2012, BIOCHEMISTRY-US, V51, P1288, DOI 10.1021/bi2015986	58	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44278	44288		10.1074/jbc.M112.418822	http://dx.doi.org/10.1074/jbc.M112.418822			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23152502	Green Published, hybrid			2022-12-28	WOS:000312938600026
J	Bhanumathy, C; da Fonseca, PCA; Morris, EP; Joseph, SK				Bhanumathy, Cunnigaiper; da Fonseca, Paula C. A.; Morris, Edward P.; Joseph, Suresh K.			Identification of Functionally Critical Residues in the Channel Domain of Inositol Trisphosphate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,4,5-TRISPHOSPHATE RECEPTOR; LIGAND-BINDING; RYANODINE RECEPTOR; CA2+ RELEASE; S4-S5 LINKER; TRANSMEMBRANE SEQUENCE; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; VOLTAGE SENSOR; K+ CHANNEL	We have combined alanine mutagenesis and functional assays to identify amino acid residues in the channel domain that are critical for inositol 1,4,5-trisphosphate receptor (IP3R) channel function. The residues selected were highly conserved in all three IP3R isoforms and were located in the cytosolic end of the S6 pore-lining helix and proximal portion of the C-tail. Two adjacent hydrophobic amino acids (Ile-2588 and Ile-2589) at the putative cytosolic interface of the S6 helix inactivated channel function and could be candidates for the channel gate. Of five negatively charged residues mutated, none completely eliminated channel function. Of five positively charged residues mutated, only one inactivated the channel (Arg-2596). In addition to the previously identified role of a pair of cysteines in the C-tail (Cys-2610 and Cys-2613), a pair of highly conserved histidines (His-2630 and His-2635) were also essential for channel function. Expression of the H2630A and H2635A mutants (but not R2596A) produced receptors with destabilized interactions between the N-terminal fragment and the channel domain. A previously unrecognized association between the cytosolic C-tail and the TM 4,5-loop was demonstrated using GST pull-down assays. However, none of the mutations in the C-tail interfered with this interaction or altered the ability of the C-tail to assemble into dimers. Our present findings and recent information on IP3R structure from electron microscopy and crystallography are incorporated into a revised model of channel gating.	[Bhanumathy, Cunnigaiper; Joseph, Suresh K.] Thomas Jefferson Univ, Dept Pathol & Cell Biol, Philadelphia, PA 19107 USA; [da Fonseca, Paula C. A.; Morris, Edward P.] Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England	Jefferson University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Joseph, SK (corresponding author), Thomas Jefferson Univ, Dept Pathol & Cell Biol, Rm 230A JAH,1020 Locust St, Philadelphia, PA 19107 USA.	suresh.joseph@jefferson.edu		da Fonseca, Paula/0000-0001-8656-5747; Morris, Edward/0000-0003-3544-0041	National Institutes of Health [DK34804]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK34804.	Anyatonwu G, 2010, J BIOL CHEM, V285, P25085, DOI 10.1074/jbc.M110.123208; Anyatonwu G, 2009, J BIOL CHEM, V284, P8093, DOI 10.1074/jbc.M806932200; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2000, EMBO J, V19, P5450, DOI 10.1093/emboj/19.20.5450; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Buguliskis JS, 2007, MOL BIOCHEM PARASIT, V155, P128, DOI 10.1016/j.molbiopara.2007.06.011; Chan J, 2010, J BIOL CHEM, V285, P36092, DOI 10.1074/jbc.M110.140160; Chatelain FC, 2005, NEURON, V47, P833, DOI 10.1016/j.neuron.2005.08.022; Csordas G, 2001, CELL CALCIUM, V29, P249, DOI 10.1054/ceca.2000.0191; da Fonseca PCA, 2003, P NATL ACAD SCI USA, V100, P3936, DOI 10.1073/pnas.0536251100; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; Du GG, 2001, J BIOL CHEM, V276, P31760, DOI 10.1074/jbc.M102751200; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Galvan DL, 2002, J BIOL CHEM, V277, P48248, DOI 10.1074/jbc.M209990200; Gillespie D, 2005, J PHYS CHEM B, V109, P15598, DOI 10.1021/jp052471j; Hurne AM, 2005, J BIOL CHEM, V280, P36994, DOI 10.1074/jbc.M506441200; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; JOSEPH SK, 1995, BIOCHEM J, V307, P859, DOI 10.1042/bj3070859; Khan MT, 2010, J BIOL CHEM, V285, P16912, DOI 10.1074/jbc.M110.114207; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Labro AJ, 2011, J BIOL CHEM, V286, P717, DOI 10.1074/jbc.M110.146977; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; Lee EH, 2007, EXP MOL MED, V39, P594, DOI 10.1038/emm.2007.65; Lin CC, 2011, NAT STRUCT MOL BIOL, V18, P1172, DOI 10.1038/nsmb.2112; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Ludtke SJ, 2011, STRUCTURE, V19, P1192, DOI 10.1016/j.str.2011.05.003; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; Ramachandran S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000367; Rojas A, 2007, BBA-BIOMEMBRANES, V1768, P39, DOI 10.1016/j.bbamem.2006.06.027; Rossi AM, 2009, NAT CHEM BIOL, V5, P631, DOI 10.1038/nchembio.195; Sackin H, 2005, BIOPHYS J, V88, P2597, DOI 10.1529/biophysj.104.051474; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Sanderson Michael J, 2008, Proc Am Thorac Soc, V5, P23, DOI 10.1513/pats.200704-050VS; Sato C, 2004, J MOL BIOL, V336, P155, DOI 10.1016/j.jmb.2003.11.024; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Serysheva II, 2003, J BIOL CHEM, V278, P21319, DOI 10.1074/jbc.C300148200; Steinmann C, 2008, J BIOL CHEM, V283, P13506, DOI 10.1074/jbc.C800029200; Stepanovic SZ, 2009, J PHYSIOL-LONDON, V587, P2555, DOI 10.1113/jphysiol.2008.166694; Stewart R, 2003, BIOCHEM J, V376, P795, DOI 10.1042/BJ20030597; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; Taylor CW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004010; Taylor CW, 2009, IMMUNOL REV, V231, P23, DOI 10.1111/j.1600-065X.2009.00807.x; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Wall-Lacelle S, 2011, J BIOL CHEM, V286, P27197, DOI 10.1074/jbc.M111.237412; Wang RW, 2004, J BIOL CHEM, V279, P3635, DOI 10.1074/jbc.M311367200; Wang RW, 2003, J BIOL CHEM, V278, P51557, DOI 10.1074/jbc.M306788200; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; Yamazaki H, 2010, J BIOL CHEM, V285, P36081, DOI 10.1074/jbc.M110.140129; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316	54	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43674	43684		10.1074/jbc.M112.415786	http://dx.doi.org/10.1074/jbc.M112.415786			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23086950	Green Published, hybrid			2022-12-28	WOS:000312940800047
J	Bachmann, M; Scheiermann, P; Hardle, L; Pfeilschifter, J; Muhl, H				Bachmann, Malte; Scheiermann, Patrick; Haerdle, Lorena; Pfeilschifter, Josef; Muehl, Heiko			IL-36 gamma/IL-1F9, an Innate T-bet Target in Myeloid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DENDRITIC CELLS; IFN-GAMMA; TRANSCRIPTION FACTOR; INTERFERON-GAMMA; FAMILY-MEMBERS; IN-VITRO; EXPRESSION; PSORIASIS; IL-36	By concerted action in dendritic (DC) and T cells, T-box expressed in T cells (T-bet, Tbx21) is pivotal for initiation and perpetuation of Th1 immunity. Identification of novel T-bet-regulated genes is crucial for further understanding the biology of this transcription factor. By combining siRNA technology with genome-wide mRNA expression analysis, we sought to identify new T-bet-regulated genes in predendritic KG1 cells activated by IL-18. One gene robustly dependent on T-bet was IL-36 gamma, a recently described novel IL-1 family member. Promoter analysis revealed a T-bet binding site that, along with a kappa B site, enables efficient IL-36 gamma induction. Using knock-out animals, IL-36 gamma reliance on T-bet was extended to murine DC. IL-36 gamma expression by human myeloid cells was confirmed using monocyte-derived DC and M1 macrophages. The latter model was employed to substantiate dependence of IL-36 gamma on endogenous T-bet in human primary cells. Ectopic expression of T-bet likewise mediated IL-36 gamma production in HaCaT keratinocytes that otherwise lack this transcription factor. Additional experiments furthermore revealed that mature IL-36 gamma has the capability to establish an inflammatory gene expression profile in human primary keratinocytes that displays enhanced mRNA levels for TNF alpha, CCL20, S100A7, inducible NOS, and IL-36 gamma itself. Data presented herein shed further light on involvement of T-bet in innate immunity and suggest that IL-36 gamma, besides IFN gamma, may contribute to functions of this transcription factor in immunopathology.	[Bachmann, Malte; Scheiermann, Patrick; Haerdle, Lorena; Pfeilschifter, Josef; Muehl, Heiko] Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Univ Hosp, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Muhl, H (corresponding author), Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Univ Hosp, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	H.Muehl@em.uni-frankfurt.de		Muhl, Heiko/0000-0002-0429-0127	August Scheidel-Stiftung, Frankfurt, Germany	August Scheidel-Stiftung, Frankfurt, Germany	This work was supported by the August Scheidel-Stiftung, Frankfurt, Germany (to M. B.).	Bachmann M, 2007, MOL CANCER THER, V6, P723, DOI 10.1158/1535-7163.MCT-06-0505; Bachmann M, 2009, J CELL MOL MED, V13, P1987, DOI 10.1111/j.1582-4934.2008.00604.x; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Carrier Y, 2011, J INVEST DERMATOL, V131, P2428, DOI 10.1038/jid.2011.234; Cho JY, 2003, INT IMMUNOL, V15, P1149, DOI 10.1093/intimm/dxg113; Debets R, 2001, J IMMUNOL, V167, P1440, DOI 10.4049/jimmunol.167.3.1440; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello C, 2010, NAT IMMUNOL, V11, P973, DOI 10.1038/ni1110-973; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Iwamoto S, 2007, J IMMUNOL, V179, P1449, DOI 10.4049/jimmunol.179.3.1449; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; KISPERT A, 1993, EMBO J, V12, P4898, DOI 10.1002/j.1460-2075.1993.tb06179.x; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Kriegova E, 2011, EUR RESPIR J, V38, P1136, DOI 10.1183/09031936.00089910; Kumar S, 2000, J BIOL CHEM, V275, P10308, DOI 10.1074/jbc.275.14.10308; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lewis DA, 2006, J INVEST DERMATOL, V126, P1885, DOI 10.1038/sj.jid.5700333; Lexberg MH, 2010, EUR J IMMUNOL, V40, P3017, DOI 10.1002/eji.201040539; Lian LH, 2012, J INVEST DERMATOL, V132, P1346, DOI 10.1038/jid.2011.482; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lind H, 2007, CYTOKINE, V38, P43, DOI 10.1016/j.cyto.2007.05.001; Lipscomb MW, 2009, J IMMUNOL, V183, P7250, DOI 10.4049/jimmunol.0901477; Lugo-Villarino G, 2005, P NATL ACAD SCI USA, V102, P13248, DOI 10.1073/pnas.0506638102; Lugo-Villarino G, 2003, P NATL ACAD SCI USA, V100, P7749, DOI 10.1073/pnas.1332767100; Magne D, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1946; ManourySchwartz B, 1997, J IMMUNOL, V158, P5501; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Matsuda JL, 2007, J IMMUNOL, V178, P3457, DOI 10.4049/jimmunol.178.6.3457; Muhl H, 2011, CELL MICROBIOL, V13, P340, DOI 10.1111/j.1462-5822.2010.01559.x; Muhl H, 2004, EUR J PHARMACOL, V500, P63, DOI 10.1016/j.ejphar.2004.07.012; Muhl H, 2003, INT IMMUNOPHARMACOL, V3, P1247, DOI 10.1016/S1567-5769(03)00131-0; Muhr P, 2011, BRIT J DERMATOL, V165, P189, DOI 10.1111/j.1365-2133.2011.10302.x; Mutamba S, 2012, EUR J IMMUNOL, V42, P607, DOI 10.1002/eji.201142035; Paulukat J, 2001, J IMMUNOL, V167, P7038, DOI 10.4049/jimmunol.167.12.7038; Powell N, 2010, MUCOSAL IMMUNOL, V3, P567, DOI 10.1038/mi.2010.53; Ravindran R, 2005, J IMMUNOL, V175, P4603, DOI 10.4049/jimmunol.175.7.4603; Rice KL, 2009, HEMATOL REP, V1, P70, DOI 10.4081/hr.2009.e13; Rutitzky LI, 2009, EUR J IMMUNOL, V39, P2470, DOI 10.1002/eji.200939325; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; St Louis DC, 1999, J IMMUNOL, V162, P3237; Stewart JJ, 2006, J BIOL CHEM, V281, P22665, DOI 10.1074/jbc.M603237200; Sullivan BM, 2005, J IMMUNOL, V175, P4593, DOI 10.4049/jimmunol.175.7.4593; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tada M, 2001, DEV GROWTH DIFFER, V43, P1; Taylor SL, 2002, GENOMICS, V79, P726, DOI 10.1006/geno.2002.6752; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Towne JE, 2012, CURR OPIN PHARMACOL, V12, P486, DOI 10.1016/j.coph.2012.02.009; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Towne JE, 2011, J BIOL CHEM, V286, P42594, DOI 10.1074/jbc.M111.267922; van de Veerdonk FL, 2012, P NATL ACAD SCI USA, V109, P3001, DOI 10.1073/pnas.1121534109; Vigne S, 2012, BLOOD, V120, P3478, DOI 10.1182/blood-2012-06-439026; Vigne S, 2011, BLOOD, V118, P5813, DOI 10.1182/blood-2011-05-356873; Wang JS, 2006, J CLIN INVEST, V116, P414, DOI 10.1172/JCI26631; Wehner R, 2011, J INNATE IMMUN, V3, P258, DOI 10.1159/000323923	65	51	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41684	41696		10.1074/jbc.M112.385443	http://dx.doi.org/10.1074/jbc.M112.385443			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23095752	Green Published, hybrid			2022-12-28	WOS:000312103000011
J	Zhang, YL; Liang, Z; Hsueh, HT; Ploplis, VA; Castellino, FJ				Zhang, Yueling; Liang, Zhong; Hsueh, Hsing-Tse; Ploplis, Victoria A.; Castellino, Francis J.			Characterization of Streptokinases from Group A Streptococci Reveals a Strong Functional Relationship That Supports the Coinheritance of Plasminogen-binding M Protein and Cluster 2b Streptokinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO CAPROIC ACID; ACTIVE-SITE; VIRULENCE; SURFACE; DOMAIN; CONFORMATION; PATHOGENESIS; INFECTIONS; ACTIVATION; EXPRESSION	Group A streptococcus (GAS) strains secrete the protein streptokinase (SK), which functions by activating host human plasminogen (hPg) to plasmin (hPm), thus providing a proteolytic framework for invasive GAS strains. The types of SK secreted by GAS have been grouped into two clusters (SK1 and SK2) and one subcluster (SK2a and SK2b). SKs from cluster 1 (SK1) and cluster 2b (SK2b) display significant evolutionary and functional differences, and attempts to relate these properties to GAS skin or pharynx tropism and invasiveness are of great interest. In this study, using four purified SKs from each cluster, new relationships between plasminogen-binding group A streptococcal M (PAM) protein and SK2b have been revealed. All SK1 proteins efficiently activated hPg, whereas all subclass SK2b proteins only weakly activated hPg in the absence of PAM. Surface plasmon resonance studies revealed that the lower affinity of SK2b to hPg served as the basis for the attenuated activation of hPg by SK2b. Binding of hPg to either human fibrinogen (hFg) or PAM greatly enhanced activation of hPg by SK2b but minimally influenced the already effective activation of hPg by SK1. Activation of hPg in the presence of GAS cells containing PAM demonstrated that PAM is the only factor on the surface of SK2b-expressing cells that enabled the direct activation of hPg by SK2b. As the binding of hPg to PAM is necessary for hPg activation by SK2b, this dependence explains the coinherant relationship between PAM and SK2b and the ability of these particular strains to generate the proteolytic activity that disrupts the innate barriers that limit invasiveness.	[Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu		Zhang, Yueling/0000-0002-5619-8410	National Institutes of Health [HL013423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013423, R37HL013423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL013423.	Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Castellino F J, 1976, Methods Enzymol, V45, P244; CHIBBER BAK, 1986, J BIOL CHEM, V261, P5289; CHIBBER BAK, 1986, P NATL ACAD SCI USA, V83, P1237, DOI 10.1073/pnas.83.5.1237; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cunningham MW, 2008, ADV EXP MED BIOL, V609, P29, DOI 10.1007/978-0-387-73960-1_3; DCosta SS, 1997, RES MICROBIOL, V148, P559, DOI 10.1016/S0923-2508(97)88080-1; Iwaki T, 2008, CYTOTECHNOLOGY, V57, P45, DOI 10.1007/s10616-008-9129-0; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lauth X, 2009, J INNATE IMMUN, V1, P202, DOI 10.1159/000203645; Le Hello S, 2010, J CLIN MICROBIOL, V48, P526, DOI 10.1128/JCM.01205-09; Lin LF, 2000, BIOCHEMISTRY-US, V39, P4740, DOI 10.1021/bi992028x; LOTTENBERG R, 1992, J BACTERIOL, V174, P5204, DOI 10.1128/JB.174.16.5204-5210.1992; Loy JA, 2001, BIOCHEMISTRY-US, V40, P14686, DOI 10.1021/bi011309d; Macheboeuf P, 2011, NATURE, V472, P64, DOI 10.1038/nature09967; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; McShan WM, 2008, J BACTERIOL, V190, P7773, DOI 10.1128/JB.00672-08; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Musser JM, 2009, J CLIN INVEST, V119, P2455, DOI 10.1172/JCI38095; Nilsen SL, 1999, PROTEIN EXPRES PURIF, V16, P136, DOI 10.1006/prep.1999.1045; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; Rios-Steiner JL, 2001, J MOL BIOL, V308, P705, DOI 10.1006/jmbi.2001.4646; ROBBINS KC, 1967, J BIOL CHEM, V242, P2333; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; Sanderson-Smith ML, 2006, J BIOL CHEM, V281, P25965, DOI 10.1074/jbc.M603846200; SCHICK LA, 1974, BIOCHEM BIOPH RES CO, V57, P47, DOI 10.1016/S0006-291X(74)80355-4; Sjogren J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-120; Smeesters PR, 2010, TRENDS MICROBIOL, V18, P275, DOI 10.1016/j.tim.2010.02.007; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Svensson MD, 1999, INFECT IMMUN, V67, P3915, DOI 10.1128/IAI.67.8.3915-3920.1999; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VIOLAND BN, 1975, ARCH BIOCHEM BIOPHYS, V170, P300, DOI 10.1016/0003-9861(75)90121-6; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; Ward PN, 2002, J BACTERIOL, V184, P119, DOI 10.1128/JB.184.1.119-125.2002	41	28	29	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42093	42103		10.1074/jbc.M112.417808	http://dx.doi.org/10.1074/jbc.M112.417808			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086939	hybrid, Green Published			2022-12-28	WOS:000312103000048
J	Park, EH; Walker, SE; Zhou, FJ; Lee, JM; Rajagopal, V; Lorsch, JR; Hinnebusch, AG				Park, Eun-Hee; Walker, Sarah E.; Zhou, Fujun; Lee, Joseph M.; Rajagopal, Vaishnavi; Lorsch, Jon R.; Hinnebusch, Alan G.			Yeast Eukaryotic Initiation Factor 4B (eIF4B) Enhances Complex Assembly between eIF4A and eIF4G in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							START CODON SELECTION; TRANSLATION INITIATION; BINDING-PROTEIN; MESSENGER-RNA; MAMMALIAN TRANSLATION; SHUTTLE VECTORS; CAP; SUBUNITS; ASSOCIATION; HOMOLOG	Translation initiation factor eIF4F (eukaryotic initiation factor 4F), composed of eIF4E, eIF4G, and eIF4A, binds to the m(7)G cap structure of mRNA and stimulates recruitment of the 43S preinitiation complex and subsequent scanning to the initiation codon. The HEAT domain of eIF4G stabilizes the active conformation of eIF4A required for its RNA helicase activity. Mammalian eIF4B also stimulates eIF4A activity, but this function appears to be lacking in yeast, making it unclear how yeast eIF4B (yeIF4B/Tif3) stimulates translation. We identified Ts- mutations in the HEAT domains of yeast eIF4G1 and eIF4G2 that are suppressed by overexpressing either yeIF4B or eIF4A, whereas others are suppressed only by eIF4A overexpression. Importantly, suppression of HEAT domain substitutions by yeIF4B overexpression was correlated with the restoration of native eIF4A.eIF4G complexes in vivo, and the rescue of specific mutant eIF4A.eIF4G complexes by yeIF4B was reconstituted in vitro. Association of eIF4A with WT eIF4G in vivo also was enhanced by yeIF4B overexpression and was impaired in cells lacking yeIF4B. Furthermore, we detected native complexes containing eIF4G and yeIF4B but lacking eIF4A. These and other findings lead us to propose that yeIF4B acts in vivo to promote eIF4F assembly by enhancing a conformation of the HEAT domain of yeast eIF4G conducive for stable binding to eIF4A.	[Park, Eun-Hee; Zhou, Fujun; Hinnebusch, Alan G.] Eunice K Shriver NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Walker, Sarah E.; Rajagopal, Vaishnavi; Lorsch, Jon R.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Lee, Joseph M.] NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hinnebusch, AG (corresponding author), Eunice K Shriver NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA.	ahinnebusch@nih.gov	Walker, Sarah/U-1609-2019	Walker, Sarah/0000-0002-9983-2485; Lorsch, Jon/0000-0002-4521-4999	National Institutes of Health; National Institutes of Health [GM62128]; American Heart Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program and National Institutes of Health Grant GM62128 (to J. R. L.). This work was also supported by an American Heart Association award (to S. E. W.).	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; ALTMANN M, 1993, EMBO J, V12, P3997, DOI 10.1002/j.1460-2075.1993.tb06077.x; ALTMANN M, 1995, EMBO J, V14, P3820, DOI 10.1002/j.1460-2075.1995.tb00051.x; [Anonymous], 1991, Methods Enzymol, V194, P1; BLUM S, 1992, P NATL ACAD SCI USA, V89, P7664, DOI 10.1073/pnas.89.16.7664; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Clarkson BK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009114; COPPOLECCHIA R, 1993, EMBO J, V12, P4005, DOI 10.1002/j.1460-2075.1993.tb06078.x; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; Dominguez D, 1999, J BIOL CHEM, V274, P26720, DOI 10.1074/jbc.274.38.26720; Dominguez D, 2001, BIOCHEM J, V355, P223, DOI 10.1042/0264-6021:3550223; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GOYER C, 1989, J BIOL CHEM, V264, P7603; GOYER C, 1993, MOL CELL BIOL, V13, P4860, DOI 10.1128/MCB.13.8.4860; GRIFO JA, 1983, J BIOL CHEM, V258, P5804; Hershey PEC, 1999, J BIOL CHEM, V274, P21297, DOI 10.1074/jbc.274.30.21297; Hilbert M, 2011, NUCLEIC ACIDS RES, V39, P2260, DOI 10.1093/nar/gkq1127; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; LANKER S, 1992, J BIOL CHEM, V267, P21167; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; METHOT N, 1994, MOL CELL BIOL, V14, P2307, DOI 10.1128/MCB.14.4.2307; Methot N, 1996, MOL CELL BIOL, V16, P5328; Methot N, 1996, RNA, V2, P38; Mitchell SF, 2010, MOL CELL, V39, P950, DOI 10.1016/j.molcel.2010.08.021; NARANDA T, 1994, J BIOL CHEM, V269, P14465; Neff CL, 1999, MOL CELL BIOL, V19, P5557; Nielsen KH, 2011, NUCLEIC ACIDS RES, V39, P2678, DOI 10.1093/nar/gkq1206; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Ozes AR, 2011, J MOL BIOL, V412, P674, DOI 10.1016/j.jmb.2011.08.004; Park EH, 2011, EMBO J, V30, P302, DOI 10.1038/emboj.2010.312; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; Pestova T. V., 2007, CSH MONOGR, P87; Phan L, 2001, EMBO J, V20, P2954, DOI 10.1093/emboj/20.11.2954; Rajagopal V, 2012, J BIOL CHEM, V287, P20301, DOI 10.1074/jbc.M112.347278; REID GA, 1982, J BIOL CHEM, V257, P3056; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; Rozovsky N, 2008, RNA, V14, P2136, DOI 10.1261/rna.1049608; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; SIKORSKI RS, 1989, GENETICS, V122, P19; Spirin AS, 2009, BIOCHEMISTRY-US, V48, P10688, DOI 10.1021/bi901379a; Tarun SZ, 1997, MOL CELL BIOL, V17, P6876, DOI 10.1128/MCB.17.12.6876; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	49	18	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2340	2354		10.1074/jbc.M112.398537	http://dx.doi.org/10.1074/jbc.M112.398537			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23184954	Green Published, hybrid			2022-12-28	WOS:000314211500023
J	Goessweiner-Mohr, N; Grumet, L; Arends, K; Pavkov-Keller, T; Gruber, CC; Gruber, K; Birner-Gruenberger, R; Kropec-Huebner, A; Huebner, J; Grohmann, E; Keller, W				Goessweiner-Mohr, Nikolaus; Grumet, Lukas; Arends, Karsten; Pavkov-Keller, Tea; Gruber, Christian C.; Gruber, Karl; Birner-Gruenberger, Ruth; Kropec-Huebner, Andrea; Huebner, Johannes; Grohmann, Elisabeth; Keller, Walter			The 2.5 angstrom Structure of the Enterococcus Conjugation Protein TraM resembles VirB8 Type IV Secretion Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUCELLA-SUIS; BACTERIAL CONJUGATION; MOLECULAR-DYNAMICS; PLASMID PIP501; COILED COILS; SYSTEM; PREDICTION; DOMAIN; SERVER; DIVERSITY	Conjugative plasmid transfer is the most important means of spreading antibiotic resistance and virulence genes among bacteria and therefore presents a serious threat to human health. The process requires direct cell-cell contact made possible by a multiprotein complex that spans cellular membranes and serves as a channel for macromolecular secretion. Thus far, well studied conjugative type IV secretion systems (T4SS) are of Gram-negative (G-) origin. Although many medically relevant pathogens (e.g., enterococci, staphylococci, and streptococci) are Gram-positive (G+), their conjugation systems have received little attention. This study provides structural information for the transfer protein TraM of the G+ broad host range Enterococcus conjugative plasmid pIP501. Immunolocalization demonstrated that the protein localizes to the cell wall. We then used opsonophagocytosis as a novel tool to verify that TraM was exposed on the cell surface. In these assays, antibodies generated to TraM recruited macrophages and enabled killing of pIP501 harboring Enteroccocus faecalis cells. The crystal structure of the C-terminal, surface-exposed domain of TraM was determined to 2.5 angstrom resolution. The structure, molecular dynamics, and cross-linking studies indicated that a TraM trimer acts as the biological unit. Despite the absence of sequence-based similarity, TraM unexpectedly displayed a fold similar to the T4SS VirB8 proteins from Agrobacterium tumefaciens and Brucella suis (G-) and to the transfer protein TcpC from Clostridium perfringens plasmid pCW3 (G+). Based on the alignments of secondary structure elements of VirB8-like proteins from mobile genetic elements and chromosomally encoded T4SS from G+ and G- bacteria, we propose a new classification scheme of VirB8-like proteins.	[Goessweiner-Mohr, Nikolaus; Grumet, Lukas; Gruber, Karl; Keller, Walter] Karl Franzens Univ Graz, Inst Mol Biosci, A-8010 Graz, Austria; [Arends, Karsten; Grohmann, Elisabeth] Tech Univ Berlin, D-10587 Berlin, Germany; [Arends, Karsten] Robert Koch Inst, D-13086 Berlin, Germany; [Pavkov-Keller, Tea; Gruber, Christian C.] Austrian Ctr Ind Biotechnol GmbH, A-8010 Graz, Austria; [Birner-Gruenberger, Ruth] Med Univ Graz, Inst Pathol, A-8010 Graz, Austria; [Birner-Gruenberger, Ruth] Core Facil Mass Spectrometry, Med Res Ctr, A-8010 Graz, Austria; [Kropec-Huebner, Andrea; Huebner, Johannes; Grohmann, Elisabeth] Univ Med Ctr Freiburg, Div Infect Dis, D-79106 Freiburg, Germany	University of Graz; Technical University of Berlin; Robert Koch Institute; Austrian Centre of Industrial Biotechnology; Medical University of Graz; University of Freiburg	Keller, W (corresponding author), Karl Franzens Univ Graz, Inst Mol Biosci Struct Biol, Humboldtstr 50-3, A-8010 Graz, Austria.	walter.keller@uni-graz.at	Gruber, Christian C/B-3818-2011; Birner-Gruenberger, Ruth/X-9433-2019; Gruber, Karl/GPP-6706-2022; Keller, Walter/AAW-1501-2021; Pavkov-Keller, Tea/K-9234-2015; Birner-Gruenberger, Ruth/E-8623-2010	Birner-Gruenberger, Ruth/0000-0003-3950-0312; Gruber, Karl/0000-0002-3485-9740; Keller, Walter/0000-0002-2261-958X; Pavkov-Keller, Tea/0000-0001-7871-6680; Birner-Gruenberger, Ruth/0000-0003-3950-0312; Gruber, Christian/0000-0003-0214-449X; Grohmann, Elisabeth/0000-0003-3061-6490; Huebner, Johannes/0000-0003-1232-4646; Gossweiner-Mohr, Nikolaus/0000-0002-6572-5606	Austrian Science Fund [P19794, F4604]; Federal Ministry of Economy, Family and Youth; Federal Ministry of Traffic, Innovation and Technology; Styrian Business Promotion Agency SFG; Standortagentur Tirol; Technology Promotion Agency of the City of Vienna through the COMET Funding Program; European Union [LSHE-CT-2007-037410]	Austrian Science Fund(Austrian Science Fund (FWF)); Federal Ministry of Economy, Family and Youth; Federal Ministry of Traffic, Innovation and Technology; Styrian Business Promotion Agency SFG; Standortagentur Tirol; Technology Promotion Agency of the City of Vienna through the COMET Funding Program; European Union(European Commission)	This work was supported by Austrian Science Fund Projects P19794 and F4604.; Supported by the Federal Ministry of Economy, Family and Youth, the Federal Ministry of Traffic, Innovation and Technology, the Styrian Business Promotion Agency SFG, the Standortagentur Tirol, and The Technology Promotion Agency of the City of Vienna through the COMET Funding Program managed by the Austrian Research Promotion Agency FFG.; Supported by the European Union Sixth Framework Program LSHE-CT-2007-037410, Approaches to Control Multi-resistant Enterococci ACE.	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Andrieux L, 2011, FEBS LETT, V585, P2431, DOI 10.1016/j.febslet.2011.07.004; Anezo C, 2003, J PHYS CHEM B, V107, P9424, DOI 10.1021/jp0348981; Atmakuri K, 2004, MOL MICROBIOL, V54, P1199, DOI 10.1111/j.1365-2958.2004.04345.x; Bailey S, 2006, P NATL ACAD SCI USA, V103, P2582, DOI 10.1073/pnas.0511216103; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Burns DL, 2003, CURR OPIN MICROBIOL, V6, P29, DOI 10.1016/S1369-5274(02)00006-1; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Buttaro BA, 2000, J BACTERIOL, V182, P4926, DOI 10.1128/JB.182.17.4926-4933.2000; Cameron TA, 2012, CHEM BIOL, V19, P934, DOI 10.1016/j.chembiol.2012.08.002; Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YQ, 2008, J BACTERIOL, V190, P3632, DOI 10.1128/JB.01999-07; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dror O, 2003, BIOINFORMATICS, V19, pi95, DOI 10.1093/bioinformatics/btg1012; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eswar N., 2006, UNIT 2 9 COMP PROTIE; Feldman M, 2005, P NATL ACAD SCI USA, V102, P12206, DOI 10.1073/pnas.0501850102; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gillespie JJ, 2010, INFECT IMMUN, V78, P1809, DOI 10.1128/IAI.01384-09; Giraldo AMV, 2012, BIOCHEMISTRY-US, V51, P3881, DOI 10.1021/bi300298v; Gomis-Ruth FX, 2004, CURR PHARM DESIGN, V10, P1551, DOI 10.2174/1381612043384817; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; GURLEY WB, 1979, P NATL ACAD SCI USA, V76, P2828, DOI 10.1073/pnas.76.6.2828; Hare S, 2006, J MOL BIOL, V360, P56, DOI 10.1016/j.jmb.2006.04.060; Harrison E, 2012, TRENDS MICROBIOL, V20, P262, DOI 10.1016/j.tim.2012.04.003; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HORODNICEANU T, 1979, PLASMID, V2, P197, DOI 10.1016/0147-619X(79)90038-6; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kopec J, 2005, BIOCHEM J, V387, P401, DOI 10.1042/BJ20041178; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar RB, 2000, MOL MICROBIOL, V36, P608, DOI 10.1046/j.1365-2958.2000.01876.x; Kurenbach B, 2006, MICROBIOL-SGM, V152, P637, DOI 10.1099/mic.0.28468-0; Kurenbach BR, 2003, PLASMID, V50, P86, DOI 10.1016/S0147-619X(03)00044-1; Li M, 2011, MOL MICROBIOL, V79, P1670, DOI 10.1111/j.1365-2958.2011.07553.x; Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Mossey P, 2010, J BACTERIOL, V192, P2830, DOI 10.1128/JB.01331-09; Neves Petersen MT, 1997, METHOD ENZYMOL, V284, P130; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Parsons JA, 2007, J BACTERIOL, V189, P7782, DOI 10.1128/JB.00783-07; Porter CJ, 2012, MOL MICROBIOL, V83, P275, DOI 10.1111/j.1365-2958.2011.07930.x; Price DJ, 2004, J CHEM PHYS, V121, P10096, DOI 10.1063/1.1808117; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; Savvides SN, 2003, EMBO J, V22, P1969, DOI 10.1093/emboj/cdg223; Schrodinger L., 2011, PYMOL MOL GRAPHICS S; Shen HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002399; Sivanesan D, 2010, BIOCHEMISTRY-US, V49, P4483, DOI 10.1021/bi902201y; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Smith MA, 2012, CHEM BIOL, V19, P1041, DOI 10.1016/j.chembiol.2012.07.007; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Steen JA, 2009, J BACTERIOL, V191, P2926, DOI 10.1128/JB.00032-09; Terradot L, 2005, P NATL ACAD SCI USA, V102, P4596, DOI 10.1073/pnas.0408927102; Thanassi DG, 2012, FEMS MICROBIOL REV, V36, P1046, DOI 10.1111/j.1574-6976.2012.00342.x; Theilacker C, 2012, J INFECT DIS, V205, P1076, DOI 10.1093/infdis/jis022; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vollmer W, 2010, TRENDS MICROBIOL, V18, P59, DOI 10.1016/j.tim.2009.12.004; Wallden K, 2012, P NATL ACAD SCI USA, V109, P11348, DOI 10.1073/pnas.1201428109; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x; Williams JJ, 2008, CURR OPIN CHEM BIOL, V12, P389, DOI 10.1016/j.cbpa.2008.06.015; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Yeo HJ, 2003, P NATL ACAD SCI USA, V100, P15947, DOI 10.1073/pnas.2535211100; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207	82	47	47	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2018	2028		10.1074/jbc.M112.428847	http://dx.doi.org/10.1074/jbc.M112.428847			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23188825	Green Published, hybrid			2022-12-28	WOS:000313751400053
J	Maga, JA; Zhou, JH; Kambampati, R; Peng, S; Wang, X; Bohnsack, RN; Thomm, A; Golata, S; Tom, P; Dahms, NM; Byrne, BJ; LeBowitz, JH				Maga, John A.; Zhou, Jianghong; Kambampati, Ravi; Peng, Susan; Wang, Xu; Bohnsack, Richard N.; Thomm, Angela; Golata, Sarah; Tom, Peggy; Dahms, Nancy M.; Byrne, Barry J.; LeBowitz, Jonathan H.			Glycosylation-independent Lysosomal Targeting of Acid alpha-Glucosidase Enhances Muscle Glycogen Clearance in Pompe Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; II BINDING-SITE; ALGLUCOSIDASE ALPHA; MOUSE MODEL; INSULIN; STORAGE; RECOMBINANT; DISEASE; INFANTILE; ENZYME	We have used a peptide-based targeting system to improve lysosomal delivery of acid alpha-glucosidase (GAA), the enzyme deficient in patients with Pompe disease. Human GAA was fused to the glycosylation-independent lysosomal targeting (GILT) tag, which contains a portion of insulin-like growth factor II, to create an active, chimeric enzyme with high affinity for the cation-independent mannose 6-phosphate receptor. GILT-tagged GAA was taken up by L6 myoblasts about 25-fold more efficiently than was recombinant human GAA (rhGAA). Once delivered to the lysosome, the mature form of GILT-tagged-GAA was indistinguishable from rhGAA and persisted with a half-life indistinguishable from rhGAA. GILT-tagged GAA was significantly more effective than rhGAA in clearing glycogen from numerous skeletal muscle tissues in the Pompe mouse model. The GILT-tagged GAA enzyme may provide an improved enzyme replacement therapy for Pompe disease patients.	[Maga, John A.; Zhou, Jianghong; Kambampati, Ravi; Peng, Susan; Thomm, Angela; Golata, Sarah; Tom, Peggy; LeBowitz, Jonathan H.] ZyStor Therapeut, Milwaukee, WI 53226 USA; [Wang, Xu; Byrne, Barry J.] Univ Florida, Coll Med, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA; [Bohnsack, Richard N.; Dahms, Nancy M.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	BioMarin Pharmaceutical Inc.; ZyStor Therapeutics, Inc.; State University System of Florida; University of Florida; Medical College of Wisconsin	LeBowitz, JH (corresponding author), BioMarin Pharmaceut Inc, 105 Digital Dr, Novato, CA 94949 USA.	jlebowitz@bmrn.com		Byrne, Barry J./0000-0002-7302-1756	BioMarin Pharmaceuticals Inc.; Advancing a Healthier Wisconsin program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042667] Funding Source: NIH RePORTER	BioMarin Pharmaceuticals Inc.; Advancing a Healthier Wisconsin program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by ZyStor Therapeutics, Inc. (now BioMarin Pharmaceuticals Inc.).; The BIAcore 3000 instrument was purchased through a grant from the Advancing a Healthier Wisconsin program. The 129-GAA<SUP>-/-</SUP> Pompe mouse line used in these experiments was derived from the original strain kindly provided by Nina Raben. We thank Denise Cloutier for expert technical assistance with in vivo studies and Dr. Richard M. Bittman for statistical analysis. We also acknowledge the many thoughtful comments on the manuscript from colleagues at BioMarin.	Amalfitano A, 2001, GENET MED, V3, P132, DOI 10.1097/00125817-200103000-00008; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRAULKE T, 1989, EMBO J, V8, P681, DOI 10.1002/j.1460-2075.1989.tb03426.x; Bremel R. D., 2005, U. S. Patent, Patent No. 6852510; BROWN BI, 1970, BIOCHEMISTRY-US, V9, P1423, DOI 10.1021/bi00808a017; CHEN JW, 1985, ARCH BIOCHEM BIOPHYS, V239, P574, DOI 10.1016/0003-9861(85)90727-1; Dahms NM, 2002, BBA-GEN SUBJECTS, V1572, P317, DOI 10.1016/S0304-4165(02)00317-3; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Garmroudi F, 1996, MOL ENDOCRINOL, V10, P642, DOI 10.1210/me.10.6.642; HERS HG, 1963, BIOCHEM J, V86, P11, DOI 10.1042/bj0860011; Hirschhorn R., 2001, METABOLIC MOL BASIS, P3389; KIESS W, 1989, J BIOL CHEM, V264, P4710; Kishnani PS, 2007, NEUROLOGY, V68, P99, DOI 10.1212/01.wnl.0000251268.41188.04; Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033; LeBowitz JH, 2004, P NATL ACAD SCI USA, V101, P3083, DOI 10.1073/pnas.0308728100; LEJEUNE N, 1963, BIOCHEM J, V86, P16, DOI 10.1042/bj0860016; Linnell J, 2001, J BIOL CHEM, V276, P23986, DOI 10.1074/jbc.M100700200; Mack GS, 2008, NAT BIOTECHNOL, V26, P1053, DOI [10.1038/nbt1008-1053, 10.1038/nbt0608-592]; McVie-Wylie AJ, 2008, MOL GENET METAB, V94, P448, DOI 10.1016/j.ymgme.2008.04.009; Moreland RJ, 2005, J BIOL CHEM, V280, P6780, DOI 10.1074/jbc.M404008200; MYERS MG, 1994, J BIOL CHEM, V269, P28783; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Nicolino M, 2009, GENET MED, V11, P210, DOI 10.1097/GIM.0b013e31819d0996; OSHIMA A, 1988, J BIOL CHEM, V263, P2553; Raben N, 2005, MOL THER, V11, P48, DOI 10.1016/j.ymthe.2004.09.017; Raben N, 2003, MOL GENET METAB, V80, P159, DOI 10.1016/j.ymgme.2003.08.022; Raben N, 1998, J BIOL CHEM, V273, P19086, DOI 10.1074/jbc.273.30.19086; REUSER AJJ, 1995, MUSCLE NERVE, pS61; SCHMIDT B, 1995, J BIOL CHEM, V270, P14975, DOI 10.1074/jbc.270.25.14975; TONG PY, 1988, J BIOL CHEM, V263, P2585; TONG PY, 1989, J BIOL CHEM, V264, P7970; Valenzano KJ, 1997, J BIOL CHEM, V272, P4804, DOI 10.1074/jbc.272.8.4804; van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859; VANDERPLOEG AT, 1991, J CLIN INVEST, V87, P513, DOI 10.1172/JCI115025; Villevalois-Cam L, 2000, J CELL BIOCHEM, V77, P310, DOI 10.1002/(SICI)1097-4644(20000501)77:2<310::AID-JCB13>3.0.CO;2-4; Winkel LPF, 2005, J NEUROL, V252, P875, DOI 10.1007/s00415-005-0922-9; WISSELAAR HA, 1993, J BIOL CHEM, V268, P2223; Yang HW, 1998, PEDIATR RES, V43, P374, DOI 10.1203/00006450-199803000-00011; Zhu YX, 2009, MOL THER, V17, P954, DOI 10.1038/mt.2009.37; Zhu YX, 2005, BIOCHEM J, V389, P619, DOI 10.1042/BJ20050364	40	73	79	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1428	1438		10.1074/jbc.M112.438663	http://dx.doi.org/10.1074/jbc.M112.438663			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23188827	hybrid, Green Published			2022-12-28	WOS:000313751400001
J	Wang, X; Xiong, LW; El Ayadi, A; Boehning, D; Putkey, JA				Wang, Xu; Xiong, Liang Wen; El Ayadi, Amina; Boehning, Darren; Putkey, John A.			The Calmodulin Regulator Protein, PEP-19, Sensitizes ATP-induced Ca2+ Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; CALCIUM-BINDING; NITRIC-OXIDE; CELL-DEATH; EXPRESSION; RC3/NEUROGRANIN; NEUROGRANIN; ACTIVATION; CHANNEL; KINASE	PEP-19 is a small, intrinsically disordered protein that binds to the C-domain of calmodulin (CaM) via an IQ motif and tunes its Ca2+ binding properties via an acidic sequence. We show here that the acidic sequence of PEP-19 has intrinsic Ca2+ binding activity, which may modulate Ca2+ binding to CaM by stabilizing an initial Ca2+-CaM complex or by electrostatically steering Ca2+ to and from CaM. Because PEP-19 is expressed in cells that exhibit highly active Ca2+ dynamics, we tested the hypothesis that it influences ligand-dependent Ca2+ release. We show that PEP-19 increases the sensitivity of HeLa cells to ATP-induced Ca2+ release to greatly increase the percentage of cells responding to sub-saturating doses of ATP and increases the frequency of Ca2+ oscillations. Mutations in the acidic sequence of PEP-19 that inhibit or prevent it from modulating Ca2+ binding to CaM greatly inhibit its effect on ATP-induced Ca2+ release. Thus, this cellular effect of PEP-19 does not depend simply on binding to CaM via the IQ motif but requires its acidic metal binding domain. Tuning the activities of Ca2+ mobilization pathways places PEP-19 at the top of CaM signaling cascades, with great potential to exert broad effects on downstream CaM targets, thus expanding the biological significance of this small regulator of CaM signaling.	[Wang, Xu; Xiong, Liang Wen; Putkey, John A.] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Wang, Xu; Xiong, Liang Wen; Putkey, John A.] Univ Texas Houston, Sch Med, Struct Biol Imaging Ctr, Houston, TX USA; [El Ayadi, Amina; Boehning, Darren] Univ Texas Med Branch, Dept Neurosci & Cell & Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Medical Branch Galveston	Putkey, JA (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, 6431 Fannin St, Houston, TX 77030 USA.	john.putkey@uth.tmc.edu	Boehning, Darren/I-8539-2015	Boehning, Darren/0000-0001-7920-6922; Wang, Xu/0000-0002-8266-098X	National Institutes of Health [GM081685, GM081685-03S1, GM06961109]; W. M. Keck Center for Interdisciplinary Biosciences [R90 DK071504]; American Heart Association [10POST3110010, GRNT2280427]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Center for Interdisciplinary Biosciences; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081685 and GM081685-03S1 (to D. B.) and GM06961109 (to J. A. P.). This work was also supported by Fellowships R90 DK071504 from the W. M. Keck Center for Interdisciplinary Biosciences, 10POST3110010 from the American Heart Association (to X. W.), and GRNT2280427 from the American Heart Association (to J. A. P.).	ALEXANDER KA, 1987, J BIOL CHEM, V262, P6108; ANDREASEN TJ, 1983, BIOCHEMISTRY-US, V22, P4615, DOI 10.1021/bi00289a001; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Carafoli E, 1987, Soc Gen Physiol Ser, V42, P21; Devireddy LR, 2003, MOL CELL BIOL, V23, P4532, DOI 10.1128/MCB.23.13.4532-4541.2003; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Erhardt JA, 2000, NEUROREPORT, V11, P3719, DOI 10.1097/00001756-200011270-00026; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Gaertner TR, 2004, J BIOL CHEM, V279, P39374, DOI 10.1074/jbc.M405352200; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; GERENDASY DD, 1994, J BIOL CHEM, V269, P22420; Gerendasy DD, 1997, MOL NEUROBIOL, V15, P131, DOI 10.1007/BF02740632; Glynne R, 2000, IMMUNOL REV, V176, P216; Gui JG, 2007, INT J BIOL SCI, V3, P212; Harashima S, 2011, J NEUROSCI RES, V89, P1519, DOI 10.1002/jnr.22688; Hartmann J, 2005, CELL CALCIUM, V37, P459, DOI 10.1016/j.ceca.2005.01.014; Iwamoto K, 2004, NEUROSCI RES, V49, P379, DOI 10.1016/j.neures.2004.04.002; Kanamori T, 2003, MOL HUM REPROD, V9, P709, DOI 10.1093/molehr/gag088; Kanazawa Y, 2008, NEUROSCIENCE, V154, P473, DOI 10.1016/j.neuroscience.2008.03.044; Kang S, 2011, FASEB J, V25, P840, DOI 10.1096/fj.10-160705; Kleerekoper QK, 2009, J BIOL CHEM, V284, P7455, DOI 10.1074/jbc.M808067200; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; LINSE S, 1991, J BIOL CHEM, V266, P8050; MARTIN SR, 1990, BIOCHEMISTRY-US, V29, P4188, DOI 10.1021/bi00469a023; McCullar JS, 2003, J BIOL CHEM, V278, P33708, DOI 10.1074/jbc.M301940200; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Mouton-Liger F, 2011, J COMP NEUROL, V519, P2779, DOI 10.1002/cne.22651; Persechini A, 1996, J BIOL CHEM, V271, P62, DOI 10.1074/jbc.271.1.62; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; Putkey JA, 2008, J BIOL CHEM, V283, P1401, DOI 10.1074/jbc.M703831200; Rakhilin SV, 2004, SCIENCE, V306, P698, DOI 10.1126/science.1099961; Rodney GG, 2000, BIOCHEMISTRY-US, V39, P7807, DOI 10.1021/bi0005660; Skold K, 2006, J PROTEOME RES, V5, P262, DOI 10.1021/pr050281f; Slemmon JR, 2000, MOL NEUROBIOL, V22, P99, DOI 10.1385/MN:22:1-3:099; Slemmon JR, 1996, J BIOL CHEM, V271, P15911, DOI 10.1074/jbc.271.27.15911; Stieren E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011992; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Utal AK, 1998, NEUROSCIENCE, V86, P1055, DOI 10.1016/S0306-4522(98)00130-4; van Dalen JJW, 2003, EUR J NEUROSCI, V18, P13, DOI 10.1046/j.1460-9568.2003.02720.x; Wang X, 2010, BIOCHEMISTRY-US, V49, P10287, DOI 10.1021/bi100500m; Wei P, 2011, MOL CELL BIOL, V31, P2838, DOI 10.1128/MCB.05208-11; Xie GX, 2007, J MOL BIOL, V366, P349, DOI 10.1016/j.jmb.2006.11.045; Xiong LW, 2010, J BIOL CHEM, V285, P8094, DOI 10.1074/jbc.M109.065243; Xiong LW, 2005, J BIOL CHEM, V280, P7070, DOI 10.1074/jbc.M410558200; Yang W, 2003, J AM CHEM SOC, V125, P6165, DOI 10.1021/ja034724x; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1; ZIAI MR, 1988, J NEUROCHEM, V51, P1771, DOI 10.1111/j.1471-4159.1988.tb01158.x	47	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2040	2048		10.1074/jbc.M112.411314	http://dx.doi.org/10.1074/jbc.M112.411314			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23204517	Green Published, hybrid			2022-12-28	WOS:000313751400055
J	Van der Meeren, R; Wen, YR; Van Gelder, P; Tommassen, J; Devreese, B; Savvides, SN				Van der Meeren, Ruben; Wen, Yurong; Van Gelder, Patrick; Tommassen, Jan; Devreese, Bart; Savvides, Savvas N.			New Insights into the Assembly of Bacterial Secretins STRUCTURAL STUDIES OF THE PERIPLASMIC DOMAIN OF XcpQ FROM PSEUDOMONAS AERUGINOSA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II SECRETION; PROTEIN-TRANSPORT; OLIGOMERIC RINGS; TERMINAL DOMAIN; OUTER-MEMBRANE; CHOLERA-TOXIN; ELASTASE; BINDING; SYSTEMS; GSPD	The type II secretion system is a multiprotein assembly spanning the inner and outer membranes in Gram-negative bacteria. It is found in almost all pathogenic bacteria where it contributes to virulence, host tissue colonization, and infection. The exoproteins are secreted across the outer membrane via a large translocation channel, the secretin, which typically adopts a dodecameric structure. These secretin channels have large periplasmic N-terminal domains that reach out into the periplasm for communication with the inner membrane platform and with a pseudopilus structure that spans the periplasm. Here we report the crystal structure of the N-terminal periplasmic domain of the secretin XcpQ from Pseudomonas aeruginosa, revealing a two-lobe dimeric assembly featuring parallel subunits engaging in well defined interactions at the tips of each lobe. We have employed structure-based engineering of disulfide bridges and native mass spectrometry to show that the periplasmic domain of XcpQ dimerizes in a concentration-dependent manner. Validation of these insights in the context of cellular full-length XcpQ and further evaluation of the functionality of disulfide-linked XcpQ establishes that the basic oligomerization unit of XcpQ is a dimer. This is consistent with the notion that the dodecameric secretin assembles as a hexamer of dimers to ensure correct projection of the N-terminal domains into the periplasm. Therefore, our studies provide a key conceptual advancement in understanding the assembly principles and dynamic function of type II secretion system secretins and challenge recent studies reporting monomers as the basic subunit of the secretin oligomer.	[Van der Meeren, Ruben; Van Gelder, Patrick; Savvides, Savvas N.] Univ Ghent, Unit Struct Biol, Lab Prot Biochem & Biomol Engn, B-9000 Ghent, Belgium; [Wen, Yurong; Devreese, Bart] Univ Ghent, Unit Biol Mass Spectrometry & Prote, Lab Prot Biochem & Biomol Engn, B-9000 Ghent, Belgium; [Tommassen, Jan] Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands; [Tommassen, Jan] Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	Ghent University; Ghent University; Utrecht University; Utrecht University	Savvides, SN (corresponding author), Univ Ghent, Unit Struct Biol, Lab Prot Biochem & Biomol Engn, KL Ledeganckstr 35, B-9000 Ghent, Belgium.	savvas.savvides@ugent.be	Devreese, Bart/K-2841-2019; Tommassen, Jan/I-1690-2016; Wen, Yurong/E-3277-2013; Devreese, Bart/B-2011-2009	Devreese, Bart/0000-0002-9764-2581; Tommassen, Jan/0000-0001-7633-4945; Wen, Yurong/0000-0001-8730-5197; Devreese, Bart/0000-0002-9764-2581; Van Gelder, Patrick/0000-0003-1785-4435	Ghent University (Bijzonder Onderzoeksfonds-Geconcentreerde Onderzoeksactie instrument); Hercules Foundation [AUGE019]; BELSPO IAP Grant iPROS [P7/44]; European Commission under the 7th Framework Programme: Research Infrastructures [226716]; CSC bilateral fellowship Ghent University	Ghent University (Bijzonder Onderzoeksfonds-Geconcentreerde Onderzoeksactie instrument); Hercules Foundation; BELSPO IAP Grant iPROS; European Commission under the 7th Framework Programme: Research Infrastructures; CSC bilateral fellowship Ghent University	This work was supported by grants from Ghent University (Bijzonder Onderzoeksfonds-Geconcentreerde Onderzoeksactie instrument and co-funding to the Chinese Scholarship Council grant), Hercules Foundation Grant AUGE019, and BELSPO IAP Grant iPROS, P7/44, and Grant Agreement Number 226716 from the European Commission under the 7th Framework Programme: Research Infrastructures.; Recipient of a CSC bilateral fellowship Ghent University.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALEXEYEV MF, 1995, GENE, V160, P63, DOI 10.1016/0378-1119(95)00108-I; [Anonymous], PYMOL MOL GRAPHICS S; Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Braun P, 2001, J BIOL CHEM, V276, P26030, DOI 10.1074/jbc.M007122200; Brok R, 1999, J MOL BIOL, V294, P1169, DOI 10.1006/jmbi.1999.3340; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Douzi B, 2011, J BIOL CHEM, V286, P40792, DOI 10.1074/jbc.M111.294843; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Filloux A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00155; GENIN S, 1994, MOL GEN GENET, V243, P112, DOI 10.1007/BF00283883; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Gu S, 2012, J BIOL CHEM, V287, P9072, DOI 10.1074/jbc.M111.300624; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Indu S, 2011, PROTEINS, V79, P244, DOI 10.1002/prot.22878; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kessler E, 1998, J BIOL CHEM, V273, P30225, DOI 10.1074/jbc.273.46.30225; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Krissinel E, 2011, ACTA CRYSTALLOGR D, V67, P376, DOI 10.1107/S0907444911007232; Kung VL, 2010, MICROBIOL MOL BIOL R, V74, P621, DOI 10.1128/MMBR.00027-10; LAZDUNSKI A, 1990, BIOCHIMIE, V72, P147, DOI 10.1016/0300-9084(90)90140-C; Lieberman JA, 2012, J BACTERIOL, V194, P1646, DOI 10.1128/JB.06330-11; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLaughlin LS, 2012, CURR OPIN STRUC BIOL, V22, P208, DOI 10.1016/j.sbi.2012.02.005; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Reichow SL, 2011, CHANNELS, V5, P215, DOI 10.4161/chan.5.3.15268; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Wang XH, 2012, J BIOL CHEM, V287, P19082, DOI 10.1074/jbc.M112.346338; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; WERB Z, 1975, J EXP MED, V142, P361, DOI 10.1084/jem.142.2.361; WRETLIND B, 1984, J BACTERIOL, V158, P801, DOI 10.1128/JB.158.3.801-808.1984	39	24	24	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1214	1225		10.1074/jbc.M112.432096	http://dx.doi.org/10.1074/jbc.M112.432096			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23188826	Green Published, hybrid			2022-12-28	WOS:000313570300042
J	Gogada, R; Yadav, N; Liu, JW; Tang, SH; Zhang, DM; Schneider, A; Seshadri, A; Sun, LM; Aldaz, CM; Tang, DG; Chandra, D				Gogada, Raghu; Yadav, Neelu; Liu, Junwei; Tang, Shaohua; Zhang, Dianmu; Schneider, Andrea; Seshadri, Athul; Sun, Leimin; Aldaz, C. Marcelo; Tang, Dean G.; Chandra, Dhyan			Bim, a Proapoptotic Protein, Up-regulated via Transcription Factor E2F1-dependent Mechanism, Functions as a Prosurvival Molecule in Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY-MEMBER BIM; NF-KAPPA-B; BCL-2 FAMILY; INDUCED APOPTOSIS; STRUCTURAL BASIS; GENE-EXPRESSION; ACTIVATION; BAX; IDENTIFICATION; INHIBITION	Proapoptotic Bcl-2 homology 3-only protein Bim plays an important role in Bax/Bak-mediated cytochrome c release and apoptosis. Here, we provide evidence for a novel prosurvival function of Bim in cancer cells. Bim was constitutively overexpressed in multiple prostate and breast cancer cells as well as in primary tumor cells. Quantitative real time PCR analysis showed that Bim was transcriptionally up-regulated. We have identified eight endogenous E2F1-binding sites on the Bim promoter using in silico analysis. Luciferase assay demonstrated that Bim expression was E2F1-dependent as mutation of the E2F1-binding sites on the Bim promoter inhibited luciferase activities. In support, E2F1 silencing led to the loss of Bim expression in cancer cells. Bim primarily localized to mitochondrial and cytoskeleton-associated fractions. Bim silencing or microinjection of anti-Bim antibodies into the cell cytoplasm resulted in cell rounding, detachment, and subsequent apoptosis. We observed up-regulation of prosurvival proteins Bcl-xL and Mcl-1, which sequester Bim in cancer cells. In addition, a phosphorylated form of Bim was also elevated in cancer cells. These findings suggest that the constitutively overexpressed Bim may function as a prosurvival molecule in epithelial cancer cells, and phosphorylation and association with Bcl-xL/Mcl-1 block its proapoptotic functions.	[Gogada, Raghu; Yadav, Neelu; Zhang, Dianmu; Schneider, Andrea; Seshadri, Athul; Sun, Leimin; Chandra, Dhyan] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Liu, Junwei; Tang, Shaohua; Aldaz, C. Marcelo; Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA	Roswell Park Cancer Institute; University of Texas System; UTMD Anderson Cancer Center	Chandra, D (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Elm & Carlton Sts, Buffalo, NY 14263 USA.	dhyan.chandra@roswellpark.org	Aldaz, C. Marcelo/E-7868-2011; Gogada, Raghu/AAG-6624-2019; Tang, Dean/AAI-3457-2020	Aldaz, C. Marcelo/0000-0002-2453-2939; Tang, Dean/0000-0001-5029-1174; Chandra, Dhyan/0000-0001-7272-9384; Gogada, Raghu/0000-0003-0933-7999	National Institutes of Health [CA123142, R1-ES015888, 1R21CA 150009]; NCI [P30 CA016056]; Department of Defense [W81XWH-11-1-0331]; American Cancer Society [RSG-12-214-01 CCG]; NATIONAL CANCER INSTITUTE [P30CA016056, K01CA123142, R21CA150009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health K01 Award CA123142 (to D. C.) and Grants R1-ES015888 and 1R21CA 150009 (to D. G. T.) and Support Grant P30 CA016056 from NCI (to Roswell Park Cancer Institute). This work was also supported by Department of Defense Grant W81XWH-11-1-0331 (to D.G.T.).; Supported by a Research Scholar Grant RSG-12-214-01 CCG from the American Cancer Society. To whom correspondence should be addressed: Dept. of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Sts., Buffalo, NY 14263. Tel.: 716-845-4882; Fax: 716-845-8857; E-mail: dhyan.chandra@roswellpark.org.	Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; Bhatia B, 2003, J BIOL CHEM, V278, P25091, DOI 10.1074/jbc.M301920200; Biswas SC, 2002, J BIOL CHEM, V277, P49511, DOI 10.1074/jbc.M208086200; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; Chen D, 2004, P NATL ACAD SCI USA, V101, P1235, DOI 10.1073/pnas.0308050100; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Cheng EH, 2012, NAT MED, V18, P494, DOI 10.1038/nm.2725; Czabotar PE, 2009, CELL DEATH DIFFER, V16, P1187, DOI 10.1038/cdd.2009.83; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Davey GM, 2002, J EXP MED, V196, P947, DOI 10.1084/jem.20020827; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; Fannjiang Y, 2003, DEV CELL, V4, P575, DOI 10.1016/S1534-5807(03)00091-1; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gogada R, 2011, CELL CYCLE, V10, P4128, DOI 10.4161/cc.10.23.18292; Gogada R, 2011, J BIOL CHEM, V286, P28749, DOI 10.1074/jbc.M110.202440; Gorgoulis VG, 2002, J PATHOL, V198, P142, DOI 10.1002/path.1121; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1432, DOI 10.1210/me.12.9.1432; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Kerr DA, 2002, J VIROL, V76, P10393, DOI 10.1128/JVI.76.20.10393-10400.2002; King SM, 1996, J BIOL CHEM, V271, P19358, DOI 10.1074/jbc.271.32.19358; King SM, 2000, J CELL SCI, V113, P2521; Lewis J, 1999, NAT MED, V5, P832, DOI 10.1038/10556; Liu JW, 2005, ONCOGENE, V24, P2020, DOI 10.1038/sj.onc.1208385; Liu JW, 2003, ONCOGENE, V22, P1475, DOI 10.1038/sj.onc.1206196; Liu JW, 2002, CANCER RES, V62, P2976; Liu WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029466; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Madden DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028530; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Miyashita MUT, 2001, FEBS LETT, V509, P135, DOI 10.1016/S0014-5793(01)03145-3; Moore PS, 2004, BBA-MOL CELL RES, V1693, P167, DOI 10.1016/j.bbamcr.2004.07.001; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Reilly LA, 2000, AM J PATHOL, V157, P449, DOI 10.1016/S0002-9440(10)64557-9; Paterson A, 2012, BLOOD, V119, P1726, DOI 10.1182/blood-2011-07-367417; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Rapali P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018818; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Rytomaa M, 1999, CURR BIOL, V9, P1043, DOI 10.1016/S0960-9822(99)80454-0; Seo SY, 2004, J BIOL CHEM, V279, P42240, DOI 10.1074/jbc.M406775200; Seward RJ, 2003, MOL IMMUNOL, V39, P983, DOI 10.1016/S0161-5890(03)00047-6; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Tang DG, 1998, CANCER RES, V58, P3466; Tang SH, 2002, J BIOL CHEM, V277, P16189, DOI 10.1074/jbc.M111936200; Villunger A, 2003, BLOOD, V101, P2393, DOI 10.1182/blood-2002-07-2132; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Woods NT, 2007, CANCER RES, V67, P10744, DOI 10.1158/0008-5472.CAN-07-3148; Yeretssian G, 2011, NATURE, V474, P96, DOI 10.1038/nature09982; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030; Zhang HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016379; Zhang SY, 2000, CANCER EPIDEM BIOMAR, V9, P395; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102; Zhu YN, 2004, P NATL ACAD SCI USA, V101, P7681, DOI 10.1073/pnas.0402293101	76	54	57	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					368	381		10.1074/jbc.M112.386102	http://dx.doi.org/10.1074/jbc.M112.386102			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23152504	Green Published, hybrid			2022-12-28	WOS:000313197200038
J	Ting, HJ; Messing, J; Yasmin-Karim, S; Lee, YF				Ting, Huei-Ju; Messing, James; Yasmin-Karim, Sayeda; Lee, Yi-Fen			Identification of microRNA-98 as a Therapeutic Target Inhibiting Prostate Cancer Growth and a Biomarker Induced by Vitamin D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-ALPHA,25-DIHYDROXYVITAMIN D-3 RESPONSIVENESS; 1,25-DIHYDROXYVITAMIN D-3; D-RECEPTOR; D ANALOG; CELLS; EXPRESSION; APOPTOSIS; PROLIFERATION; INDUCTION; CARCINOMA	The anti-tumor effect of vitamin D has been well recognized but its translational application is hindered by side effects induced by supra-physiological concentration of vitamin D required for cancer treatment. Thus, exploring the vitamin D tumor suppressive functional mechanism can facilitate improvement of its clinical application. We screened miRNA profiles in response to vitamin D and found that a tumor suppressive miRNA, miR-98, is transcriptionally induced by 1 alpha,25-dihydroxyvitamin D-3 (1,25-VD) in LNCaP. Mechanistic dissection revealed that 1,25-VD-induced miR-98 is mediated through both a direct mechanism, enhancing the VDR binding response element in the promoter region of miR-98, and an indirect mechanism, down-regulating LIN-28 expression. Knockdown of miR-98 led to a reduction of 1,25-VD anti-growth effect and overexpression of miR-98 suppressed the LNCaP cells growth via inducing G2/M arrest. And CCNJ, a protein controlling cell mitosis, is down-regulated by miR-98 via targeting 3'-untranslated region of CCNJ. Interestingly, miR-98 levels in blood are increased upon 1,25-VD treatment in mice suggesting the biomarker potential of miR-98 in predicting 1,25-VD response. Together, the finding that growth inhibitive miR-98 is induced by 1,25-VD provides a potential therapeutic target for prostate cancer and a potential biomarker for 1,25-VD anti-tumor action.	[Lee, Yi-Fen] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA; [Yasmin-Karim, Sayeda] Univ Rochester, Dept Chem Engn, Rochester, NY 14642 USA; [Ting, Huei-Ju] Natl Univ Tainan, Dept Biol Sci & Technol, Tainan 70005, Taiwan	University of Rochester; University of Rochester; National University Tainan	Lee, YF (corresponding author), Univ Rochester, Med Ctr, Dept Urol, 601 Elmwood Ave,Box 656, Rochester, NY 14642 USA.	yifen_lee@urmc.rochester.edu		Ting, Huei-Ju/0000-0003-3709-5755				Alvarez-Diaz S, 2012, HUM MOL GENET, V21, P2157, DOI 10.1093/hmg/dds031; Bao BY, 2008, INT J CANCER, V122, P2699, DOI 10.1002/ijc.23460; Bao BY, 2006, CARCINOGENESIS, V27, P1883, DOI 10.1093/carcin/bgl041; Bao BY, 2010, J STEROID BIOCHEM, V120, P11, DOI 10.1016/j.jsbmb.2010.02.030; Bao BY, 2006, CARCINOGENESIS, V27, P32, DOI 10.1093/carcin/bgi170; Beer TM, 2008, CANCER, V112, P326, DOI 10.1002/cncr.23163; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Getzenberg RH, 1997, UROLOGY, V50, P999, DOI 10.1016/S0090-4295(97)00408-1; Gocek E, 2011, CANCER RES, V71, P6230, DOI 10.1158/0008-5472.CAN-11-1717; Guzey M, 2002, MOL CANCER THER, V1, P667; Hansen CM, 2000, CURR PHARM DESIGN, V6, P803, DOI 10.2174/1381612003400371; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Heneghan HM, 2010, CURR OPIN PHARMACOL, V10, P543, DOI 10.1016/j.coph.2010.05.010; Hu GK, 2009, J IMMUNOL, V183, P1617, DOI 10.4049/jimmunol.0804362; Jensen SS, 2001, MOL ENDOCRINOL, V15, P1370, DOI 10.1210/me.15.8.1370; Jiang F, 2003, J BIOL CHEM, V278, P48030, DOI 10.1074/jbc.M308430200; Jorde Rolf, 2012, BMC Res Notes, V5, P245, DOI 10.1186/1756-0500-5-245; Kawahara H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199166; Kolonin MG, 2000, DEV BIOL, V227, P661, DOI 10.1006/dbio.2000.9916; Marchiani S, 2006, J CANCER RES CLIN, V132, P408, DOI 10.1007/s00432-006-0086-8; Mohri T, 2009, INT J CANCER, V125, P1328, DOI 10.1002/ijc.24459; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Pepper C, 2003, BLOOD, V101, P2454, DOI 10.1182/blood-2002-07-1984; Polek TC, 2003, ENDOCRINOLOGY, V144, P50, DOI 10.1210/en.2001-210109; Spina CS, 2007, J STEROID BIOCHEM, V103, P757, DOI 10.1016/j.jsbmb.2006.12.040; Ting HJ, 2007, MOL CANCER RES, V5, P967, DOI 10.1158/1541-7786.MCR-06-0318; Ting HJ, 2012, CANCER RES, V72, P958, DOI 10.1158/0008-5472.CAN-11-0042; Trump DL, 2006, ANTICANCER RES, V26, P2551; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wang QM, 1996, CANCER RES, V56, P264; Wang WLW, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-58; Ward A., 2012, ONCOGENE IN PRESS; Wouters MD, 2011, MUTAT RES-FUND MOL M, V717, P54, DOI 10.1016/j.mrfmmm.2011.03.012; Zhang LA, 2011, CELL STEM CELL, V8, P294, DOI 10.1016/j.stem.2011.01.014; Zhao YC, 2011, MOL MED, V17, P1233, DOI 10.2119/molmed.2010.00225	40	70	72	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					1	9		10.1074/jbc.M112.395947	http://dx.doi.org/10.1074/jbc.M112.395947			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23188821	hybrid, Green Published			2022-12-28	WOS:000313197200001
J	Zhang, ZH; Sun, YG; Cho, YW; Chow, CC; Simons, SS				Zhang, Zhenhuan; Sun, Yunguang; Cho, Young-Wook; Chow, Carson C.; Simons, S. Stoney, Jr.			PA1 Protein, a New Competitive Decelerator Acting at More than One Step to Impede Glucocorticoid Receptor-mediated Transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOSE-RESPONSE CURVES; NUCLEAR RECEPTOR; ANTAGONIST COMPLEXES; INDUCTION PROPERTIES; COACTIVATOR BINDING; ANDROGEN RECEPTOR; GENE INDUCTION; PROGESTERONE-RECEPTORS; TRANSCRIPTION FACTORS; COREPRESSOR BINDING	Numerous cofactors modulate the gene regulatory activity of glucocorticoid receptors (GRs) by affecting one or more of the following three major transcriptional properties: the maximal activity of agonists (A(max)), the potency of agonists (EC50), and the partial agonist activity of antisteroids (PAA). Here, we report that the recently described nuclear protein, Pax2 transactivation domain interaction protein (PTIP)-associated protein 1 (PA1), is a new inhibitor of GR transactivation. PA1 suppresses Amax, increases the EC50, and reduces the PAA of an exogenous reporter gene in a manner that is independent of associated PTIP. PA1 is fully active with, and strongly binds to, the C-terminal half of GR. PA1 reverses the effects of the coactivator TIF2 on GR-mediated gene induction but is unable to augment the actions of the corepressor SMRT. Analysis of competition assays between PA1 and TIF2 with an exogenous reporter indicates that the kinetic definition of PA1 action is a competitive decelerator at two sites upstream from where TIF2 acts. With the endogenous genes IGFBP1 and IP6K3, PA1 also represses GR induction, increases the EC50, and decreases the PAA. ChIP and re-ChIP experiments indicate that PA1 accomplishes this inhibition of the two genes via different mechanisms as follows: PA1 appears to increase GR dissociation from and reduce GR transactivation at the IGFBP1 promoter regions but blocks GR binding to the IP6K3 promoter. We conclude that PA1 is a new competitive decelerator of GR transactivation and can act at more than one molecularly defined step in a manner that depends upon the specific gene.	[Simons, S. Stoney, Jr.] NIDDK, CEB, Steroid Hormones Sect, NIH, Bethesda, MD 20892 USA; [Cho, Young-Wook] NIDDK, Nucl Receptor Biol Sect, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Chow, Carson C.] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Simons, SS (corresponding author), NIDDK, CEB, Steroid Hormones Sect, NIH, Bldg 10,Rm 8N-307B, Bethesda, MD 20892 USA.	stoneys@helix.nih.gov		Sun, Yunguang/0000-0003-4004-9514	National Institutes of Health Intramural Research Program, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK047040, ZIADK075069, ZIADK057800] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in whole by National Institutes of Health Intramural Research Program, NIDDK.	Awasthi S, 2012, MOL CELL ENDOCRINOL, V355, P121, DOI 10.1016/j.mce.2012.02.001; Bamberger CM, 1996, ENDOCR REV, V17, P245, DOI 10.1210/er.17.3.245; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Blackford JA, 2012, J BIOL CHEM, V287, P40982, DOI 10.1074/jbc.M112.414805; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; Cho SY, 2005, BIOCHEMISTRY-US, V44, P3547, DOI 10.1021/bi048777i; Cho SY, 2005, MOL ENDOCRINOL, V19, P290, DOI 10.1210/me.2004-0134; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Chow CC, 2011, METHOD ENZYMOL, P465, DOI [10.1016/S0076-6879(11)87016-3, 10.1016/B978-0-12-381270-4.00016-0]; de Felipe KS, 2004, BIOCHEMISTRY-US, V43, P10353, DOI 10.1021/bi049716n; Dougherty EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030225; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; He YZ, 2007, MOL CELL BIOL, V27, P1467, DOI 10.1128/MCB.01360-06; He YZ, 2002, J BIOL CHEM, V277, P49256, DOI 10.1074/jbc.M205536200; Heemers HV, 2009, MOL ENDOCRINOL, V23, P572, DOI 10.1210/me.2008-0363; Hwang JY, 2009, J MED CHEM, V52, P3892, DOI 10.1021/jm9002704; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; Kaul S, 2002, J BIOL CHEM, V277, P12541, DOI 10.1074/jbc.M112330200; Khan SH, 2012, J BIOL CHEM, V287, P44546, DOI 10.1074/jbc.M112.411330; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim Y, 2006, J STEROID BIOCHEM, V100, P3, DOI 10.1016/j.jsbmb.2006.03.003; Lee GS, 2011, BIOCHEMISTRY-US, V50, P356, DOI 10.1021/bi101792d; Liang J, 2009, EMBO REP, V10, P51, DOI 10.1038/embor.2008.223; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Luo M, 2009, HUM IMMUNOL, V70, P785, DOI 10.1016/j.humimm.2009.07.029; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; MUNCK A, 1984, J BIOL CHEM, V259, P820; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; OJASOO T, 1988, J MED CHEM, V31, P1160, DOI 10.1021/jm00401a015; Ong KM, 2010, P NATL ACAD SCI USA, V107, P7107, DOI 10.1073/pnas.0911095107; Ordentlich P, 1999, P NATL ACAD SCI USA, V96, P2639, DOI 10.1073/pnas.96.6.2639; Parent AA, 2008, J MED CHEM, V51, P6512, DOI 10.1021/jm800698b; Rogalska J, 2010, VITAM HORM, V82, P391, DOI 10.1016/S0083-6729(10)82020-5; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Simons SS, 2008, BIOESSAYS, V30, P744, DOI 10.1002/bies.20792; Simons SS, 2012, MOL CELL ENDOCRINOL, V348, P373, DOI 10.1016/j.mce.2011.05.030; Simons SS, 2010, CURR OPIN PHARMACOL, V10, P613, DOI 10.1016/j.coph.2010.08.001; SIMONS SS, 1980, J ORG CHEM, V45, P3084, DOI 10.1021/jo01303a030; SIMONS SS, 1994, VITAM HORM, V49, P49; Simons SS, 2003, TRENDS PHARMACOL SCI, V24, P253, DOI 10.1016/S0165-6147(03)00101-9; Song LN, 2001, J BIOL CHEM, V276, P24806, DOI 10.1074/jbc.M102610200; Sun JL, 2011, J BIOL CHEM, V286, P36248, DOI 10.1074/jbc.M111.269167; Szapary D, 1999, MOL ENDOCRINOL, V13, P2108, DOI 10.1210/me.13.12.2108; Szapary D, 2008, MOL CELL ENDOCRINOL, V283, P114, DOI 10.1016/j.mce.2007.11.031; Tao YG, 2008, BIOCHEMISTRY-US, V47, P7648, DOI 10.1021/bi800472w; TRUSS M, 1992, J STEROID BIOCHEM, V43, P365, DOI 10.1016/0960-0760(92)90071-P; Wang DQ, 2007, BIOCHEMISTRY-US, V46, P8036, DOI 10.1021/bi7004575; Wang DQ, 2005, MOL ENDOCRINOL, V19, P1483, DOI 10.1210/me.2005-0012; Wang Q, 2004, MOL ENDOCRINOL, V18, P1376, DOI 10.1210/me.2003-0421; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; WILLMANN T, 1986, NATURE, V324, P688, DOI 10.1038/324688a0; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324; Yu X, 2001, MOL CELL BIOL, V21, P4614, DOI 10.1128/MCB.21.14.4614-4625.2001	60	18	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					42	58		10.1074/jbc.M112.427740	http://dx.doi.org/10.1074/jbc.M112.427740			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23161582	Green Published, hybrid			2022-12-28	WOS:000313197200005
J	Bras, JLA; Alves, VD; Carvalho, AL; Najmudin, S; Prates, JAM; Ferreira, LMA; Bolam, DN; Romao, MJ; Gilbert, HJ; Fontes, CMGA				Bras, Joana L. A.; Alves, Victor D.; Carvalho, Ana Luia; Najmudin, Shabir; Prates, Jose A. M.; Ferreira, Luis M. A.; Bolam, David N.; Romao, Maria Joao; Gilbert, Harry J.; Fontes, Carlos M. G. A.			Novel Clostridium thermocellum Type I Cohesin-Dockerin Complexes Reveal a Single Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CELLULOSOME; SPECIFICITY; INSIGHTS; SYSTEM	Protein-protein interactions play a pivotal role in a large number of biological processes exemplified by the assembly of the cellulosome. Integration of cellulosomal components occurs through the binding of type I cohesin modules located in a non-catalytic molecular scaffold to type I dockerin modules located at the C terminus of cellulosomal enzymes. The majority of type I dockerins display internal symmetry reflected by the presence of two essentially identical cohesin-binding surfaces. Here we report the crystal structures of two novel Clostridium thermocellum type I cohesin-dockerin complexes (CohOlpC-Doc124A and CohOlpA-Doc918). The data revealed that the two dockerins, Doc918 and Doc124A, are unusual because they lack the structural symmetry required to support a dual binding mode. Thus, in both cases, cohesin recognition is dominated by residues located at positions 11, 12, and 19 of one of the dockerin binding surfaces. The alternative binding mode is not possible (Doc918) or highly limited (Doc124A) because residues that assume the critical interacting positions, when dockerins are reoriented by 180, make steric clashes with the cohesin. In common with a third dockerin (Doc258) that also presents a single binding mode, Doc124A directs the appended cellulase, Cel124A, to the surface of C. thermocellum and not to cellulosomes because it binds preferentially to type I cohesins located at the cell envelope. Although there are a few exceptions, such as Doc918 described here, these data suggest that there is considerable selective pressure for the evolution of a dual binding mode in type I dockerins that direct enzymes into cellulosomes.	[Bras, Joana L. A.; Alves, Victor D.; Najmudin, Shabir; Prates, Jose A. M.; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.] Univ Tecn Lisboa, Fac Med Vet, Ctr Invest Interdisciplinar Sanidade Anim, P-1300477 Lisbon, Portugal; [Carvalho, Ana Luia; Romao, Maria Joao] FCT UNL, Dept Quim, REQUIMTE CQFB, P-2829516 Caparica, Portugal; [Bolam, David N.; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Universidade de Lisboa; Newcastle University - UK	Alves, VD (corresponding author), Univ Tecn Lisboa, Fac Med Vet, Ctr Invest Interdisciplinar Sanidade Anim, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	vdalves@fmv.utl.pt; cafontes@fmv.utl.pt	UCIBIO, U Cienc Biom Apl/F-7948-2017; Carvalho, Ana Luísa/G-5638-2011; Prates, José A M/K-9934-2013; Romao, Maria J/A-4115-2013	UCIBIO, U Cienc Biom Apl/0000-0002-3004-0543; Carvalho, Ana Luísa/0000-0002-3824-0240; Prates, José A M/0000-0003-1032-5987; Romao, Maria J/0000-0002-3004-0543; Ferreira, Luis/0000-0002-3543-9166; Alves, Victor Diogo/0000-0002-8430-4380; Fontes, Carlos/0000-0002-1219-9753; Najmudin, Shabir/0000-0002-0429-5454; Bras, Joana/0000-0002-1141-5530; Bolam, David/0000-0003-0314-3122	Fundacao para a Ciencia e a Tecnologia [PEst-C/EQB/LA0006/2011, PTDC/BIA-PRO/69732/2006, PTDC/QUI-BIQ/100359/2008, PTDC/BIA-PRO/103980/2008, SFRH/BD/38667/2007]; BBSRC [BB/G016224/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G016224/1] Funding Source: researchfish; Fundação para a Ciência e a Tecnologia [PTDC/QUI-BIQ/100359/2008, PTDC/BIA-PRO/103980/2008, PTDC/BIA-PRO/69732/2006] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fundação para a Ciência e a Tecnologia	This work was supported by Fundacao para a Ciencia e a Tecnologia Grants PEst-C/EQB/LA0006/2011, PTDC/BIA-PRO/69732/2006, PTDC/QUI-BIQ/100359/2008, and PTDC/BIA-PRO/103980/2008.; Supported by Fundacao para a Ciencia e a Tecnologia individual fellowship SFRH/BD/38667/2007.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; BAYER EA, 1986, J BACTERIOL, V167, P828, DOI 10.1128/jb.167.3.828-836.1986; Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; Beguin P, 1998, BIOCHEM SOC T, V26, P178, DOI 10.1042/bst0260178; Bras JLA, 2012, METHOD ENZYMOL, V510, P395, DOI 10.1016/B978-0-12-415931-0.00021-5; Bras JLA, 2011, P NATL ACAD SCI USA, V108, P5237, DOI 10.1073/pnas.1015006108; Carvalho AL, 2005, J MOL BIOL, V349, P909, DOI 10.1016/j.jmb.2005.04.037; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leibovitz E, 1996, J BACTERIOL, V178, P3077, DOI 10.1128/jb.178.11.3077-3084.1996; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lu YP, 2006, P NATL ACAD SCI USA, V103, P16165, DOI 10.1073/pnas.0605381103; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinheiro BA, 2008, J BIOL CHEM, V283, P18422, DOI 10.1074/jbc.M801533200; Pinheiro BA, 2009, BIOCHEM J, V424, P375, DOI 10.1042/BJ20091152; SALAMITOU S, 1994, J BACTERIOL, V176, P2822, DOI 10.1128/JB.176.10.2822-2827.1994; SALAMITOU S, 1992, FEBS LETT, V304, P89, DOI 10.1016/0014-5793(92)80595-8; TOKATLIDIS K, 1991, FEBS LETT, V291, P185, DOI 10.1016/0014-5793(91)81279-H; Urzhumtseva L, 2009, ACTA CRYSTALLOGR D, V65, P297, DOI 10.1107/S0907444908044296; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	33	22	23	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44394	44405		10.1074/jbc.M112.407700	http://dx.doi.org/10.1074/jbc.M112.407700			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23118225	Green Published, hybrid			2022-12-28	WOS:000312938600036
J	Liu, YJ; Gao, LP; Liu, L; Yang, Q; Lu, ZW; Nie, ZY; Wang, YS; Xia, T				Liu, Yajun; Gao, Liping; Liu, Li; Yang, Qin; Lu, Zhongwei; Nie, Zhiyin; Wang, Yunsheng; Xia, Tao			Purification and Characterization of a Novel Galloyltransferase Involved in Catechin Galloylation in the Tea Plant (Camellia sinensis)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS SERINE CARBOXYPEPTIDASE; AUXIN TRANSPORT; PROANTHOCYANIDIN BIOSYNTHESIS; GREEN TEA; GALLOTANNIN BIOSYNTHESIS; FLAVAN-3-OL BIOSYNTHESIS; ANTHOCYANIDIN REDUCTASE; FLAVONOID BIOSYNTHESIS; BETA-GLUCOGALLIN; EXPRESSION	Catechins (flavan-3-ols), the most important secondary metabolites in the tea plant, have positive effects on human health and are crucial in defense against pathogens of the tea plant. The aim of this study was to elucidate the biosynthetic pathway of galloylated catechins in the tea plant. The results suggested that galloylated catechins were biosynthesized via 1-O-glucose ester-dependent two-step reactions by acyltransferases, which involved two enzymes, UDP-glucose:galloyl-1-O-beta-D-glucosyltransferase (UGGT) and a newly discovered enzyme, epicatechin:1-O-galloyl-beta-D-glucose O-galloyltransferase (ECGT). In the first reaction, the galloylated acyl donor beta-glucogallin was biosynthesized by UGGT from gallic acid and uridine diphosphate glucose. In the second reaction, galloylated catechins were produced by ECGT catalysis from beta-glucogallin and 2,3-cis-flavan-3-ol. 2,3-cis-Flavan-3-ol and 1-O-galloyl-beta-D-glucose were appropriate substrates of ECGT rather than 2,3-trans-flavan3-ol and 1,2,3,4,6-pentagalloylglucose. Purification by more than 1641-fold to apparent homogeneity yielded ECGT with an estimated molecular mass of 241 to 121 kDa by gel filtration. Enzyme activity and SDS-PAGE analysis indicated that the native ECGT might be a dimer, trimer, or tetramer of 60-and/or 58-kDa monomers, and these monomers represent a heterodimer consisting of pairs of 36- or 34- of and 28-kDa subunits. MALDI-TOF-TOF MS showed that the protein SCPL1199 was identified. Epigallocatechin and epicatechin exhibited higher substrate affinities than beta-glucogallin. ECGT had an optimum temperature of 30 degrees C and maximal reaction rates between pH 4.0 and 6.0. The enzyme reaction was inhibited dramatically by phenylmethylsulfonyl fluoride, HgCl2, and sodium deoxycholate.	[Liu, Yajun; Gao, Liping; Yang, Qin; Lu, Zhongwei; Nie, Zhiyin; Wang, Yunsheng] Anhui Agr Univ, Sch Life Sci, Hefei 230036, Anhui, Peoples R China; [Liu, Li; Xia, Tao] Anhui Agr Univ, Minist Educ China, Key Lab Tea Biochem & Biotechnol, Hefei 230036, Anhui, Peoples R China	Anhui Agricultural University; Anhui Agricultural University; Ministry of Education, China	Xia, T (corresponding author), Anhui Agr Univ, Minist Educ China, Key Lab Tea Biochem & Biotechnol, 130 W Changjiang Rd, Hefei 230036, Anhui, Peoples R China.	xiatao62@126.com			Natural Science Foundation of China [30972401, 31170647, 31170282]; Natural Science Foundation of Anhui Province [11040606M73]; Collegiate Natural Science Foundation of Anhui Province [KJ2012A110]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1101]; Major Project of Chinese National Programmes for Fundamental Research and Development [2012CB722903]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Collegiate Natural Science Foundation of Anhui Province; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Major Project of Chinese National Programmes for Fundamental Research and Development	This work was supported by the Natural Science Foundation of China (30972401, 31170647, and 31170282), the Natural Science Foundation of Anhui Province (11040606M73), the Collegiate Natural Science Foundation of Anhui Province (KJ2012A110), the Program for Changjiang Scholars and Innovative Research Team in University (IRT1101), and the Major Project of Chinese National Programmes for Fundamental Research and Development (2012CB722903).	Ashihara H, 2010, PHYTOCHEMISTRY, V71, P559, DOI 10.1016/j.phytochem.2010.01.010; Bais HP, 2004, TRENDS PLANT SCI, V9, P26, DOI 10.1016/j.tplants.2003.11.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buer CS, 2007, PLANT PHYSIOL, V145, P478, DOI 10.1104/pp.107.101824; Buer CS, 2006, PLANT PHYSIOL, V140, P1384, DOI 10.1104/pp.105.075671; Buer CS, 2004, PLANT CELL, V16, P1191, DOI 10.1105/tpc.020313; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; Debeaujon I, 2000, PLANT PHYSIOL, V122, P403, DOI 10.1104/pp.122.2.403; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Eungwanichayapant PD, 2009, PLANT PHYSIOL BIOCH, V47, P94, DOI 10.1016/j.plaphy.2008.11.002; FORREST GI, 1969, BIOCHEM J, V113, P741, DOI 10.1042/bj1130741; Fraser CM, 2007, PLANT PHYSIOL, V144, P1986, DOI 10.1104/pp.107.098970; Fraser CM, 2005, PLANT PHYSIOL, V138, P1136, DOI 10.1104/pp.104.057950; GRAWE W, 1992, PLANTA, V187, P236, DOI 10.1007/BF00201945; GROSS GG, 1983, PHYTOCHEMISTRY, V22, P2179, DOI 10.1016/S0031-9422(00)80141-7; Grotewold E., 2006, SCI FLAVONOIDS, P123; He Q, 2009, NAT PROD RES, V23, P93, DOI 10.1080/14786410801886682; Ikegami A, 2007, PLANT SCI, V172, P1037, DOI 10.1016/j.plantsci.2007.02.010; JACOBS M, 1988, SCIENCE, V241, P346, DOI 10.1126/science.241.4863.346; Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109; Khater F, 2012, J EXP BOT, V63, P1201, DOI 10.1093/jxb/err340; Kuai JP, 1997, PLANT PHYSIOL, V115, P1581, DOI 10.1104/pp.115.4.1581; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehfeldt C, 2000, PLANT CELL, V12, P1295, DOI 10.1105/tpc.12.8.1295; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li AX, 1999, PLANT PHYSIOL, V121, P453, DOI 10.1104/pp.121.2.453; Li AX, 2000, P NATL ACAD SCI USA, V97, P6902, DOI 10.1073/pnas.110154197; LI JY, 1993, PLANT CELL, V5, P171, DOI 10.1105/tpc.5.2.171; Lim EK, 2002, J BIOL CHEM, V277, P586, DOI 10.1074/jbc.M109287200; Liu YJ, 2009, J AGR FOOD CHEM, V57, P10371, DOI 10.1021/jf902614n; Miketova P, 1998, J NAT PROD, V61, P461, DOI 10.1021/np9703959; Niemetz R, 2005, PHYTOCHEMISTRY, V66, P2001, DOI 10.1016/j.phytochem.2005.01.009; Niemetz R, 2001, PHYTOCHEMISTRY, V58, P657, DOI 10.1016/S0031-9422(01)00300-4; Niemetz R, 1998, PHYTOCHEMISTRY, V49, P327, DOI 10.1016/S0031-9422(98)00014-4; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; Pang YZ, 2007, PLANT PHYSIOL, V145, P601, DOI 10.1104/pp.107.107326; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Punyasiri PAN, 2004, ARCH BIOCHEM BIOPHYS, V431, P22, DOI 10.1016/j.abb.2004.08.003; REDMOND JW, 1986, NATURE, V323, P632, DOI 10.1038/323632a0; SAIJO R, 1983, AGR BIOL CHEM TOKYO, V47, P455, DOI 10.1080/00021369.1983.10865673; Shirley AM, 2001, PLANT J, V28, P83, DOI 10.1046/j.1365-313X.2001.01123.x; STAFFORD HA, 1985, PLANT PHYSIOL, V78, P791, DOI 10.1104/pp.78.4.791; STAFFORD HA, 1984, PLANT PHYSIOL, V76, P184, DOI 10.1104/pp.76.1.184; Stafford HA, 1990, FLAVONOID METABOLISM, P63; Stehle F, 2006, FEBS LETT, V580, P6366, DOI 10.1016/j.febslet.2006.10.046; STRACK D, 1983, Z NATURFORSCH C, V38, P21; Terrier N, 2009, PLANT PHYSIOL, V149, P1028, DOI 10.1104/pp.108.131862; Teutschbein J, 2010, J BIOL CHEM, V285, P38374, DOI 10.1074/jbc.M110.171637; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; WAJANT H, 1994, PLANT MOL BIOL, V26, P735, DOI 10.1007/BF00013758; Wang R, 2008, J AGR FOOD CHEM, V56, P2694, DOI 10.1021/jf0730338; Wasson AP, 2006, PLANT CELL, V18, P1617, DOI 10.1105/tpc.105.038232; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Xie DY, 2004, PLANT PHYSIOL, V134, P979, DOI 10.1104/pp.103.030221; Zhang XL, 2012, J SCI FOOD AGR, V92, P1533, DOI 10.1002/jsfa.4739	58	118	132	13	102	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44406	44417		10.1074/jbc.M112.403071	http://dx.doi.org/10.1074/jbc.M112.403071			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23132863	Green Published, hybrid			2022-12-28	WOS:000312938600037
J	Wilkerson, BA; Grass, GD; Wing, SB; Argraves, WS; Argraves, KM				Wilkerson, Brent A.; Grass, G. Daniel; Wing, Shane B.; Argraves, W. Scott; Argraves, Kelley M.			Sphingosine 1-Phosphate (S1P) Carrier-dependent Regulation of Endothelial Barrier HIGH DENSITY LIPOPROTEIN (HDL)-S1P PROLONGS ENDOTHELIAL BARRIER ENHANCEMENT AS COMPARED WITH ALBUMIN-S1P VIA EFFECTS ON LEVELS, TRAFFICKING, AND SIGNALING OF S1P1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; LIPID RAFTS; RECEPTOR; SPHINGOSINE-1-PHOSPHATE; PERMEABILITY; MECHANISMS; INCREASES; INDUCTION; INTEGRITY; SURFACE	Sphingosine 1-phosphate (S1P) is a blood-borne lysosphingolipid that acts to promote endothelial cell (EC) barrier function. In plasma, S1P is associated with both high density lipoproteins (HDL) and albumin, but it is not known whether the carriers impart different effects on S1P signaling. Here we establish that HDL-S1P sustains EC barrier longer than albumin-S1P. We showed that the sustained barrier effects of HDL-S1P are dependent on signaling by the S1P receptor, S1P1, and involve persistent activation of Akt and endothelial NOS (eNOS), as well as activity of the downstream NO target, soluble guanylate cyclase (sGC). Total S1P1 protein levels were found to be higher in response to HDL-S1P treatment as compared with albumin-S1P, and this effect was not associated with increased S1P1 mRNA or dependent on de novo provtein synthesis. Several pieces of evidence indicate that long term EC barrier enhancement activity of HDL-S1P is due to specific effects on S1P1 trafficking. First, the rate of S1P1 degradation, which is proteasome-mediated, was slower in HDL-S1P-treated cells as compared with cells treated with albumin-S1P. Second, the long term barrier-promoting effects of HDL-S1P were abrogated by treatment with the recycling blocker, monensin. Finally, cell surface levels of S1P1 and levels of S1P1 in caveolin-enriched microdomains were higher after treatment with HDL-S1P as compared with albumin-S1P. Together, the findings reveal S1P carrier-specific effects on S1P1 and point to HDL as the physiological mediator of sustained S1P1-PI3K-Akt-eNOS-sGC-dependent EC barrier function.	[Wilkerson, Brent A.; Grass, G. Daniel; Wing, Shane B.; Argraves, W. Scott; Argraves, Kelley M.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Argraves, KM (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	argravek@musc.edu		Wilkerson, Brent/0000-0002-3532-3075	National Institutes of Health [HL094883, HL080404, HL061873]; National Institutes of Health Training Grant [T32HL007260]; American Heart Association [10PRE3910006]; United States Department of Defense predoctoral fellowship [W81XWH-10-1-0083]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061873, T32HL007260, R01HL080404, R21HL094883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); United States Department of Defense predoctoral fellowship(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL094883 and HL080404 (to K.M.A.) and HL061873 (to W.S.A.).; Supported by National Institutes of Health Training Grant T32HL007260 and by a fellowship from the American Heart Association (Grant 10PRE3910006).; Supported by a United States Department of Defense predoctoral fellowship (Grant W81XWH-10-1-0083).	Argraves KM, 2008, J BIOL CHEM, V283, P25074, DOI 10.1074/jbc.M801214200; Argraves KM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-70; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Drew A. F., 2000, ATHEROSCLEROSIS EXPT, P27; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gunduz D, 2010, ARTERIOSCL THROM VAS, V30, P1237, DOI 10.1161/ATVBAHA.110.203901; Karuna R, 2011, ATHEROSCLEROSIS, V219, P855, DOI 10.1016/j.atherosclerosis.2011.08.049; Kohno T, 2003, J BIOCHEM, V134, P667, DOI 10.1093/jb/mvg191; Kohno T, 2002, FASEB J, V16, P983, DOI 10.1096/fj.01-0809com; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Lee JF, 2009, AM J PHYSIOL-HEART C, V296, pH33, DOI 10.1152/ajpheart.00097.2008; Li X, 2008, BLOOD, V111, P3489, DOI 10.1182/blood-2007-05-092148; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; May JM, 2011, BIOCHEM BIOPH RES CO, V404, P701, DOI 10.1016/j.bbrc.2010.12.046; McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; Peng XQ, 2010, ACTA PHARMACOL SIN, V31, P175, DOI 10.1038/aps.2009.190; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramet ME, 2003, J AM COLL CARDIOL, V41, P2288, DOI 10.1016/S0735-1097(03)00481-9; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanchez T, 2007, ARTERIOSCL THROM VAS, V27, P1312, DOI 10.1161/ATVBAHA.107.143735; Sarai K, 2009, AM J PHYSIOL-CELL PH, V297, pC945, DOI 10.1152/ajpcell.00606.2008; Sensken SC, 2010, J BIOL CHEM, V285, P6298, DOI 10.1074/jbc.M109.049692; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; Thankamony SP, 2006, J BIOL CHEM, V281, P34601, DOI 10.1074/jbc.M601530200; Whetzel AM, 2009, AM J PHYSIOL-CELL PH, V296, pC339, DOI 10.1152/ajpcell.00293.2008; Xu M, 2007, AM J PHYSIOL-CELL PH, V293, pC1309, DOI 10.1152/ajpcell.00014.2007; Zhang GQ, 2010, AM J PHYSIOL-HEART C, V299, pH1494, DOI 10.1152/ajpheart.00462.2010; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zyblewski SC, 2012, PEDIATR CARDIOL, V33, P1154, DOI 10.1007/s00246-012-0274-z	39	121	124	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44645	44653		10.1074/jbc.M112.423426	http://dx.doi.org/10.1074/jbc.M112.423426			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23135269	hybrid, Green Published			2022-12-28	WOS:000312938600060
J	Mcmahon, C; Studer, SM; Clendinen, C; Dann, GP; Jeffrey, PD; Hughson, FM				Mcmahon, Conor; Studer, Sean M.; Clendinen, Chaevia; Dann, Geoffrey P.; Jeffrey, Philip D.; Hughson, Frederick M.			The Structure of Sec12 Implicates Potassium Ion Coordination in Sar1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; CHROMOSOME CONDENSATION RCC1; COPII-COATED VESICLE; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; BETA-PROPELLERS; PROTEINS; ER; YEAST; REGULATOR	Coat protein II (COPII)-coated vesicles transport proteins and lipids from the endoplasmic reticulum to the Golgi. Crucial for the initiation of COPII coat assembly is Sec12, a guanine nucleotide exchange factor responsible for activating the small Gprotein Sar1. Once activated, Sar1/GTP binds to endoplasmic reticulum membranes and recruits COPII coat components (Sec23/24 and Sec13/31). Here, we report the 1.36 angstrom resolution crystal structure of the catalytically active, 38-kDa cytoplasmic portion of Saccharomyces cerevisiae Sec12. Sec12 adopts a beta propeller fold. Conserved residues cluster around a loop we term the "K loop," which extends from the N-terminal propeller blade. Structure-guided site-directed mutagenesis, in conjunction with in vitro and in vivo functional studies, reveals that this region of Sec12 is catalytically essential, presumably because it makes direct contact with Sar1. Strikingly, the crystal structure also reveals that a single potassium ion stabilizes the K loop; bound potassium is, moreover, essential for optimum guanine nucleotide exchange activity in vitro. Thus, our results reveal a novel role for a potassium-stabilized loop in catalyzing guanine nucleotide exchange.	[Mcmahon, Conor; Clendinen, Chaevia; Dann, Geoffrey P.; Jeffrey, Philip D.; Hughson, Frederick M.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Studer, Sean M.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Princeton University; Scripps Research Institute	Hughson, FM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hughson@princeton.edu		McMahon, Conor/0000-0001-9971-7869; Jeffrey, Philip/0000-0002-4351-5341	National Institutes of Health [R01 GM071574]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388, R01GM071574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM071574 (to F.M.H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chardin P, 2002, FEBS LETT, V525, P171, DOI 10.1016/S0014-5793(02)03068-5; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; Itzen A, 2007, J MOL BIOL, V365, P1359, DOI 10.1016/j.jmb.2006.10.096; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Lee MCS, 2007, SEMIN CELL DEV BIOL, V18, P424, DOI 10.1016/j.semcdb.2007.06.007; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Matsuoka K, 2001, P NATL ACAD SCI USA, V98, P13705, DOI 10.1073/pnas.241522198; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SIKORSKI RS, 1989, GENETICS, V122, P19; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Weissman JT, 2001, TRAFFIC, V2, P465, DOI 10.1034/j.1600-0854.2001.20704.x	36	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43599	43606		10.1074/jbc.M112.420141	http://dx.doi.org/10.1074/jbc.M112.420141			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23109340	Green Published, hybrid			2022-12-28	WOS:000312940800040
J	Resenberger, UK; Muller, V; Munter, LM; Baier, M; Multhaup, G; Wilson, MR; Winklhofer, KF; Tatzelt, J				Resenberger, Ulrike K.; Mueller, Veronika; Munter, Lisa M.; Baier, Michael; Multhaup, Gerd; Wilson, Mark R.; Winklhofer, Konstanze F.; Tatzelt, Joerg			The Heat Shock Response Is Modulated by and Interferes with Toxic Effects of Scrapie Prion Protein and Amyloid beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; IN-VIVO; A-BETA; CAENORHABDITIS-ELEGANS; NEUROBLASTOMA-CELLS; MONOCLONAL-ANTIBODY; IDENTIFIES VARIANTS; MISFOLDED PROTEINS; CHAPERONE PROTEINS	The heat shock response (HSR) is an evolutionarily conserved pathway designed to maintain proteostasis and to ameliorate toxic effects of aberrant protein folding. We have studied the modulation of the HSR by the scrapie prion protein (PrPSc) and amyloid beta peptide (A beta) and investigated whether an activated HSR or the ectopic expression of individual chaperones can interfere with PrPSc- or A beta-induced toxicity. First, we observed different effects on the HSR under acute or chronic exposure of cells to PrPSc or A beta. In chronically exposed cells the threshold to mount a stress response was significantly increased, evidenced by a decreased expression of Hsp72 after stress, whereas an acute exposure lowered the threshold for stress-induced expression of Hsp72. Next, we employed models of PrPSc- and A beta-induced toxicity to demonstrate that the induction of the HSR ameliorates the toxic effects of both PrPSc and A beta. Similarly, the ectopic expression of cytosolic Hsp72 or the extracellular chaperone clusterin protected against PrPSc- or A beta-induced toxicity. However, toxic signaling induced by a pathogenic PrP mutant located at the plasma membrane was prevented by an activated HSR or Hsp72 but not by clusterin, indicating a distinct mode of action of this extracellular chaperone. Our study supports the notion that different pathological protein conformers mediate toxic effects via similar cellular pathways and emphasizes the possibility to exploit the heat shock response therapeutically.	[Resenberger, Ulrike K.; Mueller, Veronika; Winklhofer, Konstanze F.; Tatzelt, Joerg] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Munter, Lisa M.; Multhaup, Gerd] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Munter, Lisa M.; Multhaup, Gerd] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3A 0G4, Canada; [Baier, Michael] Robert Koch Inst, D-13302 Berlin, Germany; [Wilson, Mark R.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Winklhofer, Konstanze F.; Tatzelt, Joerg] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany	University of Munich; Free University of Berlin; McGill University; Robert Koch Institute; University of Wollongong; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Tatzelt, J (corresponding author), Univ Munich, Adolf Butenandt Inst, Schillerstr 44, D-80336 Munich, Germany.	Joerg.Tatzelt@med.uni-muenchen.de	Wilson, Mark R/B-3254-2018	Wilson, Mark R/0000-0002-9551-7445; Winklhofer, Konstanze/0000-0002-7256-8231; Munter, Lisa/0000-0001-5736-1462; Tatzelt, Jorg/0000-0001-5017-5528	Deutsche Forschungsgemeinschaft [SFB 596, GRK1123, SFB 740]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	The work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 596, GRK1123 (to G. M.) and SFB 740 (to L. M. M. and G. M.)) and by the Max Planck Society.	Alier K, 2011, J NEUROSCI, V31, P16292, DOI 10.1523/JNEUROSCI.4367-11.2011; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; BEHL C, 1993, NEUROSCI LETT, V154, P1, DOI 10.1016/0304-3940(93)90156-F; Beland M, 2012, J NEUROSCI, V32, P13255, DOI 10.1523/JNEUROSCI.2236-12.2012; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Chesebro B, 2003, BRIT MED BULL, V66, P1, DOI 10.1093/bmb/66.1.1; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Dabbs R. A., 2011, TOP CURR CH IN PRESS; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Freixes M, 2004, ACTA NEUROPATHOL, V108, P295, DOI 10.1007/s00401-004-0891-6; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; Gehrig SM, 2012, NATURE, V484, P394, DOI 10.1038/nature10980; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Humphreys D, 1997, BIOCHEMISTRY-US, V36, P15233, DOI 10.1021/bi9703507; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jurivich D.A., 1994, BIOL HEAT SHOCK PROT, P417; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; KENWARD N, 1994, J NEUROCHEM, V62, P1870; Kharlamov A, 2002, EXP BRAIN RES, V147, P353, DOI 10.1007/s00221-002-1251-1; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lindquist SL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004507; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Masison DC, 2009, PRION, V3, P65, DOI 10.4161/pri.3.2.9134; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; Morimoto RI, 2011, COLD SPRING HARB SYM, V76, P91, DOI DOI 10.1101/SQB.2012.76.010637; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Prahlad V, 2011, P NATL ACAD SCI USA, V108, P14204, DOI 10.1073/pnas.1106557108; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Resenberger UK, 2011, TOP CURR CHEM, V305, P101, DOI 10.1007/128_2011_160; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Romanova NV, 2009, PROTEIN PEPTIDE LETT, V16, P598, DOI 10.2174/092986609788490078; Sakthivelu V, 2011, J BIOL CHEM, V286, P8901, DOI 10.1074/jbc.M110.185470; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Schatzl HM, 1997, J VIROL, V71, P8821; Sharp FR, 1999, TRENDS NEUROSCI, V22, P97, DOI 10.1016/S0166-2236(98)01392-7; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; Solomon IH, 2010, CURR ISSUES MOL BIOL, V12, P51; Steele AD, 2008, P NATL ACAD SCI USA, V105, P13626, DOI 10.1073/pnas.0806319105; Sweeny EA, 2008, PRION, V2, P135, DOI 10.4161/pri.2.4.7952; TATZELT J, 1995, P NATL ACAD SCI USA, V92, P2944, DOI 10.1073/pnas.92.7.2944; Tatzelt J, 1996, EMBO J, V15, P6363, DOI 10.1002/j.1460-2075.1996.tb01027.x; Tuite MF, 2011, TOP CURR CHEM, V305, P257, DOI 10.1007/128_2011_172; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; VOELLMY R, 1985, P NATL ACAD SCI USA, V82, P4949, DOI 10.1073/pnas.82.15.4949; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Weissmann C, 1996, COLD SPRING HARB SYM, V61, P511; WELCH WJ, 1986, J CELL BIOL, V103, P2035, DOI 10.1083/jcb.103.5.2035; Welch WJ, 1998, NATURE, V392, P23, DOI 10.1038/32049; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Winklhofer KF, 2000, BIOL CHEM, V381, P463, DOI 10.1515/BC.2000.061; Winklhofer KF, 2003, TRAFFIC, V4, P313, DOI 10.1034/j.1600-0854.2003.00088.x; Winklhofer KF, 2003, J BIOL CHEM, V278, P14961, DOI 10.1074/jbc.M209942200; Winklhofer KF, 2001, J BIOL CHEM, V276, P45160, DOI 10.1074/jbc.M104873200; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Wyatt AR, 2011, CELL MOL LIFE SCI, V68, P3919, DOI [10.1007/s00018-011-0684-8, 10.1007/s00018-011-0684-8)]; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	103	5	6	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43765	43776		10.1074/jbc.M112.389007	http://dx.doi.org/10.1074/jbc.M112.389007			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115236	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000312940800055
J	Karch, CM; Jeng, AT; Goate, AM				Karch, Celeste M.; Jeng, Amanda T.; Goate, Alison M.			Extracellular Tau Levels Are Influenced by Variability in Tau That Is Associated with Tauopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBROSPINAL-FLUID TAU; MICROTUBULE-ASSOCIATED PROTEIN; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; CELLS; RELEASE; SECRETION; HAPLOTYPE; MEMBRANE; DEMENTIA	Tauopathies are a class of neurodegenerative diseases marked by intracellular aggregates of hyperphosphorylated Tau. These diseases may occur by sporadic mechanisms in which genetic variants represent risk factors for disease, as is the case in Alzheimer disease (AD). In AD, cerebrospinal fluid (CSF) levels of soluble Tau/pTau-181 are higher in cases compared with controls. A subset of frontotemporal dementia (FTD) cases occur by a familial mechanism in which MAPT, the gene that encodes Tau, mutations are dominantly inherited. In symptomatic FTD patients expressing a MAPT mutation, CSF Tau levels are slightly elevated but are significantly lower than in AD patients. We sought to model CSF Tau changes by measuring extracellular Tau in cultured cells. Full-length, monomeric extracellular total Tau and pTau-181 were detectable in human neuroblastoma cells expressing endogenous Tau, in human non-neuronal cells overexpressing wild-type Tau, and in mouse cortical neurons. Tau isoforms influence the rate of Tau release, whereby the N terminus (exons 2/3) and microtubule binding repeat length contribute to Tau release from the cell. Compared with cells overexpressing wild-type Tau, cells overexpressing FTD-associated MAPT mutations produce significantly less extracellular total Tau without altering intracellular total Tau levels. This study demonstrates that cells actively release Tau in the absence of disease or toxicity, and Tau release is modified by changes in the Tau protein that are associated with tauopathies.	Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Goate, AM (corresponding author), 425 S Euclid Ave, St Louis, MO 63110 USA.	goatea@psychiatry.wustl.edu		Karch, Celeste/0000-0002-6854-5547; Goate, Alison/0000-0002-0576-2472	National Institutes of Health [5P01AG003991-29]; AstraZeneca; NATIONAL INSTITUTE ON AGING [P50AG005681, P01AG003991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca(AstraZeneca); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 5P01AG003991-29 (to John C. Morris) and AstraZeneca.	Agholme L, 2010, J ALZHEIMERS DIS, V20, P1069, DOI 10.3233/JAD-2010-091363; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Barclay JW, 2005, CELL CALCIUM, V38, P343, DOI 10.1016/j.ceca.2005.06.012; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; CHOI DW, 1987, J NEUROSCI, V7, P369; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; Craig-Schapiro R, 2009, NEUROBIOL DIS, V35, P128, DOI 10.1016/j.nbd.2008.10.003; Cruchaga C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001101; Csernansky JG, 2002, ALZ DIS ASSOC DIS, V16, P144, DOI 10.1097/00002093-200207000-00003; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Dayanandan R, 1999, FEBS LETT, V446, P228, DOI 10.1016/S0014-5793(99)00222-7; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Galasko D, 1998, ARCH NEUROL-CHICAGO, V55, P937, DOI 10.1001/archneur.55.7.937; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Geetha T, 2008, TRAFFIC, V9, P1146, DOI 10.1111/j.1600-0854.2008.00751.x; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gomez-Ramos A, 2009, EUR NEUROPSYCHOPHARM, V19, P708, DOI 10.1016/j.euroneuro.2009.04.006; Green AJE, 1999, NEUROSCI LETT, V259, P133, DOI 10.1016/S0304-3940(98)00904-5; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hampel H, 2004, DEMENT GERIATR COGN, V17, P350, DOI 10.1159/000077170; Hesse C, 2001, NEUROSCI LETT, V297, P187, DOI 10.1016/S0304-3940(00)01697-9; Horowitz PM, 2004, J NEUROSCI, V24, P7895, DOI 10.1523/JNEUROSCI.1988-04.2004; Houlden H, 2001, NEUROLOGY, V56, P1702, DOI 10.1212/WNL.56.12.1702; JENSEN M, 1995, NEUROSCI LETT, V186, P189, DOI 10.1016/0304-3940(95)11297-A; Karch C. M., 2012, NEUROBIOL A IN PRESS; Kauwe JSK, 2008, P NATL ACAD SCI USA, V105, P8050, DOI 10.1073/pnas.0801227105; Kim W, 2010, FEBS LETT, V584, P3085, DOI 10.1016/j.febslet.2010.05.042; Kim W, 2010, J ALZHEIMERS DIS, V19, P647, DOI 10.3233/JAD-2010-1273; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lee G, 1998, J CELL SCI, V111, P3167; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; LINDSTEDT R, 1993, J BIOL CHEM, V268, P11750; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; MELCHIOR F, 1995, CURR OPIN CELL BIOL, V7, P310, DOI 10.1016/0955-0674(95)80084-0; Mills IG, 2001, J CELL SCI, V114, P1959; Misra UK, 1997, J CELL BIOCHEM, V64, P225, DOI 10.1002/(SICI)1097-4644(199702)64:2<225::AID-JCB6>3.0.CO;2-Z; Myers AJ, 2005, HUM MOL GENET, V14, P2399, DOI 10.1093/hmg/ddi241; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; ONO T, 1995, NEUROCHEM INT, V26, P205, DOI 10.1016/0197-0186(94)00135-H; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Santa-Maria I, 2012, J BIOL CHEM, V287, P20522, DOI 10.1074/jbc.M111.323279; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Simon D, 2012, NEURODEGENER DIS, V10, P73, DOI 10.1159/000334915; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Stutzmann GE, 2005, NEUROSCIENTIST, V11, P110, DOI 10.1177/1073858404270899; TATO RE, 1995, J NEUROL NEUROSUR PS, V59, P280, DOI 10.1136/jnnp.59.3.280; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; VIGOPELFREY C, 1995, NEUROLOGY, V45, P788, DOI 10.1212/WNL.45.4.788; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011	68	126	129	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42751	42762		10.1074/jbc.M112.380642	http://dx.doi.org/10.1074/jbc.M112.380642			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105105	Green Published, hybrid			2022-12-28	WOS:000312501600034
J	Lera, RF; Burkard, ME				Lera, Robert F.; Burkard, Mark E.			High Mitotic Activity of Polo-like Kinase 1 Is Required for Chromosome Segregation and Genomic Integrity in Human Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEROTELIC KINETOCHORE ORIENTATION; TOPOISOMERASE-II-ALPHA; BOX DOMAIN; MAMMALIAN-CELLS; PLK1; CYTOKINESIS; INHIBITOR; PHOSPHORYLATION; INITIATION; MECHANISM	Protein kinases play key roles in regulating human cell biology, but manifold substrates and functions make it difficult to understand mechanism. We tested whether we could dissect functions of a pleiotropic mitotic kinase, Polo-like kinase 1 (Plk1), via distinct thresholds of kinase activity. We accomplished this by titrating Plk1 activity in RPE1 human epithelial cells using chemical genetics and verifying results in additional lines. We found that distinct activity thresholds are required for known functions of Plk1 including (from low to high activity) bipolar spindle formation, timely mitotic entry, and formation of a cytokinesis cleavage furrow. Subtle losses in Plk1 activity impaired chromosome congression and produced severe anaphase dysfunction characterized by poor separation of chromosome masses. These two phenotypes were separable, suggesting that they stem from distinct phosphorylation events. Impaired chromosome segregation in anaphase was the most sensitive to modest loss in Plk1 activity. Mechanistically, it was associated with unpaired sister chromatids with stretched kinetochores, suggestive of merotelic attachments. The C-terminal Polo box domain of Plk1 was required for its anaphase function, although it was dispensable for forming a bipolar spindle. The ultimate effect of partial inhibition of Plk1 was the formation of micronuclei, an increase in tetraploid progeny, and senescence. These results demonstrate that different thresholds of Plk1 activity can elicit distinct phenotypes, illustrating a general method for separating pleiotropic functions of a protein kinase even when these are executed close in time.	[Burkard, Mark E.] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; Univ Wisconsin, Univ Wisconsin Carbone Canc Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Burkard, ME (corresponding author), Univ Wisconsin, Dept Med, Madison, WI 53705 USA.	mburkard@wisc.edu		Burkard, Mark/0000-0002-4215-7722; Lera, Robert/0000-0001-8713-4279	National Institutes of Health [R01 GM097245, P30 CA014520]; National Center for Advancing Translational Sciences [9U54TR000021]; Flight Attendant Medical Research Institute [062541_YCSA]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097245] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM097245 (to M. E. B.) and P30 CA014520 (for R. L.) and Clinical and Translational Science Award 9U54TR000021 from the National Center for Advancing Translational Sciences (K Award to M. E. B.) This work was also supported by Flight Attendant Medical Research Institute Grant 062541_YCSA.	Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Burkard ME, 2012, ACS CHEM BIOL, V7, P978, DOI 10.1021/cb200551p; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Carmena M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001250; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Cimini D, 2002, J CELL SCI, V115, P507; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; CLARKE DJ, 1993, J CELL SCI, V105, P563; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Gilmartin AG, 2009, CANCER RES, V69, P6969, DOI 10.1158/0008-5472.CAN-09-0945; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li H, 2008, J BIOL CHEM, V283, P6209, DOI 10.1074/jbc.M709007200; Liu F, 2012, ACS CHEM BIOL, V7, P805, DOI 10.1021/cb200469a; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Maresca TJ, 2010, J CELL SCI, V123, P825, DOI 10.1242/jcs.064790; Medema RH, 2011, CLIN CANCER RES, V17, P6459, DOI 10.1158/1078-0432.CCR-11-0541; Moutinho-Santos T, 2012, J CELL SCI, V125, P576, DOI 10.1242/jcs.092445; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Oppermann FS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.012351; Paschal C. R., 2012, CHROMOSOMA, DOI 1007/s00412-012-375-8; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Randall CL, 2007, CELL CYCLE, V6, P1713, DOI 10.4161/cc.6.14.4501; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoffski P, 2012, EUR J CANCER, V48, P179, DOI 10.1016/j.ejca.2011.11.001; Spence JM, 2007, J CELL SCI, V120, P3952, DOI 10.1242/jcs.013730; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Yun SM, 2009, NAT STRUCT MOL BIOL, V16, P876, DOI 10.1038/nsmb.1628	42	39	41	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42812	42825		10.1074/jbc.M112.412544	http://dx.doi.org/10.1074/jbc.M112.412544			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105120	hybrid, Green Published			2022-12-28	WOS:000312501600040
J	Liu, YS; Zheng, XH; Mueller, GA; Sobhany, M; DeRose, EF; Zhang, YP; London, RE; Birnbaumer, L				Liu, Yanshun; Zheng, Xunhai; Mueller, Geoffrey A.; Sobhany, Mack; DeRose, Eugene F.; Zhang, Yingpei; London, Robert E.; Birnbaumer, Lutz			Crystal Structure of Calmodulin Binding Domain of Orai1 in Complex with Ca2+center dot Calmodulin Displays a Unique Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATES CRAC CHANNELS; IQ MOTIF; APO-CALMODULIN; CA2+ STORE; STIM1; SYSTEM; OLIGOMERIZATION; PEPTIDE	Orai1 is a plasma membrane protein that in its tetrameric form is responsible for calcium influx from the extracellular environment into the cytosol in response to interaction with the Ca2+-depletion sensor STIM1. This is followed by a fast Ca2+center dot calmodulin (CaM)-dependent inhibition, resulting from CaM binding to an Orai1 region called the calmodulin binding domain (CMBD). The interaction between Orai1 and CaM at the atomic level remains unknown. Here, we report the crystal structure of a CaM center dot Orai1-CMBD complex showing one CMBD bound to the C-terminal lobe of CaM, differing from other CaM-target protein complexes, in which both N- and C-terminal lobes of CaM (CaM-N and CaM-C) are involved in target binding. Orai1-CMBD binds CaM-C mainly through hydrophobic interactions, primarily involving residue Trp(76) of Orai1-CMBD, which interacts with the hydrophobic pocket of CaM-C. However, NMRdata, isothermal titration calorimetry data, and pull-down assays indicated that CaM-N and CaM-C both can bind Orai1-CMBD, with CaM-N having similar to 4 times weaker affinity than CaM-C. Pulldown assays of a Orai1-CMBD(W76E) mutant, gel filtration chromatography data, and NOE signals indicated that CaM-N and CaM-C can each bind one Orai1-CMBD. Thus our studies support an unusual, extended 1: 2 binding mode of CaM to Orai1-CMBDs, and quantify the affinity of Orai1 for CaM. We propose a two-step mechanism for CaM-dependent Orai1 inactivation initiated by binding of the C-lobe of CaM to the CMBD of one Orai1 followed by the binding of the N-lobe of CaM to the CMBD of a neighboring Orai1.	[Liu, Yanshun; Zhang, Yingpei; Birnbaumer, Lutz] NIEHS, Neurobiol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Zheng, Xunhai; Mueller, Geoffrey A.; DeRose, Eugene F.; London, Robert E.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Sobhany, Mack] NIEHS, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Liu, YS (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	liuy3@niehs.nih.gov; birnbau1@niehs.nih.gov	Zheng, Xunhai/G-1187-2015; London, Robert E/F-7990-2019; Mueller, Geoffrey A/I-2909-2017	Zheng, Xunhai/0000-0003-0390-2491; London, Robert E/0000-0001-9108-8463; Mueller, Geoffrey A/0000-0001-8361-5323	National Institutes of Health Intramural Research Program [Z01-ES101684]; Collaborative Crystallography Group NIEHS [Z01 ES102645]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101643, Z01ES101684] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaborative Crystallography Group NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program Grant Z01-ES101684 and Collaborative Crystallography Group NIEHS Grant Z01 ES102645.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ataman ZA, 2007, STRUCTURE, V15, P1603, DOI 10.1016/j.str.2007.10.012; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Chagot B, 2011, J MOL BIOL, V406, P106, DOI 10.1016/j.jmb.2010.11.046; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feldkamp MD, 2011, STRUCTURE, V19, P733, DOI 10.1016/j.str.2011.02.009; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Juranic N, 2010, J BIOL CHEM, V285, P4015, DOI 10.1074/jbc.M109.060491; KREBS J, 1984, BIOCHEMISTRY-US, V23, P400, DOI 10.1021/bi00298a002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; PRESS WH, 1989, NUMERICAL RECIPES FO; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; Putkey JA, 2008, J BIOL CHEM, V283, P1401, DOI 10.1074/jbc.M703831200; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; TAKEMURA H, 1989, BIOCHEM J, V258, P409, DOI 10.1042/bj2580409; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wang X, 2010, BIOCHEMISTRY-US, V49, P10287, DOI 10.1021/bi100500m; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Yap KL, 2003, J MOL BIOL, V328, P193, DOI 10.1016/S0022-2836(03)00271-7; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	39	51	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43030	43041		10.1074/jbc.M112.380964	http://dx.doi.org/10.1074/jbc.M112.380964			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23109337	Green Published, hybrid			2022-12-28	WOS:000312501600059
J	Torres-Bacete, J; Sinha, PK; Sato, M; Patki, G; Kao, MC; Matsuno-Yagi, A; Yagi, T				Torres-Bacete, Jesus; Sinha, Prem Kumar; Sato, Motoaki; Patki, Gaurav; Kao, Mou-Chieh; Matsuno-Yagi, Akemi; Yagi, Takao			Roles of Subunit NuoK (ND4L) in the Energy-transducing Mechanism of Escherichia coli NDH-1 (NADH:Quinone Oxidoreductase)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; RESPIRATORY COMPLEX-I; CONSERVED CHARGED RESIDUES; MEMBRANE DOMAIN; PARACOCCUS-DENITRIFICANS; UBIQUINONE OXIDOREDUCTASE; ATP SYNTHASE; SUBMITOCHONDRIAL PARTICLES; PROTON TRANSLOCATION; PERIPHERAL SUBUNITS	The bacterial H+-translocating NADH: quinone oxidoreductase (NDH-1) catalyzes electron transfer from NADH to quinone coupled with proton pumping across the cytoplasmic membrane. The NuoK subunit (counterpart of the mitochondrial ND4L subunit) is one of the seven hydrophobic subunits in the membrane domain and bears three transmembrane segments (TM1-3). Two glutamic residues located in the adjacent transmembrane helices of NuoK are important for the energy coupled activity of NDH-1. In particular, mutation of the highly conserved carboxyl residue ((K)Glu-36 in TM2) to Ala led to a complete loss of the NDH-1 activities. Mutation of the second conserved carboxyl residue ((K)Glu-72 in TM3) moderately reduced the activities. To clarify the contribution of NuoK to the mechanism of proton translocation, we relocated these two conserved residues. When we shifted (K)Glu-36 along TM2 to positions 32, 38, 39, and 40, the mutants largely retained energy transducing NDH-1 activities. According to the recent structural information, these positions are located in the vicinity of (K)Glu-36, present in the same helix phase, in an immediately before and after helix turn. In an earlier study, a double mutation of two arginine residues located in a short cytoplasmic loop between TM1 and TM2 (loop-1) showed a drastic effect on energy transducing activities. Therefore, the importance of this cytosolic loop of NuoK ((K)Arg-25, (K)Arg-26, and (K)Asn-27) for the energy transducing activities was extensively studied. The probable roles of subunit NuoK in the energy transducing mechanism of NDH-1 are discussed.	[Torres-Bacete, Jesus; Sinha, Prem Kumar; Sato, Motoaki; Patki, Gaurav; Kao, Mou-Chieh; Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Yagi, T (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd,MEM256, La Jolla, CA 92037 USA.	yagi@scripps.edu		Torres, Jesus/0000-0003-3410-6930	National Institutes of Health from the United States Public Health Service [GM33712]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM33712 from the United States Public Health Service (to T. Y.).	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Castro-Guerrero N, 2010, BIOCHEMISTRY-US, V49, P10072, DOI 10.1021/bi100885v; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Di Bernardo S, 2000, BIOCHEMISTRY-US, V39, P9411; Drose S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001128; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Galkin AS, 2001, BIOCHEMISTRY-MOSCOW+, V66, P435, DOI 10.1023/A:1010257630935; Garczarek F, 2005, P NATL ACAD SCI USA, V102, P3633, DOI 10.1073/pnas.0500421102; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; Kao MC, 2003, BIOCHEMISTRY-US, V42, P4534, DOI 10.1021/bi034166z; Kao MC, 2002, BIOCHEMISTRY-US, V41, P4377, DOI 10.1021/bi025525d; Kervinen M, 2004, BIOCHEMISTRY-US, V43, P773, DOI 10.1021/bi0355903; Langemeyer L, 2007, BBA-BIOENERGETICS, V1767, P998, DOI 10.1016/j.bbabio.2007.05.007; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Michel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017420; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; Murai M, 2009, BIOCHEMISTRY-US, V48, P688, DOI 10.1021/bi8019977; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; Satoh T, 1996, BBA-BIOENERGETICS, V1273, P21, DOI 10.1016/0005-2728(95)00131-X; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Schuler F, 1999, P NATL ACAD SCI USA, V96, P4149, DOI 10.1073/pnas.96.7.4149; Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578; SHIMOMURA Y, 1989, ARCH BIOCHEM BIOPHYS, V270, P573, DOI 10.1016/0003-9861(89)90539-0; Shiraishi Y, 2012, BIOCHEMISTRY-US, V51, P1953, DOI 10.1021/bi300047h; Sinha P.K, 2009, CURR TOP BIOCH RES, V11, P79; Sinha PK, 2012, J BIOL CHEM, V287, P17363, DOI 10.1074/jbc.M111.329649; Sinha PK, 2009, J BIOL CHEM, V284, P9814, DOI 10.1074/jbc.M809468200; Steimle S, 2011, BIOCHEMISTRY-US, V50, P3386, DOI 10.1021/bi200264q; Symersky J, 2012, NAT STRUCT MOL BIOL, V19, P485, DOI 10.1038/nsmb.2284; Takano S, 1996, BIOCHEMISTRY-US, V35, P9120, DOI 10.1021/bi9605853; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2011, J BIOL CHEM, V286, P34007, DOI 10.1074/jbc.M111.260968; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; Umemoto H, 2009, BIOSCI BIOTECH BIOCH, V73, P965, DOI 10.1271/bbb.80869; Wikstrom M, 2012, P NATL ACAD SCI USA, V109, P4431, DOI 10.1073/pnas.1120949109; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9; YAGI T, 1990, ARCH BIOCHEM BIOPHYS, V281, P305, DOI 10.1016/0003-9861(90)90448-8; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Zickermann V, 1998, BIOCHEMISTRY-US, V37, P11792, DOI 10.1021/bi9810555	60	9	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42763	42772		10.1074/jbc.M112.422824	http://dx.doi.org/10.1074/jbc.M112.422824			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105119	hybrid, Green Published			2022-12-28	WOS:000312501600035
J	Yamagami, R; Yamashita, K; Nishimasu, H; Tomikawa, C; Ochi, A; Iwashita, C; Hirata, A; Ishitani, R; Nureki, O; Hori, H				Yamagami, Ryota; Yamashita, Koki; Nishimasu, Hiroshi; Tomikawa, Chie; Ochi, Anna; Iwashita, Chikako; Hirata, Akira; Ishitani, Ryuichiro; Nureki, Osamu; Hori, Hiroyuki			The tRNA Recognition Mechanism of Folate/FAD-dependent tRNA Methyltransferase (TrmFO)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; AEOLICUS TRANSFER-RNA; ACID-SEQUENCE MOTIFS; THERMUS-THERMOPHILUS; AQUIFEX-AEOLICUS; RIBOSOMAL-RNA; M(7)G46 METHYLTRANSFERASE; EVOLUTIONARY IMPLICATIONS; M(5)U METHYLTRANSFERASES; GM18 METHYLTRANSFERASE	The conserved U54 in tRNA is often modified to 5-methyluridine (m(5)U) and forms a reverse Hoogsteen base pair with A58 that stabilizes the L-shaped tRNA structure. In Gram-positive and some Gram-negative eubacteria, m(5)U54 is produced by folate/FAD-dependent tRNA (m(5)U54) methyltransferase (TrmFO). TrmFO utilizes N-5,N-10-methylenetetrahydrofolate (CH2THF) as a methyl donor. We previously reported an in vitro TrmFO assay system, in which unstable [C-14]CH2THF was supplied from [C-14]serine and tetrahydrofolate by serine hydroxymethyltransferase. In the current study, we have improved the TrmFO assay system by optimization of enzyme and substrate concentrations and introduction of a filter assay system. Using this assay, we have focused on the tRNA recognition mechanism of TrmFO. 42 tRNA mutant variants were prepared, and experiments with truncated tRNA and microhelix RNAs revealed that the minimum requirement of TrmFO exists in the T-arm structure. The positive determinants for TrmFO were found to be the U54U55C56 sequence and G53-C61 base pair. The gel mobility shift assay and fluorescence quenching showed that the affinity of TrmFO for tRNA in the initial binding process is weak. The inhibition experiments showed that the methylated tRNA is released before the structural change process. Furthermore, we found that A38 prevents incorrect methylation of U32 in the anticodon loop. Moreover, the m(1)A58 modification clearly accelerates the TrmFO reaction, suggesting a synergistic effect of the m(5)U54, m(1)A58, and s(2)U54 modifications on m(5)s(2)U54 formation in Thermus thermophilus cells. The docking model of TrmFO and the T-arm showed that the G53-C61 base pair is not able to directly contact the enzyme.	[Yamagami, Ryota; Yamashita, Koki; Tomikawa, Chie; Ochi, Anna; Iwashita, Chikako; Hirata, Akira; Hori, Hiroyuki] Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, Matsuyama, Ehime 7908577, Japan; [Nishimasu, Hiroshi; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan; [Hori, Hiroyuki] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan	Ehime University; University of Tokyo; Ehime University	Hori, H (corresponding author), Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, 3 Bunkyo, Matsuyama, Ehime 7908577, Japan.	hori@eng.ehime-u.ac.jp	Hori, Hiroyuki/AAB-3911-2021; NUREKI, OSAMU/G-4960-2014	Yamagami, Ryota/0000-0002-6947-1906	Japan Society for the Promotion of Science [23350081, 24655156]; Grants-in-Aid for Scientific Research [24655156, 23350081] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-aid for Scientific Research 23350081 (to H. H.) and Grant-in-aid for Exploratory Research 24655156 (to H. H.) from the Japan Society for the Promotion of Science.	Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; Armengod ME, 2012, BIOCHIMIE, V94, P1510, DOI 10.1016/j.biochi.2012.02.019; Auxilien S, 2011, RNA, V17, P45, DOI 10.1261/rna.2323411; Awai T, 2011, J BIOL CHEM, V286, P35236, DOI 10.1074/jbc.M111.253641; Awai T, 2009, J BIOL CHEM, V284, P20467, DOI 10.1074/jbc.M109.020024; BARAT C, 1989, EMBO J, V8, P3279, DOI 10.1002/j.1460-2075.1989.tb08488.x; DAVANLOO P, 1979, NUCLEIC ACIDS RES, V6, P1571, DOI 10.1093/nar/6.4.1571; De Bie LGS, 2003, J BACTERIOL, V185, P3238, DOI 10.1128/JB.185.10.3238-3243.2003; DELK AS, 1980, J BIOL CHEM, V255, P4387; DELK AS, 1976, J BIOL CHEM, V251, P7649; Droogmans L, 2003, NUCLEIC ACIDS RES, V31, P2148, DOI 10.1093/nar/gkg314; Dunin-Horkawicz S, 2006, NUCLEIC ACIDS RES, V34, pD145, DOI 10.1093/nar/gkj084; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GARCIA GR, 1998, MODIFICATION EDITING, P555; GOLD M, 1963, P NATL ACAD SCI USA, V50, P164, DOI 10.1073/pnas.50.1.164; GREENBERG R, 1980, J BIOL CHEM, V255, P8296; GU XG, 1991, BIOCHEMISTRY-US, V30, P2999, DOI 10.1021/bi00226a003; GU XG, 1994, BIOCHEMISTRY-US, V33, P2255, DOI 10.1021/bi00174a036; GU XG, 1992, BIOCHEMISTRY-US, V31, P10295, DOI 10.1021/bi00157a017; Gu XR, 1996, NUCLEIC ACIDS RES, V24, P1059, DOI 10.1093/nar/24.6.1059; Gu XR, 1998, BIOCHEMISTRY-US, V37, P339, DOI 10.1021/bi971590p; Gu XR, 1996, BIOCHEMISTRY-US, V35, P11652, DOI 10.1021/bi9612125; GUSTAFSSON C, 1993, J BIOL CHEM, V268, P1326; Hamdane D, 2011, J BIOL CHEM, V286, P36268, DOI 10.1074/jbc.M111.256966; Hamdane D, 2011, BIOCHEMISTRY-US, V50, P5208, DOI 10.1021/bi1019463; Hori H, 2003, J BIOL CHEM, V278, P25081, DOI 10.1074/jbc.M212577200; Hori H, 2002, GENES CELLS, V7, P259, DOI 10.1046/j.1365-2443.2002.00520.x; Ihsanawati, 2008, J MOL BIOL, V383, P871, DOI 10.1016/j.jmb.2008.08.068; Ishida K, 2011, NUCLEIC ACIDS RES, V39, P2304, DOI 10.1093/nar/gkq1180; Johansson MJO, 2002, RNA, V8, P324, DOI 10.1017/S1355838202027851; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; KEALEY JT, 1991, NUCLEIC ACIDS RES, V19, P6465, DOI 10.1093/nar/19.23.6465; KEALEY JT, 1994, PROTEIN EXPRES PURIF, V5, P149, DOI 10.1006/prep.1994.1023; KIM SH, 1974, P NATL ACAD SCI USA, V71, P4970, DOI 10.1073/pnas.71.12.4970; KOWALAK JA, 1994, BIOCHEMISTRY-US, V33, P7869, DOI 10.1021/bi00191a014; Lamichhane TN, 2011, RNA, V17, P1846, DOI 10.1261/rna.2628611; Leung HCE, 1997, J BIOL CHEM, V272, P13073, DOI 10.1074/jbc.272.20.13073; Meyer S, 2008, J MOL BIOL, V380, P532, DOI 10.1016/j.jmb.2008.04.072; NAKANISHI S, 1994, J BIOL CHEM, V269, P32221; Nishimasu H, 2009, P NATL ACAD SCI USA, V106, P8180, DOI 10.1073/pnas.0901330106; Nordlund ME, 2000, RNA, V6, P844, DOI 10.1017/S1355838200992422; Nureki O, 2004, STRUCTURE, V12, P593, DOI 10.1016/j.str.2004.03.003; NY T, 1980, J BACTERIOL, V142, P371, DOI 10.1128/JB.142.2.371-379.1980; NY T, 1988, EUR J BIOCHEM, V177, P467, DOI 10.1111/j.1432-1033.1988.tb14396.x; Ochi A, 2010, J BIOL CHEM, V285, P9018, DOI 10.1074/jbc.M109.065698; Okamoto H, 2004, J BIOL CHEM, V279, P49151, DOI 10.1074/jbc.M408209200; Osawa T, 2009, STRUCTURE, V17, P713, DOI 10.1016/j.str.2009.03.013; Persson BC, 1997, NUCLEIC ACIDS RES, V25, P4093, DOI 10.1093/nar/25.20.4093; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; ROMBY P, 1987, J BIOMOL STRUCT DYN, V5, P669, DOI 10.1080/07391102.1987.10506419; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shigi N, 2006, J BIOL CHEM, V281, P2104, DOI 10.1074/jbc.M510771200; Shigi N, 2002, J BIOL CHEM, V277, P39128, DOI 10.1074/jbc.M207323200; Shigi N, 2008, EMBO J, V27, P3267, DOI 10.1038/emboj.2008.246; Takeda H, 2006, GENES CELLS, V11, P1353, DOI 10.1111/j.1365-2443.2006.01022.x; Tomikawa C, 2010, NUCLEIC ACIDS RES, V38, P942, DOI 10.1093/nar/gkp1059; Urbonavicius J, 2005, NUCLEIC ACIDS RES, V33, P3955, DOI 10.1093/nar/gki703; Urbonavicius J, 2007, METHOD ENZYMOL, V425, P103; Urbonavicius J, 2008, MOL MICROBIOL, V67, P323, DOI 10.1111/j.1365-2958.2007.06047.x; WATANABE K, 1976, BIOCHEM BIOPH RES CO, V72, P1137, DOI 10.1016/S0006-291X(76)80250-1; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; Yaremchuk A, 2000, EMBO J, V19, P4745, DOI 10.1093/emboj/19.17.4745	63	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42480	42494		10.1074/jbc.M112.390112	http://dx.doi.org/10.1074/jbc.M112.390112			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095745	Green Published, hybrid			2022-12-28	WOS:000312501600010
J	Dewan, V; Wei, M; Kleiman, L; Musier-Forsyth, K				Dewan, Varun; Wei, Min; Kleiman, Lawrence; Musier-Forsyth, Karin			Dual Role for Motif 1 Residues of Human Lysyl-tRNA Synthetase in Dimerization and Packaging into HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; C-TERMINAL DOMAIN; ESCHERICHIA-COLI; IN-VITRO; TRNA(LYS) INCORPORATION; VIRAL INFECTIVITY; CRYSTAL-STRUCTURE; CYCLOPHILIN-A; GAG; PROTEIN	The primer for reverse transcription in human immunodeficiency virus type 1, human tRNA(Lys, 3), is selectively packaged into the virion along with tRNA(Lys1,2). Human lysyl-tRNA synthetase (hLysRS), the only cellular factor known to interact specifically with all three tRNA(Lys) isoacceptors, is also selectively packaged into HIV-1. We have previously defined a tRNA(Lys) packaging complex that includes the tRNA(Lys) isoacceptors, LysRS, HIV-1 Gag, GagPol, and viral RNA. Numerous studies support the hypothesis that during tRNA(Lys) packaging, a Gag.GagPol complex interacts with a tRNA(Lys). LysRS complex, with Gag interacting specifically with the catalytic domain of LysRS, and GagPol interacting with both Gag and tRNA(Lys). In this work, we have identified residues along one face of the motif 1 dimerization helix (H7) of hLysRS that are critical for packaging of the synthetase into virions. Mutation of these residues affects binding to Gag in vitro, as well as the oligomerization state and aminoacylation activity of the synthetase. Taken together, these data suggest that H7 of LysRS has a dual function. In its canonical role it maintains the synthetase dimer interface, whereas in its function in tRNA primer recruitment, it bridges interactions with HIV-1 Gag.	[Dewan, Varun; Musier-Forsyth, Karin] Ohio State Univ, Dept Chem & Biochem, Ohio State Biochem Program, Ctr RNA Biol, Columbus, OH 43210 USA; [Dewan, Varun; Musier-Forsyth, Karin] Ohio State Univ, Ctr Retroviral Res, Columbus, OH 43210 USA; [Wei, Min; Kleiman, Lawrence] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Wei, Min; Kleiman, Lawrence] McGill Univ, Jewish Gen Hosp, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Lady Davis Institute; McGill University; McGill University	Musier-Forsyth, K (corresponding author), Ohio State Univ, Dept Chem & Biochem, Ohio State Biochem Program, Ctr RNA Biol, 100 W 18th Ave, Columbus, OH 43210 USA.	musier@chemistry.ohio-state.edu			National Institutes of Health [AI077387]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI077387 (to L.K. and K.M.-F.).	Cen S, 2004, J VIROL, V78, P1595, DOI 10.1128/JVI.78.3.1595-1601.2004; Cen S, 2001, J VIROL, V75, P5043, DOI 10.1128/JVI.75.11.5043-5048.2001; Chu H, 2009, CURR TOP MICROBIOL, V339, P67, DOI 10.1007/978-3-642-02175-6_4; Cusack S, 1996, EMBO J, V15, P6321, DOI 10.1002/j.1460-2075.1996.tb01022.x; Datta Siddhartha A. K., 2009, V485, P197, DOI 10.1007/978-1-59745-170-3_14; Dewan V, 2012, ACS CHEM BIOL, V7, P761, DOI 10.1021/cb200450w; ERIANI G, 1990, NUCLEIC ACIDS RES, V18, P7109, DOI 10.1093/nar/18.23.7109; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fang PF, 2011, P NATL ACAD SCI USA, V108, P8239, DOI 10.1073/pnas.1100224108; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Gabor J, 2002, J VIROL, V76, P9096, DOI 10.1128/JVI.76.18.9096-9102.2002; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Guo F, 2003, J VIROL, V77, P9817, DOI 10.1128/JVI.77.18.9817-9822.2003; Guo M, 2008, P NATL ACAD SCI USA, V105, P2331, DOI 10.1073/pnas.0712072105; Guo M, 2010, J PHYS CHEM B, V114, P16273, DOI 10.1021/jp1082517; Halwani R, 2004, J VIROL, V78, P7553, DOI 10.1128/JVI.78.14.7553-7564.2004; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Javanbakht H, 2003, J BIOL CHEM, V278, P27644, DOI 10.1074/jbc.M301840200; Javanbakht H, 2002, J BIOL CHEM, V277, P17389, DOI 10.1074/jbc.M112479200; Kaminska M, 2007, J VIROL, V81, P68, DOI 10.1128/JVI.01267-06; Kleiman L, 2004, CURR HIV RES, V2, P163, DOI 10.2174/1570162043484988; Kleiman L, 2010, FEBS LETT, V584, P359, DOI 10.1016/j.febslet.2009.11.038; Kobbi L, 2011, J MOL BIOL, V410, P875, DOI 10.1016/j.jmb.2011.03.005; Kovaleski BJ, 2007, J BIOL CHEM, V282, P32274, DOI 10.1074/jbc.M706256200; Kovaleski BJ, 2006, J BIOL CHEM, V281, P19449, DOI 10.1074/jbc.M601189200; MAK J, 1994, J VIROL, V68, P2065, DOI 10.1128/JVI.68.4.2065-2072.1994; Mak J, 1997, J VIROL, V71, P8087, DOI 10.1128/JVI.71.11.8087-8095.1997; Mascarenhas AP, 2009, FEBS J, V276, P6118, DOI 10.1111/j.1742-4658.2009.07315.x; Nakorn PN, 2011, J THEOR BIOL, V270, P88, DOI 10.1016/j.jtbi.2010.11.010; ONESTI S, 1995, STRUCTURE, V3, P163, DOI 10.1016/S0969-2126(01)00147-2; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Rein A, 2011, TRENDS BIOCHEM SCI, V36, P373, DOI 10.1016/j.tibs.2011.04.001; Stello T, 1999, NUCLEIC ACIDS RES, V27, P4823, DOI 10.1093/nar/27.24.4823; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; SWANSTROM R, 1997, SYNTHESIS ASSEMBLY P, P263; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Wei M, 2008, J VIROL, V82, P12049, DOI 10.1128/JVI.01744-08; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Zimmerman C, 2002, NATURE, V415, P88, DOI 10.1038/415088a	44	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41955	41962		10.1074/jbc.M112.421842	http://dx.doi.org/10.1074/jbc.M112.421842			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23095741	Green Published, hybrid			2022-12-28	WOS:000312103000035
J	Ge, Q; Huang, N; Wynn, RM; Li, Y; Du, XL; Miller, B; Zhang, H; Uyeda, K				Ge, Qiang; Huang, Nian; Wynn, R. Max; Li, Yang; Du, Xinlin; Miller, Bonnie; Zhang, Hong; Uyeda, Kosaku			Structural Characterization of a Unique Interface between Carbohydrate Response Element-binding Protein (ChREBP) and 14-3-3 beta Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT SIGNAL; TRANSCRIPTION FACTOR; EXOENZYME-S; GLUCOSE; PHOSPHORYLATION; LOCALIZATION; LIPOGENESIS; DEFICIENCY; REGULATOR; LIGAND	Carbohydrate response element-binding protein (ChREBP) is an insulin-independent, glucose-responsive transcription factor that is expressed at high levels in liver hepatocytes where it plays a critical role in converting excess carbohydrates to fat for storage. In response to fluctuating glucose levels, hepatic ChREBP activity is regulated in large part by nucleocytoplasmic shuttling of ChREBP protein via interactions with 14-3-3 proteins. The N-terminal ChREBP regulatory region is necessary and sufficient for glucose-responsive ChREBP nuclear import and export. Here, we report the crystal structure of a complex of 14-3-3 beta bound to the N-terminal regulatory region of ChREBP at 2.4 angstrom resolution. The crystal structure revealed that the alpha 2 helix of ChREBP (residues 117-137) adopts a well defined alpha-helical conformation and binds 14-3-3 in a phosphorylation-independent manner that is different from all previously characterized 14-3-3 and target protein-bindingmodes. ChREBP alpha 2 interacts with 14-3-3 through both electrostatic and van der Waals interactions, and the binding is partially mediated by a free sulfate or phosphate. Structure-based mutagenesis and binding assays indicated that disrupting the observed 14-3-3 and ChREBP alpha 2 interface resulted in a loss of complex formation, thus validating the novel protein interaction mode in the 14-3-3 beta. ChREBP alpha 2 complex.	[Ge, Qiang; Wynn, R. Max; Li, Yang; Du, Xinlin; Miller, Bonnie; Zhang, Hong; Uyeda, Kosaku] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Huang, Nian; Zhang, Hong] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Uyeda, Kosaku] Dallas Vet Affairs Med Ctr, Dallas, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, H (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	zhang@chop.swmed.edu; Kosaku.Uyeda@UTSouthwestern.edu		Wynn, Richard/0000-0002-1879-2136	National Institutes of Health from NIDDK [R01 DK063948]; Veterans Affairs merit review grant; Welch Foundation [I-1720]; American Heart Association [10GRNT4310090]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063948] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Veterans Affairs merit review grant(US Department of Veterans Affairs); Welch Foundation(The Welch Foundation); American Heart Association(American Heart Association); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK063948 from NIDDK. This work was also supported by a Veterans Affairs merit review grant, Welch Foundation Grant I-1720 (to K.U.), and American Heart Association Grant 10GRNT4310090 (to H.Z.).; We thank Yuh Min Chook for helpful discussions. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by University of Chicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukasawa M, 2010, BIOCHEM BIOPH RES CO, V391, P1166, DOI 10.1016/j.bbrc.2009.11.115; Ge Q, 2011, J BIOL CHEM, V286, P28119, DOI 10.1074/jbc.M111.237016; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Havula E, 2012, SEMIN CELL DEV BIOL, V23, P640, DOI 10.1016/j.semcdb.2012.02.007; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Jeong YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022544; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kleppe R, 2011, SEMIN CELL DEV BIOL, V22, P713, DOI 10.1016/j.semcdb.2011.08.008; Li MV, 2008, MOL ENDOCRINOL, V22, P1658, DOI 10.1210/me.2007-0560; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merla G, 2004, HUM MOL GENET, V13, P1505, DOI 10.1093/hmg/ddh163; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Sakiyama H, 2010, BIOCHEM BIOPH RES CO, V402, P784, DOI 10.1016/j.bbrc.2010.10.113; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Towle HC, 2005, TRENDS ENDOCRIN MET, V16, P489, DOI 10.1016/j.tem.2005.10.003; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Zhai JB, 2001, J BIOL CHEM, V276, P41318, DOI 10.1074/jbc.M107709200	38	23	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41914	41921		10.1074/jbc.M112.418855	http://dx.doi.org/10.1074/jbc.M112.418855			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086940	hybrid, Green Published			2022-12-28	WOS:000312103000031
J	Song, SS; Li, JS; Zhu, LP; Cai, L; Xu, Q; Ling, C; Su, Y; Hu, QH				Song, Shanshan; Li, Jiansha; Zhu, Liping; Cai, Lei; Xu, Qian; Ling, Chen; Su, Yuan; Hu, Qinghua			Irregular Ca2+ Oscillations Regulate Transcription via Cumulative Spike Duration and Spike Amplitude	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B; FREE CALCIUM; SIGNALS; DYNAMICS; CELLS; NFAT	Agonist-stimulated [Ca2+](i) oscillations are universally irregular in their kinetics. How irregular [Ca2+](i) oscillations dynamically regulate agonist-stimulated downstream events has not been studied. To overcome the obstacles of irregularity and heterogeneity of [Ca2+](i) oscillations, agonist-stimulated [Ca2+](i) signaling and NF kappa B/STAT3-GFP nuclear translocation were simultaneously monitored in each single cell examined. The cause-effect relationship between [Ca2+](i) oscillation parameters and transcriptional activities was validated in cell populations through irregular [Ca2+](i) oscillations with varied parameters. The time duration of cumulative [Ca2+](i) elevations reaching the threshold [Ca2+](i) level for a transcriptional factor activation and [Ca2+](i) spike amplitude was found to control agonist-stimulated transcription and gene expression.	[Song, Shanshan; Zhu, Liping; Cai, Lei; Xu, Qian; Ling, Chen; Hu, Qinghua] Huazhong Univ Sci & Technol, Dept Pathophysiol, Union Hosp, Wuhan 430030, Peoples R China; [Song, Shanshan; Li, Jiansha; Zhu, Liping; Cai, Lei; Xu, Qian; Ling, Chen; Su, Yuan; Hu, Qinghua] Huazhong Univ Sci & Technol, Key Lab Pulm Dis, Union Hosp, Minist Hlth China, Wuhan 430030, Peoples R China; [Li, Jiansha] Huazhong Univ Sci & Technol, Dept Pathol, Union Hosp, Wuhan 430030, Peoples R China; [Su, Yuan] Huazhong Univ Sci & Technol, Dept Resp Med, Union Hosp, Wuhan 430030, Peoples R China; [Hu, Qinghua] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Hu, QH (corresponding author), HUST, Tongji Med Coll, Dept Pathophysiol, Wuhan 430030, Peoples R China.	qinghuaa@mails.tjmu.edu.cn			National Natural Science Foundation of China; Ministry of Education of China [20090142120015]; Tongji Medical College, Huazhong Science and Technology University;  [30971162];  [81170048];  [30900750];  [31270031];  [30900545]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Tongji Medical College, Huazhong Science and Technology University; ; ; ; ; 	This work was supported by Research Grants 30971162, 81170048, 30900750, 31270031, and 30900545 from the National Natural Science Foundation of China, New Teacher Grant 20090142120015 from the Ministry of Education of China, and a Student Research Award from Tongji Medical College, Huazhong Science and Technology University (to Q. X. and C. L.).	Berkova Z, 2003, CELL CALCIUM, V34, P55, DOI 10.1016/S0143-4160(03)00022-8; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; Brasen JC, 2011, BBA-MOL CELL RES, V1813, P1446, DOI 10.1016/j.bbamcr.2011.05.002; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; DILIBERTO PA, 1994, J BIOL CHEM, V269, P26349; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dupont G., 2011, COLD SPRING HARBOR P, V3; Dupont G, 2009, CHAOS, V19, DOI 10.1063/1.3160569; Fisher WG, 2006, ANN BIOMED ENG, V34, P1712, DOI 10.1007/s10439-006-9179-4; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Heemskerk JWM, 2001, J PHYSIOL-LONDON, V535, P625, DOI 10.1111/j.1469-7793.2001.00625.x; Hernandez-SanMiguel E, 2006, CELL CALCIUM, V40, P53, DOI 10.1016/j.ceca.2006.03.009; Jin S, 2005, J BIOCHEM BIOPH METH, V65, P20, DOI 10.1016/j.jbbm.2005.08.006; MARKS PW, 1990, J CELL BIOL, V110, P43, DOI 10.1083/jcb.110.1.43; Martin-Cano FE, 2009, J PHYSIOL PHARMACOL, V60, P93; Mohri T, 2005, BIOCHEM BIOPH RES CO, V326, P166, DOI 10.1016/j.bbrc.2004.11.024; Narenjkar J, 1999, CELL CALCIUM, V26, P261, DOI 10.1054/ceca.1999.0065; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; RIDGWAY EB, 1976, J CELL BIOL, V69, P223, DOI 10.1083/jcb.69.1.223; Skupin A, 2007, GENOME INFORM SER, V18, P44; Skupin A, 2008, BIOPHYS J, V94, P2404, DOI 10.1529/biophysj.107.119495; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; Thurley K, 2011, P NATL ACAD SCI USA, V108, P427, DOI 10.1073/pnas.1008435108; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Turner DA, 2010, J CELL SCI, V123, P2834, DOI 10.1242/jcs.069641; VANDENPOL AN, 1992, J NEUROSCI, V12, P2648; Voronina S, 2002, J PHYSIOL-LONDON, V539, P41, DOI 10.1113/jphysiol.2001.013134; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; Wu YM, 1997, AM J PHYSIOL-HEART C, V273, pH2161, DOI 10.1152/ajpheart.1997.273.5.H2161; Zhang JW, 2012, ANTIOXID REDOX SIGN, V17, P471, DOI 10.1089/ars.2011.4168; Zhang M, 2003, BIOPHYS J, V84, P2852, DOI 10.1016/S0006-3495(03)70014-9; Zhu LP, 2008, J CELL SCI, V121, P2511, DOI 10.1242/jcs.031997; Zhu LP, 2011, J CELL SCI, V124, P2591, DOI 10.1242/jcs.082727	34	34	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40246	40255		10.1074/jbc.M112.417154	http://dx.doi.org/10.1074/jbc.M112.417154			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23071118	Green Published, hybrid			2022-12-28	WOS:000311448800017
J	Zhang, JS; Xie, SS; Ma, WB; Teng, Y; Tian, Y; Huang, XX; Zhang, YL				Zhang, Jinsong; Xie, Shengsong; Ma, Wubin; Teng, Yu; Tian, Ye; Huang, Xingxu; Zhang, Yonglian			A Newly Identified MicroRNA, mmu-miR-7578, Functions as a Negative Regulator on Inflammatory Cytokines Tumor Necrosis Factor-alpha and Interleukin-6 via Targeting Egr1 in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-RESPONSES; POSSIBLE ROLES; EXPRESSION; CELLS; EGR-1; INDUCTION; MURINE; LIPOPOLYSACCHARIDE; STIMULATION; PROTEINS	Appropriate innate immune responses are required to protect an organism against foreign pathogens, and the immune response must be tightly controlled. Here, we report a new microRNA (miRNA) identified from a small RNA library from the epididymis, termed miR-7578, that acts as a negative regulator of inflammatory responses. It was abundantly expressed in immune-related organs and induced by lipopolysaccharide in the lung and epididymis, as well as macrophages stimulated with diverse Toll-like receptor ligands, in an NF-kappa B-dependent manner. mmu-miR-7578 inhibited the release of pro-inflammatory cytokines, including TNF alpha and IL6, by regulating its target gene Egr1, which encodes a transcription factor that activates TNF alpha and NF-kappa B expression. Transgenic mice overexpressing mmu-miR-7578 displayed higher resistance to endotoxin shock and lower plasma levels of TNF alpha and IL6, indicating that this miRNA acted as a negative molecule of immune response. In sum, we report a previously uncharacterized LPS-responsive miRNA that controls inflammatory response in a feedback loop by fine-tuning a key transcription factor in vivo.	[Zhang, Jinsong; Xie, Shengsong; Ma, Wubin; Tian, Ye; Zhang, Yonglian] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Key Lab Mol Androl, State Key Lab Mol Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Huang, Xingxu] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; [Teng, Yu] Tsinghua Univ, Peking Union Med Coll, Chinese Acad Med Sci, State Key Lab Med Mol Biol,Inst Basic Med Sci, Beijing 100005, Peoples R China; [Zhang, Yonglian] Shanghai Inst Planned Parenthood Res, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Tsinghua University	Huang, XX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Key Lab Mol Androl, State Key Lab Mol Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	xingxuhuang@mail.nju.edu.cn; ylzhang@sibcb.ac.cn	Ma, Wubin/P-3045-2017	Zhang, Jinsong/0000-0002-6457-0235; huang, xingxu/0000-0001-8934-1247	National Natural Science Foundation of China [30930053, 31040025]; Chinese Academy of Sciences Knowledge Innovation Program [KSXC2-EW-R-07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Knowledge Innovation Program(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 30930053 and 31040025 and Chinese Academy of Sciences Knowledge Innovation Program Grant KSXC2-EW-R-07.	Albrecht C, 2010, CARDIOVASC RES, V86, P321, DOI 10.1093/cvr/cvq032; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; El Gazzar M, 2010, J BIOL CHEM, V285, P20940, DOI 10.1074/jbc.M110.115063; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Harja E, 2004, CIRC RES, V94, P333, DOI 10.1161/01.RES.0000112405.61577.95; Johnston DS, 2005, BIOL REPROD, V73, P404, DOI 10.1095/biolreprod.105.039719; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; ORGEBINCRIST MC, 1967, NATURE, V216, P816, DOI 10.1038/216816a0; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Schmidt J, 2008, GASTROENTEROLOGY, V135, P926, DOI 10.1053/j.gastro.2008.05.079; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Silverman ES, 2001, AM J RESP CRIT CARE, V163, P778, DOI 10.1164/ajrccm.163.3.2003123; SKERKA C, 1995, J BIOL CHEM, V270, P22500, DOI 10.1074/jbc.270.38.22500; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Zhao YT, 2008, IMMUNOL LETT, V119, P84, DOI 10.1016/j.imlet.2008.05.002	35	22	24	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4310	4320		10.1074/jbc.M112.351197	http://dx.doi.org/10.1074/jbc.M112.351197			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23184950	hybrid, Green Published			2022-12-28	WOS:000314845000059
J	Vartanian, S; Bentley, C; Brauer, MJ; Li, L; Shirasawa, S; Sasazuki, T; Kim, JS; Haverty, P; Stawiski, E; Modrusan, Z; Waldman, T; Stokoe, D				Vartanian, Steffan; Bentley, Carolyn; Brauer, Matthew J.; Li, Li; Shirasawa, Senji; Sasazuki, Takehiko; Kim, Jung-Sik; Haverty, Pete; Stawiski, Eric; Modrusan, Zora; Waldman, Todd; Stokoe, David			Identification of Mutant K-Ras-dependent Phenotypes Using a Panel of Isogenic Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTATIC COLORECTAL-CANCER; ONCOGENIC KRAS; TUMOR-CELLS; EPITHELIAL-CELLS; LUNG-CANCER; KNOCK-IN; ACTIVATION; TRANSFORMATION; INHIBITION; EXPRESSION	To assess the consequences of endogenous mutant K-Ras, we analyzed the signaling and biological properties of a small panel of isogenic cell lines. These include the cancer cell lines DLD1, HCT116, and Hec1A, in which either the WT or mutant K-ras allele has been disrupted, and SW48 colorectal cancer cells and human mammary epithelial cells in which a single copy of mutant K-ras was introduced at its endogenous genomic locus. We find that single copy mutant K-Ras causes surprisingly modest activation of downstream signaling to ERK and Akt. In contrast, a negative feedback signaling loop to EGFR and N-Ras occurs in some, but not all, of these cell lines. Mutant K-Ras also had relatively minor effects on cell proliferation and cell migration but more dramatic effects on cell transformation as assessed by growth in soft agar. Surprisingly, knock-out of the wild type K-ras allele consistently increased growth in soft agar, suggesting tumor-suppressive properties of this gene under these conditions. Finally, we examined the effects of single copy mutant K-Ras on global gene expression. Although transcriptional programs triggered by mutant K-Ras were generally quite distinct in the different cell lines, there was a small number of genes that were consistently overexpressed, and these could be used to monitor K-Ras inhibition in a panel of human tumor cell lines. We conclude that there are conserved components of mutant K-Ras signaling and phenotypes but that many depend on cell context and environmental cues.	[Vartanian, Steffan; Bentley, Carolyn; Stokoe, David] Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA; [Brauer, Matthew J.; Li, Li; Haverty, Pete] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Stawiski, Eric; Modrusan, Zora] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Shirasawa, Senji] Fukuoka Univ, Fac Med, Dept Cell Biol, Fukuoka 8140180, Japan; [Sasazuki, Takehiko] Kyushu Univ, Inst Adv Study, Fukuoka 8128581, Japan; [Kim, Jung-Sik; Waldman, Todd] Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20037 USA; [Kim, Jung-Sik; Waldman, Todd] Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Tumor Biol Training Program, Washington, DC 20037 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Fukuoka University; Kyushu University; Georgetown University; Georgetown University	Stokoe, D (corresponding author), Genentech Inc, Dept Discovery Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	stokoe.david@gene.com			NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016672] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arena S, 2007, CANCER RES, V67, P8468, DOI 10.1158/0008-5472.CAN-07-1126; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Del Duca D, 2004, J NEURO-ONCOL, V67, P295, DOI 10.1023/B:NEON.0000024220.07063.70; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; Diaz R, 2004, CARCINOGENESIS, V25, P535, DOI 10.1093/carcin/bgh026; Diaz R, 2002, CANCER RES, V62, P4514; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; GUERRERO I, 1985, P NATL ACAD SCI USA, V82, P7810, DOI 10.1073/pnas.82.23.7810; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim JS, 2004, CANCER RES, V64, P1932, DOI 10.1158/0008-5472.CAN-03-3862; Konishi H, 2007, CANCER RES, V67, P8460, DOI 10.1158/0008-5472.CAN-07-0108; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Q, 2011, BLOOD, V117, P2022, DOI 10.1182/blood-2010-04-280750; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Mao C, 2010, LUNG CANCER, V69, P272, DOI 10.1016/j.lungcan.2009.11.020; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Packer LM, 2009, PIGM CELL MELANOMA R, V22, P785, DOI 10.1111/j.1755-148X.2009.00618.x; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Tchernitsa OI, 2004, ONCOGENE, V23, P4536, DOI 10.1038/sj.onc.1207585; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; van Houdt WJ, 2010, NEOPLASIA, V12, P443, DOI 10.1593/neo.92088; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721; Zhi XL, 2010, CANCER SCI, V101, P2561, DOI 10.1111/j.1349-7006.2010.01733.x	44	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2403	2413		10.1074/jbc.M112.394130	http://dx.doi.org/10.1074/jbc.M112.394130			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23188824	Green Published, hybrid			2022-12-28	WOS:000314211500028
J	Cavazzini, D; Meschi, F; Corsini, R; Bolchi, A; Rossi, GL; Einsle, O; Ottonello, S				Cavazzini, Davide; Meschi, Francesca; Corsini, Romina; Bolchi, Angelo; Rossi, Gian Luigi; Einsle, Oliver; Ottonello, Simone			Autoproteolytic Activation of a Symbiosis-regulated Truffle Phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBER-BORCHII; PROPROTEIN CONVERTASE; SIGNAL-TRANSDUCTION; PC12 CELLS; FURIN; MECHANISM; CLONING; PROTEIN; LOCALIZATION; PURIFICATION	Fungal phospholipases are members of the fungal/bacterial group XIV secreted phospholipases A(2) (sPLA(2)s). TbSP1, the sPLA(2) primarily addressed in this study, is up-regulated by nutrient deprivation and is preferentially expressed in the symbiotic stage of the ectomycorrhizal fungus Tuber borchii. A peculiar feature of this phospholipase and of its ortholog from the black truffle Tuber melanosporum is the presence of a 54-amino acid sequence of unknown functional significance, interposed between the signal peptide and the start of the conserved catalytic core of the enzyme. X-ray diffraction analysis of a recombinant TbSP1 form corresponding to the secreted protein previously identified in T. borchii mycelia revealed a structure comprising the five alpha-helices that form the phospholipase catalytic module but lacking the N-terminal 54 amino acids. This finding led to a series of functional studies that showed that TbSP1, as well as its T. melanosporum ortholog, is a self-processing pro-phospholipase A(2), whose phospholipase activity increases up to 80-fold following autoproteolytic removal of the N-terminal peptide. Proteolytic cleavage occurs within a serine-rich, intrinsically flexible region of TbSP1, does not involve the phospholipase active site, and proceeds via an intermolecular mechanism. Autoproteolytic activation, which also takes place at the surface of nutrient-starved, sPLA(2) overexpressing hyphae, may strengthen and further control the effects of phospholipase up-regulation in response to nutrient deprivation, also in the context of symbiosis establishment and mycorrhiza formation.	[Cavazzini, Davide; Meschi, Francesca; Corsini, Romina; Bolchi, Angelo; Rossi, Gian Luigi; Ottonello, Simone] Univ Parma, Lab Funct Genom & Prot Engn, Biochem & Mol Biol Unit, Dept Biosci, I-43124 Parma, Italy; [Einsle, Oliver] Univ Freiburg, Lehrstuhl Biochem, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	University of Parma; University of Freiburg	Ottonello, S (corresponding author), Univ Parma, Lab Funct Genom & Prot Engn, Biochem & Mol Biol Unit, Dept Biosci, Parco Area Sci 23-A, I-43124 Parma, Italy.	simone.ottonello@unipr.it	Corsini, Romina/ABB-4619-2021; Cavazzini, Davide/C-8154-2014; Bolchi, Angelo/GOJ-9730-2022	Cavazzini, Davide/0000-0002-1743-2390; Einsle, Oliver/0000-0001-8722-2893	Italian Ministry of Education and Research (MIUR-PRIN); Fondazione Cariparma	Italian Ministry of Education and Research (MIUR-PRIN)(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariparma(Fondazione Cariparma)	This work was supported by grants from the Italian Ministry of Education and Research (MIUR-PRIN) (to G. L. R. and S. O.) and by a grant from the Fondazione Cariparma (to S. O.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Ali SA, 1999, TOXICON, V37, P1505, DOI 10.1016/S0041-0101(99)00091-4; Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bolchi A, 2005, BIOTECHNOL APPL BIOC, V42, P205, DOI 10.1042/BA20050050; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Buscot F, 2000, FEMS MICROBIOL REV, V24, P601, DOI 10.1111/j.1574-6976.2000.tb00561.x; CREEMERS JWM, 1995, J BIOL CHEM, V270, P2695, DOI 10.1074/jbc.270.6.2695; De Maria L, 2007, APPL MICROBIOL BIOT, V74, P290, DOI 10.1007/s00253-006-0775-x; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Dippe M, 2011, FUNGAL GENET BIOL, V48, P921, DOI 10.1016/j.fgb.2011.05.008; Drissner D, 2007, SCIENCE, V318, P265, DOI 10.1126/science.1146487; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESKOLA JU, 1983, CLIN CHEM, V29, P1772; Fink DL, 2001, J BIOL CHEM, V276, P39492, DOI 10.1074/jbc.M106913200; Ghosh K, 2004, BIOCHEM J, V379, P325, DOI 10.1042/BJ20031834; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hostetter MK, 2000, CURR OPIN MICROBIOL, V3, P344, DOI 10.1016/S1369-5274(00)00101-6; Jemel I, 2011, J BIOL CHEM, V286, P36509, DOI 10.1074/jbc.M111.268540; Kohler GA, 2006, BBA-MOL CELL BIOL L, V1761, P1391, DOI 10.1016/j.bbalip.2006.09.011; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lee HY, 2005, PROG LIPID RES, V44, P52, DOI 10.1016/j.plipres.2004.10.002; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Matoba Y, 2002, J BIOL CHEM, V277, P20059, DOI 10.1074/jbc.M200263200; Mayer JM, 2000, DIGESTION, V62, P164, DOI 10.1159/000007809; Minder AC, 2001, MOL MICROBIOL, V39, P1186, DOI 10.1111/j.1365-2958.2001.02325.x; Miozzi L, 2005, NEW PHYTOL, V167, P229, DOI 10.1111/j.1469-8137.2005.01400.x; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Montanini B, 2006, FUNGAL GENET BIOL, V43, P630, DOI 10.1016/j.fgb.2006.04.001; Moretto N, 2007, J BIOL CHEM, V282, P11436, DOI 10.1074/jbc.M609690200; Murakami M, 2011, J BIOCHEM, V150, P233, DOI 10.1093/jb/mvr088; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nakahama T, 2010, FUNGAL GENET BIOL, V47, P318, DOI 10.1016/j.fgb.2009.12.011; NAKANO T, 1994, BIOCHEM BIOPH RES CO, V198, P10, DOI 10.1006/bbrc.1994.1002; Nakashima S, 2003, BIOCHEM J, V376, P655, DOI 10.1042/BJ20030830; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; Powner D, 1998, MOL CELL BIOL, V18, P400, DOI 10.1128/MCB.18.1.400; PRECIADOPATT L, 1994, EUR J BIOCHEM, V223, P35, DOI 10.1111/j.1432-1033.1994.tb18963.x; Rae D., 1996, SCAND J GASTROENTE S, V219, P24; Richter C, 1998, BIOCHEM J, V335, P481, DOI 10.1042/bj3350481; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soragni E, 2001, EMBO J, V20, P5079, DOI 10.1093/emboj/20.18.5079; Sugiyama M, 2002, J BIOL CHEM, V277, P20051, DOI 10.1074/jbc.M200264200; vandeLoo JWHP, 1997, J BIOL CHEM, V272, P27116, DOI 10.1074/jbc.272.43.27116; Wakatsuki S, 2001, BBA-GENE STRUCT EXPR, V1522, P74, DOI 10.1016/S0167-4781(01)00308-6; Wang XM, 2002, PHYSIOL PLANTARUM, V115, P331, DOI 10.1034/j.1399-3054.2002.1150301.x; Wang YM, 2003, J BIOL CHEM, V278, P3210, DOI 10.1074/jbc.M210431200; Xu W, 2009, J BIOL CHEM, V284, P16659, DOI 10.1074/jbc.M808029200	51	12	12	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1533	1547		10.1074/jbc.M112.384156	http://dx.doi.org/10.1074/jbc.M112.384156			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23192346	Green Published, hybrid			2022-12-28	WOS:000313751400011
J	Westphal, CH; Chandra, SS				Westphal, Christopher H.; Chandra, Sreeganga S.			Monomeric Synucleins Generate Membrane Curvature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; MICE LACKING; SECONDARY STRUCTURE; SYNAPTIC VESICLES; GAMMA-SYNUCLEIN; LIPID VESICLES; CSP-ALPHA; BINDING; MUTATION	Synucleins are a family of presynaptic membrane binding proteins. alpha-Synuclein, the principal member of this family, is mutated in familial Parkinson disease. To gain insight into the molecular functions of synucleins, we performed an unbiased proteomic screen and identified synaptic protein changes in alpha beta gamma-synuclein knock-out brains. We observed increases in the levels of select membrane curvature sensing/generating proteins. One of the most prominent changes was for the N-BAR protein endophilin A1. Here we demonstrate that the levels of synucleins and endophilin A1 are reciprocally regulated and that they are functionally related. We show that all synucleins can robustly generate membrane curvature similar to endophilins. However, only monomeric but not tetrameric alpha-synuclein can bend membranes. Further, A30P alpha-synuclein, a Parkinson disease mutant that disrupts protein folding, is also deficient in this activity. This suggests that synucleins generate membrane curvature through the asymmetric insertion of their N-terminal amphipathic helix. Based on our findings, we propose to include synucleins in the class of amphipathic helix-containing proteins that sense and generate membrane curvature. These results advance our understanding of the physiological function of synucleins.	[Chandra, Sreeganga S.] Yale Univ, Dept Neurol, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06536 USA; [Westphal, Christopher H.] Yale Univ, Dept Cell Biol, New Haven, CT 06536 USA; [Chandra, Sreeganga S.] Yale Univ, Dept Mol Cell & Dev Biol, New Haven, CT 06536 USA	Yale University; Yale University; Yale University	Chandra, SS (corresponding author), Yale Univ, Dept Neurol, Program Cellular Neurosci Neurodegenerat & Repair, 295 Congress Ave, New Haven, CT 06536 USA.	sreeganga.chandra@yale.edu			National Institutes of Health [R01 NS064963, T32GM7223]; Bumpus Foundation; Anonymous Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bumpus Foundation; Anonymous Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by grants from the National Institutes of Health (R01 NS064963), the Bumpus Foundation, and an Anonymous Foundation grant (to S. S. C.). The proteomics was done with the support of the Yale Keck NIDA Neuroproteomic Center (P30 DA018343).; Supported in part by NIH Grant T32GM7223.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Anwar S, 2011, J NEUROSCI, V31, P7264, DOI 10.1523/JNEUROSCI.6194-10.2011; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Davalos A, 2010, MOL CELL PROTEOMICS, V9, P2109, DOI 10.1074/mcp.M110.001289; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Drescher M, 2012, CHEMBIOCHEM, V13, P761, DOI 10.1002/cbic.201200059; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fernandez-Busnadiego R, 2011, J ELECTRON MICROSC, V60, pS137, DOI 10.1093/jmicro/dfr018; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gaugler MN, 2012, ACTA NEUROPATHOL, V123, P653, DOI 10.1007/s00401-012-0963-y; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; JAHN R, 1993, J NEUROCHEM, V61, P12, DOI 10.1111/j.1471-4159.1993.tb03533.x; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; McMahon HT, 2010, CELL, V140, P601, DOI 10.1016/j.cell.2010.02.017; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Mizuno N, 2012, J BIOL CHEM, V287, P29301, DOI 10.1074/jbc.M112.365817; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nakajo S, 1996, BRAIN RES, V741, P180, DOI 10.1016/S0006-8993(96)00914-6; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Oling F, 2000, J MOL BIOL, V304, P561, DOI 10.1006/jmbi.2000.4183; Pandey AP, 2011, J PHYS CHEM B, V115, P5886, DOI 10.1021/jp1121917; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sorre B, 2012, P NATL ACAD SCI USA, V109, P173, DOI 10.1073/pnas.1103594108; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sung YH, 2006, PROTEIN SCI, V15, P1162, DOI 10.1110/ps.051803606; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tannu NS, 2006, PROG BRAIN RES, V158, P41, DOI 10.1016/S0079-6123(06)58003-3; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Wu Terence L., 2006, V328, P71; Yoon Y, 2010, J BIOL CHEM, V285, P531, DOI 10.1074/jbc.M109.068015; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang YQ, 2012, NEURON, V74, P136, DOI 10.1016/j.neuron.2012.01.029	65	127	128	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1829	1840		10.1074/jbc.M112.418871	http://dx.doi.org/10.1074/jbc.M112.418871			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184946	hybrid, Green Published			2022-12-28	WOS:000313751400038
J	Cheng, JD; Yang, Y; Fang, J; Xiao, JX; Zhu, TT; Chen, F; Wang, P; Li, Z; Yang, HR; Xu, YH				Cheng, Jingdong; Yang, Yi; Fang, Jian; Xiao, Jianxiong; Zhu, Tingting; Chen, Fei; Wang, Ping; Li, Ze; Yang, Huirong; Xu, Yanhui			Structural Insight into Coordinated Recognition of Trimethylated Histone H3 Lysine 9 (H3K9me3) by the Plant Homeodomain (PHD) and Tandem Tudor Domain (TTD) of UHRF1 (Ubiquitin-like, Containing PHD and RING Finger Domains, 1) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; EPIGENETIC INHERITANCE; MULTIDOMAIN PROTEIN; NP95; ICBP90; DNMT1; HETEROCHROMATIN; GENE; METHYLTRANSFERASES; PHOSPHORYLATION	UHRF1 is an important epigenetic regulator connecting DNA methylation and histone methylations. UHRF1 is required for maintenance of DNA methylation through recruiting DNMT1 to DNA replication forks. Recent studies have shown that the plant homeodomain (PHD) of UHRF1 recognizes the N terminus of unmodified histone H3, and the interaction is inhibited by methylation of H3R2, whereas the tandem tudor domain (TTD) of UHRF1 recognizes trimethylated histone H3 lysine 9 (H3K9me3). However, how the two domains of UHRF1 coordinately recognize histone methylations remains elusive. In this report, we identified that PHD largely enhances the interaction between TTD and H3K9me3. We present the crystal structure of UHRF1 containing both TTD and PHD (TTD-PHD) in complex with H3K9m3 peptide at 3.0 angstrom resolution. The structure shows that TTD-PHD binds to the H3K9me3 peptide with 1:1 stoichiometry with the two domains connected by the H3K9me3 peptide and a linker region. The TTD interacts with residues Arg-8 and trimethylated Lys-9, and the PHD interacts with residues Ala-1, Arg-2, and Lys-4 of the H3K9me3 peptide. The biochemical experiments indicate that PHD-mediated recognition of unmodified H3 is independent of the TTD, whereas TTD-mediated recognition of H3K9me3 PHD. Thus, both TTD and PHD are essential for specific recognition of H3K9me3 by UHRF1. Interestingly, the H3K9me3 peptide induces conformational changes of TTD-PHD, which do not affect the autoubiquitination activity or hemimethylated DNA binding affinity of UHRF1 in vitro. Taken together, our studies provide structural insight into the coordinated recognition of H3K9me3 by the TTD and PHD of UHRF1.	[Cheng, Jingdong; Li, Ze; Yang, Huirong; Xu, Yanhui] Fudan Univ, Shanghai Med Coll, Canc Inst,Shanghai Canc Ctr, Dept Oncol, Shanghai 200032, Peoples R China; [Cheng, Jingdong; Yang, Yi; Fang, Jian; Xiao, Jianxiong; Zhu, Tingting; Chen, Fei; Wang, Ping; Li, Ze; Yang, Huirong; Xu, Yanhui] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Xu, Yanhui] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Xu, YH (corresponding author), Fudan Univ, Inst Biomed Sci, 138 Yixue Yuan Rd, Shanghai 200032, Peoples R China.	xuyh@fudan.edu.cn	Xu, Yanhui/D-5119-2019; Wang, Ping/GZB-2001-2022; Xiao, Jianxiong/ABA-4938-2021	Xiao, Jianxiong/0000-0002-7263-0226; CHEN, FEI/0000-0002-7827-7988; Wang, Ping/0000-0002-2710-7188	National Basic Research Program of China [2011CB965300, 2009CB918600]; National Natural Science Foundation of China [11079016, 31270779, 31030019]; Fok Ying Tung Education Foundation [20090071220012]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation)	This work was supported by National Basic Research Program of China Grants 2011CB965300 and 2009CB918600; National Natural Science Foundation of China Grants 11079016, 31270779, and 31030019; and Fok Ying Tung Education Foundation Grant 20090071220012.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Achour M, 2009, BIOCHEM BIOPH RES CO, V390, P523, DOI 10.1016/j.bbrc.2009.09.131; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alhosin M, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-41; Arita K, 2012, P NATL ACAD SCI USA, V109, P12950, DOI 10.1073/pnas.1203701109; Babbio F, 2012, ONCOGENE, V31, P4878, DOI 10.1038/onc.2011.641; BESTOR TH, 1983, P NATL ACAD SCI-BIOL, V80, P5559, DOI 10.1073/pnas.80.18.5559; Bonapace IM, 2002, J CELL BIOL, V157, P909, DOI 10.1083/jcb.200201025; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bronner C, 2004, ANN NY ACAD SCI, V1030, P355, DOI 10.1196/annals.1329.044; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Bronner C, 2009, GENET EPIGENETICS, V2, P29; Bronner C, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001764; Chu J, 2012, MOL BIOL CELL, V23, P59, DOI 10.1091/mbc.E11-06-0487; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; DeLano W.L, PYMOL MOL GRAPHICS S; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felle M, 2011, NUCLEIC ACIDS RES, V39, P8355, DOI 10.1093/nar/gkr528; Fujimori A, 1998, MAMM GENOME, V9, P1032, DOI 10.1007/s003359900920; Hashimoto H, 2009, EPIGENETICS-US, V4, P8, DOI 10.4161/epi.4.1.7370; Hu LL, 2011, CELL RES, V21, P1374, DOI 10.1038/cr.2011.124; Jeanblanc M, 2005, ONCOGENE, V24, P7337, DOI 10.1038/sj.onc.1208878; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Jin W, 2010, BREAST CANCER RES TR, V123, P359, DOI 10.1007/s10549-009-0652-2; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li XL, 2012, ONCOL REP, V28, P375, DOI 10.3892/or.2012.1792; Ma HH, 2012, P NATL ACAD SCI USA, V109, P4828, DOI 10.1073/pnas.1116349109; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miura M, 2001, EXP CELL RES, V263, P202, DOI 10.1006/excr.2000.5115; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Mousli M, 2003, BRIT J CANCER, V89, P120, DOI 10.1038/sj.bjc.6601068; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papait R, 2008, MOL BIOL CELL, V19, P3554, DOI 10.1091/mbc.E07-10-1059; Papait R, 2007, MOL BIOL CELL, V18, P1098, DOI 10.1091/mbc.E06-09-0874; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Qin WH, 2011, J CELL BIOCHEM, V112, P439, DOI 10.1002/jcb.22998; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Trotzier MA, 2004, BIOCHEM BIOPH RES CO, V319, P590, DOI 10.1016/j.bbrc.2004.05.028; Uemura T, 2000, CELL STRUCT FUNCT, V25, P149, DOI 10.1247/csf.25.149; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Unoki M, 2010, BRIT J CANCER, V103, P217, DOI 10.1038/sj.bjc.6605717; Wang F, 2012, ANN SURG ONCOL, V19, P2753, DOI 10.1245/s10434-011-2194-1; Yan F, 2011, CANCER BIOTHER RADIO, V26, P183, DOI 10.1089/cbr.2010.0886; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	54	79	81	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1329	1339		10.1074/jbc.M112.415398	http://dx.doi.org/10.1074/jbc.M112.415398			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23161542	hybrid, Green Published			2022-12-28	WOS:000313570300054
J	Yuan, ZZ; Yan, XJ; Zhang, AD; Chen, B; Shen, YQ; Jin, ML				Yuan, Zeng-zhi; Yan, Xiao-jie; Zhang, An-ding; Chen, Bo; Shen, Yue-quan; Jin, Mei-lin			Molecular Mechanism by Which Surface Antigen HP0197 Mediates Host Cell Attachment in the Pathogenic Bacteria Streptococcus suis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEIN; CRYSTAL-STRUCTURE; HEPARIN; GLYCOSAMINOGLYCANS; IDENTIFICATION; WALL; ADHERENCE; SORTASE	Streptococcus suis, one of the most important and prevalent pathogens in swine, presents a major challenge to global public health. HP0197 is an S. suis surface antigen that was previously identified by immunoproteomics and can bind to the host cell surface. Here, we investigated the interaction between HP0197 and the host cell surface glycosaminoglycans (GAGs) using indirect immunofluorescence and cell adhesion inhibition assays. In addition, we determined that a novel 18-kDa domain in the N-terminal region of HP0197 functions as the GAG-binding domain. We then solved the three-dimensional structures of the N-terminal 18-kDa and C-terminal G5 domains using x-ray crystallography. Based on this structural information, the GAG-binding sites in HP0197 were predicted and subsequently verified using site-directed mutagenesis and indirect immunofluorescence. The results indicate that the positively charged residues on the exposed surface of the 18-kDa domain, which are primarily lysines, likely play a critical role in the HP0197-heparin interaction that mediates bacterium-host cell adhesion. Understanding this molecular mechanism may provide a basis for the development of effective drugs and therapeutic strategies for treating streptococcal infections.	[Yuan, Zeng-zhi; Zhang, An-ding; Chen, Bo; Jin, Mei-lin] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Unit Anim Infect Dis, Wuhan 430070, Hubei, Peoples R China; [Yan, Xiao-jie; Shen, Yue-quan] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 30071, Peoples R China; [Yan, Xiao-jie; Shen, Yue-quan] Nankai Univ, Coll Life Sci, Tianjin 30071, Peoples R China	Huazhong Agricultural University; Nankai University; Nankai University	Shen, YQ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 30071, Peoples R China.	yshen@nankai.edu.cn; jml8328@126.com	Shen, Yuequan/C-8950-2013; yuan, zonghui/A-1158-2017	Shen, Yuequan/0000-0002-3775-0900; 	National Natural Science Foundation of China [31121004, 30901076]; 973 Program [2012CB518805]; 863 Program [2011AA10A210]; Chinese Major Special Science and Technology Project [2012ZX10004214]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); Chinese Major Special Science and Technology Project	This work was supported by National Natural Science Foundation of China Grants 31121004 and 30901076, 973 Program Grant 2012CB518805, 863 Program Grant 2011AA10A210, and Chinese Major Special Science and Technology Project Grant 2012ZX10004214.	Baron MJ, 2004, J BIOL CHEM, V279, P24714, DOI 10.1074/jbc.M402164200; Bateman A, 2005, BIOINFORMATICS, V21, P1301, DOI 10.1093/bioinformatics/bti206; Baums Christoph Georg, 2009, Animal Health Research Reviews, V10, P65, DOI 10.1017/S146625230999003X; Benga L, 2005, J VET MED B, V52, P392, DOI 10.1111/j.1439-0450.2005.00880.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; Chang YC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002082; de Greeff A, 2002, INFECT IMMUN, V70, P1319, DOI 10.1128/IAI.70.3.1319-1325.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Feng YJ, 2010, TRENDS MICROBIOL, V18, P124, DOI 10.1016/j.tim.2009.12.003; Frick IM, 2003, EUR J BIOCHEM, V270, P2303, DOI 10.1046/j.1432-1033.2003.03600.x; Fry EE, 1999, EMBO J, V18, P543, DOI 10.1093/emboj/18.3.543; Hui ACF, 2005, CLIN NEUROL NEUROSUR, V107, P366, DOI 10.1016/j.clineuro.2004.10.006; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; KAY R, 1995, QJM-INT J MED, V88, P39; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Patrie KM, 1999, BIOCHEMISTRY-US, V38, P9264, DOI 10.1021/bi9903345; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rostand KS, 1997, INFECT IMMUN, V65, P1; Ruggiero A, 2009, J MOL BIOL, V385, P153, DOI 10.1016/j.jmb.2008.10.042; Rusnati M, 1999, J BIOL CHEM, V274, P28198, DOI 10.1074/jbc.274.40.28198; Sava IG, 2009, J BIOL CHEM, V284, P18194, DOI 10.1074/jbc.M901460200; Sawitzky D, 1996, MED MICROBIOL IMMUN, V184, P155, DOI 10.1007/BF02456129; Siepen JA, 2003, PROTEIN SCI, V12, P2348, DOI 10.1110/ps.03234503; Suankratay Chusana, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P868; Tonnaer ELGM, 2006, MICROBES INFECT, V8, P316, DOI 10.1016/j.micinf.2005.06.028; WESTERLUND B, 1993, MOL MICROBIOL, V9, P687, DOI 10.1111/j.1365-2958.1993.tb01729.x; Zhang AD, 2008, PROTEOMICS, V8, P3506, DOI 10.1002/pmic.200800007; Zhang AD, 2010, VET MICROBIOL, V140, P171, DOI 10.1016/j.vetmic.2009.06.034; Zhang AD, 2009, VACCINE, V27, P5209, DOI 10.1016/j.vaccine.2009.06.074; Zhu Hong, 2006, Weishengwu Xuebao, V46, P635; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	39	13	18	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					956	963		10.1074/jbc.M112.388686	http://dx.doi.org/10.1074/jbc.M112.388686			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184929	Green Published, hybrid			2022-12-28	WOS:000313570300020
J	Moore, SJ; Biedendieck, R; Lawrence, AD; Deery, E; Howard, MJ; Rigby, SEJ; Warren, MJ				Moore, Simon J.; Biedendieck, Rebekka; Lawrence, Andrew D.; Deery, Evelyne; Howard, Mark J.; Rigby, Stephen E. J.; Warren, Martin J.			Characterization of the Enzyme CbiH(60) Involved in Anaerobic Ring Contraction of the Cobalamin (Vitamin B-12) Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-MEGATERIUM; COBYRINIC ACID; IRON; IDENTIFICATION; FERROCHELATASE; SPECIFICITY; EVOLUTION; SUBSTRATE; INSERTION; PROTEINS	The anaerobic pathway for the biosynthesis of cobalamin (vitamin B-12) has remained poorly characterized because of the sensitivity of the pathway intermediates to oxygen and the low activity of enzymes. One of the major bottlenecks in the anaerobic pathway is the ring contraction step, which has not been observed previously with a purified enzyme system. The Gram-positive aerobic bacterium Bacillus megaterium has a complete anaerobic pathway that contains an unusual ring contraction enzyme, CbiH(60), that harbors a C-terminal extension with sequence similarity to the nitrite/sulfite reductase family. To improve solubility, the enzyme was homologously produced in the host B. megaterium DSM319. CbiH(60) was characterized by electron paramagnetic resonance and shown to contain a [4Fe-4S] center. Assays with purified recombinant CbiH(60) demonstrate that the enzyme converts both cobalt-precorrin-3 and cobalt factor III into the ring-contracted product cobalt-precorrin-4 in high yields, with the latter transformation dependent upon DTT and an intact Fe-S center. Furthermore, the ring contraction process was shown not to involve a change in the oxidation state of the central cobalt ion of the macrocycle.	[Warren, Martin J.] Univ Kent, Dept Biosci, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Biedendieck, Rebekka] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Rigby, Stephen E. J.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England	University of Kent; Braunschweig University of Technology; University of Manchester	Warren, MJ (corresponding author), Univ Kent, Dept Biosci, Sch Biosci, Canterbury CT2 7NJ, Kent, England.	m.j.warren@kent.ac.uk	Moore, Simon/J-2339-2012	Howard, Mark/0000-0002-0762-2887; Moore, Simon/0000-0002-1968-206X; Biedendieck, Rebekka/0000-0002-3567-6196; Warren, Martin/0000-0002-6028-6456	Biotechnology and Biological Sciences Research Council [BB/I012079, BB/E024203]; BBSRC [BB/E013007/1, BB/I020047/1, BB/I012079/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013007/1, BB/I012079/1, BB/I020047/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council studentship and Grants BB/I012079 and BB/E024203.	BARG H, 2005, MICROBIAL PROCESSES, P165; Biedendieck R, 2007, BIOTECHNOL BIOENG, V96, P525, DOI 10.1002/bit.21145; Brindley AA, 2003, J BIOL CHEM, V278, P22388, DOI 10.1074/jbc.M302468200; DAILEY HA, 1994, BIOCHEMISTRY-US, V33, P403, DOI 10.1021/bi00168a003; Frank S, 2005, BIOCHEM SOC T, V33, P811, DOI 10.1042/BST0330811; Frank S., 2007, THESIS QUEEN MARY U; Frank S, 2007, J BIOL CHEM, V282, P23957, DOI 10.1074/jbc.M703827200; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; Leech HK, 2003, J BIOL CHEM, V278, P41900, DOI 10.1074/jbc.M306112200; Minot GR, 1926, J AMER MED ASSOC, V87, P470, DOI 10.1001/jama.1926.02680070016005; NUSSBAUMER C, 1981, P NATL ACAD SCI USA, V78, P9, DOI 10.1073/pnas.78.1.9; Ollagnier-de Choudens S, 2000, BIOCHEMISTRY-US, V39, P4165, DOI 10.1021/bi992090u; Raux E, 1998, BIOCHEM J, V335, P167, DOI 10.1042/bj3350167; Raux E, 1998, BIOCHEM J, V335, P159, DOI 10.1042/bj3350159; Raux E, 2003, BIOCHEM J, V370, P505, DOI 10.1042/BJ20021443; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Roessner CA, 2001, VITAM HORM, V61, P267; Roessner CA, 2006, J BACTERIOL, V188, P7331, DOI 10.1128/JB.00918-06; Romao CV, 2011, P NATL ACAD SCI USA, V108, P97, DOI 10.1073/pnas.1014298108; Saha K, 2012, BIOCHEM J, V444, P227, DOI 10.1042/BJ20111993; Santander PJ, 1997, CHEM BIOL, V4, P659, DOI 10.1016/S1074-5521(97)90221-0; Schroeder S, 2009, J BIOL CHEM, V284, P4796, DOI 10.1074/jbc.M807184200; Schubert HL, 2008, BIOCHEM J, V415, P257, DOI 10.1042/BJ20080785; Scott AI, 1996, P NATL ACAD SCI USA, V93, P14316, DOI 10.1073/pnas.93.25.14316; SCOTT AI, 1993, FEBS LETT, V331, P105, DOI 10.1016/0014-5793(93)80306-F; Spencer P, 1998, BIOCHEMISTRY-US, V37, P14917, DOI 10.1021/bi981366f; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; WARREN MJ, 1990, TRENDS BIOCHEM SCI, V15, P486, DOI 10.1016/0968-0004(90)90304-T	29	11	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					297	305		10.1074/jbc.M112.422535	http://dx.doi.org/10.1074/jbc.M112.422535			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23155054	hybrid, Green Published			2022-12-28	WOS:000313197200032
J	Yang, Y; Bhatti, A; Ke, DX; Gonzalez-Juarrero, M; Lenaerts, A; Kremer, L; Guerardel, Y; Zhang, PJ; Ojha, AK				Yang, Yong; Bhatti, Alexandra; Ke, Danxia; Gonzalez-Juarrero, Mercedes; Lenaerts, Anne; Kremer, Laurent; Guerardel, Yann; Zhang, Peijun; Ojha, Anil K.			Exposure to a Cutinase-like Serine Esterase Triggers Rapid Lysis of Multiple Mycobacterial Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE MYCOLIC ACIDS; CORD FACTOR; TUBERCULOSIS; ANTIGEN; GROWTH; IDENTIFICATION; PERMEABILITY; MONOMYCOLATE; INHIBITION; MEMBRANE	Mycobacteria are shaped by a thick envelope made of an array of uniquely structured lipids and polysaccharides. However, the spatial organization of these molecules remains unclear. Here, we show that exposure to an esterase from Mycobacterium smegmatis (Msmeg_1529), hydrolyzing the ester linkage of trehalose dimycolate in vitro, triggers rapid and efficient lysis of Mycobacterium tuberculosis, Mycobacterium bovis BCG, and Mycobacterium marinum. Exposure to the esterase immediately releases free mycolic acids, while concomitantly depleting trehalose mycolates. Moreover, lysis could be competitively inhibited by an excess of purified trehalose dimycolate and was abolished by a S124A mutation affecting the catalytic activity of the esterase. These findings are consistent with an indispensable structural role of trehalose mycolates in the architectural design of the exposed surface of the mycobacterial envelope. Importantly, we also demonstrate that the esterase-mediated rapid lysis of M. tuberculosis significantly improves its detection in paucibacillary samples.	[Yang, Yong; Bhatti, Alexandra; Ojha, Anil K.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA; [Ke, Danxia; Zhang, Peijun] Univ Pittsburgh, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Gonzalez-Juarrero, Mercedes; Lenaerts, Anne] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Kremer, Laurent] Univ Montpellier 2, CNRS, UMR 5235, Lab Dynam Interact Membranaires Normales & Pathol, Montpellier 05, France; [Kremer, Laurent] INSERM, F-34095 Montpellier 05, France; [Guerardel, Yann] CNRS, UMR 8576, F-596 Villeneuve Dascq, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Colorado State University; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Ojha, AK (corresponding author), Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA.	ano7@pitt.edu	Lenaerts, Anne/F-1353-2017; Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Bhatti, Alexandra/0000-0002-5783-2911; gonzalez-juarrero, mercedes/0000-0002-4045-2365; Guerardel, Yann/0000-0003-4967-9512	National Institutes of Health [AI079288, GM085043]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085043] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI079288 (to A. O.) and GM085043 (to P.Z.).	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Besra GS, 1998, METH MOL B, V101, P91, DOI 10.1385/0-89603-471-2:91; BLOCH H, 1950, J EXP MED, V91, P197, DOI 10.1084/jem.91.2.197; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brust B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025078; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; El-Hajj HH, 2001, J CLIN MICROBIOL, V39, P4131, DOI 10.1128/JCM.39.11.4131-4137.2001; Fujita Y, 2005, MICROBIOL-SGM, V151, P3403, DOI 10.1099/mic.0.28158-0; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; Grange J, 1996, MYCOBACTERIA HUMAN D, P41; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Harth G, 2007, P NATL ACAD SCI USA, V104, P7199, DOI 10.1073/pnas.0701725104; Hattori Y, 2011, BIOCHEM BIOPH RES CO, V409, P304, DOI 10.1016/j.bbrc.2011.04.146; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Kai M, 2007, FEBS LETT, V581, P3345, DOI 10.1016/j.febslet.2007.06.029; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Matsunaga I, 2008, J BIOL CHEM, V283, P28835, DOI 10.1074/jbc.M805776200; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Niederweis M, 2010, TRENDS MICROBIOL, V18, P109, DOI 10.1016/j.tim.2009.12.005; NIKAIDO H, 1991, RES MICROBIOL, V142, P437, DOI 10.1016/0923-2508(91)90117-S; NOLL H, 1956, BIOCHIM BIOPHYS ACTA, V20, P299, DOI 10.1016/0006-3002(56)90289-X; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Ojha AK, 2010, J BIOL CHEM, V285, P17380, DOI 10.1074/jbc.M110.112813; OrtaloMagne A, 1996, J BACTERIOL, V178, P456, DOI 10.1128/jb.178.2.456-461.1996; Parish T, 1998, METH MOL B, V101, P77, DOI 10.1385/0-89603-471-2:77; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rombouts Y, 2012, J BIOL CHEM, V287, P11060, DOI 10.1074/jbc.M111.327387; SHINNICK TM, 1994, EUR J CLIN MICROBIOL, V13, P884, DOI 10.1007/BF02111489; Studer D, 2001, J MICROSC-OXFORD, V203, P285, DOI 10.1046/j.1365-2818.2001.00919.x; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; VANBOXTEL RM, 1990, ANTIMICROB AGENTS CH, V34, P2300, DOI 10.1128/AAC.34.12.2300; Villeneuve M, 2005, BBA-BIOMEMBRANES, V1715, P71, DOI 10.1016/j.bbamem.2005.07.005; Warrier T, 2012, ANTIMICROB AGENTS CH, V56, P1735, DOI 10.1128/AAC.05742-11	40	9	9	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					382	392		10.1074/jbc.M112.419754	http://dx.doi.org/10.1074/jbc.M112.419754			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23155047	hybrid, Green Published			2022-12-28	WOS:000313197200039
J	Courilleau, D; Bisserier, M; Jullian, JC; Lucas, A; Bouyssou, P; Fischmeister, R; Blondeau, JP; Lezoualc'h, F				Courilleau, Delphine; Bisserier, Malik; Jullian, Jean-Christophe; Lucas, Alexandre; Bouyssou, Pascal; Fischmeister, Rodolphe; Blondeau, Jean-Paul; Lezoualc'h, Frank			Identification of a Tetrahydroquinoline Analog as a Pharmacological Inhibitor of the cAMP-binding Protein Epac	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR; RAP1; ACTIVATION; MECHANISM; FAMILY	The cAMP-binding protein Epac is a therapeutic target for the treatment of various diseases such as cardiac hypertrophy and tumor invasion. This points out the importance to develop Epac inhibitors to better understand the involvement of these cAMP sensors in physiology and pathophysiology. Here, we have developed a functional fluorescence-based high-throughput assay with a Z' value around 0.7 for screening Epac-specific antagonists. We identified an Epac1 inhibitor compound named CE3F4 that blocked Epac1 guanine nucleotide exchange activity toward its effector Rap1 both in cell-free systems and in intact cells. CE3F4 is a tetrahydroquinoline analog that fails to influence protein kinase A holoenzyme activity. CE3F4 inhibited neither the interaction of Rap1 with Epac1 nor directly the GDP exchange on Rap1. The kinetics of inhibition by CE3F4 indicated that this compound did not compete for binding of agonists to Epac1 and suggested an uncompetitive inhibition mechanism with respect to Epac1 agonists. A structure-activity study showed that the formyl group on position 1 and the bromine atom on position 5 of the tetrahydroquinoline skeleton were important for CE3F4 to exert its inhibitory activity. Finally, CE3F4 inhibited Rap1 activation in living cultured cells, following Epac activation by either 8-(4-chlorophenylthio)-2'-O-methyl-cAMP, an Epac-selective agonist, or isoprenaline, a non-selective beta-adrenergic receptor agonist. Our study shows that CE3F4 and related compounds may serve as a basis for the development of new therapeutic drugs.	[Courilleau, Delphine; Fischmeister, Rodolphe; Blondeau, Jean-Paul] Univ Paris 11, Fac Pharm, CIBLOT, IFR 141, F-92296 Chatenay Malabry, France; [Bisserier, Malik; Lucas, Alexandre; Lezoualc'h, Frank] Inst Malad Metabol & Cardiovasc, UMR 1048, INSERM, F-31432 Toulouse 04, France; [Jullian, Jean-Christophe] CNRS, Fac Pharm, UMR 8076, BioCIS, F-92296 Chatenay Malabry, France; [Bisserier, Malik; Lucas, Alexandre; Lezoualc'h, Frank] Univ Toulouse 3, F-31432 Toulouse 04, France; [Bouyssou, Pascal] Univ Orleans, CNRS, UMR 7311, Inst Chim Organ & Analyt, F-45067 Orleans 2, France; [Fischmeister, Rodolphe] INSERM, UMR S 769, LabEx LERMIT, F-92296 Chatenay Malabry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Institut National de la Sante et de la Recherche Medicale (Inserm)	Blondeau, JP (corresponding author), Univ Paris 11, Fac Pharm, CIBLOT, IFR 141, F-92296 Chatenay Malabry, France.	jean-paul.blondeau@u-psud.fr; frank.lezoualch@inserm.fr	Bisserier, Malik/AAI-3730-2021; Lezoualc'h, Frank/E-5031-2016; Lucas, Ana/GZA-9861-2022; Fischmeister, Rodolphe/L-6061-2018; Blondeau, Jean-Paul/AAH-6395-2019	Bisserier, Malik/0000-0001-8826-4649; Fischmeister, Rodolphe/0000-0003-2086-9865; Blondeau, Jean-Paul/0000-0003-4520-6822	Agence Nationale de la Recherche ("HyperEpac" Genopath09); Region Midi-Pyrenees; Association Francaise contre les Myopathies; Fondation pour la Recherche Medicale (Programme Cardiovasculaire); Centre National de la Recherche Scientifique	Agence Nationale de la Recherche ("HyperEpac" Genopath09)(French National Research Agency (ANR)); Region Midi-Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Fondation pour la Recherche Medicale (Programme Cardiovasculaire)(Fondation pour la Recherche Medicale); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the Agence Nationale de la Recherche ("HyperEpac" Genopath09), Region Midi-Pyrenees, and Association Francaise contre les Myopathies and Fondation pour la Recherche Medicale (Programme Cardiovasculaire) (to F.L.). This work was also supported by a grant from the Centre National de la Recherche Scientifique (Programme Interdisciplinaire de Recherche Innovation Therapeutique 2010) (to J.P.B.).	BOUYSSOU P, 1992, J HETEROCYCLIC CHEM, V29, P895, DOI 10.1002/jhet.5570290436; Breckler M, 2011, CELL SIGNAL, V23, P1257, DOI 10.1016/j.cellsig.2011.03.007; Chen HJ, 2012, BIOORG MED CHEM LETT, V22, P4038, DOI 10.1016/j.bmcl.2012.04.082; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; CORNISHB.A, 1974, BIOCHEM J, V137, P143, DOI 10.1042/bj1370143; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Metrich M, 2008, CIRC RES, V102, P959, DOI 10.1161/CIRCRESAHA.107.164947; Metrich M, 2010, PFLUG ARCH EUR J PHY, V459, P535, DOI 10.1007/s00424-009-0747-y; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Rehmann H, 2006, METHOD ENZYMOL, V407, P159, DOI 10.1016/S0076-6879(05)07014-X; Tsalkova T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030441; vandenBerghe N, 1997, ONCOGENE, V15, P845, DOI 10.1038/sj.onc.1201407; Wollert KC, 1996, J BIOL CHEM, V271, P9535, DOI 10.1074/jbc.271.16.9535; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhong N, 2005, J NEUROSCI, V25, P208, DOI 10.1523/JNEUROSCI.3703-04.2005	22	79	82	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44192	44202		10.1074/jbc.M112.422956	http://dx.doi.org/10.1074/jbc.M112.422956			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23139415	hybrid, Green Published			2022-12-28	WOS:000312938600018
J	Zhang, HS; Yan, B; Li, XB; Fan, L; Zhang, YF; Wu, GH; Li, M; Fang, J				Zhang, Hai-Sheng; Yan, Bing; Li, Xue-Bing; Fan, Li; Zhang, Yun-Fang; Wu, Guo-Hao; Li, Min; Fang, Jing			PAX2 Protein Induces Expression of Cyclin D1 through Activating AP-1 Protein and Promotes Proliferation of Colon Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; KAPPA-B; PHOSPHORYLATION; CARCINOMA; APOPTOSIS; TARGET; GENES; TUMORIGENESIS; INHIBITION; REGULATOR	Paired box (PAX) 2, a transcription factor, plays a critical role in embryogenesis. When aberrantly expressed in adult tissues, it generally exhibits oncogenic properties. However, the underlying mechanisms remain unclear. We reported previously that the expression of PAX2 was up-regulated in human colon cancers. However, the role of PAX2 in colon cancer cells has yet to be determined. The aim of this study is to determine the function of PAX2 in colon cancer cells and to investigate the possible mechanisms underlain. We find that knockdown of PAX2 inhibits proliferation and xenograft growth of colon cancer cells. Inhibition of PAX2 results in a decreased expression of cyclin D1. Expression of cyclin D1 is found increased in human primary colon malignant tumors, and its expression is associated with that of PAX2. These data indicate that PAX2 is a positive regulator of expression of cyclin D1. We find that knockdown of PAX2 inhibits the activity of AP-1, a transcription factor that induces cyclin D1 expression, implying that PAX2 induces cyclin D1 through AP-1. PAX2 has little effect on expression of AP-1 members including c-Jun, c-Fos, and JunB. Our data show that PAX2 prevents JunB from binding c-Jun and enhances phosphorylation of c-Jun, which may elevate the activity of AP-1. Taken together, these results suggest that PAX2 promotes proliferation of colon cancer cells through AP-1.	[Zhang, Hai-Sheng; Yan, Bing; Li, Xue-Bing; Fan, Li; Fang, Jing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China; [Wu, Guo-Hao] Fudan Univ, Zhongshan Hosp, Sch Med, Dept Surg, Shanghai 200030, Peoples R China; [Li, Min] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Vivian L Smith Dept Neurosurg, Houston, TX 77030 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; University of Texas System; University of Texas Health Science Center Houston	Fang, J (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China.	jfang@sibs.ac.cn	Yan, Binghua/ACD-0393-2022	Yan, Binghua/0000-0003-3255-6559; Wu, Guohao/0000-0001-9490-4200	Natural Science Foundation of China [30970586]; Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-R-09]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by the Natural Science Foundation of China (Grant 30970586) and the Innovation Program of the Chinese Academy of Sciences (Grant KSCX2-EW-R-09).	ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Arber N, 1996, GASTROENTEROLOGY, V110, P669, DOI 10.1053/gast.1996.v110.pm8608874; Ashida Reiko, 2005, Inflammopharmacology, V13, P113, DOI 10.1163/156856005774423935; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Buttiglieri S, 2004, J BIOL CHEM, V279, P4136, DOI 10.1074/jbc.M306824200; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; Davies RJ, 2005, NAT REV CANCER, V5, P199, DOI 10.1038/nrc1569; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fang J, 2007, CARCINOGENESIS, V28, P713, DOI 10.1093/carcin/bgl189; Gibson W, 2007, CANCER LETT, V248, P251, DOI 10.1016/j.canlet.2006.08.007; GNARRA JR, 1995, CANCER RES, V55, P4092; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hueber PA, 2006, KIDNEY INT, V69, P1139, DOI 10.1038/sj.ki.5000136; Hueber PA, 2008, CANCER LETT, V265, P148, DOI 10.1016/j.canlet.2008.02.016; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Li ZD, 2012, J BIOL CHEM, V287, P17737, DOI 10.1074/jbc.M111.291708; Luu VD, 2009, CLIN CANCER RES, V15, P3297, DOI 10.1158/1078-0432.CCR-08-2779; Maeda S, 2003, CANCER CELL, V3, P102, DOI 10.1016/S1535-6108(03)00025-4; Matthews CP, 2007, CURR CANCER DRUG TAR, V7, P317, DOI 10.2174/156800907780809723; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Nagata D, 2001, J BIOL CHEM, V276, P662, DOI 10.1074/jbc.M005522200; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Palmqvist R, 2000, AM J PATHOL, V157, P1947, DOI 10.1016/S0002-9440(10)64833-X; Palmqvist R, 1998, EUR J CANCER, V34, P1575, DOI 10.1016/S0959-8049(98)00162-2; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Reddy SPM, 2002, AM J PHYSIOL-LUNG C, V283, pL1161, DOI 10.1152/ajplung.00140.2002; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Sancho R, 2009, EMBO J, V28, P1843, DOI 10.1038/emboj.2009.153; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Suto R, 2004, GENE THER, V11, P187, DOI 10.1038/sj.gt.3302158; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Torban E, 2000, AM J PATHOL, V157, P833, DOI 10.1016/S0002-9440(10)64597-X; Wang HLL, 2002, INT J CANCER, V101, P301, DOI 10.1002/ijc.10630; Xu YM, 2010, CANCER RES, V70, P3218, DOI 10.1158/0008-5472.CAN-09-4306; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yan B, 2011, BIOCHEM BIOPH RES CO, V409, P315, DOI 10.1016/j.bbrc.2011.05.012	41	25	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44164	44172		10.1074/jbc.M112.401521	http://dx.doi.org/10.1074/jbc.M112.401521			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23135283	Green Published, hybrid			2022-12-28	WOS:000312938600015
J	Hori, N; Yamane, M; Kouno, K; Sato, K				Hori, Naohiro; Yamane, Mariko; Kouno, Kaori; Sato, Kenzo			Induction of DNA Demethylation Depending on Two Sets of Sox2 and Adjacent Oct3/4 Binding Sites (Sox-Oct Motifs) within the Mouse H19/Insulin-like Growth Factor 2 (Igf2) Imprinted Control Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTIONAL REGULATION; PATERNAL METHYLATION; GENE-EXPRESSION; CPG ISLAND; H19 LOCUS; PROMOTER; COMPLEX; ELEMENTS; OCTAMER	DNA demethylation is used to establish and maintain an unmethylated state. The molecular mechanisms to induce DNA demethylation at a particular genomic locus remain unclear. The mouse H19/insulin-like growth factor 2 (Igf2) imprinted control region (ICR) is a methylation state-sensitive insulator that regulates transcriptional activation of both genes. The unmethylated state of the ICR established in female germ cells is maintained during development, resisting the wave of genome-wide de novo methylation. We previously demonstrated that a DNA fragment (fragment b) derived from this ICR-induced DNA demethylation when it was transfected into undifferentiated mouse embryonal carcinoma cell lines. Moreover, two octamer motifs within fragment b were necessary to induce this DNA demethylation. Here, we demonstrated that both octamer motifs and their flanking sequences constitute Sox-Oct motifs (SO1 and SO2) and that the SO1 region, which requires at least four additional elements, including the SO2 region, contributes significantly to the induction of high-frequency DNA demethylation as a Sox-Oct motif. Moreover, RNAi-mediated inhibition of Oct3/4 expression in P19 cells resulted in a reduced DNA demethylation frequency of fragment b but not of the adenine phosphoribosyltransferase gene CpG island. The Sox motif of SO1 could function as a sensor for a hypermethylated state of the ICR to repress demethylation activity. These results indicate that Sox-Oct motifs in the ICR determine the cell type, DNA region, and allele specificity of DNA demethylation. We propose a link between the mechanisms for maintenance of the unmethylated state of the H19/Igf2 ICR and the undifferentiated cell-specific induction of DNA demethylation.	[Hori, Naohiro; Yamane, Mariko; Kouno, Kaori; Sato, Kenzo] Tottori Univ, Div Mol Biol, Dept Mol & Cellular Biol, Sch Life Sci,Fac Med, Yonago, Tottori 6838503, Japan; [Hori, Naohiro; Sato, Kenzo] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori 6838503, Japan	Tottori University; Tottori University	Hori, N (corresponding author), Tottori Univ, Div Mol Biol, Dept Mol & Cellular Biol, Sch Life Sci,Fac Med, Nishi Cho 86, Yonago, Tottori 6838503, Japan.	horinao@med.tottori-u.ac.jp		Yamane, Mariko/0000-0001-8354-174X				Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Demars J, 2010, HUM MOL GENET, V19, P803, DOI 10.1093/hmg/ddp549; Hori N, 2002, J BIOL CHEM, V277, P27960, DOI 10.1074/jbc.M202280200; Jin ZG, 2009, J BIOL CHEM, V284, P8160, DOI 10.1074/jbc.M805632200; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Rand E, 2004, CURR BIOL, V14, P1007, DOI 10.1016/j.cub.2004.05.041; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Xia CH, 2007, DIFFERENTIATION, V75, P912, DOI 10.1111/j.1432-0436.2007.00188.x	30	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					44006	44016		10.1074/jbc.M112.424580	http://dx.doi.org/10.1074/jbc.M112.424580			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115243	hybrid, Green Published			2022-12-28	WOS:000312940800075
J	Lu, H; Hu, L; Li, TS; Lahiri, S; Shen, C; Wason, MS; Mukherjee, D; Xie, H; Yu, L; Zhao, JH				Lu, Heng; Hu, Liu; Li, Tianshu; Lahiri, Satadru; Shen, Chao; Wason, Melissa S.; Mukherjee, Debarati; Xie, Hui; Yu, Lin; Zhao, Jihe			A Novel Role of Kruppel-like Factor 8 in DNA Repair in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CYCLIN D1; KLF8 TRANSCRIPTION; GENOMIC STABILITY; DAMAGE RESPONSE; EXCISION-REPAIR; ACTIVATION; PROTEIN; PARP-1; IDENTIFICATION	Kruppel-like factor 8 (KLF8) regulates critical gene transcription and cellular events associated with cancer. However, the role of KLF8 in cancer remains largely unknown. Here, we report a surprisingly novel role for KLF8 inDNArepair in breast cancer cells. Comet, clonogenic, and WST-1 assays showed that KLF8 expression is required for protecting human breast cancer cells from doxorubicin-induced DNA damage and cell death. Western blotting indicated that overexpression of ectopic KLF8 attenuated the levels of the DNA damage marker gamma H2A.X in doxorubicin-treated PARP-1(+/+) but not PARP-1(-/-) mouse embryonic fibroblasts, whereas the PARP-1-binding-defective KLF8 mutant failed to do so. Interestingly, in response to the DNA damage, KLF8 was phosphorylated by the DNA-dependent protein kinase catalytic subunit and, subsequently, SUMOylated by SUMO E3 ligases protein inhibitors of activated STAT (PIASs), which depends upon the interaction of KLF8 with DNA-dependent protein kinase catalytic subunit, PIASs, and PARP-1 as well as their enzymatic activities. Lastly, we show evidence that KLF8 was recruited to the DNA damage site. These results suggest a novel role and mechanism for KLF8 in the regulation of DNA repair and therapeutic resistance in breast cancer cells.	[Lu, Heng; Hu, Liu; Li, Tianshu; Lahiri, Satadru; Shen, Chao; Wason, Melissa S.; Mukherjee, Debarati; Yu, Lin; Zhao, Jihe] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA; [Xie, Hui] Florida Hosp, Translat Res Inst Metab & Diabet, Orlando, FL 32804 USA	State University System of Florida; University of Central Florida; Adventist Health Services; AdventHealth	Zhao, JH (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.	jihe.zhao@ucf.edu	Lahiri, Satadru/J-3483-2019; Li, Tianshu/L-6426-2014	Li, Tianshu/0000-0002-9972-4644	NCI [CA132977]; Susan G. Komen for the Cure Grants [KG090444, KG080616]; NATIONAL CANCER INSTITUTE [R01CA132977] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen for the Cure Grants(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI Grant CA132977 and Susan G. Komen for the Cure Grants KG090444 and KG080616 (to J. Z.).	Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Cao Q, 2011, MOL CARCINOGEN, V50, P863, DOI 10.1002/mc.20791; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fu WJ, 2010, J CANCER RES CLIN, V136, P1255, DOI 10.1007/s00432-010-0776-0; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Li JC, 2010, GASTROENTEROLOGY, V139, P2146, DOI 10.1053/j.gastro.2010.08.004; Lieber MR, 2010, SUBCELL BIOCHEM, V50, P279, DOI 10.1007/978-90-481-3471-7_14; Liu LL, 2012, TUMOR BIOL, V33, P53, DOI 10.1007/s13277-011-0245-7; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Lu H, 2011, J BIOL CHEM, V286, P20335, DOI 10.1074/jbc.M110.215632; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Sajish M, 2012, NAT CHEM BIOL, V8, P547, DOI [10.1038/NCHEMBIO.937, 10.1038/nchembio.937]; Schnell O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030429; Urvalek AM, 2011, AM J TRANSL RES, V3, P121; Urvalek AM, 2010, CELL CYCLE, V9, P601, DOI 10.4161/cc.9.3.10606; Wan WF, 2012, MOL MED REP, V5, P347, DOI 10.3892/mmr.2011.669; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Wang X, 2011, ONCOGENE, V30, P1901, DOI 10.1038/onc.2010.563; Wang XH, 2008, J BIOL CHEM, V283, P13934, DOI 10.1074/jbc.M709300200; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Yoon JH, 2012, BIOCHEM PHARMACOL, V83, P747, DOI 10.1016/j.bcp.2011.12.029; Zerfaoui M, 2010, J IMMUNOL, V185, P1894, DOI 10.4049/jimmunol.1000646; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	37	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43720	43729		10.1074/jbc.M112.418053	http://dx.doi.org/10.1074/jbc.M112.418053			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23105099	Green Published, hybrid			2022-12-28	WOS:000312940800051
J	Ohlig, S; Pickhinke, U; Sirko, S; Bandari, S; Hoffmann, D; Dreier, R; Farshi, P; Gotz, M; Grobe, K				Ohlig, Stefanie; Pickhinke, Ute; Sirko, Svetlana; Bandari, Shyam; Hoffmann, Daniel; Dreier, Rita; Farshi, Pershang; Goetz, Magdalena; Grobe, Kay			An Emerging Role of Sonic Hedgehog Shedding as a Modulator of Heparan Sulfate Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-RANGE ACTIVITY; PSEUDO-ACTIVE-SITE; CHOLESTEROL MODIFICATION; CELLULAR CHOLESTEROL; MORPHOGEN GRADIENTS; LIPID RAFTS; TOUT-VELU; PROTEIN; DROSOPHILA; FORM	Major developmental morphogens of the Hedgehog (Hh) family act at short range and long range to direct cell fate decisions in vertebrate and invertebrate tissues. To this end, Hhs are released from local sources and act at a distance on target cells that express the Hh receptor Patched. However, morphogen secretion and spreading are not passive processes because all Hhs are synthesized as dually (N- and C-terminal) lipidated proteins that firmly tether to the surface of producing cells. On the cell surface, Hhs associate with each other and with heparan sulfate (HS) proteoglycans. This raises the question of how Hh solubilization and spreading is achieved. We recently discovered that Sonic hedgehog (Shh) is solubilized by proteolytic processing (shedding) of lipidated peptide termini in vitro. Because unprocessed N termini block Patched receptor binding sites in the cluster, we further suggested that their proteolytic removal is required for simultaneous Shh activation. In this work we confirm inactivity of unprocessed protein clusters and demonstrate restored biological Shh function upon distortion or removal of N-terminal amino acids and peptides. We further show that N-terminal Shh processing targets and inactivates the HS binding Cardin-Weintraub (CW) motif, resulting in soluble Shh clusters with their HS binding capacities strongly reduced. This may explain the ability of Shh to diffuse through the HS-containing extracellular matrix, whereas other HS-binding proteins are quickly immobilized. Our in vitro findings are supported by the presence of CW-processed Shh in murine brain samples, providing the first in vivo evidence for Shh shedding and subsequent solubilization of N-terminal-truncated proteins.	[Ohlig, Stefanie; Pickhinke, Ute; Bandari, Shyam; Dreier, Rita; Farshi, Pershang; Grobe, Kay] Univ Hosp Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Sirko, Svetlana; Goetz, Magdalena] Univ Munich, Inst Physiol Genom, D-80336 Munich, Germany; [Hoffmann, Daniel] Univ Duisburg Essen, Ctr Med Biotechnol, D-45117 Essen, Germany	University of Munster; University of Munich; University of Duisburg Essen	Grobe, K (corresponding author), Univ Hosp Munster, Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-48149 Munster, Germany.	kgrobe@uni-muenster.de	Grobe, Kay/F-2399-2011; Hoffmann, Daniel/B-1314-2018; Sirko, Swetlana/O-5725-2019; Hoffmann, Daniel/P-5624-2019	Hoffmann, Daniel/0000-0003-2973-7869; Sirko, Swetlana/0000-0001-5950-616X; Hoffmann, Daniel/0000-0003-2973-7869	German Research Council (DFG) [SFB 492-B15]; Heinrich-Hertz fellowship; DFG fellowship [GRK1549/1]	German Research Council (DFG)(German Research Foundation (DFG)); Heinrich-Hertz fellowship; DFG fellowship(German Research Foundation (DFG))	This work was supported by German Research Council (DFG) Grant SFB 492-B15 and a Heinrich-Hertz fellowship (to K. G.) and DFG fellowship GRK1549/1 (to S. O., S. B., and U. P.).	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Amanai K, 2001, DEVELOPMENT, V128, P5119; Ayers KL, 2010, DEV CELL, V18, P605, DOI 10.1016/j.devcel.2010.02.015; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Bishop B, 2009, NAT STRUCT MOL BIOL, V16, P698, DOI 10.1038/nsmb.1607; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; BUMCROT DA, 1995, MOL CELL BIOL, V15, P2294; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Caspary T, 2002, CURR BIOL, V12, P1628, DOI 10.1016/S0960-9822(02)01147-8; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chan JA, 2009, NAT NEUROSCI, V12, P409, DOI 10.1038/nn.2287; Chang SC, 2011, J BIOL CHEM, V286, P44391, DOI 10.1074/jbc.M111.285361; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Creanga A, 2012, GENE DEV, V26, P1312, DOI 10.1101/gad.191866.112; Dawber RJ, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-21; Dierker T, 2009, J BIOL CHEM, V284, P32562, DOI 10.1074/jbc.M109.044867; Dierker T, 2009, J BIOL CHEM, V284, P8013, DOI 10.1074/jbc.M806838200; Dreier R, 2008, J BIOL CHEM, V283, P1104, DOI 10.1074/jbc.M703336200; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Farshi P, 2011, J BIOL CHEM, V286, P23608, DOI 10.1074/jbc.M110.206474; Gallet A, 2006, DEVELOPMENT, V133, P407, DOI 10.1242/dev.02212; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Kerszberg M, 1998, J THEOR BIOL, V191, P103, DOI 10.1006/jtbi.1997.0575; Kohtz JD, 2001, DEVELOPMENT, V128, P2351; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lee JD, 2001, DEV BIOL, V233, P122, DOI 10.1006/dbio.2001.0218; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Liu XQ, 2000, ANNU REV GENET, V34, P61, DOI 10.1146/annurev.genet.34.1.61; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Maun HR, 2010, J BIOL CHEM, V285, P26570, DOI 10.1074/jbc.M110.112284; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Micchelli CA, 2002, DEVELOPMENT, V129, P843; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Ohlig S, 2011, DEV CELL, V20, P764, DOI 10.1016/j.devcel.2011.05.010; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pepinsky RB, 2000, J BIOL CHEM, V275, P10995, DOI 10.1074/jbc.275.15.10995; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Peters C, 2004, P NATL ACAD SCI USA, V101, P8531, DOI 10.1073/pnas.0308449101; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rubin JB, 2002, DEVELOPMENT, V129, P2223; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; von Tresckow B, 2004, J IMMUNOL, V172, P4324, DOI 10.4049/jimmunol.172.7.4324; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Walev I, 2000, J LEUKOCYTE BIOL, V68, P865; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039; Zimina EP, 2005, J BIOL CHEM, V280, P34019, DOI 10.1074/jbc.M503751200	70	43	45	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43708	43719		10.1074/jbc.M112.356667	http://dx.doi.org/10.1074/jbc.M112.356667			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118222	Green Published, hybrid			2022-12-28	WOS:000312940800050
J	Li, CM; Fan, Y; Lan, TH; Lambert, NA; Wu, GY				Li, Chunman; Fan, Yi; Lan, Tien-Hung; Lambert, Nevin A.; Wu, Guangyu			Rab26 Modulates the Cell Surface Transport of alpha(2)-Adrenergic Receptors from the Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; GTP-BINDING PROTEIN; ANGIOTENSIN-II; ENDOPLASMIC-RETICULUM; CARDIAC MYOCYTES; INTRACELLULAR TRAFFICKING; ANTEROGRADE TRAFFICKING; MEMBRANE TRAFFICKING; RETINITIS-PIGMENTOSA; ADRENERGIC-RECEPTOR	The molecular mechanisms underlying the transport from the Golgi to the cell surface of G protein-coupled receptors remain poorly elucidated. Here we determined the role of Rab26, a Ras-like small GTPase involved in vesicle-mediated secretion, in the cell surface export of alpha(2)-adrenergic receptors. We found that transient expression of Rab26 mutants and siRNA-mediated depletion of Rab26 significantly attenuated the cell surface numbers of alpha(2A)-AR and alpha(2B)-AR, as well as ERK1/2 activation by alpha(2B)-AR. Furthermore, the receptors were extensively arrested in the Golgi by Rab26 mutants and siRNA. Moreover, Rab26 directly and activation-dependently interacted with alpha(2B)-AR, specifically the third intracellular loop. These data demonstrate that the small GTPase Rab26 regulates the Golgi to cell surface traffic of alpha(2)-adrenergic receptors, likely through a physical interaction. These data also provide the first evidence implicating an important function of Rab26 in coordinating plasma membrane protein transport.	[Li, Chunman; Fan, Yi; Lan, Tien-Hung; Lambert, Nevin A.; Wu, Guangyu] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Wu, GY (corresponding author), Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	guwu@georgiahealth.edu	Fan, Yi/Q-9252-2018	Fan, Yi/0000-0003-1783-3220	National Institutes of Health [R01GM076167, R01GM096762, R01GM078319]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078319, R01GM076167, R01GM096762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM076167 (to G. W.) and R01GM096762 and R01GM078319 (to N. A. L.).	Bustos MA, 2012, P NATL ACAD SCI USA, V109, pE2057, DOI 10.1073/pnas.1121173109; Charron AJ, 2000, TRAFFIC, V1, P675, DOI 10.1034/j.1600-0854.2000.010811.x; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Dong CM, 2006, J BIOL CHEM, V281, P38543, DOI 10.1074/jbc.M605734200; Dong CM, 2012, TRAFFIC, V13, P857, DOI 10.1111/j.1600-0854.2012.01351.x; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Dong CM, 2010, J PHARMACOL EXP THER, V333, P174, DOI 10.1124/jpet.109.161489; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Filipeanu CM, 2006, MOL PHARMACOL, V69, P1571, DOI 10.1124/mol.105.019984; Filipeanu CM, 2006, J BIOL CHEM, V281, P11097, DOI 10.1074/jbc.M511460200; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Gimelbrant AA, 2001, J BIOL CHEM, V276, P7285, DOI 10.1074/jbc.M005433200; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Luo WB, 2007, J BIOL CHEM, V282, P30246, DOI 10.1074/jbc.M703205200; Madziva MT, 2006, J BIOL CHEM, V281, P12178, DOI 10.1074/jbc.M601357200; Masuda ES, 2000, FEBS LETT, V470, P61, DOI 10.1016/S0014-5793(00)01288-6; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Morello JP, 2001, ANNU REV PHYSIOL, V63, P607, DOI 10.1146/annurev.physiol.63.1.607; Nashida T, 2006, ARCH ORAL BIOL, V51, P89, DOI 10.1016/j.archoralbio.2005.06.005; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Sanchez-Laorden BL, 2009, J CELL PHYSIOL, V220, P640, DOI 10.1002/jcp.21804; Seachrist JL, 2002, J BIOL CHEM, V277, P679, DOI 10.1074/jbc.M109022200; Stojanovic A, 2002, RECEPTOR CHANNEL, V8, P33, DOI 10.1080/10606820212137; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; Themmen APN, 1996, EUR J ENDOCRINOL, V134, P533, DOI 10.1530/eje.0.1340533; Tian XL, 2010, MOL CELL BIOL, V30, P1269, DOI 10.1128/MCB.01328-09; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Venkatesan S, 2002, J BIOL CHEM, V277, P2287, DOI 10.1074/jbc.M108321200; WAGNER ACC, 1995, BIOCHEM BIOPH RES CO, V207, P950, DOI 10.1006/bbrc.1995.1277; Wang GS, 2012, TRENDS PHARMACOL SCI, V33, P28, DOI 10.1016/j.tips.2011.09.002; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Wu GY, 2001, CIRC RES, V89, P1130, DOI 10.1161/hh2401.100427; Wu GY, 1998, J BIOL CHEM, V273, P7197, DOI 10.1074/jbc.273.13.7197; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; Yoshie S, 2000, HISTOCHEM CELL BIOL, V113, P259, DOI 10.1007/s004180000130; Zhu L, 2006, J BIOL CHEM, V281, P22289, DOI 10.1074/jbc.M602664200; Zhuang XL, 2010, ENDOCRINOLOGY, V151, P5114, DOI 10.1210/en.2010-0422	54	34	39	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42784	42794		10.1074/jbc.M112.410936	http://dx.doi.org/10.1074/jbc.M112.410936			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105096	Green Published, hybrid			2022-12-28	WOS:000312501600037
J	Zhao, YG; Zhao, HY; Miao, L; Wang, L; Sun, F; Zhang, H				Zhao, Yan G.; Zhao, Hongyu; Miao, Lin; Wang, Li; Sun, Fei; Zhang, Hong			The p53-induced Gene Ei24 Is an Essential Component of the Basal Autophagy Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENT MICE; BREAST-CANCER; CELLS; APOPTOSIS; P62; MEMBRANE; PROTEIN; P53; MYELINATION; SUPPRESSION	Ei24 is a DNA damage response gene involved in growth suppression and apoptosis. The physiological function of Ei24, however, is poorly understood. Here we generated conditional knock-out mice of Ei24 and demonstrated that EI24 is an essential component of the basal autophagy pathway. Mice with neural-specific Ei24 deficiency develop age-dependent neurological abnormalities caused by massive axon degeneration and extensive neuron loss in brain and spinal cord. Notably, ablation of Ei24 leads to vacuolated oligodendroglial cells and demyelination of axons. Liver- specific depletion of Ei24 causes severe hepatomegaly with hepatocyte hypertrophy. Ei24 deficiency impairs autophagic flux, leading to accumulation of LC3, p62 aggregates, and ubiquitin-positive inclusions. Our study indicates that Ei24 is an essential autophagy gene and plays an important role in clearance of aggregate-prone proteins in neurons and hepatocytes.	[Zhao, Yan G.; Zhao, Hongyu; Wang, Li; Sun, Fei; Zhang, Hong] Chinese Acad Sci, Inst Biophys, State Key Lab Biomacromol, Beijing 100101, Peoples R China; [Zhao, Yan G.; Zhao, Hongyu; Miao, Lin; Zhang, Hong] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; National Institute of Biological Sciences, Beijing	Zhang, H (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Biomacromol, Beijing 100101, Peoples R China.	hongzhang@sun5.ibp.ac.cn	Sun, Fei/C-4190-2015; Sun, Fei/AAR-3186-2020	Sun, Fei/0000-0002-0351-5144; Sun, Fei/0000-0002-0351-5144; Zhao, Yan/0000-0002-4588-6752	National Basic Research Program of China [2011CB910100, 2010CB835201]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (2011CB910100, 2010CB835201) (to H. Z.).	Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Gentile M, 2001, ONCOGENE, V20, P7753, DOI 10.1038/sj.onc.1204993; Gu ZM, 2000, MOL CELL BIOL, V20, P233, DOI 10.1128/MCB.20.1.233-241.2000; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Ichimura Y, 2011, EXP ANIM TOKYO, V60, P329, DOI 10.1538/expanim.60.329; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lehar SM, 1996, ONCOGENE, V12, P1181; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mork CN, 2007, FEBS LETT, V581, P5440, DOI 10.1016/j.febslet.2007.10.046; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nishiyama J, 2007, AUTOPHAGY, V3, P591, DOI 10.4161/auto.4964; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhao XS, 2005, CANCER RES, V65, P2125, DOI 10.1158/0008-5472.CAN-04-3377	30	55	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42053	42063		10.1074/jbc.M112.415968	http://dx.doi.org/10.1074/jbc.M112.415968			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23074225	Green Published, hybrid			2022-12-28	WOS:000312103000044
J	Crosby, HA; Rank, KC; Rayment, I; Escalante-Semerena, JC				Crosby, Heidi A.; Rank, Katherine C.; Rayment, Ivan; Escalante-Semerena, Jorge C.			Structural Insights into the Substrate Specificity of the Rhodopseudomonas palustris Protein Acetyltransferase RpPat IDENTIFICATION OF A LOOP CRITICAL FOR RECOGNITION BY RpPat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA SYNTHETASE; X-RAY-DIFFRACTION; COENZYME-A; REDUCTIVE METHYLATION; SALMONELLA-ENTERICA; ESCHERICHIA-COLI; LYSINE RESIDUES; RNASE R; CRYSTALLIZATION; SYNTHASE	Lysine acetylation is a post-translational modification that is important for the regulation of metabolism in both prokaryotes and eukaryotes. In bacteria, the best studied protein acetyltransferase is Pat. In the purple photosynthetic bacterium Rhodopseudomonas palustris, at least 10 AMP-forming acyl-CoA synthetase enzymes are acetylated by the Pat homologue RpPat. All bona fide RpPat substrates contain the conserved motif PX(4)GK. Here, we show that the presence of such a motif is necessary but not sufficient for recognition by RpPat. RpPat failed to acetylate the methylmalonyl-CoA synthetase of this bacterium (hereafter RpMatB) in vivo and in vitro, despite the homology of RpMatB to known RpPat substrates. We used RpMatB to identify structural determinants that are recognized by RpPat. To do this, we constructed a series of RpMatB chimeras that became substrates of RpPat. In such chimeras, a short region (11-25 residues) of RpMatB located > 20 residues N-terminal to the acetylation site was replaced with the corresponding sequences from other AMP-forming acyl-CoA synthetases that were known RpPat substrates. Strikingly, the enzymatic activity of RpMatB chimeras was regulated by acetylation both in vitro and in vivo. Crystal structures of two of these chimeras showed that the major difference between them and wild-type RpMatB was within a loop region similar to 23 angstrom from the acetylation site. On the basis of these results, we suggest that RpPat likely interacts with a relatively large surface of its substrates, in addition to the PX(4)GK motif, and that RpPat probably has relatively narrow substrate specificity.	[Escalante-Semerena, Jorge C.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Rank, Katherine C.; Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University System of Georgia; University of Georgia; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Escalante-Semerena, JC (corresponding author), Univ Georgia, Dept Microbiol, 527 Biol Sci Bldg,120 Cedar St, Athens, GA 30602 USA.	jcescala@uga.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835; Crosby, Heidi/0000-0002-0360-0779	National Institutes of Health [R01 GM62203, R01 GM83987]; National Institutes of Health Biotechnology Training Grant from USPHS [T32-GM08349]; National Institutes of Health Molecular Biosciences Training Grant from USPHS [T32-GM07215]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, T32GM008349, R01GM083987, R01GM062203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Biotechnology Training Grant from USPHS; National Institutes of Health Molecular Biosciences Training Grant from USPHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM62203 (to J. C. E.-S.) and R01 GM83987 (to I. R.).; Supported by National Institutes of Health Biotechnology Training Grant T32-GM08349 from USPHS.; Supported by National Institutes of Health Molecular Biosciences Training Grant T32-GM07215 from USPHS.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bains J, 2007, J MOL BIOL, V373, P965, DOI 10.1016/j.jmb.2007.08.008; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Brent MM, 2009, J BIOL CHEM, V284, P19412, DOI 10.1074/jbc.M109.014951; Crosby HA, 2012, APPL ENVIRON MICROB, V78, P6619, DOI 10.1128/AEM.01733-12; Crosby HA, 2012, J BIOL CHEM, V287, P15590, DOI 10.1074/jbc.M112.352104; Crosby HA, 2010, MOL MICROBIOL, V76, P874, DOI 10.1111/j.1365-2958.2010.07127.x; D'Arcy A, 1999, ACTA CRYSTALLOGR D, V55, P1623, DOI 10.1107/S0907444999008136; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gardner JG, 2006, J BACTERIOL, V188, P5460, DOI 10.1128/JB.00215-06; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Hughes AJ, 2011, CHEM BIOL, V18, P165, DOI 10.1016/j.chembiol.2010.12.014; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; KIM MK, 1991, FEMS MICROBIOL LETT, V83, P199, DOI 10.1016/0378-1097(91)90354-D; Kim YC, 2008, NAT METHODS, V5, P853, DOI 10.1038/nmeth1008-853; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kobayashi M, 1999, ACTA CRYSTALLOGR D, V55, P931, DOI 10.1107/S0907444999002115; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kurinov IV, 2003, BIOCHEM PHARMACOL, V65, P1709, DOI 10.1016/S0006-2952(03)00144-8; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Liang WX, 2012, RNA, V18, P37, DOI 10.1261/rna.030213.111; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Lima BP, 2011, MOL MICROBIOL, V81, P1190, DOI 10.1111/j.1365-2958.2011.07742.x; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCELROY HE, 1992, J CRYST GROWTH, V122, P265, DOI 10.1016/0022-0248(92)90255-H; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moore D. D, 2002, CURRENT PROTOCOLS MO, P201; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; RYPNIEWSKI WR, 1993, BIOCHEMISTRY-US, V32, P9851, DOI 10.1021/bi00088a041; Schubot FD, 2004, ACTA CRYSTALLOGR D, V60, P1981, DOI [10.1107/S0907444904023005, 10.1107/S090744490402.1005]; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Starai VJ, 2005, J BIOL CHEM, V280, P26200, DOI 10.1074/jbc.M504863200; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2003, GENETICS, V163, P545; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thao S, 2011, CURR OPIN MICROBIOL, V14, P200, DOI 10.1016/j.mib.2010.12.013; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687	60	12	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41392	41404		10.1074/jbc.M112.417360	http://dx.doi.org/10.1074/jbc.M112.417360			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23076154	Green Published, hybrid			2022-12-28	WOS:000311887600052
J	Deliu, E; Brailoiu, GC; Mallilankaraman, K; Wang, H; Madesh, M; Undieh, AS; Koch, WJ; Brailoiu, E				Deliu, Elena; Brailoiu, G. Cristina; Mallilankaraman, Karthik; Wang, Hong; Madesh, Muniswamy; Undieh, Ashiwel S.; Koch, Walter J.; Brailoiu, Eugen			Intracellular Endothelin Type B Receptor-driven Ca2+ Signal Elicits Nitric Oxide Production in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; VASCULAR ENDOTHELIN; RAT MYOMETRIUM; BLOOD-PRESSURE; CB1 RECEPTORS; IN-VITRO; DISEASE; ACTIVATION; NEURONS	Endothelin-1 exerts its actions via activation of ETA and ETB G(q/11) protein-coupled receptors, located in the plasmalemma, cytoplasm, and nucleus. Although the autocrine/paracrine nature of endothelin-1 signaling has been extensively studied, its intracrine role has been largely attributed to interaction with receptors located on nuclear membranes and the nucleoplasm. Because ETB receptors have been shown to be targeted to endolysosomes, we used intracellular microinjection and concurrent imaging methods to test their involvement in Ca2+ signaling and subsequential NO production. We provide evidence that microinjected endothelin-1 produces a dose-dependent elevation in cytosolic calcium concentration in ETB-transfected cells and endothelial cells; this response is sensitive to ETB but not ETA receptor blockade. In endothelial cells, the endothelin-1-induced Ca2+ response is abolished upon endolysosomal but not Golgi disruption. Moreover, the effect is prevented by inhibition of microautophagy and is sensitive to inhibitors of the phospholipase C and inositol 1,4,5-trisphosphate receptor. Furthermore, intracellular endothelin-1 increases nitric oxide via an ETB-dependent mechanism. Our results indicate for the first time that intracellular endothelin-1 activates endolysosomal ETB receptors and increase cytosolic Ca2+ and nitric oxide production. Endothelin-1 acts in an intracrine fashion on endolysosomal ETB to induce nitric oxide formation, thus modulating endothelial function.	[Mallilankaraman, Karthik; Madesh, Muniswamy; Koch, Walter J.; Brailoiu, Eugen] Temple Univ, Ctr Translat Med, Sch Med, Philadelphia, PA 19140 USA; [Deliu, Elena; Wang, Hong; Koch, Walter J.; Brailoiu, Eugen] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19140 USA; [Brailoiu, G. Cristina; Undieh, Ashiwel S.] Thomas Jefferson Univ, Jefferson Sch Pharm, Dept Pharmaceut Sci, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Jefferson University	Brailoiu, E (corresponding author), Temple Univ, Ctr Translat Med, Sch Med, 3500 N Broad St,Rm 951, Philadelphia, PA 19140 USA.	ebrailou@temple.edu	Deliu, Elena/O-7379-2019; Undieh, Ashiwel/ABG-4004-2020	Undieh, Ashiwel/0000-0003-1823-5230; MALLILANKARAMAN, KARTHIK/0000-0002-9492-9050	National Institutes of Health [RO1HL90804]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117654, R01HL090804, R01HL110764, R01HL077288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1HL90804 (to E. B.).	Abe Y, 2000, J BIOL CHEM, V275, P8664, DOI 10.1074/jbc.275.12.8664; Avedanian L, 2010, CAN J PHYSIOL PHARM, V88, P817, DOI 10.1139/Y10-057; Bagnall AJ, 2006, HYPERTENSION, V48, P286, DOI 10.1161/01.HYP.0000229907.58470.4c; Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; BERG TO, 1994, BIOCHEM J, V300, P229, DOI 10.1042/bj3000229; BETINA V, 1992, FOLIA MICROBIOL, V37, P3, DOI 10.1007/BF02814572; Bkaily G, 2011, AM J PHYSIOL-REG I, V300, pR251, DOI 10.1152/ajpregu.00736.2009; Black SM, 2006, VASC PHARMACOL, V45, P308, DOI 10.1016/j.vph.2006.08.005; Bourque SL, 2011, AM J PHYSIOL-REG I, V300, pR1288, DOI 10.1152/ajpregu.00397.2010; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Boya P, 2012, ANTIOXID REDOX SIGN, V17, P766, DOI 10.1089/ars.2011.4405; Brailoiu GC, 2012, J NEUROCHEM, V122, P1129, DOI 10.1111/j.1471-4159.2012.07869.x; Brailoiu GC, 2011, J BIOL CHEM, V286, P29166, DOI 10.1074/jbc.M110.217463; Brailoiu GC, 2010, J BIOL CHEM, V285, P37133, DOI 10.1074/jbc.C110.169763; Brailoiu GC, 2009, BIOCHEM J, V419, P91, DOI 10.1042/BJ20081138; Bremnes T, 2000, J BIOL CHEM, V275, P17596, DOI 10.1074/jbc.M000142200; Calebiro D, 2010, J MOL ENDOCRINOL, V45, P1, DOI 10.1677/JME-10-0014; Cook JL, 2012, AM J PHYSIOL-REG I, V302, pR482, DOI 10.1152/ajpregu.00493.2011; Deliu E, 2012, J PAIN, V13, P742, DOI 10.1016/j.jpain.2012.05.011; Deliu E, 2011, AM J PHYSIOL-CELL PH, V301, pC559, DOI 10.1152/ajpcell.00123.2011; den Boon FS, 2012, P NATL ACAD SCI USA, V109, P3534, DOI 10.1073/pnas.1118167109; EGUCHI S, 1995, J CARDIOVASC PHARM, V26, pS279; Filipeanu CM, 2001, EUR J PHARMACOL, V420, P9, DOI 10.1016/S0014-2999(01)01004-4; Foster N, 2003, BBA-MOL CELL RES, V1642, P45, DOI 10.1016/S0167-4889(03)00097-1; Gerasimenko JV, 2009, P NATL ACAD SCI USA, V106, P10758, DOI 10.1073/pnas.0904818106; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guse AH, 1997, CELL CALCIUM, V22, P91, DOI 10.1016/S0143-4160(97)90109-3; Haller H, 1996, CIRC RES, V79, P765, DOI 10.1161/01.RES.79.4.765; Jafri F, 2003, ARTERIOSCL THROM VAS, V23, P2192, DOI 10.1161/01.ATV.0000099787.21778.55; Kunz JB, 2004, J BIOL CHEM, V279, P9987, DOI 10.1074/jbc.M307905200; Li WW, 2012, CELL MOL LIFE SCI, V69, P1125, DOI 10.1007/s00018-011-0865-5; Li XC, 2011, AM J PHYSIOL-RENAL, V300, pF1076, DOI 10.1152/ajprenal.00329.2010; Loesch A, 2005, J MOL HISTOL, V36, P25, DOI 10.1007/s10735-004-2912-0; Loesch Andrzej, 2005, Current Vascular Pharmacology, V3, P381, DOI 10.2174/157016105774329381; MATSUZAWA Y, 1980, J BIOL CHEM, V255, P646; Mazzuca MQ, 2012, BIOCHEM PHARMACOL, V84, P147, DOI 10.1016/j.bcp.2012.03.020; Muller G, 2009, ANTIOXID REDOX SIGN, V11, P1711, DOI 10.1089/ARS.2008.2403; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; OBRIEN RF, 1987, J CELL PHYSIOL, V132, P263, DOI 10.1002/jcp.1041320210; Oksche A, 2000, MOL PHARMACOL, V57, P1104; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Re RN, 2007, NAT CLIN PRACT CARD, V4, P549, DOI 10.1038/ncpcardio0985; Re RN, 2011, J AM SOC HYPERTENS, V5, P435, DOI 10.1016/j.jash.2011.07.001; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; RUBIN DB, 1989, J APPL PHYSIOL, V67, P1585, DOI 10.1152/jappl.1989.67.4.1585; Russell FD, 1999, CIRC RES, V84, P891; Schiffrin EL, 2005, VASC PHARMACOL, V43, P19, DOI 10.1016/j.vph.2005.03.004; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Tadevosyan A, 2012, J PHYSIOL-LONDON, V590, P1313, DOI 10.1113/jphysiol.2011.222794; TAKAYANAGI R, 1991, FEBS LETT, V282, P103, DOI 10.1016/0014-5793(91)80454-B; Tang LP, 2007, AM J PHYSIOL-LUNG C, V292, pL1467, DOI 10.1152/ajplung.00446.2006; Tawfeek HAW, 2004, AM J PHYSIOL-ENDOC M, V286, pE704, DOI 10.1152/ajpendo.00404.2003; Tica AA, 2011, AM J PHYSIOL-CELL PH, V301, pC1262, DOI 10.1152/ajpcell.00501.2010; Xiao ZH, 2011, J BIOL CHEM, V286, P20100, DOI 10.1074/jbc.M111.220236; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhuo JL, 2006, AM J PHYSIOL-RENAL, V290, pF1382, DOI 10.1152/ajprenal.00269.2005	61	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41023	41031		10.1074/jbc.M112.418533	http://dx.doi.org/10.1074/jbc.M112.418533			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23086942	Green Published, hybrid			2022-12-28	WOS:000311887600020
J	You, CJ; Dai, XX; Yuan, BF; Wang, YS				You, Changjun; Dai, Xiaoxia; Yuan, Bifeng; Wang, Yinsheng			Effects of 6-Thioguanine and S-6-Methylthioguanine on Transcription in Vitro and in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; NUCLEOTIDE EXCISION-REPAIR; DNA MISMATCH REPAIR; MUTAGENESIS CAUSES; CROSS-LINKING; CANCER; INHIBITION; OXIDATION; MECHANISM; THERAPY	Thiopurine drugs are extensively used as chemotherapeutic agents in clinical practice, even though there is concern about the risk of therapy-related cancers. It has been previously suggested that the cytotoxicity of thiopurine drugs involves their metabolic activation, the resultant generation of 6-thioguanine ((S)G) and S-6-methylthioguanine (S(6)mG) in DNA, and the futile mismatch repair triggered by replication-induced SG: T and S(6)mG: T mispairs. Disruption of transcription is known to be one of the major consequences of DNA damage induced by many antiviral and antitumor agents; however, it remains undefined how SG and S(6)mG compromise the efficiency and fidelity of transcription. Using our recently developed competitive transcription and adduct bypass assay, herein we examined the impact of SG and S(6)mG on transcription in vitro and in human cells. Our results revealed that, when situated on the transcribed strand, S(6)mG exhibited both inhibitory and mutagenic effects during transcription mediated by single-subunit T7 RNA polymerase or multisubunit human RNA polymerase II in vitro and in human cells. Moreover, we found that the impact of S(6)mG on transcriptional efficiency and fidelity is modulated by the transcription-coupled nucleotide excision repair capacity. In contrast, (S)G did not considerably compromise the efficiency or fidelity of transcription, and it was a poor substrate for NER. We propose that S(6)mG might contribute, at least in part, to thiopurine-mediated cytotoxicity through inhibition of transcription and to potential therapy-related carcinogenesis via transcriptional mutagenesis.	[You, Changjun; Dai, Xiaoxia; Yuan, Bifeng; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Yuan, Bi-Feng/K-5803-2013	Yuan, Bi-Feng/0000-0001-5223-4659; Dai, Xiaoxia/0000-0002-3514-5061; You, Changjun/0000-0003-4301-2098	National Institutes of Health [R01 DK082779]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK082779.	Ang WH, 2010, J AM CHEM SOC, V132, P7429, DOI 10.1021/ja101495v; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Bregeon D, 2011, NAT REV CANCER, V11, P218, DOI 10.1038/nrc3006; Bregeon D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000577; Brem R, 2012, CANCER RES, V72, P4787, DOI 10.1158/0008-5472.CAN-12-1278; Brem R, 2009, NUCLEIC ACIDS RES, V37, P1951, DOI 10.1093/nar/gkp070; Burns JA, 2010, NUCLEIC ACIDS RES, V38, P8178, DOI 10.1093/nar/gkq706; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; Chifotides HT, 2004, INORG CHEM, V43, P1175, DOI 10.1021/ic034438m; Chouchana L, 2012, ALIMENT PHARM THER, V35, P15, DOI 10.1111/j.1365-2036.2011.04905.x; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Derheimer FA, 2005, EUR J CANCER, V41, P2569, DOI 10.1016/j.ejca.2005.08.012; Dimitri A, 2008, NUCLEIC ACIDS RES, V36, P6459, DOI 10.1093/nar/gkn657; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Glaab WE, 1998, CARCINOGENESIS, V19, P1931, DOI 10.1093/carcin/19.11.1931; GRIFFIN S, 1994, BIOCHEMISTRY-US, V33, P4787, DOI 10.1021/bi00182a006; Gu CN, 2007, NUCLEIC ACIDS RES, V35, P3693, DOI 10.1093/nar/gkm247; Gueranger Q, 2011, NUCLEIC ACIDS RES, V39, P5057, DOI 10.1093/nar/gkr112; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; HAWN MT, 1995, CANCER RES, V55, P3721; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; Karran P, 2006, BRIT MED BULL, V79-80, P153, DOI 10.1093/bmb/ldl020; Koumenis C, 1997, MOL CELL BIOL, V17, P7306, DOI 10.1128/MCB.17.12.7306; Krynetski EY, 2001, MOL PHARMACOL, V59, P367, DOI 10.1124/mol.59.2.367; Kuraoka I, 2006, METHOD ENZYMOL, V408, P214, DOI 10.1016/S0076-6879(06)08013-X; Lam LT, 2001, GENOME BIOL, V2; LENNARD L, 1985, BRIT J DERMATOL, V113, P723, DOI 10.1111/j.1365-2133.1985.tb02408.x; LEPAGE GA, 1963, CANCER RES, V23, P1202; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; MCLUCKEY SA, 1992, J AM SOC MASS SPECTR, V3, P60, DOI 10.1016/1044-0305(92)85019-G; O'Donovan P, 2005, SCIENCE, V309, P1871, DOI 10.1126/science.1114233; Penn I, 2000, DRUG SAFETY, V23, P101, DOI 10.2165/00002018-200023020-00002; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Relling MV, 1999, LANCET, V354, P34, DOI 10.1016/S0140-6736(98)11079-6; Ren XL, 2010, NUCLEIC ACIDS RES, V38, P1832, DOI 10.1093/nar/gkp1165; Saxowsky TT, 2008, P NATL ACAD SCI USA, V105, P18877, DOI 10.1073/pnas.0806464105; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Stellrecht Christine M, 2011, Cancers (Basel), V3, P4170, DOI 10.3390/cancers3044170; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Tiede I, 2003, J CLIN INVEST, V111, P1133, DOI 10.1172/JCI200316432; Todd RC, 2009, METALLOMICS, V1, P280, DOI 10.1039/b907567d; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang HX, 2010, ANAL CHEM, V82, P5797, DOI 10.1021/ac1008628; WARREN DJ, 1995, CANCER RES, V55, P1670; Waters TR, 1997, BIOCHEMISTRY-US, V36, P2501, DOI 10.1021/bi9621573; Yan T, 2003, CLIN CANCER RES, V9, P2327; You CJ, 2012, NAT CHEM BIOL, V8, P817, DOI 10.1038/NCHEMBIO.1046; Yuan BF, 2008, J BIOL CHEM, V283, P23665, DOI 10.1074/jbc.M804047200; Yuan BF, 2011, J BIOL CHEM, V286, P17503, DOI 10.1074/jbc.M111.232835; Yuan BF, 2011, CANCER RES, V71, P1904, DOI 10.1158/0008-5472.CAN-10-3430; Yuan BF, 2010, ACS CHEM BIOL, V5, P1021, DOI 10.1021/cb100214b; Zhu GY, 2012, CANCER RES, V72, P790, DOI 10.1158/0008-5472.CAN-11-3151	55	22	22	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40915	40923		10.1074/jbc.M112.418681	http://dx.doi.org/10.1074/jbc.M112.418681			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23076150	Green Published, hybrid			2022-12-28	WOS:000311887600011
J	Chu, J; Pham, NT; Olate, N; Kislitsyna, K; Day, MC; LeTourneau, PA; Kots, A; Stewart, RH; Laine, GA; Cox, CS; Uray, K				Chu, Ji; Pham, Ngoc T.; Olate, Nicole; Kislitsyna, Karina; Day, Mary-Clare; LeTourneau, Phillip A.; Kots, Alexander; Stewart, Randolph H.; Laine, Glen A.; Cox, Charles S., Jr.; Uray, Karen			Biphasic Regulation of Myosin Light Chain Phosphorylation by p21-activated Kinase Modulates Intestinal Smooth Muscle Contractility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATASE TARGET SUBUNIT; PROTEIN PHOSPHATASE; PAK1; RHO; STRETCH; DEPHOSPHORYLATION; IDENTIFICATION; DYSFUNCTION; INHIBITION; RELAXATION	Supraphysiological mechanical stretching in smooth muscle results in decreased contractile activity. However, the mechanism is unclear. Previous studies indicated that intestinal motility dysfunction after edema development is associated with increased smooth muscle stress and decreased myosin light chain (MLC) phosphorylation in vivo, providing an ideal model for studying mechanical stress-mediated decrease in smooth muscle contraction. Primary human intestinal smooth muscle cells (hISMCs) were subjected to either control cyclical stretch (CCS) or edema (increasing) cyclical stretch (ECS), mimicking the biophysical forces in non-edematous and edematous intestinal smooth muscle in vivo. ECS induced significant decreases in phosphorylation of MLC and MLC phosphatase targeting subunit (MYPT1) and a significant increase in p21-activated kinase (PAK) activity compared with CCS. PAK regulated MLC phosphorylation in an activity-dependent biphasic manner. PAK activation increased MLC and MYPT1 phosphorylation in CCS but decreased MLC and MYPT1 phosphorylation in hISMCs subjected to ECS. PAK inhibition had the opposite results. siRNA studies showed that PAK1 plays a critical role in regulating MLC phosphorylation in hISMCs. PAK1 enhanced MLC phosphorylation via phosphorylating MYPT1 on Thr-696, whereas PAK1 inhibited MLC phosphorylation via decreasing MYPT1 on both Thr-696 and Thr-853. Importantly, in vivo data indicated that PAK activity increased in edematous tissue, and inhibition of PAK in edematous intestine improved intestinal motility. We conclude that PAK1 positively regulates MLC phosphorylation in intestinal smooth muscle through increasing inhibitory phosphorylation of MYPT1 under physiologic conditions, whereas PAK1 negatively regulates MLC phosphorylation via inhibiting MYPT1 phosphorylation when PAK activity is increased under pathologic conditions.	[Chu, Ji; Pham, Ngoc T.; Olate, Nicole; Kislitsyna, Karina; Day, Mary-Clare; LeTourneau, Phillip A.; Cox, Charles S., Jr.; Uray, Karen] Univ Texas Med Sch, Dept Pediat Surg, Houston, TX 77030 USA; [Kots, Alexander] George Washington Univ, Sch Med & Hlth, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Stewart, Randolph H.; Laine, Glen A.; Cox, Charles S., Jr.; Uray, Karen] Texas A&M Univ, Michael E DeBakey Inst, College Stn, TX 77483 USA	University of Texas System; University of Texas Health Science Center Houston; George Washington University; Texas A&M University System; Texas A&M University College Station	Uray, K (corresponding author), Univ Texas Med Sch, Dept Pediat Surg, Houston, TX 77030 USA.	karen.l.davis@uth.tmc.edu		Uray, Karen/0000-0001-6997-459X	National Institutes of Health, NIDDK [KO1 DK 070758, P30 DK56338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK070758, P30DK056338] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grants KO1 DK 070758 and P30 DK56338.	Balogh Z, 2003, ARCH SURG-CHICAGO, V138, P637, DOI 10.1001/archsurg.138.6.637; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; BURNSTOCK G, 1960, AM J PHYSIOL, V198, P921, DOI 10.1152/ajplegacy.1960.198.5.921; Chew TL, 1998, J MUSCLE RES CELL M, V19, P839, DOI 10.1023/A:1005417926585; Chu J, 2012, NEUROGASTROENT MOTIL, V24, P257, DOI 10.1111/j.1365-2982.2011.01855.x; Coniglio SJ, 2008, MOL CELL BIOL, V28, P4162, DOI 10.1128/MCB.01532-07; Cox CS, 2008, SHOCK, V29, P598, DOI 10.1097/SHK.0b013e318157eba7; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Farrugia G, 1999, GASTROENTEROLOGY, V117, P900, DOI 10.1016/S0016-5085(99)70349-5; Funk SD, 2010, CIRC RES, V106, P1394, DOI 10.1161/CIRCRESAHA.109.210286; Girish V, 2004, Indian J Cancer, V41, P47; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Hirano K, 2003, MOL CELL BIOCHEM, V248, P105, DOI 10.1023/A:1024180101032; IKEBE M, 1986, J BIOL CHEM, V261, P36; IKEBE M, 1985, J BIOL CHEM, V260, P27; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kaneko-Kawano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039269; KASAI Y, 1995, J PHYSIOL-LONDON, V486, P373, DOI 10.1113/jphysiol.1995.sp020819; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Kehlet H, 2001, AM J SURG, V182, p3S, DOI 10.1016/S0002-9610(01)00781-4; Kiss E, 2002, BIOCHEM J, V365, P79, DOI 10.1042/BJ20011295; Kosako H., 2009, PROTOC EXCHANGE, DOI [10.1038/nprot.2009.170, DOI 10.1038/NPROT.2009.170]; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; Mann JM, 2012, LAB CHIP, V12, P731, DOI 10.1039/c2lc20896b; Mori S, 2009, PROTEINS, V77, P732, DOI 10.1002/prot.22529; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Murthy KS, 2003, BIOCHEM J, V374, P145, DOI 10.1042/BJ20021274; Niiro N, 2001, J BIOL CHEM, V276, P29567, DOI 10.1074/jbc.M102753200; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; Ramos E, 1997, RECEPT SIGNAL TRANS, V7, P99; Rudrabhatla RS, 2003, INFECT IMMUN, V71, P2787, DOI 10.1128/IAI.71.5.2787-2797.2003; Sanders KM, 2006, J PHYSIOL-LONDON, V570, P37, DOI 10.1113/jphysiol.2005.098897; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Seasholtz TM, 2004, J NEUROCHEM, V91, P501, DOI 10.1111/j.1471-4159.2004.02749.x; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Shah SK, 2010, SURGERY, V147, P772, DOI 10.1016/j.surg.2009.11.014; Sheehan KA, 2007, AM J PHYSIOL-REG I, V293, pR963, DOI 10.1152/ajpregu.00253.2007; Shi XZ, 2011, AM J PHYSIOL-GASTR L, V300, pG99, DOI 10.1152/ajpgi.00379.2010; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Sutherland C, 2012, J BIOL CHEM, V287, P24064, DOI 10.1074/jbc.M112.371609; Takizawa N, 2002, BIOCHEM BIOPH RES CO, V297, P773, DOI 10.1016/S0006-291X(02)02302-1; Takuwa Y, 1996, JPN HEART J, V37, P793; Uray KS, 2007, SHOCK, V28, P239, DOI 10.1097/shk.0b013e318033eaae; Uray KS, 2006, CRIT CARE MED, V34, P2630, DOI 10.1097/01.CCM.0000239195.06781.8C; Uray KS, 2010, CRIT CARE MED, V38, P861, DOI 10.1097/CCM.0b013e3181ce4aaa; Wirth A, 2003, J PHYSIOL-LONDON, V549, P489, DOI 10.1113/jphysiol.2002.033167; Zeng Q, 2000, J CELL SCI, V113, P471; Zhang HM, 2011, NATURE, V471, P99, DOI 10.1038/nature09765	56	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1200	1213		10.1074/jbc.M112.370718	http://dx.doi.org/10.1074/jbc.M112.370718			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23161543	Green Published, hybrid			2022-12-28	WOS:000313570300041
J	Chowdhury, B; Hemming, R; Hombach-Klonisch, S; Flamion, B; Triggs-Raine, B				Chowdhury, Biswajit; Hemming, Richard; Hombach-Klonisch, Sabine; Flamion, Bruno; Triggs-Raine, Barbara			Murine Hyaluronidase 2 Deficiency Results in Extracellular Hyaluronan Accumulation and Severe Cardiopulmonary Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART-VALVE; MUCOPOLYSACCHARIDOSIS-IX; MOUSE MODEL; EXPRESSION; CD44; MANIFESTATIONS; MORPHOGENESIS; PROTEOGLYCAN; ACTIVATION; CATABOLISM	Hyaluronidase (HYAL) 2 is a membrane-anchored protein that is proposed to hydrolyze hyaluronan (HA) to smaller fragments that are internalized for breakdown. Initial studies of a Hyal2 knock-out (KO) mouse revealed a mild phenotype with high serum HA, supporting a role for HYAL2 in HA breakdown. We now describe a severe cardiac phenotype, deemed acute, in 54% of Hyal2 KO mice on an outbred background; Hyal2 KO mice without the severe cardiac phenotype were designated non-acute. Histological studies of the heart revealed that the valves of all Hyal2 KO mice were expanded and the extracellular matrix was disorganized. HA was detected throughout the expanded valves, and electron microscopy confirmed that the accumulating material, presumed to be HA, was extracellular. Both acute and non-acute Hyal2 KO mice also exhibited increased HA in the interstitial extracellular matrix of atrial cardiomyocytes compared with control mice. Consistent with the changes in heart structure, upper ventricular cardiomyocytes in acute Hyal2 KO mice demonstrated significant hypertrophy compared with non-acute KO and control mice. When the lungs were examined, evidence of severe fibrosis was detected in acute Hyal2 KO mice but not in non-acute Hyal2 KO or control mice. Total serum and heart HA levels, as well as size, were increased in acute and non-acute Hyal2 KO mice compared with control mice. These findings indicate that HYAL2 is essential for the breakdown of extracellular HA. In its absence, extracellular HA accumulates and, in some cases, can lead to cardiopulmonary dysfunction. Alterations in HYAL2 function should be considered as a potential contributor to cardiac pathologies in humans.	[Chowdhury, Biswajit; Hemming, Richard; Triggs-Raine, Barbara] Univ Manitoba, Fac Med, Dept Biochem & Med Genet, Winnipeg, MB R3E 0J9, Canada; [Hombach-Klonisch, Sabine] Univ Manitoba, Fac Med, Dept Human Anat & Cell Sci, Winnipeg, MB R3E 0J9, Canada; [Hombach-Klonisch, Sabine] Univ Manitoba, Fac Med, Dept Obstet Gynecol & Reprod Med, Winnipeg, MB R3E 0J9, Canada; [Hombach-Klonisch, Sabine; Triggs-Raine, Barbara] Univ Manitoba, Fac Med, Dept Pediat & Child Hlth, Winnipeg, MB R3E 0J9, Canada; [Flamion, Bruno] Univ Namur, Namur Res Inst Life Sci NARILIS, Mol Physiol Res Unit URPHYM, B-5000 Namur, Belgium	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Namur	Triggs-Raine, B (corresponding author), Univ Manitoba, Fac Med, Dept Biochem & Med Genet, 745 Bannatyne Ave, Winnipeg, MB R3E 0J9, Canada.	traine@cc.umanitoba.ca	Triggs-Raine, Barbara/AAF-6209-2021; Chowdhury, Biswajit/AAN-9131-2020	Triggs-Raine, Barbara/0000-0003-4719-6779; Chowdhury, Biswajit/0000-0003-0203-8072; Hombach-Klonisch, Sabine/0000-0001-8071-2486	Canadian Institutes of Health Research [MP-89873]; Manitoba Health Research Council; University of Manitoba	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council; University of Manitoba	This work was supported in part by Canadian Institutes of Health Research Grant MP-89873.; Supported by a joint studentship from the Manitoba Health Research Council and the University of Manitoba.	ALLEN T. C., 1994, LAB METHODS HISTOTEC, P53; Andre B, 2011, BIOCHEM BIOPH RES CO, V411, P175, DOI 10.1016/j.bbrc.2011.06.125; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Atmuri V, 2008, MATRIX BIOL, V27, P653, DOI 10.1016/j.matbio.2008.07.006; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Braunlin EA, 2011, J INHERIT METAB DIS, V34, P1183, DOI 10.1007/s10545-011-9359-8; Camenisch T D, 2001, Exp Clin Cardiol, V6, P4; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Chow G, 2006, OSTEOARTHR CARTILAGE, V14, P849, DOI 10.1016/j.joca.2006.02.009; Csoka AB, 1999, GENOMICS, V60, P356, DOI 10.1006/geno.1999.5876; Csoka TB, 1998, GENOMICS, V48, P63, DOI 10.1006/geno.1997.5158; Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5; GAFFNEY E, 1994, LAB METHODS HISTOTEC, P149; Gordon LB, 2003, HUM GENET, V113, P178, DOI 10.1007/s00439-003-0958-9; Gupta V, 2009, CARDIOVASC PATHOL, V18, P191, DOI 10.1016/j.carpath.2008.05.001; Gushulak L, 2012, J BIOL CHEM, V287, P16689, DOI 10.1074/jbc.M112.350447; HASCALL VC, 1999, BIOL SYNOVIAL JOINT, P101; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Hoffmeister A, 1999, EUR J HEART FAIL, V1, P293, DOI 10.1016/S1388-9842(99)00030-6; Jadin L, 2008, FASEB J, V22, P4316, DOI 10.1096/fj.08-111997; Jordan MC, 2005, MOL GENET METAB, V86, P233, DOI 10.1016/j.ymgme.2005.05.003; Kern CB, 2010, MATRIX BIOL, V29, P304, DOI 10.1016/j.matbio.2010.01.005; Lepperdinger G, 2001, MATRIX BIOL, V20, P509, DOI 10.1016/S0945-053X(01)00170-6; Martin DC, 2008, HUM MOL GENET, V17, P1904, DOI 10.1093/hmg/ddn088; Natowicz MR, 1996, NEW ENGL J MED, V335, P1029, DOI 10.1056/NEJM199610033351405; Plaas A H, 2001, Methods Mol Biol, V171, P117; Pohl M, 2000, DEV BIOL, V224, P312, DOI 10.1006/dbio.2000.9783; Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740; Stephens EH, 2008, ACTA BIOMATER, V4, P1148, DOI 10.1016/j.actbio.2008.03.014; Stephens EH, 2011, CARDIOVASC PATHOL, V20, P334, DOI [10.1016/j.carpath.2010.10.002, 10.1016/j.carpath.2010.07.004]; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Strauch OF, 2003, PEDIATR RES, V54, P701, DOI 10.1203/01.PDR.0000084085.65972.3F; Triggs-Raine B, 1999, P NATL ACAD SCI USA, V96, P6296, DOI 10.1073/pnas.96.11.6296; UNDERHILL CB, 1993, DEV BIOL, V155, P324, DOI 10.1006/dbio.1993.1032; Vyavahare N, 1999, J BIOMED MATER RES, V46, P44	37	41	42	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					520	528		10.1074/jbc.M112.393629	http://dx.doi.org/10.1074/jbc.M112.393629			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23172227	Green Published, hybrid			2022-12-28	WOS:000313197200052
J	Liang, CY; Xiong, K; Szulwach, KE; Zhang, Y; Wang, ZH; Peng, JM; Fu, MG; Jin, P; Suzuki, HI; Liu, QH				Liang, Chunyang; Xiong, Ke; Szulwach, Keith E.; Zhang, Yi; Wang, Zhaohui; Peng, Junmin; Fu, Mingui; Jin, Peng; Suzuki, Hiroshi I.; Liu, Qinghua			Sjogren Syndrome Antigen B (SSB)/La Promotes Global MicroRNA Expression by Binding MicroRNA Precursors through Stem-Loop Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LA-PROTEIN; TRANSFER-RNA PRECURSORS; DROSOPHILA-MELANOGASTER; MICROPROCESSOR COMPLEX; DROSHA-DGCR8 COMPLEX; STRUCTURAL-ANALYSIS; NUCLEAR EXPORT; BREAST-CANCER; KSRP PROMOTES; SELF-RENEWAL	MicroRNAs (miRNA) control numerous physiological and pathological processes. Typically, the primary miRNA (pri-miRNA) transcripts are processed by nuclear Drosha complex into similar to 70-nucleotide stem-loop precursor miRNAs (pre-miRNA), which are further cleaved by cytoplasmic Dicer complex into similar to 21-nucleotide mature miRNAs. However, it is unclear how nascent pre-miRNAs are protected from ribonucleases, such as MCPIP1, that degrade pre-miRNAs to abort miRNA production. Here, we identify Sjogren syndrome antigen B (SSB)/La as a pre-miRNA-binding protein that regulates miRNA processing in vitro. All three RNA-binding motifs (LAM, RRM1, and RRM2) of La/SSB are required for efficient pre-miRNA binding. Intriguingly, La/SSB recognizes the characteristic stem-loop structure of pre-miRNAs, of which the majority lack a 3' UUU terminus. Moreover, La/SSB associates with endogenous pri-/pre-miRNAs and promotes miRNA biogenesis by stabilizing pre-miRNAs from nuclease (e.g. MCPIP1)-mediated decay in mammalian cells. Accordingly, we observed positive correlations between the expression status of La/SSB and Dicer in human cancer transcriptome and prognosis. These studies identify an important function of La/SSB as a global regulator of miRNA expression, and implicate stem-loop recognition as a major mechanism that mediates association between La/SSB and diverse RNA molecules.	[Liang, Chunyang; Xiong, Ke; Zhang, Yi; Wang, Zhaohui; Liu, Qinghua] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Xiong, Ke] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100094, Peoples R China; [Szulwach, Keith E.; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Peng, Junmin] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Fu, Mingui] Univ Missouri, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Suzuki, Hiroshi I.] Univ Tokyo, Dept Mol Pathol, Bunkyo Ku, Tokyo, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; China Agricultural University; Emory University; St Jude Children's Research Hospital; University of Missouri System; University of Missouri Kansas City; University of Tokyo	Liu, QH (corresponding author), 5323 Harry Hines Blvd,K3-219, Dallas, TX USA.	qinghua.liu@utsouthwestern.edu	Wang, Zhaohui/E-8139-2013; Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; Suzuki, Hiroshi/0000-0003-4682-5086	Ministry of Education, Culture, Sports, Science and Technology of Japan [23112702, 24689018]; Welch Foundation [I-1608]; National Institute of Health; China Scholarship Council (CSC).	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Welch Foundation(The Welch Foundation); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council (CSC).(China Scholarship Council)	This work was supported in part by Grants 23112702 and 24689018 (to H. I. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant (I-1608 to Q. L.) from the Welch Foundation, and grants from the National Institute of Health awarded to M. F., P. J., and Q. L.; Supported by an award from the China Scholarship Council (CSC).	Alfano C, 2004, NAT STRUCT MOL BIOL, V11, P323, DOI 10.1038/nsmb747; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai CY, 2000, NUCLEIC ACIDS RES, V28, P1078, DOI 10.1093/nar/28.5.1078; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bousquet-Antonelli C, 2009, RNA, V15, P750, DOI 10.1261/rna.1478709; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chakshusmathi G, 2003, EMBO J, V22, P6562, DOI 10.1093/emboj/cdg625; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Copela LA, 2006, RNA, V12, P644, DOI 10.1261/rna.2307206; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fan H, 1998, MOL CELL BIOL, V18, P3201, DOI 10.1128/MCB.18.6.3201; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jakymiw A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1959; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kotik-Kogan O, 2008, STRUCTURE, V16, P852, DOI 10.1016/j.str.2008.02.021; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Liu X, 2007, RNA, V13, P2324, DOI 10.1261/rna.723707; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Martino L, 2012, NUCLEIC ACIDS RES, V40, P1381, DOI 10.1093/nar/gkr890; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; MATTIOLI M, 1974, ARTHRITIS RHEUM-US, V17, P421, DOI 10.1002/art.1780170413; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Merritt W. M., 2010, NEW ENGL J MED, V359, P2641; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Park JM, 2006, MOL CELL BIOL, V26, P1445, DOI 10.1128/MCB.26.4.1445-1451.2006; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Pawlicki JM, 2008, J CELL BIOL, V182, P61, DOI 10.1083/jcb.200803111; Pruijn GJM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1987; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Teplova M, 2006, MOL CELL, V21, P75, DOI 10.1016/j.molcel.2005.10.027; Trabucchi M, 2010, ADV EXP MED BIOL, V700, P36, DOI 10.1007/978-1-4419-7823-3_4; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; YOO CJ, 1994, MOL CELL BIOL, V14, P5412, DOI 10.1128/MCB.14.8.5412; Yoo CJ, 1997, CELL, V89, P393, DOI 10.1016/S0092-8674(00)80220-2	66	48	48	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					723	736		10.1074/jbc.M112.401323	http://dx.doi.org/10.1074/jbc.M112.401323			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23129761	hybrid, Green Published			2022-12-28	WOS:000313197200072
J	Bachu, M; Yalla, S; Asokan, M; Verma, A; Neogi, U; Sharma, S; Murali, RV; Mukthey, AB; Bhatt, R; Chatterjee, S; Rajan, RE; Cheedarla, N; Yadavalli, VS; Mahadevan, A; Shankar, SK; Rajagopalan, N; Shet, A; Saravanan, S; Balakrishnan, P; Solomon, S; Vajpayee, M; Satish, KS; Kundu, TK; Jeang, KT; Ranga, U				Bachu, Mahesh; Yalla, Swarupa; Asokan, Mangaiarkarasi; Verma, Anjali; Neogi, Ujjwal; Sharma, Shilpee; Murali, Rajesh V.; Mukthey, Anil Babu; Bhatt, Raghavendra; Chatterjee, Snehajyoti; Rajan, Roshan Elizabeth; Cheedarla, Narayana; Yadavalli, Venkat S.; Mahadevan, Anita; Shankar, Susarla K.; Rajagopalan, Nirmala; Shet, Anita; Saravanan, Shanmugam; Balakrishnan, Pachamuthu; Solomon, Suniti; Vajpayee, Madhu; Satish, Kadappa Shivappa; Kundu, Tapas K.; Jeang, Kuan-Teh; Ranga, Udaykumar			Multiple NF-kappa B Sites in HIV-1 Subtype C Long Terminal Repeat Confer Superior Magnitude of Transcription and Thereby the Enhanced Viral Predominance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CLADE-SPECIFIC DIFFERENCES; GENE-EXPRESSION; BINDING MOTIFS; TAT PROTEIN; WIDE-RANGE; REPLICATION; IDENTIFICATION; INFECTION; SEQUENCE	Wedemonstrate that at least three different promoter variant strains of HIV-1 subtype C have been gradually expanding and replacing the standard subtype C viruses in India, and possibly in South Africa and other global regions, over the past decade. The new viral strains contain an additional NF-kappa B, NF-kappa B-like, or RBEIII site in the viral promoter. Although the acquisition of an additional RBEIII site is a property shared by all the HIV-1 subtypes, acquiring an additional NF-kappa B site remains an exclusive property of subtype C. The acquired kappa B site is genetically distinct, binds the p50-p65 heterodimer, and strengthens the viral promoter at the levels of transcription initiation and elongation. The 4-kappa B viruses dominate the 3-kappa B "isogenic" viral strains in pairwise competition assays in T-cell lines, primary cells, and the ecotropic human immunodeficiency virus mouse model. The dominance of the 4-kappa B viral strains is also evident in the natural context when the subjects are coinfected with kappa B-variant viral strains. The mean plasma viral loads, but not CD4 counts, are significantly different in 4-kappa B infection suggesting that these newly emerging strains are probably more infectious. It is possible that higher plasma viral loads underlie selective transmission of the 4-kappa B viral strains. Several publications previously reported duplication or deletion of diverse transcription factor-binding sites in the viral promoter. Unlike previous reports, our study provides experimental evidence that the new viral strains gained a potential selective advantage as a consequence of the acquired transcription factor-binding sites and importantly that these strains have been expanding at the population level.	[Neogi, Ujjwal; Shet, Anita] St Johns Natl Acad Hlth Sci, Bengaluru 560034, India; [Bhatt, Raghavendra; Rajagopalan, Nirmala] Freedom Fdn, Bengaluru 560043, India; [Chatterjee, Snehajyoti; Kundu, Tapas K.] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Transcript & Dis Lab, Bengaluru 560064, India; [Bachu, Mahesh; Yalla, Swarupa; Asokan, Mangaiarkarasi; Verma, Anjali; Sharma, Shilpee; Murali, Rajesh V.; Mukthey, Anil Babu; Rajan, Roshan Elizabeth; Cheedarla, Narayana; Ranga, Udaykumar] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, HIV AIDS Lab, Bengaluru 560064, India; [Yadavalli, Venkat S.; Jeang, Kuan-Teh] NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Mahadevan, Anita; Shankar, Susarla K.] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bengaluru 560029, India; [Saravanan, Shanmugam; Balakrishnan, Pachamuthu; Solomon, Suniti] YRG Ctr AIDS Res & Educ, Madras 600113, Tamil Nadu, India; [Vajpayee, Madhu] All India Inst Med Sci, Dept Microbiol, HIV & Immunol Div, New Delhi 110029, India; [Satish, Kadappa Shivappa] Seva Free Clin, Bengaluru 560010, India; [Satish, Kadappa Shivappa] Chest & Matern Ctr, Bengaluru 560010, India	St. John's National Academy of Health Sciences; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institute of Mental Health & Neurosciences - India; All India Institute of Medical Sciences (AIIMS) New Delhi	Ranga, U (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, HIV AIDS Lab, Jakkur PO, Bangalore 560064, Karnataka, India.	udaykumar@jncasr.ac.in	Neogi, Ujjwal/E-4274-2012; Chatterjee, Snehajyoti/AAV-3919-2021; Verma, Anjali/HHN-5385-2022; Balakrishnan, Pachamuthu/ABV-6282-2022; Neogi, Ujjwal/ABF-1172-2021; Saravanan, Shanmugam/GOG-9024-2022; Bachu, Mahesh/I-4343-2015	Chatterjee, Snehajyoti/0000-0002-4873-9416; Balakrishnan, Pachamuthu/0000-0002-1710-9155; Neogi, Ujjwal/0000-0002-0844-3338; Saravanan, Shanmugam/0000-0002-5991-8022; Bachu, Mahesh/0000-0002-6494-6642; Kundu, Tapas/0000-0001-7790-214X; Sharma, Shilpee/0000-0003-4645-9442; Shet, Anita/0000-0002-7204-8164; Asokan, Mangaiarkarasi/0000-0001-9294-1833	Freedom Foundation were generated at the Foundation's Center for HIV/AIDS Medicine and Research at Bengaluru, India; Department of BioTechnology, Government of India [BT/01CEIB/10/III/01]; intramural funds from Jawaharlal Nehru Centre for Advanced Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000547] Funding Source: NIH RePORTER	Freedom Foundation were generated at the Foundation's Center for HIV/AIDS Medicine and Research at Bengaluru, India; Department of BioTechnology, Government of India(Department of Biotechnology (DBT) India); intramural funds from Jawaharlal Nehru Centre for Advanced Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Several reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, National Institutes of Health. We thank Drs. Vinayaka Prasad and Brian Wigdahl for critical reading of the manuscript. The clinical samples provide by the Freedom Foundation were generated at the Foundation's Center for HIV/AIDS Medicine and Research at Bengaluru, India, funded through a unique partnership with the Institute for Molecular Medicine and Infectious Disease at the Drexel University College of Medicine in Philadelphia, PA, under the direction of Dr. Brian Wigdahl.; This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by the Department of BioTechnology, Government of India (Chromatin and Disease) Program Support Grant BT/01CEIB/10/III/01 and intramural funds from Jawaharlal Nehru Centre for Advanced Scientific Research (to T. K. K. and U. R.).	AboulEla F, 1996, NUCLEIC ACIDS RES, V24, P3974, DOI 10.1093/nar/24.20.3974; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; Bachu M, 2012, AIDS RES HUM RETROV, V28, P1362, DOI 10.1089/aid.2011.0388; Bjorndal A, 1999, AIDS RES HUM RETROV, V15, P647, DOI 10.1089/088922299310944; Bongertz V, 2000, J ACQ IMMUN DEF SYND, V23, P184; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Burnett JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000260; Campbell GR, 2007, J VIROL, V81, P5919, DOI 10.1128/JVI.01938-06; de Arellano ER, 2006, AIDS REV, V8, P9; De Baar MP, 2000, AIDS RES HUM RETROV, V16, P499; ENGLUND G, 1991, VIROLOGY, V181, P150, DOI 10.1016/0042-6822(91)90479-U; Estable MC, 2007, INT J BIOL SCI, V3, P318; Estable MC, 1996, J VIROL, V70, P4053, DOI 10.1128/JVI.70.6.4053-4062.1996; Estable MC, 1998, J VIROL, V72, P6465, DOI 10.1128/JVI.72.8.6465-6474.1998; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; Fusuma EE, 2005, AIDS RES HUM RETROV, V21, P965, DOI 10.1089/aid.2005.21.965; Gandhi N, 2009, AIDS RES HUM RETROV, V25, P691, DOI 10.1089/aid.2008.0299; Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Hadas E, 2007, AIDS, V21, P905, DOI 10.1097/QAD.0b013e3281574549; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hunt G, 2000, AIDS RES HUM RETROV, V16, P305, DOI 10.1089/088922200309412; Hunt GM, 2001, VIRUS GENES, V23, P27, DOI 10.1023/A:1011171027134; Ilyinskii PO, 1996, J VIROL, V70, P3118, DOI 10.1128/JVI.70.5.3118-3126.1996; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; JOHANSSON B, 1995, AIDS RES HUM RETROV, V11, P761, DOI 10.1089/aid.1995.11.761; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kaminuma O, 2008, J IMMUNOL, V180, P319, DOI 10.4049/jimmunol.180.1.319; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KOKEN SEC, 1992, VIROLOGY, V191, P968, DOI 10.1016/0042-6822(92)90274-S; Lemieux AM, 2004, J BIOL CHEM, V279, P52949, DOI 10.1074/jbc.M409896200; LEONARD J, 1989, J VIROL, V63, P4919, DOI 10.1128/JVI.63.11.4919-4924.1989; Locateli D, 2007, J MED VIROL, V79, P1455, DOI 10.1002/jmv.20955; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MICHAEL NL, 1994, J VIROL, V68, P3163, DOI 10.1128/JVI.68.5.3163-3174.1994; Mishra M, 2008, ANN NEUROL, V63, P366, DOI 10.1002/ana.21292; Montano MA, 1997, J VIROL, V71, P8657, DOI 10.1128/JVI.71.11.8657-8665.1997; Montano MA, 2000, J INFECT DIS, V181, P76, DOI 10.1086/315185; Munkanta M, 2005, AIDS RES HUM RETROV, V21, P901, DOI 10.1089/aid.2005.21.901; Naghavi MH, 1999, AIDS RES HUM RETROV, V15, P485, DOI 10.1089/088922299311240; Naghavi MH, 1999, AIDS RES HUM RETROV, V15, P1293, DOI 10.1089/088922299310197; Papathanasopoulos MA, 2002, AIDS RES HUM RETROV, V18, P879, DOI 10.1089/08892220260190362; PARROTT C, 1991, J VIROL, V65, P1414, DOI 10.1128/JVI.65.3.1414-1419.1991; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pohlmann S, 1998, J VIROL, V72, P5589; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Quinones-Mateu ME, 2005, AIDS, V19, P1689, DOI 10.1097/01.aids.0000186018.39673.1c; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; Ranga U., 2012, INDIAN J ME IN PRESS; Ranga U, 2010, CURR SCI INDIA, V98, P335; Rao VR, 2008, J NEUROSCI, V28, P10010, DOI 10.1523/JNEUROSCI.2955-08.2008; Roof P, 2002, VIROLOGY, V296, P77, DOI 10.1006/viro.2001.1397; ROSS EK, 1991, J VIROL, V65, P4350, DOI 10.1128/JVI.65.8.4350-4358.1991; Rousseau CM, 2006, J VIROL METHODS, V136, P118, DOI 10.1016/j.jviromet.2006.04.009; Saini M, 2007, VACCINE, V25, P8660, DOI 10.1016/j.vaccine.2007.10.019; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sambrook J., 2001, MOL CLONING LAB MANU; Scriba TJ, 2001, AIDS RES HUM RETROV, V17, P775, DOI 10.1089/088922201750237059; Siddappa NB, 2007, AIDS RES HUM RETROV, V23, P1268, DOI 10.1089/aid.2006.0305; Siddappa NB, 2005, AIDS, V19, P1426, DOI 10.1097/01.aids.0000180795.49016.89; Siddappa NB, 2004, J CLIN MICROBIOL, V42, P2742, DOI 10.1128/JCM.42.6.2742-2751.2004; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Soares MA, 2003, AIDS, V17, P11, DOI 10.1097/00002030-200301030-00004; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9; van Opijnen T, 2004, J VIROL, V78, P3675, DOI 10.1128/JVI.78.7.3675-3683.2004; Verhoef K, 1999, J VIROL, V73, P1331, DOI 10.1128/JVI.73.2.1331-1340.1999; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wong JK, 2010, J BIOL CHEM, V285, P18319, DOI 10.1074/jbc.M110.120840; Zhang LQ, 1997, J VIROL, V71, P1651, DOI 10.1128/JVI.71.2.1651-1656.1997	73	53	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44714	44735		10.1074/jbc.M112.397158	http://dx.doi.org/10.1074/jbc.M112.397158			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23132857	Green Published, hybrid			2022-12-28	WOS:000312938600067
J	Gagne, D; Charest, LA; Morin, S; Kovrigin, EL; Doucet, N				Gagne, Donald; Charest, Laurie-Anne; Morin, Sebstien; Kovrigin, Evgenii L.; Doucet, Nicolas			Conservation of Flexible Residue Clusters among Structural and Functional Enzyme Homologues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC-RESONANCE RELAXATION; EOSINOPHIL CATIONIC PROTEIN; MODEL-FREE APPROACH; RIBONUCLEASE-A; CRYSTAL-STRUCTURE; CHEMICAL-EXCHANGE; BACKBONE DYNAMICS; MOTIONS; RNASE; MACROMOLECULES	Conformational flexibility between structural ensembles is an essential component of enzyme function. Although the broad dynamical landscape of proteins is known to promote a number of functional events on multiple time scales, it is yet unknown whether structural and functional enzyme homologues rely on the same concerted residue motions to perform their catalytic function. It is hypothesized that networks of contiguous and flexible residue motions occurring on the biologically relevant millisecond time scale evolved to promote and/or preserve optimal enzyme catalysis. In this study, we use a combination of NMR relaxation dispersion, model-free analysis, and ligand titration experiments to successfully capture and compare the role of conformational flexibility between two structural homologues of the pancreatic ribonuclease family: RNaseA and eosinophil cationic protein (or RNase 3). In addition to conserving the same catalytic residues and structural fold, both homologues show similar yet functionally distinct clusters of millisecond dynamics, suggesting that conformational flexibility can be conserved among analogous protein folds displaying low sequence identity. Our work shows that the reduced conformational flexibility of eosinophil cationic protein can be dynamically and functionally reproduced in the RNase A scaffold upon creation of a chimeric hybrid between the two proteins. These results support the hypothesis that conformational flexibility is partly required for catalytic function in homologous enzyme folds, further highlighting the importance of dynamic residue sectors in the structural organization of proteins.	[Gagne, Donald; Charest, Laurie-Anne; Doucet, Nicolas] Univ Quebec, INRS Inst Armand Frappier, Laval, PQ H7V 1B7, Canada; [Morin, Sebstien] Univ Basel, Swiss Inst Bioinformat & Biozentrum, CH-4056 Basel, Switzerland; [Kovrigin, Evgenii L.] Marquette Univ, Dept Chem, Milwaukee, WI 53201 USA	University of Quebec; Institut national de la recherche scientifique (INRS); Swiss Institute of Bioinformatics; University of Basel; Marquette University	Doucet, N (corresponding author), Univ Quebec, INRS Inst Armand Frappier, 531 Blvd Prairies, Laval, PQ H7V 1B7, Canada.	nicolas.doucet@iaf.inrs.ca		Morin, Sebastien/0000-0003-4426-326X	Natural Sciences and Engineering Research Council of Canada [RGPIN 402623-2011]; Fonds de Recherche du Quebec Sante Research Scholar-Junior 1 career award; "Fondation Universitaire Armand-Frappier de l'INRS" Ph.D. scholarship; Fonds de Recherche du Quebec, Nature et Technologies, Strategic Cluster "Regroupement Quebecois de Recherche sur la Fonction, la Structure et l'Ingenierie des Proteines" (PROTEO); Fonds de Recherche du Quebec Sante (FRQS) Strategic Cluster "Groupe de Recherche Axe sur la Structure des Proteines" (GRASP)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de Recherche du Quebec Sante Research Scholar-Junior 1 career award; "Fondation Universitaire Armand-Frappier de l'INRS" Ph.D. scholarship; Fonds de Recherche du Quebec, Nature et Technologies, Strategic Cluster "Regroupement Quebecois de Recherche sur la Fonction, la Structure et l'Ingenierie des Proteines" (PROTEO); Fonds de Recherche du Quebec Sante (FRQS) Strategic Cluster "Groupe de Recherche Axe sur la Structure des Proteines" (GRASP)	This work was supported in part by Natural Sciences and Engineering Research Council of Canada Discovery Grant RGPIN 402623-2011 (to N. D.) and a Fonds de Recherche du Quebec Sante Research Scholar-Junior 1 career award (to N. D.).; Recipient of a "Fondation Universitaire Armand-Frappier de l'INRS" Ph.D. scholarship.; Supported by the Fonds de Recherche du Quebec, Nature et Technologies, Strategic Cluster "Regroupement Quebecois de Recherche sur la Fonction, la Structure et l'Ingenierie des Proteines" (PROTEO) and the Fonds de Recherche du Quebec Sante (FRQS) Strategic Cluster "Groupe de Recherche Axe sur la Structure des Proteines" (GRASP).	Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481; Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Boix E, 1999, BIOCHEMISTRY-US, V38, P16794, DOI 10.1021/bi9919145; Boix E, 2001, METHOD ENZYMOL, V341, P287, DOI 10.1016/S0076-6879(01)41159-1; Boix E, 2007, MOL BIOSYST, V3, P317, DOI 10.1039/b617527a; Branden C., 1999, INTRO PROTEIN STRUCT; Butterwick JA, 2004, J MOL BIOL, V339, P855, DOI 10.1016/j.jmb.2004.03.055; Carnevale V, 2006, J AM CHEM SOC, V128, P9766, DOI 10.1021/ja060896t; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Chatani E, 2002, BIOCHEMISTRY-US, V41, P4567, DOI 10.1021/bi011365e; Cole R, 2002, BIOCHEMISTRY-US, V41, P6072, DOI 10.1021/bi025655m; Cuchillo CM, 2011, BIOCHEMISTRY-US, V50, P7835, DOI 10.1021/bi201075b; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; Davey JA, 2012, PROTEIN SCI, V21, P1241, DOI 10.1002/pro.2128; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doucet N, 2007, J BIOL CHEM, V282, P21448, DOI 10.1074/jbc.M609777200; Doucet N, 2011, PROTEIN PEPTIDE LETT, V18, P336, DOI 10.2174/092986611794653950; Doucet N, 2011, BIOCHEMISTRY-US, V50, P1723, DOI 10.1021/bi1018539; Doucet N, 2010, PROTEINS, V78, P2459, DOI 10.1002/prot.22754; Doucet N, 2009, BIOCHEMISTRY-US, V48, P7160, DOI 10.1021/bi900830g; Dyer KD, 2006, MOL DIVERS, V10, P585, DOI 10.1007/s11030-006-9028-2; Eiben CB, 2012, NAT BIOTECHNOL, V30, P190, DOI 10.1038/nbt.2109; Fisher BM, 1998, BIOCHEMISTRY-US, V37, P17386, DOI 10.1021/bi981369s; Goddard TD, 2008, SPARKY VERSION 3; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Huang YC, 2007, J BIOL CHEM, V282, P4626, DOI 10.1074/jbc.M607321200; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; Kadonosono T, 2003, BIOCHEMISTRY-US, V42, P10651, DOI 10.1021/bi034499w; Kaplan J.I., 1980, NMR CHEM EXCHANGING; Kay LE, 2005, J MAGN RESON, V173, P193, DOI 10.1016/j.jmr.2004.11.021; Kovrigin EL, 2006, BIOCHEMISTRY-US, V45, P2636, DOI 10.1021/bi0525066; Kovrigin EL, 2006, J MAGN RESON, V180, P93, DOI 10.1016/j.jmr.2006.01.010; Kovrigin EL, 2012, J BIOMOL NMR, V53, P257, DOI 10.1007/s10858-012-9636-3; Lassila JK, 2010, CURR OPIN CHEM BIOL, V14, P676, DOI 10.1016/j.cbpa.2010.08.010; Lee GM, 2009, SCIENCE, V324, P213, DOI 10.1126/science.1169378; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Loria JP, 2008, ACCOUNTS CHEM RES, V41, P214, DOI 10.1021/ar700132n; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Mallorqui-Fernandez G, 2000, J MOL BIOL, V300, P1297, DOI 10.1006/jmbi.2000.3939; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Manley G, 2012, ARCH BIOCHEM BIOPHYS, V519, P223, DOI 10.1016/j.abb.2011.10.023; Marcos E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000738; Marshall GR, 2008, BIOPOLYMERS, V90, P259, DOI 10.1002/bip.20845; Merlino A, 2003, PROTEINS, V53, P101, DOI 10.1002/prot.10466; Merlino A, 2002, BIOPOLYMERS, V65, P274, DOI 10.1002/bip.10225; Morin S, 2011, PROG NUCL MAG RES SP, V59, P245, DOI 10.1016/j.pnmrs.2010.12.003; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Palmer AG, 2001, ANNU REV BIOPH BIOM, V30, P129, DOI 10.1146/annurev.biophys.30.1.129; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Ramanathan A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001193; RAO BDN, 1989, METHOD ENZYMOL, V176, P279; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; SELA M, 1957, BIOCHIM BIOPHYS ACTA, V24, P229, DOI 10.1016/0006-3002(57)90186-5; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Sorrentino S, 2010, FEBS LETT, V584, P2194, DOI 10.1016/j.febslet.2010.04.018; Vila R, 2009, BIOPOLYMERS, V91, P1038, DOI 10.1002/bip.21204; Vitagliano L, 2002, PROTEINS, V46, P97, DOI 10.1002/prot.10033; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Watt ED, 2011, BIOPHYS J, V101, P411, DOI 10.1016/j.bpj.2011.05.039	68	29	30	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44289	44300		10.1074/jbc.M112.394866	http://dx.doi.org/10.1074/jbc.M112.394866			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23135272	hybrid, Green Published			2022-12-28	WOS:000312938600027
J	Adnan, M; Malathi, SK				Adnan, Mohammad; Malathi, Siddiqui Krishnamurthy			RNase L Induces Autophagy via c-Jun N-terminal Kinase and Double-stranded RNA-dependent Protein Kinase Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; BCL-X-L; ENCEPHALOMYOCARDITIS VIRUS; BECLIN 1; JNK1-MEDIATED PHOSPHORYLATION; CRYSTAL-STRUCTURE; INTERFERON ACTION; CANCER-CELLS; APOPTOSIS; ACTIVATION	Autophagy is a tightly regulated mechanism that mediates sequestration, degradation, and recycling of cellular proteins, organelles, and pathogens. Several proteins associated with autophagy regulate host responses to viral infections. Ribonuclease L (RNase L) is activated during viral infections and cleaves cellular and viral single-stranded RNAs, including rRNAs in ribosomes. Here we demonstrate that direct activation of RNase L coordinates the activation of c-Jun N-terminal kinase (JNK) and double-stranded RNA-dependent protein kinase (PKR) to induce autophagy with hallmarks as accumulation of autophagic vacuoles, p62(SQSTM1) degradation and conversion of Microtubule-associated Protein Light Chain 3-I (LC3-I) to LC3-II. Accordingly, treatment of cells with pharmacological inhibitors of JNK or PKR and mouse embryonic fibroblasts (MEFs) lacking JNK1/2 or PKR showed reduced autophagy levels. Furthermore, RNase L-induced JNK activity promoted Bcl-2 phosphorylation, disrupted the Beclin1-Bcl-2 complex and stimulated autophagy. Viral infection with Encephalomyocarditis virus (EMCV) or Sendai virus led to higher levels of autophagy in wild-type (WT) MEFs compared with RNase L knock out (KO) MEFs. Inhibition of RNase L-induced autophagy using Bafilomycin A1 or 3-methyladenine suppressed viral growth in initial stages; in later stages autophagy promoted viral replication dampening the antiviral effect. Induction of autophagy by activated RNase L is independent of the paracrine effects of interferon (IFN). Our findings suggest a novel role of RNase L in inducing autophagy affecting the outcomes of viral pathogenesis.	[Adnan, Mohammad; Malathi, Siddiqui Krishnamurthy] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Malathi, SK (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	Malathi.Krishnamurthy@utoledo.edu			National Institutes of Health [AI089518]; University of Toledo; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI089518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Toledo; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI089518 (to K. M.) and startup funds from the University of Toledo.	Baltanas FC, 2011, BRAIN PATHOL, V21, P374, DOI 10.1111/j.1750-3639.2010.00461.x; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Cebollero Eduardo, 2012, Int J Cell Biol, V2012, P182834, DOI 10.1155/2012/182834; Chakrabarti A, 2012, J VIROL, V86, P11311, DOI 10.1128/JVI.00270-12; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006; Dreux M, 2010, CELL CYCLE, V9, P1295, DOI 10.4161/cc.9.7.11109; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Espert L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005787; FLOYDSMITH G, 1981, SCIENCE, V212, P1030, DOI 10.1126/science.6165080; GUSELLA GL, 1995, J IMMUNOL, V154, P345; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Iordanov MS, 2000, MOL CELL BIOL, V20, P617, DOI 10.1128/MCB.20.2.617-627.2000; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; KERR IM, 1981, ADV CYCL NUCL RES<D>, V14, P469; Komiya K, 2010, BIOCHEM BIOPH RES CO, V401, P561, DOI 10.1016/j.bbrc.2010.09.101; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Ku B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040025; Lee HK, 2008, CURR OPIN IMMUNOL, V20, P23, DOI 10.1016/j.coi.2008.01.001; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Li GQ, 2004, J BIOL CHEM, V279, P1123, DOI 10.1074/jbc.M305893200; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; MacIntosh GC, 2011, AUTOPHAGY, V7, P662, DOI 10.4161/auto.7.6.15447; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Malathi K, 2005, P NATL ACAD SCI USA, V102, P14533, DOI 10.1073/pnas.0507551102; Malathi K, 2004, CANCER RES, V64, P9144, DOI 10.1158/0008-5472.CAN-04-2226; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Rusch L, 2000, J INTERF CYTOK RES, V20, P1091, DOI 10.1089/107999000750053762; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Shoji-Kawata S, 2009, BBA-MOL CELL RES, V1793, P1478, DOI 10.1016/j.bbamcr.2009.02.008; SILVERMAN RH, 1983, J VIROL, V46, P1051, DOI 10.1128/JVI.46.3.1051-1055.1983; SILVERMAN RH, 1982, EUR J BIOCHEM, V124, P131, DOI 10.1111/j.1432-1033.1982.tb05915.x; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Silverman RH, 2007, CYTOKINE GROWTH F R, V18, P381, DOI 10.1016/j.cytogfr.2007.06.012; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Thakur CS, 2007, P NATL ACAD SCI USA, V104, P9585, DOI 10.1073/pnas.0700590104; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; WRESCHNER DH, 1981, NUCLEIC ACIDS RES, V9, P1571, DOI 10.1093/nar/9.7.1571; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhang YN, 2011, AUTOPHAGY, V7, P613, DOI 10.4161/auto.7.6.15267; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355	65	45	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43651	43664		10.1074/jbc.M112.399964	http://dx.doi.org/10.1074/jbc.M112.399964			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23109342	Green Published, hybrid			2022-12-28	WOS:000312940800045
J	Eckert, C; Boehm, M; Carrieri, D; Yu, JP; Dubini, A; Nixon, PJ; Maness, PC				Eckert, Carrie; Boehm, Marko; Carrieri, Damian; Yu, Jianping; Dubini, Alexandra; Nixon, Peter J.; Maness, Pin-Ching			Genetic Analysis of the Hox Hydrogenase in the Cyanobacterium Synechocystis sp PCC 6803 Reveals Subunit Roles in Association, Assembly, Maturation, and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN PCC-6803; THIOCAPSA-ROSEOPERSICINA BBS; RALSTONIA-EUTROPHA H16; NOCARDIA-OPACA 1B; BIDIRECTIONAL HYDROGENASE; NIFE HYDROGENASE; REVERSIBLE HYDROGENASE; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; ANACYSTIS-NIDULANS	Hydrogenases are metalloenzymes that catalyze 2H(+) + 2e(-) <-> H-2. A multisubunit, bidirectional [NiFe]-hydrogenase has been identified and characterized in a number of bacteria, including cyanobacteria, where it is hypothesized to function as an electron valve, balancing reductant in the cell. In cyanobacteria, this Hox hydrogenase consists of five proteins in two functional moieties: a hydrogenase moiety (HoxYH) with homology to heterodimeric [NiFe]-hydrogenases and a diaphorase moiety (HoxEFU) with homology to NuoEFG of respiratory Complex I, linking NAD(P)H <-> NAD(P)(+) as a source/sink for electrons. Here, we present an extensive study of Hox hydrogenase in the cyanobacterium Synechocystis sp. PCC 6803. We identify the presence of HoxEFUYH, HoxFUYH, HoxEFU, HoxFU, and HoxYH subcomplexes as well as association of the immature, unprocessed large subunit (HoxH) with other Hox subunits and unidentified factors, providing a basis for understanding Hox maturation and assembly. The analysis of mutants containing individual and combined hox gene deletions in a common parental strain reveals apparent alterations in subunit abundance and highlights an essential role for HoxF and HoxU in complex/subcomplex association. In addition, analysis of individual and combined hox mutant phenotypes in a single strain background provides a clear view of the function of each subunit in hydrogenase activity and presents evidence that its physiological function is more complicated than previously reported, with no outward defects apparent in growth or photosynthesis under various growth conditions.	[Eckert, Carrie; Boehm, Marko; Carrieri, Damian; Yu, Jianping; Dubini, Alexandra; Maness, Pin-Ching] NREL, Biosci Ctr, Golden, CO 80401 USA; [Boehm, Marko; Nixon, Peter J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Imperial College London	Eckert, C (corresponding author), NREL, Biosci Ctr, 15013 Denver W Pkwy, Golden, CO 80401 USA.	carrie.eckert@nrel.gov	dubini, alexandra/Q-6277-2019; dubini, alexandra/A-7252-2016; ECKERT, CARRIE/V-8199-2017	dubini, alexandra/0000-0001-8825-3915; dubini, alexandra/0000-0001-8825-3915; ECKERT, CARRIE/0000-0003-4201-2926; Yu, Jianping/0000-0003-0466-3197; Nixon, Peter/0000-0003-1952-6937	National Renewable Energy Laboratory's Laboratory Directed Research and Development Program; United States Department of Energy Fuel Cell Technologies Program [DE-AC36-08-GO28308]; United States Department of Energy Biological and Environmental Research Program [KP160103]; Engineering and Physical Sciences Research Council Grant [EP/F002070X/1]	National Renewable Energy Laboratory's Laboratory Directed Research and Development Program; United States Department of Energy Fuel Cell Technologies Program; United States Department of Energy Biological and Environmental Research Program; Engineering and Physical Sciences Research Council Grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the National Renewable Energy Laboratory's Laboratory Directed Research and Development Program (to P. M., J. Y., C. E., and D. C.), the United States Department of Energy Fuel Cell Technologies Program (contract number DE-AC36-08-GO28308) (to P. M. and J. Y.), the United States Department of Energy Biological and Environmental Research Program (contract KP160103) (to M. B. and A. D.), and Engineering and Physical Sciences Research Council Grant (EP/F002070X/1) (to M. B. and P. N.).	Antal TK, 2006, INT J HYDROGEN ENERG, V31, P1439, DOI 10.1016/j.ijhydene.2006.06.037; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Appel J, 1996, BBA-PROTEIN STRUCT M, V1298, P141, DOI 10.1016/S0167-4838(96)00176-8; Appel J, 2012, ADV PHOTOSYNTH RESP, V33, P357, DOI 10.1007/978-94-007-1533-2_15; Aubert-Jousset E, 2011, FEBS J, V278, P4035, DOI 10.1111/j.1742-4658.2011.08308.x; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boehm M, 2009, J BACTERIOL, V191, P6425, DOI 10.1128/JB.00644-09; Boison G, 1998, CURR MICROBIOL, V36, P253, DOI 10.1007/s002849900305; Boison G, 1999, FEMS MICROBIOL LETT, V174, P159, DOI 10.1111/j.1574-6968.1999.tb13563.x; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; Burgdorf T, 2005, J BACTERIOL, V187, P3122, DOI 10.1128/JB.187.9.3122-3132.2005; Carrieri D, 2011, BIORESOURCE TECHNOL, V102, P8368, DOI 10.1016/j.biortech.2011.03.103; Casalot L, 2001, TRENDS MICROBIOL, V9, P228, DOI 10.1016/S0966-842X(01)02009-1; Cournac L, 2004, J BACTERIOL, V186, P1737, DOI 10.1128/JB.186.6.1737-1746.2003; Cournac L, 2002, INT J HYDROGEN ENERG, V27, P1229, DOI 10.1016/S0360-3199(02)00105-2; Dutheil J, 2012, J BACTERIOL, V194, P5423, DOI 10.1128/JB.00543-12; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Germer F, 2009, J BIOL CHEM, V284, P36462, DOI 10.1074/jbc.M109.028795; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gutekunst K, 2005, MOL MICROBIOL, V58, P810, DOI 10.1111/j.1365-2958.2005.04867.x; Gutthann F, 2007, BBA-BIOENERGETICS, V1767, P161, DOI 10.1016/j.bbabio.2006.12.003; Hoffmann D, 2006, FEBS J, V273, P4516, DOI 10.1111/j.1742-4658.2006.05460.x; Howitt CA, 1999, PHOTOTROPHIC PROKARY, P595; Ikeuchi M, 2001, PHOTOSYNTH RES, V70, P73, DOI 10.1023/A:1013887908680; Jones AK, 2004, BIOCHEMISTRY-US, V43, P13467, DOI 10.1021/bi048837k; Kanesaki Y, 2012, DNA RES, V19, P67, DOI 10.1093/dnares/dsr042; KENTEMICH T, 1989, Z NATURFORSCH C, V44, P384; KENTEMICH T, 1991, NATURWISSENSCHAFTEN, V78, P559, DOI 10.1007/BF01134448; Kiss E, 2009, J BIOTECHNOL, V142, P31, DOI 10.1016/j.jbiotec.2009.02.007; Kommalapati M, 2007, PHOTOSYNTH RES, V92, P315, DOI 10.1007/s11120-007-9186-9; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Lagarde D, 2000, APPL ENVIRON MICROB, V66, P64, DOI 10.1128/AEM.66.1.64-72.2000; Long MN, 2007, J BIOL INORG CHEM, V12, P62, DOI 10.1007/s00775-006-0162-1; LUTZ S, 1991, MOL MICROBIOL, V5, P123, DOI 10.1111/j.1365-2958.1991.tb01833.x; Magalon A, 2000, FEBS LETT, V473, P254, DOI 10.1016/S0014-5793(00)01542-8; Maroti J, 2010, APPL ENVIRON MICROB, V76, P5113, DOI 10.1128/AEM.00351-10; Massanz C, 1998, J BACTERIOL, V180, P1023, DOI 10.1128/JB.180.5.1023-1029.1998; McIntosh CL, 2011, J AM CHEM SOC, V133, P11308, DOI 10.1021/ja203376y; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Oliveira P, 2005, FEMS MICROBIOL LETT, V251, P59, DOI 10.1016/j.femsle.2005.07.024; Oliveira P, 2008, J BACTERIOL, V190, P1011, DOI 10.1128/JB.01605-07; Oliveira P, 2009, DALTON T, P9990, DOI 10.1039/b908593a; Palagyi-Meszaros LS, 2009, FEBS J, V276, P164, DOI 10.1111/j.1742-4658.2008.06770.x; Pinto F, 2012, MICROBIOL-SGM, V158, P448, DOI 10.1099/mic.0.052282-0; Rakhely G, 2004, APPL ENVIRON MICROB, V70, P722, DOI 10.1128/AEM.70.2.722-728.2004; Rakhely G, 2007, BBA-BIOENERGETICS, V1767, P671, DOI 10.1016/j.bbabio.2007.02.004; Schmitz O, 1996, NATURWISSENSCHAFTEN, V83, P525; Schmitz O, 2002, BBA-BIOENERGETICS, V1554, P66, DOI 10.1016/S0005-2728(02)00214-1; SCHMITZ O, 1995, EUR J BIOCHEM, V233, P266, DOI 10.1111/j.1432-1033.1995.266_1.x; SCHNEIDER K, 1984, EUR J BIOCHEM, V138, P533, DOI 10.1111/j.1432-1033.1984.tb07948.x; SCHNEIDER K, 1984, EUR J BIOCHEM, V142, P75, DOI 10.1111/j.1432-1033.1984.tb08252.x; Schutz K, 2004, PLANTA, V218, P350, DOI 10.1007/s00425-003-1113-5; SEREBRIAKOVA L, 1994, ARCH MICROBIOL, V161, P140, DOI 10.1007/BF00276474; Serebryakova LT, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1370, DOI 10.1134/S0006297906120133; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wunschiers R, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-8; XU QA, 1994, J BIOL CHEM, V269, P3205	57	28	30	1	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43502	43515		10.1074/jbc.M112.392407	http://dx.doi.org/10.1074/jbc.M112.392407			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23139416	hybrid, Green Published			2022-12-28	WOS:000312940800031
J	Leiba, J; Hartmann, T; Cluzel, ME; Cohen-Gonsaud, M; Delolme, F; Bischoff, M; Molle, V				Leiba, Jade; Hartmann, Torsten; Cluzel, Marie-Eve; Cohen-Gonsaud, Martin; Delolme, Frederic; Bischoff, Markus; Molle, Virginie			A Novel Mode of Regulation of the Staphylococcus aureus Catabolite Control Protein A (CcpA) Mediated by Stk1 Protein Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOLIC ACID BIOSYNTHESIS; TOXIN GENE-EXPRESSION; MYCOBACTERIUM-TUBERCULOSIS; BACILLUS-SUBTILIS; SERINE/THREONINE KINASE; ANTIBIOTIC-RESISTANCE; SER/THR PHOSPHORYLATION; BIOFILM FORMATION; VIRULENCE; REPRESSION	The Staphylococcus aureus serine/threonine protein kinase Stk1 (also known as PknB) affects different key pathways such as cell wall metabolism, antibiotic susceptibility, and regulation of virulence. Here we report that the catabolite control protein A (CcpA), a highly conserved regulator of carbon catabolite repression and virulence in a number of Gram-positive pathogens, was efficiently phosphorylated in vitro and in vivo by Stk1 in S. aureus, whereas the CcpA homologues of Bacillus subtilis and Bacillus anthracis were not affected by the Stk1 orthologue PrkC. Mass spectrometry and mutational analyses identified Thr-18 and Thr-33 as the phosphoacceptors; both are located in the DNA binding domain of this protein. Electrophoretic mobility shift assays demonstrated that the CcpA DNA binding activity was completely abrogated for the phosphorylated CcpA. The physiological relevance of CcpA phosphorylation was assessed by generating CcpA phosphoablative (T18A/T33A) or phosphomimetic (T18D/T33D) mutants. In contrast to the wild-type and phosphoablative ccpA alleles, introduction of the phosphomimetic ccpA allele in a Delta ccpA mutant failed to restore the parental biofilm formation profile and the transcription of citZ and hla to levels seen with the wild type. The strong up regulation of ccpA transcripts and CcpA level in the ccpA mutant trans-complemented with the phosphomimetic CcpA variant suggest furthermore that CcpA acts as a negative regulator of its own expression. Together, these findings demonstrate that Stk1-driven phosphorylation of CcpA inhibits its DNA binding activity toward its regulon in S. aureus, representing a novel regulatory mechanism of CcpA activity in addition to the well known regulation via HprKP/Hpr in this clinically important pathogen.	[Hartmann, Torsten; Bischoff, Markus] Univ Saarland Hosp, Inst Med Microbiol & Hyg, D-66421 Homburg, Germany; [Leiba, Jade; Cluzel, Marie-Eve; Molle, Virginie] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, CNRS UMR 5235, F-34095 Montpellier 05, France; [Cohen-Gonsaud, Martin] Univ Montpellier I & II, Ctr Biochim Struct, CNRS UMR 5048, INSERM U554, F-34090 Montpellier, France; [Delolme, Frederic] Univ Lyon 1, Inst Biol & Chim Prot, CNRS UMR 5086, BioSci IFR128, F-69367 Lyon, France	Universitatsklinikum des Saarlandes; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bischoff, M (corresponding author), Univ Saarland Hosp, Inst Med Microbiol & Hyg, D-66421 Homburg, Germany.	markus.bischoff@uniklinikum-saarland.de; virginie.molle@univ-montp2.fr	MOLLE, Virginie/D-4050-2019; Bischoff, Markus/D-2130-2014	MOLLE, Virginie/0000-0002-6573-3411; Bischoff, Markus/0000-0001-6734-2732; Cohen-Gonsaud, Martin/0000-0002-0150-9912; Leiba, Jade/0000-0003-0584-9524	National Research Agency [ANR-09-MIEN-004]; Deutsche Forschungsgemeinschaft [BI 1350/1-1, 1-2]	National Research Agency(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by National Research Agency Grant ANR-09-MIEN-004 (to V. M.) and Deutsche Forschungsgemeinschaft Grants BI 1350/1-1 and 1-2 to (to M. B.).	Antunes A, 2011, MOL MICROBIOL, V79, P882, DOI 10.1111/j.1365-2958.2010.07495.x; Archambaud C, 2005, MOL MICROBIOL, V56, P383, DOI 10.1111/j.1365-2958.2005.04551.x; Barthe P, 2009, STRUCTURE, V17, P568, DOI 10.1016/j.str.2009.02.012; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Burnside K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011071; Canova MJ, 2008, PLASMID, V60, P149, DOI 10.1016/j.plasmid.2008.05.002; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Chatterjee I, 2005, J BACTERIOL, V187, P4488, DOI 10.1128/JB.187.13.4488-4496.2005; Chiang C, 2011, J BACTERIOL, V193, P52, DOI 10.1128/JB.01656-09; Cluzel ME, 2010, J BACTERIOL, V192, P6295, DOI 10.1128/JB.00853-10; Corrales RM, 2012, J BIOL CHEM, V287, P26187, DOI 10.1074/jbc.M112.373209; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Didier JP, 2010, FEMS MICROBIOL LETT, V306, P30, DOI 10.1111/j.1574-6968.2010.01930.x; Donat S, 2009, J BACTERIOL, V191, P4056, DOI 10.1128/JB.00117-09; Egeter O, 1996, MOL MICROBIOL, V21, P739, DOI 10.1046/j.1365-2958.1996.301398.x; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; HUECK CJ, 1995, MOL MICROBIOL, V16, P855, DOI 10.1111/j.1365-2958.1995.tb02313.x; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Li CL, 2010, J BACTERIOL, V192, P3883, DOI 10.1128/JB.00237-10; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MIWA Y, 1994, MICROBIOL-UK, V140, P2567, DOI 10.1099/00221287-140-10-2567; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; Molle V, 2010, PROTEOMICS, V10, P3910, DOI 10.1002/pmic.201000316; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P137, DOI 10.1016/j.ijmm.2009.08.016; Sadykov MR, 2011, MICROBIOL-SGM, V157, P3458, DOI 10.1099/mic.0.051243-0; Schulthess B, 2011, J BACTERIOL, V193, P4954, DOI 10.1128/JB.05362-11; Schumacher MA, 2004, CELL, V118, P731, DOI 10.1016/j.cell.2004.08.027; Seidel G, 2005, FEBS J, V272, P2566, DOI 10.1111/j.1742-4658.2005.04682.x; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Seidl K, 2008, INFECT IMMUN, V76, P5093, DOI 10.1128/IAI.00724-08; Seidl K, 2008, INFECT IMMUN, V76, P2044, DOI 10.1128/IAI.00035-08; Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Singh KD, 2008, J BACTERIOL, V190, P7275, DOI 10.1128/JB.00848-08; Slama N, 2011, BIOCHEM BIOPH RES CO, V412, P401, DOI 10.1016/j.bbrc.2011.07.051; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Sun F, 2012, P NATL ACAD SCI USA, V109, P15461, DOI 10.1073/pnas.1205952109; Tamber S, 2010, INFECT IMMUN, V78, P3637, DOI 10.1128/IAI.00296-10; Truong-Bolduc QC, 2010, J BACTERIOL, V192, P2525, DOI 10.1128/JB.00018-10; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200	46	52	53	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43607	43619		10.1074/jbc.M112.418913	http://dx.doi.org/10.1074/jbc.M112.418913			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23132867	Green Published, hybrid			2022-12-28	WOS:000312940800041
J	Wynia-Smith, SL; Brown, MJ; Chirichella, G; Kemalyan, G; Krantz, BA				Wynia-Smith, Sarah L.; Brown, Michael J.; Chirichella, Gina; Kemalyan, Gigi; Krantz, Bryan A.			Electrostatic Ratchet in the Protective Antigen Channel Promotes Anthrax Toxin Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN TRANSLOCATION; LETHAL FACTOR; TRANSMEMBRANE PORE; CRYSTAL-STRUCTURE; PROTON GRADIENT; EDEMA FACTORS; MECHANISM; MEMBRANES; CALMODULIN; DELIVERY	Central to the power-stroke and Brownian-ratchet mechanisms of protein translocation is the process through which nonequilibrium fluctuations are rectified or ratcheted by the molecular motor to transport substrate proteins along a specific axis. We investigated the ratchet mechanism using anthrax toxin as a model. Anthrax toxin is a tripartite toxin comprised of the protective antigen (PA) component, a homooligomeric transmembrane translocase, which translocates two other enzyme components, lethal factor (LF) and edema factor (EF), into the cytosol of the host cell under the proton motive force (PMF). The PA-binding domains of LF and EF (LFN and EFN) possess identical folds and similar solution stabilities; however, EFN translocates similar to 10-200-fold slower than LFN, depending on the electrical potential (Delta psi) and chemical potential (Delta pH) compositions of the PMF. From an analysis of LFN/EFN chimera proteins, we identified two 10-residue cassettes comprised of charged sequence that were responsible for the impaired translocation kinetics of EFN. These cassettes have nonspecific electrostatic requirements: one surprisingly prefers acidic residues when driven by either a Delta psi or a Delta pH; the second requires basic residues only when driven by a Delta psi. Through modeling and experiment, we identified a charged surface in the PA channel responsible for charge selectivity. The charged surface latches the substrate and promotes PMF-driven transport. We propose an electrostatic ratchet in the channel, comprised of opposing rings of charged residues, enforces directionality by interacting with charged cassettes in the substrate, thereby generating forces sufficient to drive unfolding.	[Kemalyan, Gigi] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Chirichella, Gina; Krantz, Bryan A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Brown, Michael J.; Krantz, Bryan A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wynia-Smith, Sarah L.; Krantz, Bryan A.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Krantz, BA (corresponding author), 476 Stanley Hall 3220, Berkeley, CA 94720 USA.	bakrantz@berkeley.edu		Wynia-Smith, Sarah/0000-0003-0985-2843; Krantz, Bryan/0000-0002-4911-5824	National Institutes of Health [R01-AI077703]; University of California; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI077703 and University of California start-up funds.	Basilio D, 2009, J GEN PHYSIOL, V133, P307, DOI 10.1085/jgp.200810170; Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; Blanke SR, 1996, P NATL ACAD SCI USA, V93, P8437, DOI 10.1073/pnas.93.16.8437; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; Brown MJ, 2011, J BIOL CHEM, V286, P23189, DOI 10.1074/jbc.M111.231167; Collier RJ, 2009, MOL ASPECTS MED, V30, P413, DOI 10.1016/j.mam.2009.06.003; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feld GK, 2012, PROTEIN SCI, V21, P606, DOI 10.1002/pro.2052; Feld GK, 2012, J MOL BIOL, V415, P159, DOI 10.1016/j.jmb.2011.10.035; Feld GK, 2010, NAT STRUCT MOL BIOL, V17, P1383, DOI 10.1038/nsmb.1923; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Katayama H, 2010, P NATL ACAD SCI USA, V107, P3453, DOI 10.1073/pnas.1000100107; Katayama H, 2008, NAT STRUCT MOL BIOL, V15, P754, DOI 10.1038/nsmb.1442; Kintzer AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013888; Kintzer AF, 2010, J MOL BIOL, V399, P741, DOI 10.1016/j.jmb.2010.04.041; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Krantz BA, 2004, J MOL BIOL, V344, P739, DOI 10.1016/j.jmb.2004.09.067; Krantz BA, 2006, J MOL BIOL, V355, P968, DOI 10.1016/j.jmb.2005.11.030; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Lacy DB, 2002, J BIOL CHEM, V277, P3006, DOI 10.1074/jbc.M109997200; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; MUELLER P, 1963, J PHYS CHEM-US, V67, P534, DOI 10.1021/j100796a529; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Pentelute BL, 2011, ANGEW CHEM INT EDIT, V50, P2294, DOI 10.1002/anie.201006460; Pentelute BL, 2010, ACS CHEM BIOL, V5, P359, DOI 10.1021/cb100003r; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robinson R.A., 2002, ELECTROLYTE SOLUTION; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Shen YQ, 2005, EMBO J, V24, P929, DOI 10.1038/sj.emboj.7600574; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Thoren KL, 2011, MOL MICROBIOL, V80, P588, DOI 10.1111/j.1365-2958.2011.07614.x; Thoren KL, 2009, P NATL ACAD SCI USA, V106, P21555, DOI 10.1073/pnas.0905880106; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vernier G, 2009, PROTEIN SCI, V18, P1882, DOI 10.1002/pro.199; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101; Zhang S, 2004, BIOPHYS J, V87, P3842, DOI 10.1529/biophysj.104.050864	43	29	29	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43753	43764		10.1074/jbc.M112.419598	http://dx.doi.org/10.1074/jbc.M112.419598			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115233	Green Published, hybrid			2022-12-28	WOS:000312940800054
J	Amin, DN; Hazelbauer, GL				Amin, Divya N.; Hazelbauer, Gerald L.			Influence of Membrane Lipid Composition on a Transmembrane Bacterial Chemoreceptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CHEMOTAXIS RECEPTOR; SIGNALING COMPLEXES; CRYSTAL-STRUCTURE; PHASE-TRANSITION; DOMAIN; PHOSPHATIDYLETHANOLAMINE; NANODISCS; BILAYERS; KINASE	Most bacterial chemoreceptors are transmembrane proteins. Although less than 10% of a transmembrane chemoreceptor is embedded in lipid, separation from the natural membrane environment by detergent solubilization eliminates most receptor activities, presumably because receptor structure is perturbed. Reincorporation into a lipid bilayer can restore these activities and thus functionally native structure. However, the extent to which specific lipid features are important for effective restoration is unknown. Thus we investigated effects of membrane lipid composition on chemoreceptor Tar from Escherichia coli using Nanodiscs, small (similar to 10-nm) plugs of lipid bilayer rendered water-soluble by an annulus of "membrane scaffold protein." Disc-enclosed bilayers can be made with different lipids or lipid combinations. Nanodiscs carrying an inserted receptor dimer have high protein-to-lipid ratios approximating native membranes and in this way mimic the natural chemoreceptor environment. To identify features important for functionally native receptor structure, we made Nanodiscs using natural and synthetic lipids, assaying extents and rates of adaptational modification. The proportion of functionally native Tar was highest in bilayers closest in composition to E. coli cytoplasmic membrane. Some other lipid compositions resulted in a significant proportion of functionally native receptor, but simply surrounding the chemoreceptor transmembrane segment with a lipid bilayer was not sufficient. Membranes effective in supporting functionally native Tar contained as the majority lipid phosphatidylethanolamine or a related zwitterionic lipid plus a rather specific proportion of anionic lipids, as well as unsaturated fatty acids. Thus the chemoreceptor is strongly influenced by its lipid environment and is tuned to its natural one.	[Amin, Divya N.; Hazelbauer, Gerald L.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Hazelbauer, GL (corresponding author), Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA.	hazelbauerg@missouri.edu			National Institutes of Health through the NIGMS [GM29963]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029963, R01GM029963] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM29963 (to G. L. H.) through the NIGMS.	Amin DN, 2010, MOL MICROBIOL, V78, P1313, DOI 10.1111/j.1365-2958.2010.07408.x; Amin DN, 2010, J BACTERIOL, V192, P1193, DOI 10.1128/JB.01391-09; Barnakov A, 2002, PROTEIN SCI, V11, P1472, DOI 10.1110/ps.0202502; Barnakov AN, 1998, J BACTERIOL, V180, P6713, DOI 10.1128/JB.180.24.6713-6718.1998; Barnakov AN, 1999, P NATL ACAD SCI USA, V96, P10667, DOI 10.1073/pnas.96.19.10667; Bogdanov M, 2010, P NATL ACAD SCI USA, V107, P15057, DOI 10.1073/pnas.1006286107; BOGONEZ E, 1985, P NATL ACAD SCI USA, V82, P4891, DOI 10.1073/pnas.82.15.4891; Boldog T, 2004, PROTEIN SCI, V13, P1466, DOI 10.1110/ps.04648604; Boldog T, 2007, METHOD ENZYMOL, V423, P317, DOI 10.1016/S0076-6879(07)23014-9; Boldog T, 2006, P NATL ACAD SCI USA, V103, P11509, DOI 10.1073/pnas.0604988103; Briegel A, 2012, P NATL ACAD SCI USA, V109, P3766, DOI 10.1073/pnas.1115719109; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Denisov IG, 2005, J PHYS CHEM B, V109, P15580, DOI 10.1021/jp051385g; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Djordjevic S, 1997, STRUCTURE, V5, P545, DOI 10.1016/S0969-2126(97)00210-4; Djordjevic S, 1998, P NATL ACAD SCI USA, V95, P1381, DOI 10.1073/pnas.95.4.1381; Draheim RR, 2006, BIOCHEMISTRY-US, V45, P14655, DOI 10.1021/bi061259i; ELLENS H, 1986, BIOCHEMISTRY-US, V25, P4141, DOI 10.1021/bi00362a023; Erbse AH, 2009, BIOCHEMISTRY-US, V48, P6975, DOI 10.1021/bi900641c; Fiske CH, 1925, J BIOL CHEM, V66, P375; Hall BA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002685; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Kijac A, 2010, BIOCHEMISTRY-US, V49, P9190, DOI 10.1021/bi1013722; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Kitanovic S, 2011, J BACTERIOL, V193, P5062, DOI 10.1128/JB.05683-11; Lai WC, 2005, J BACTERIOL, V187, P5115, DOI 10.1128/JB.187.15.5115-5121.2005; Levit MN, 2002, J BIOL CHEM, V277, P36760, DOI 10.1074/jbc.M204325200; Li MS, 2011, P NATL ACAD SCI USA, V108, P9390, DOI 10.1073/pnas.1104824108; Li MS, 2011, MOL MICROBIOL, V79, P677, DOI 10.1111/j.1365-2958.2010.07478.x; Li MS, 2005, MOL MICROBIOL, V56, P1617, DOI 10.1111/j.1365-2958.2005.04641.x; Miller AS, 2004, BIOCHEMISTRY-US, V43, P1763, DOI 10.1021/bi0360206; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; MULUKUTLA S, 1984, BIOCHEMISTRY-US, V23, P2514, DOI 10.1021/bi00306a030; Murzyn K, 2005, BIOPHYS J, V88, P1091, DOI 10.1529/biophysj.104.048835; NINFA EG, 1991, J BIOL CHEM, V266, P9764; Parkinson JS, 2010, ANNU REV MICROBIOL, V64, P101, DOI 10.1146/annurev.micro.112408.134215; Peach ML, 2002, PROTEIN SCI, V11, P912, DOI 10.1110/ps.4640102; Roos C, 2012, BBA-BIOMEMBRANES, V1818, P3098, DOI 10.1016/j.bbamem.2012.08.007; Shaw AW, 2004, FEBS LETT, V556, P260, DOI 10.1016/S0014-5793(03)01400-5; WEST AH, 1995, J MOL BIOL, V250, P276, DOI 10.1006/jmbi.1995.0376; Zhulin IB, 2001, ADV MICROB PHYSIOL, V45, P157, DOI 10.1016/S0065-2911(01)45004-1	41	22	22	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41697	41705		10.1074/jbc.M112.415588	http://dx.doi.org/10.1074/jbc.M112.415588			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23071117	Green Published, hybrid			2022-12-28	WOS:000312103000012
J	Henke, N; Albrecht, P; Pfeiffer, A; Toutzaris, D; Zanger, K; Methner, A				Henke, Nadine; Albrecht, Philipp; Pfeiffer, Annika; Toutzaris, Diamandis; Zanger, Klaus; Methner, Axel			Stromal Interaction Molecule 1 (STIM1) Is Involved in the Regulation of Mitochondrial Shape and Bioenergetics and Plays a Role in Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ CHANNELS; ENDOPLASMIC-RETICULUM; CALCIUM-ENTRY; STORE; ORAI1; SUBSTRATE; DEPLETION; RELEASE; SERCA; KEAP1	Calcium ions are involved in a plethora of cellular functions including cell death and mitochondrial energy metabolism. Store-operated Ca2+ entry over the plasma membrane is activated by depletion of intracellular Ca2+ stores and is mediated by the sensor STIM1 and the channel ORAI1. We compared cell death susceptibility to oxidative stress in STIM1 knock-out and ORAI1 knockdown mouse embryonic fibroblasts and in knockout cells with reconstituted wild type and dominant active STIM1. We show that STIM1 and ORAI1 deficiency renders cells more susceptible to oxidative stress, which can be rescued by STIM1 and ORAI1 overexpression. STIM1 knock-out mitochondria are tubular, have a higher Ca2+ concentration, and are metabolically more active, resulting in constitutive oxidative stress causing increased nuclear translocation of the antioxidant transcription factor NRF2 triggered by increased phosphorylation of the translation initiation factor eIF2 alpha and the protein kinase-like endoplasmic reticulum kinase PERK. This leads to increased transcription of antioxidant genes and a high basal glutathione in STIM1 knock-out cells, which is, however, more rapidly expended upon additional stress, resulting in increased release and nuclear translocation of apoptosis-inducing factor with subsequent cell death. Our data suggest that store-operated Ca2+ entry and STIM1 are involved in the regulation of mitochondrial shape and bioenergetics and play a role in oxidative stress.	[Methner, Axel] Johannes Gutenberg Univ Mainz, Med Ctr Mainz, Focus Program Translat Neurosci, Rhine Main Neurosci Network,Dept Neurol, D-55131 Mainz, Germany; [Henke, Nadine; Albrecht, Philipp; Pfeiffer, Annika; Toutzaris, Diamandis; Methner, Axel] Univ Dusseldorf, Fac Med, Dept Neurol, D-40225 Dusseldorf, Germany; [Zanger, Klaus] Univ Dusseldorf, Fac Med, Ctr Anat & Brain Res, D-40225 Dusseldorf, Germany	Johannes Gutenberg University of Mainz; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Methner, A (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr Mainz, Focus Program Translat Neurosci, Rhine Main Neurosci Network,Dept Neurol, Langenbeckstr 1, D-55131 Mainz, Germany.	axel.methner@gmail.com		Nickel, Nadine/0000-0002-0609-0735; Methner, Axel/0000-0002-8774-0057	Deutsche Forschungsgemeinschaft Grant [ME1922/9-1]	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant ME1922/9-1 (to A. M.).	Albrecht P, 2010, CNS NEUROL DISORD-DR, V9, P373, DOI 10.2174/187152710791292567; Arnaudeau S, 2001, J BIOL CHEM, V276, P29430, DOI 10.1074/jbc.M103274200; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Chiu WT, 2008, MOL BIOL CELL, V19, P2220, DOI 10.1091/mbc.E07-11-1170; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Frieden M, 2005, J BIOL CHEM, V280, P43198, DOI 10.1074/jbc.M510279200; Grohm J, 2010, BRAIN BEHAV IMMUN, V24, P831, DOI 10.1016/j.bbi.2009.11.015; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Kuster GM, 2010, FREE RADICAL BIO MED, V48, P1182, DOI 10.1016/j.freeradbiomed.2010.01.038; Landshamer S, 2008, CELL DEATH DIFFER, V15, P1553, DOI 10.1038/cdd.2008.78; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu HL, 2011, EXP MOL PATHOL, V91, P753, DOI 10.1016/j.yexmp.2011.09.005; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Manjarres IM, 2010, CELL CALCIUM, V47, P412, DOI 10.1016/j.ceca.2010.03.001; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prins D, 2011, EMBO REP, V12, P1182, DOI 10.1038/embor.2011.173; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sabbioni S, 1997, CANCER RES, V57, P4493; Sampieri A, 2009, CELL CALCIUM, V45, P439, DOI 10.1016/j.ceca.2009.02.010; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; TAKEMURA H, 1989, BIOCHEM J, V258, P409, DOI 10.1042/bj2580409; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003	37	51	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42042	42052		10.1074/jbc.M112.417212	http://dx.doi.org/10.1074/jbc.M112.417212			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23076152	hybrid, Green Published			2022-12-28	WOS:000312103000043
J	Kawahara, R; Saburi, W; Odaka, R; Taguchi, H; Ito, S; Mori, H; Matsui, H				Kawahara, Ryosuke; Saburi, Wataru; Odaka, Rei; Taguchi, Hidenori; Ito, Shigeaki; Mori, Haruhide; Matsui, Hirokazu			Metabolic Mechanism of Mannan in a Ruminal Bacterium, Ruminococcus albus, Involving Two Mannoside Phosphorylases and Cellobiose 2-Epimerase DISCOVERY OF A NEW CARBOHYDRATE PHOSPHORYLASE, beta-1,4-MANNOOLIGOSACCHARIDE PHOSPHORYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOTHERMUS-MARINUS JCM9785; CRYSTAL-STRUCTURE; GEOBACILLUS-STEAROTHERMOPHILUS; EVOLUTIONARY RELATIONSHIP; BETA-GLUCOSIDASE; SUBSTRATE; ENZYME; IDENTIFICATION; LEVANSUCRASE; REVEALS	Ruminococcus albus is a typical ruminal bacterium digesting cellulose and hemicellulose. Cellobiose 2-epimerase (CE; EC 5.1.3.11), which converts cellobiose to 4-O-beta-D-glucosyl-D-mannose, is a particularly unique enzyme in R. albus, but its physiological function is unclear. Recently, a new metabolic pathway of mannan involving CE was postulated for another CE-producing bacterium, Bacteroides fragilis. In this pathway, beta-1,4-mannobiose is epimerized to 4-O-beta-D-mannosyl-D-glucose (Man-Glc) by CE, and Man-Glc is phosphorolyzed to alpha-D-mannosyl 1-phosphate (Man1P) and D-glucose by Man-Glc phosphorylase (MP; EC 2.4.1.281). Ruminococcus albus NE1 showed intracellular MP activity, and two MP isozymes, RaMP1 and RaMP2, were obtained from the cell-free extract. These enzymes were highly specific for the mannosyl residue at the non-reducing end of the substrate and catalyzed the phosphorolysis and synthesis of Man-Glc through a sequential Bi Bi mechanism. In a synthetic reaction, RaMP1 showed high activity only toward D-glucose and 6-deoxy-D-glucose in the presence of Man1P, whereas RaMP2 showed acceptor specificity significantly different from RaMP1. RaMP2 acted on D-glucose derivatives at the C2- and C3-positions, including deoxy- and deoxyfluoro-analogues and epimers, but not on those substituted at the C6-position. Furthermore, RaMP2 had high synthetic activity toward the following oligosaccharides: beta-linked glucobioses, maltose, N, N'-diacetylchitobiose, and beta-1,4-mannooligosaccharides. Particularly, beta-1,4-mannooligosaccharides served as significantly better acceptor substrates for RaMP2 than D-glucose. In the phosphorolytic reactions, RaMP2 had weak activity toward beta-1,4-mannobiose but efficiently degraded beta-1,4-mannooligosaccharides longer than beta-1,4-mannobiose. Consequently, RaMP2 is thought to catalyze the phosphorolysis of beta-1,4-mannooligosaccharides longer than beta-1,4-mannobiose to produce Man1P and beta-1,4-mannobiose.	[Kawahara, Ryosuke; Saburi, Wataru; Odaka, Rei; Taguchi, Hidenori; Ito, Shigeaki; Mori, Haruhide; Matsui, Hirokazu] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan	Hokkaido University	Saburi, W (corresponding author), Hokkaido Univ, Res Fac Agr, N-9,W-9, Sapporo, Hokkaido 0608589, Japan.	saburiw@chem.agr.hokudai.ac.jp	Mori, Haruhide/AAV-6374-2021; Saburi, Wataru/A-4271-2012	Mori, Haruhide/0000-0001-7346-9131; Saburi, Wataru/0000-0002-2015-7086	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24780091]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Kakenhi, Grants-in-aid for Young Scientists (B) 24780091, of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Alhassid A, 2009, BIOCHEM J, V422, P73, DOI 10.1042/BJ20090180; BOCK K, 1974, J CHEM SOC PERK T 2, P293, DOI 10.1039/p29740000293; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cartmell A, 2011, J BIOL CHEM, V286, P15483, DOI 10.1074/jbc.M110.215962; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; Dixon M., 1979, ENZYMES, P109; Egloff MP, 2001, STRUCTURE, V9, P689, DOI 10.1016/S0969-2126(01)00626-8; Fujimoto Z, 2010, J BIOL CHEM, V285, P34134, DOI 10.1074/jbc.M110.164251; Hamura K, 2012, BIOSCI BIOTECH BIOCH, V76, P812, DOI 10.1271/bbb.110954; Hidaka M, 2006, BIOCHEM J, V398, P37, DOI 10.1042/BJ20060274; Ito S, 2008, APPL MICROBIOL BIOT, V79, P433, DOI 10.1007/s00253-008-1449-7; Ito S, 2007, BIOCHEM BIOPH RES CO, V360, P640, DOI 10.1016/j.bbrc.2007.06.091; KITAOKA M, 1992, BIOSCI BIOTECH BIOCH, V56, P652, DOI 10.1271/bbb.56.652; Kitaoka M, 2012, BIOSCI BIOTECH BIOCH, V76, P343, DOI 10.1271/bbb.110772; LEATHERW.JM, 1965, APPL MICROBIOL, V13, P771, DOI 10.1128/AEM.13.5.771-775.1965; LOWRY OH, 1946, J BIOL CHEM, V162, P421; Martinez-Fleites C, 2005, BIOCHEM J, V390, P19, DOI 10.1042/BJ20050324; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; MIWA I, 1972, CLIN CHIM ACTA, V37, P538, DOI 10.1016/0009-8981(72)90483-4; MOORE S, 1948, J BIOL CHEM, V176, P367; Nagem RAP, 2004, J MOL BIOL, V344, P471, DOI 10.1016/j.jmb.2004.09.024; Nihira T, 2012, APPL MICROBIOL BIOT, V93, P1513, DOI 10.1007/s00253-011-3515-9; Nurizzo D, 2002, NAT STRUCT BIOL, V9, P665, DOI 10.1038/nsb835; OHMIYA K, 1985, J BACTERIOL, V161, P432, DOI 10.1128/JB.161.1.432-434.1985; Ojima T, 2011, BIOSCI BIOTECH BIOCH, V75, P2162, DOI 10.1271/bbb.110456; Rajashekhara E, 2002, BIOSCI BIOTECH BIOCH, V66, P2578, DOI 10.1271/bbb.66.2578; Sato H, 2012, BIOSCI BIOTECH BIOCH, V76, P1584, DOI 10.1271/bbb.120284; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; Senoura T, 2009, BIOSCI BIOTECH BIOCH, V73, P400, DOI 10.1271/bbb.80691; TYLER TR, 1967, ARCH BIOCHEM BIOPHYS, V119, P363, DOI 10.1016/0003-9861(67)90466-3; Wakuta S, 2010, PHYTOCHEMISTRY, V71, P1280, DOI 10.1016/j.phytochem.2010.04.025; Yamaguchi A, 2005, J BIOCHEM, V137, P587, DOI 10.1093/jb/mvi078	34	52	56	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42389	42399		10.1074/jbc.M112.390336	http://dx.doi.org/10.1074/jbc.M112.390336			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23093406	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000312103000074
J	Kim, JJ; Khalid, O; Vo, S; Sun, HH; Wong, DTW; Kim, Y				Kim, Jeffrey J.; Khalid, Omar; Vo, Sheynie; Sun, Ho-hyun; Wong, David T. W.; Kim, Yong			A Novel Regulatory Factor Recruits the Nucleosome Remodeling Complex to Wingless Integrated (Wnt) Signaling Gene Promoters in Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR FOLLICLE MORPHOGENESIS; INTRAGENIC DNA METHYLATION; BETA-CATENIN; CHROMATIN-STRUCTURE; DIFFERENTIATION; NURD; PLURIPOTENCY; TRANSCRIPTION; EXPRESSION; THERAPY	The nucleosome remodeling and deacetylation (NuRD) complex is required for modulating the transcription of essential pluripotency genes in ESC self-renewal. MBD3 is considered a key player in the formation of a functional NuRD complex. The recruitment of MBD3 to methylated promoters may require other prerequisite factors. We show that cyclin-dependent kinase 2-associated protein 1 (CDK2AP1), an essential gene for early embryonic development, plays a role in pluripotency of ESC by engaging MBD3 to the promoter region of Wnt signaling genes. The occupancy of MBD3 on several promoters of Wnt genes was significantly lost in the absence of CDK2AP1, resulting in hyperactivation of Wnt. We propose that the transcriptional modulation of the Wnt pathway mediated by NuRD requires the presence of essential auxiliary components such as CDK2AP1, which may aid the association of the complex with specific focal regions of the target promoters.	[Kim, Jeffrey J.; Khalid, Omar; Vo, Sheynie; Sun, Ho-hyun; Kim, Yong] Univ Calif Los Angeles, Lab Stem Cell & Canc Epigenet Res, Los Angeles, CA 90095 USA; [Kim, Jeffrey J.; Khalid, Omar; Wong, David T. W.; Kim, Yong] Univ Calif Los Angeles, Sch Dent, Dent Res Inst, Los Angeles, CA 90095 USA; [Wong, David T. W.; Kim, Yong] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Kim, Y (corresponding author), Univ Calif Los Angeles, Lab Stem Cell & Canc Epigenet Res, 10833 Le Conte Ave,73-035 CHS, Los Angeles, CA 90095 USA.	thadyk@ucla.edu		Sun, Ho-Hyun/0000-0002-7963-4633	California Institute of Regenerative Medicine [RB2-01562]; National Institutes of Health, NIDCR [R01DE014857, F30DE020003, T32DE07269]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F30DE020003, R01DE014857] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a California Institute of Regenerative Medicine grant (Basic Biology Award II, RB2-01562) (to Y. K.) and National Institutes of Health, NIDCR Grants R01DE014857 (to D. T. W. W.), F30DE020003 (to J. J. K.), and T32DE07269 (to O. K.).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Bridgewater D, 2008, DEV BIOL, V317, P83, DOI 10.1016/j.ydbio.2008.02.010; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chung YS, 2009, BLOOD, V114, P4968, DOI 10.1182/blood-2009-01-197780; Collins CA, 2011, DEVELOPMENT, V138, P5189, DOI 10.1242/dev.064592; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deshpande AM, 2009, J BIOL CHEM, V284, P6043, DOI 10.1074/jbc.C800158200; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Galea MA, 2001, J BIOL CHEM, V276, P45833, DOI 10.1074/jbc.M107149200; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; Hu QR, 2010, STEM CELLS, V28, P1981, DOI 10.1002/stem.531; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jin SG, 2005, J BIOL CHEM, V280, P12700, DOI 10.1074/jbc.M413492200; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Kim Y, 2009, J BIOL CHEM, V284, P23405, DOI 10.1074/jbc.M109.026088; Kim Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004518; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Latos PA, 2012, BIOL OPEN, V1, P341, DOI 10.1242/bio.2012513; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Maniatis T., 1982, MOL CLONING LABORATO, pA840 A851; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Miki T, 2011, STEM CELL REV REP, V7, P836, DOI 10.1007/s12015-011-9275-1; Mohn Fabio, 2009, V507, P55, DOI 10.1007/978-1-59745-522-0_5; Reddy BA, 2010, MOL CELL BIOL, V30, P5234, DOI 10.1128/MCB.00266-10; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Rhee J, 2007, NAT CELL BIOL, V9, P883, DOI 10.1038/ncb1614; Sambrook J, 2006, CSH PROTOC, V1; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schroeder IS, 2012, CURR DIABETES REP, V12, P490, DOI 10.1007/s11892-012-0292-5; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Shintani S, 2000, MOL CELL BIOL, V20, P6300, DOI 10.1128/MCB.20.17.6300-6307.2000; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Spruijt CG, 2010, MOL BIOSYST, V6, P1700, DOI 10.1039/c004108d; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; TODD R, 1995, FASEB J, V9, P1362, DOI 10.1096/fasebj.9.13.7557027; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	57	12	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41103	41117		10.1074/jbc.M112.416545	http://dx.doi.org/10.1074/jbc.M112.416545			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23074223	Green Published, hybrid			2022-12-28	WOS:000311887600027
J	Loya, TJ; O'Rourke, TW; Reines, D				Loya, Travis J.; O'Rourke, Thomas W.; Reines, Daniel			Yeast Nab3 Protein Contains a Self-assembly Domain Found in Human Heterogeneous Nuclear Ribonucleoprotein-C (hnRNP-C) That Is Necessary for Transcription Termination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; CELL-FREE FORMATION; BINDING PROTEINS; NRD1; ACCUMULATION; EXPRESSION; INTERACTS; FEATURES; GENE	Nab3 is an RNA-binding protein whose function is important for terminating transcription by RNA polymerase II. It co-assembles with Nrd1, and the resulting heterodimer of these heterogeneous nuclear ribonucleoprotein-C (hnRNP)-like proteins interacts with the nascent transcript and RNA polymerase II. Previous genetic analysis showed that a short carboxyl-terminal region of Nab3 is functionally important for termination and is located far from the Nab3 RNA recognition domain in the primary sequence. The domain is structurally homologous to hnRNP-C from higher organisms. Here we provide biochemical evidence that this short region is sufficient to enable self-assembly of Nab3 into a tetrameric form in a manner similar to the cognate region of human hnRNP-C. Within this region, there is a stretch of low complexity protein sequence (16 glutamines) adjacent to a putative alpha-helix that potentiates the ability of the conserved region to self-assemble. The glutamine stretch and the final 18 amino acids of Nab3 are both important for termination in living yeast cells. The findings herein describe an additional avenue by which these hnRNP-like proteins can polymerize on target transcripts. This process is independent of, but acts in concert with, the interactions of the proteins with RNA and RNA polymerase and extends the relationship of Nab3 as a functional orthologue of a higher eukaryotic hnRNP.	[Loya, Travis J.; O'Rourke, Thomas W.; Reines, Daniel] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Reines, D (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	dreines@emory.edu	excellency, Your/R-2357-2019	excellency, Your/0000-0003-0832-6243	National Institutes of Health [GM46331]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, R01GM046331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46331.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Jenks MH, 2008, MOL CELL BIOL, V28, P3883, DOI 10.1128/MCB.00380-08; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Loya TJ, 2012, NUCLEIC ACIDS RES, V40, P7476, DOI 10.1093/nar/gks377; Lykke-Andersen S, 2007, BIOCHIMIE, V89, P1177, DOI 10.1016/j.biochi.2007.05.007; McAfee JG, 1996, BIOCHEMISTRY-US, V35, P1212, DOI 10.1021/bi951974k; McCloskey A, 2012, SCIENCE, V335, P1643, DOI 10.1126/science.1218469; Orr HT, 2012, CURR OPIN GENET DEV, V22, P251, DOI 10.1016/j.gde.2012.01.001; Schaefer MH, 2012, NUCLEIC ACIDS RES, V40, P4273, DOI 10.1093/nar/gks011; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shaw RJ, 2001, J BIOL CHEM, V276, P32905, DOI 10.1074/jbc.M105075200; Steinmetz EJ, 1998, P NATL ACAD SCI USA, V95, P6699, DOI 10.1073/pnas.95.12.6699; Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993; Tan JH, 2001, J MOL BIOL, V305, P829, DOI 10.1006/jmbi.2000.4332; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Whitson SR, 2005, J MOL BIOL, V350, P319, DOI 10.1016/j.jmb.2005.05.002; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975	25	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2111	2117		10.1074/jbc.M112.430678	http://dx.doi.org/10.1074/jbc.M112.430678			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23192344	Green Published, hybrid			2022-12-28	WOS:000314211500002
J	Chen, K; Piszczek, G; Carter, C; Tjandra, N				Chen, Kang; Piszczek, Grzegorz; Carter, Carol; Tjandra, Nico			The Maturational Refolding of the beta-Hairpin Motif of Equine Infectious Anemia Virus Capsid Protein Extends Its Helix alpha 1 at Capsid Assembly Locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ROUS-SARCOMA-VIRUS; N-TERMINAL DOMAIN; MOLECULAR-STRUCTURE DETERMINATION; PFIZER MONKEY VIRUS; NMR CHEMICAL-SHIFTS; HUMAN CYCLOPHILIN-A; IN-VITRO; CRYSTAL-STRUCTURE; BIOCHEMICAL-CHARACTERIZATION	A retroviral capsid (CA) protein consists of two helical domains, CA(N) and CA(C), which drive hexamer and dimer formations, respectively, to form a capsid lattice. The N-terminal 13 residues of CA refold to a beta-hairpin motif upon processing from its precursor polyprotein Gag. The beta-hairpin is essential for correct CA assembly but unexpectedly it is not within any CA oligomeric interfaces. To understand the beta-hairpin function we studied the full-length CA protein from equine infectious anemia virus (EIAV), a lentivirus sharing the same cone-shaped capsid core as HIV-1. Solution NMR spectroscopy is perfectly suited to study EIAV-CA that dimerizes weaker than HIV-1-CA. Comparison between the wild-type (wt) EIAV-CA and a variant lacking the beta-hairpin structure demonstrated that folding of the beta-hairpin specifically extended the N terminus of helix alpha 1 from Tyr(20) to Pro(17). This coil to helix transition involves the conserved sequence of Thr(16)-Pro(17)-Arg(18) (Ser(16)-Pro(17)-Arg(18) in HIV-1-CA). The extended region of helix alpha 1 constituted an expanded EIAV-CA(N) oligomeric interface and overlapped with the HIV-1-CA hexamer-core residue Arg(18), helical in structure and pivotal in assembly. Therefore we propose the function of the maturational refolding of the beta-hairpin in CA assembly is to extend helix alpha 1 at the N terminus to enhance the CA(N) oligomerization along the capsid assembly core interface. In addition, NMR resonance line broadening indicated the presence of micro-millisecond exchange kinetics due to the EIAV-CA(N) domain oligomerization, independent to the faster EIAV-CA(C) domain dimerization.	[Chen, Kang; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Piszczek, Grzegorz] NHLBI, Biophys Facil, NIH, Bethesda, MD 20892 USA; [Carter, Carol] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Carter, C (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	ccarter@ms.cc.sunysb.edu; tjandran@nhlbi.nih.gov	Piszczek, Grzegorz/GYU-2029-2022	Chen, Kang/0000-0003-0276-2474	National Institutes of Health Intramural Research Program of NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL000338, ZIAHL001048] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of NHLBI.	Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Bouamr F, 2005, J BIOL CHEM, V280, P6792, DOI 10.1074/jbc.M408119200; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; Cairns TM, 2001, J VIROL, V75, P242, DOI 10.1128/JVI.75.1.242-250.2001; CAMPBELL S, 1995, J VIROL, V69, P6487, DOI 10.1128/JVI.69.10.6487-6497.1995; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Carter CA, 2008, ANNU REV MICROBIOL, V62, P425, DOI 10.1146/annurev.micro.62.081307.162758; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Cornilescu CC, 2001, J MOL BIOL, V306, P783, DOI 10.1006/jmbi.2000.4395; Cortines JR, 2011, J MOL BIOL, V410, P641, DOI 10.1016/j.jmb.2011.03.052; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du SC, 2011, J MOL BIOL, V406, P371, DOI 10.1016/j.jmb.2010.11.027; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; Ehrlich LS, 2001, BIOPHYS J, V81, P586, DOI 10.1016/S0006-3495(01)75725-6; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; GELDERBLOM HR, 1991, AIDS, V5, P617, DOI 10.1097/00002030-199106000-00001; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; GRONENBORN AM, 1994, J BIOMOL NMR, V4, P455; Gross I, 1998, J VIROL, V72, P4798, DOI 10.1128/JVI.72.6.4798-4810.1998; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; HARPER ET, 1993, BIOCHEMISTRY-US, V32, P7605, DOI 10.1021/bi00081a001; HAUSDORF G, 1994, J VIROL METHODS, V50, P1, DOI 10.1016/0166-0934(94)90158-9; Jin ZM, 1999, J MOL BIOL, V286, P83, DOI 10.1006/jmbi.1998.2443; Kelly BN, 2006, BIOCHEMISTRY-US, V45, P11257, DOI 10.1021/bi060927x; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Khorasanizadeh S, 1999, J MOL BIOL, V291, P491, DOI 10.1006/jmbi.1999.2986; Langelier CR, 2008, J VIROL, V82, P11682, DOI 10.1128/JVI.01562-08; LAURENT AG, 1989, J VIROL, V63, P4074, DOI 10.1128/JVI.63.9.4074-4078.1989; Lopez CS, 2011, VIROLOGY, V417, P137, DOI 10.1016/j.virol.2011.05.011; Macek P, 2009, J MOL BIOL, V392, P100, DOI 10.1016/j.jmb.2009.06.029; Meinhold DW, 2011, P NATL ACAD SCI USA, V108, P9078, DOI 10.1073/pnas.1105682108; METZLER WJ, 1993, BIOCHEMISTRY-US, V32, P13818, DOI 10.1021/bi00213a010; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Nandhagopal N, 2004, J MOL BIOL, V335, P275, DOI 10.1016/j.jmb.2003.10.034; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Purdy JG, 2008, J VIROL, V82, P5951, DOI 10.1128/JVI.00214-08; Rance M, 1999, J MAGN RESON, V136, P92, DOI 10.1006/jmre.1998.1626; Rayne F, 2001, J VIROL, V75, P5277, DOI 10.1128/JVI.75.11.5277-5287.2001; Roa A, 2012, J VIROL, V86, P1717, DOI 10.1128/JVI.05811-11; ROBERTS MM, 1989, BIOCHEM BIOPH RES CO, V160, P486, DOI 10.1016/0006-291X(89)92459-5; ROSE S, 1992, PROTEINS, V13, P112, DOI 10.1002/prot.340130204; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Scarlata S, 2003, BBA-BIOMEMBRANES, V1614, P62, DOI 10.1016/S0005-2736(03)00163-9; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2010, J BIOMOL NMR, V46, P199, DOI 10.1007/s10858-009-9395-y; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; STEPHENS RM, 1986, SCIENCE, V231, P589, DOI 10.1126/science.3003905; Strauss J.H., 2008, VIRUSES HUMAN DIS, pvii+468; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Wildova M, 2008, VIROLOGY, V380, P157, DOI 10.1016/j.virol.2008.07.021; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Yang DW, 1999, J BIOMOL NMR, V14, P333, DOI 10.1023/A:1008314803561; Yang DW, 1999, J AM CHEM SOC, V121, P2571, DOI 10.1021/ja984056t; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051; Zhu G, 1999, J BIOMOL NMR, V13, P77, DOI 10.1023/A:1008398227519	80	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1511	1520		10.1074/jbc.M112.425140	http://dx.doi.org/10.1074/jbc.M112.425140			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184932	hybrid, Green Published			2022-12-28	WOS:000313751400009
J	Minges, JT; Su, SF; Grossman, G; Blackwelder, AJ; Pop, EA; Mohler, JL; Wilson, EM				Minges, John T.; Su, Shifeng; Grossman, Gail; Blackwelder, Amanda J.; Pop, Elena A.; Mohler, James L.; Wilson, Elizabeth M.			Melanoma Antigen-A11 (MAGE-A11) Enhances Transcriptional Activity by Linking Androgen Receptor Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; COOH-TERMINAL INTERACTION; PROSTATE-CANCER CELLS; ACTIVATION FUNCTION 2; TUMOR VIRUS PROMOTER; PROTEIN-KINASE; GENE-EXPRESSION; COACTIVATOR INTERACTIONS; PROGESTERONE-RECEPTOR; COREGULATOR MAGE-11	Prostate cancer growth and progression depend on androgen receptor (AR) signaling through transcriptional mechanisms that require interactions with coregulatory proteins, one of which is the primate-specific steroid receptor coregulator melanoma antigen-A11 (MAGE-A11). In this report, we provide evidence how increased expression of MAGE-A11 during prostate cancer progression enhances AR signaling and prostate cancer growth. MAGE-A11 protein levels were highest in castration-recurrent prostate cancer. The cyclic AMP-induced increase in androgen-dependent and androgen-independent AR transcriptional activity correlated with an increase in MAGE-A11 and was inhibited by silencing MAGE-A11 expression. MAGE-A11 mediated synergistic AR transcriptional activity in LAPC-4 prostate cancer cells. The ability of MAGE-A11 to rescue transcriptional activity of complementary inactive AR mutants and promote coimmunoprecipitation between unlike forms of AR suggests that MAGE-A11 links transcriptionally active AR dimers. A model for the AR.MAGE-A11 multidimeric complex is proposed in which one AR FXXLF motif of the AR dimer engages in the androgen-dependent AR NH2- and carboxyl-terminal interaction, whereas the second FXXLF motif region of the AR dimer interacts with dimeric MAGE-A11. The AR.MAGE-A11 multidimeric complex accounts for the dual functions of the AR FXXLF motif in the androgen-dependent AR NH2- and carboxyl-terminal interaction and binding MAGE-A11 and for synergy between reported AR splice variants and full-length AR. We conclude that the increased expression of MAGE-A11 in castration-recurrent prostate cancer, which is enhanced by cyclic AMP signaling, increases AR-dependent growth of prostate cancer by MAGE-A11 forming a molecular bridge between transcriptionally active AR dimers.	[Minges, John T.; Su, Shifeng; Blackwelder, Amanda J.; Wilson, Elizabeth M.] Univ N Carolina, Labs Reprod Biol, Dept Pediat, Chapel Hill, NC 27599 USA; [Grossman, Gail; Wilson, Elizabeth M.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Pop, Elena A.; Mohler, James L.] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA; [Mohler, James L.] SUNY Buffalo, Dept Urol, Buffalo, NY 14263 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wilson, EM (corresponding author), Univ N Carolina, Labs Reprod Biol, Dept Pediat, CB7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu			National Institutes of Health, United States Public Health Service grant from NICHD [HD16910]; Eunice Kennedy Shriver NICHD as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research [HD067721, U54-HD35041]; NCI [P01-CA77739]; NCI Cancer Center [CA016056, CA034026]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067721] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD016910, U54HD035041, R01HD016910] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016056, P01CA077739] Funding Source: NIH RePORTER	National Institutes of Health, United States Public Health Service grant from NICHD; Eunice Kennedy Shriver NICHD as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants HD16910, a United States Public Health Service grant from NICHD; HD067721 of Cooperative Agreement U54-HD35041 from the Eunice Kennedy Shriver NICHD as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research; P01-CA77739 from the NCI; and CA016056 and CA034026, NCI Cancer Center support grants (to Roswell Park Cancer Institute and the University of North Carolina at Chapel Hill, respectively).	ARCHER TK, 1994, MOL ENDOCRINOL, V8, P568, DOI 10.1210/me.8.5.568; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Askew EB, 2012, MOL CELL ENDOCRINOL, V348, P403, DOI 10.1016/j.mce.2011.03.026; Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Bai S, 2008, MOL HUM REPROD, V14, P107, DOI 10.1093/molehr/gam080; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Beato M, 1996, J MOL MED, V74, P711, DOI 10.1007/s001090050076; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Burchardt T, 1999, J UROLOGY, V162, P1800, DOI 10.1016/S0022-5347(05)68241-9; Centenera MM, 2008, MOL ENDOCRINOL, V22, P2373, DOI 10.1210/me.2008-0017; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; DEBELLIS A, 1992, MOL ENDOCRINOL, V6, P1909, DOI 10.1210/me.6.11.1909; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Godoy A, 2011, PROSTATE, V71, P1033, DOI 10.1002/pros.21318; Gregory CW, 2004, J BIOL CHEM, V279, P7119, DOI 10.1074/jbc.M307649200; Gregory CW, 1998, CANCER RES, V58, P5718; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2003, MOL CELL BIOL, V23, P2135, DOI 10.1128/MCB.23.6.2135-2150.2003; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; Jain A, 2002, MOL ENDOCRINOL, V16, P2323, DOI 10.1210/me.2002-0004; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Kim J, 2005, J MOL ENDOCRINOL, V34, P107, DOI 10.1677/jme.1.01701; Lagarde WH, 2012, J BIOL CHEM, V287, P10905, DOI 10.1074/jbc.M111.336081; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; LUISI B, 1995, NATURE, V375, P359, DOI 10.1038/375359a0; MAJORS J, 1983, P NATL ACAD SCI-BIOL, V80, P5866, DOI 10.1073/pnas.80.19.5866; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Merkle D, 2011, CELL SIGNAL, V23, P507, DOI 10.1016/j.cellsig.2010.08.017; Mohler JL, 2011, CANCER RES, V71, P1486, DOI 10.1158/0008-5472.CAN-10-1343; Nazareth LV, 1996, J BIOL CHEM, V271, P19900, DOI 10.1074/jbc.271.33.19900; Prefontaine GG, 1999, J BIOL CHEM, V274, P26713, DOI 10.1074/jbc.274.38.26713; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P1399, DOI 10.1210/mend-4-9-1399; QUIGLEY A, 1992, MOL ENDOCRINOL, V6, P1103; Raaijmakers HCA, 2009, J BIOL CHEM, V284, P19572, DOI 10.1074/jbc.M109.007872; Sack JS, 2001, P NATL ACAD SCI USA, V98, P4904, DOI 10.1073/pnas.081565498; Sadar MD, 1999, J BIOL CHEM, V274, P7777, DOI 10.1074/jbc.274.12.7777; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Singh SS, 2004, ANAL QUANT CYTOL, V26, P194; Steketee K, 2002, EUR J BIOCHEM, V269, P5780, DOI 10.1046/j.1432-1033.2002.03276.x; Su SF, 2012, J BIOL CHEM, V287, P34809, DOI 10.1074/jbc.M112.372797; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tamrazi A, 2002, MOL ENDOCRINOL, V16, P2706, DOI 10.1210/me.2002-0250; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; van Royen ME, 2007, J CELL BIOL, V177, P63, DOI 10.1083/jcb.200609178; van Royen ME, 2012, J CELL SCI, V125, P1970, DOI 10.1242/jcs.096792; Wang G, 2006, ONCOGENE, V25, P7311, DOI 10.1038/sj.onc.1209715; Wang L, 2006, J BIOL CHEM, V281, P37773, DOI 10.1074/jbc.M608410200; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Wilson EM, 2010, THER ADV UROL, V2, P105, DOI 10.1177/1756287210372380; WONG CI, 1993, J BIOL CHEM, V268, P19004; Zentner GE, 2012, J BIOL CHEM, V287, P30888, DOI 10.1074/jbc.R111.296491; ZHOU ZX, 1994, RECENT PROG HORM RES, V49, P249; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	67	32	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1939	1952		10.1074/jbc.M112.428409	http://dx.doi.org/10.1074/jbc.M112.428409			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23172223	hybrid, Green Published			2022-12-28	WOS:000313751400047
J	New, LA; Chahi, AK; Jones, N				New, Laura A.; Chahi, Ava Keyvani; Jones, Nina			Direct Regulation of Nephrin Tyrosine Phosphorylation by Nck Adaptor Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; KIDNEY SLIT DIAPHRAGM; ACTIN POLYMERIZATION; CELL MORPHOLOGY; KINASE; SRC; FYN; DOMAIN; ACTIVATION; PODOCYTE	The transmembrane protein nephrin is a key component of the kidney slit diaphragm that contributes to the morphology of podocyte foot processes through signaling to the underlying actin cytoskeleton. We have recently reported that tyrosine phosphorylation of the cytoplasmic tail of nephrin facilitates recruitment of Nck SH2/SH3 adaptor proteins and subsequent actin remodeling and that phosphorylation of the Nck binding sites on nephrin is decreased during podocyte injury. We now demonstrate that Nck directly modulates nephrin phosphorylation through formation of a signaling complex with the Src family kinase Fyn. The ability of Nck to enhance nephrin phosphorylation is compromised in the presence of a Src family kinase inhibitor and when the SH3 domains of Nck are mutated. Furthermore, induced loss of Nck expression in podocytes in vivo is associated with a rapid reduction in nephrin tyrosine phosphorylation. Our results suggest that Nck may facilitate dynamic signaling events at the slit diaphragm by promoting Fyn-dependent phosphorylation of nephrin, which may be important in the regulation of foot process morphology and response to podocyte injury.	[New, Laura A.; Chahi, Ava Keyvani; Jones, Nina] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Jones, N (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E,Rm 3461,New Sci Complex, Guelph, ON N1G 2W1, Canada.	jonesmcb@uoguelph.ca			Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC); New Investigator Award from the Kidney Research Scientist Core Education and National Training (KRESCENT) Program	Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); New Investigator Award from the Kidney Research Scientist Core Education and National Training (KRESCENT) Program	This work was supported by grants from the Kidney Foundation of Canada (to N. J.).; Supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Alexander Graham Bell Canada Graduate Scholarship.; The recipient of a New Investigator Award from the Kidney Research Scientist Core Education and National Training (KRESCENT) Program. Holds a Tier II Canada Research Chair in Eukaryotic Cellular Signaling.	Ashworth S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012626; Barda-Saad M, 2010, EMBO J, V29, P2315, DOI 10.1038/emboj.2010.133; Berger K, 2011, INT UROL NEPHROL, V43, P273, DOI 10.1007/s11255-010-9898-1; Blasutig IM, 2008, MOL CELL BIOL, V28, P2035, DOI 10.1128/MCB.01770-07; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Frese S, 2006, J BIOL CHEM, V281, P18236, DOI 10.1074/jbc.M512917200; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Garg P, 2010, J BIOL CHEM, V285, P22676, DOI 10.1074/jbc.M110.122929; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Hake MJ, 2008, BIOCHEMISTRY-US, V47, P3096, DOI 10.1021/bi701549a; Harita Y, 2008, J BIOL CHEM, V283, P9177, DOI 10.1074/jbc.M707247200; Harita Y, 2009, J BIOL CHEM, V284, P8951, DOI 10.1074/jbc.M806851200; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Jones N, 2009, J AM SOC NEPHROL, V20, P1533, DOI 10.1681/ASN.2009010056; Kriz W, 1996, KIDNEY INT, V49, P1570, DOI 10.1038/ki.1996.227; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Lettau M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-1; Li CJ, 2009, CELL SIGNAL, V21, P111, DOI 10.1016/j.cellsig.2008.09.014; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Li HP, 2006, BIOCHEM BIOPH RES CO, V349, P310, DOI 10.1016/j.bbrc.2006.08.053; Miyoshi-Akiyama T, 2001, ONCOGENE, V20, P4058, DOI 10.1038/sj.onc.1204528; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; PANCHAMOORTHY G, 1994, MOL CELL BIOL, V14, P6372, DOI 10.1128/MCB.14.9.6372; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Simarro M, 2004, INT IMMUNOL, V16, P727, DOI 10.1093/intimm/dxh074; Smith JM, 1999, J BIOL CHEM, V274, P27956, DOI 10.1074/jbc.274.39.27956; Solheim SA, 2008, J BIOL CHEM, V283, P2773, DOI 10.1074/jbc.M705215200; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Uchida K, 2008, KIDNEY INT, V73, P926, DOI [10.1038/ki.2008.19, 10.1038/KI.2008.19]; Vaynberg J, 2005, MOL CELL, V17, P513, DOI 10.1016/j.molcel.2004.12.031; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Welsh GI, 2010, J PATHOL, V220, P328, DOI 10.1002/path.2661; Yu CCK, 2001, CURR BIOL, V11, P34, DOI 10.1016/S0960-9822(00)00024-5; Zhang SY, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000678; Zhang Y, 2010, NEPHROL DIAL TRANSPL, V25, P1785, DOI 10.1093/ndt/gfp697; Zhu J, 2008, KIDNEY INT, V73, P556, DOI 10.1038/sj.ki.5002691	39	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1500	1510		10.1074/jbc.M112.439463	http://dx.doi.org/10.1074/jbc.M112.439463			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23188823	hybrid, Green Published			2022-12-28	WOS:000313751400008
J	El Bakkouri, M; Rathore, S; Calmettes, C; Wernimont, AK; Liu, KY; Sinha, D; Asad, M; Jung, P; Hui, R; Mohmmed, A; Houry, WA				El Bakkouri, Majida; Rathore, Sumit; Calmettes, Charles; Wernimont, Amy K.; Liu, Kaiyin; Sinha, Dipto; Asad, Mohd; Jung, Patrick; Hui, Raymond; Mohmmed, Asif; Houry, Walid A.			Structural Insights into the Inactive Subunit of the Apicoplast-localized Caseinolytic Protease Complex of Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Malaria; Plasmodium; Protease; Protein Assembly; Protein Degradation; Protein Structure; ClpP; ClpR; X-ray Structure	ERYTHROCYTE BINDING; CLPP; CLASSIFICATION; RECOGNITION; PROTEINS; SWITCH; MODEL	The ATP-dependent caseinolytic protease, ClpP, is highly conserved in bacteria and in the organelles of different organisms. In cyanobacteria, plant plastids, and the apicoplast of the genus Plasmodium, a noncatalytic paralog of ClpP, termed ClpR, has been identified. ClpRs are found to form heterocomplexes with ClpP resulting in a ClpRP tetradecameric cylinder having less than 14 catalytic triads. The exact role of ClpR in such a complex remains enigmatic. Here we describe the x-ray crystal structure of ClpR protein heptamer from (Plasmodium falciparum) ((PfClpR)). This is the first structure of a ClpR protein. The structure shows that the (PfClpR) monomer adopts a fold similar to that of ClpP, but has a unique motif, which we named the (R)-motif, forming a beta turn located near the inactive catalytic triad in a three-dimensional space. The (PfClpR) heptamer exhibits a more open and flat ring than a ClpP heptamer. (PfClpR) was localized in the (P. falciparum) apicoplast as is the case of PfClpP. However, biochemical and structural data suggest that, contrary to what has been observed in other organisms, (PfClpP) and (PfClpR) do not form a stable heterocomplex in the apicoplast of (P. falciparum).	[El Bakkouri, Majida; Calmettes, Charles; Liu, Kaiyin; Jung, Patrick; Houry, Walid A.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Rathore, Sumit; Sinha, Dipto; Asad, Mohd; Mohmmed, Asif] Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi 110067, India; [Wernimont, Amy K.; Hui, Raymond] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada	University of Toronto; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Toronto; Structural Genomics Consortium	Mohmmed, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	amohd@icgeb.res.in; walid.houry@utoronto.ca	Sinha, Dipto/GLU-5171-2022	Sinha, Dipto/0000-0001-9118-5079; calmettes, charles/0000-0002-2542-4382	ICMR, Government of India; Department of Biotechnology,Government of India; Canadian Institutes of Health Research (CIHR) [MOP-67210]	ICMR, Government of India(Indian Council of Medical Research (ICMR)); Department of Biotechnology,Government of India(Department of Biotechnology (DBT) India); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We are grateful to Alan Cowman (Walter and Eliza Hall Institute of Medical Research, Australia) for pARL1 vector, and Guy Schiehser and David Jacobus (Jacobus Pharmaceuticals, NJ, USA) for the drug WR99210. We thank Wandy Beatty for help with the immunoelectron microscopic studies and the Rotary blood bank, New Delhi, for providing the human RBCs. SR and MA were supported by research fellowships from ICMR, Government of India. AM is the recipient of National Bioscience Award for Career Development from Department of Biotechnology, Government of India. MEB is the recipient of a fellowship from the Canadian Institutes of Health Research (CIHR) Strategic Training Program in Protein Folding and Interaction Dynamics: Principles and Diseases (TGF-53910). KL is the recipient of the Ontario Graduate Scholarship. This work was supported by a Program support grant from Department of Biotechnology, Government of India to AM and by a grant from CIHR (MOP-67210) to WAH.	Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Andersson FI, 2009, J BIOL CHEM, V284, P13519, DOI 10.1074/jbc.M809588200; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Blair PL, 2002, NUCLEIC ACIDS RES, V30, P2224, DOI 10.1093/nar/30.10.2224; Choi KH, 2005, BIOCHEMISTRY-US, V44, P13921, DOI 10.1021/bi0505060; Ciechanover A, 2012, BBA-PROTEINS PROTEOM, V1824, P3, DOI 10.1016/j.bbapap.2011.03.007; Crabb BS, 2004, METH MOL B, V270, P263; Dasaradhi PVN, 2005, BIOCHEM BIOPH RES CO, V336, P1062, DOI 10.1016/j.bbrc.2005.08.213; De Mot R, 1999, TRENDS MICROBIOL, V7, P88, DOI 10.1016/S0966-842X(98)01432-2; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; El Bakkouri M, 2010, J MOL BIOL, V404, P456, DOI 10.1016/j.jmb.2010.09.051; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geiger SR, 2011, ANGEW CHEM INT EDIT, V50, P5748, DOI 10.1002/anie.201100666; Gersch M, 2012, J BIOL CHEM, V287, P9484, DOI 10.1074/jbc.M111.336222; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gribun A, 2005, J BIOL CHEM, V280, P16185, DOI 10.1074/jbc.M414124200; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jennings LD, 2008, BIOCHEMISTRY-US, V47, P11536, DOI 10.1021/bi801101p; Kato Y, 2010, INT REV CEL MOL BIO, V280, P185, DOI 10.1016/S1937-6448(10)80004-8; Kim DY, 2008, J MOL BIOL, V379, P760, DOI 10.1016/j.jmb.2008.04.036; Kimber MS, 2010, STRUCTURE, V18, P798, DOI 10.1016/j.str.2010.04.008; Kress W, 2009, RES MICROBIOL, V160, P618, DOI 10.1016/j.resmic.2009.08.006; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee BG, 2011, MOL CELLS, V32, P589, DOI 10.1007/s10059-011-0197-1; LJUNGSTROM I, 2004, METH MALARIA RES; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuwald AF, 1999, GENOME RES, V9, P27; Olinares PDB, 2011, PLANT CELL, V23, P2348, DOI 10.1105/tpc.111.086454; Olinares PDB, 2011, BBA-BIOENERGETICS, V1807, P999, DOI 10.1016/j.bbabio.2010.12.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peltier JB, 2004, J BIOL CHEM, V279, P4768, DOI 10.1074/jbc.M309212200; Ramasamy G, 2007, MOL BIOCHEM PARASIT, V152, P139, DOI 10.1016/j.molbiopara.2007.01.002; Rathore S, 2010, MOL MICROBIOL, V77, P873, DOI 10.1111/j.1365-2958.2010.07251.x; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Sakamoto W, 2006, ANNU REV PLANT BIOL, V57, P599, DOI 10.1146/annurev.arplant.57.032905.105401; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; Snider J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-216; Stanne TM, 2007, J BIOL CHEM, V282, P14394, DOI 10.1074/jbc.M700275200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Wickramarachchi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001732; Yu AYH, 2007, FEBS LETT, V581, P3749, DOI 10.1016/j.febslet.2007.04.076; Zhang J, 2011, J BIOL CHEM, V286, P37590, DOI 10.1074/jbc.M111.277848	51	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1022	1031		10.1074/jbc.M112.416560	http://dx.doi.org/10.1074/jbc.M112.416560			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23192353	hybrid, Green Published			2022-12-28	WOS:000313570300063
J	Arsenault, DJ; Yoo, BH; Rosen, KV; Ridgway, ND				Arsenault, Daniel J.; Yoo, Byong H.; Rosen, Kirill V.; Ridgway, Neale D.			ras-induced Up-regulation of CTP:Phosphocholine Cytidylyltransferase alpha Contributes to Malignant Transformation of Intestinal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; FATTY-ACID SYNTHASE; CHOLINE PHOSPHOLIPID-METABOLISM; ACETYL-COA-CARBOXYLASE; ATP CITRATE LYASE; CANCER-CELLS; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; NUCLEOPLASMIC RETICULUM; ONCOGENE EXPRESSION; KINASE-ACTIVITY	Cancer cells have enhanced lipogenic capacity characterized by increased synthesis of fatty acids and complex lipids, including phosphatidylcholine (PC). As the rate-limiting enzyme in the CDP-choline pathway for PC synthesis, CTP:phosphocholine cytidylyltransferase alpha (CCT alpha) is implicated in the provision of membranes and bioactive lipids necessary of cell proliferation. In this study, we assessed the role of CCT alpha in malignant intestinal epithelial cells transformed with activated H-ras (IEC-ras). Three IEC-ras clones had significant up-regulation CCT alpha expression, but PC synthesis and in vitro activity of CCT alpha were similar to control IEC. RNA interference of CCT alpha in adherent IEC-ras did not affect PC synthesis, confirming that the enzyme was relatively inactive. However, CCT alpha silencing in ras-transformed IEC reduced anchorage-independent growth, a criterion for malignant transformation, as well as tumorigenicity in mice. Relative to their adherent counterparts, detached IEC-ras had increased PC synthesis that was attenuated by inducible CCT alpha silencing. Detachment of IEC-ras was accompanied by increased CCT alpha phosphorylation and cytosolic enzyme activity. We conclude that the expanded pool of CCT alpha in IEC-ras is activated by detachment. This provides the increased PC biosynthetic capacity that contributes to malignant transformation of intestinal epithelial cells when detached from the extracellular matrix.	[Ridgway, Neale D.] Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Halifax, NS B3H 4R2, Canada; Dalhousie Univ, Atlantic Res Ctr, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University	Ridgway, ND (corresponding author), Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, 5849 Univ Ave,POB 15000, Halifax, NS B3H 4R2, Canada.	nridgway@dal.ca		Rosen, Kirill/0000-0002-4317-9907; Ridgway, Neale/0000-0002-0441-6228	Canadian Institutes of Health Research [MOP62916, MOP88914]; Nova Scotia Health Research Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation	This work was supported by Canadian Institutes of Health Research Grants MOP62916 (to N. D. R.) and MOP88914 (to K. V. R.) and a Nova Scotia Health Research Foundation grant (to N. D. R.).	Aboagye EO, 1999, CANCER RES, V59, P80; Anthony ML, 1999, J BIOL CHEM, V274, P19686, DOI 10.1074/jbc.274.28.19686; Bakovic M, 2003, J BIOL CHEM, V278, P14753, DOI 10.1074/jbc.M300162200; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Chua BT, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-131; Coll ML, 2002, ONCOGENE, V21, P2908, DOI 10.1038/sj.onc.1205388; CORNELL R, 1989, J BIOL CHEM, V264, P9077; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; Gallego-Ortega D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007819; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Gehrig K, 2009, J LIPID RES, V50, P966, DOI 10.1194/jlr.M800632-JLR200; Geilen CC, 1996, BBA-LIPID LIPID MET, V1299, P299, DOI 10.1016/0005-2760(95)00221-9; Glunde K, 2005, CANCER RES, V65, P11034, DOI 10.1158/0008-5472.CAN-05-1807; Glunde K, 2006, PHARMACOGENOMICS, V7, P1109, DOI 10.2217/14622416.7.7.1109; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; Jackowski S, 2004, MOL CELL BIOL, V24, P4720, DOI 10.1128/MCB.24.11.4720-4733.2004; Janssen KP, 2005, BBA-REV CANCER, V1756, P145, DOI 10.1016/j.bbcan.2005.07.004; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Lagace TA, 2005, BIOCHEM J, V392, P449, DOI 10.1042/BJ20051021; Lagace TA, 2005, MOL BIOL CELL, V16, P1120, DOI 10.1091/mbc.E04-10-0874; Lagace TA, 2002, MOL CELL BIOL, V22, P4851, DOI 10.1128/MCB.22.13.4851-4862.2002; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Liu ZP, 2005, J BIOL CHEM, V280, P37383, DOI 10.1074/jbc.M503724200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Menendez JA, 2004, P NATL ACAD SCI USA, V101, P10715, DOI 10.1073/pnas.0403390101; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Momchilova A, 1999, CELL BIOL INT, V23, P603, DOI 10.1006/cbir.1999.0430; Ng MNP, 2004, BBA-MOL CELL BIOL L, V1686, P85, DOI 10.1016/j.bbalip.2004.09.001; Northwood IC, 1999, J BIOL CHEM, V274, P26240, DOI 10.1074/jbc.274.37.26240; Pizer ES, 1996, CANCER RES, V56, P745; Pizer ES, 1998, CANCER-AM CANCER SOC, V83, P528, DOI 10.1002/(SICI)1097-0142(19980801)83:3<528::AID-CNCR22>3.0.CO;2-X; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; RAK J, 1995, J CELL BIOL, V131, P1587, DOI 10.1083/jcb.131.6.1587; Ramirez de Molina A, 2005, CANCER RES, V65, P5647, DOI 10.1158/0008-5472.CAN-04-4416; RATNAM S, 1995, ARCH BIOCHEM BIOPHYS, V323, P313, DOI 10.1006/abbi.1995.9959; Rodriguez-Gonzalez A, 2003, ONCOGENE, V22, P8803, DOI 10.1038/sj.onc.1207062; ROFSTAD EK, 1986, CELL TISSUE KINET, V19, P205, DOI 10.1111/j.1365-2184.1986.tb00731.x; Rosen K, 1998, CURR BIOL, V8, P1331, DOI 10.1016/S0960-9822(07)00564-7; Scaglia N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006812; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Swinnen JV, 2003, BIOCHEM BIOPH RES CO, V302, P898, DOI 10.1016/S0006-291X(03)00265-1; TEEGARDEN D, 1990, J BIOL CHEM, V265, P6042; Tessitore L, 1999, BIOCHEM J, V337, P23, DOI 10.1042/0264-6021:3370023; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; WANG YL, 1993, J BIOL CHEM, V268, P5899; Yalcin A, 2010, ONCOGENE, V29, P139, DOI 10.1038/onc.2009.317; YANG W, 1995, J BIOL CHEM, V270, P16503, DOI 10.1074/jbc.270.28.16503; Yu K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000129	58	13	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					633	643		10.1074/jbc.M112.347682	http://dx.doi.org/10.1074/jbc.M112.347682			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23155050	Green Published, hybrid			2022-12-28	WOS:000313197200064
J	Muili, KA; Wang, D; Orabi, AI; Sarwar, S; Luo, YH; Javed, TA; Eisses, JF; Mahmood, SM; Jin, SQ; Singh, VP; Ananthanaravanan, M; Perides, G; Williams, JA; Molkentin, JD; Husain, SZ				Muili, Kamaldeen A.; Wang, Dong; Orabi, Abrahim I.; Sarwar, Sheharyar; Luo, Yuhuan; Javed, Tanveer A.; Eisses, John F.; Mahmood, Syeda M.; Jin, Shunqian; Singh, Vijay P.; Ananthanaravanan, Meena; Perides, George; Williams, John A.; Molkentin, Jeffery D.; Husain, Sohail Z.			Bile Acids Induce Pancreatic Acinar Cell Injury and Pancreatitis by Activating Calcineurin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROTEIN-KINASE-C; TRYPSINOGEN ACTIVATION; ZYMOGEN ACTIVATION; BILIARY PANCREATITIS; ENZYME ACTIVATION; TACROLIMUS FK-506; TISSUE-DAMAGE; CALCIUM; FK506	Biliary pancreatitis is the leading cause of acute pancreatitis in both children and adults. A proposed mechanism is the reflux of bile into the pancreatic duct. Bile acid exposure causes pancreatic acinar cell injury through a sustained rise in cytosolic Ca2+. Thus, it would be clinically relevant to know the targets of this aberrant Ca2+ signal. We hypothesized that the Ca2+-activated phosphatase calcineurin is such a Ca2+ target. To examine calcineurin activation, we infected primary acinar cells from mice with an adenovirus expressing the promoter for a downstream calcineurin effector, nuclear factor of activated T-cells (NFAT). The bile acid taurolithocholic acid-3-sulfate (TLCS) was primarily used to examine bile acid responses. TLCS caused calcineurin activation only at concentrations that cause acinar cell injury. The activation of calcineurin by TLCS was abolished by chelating intracellular Ca2+. Pretreatment with 1,2-bis(o-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid (acetoxymethyl ester) (BAPTA-AM) or the three specific calcineurin inhibitors FK506, cyclosporine A, or calcineurin inhibitory peptide prevented bile acid-induced acinar cell injury as measured by lactate dehydrogenase leakage and propidium iodide uptake. The calcineurin inhibitors reduced the intra-acinar activation of chymotrypsinogen within 30 min of TLCS administration, and they also prevented NF-kappa B activation. In vivo, mice that received FK506 or were deficient in the calcineurin isoform A beta (CnA beta) subunit had reduced pancreatitis severity after infusion of TLCS or taurocholic acid into the pancreatic duct. In summary, we demonstrate that acinar cell calcineurin is activated in response to Ca2+ generated by bile acid exposure, bile acid-induced pancreatic injury is dependent on calcineurin activation, and calcineurin inhibitors may provide an adjunctive therapy for biliary pancreatitis.	[Muili, Kamaldeen A.; Wang, Dong; Orabi, Abrahim I.; Sarwar, Sheharyar; Luo, Yuhuan; Javed, Tanveer A.; Eisses, John F.; Mahmood, Syeda M.; Jin, Shunqian; Husain, Sohail Z.] UPMC, Childrens Hosp Pittsburgh, Rangos Res Ctr, Dept Pediat, Pittsburgh, PA 15224 USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA 15224 USA; [Wang, Dong] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China; [Wang, Dong] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Ananthanaravanan, Meena] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06519 USA; [Perides, George] Tufts Univ, Med Ctr, Dept Surg, Boston, MA 02111 USA; [Williams, John A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Molkentin, Jeffery D.] Univ Cincinnati, Howard Hughes Med Inst, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fudan University; Fudan University; Yale University; Tufts University; University of Michigan System; University of Michigan; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati	Husain, SZ (corresponding author), UPMC, Childrens Hosp Pittsburgh, Rangos Res Ctr, Dept Pediat, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	sohail.husain@chp.edu	Wang, Dong/A-6518-2018	Husain, Sohail Z/0000-0003-3012-1308; Molkentin, Jeffery/0000-0002-3558-6529; Williams, John/0000-0002-6063-7615; Singh, Vijay/0000-0001-6611-1908	National Institutes of Health [DK083327, DK093491, DK091327, DK092460, DK041122]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091327, R01DK092460, R37DK041122, R01DK083327, T32DK007017, T32DK071492, R01DK093491, R01DK041122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK083327 and DK093491 (to S. Z. H.), DK091327 (to Michael L. Steer), DK092460 (to V. P. S.), and DK041122 (to J. A. W.).	Abdulla A, 2011, J LEUKOCYTE BIOL, V90, P975, DOI 10.1189/jlb.0411195; Awla D, 2012, GASTROENTEROLOGY, V143, P1352, DOI 10.1053/j.gastro.2012.07.098; Bai HX, 2011, J PEDIATR GASTR NUTR, V52, P262, DOI 10.1097/MPG.0b013e3182061d75; Biswas A, 2011, J BIOL CHEM, V286, P3129, DOI 10.1074/jbc.M110.188565; Booth DM, 2011, GASTROENTEROLOGY, V140, P2116, DOI 10.1053/j.gastro.2011.02.054; Burkard N, 2005, CIRCULATION, V111, P1045, DOI 10.1161/01.CIR.0000156458.80515.F7; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; D Frank C, 2006, NAT CLIN PRACT GASTR, V3, P680, DOI 10.1038/ncpgasthep0654; Dawra R, 2011, GASTROENTEROLOGY, V141, P2210, DOI 10.1053/j.gastro.2011.08.033; ECHIGO Y, 1995, ARCH SURG-CHICAGO, V130, P64; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; FISHER MM, 1973, CAN MED ASSOC J, V109, P190; Frossard JL, 2008, LANCET, V371, P143, DOI 10.1016/S0140-6736(08)60107-5; Gerasimenko JV, 2011, P NATL ACAD SCI USA, V108, P5873, DOI 10.1073/pnas.1016534108; Gukovskaya AS, 2004, AM J PHYSIOL-GASTR L, V286, pG204, DOI 10.1152/ajpgi.00088.2003; Gukovskaya AS, 2002, GASTROENTEROLOGY, V122, P974, DOI 10.1053/gast.2002.32409; Gukovsky I, 1998, AM J PHYSIOL-GASTR L, V275, pG1402, DOI 10.1152/ajpgi.1998.275.6.G1402; Gukovsky I, 2012, J GASTROEN HEPATOL, V27, P27, DOI 10.1111/j.1440-1746.2011.07004.x; Gurda GT, 2008, MOL BIOL CELL, V19, P198, DOI 10.1091/mbc.E07-05-0430; Gurda GT, 2010, GASTROENTEROLOGY, V139, P609, DOI 10.1053/j.gastro.2010.04.050; Hackert T, 2006, PANCREAS, V32, P145, DOI 10.1097/01.mpa.0000194610.62723.18; Hegyi P, 2011, GUT, V60, P544, DOI 10.1136/gut.2010.218461; HOFMANN AF, 1984, J LIPID RES, V25, P1477; Husain SZ, 2007, AM J PHYSIOL-GASTR L, V292, pG1594, DOI 10.1152/ajpgi.00500.2006; Husain SZ, 2012, AM J PHYSIOL-GASTR L, V302, pG1423, DOI 10.1152/ajpgi.00546.2011; Husain SZ, 2005, P NATL ACAD SCI USA, V102, P14386, DOI 10.1073/pnas.0503215102; ITO T, 1994, J GASTROENTEROL, V29, P305, DOI 10.1007/BF02358370; Ji BA, 2009, J BIOL CHEM, V284, P17488, DOI 10.1074/jbc.M109.005520; JONES BA, 1987, ANN SURG, V205, P123, DOI 10.1097/00000658-198702000-00003; Kim JY, 2002, GASTROENTEROLOGY, V122, P1941, DOI 10.1053/gast.2002.33617; Kim MS, 2011, GASTROENTEROLOGY, V140, P2107, DOI 10.1053/j.gastro.2011.02.052; Kim MS, 2009, GASTROENTEROLOGY, V137, P1509, DOI 10.1053/j.gastro.2009.07.042; Kruger B, 2000, AM J PATHOL, V157, P43, DOI 10.1016/S0002-9440(10)64515-4; Lerch MM, 2000, MED CLIN N AM, V84, P549, DOI 10.1016/S0025-7125(05)70239-X; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Lowenfels Albert B, 2005, Curr Gastroenterol Rep, V7, P90, DOI 10.1007/s11894-005-0045-6; Ma MH, 2012, J PEDIATR GASTR NUTR, V54, P651, DOI 10.1097/MPG.0b013e31823a897d; Maleth J, 2011, GUT, V60, P136, DOI 10.1136/gut.2009.192153; Mayer JM, 2000, EUR J SURG, V166, P734; MCDIARMID SV, 1991, TRANSPLANT P, V23, P2996; Muili K., 2011, PANCREAPEDIA EXOCRIN, DOI [10.3998/panc.2011.4, DOI 10.3998/PANC.2011.4]; Muili KA, 2012, AM J PHYSIOL-GASTR L, V302, pG898, DOI 10.1152/ajpgi.00545.2011; Nieto Y, 2000, BONE MARROW TRANSPL, V26, P109, DOI 10.1038/sj.bmt.1702471; Ogunseinde BA, 2003, TRANSPLANTATION, V76, P448, DOI 10.1097/01.TP.0000070434.73865.7A; Oliveria SF, 2012, J NEUROSCI, V32, P15328, DOI 10.1523/JNEUROSCI.2302-12.2012; Opie EL, 1909, J EXP MED, V11, P561, DOI 10.1084/jem.11.4.561; Orabi AI, 2011, J BIOL CHEM, V286, P14090, DOI 10.1074/jbc.M110.196832; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Perides G, 2010, NAT PROTOC, V5, P335, DOI 10.1038/nprot.2009.243; Perides G, 2010, GASTROENTEROLOGY, V138, P715, DOI 10.1053/j.gastro.2009.10.052; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Rakonczay Z, 2008, GUT, V57, P259, DOI 10.1136/gut.2007.124115; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; Sastry J, 2004, BONE MARROW TRANSPL, V33, P867, DOI 10.1038/sj.bmt.1704429; Sendler M., 2012, GUT IN PRESS; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; Tantral L., 2004, CELL BIOCHEM FUNCT, V22, P35; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Udina E, 2003, J PERIPHER NERV SYST, V8, P145, DOI 10.1046/j.1529-8027.2003.03020.x; UEMOTO S, 1993, TRANSPLANTATION, V55, P288, DOI 10.1097/00007890-199302000-00011; van Geenen EJM, 2010, NAT REV GASTRO HEPAT, V7, P495, DOI 10.1038/nrgastro.2010.114; Venglovecz V, 2008, GUT, V57, P1102, DOI 10.1136/gut.2007.134361; Voronina S, 2002, J PHYSIOL-LONDON, V540, P49, DOI 10.1113/jphysiol.2002.017525; Voronina SG, 2004, J BIOL CHEM, V279, P27327, DOI 10.1074/jbc.M311698200; Voronina SG, 2010, GASTROENTEROLOGY, V138, P1976, DOI 10.1053/j.gastro.2010.01.037; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Weinman SA, 2008, TXB GASTROENTEROLOGY, P401; Wildi S, 2007, GUT, V56, P685, DOI 10.1136/gut.2006.105833; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Yamada T, 2001, AM J PHYSIOL-GASTR L, V281, pG1397, DOI 10.1152/ajpgi.2001.281.6.G1397	76	64	67	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					570	580		10.1074/jbc.M112.428896	http://dx.doi.org/10.1074/jbc.M112.428896			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23148215	Green Published, hybrid			2022-12-28	WOS:000313197200057
J	Yu, JJ; He, XM; Chen, YG; Hao, Y; Yang, S; Wang, L; Pan, L; Tang, H				Yu, Junjing; He, Xiaomeng; Chen, Ye-Guang; Hao, Yan; Yang, Shuo; Wang, Lei; Pan, Lei; Tang, Hong			Myotubularin- related Protein 4 (MTMR4) Attenuates BMP/Dpp Signaling by Dephosphorylation of Smad Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEINS; TGF-BETA SUPERFAMILY; DPP RECEPTORS; SELF-RENEWAL; DROSOPHILA; GENE; PATHWAY; PHOSPHATASES; FAMILY; IDENTIFICATION	Bone morphogenetic proteins (BMPs) signaling essentially regulates a wide range of biological responses. Although multiple regulators at different layers of the receptor-effectors axis have been identified, the mechanisms of homeostatic BMP signaling remain vague. Herein we demonstrated that myotubularin-related protein 4 (MTMR4), a FYVE domain-containing dual-specificity protein phosphatase (DUSP), preferentially associated with and dephosphorylated the activated R-Smads in cytoplasm, which is a critical checkpoint in BMP signal transduction. Therefore, transcriptional activation by BMPs was tightly controlled by the expression level and the intrinsic phosphatase activity of MTMR4. More profoundly, ectopic expression of MTMR4 or its Drosophila homolog CG3632 genetically interacted with BMP/Dppsignaling axis in regulation of the vein development of Drosophila wings. By doing so, MTMR4 could interact with and dephosphorylate Mothers against Decapentaplegic (Mad), the sole R-Smad in Drosophila BMP pathway, and hence affected the target genes expression of Mad. In conclusion, this study has suggested that MTMR4 is a necessary negative modulator for the homeostasis of BMP/Dpp signaling.	[Yu, Junjing; He, Xiaomeng; Hao, Yan; Yang, Shuo; Pan, Lei; Tang, Hong] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun CASKLII, Beijing 100101, Peoples R China; [Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Wang, Lei; Tang, Hong] Chinese Acad Sci, Wuhan Inst Virol, Wuhan 430071, Peoples R China; [Wang, Lei; Tang, Hong] Chinese Acad Sci, State Key Lab Virol, Wuhan 430071, Peoples R China; [Yu, Junjing; Pan, Lei; Tang, Hong] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing 100101, Peoples R China; [He, Xiaomeng; Hao, Yan; Yang, Shuo; Wang, Lei] Univ Chinese Acad Sci, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Tsinghua University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Pan, L (corresponding author), 15 Da Tun Rd, Beijing 10010, Peoples R China.	panlei@moon.ibp.ac.cn; tanghong@moon.ibp.ac.cn	Chen, Ye-Guang/L-6998-2019; Wang, Li/E-4222-2014; Yang, Shuo/ABH-8550-2020	Wang, Li/0000-0002-9615-1879; Yang, Shuo/0000-0002-7929-0244; Pan, Lei/0000-0002-0500-8904	National Natural Science Foundation of China [31000403, 31200685]; Ministry of Science and Technology of China [2011CB946104, 2011DFG32790, 2012CB518900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported in part by funding from the National Natural Science Foundation of China (31000403) (to L. P.) and (31200685) (to J. Y.) and from the Ministry of Science and Technology of China (2011CB946104 and 2011DFG32790) (to H. T.) and (2012CB518900) (to L. P.).	Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bangi E, 2006, DEV BIOL, V295, P178, DOI 10.1016/j.ydbio.2006.03.021; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Burke R, 1996, DEVELOPMENT, V122, P2261; Chauvet C, 2012, J HYPERTENS, V30, P81, DOI 10.1097/HJH.0b013e32834dddb1; Chen HB, 2006, GENE DEV, V20, P648, DOI 10.1101/gad.1384706; Duan XY, 2006, J BIOL CHEM, V281, P36526, DOI 10.1074/jbc.M605169200; Eivers E, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002034; Green J, 2002, DEV DYNAM, V225, P392, DOI 10.1002/dvdy.10170; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Khalsa O, 1998, DEVELOPMENT, V125, P2723; KHERADMAND F, 1994, AM J PHYSIOL-LUNG C, V267, pL728, DOI 10.1152/ajplung.1994.267.6.L728; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kusanagi K, 2000, MOL BIOL CELL, V11, P555, DOI 10.1091/mbc.11.2.555; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Liang YY, 2003, J BIOL CHEM, V278, P26307, DOI 10.1074/jbc.C300028200; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Lorenzo O, 2006, J CELL SCI, V119, P2953, DOI 10.1242/jcs.03040; Marty T, 2000, NAT CELL BIOL, V2, P745, DOI 10.1038/35036383; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; MIYAZONO K, 2002, SCI STKE, pPE40; Monteiro RM, 2004, J CELL SCI, V117, P4653, DOI 10.1242/jcs.01337; Naughtin MJ, 2010, J CELL SCI, V123, P3071, DOI 10.1242/jcs.060103; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Pardali K, 2005, J CELL PHYSIOL, V204, P260, DOI 10.1002/jcp.20304; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; RAFTERY LA, 1995, GENETICS, V139, P241; Satow R, 2006, DEV CELL, V11, P763, DOI 10.1016/j.devcel.2006.10.001; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Shi WB, 2007, J CELL SCI, V120, P1216, DOI 10.1242/jcs.03400; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SIMMONDS AJ, 1995, NATURE, V376, P424, DOI 10.1038/376424a0; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; STURTEVANT MA, 1995, DEVELOPMENT, V121, P785; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; WHARTON KA, 1991, P NATL ACAD SCI USA, V88, P9214, DOI 10.1073/pnas.88.20.9214; XIE T, 1994, SCIENCE, V263, P1756, DOI 10.1126/science.8134837; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JJ, 2010, J BIOL CHEM, V285, P8454, DOI 10.1074/jbc.M109.075036	44	15	16	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					79	88		10.1074/jbc.M112.413856	http://dx.doi.org/10.1074/jbc.M112.413856			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23150675	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000313197200008
J	Yu, Y; Mishra, S; Song, XZ; Lasanajak, Y; Bradley, KC; Tappert, MM; Air, GM; Steinhauer, DA; Halder, S; Cotmore, S; Tattersall, P; Agbandje-McKenna, M; Cummings, RD; Smith, DF				Yu, Ying; Mishra, Shreya; Song, Xuezheng; Lasanajak, Yi; Bradley, Konrad C.; Tappert, Mary M.; Air, Gillian M.; Steinhauer, David A.; Halder, Sujata; Cotmore, Susan; Tattersall, Peter; Agbandje-McKenna, Mavis; Cummings, Richard D.; Smith, David F.			Functional Glycomic Analysis of Human Milk Glycans Reveals the Presence of Virus Receptors and Embryonic Stem Cell Biomarkers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTOSAMINE-SPECIFIC LECTIN; RICINUS-COMMUNIS AGGLUTININ; BINDING-SPECIFICITY; SIALIC ACIDS; MINUTE VIRUS; STRUCTURAL DETERMINANTS; MICROARRAY STRATEGY; COMBINING SITE; OLIGOSACCHARIDES; AFFINITY	Human milk contains a large diversity of free glycans beyond lactose, but their functions are not well understood. To explore their functional recognition, here we describe a shotgun glycan microarray prepared from isolated human milk glycans (HMGs), and our studies on their recognition by viruses, antibodies, and glycan-binding proteins (GBPs), including lectins. The total neutral and sialylated HMGs were derivatized with a bifunctional fluorescent tag, separated by multidimensional HPLC, and archived in a tagged glycan library, which was then used to print a shotgun glycan microarray (SGM). This SGM was first interrogated with well defined GBPs and antibodies. These data demonstrated both the utility of the array and provided preliminary structural information (metadata) about this complex glycome. Anti-TRA-1 antibodies that recognize human pluripotent stem cells specifically recognized several HMGs that were then further structurally defined as novel epitopes for these antibodies. Human influenza viruses and Parvovirus Minute Viruses of Mice also specifically recognized several HMGs. For glycan sequencing, we used a novel approach termed metadata-assisted glycan sequencing (MAGS), in which we combine information from analyses of glycans by mass spectrometry with glycan interactions with defined GBPs and antibodies before and after exoglycosidase treatments on the microarray. Together, these results provide novel insights into diverse recognition functions of HMGs and show the utility of the SGM approach and MAGS as resources for defining novel glycan recognition by GBPs, antibodies, and pathogens.	[Cummings, Richard D.; Smith, David F.] Emory Univ, Sch Med, Dept Biochem, O Wayne Rollins Res Ctr, Atlanta, GA 30322 USA; [Yu, Ying; Mishra, Shreya; Song, Xuezheng; Lasanajak, Yi; Cummings, Richard D.; Smith, David F.] Emory Univ, Sch Med, Glyc Ctr, Atlanta, GA 30322 USA; [Yu, Ying; Bradley, Konrad C.; Steinhauer, David A.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Tappert, Mary M.; Air, Gillian M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA; [Halder, Sujata; Agbandje-McKenna, Mavis] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32607 USA; [Cotmore, Susan; Tattersall, Peter] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06519 USA	Emory University; Emory University; Emory University; University of Oklahoma System; University of Oklahoma Health Sciences Center; State University System of Florida; University of Florida; Yale University	Cummings, RD (corresponding author), Emory Univ, Sch Med, Dept Biochem, O Wayne Rollins Res Ctr, 1510 Clifton Rd,Ste 4001, Atlanta, GA 30322 USA.	rdcummi@emory.edu; dfsmith@emory.edu		Air, Gillian/0000-0001-5724-3108; Bradley, Konrad/0000-0001-8761-6219	National Institutes of Health [GM62116, RO1 GM085448]; National Science Foundation [MCB 0718948]; United States Department of Health and Human Services [HHSN266200700006C]; NATIONAL CANCER INSTITUTE [R01CA029303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, R24GM098791, R01GM085448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); United States Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62116 (to the Consortium for Functional Glycomics) and RO1 GM085448 (to D. F. S.). This work was also supported by National Science Foundation Grant MCB 0718948 (to M. A.-M.) and United States Department of Health and Human Services Contract HHSN266200700006C (to the NIAID Centers of Excellence for Influenza Research and Surveillance).	Amonsen M, 2007, J VIROL, V81, P8341, DOI 10.1128/JVI.00718-07; Badcock G, 1999, CANCER RES, V59, P4715; BAENZIGER JU, 1979, J BIOL CHEM, V254, P2400; BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; Blank D, 2011, ANAL BIOANAL CHEM, V401, P2495, DOI 10.1007/s00216-011-5349-9; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bode L, 2004, THROMB HAEMOSTASIS, V92, P1402, DOI 10.1160/TH04-01-0055; Bode L, 2006, J NUTR, V136, P2127, DOI 10.1093/jn/136.8.2127; Bode L, 2009, NUTR REV, V67, pS183, DOI 10.1111/j.1753-4887.2009.00239.x; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Bradley KC, 2011, VIROLOGY, V413, P169, DOI 10.1016/j.virol.2011.01.027; BREWER CF, 1986, J BIOL CHEM, V261, P7306; Cotmore SF, 2010, J VIROL, V84, P1945, DOI 10.1128/JVI.01563-09; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; D'Abramo AM, 2005, VIROLOGY, V340, P143, DOI 10.1016/j.virol.2005.06.019; de Paz JL, 2012, METHODS MOL BIOL, V808, P1, DOI 10.1007/978-1-61779-373-8_1; Donovan SM, 2009, BRIT J NUTR, V101, P1267, DOI 10.1017/S0007114508091241; German JB, 2008, NESTLE NUTR WORKS SE, V62, P205, DOI 10.1159/000146322; GREEN ED, 1987, J BIOL CHEM, V262, P12030; GROLLMAN EF, 1969, J CLIN INVEST, V48, P1489, DOI 10.1172/JCI106115; Heimburg-Molinaro Jamie, 2011, Curr Protoc Protein Sci, VChapter 12, DOI 10.1002/0471140864.ps1210s64; IDOTA T, 1995, BIOSCI BIOTECH BIOCH, V59, P417, DOI 10.1271/bbb.59.417; IGLESIAS JL, 1982, EUR J BIOCHEM, V123, P247, DOI 10.1111/j.1432-1033.1982.tb19760.x; KALADAS PM, 1982, ARCH BIOCHEM BIOPHYS, V217, P624, DOI 10.1016/0003-9861(82)90544-6; KALADAS PM, 1983, ARCH BIOCHEM BIOPHYS, V223, P309, DOI 10.1016/0003-9861(83)90596-9; Kannicht Christoph, 2008, V446, P255, DOI 10.1007/978-1-60327-084-7_18; Kobata A, 2000, GLYCOCONJUGATE J, V17, P443, DOI 10.1023/A:1011006122704; KOBATA A, 1969, ARCH BIOCHEM BIOPHYS, V130, P509, DOI 10.1016/0003-9861(69)90063-0; Kobata A, 2010, P JPN ACAD B-PHYS, V86, P731, DOI 10.2183/pjab.86.731; KOCHIBE N, 1980, BIOCHEMISTRY-US, V19, P2841, DOI 10.1021/bi00554a004; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Kuntz S, 2008, BRIT J NUTR, V99, P462, DOI 10.1017/S0007114507824068; Kuntz S, 2009, BRIT J NUTR, V101, P1306, DOI 10.1017/S0007114508079622; Liu Y, 2012, METHODS MOL BIOL, V808, P117, DOI 10.1007/978-1-61779-373-8_8; Lopez-Bueno A, 2006, J VIROL, V80, P1563, DOI 10.1128/JVI.80.3.1563-1573.2006; Lyer P N, 1976, Arch Biochem Biophys, V177, P330; Espinosa RM, 2007, BRIT J NUTR, V98, pS74, DOI 10.1017/S0007114507838062; Marionneau S, 2002, GLYCOBIOLOGY, V12, P851, DOI 10.1093/glycob/cwf103; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; MATSUMOT.I, 1969, BIOCHIM BIOPHYS ACTA, V194, P180, DOI 10.1016/0005-2795(69)90193-7; Naismith JH, 1996, J BIOL CHEM, V271, P972, DOI 10.1074/jbc.271.2.972; Nam HJ, 2006, J BIOL CHEM, V281, P25670, DOI 10.1074/jbc.M604421200; Natunen S, 2011, GLYCOBIOLOGY, V21, P1125, DOI 10.1093/glycob/cwq209; Newburg DS, 2005, J NUTR, V135, P1308, DOI 10.1093/jn/135.5.1308; Newburg DS, 2005, ANNU REV NUTR, V25, P37, DOI 10.1146/annurev.nutr.25.050304.092553; Ninonuevo MR, 2006, J AGR FOOD CHEM, V54, P7471, DOI 10.1021/jf0615810; Ninonuevo MR, 2009, NUTR REV, V67, pS216, DOI 10.1111/j.1753-4887.2009.00243.x; PEREIRA MEA, 1978, ARCH BIOCHEM BIOPHYS, V185, P108, DOI 10.1016/0003-9861(78)90149-2; PEREIRA MEA, 1974, BIOCHEMISTRY-US, V13, P3184, DOI 10.1021/bi00712a029; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Ruvoen-Clouet N, 2000, J VIROL, V74, P11950, DOI 10.1128/JVI.74.24.11950-11954.2000; Schack-Nielsen L, 2007, J NUTR, V137, p503S, DOI 10.1093/jn/137.2.503S; Seko A, 1997, BBA-GEN SUBJECTS, V1335, P23, DOI 10.1016/S0304-4165(96)00118-3; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; SMITH DF, 1978, ANAL BIOCHEM, V85, P602, DOI 10.1016/0003-2697(78)90261-0; Song XZ, 2012, METHODS MOL BIOL, V800, P163, DOI 10.1007/978-1-61779-349-3_11; Song XZ, 2011, J BIOL CHEM, V286, P31610, DOI 10.1074/jbc.M111.274217; Song XZ, 2011, NAT METHODS, V8, P85, DOI 10.1038/NMETH.1540; Song XZ, 2009, J BIOL CHEM, V284, P35201, DOI 10.1074/jbc.M109.056119; Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004; Svensson C, 2002, J MOL BIOL, V321, P69, DOI 10.1016/S0022-2836(02)00554-5; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Thurl S, 1997, GLYCOCONJUGATE J, V14, P795, DOI 10.1023/A:1018529703106; Thurl S, 2010, BRIT J NUTR, V104, P1261, DOI 10.1017/S0007114510002072; TOLLEFSEN SE, 1983, J BIOL CHEM, V258, P5172; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; WANG WC, 1988, J BIOL CHEM, V263, P4576; Yan LY, 1997, GLYCOCONJUGATE J, V14, P45, DOI 10.1023/A:1018508914551	71	74	75	2	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44784	44799		10.1074/jbc.M112.425819	http://dx.doi.org/10.1074/jbc.M112.425819			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23115247	hybrid, Green Published			2022-12-28	WOS:000312938600072
J	Banerjee, A; Ghosh, A; Mills, DJ; Kahnt, J; Vonck, J; Albers, SV				Banerjee, Ankan; Ghosh, Abhrajyoti; Mills, Deryck J.; Kahnt, Joerg; Vonck, Janet; Albers, Sonja-Verena			FlaX, A Unique Component of the Crenarchaeal Archaellum, Forms Oligomeric Ring-shaped Structures and Interacts with the Motor ATPase FlaI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMONELLA-TYPHIMURIUM; FLAGELLAR FILAMENT; ROTARY MOTOR; C-RING; PROTEIN; SYMMETRY; MECHANISM; APPARATUS; EXPORT; ROTOR	Archaella are the archaeal motility structure, which are structurally similar to Gram-negative bacterial type IV pili but functionally resemble bacterial flagella. Structural and biochemical data of archaellum subunits are missing. FlaX, a conserved subunit in crenarchaeal archaella, formed high molecular weight complexes that adapted a ring-like structure with an approximate diameter of 30 nm. The C terminus of FlaX was not only involved in the oligomerization, but also essential for FlaX interaction with FlaI, the bifunctional ATPase that is involved in assembly and rotation of the archaellum. This study gives first insights in the assembly apparatus of archaella.	[Banerjee, Ankan; Ghosh, Abhrajyoti; Albers, Sonja-Verena] Max Planck Inst Terr Microbiol, Dept Mol Biol Archaea, D-35043 Marburg, Germany; [Kahnt, Joerg] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany; [Mills, Deryck J.; Vonck, Janet] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Albers, SV (corresponding author), Max Planck Inst Terr Microbiol, Dept Mol Biol Archaea, Karl von Frisch Str 10, D-35043 Marburg, Germany.	albers@mpi-marburg.mpg.de	Albers, Sonja-Verena/H-8689-2019; Banerjee, Ankan/AAE-7382-2019; Ghosh, Abhrajyoti/H-8550-2012; Ghosh, Abhrajyoti/AAZ-8517-2020	Albers, Sonja-Verena/0000-0003-2459-2226; Banerjee, Ankan/0000-0002-1791-252X; Ghosh, Abhrajyoti/0000-0002-2469-3740; Mills, Deryck/0000-0003-0904-1119; Vonck, Janet/0000-0001-5659-8863				Albers SV, 2003, J BACTERIOL, V185, P3918, DOI 10.1128/JB.185.13.3918-3925.2003; Bardy S, 2004, J MOL MICROB BIOTECH, V7, P41, DOI 10.1159/000077868; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; Cohen-Krausz S, 2008, J MOL BIOL, V375, P1113, DOI 10.1016/j.jmb.2007.10.048; Das U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001176; Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299; Ghosh A, 2011, BIOCHEM J, V437, P43, DOI 10.1042/BJ20110410; Ghosh A, 2011, BIOCHEM SOC T, V39, P64, DOI 10.1042/BST0390064; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; Gonzalez-Pedrajo B, 2006, MOL MICROBIOL, V60, P984, DOI 10.1111/j.1365-2958.2006.05149.x; Henche AL, 2012, ENVIRON MICROBIOL, V14, P3188, DOI 10.1111/j.1462-2920.2012.02898.x; Henche AL, 2012, ENVIRON MICROBIOL, V14, P779, DOI 10.1111/j.1462-2920.2011.02638.x; Jarrell KF, 2012, TRENDS MICROBIOL, V20, P307, DOI 10.1016/j.tim.2012.04.007; Lassak K, 2012, MOL MICROBIOL, V83, P110, DOI 10.1111/j.1365-2958.2011.07916.x; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Minamino T, 2012, MOL MICROBIOL, V83, P775, DOI 10.1111/j.1365-2958.2011.07964.x; Paul K, 2011, EMBO J, V30, P2962, DOI 10.1038/emboj.2011.188; Pecorari F, 1996, J BIOL CHEM, V271, P5270; Peng GH, 2003, BIOCHEMISTRY-US, V42, P3032, DOI 10.1021/bi026876v; Pohlschroder M, 2011, CURR OPIN MICROBIOL, V14, P357, DOI 10.1016/j.mib.2011.03.002; Schlesner M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-56; SOSINSKY GE, 1992, J MOL BIOL, V223, P171, DOI 10.1016/0022-2836(92)90724-X; Streif S, 2008, J MOL BIOL, V384, P1, DOI 10.1016/j.jmb.2008.08.057; Suzuki H, 2004, J MOL BIOL, V337, P105, DOI 10.1016/j.jmb.2004.01.034; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Terradot L, 2004, MOL CELL PROTEOMICS, V3, P809, DOI 10.1074/mcp.M400048-MCP200; Thomas DR, 1999, P NATL ACAD SCI USA, V96, P10134, DOI 10.1073/pnas.96.18.10134; Trachtenberg S, 2006, J MOL MICROB BIOTECH, V11, P208, DOI 10.1159/000094055; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wagner M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00214; Wu JW, 1999, ACTA BIOCHIM POL, V46, P591, DOI 10.18388/abp.1999_4131; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Young HS, 2003, BIOPHYS J, V84, P571, DOI [10.1016/s0006-3495(03)74877-2, 10.1016/S0006-3495(03)74877-2]	36	26	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43322	43330		10.1074/jbc.M112.414383	http://dx.doi.org/10.1074/jbc.M112.414383			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129770	hybrid, Green Published			2022-12-28	WOS:000312940800013
J	Idigo, WO; Reilly, S; Zhang, MH; Zhang, YH; Jayaram, R; Carnicer, R; Crabtree, MJ; Balligand, JL; Casadei, B				Idigo, Winifred O.; Reilly, Svetlana; Zhang, Mei Hua; Zhang, Yin Hua; Jayaram, Raja; Carnicer, Ricardo; Crabtree, Mark J.; Balligand, Jean-Luc; Casadei, Barbara			Regulation of Endothelial Nitric-oxide Synthase (NOS) S-Glutathionylation by Neuronal NOS EVIDENCE OF A FUNCTIONAL INTERACTION BETWEEN MYOCARDIAL CONSTITUTIVE NOS ISOFORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENT SKELETAL-MUSCLE; XANTHINE OXIDOREDUCTASE; SUPEROXIDE GENERATION; VENTRICULAR MYOCYTES; MUSCULAR-DYSTROPHY; UP-REGULATION; HUMAN HEART; PHOSPHORYLATION; ACTIVATION; BETA(3)-ADRENOCEPTOR	Myocardial constitutive No production depends on the activity of both endothelial and neuronal NOS (eNOS and nNOS, respectively). Stimulation of myocardial beta(3)-adrenergic receptor (beta(3)-AR) produces a negative inotropic effect that is dependent on eNOS. We evaluated whether nNOS also plays a role in beta(3)-AR signaling and found that the beta(3)-AR-mediated reduction in cell shortening and [Ca2+](i) transient amplitude was abolished both in eNOS(-/-) and nNOS(-/-) left ventricular (LV) myocytes and in wild type LV myocytes after nNOS inhibition with S-methyl-L-thiocitrulline. LV superoxide (O-2(radical anion)) production was increased in nNOS(-/-) mice and reduced by L-N-omega-nitroarginine methyl ester (L-NAME), indicating uncoupling of eNOS activity. eNOS S-glutathionylation and Ser-1177 phosphorylation were significantly increased in nNOS(-/-) myocytes, whereas myocardial tetrahydrobiopterin, eNOS Thr-495 phosphorylation, and arginase activity did not differ between genotypes. Although inhibitors of xanthine oxidoreductase (XOR) or NOX2 NADPH oxidase caused a similar reduction in myocardial O-2(radical anion), only XOR inhibition reduced eNOS S-glutathionylation and Ser-1177 phosphorylation and restored both eNOS coupled activity and the negative inotropic and [Ca2+] i transient response to beta(3)-AR stimulation in nNOS(-/-) mice. In summary, our data show that increased O-2(radical anion) production by XOR selectively uncouples eNOS activity and abolishes the negative inotropic effect of beta(3)-AR stimulation in nNOS(-/-) myocytes. These findings provide unequivocal evidence of a functional interaction between the myocardial constitutive NOS isoforms and indicate that aspects of the myocardial phenotype of nNOS(-/-) mice result from disruption of eNOS signaling.	[Idigo, Winifred O.; Reilly, Svetlana; Zhang, Mei Hua; Zhang, Yin Hua; Jayaram, Raja; Carnicer, Ricardo; Crabtree, Mark J.; Casadei, Barbara] Univ Oxford, Dept Cardiovasc Med, John Radcliffe Hosp, Oxford OX3 9DU, England; [Balligand, Jean-Luc] Catholic Univ Louvain, Unit Pharmacol & Therapeut, B-1348 Louvain, Belgium	University of Oxford; Universite Catholique Louvain	Casadei, B (corresponding author), Univ Oxford, Dept Cardiovasc Med, John Radcliffe Hosp, Level 6, Oxford OX3 9DU, England.	barbara.casadei@cardiov.ox.ac.uk	Zhang, Yin Hua/J-2785-2012; Balligand, Jean-Luc J/D-7543-2012; JAYARAM, RAJA/O-6068-2019	JAYARAM, RAJA/0000-0002-7861-9546; Crabtree, Mark/0000-0003-3298-2697; Reilly, Svetlana/0000-0003-1231-1239; Casadei, Barbara/0000-0002-6801-1617; Carnicer Hijazo, Ricardo/0000-0002-7440-2964; BALLIGAND, Jean-Luc/0000-0002-0522-4156	Wellcome Trust; British Heart Foundation; Oxford Biomedical Research Centre; Fondation Leducq; British Heart Foundation [RG/11/15/29375] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Oxford Biomedical Research Centre; Fondation Leducq(Leducq Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by a Wellcome Trust Prize Studentship (to W. O. I.) and funds from the British Heart Foundation (to Y. H. Z., M. H. Z., R. C., M. J. C., and B. C.), the Oxford Biomedical Research Centre (to R. J. and B. C.), and the Fondation Leducq (to B. C., S. R., and J.-L.B.).	Ashley EA, 2002, CIRCULATION, V105, P3011, DOI 10.1161/01.CIR.0000019516.31040.2D; Au ALS, 2002, J CARDIAC SURG, V17, P465; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Bendall JK, 2004, CIRCULATION, V110, P2368, DOI 10.1161/01.CIR.0000145160.04084.AC; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Brixius K, 2004, BRIT J PHARMACOL, V143, P1014, DOI 10.1038/sj.bjp.0705983; Burger DE, 2009, CIRCULATION, V120, P1345, DOI 10.1161/CIRCULATIONAHA.108.846402; Carnicer R, 2012, CIRC RES, V111, P718, DOI 10.1161/CIRCRESAHA.112.274464; Chen CA, 2008, J BIOL CHEM, V283, P27038, DOI 10.1074/jbc.M802269200; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Cheng HJ, 2001, CIRC RES, V89, P599, DOI 10.1161/hh1901.098042; Damy T, 2004, LANCET, V363, P1365, DOI 10.1016/S0140-6736(04)16048-0; Dawson D, 2005, CIRCULATION, V112, P3729, DOI 10.1161/CIRCULATIONAHA.105.539437; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Gauthier C, 1996, J CLIN INVEST, V98, P556, DOI 10.1172/JCI118823; Gauthier C, 1998, J CLIN INVEST, V102, P1377, DOI 10.1172/JCI2191; Hoshino S, 2005, FREE RADICAL RES, V39, P481, DOI 10.1080/10715760500073840; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Iyamu EW, 2008, BIOCHEM BIOPH RES CO, V376, P116, DOI 10.1016/j.bbrc.2008.08.102; Khan SA, 2004, P NATL ACAD SCI USA, V101, P15944, DOI 10.1073/pnas.0404136101; Kinugawa S, 2005, CIRC RES, V96, P355, DOI 10.1161/01.RES.0000155331.09458.A7; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; McManaman JL, 1999, ARCH BIOCHEM BIOPHYS, V371, P308, DOI 10.1006/abbi.1999.1432; Mohamed TMA, 2009, J BIOL CHEM, V284, P12091, DOI 10.1074/jbc.M809112200; Moniotte S, 2001, CIRCULATION, V103, P1649, DOI 10.1161/01.CIR.103.12.1649; Nishino T, 1997, J BIOL CHEM, V272, P29859, DOI 10.1074/jbc.272.47.29859; Reilly SN, 2011, CIRCULATION, V124, P1107, DOI 10.1161/CIRCULATIONAHA.111.029223; Sander M, 2000, P NATL ACAD SCI USA, V97, P13818, DOI 10.1073/pnas.250379497; Saraiva RM, 2005, CIRCULATION, V112, P3415, DOI 10.1161/CIRCULATIONAHA.105.557892; Schuhmacher S, 2011, DIABETES, V60, P2608, DOI 10.2337/db10-1395; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Silberman GA, 2010, CIRCULATION, V121, P519, DOI 10.1161/CIRCULATIONAHA.109.883777; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Venardos K, 2009, INT J BIOCHEM CELL B, V41, P2522, DOI 10.1016/j.biocel.2009.08.008; Wang H, 2008, AM J PHYSIOL-CELL PH, V294, pC1566, DOI 10.1152/ajpcell.00367.2007; Zhang YH, 2008, CIRC RES, V102, P242, DOI 10.1161/CIRCRESAHA.107.164798; Zhang YH, 2012, J MOL CELL CARDIOL, V52, P341, DOI 10.1016/j.yjmcc.2011.09.006; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	46	37	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43665	43673		10.1074/jbc.M112.412031	http://dx.doi.org/10.1074/jbc.M112.412031			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23091050	Green Published, hybrid			2022-12-28	WOS:000312940800046
J	Cai, B; Siminszky, B; Chappell, J; Dewey, RE; Bush, LP				Cai, Bin; Siminszky, Balazs; Chappell, Joseph; Dewey, Ralph E.; Bush, Lowell P.			Enantioselective Demethylation of Nicotine as a Mechanism for Variable Nornicotine Composition in Tobacco Leaf	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SUSPENSION-CULTURES; ENANTIOMERIC COMPOSITION; N-DEMETHYLATION; ALKALOIDS; BIOSYNTHESIS; TABACUM; GLAUCA; GENE; TRANSFORMATION; DEGRADATION	Nicotine and its N-demethylation product nornicotine are two important alkaloids in Nicotiana tabacum L. (tobacco). Both nicotine and nornicotine have two stereoisomers that differ from each other at 2'-C position on the pyrrolidine ring. (S)-Nicotine is the predominant form in the tobacco leaf, whereas the (R)-enantiomer only accounts for similar to 0.2% of the total nicotine pool. Despite considerable past efforts, a comprehensive understanding of the factors responsible for generating an elevated and variable enantiomer fraction of nornicotine (EFnnic of 0.04 to 0.75) from the consistently low EF observed for nicotine has been lacking. The objective of this study was to determine potential roles of enantioselective demethylation in the formation of the nornicotine EF. Recombinant CYP82E4, CYP82E5v2, and CYP82E10, three known tobacco nicotine demethylases, were expressed in yeast and assayed for their enantioselectivities in vitro. Recombinant CYP82E4, CYP82E5v2, and CYP82E10 demethylated (R)-nicotine 3-, 10-, and 10-fold faster than (S)-nicotine, respectively. The combined enantioselective properties of the three nicotine demethylases can reasonably account for the nornicotine composition observed in tobacco leaves, which was confirmed in planta. Collectively, our studies suggest that an enantioselective mechanism facilitates the maintenance of a reduced (R)-nicotine pool and, depending on the relative abundances of the three nicotine demethylase enzymes, can confer a high (R)-enantiomer percentage within the nornicotine fraction of the leaf.	[Cai, Bin; Siminszky, Balazs; Chappell, Joseph; Bush, Lowell P.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA; [Dewey, Ralph E.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA	University of Kentucky; University of North Carolina; North Carolina State University	Bush, LP (corresponding author), Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA.	lpbush@email.uky.edu		Dewey, Ralph/0000-0003-1924-3777; Cai, Bin/0000-0002-8046-6040	Altria Client Services; Philip Morris International	Altria Client Services; Philip Morris International	The work described in this paper was supported in part by Altria Client Services and Philip Morris International.	Armstrong DW, 1998, CHIRALITY, V10, P587, DOI 10.1002/(SICI)1520-636X(1998)10:7<587::AID-CHIR6>3.3.CO;2-R; Armstrong DW, 1999, CHIRALITY, V11, P82, DOI 10.1002/(SICI)1520-636X(1999)11:1&lt;82::AID-CHIR14&gt;3.0.CO;2-C; Bartholomeusz TA, 2005, PHYTOCHEMISTRY, V66, P1890, DOI 10.1016/j.phytochem.2005.07.012; CHELVARAJAN RL, 1993, J AGR FOOD CHEM, V41, P858, DOI 10.1021/jf00030a003; DAWSON RF, 1951, J AM CHEM SOC, V73, P4218, DOI 10.1021/ja01153a052; DAWSON RF, 1945, AM J BOT, V32, P416, DOI 10.2307/2437360; DeBoer KD, 2009, PLANT MOL BIOL, V69, P299, DOI 10.1007/s11103-008-9425-2; FRIESEN JB, 1990, TETRAHEDRON LETT, V31, P6295; Gavilano LB, 2007, PLANT CELL PHYSIOL, V48, P1567, DOI 10.1093/pcp/pcm128; Hao DY, 1996, PHYTOCHEMISTRY, V41, P477, DOI 10.1016/0031-9422(95)00532-3; Harner T, 2000, ENVIRON SCI TECHNOL, V34, P218, DOI 10.1021/es9906958; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Hecht SS, 2006, LANGENBECK ARCH SURG, V391, P603, DOI 10.1007/s00423-006-0111-z; Kajikawa M, 2011, PLANT PHYSIOL, V155, P2010, DOI 10.1104/pp.110.170878; Kajikawa M, 2009, PLANT MOL BIOL, V69, P287, DOI 10.1007/s11103-008-9424-3; KISAKI T, 1978, BEITR TABAKFORSCH, V9, P308, DOI 10.2478/cttr-2013-0461; KISAKI T, 1966, PHYTOCHEMISTRY, V5, P293; KISAKI T, 1964, AGR BIOL CHEM TOKYO, V28, P492, DOI 10.1080/00021369.1964.10858265; KISAKI T, 1961, ARCH BIOCHEM BIOPHYS, V92, P351, DOI 10.1016/0003-9861(61)90360-5; LEETE E, 1974, PHYTOCHEMISTRY, V13, P1853, DOI 10.1016/0031-9422(74)85101-0; LEETE E, 1972, PHYTOCHEMISTRY, V11, P2751, DOI 10.1016/S0031-9422(00)86508-5; Leete E., 1992, 2 METABOLITE BIOSYNT, P121; Lewis RS, 2010, PHYTOCHEMISTRY, V71, P1988, DOI 10.1016/j.phytochem.2010.09.011; Liu BZ, 2008, J CHROMATOGR B, V865, P13, DOI 10.1016/j.jchromb.2008.01.034; Lochmann H, 2001, J CHROMATOGR A, V917, P311, DOI 10.1016/S0021-9673(01)00627-6; MANN T. J., 1964, CROP SCI, V4, P349, DOI 10.2135/cropsci1964.0011183X000400040003x; MATSUSHIMA S, 1983, AGR BIOL CHEM TOKYO, V47, P507, DOI 10.1080/00021369.1983.10865670; McIntee EJ, 2000, CHEM RES TOXICOL, V13, P192, DOI 10.1021/tx990171l; Mesnard F, 2002, PLANTA, V214, P911, DOI 10.1007/s00425-001-0702-4; Mesnard F, 2001, PLANT SCI, V161, P1011, DOI 10.1016/S0168-9452(01)00509-X; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; MIZUSAKI S, 1965, AGR BIOL CHEM TOKYO, V29, P78, DOI 10.1080/00021369.1965.10858351; Pogocki D, 2007, EUR J PHARMACOL, V563, P18, DOI 10.1016/j.ejphar.2007.02.038; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Robins Richard J., 2007, Phytochemistry Reviews, V6, P51, DOI 10.1007/s11101-006-9030-4; Siminszky B, 2005, P NATL ACAD SCI USA, V102, P14919, DOI 10.1073/pnas.0506581102; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Xu DM, 2007, PHYSIOL PLANTARUM, V129, P307, DOI 10.1111/j.1399-3054.2006.00811.x; Yamanaka H, 2005, DRUG METAB DISPOS, V33, P1811, DOI 10.1124/dmd.105.006254	39	17	18	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42804	42811		10.1074/jbc.M112.413807	http://dx.doi.org/10.1074/jbc.M112.413807			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23100254	Green Published, hybrid			2022-12-28	WOS:000312501600039
J	Lew, CR; Tolan, DR				Lew, Carolyn Ritterson; Tolan, Dean R.			Targeting of Several Glycolytic Enzymes Using RNA Interference Reveals Aldolase Affects Cancer Cell Proliferation through a Non-glycolytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; NF-KAPPA-B; F-ACTIN; CENTROSOME SEPARATION; PYRUVATE-KINASE; MOTILITY FACTOR; IN-VITRO; BINDING; METABOLISM; GROWTH	In cancer, glucose uptake and glycolysis are increased regardless of the oxygen concentration in the cell, a phenomenon known as the Warburg effect. Several (but not all) glycolytic enzymes have been investigated as potential therapeutic targets for cancer treatment using RNAi. Here, four previously untargeted glycolytic enzymes, aldolase A, glyceraldehyde 3-phosphate dehydrogenase, triose phosphate isomerase, and enolase 1, are targeted using RNAi in Ras-transformed NIH-3T3 cells. Of these enzymes, knockdown of aldolase causes the greatest effect, inhibiting cell proliferation by 90%. This defect is rescued by expression of exogenous aldolase. However, aldolase knockdown does not affect glycolytic flux or intracellular ATP concentration, indicating a non-metabolic cause for the cell proliferation defect. Furthermore, this defect could be rescued with an enzymatically dead aldolase variant that retains the known F-actin binding ability of aldolase. One possible model for how aldolase knockdown may inhibit transformed cell proliferation is through its disruption of actin-cytoskeleton dynamics in cell division. Consistent with this hypothesis, aldolase knockdown cells show increased multinucleation. These results are compared with other studies targeting glycolytic enzymes with RNAi in the context of cancer cell proliferation and suggest that aldolase may be a useful target in the treatment of cancer.	[Lew, Carolyn Ritterson; Tolan, Dean R.] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Tolan, DR (corresponding author), 5 Cummington St, Boston, MA 02215 USA.	tolan@bu.edu		Tolan, Dean/0000-0002-0598-7241				APPLEMAN LJ, 1995, INT J CANCER, V61, P887, DOI 10.1002/ijc.2910610623; ARNOLD H, 1970, EUR J BIOCHEM, V15, P360, DOI 10.1111/j.1432-1033.1970.tb01016.x; ARNOLD H, 1968, EUR J BIOCHEM, V6, P163, DOI 10.1111/j.1432-1033.1968.tb00434.x; BARON CB, 1995, J BIOL CHEM, V270, P20459, DOI 10.1074/jbc.270.35.20459; BEERNINK PT, 1992, PROTEIN EXPRES PURIF, V3, P332, DOI 10.1016/1046-5928(92)90009-L; BERGMEYER HU, 1974, METHOD ENZYMAT AN, P1205; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS DE, 1976, BIOCHEM J, V156, P527, DOI 10.1042/bj1560527; Buscaglia CA, 2006, J BIOL CHEM, V281, P1324, DOI 10.1074/jbc.M506346200; Calvo MN, 2006, FEBS LETT, V580, P3308, DOI 10.1016/j.febslet.2006.04.093; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Chiaradonna F, 2005, BIOCHEM SOC T, V33, P297, DOI 10.1042/BST0330297; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fell D. A., 1997, UNDERSTANDING CONTRO, P90; Forer A, 2007, PROTOPLASMA, V232, P79, DOI 10.1007/s00709-007-0265-8; Funasaka T, 2007, CANCER RES, V67, P4236, DOI 10.1158/0008-5472.CAN-06-3935; Gapuzan MER, 2005, ONCOGENE, V24, P6574, DOI 10.1038/sj.onc.1208809; Gapuzan MER, 2002, ONCOGENE, V21, P2484, DOI 10.1038/sj.onc.1205333; Gilmore TD, 2003, VIROLOGY, V316, P9, DOI 10.1016/S0042-6822(03)00562-2; GUGUENGUILLOUZO C, 1981, IN VITRO CELL DEV B, V17, P369; Gutman I., 1983, METHOD ENZYMAT AN, P1464; HATTON JD, 1992, CANCER RES, V52, P1933; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ishida A, 2005, ARCH BIOCHEM BIOPHYS, V435, P134, DOI 10.1016/j.abb.2004.11.022; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kao AW, 1999, J BIOL CHEM, V274, P17742, DOI 10.1074/jbc.274.25.17742; KENG PC, 1984, BRIT J CANCER, V50, P519, DOI 10.1038/bjc.1984.209; Kim JH, 2002, BIOCHEMISTRY-US, V41, P3414, DOI 10.1021/bi015700a; Knight RJ, 1996, CARDIOVASC RES, V32, P1016, DOI 10.1016/S0008-6363(96)00137-X; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Lee KG, 2007, CELL CYCLE, V6, P1487; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; MARKS J, 1986, J CELL SCI, P229; MORRIS AJ, 1993, J BIOL CHEM, V268, P1095; Moulding DA, 2007, J EXP MED, V204, P2213, DOI 10.1084/jem.20062324; OROSZ F, 1988, BIOCHIM BIOPHYS ACTA, V957, P293, DOI 10.1016/0167-4838(88)90286-5; PAGLIARO L, 1992, J CELL BIOL, V118, P859, DOI 10.1083/jcb.118.4.859; Park SJ, 2011, MOL CELLS, V31, P515, DOI 10.1007/s10059-011-2292-8; Peng QP, 2008, CANCER BIOL THER, V7, P1128, DOI 10.4161/cbt.7.7.6199; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Puschner B, 1997, HEARING RES, V114, P102, DOI 10.1016/S0378-5955(97)00163-9; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; SHIMIZU K, 1983, P NATL ACAD SCI-BIOL, V80, P2112, DOI 10.1073/pnas.80.8.2112; St-Jean M, 2007, J BIOL CHEM, V282, P14309, DOI 10.1074/jbc.M611505200; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Uzbekov R, 2002, BIOL CELL, V94, P275, DOI 10.1016/S0248-4900(02)01202-9; Wang J, 1997, EXP CELL RES, V237, P445, DOI 10.1006/excr.1997.3811; Wang JA, 1996, J BIOL CHEM, V271, P6861, DOI 10.1074/jbc.271.12.6861; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Watanabe H, 1996, CANCER RES, V56, P2960; Withee J, 2004, GENETICS, V167, P1165, DOI 10.1534/genetics.103.025676; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278	55	64	65	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42554	42563		10.1074/jbc.M112.405969	http://dx.doi.org/10.1074/jbc.M112.405969			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23093405	Green Published, hybrid			2022-12-28	WOS:000312501600017
J	Souza, CM; Davidson, D; Rhee, I; Gratton, JP; Davis, EC; Veillette, A				Souza, Cleiton Martins; Davidson, Dominique; Rhee, Inmoo; Gratton, Jean-Philippe; Davis, Elaine C.; Veillette, Andre			The Phosphatase PTP-PEST/PTPN12 Regulates Endothelial Cell Migration and Adhesion, but Not Permeability, and Controls Vascular Development and Embryonic Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; PTP-PEST; SH3 DOMAIN; ANGIOGENESIS; KINASE; MICE; ASSOCIATION; VASCULOGENESIS; SUBSTRATE; P130(CAS)	Protein-tyrosine phosphatase (PTP)-PEST (PTPN12) is ubiquitously expressed. It is essential for normal embryonic development and embryonic viability in mice. Herein we addressed the involvement of PTP-PEST in endothelial cell functions using a combination of genetic and biochemical approaches. By generating primary endothelial cells from an inducible PTP-PEST-deficient mouse, we found that PTP-PEST is not needed for endothelial cell differentiation and proliferation or for the control of endothelial cell permeability. Nevertheless, it is required for integrin-mediated adhesion and migration of endothelial cells. PTP-PEST-deficient endothelial cells displayed increased tyrosine phosphorylation of Cas, paxillin, and Pyk2, which were previously also implicated in integrin functions. By eliminating PTP-PEST in endothelial cells in vivo, we obtained evidence that expression of PTP-PEST in endothelial cells is required for normal vascular development and embryonic viability. Therefore, PTP-PEST is a key regulator of integrin-mediated functions in endothelial cells seemingly through its capacity to control Cas, paxillin, and Pyk2. This function explains at least in part the essential role of PTP-PEST in embryonic development and viability.	[Souza, Cleiton Martins; Davidson, Dominique; Rhee, Inmoo; Veillette, Andre] Clin Res Inst Montreal, Lab Mol Oncol, Montreal, PQ H2W 1R7, Canada; [Gratton, Jean-Philippe] Clin Res Inst Montreal, Lab Endothelial Cell Biol, Montreal, PQ H2W 1R7, Canada; [Rhee, Inmoo; Veillette, Andre] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; [Gratton, Jean-Philippe; Veillette, Andre] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada; [Davis, Elaine C.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; Universite de Montreal; McGill University	Veillette, A (corresponding author), Clin Res Inst Montreal, Lab Mol Oncol, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	veillea@ircm.qc.ca		Gratton, Jean-Philippe/0000-0001-9877-8520	Canadian Institutes of Health Research; Canadian Cancer Society Research Institute; Angelo Pizzagalli Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Angelo Pizzagalli Fellowship	This work was supported in part by grants from the Canadian Institutes of Health Research and the Canadian Cancer Society Research Institute (to A. V., J.-P. G., and E. C. D.).; Recipient of the Angelo Pizzagalli Fellowship.	Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Angers-Loustau A, 1999, BIOCHEM CELL BIOL, V77, P493, DOI 10.1139/bcb-77-6-493; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Carlson TR, 2008, DEVELOPMENT, V135, P2193, DOI 10.1242/dev.016378; Charest A, 1996, J BIOL CHEM, V271, P8424, DOI 10.1074/jbc.271.14.8424; CHAREST A, 1995, BIOCHEM J, V308, P425, DOI 10.1042/bj3080425; Charest A, 1997, ONCOGENE, V14, P1643, DOI 10.1038/sj.onc.1201008; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cote JF, 2002, J BIOL CHEM, V277, P2973, DOI 10.1074/jbc.M106428200; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Davidson D, 2010, IMMUNITY, V33, P167, DOI 10.1016/j.immuni.2010.08.001; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Garton AJ, 1999, J BIOL CHEM, V274, P3811, DOI 10.1074/jbc.274.6.3811; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Garton AJ, 1997, ONCOGENE, V15, P877, DOI 10.1038/sj.onc.1201279; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Halle M, 2007, CELL CYCLE, V6, P2773, DOI 10.4161/cc.6.22.4926; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Jamieson JS, 2005, J CELL SCI, V118, P5835, DOI 10.1242/jcs.02693; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lyons PD, 2001, J BIOL CHEM, V276, P24422, DOI 10.1074/jbc.M011080200; Ohmori T, 2001, J BIOL CHEM, V276, P5274, DOI 10.1074/jbc.M005405200; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Shen Y, 1998, J BIOL CHEM, V273, P6474, DOI 10.1074/jbc.273.11.6474; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; Sirois J, 2006, MECH DEVELOP, V123, P869, DOI 10.1016/j.mod.2006.08.011; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Tanjore H, 2008, DEV DYNAM, V237, P75, DOI 10.1002/dvdy.21385; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Veillette A, 2009, IMMUNOL REV, V228, P312, DOI 10.1111/j.1600-065X.2008.00747.x; Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159	42	27	27	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43180	43190		10.1074/jbc.M112.387456	http://dx.doi.org/10.1074/jbc.M112.387456			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105101	Green Published, hybrid			2022-12-28	WOS:000312501600072
J	Vazquez-Cedeira, M; Lazo, PA				Vazquez-Cedeira, Marta; Lazo, Pedro A.			Human VRK2 (Vaccinia-related Kinase 2) Modulates Tumor Cell Invasion by Hyperactivation of NFAT1 and Expression of Cyclooxygenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED T-CELLS; TRANSCRIPTION FACTOR NFAT1; BREAST-CANCER METASTASIS; COLON-CARCINOMA CELLS; N-TERMINAL KINASE; NUCLEAR FACTOR; SIGNALING PATHWAY; BINDING-SITE; PHOSPHORYLATION; CALCINEURIN	Human VRK2 (vaccinia-related kinase 2), a kinase that emerged late in evolution, affects different signaling pathways, and some carcinomas express high levels of VRK2. Invasion by cancer cells has been associated with NFAT1 (nuclear factor of activated T cells) activation and expression of the COX-2 (cyclooxygenase 2) gene. We hypothesized that VRK proteins might play a regulatory role in NFAT1 activation in tumor cells. We demonstrate that VRK2 directly interacts and phosphorylates NFAT1 in Ser-32 within its N-terminal transactivation domain. VRK2 increases NFAT1-dependent transcription by phosphorylation, and this effect is only detected following cell phorbol 12-myristate 13-acetate and ionomycin stimulation and calcineurin activation. This NFAT1 hyperactivation by VRK2 increases COX-2 gene expression through the proximal NFAT1 binding site in the COX-2 gene promoter. Furthermore, VRK2A down-regulation by RNA interference reduces COX-2 expression at transcriptional and protein levels. Therefore, VRK2 down-regulation reduces cell invasion by tumor cells, such as MDA-MB-231 and MDA-MB-435, upon stimulation with phorbol 12-myristate 13-acetate plus ionomycin. These findings identify the first reported target and function of human VRK2 as an active kinase playing a role in regulation of cancer cell invasion through the NFAT pathway and COX-2 expression.	[Lazo, Pedro A.] Univ Salamanca, CSIC, Expt Therapeut & Translat Oncol Program, Inst Biol Mol & Celular Canc,IBMCC Ctr Invest Can, E-37007 Salamanca, Spain; [Vazquez-Cedeira, Marta] Hosp Univ Salamanca, Inst Invest Biomed Salamanca, E-37007 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC)	Lazo, PA (corresponding author), Univ Salamanca, CSIC, Expt Therapeut & Translat Oncol Program, Inst Biol Mol & Celular Canc,IBMCC Ctr Invest Can, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.	pedro.lazo@csic.es	Lazo, Pedro A./M-6435-2014	Lazo, Pedro A./0000-0001-8997-3025	Ministerio de Educacion, Ciencia e Innovacion [SAF2010-14935]; Consolider-Ingenio Grant [CSD07-0017]; Junta de Castilla y Leon (Consejeria de Educacion) [CSI-006A11-2]; Fundacion Sandra Ibarra; Kutxa-Fundacion Inbiomed; Junta para Ampliacion de Estudios e Investigaciones Cientificas-Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo fellowship	Ministerio de Educacion, Ciencia e Innovacion; Consolider-Ingenio Grant; Junta de Castilla y Leon (Consejeria de Educacion)(Junta de Castilla y Leon); Fundacion Sandra Ibarra; Kutxa-Fundacion Inbiomed; Junta para Ampliacion de Estudios e Investigaciones Cientificas-Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo fellowship	This work was supported by grants from Ministerio de Educacion, Ciencia e Innovacion Grant SAF2010-14935, Consolider-Ingenio 2010 Grant CSD07-0017, Junta de Castilla y Leon (Consejeria de Educacion, Grant CSI-006A11-2), Fundacion Sandra Ibarra, and Kutxa-Fundacion Inbiomed.; Supported by a Junta para Ampliacion de Estudios e Investigaciones Cientificas-Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo fellowship.	Abbasi S, 2006, J BIOL CHEM, V281, P7717, DOI 10.1074/jbc.M510775200; Abbasi S, 2005, J BIOL CHEM, V280, P36737, DOI 10.1074/jbc.M506493200; Barcia R, 2002, ARCH BIOCHEM BIOPHYS, V399, P1, DOI 10.1006/abbi.2001.2746; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Bergmann C, 2007, CANCER RES, V67, P8865, DOI 10.1158/0008-5472.CAN-07-0767; Blanco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001660; Blanco S, 2007, MOL CELL BIOL, V27, P7273, DOI 10.1128/MCB.00025-07; Blanco S, 2006, FEBS J, V273, P2487, DOI 10.1111/j.1742-4658.2006.05256.x; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Corral RS, 2007, ONCOGENE, V26, P958, DOI 10.1038/sj.onc.1209856; de Gregorio R, 2001, J BIOL CHEM, V276, P27003, DOI 10.1074/jbc.M100885200; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Fedorov O, 2007, DRUG DISCOV TODAY, V12, P365, DOI 10.1016/j.drudis.2007.03.006; Fernandez IF, 2012, CELL MOL LIFE SCI, V69, P3881, DOI 10.1007/s00018-012-1056-8; Fernandez IF, 2010, MOL CELL BIOL, V30, P4687, DOI 10.1128/MCB.01581-09; Flockhart RJ, 2009, BRIT J CANCER, V101, P1448, DOI 10.1038/sj.bjc.6605277; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Gomez-Casero E, 2007, CELL SIGNAL, V19, P1652, DOI 10.1016/j.cellsig.2007.02.010; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Iniguez MA, 2000, J BIOL CHEM, V275, P23627, DOI 10.1074/jbc.M001381200; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jiang XG, 2009, MOL CELL BIOL, V29, P5104, DOI 10.1128/MCB.00465-09; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kim HS, 2012, BREAST CANCER RES TR, V132, P51, DOI 10.1007/s10549-011-1521-3; Kim TH, 2009, MOL CANCER RES, V7, P1605, DOI 10.1158/1541-7786.MCR-09-0102; Klerkx EPF, 2009, HISTOL HISTOPATHOL, V24, P749, DOI 10.14670/HH-24.749; Li ZG, 2008, CLIN EXP METASTAS, V25, P389, DOI 10.1007/s10585-007-9117-3; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Luo C, 1996, P NATL ACAD SCI USA, V93, P8907, DOI 10.1073/pnas.93.17.8907; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nichols RJ, 2004, J BIOL CHEM, V279, P7934, DOI 10.1074/jbc.M310813200; Ogunwobi OO, 2012, J GASTROEN HEPATOL, V27, P566, DOI 10.1111/j.1440-1746.2011.06980.x; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Ortega-Perez I, 2005, J BIOL CHEM, V280, P20867, DOI 10.1074/jbc.M501898200; Rainio EM, 2002, J IMMUNOL, V168, P1524, DOI 10.4049/jimmunol.168.4.1524; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Sanna B, 2006, P NATL ACAD SCI USA, V103, P7327, DOI 10.1073/pnas.0509340103; Santos CR, 2006, MOL CANCER RES, V4, P177, DOI 10.1158/1541-7786.MCR-05-0212; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Sihto H, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2944; Singh B, 2007, ONCOGENE, V26, P3789, DOI 10.1038/sj.onc.1210154; Singh B, 2006, J SURG RES, V131, P267, DOI 10.1016/j.jss.2005.11.582; Singh B, 2005, INT J ONCOL, V26, P1393; Singh B, 2006, J SURG RES, V134, P44, DOI 10.1016/j.jss.2006.03.018; Tsatsanis C, 1998, P NATL ACAD SCI USA, V95, P3827, DOI 10.1073/pnas.95.7.3827; Tuynman JB, 2008, CANCER RES, V68, P1213, DOI 10.1158/0008-5472.CAN-07-5172; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2006, MOL CELL BIOL, V26, P4782, DOI 10.1128/MCB.00069-06; Valbuena A, 2011, CELL SIGNAL, V23, P1267, DOI 10.1016/j.cellsig.2011.04.002; Valbuena A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017320; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002649; Vazquez-Cedeira M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023235; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Vega FM, 2003, FEBS LETT, V544, P176, DOI 10.1016/S0014-5793(03)00501-5; Vinogradova Y, 2011, BRIT J CANCER, V105, P452, DOI 10.1038/bjc.2011.252; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	68	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42739	42750		10.1074/jbc.M112.404285	http://dx.doi.org/10.1074/jbc.M112.404285			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105117	Green Published, hybrid			2022-12-28	WOS:000312501600033
J	Watari, R; Yamaguchi, C; Zemba, W; Kubo, Y; Okano, K; Okano, T				Watari, Ryuji; Yamaguchi, Chiaki; Zemba, Wataru; Kubo, Yoko; Okano, Keiko; Okano, Toshiyuki			Light-dependent Structural Change of Chicken Retinal Cryptochrome4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; PINEAL; LOCALIZATION; EXPRESSION	Animals have several classes of cryptochromes (CRYs), some of which function as core elements of circadian clockwork, circadian photoreceptors, and/or light-dependent magnetoreceptors. In addition to the circadian clock genes Cry1 and Cry2, nonmammalian vertebrates have the Cry4 gene, the molecular function of which remains unknown. Here we analyzed chicken CRY4 (cCRY4) expression in the retina with in situ hybridization and found that cCRY4 was likely transcribed in the visual pigment cells, cells in the inner nuclear layer, and retinal ganglion cells. We further developed several monoclonal antibodies to the carboxyl-terminal extension of cCRY4 and localized cCRY4 protein with immunohistochemistry. Consistent with the results of in situ hybridization, cCRY4 immunoreactivity was found in visual pigment cells and cells located at the inner nuclear layer and the retinal ganglion cell layer. Among the antibodies, one termed C1-mAb had its epitope within the carboxyl-terminal 14-amino acid sequence (QLTRDDADDPMEMK) and associated with cCRY4 in the retinal soluble fraction more strongly in the dark than under blue light conditions. Immunoprecipitation experiments under various light conditions indicated that cCRY4 from the immunocomplex formed in the dark dissociated from C1-mAb during blue light illumination as weak as 25 mu W/cm(2) and that the release occurred with not only blue but also near UV light. These results suggest that cCRY4 reversibly changes its structure within the carboxyl-terminal region in a light-dependent manner and operates as a photoreceptor or magnetoreceptor with short wavelength sensitivity in the retina.	[Watari, Ryuji; Yamaguchi, Chiaki; Zemba, Wataru; Kubo, Yoko; Okano, Keiko; Okano, Toshiyuki] Waseda Univ, Dept Elect Engn & Biosci, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan; [Okano, Toshiyuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Waseda University; Japan Science & Technology Agency (JST)	Okano, T (corresponding author), Waseda Univ, Dept Elect Engn & Biosci, Grad Sch Adv Sci & Engn, Shinjuku Ku, Wakamatsu Cho 2-2, Tokyo 1628480, Japan.	okano@waseda.jp		Okano, Toshiyuki/0000-0001-6740-6265	Japanese Society for the Promotion of Science [KAKENHI 24657109, 23248033]; Ministry of Education, Culture, Sports, Science & Technology in Japan (MEXT)	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science & Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in part, by Grants-in-aid for Scientific Research KAKENHI 24657109 and 23248033 from the Japanese Society for the Promotion of Science (to T. O.) and the Ministry of Education, Culture, Sports, Science & Technology in Japan (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities.	Akiyama M, 2009, FEBS LETT, V583, P933, DOI 10.1016/j.febslet.2009.02.006; Bayram O, 2010, FUNGAL GENET BIOL, V47, P900, DOI 10.1016/j.fgb.2010.05.008; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Chaurasia SS, 2005, J NEUROCHEM, V92, P158, DOI 10.1111/j.1471-4159.2004.02874.x; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Kasahara T, 2000, J NEUROCHEM, V75, P217, DOI 10.1046/j.1471-4159.2000.0750217.x; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kubo Y, 2006, J NEUROCHEM, V97, P1155, DOI 10.1111/j.1471-4159.2006.03826.x; Li QH, 2007, PHOTOCHEM PHOTOBIOL, V83, P94, DOI 10.1562/2006-02-28-IR-826; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Niessner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020091; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Okano T, 2003, J BIOCHEM, V134, P791, DOI 10.1093/jb/mvg221; OKANO T, 1994, NATURE, V372, P94, DOI 10.1038/372094a0; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Ozturk N, 2009, BIOCHEMISTRY-US, V48, P8585, DOI 10.1021/bi901043s; PIERCE ME, 1993, NEURON, V10, P579, DOI 10.1016/0896-6273(93)90161-J; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Tu DC, 2004, SCIENCE, V306, P129, DOI 10.1126/science.1101484; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Yamamoto K, 2001, NEUROSCI LETT, V313, P13, DOI 10.1016/S0304-3940(01)02227-3; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618	24	44	47	0	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42634	42641		10.1074/jbc.M112.395731	http://dx.doi.org/10.1074/jbc.M112.395731			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095750	hybrid, Green Published			2022-12-28	WOS:000312501600024
J	de la Parra, C; Otero-Franqui, E; Martinez-Montemayor, M; Dharmawardhane, S				de la Parra, Columba; Otero-Franqui, Elisa; Martinez-Montemayor, Michelle; Dharmawardhane, Suranganie			The Soy Isoflavone Equol May Increase Cancer Malignancy via Up-regulation of Eukaryotic Protein Synthesis Initiation Factor eIF4G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERNAL RIBOSOME ENTRY; ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; IN-VITRO; S-EQUOL; TRANSLATIONAL CONTROL; CELL-PROLIFERATION; GENE-EXPRESSION; CYCLIN D1; MYC	Dietary soy is thought to be cancer-preventive; however, the beneficial effects of soy on established breast cancer is controversial. We recently demonstrated that dietary daidzein or combined soy isoflavones (genistein, daidzein, and glycitein) increased primary mammary tumor growth and metastasis. Cancer-promoting molecules, including eukaryotic protein synthesis initiation factors (eIF) eIF4G and eIF4E, were up-regulated in mammary tumors from mice that received dietary daidzein. Herein, we show that increased eIF expression in tumor extracts of mice after daidzein diets is associated with protein expression of mRNAs with internal ribosome entry sites (IRES) that are sensitive to eIF4E and eIF4G levels. Results with metastatic cancer cell lines show that some of the effects of daidzein in vivo can be recapitulated by the daidzein metabolite equol. In vitro, equol, but not daidzein, up-regulated eIF4G without affecting eIF4E or its regulator, 4E-binding protein (4E-BP), levels. Equol also increased metastatic cancer cell viability. Equol specifically increased the protein expression of IRES containing cell survival and proliferation-promoting molecules and up-regulated gene and protein expression of the transcription factor c-Myc. Moreover, equol increased the polysomal association of mRNAs for p 120 catenin and eIF4G. The elevated eIF4G in response to equol was not associated with eIF4E or 4E-binding protein in 5' cap co-capture assays or co-immunoprecipitations. In dual luciferase assays, IRES-dependent protein synthesis was increased by equol. Therefore, up-regulation of eIF4G by equol may result in increased translation of pro-cancer mRNAs with IRESs and, thus, promote cancer malignancy.	[de la Parra, Columba; Otero-Franqui, Elisa; Dharmawardhane, Suranganie] Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA; [Martinez-Montemayor, Michelle] Univ Cent Caribe, Sch Med, Dept Biochem, Bayamon, PR 00960 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Dharmawardhane, S (corresponding author), POB 365067, San Juan, PR 00936 USA.	su.d@upr.edu	Martínez-Montemayor, Michelle/X-6880-2019	Martínez-Montemayor, Michelle/0000-0002-6933-9905	National Institutes of Health [SC3GM084824]; National Institute of General Medical Sciences [G12RR003035, G12RR035051]; United States Army/BCRP [W81XWH-11-1-0199]; University of Puerto Rico Medical Sciences Campus Biomedical Graduate Program; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM084824] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007583, G12MD007600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Army/BCRP; University of Puerto Rico Medical Sciences Campus Biomedical Graduate Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants SC3GM084824 (NIGMS; to S. D.) and G12RR003035 (National Institute of General Medical Sciences to Universidad Central del Caribe) and National Institute of General Medical Sciences Grant G12RR035051 (to the University of Puerto Rico Medical Sciences Campus), This work was also supported by the United States Army/BCRP W81XWH-11-1-0199 and the University of Puerto Rico Medical Sciences Campus Biomedical Graduate Program (to C. D.).	Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Atkinson C, 2008, AM J CLIN NUTR, V87, P679, DOI 10.1093/ajcn/87.3.679; Bandera EV, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-40; Bauer C, 2002, INT J CANCER, V98, P181, DOI 10.1002/ijc.10180; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Carreau C, 2009, MOL NUTR FOOD RES, V53, P652, DOI 10.1002/mnfr.200800061; Chida D, 1999, BLOOD, V93, P1567, DOI 10.1182/blood.V93.5.1567.405k29_1567_1578; Choi EJ, 2008, MOL MED REP, V1, P239; Choi EJ, 2009, CHEM-BIOL INTERACT, V177, P7, DOI 10.1016/j.cbi.2008.09.031; Dang Chi V, 2010, Genes Cancer, V1, P526; DHARMAWARDHANE S, 1991, CELL MOTIL CYTOSKEL, V20, P279, DOI 10.1002/cm.970200404; Doe MR, 2012, CANCER RES, V72, P949, DOI 10.1158/0008-5472.CAN-11-2371; DUBIK D, 1992, ONCOGENE, V7, P1587; Fukuda S, 2002, BLOOD, V100, P2463, DOI 10.1182/blood.V100.7.2463; Goodman MT, 2009, CANCER PREV RES, V2, P887, DOI 10.1158/1940-6207.CAPR-09-0039; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Graff JR, 2007, J CLIN INVEST, V117, P2638, DOI 10.1172/JCI32044; Han BG, 2002, MOL CELL BIOL, V22, P7372, DOI 10.1128/MCB.22.21.7372-7384.2002; Haron H, 2011, INT J FOOD SCI NUTR, V62, P642, DOI 10.3109/09637486.2011.570742; Hedlund TE, 2003, PROSTATE, V54, P68, DOI 10.1002/pros.10137; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Jackson RL, 2011, NUTR REV, V69, P432, DOI 10.1111/j.1753-4887.2011.00400.x; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Ju YH, 2006, CARCINOGENESIS, V27, P856, DOI 10.1093/carcin/bgi320; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Khan SA, 2012, CANCER PREV RES, V5, P309, DOI 10.1158/1940-6207.CAPR-11-0251; Kim YY, 2009, CANCER RES, V69, P8455, DOI 10.1158/0008-5472.CAN-09-1923; Ko KP, 2010, CANCER EPIDEM BIOMAR, V19, P1292, DOI 10.1158/1055-9965.EPI-09-1004; Krepela E, 2009, INT J ONCOL, V35, P1449, DOI 10.3892/ijo_00000464; Kuhnle GGC, 2008, J AGR FOOD CHEM, V56, P10099, DOI 10.1021/jf801344x; Kumar N, 2004, FRONT BIOSCI-LANDMRK, V9, P2927, DOI 10.2741/1448; Labisso WL, 2012, CELL CYCLE, V11, P1593, DOI 10.4161/cc.20008; Lamartiniere CA, 2002, TOXICOL SCI, V65, P228, DOI 10.1093/toxsci/65.2.228; Lampe JW, 2010, J NUTR, V140, p1369S, DOI 10.3945/jn.109.118323; Lerner RS, 2006, RNA, V12, P775, DOI 10.1261/rna.2318906; Lin CJ, 2009, CANCER RES, V69, P7491, DOI 10.1158/0008-5472.CAN-09-0813; Ling J, 2005, EMBO J, V24, P4094, DOI 10.1038/sj.emboj.7600868; Liu HQ, 2010, J NUTR BIOCHEM, V21, P390, DOI 10.1016/j.jnutbio.2009.01.016; Liu WZ, 2009, J BIOL CHEM, V284, P31336, DOI 10.1074/jbc.M109.049858; Lund TD, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-4; Magee PJ, 2006, NUTR CANCER, V54, P232, DOI 10.1207/s15327914nc5402_10; Magee PJ, 2011, P NUTR SOC, V70, P10, DOI 10.1017/S0029665110003940; Magee PJ, 2004, CANCER LETT, V208, P35, DOI 10.1016/j.canlet.2003.11.012; Martinez-Montemayor MM, 2011, NUTR CANCER, V63, P1085, DOI 10.1080/01635581.2011.601845; Martinez-Montemayor MM, 2010, CLIN EXP METASTAS, V27, P465, DOI 10.1007/s10585-010-9336-x; McMichael-Phillips DF, 1998, AM J CLIN NUTR, V68, p1431S, DOI 10.1093/ajcn/68.6.1431S; McNeil CM, 2006, J STEROID BIOCHEM, V102, P147, DOI 10.1016/j.jsbmb.2006.09.028; Messina M, 2010, J NUTR, V140, p1350S, DOI 10.3945/jn.109.118315; Messina M, 2009, J NUTR, V139, p796S, DOI 10.3945/jn.108.104182; Mezquita P, 2005, ONCOGENE, V24, P889, DOI 10.1038/sj.onc.1208251; Munoz Y, 2009, THROMB RES, V123, P740, DOI 10.1016/j.thromres.2008.07.011; Muthyala RS, 2004, BIOORGAN MED CHEM, V12, P1559, DOI 10.1016/j.bmc.2003.11.035; Onoda A, 2011, FOOD CHEM TOXICOL, V49, P2279, DOI 10.1016/j.fct.2011.06.027; Pieters T, 2012, FRONT BIOSCI-LANDMRK, V17, P760, DOI 10.2741/3956; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Rice S, 2006, ENDOCR-RELAT CANCER, V13, P995, DOI 10.1677/erc.1.01159; Rivera-Ruiz ME, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-690; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Setchell KDR, 2003, AM J CLIN NUTR, V77, P411, DOI 10.1093/ajcn/77.2.411; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Setchell KDR, 2010, J NUTR, V140, p1363S, DOI 10.3945/jn.109.119784; Sherrill KW, 2004, J BIOL CHEM, V279, P29066, DOI 10.1074/jbc.M402727200; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Spriggs KA, 2009, MOL CELL BIOL, V29, P1565, DOI 10.1128/MCB.01283-08; Staber PB, 2007, BLOOD, V110, P3374, DOI 10.1182/blood-2007-02-071258; Stoneley M, 2000, MOL CELL BIOL, V20, P1162, DOI 10.1128/MCB.20.4.1162-1169.2000; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Tonetti DA, 2007, NUTR CANCER, V58, P222, DOI 10.1080/01635580701328545; Van Der Kelen K, 2009, CRIT REV BIOCHEM MOL, V44, P143, DOI 10.1080/10409230902882090; Wang XM, 2007, METHOD ENZYMOL, V431, P113, DOI 10.1016/S0076-6879(07)31007-0; WELSHONS WV, 1987, BREAST CANCER RES TR, V10, P169, DOI 10.1007/BF01810580; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; XU X, 1994, J NUTR, V124, P825, DOI 10.1093/jn/124.6.825; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	77	17	18	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41640	41650		10.1074/jbc.M112.393470	http://dx.doi.org/10.1074/jbc.M112.393470			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23095751	Green Published, hybrid			2022-12-28	WOS:000312103000008
J	Xu, JK; Jaiswal, AK				Xu, Junkang; Jaiswal, Anil K.			NAD(P) H:quinone Oxidoreductase 1 (NQO1) Competes with 20S Proteasome for Binding with C/EBP alpha Leading to Its Stabilization and Protection against Radiation-induced Myeloproliferative Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; QUINONE OXIDOREDUCTASE-1; MICE LEADS; TRANSCRIPTION FACTOR; INCREASED RISK; GENE PROMOTER; DEGRADATION; DISRUPTION; ENHANCER; POLYMORPHISM	NAD(P)H:quinone oxidoreductase 1 (NQO1) is a flavoprotein that protects cells against radiation and chemical-induced oxidative stress. Disruption of NQO1 gene in mice leads to increased susceptibility to myeloproliferative disease. In this report, we demonstrate that NQO1 controls the stability of myeloid differentiation factor C/EBP alpha against 20S proteasomal degradation during radiation exposure stress. Co-immunoprecipitation studies showed that NQO1, C/EBP alpha, and 20S all interacted with each other. C/EBP alpha interaction with 20S led to the degradation of C/EBP alpha. NQO1 in presence of its cofactor NADH protected C/EBP alpha against 20S degradation. Deletion and site-directed mutagenesis demonstrated that NQO1 and 20S competed for the same binding region (268)SGAGAG-KAKKSV(279) in C/EBP alpha. Mutagenesis studies also revealed that NQO1Y127/Y129 required for NADH binding is essential for NQO1 stabilization of C/EBP alpha. Exposure of mice and HL-60 cells to 3 Grays of alpha-radiation led to increased NQO1 that stabilized C/EBP alpha against 20S proteasomal degradation. This mechanism of NQO1 regulation of C/EBP alpha may provide protection to bone marrow against adverse effects of radiation exposure. The studies have significance for human individuals carrying hetero- or homozygous NQO1P187S mutation and are deficient or lack NQO1 protein.	[Xu, Junkang; Jaiswal, Anil K.] Univ Maryland, Dept Pharmacol & Expt Therapeut, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Jaiswal, AK (corresponding author), Univ Maryland, Dept Pharmacol & Expt Therapeut, Sch Med, 655 W Baltimore St, Baltimore, MD 21201 USA.	ajaiswal@som.umaryland.edu			National Institutes of Health Grant [R01 ES007943]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007943] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 ES007943.	Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2006, BIOCHEMISTRY-US, V45, P6372, DOI 10.1021/bi0600087; Begleiter A, 2009, LEUKEMIA RES, V33, P74, DOI 10.1016/j.leukres.2008.06.030; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; Eguchi-Ishimae M, 2005, HAEMATOLOGICA, V90, P1511; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Frohling S, 2004, J CLIN ONCOL, V22, P624, DOI 10.1200/JCO.2004.06.060; Garate M, 2008, EMBO REP, V9, P576, DOI 10.1038/embor.2008.48; Gong X, 2007, CANCER RES, V67, P5380, DOI 10.1158/0008-5472.CAN-07-0323; Iskander K, 2008, CANCER RES, V68, P7915, DOI 10.1158/0008-5472.CAN-08-0766; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jia ZQ, 2008, NEUROCHEM RES, V33, P790, DOI 10.1007/s11064-007-9496-5; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Kockar FT, 2001, NUCLEIC ACIDS RES, V29, P362, DOI 10.1093/nar/29.2.362; Larson RA, 1999, BLOOD, V94, P803, DOI 10.1182/blood.V94.2.803.414k44_803_807; LEGRAVEREND C, 1993, NUCLEIC ACIDS RES, V21, P1735, DOI 10.1093/nar/21.8.1735; Leroy H, 2005, LEUKEMIA, V19, P329, DOI 10.1038/sj.leu.2403614; LI RB, 1995, P NATL ACAD SCI USA, V92, P8846, DOI 10.1073/pnas.92.19.8846; Long DJ, 2002, CANCER RES, V62, P3030; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Patrick BA, 2011, ONCOGENE, V30, P1098, DOI 10.1038/onc.2010.491; Radjendirane V, 1998, J BIOL CHEM, V273, P7382, DOI 10.1074/jbc.273.13.7382; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Rothman N, 1997, CANCER RES, V57, P2839; SCOTT LM, 1992, BLOOD, V80, P1725; Siegel D, 1999, PHARMACOGENETICS, V9, P113, DOI 10.1097/00008571-199902000-00015; Siegel D, 2001, MOL PHARMACOL, V59, P263, DOI 10.1124/mol.59.2.263; Smith MT, 2001, BLOOD, V97, P1422, DOI 10.1182/blood.V97.5.1422; Smith MT, 2002, BLOOD, V100, P4590, DOI 10.1182/blood-2001-12-0264; Talalay P, 1995, TOXICOL LETT, V82-3, P173, DOI 10.1016/0378-4274(95)03553-2; TRAVER RD, 1992, CANCER RES, V52, P797; Wiemels JL, 1999, CANCER RES, V59, P4095; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Zhu H, 2007, CARDIOVASC TOXICOL, V7, P202, DOI 10.1007/s12012-007-9001-z	34	11	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41608	41618		10.1074/jbc.M112.387738	http://dx.doi.org/10.1074/jbc.M112.387738			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086932	Green Published, hybrid			2022-12-28	WOS:000312103000005
J	Zhang, NR; Planer, W; Siuda, ER; Zhao, HC; Stickler, L; Chang, SD; Baird, MA; Cao, YQ; Bruchas, MR				Zhang, Nancy R.; Planer, William; Siuda, Edward R.; Zhao, Hu-Chen; Stickler, Lucy; Chang, Steven D.; Baird, Madison A.; Cao, Yu-Qing; Bruchas, Michael R.			Serine 363 Is Required for Nociceptin/Orphanin FQ Opioid Receptor (NOPR) Desensitization, Internalization, and Arrestin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; N-TERMINAL KINASE; BETA-ARRESTIN; NONVISUAL ARRESTINS; CALCIUM-CHANNELS; ORL1 RECEPTORS; P38 MAPK; ACTIVATION; PHOSPHORYLATION; COMPLEX	We determined the role of carboxyl-terminal regulation of NOPR (nociceptin, orphanin FQ receptor) signaling and function. We mutated C-terminal serine and threonine residues and examined their role in NOPR trafficking, homologous desensitization, and arrestin-dependent MAPK signaling. The NOPR agonist, nociceptin, caused robust NOPR-YFP receptor internalization, peaking at 30 min. Mutation of serine 337, 346, and 351, had no effect on NOPR internalization. However, mutation of C-terminal threonine 362, serine 363, and threonine 365 blocked nociceptin-induced internalization of NOPR. Furthermore, point mutation of only Ser-363 was sufficient to block NOPR internalization. Homologous desensitization of NOPR-mediated calcium channel blockade and inhibition of cAMP were also shown to require Ser-363. Additionally, NOPR internalization was absent when GRK3, and Arrestin3 were knocked down using siRNA, but not when GRK2 and Arrestin2 were knocked down. We also found that nociceptin-induced NOPR-mediated JNK but not ERK signaling requires Ser-363, GRK3, and Arrestin3. Dominant-positive Arrestin3 but not Arrestin2 was sufficient to rescue NOPR-S363A internalization and JNK signaling. These findings suggest that NOPR function may be regulated by GRK3 phosphorylation of Ser-363 and Arrestin3 and further demonstrates the complex nature of G-protein-dependent and -independent signaling in opioid receptors.	[Zhang, Nancy R.; Planer, William; Siuda, Edward R.; Zhao, Hu-Chen; Stickler, Lucy; Chang, Steven D.; Baird, Madison A.; Cao, Yu-Qing; Bruchas, Michael R.] Washington Univ, Sch Med, Dept Anesthesiol, Basic Res Div, St Louis, MO 63110 USA; [Bruchas, Michael R.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Cao, Yu-Qing; Bruchas, Michael R.] Washington Univ, Sch Med, Pain Ctr, St Louis, MO 63110 USA; [Siuda, Edward R.; Cao, Yu-Qing; Bruchas, Michael R.] Washington Univ, Sch Med, Div Biol & Biomed Sci, Program Neurosci, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bruchas, MR (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol & Anat Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	bruchasm@wustl.edu	Bruchas, Michael/G-7616-2012		National Institutes of Health [R00DA034929, T32DA007261]; Howard Hughes Medical Institute SURF Fellowship Program; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007261, R00DA025182, R21DA034929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute SURF Fellowship Program; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R00DA034929 (to M.R.B.) and T32DA007261 (to S.D.C.) and the Howard Hughes Medical Institute SURF Fellowship Program (to N.Z. and L.S.).	Al-Hasani R, 2011, ANESTHESIOLOGY, V115, P1363, DOI 10.1097/ALN.0b013e318238bba6; Altier C, 2006, NAT NEUROSCI, V9, P31, DOI 10.1038/nn1605; Antoniou X, 2011, J ALZHEIMERS DIS, V24, P633, DOI 10.3233/JAD-2011-091567; Bohn LM, 2004, NEUROMOL MED, V5, P41, DOI 10.1385/NMM:5:1:041; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Bruchas MR, 2011, NEURON, V71, P498, DOI 10.1016/j.neuron.2011.06.011; Bruchas MR, 2010, PSYCHOPHARMACOLOGY, V210, P137, DOI 10.1007/s00213-010-1806-y; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Chan ASL, 2000, J PHARMACOL EXP THER, V295, P1094; Connor M, 1996, BRIT J PHARMACOL, V118, P205, DOI 10.1111/j.1476-5381.1996.tb15387.x; Corbani M, 2004, ENDOCRINOLOGY, V145, P2876, DOI 10.1210/en.2004-0062; Davies C, 2012, BIOCHEM SOC T, V40, P85, DOI 10.1042/BST20110641; Goeldner C, 2008, J NEUROSCI, V28, P2190, DOI 10.1523/JNEUROSCI.3711-07.2008; Grecksch G, 2011, J NEUROSCI, V31, P13890, DOI 10.1523/JNEUROSCI.2304-11.2011; Groer CE, 2011, J BIOL CHEM, V286, P31731, DOI 10.1074/jbc.M111.248310; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Land BB, 2009, P NATL ACAD SCI USA, V106, P19168, DOI 10.1073/pnas.0910705106; Lau EK, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001748; LAW PY, 1982, MOL PHARMACOL, V22, P1; Macey TA, 2006, J BIOL CHEM, V281, P34515, DOI 10.1074/jbc.M604278200; Manassero G, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-39; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Marti M, 2004, J NEUROSCI, V24, P6659, DOI 10.1523/JNEUROSCI.0987-04.2004; McLaughlin JP, 2003, J BIOL CHEM, V278, P34631, DOI 10.1074/jbc.M304022200; McLennan GP, 2008, J NEUROCHEM, V107, P1753, DOI 10.1111/j.1471-4159.2008.05745.x; Melief EJ, 2010, P NATL ACAD SCI USA, V107, P11608, DOI 10.1073/pnas.1000751107; Mika J, 2011, NEUROPEPTIDES, V45, P247, DOI 10.1016/j.npep.2011.03.002; Mogil JS, 2001, PHARMACOL REV, V53, P381; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; Murali SS, 2012, J PHYSIOL-LONDON, V590, P1655, DOI 10.1113/jphysiol.2012.228429; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Rozenfeld R, 2007, FASEB J, V21, P2455, DOI 10.1096/fj.06-7793com; Schmid C, 2008, INT J COMPUT VISION, V76, P105, DOI 10.1007/s11263-007-0073-9; Schmid CL, 2010, J NEUROSCI, V30, P13513, DOI 10.1523/JNEUROSCI.1665-10.2010; Schmid CL, 2009, PHARMACOL THERAPEUT, V121, P285, DOI 10.1016/j.pharmthera.2008.11.005; Seo J, 2011, J BIOL CHEM, V286, P27894, DOI 10.1074/jbc.M111.260448; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Zhan XZ, 2011, BIOCHEMISTRY-US, V50, P10520, DOI 10.1021/bi201506g; Zhang Z, 1999, J NEUROCHEM, V73, P1502, DOI 10.1046/j.1471-4159.1999.0731502.x	51	31	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42019	42030		10.1074/jbc.M112.405696	http://dx.doi.org/10.1074/jbc.M112.405696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086955	hybrid, Green Published			2022-12-28	WOS:000312103000041
J	Giang, KTN; Lian, YL; Pang, EWH; Phuong, QTN; Tran, TD; Tam, JP				Giang Kien Truc Nguyen; Lian, Yilong; Pang, Edmund Weng Hou; Phuong Quoc Thuc Nguyen; Tuan Dinh Tran; Tam, James P.			Discovery of Linear Cyclotides in Monocot Plant Panicum laxum of Poaceae Family Provides New Insights into Evolution and Distribution of Cyclotides in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC CYSTINE KNOT; KALATA B1; OLDENLANDIA-AFFINIS; CIRCULAR PROTEINS; ANTIMICROBIAL PEPTIDES; MEMBRANE INTERACTIONS; CYTOTOXIC CYCLOTIDES; MACROCYCLIC PEPTIDES; HYBANTHUS VIOLACEAE; TRYPSIN-INHIBITORS	Cyclotides are disulfide-rich macrocyclic peptides that display a wide range of bioactivities and represent an important group of plant defense peptide biologics. A few linear variants of cyclotides have recently been identified. They share a high sequence homology with cyclotides but are biosynthetically unable to cyclize from their precursors. All hitherto reported cyclotides and their acyclic variants were isolated from dicot plants of the Rubiaceae, Violaceae, Cucurbitaceae, and recently the Fabaceae and Solanaceae families. Although several cyclotide-like genes in the Poaceae family were known from the data mining of the National Center for Biotechnology Information (NCBI) nucleotide database, their expression at the protein level has yet to be proven. Here, we report the discovery and characterization of nine novel linear cyclotides, designated as panitides L1-9, from the Panicum laxum of the Poaceae family and provide the first evidence of linear cyclotides at the protein level in a monocot plant. Disulfide mapping of panitide L3 showed that it possesses a cystine knot arrangement similar to cyclotides. Several panitides were shown to be active against Escherichia coli and cytotoxic to HeLa cells. They also displayed a high stability against heat and proteolytic degradation. Oxidative folding of the disulfide-reduced panitide L1 showed that it can fold efficiently into its native form. The presence of linear cyclotides in both dicots and monocots suggests their ancient origin and existence before the divergence of these two groups of flowering plants. Moreover, the Poaceae family contains many important food crops, and our discovery may open up new avenues of research using cyclotides and their acyclic variants in crop protection.	[Giang Kien Truc Nguyen; Lian, Yilong; Pang, Edmund Weng Hou; Phuong Quoc Thuc Nguyen; Tuan Dinh Tran; Tam, James P.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Tuan Dinh Tran] Korea Adv Inst Sci & Technol, Taejon 305701, South Korea	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Korea Advanced Institute of Science & Technology (KAIST)	Tam, JP (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.	jptam@ntu.edu.sg	Tam, James P/A-2176-2011	Tam, James P/0000-0003-4433-198X; Lian, Yilong/0000-0003-0139-1245	A*STAR Biomedical Research Council Grant [09/1/22/19/612]; Competitive Research Grant by National Research Foundation in Singapore	A*STAR Biomedical Research Council Grant(Agency for Science Technology & Research (A*STAR)); Competitive Research Grant by National Research Foundation in Singapore	This work was supported by A*STAR Biomedical Research Council Grant 09/1/22/19/612 and the Competitive Research Grant by National Research Foundation in Singapore.	Broussalis AM, 2001, PHYTOCHEMISTRY, V58, P47, DOI 10.1016/S0031-9422(01)00173-X; CAMPBELL CS, 1985, J ARNOLD ARBORETUM, V66, P123, DOI 10.5962/bhl.part.13181; Colgrave ML, 2008, BIOCHEMISTRY-US, V47, P5581, DOI 10.1021/bi800223y; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Cordain L, 1999, World Rev Nutr Diet, V84, P19; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Daly NL, 2003, J BIOL CHEM, V278, P6314, DOI 10.1074/jbc.M210492200; Dutton JL, 2004, J BIOL CHEM, V279, P46858, DOI 10.1074/jbc.M407421200; Firth DJ, 2002, TROP GRASSLANDS, V36, P1; Gerlach SL, 2010, J NAT PROD, V73, P1207, DOI 10.1021/np9007365; Giang KTN, 2011, J BIOL CHEM, V286, P44833, DOI 10.1074/jbc.M111.290296; Giang KTN, 2011, J BIOL CHEM, V286, P24275, DOI 10.1074/jbc.M111.229922; Goransson U, 2003, J BIOL CHEM, V278, P48188, DOI 10.1074/jbc.M308771200; Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939; Gran L, 2000, J ETHNOPHARMACOL, V70, P197, DOI 10.1016/S0378-8741(99)00175-0; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Gustafson KR, 2004, CURR PROTEIN PEPT SC, V5, P331, DOI 10.2174/1389203043379468; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Hallock YF, 2000, J ORG CHEM, V65, P124, DOI 10.1021/jo990952r; He WJ, 2011, PEPTIDES, V32, P1719, DOI 10.1016/j.peptides.2011.06.016; Henriques ST, 2012, J BIOL CHEM, V287, P33629, DOI 10.1074/jbc.M112.372011; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Ireland DC, 2006, J MOL BIOL, V357, P1522, DOI 10.1016/j.jmb.2006.01.051; Desbiez ALJ, 2011, MAMM BIOL, V76, P351, DOI 10.1016/j.mambio.2010.10.008; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Kamimori H, 2005, ANAL BIOCHEM, V337, P149, DOI 10.1016/j.ab.2004.10.028; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Mar RI, 1996, PHYTOCHEMISTRY, V41, P1265, DOI 10.1016/0031-9422(95)00734-2; Mulvenna JP, 2006, PLANT CELL, V18, P2134, DOI 10.1105/tpc.106.042812; Mylne JS, 2012, PLANT CELL, V24, P2765, DOI 10.1105/tpc.112.099085; Mylne JS, 2010, BIOPOLYMERS, V94, P635, DOI 10.1002/bip.21419; Ng KF, 1997, J AGR SCI, V128, P347, DOI 10.1017/S0021859696004248; Nguyen GKT, 2012, J BIOL CHEM, V287, P17598, DOI 10.1074/jbc.M111.338970; Paterson AH, 2005, GENOME RES, V15, P1643, DOI 10.1101/gr.3725905; Poth AG, 2012, J BIOL CHEM, V287, P27033, DOI 10.1074/jbc.M112.370841; Poth AG, 2011, ACS CHEM BIOL, V6, P345, DOI 10.1021/cb100388j; SHANTZ HL, 1954, ECOLOGY, V35, P143, DOI 10.2307/1931110; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; Svangard E, 2004, J NAT PROD, V67, P144, DOI 10.1021/np030101l; Tailor RH, 1997, J BIOL CHEM, V272, P24480, DOI 10.1074/jbc.272.39.24480; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tam JP, 2002, EUR J BIOCHEM, V269, P923, DOI 10.1046/j.0014-2956.2001.02728.x; Trabi M, 2009, ORG BIOMOL CHEM, V7, P2378, DOI 10.1039/b823020j; Wang CK, 2009, BIOPHYS J, V97, P1471, DOI 10.1016/j.bpj.2009.06.032; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002	46	79	84	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3370	3380		10.1074/jbc.M112.415356	http://dx.doi.org/10.1074/jbc.M112.415356			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23195955	Green Published, hybrid			2022-12-28	WOS:000314397900042
J	Azarias, G; Kruusmagi, M; Connor, S; Akkuratov, EE; Liu, XL; Lyons, D; Brismar, H; Broberger, C; Aperia, A				Azarias, Guillaume; Kruusmagi, Markus; Connor, Siobhan; Akkuratov, Evgeny E.; Liu, Xiao-Li; Lyons, David; Brismar, Hjalmar; Broberger, Christian; Aperia, Anita			A Specific and Essential Role for Na,K-ATPase alpha 3 in Neurons Co-expressing alpha 1 and alpha 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNEL; DE-NOVO MUTATIONS; ENZYMATIC-PROPERTIES; ALTERNATING HEMIPLEGIA; PROTEIN-KINASE; BINDING SITE; K+-ATPASE; NA+; SODIUM; ISOFORMS	Most neurons co-express two catalytic isoforms of Na,K-ATPase, the ubiquitous alpha 1, and the more selectively expressed alpha 3. Although neurological syndromes are associated with alpha 3 mutations, the specific role of this isoform is not completely understood. Here, we used electrophysiological and Na+ imaging techniques to study the role of alpha 3 in central nervous system neurons expressing both isoforms. Under basal conditions, selective inhibition of alpha 3 using a low concentration of the cardiac glycoside, ouabain, resulted in a modest increase in intracellular Na+ concentration ([Na+](i)) accompanied by membrane potential depolarization. When neurons were challenged with a large rapid increase in [Na+](i), similar to what could be expected following suprathreshold neuronal activity, selective inhibition of alpha 3 almost completely abolished the capacity to restore [Na+](i) in soma and dendrite. Recordings of Na, K-ATPase specific current supported the notion that when [Na+](i) is elevated in the neuron, alpha 3 is the predominant isoform responsible for rapid extrusion of Na+. Low concentrations of ouabain were also found to disrupt cortical network oscillations, providing further support for the importance of alpha 3 function in the central nervous system. The alpha isoforms express a well conserved protein kinase A consensus site, which is structurally associated with an Na+ binding site. Following activation of protein kinase A, both the alpha 3-dependent current and restoration of dendritic [Na+](i) were significantly attenuated, indicating that alpha 3 is a target for phosphorylation and may participate in short term regulation of neuronal function.	[Azarias, Guillaume; Kruusmagi, Markus; Connor, Siobhan; Liu, Xiao-Li; Brismar, Hjalmar; Aperia, Anita] Karolinska Inst, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden; [Connor, Siobhan; Lyons, David; Broberger, Christian] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Akkuratov, Evgeny E.] Moscow MV Lomonosov State Univ, Int Ctr Biotechnol, Moscow 119991, Russia; [Brismar, Hjalmar] Royal Inst Technol, Dept Cell Phys, Sci Life Lab, S-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Lomonosov Moscow State University; Royal Institute of Technology	Aperia, A (corresponding author), Karolinska Univ Hosp, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden.	anita.aperia@ki.se	Liu, Xiaoli/HGE-7614-2022; Brismar, Hjalmar/E-8524-2011	Brismar, Hjalmar/0000-0003-0578-4003; Lyons, David/0000-0002-3391-5878; Akkuratov, Evgeny/0000-0002-2552-9512	Swedish Research Council; Familjen Erling Perssons Stiftelse; Torsten Soderberg Foundation; Rut and Arvid Wolffs stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Familjen Erling Perssons Stiftelse; Torsten Soderberg Foundation; Rut and Arvid Wolffs stiftelse	This work was supported by grants from the Swedish Research Council (to A. A. and C. B.), Familjen Erling Perssons Stiftelse (to A. A.), The Torsten Soderberg Foundation (to A. A.), and Rut and Arvid Wolffs stiftelse (to C. B.).	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; BLANCO G, 1995, BIOCHEMISTRY-US, V34, P9897, DOI 10.1021/bi00031a011; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Bottger P, 2011, J COMP NEUROL, V519, P376, DOI 10.1002/cne.22524; CAMERON R, 1994, MOL BRAIN RES, V21, P333, DOI 10.1016/0169-328X(94)90264-X; Cheng XJ, 1997, AM J PHYSIOL-CELL PH, V273, pC893, DOI 10.1152/ajpcell.1997.273.3.C893; Cornelius F, 2009, BIOCHEMISTRY-US, V48, P10056, DOI 10.1021/bi901212r; Diarra A, 2001, AM J PHYSIOL-CELL PH, V280, pC1623, DOI 10.1152/ajpcell.2001.280.6.C1623; Dobretsov M, 2005, FRONT BIOSCI-LANDMRK, V10, P2373, DOI 10.2741/1704; DRYER SE, 1994, TRENDS NEUROSCI, V17, P155, DOI 10.1016/0166-2236(94)90093-0; FISONE G, 1994, J BIOL CHEM, V269, P9368; Hallermann S, 2012, NAT NEUROSCI, V15, P1007, DOI 10.1038/nn.3132; Hamada L, 2003, BRIT J PHARMACOL, V138, P1517, DOI 10.1038/sj.bjp.0705170; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; HIEBER V, 1991, CELL MOL NEUROBIOL, V11, P253, DOI 10.1007/BF00769038; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Khan F, 2008, AM J PHYSIOL-RENAL, V295, pF1110, DOI 10.1152/ajprenal.90336.2008; Kim JH, 2007, NAT NEUROSCI, V10, P196, DOI 10.1038/nn1839; Kirshenbaum GS, 2011, GENES BRAIN BEHAV, V10, P542, DOI 10.1111/j.1601-183X.2011.00691.x; Kirshenbaum GS, 2011, P NATL ACAD SCI USA, V108, P18144, DOI 10.1073/pnas.1108416108; Lingrel JB, 2007, J BIOENERG BIOMEMBR, V39, P385, DOI 10.1007/s10863-007-9107-9; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; MARKS MJ, 1978, LIFE SCI, V23, P2735, DOI 10.1016/0024-3205(78)90654-9; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; McKenzie S, 2011, NEURON, V71, P224, DOI 10.1016/j.neuron.2011.06.037; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Munakata M, 1998, BRAIN RES, V800, P282, DOI 10.1016/S0006-8993(98)00533-2; MUNZER JS, 1994, J BIOL CHEM, V269, P16668; PIETRINI G, 1992, P NATL ACAD SCI USA, V89, P8414, DOI 10.1073/pnas.89.18.8414; Poulsen H, 2012, J BIOL CHEM, V287, P15959, DOI 10.1074/jbc.M112.340406; Poulsen H, 2010, FEBS LETT, V584, P2589, DOI 10.1016/j.febslet.2010.04.035; Rose CR, 1997, J PHYSIOL-LONDON, V499, P573, DOI 10.1113/jphysiol.1997.sp021951; Rose CR, 2001, J NEUROSCI, V21, P4207, DOI 10.1523/JNEUROSCI.21-12-04207.2001; Rose CR, 1999, PFLUG ARCH EUR J PHY, V439, P201, DOI 10.1007/s004240051145; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; SCHATZMANN HJ, 1953, HELV PHYSIOL PHARM A, V11, P346; SHYJAN AW, 1990, P NATL ACAD SCI USA, V87, P1178, DOI 10.1073/pnas.87.3.1178; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; SWEADNER KJ, 1985, J BIOL CHEM, V260, P1508; SWEADNER KJ, 1979, J BIOL CHEM, V254, P6060; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; URAYAMA O, 1988, BIOCHEM BIOPH RES CO, V156, P796, DOI 10.1016/S0006-291X(88)80914-8; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Zahler R, 1997, J GEN PHYSIOL, V110, P201, DOI 10.1085/jgp.110.2.201	47	81	84	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2734	2743		10.1074/jbc.M112.425785	http://dx.doi.org/10.1074/jbc.M112.425785			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23195960	Green Published, hybrid			2022-12-28	WOS:000314211500057
J	da Silva, DV; Nordholm, J; Madjo, U; Pfeiffer, A; Daniels, R				da Silva, Diogo V.; Nordholm, Johan; Madjo, Ursula; Pfeiffer, Annika; Daniels, Robert			Assembly of Subtype 1 Influenza Neuraminidase Is Driven by Both the Transmembrane and Head Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A VIRUS NEURAMINIDASE; CYTOPLASMIC TAIL; PROTEIN; STALK; GENES; HEMAGGLUTININ; REPLICATION; MATURATION; SIGNAL; NA	Neuraminidase (NA) is one of the two major influenza surface antigens and the main influenza drug target. Although NA has been well characterized and thought to function as a tetramer, the role of the transmembrane domain (TMD) in promoting proper NA assembly has not been systematically studied. Here, we demonstrate that in the absence of the TMD, NA is synthesized and transported in a predominantly inactive state. Substantial activity was rescued by progressive truncations of the stalk domain, suggesting the TMD contributes to NA maturation by tethering the stalk to the membrane. To analyze how the TMD supports NA assembly, the TMD was examined by itself. The NA TMD formed a homotetramer and efficiently trafficked to the plasma membrane, indicating the TMD and enzymatic head domain drive assembly together through matching oligomeric states. In support of this, an unrelated strong oligomeric TMD rescued almost full NA activity, whereas the weak oligomeric mutant of this TMD restored only half of wild type activity. These data illustrate that a large soluble domain can force assembly with a poorly compatible TMD; however, optimal assembly requires coordinated oligomerization between the TMD and the soluble domain.	[da Silva, Diogo V.; Nordholm, Johan; Madjo, Ursula; Pfeiffer, Annika; Daniels, Robert] Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Stockholm University	Daniels, R (corresponding author), Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	robertd@dbb.su.se		daniels, Robert/0000-0002-5988-2920; Pfeiffer, Annika/0000-0002-0340-5797; nordholm, johan/0000-0002-5864-8489	Swedish Research Council; Swedish Foundation for Strategic Research; Carl Trygger Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Carl Trygger Foundation	This work was supported by grants from the Swedish Research Council, Swedish Foundation for Strategic Research, and the Carl Trygger Foundation (to R. D.).	Barman S, 2004, J VIROL, V78, P5258, DOI 10.1128/JVI.78.10.5258-5269.2004; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; BLOK J, 1982, BIOCHEMISTRY-US, V21, P4001, DOI 10.1021/bi00260a015; BLOK J, 1982, VIROLOGY, V118, P229, DOI 10.1016/0042-6822(82)90337-3; BOS TJ, 1984, P NATL ACAD SCI-BIOL, V81, P2327, DOI 10.1073/pnas.81.8.2327; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Daniels R, 2004, CELL BIOCHEM BIOPHYS, V41, P113, DOI 10.1385/CBB:41:1:113; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; ELS MC, 1985, VIROLOGY, V142, P241, DOI 10.1016/0042-6822(85)90332-0; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; GOTTSCHALK A, 1957, BIOCHIM BIOPHYS ACTA, V23, P645, DOI 10.1016/0006-3002(57)90389-X; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hirst GK, 1942, J EXP MED, V76, P195, DOI 10.1084/jem.76.2.195; Hoffmann TW, 2012, J VIROL, V86, P584, DOI 10.1128/JVI.05474-11; HOGUE BG, 1992, VIROLOGY, V188, P510, DOI 10.1016/0042-6822(92)90505-J; Jejcic A, 2009, J VIROL, V83, P10075, DOI 10.1128/JVI.01700-08; Kundu A, 1996, J VIROL, V70, P6508, DOI 10.1128/JVI.70.9.6508-6515.1996; KUNDU A, 1991, MOL CELL BIOL, V11, P2675, DOI 10.1128/MCB.11.5.2675; LAVER WG, 1978, VIROLOGY, V86, P78, DOI 10.1016/0042-6822(78)90009-0; LAVER WG, 1969, VIROLOGY, V38, P105, DOI 10.1016/0042-6822(69)90132-9; Lew W, 2000, CURR MED CHEM, V7, P663, DOI 10.2174/0929867003374886; Li JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014722; Li QL, 2010, CONSTRUCTIVE COMPUTATION IN STOCHASTIC MODELS WITH APPLICATIONS: THE RG-FACTORIZATION, P1; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; LUO GX, 1993, VIRUS RES, V29, P141; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Mellroth P, 2012, J BIOL CHEM, V287, P11018, DOI 10.1074/jbc.M111.318584; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mitnaul LJ, 1996, J VIROL, V70, P873, DOI 10.1128/JVI.70.2.873-879.1996; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; PALESE P, 1976, J GEN VIROL, V33, P159, DOI 10.1099/0022-1317-33-1-159; Papavasiliou FN, 2002, CELL, V109, pS35, DOI 10.1016/S0092-8674(02)00706-7; PATERSON RG, 1990, J CELL BIOL, V110, P999, DOI 10.1083/jcb.110.4.999; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; SAITO T, 1995, J VIROL, V69, P5011, DOI 10.1128/JVI.69.8.5011-5017.1995; Schneider D, 2003, J BIOL CHEM, V278, P3105, DOI 10.1074/jbc.M206287200; SIVASUBRAMANIAN N, 1987, P NATL ACAD SCI USA, V84, P1, DOI 10.1073/pnas.84.1.1; Sorrell EM, 2010, J VIROL, V84, P11831, DOI 10.1128/JVI.01460-10; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wang N, 2008, J BIOL CHEM, V283, P33826, DOI 10.1074/jbc.M806897200; WEBSTER RG, 1967, J IMMUNOL, V99, P49; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08; Zhirnov OP, 2009, J CLIN VIROL, V45, P322, DOI 10.1016/j.jcv.2009.05.030	50	32	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					644	653		10.1074/jbc.M112.424150	http://dx.doi.org/10.1074/jbc.M112.424150			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23150659	hybrid, Green Published			2022-12-28	WOS:000313197200065
J	Harding, HP; Zyryanova, AF; Ron, D				Harding, Heather P.; Zyryanova, Alisa F.; Ron, David			Uncoupling Proteostasis and Development in Vitro with a Small Molecule Inhibitor of the Pancreatic Endoplasmic Reticulum Kinase, PERK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATED STRESS-RESPONSE; MESSENGER-RNA TRANSLATION; UNFOLDED PROTEIN RESPONSE; GENE-EXPRESSION; ALPHA-SUBUNIT; INITIATION; PHOSPHORYLATION; EIF2AK3; REINITIATION; MAINTAINS	Loss-of-function mutations in EIF2AK3, encoding the pancreatic endoplasmic reticulum (ER) kinase, PERK, are associated with dysfunction of the endocrine pancreas and diabetes. However, to date it has not been possible to uncouple the long term developmental effects of PERK deficiency from sensitization to physiological levels of ER unfolded protein stress upon interruption of PERK modulation of protein synthesis rates. Here, we report that a selective PERK inhibitor acutely deregulates protein synthesis in freshly isolated islets of Langerhans, across a range of glucose concentrations. Acute loss of the PERK-mediated strand of the unfolded protein response leads to rapid accumulation of misfolded pro-insulin in cultured beta cells and is associated with a kinetic defect in pro-insulin processing. These in vitro observations uncouple the latent role of PERK in beta cell development from the regulation of unfolded protein flux through the ER and attest to the importance of the latter in beta cell proteostasis.	[Harding, Heather P.] Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England; Addenbrookes Hosp, Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Cambridge CB2 0QQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Harding, HP (corresponding author), Univ Cambridge, Metab Res Labs, Hills Rd, Cambridge CB2 0QQ, England.	hph23@medschl.cam.ac.uk; dr360@medschl.cam.ac.uk		Ron, David/0000-0002-3014-5636; Harding, Heather P/0000-0002-7359-7974	Wellcome Trust Principal Research Fellowship [084812/Z/08/Z]; European Union [277713]; Medical Research Council [G0600717B] Funding Source: researchfish	Wellcome Trust Principal Research Fellowship(Wellcome Trust); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust Principal Research Fellowship 084812/Z/08/Z and by European Union FP7 BetaBat Grant 277713.	Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Cavener DR, 2010, TRENDS ENDOCRIN MET, V21, P714, DOI 10.1016/j.tem.2010.08.005; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; MATTS RL, 1983, P NATL ACAD SCI-BIOL, V80, P2559, DOI 10.1073/pnas.80.9.2559; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Yesil P, 2009, ISLETS, V1, P185, DOI 10.4161/isl.1.3.9556; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	31	81	81	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44338	44344		10.1074/jbc.M112.428987	http://dx.doi.org/10.1074/jbc.M112.428987			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23148209	hybrid, Green Published			2022-12-28	WOS:000312938600031
J	Kim, DH; Zhang, W; Koepp, DM				Kim, Dong-Hwan; Zhang, Wei; Koepp, Deanna M.			The Hect Domain E3 Ligase Tom1 and the F-box Protein Dia2 Control Cdc6 Degradation in G(1) Phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-REPLICATIVE COMPLEXES; DNA-REPLICATION; MCM PROTEINS; S-PHASE; UBIQUITIN LIGASE; CELL-CYCLE; PROTEOLYSIS; CDT1; PHOSPHORYLATION; INITIATION	The accurate replication of genetic information is critical to maintaining chromosomal integrity. Cdc6 functions in the assembly of pre-replicative complexes and is specifically required to load the Mcm2-7 replicative helicase complex at replication origins. Cdc6 is targeted for protein degradation by multiple mechanisms in Saccharomyces cerevisiae, although only a single pathway and E3 ubiquitin ligase for Cdc6 has been identified, the SCFCdc4 (Skp1/Cdc53/F-box protein) complex. Notably, Cdc6 is unstable during the G(1) phase of the cell cycle, but the ubiquitination pathway has not been previously identified. Using a genetic approach, we identified two additional E3 ubiquitin ligase components required for Cdc6 degradation, the F-box protein Dia2 and the Hect domain E3 Tom1. Both Dia2 and Tom1 control Cdc6 turnover during G1 phase of the cell cycle and act separately from SCFCdc4. Ubiquitination of Cdc6 is significantly reduced in dia2 Delta and tom1 Delta cells. Tom1 and Dia2 each independently immunoprecipitate Cdc6, binding to a C-terminal region of the protein. Tom1 and Dia2 cannot compensate for each other in Cdc6 degradation. Cdc6 and Mcm4 chromatin association is aberrant in tom1 Delta and dia2 Delta cells in G1 phase. Together, these results present evidence for a novel degradation pathway that controls Cdc6 turnover in G(1) that may regulate pre-replicative complex assembly.	[Kim, Dong-Hwan; Zhang, Wei; Koepp, Deanna M.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Koepp, DM (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 6-160 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	koepp015@umn.edu			National Institutes of Health [R01 GM076663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM076663 (to D.M.K.).	Blake D, 2006, GENETICS, V174, P1709, DOI 10.1534/genetics.106.057836; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; BUENO A, 1992, EMBO J, V11, P2167, DOI 10.1002/j.1460-2075.1992.tb05276.x; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Devault A, 2002, CURR BIOL, V12, P689, DOI 10.1016/S0960-9822(02)00768-6; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Elsasser S, 1996, MOL BIOL CELL, V7, P1723, DOI 10.1091/mbc.7.11.1723; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; Escobar-Henriques M, 2006, J CELL BIOL, V173, P645, DOI 10.1083/jcb.200512079; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Hall JR, 2008, J BIOL CHEM, V283, P25356, DOI 10.1074/jbc.M802667200; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Kim DH, 2012, MOL BIOL CELL, V23, P4203, DOI 10.1091/mbc.E12-07-0548; Koepp DM, 2006, MOL BIOL CELL, V17, P1540, DOI 10.1091/mbc.E05-09-0884; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Mimura S, 2009, EMBO J, V28, P3693, DOI 10.1038/emboj.2009.320; Morohashi H, 2009, CURR BIOL, V19, P1943, DOI 10.1016/j.cub.2009.09.062; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Perkins G, 2001, EMBO J, V20, P4836, DOI 10.1093/emboj/20.17.4836; Perkins G, 1998, MOL CELL, V2, P23, DOI 10.1016/S1097-2765(00)80110-0; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Saleh A, 1998, J MOL BIOL, V282, P933, DOI 10.1006/jmbi.1998.2036; Sanchez M, 1999, J BIOL CHEM, V274, P9092, DOI 10.1074/jbc.274.13.9092; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Tafforeau L, 2006, EMBO J, V25, P4547, DOI 10.1038/sj.emboj.7601329; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Weinreich M, 1999, P NATL ACAD SCI USA, V96, P441, DOI 10.1073/pnas.96.2.441; Yoshida Y, 2007, J BIOL CHEM, V282, P7137, DOI 10.1074/jbc.M611168200	37	11	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44212	44220		10.1074/jbc.M112.401778	http://dx.doi.org/10.1074/jbc.M112.401778			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23129771	Green Published, hybrid			2022-12-28	WOS:000312938600020
J	Monfregola, J; Johnson, JL; Meijler, MM; Napolitano, G; Catz, SD				Monfregola, Jlenia; Johnson, Jennifer Linda; Meijler, Michael M.; Napolitano, Gennaro; Catz, Sergio Daniel			MUNC13-4 Protein Regulates the Oxidative Response and Is Essential for Phagosomal Maturation and Bacterial Killing in Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; NADPH OXIDASE ACTIVITY; CHRONIC GRANULOMATOUS-DISEASE; BINDING-PROTEIN; AZUROPHILIC GRANULES; RESPIRATORY BURST; SUPEROXIDE ANION; MOUSE MODEL; NOX-FAMILY; RAB27A	Neutrophils use diverse mechanisms to kill pathogens including phagocytosis, exocytosis, generation of reactive oxygen species (ROS), and neutrophil extracellular traps. These mechanisms rely on their ability to mobilize intracellular organelles and to deliver granular cargoes to specific cellular compartments or into the extracellular milieu, but the molecular mechanisms regulating vesicular trafficking in neutrophils are not well understood. MUNC13-4 is a RAB27A effector that coordinates exocytosis in hematopoietic cells, and its deficiency is associated with the human immunodeficiency familial hemophagocytic lymphohistiocytosis type 3. In this work, we have established an essential role for MUNC13-4 in selective vesicular trafficking, phagosomal maturation, and intracellular bacterial killing in neutrophils. Using neutrophils from munc13-4 knock-out (KO) mice, we show that MUNC13-4 is necessary for the regulation of p22(phox)-expressing granule trafficking to the plasma membrane and regulates extracellular ROS production. MUNC13-4 was also essential for the regulation of intracellular ROS production induced by Pseudomonas aeruginosa despite normal trafficking of p22(phox)-expressing vesicles toward the phagosome. Importantly, in the absence of MUNC13-4, phagosomal maturation was impaired as observed by the defective delivery of azurophilic granules and multive-sicular bodies to the phagosome. Significantly, this mechanism was intact in RAB27A KO neutrophils. Intracellular bacterial killing was markedly impaired in MUNC13-4 KO neutrophils. MUNC13-4-deficient cells showed a significant increase in neutrophil extracellular trap formation but were unable to compensate for the impaired bacterial killing. Altogether, these findings characterize novel functions of MUNC13-4 in the innate immune response of the neutrophil and have direct implications for the understanding of immunodeficiencies in patients with MUNC13-4 deficiency.	[Monfregola, Jlenia; Johnson, Jennifer Linda; Napolitano, Gennaro; Catz, Sergio Daniel] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Meijler, Michael M.] Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel; [Meijler, Michael M.] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Scripps Research Institute; Ben Gurion University; Ben Gurion University	Catz, SD (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	scatz@scripps.edu	Napolitano, Gennaro/O-5377-2016; Monfregola, Jlenia/AAW-9055-2021	Napolitano, Gennaro/0000-0002-8615-4654; Catz, Sergio/0000-0002-1873-0277; Meijler, Michael/0000-0001-7095-1467	National Institutes of Health from the United States Public Health Service [HL088256]; National Center for Research Resources [UL1 RR025774]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088256] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL088256 (to S.D.C.) from the United States Public Health Service and UL1 RR025774 from the National Center for Research Resources.	Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; BABIOR BM, 1991, AM J HEMATOL, V37, P263, DOI 10.1002/ajh.2830370410; BABIOR BM, 1990, SEMIN HEMATOL, V27, P247; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Boswell KL, 2012, J CELL BIOL, V197, P301, DOI 10.1083/jcb.201109132; BOXER LA, 1979, J LAB CLIN MED, V93, P506; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brzezinska AA, 2008, TRAFFIC, V9, P2151, DOI 10.1111/j.1600-0854.2008.00838.x; Cieutat AM, 1998, BLOOD, V91, P1044, DOI 10.1182/blood.V91.3.1044.1044_1044_1058; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; DAHLGREN C, 1995, BIOCHEM J, V311, P667, DOI 10.1042/bj3110667; Elstak ED, 2011, BLOOD, V118, P1570, DOI 10.1182/blood-2011-02-339523; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gobor T, 2011, J MICROBIOL METH, V84, P299, DOI 10.1016/j.mimet.2010.12.018; Green SP, 2001, J CEREBR BLOOD F MET, V21, P374, DOI 10.1097/00004647-200104000-00006; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jankowski A, 2002, J BIOL CHEM, V277, P6059, DOI 10.1074/jbc.M110059200; Johnson JL, 2012, MOL BIOL CELL, V23, P1902, DOI 10.1091/mbc.E11-12-1001; Johnson JL, 2011, J BIOL CHEM, V286, P5647, DOI 10.1074/jbc.M110.184762; Johnson JL, 2010, TRAFFIC, V11, P533, DOI 10.1111/j.1600-0854.2009.01029.x; Kantonen S, 2011, MOL CELL BIOL, V31, P4524, DOI 10.1128/MCB.05684-11; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; Kutter D, 2000, ACTA HAEMATOL-BASEL, V104, P10, DOI 10.1159/000041062; Lee WL, 2003, MICROBES INFECT, V5, P1299, DOI 10.1016/j.micinf.2003.09.014; Li YM, 2002, P NATL ACAD SCI USA, V99, P8289, DOI 10.1073/pnas.122244799; Lin JS, 2001, CLIN DIAGN LAB IMMUN, V8, P528, DOI 10.1128/CDLI.8.3.528-533.2001; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Lundqvist H, 1996, FREE RADICAL BIO MED, V20, P785, DOI 10.1016/0891-5849(95)02189-2; Mahlaoui N, 2007, PEDIATRICS, V120, pE622, DOI 10.1542/peds.2006-3164; Marcenaro S, 2006, BLOOD, V108, P2316, DOI 10.1182/blood-2006-04-015693; MARKERT M, 1984, METHOD ENZYMOL, V105, P358; Mattheyses AL, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2161018; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Munafo DB, 2007, BIOCHEM J, V402, P229, DOI 10.1042/BJ20060950; Munafo DB, 2009, J INNATE IMMUN, V1, P527, DOI 10.1159/000235860; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; Nold-Petry CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008663; Pacquelet S, 2007, BIOCHEM J, V403, P451, DOI 10.1042/BJ20061184; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Perskvist N, 2002, J CELL SCI, V115, P1321; Pivot-Pajot C, 2008, J IMMUNOL, V180, P6786, DOI 10.4049/jimmunol.180.10.6786; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Ren QS, 2010, BLOOD, V116, P869, DOI 10.1182/blood-2010-02-270934; Rohr J, 2010, HAEMATOL-HEMATOL J, V95, P2080, DOI 10.3324/haematol.2010.029389; Schwartz J, 2009, J IMMUNOL, V183, P2632, DOI 10.4049/jimmunol.0804110; SENGELOV H, 1992, J BIOL CHEM, V267, P14912; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; SPEERT DP, 1994, J INFECT DIS, V170, P1524, DOI 10.1093/infdis/170.6.1524; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Tian W, 2008, BLOOD, V112, P3867, DOI 10.1182/blood-2007-11-126029; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Tolmachova T, 2004, MOL BIOL CELL, V15, P332, DOI 10.1091/mbc.e03-07-0452; Tse SML, 2003, J BIOL CHEM, V278, P3331, DOI 10.1074/jbc.M207966200; Tunney MM, 2004, ANTIMICROB AGENTS CH, V48, P1879, DOI 10.1128/AAC.48.5.1879-1881.2004; Uriarte Silvia M, 2011, J Immunol, V187, P391, DOI 10.4049/jimmunol.1003112; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Ward RA, 2000, J BIOL CHEM, V275, P36713, DOI 10.1074/jbc.M003017200; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Wood SM, 2009, BLOOD, V114, P4117, DOI 10.1182/blood-2009-06-225359; Yokoyama K, 2011, J BIOL CHEM, V286, P5375, DOI 10.1074/jbc.M110.171702; Zhang ST, 2008, BRIT J HAEMATOL, V142, P469, DOI 10.1111/j.1365-2141.2008.07191.x	71	28	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44603	44618		10.1074/jbc.M112.414029	http://dx.doi.org/10.1074/jbc.M112.414029			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23115246	Green Published, hybrid			2022-12-28	WOS:000312938600057
J	Chen, YL; Duan, YJ; Kang, YH; Yang, XX; Jiang, MX; Zhang, L; Li, GL; Yin, ZN; Hu, WQ; Dong, PZ; Li, XJ; Hajjar, DP; Han, JH				Chen, Yuanli; Duan, Yajun; Kang, Yanhua; Yang, Xiaoxiao; Jiang, Meixiu; Zhang, Ling; Li, Guangliang; Yin, Zhinan; Hu, Wenquan; Dong, Pengzhi; Li, Xiaoju; Hajjar, David P.; Han, Jihong			Activation of Liver X Receptor Induces Macrophage Interleukin-5 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; OXIDATION-SPECIFIC EPITOPES; OXIDIZED LDL; DEFICIENT MICE; MONOCLONAL AUTOANTIBODIES; ATHEROSCLEROTIC LESIONS; PROTECTIVE IMMUNITY; NATURAL ANTIBODIES; T-LYMPHOCYTES; LXR	IL-5 stimulates production of T15/EO6 IgM antibodies that can block the uptake of oxidized low density lipoprotein by macrophages, whereas a deficiency in macrophage IL-5 expression accelerates development of atherosclerosis. Liver X receptors (LXRs) are ligand-activated transcription factors that can induce macrophage ABCA1 expression and cholesterol efflux, thereby inhibiting the development of atherosclerosis. However, it remains unknown whether additional mechanisms, such as the regulation of macrophage IL-5 expression, are related to the anti-atherogenic properties of LXR. We initially defined IL-5 expression in macrophages where the LXR ligand (T0901317) induced macrophage IL-5 protein expression and secretion. The overexpression of LXR increased, whereas its knockdown inhibited IL-5 expression. Furthermore, we found that LXR activation increased IL-5 transcripts, promoter activity, formation of an LXR.LXR-responsive element complex, and IL-5 protein stability. In vivo, we found that T0901317 increased IL-5 and total IgM levels in plasma and IL-5 expression in multiple tissues in wild type mice. In LDL receptor knock-out (LDLR-/-) mice, T0901317 increased IL-5 expression in the aortic root area. Taken together, our studies demonstrate that macrophage IL-5 is a target gene for LXR activation, and the induction of macrophage IL-5 expression can be related to LXR-inhibited atherosclerosis.	[Chen, Yuanli; Duan, Yajun; Kang, Yanhua; Yang, Xiaoxiao; Jiang, Meixiu; Zhang, Ling; Li, Guangliang; Yin, Zhinan; Hu, Wenquan; Dong, Pengzhi; Li, Xiaoju; Han, Jihong] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Chen, Yuanli; Duan, Yajun; Kang, Yanhua; Yang, Xiaoxiao; Jiang, Meixiu; Zhang, Ling; Li, Guangliang; Yin, Zhinan; Hu, Wenquan; Dong, Pengzhi; Li, Xiaoju; Han, Jihong] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Hajjar, David P.] Cornell Univ, Weill Med Coll, New York, NY 10067 USA	Nankai University; Nankai University; Cornell University	Duan, YJ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China.	yajunduan@nankai.edu.cn; jihonghan2008@nankai.edu.cn			Ministry of Science and Technology of China [2010CB945003]; National Science Foundation of China (NSFC) [30971271, 81272460, 81000128]; Tianjin Municipal Science and Technology Commission of China [08ZCKFSH04400, 11JCYBJC10600]; J & S Gross Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission of China; J & S Gross Foundation	This work was supported by the Ministry of Science and Technology of China Grant 2010CB945003 to JH; the National Science Foundation of China (NSFC) Grants 30971271 and 81272460 to JH and 81000128 to YD; Tianjin Municipal Science and Technology Commission of China Grants 08ZCKFSH04400 and 11JCYBJC10600 to JH, and funds from the J & S Gross Foundation awarded to DH.	APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Binder CJ, 2008, CURR DRUG TARGETS, V9, P190; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Chou MY, 2008, J INTERN MED, V263, P479, DOI 10.1111/j.1365-2796.2008.01968.x; Duan YJ, 2012, J BIOL CHEM, V287, P23667, DOI 10.1074/jbc.M112.350181; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Frostegard Johan, 2002, Autoimmunity Reviews, V1, P233, DOI 10.1016/S1568-9972(02)00059-9; Hogan SP, 1997, IMMUNOL CELL BIOL, V75, P284, DOI 10.1038/icb.1997.43; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Hulthe J, 2004, CLIN CHIM ACTA, V348, P1, DOI 10.1016/j.cccn.2004.05.021; Im SS, 2011, CIRC RES, V108, P996, DOI 10.1161/CIRCRESAHA.110.226878; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Karlen S, 1998, Int Rev Immunol, V16, P227, DOI 10.3109/08830189809042996; Karvonen J, 2003, CIRCULATION, V108, P2107, DOI 10.1161/01.CIR.0000092891.55157.A7; Kim KH, 2009, MOL ENDOCRINOL, V23, P466, DOI 10.1210/me.2008-0295; LASSER EC, 1987, ALLERGY, V42, P549, DOI 10.1111/j.1398-9995.1987.tb00381.x; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Linton MF, 2001, CURR OPIN LIPIDOL, V12, P489, DOI 10.1097/00041433-200110000-00003; MASUDA ES, 1993, MOL CELL BIOL, V13, P7399, DOI 10.1128/MCB.13.12.7399; Miller YI, 2003, CURR OPIN LIPIDOL, V14, P437, DOI 10.1097/00041433-200310000-00004; Mitra S, 2011, AM J MED SCI, V342, P135, DOI 10.1097/MAJ.0b013e318224a147; NAORA H, 1994, J IMMUNOL, V153, P3466; PALINSKI W, 1995, ARTERIOSCL THROM VAS, V15, P1569, DOI 10.1161/01.ATV.15.10.1569; PALINSKI W, 1994, ARTERIOSCLER THROMB, V14, P605, DOI 10.1161/01.ATV.14.4.605; PALINSKI W, 1989, P NATL ACAD SCI USA, V86, P1372, DOI 10.1073/pnas.86.4.1372; Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; Parikh N, 2010, CARDIOL REV, V18, P269, DOI 10.1097/CRD.0b013e3181e8067a; Sampi M, 2008, J AM COLL CARDIOL, V52, P1370, DOI 10.1016/j.jacc.2008.06.047; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Tsimikas S, 2001, ARTERIOSCL THROM VAS, V21, P95, DOI 10.1161/01.ATV.21.1.95; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; YLAHERTTUALA S, 1994, ARTERIOSCLER THROMB, V14, P32, DOI 10.1161/01.ATV.14.1.32; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; Zhou XY, 2010, J BIOL CHEM, V285, P6316, DOI 10.1074/jbc.M109.073601	42	38	40	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43340	43350		10.1074/jbc.M112.403394	http://dx.doi.org/10.1074/jbc.M112.403394			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23150660	Green Published, hybrid			2022-12-28	WOS:000312940800015
J	Donegan, RK; Hill, SE; Turnage, KC; Orwig, SD; Lieberman, RL				Donegan, Rebecca K.; Hill, Shannon E.; Turnage, Katherine C.; Orwig, Susan D.; Lieberman, Raquel L.			The Glaucoma-associated Olfactomedin Domain of Myocilin Is a Novel Calcium Binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TRABECULAR MESHWORK; AQUEOUS-HUMOR; CIRCULAR-DICHROISM; CANCER CELLS; STABILITY; IDENTIFICATION; MECHANISMS; ADHESION; OUTFLOW; GROWTH	Myocilin is a protein found in the trabecular meshwork extracellular matrix tissue of the eye that plays a role in regulating intraocular pressure. Both wild-type and certain myocilin variants containing mutations in the olfactomedin (OLF) domain are linked to the optic neuropathy glaucoma. Because calcium ions are important biological cofactors that play numerous roles in extracellular matrix proteins, we examined the calcium binding properties of the myocilin OLF domain (myoc-OLF). Our study reveals an unprecedented high affinity calcium binding site within myoc-OLF. The calcium ion remains bound to wildtype OLF at neutral and acidic pH. A glaucoma-causing OLF variant, myoc-OLF(D380A), is calcium-depleted. Key differences in secondary and tertiary structure between myoc-OLF(D380A) and wild-type myoc-OLF, as well as limited access to chelators, indicate that the calcium binding site is largely buried in the interior of the protein. Analysis of six conserved aspartate or glutamate residues and an additional 18 disease-causing variants revealed two other candidate residues that may be involved in calcium coordination. Our finding expands our knowledge of calcium binding in extracellular matrix proteins; provides new clues into domain structure, function, and pathogenesis for myocilin; and offers insights into highly conserved, biomedically relevant OLF domains.	[Donegan, Rebecca K.; Hill, Shannon E.; Turnage, Katherine C.; Orwig, Susan D.; Lieberman, Raquel L.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Lieberman, RL (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, 901 Atlantic Dr NW, Atlanta, GA 30332 USA.	Raquel.lieberman@chemistry.gatech.edu			National Institutes of Health [R01EY021205]; United States Department of Education Graduate Assistance in Areas of National Need Program [P200A060188]; NATIONAL EYE INSTITUTE [R01EY021205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Education Graduate Assistance in Areas of National Need Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grant R01EY021205 (to R. L. L.).; Supported in part by United States Department of Education Graduate Assistance in Areas of National Need Program P200A060188.	Aravind P, 2009, BIOCHEMISTRY-US, V48, P12180, DOI 10.1021/bi9017076; Borras T, 2009, EXP EYE RES, V88, P738, DOI 10.1016/j.exer.2008.11.027; BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X; BRYANT DTW, 1985, BIOCHEM J, V226, P613, DOI 10.1042/bj2260613; Burns JN, 2011, BIOCHEMISTRY-US, V50, P5824, DOI 10.1021/bi200231x; Burns JN, 2010, ACS CHEM BIOL, V5, P477, DOI 10.1021/cb900282e; Carbone MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004216; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clark AF, 2009, EXP EYE RES, V88, P752, DOI 10.1016/j.exer.2008.10.004; Cruciani F, 2004, J TRACE ELEM MED BIO, V18, P141, DOI 10.1016/j.jtemb.2004.02.005; Dudev T, 2003, CHEM REV, V103, P773, DOI 10.1021/cr020467n; Evenas J, 1998, CURR OPIN CHEM BIOL, V2, P293, DOI 10.1016/S1367-5931(98)80072-0; Fautsch MP, 2006, EXP EYE RES, V82, P1046, DOI 10.1016/j.exer.2005.09.016; Fautsch MP, 2001, INVEST OPHTH VIS SCI, V42, P2324; Gersemann M, 2012, J CROHNS COLITIS, V6, P425, DOI 10.1016/j.crohns.2011.09.013; Goldwich A, 2009, HISTOCHEM CELL BIOL, V131, P167, DOI 10.1007/s00418-008-0518-4; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; Hillier BJ, 2003, J CELL BIOL, V160, P597, DOI 10.1083/jcb.200210053; Hillier BJ, 2007, BIOCHEM CELL BIOL, V85, P552, DOI 10.1139/O07-055; Innis CA, 2000, PROTEIN ENG, V13, P839, DOI 10.1093/protein/13.12.839; Joe MK, 2005, BIOCHEM BIOPH RES CO, V336, P1201, DOI 10.1016/j.bbrc.2005.09.006; Kennedy KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036301; Kobayashi D, 2007, CANCER SCI, V98, P334, DOI 10.1111/j.1349-7006.2007.00397.x; Labasque M, 2011, J BIOL CHEM, V286, P42426, DOI 10.1074/jbc.M111.266353; Liu RH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-38; Maurer P, 1997, MATRIX BIOL, V15, P569, DOI 10.1016/S0945-053X(97)90033-0; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; Maurer P, 1996, CURR OPIN CELL BIOL, V8, P609, DOI 10.1016/S0955-0674(96)80101-3; McLaughlin CW, 2008, AM J PHYSIOL-CELL PH, V295, pC1083, DOI 10.1152/ajpcell.340.2008; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; MORRISETT JD, 1971, J AM CHEM SOC, V93, P7297, DOI 10.1021/ja00755a030; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Orwig SD, 2012, J MOL BIOL, V421, P242, DOI 10.1016/j.jmb.2011.12.016; Orwig SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016347; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Peters DM, 2005, EXP CELL RES, V303, P218, DOI 10.1016/j.yexcr.2004.09.026; Pidcock E, 2001, J BIOL INORG CHEM, V6, P479, DOI 10.1007/s007750100214; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Rajini B, 2001, J BIOL CHEM, V276, P38464, DOI 10.1074/jbc.M102164200; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Resch ZT, 2009, EXP EYE RES, V88, P704, DOI 10.1016/j.exer.2008.08.011; Rigden DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021507; Rigden DJ, 2004, J MOL BIOL, V343, P971, DOI 10.1016/j.jmb.2004.08.077; RINGVOLD A, 1988, ACTA OPHTHALMOL, V66, P153; Sanchez-Ruiz JM, 2007, BIOPHYS CHEM, V126, P43, DOI 10.1016/j.bpc.2006.05.021; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; SMITH PD, 1984, ANAL BIOCHEM, V143, P188, DOI 10.1016/0003-2697(84)90575-X; Tamm ER, 1999, INVEST OPHTH VIS SCI, V40, P2577; Thompson J, 2011, PROTEINS, V79, P2380, DOI 10.1002/prot.23046; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; Tumminia SJ, 1998, INVEST OPHTH VIS SCI, V39, P1361; Wentz-Hunter K, 2002, INVEST OPHTH VIS SCI, V43, P176; Yu L, 2011, NEOPLASMA, V58, P9, DOI 10.4149/neo_2011_01_9; Zhang K, 2012, NAT REV DRUG DISCOV, V11, P541, DOI 10.1038/nrd3745	54	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43370	43377		10.1074/jbc.M112.408906	http://dx.doi.org/10.1074/jbc.M112.408906			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129764	Green Published, hybrid			2022-12-28	WOS:000312940800018
J	Frase, H; Toth, M; Vakulenko, SB				Frase, Hilary; Toth, Marta; Vakulenko, Sergei B.			Revisiting the Nucleotide and Aminoglycoside Substrate Specificity of the Bifunctional Aminoglycoside Acetyltransferase(6 ')-Ie/Aminoglycoside Phosphotransferase(2 '')-Ia Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBIOTIC-RESISTANCE ENZYME; STAPHYLOCOCCUS-AUREUS; KINETIC MECHANISM; ATP; ENTEROCOCCUS; DETERMINANT; ARBEKACIN; SITE; COLI; IIIA	The bifunctional aminoglycoside-modifying enzyme aminoglycoside acetyltransferase(6')-Ie/aminoglycoside phosphotransferase(2 '')-Ia, or AAC(6')-Ie/APH(2 '')-Ia, is the major source of aminoglycoside resistance in Gram-positive bacterial pathogens. In previous studies, using ATP as the cosubstrate, it was reported that the APH(2 '')-Ia domain of this enzyme is unique among aminoglycoside phosphotransferases, having the ability to inactivate an unusually broad spectrum of aminoglycosides, including 4,6- and 4,5-disubstituted and atypical. We recently demonstrated that GTP, and not ATP, is the preferred cosubstrate of this enzyme. We now show, using competition assays between ATP and GTP, that GTP is the exclusive phosphate donor at intracellular nucleotide levels. In light of these findings, we reevaluated the substrate profile of the phosphotransferase domain of this clinically important enzyme. Steady-state kinetic characterization using the phosphate donor GTP demonstrates that AAC(6')-Ie/APH(2 '')-Ia phosphorylates 4,6-disubstituted aminoglycosides with high efficiency (k(cat)/K-m = 10(5)-10(7) M-1 s(-1)). Despite this proficiency, no resistance is conferred to some of these antibiotics by the enzyme in vivo. We now show that phosphorylation of 4,5-disubstituted and atypical aminoglycosides are negligible and thus these antibiotics are not substrates. Instead, these aminoglycosides tend to stimulate an intrinsic GTPase activity of the enzyme. Taken together, our data show that the bifunctional enzyme efficiently phosphorylates only 4,6-disubstituted antibiotics; however, phosphorylation does not necessarily result in bacterial resistance. Hence, the APH(2 '')-Ia domain of the bifunctional AAC(6')-Ie/APH(2 '')-Ia enzyme is a bona fide GTP-dependent kinase with a narrow substrate profile, including only 4,6-disubstituted aminoglycosides.	[Frase, Hilary; Toth, Marta; Vakulenko, Sergei B.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame	Vakulenko, SB (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 417 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.	svakulen@nd.edu			National Institutes of Health [RO1 AI057393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI057393 (to S. B. V.).	Azucena E, 1997, J AM CHEM SOC, V119, P2317, DOI 10.1021/ja964278w; Badarau A, 2008, J BIOL CHEM, V283, P7638, DOI 10.1074/jbc.M709645200; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Boehr DD, 2004, BIOCHEMISTRY-US, V43, P9846, DOI 10.1021/bi049135y; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Chow JW, 2000, CLIN INFECT DIS, V31, P586, DOI 10.1086/313949; Clinical and Laboratory Standards Institute, 2009, METH DIL ANT SUSC TE; Copeland R. A., 2000, ENZYMES PRACTICAL IN, P310; Culebras Esther, 1999, Frontiers in Bioscience, V4, pD1, DOI 10.2741/culebras; Daigle DM, 1999, CHEM BIOL, V6, P99, DOI 10.1016/S1074-5521(99)80006-4; De Mey M, 2010, METAB ENG, V12, P477, DOI 10.1016/j.ymben.2010.04.003; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Hotta K, 2000, J ANTIBIOT, V53, P1168, DOI 10.7164/antibiotics.53.1168; Hotta K, 1996, J ANTIBIOT, V49, P458, DOI 10.7164/antibiotics.49.458; Kim C, 2006, J BIOL CHEM, V281, P6964, DOI 10.1074/jbc.M513257200; Liebeke M, 2010, CHEM BIOL, V17, P820, DOI 10.1016/j.chembiol.2010.06.012; Llano-Sotelo B, 2002, CHEM BIOL, V9, P455, DOI 10.1016/S1074-5521(02)00125-4; MARTEL A, 1983, EUR J BIOCHEM, V133, P515, DOI 10.1111/j.1432-1033.1983.tb07494.x; Matsuo H, 2003, FEBS LETT, V546, P401, DOI 10.1016/S0014-5793(03)00644-6; ROUCH DA, 1987, J GEN MICROBIOL, V133, P3039; Smith CA, 2012, J BIOL CHEM, V287, P12893, DOI 10.1074/jbc.M112.341206; Toth M, 2007, BIOCHEMISTRY-US, V46, P5570, DOI 10.1021/bi6024512; Toth M, 2010, PROTEIN SCI, V19, P1565, DOI 10.1002/pro.437; Toth M, 2009, J BIOL CHEM, V284, P6690, DOI 10.1074/jbc.M808148200; UBUKATA K, 1984, ANTIMICROB AGENTS CH, V25, P754, DOI 10.1128/AAC.25.6.754; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Young PG, 2009, J BACTERIOL, V191, P4133, DOI 10.1128/JB.00149-09; Zhang WL, 2009, CURR OPIN MICROBIOL, V12, P505, DOI 10.1016/j.mib.2009.06.013	30	16	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43262	43269		10.1074/jbc.M112.416453	http://dx.doi.org/10.1074/jbc.M112.416453			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115238	hybrid, Green Published			2022-12-28	WOS:000312940800007
J	Lewis, EM; Wilkinson, AS; Jackson, JS; Mehra, R; Varambally, S; Chinnaiyan, AM; Wilkinson, JC				Lewis, Eric M.; Wilkinson, Amanda S.; Jackson, Jacqueline S.; Mehra, Rohit; Varambally, Sooryanarayana; Chinnaiyan, Arul M.; Wilkinson, John C.			The Enzymatic Activity of Apoptosis-inducing Factor Supports Energy Metabolism Benefiting the Growth and Invasiveness of Advanced Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION ANALYSIS; NF-KAPPA-B; OXIDATIVE STRESS; FACTOR AIF; COLON-CANCER; PROGRESSION; PATHWAYS; HYPOXIA; DEATH; RAS	Apoptosis-inducing factor (AIF) promotes cell death yet also controls mitochondrial homeostasis and energy metabolism. It is unclear how these activities are coordinated, and the impact of AIF upon human disease, in particular cancer, is not well documented. In this study we have explored the contribution of AIF to the progression of prostate cancer. Analysis of archival gene expression data demonstrated that AIF transcript levels are elevated in human prostate cancer, and we found that AIF protein is increased in prostate tumors. Suppression of AIF expression in the prostate cancer cell lines LNCaP, DU145, and PC3 demonstrated that AIF does not contribute to cell toxicity via a variety of chemical death triggers, and growth under nutrient-rich conditions is largely unaffected by AIF ablation. However, under growth stress conditions, AIF depletion from DU145 and PC3 cell lines led to significant reductions in cell survival and growth that were not observed in LNCaP cells. Moreover AIF-deficient PC3 cells exhibited substantial reduction of tumorigenic growth in vivo. This reduced survival correlated with decreased expression of mitochondrial complex I protein subunits and concomitant changes in glucose metabolism. Finally, restoration of AIF-deficient PC3 cells with AIF variants demonstrated that the enzymatic activity of AIF is required for aggressive growth. Overall these studies show that AIF is an important factor for advanced prostate cancer cells and that through control of energy metabolism and redox balance, the enzymatic activity of AIF is critical for this support.	[Lewis, Eric M.; Wilkinson, Amanda S.; Jackson, Jacqueline S.; Wilkinson, John C.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Mehra, Rohit; Varambally, Sooryanarayana; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Mehra, Rohit; Varambally, Sooryanarayana; Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Varambally, Sooryanarayana; Chinnaiyan, Arul M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	Wake Forest University; Wake Forest Baptist Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Wilkinson, JC (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jcwilkin@wakehealth.edu			National Institutes of Health Grant from the SPORE in Prostate Cancer [P50 CA69568]; Early Detection Research Network [U01 CA111275]; Department of Defense Prostate Cancer Research Program [W81XWH-08-1-0045]; American Cancer Society [RSG-09-166-01-CCG]; NATIONAL CANCER INSTITUTE [P50CA069568, U01CA111275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM064249] Funding Source: NIH RePORTER	National Institutes of Health Grant from the SPORE in Prostate Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network; Department of Defense Prostate Cancer Research Program(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P50 CA69568 (to A. M. C.) from the SPORE in Prostate Cancer. This work was also supported by Grant U01 CA111275 (to A. M. C.) from the Early Detection Research Network, Grant W81XWH-08-1-0045 (to J. C. W.) from the Department of Defense Prostate Cancer Research Program, and Grant RSG-09-166-01-CCG (to J. C. W.) from the American Cancer Society.	Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Bernard D, 2003, J CLIN INVEST, V112, P1724; Bhat HK, 2003, P NATL ACAD SCI USA, V100, P3913, DOI 10.1073/pnas.0437929100; Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; Brown D, 2006, P NATL ACAD SCI USA, V103, P9918, DOI 10.1073/pnas.0603950103; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Devi GR, 2004, DRUG NEWS PERSPECT, V17, P127, DOI 10.1358/dnp.2004.17.2.829046; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Duesbery NS, 2001, P NATL ACAD SCI USA, V98, P4089, DOI 10.1073/pnas.061031898; Galban S, 2009, BIOCHEM J, V417, P765, DOI 10.1042/BJ20081677; Ghafar MA, 2003, PROSTATE, V54, P58, DOI 10.1002/pros.10162; Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Huerta S, 2007, J SURG RES, V142, P184, DOI 10.1016/j.jss.2006.12.551; Jeong EG, 2006, APMIS, V114, P867, DOI 10.1111/j.1600-0463.2006.apm_502.x; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; LaTulippe E, 2002, CANCER RES, V62, P4499; Lewis EM, 2011, BIOCHEMISTRY-US, V50, P11084, DOI 10.1021/bi201483g; Li SY, 2011, ARCH PATHOL LAB MED, V135, P903, DOI 10.1043/2010-0003-OAR1.1; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; Mabjeesh NJ, 2003, CLIN CANCER RES, V9, P2416; Mehraein-Ghomi F, 2010, CANCER RES, V70, P4560, DOI 10.1158/0008-5472.CAN-09-3596; Millan A, 2009, J SURG RES, V151, P163, DOI 10.1016/j.jss.2007.05.020; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Movsas B, 1999, UROLOGY, V53, P11, DOI 10.1016/S0090-4295(98)00500-7; Norris JL, 1999, J BIOL CHEM, V274, P13841, DOI 10.1074/jbc.274.20.13841; Pinthus JH, 2007, NEOPLASIA, V9, P68, DOI 10.1593/neo.06739; Porter AG, 2006, BIOESSAYS, V28, P834, DOI 10.1002/bies.20444; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Ravi RK, 1999, J CELL BIOCHEM, V72, P458, DOI 10.1002/(SICI)1097-4644(19990315)72:4<458::AID-JCB2>3.0.CO;2-C; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rubin MA, 2002, JAMA-J AM MED ASSOC, V287, P1662, DOI 10.1001/jama.287.13.1662; Shanware NP, 2011, J MOL MED, V89, P229, DOI 10.1007/s00109-011-0731-9; Shiota M, 2010, ONCOGENE, V29, P237, DOI 10.1038/onc.2009.322; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Skyrlas A, 2011, EXP DERMATOL, V20, P674, DOI 10.1111/j.1600-0625.2011.01249.x; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Troutaud D, 2010, CL LYMPH MYELOM LEUK, V10, P118, DOI 10.3816/CLML.2010.n.016; Urbano A, 2005, EMBO J, V24, P2815, DOI 10.1038/sj.emboj.7600746; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Welsh JB, 2001, CANCER RES, V61, P5974; Wilkinson JC, 2008, MOL CELL BIOL, V28, P237, DOI 10.1128/MCB.01065-07; Williams KJ, 2001, BREAST CANCER RES, V3, P328, DOI 10.1186/bcr316; Yu J, 2007, ONCOGENE, V26, P4189, DOI 10.1038/sj.onc.1210196; Yu QY, 2005, ONCOGENE, V24, P7114, DOI 10.1038/sj.onc.1208853; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhang W, 2007, CANCER LETT, V255, P127, DOI 10.1016/j.canlet.2007.04.006	67	16	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43862	43875		10.1074/jbc.M112.407650	http://dx.doi.org/10.1074/jbc.M112.407650			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118229	Green Published, hybrid			2022-12-28	WOS:000312940800063
J	Radhakrishnan, VM; Putnam, CW; Martinez, JD				Radhakrishnan, Vijayababu M.; Putnam, Charles W.; Martinez, Jesse D.			Activation of Phosphatidylinositol 3-Kinase (PI3K) and Mitogen-activated Protein Kinase (MAPK) Signaling and the Consequent Induction of Transformation by Overexpressed 14-3-3 gamma Protein Require Specific Amino Acids within 14-3-3 gamma N-terminal Variable Region II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGMA PROTEIN; IMMUNOHISTOCHEMICAL EXPRESSION; STRUCTURAL BASIS; LUNG-CANCER; T-CELLS; 14-3-3-SIGMA; RECEPTOR; TUMOR; CARCINOMA; PATHWAY	Members of the 14-3-3 superfamily regulate numerous cellular functions by binding phosphoproteins. The seven human isoforms (and the myriad of other eukaryotic 14-3-3 proteins) are highly conserved in amino acid sequence and secondary structure, yet there is abundant evidence that the various isoforms manifest disparate as well as common functions. Several of the human 14-3-3 isoforms are dysregulated in certain cancers and thus have been implicated in oncogenesis; experimentally, 14-3-3 gamma behaves as an oncogene, whereas 14-3-3 gamma acts as a tumor suppressor. In this study, we sought to localize these opposing phenotypes to specific regions of the two isoforms and then to individual amino acids therein. Using a bioinformatics approach, six variable regions (VRI-VRVI) were identified. Using this information, two sets of constructs were created in which N-terminal portions (including either VRI-IV or only VRI and VRII) of 14-3-3 gamma and 14-3-3 gamma were swapped; NIH3T3 cells overexpressing the four chimeric proteins were tested for transformation activity (focus formation, growth in soft agar) and activation of PI3K and MAPK signaling. We found that the specific phenotypes of 14-3-3 gamma are associated with the N-terminal 40 amino acids (VRI and VRII); in like fashion, VRI and VRII of 14-3-3 gamma dictated its tumor suppressor function. Using individual amino acid substitutions within the 14-3-3 gamma VRII, we identified two residues required for and two contributing to the gamma-specific phenotypes. Our observations suggest that isoform-specific phenotypes are dictated by a relatively few amino acids within variable regions.	[Martinez, Jesse D.] Univ Arizona, Arizona Canc Ctr, Dept Cell & Mol Med, Tucson, AZ 85724 USA	Arizona Center Cancer Care; University of Arizona	Martinez, JD (corresponding author), Univ Arizona, Arizona Canc Ctr, Dept Cell & Mol Med, 1515 N Campbell Ave, Tucson, AZ 85724 USA.	jmartinez@azcc.arizona.edu			National Institutes of Health [CA107510, R56CA107510, CA023074]; NATIONAL CANCER INSTITUTE [R56CA107510, P30CA023074, R01CA107510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA107510, R56CA107510, and CA023074 (to J. D. M.).	Akahira J, 2004, CLIN CANCER RES, V10, P2687, DOI 10.1158/1078-0432.CCR-03-0510; Ballare E, 2001, J CLIN ENDOCR METAB, V86, P3809, DOI 10.1210/jc.86.8.3809; Ballif BA, 2006, J PROTEOME RES, V5, P2372, DOI 10.1021/pr060206k; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Choi JE, 2011, CANCER LETT, V303, P99, DOI 10.1016/j.canlet.2011.01.015; Craparo A, 1997, J BIOL CHEM, V272, P11663; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Fernandez A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-604; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Higaki M, 1996, J BIOL CHEM, V271, P29342, DOI 10.1074/jbc.271.46.29342; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Ito Y, 2003, CANCER LETT, V200, P161, DOI 10.1016/S0304-3835(03)00282-9; Kuramitsu Y, 2010, ANTICANCER RES, V30, P4459; LEFFERS H, 1993, J MOL BIOL, V231, P982, DOI 10.1006/jmbi.1993.1346; Liu YC, 1997, J BIOL CHEM, V272, P9979, DOI 10.1074/jbc.272.15.9979; Meller N, 1996, MOL CELL BIOL, V16, P5782; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Moreira JMA, 2005, MOL CELL PROTEOMICS, V4, P555, DOI 10.1074/mcp.M400205-MCP200; Moreira JMA, 2004, MOL CELL PROTEOMICS, V3, P410, DOI 10.1074/mcp.M300134-MCP200; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Okada T, 2006, ANTICANCER RES, V26, P3105; Qi WQ, 2007, MOL CARCINOGEN, V46, P847, DOI 10.1002/mc.20314; Radhakrishnan VM, 2011, GENE CHROMOSOME CANC, V50, P830, DOI 10.1002/gcc.20904; Radhakrishnan VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011433; Rodriguez JA, 2005, WORLD J SURG, V29, P297, DOI 10.1007/s00268-004-7843-0; Sano T, 2004, PATHOL INT, V54, P743, DOI 10.1111/j.1440-1827.2004.01747.x; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Tanaka K, 2004, INT J ONCOL, V25, P1591; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; Wakui H, 1997, J BIOL CHEM, V272, P8153, DOI 10.1074/jbc.272.13.8153; Wang WF, 1996, J MOL EVOL, V43, P384; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Wurch T, 1998, MOL PHARMACOL, V54, P1088, DOI 10.1124/mol.54.6.1088; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	34	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43300	43311		10.1074/jbc.M112.397877	http://dx.doi.org/10.1074/jbc.M112.397877			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115241	hybrid, Green Published			2022-12-28	WOS:000312940800011
J	Wang, JY; Muntean, AG; Wu, L; Hess, JL				Wang, Jingya; Muntean, Andrew G.; Wu, Laura; Hess, Jay L.			A Subset of Mixed Lineage Leukemia Proteins Has Plant Homeodomain (PHD)-mediated E3 Ligase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3K4 METHYLASES; UBIQUITIN LIGASE; COMPASS FAMILY; PHD FINGERS; CELL-CYCLE; MLL; GENE; DOMAIN; DEGRADATION; MECHANISMS	The mixed lineage leukemia protein MLL1 contains four highly conserved plant homeodomain (PHD) fingers, which are invariably deleted in oncogenic MLL1 fusion proteins in human leukemia. Here we show that the second PHD finger (PHD2) of MLL1 is an E3 ubiquitin ligase in the presence of the E2-conjugating enzyme CDC34. This activity is conserved in the second PHD finger of MLL4, the closest homolog to MLL1 but not in MLL2 or MLL3. Mutation of PHD2 leads to MLL1 stabilization, as well as increased transactivation ability and MLL1 recruitment to the target gene loci, suggesting that PHD2 negatively regulates MLL1 activity.	[Wang, Jingya; Muntean, Andrew G.; Wu, Laura; Hess, Jay L.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hess, JL (corresponding author), Univ Michigan, Sch Med, Dept Pathol, M5240 Med Sci 1,1301 Catherine Ave, Ann Arbor, MI 48109 USA.	jayhess@umich.edu		Muntean, Andrew/0000-0003-3034-0682	National Institutes of Health [K99 CA158136-01, R01 CA151425]; American Society of Hematology Scholar Award; Leukemia and Lymphoma Society Specialized Center of Research grant; NATIONAL CANCER INSTITUTE [K99CA158136, R00CA158136, R01CA151425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology Scholar Award; Leukemia and Lymphoma Society Specialized Center of Research grant(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants K99 CA158136-01 (to A. G. M) and R01 CA151425 (to J. L. H.). This work was also supported by an American Society of Hematology Scholar Award (to A. G. M.) and a Leukemia and Lymphoma Society Specialized Center of Research grant (to J. L. H.).	Aplan PD, 2006, DNA REPAIR, V5, P1265, DOI 10.1016/j.dnarep.2006.05.034; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Chang PY, 2010, J MOL BIOL, V400, P137, DOI 10.1016/j.jmb.2010.05.005; Chen J, 2008, CANCER RES, V68, P6199, DOI 10.1158/0008-5472.CAN-07-6514; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Dul BE, 2007, J BIOL CHEM, V282, P18397, DOI 10.1074/jbc.M700729200; Hess JL, 2004, CRIT REV EUKAR GENE, V14, P235, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.10; Hess JL, 1997, BLOOD, V90, P1799, DOI 10.1182/blood.V90.5.1799; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Huntsman DG, 1999, ONCOGENE, V18, P7975, DOI 10.1038/sj.onc.1203291; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Lee S, 2009, PROG MOL BIOL TRANSL, V87, P343, DOI 10.1016/S1877-1173(09)87010-5; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li YY, 2012, ACTA BIOCH BIOPH SIN, V44, P28, DOI 10.1093/abbs/gmr117; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Mohan M, 2011, MOL CELL BIOL, V31, P4310, DOI 10.1128/MCB.06092-11; Muntean AG, 2008, BLOOD, V112, P4690, DOI 10.1182/blood-2008-01-134056; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Park S, 2010, BIOCHEMISTRY-US, V49, P6576, DOI 10.1021/bi1009387; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ruault M, 2002, GENE, V284, P73, DOI 10.1016/S0378-1119(02)00392-X; Saigo K, 2008, HUM MUTAT, V29, P703, DOI 10.1002/humu.20701; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Takahashi Y, 2011, P NATL ACAD SCI USA, V108, P20526, DOI 10.1073/pnas.1109360108; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Wang JY, 2012, BLOOD, V119, P1151, DOI 10.1182/blood-2011-06-362079; Yokoyama A, 2011, J CELL SCI, V124, P2208, DOI 10.1242/jcs.080523	35	26	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43410	43416		10.1074/jbc.M112.423855	http://dx.doi.org/10.1074/jbc.M112.423855			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129768	hybrid, Green Published			2022-12-28	WOS:000312940800022
J	Yadav, PK; Banerjee, R				Yadav, Pramod Kumar; Banerjee, Ruma			Detection of Reaction Intermediates during Human Cystathionine beta-Synthase-monitored Turnover and H2S Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST CYSTATHIONINE; HYDROGEN-SULFIDE; HEME; SULFURTRANSFERASE; AMINOACRYLATE; MECHANISM; INSIGHTS	Human cystathionine beta-synthase (CBS), a novel heme-containing pyridoxal 5'-phosphate enzyme, catalyzes the condensation of homocysteine and serine or cysteine to produce cystathionine and H2O or H2S, respectively. The presence of heme in CBS has limited spectrophotometric characterization of reaction intermediates by masking the absorption of the pyridoxal 5'-phosphate cofactor. In this study, we employed difference stopped-flow spectroscopy to characterize reaction intermediates formed under catalytic turnover conditions. The reactions of L-serine and L-cysteine with CBS resulted in the formation of a common aminoacrylate intermediate (k(obs) = 0.96 +/- 0.02 and 0.38 +/- 0.01 mM(-1) s(-1), respectively, at 24 degrees C) with concomitant loss of H2O and H2S and without detectable accumulation of the external aldimine or other intermediates. Homocysteine reacted with the aminoacrylate intermediate with k(obs) = 40.6 +/- 3.8 s(-1) and re-formed the internal aldimine. In the reverse direction, CBS reacted with cystathionine, forming the aminoacrylate intermediate with k(obs) = 0.38 +/- 0.01 mM(-1) s(-1). This study provides the first insights into the pre-steady-state kinetic mechanism of human CBS and indicates that the reaction is likely to be limited by a conformational change leading to product release.	[Yadav, Pramod Kumar; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 3320B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Yadav, Pramod K./A-6166-2010	Yadav, Pramod K./0000-0003-0026-1684	National Institutes of Health [HL58984]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL58984.	Abe K, 1996, J NEUROSCI, V16, P1066; BORCSOK E, 1982, ARCH BIOCHEM BIOPHYS, V213, P695, DOI 10.1016/0003-9861(82)90600-2; DREWE WF, 1985, BIOCHEMISTRY-US, V24, P3977, DOI 10.1021/bi00336a027; Evande R, 2004, ARCH BIOCHEM BIOPHYS, V427, P188, DOI 10.1016/j.abb.2004.04.027; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; Hwang CC, 1996, BIOCHEMISTRY-US, V35, P6358, DOI 10.1021/bi9602472; Jhee KH, 2001, BIOCHEMISTRY-US, V40, P10873, DOI 10.1021/bi011087j; Jhee KH, 2000, BIOCHEMISTRY-US, V39, P10548, DOI 10.1021/bi001020g; Kabil O, 2011, BIOCHEMISTRY-US, V50, P8261, DOI 10.1021/bi201270q; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Kraus JP, 1999, HUM MUTAT, V13, P362; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Mudd S., 2001, METABOLIC MOL BASES, P2007; NAGAHARA N, 1995, J BIOL CHEM, V270, P16230, DOI 10.1074/jbc.270.27.16230; Rabeh WM, 2004, J BIOL CHEM, V279, P26803, DOI 10.1074/jbc.R400001200; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Singh S, 2007, NAT PROD REP, V24, P631, DOI 10.1039/b604182p; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Singh S, 2011, BIOCHEMISTRY-US, V50, P419, DOI 10.1021/bi1010893; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 2002, J BIOL CHEM, V277, P22421, DOI 10.1074/jbc.M202513200; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Weeks CL, 2009, J AM CHEM SOC, V131, P12809, DOI 10.1021/ja904468w; Woehl EU, 1996, BIOCHEMISTRY-US, V35, P4776, DOI 10.1021/bi952938o; Zou CG, 2005, ANTIOXID REDOX SIGN, V7, P547, DOI 10.1089/ars.2005.7.547	31	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43464	43471		10.1074/jbc.M112.414722	http://dx.doi.org/10.1074/jbc.M112.414722			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23124209	hybrid, Green Published			2022-12-28	WOS:000312940800027
J	Horner, A; Goetz, F; Tampe, R; Klussmann, E; Pohl, P				Horner, Andreas; Goetz, Frank; Tampe, Robert; Klussmann, Enno; Pohl, Peter			Mechanism for Targeting the A-kinase Anchoring Protein AKAP18 delta to the Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL PRINCIPAL CELLS; FLUORESCENCE CORRELATION SPECTROSCOPY; CYCLIC-AMP; PEPTIDES; AQUAPORIN-2; LOCALIZATION; DIFFUSION; BINDING; AKAP15	A-kinase anchoring proteins (AKAPs) are a family of scaffolding proteins that target PKA and other signaling molecules to cellular compartments and thereby spatiotemporally define cellular signaling events. The AKAP18 family comprises AKAP18 alpha, AKAP18 beta, AKAP18 gamma, and AKAP18 delta. The delta isoform targets PKA and phosphodiesterase PDE4D to AQP2 (aquaporin-2)-bearing vesicles to orchestrate the acute regulation of body water balance. Therefore, AKAP18 delta must adopt a membrane localization that seems at odds with (i) its lack of palmitoylation or myristoylation sites that tailor its isoforms AKAP18 alpha and AKAP18 beta to membrane compartments and (ii) the high sequence identity to the preferentially cytoplasmic AKAP18 gamma. Here, we show that the electrostatic attraction of the positively charged amino acids of AKAP18 delta to negatively charged lipids explains its membrane targeting. As revealed by fluorescence correlation spectroscopy, the binding constant of purified AKAP18 delta fragments to large unilamellar vesicles correlates (i) with the fraction of net negatively charged lipids in the bilayer and (ii) with the total amount of basic residues in the protein. Although distantly located on the sequence, these positively charged residues concentrate in the tertiary structure and form a clear binding surface. Thus, specific recruitment of the AKAP18 delta-based signaling module to membranes such as those of AQP2-bearing vesicles must be achieved by additional mechanisms, most likely compartment-specific protein-protein interactions.	[Horner, Andreas; Pohl, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Goetz, Frank; Klussmann, Enno] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Tampe, Robert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, D-60438 Frankfurt, Germany	Johannes Kepler University Linz; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Goethe University Frankfurt	Pohl, P (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40-42, A-4020 Linz, Austria.	peter.pohl@jku.at	Tampé, Robert/H-2953-2015; Horner, Andreas/F-6427-2013; Pohl, Peter/A-5361-2008	Tampé, Robert/0000-0002-0403-2160; Horner, Andreas/0000-0002-5328-1745; Pohl, Peter/0000-0002-1792-2314	Upper Austrian Government; Deutsche Forschungsgemeinschaft [DFG KL1415/3-2, KL1415/4-2]	Upper Austrian Government; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Upper Austrian Government and Deutsche Forschungsgemeinschaft Grants DFG KL1415/3-2 and KL1415/4-2 (to E. K.).	Arbuzova A, 1998, BBA-REV BIOMEMBRANES, V1376, P369, DOI 10.1016/S0304-4157(98)00011-2; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; Gadjev Ilya, INT REV CELL MOL BIO, P87, DOI [DOI 10.1016/S1937-6448(10)8305-9, 10.1016/S1937-6448(08)01403-2, DOI 10.1016/S1937-6448(08)01403-2]; Gold MG, 2008, J MOL BIOL, V375, P1329, DOI 10.1016/j.jmb.2007.11.037; Henn V, 2004, J BIOL CHEM, V279, P26654, DOI 10.1074/jbc.M312835200; Horner A, 2009, BIOPHYS J, V96, P2689, DOI 10.1016/j.bpj.2008.12.3931; Hulme JT, 2002, J BIOL CHEM, V277, P4079, DOI 10.1074/jbc.M109814200; Hundsrucker C, 2006, BIOCHEM J, V396, P297, DOI 10.1042/BJ20051970; Kleinschmidt JH, 1997, BIOPHYS J, V73, P2546, DOI 10.1016/S0006-3495(97)78283-3; Klussmann E, 1999, J BIOL CHEM, V274, P4934, DOI 10.1074/jbc.274.8.4934; Lata S, 2006, J AM CHEM SOC, V128, P2365, DOI 10.1021/ja0563105; Lorenz D, 2003, EMBO REP, V4, P88, DOI 10.1038/sj.embor.embor711; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Nedvetsky Pavel I, 2009, Handb Exp Pharmacol, P133, DOI 10.1007/978-3-540-79885-9_6; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Pohl EE, 2000, BIOCHEMISTRY-US, V39, P1834, DOI 10.1021/bi9919549; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rusu L, 2004, BIOPHYS J, V87, P1044, DOI 10.1529/biophysj.104.039958; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Streb JW, 2005, J BIOL CHEM, V280, P28007, DOI 10.1074/jbc.M414017200; Tao JC, 2006, J BIOL CHEM, V281, P23932, DOI 10.1074/jbc.M601813200; Tibbs VC, 1998, J BIOL CHEM, V273, P25783, DOI 10.1074/jbc.273.40.25783; Trotter KW, 1999, J CELL BIOL, V147, P1481, DOI 10.1083/jcb.147.7.1481; Wruss J, 2009, J AM CHEM SOC, V131, P5478, DOI 10.1021/ja807917t	26	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42495	42501		10.1074/jbc.M112.414946	http://dx.doi.org/10.1074/jbc.M112.414946			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095754	hybrid, Green Published			2022-12-28	WOS:000312501600011
J	Tringali, C; Lupo, B; Silvestri, I; Papini, N; Anastasia, L; Tettamanti, G; Venerando, B				Tringali, Cristina; Lupo, Barbara; Silvestri, Ilaria; Papini, Nadia; Anastasia, Luigi; Tettamanti, Guido; Venerando, Bruno			The Plasma Membrane Sialidase NEU3 Regulates the Malignancy of Renal Carcinoma Cells by Controlling beta 1 Integrin Internalization and Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; APOPTOSIS SUPPRESSION; DOWN-REGULATION; EXPRESSION; GANGLIOSIDES; AUTOPHAGY; DIFFERENTIATION; IDENTIFICATION; INVASIVENESS; INHIBITION	The human plasma membrane sialidase NEU3 is a key enzyme in the catabolism of membrane gangliosides, is crucial in the regulation of cell surface processes, and has been demonstrated to be significantly up-regulated in renal cell carcinomas (RCCs). In this report, we show that NEU3 regulates beta 1 integrin trafficking in RCC cells by controlling beta 1 integrin recycling to the plasma membrane and controlling activation of the epidermal growth factor receptor (EGFR) and focal adhesion kinase (FAK)/protein kinase B (AKT) signaling. NEU3 silencing in RCC cells increased the membrane ganglioside content, in particular the GD1a content, and changed the expression of key regulators of the integrin recycling pathway. In addition, NEU3 silencing upregulated the Ras-related protein RAB25, which directs internalized integrins to lysosomes, and down-regulated the chloride intracellular channel protein 3 (CLIC3), which induces the recycling of internalized integrins to the plasma membrane. In this manner, NEU3 silencing enhanced the caveolar endocytosis of beta 1 integrin, blocked its recycling and reduced its levels at the plasma membrane, and, consequently, inhibited EGFR and FAK/AKT. These events had the following effects on the behavior of RCC cells: they (a) decreased drug resistance mediated by the block of autophagy and the induction of apoptosis; (b) decreased metastatic potential mediated by down-regulation of the metalloproteinases MMP1 and MMP7; and (c) decreased adhesion to collagen and fibronectin. Therefore, our data identify NEU3 as a key regulator of the beta 1 integrin-recycling pathway and FAK/AKT signaling and demonstrate its crucial role in RCC malignancy.	[Tringali, Cristina; Lupo, Barbara; Silvestri, Ilaria; Papini, Nadia; Venerando, Bruno] Univ Milan, Dept Med Biotechnol & Translat Med, I-20090 Milan, Italy; [Anastasia, Luigi] Univ Milan, Dept Biomed Sci Hlth, I-20090 Milan, Italy; [Anastasia, Luigi; Tettamanti, Guido; Venerando, Bruno] IRCCS Policlin San Donato, I-20097 Milan, Italy	University of Milan; University of Milan; IRCCS Policlinico San Donato	Venerando, B (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, Via Flli Cervi 93, I-20090 Segrate, Italy.	bruno.venerando@unimi.it	Tringali, Cristina Alessandra/Q-7259-2017; papini, nadia/M-2425-2017; Anastasia, Luigi/AAN-1964-2020	Tringali, Cristina Alessandra/0000-0002-0632-6197; papini, nadia/0000-0003-4066-4955; Anastasia, Luigi/0000-0002-0712-2161; Lupo, Barbara/0000-0002-4383-6882	MIUR; Fondazione Cariplo [2010-0700]	MIUR(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by MIUR (PRIN 2008) and Fondazione Cariplo (2010-0700) (to B. V.).	Anastasia L, 2008, J BIOL CHEM, V283, P36265, DOI 10.1074/jbc.M805755200; Aoki H, 2004, FEBS LETT, V567, P203, DOI 10.1016/j.febslet.2004.04.060; Azim H, 2010, TARGET ONCOL, V5, P269, DOI 10.1007/s11523-010-0141-x; Banumathy G, 2010, CANCER BIOL THER, V10, P658, DOI 10.4161/cbt.10.7.13247; Biswas S, 2009, J IMMUNOL, V183, P5050, DOI 10.4049/jimmunol.0900259; Brenner W, 2008, INT J ONCOL, V32, P1125; Cairns P, 2011, CANCER BIOMARK, V9, P461, DOI 10.3233/CBM-2011-0176; Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Finley DS, 2011, ONCOLOGIST, V16, P4, DOI 10.1634/theoncologist.2011-S2-04; Hetz C, 2008, TRENDS CELL BIOL, V18, P38, DOI 10.1016/j.tcb.2007.10.003; HOON DSB, 1993, J UROLOGY, V150, P2013, DOI 10.1016/S0022-5347(17)35956-6; Hua H, 2011, CELL MOL LIFE SCI, V68, P3853, DOI 10.1007/s00018-011-0763-x; Li LJ, 2011, HEMATOL ONCOL CLIN N, V25, P667, DOI 10.1016/j.hoc.2011.04.004; Liang XY, 2012, CANCER RES, V72, P2791, DOI 10.1158/0008-5472.CAN-12-0320; Mandal C, 2010, INT J CANCER, V126, P337, DOI 10.1002/ijc.24733; Mikhaylova O, 2012, CANCER CELL, V21, P532, DOI 10.1016/j.ccr.2012.02.019; Miyagi T, 2008, J BIOCHEM, V144, P279, DOI 10.1093/jb/mvn089; Miyagi T, 2012, GLYCOCONJUGATE J, V29, P567, DOI 10.1007/s10719-012-9394-1; Monti E, 2000, BIOCHEM J, V349, P343, DOI 10.1042/0264-6021:3490343; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Park SY, 2012, BBA-GEN SUBJECTS, V1820, P1141, DOI 10.1016/j.bbagen.2012.04.008; Ramankulov A, 2008, CANCER SCI, V99, P1188, DOI 10.1111/j.1349-7006.2008.00802.x; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Saito S, 2000, TOHOKU J EXP MED, V190, P271, DOI 10.1620/tjem.190.271; Saito S, 1997, JPN J CANCER RES, V88, P652, DOI 10.1111/j.1349-7006.1997.tb00433.x; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Senda M, 2007, BIOCHEM J, V402, P459, DOI 10.1042/BJ20061118; Singh RD, 2010, TRAFFIC, V11, P348, DOI 10.1111/j.1600-0854.2009.01022.x; Sonnino S, 1996, GLYCOBIOLOGY, V6, P479, DOI 10.1093/glycob/6.5.479-e; Sonnino S, 2010, ADV EXP MED BIOL, V688, P165; Sonnino S, 2009, FEBS LETT, V583, P597, DOI 10.1016/j.febslet.2009.01.007; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Tringali C, 2009, CELL DEATH DIFFER, V16, P164, DOI 10.1038/cdd.2008.141; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; Wada T, 2007, ONCOGENE, V26, P2483, DOI 10.1038/sj.onc.1210341; Wang FQ, 2006, CANCER LETT, V236, P292, DOI 10.1016/j.canlet.2005.05.042; Wang SY, 2011, ANTI-CANCER AGENT ME, V11, P993, DOI 10.2174/187152011797927661; Wang Y, 2002, J BIOL CHEM, V277, P26252, DOI 10.1074/jbc.M110515200; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	42	49	50	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42835	42845		10.1074/jbc.M112.407718	http://dx.doi.org/10.1074/jbc.M112.407718			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23139422	hybrid, Green Published			2022-12-28	WOS:000312501600042
J	Keuerleber, S; Thurner, P; Gruber, CW; Zezula, J; Freissmuth, M				Keuerleber, Simon; Thurner, Patrick; Gruber, Christian W.; Zezula, Juergen; Freissmuth, Michael			Reengineering the Collision Coupling and Diffusion Mode of the A(2A)-adenosine Receptor PALMITOYLATION IN HELIX 8 RELIEVES CONFINEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A(2A) ADENOSINE RECEPTOR; SINGLE-PARTICLE TRACKING; ACTIVATED PROTEIN-KINASE; PARKINSONS-DISEASE; CARBOXYL-TERMINUS; ADENYLATE-CYCLASE; LATERAL DIFFUSION; ESCHERICHIA-COLI; MAMMALIAN-CELLS; STIMULATION	The A(2A)-adenosine receptor undergoes restricted collision coupling with its cognate G protein G(s) and lacks a palmitoylation site at the end of helix 8 in its intracellular C terminus. We explored the hypothesis that there was a causal link between the absence of a palmitoyl moiety and restricted collision coupling by introducing a palmitoylation site. The resulting mutant A(2A)-R309C receptor underwent palmitoylation as verified by both mass spectrometry and metabolic labeling. In contrast to the wild type A(2A) receptor, the concentration-response curve for agonist-induced cAMP accumulation was shifted to the left with increasing expression levels receptor, an observation consistent with collision coupling. Single particle tracking of quantum dot-labeled receptors confirmed that wild type and mutant A(2A) receptor differed in diffusivity and diffusion mode; agonist activation resulted in a decline in mean square displacement of both receptors, but the drop was substantially more pronounced for the wild type receptor. In addition, in the agonist- bound state, the wild type receptor was frequently subject to confinement events (estimated radius 110 nm). These were rarely seen with the palmitoylated A(2A)-R309C receptor, the preferred diffusion mode of which was a random walk in both the basal and the agonist-activated state. Taken together, the observations link restricted collision coupling to diffusion limits imposed by the absence of a palmitoyl moiety in the C terminus of the A(2A) receptor. The experiments allowed for visualizing local confinement of an agonist-activated G protein- coupled receptor in an area consistent with the dimensions of a lipid raft.	[Keuerleber, Simon; Thurner, Patrick; Gruber, Christian W.; Zezula, Juergen; Freissmuth, Michael] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria	Medical University of Vienna	Freissmuth, M (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Wahringer Str 13A, A-1090 Vienna, Austria.	michael.freissmuth@meduniwien.ac.at	Gruber, Christian/C-4406-2011	Gruber, Christian/0000-0001-6060-7048; Freissmuth, Michael/0000-0001-9398-1765	Ph.D. Program "Cell Communication in Health and Disease"; Austrian Science Fund/Fonds zur Forderung der wissenschaftlichen Forschung (FWF) [P20012, PIRG-GA-2008-230970]; European Union; Medical University of Vienna; Austrian Science Fund (FWF) [P 21002] Funding Source: researchfish	Ph.D. Program "Cell Communication in Health and Disease"; Austrian Science Fund/Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); European Union(European Commission); Medical University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Ph.D. Program "Cell Communication in Health and Disease" funded jointly by the Medical University of Vienna and the Austrian Science Fund/Fonds zur Forderung der wissenschaftlichen Forschung (FWF), Grants P20012 and PIRG-GA-2008-230970 from the Austrian Science Fund/FWF, and the European Union-funded Marie Curie training and mobility program.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; BERTIN B, 1992, J BIOL CHEM, V267, P8200; BRAUN S, 1979, BIOCHEMISTRY-US, V18, P2134, DOI 10.1021/bi00577a045; Charalambous C, 2008, J BIOL CHEM, V283, P9276, DOI 10.1074/jbc.M706275200; Chini B, 2009, J MOL ENDOCRINOL, V42, P371, DOI 10.1677/JME-08-0114; Ehrensperger MV, 2007, BIOPHYS J, V92, P3706, DOI 10.1529/biophysj.106.095596; Fredholm BB, 2010, EXP CELL RES, V316, P1284, DOI 10.1016/j.yexcr.2010.02.004; FREISSMUTH M, 1991, P NATL ACAD SCI USA, V88, P8548, DOI 10.1073/pnas.88.19.8548; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; Gao ZH, 1999, BIOCHEM J, V342, P387, DOI 10.1042/0264-6021:3420387; GROSS W, 1991, MOL PHARMACOL, V39, P524; Gsandtner I, 2005, J BIOL CHEM, V280, P31898, DOI 10.1074/jbc.M506515200; Gsandtner I, 2006, MOL PHARMACOL, V70, P447, DOI 10.1124/mol.106.026757; Hauser RA, 2008, MOVEMENT DISORD, V23, P2177, DOI 10.1002/mds.22095; Hohenegger M, 1996, MOL PHARMACOL, V49, P73; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; JOCKERS R, 1994, J BIOL CHEM, V269, P32077; Keuerleber S, 2011, BBA-BIOMEMBRANES, V1808, P1350, DOI 10.1016/j.bbamem.2010.05.009; Klinger M, 2002, J BIOL CHEM, V277, P32490, DOI 10.1074/jbc.M200556200; Kudlacek O, 2001, J BIOL CHEM, V276, P3010, DOI 10.1074/jbc.M007910200; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lebon G, 2012, CURR OPIN STRUC BIOL, V22, P482, DOI 10.1016/j.sbi.2012.03.007; LeWitt PA, 2008, ANN NEUROL, V63, P295, DOI 10.1002/ana.21315; Liu R, 2012, AM J EPIDEMIOL, V175, P1200, DOI 10.1093/aje/kwr451; Loisel TP, 1999, J BIOL CHEM, V274, P31014, DOI 10.1074/jbc.274.43.31014; Loisel TP, 1996, BIOCHEMISTRY-US, V35, P15923, DOI 10.1021/bi9611321; Lyman E, 2009, STRUCTURE, V17, P1660, DOI 10.1016/j.str.2009.10.010; Malaga-Dieguez L, 2010, MOL PHARMACOL, V77, P940, DOI 10.1124/mol.110.063511; Mantell Simon, 2010, Expert Rev Clin Pharmacol, V3, P55, DOI 10.1586/ecp.09.57; Martin DS, 2002, BIOPHYS J, V83, P2109, DOI 10.1016/S0006-3495(02)73971-4; Milan-Lobo L, 2009, MOL PHARMACOL, V76, P1196, DOI 10.1124/mol.109.059139; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/nmeth.1447, 10.1038/NMETH.1447]; NANOFF C, 1991, MOL PHARMACOL, V39, P130; Palmer TM, 2008, BRIT J PHARMACOL, V153, pS27, DOI 10.1038/sj.bjp.0707524; Pankevych H, 2003, J BIOL CHEM, V278, P30283, DOI 10.1074/jbc.M212918200; Pucadyil TJ, 2004, BIOCHEMISTRY-US, V43, P15852, DOI 10.1021/bi0480887; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; SAXTON MJ, 1993, BIOPHYS J, V64, P1766, DOI 10.1016/S0006-3495(93)81548-0; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Seidel MG, 1999, J BIOL CHEM, V274, P25833, DOI 10.1074/jbc.274.36.25833; Sexl V, 1997, J BIOL CHEM, V272, P5792, DOI 10.1074/jbc.272.9.5792; SEXL V, 1995, BRIT J PHARMACOL, V114, P1577, DOI 10.1111/j.1476-5381.1995.tb14942.x; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3811, DOI 10.1021/bi00611a021; Trester-Zedlitz M, 2005, BIOCHEMISTRY-US, V44, P6133, DOI 10.1021/bi0475469; Valls MD, 2009, BIOCHEM PHARMACOL, V77, P1117, DOI 10.1016/j.bcp.2008.11.002; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Zezula J, 2008, BRIT J PHARMACOL, V153, pS184, DOI 10.1038/sj.bjp.0707674	50	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42104	42118		10.1074/jbc.M112.393579	http://dx.doi.org/10.1074/jbc.M112.393579			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23071116	Green Published, hybrid			2022-12-28	WOS:000312103000049
J	Zhou, Y; Lee, JY; Lee, CM; Cho, WK; Kang, MJ; Koff, JL; Yoon, PO; Chae, J; Park, HO; Elias, JA; Lee, CG				Zhou, Yang; Lee, Jae-Young; Lee, Chang-Min; Cho, Won-Kyung; Kang, Min-Jong; Koff, Jonathan L.; Yoon, Pyeong-Oh; Chae, Jeiwook; Park, Han-Oh; Elias, Jack A.; Lee, Chun Geun			Amphiregulin, an Epidermal Growth Factor Receptor Ligand, Plays an Essential Role in the Pathogenesis of Transforming Growth Factor-beta-induced Pulmonary Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED LUNG FIBROSIS; TGF-BETA; FACTOR-ALPHA; MYOFIBROBLAST DIFFERENTIATION; SIGNALING PATHWAY; GENE-EXPRESSION; TRANSGENIC MICE; IN-VIVO; INFLAMMATION; APOPTOSIS	Dysregulated amphiregulin (AR) expression and EGR receptor (EGFR) activation have been described in animal models of pulmonary fibrosis and in patients with idiopathic pulmonary fibrosis. However, the exact role of AR in the pathogenesis of pulmonary fibrosis has not been clearly defined. Here, we show that a potent profibrogenic cytokine TGF-beta 1 significantly induced the expression of AR in lung fibroblasts in vitro and in murine lungs in vivo. AR stimulated NIH3T3 fibroblast cell proliferation in a dose-dependent manner. Silencing of AR expression by siRNA or chemical inhibition of EGFR signaling, utilizing AG1478 and gefitinib, significantly reduced the ability of TGF-beta 1 to stimulate fibroblast proliferation and expression of alpha-smooth muscle actin, collagen, and other extracellular matrix-associated genes. TGF-beta 1-stimulated activation of Akt, ERK, and Smad signaling was also significantly inhibited by these interventions. Consistent with these in vitro findings, AR expression was impressively increased in the lungs of TGF-beta 1 transgenic mice, and either siRNA silencing of AR or chemical inhibition of EGFR signaling significantly reduced TGF-beta 1 stimulated collagen accumulation in the lung. These studies showed a novel regulatory role for AR in the pathogenesis of TGF-beta 1-induced pulmonary fibrosis. In addition, these studies suggest that AR, or AR-activated EGFR signaling, is a potential therapeutic target for idiopathic pulmonary fibrosis associated with TGF-beta 1 activation.	[Zhou, Yang; Lee, Chang-Min; Cho, Won-Kyung; Kang, Min-Jong; Koff, Jonathan L.; Elias, Jack A.; Lee, Chun Geun] Yale Univ, Sch Med, Dept Internal Med, Sect Pulm & Crit Care Med, New Haven, CT 06520 USA; [Lee, Jae-Young] Hallym Univ, Sch Med, Dept Internal Med, Seoul 150030, South Korea; [Yoon, Pyeong-Oh; Chae, Jeiwook; Park, Han-Oh] Bioneer Corp, Taejon 306220, South Korea	Yale University; Hallym University	Lee, CG (corresponding author), 300 Cedar St,TAC S425A, New Haven, CT 06520 USA.	chungeun.lee@yale.edu	Lee, Chun Geun/AAC-2838-2021	Cho, Won-Kyung/0000-0003-1540-545X; Kang, Min-Jong/0000-0003-3245-144X; Lee, Chun Geun/0000-0002-9514-3658				Amendt C, 2002, J CELL SCI, V115, P2189; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494; Borrell-Pages M, 2003, EMBO J, V22, P1114, DOI 10.1093/emboj/cdg111; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Forsythe B, 2004, DRUG SAFETY, V27, P1081, DOI 10.2165/00002018-200427140-00002; Fukumoto J, 2010, AM J PHYSIOL-LUNG C, V298, pL131, DOI 10.1152/ajplung.90576.2008; Homer RJ, 2011, ARCH PATHOL LAB MED, V135, P780, DOI 10.1043/2010-0296-RA.1; Hu B, 2007, AM J RESP CELL MOL, V36, P78, DOI 10.1165/rcmb.2006-0043OC; Ishii Y, 2006, AM J RESP CRIT CARE, V174, P550, DOI 10.1164/rccm.200509-1534OC; Kang HR, 2007, J EXP MED, V204, P1083, DOI 10.1084/jem.20061273; Kang HR, 2007, J BIOL CHEM, V282, P7723, DOI 10.1074/jbc.M610764200; Kang Hye-Ryun, 2008, Expert Rev Clin Pharmacol, V1, P547, DOI 10.1586/17512433.1.4.547; Kawakami T, 1998, J INVEST DERMATOL, V110, P47, DOI 10.1046/j.1523-1747.1998.00073.x; KHALIL N, 1991, AM J RESP CELL MOL, V5, P155, DOI 10.1165/ajrcmb/5.2.155; Khalil N, 2001, THORAX, V56, P907, DOI 10.1136/thorax.56.12.907; KORFHAGEN TR, 1994, J CLIN INVEST, V93, P1691, DOI 10.1172/JCI117152; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Liu M, 2007, AM J RESP CELL MOL, V37, P578, DOI 10.1165/rcmb.2007-0100OC; Madtes DK, 1999, AM J RESP CELL MOL, V20, P924, DOI 10.1165/ajrcmb.20.5.3526; MADTES DK, 1994, AM J RESP CELL MOL, V11, P540, DOI 10.1165/ajrcmb.11.5.7524566; Martinelli M, 2011, MOL BIOL REP, V38, P4613, DOI 10.1007/s11033-010-0594-0; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; Mundle SD, 1995, ANTICANCER RES, V15, P1895; Nakao A, 1999, J CLIN INVEST, V104, P5, DOI 10.1172/JCI6094; Noble PW, 2004, CLIN CHEST MED, V25, P749, DOI 10.1016/j.ccm.2004.04.003; Perugorria MJ, 2008, HEPATOLOGY, V48, P1251, DOI 10.1002/hep.22437; Roy SG, 2001, INT J BIOCHEM CELL B, V33, P723, DOI 10.1016/S1357-2725(01)00041-3; Samarakoon R, 2008, THROMB HAEMOSTASIS, V100, P976, DOI 10.1160/TH08-05-0273; Scartozzi M, 2007, BRIT J CANCER, V97, P92, DOI 10.1038/sj.bjc.6603847; Schuger L, 1996, DEVELOPMENT, V122, P1759; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2033; Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW; SHOYAB M, 1988, P NATL ACAD SCI USA, V85, P6528, DOI 10.1073/pnas.85.17.6528; Siner JM, 2007, FASEB J, V21, P1422, DOI 10.1096/fj.06-6661com; Wang SW, 2005, J ALLERGY CLIN IMMUN, V115, P287, DOI 10.1016/j.jaci.2004.11.037; Ward PA, 1998, AM J RESP CRIT CARE, V157, pS123, DOI 10.1164/ajrccm.157.4.nhlbi-10; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yamasaki M, 2008, AM J RESP CELL MOL, V38, P346, DOI 10.1165/rcmb.2007-0276OC; Yehualaeshet T, 2000, AM J RESP CELL MOL, V23, P204, DOI 10.1165/ajrcmb.23.2.4089	46	95	104	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41991	42000		10.1074/jbc.M112.356824	http://dx.doi.org/10.1074/jbc.M112.356824			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086930	hybrid, Green Published			2022-12-28	WOS:000312103000038
J	Xie, Y; Avello, M; Schirle, M; McWhinnie, E; Feng, Y; Bric-Furlong, E; Wilson, C; Nathans, R; Zhang, J; Kirschner, MW; Huang, SMA; Cong, F				Xie, Yang; Avello, Monika; Schirle, Markus; McWhinnie, Elizabeth; Feng, Yan; Bric-Furlong, Eva; Wilson, Christopher; Nathans, Robin; Zhang, Jing; Kirschner, Marc W.; Huang, Shih-Min A.; Cong, Feng			Deubiquitinase FAM/USP9X Interacts with the E3 Ubiquitin Ligase SMURF1 Protein and Protects It from Ligase Activity-dependent Self-degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; FUNCTIONAL DIVERSITY; NEDD4 FAMILY; HECT FAMILY; WW DOMAINS; C2 DOMAIN; ENZYME; RHOA; PHOSPHORYLATION; INHIBITION	Ubiquitination is an essential post-translational modification that mediates diverse cellular functions. SMAD-specific E3 ubiquitin protein ligase 1 (SMURF1) belongs to the Nedd4 family of HECT ubiquitin ligases that directly catalyzes ubiquitin conjugation onto diverse substrates. As a result, SMURF1 regulates a great variety of cellular physiologies including bone morphogenetic protein (BMP) signaling, cell migration, and planar cell polarity. Structurally, SMURF1 consists of a C2 domain, two WW domain repeats, and a catalytic HECT domain essential for its E3 ubiquitin ligase activity. This modular architecture allows for interactions with other proteins, which are either substrates or adaptors of SMURF1. Despite the increasing number of SMURF1 substrates identified, current knowledge regarding regulatory proteins and their modes of action on controlling SMURF1 activity is still limited. In this study, we employed quantitative mass spectrometry to analyze SMURF1-associated cellular complexes, and identified the deubiquitinase FAM/USP9X as a novel interacting protein for SMURF1. Through domain mapping study, we found the second WW domain of SMURF1 and the carboxyl terminus of USP9X critical for this interaction. SMURF1 is autoubiquitinated through its intrinsic HECT E3 ligase activity, and is degraded by the proteasome. USP9X association antagonizes this activity, resulting in deubiquitination and stabilization of SMURF1. In MDA-MB-231 breast cancer cells, SMURF1 expression is elevated and is required for cellular motility. USP9X stabilizes endogenous SMURF1 in MDA-MB-231 cells. Depletion of USP9X led to down-regulation of SMURF1 and significantly impaired cellular migration. Taken together, our data reveal USP9X as an important regulatory protein of SMURF1 and suggest that the association between deubiquitinase and E3 ligase may serve as a common strategy to control the cellular protein dynamics through modulating E3 ligase stability.	[Xie, Yang; Avello, Monika; Schirle, Markus; McWhinnie, Elizabeth; Feng, Yan; Bric-Furlong, Eva; Wilson, Christopher; Nathans, Robin; Zhang, Jing; Huang, Shih-Min A.; Cong, Feng] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Novartis; Harvard University; Harvard Medical School	Cong, F (corresponding author), Novartis Inst BioMed Res, Cambridge, MA 02139 USA.	alex.huang@sanofi.com; feng.cong@novartis.com		Wilson, Christopher/0000-0002-9146-522X				Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Cheng PL, 2011, NEURON, V69, P231, DOI 10.1016/j.neuron.2010.12.021; Crose LES, 2009, J BIOL CHEM, V284, P13301, DOI 10.1074/jbc.C900009200; Cui Y, 2011, EMBO J, V30, P2675, DOI 10.1038/emboj.2011.155; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Fukunaga E, 2008, J BIOL CHEM, V283, P35660, DOI 10.1074/jbc.M710496200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Jin CY, 2009, CANCER RES, V69, P735, DOI 10.1158/0008-5472.CAN-08-1463; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kanelis V, 1998, BIOCHEM CELL BIOL, V76, P341, DOI 10.1139/bcb-76-2-3-341; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kee Y, 2006, J BIOL CHEM, V281, P36724, DOI 10.1074/jbc.M608756200; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kwei KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023924; Li S, 2010, MOL CELL BIOCHEM, V338, P11, DOI 10.1007/s11010-009-0315-y; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rotin D, 1998, CURR TOP MICROBIOL, V228, P115; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rott R, 2011, P NATL ACAD SCI USA, V108, P18666, DOI 10.1073/pnas.1105725108; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sangadala S, 2007, PROTEINS, V68, P690, DOI 10.1002/prot.21429; Sangadala S, 2006, J BIOL CHEM, V281, P17212, DOI 10.1074/jbc.M511013200; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Taya S, 1998, J CELL BIOL, V142, P1053, DOI 10.1083/jcb.142.4.1053; Theard D, 2010, EMBO J, V29, P1499, DOI 10.1038/emboj.2010.46; THOMPSON EW, 1988, CANCER RES, V48, P6764; Wan LX, 2011, MOL CELL, V44, P721, DOI 10.1016/j.molcel.2011.09.024; Wang HR, 2006, METHOD ENZYMOL, V406, P437, DOI 10.1016/S0076-6879(06)06032-0; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wilkinson S C, 1997, Adv Dent Res, V11, P515; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yuan C, 2012, J BIOL CHEM, V287, P17006, DOI 10.1074/jbc.M112.341198; Zhao L, 2010, J BONE MINER RES, V25, P1246, DOI 10.1002/jbmr.28; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	59	82	84	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2976	2985		10.1074/jbc.M112.430066	http://dx.doi.org/10.1074/jbc.M112.430066			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23184937	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000314397900008
J	Yang, HJ; Youn, H; Seong, KM; Jin, YW; Kim, J; Youn, B				Yang, Hee Jung; Youn, HyeSook; Seong, Ki Moon; Jin, Young-Woo; Kim, Joon; Youn, BuHyun			Phosphorylation of Ribosomal Protein S3 and Antiapoptotic TRAF2 Protein Mediates Radioresistance in Non-small Cell Lung Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZING-RADIATION; FACTOR RECEPTOR; KINASE CK2; DNA-REPAIR; APOPTOSIS; RPS3; RADIOTHERAPY; RESISTANCE; DAMAGE; ENDONUCLEASE	Radioresistance is considered as a main factor restricting efficacy of radiotherapy. However, the exact molecular mechanism of radioresistance has not been explained yet. In this study, to elucidate radioresistance mechanism in lung cancer, we compared radiation responses in two types of non-small cell lung cancer (NSCLC) cells with different radiosensitivity and identified key molecules conferring radioresistance. In radioresistant NSCLC cells, ionizing radiation (IR) led to casein kinase 2 alpha (CK2 alpha)- and PKC-mediated phosphorylation of rpS3 and TRAF2, respectively, which induced dissociation of rpS3-TRAF2 complex and NF-kappa B activation, resulting in significant up-regulation of prosurvival genes (cIAP1, cIAP2, and survivin). Also, dissociated phospho-rpS3 translocated into nucleus and bound with NF-kappa B complex (p65 and p50), contributing to p65 DNA binding property and specificity. However, in radiosensitive NSCLC cells, IR-mediated rpS3 phosphorylation was not detected due to the absence of CK2 alpha overexpression. Consequently, IR-induced rpS3-TRAF2 complex dissociation, NF-kappa B activation, and prosurvival gene expression were not presented. Taken together, our findings revealed a novel radioresistance mechanism through functional orchestration of rpS3, TRAF2, and NF-kappa B in NSCLC cells. Moreover, we provided the first evidence for the function of rpS3 as a new TRAF2-binding protein and demonstrated that phosphorylation of both rpS3 and TRAF2 is a key control point of radioresistance in NSCLC cells. These results suggest that regulation of rpS3 and TRAF2 in combination with radiotherapy could have high pharmacological therapeutic potency for radioresistance of NSCLC.	[Yang, Hee Jung; Youn, BuHyun] Pusan Natl Univ, Dept Biol Sci, Pusan 609735, South Korea; [Youn, HyeSook] Sejong Univ, Inst Biosci, Dept Biosci & Biotechnol, Seoul 143737, South Korea; [Seong, Ki Moon; Jin, Young-Woo] Korea Hydro & Nucl Power Co Ltd, Div Radiat Effect Res, Radiat Hlth Res Inst, Seoul 132703, South Korea; [Kim, Joon] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Kim, Joon] Korea Univ, BioInst, Seoul 136701, South Korea	Pusan National University; Sejong University; Korea Hydro & Nuclear Power; Korea University; Korea University	Youn, B (corresponding author), Pusan Natl Univ, Dept Biol Sci, Pusan 609735, South Korea.	bhyoun72@pusan.ac.kr	Seong, Ki Moon/Y-6083-2019		Nuclear R&D Program through the National Research Foundation of Korea [2011-0030601, 2011-0020777]; Basic Science Research Program through the National Research Foundation of Korea [2011-0007625]; Ministry of Education, Science and Technology	Nuclear R&D Program through the National Research Foundation of Korea(National Research Foundation of Korea); Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Nuclear R&D Program (Grants 2011-0030601 and 2011-0020777) and by the Basic Science Research Program (Grant 2011-0007625) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology.	Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Baumann M, 2004, LUNG CANCER, V45, pS187, DOI 10.1016/j.lungcan.2004.07.975; Billie Au PY, 2007, ADV EXP MED BIOL, V597, P32; Blackwell K, 2009, MOL CELL BIOL, V29, P303, DOI 10.1128/MCB.00699-08; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Bussink J, 2008, LANCET ONCOL, V9, P288, DOI 10.1016/S1470-2045(08)70073-1; Criswell T, 2003, ONCOGENE, V22, P5813, DOI 10.1038/sj.onc.1206680; Das AK, 2006, CANCER RES, V66, P9601, DOI 10.1158/0008-5472.CAN-06-2627; Guo WF, 2005, RADIAT RES, V164, P27, DOI 10.1667/RR3401; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Jang CY, 2012, BIOCHEM BIOPH RES CO, V429, P57, DOI 10.1016/j.bbrc.2012.10.093; Jang CY, 2004, FEBS LETT, V560, P81, DOI 10.1016/S0014-5793(04)00074-2; Kim SH, 2005, BIOCHEM BIOPH RES CO, V328, P962, DOI 10.1016/j.bbrc.2005.01.045; Kim TS, 2009, BBA-MOL CELL RES, V1793, P395, DOI 10.1016/j.bbamcr.2008.10.017; Kim W, 2011, RADIAT RES, V176, P539, DOI 10.1667/RR2609.1; Kim WY, 2009, CANCER RES, V69, P1624, DOI 10.1158/0008-5472.CAN-08-0505; Koh PK, 2012, CANCER TREAT REV, V38, P626, DOI 10.1016/j.ctrv.2011.11.003; Koukourakis MI, 2012, BRIT J RADIOL, V85, P313, DOI 10.1259/bjr/16386034; Lee SB, 2010, J BIOL CHEM, V285, P29457, DOI 10.1074/jbc.M110.131367; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Murley JS, 2011, FREE RADICAL BIO MED, V51, P1918, DOI 10.1016/j.freeradbiomed.2011.08.032; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; Niyazi M, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-4; Olsen BB, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-7; Sause WT, 1999, CHEST, V116, p504S, DOI 10.1378/chest.116.suppl_3.504S; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Shimura T, 2010, ONCOGENE, V29, P4826, DOI 10.1038/onc.2010.238; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan FY, 2011, NAT IMMUNOL, V12, P335, DOI 10.1038/ni.2007; Xia Zong-Ping, 2005, Sci STKE, V2005, ppe7, DOI 10.1126/stke.2722005pe7; Yang HJ, 2011, BIOCHEM PHARMACOL, V82, P524, DOI 10.1016/j.bcp.2011.05.027; Yoshida K, 2010, HEAD NECK-J SCI SPEC, V32, P646, DOI 10.1002/hed.21239; Zheng M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632	38	45	47	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2965	2975		10.1074/jbc.M112.385989	http://dx.doi.org/10.1074/jbc.M112.385989			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23188828	Green Published, hybrid			2022-12-28	WOS:000314397900007
J	Feller, A; Georis, I; Tate, JJ; Cooper, TG; Dubois, E				Feller, Andre; Georis, Isabelle; Tate, Jennifer J.; Cooper, Terrance G.; Dubois, Evelyne			Alterations in the Ure2 alpha Cap Domain Elicit Different GATA Factor Responses to Rapamycin Treatment and Nitrogen Limitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 GLUTAMATE-DEHYDROGENASES; UREIDOSUCCINIC ACID UPTAKE; TOR SIGNALING PATHWAY; SACCHAROMYCES-CEREVISIAE; CATABOLITE REPRESSION; NUCLEAR-LOCALIZATION; INTRACELLULAR-LOCALIZATION; METHIONINE SULFOXIMINE; GLN3 PHOSPHORYLATION; CARBON STARVATION	Ure2 is a phosphoprotein and central negative regulator of nitrogen-responsive Gln3/Gat1 localization and their ability to activate transcription. This negative regulation is achieved by the formation of Ure2-Gln3 and -Gat1 complexes that are thought to sequester these GATA factors in the cytoplasm of cells cultured in excess nitrogen. Ure2 itself is a dimer the monomer of which consists of two core domains and a flexible protruding alpha cap. Here, we show that alterations in this alpha cap abolish rapamycin-elicited nuclear Gln3 and, to a more limited extent, Gat1 localization. In contrast, these alterations have little demonstrable effect on the Gln3 and Gat1 responses to nitrogen limitation. Using two-dimensional PAGE we resolved eight rather than the two previously reported Ure2 isoforms and demonstrated Ure2 dephosphorylation to be stimulus-specific, occurring after rapamycin treatment but only minimally if at all in nitrogen-limited cells. Alteration of the alpha cap significantly diminished the response of Ure2 dephosphorylation to the TorC1 inhibitor, rapamycin. Furthermore, in contrast to Gln3, rapamycin-elicited Ure2 dephosphorylation occurred independently of Sit4 and Pph21/22 (PP2A) as well as Siw14, Ptc1, and Ppz1. Together, our data suggest that distinct regions of Ure2 are associated with the receipt and/or implementation of signals calling for cessation of GATA factor sequestration in the cytoplasm. This in turn is more consistent with the existence of distinct pathways for TorC1- and nitrogen limitation-dependent control than it is with these stimuli representing sequential steps in a single regulatory pathway.	[Feller, Andre; Georis, Isabelle; Dubois, Evelyne] Univ Libre Bruxelles, Microbiol Lab, Inst Rech Microbiol JM Wiame, B-1070 Brussels, Belgium; [Tate, Jennifer J.; Cooper, Terrance G.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	Universite Libre de Bruxelles; University of Tennessee System; University of Tennessee Health Science Center	Cooper, TG (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.	tcooper@uthsc.edu		Cooper, Terrance G./0000-0002-7651-9963	National Institutes of Health [GM-35642-23A1]; Commission Communautaire Francaise (COCOF); Fonds de la Recherche Fondamentale Collective [FRFC 2.4547.11]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commission Communautaire Francaise (COCOF); Fonds de la Recherche Fondamentale Collective(Fonds de la Recherche Scientifique - FNRS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-35642-23A1 and (to J.J.T., R. Rai, and T. G. C.). This work was also supported by Commission Communautaire Francaise (COCOF) and the Fonds de la Recherche Fondamentale Collective (FRFC 2.4547.11) (to I. G. and E. D.).	AIGLE M, 1975, MOL GEN GENET, V136, P327, DOI 10.1007/BF00341717; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Blinder D, 1996, J BACTERIOL, V178, P4734, DOI 10.1128/jb.178.15.4734-4736.1996; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Bousset L, 2001, BIOCHEMISTRY-US, V40, P13564, DOI 10.1021/bi011007b; Bousset L, 2001, STRUCTURE, V9, P39, DOI 10.1016/S0969-2126(00)00553-0; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Carvalho J, 2003, J BIOL CHEM, V278, P16878, DOI 10.1074/jbc.M300429200; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cooper TG, 2004, TOP CURR GENET, V7, P225; Cox KH, 2004, J BIOL CHEM, V279, P19294, DOI 10.1074/jbc.M309240200; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Cunningham TS, 2000, J BIOL CHEM, V275, P14408, DOI 10.1074/jbc.275.19.14408; DRILLIEN R, 1972, J BACTERIOL, V109, P203, DOI 10.1128/JB.109.1.203-208.1972; DRILLIEN R, 1973, BIOCHEM BIOPH RES CO, V53, P367, DOI 10.1016/0006-291X(73)90671-2; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Georis I, 2011, J BIOL CHEM, V286, P44897, DOI 10.1074/jbc.M111.290577; Georis I, 2011, MOL CELL BIOL, V31, P92, DOI 10.1128/MCB.00482-10; Georis I, 2009, GENETICS, V181, P861, DOI 10.1534/genetics.108.099051; Gonzalez A, 2009, MOL CELL BIOL, V29, P2876, DOI 10.1128/MCB.01740-08; GRENSON M, 1974, MOL GEN GENET, V128, P73, DOI 10.1007/BF00267295; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hirasaki M, 2008, GENE, V409, P34, DOI 10.1016/j.gene.2007.11.005; Hirasaki M, 2011, J BIOSCI BIOENG, V111, P249, DOI 10.1016/j.jbiosc.2010.11.013; Hirasaki M, 2010, J BIOSCI BIOENG, V109, P433, DOI 10.1016/j.jbiosc.2009.10.023; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Ingrell CR, 2007, BIOINFORMATICS, V23, P895, DOI 10.1093/bioinformatics/btm020; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Jiang Y, 2006, MICROBIOL MOL BIOL R, V70, P440, DOI 10.1128/MMBR.00049-05; Kulkarni AA, 2001, J BIOL CHEM, V276, P32136, DOI 10.1074/jbc.M104580200; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; Liu ZC, 2008, MOL CELL BIOL, V28, P551, DOI 10.1128/MCB.00929-07; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Maddelein ML, 1999, MOL CELL BIOL, V19, P4516; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; Puria R, 2008, P NATL ACAD SCI USA, V105, P7194, DOI 10.1073/pnas.0801087105; Schwartz K, 1997, MOL BIOL CELL, V8, P2677, DOI 10.1091/mbc.8.12.2677; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Tate JJ, 2007, J BIOL CHEM, V282, P18467, DOI 10.1074/jbc.M609550200; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tate JJ, 2006, J BIOL CHEM, V281, P28460, DOI 10.1074/jbc.M604171200; Tate JJ, 2010, J BIOL CHEM, V285, P17880, DOI 10.1074/jbc.M109.085712; Tate JJ, 2009, J BIOL CHEM, V284, P2522, DOI 10.1074/jbc.M806162200; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Wickner RB, 1999, J BIOL CHEM, V274, P555, DOI 10.1074/jbc.274.2.555; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239	59	22	23	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1841	1855		10.1074/jbc.M112.385054	http://dx.doi.org/10.1074/jbc.M112.385054			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184930	Green Published, hybrid			2022-12-28	WOS:000313751400039
J	Alapatt, P; Guo, FJ; Komanetsky, SM; Wang, SP; Cai, JJ; Sargsyan, A; Diaz, ER; Bacon, BT; Aryal, P; Graham, TE				Alapatt, Philomena; Guo, Fangjian; Komanetsky, Susan M.; Wang, Shuping; Cai, Jinjin; Sargsyan, Ashot; Diaz, Eduardo Rodriguez; Bacon, Brandon T.; Aryal, Pratik; Graham, Timothy E.			Liver Retinol Transporter and Receptor for Serum Retinol-binding Protein (RBP4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATTHEW-WOOD-SYNDROME; VITAMIN-A; GENE-EXPRESSION; CELLULAR UPTAKE; RETINOL-BINDING-PROTEIN-4 LEVELS; SYNERGISTIC INDUCTION; INSULIN-RESISTANCE; GLUCOSE-TRANSPORT; MEMBRANE-RECEPTOR; ACID	Vitamin A (retinol) is absorbed in the small intestine, stored in liver, and secreted into circulation bound to serum retinol-binding protein (RBP4). Circulating retinol may be taken up by extrahepatic tissues or recycled back to liver multiple times before it is finally metabolized or degraded. Liver exhibits high affinity binding sites for RBP4, but specific receptors have not been identified. The only known high affinity receptor for RBP4, Stra6, is not expressed in the liver. Here we report discovery of RBP4 receptor-2 (RBPR2), a novel retinol transporter expressed primarily in liver and intestine and induced in adipose tissue of obese mice. RBPR2 is structurally related to Stra6 and highly conserved in vertebrates, including humans. Expression of RBPR2 in cultured cells confers high affinity RBP4 binding and retinol transport, and RBPR2 knockdown reduces RBP4 binding/retinol transport. RBPR2 expression is suppressed by retinol and retinoic acid and correlates inversely with liver retinol stores in vivo. We conclude that RBPR2 is a novel retinol transporter that potentially regulates retinol homeostasis in liver and other tissues. In addition, expression of RBPR2 in liver and fat suggests a possible role in mediating established metabolic actions of RBP4 in those tissues.	[Graham, Timothy E.] Univ Utah, Program Mol Med, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; [Alapatt, Philomena; Guo, Fangjian; Komanetsky, Susan M.; Wang, Shuping; Cai, Jinjin; Sargsyan, Ashot; Diaz, Eduardo Rodriguez; Bacon, Brandon T.; Graham, Timothy E.] Univ Utah, Dept Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT 84112 USA; [Alapatt, Philomena; Guo, Fangjian; Komanetsky, Susan M.; Wang, Shuping; Cai, Jinjin; Sargsyan, Ashot; Diaz, Eduardo Rodriguez; Bacon, Brandon T.; Graham, Timothy E.] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Aryal, Pratik] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Harvard University; Beth Israel Deaconess Medical Center	Graham, TE (corresponding author), Univ Utah, Program Mol Med, Eccles Inst Human Genet, Rm 3110A,15 N 2030 E, Salt Lake City, UT 84112 USA.	tgraham@u2m2.utah.edu	Guo, Fangjian/B-7705-2015; cai, jinjin/I-7005-2012; Sargsyan, Ashot/AAH-3724-2021	Guo, Fangjian/0000-0003-3729-2724; Sargsyan, Ashot/0000-0003-1662-7548; Bacon, Brandon/0000-0002-3793-0549; Aryal, Pratik/0000-0001-6443-8974	National Institutes of Health [R03 DK080195]; Bio-medical Laboratory Research and Development Merit Review Award from the Department of Veterans Affairs [01BX000937]; Physician Scientist Early Career Award from the Howard Hughes Medical Institute; Clinical Scientist Development Award from the Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK080195] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bio-medical Laboratory Research and Development Merit Review Award from the Department of Veterans Affairs(US Department of Veterans Affairs); Physician Scientist Early Career Award from the Howard Hughes Medical Institute; Clinical Scientist Development Award from the Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant R03 DK080195 (to T. E. G.). This work was also supported by a Bio-medical Laboratory Research and Development Merit Review Award from the Department of Veterans Affairs (01BX000937) (to T. E. G.) and a Physician Scientist Early Career Award from the Howard Hughes Medical Institute (to T. E. G.). Cloning of human RBPR2 orthologues (and no animal-related work) was supported by a Clinical Scientist Development Award from the Doris Duke Charitable Foundation (to T. E. G.).	Ahmad B, 1930, BIOCHEM J, V24, P27, DOI 10.1042/bj0240027; Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; [Anonymous], 1990, Methods Enzymol, V189, P3; BERNHARD HP, 1973, DEV BIOL, V35, P83, DOI 10.1016/0012-1606(73)90008-0; Berry DC, 2012, BBA-MOL CELL BIOL L, V1821, P168, DOI 10.1016/j.bbalip.2011.07.002; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; BLANER WS, 1989, ENDOCR REV, V10, P308, DOI 10.1210/edrv-10-3-308; BLOMHOFF R, 1985, J BIOL CHEM, V260, P3571; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Capper NS, 1930, BIOCHEM J, V24, P980, DOI 10.1042/bj0240980; CHAM BE, 1976, J LIPID RES, V17, P176; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chassaing N, 2009, HUM MUTAT, V30, pE673, DOI 10.1002/humu.21023; CHEN CC, 1977, J BIOL CHEM, V252, P5216; Chitayat D, 2007, AM J MED GENET A, V143A, P1268, DOI 10.1002/ajmg.a.31788; Cifelli CJ, 2008, J NUTR, V138, P971, DOI 10.1093/jn/138.5.971; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; FARAONIO R, 1993, EUR J BIOCHEM, V211, P835, DOI 10.1111/j.1432-1033.1993.tb17616.x; Ganguly J., 1989, BIOCH VITAMIN A, P63; GJOEN T, 1987, J BIOL CHEM, V262, P10926; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; GOODMAN DS, 1972, J LIPID RES, V13, P338; Graham TE, 2007, HORM METAB RES, V39, P717, DOI 10.1055/s-2007-985879; Graham TE, 2006, NEW ENGL J MED, V355, P1394; Hahn S, 2007, EUR J ENDOCRINOL, V157, P201, DOI 10.1530/EJE-07-0143; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kawaguchi R, 2008, BIOCHEMISTRY-US, V47, P5387, DOI 10.1021/bi8002082; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2012, J MEMBRANE BIOL, V245, P731, DOI 10.1007/s00232-012-9463-1; Kawaguchi R, 2011, ACS CHEM BIOL, V6, P1041, DOI 10.1021/cb200178w; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Kovacs P, 2007, DIABETES, V56, P3095, DOI 10.2337/db06-1647; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; LEWIS KC, 1990, J LIPID RES, V31, P1535; MATSUURA T, 1993, ARCH BIOCHEM BIOPHYS, V301, P221, DOI 10.1006/abbi.1993.1137; McGrane MM, 2007, J NUTR BIOCHEM, V18, P497, DOI 10.1016/j.jnutbio.2006.10.006; Mendoza-Parra MA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.73; Munkhtulga L, 2007, HUM GENET, V120, P879, DOI 10.1007/s00439-006-0264-4; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; NORUM KR, 1992, AM J CLIN NUTR, V56, P735, DOI 10.1093/ajcn/56.4.735; Ost A, 2007, FASEB J, V21, P3696, DOI 10.1096/fj.07-8173com; Paschaki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032447; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; PITOT H. C., 1964, NAT CANCER INST MONOGR, V13, P229; Qi QB, 2007, J CLIN ENDOCR METAB, V92, P4827, DOI 10.1210/jc.2007-1219; Quadro L, 2004, J LIPID RES, V45, P1975, DOI 10.1194/jlr.M400137-JLR200; RANDOLPH RK, 1991, J LIPID RES, V32, P809; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Robinson JF, 2012, TOXICOL SCI, V126, P242, DOI 10.1093/toxsci/kfr342; Schnitzer Jay J, 2004, Semin Pediatr Surg, V13, P37, DOI 10.1053/j.sempedsurg.2003.09.006; Senoo H, 2007, VITAM HORM, V75, P131, DOI 10.1016/S0083-6729(06)75006-3; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shirakami Y, 2012, BBA-MOL CELL BIOL L, V1821, P124, DOI 10.1016/j.bbalip.2011.06.023; SIVAPRASADARAO A, 1988, BIOCHEM J, V255, P571; Slavotinek AM, 2011, MOL GENET METAB, V104, P448, DOI 10.1016/j.ymgme.2011.09.029; SMELAND S, 1995, BIOCHEM J, V305, P419, DOI 10.1042/bj3050419; STGEORGE S, 1954, SCIENCE, V120, P463; Sun H, 2011, INT REV CEL MOL BIO, V288, P1, DOI 10.1016/B978-0-12-386041-5.00001-7; Szeto W, 2001, CANCER RES, V61, P4197; Tanumihardjo SA, 2011, AM J CLIN NUTR, V94, p658S, DOI 10.3945/ajcn.110.005777; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tice DA, 2002, J BIOL CHEM, V277, P14329, DOI 10.1074/jbc.M200334200; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; van Hoek M, 2008, DIABETOLOGIA, V51, P1423, DOI 10.1007/s00125-008-1042-8; Venable CL, 2000, J BIOL CHEM, V275, P18318, DOI 10.1074/jbc.M908392199; Vogel S, 2000, J LIPID RES, V41, P882; Wang YP, 2002, ARCH BIOCHEM BIOPHYS, V401, P235, DOI 10.1016/S0003-9861(02)00043-7; Wu Y, 2009, J LIPID RES, V50, P1479, DOI 10.1194/jlr.P900014-JLR200; Yamamoto Y, 1997, EXP CELL RES, V234, P373, DOI 10.1006/excr.1997.3642; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zanotti G, 2004, VITAM HORM, V69, P271, DOI 10.1016/S0083-6729(04)69010-8	76	81	85	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1250	1265		10.1074/jbc.M112.369132	http://dx.doi.org/10.1074/jbc.M112.369132			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23105095	hybrid, Green Published			2022-12-28	WOS:000313570300045
J	Ortega, F; Stott, J; Visser, SAG; Bendtsen, C				Ortega, Fernando; Stott, Jonathan; Visser, Sandra A. G.; Bendtsen, Claus			Interplay between alpha-, beta-, and gamma-Secretases Determines Biphasic Amyloid-beta Protein Level in the Presence of a gamma-Secretase Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; IN-VIVO; CLEAVAGE; ADAM10; PHARMACODYNAMICS; METABOLISM; MODULATION; PLASMA	Amyloid-beta (A beta) is produced by the consecutive cleavage of amyloid precursor protein (APP) first by beta-secretase, generating C99, and then by gamma-secretase. APP is also cleaved by alpha-secretase. It is hypothesized that reducing the production of A beta in the brain may slow the progression of Alzheimer disease. Therefore, different gamma-secretase inhibitors have been developed to reduce A beta production. Paradoxically, it has been shown that low to moderate inhibitor concentrations cause a rise in A beta production in different cell lines, in different animal models, and also in humans. A mechanistic understanding of the A beta rise remains elusive. Here, a minimal mathematical model has been developed that quantitatively describes the A beta dynamics in cell lines that exhibit the rise as well as in cell lines that do not. The model includes steps of APP processing through both the so-called amyloidogenic pathway and the so-called non-amyloidogenic pathway. It is shown that the cross-talk between these two pathways accounts for the increase in A beta production in response to inhibitor, i.e. an increase in C99 will inhibit the non-amyloidogenic pathway, redirecting APP to be cleaved by beta-secretase, leading to an additional increase in C99 that overcomes the loss in gamma-secretase activity. With a minor extension, the model also describes plasma A beta profiles observed in humans upon dosing with a gamma-secretase inhibitor. In conclusion, this mechanistic model rationalizes a series of experimental results that spans from in vitro to in vivo and to humans. This has important implications for the development of drugs targeting A beta production in Alzheimer disease.	[Ortega, Fernando; Stott, Jonathan; Bendtsen, Claus] AstraZeneca, Discovery Sci, Computat Biol, Macclesfield SK10 4TG, Cheshire, England; [Visser, Sandra A. G.] AstraZeneca Sodertalje, Innovat Med, Global Drug Metab Pharmacokinet Ctr Excellence, SE-15185 Sodertalje, Sweden	AstraZeneca; AstraZeneca	Bendtsen, C (corresponding author), AstraZeneca, Discovery Sci, Computat Biol, Mereside 50S21,Alderley Pk, Macclesfield SK10 4TG, Cheshire, England.	claus.bendtsen@astrazeneca.com	Ortega, Fernando/G-2129-2015	Ortega, Fernando/0000-0002-3172-2095; Bendtsen, Claus/0000-0002-8338-987X				Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Barthet G, 2011, FASEB J, V25, P2937, DOI 10.1096/fj.11-183806; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Burton CR, 2008, J BIOL CHEM, V283, P22992, DOI 10.1074/jbc.M804175200; Cirrito JR, 2003, J NEUROSCI, V23, P8844; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cook JJ, 2010, J NEUROSCI, V30, P6743, DOI 10.1523/JNEUROSCI.1381-10.2010; Das R, 2011, B MATH BIOL, V73, P230, DOI 10.1007/s11538-010-9540-5; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Dockens R, 2012, CLIN PHARMACOKINET, V51, P681, DOI 10.1007/s40262-012-0005-x; Durkin JT, 1999, J BIOL CHEM, V274, P20499, DOI 10.1074/jbc.274.29.20499; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; Hone E, 2003, J ALZHEIMERS DIS, V5, P1, DOI 10.3233/JAD-2003-5101; Hook V, 2008, BIOL CHEM, V389, P993, DOI 10.1515/BC.2008.124; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; Jager S, 2009, J NEUROCHEM, V111, P1369, DOI 10.1111/j.1471-4159.2009.06420.x; Jamsa A, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-76; Korczyn AD, 2008, ALZHEIMERS DEMENT, V4, P176, DOI 10.1016/j.jalz.2007.11.008; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; KUMAMOTO M, 2008, ALZHEIMERS DEMENT, V4, pT785; Lanz TA, 2004, J PHARMACOL EXP THER, V309, P49, DOI 10.1124/jpet.103.060715; Lanz TA, 2006, J PHARMACOL EXP THER, V319, P924, DOI 10.1124/jpet.106.110700; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lu YS, 2011, J PHARMACOL EXP THER, V339, P922, DOI 10.1124/jpet.111.186791; Martone RL, 2009, J PHARMACOL EXP THER, V331, P598, DOI 10.1124/jpet.109.152975; McLendon C, 2000, FASEB J, V14, P2383; Niva C., 2012, EUR J CLIN IN PRESS; Ortega F, 2002, P NATL ACAD SCI USA, V99, P1170, DOI 10.1073/pnas.022267399; Ortega F, 2006, FEBS J, V273, P3915, DOI 10.1111/j.1742-4658.2006.05394.x; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Prasad CVC, 2007, BIOORG MED CHEM LETT, V17, P4006, DOI 10.1016/j.bmcl.2007.04.082; Prox J, 2012, EXP BRAIN RES, V217, P331, DOI 10.1007/s00221-011-2952-0; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Siemers ER, 2007, CLIN NEUROPHARMACOL, V30, P317, DOI 10.1097/WNF.0b013e31805b7660; Tian GC, 2002, J BIOL CHEM, V277, P31499, DOI 10.1074/jbc.M112328200; Tomasselli AG, 2003, J NEUROCHEM, V84, P1006, DOI 10.1046/j.1471-4159.2003.01597.x; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Zhang LL, 2001, BIOCHEMISTRY-US, V40, P5049, DOI 10.1021/bi0028800	41	29	29	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					785	792		10.1074/jbc.M112.419135	http://dx.doi.org/10.1074/jbc.M112.419135			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23152503	hybrid, Green Published			2022-12-28	WOS:000313570300004
J	Gonzalez-Gronow, M; Ray, R; Wang, F; Pizzo, SV				Gonzalez-Gronow, Mario; Ray, Rupa; Wang, Fang; Pizzo, Salvatore V.			The Voltage-dependent Anion Channel (VDAC) Binds Tissue-type Plasminogen Activator and Promotes Activation of Plasminogen on the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL DEATH; RECEPTOR; KRINGLE-5; SYSTEM; PROTEIN; PLASMA; PURIFICATION; CLEAVAGE; STIMULATION; PROTEOLYSIS	The voltage-dependent anion channel (VDAC), a major pore-forming protein in the outer membrane of mitochondria, is also found in the plasma membrane of a large number of cells where in addition to its role in regulating cellular ATP release and volume control it is important for maintaining redox homeostasis. Cell surface VDAC is a receptor for plasminogen kringle 5, which promotes partial closure of the channel. In this study, we demonstrate that VDAC binds tissue-type plasminogen activator (t-PA) on human neuroblastoma SK-N-SH cells. Binding of t-PA to VDAC induced a decrease in K-m and an increase in the V-max for activation of its substrate, plasminogen (Pg). This resulted in accelerated Pg activation when VDAC, t-PA, and Pg were bound together. VDAC is also a substrate for plasmin; hence, it mimics fibrin activity. Binding of t-PA to VDAC occurs between a t-PA fibronectin type I finger domain located between amino acids Ile(5) and Asn(37) and a VDAC region including amino acids (20)GYGFG(24). These VDAC residues correspond to a GXXXG repeat motif commonly found in amyloid beta peptides that is necessary for aggregation when these peptides form fibrillar deposits on the cell surface. Furthermore, we also show that Pg kringle 5 is a substrate for the NADH-dependent reductase activity of VDAC. This ternary complex is an efficient proteolytic complex that may facilitate removal of amyloid beta peptide deposits from the normal brain and cell debris from injured brain tissue.	[Gonzalez-Gronow, Mario; Ray, Rupa; Wang, Fang; Pizzo, Salvatore V.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University	Gonzalez-Gronow, M (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Box 3712, Durham, NC 27710 USA.	gonza002@mc.duke.edu						Baker MA, 2004, BIOFACTORS, V21, P215, DOI 10.1002/biof.552210143; Baker MA, 2004, J BIOL CHEM, V279, P4811, DOI 10.1074/jbc.M311020200; Banerjee J, 2004, BBA-BIOMEMBRANES, V1663, P6, DOI 10.1016/j.bbamem.2004.02.005; BarrettBergshoeff M, 1997, THROMB HAEMOSTASIS, V77, P718; BIZIK J, 1993, J CELL BIOCHEM, V51, P326, DOI 10.1002/jcb.240510312; BU GJ, 1992, P NATL ACAD SCI USA, V89, P7427, DOI 10.1073/pnas.89.16.7427; Cao YH, 1997, J BIOL CHEM, V272, P22924, DOI 10.1074/jbc.272.36.22924; Chae HJ, 2000, PHARMACOL RES, V42, P373, DOI 10.1006/phrs.2000.0700; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; COLOMBINI M, 1979, NATURE, V279, P643, DOI 10.1038/279643a0; Cunningham O, 2009, GLIA, V57, P1802, DOI 10.1002/glia.20892; Das R, 2010, TRENDS CARDIOVAS MED, V20, P120, DOI 10.1016/j.tcm.2010.10.002; De Pinto V, 2010, FEBS LETT, V584, P1793, DOI 10.1016/j.febslet.2010.02.049; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; GHISO J, 1992, BIOCHEM J, V288, P1053, DOI 10.1042/bj2881053; GIMEL JC, 1994, MACROMOLECULES, V27, P583, DOI 10.1021/ma00080a037; Gonzalez-Gronow M, 2003, J BIOL CHEM, V278, P27312, DOI 10.1074/jbc.M303172200; Gonzalez-Gronow M, 2002, BLOOD, V99, P4562, DOI 10.1182/blood.V99.12.4562; Gonzalez-Gronow M, 2008, FRONT BIOSCI-LANDMRK, V13, P1610, DOI 10.2741/2785; Gonzalez-Gronow M, 2007, J BIOL CHEM, V282, P32811, DOI 10.1074/jbc.M703342200; Gonzalez-Gronow M, 2010, J NEUROIMMUNOL, V227, P153, DOI 10.1016/j.jneuroim.2010.06.001; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; HOYLAERTS M, 1981, BIOCHIM BIOPHYS ACTA, V673, P75; Ji WR, 1998, BIOCHEM BIOPH RES CO, V247, P414, DOI 10.1006/bbrc.1998.8825; KINGSTON IB, 1995, NAT MED, V1, P138; Kranenburg O, 2002, CURR BIOL, V12, P1833, DOI 10.1016/S0960-9822(02)01224-1; Kwon M, 2002, J BIOL CHEM, V277, P10903, DOI 10.1074/jbc.M111219200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lay AJ, 2000, NATURE, V408, P869, DOI 10.1038/35048596; Liu W, 2005, BIOCHEMISTRY-US, V44, P3591, DOI 10.1021/bi047827g; Maas C, 2008, AMYLOID, V15, P166, DOI 10.1080/13506120802193498; Marin R, 2007, MOL MEMBR BIOL, V24, P148, DOI 10.1080/09687860601055559; MARKWELL MAK, 1982, ANAL BIOCHEM, V125, P427, DOI 10.1016/0003-2697(82)90025-2; MCENERY MW, 1993, J BIOL CHEM, V268, P23289; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; Okada SF, 2004, J GEN PHYSIOL, V124, P513, DOI 10.1085/jgp.200409154; Ostermeier C, 1996, CURR OPIN STRUC BIOL, V6, P460, DOI 10.1016/S0959-440X(96)80110-2; Ovstebo R, 2003, CLIN CHEM, V49, P425, DOI 10.1373/49.3.425; Park K, 2009, DIABETES, V58, P1902, DOI 10.2337/db08-1327; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Reuning U, 1998, INT J ONCOL, V13, P893; Samson AL, 2009, BLOOD, V114, P1937, DOI 10.1182/blood-2009-02-203448; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; SHI GY, 1988, J BIOL CHEM, V263, P17071; Shi Y, 2003, BIOCHEM BIOPH RES CO, V303, P475, DOI 10.1016/S0006-291X(03)00359-0; SOTTRUPJENSEN L, 1975, P NATL ACAD SCI USA, V72, P2577, DOI 10.1073/pnas.72.7.2577; STACK S, 1990, BIOCHEMISTRY-US, V29, P4966, DOI 10.1021/bi00472a029; Stathakis P, 1997, J BIOL CHEM, V272, P20641, DOI 10.1074/jbc.272.33.20641; THEWES T, 1987, BIOCHIM BIOPHYS ACTA, V912, P254, DOI 10.1016/0167-4838(87)90096-3; Thinnes FP, 1997, NATURWISSENSCHAFTEN, V84, P480, DOI 10.1007/s001140050432; Thinnes FP, 2011, WIEN MED WOCHENSCHR, V161, P274, DOI 10.1007/s10354-011-0887-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsirka SE, 1997, J NEUROSCI, V17, P543; Tsirka SE, 1997, P NATL ACAD SCI USA, V94, P9779, DOI 10.1073/pnas.94.18.9779; Tucker HM, 2000, J NEUROSCI, V20, P3937; Van Nostrand WE, 1999, BIOCHEMISTRY-US, V38, P11570, DOI 10.1021/bi990610f; VARADI A, 1981, BIOCHEM BIOPH RES CO, V103, P97, DOI 10.1016/0006-291X(81)91665-X; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Wnendt S, 1997, THROMB RES, V85, P217, DOI 10.1016/S0049-3848(97)00006-6; WOHL RC, 1980, J BIOL CHEM, V255, P2005	64	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					498	509		10.1074/jbc.M112.412502	http://dx.doi.org/10.1074/jbc.M112.412502			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23161549	hybrid, Green Published			2022-12-28	WOS:000313197200050
J	Dobierzewska, A; Shi, LH; Karakashian, AA; Nikolova-Karakashian, MN				Dobierzewska, Aneta; Shi, Lihua; Karakashian, Alexander A.; Nikolova-Karakashian, Mariana N.			Interleukin 1 beta Regulation of FoxO1 Protein Content and Localization EVIDENCE FOR A NOVEL CERAMIDE-DEPENDENT MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; PLECKSTRIN HOMOLOGY DOMAIN; TRANSCRIPTION FACTOR FOXO1; NEUTRAL SPHINGOMYELINASE-2; OXIDATIVE STRESS; LIFE-SPAN; PKC-ZETA; JNK; PHOSPHORYLATION; RESISTANCE	FoxO1 transcription factor controls the glucose and lipid metabolism, as well as cell proliferation and stress response. Akt, activated by insulin and other growth factors, phosphorylates FoxO1 causing its nuclear export and activity suppression. In this manuscript, we show that IL-1 beta, a pro-inflammatory cytokine, has the opposite effects on FoxO1. IL-1 beta stimulation of primary rat hepatocytes and HEK293 cells overexpressing the IL-1 beta receptor (293-IL-1RI) results in increased nuclear and cytosolic FoxO1 protein but not mRNA levels. IL-1 beta stimulation also elevates the levels of a mutant FoxO1 that is resistant to Akt phosphorylation. This suggests that an Akt-independent mechanism is involved. Co-stimulation with insulin does not affect the IL-1 beta induction of FoxO1. The IL-1 beta effects on FoxO1 are counteracted, however, by the silencing or inhibition of neutral sphingomyelinase 2 (nSMase-2) using shRNAi, scyphostatin, or GW4869, as well as by the pharmacological inhibition of JNK and ERK. Reversely, the overexpression of nSMase-2 through adenovirus-mediated gene transfer potentiates, in a JNK- and ERK-dependent manner, the IL-1 beta effects. We also show that transcription of insulin-like growth factor-binding protein-1 mRNA, which requires active FoxO1, is stimulated by IL-1 beta and is suppressed by the inhibition of nSMase-2 and JNK. In conclusion, we propose that IL-1 beta regulates FoxO1 activity through a novel nSMase-2-dependent pathway.	[Nikolova-Karakashian, Mariana N.] Univ Kentucky, Coll Med, AB Chandler Med Ctr, Dept Physiol, Lexington, KY 40536 USA	University of Kentucky	Nikolova-Karakashian, MN (corresponding author), Univ Kentucky, Coll Med, AB Chandler Med Ctr, Dept Physiol, 800 Rose St, Lexington, KY 40536 USA.	mnikolo@uky.edu			National Institutes of Health [AG019223]; NATIONAL INSTITUTE ON AGING [R56AG019223, R01AG019223, R01AG026711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG019223 (to M. N. K.).	Arboleda G, 2007, EUR J NEUROSCI, V25, P3030, DOI 10.1111/j.1460-9568.2007.05557.x; Bartolome N, 2008, INNATE IMMUN-LONDON, V14, P255, DOI 10.1177/1753425908094718; Chen YJ, 2007, J BIOL CHEM, V282, P27215, DOI 10.1074/jbc.M700264200; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Dobierzewska A, 2011, J BIOL CHEM, V286, P32064, DOI 10.1074/jbc.M111.238030; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Giltiay NV, 2005, J LIPID RES, V46, P2497, DOI 10.1194/jlr.M500337-JLR200; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hajduch E, 2008, BIOCHEM J, V410, P369, DOI 10.1042/BJ20070936; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jia GH, 2011, EXP MOL PATHOL, V90, P1, DOI 10.1016/j.yexmp.2010.11.001; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; KANETY H, 1995, J BIOL CHEM, V270, P23780, DOI 10.1074/jbc.270.40.23780; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kim JA, 2005, J BIOL CHEM, V280, P23173, DOI 10.1074/jbc.M501439200; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; NikolovaKarakashian M, 1997, J BIOL CHEM, V272, P18718, DOI 10.1074/jbc.272.30.18718; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Rutkute K, 2007, J LIPID RES, V48, P2443, DOI 10.1194/jlr.M700227-JLR200; Rutkute K, 2007, HEPATOLOGY, V46, P1166, DOI 10.1002/HEP.21777; Rutkute K, 2007, BIOCHEM BIOPH RES CO, V361, P263, DOI 10.1016/j.bbrc.2007.06.079; SANDBERG JO, 1994, BIOCHEM BIOPH RES CO, V202, P543, DOI 10.1006/bbrc.1994.1962; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Senf SM, 2011, AM J PHYSIOL-CELL PH, V300, pC1490, DOI 10.1152/ajpcell.00255.2010; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Stratford S, 2001, BIOCHEM J, V354, P359, DOI 10.1042/0264-6021:3540359; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	44	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44749	44760		10.1074/jbc.M112.378836	http://dx.doi.org/10.1074/jbc.M112.378836			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23105097	hybrid, Green Published			2022-12-28	WOS:000312938600069
J	Nakatsu, Y; Otani, Y; Sakoda, H; Zhang, J; Guo, Y; Okubo, H; Kushiyama, A; Fujishiro, M; Kikuch, T; Fukushima, T; Ohno, H; Tsuchiya, Y; Kamata, H; Nagamachi, A; Inaba, T; Nishimura, F; Katagiri, H; Takahashi, S; Kurihara, H; Uchida, T; Asano, T				Nakatsu, Yusuke; Otani, Yuichiro; Sakoda, Hideyuki; Zhang, Jun; Guo, Ying; Okubo, Hirofumi; Kushiyama, Akifumi; Fujishiro, Midori; Kikuch, Takako; Fukushima, Toshiaki; Ohno, Haruya; Tsuchiya, Yoshihiro; Kamata, Hideaki; Nagamachi, Akiko; Inaba, Toshiya; Nishimura, Fusanori; Katagiri, Hideki; Takahashi, Shin-ichiro; Kurihara, Hiroki; Uchida, Takafumi; Asano, Tomoichiro			Role of Pin1 Protein in the Pathogenesis of Nonalcoholic Steatohepatitis in a Rodent Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL ISOMERASE PIN1; PP2A PHOSPHATASE ACTIVATOR; CRYSTAL-STRUCTURE; CELL-CYCLE; CANCER; ISOMERIZATION; EXPRESSION; FIBROSIS; P53; CONTRIBUTES	Nonalcoholic steatohepatitis (NASH) is a disorder characterized by simultaneous fat accumulation and chronic inflammation in the liver. In this study, Pin1 expression was revealed to be markedly increased in the livers of mice with methionine choline-deficient (MCD) diet-induced NASH, a rodent model of NASH. In addition, Pin1 KO mice were highly resistant to MCD-induced NASH, based on a series of data showing simultaneous fat accumulation, chronic inflammation, and fibrosis in the liver. In terms of Pin1-induced fat accumulation, it was revealed that the expression levels of peroxisome proliferator-activated receptor alpha and its target genes were higher in the livers of Pin1 KO mice than in controls. Thus, resistance of Pin1 KO mice to hepatic steatosis is partially attributable to the lack of Pin1-induced down-regulation of peroxisome proliferator-activated receptor alpha, although multiple other mechanisms are apparently involved. Another mechanism involves the enhancing effect of hematopoietic Pin1 on the expressions of inflammatory cytokines such as tumor necrosis factor and monocyte chemoattractant protein 1 through NF-kappa B activation, eventually leading to hepatic fibrosis. Finally, to distinguish the roles of hematopoietic or nonhematopoietic Pin1 in NASH development, mice lacking Pin1 in either nonhematopoietic or hematopoietic cells were produced by bone marrow transplantation between wild-type and Pin1 KO mice. The mice having nonhematopoietic Pin1 exhibited fat accumulation without liver fibrosis on the MCD diet. Thus, hepatic Pin1 appears to be directly involved in the fat accumulation in hepatocytes, whereas Pin1 in hematopoietic cells contributes to inflammation and fibrosis. In summary, this is the first study to demonstrate that Pin1 plays critical roles in NASH development. This report also raises the possibility that hepatic Pin1 inhibition to the appropriate level might provide a novel therapeutic strategy for NASH.	[Nakatsu, Yusuke; Otani, Yuichiro; Zhang, Jun; Guo, Ying; Okubo, Hirofumi; Fukushima, Toshiaki; Ohno, Haruya; Tsuchiya, Yoshihiro; Kamata, Hideaki; Asano, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, Hiroshima, Japan; [Sakoda, Hideyuki; Fujishiro, Midori; Kikuch, Takako] Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, Tokyo, Japan; [Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Chiyoda Ku, Tokyo, Japan; [Nagamachi, Akiko; Inaba, Toshiya] Hiroshima Univ, Dept Mol Oncol, Hiroshima 7348553, Japan; [Nagamachi, Akiko; Inaba, Toshiya] Hiroshima Univ, Leukemia Program Project, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan; [Nishimura, Fusanori] Hiroshima Univ, Grad Sch Biomed Sci, Dept Dent Sci Hlth Promot, Hiroshima 7348553, Japan; [Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Div Mol Metab & Diabet, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Takahashi, Shin-ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metab, Bunkyo Ku, Tokyo, Japan; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Biol, Sendai, Miyagi 9818555, Japan	Hiroshima University; University of Tokyo; Asahi Life Foundation; Hiroshima University; Hiroshima University; Hiroshima University; Tohoku University; University of Tokyo; University of Tokyo; Tohoku University	Asano, T (corresponding author), Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima, Japan.	asano-tky@umin.ac.jp	Kushiyama, Akifumi/A-6386-2011; 祐介, 中津/AAP-8396-2020; Kamata, Hideaki/N-3907-2017; Kushiyama, Akifumi/W-5988-2019	Kushiyama, Akifumi/0000-0003-1385-7487; Kushiyama, Akifumi/0000-0003-1385-7487; Nakatsu, Yusuke/0000-0003-3279-1276; Ohno, Haruya/0000-0001-5400-1162; Okubo, Hirofumi/0000-0002-9220-9084; Uchida, Takafumi/0000-0003-3665-4906; Takahashi, Shin-Ichiro/0000-0002-2323-2010; Kurihara, Hiroki/0000-0002-6476-5593	Ministry of Education, Science, Sports, and Culture, Japan; Tsuchiya Foundation; Grants-in-Aid for Scientific Research [23659107, 24790928] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tsuchiya Foundation(Tsuchiya Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for young scientists (B) (to Y. N.), a grant-in-aid for scientific research on innovative areas (to T. A.), a grant-in-aid for scientific research (B) (to T. A.) from the Ministry of Education, Science, Sports, and Culture, Japan, and by Tsuchiya Foundation Grant 2010-2012 (to Y. N.).	Atkinson GP, 2009, ONCOGENE, V28, P3735, DOI 10.1038/onc.2009.232; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Chao Y, 2006, MOL CELL, V23, P535, DOI 10.1016/j.molcel.2006.07.027; Chiang DAJ, 2011, AM J PHYSIOL-GASTR L, V300, pG697, DOI 10.1152/ajpgi.00426.2010; Driver Jane A, 2010, Curr Aging Sci, V3, P158; Duvnjak M, 2009, J PHYSIOL PHARMACOL, V60, P57; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Fujimoto Y, 2010, J BIOL CHEM, V285, P3126, DOI 10.1074/jbc.M109.055095; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Haque JA, 2010, LAB INVEST, V90, P1704, DOI 10.1038/labinvest.2010.112; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; Kassel KM, 2010, LAB INVEST, V90, P1794, DOI 10.1038/labinvest.2010.143; Kim MR, 2009, CANCER SCI, V100, P1834, DOI 10.1111/j.1349-7006.2009.01260.x; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Kodama T, 2011, J CLIN INVEST, V121, P3343, DOI 10.1172/JCI44957; Lee TH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001906; Leulliot N, 2006, MOL CELL, V23, P413, DOI 10.1016/j.molcel.2006.07.008; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Lu KP, 2003, CANCER CELL, V4, P175, DOI 10.1016/S1535-6108(03)00218-6; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Magnusdottir A, 2006, J BIOL CHEM, V281, P22434, DOI 10.1074/jbc.C600100200; Morais ADS, 2009, J HEPATOL, V50, P489, DOI 10.1016/j.jhep.2008.10.027; Nakatsu Y, 2011, J BIOL CHEM, V286, P20812, DOI 10.1074/jbc.M110.206904; Nakatsu Y, 2010, J BIOL CHEM, V285, P33018, DOI 10.1074/jbc.M110.137836; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saberi M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1137, DOI 10.1152/ajpendo.00158.2009; Satapathy SK, 2010, TRENDS ENDOCRIN MET, V21, P668, DOI 10.1016/j.tem.2010.08.003; Schattenberg JM, 2011, CURR OPIN LIPIDOL, V22, P479, DOI 10.1097/MOL.0b013e32834c7cfc; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Serviddio G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024084; Shen ZJ, 2008, J CLIN INVEST, V118, P479, DOI [10.1172/JC132789, 10.1172/JCI32789]; Takahashi K, 2008, CELL MOL LIFE SCI, V65, P359, DOI 10.1007/s00018-007-7270-0; Tan XG, 2010, CANCER BIOL THER, V9, P111, DOI 10.4161/cbt.9.2.10341; Tomita K, 2008, HEPATOLOGY, V48, P458, DOI 10.1002/hep.22365; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Uno M, 2008, HEPATOLOGY, V48, P109, DOI 10.1002/hep.22338; Witek RP, 2009, HEPATOLOGY, V50, P1421, DOI 10.1002/hep.23167; Wulf G, 2003, BREAST CANCER RES, V5, P76, DOI 10.1186/bcr572; Yamaguchi K, 2010, LAB INVEST, V90, P1169, DOI 10.1038/labinvest.2010.75; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Yun H. J., 2012, MOL CARCINO IN PRESS; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	47	27	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44526	44535		10.1074/jbc.M112.397133	http://dx.doi.org/10.1074/jbc.M112.397133			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23112047	Green Published, hybrid			2022-12-28	WOS:000312938600049
J	Wang, P; Li, ZW; Wei, JS; Zhao, ZL; Sun, DY; Cui, SJ				Wang, Peng; Li, Zhaowei; Wei, Jingshuang; Zhao, Zenglin; Sun, Daye; Cui, Sujuan			ANa(+)/Ca2+ Exchanger-like Protein (AtNCL) Involved in Salt Stress in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; SIGNAL-TRANSDUCTION; FUNCTIONAL EXPRESSION; NA+/CA2+ EXCHANGER; MOLECULAR-CLONING; PLANT-CELLS; MEMBRANE; IDENTIFICATION; CA2+; TEMPERATURE	Calcium ions (Ca2+) play a crucial role in many key physiological processes; thus, the maintenance of Ca2+ homeostasis is of primary importance. Na+/Ca2+ exchangers (NCXs) play an important role in Ca2+ homeostasis in animal excitable cells. Bioinformatic analysis of the Arabidopsis genome suggested the existence of a putative NCX gene, Arabidopsis NCX-like (AtNCL), encoding a protein with an NCX-like structure and different from Ca2+/H+ exchangers and Na+/H+ exchangers previously identified in plant. AtNCL was identified to localize in the Arabidopsis cell membrane fraction, have the ability of binding Ca2+, and possess NCX-like activity in a heterologous expression system of cultured mammalian CHO-K1 cells. AtNCL is broadly expressed in Arabidopsis, and abiotic stresses stimulated its transcript expression. Loss-of-function atncl mutants were less sensitive to salt stress than wild-type or AtNCL transgenic overexpression lines. In addition, the total calcium content in whole atncl mutant seedlings was higher than that in wild type by atomic absorption spectroscopy. The level of free Ca2+ in the cytosol and Ca2+ flux at the root tips of atncl mutant plants, as detected using transgenic aequorin and a scanning ion-selective electrode, required a longer recovery time following NaCl stress compared with that in wild type. All of these data suggest that AtNCL encodes a Na+/Ca2+ exchanger-like protein that participates in the maintenance of Ca2+ homeostasis in Arabidopsis. AtNCL may represent a new type of Ca2+ transporter in higher plants.	[Wang, Peng; Li, Zhaowei; Zhao, Zenglin; Sun, Daye; Cui, Sujuan] Hebei Normal Univ, Coll Life Sci, Hebei Key Lab Mol Cell Biol, Shijiazhuang 050024, Peoples R China; [Li, Zhaowei] Hebei Univ Sci & Technol, Coll Biol Sci & Engn, Shijiazhuang 050018, Hebei, Peoples R China; [Wei, Jingshuang] N China Pharmaceutical Grp Corp, State Key Lab Dev Antibody Drugs, New Drug R&D Ctr, Shijiazhuang 050015, Peoples R China	Hebei Normal University; Hebei University of Science & Technology	Cui, SJ (corresponding author), Hebei Normal Univ, Coll Life Sci, Hebei Key Lab Mol Cell Biol, Shijiazhuang 050024, Peoples R China.	cuisujuan@mail.hebtu.edu.cn	WANG, PENG/E-4804-2013	Wang, Peng/0000-0002-7521-5925	National Basic Research Program of China [2006CB100101, 2006CB910600]; Research Program of the Ministry of Agriculture, China [2008ZX08009-003]; National Science Foundation of Hebei Province, China [C2009001516]; New Century Excellent Teacher Project of Education Department, China [NCET-06- 0256]	National Basic Research Program of China(National Basic Research Program of China); Research Program of the Ministry of Agriculture, China; National Science Foundation of Hebei Province, China; New Century Excellent Teacher Project of Education Department, China	This work was supported by National Basic Research Program of China Grant 2006CB100101 and Research Program of the Ministry of Agriculture, China, Grant 2008ZX08009-003 (to D. S.); National Science Foundation of Hebei Province, China, Grant C2009001516, New Century Excellent Teacher Project of Education Department, China, Grant NCET-06-0256, and National Basic Research Program of China Grant 2006CB910600 (to S. C.).	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baba Y, 2011, TRENDS IMMUNOL, V32, P589, DOI 10.1016/j.it.2011.09.004; Baczyk D, 2011, CELL CALCIUM, V49, P350, DOI 10.1016/j.ceca.2010.12.003; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BRISKIN DP, 1990, PLANT PHYSIOL, V94, P397, DOI 10.1104/pp.94.2.397; BUSH DS, 1995, ANNU REV PLANT PHYS, V46, P95, DOI 10.1146/annurev.pp.46.060195.000523; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Dunkley TPJ, 2006, P NATL ACAD SCI USA, V103, P6518, DOI 10.1073/pnas.0506958103; Eisner DA, 2004, CIRC RES, V95, P549, DOI 10.1161/01.RES.0000143419.87518.9e; Ferrol N, 1996, PLANT CELL, V8, P1159, DOI 10.2307/3870359; He ZP, 1998, J GEN PHYSIOL, V111, P857, DOI 10.1085/jgp.111.6.857; Hirschi KD, 1996, P NATL ACAD SCI USA, V93, P8782, DOI 10.1073/pnas.93.16.8782; Hong BM, 1999, PLANT PHYSIOL, V119, P1165, DOI 10.1104/pp.119.4.1165; HUANG LQ, 1993, P NATL ACAD SCI USA, V90, P10066, DOI 10.1073/pnas.90.21.10066; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kimura J, 1996, ANN NY ACAD SCI, V779, P515, DOI 10.1111/j.1749-6632.1996.tb44825.x; KIMURA J, 1987, J PHYSIOL-LONDON, V384, P199, DOI 10.1113/jphysiol.1987.sp016450; Knight H, 1998, PLANT J, V16, P681, DOI 10.1046/j.1365-313x.1998.00332.x; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kronzucker HJ, 2011, NEW PHYTOL, V189, P54, DOI 10.1111/j.1469-8137.2010.03540.x; KUHTREIBER WM, 1990, J CELL BIOL, V110, P1565, DOI 10.1083/jcb.110.5.1565; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; Manohar M, 2011, PLANT BIOLOGY, V13, P561, DOI 10.1111/j.1438-8677.2011.00466.x; Calderon-Sanchez EM, 2011, CELL CALCIUM, V50, P84, DOI 10.1016/j.ceca.2011.05.010; Marshall CR, 2005, J BIOL CHEM, V280, P28903, DOI 10.1074/jbc.M504807200; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Mitra SK, 2007, J PROTEOME RES, V6, P1933, DOI 10.1021/pr060525b; MONROY AF, 1995, PLANT CELL, V7, P321, DOI 10.1105/tpc.7.3.321; NAKASAKI Y, 1993, J BIOCHEM-TOKYO, V114, P528, DOI 10.1093/oxfordjournals.jbchem.a124211; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Paredes-Gamero Edgar Julian, 2012, Front Biosci (Elite Ed), V4, P1375; PFEIFFER W, 1993, PLANTA, V191, P377, DOI 10.1007/BF00195696; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Rodriguez-Rosales M, 2009, PLANT SIGNAL BEHAV, V4, P265, DOI 10.4161/psb.4.4.7919; Pineros M, 1997, J EXP BOT, V48, P551, DOI 10.1093/jxb/48.Special_Issue.551; Pittman JK, 2002, J BIOL CHEM, V277, P26452, DOI 10.1074/jbc.M202563200; Pittman JK, 2002, PLANT PHYSIOL, V130, P1054, DOI 10.1104/pp.008193; Pittman JK, 2001, PLANT PHYSIOL, V127, P1020, DOI 10.1104/pp.010409; Pittman JK, 2011, CELL CALCIUM, V50, P139, DOI 10.1016/j.ceca.2011.01.004; POOVAIAH BW, 1993, CRIT REV PLANT SCI, V12, P185, DOI 10.1080/713608046; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; REUTER H, 1968, J PHYSIOL-LONDON, V195, P451, DOI 10.1113/jphysiol.1968.sp008467; Ruknudin A, 1997, AM J PHYSIOL-CELL PH, V273, pC257, DOI 10.1152/ajpcell.1997.273.1.C257; Sambrook J., 2006, CONDENSED PROTOCOLS, P599; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; Shabala S, 2000, ANN BOT-LONDON, V85, P681, DOI 10.1006/anbo.2000.1131; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Spalding EP, 2011, CURR OPIN PLANT BIOL, V14, P715, DOI 10.1016/j.pbi.2011.08.001; Srikanth S, 2006, CELL CALCIUM, V39, P187, DOI 10.1016/j.ceca.2005.10.013; Szponarski W, 2004, PROTEOMICS, V4, P397, DOI 10.1002/pmic.200300607; Tang WQ, 2008, MOL CELL PROTEOMICS, V7, P728, DOI 10.1074/mcp.M700358-MCP200; TSURUYA Y, 1994, BBA-BIOMEMBRANES, V1196, P97, DOI 10.1016/0005-2736(94)90301-8; Vincent P, 2005, J CELL BIOL, V168, P801, DOI 10.1083/jcb.200412074; Wang Z., 1994, J WUHAN U NAT SCI ED, V5, P111; Weber CR, 2002, CIRC RES, V90, P182, DOI 10.1161/hh0202.103940; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Yang YC, 2010, J BIOL CHEM, V285, P28275, DOI 10.1074/jbc.M110.141424; Yin D, 2000, CHEM RES TOXICOL, V13, P103, DOI 10.1021/tx990142a; Zhao J, 2009, J BIOL CHEM, V284, P34075, DOI 10.1074/jbc.M109.070235; Zheng SZ, 2012, PLANT J, V69, P689, DOI 10.1111/j.1365-313X.2011.04823.x	67	55	55	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44062	44070		10.1074/jbc.M112.351643	http://dx.doi.org/10.1074/jbc.M112.351643			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23148213	hybrid, Green Published			2022-12-28	WOS:000312938600005
J	Gang, TB; Hammond, DJ; Singh, SK; Ferguson, DA; Mishra, VK; Agrawal, A				Gang, Toh B.; Hammond, David J., Jr.; Singh, Sanjay K.; Ferguson, Donald A., Jr.; Mishra, Vinod K.; Agrawal, Alok			The Phosphocholine-binding Pocket on C-reactive Protein Is Necessary for Initial Protection of Mice against Pneumococcal Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM AMYLOID-P; STREPTOCOCCUS-PNEUMONIAE INFECTION; SITE-DIRECTED MUTAGENESIS; PLATELET-ACTIVATING-FACTOR; FC-GAMMA-RIIA; FACTOR-H; MONOCLONAL-ANTIBODIES; COMPLEMENT ACTIVATION; COMPONENT; POLYSACCHARIDE	Human C-reactive protein (CRP) protects mice from lethal Streptococcus pneumoniae infection when injected into mice within the range of 6 h before to 2 h after the administration of pneumococci. Because CRP binds to phosphocholine-containing substances and subsequently activates the complement system, it has been proposed that the antipneumococcal function of CRP requires the binding of CRP to phosphocholine moieties present in pneumococcal cell wall C-polysaccharide. To test this proposal experimentally, in this study, we utilized a new CRP mutant incapable of binding to phosphocholine. Based on the structure of CRP-phosphocholine complexes, which showed that Phe(66), Thr(76), and Glu(81) formed the phosphocholine-binding pocket, we constructed a CRP mutant F66A/T76Y/E81A in which the pocket was blocked by substituting Tyr for Thr(76). When compared with wild-type CRP, mutant CRP bound more avidly to phosphoethanolamine and could be purified by affinity chromatography using phosphoethanolamine-conjugated Sepharose. Mutant CRP did not bind to phosphocholine, C-polysaccharide, or pneumococci. Mutant CRP was free in the mouse serum, and its rate of clearance in vivo was not faster than that of wild-type CRP. When either 25 mu g or 150 mu g of CRP was administered into mice, unlike wild-type CRP, mutant CRP did not protect mice from lethal pneumococcal infection. Mice injected with mutant CRP had higher mortality rates than mice that received wild-type CRP. Decreased survival was due to the increased bacteremia in mice treated with mutant CRP. We conclude that the phosphocholine-binding pocket on CRP is necessary for CRP-mediated initial protection of mice against lethal pneumococcal infection.	[Gang, Toh B.; Hammond, David J., Jr.; Singh, Sanjay K.; Ferguson, Donald A., Jr.; Agrawal, Alok] E Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA; [Mishra, Vinod K.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	East Tennessee State University; University of Alabama System; University of Alabama Birmingham	Agrawal, A (corresponding author), E Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, POB 70577, Johnson City, TN 37614 USA.	agrawal@etsu.edu	Mishra, Vinod/S-1151-2019	Mishra, Vinod/0000-0002-4527-1512	National Institutes of Health [R01HL071233]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL071233 (to A. A.).	Abernethy TJ, 1941, J EXP MED, V73, P173, DOI 10.1084/jem.73.2.173; Agrawal A, 2002, J IMMUNOL, V169, P3217, DOI 10.4049/jimmunol.169.6.3217; Agrawal A, 1997, J IMMUNOL, V158, P345; Agrawal Alok, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P231, DOI 10.2174/187153008786848321; ANDERSON JK, 1978, FED PROC, V37, P1495; Bang R, 2005, J BIOL CHEM, V280, P25095, DOI 10.1074/jbc.M504782200; Bharadwaj D, 1999, J EXP MED, V190, P585, DOI 10.1084/jem.190.4.585; Bitsaktsis C, 2012, INFECT IMMUN, V80, P1166, DOI 10.1128/IAI.05511-11; Black S, 2005, J IMMUNOL, V175, P1192, DOI 10.4049/jimmunol.175.2.1192; Chi M, 2002, J IMMUNOL, V168, P1413, DOI 10.4049/jimmunol.168.3.1413; CHRISTNER RB, 1994, ARCH BIOCHEM BIOPHYS, V314, P337, DOI 10.1006/abbi.1994.1451; CHUDWIN DS, 1985, INFECT IMMUN, V50, P213, DOI 10.1128/IAI.50.1.213-217.1985; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Gould JM, 2002, J INFECT DIS, V186, P361, DOI 10.1086/341658; Hakobyan S, 2008, J BIOL CHEM, V283, P30451, DOI 10.1074/jbc.M803648200; Hammond DJ, 2010, J BIOL CHEM, V285, P36235, DOI 10.1074/jbc.M110.142026; HIND CRK, 1984, J EXP MED, V159, P1058, DOI 10.1084/jem.159.4.1058; HOROWITZ J, 1987, J IMMUNOL, V138, P2598; Jones NR, 2011, ARTHRITIS RHEUM-US, V63, P2641, DOI 10.1002/art.30444; KILPATRICK JM, 1982, MOL IMMUNOL, V19, P1159, DOI 10.1016/0161-5890(82)90326-1; Kopp A, 2012, BIOMOLECULES, V2, P46, DOI 10.3390/biom2010046; Kushner Irving, 2011, Pharos Alpha Omega Alpha Honor Med Soc, V74, P14; Loeffler J.M., 2009, Q J MED, V102, P644; LOVELESS RW, 1992, EMBO J, V11, P813, DOI 10.1002/j.1460-2075.1992.tb05118.x; Malley R, 2012, P NATL ACAD SCI USA, V109, P3623, DOI 10.1073/pnas.1121383109; Mikolajek H, 2011, J MOL RECOGNIT, V24, P371, DOI 10.1002/jmr.1090; MOLD C, 1982, INFECT IMMUN, V37, P987, DOI 10.1128/IAI.37.3.987-992.1982; Mold C, 2002, J IMMUNOL, V168, P6375, DOI 10.4049/jimmunol.168.12.6375; MOLD C, 1981, J EXP MED, V154, P1703, DOI 10.1084/jem.154.5.1703; MOLD C, 1982, INFECT IMMUN, V38, P392, DOI 10.1128/IAI.38.1.392-395.1982; MOLD C, 1984, J IMMUNOL, V133, P882; NAKAYAMA S, 1983, CLIN EXP IMMUNOL, V54, P319; Noursadeghi M, 2000, P NATL ACAD SCI USA, V97, P14584, DOI 10.1073/pnas.97.26.14584; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; OLIVEIRA EB, 1980, J IMMUNOL, V124, P1396; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; ROUX KH, 1983, J IMMUNOL, V131, P2411; Rutemark C, 2011, P NATL ACAD SCI USA, V108, pE934, DOI 10.1073/pnas.1109831108; SCHWALBE RA, 1992, BIOCHEMISTRY-US, V31, P4907, DOI 10.1021/bi00135a023; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Singh SK, 2012, J BIOL CHEM, V287, P3550, DOI 10.1074/jbc.M111.310011; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200; SRINIVASAN N, 1994, STRUCTURE, V2, P1017, DOI 10.1016/S0969-2126(94)00105-7; Suresh MV, 2007, J IMMUNOL, V178, P1158, DOI 10.4049/jimmunol.178.2.1158; Suresh MV, 2006, J IMMUNOL, V176, P4369, DOI 10.4049/jimmunol.176.7.4369; Suresh MV, 2004, J BIOL CHEM, V279, P52552, DOI 10.1074/jbc.M409054200; SZALAI AJ, 1995, J IMMUNOL, V155, P2557; Teupser D, 2011, J BIOL CHEM, V286, P6272, DOI 10.1074/jbc.M110.161414; Thomas-Rudolph D, 2007, J IMMUNOL, V178, P7283, DOI 10.4049/jimmunol.178.11.7283; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Togashi S, 1997, LAB INVEST, V77, P525; TUOMANEN EI, 1995, NEW ENGL J MED, V332, P1280, DOI 10.1056/NEJM199505113321907; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; VOLANAKI.JE, 1971, P SOC EXP BIOL MED, V136, P612; VOLANAKIS JE, 1982, ANN NY ACAD SCI, V389, P235, DOI 10.1111/j.1749-6632.1982.tb22140.x; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741; WHITEHEAD AS, 1990, BIOCHEM J, V266, P283, DOI 10.1042/bj2660283; YING SC, 1989, J IMMUNOL, V143, P221; YOTHER J, 1982, J IMMUNOL, V128, P2374; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120; Zhang J, 2011, BIOCHIMIE, V93, P1710, DOI 10.1016/j.biochi.2011.06.003; Zipfel PF, 2008, VACCINE, V26, pI67, DOI 10.1016/j.vaccine.2008.11.015	66	18	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43116	43125		10.1074/jbc.M112.427310	http://dx.doi.org/10.1074/jbc.M112.427310			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23139417	hybrid, Green Published			2022-12-28	WOS:000312501600067
J	Goksenin, AY; Zahurancik, W; LeCompte, KG; Taggart, DJ; Suo, Z; Pursell, ZF				Goeksenin, A. Yasemin; Zahurancik, Walter; LeCompte, Kimberly G.; Taggart, David J.; Suo, Zucai; Pursell, Zachary F.			Human DNA Polymerase epsilon Is Able to Efficiently Extend from Multiple Consecutive Ribonucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES-SYNDROME; YEAST REPLICATIVE POLYMERASES; SACCHAROMYCES-CEREVISIAE; RNA-POLYMERASE; MITOCHONDRIAL-DNA; GENOME INTEGRITY; MISMATCH REPAIR; TOPOISOMERASE 1; IN-VIVO; DISCRIMINATION	Replicative DNA polymerases (Pols) help to maintain the high fidelity of replication in large part through their strong selectivity against mispaired deoxyribonucleotides. It has recently been demonstrated that several replicative Pols from yeast have surprisingly low selectivity for deoxyribonucleotides over their analogous ribonucleotides. In human cells, ribonucleotides are found in great abundance over deoxyribonucleotides, raising the possibility that ribonucleotides are incorporated in the human genome at significant levels during normal cellular functions. To address this possibility, the ability of human DNA polymerase epsilon to incorporate ribonucleotides was tested. At physiological concentrations of nucleotides, human Pol epsilon readily inserts and extends from incorporated ribonucleotides. Almost half of inserted ribonucleotides escape proofreading by 3' -> 5' exonuclease-proficient Pol epsilon, indicating that ribonucleotide incorporation by Pol epsilon is likely a significant event in human cells. Human Pol epsilon is also efficient at extending from primers terminating in up to five consecutive ribonucleotides. This efficient extension appears to result from reduced exonuclease activity on primers containing consecutive 3'-terminal ribonucleotides. These biochemical properties suggest that Pol epsilon is a likely source of ribonucleotides in human genomic DNA.	[Goeksenin, A. Yasemin; LeCompte, Kimberly G.; Pursell, Zachary F.] Tulane Univ, Dept Biochem & Mol Biol, Sch Med, New Orleans, LA 70112 USA; [Goeksenin, A. Yasemin; LeCompte, Kimberly G.; Pursell, Zachary F.] Tulane Univ, Tulane Canc Ctr, Sch Med, New Orleans, LA 70112 USA; [Zahurancik, Walter; Taggart, David J.; Suo, Zucai] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	Tulane University; Tulane University; University System of Ohio; Ohio State University	Pursell, ZF (corresponding author), Tulane Univ, Dept Biochem & Mol Biol, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.	zpursell@tulane.edu		Goksenin, Alexandra Yasemin/0000-0002-1120-1356; Pursell, Zachary/0000-0001-5871-7192; Zahurancik, Walter/0000-0002-0084-3644	National Institutes of Health [ES016780, RR020152, GM079403]; Tulane University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES016780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079403, P20GM103518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES016780 and RR020152 (to Z. F. P.) and GM079403 (to Z. S.). This work was also supported by Tulane University start-up funds (to Z. F. P.).	Albertson TM, 2009, P NATL ACAD SCI USA, V106, P17101, DOI 10.1073/pnas.0907147106; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Brown JA, 2010, J MOL BIOL, V395, P282, DOI 10.1016/j.jmb.2009.11.003; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Cavanaugh NA, 2010, J BIOL CHEM, V285, P24457, DOI 10.1074/jbc.M110.132407; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chen JJZ, 2000, NUCLEIC ACIDS RES, V28, P3649, DOI 10.1093/nar/28.18.3649; Clark AB, 2011, DNA REPAIR, V10, P476, DOI 10.1016/j.dnarep.2011.02.001; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Coffin SR, 2011, J BIOL CHEM, V286, P16984, DOI 10.1074/jbc.M111.228833; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; EDER PS, 1991, J BIOL CHEM, V266, P6472; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Frank P, 1998, BIOL CHEM, V379, P1407, DOI 10.1515/bchm.1998.379.12.1407; Fuste JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kasiviswanathan R, 2011, J BIOL CHEM, V286, P31490, DOI 10.1074/jbc.M111.252460; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Korona DA, 2011, NUCLEIC ACIDS RES, V39, P1763, DOI 10.1093/nar/gkq1034; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Kunkel TA, 2011, CURR OPIN CHEM BIOL, V15, P620, DOI 10.1016/j.cbpa.2011.07.025; Lin TC, 2001, BIOCHEMISTRY-US, V40, P8749, DOI 10.1021/bi0105936; Lippert MJ, 2011, P NATL ACAD SCI USA, V108, P698, DOI 10.1073/pnas.1012363108; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P21070, DOI 10.1073/pnas.1013048107; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Pavlov YI, 2001, GENETICS, V159, P47; Perrino FW, 2009, J MOL MED-JMM, V87, P25, DOI 10.1007/s00109-008-0422-3; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Ruiz JF, 2003, NUCLEIC ACIDS RES, V31, P4441, DOI 10.1093/nar/gkg637; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664; Takahashi T, 2011, P NATL ACAD SCI USA, V108, P692, DOI 10.1073/pnas.1012582108; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Watt DL, 2011, DNA REPAIR, V10, P897, DOI 10.1016/j.dnarep.2011.05.009; Williams JS, 2012, DNA REPAIR, V11, P649, DOI 10.1016/j.dnarep.2012.05.004; Zenkin N, 2008, CELL MOL LIFE SCI, V65, P2280, DOI 10.1007/s00018-008-8020-7	49	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42675	42684		10.1074/jbc.M112.422733	http://dx.doi.org/10.1074/jbc.M112.422733			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23093410	Green Published, hybrid			2022-12-28	WOS:000312501600028
J	Sapio, MR; Salzmann, A; Vessaz, M; Crespel, A; Lyons, PJ; Malafosse, A; Fricker, LD				Sapio, Matthew R.; Salzmann, Annick; Vessaz, Monique; Crespel, Arielle; Lyons, Peter J.; Malafosse, Alain; Fricker, Lloyd D.			Naturally Occurring Carboxypeptidase A6 Mutations EFFECT ON ENZYME FUNCTION AND ASSOCIATION WITH EPILEPSY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FEBRILE SEIZURES-PLUS; LOBE EPILEPSY; SCN1A; GENE; VARIANT; IDENTIFICATION; POPULATION; PREVALENCE	Carboxypeptidase A6 (CPA6) is a member of the A/B subfamily of M14 metallocarboxypeptidases that is expressed in brain and many other tissues during development. Recently, two mutations in human CPA6 were associated with febrile seizures and/or temporal lobe epilepsy. In this study we screened for additional CPA6 mutations in patients with febrile seizures and focal epilepsy, which encompasses the temporal lobe epilepsy subtype. Mutations found from this analysis as well as CPA6 mutations reported in databases of single nucleotide polymorphisms were further screened by analysis of the modeled proCPA6 protein structure and the functional role of the mutated amino acid. The point mutations predicted to affect activity and/or protein folding were tested by expression of the mutant in HEK293 cells and analysis of the resulting CPA6 protein. Common polymorphisms in CPA6 were also included in this analysis. Several mutations resulted in reduced enzyme activity or CPA6 protein levels in the extracellular matrix. The mutants with reduced extracellular CPA6 protein levels showed normal levels of 50-kDa proCPA6 in the cell, and this could be converted into 37-kDa CPA6 by trypsin, suggesting that protein folding was not greatly affected by the mutations. Interestingly, three of the mutations that reduced extracellular CPA6 protein levels were found in patients with epilepsy. Taken together, these results provide further evidence for the involvement of CPA6 mutations in human epilepsy and reveal additional rare mutations that inactivate CPA6 and could, therefore, also be associated with epileptic phenotypes.	[Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Sapio, Matthew R.; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Salzmann, Annick; Malafosse, Alain] Univ Geneva, Dept Psychiat, CH-1205 Geneva, Switzerland; [Vessaz, Monique; Malafosse, Alain] Univ Hosp Geneva, Dept Genet Med & Lab, CH-1205 Geneva, Switzerland; [Crespel, Arielle] Montpellier Univ Hosp, Dept Neurol, Montpellier, France; [Lyons, Peter J.] Andrews Univ, Dept Biol, Berrien Springs, MI 49104 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Geneva; University of Geneva; Universite de Montpellier; CHU de Montpellier; Andrews University	Fricker, LD (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	lloyd.fricker@einstein.yu.edu	Sapio, Matthew R/J-5096-2016	Sapio, Matthew R/0000-0002-8855-5419; Lyons, Peter/0000-0001-5214-5445; Salzmann, Annick/0000-0003-0571-251X	National Institutes of Health [DA-004494]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA-004494 (to L. D. F.)	[Anonymous], 1980, PEDIATRICS, V66, P1009; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Baulac S, 2004, LANCET NEUROL, V3, P421, DOI 10.1016/S1474-4422(04)00808-7; Chen H, 2001, HUM MUTAT, V18, P120, DOI 10.1002/humu.1161; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dibbens LM, 2010, ANN NEUROL, V67, P542, DOI 10.1002/ana.21909; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P360, DOI 10.1002/gepi.10264; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; FALCONER MA, 1964, ARCH NEUROL-CHICAGO, V10, P233, DOI 10.1001/archneur.1964.00460150003001; Fontenele-Neto JD, 2005, MOL BRAIN RES, V137, P132, DOI 10.1016/j.molbrainres.2005.02.026; Hauser WA, 1996, MAYO CLIN PROC, V71, P576, DOI 10.4065/71.6.576; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Kang JQ, 2009, J NEUROSCI, V29, P2845, DOI 10.1523/JNEUROSCI.4772-08.2009; Kim YH, 2001, PROTEIN ENG, V14, P343, DOI 10.1093/protein/14.5.343; Le Gal F, 2011, EPILEPSIA, V52, pE135, DOI 10.1111/j.1528-1167.2011.03164.x; Liao WP, 2010, EPILEPSIA, V51, P1669, DOI 10.1111/j.1528-1167.2010.02645.x; Lossin C, 2009, BRAIN DEV-JPN, V31, P114, DOI 10.1016/j.braindev.2008.07.011; Lyons PJ, 2008, J BIOL CHEM, V283, P7054, DOI 10.1074/jbc.M707680200; Lyons PJ, 2010, J BIOL CHEM, V285, P38234, DOI 10.1074/jbc.M110.158626; Lyons PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012967; Montgomery J, 2007, NAT PROTOC, V2, P59, DOI 10.1038/nprot.2007.10; Moulard B, 2001, BRAIN RES REV, V36, P275, DOI 10.1016/S0165-0173(01)00104-7; Mulley JC, 2005, HUM MOL GENET, V14, pR243, DOI 10.1093/hmg/ddi355; Nakayama J, 2009, BRAIN DEV-JPN, V31, P359, DOI 10.1016/j.braindev.2008.11.014; OTTMAN R, 1989, EPILEPSIA, V30, P107, DOI 10.1111/j.1528-1157.1989.tb05290.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Phillips MA, 1996, BIOCHEMISTRY-US, V35, P6771, DOI 10.1021/bi960113o; Pizzuti A, 2002, INVEST OPHTH VIS SCI, V43, P3609; RICH SS, 1987, AM J HUM GENET, V41, P249; Roshal D, 2011, EPILEPSY BEHAV, V21, P206, DOI 10.1016/j.yebeh.2011.03.003; Salzmann Annick, 2012, Epilepsy Res Treat, V2012, P863702, DOI 10.1155/2012/863702; Salzmann A, 2012, HUM MUTAT, V33, P124, DOI 10.1002/humu.21613; SANDER JWAS, 1990, LANCET, V336, P1267, DOI 10.1016/0140-6736(90)92959-L; Schlachter K, 2009, NEUROLOGY, V72, P974, DOI 10.1212/01.wnl.0000344401.02915.00; Stern Curt, 1943, SCIENCE, V97, P137, DOI 10.1126/science.97.2510.137; Taylor CF, 2009, BIOCHEM SOC T, V37, P433, DOI 10.1042/BST0370433; Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; Volkers L, 2011, EUR J NEUROSCI, V34, P1268, DOI 10.1111/j.1460-9568.2011.07826.x; Wallace H, 1998, LANCET, V352, P1970, DOI 10.1016/S0140-6736(98)04512-7; Wei SW, 2002, J BIOL CHEM, V277, P14954, DOI 10.1074/jbc.M112254200; Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A; Wojdacz TK, 2008, NAT PROTOC, V3, P1903, DOI 10.1038/nprot.2008.191; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Gomis-Ruth FX, 2012, BBA-PROTEINS PROTEOM, V1824, P157, DOI 10.1016/j.bbapap.2011.04.014	45	15	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42900	42909		10.1074/jbc.M112.414094	http://dx.doi.org/10.1074/jbc.M112.414094			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105115	Green Published, hybrid			2022-12-28	WOS:000312501600048
J	Tashiro, Y; Urushitani, M; Inoue, H; Koike, M; Uchiyama, Y; Komatsu, M; Tanaka, K; Yamazaki, M; Abe, M; Misawa, H; Sakimura, K; Ito, H; Takahashi, R				Tashiro, Yoshitaka; Urushitani, Makoto; Inoue, Haruhisa; Koike, Masato; Uchiyama, Yasuo; Komatsu, Masaaki; Tanaka, Keiji; Yamazaki, Maya; Abe, Manabu; Misawa, Hidemi; Sakimura, Kenji; Ito, Hidefumi; Takahashi, Ryosuke			Motor Neuron-specific Disruption of Proteasomes, but Not Autophagy, Replicates Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN; SUPEROXIDE-DISMUTASE; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASE; MOUSE MODEL; CRE RECOMBINASE; TRANSGENIC MICE; CELL-DEATH; TDP-43	Evidence suggests that protein misfolding is crucially involved in the pathogenesis of amyotrophic lateral sclerosis (ALS). However, controversy still exists regarding the involvement of proteasomes or autophagy in ALS due to previous conflicting results. Here, we show that impairment of the ubiquitin-proteasome system, but not the autophagy-lysosome system in motor neurons replicates ALS in mice. Conditional knock-out mice of the proteasome subunit Rpt3 in a motor neuron-specific manner (Rpt3-CKO) showed locomotor dysfunction accompanied by progressive motor neuron loss and gliosis. Moreover, diverse ALS-linked proteins, including TAR DNA-binding protein 43 kDa (TDP-43), fused in sarcoma (FUS), ubiquilin 2, and optineurin were mislocalized or accumulated in motor neurons, together with other typical ALS hallmarks such as basophilic inclusion bodies. On the other hand, motor neuron-specific knock-out of Atg7, a crucial component for the induction of autophagy (Atg7-CKO), only resulted in cytosolic accumulation of ubiquitin and p62, and no TDP-43 or FUS pathologies or motor dysfunction was observed. These results strongly suggest that proteasomes, but not autophagy, fundamentally govern the development of ALS in which TDP-43 and FUS proteinopathy may play a crucial role. Enhancement of proteasome activity may be a promising strategy for the treatment of ALS.	[Ito, Hidefumi] Wakayama Med Univ, Dept Neurol, Grad Sch Med, Wakayama 6418510, Japan; [Tashiro, Yoshitaka; Takahashi, Ryosuke] Kyoto Univ, Dept Neurol, Grad Sch Med, Kyoto 6068507, Japan; [Urushitani, Makoto] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Unit Neurobiol & Therapeut, Shiga 5202192, Japan; [Inoue, Haruhisa] Kyoto Univ, Inst Integrated Cell Mat Sci, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Koike, Masato; Uchiyama, Yasuo] Juntendo Univ, Dept Cell Biol & Neurosci, Grad Sch Med, Tokyo 1138421, Japan; [Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Protein Metab Project, Tokyo 1568506, Japan; [Yamazaki, Maya; Abe, Manabu; Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata 9518585, Japan; [Misawa, Hidemi] Keio Univ, Dept Pharmacol, Fac Pharm, Tokyo 1058512, Japan; [Takahashi, Ryosuke] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Saitama 3320012, Japan	Wakayama Medical University; Kyoto University; Shiga University of Medical Science; Kyoto University; Juntendo University; Tokyo Metropolitan Institute of Medical Science; Niigata University; Keio University; Japan Science & Technology Agency (JST)	Ito, H (corresponding author), Wakayama Med Univ, Dept Neurol, Grad Sch Med, 811-1 Kimiidera, Wakayama 6418510, Japan.	ito@wakayama-med.ac.jp; ryosuket@kuhp.kyoto-u.ac.jp	Koike, Masato/F-9584-2010; Yamazaki, Maya/C-6952-2012; Komatsu, Masaaki/B-8321-2011	Koike, Masato/0000-0002-3174-5684; Komatsu, Masaaki/0000-0001-7672-7722; Urushitani, Makoto/0000-0003-2773-9836; Inoue, Haruhisa/0000-0003-4736-9537	Japan Society for the Promotion of Science [21500336, 24300132]; Ministry of Education, Culture, Sports, Science and Technology of Japan [22110007, 23111002]; Funding Program for Next Generation World-Leading Researchers [L132]; Japan Science and Technology Agency [AS2211173G]; Research Committee of CNS Degenerative Diseases and Comprehensive Research on Disability Health and Welfare, the Ministry of Health, Labour and Welfare of Japan; Japan Science and Technology Agency; Core Research for Evolutional Science and Technology; Grants-in-Aid for Scientific Research [23300131] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Research Committee of CNS Degenerative Diseases and Comprehensive Research on Disability Health and Welfare, the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for scientific research from the Japan Society for the Promotion of Science (21500336 and 24300132), Grants-in-Aid for scientific research on Innovative Areas Foundation of Synapse and Neurocircuit Pathology (22110007), Brain Environment (23111002), and Comprehensive Brain Science Network) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Funding Program for Next Generation World-Leading Researchers (L132), the Japan Science and Technology Agency (AS2211173G), the Research Committee of CNS Degenerative Diseases and Comprehensive Research on Disability Health and Welfare, the Ministry of Health, Labour and Welfare of Japan, Japan Science and Technology Agency, and Core Research for Evolutional Science and Technology.	Aquilano K, 2003, J NEUROCHEM, V85, P1324, DOI 10.1046/j.1471-4159.2003.01783.x; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bentmann E, 2012, J BIOL CHEM, V287, P23079, DOI 10.1074/jbc.M111.328757; Bhattacharya A, 2012, NEUROBIOL AGING, V33, P1829, DOI 10.1016/j.neurobiolaging.2011.06.002; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Casciati A, 2002, J NEUROCHEM, V83, P1019, DOI 10.1046/j.1471-4159.2002.01232.x; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Droggiti A, 2011, J NEUROCHEM, V119, P630, DOI 10.1111/j.1471-4159.2011.07444.x; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lang-Rollin I, 2005, APOPTOSIS, V10, P809, DOI 10.1007/s10495-005-0378-5; Lang-Rollin I, 2004, J NEUROCHEM, V90, P1511, DOI 10.1111/j.1471-4159.2004.02684.x; Lee J.A., 2012, EXP NEUROBIOL, V21, P1, DOI DOI 10.5607/EN.2012.21.1.1; Lee M, 2001, FREE RADICAL BIO MED, V31, P1550, DOI 10.1016/S0891-5849(01)00633-5; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Matsui H, 2010, J NEUROCHEM, V115, P178, DOI 10.1111/j.1471-4159.2010.06918.x; McNaught KSP, 2002, NEUROSCI LETT, V326, P155, DOI 10.1016/S0304-3940(02)00296-3; Misawa H, 2003, GENESIS, V37, P44, DOI 10.1002/gene.10224; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; MIZUSAWA H, 1989, ACTA NEUROPATHOL, V79, P37, DOI 10.1007/BF00308955; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; OKAMOTO K, 1991, ACTA NEUROPATHOL, V81, P610, DOI 10.1007/BF00296370; Papadeas ST, 2011, P NATL ACAD SCI USA, V108, P17803, DOI 10.1073/pnas.1103141108; Rideout HJ, 2005, J NEUROCHEM, V93, P1304, DOI 10.1111/j.1471-4159.2005.03124.x; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sakao Y, 2000, GENOMICS, V67, P1, DOI 10.1006/geno.2000.6231; Takeuchi T, 2002, BIOCHEM BIOPH RES CO, V293, P953, DOI 10.1016/S0006-291X(02)00321-2; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tsvetkov AS, 2010, P NATL ACAD SCI USA, V107, P16982, DOI 10.1073/pnas.1004498107; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Urushitani M, 2010, J NEUROSCI RES, V88, P784, DOI 10.1002/jnr.22243; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vlug AS, 2004, AMYOTROPH LATERAL SC, V5, P16, DOI 10.1080/14660820310016804; Wahl C, 2008, J NEURAL TRANSM, V115, P1141, DOI 10.1007/s00702-008-0054-3; Wang HQ, 2008, J NEUROCHEM, V107, P171, DOI 10.1111/j.1471-4159.2008.05607.x; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhang XJ, 2011, AUTOPHAGY, V7, P412, DOI 10.4161/auto.7.4.14541	61	129	131	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42984	42994		10.1074/jbc.M112.417600	http://dx.doi.org/10.1074/jbc.M112.417600			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095749	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000312501600055
J	Baaklini, I; Wong, MJH; Hantouche, C; Patel, Y; Shrier, A; Young, JC				Baaklini, Imad; Wong, Michael J. H.; Hantouche, Christine; Patel, Yogita; Shrier, Alvin; Young, Jason C.			The DNAJA2 Substrate Release Mechanism Is Essential for Chaperone-mediated Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FINGER-LIKE REGION; I HSP40; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; HSP70 CHAPERONES; YEAST HSP40; PROTEIN; YDJ1; BINDING; HSC70	DNAJA1 (DJA1/Hdj2) and DNAJA2 (DJA2) are the major J domain partners of human Hsp70/Hsc70 chaperones. Although they have overall similarity with the well characterized type I co-chaperones from yeast and bacteria, they are biologically distinct, and their functional mechanisms are poorly characterized. We identified DJA2-specific activities in luciferase folding and repression of human ether-a-go-go-related gene (HERG) trafficking that depended on its expression levels in cells. Mutations in different internal domains of DJA2 abolished these effects. Using purified proteins, we addressed the mechanistic defects. A mutant lacking the region between the zinc finger motifs (DJA2-Delta m2) was able to bind substrate similar to wild type but was incapable of releasing substrate during its transfer to Hsc70. The equivalent mutation in DJA1 also abolished its substrate release. A DJA2 mutant (DJA-221), which had its C-terminal dimerization region replaced by that of DJA1, was inactive but retained its ability to release substrate. The release mechanism required the J domain and ATP hydrolysis by Hsc70, although the nucleotide dependence diverged between DJA2 and DJA1. Limited proteolysis suggested further conformational differences between the two wild-type co-chaperones and the mutants. Our results demonstrate an essential role of specific DJA domains in the folding mechanism of Hsc70.	[Baaklini, Imad; Wong, Michael J. H.; Patel, Yogita; Young, Jason C.] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Hantouche, Christine; Shrier, Alvin] McGill Univ, Dept Physiol, Montreal, PQ H3G 0B1, Canada; Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Young, JC (corresponding author), McGill Univ, Dept Biochem, 3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	jason.young2@mcgill.ca			Canadian Institutes of Health Research; Groupe de Recherche Axe sur la Structure des Proteines; McGill Training Program in Systems Biology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Groupe de Recherche Axe sur la Structure des Proteines; McGill Training Program in Systems Biology	This work was supported in part by the Canadian Institutes of Health Research.; Supported by a fellowship from Groupe de Recherche Axe sur la Structure des Proteines.; Supported by a scholarship from the McGill Training Program in Systems Biology.	Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Banecki B, 1996, J BIOL CHEM, V271, P14840, DOI 10.1074/jbc.271.25.14840; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Borges JC, 2005, J BIOL CHEM, V280, P13671, DOI 10.1074/jbc.M408349200; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Fan CY, 2005, J BIOL CHEM, V280, P695, DOI 10.1074/jbc.M410645200; Fewell SW, 2004, J BIOL CHEM, V279, P51131, DOI 10.1074/jbc.M404857200; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Flom GA, 2008, MOL BIOL CELL, V19, P5249, DOI 10.1091/mbc.E08-04-0435; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Inobe T, 2003, J MOL BIOL, V329, P121, DOI 10.1016/S0022-2836(03)00409-1; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Jin Y, 2008, EMBO J, V27, P2873, DOI 10.1038/emboj.2008.207; Johnson JL, 2001, J CELL BIOL, V152, P851, DOI 10.1083/jcb.152.4.851; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kota P, 2009, P NATL ACAD SCI USA, V106, P11073, DOI 10.1073/pnas.0900746106; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Linke K, 2003, J BIOL CHEM, V278, P44457, DOI 10.1074/jbc.M307491200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Michels AA, 1997, J BIOL CHEM, V272, P33283, DOI 10.1074/jbc.272.52.33283; MILARSKI KL, 1989, J CELL BIOL, V109, P1947, DOI 10.1083/jcb.109.5.1947; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019; Rosales-Hernandez A, 2009, CELL STRESS CHAPERON, V14, P71, DOI 10.1007/s12192-008-0056-y; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Summers DW, 2009, J BIOL CHEM, V284, P3628, DOI 10.1074/jbc.M807369200; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200; Terada K, 2010, J BIOL CHEM, V285, P16789, DOI 10.1074/jbc.M110.101501; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Walker VE, 2007, J BIOL CHEM, V282, P23509, DOI 10.1074/jbc.M701006200; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Wu YK, 2005, J MOL BIOL, V346, P1005, DOI 10.1016/j.jmb.2004.12.040; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]	42	29	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41939	41954		10.1074/jbc.M112.413278	http://dx.doi.org/10.1074/jbc.M112.413278			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23091061	Green Published, hybrid			2022-12-28	WOS:000312103000034
J	Sharma, B; Joshi, S; Sassano, A; Majchrzak, B; Kaur, S; Aggarwal, P; Nabet, B; Bulic, M; Stein, BL; McMahon, B; Baker, DP; Fukunaga, R; Altman, JK; Licht, JD; Fish, EN; Platanias, LC				Sharma, Bhumika; Joshi, Sonali; Sassano, Antonella; Majchrzak, Beata; Kaur, Surinder; Aggarwal, Priya; Nabet, Behnam; Bulic, Marinka; Stein, Brady L.; McMahon, Brandon; Baker, Darren P.; Fukunaga, Rikiro; Altman, Jessica K.; Licht, Jonathan D.; Fish, Eleanor N.; Platanias, Leonidas C.			Sprouty Proteins Are Negative Regulators of Interferon (IFN) Signaling and IFN-inducible Biological Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE PATHWAY; CELLS RESPOND; I INTERFERONS; MAP KINASE; ACTIVATION; GROWTH; PHOSPHORYLATION; GENES; ANTAGONIST; GENERATION	Interferons (IFNs) have important antiviral and antineoplastic properties, but the precise mechanisms required for generation of these responses remain to be defined. We provide evidence that during engagement of the Type I IFN receptor (IFNR), there is up-regulation of expression of Sprouty (Spry) proteins 1, 2, and 4. Our studies demonstrate that IFN-inducible up-regulation of Spry proteins is Mnk kinase-dependent and results in suppressive effects on the IFN-activated p38 MAP kinase (MAPK), the function of which is required for transcription of interferon-stimulated genes (ISGs). Our data establish that ISG15 mRNA expression and IFN-dependent antiviral responses are enhanced in Spry1,2,4 triple knock-out mouse embryonic fibroblasts, consistent with negative feedback regulatory roles for Spry proteins in IFN-mediated signaling. In other studies, we found that siRNA-mediated knockdown of Spry1, Spry2, or Spry4 promotes IFN-inducible antileukemic effects in vitro and results in enhanced suppressive effects on malignant hematopoietic progenitors from patients with polycythemia vera. Altogether, our findings demonstrate that Spry proteins are potent regulators of Type I IFN signaling and negatively control induction of Type I IFN-mediated biological responses.	[Sharma, Bhumika; Joshi, Sonali; Sassano, Antonella; Kaur, Surinder; Aggarwal, Priya; Nabet, Behnam; Bulic, Marinka; Stein, Brady L.; McMahon, Brandon; Altman, Jessica K.; Licht, Jonathan D.; Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Sharma, Bhumika; Joshi, Sonali; Sassano, Antonella; Kaur, Surinder; Aggarwal, Priya; Nabet, Behnam; Bulic, Marinka; Stein, Brady L.; McMahon, Brandon; Altman, Jessica K.; Licht, Jonathan D.; Platanias, Leonidas C.] Northwestern Univ, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Altman, Jessica K.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Div Hematol Oncol, Dept Med, Chicago, IL 60612 USA; [Majchrzak, Beata; Fish, Eleanor N.] Univ Toronto, Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 2M1, Canada; [Majchrzak, Beata; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M1, Canada; [Baker, Darren P.] Biogen Idec Inc, Cambridge, MA 02142 USA; [Fukunaga, Rikiro] Osaka Univ Pharmaceut Sci, Biochem Lab, Osaka 5691094, Japan	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Biogen; Osaka University of Pharmaceutical Sciences	Platanias, LC (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, 303 E Super St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Nabet, Behnam/AAZ-4987-2020; Licht, Jonathan/L-4239-2019; Licht, Jonathan/AAL-9184-2020; Fukunaga, Rikiro/CAG-2891-2022	Nabet, Behnam/0000-0002-6738-4200; Licht, Jonathan/0000-0002-3942-1369; 	National Institutes of Health [CA155566, CA77816, CA161796]; Merit Review grant from the Department of Veterans Affairs; Lynn Sage Foundation; Canadian Institutes of Health Research Grant [285791]; NATIONAL CANCER INSTITUTE [R01CA155566, R01CA161796, R01CA077816, P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24590105] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review grant from the Department of Veterans Affairs(US Department of Veterans Affairs); Lynn Sage Foundation; Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA155566, CA77816, and CA161796 (to L. C. P.). This work was also supported by a Merit Review grant from the Department of Veterans Affairs (to L. C. P.); by the Lynn Sage Foundation (to J. D. L.); and by Canadian Institutes of Health Research Grant 285791 (to E. N. F.).	Akbulut S, 2010, MOL BIOL CELL, V21, P3487, DOI 10.1091/mbc.E10-02-0123; Basson MA, 2006, DEV BIOL, V299, P466, DOI 10.1016/j.ydbio.2006.08.051; Bracarda S, 2010, EUR J CANCER, V46, P284, DOI 10.1016/j.ejca.2009.10.013; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Cheon H, 2011, J INTERF CYTOK RES, V31, P33, DOI 10.1089/jir.2010.0100; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Joshi S, 2011, J BIOL CHEM, V286, P6017, DOI 10.1074/jbc.M110.197921; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kaur S, 2012, P NATL ACAD SCI USA, V109, P7723, DOI 10.1073/pnas.1118122109; Kiladjian JJ, 2008, BLOOD, V112, P3065, DOI 10.1182/blood-2008-03-143537; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Lasfar A, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/349575; Leeksma OC, 2002, EUR J BIOCHEM, V269, P2546, DOI 10.1046/j.1432-1033.2002.02921.x; Li X, 2003, BIOCHEM SOC T, V31, P1445; Lu M, 2010, EXP HEMATOL, V38, P472, DOI 10.1016/j.exphem.2010.03.005; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; Minowada G, 1999, DEVELOPMENT, V126, P4465; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2003, PHARMACOL THERAPEUT, V98, P129, DOI 10.1016/S0163-7258(03)00016-0; Quintas-Cardama A, 2009, J CLIN ONCOL, V27, P5418, DOI 10.1200/JCO.2009.23.6075; Ritchie KJ, 2004, SEMIN CELL DEV BIOL, V15, P237, DOI 10.1016/j.semcdb.2003.12.005; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Stark GR, 2007, CYTOKINE GROWTH F R, V18, P419, DOI 10.1016/j.cytogfr.2007.06.013; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tefft D, 2002, AM J PHYSIOL-LUNG C, V283, pL700, DOI 10.1152/ajplung.00372.2001; Uddin S, 2000, J BIOL CHEM, V275, P27634; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200	45	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42352	42360		10.1074/jbc.M112.400721	http://dx.doi.org/10.1074/jbc.M112.400721			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23074222	hybrid, Green Published			2022-12-28	WOS:000312103000070
J	Tu-Sekine, B; Raben, DM				Tu-Sekine, Becky; Raben, Daniel M.			Dual Regulation of Diacylglycerol Kinase (DGK)-theta POLYBASIC PROTEINS PROMOTE ACTIVATION BY PHOSPHOLIPIDS AND INCREASE SUBSTRATE AFFINITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; ALPHA; THETA; RAS; ORGANIZATION; ENDOCYTOSIS; RECEPTORS; PEPTIDES; FAMILY	Diacylglycerol kinases are important mediators of lipid signaling cascades, and insight into their regulation is of increasing interest. Using purified DGK-theta, we show that this isoform is subject to dual regulation and that the previously characterized stimulation by acidic phospholipids is dependent on the presence of a positively charged protein or peptide. Polybasic cofactors lowered the K-m for diacylglycerol at the membrane surface (K-m(surf)), and worked synergistically with acidic phospholipids to increase activity 10- to 30-fold, suggesting that the purified enzyme is autoinhibited. Vesicle pulldown studies showed that acidic phospholipids recruit polybasic cofactors to the vesicle surface but have little effect on the membrane association of DGK-theta, suggesting that a triad of enzyme, acidic lipid and basic protein are necessary for interfacial activity. Importantly, these data demonstrate that the interfacial association and catalytic activity of DGK-theta are independently regulated. Finally, we show that DGK-theta directly interacts with, and is activated by, basic proteins such as histone H1 and Tau with nM affinity, consistent with a potential role for a polybasic protein or protein domain in the activation of this enzyme.	[Tu-Sekine, Becky; Raben, Daniel M.] Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 20120 USA	Johns Hopkins University; Johns Hopkins Medicine	Raben, DM (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 20120 USA.	draben@jhmi.edu			National Institutes of Health [GM059251]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grant GM059251 from the National Institutes of Health (to D. M. R.).	Allen D, 2007, J NEUROSCI, V27, P2369, DOI 10.1523/JNEUROSCI.3565-06.2007; Brose N, 2004, CURR OPIN NEUROBIOL, V14, P328, DOI 10.1016/j.conb.2004.05.006; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Flores I, 1996, J BIOL CHEM, V271, P10334, DOI 10.1074/jbc.271.17.10334; Fuchs B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-20; Golebiewska U, 2006, BIOPHYS J, V91, P588, DOI 10.1529/biophysj.106.081562; Hasegawa H, 2008, J CELL BIOCHEM, V105, P756, DOI 10.1002/jcb.21873; Houssa B, 1999, J BIOL CHEM, V274, P6820, DOI 10.1074/jbc.274.11.6820; Jones DR, 2000, FEBS LETT, V476, P160, DOI 10.1016/S0014-5793(00)01702-6; Kawasaki T, 2008, BIOCHEM J, V409, P471, DOI 10.1042/BJ20070755; Kiselev VY, 2011, BIOPHYS J, V100, P1261, DOI 10.1016/j.bpj.2011.01.025; Leach NT, 2007, AM J HUM GENET, V80, P792, DOI 10.1086/513019; Los AP, 2006, J BIOL CHEM, V281, P858, DOI 10.1074/jbc.M502693200; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McMullan R, 2006, GENE DEV, V20, P65, DOI 10.1101/gad.359706; MEGGIO F, 1994, BIOCHEMISTRY-US, V33, P4336, DOI 10.1021/bi00180a030; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Mills JC, 1998, J CELL SCI, V111, P625; Perez-Victoria I, 2011, BBA-BIOMEMBRANES, V1808, P717, DOI 10.1016/j.bbamem.2010.11.031; Rainero E, 2012, J CELL BIOL, V196, P277, DOI 10.1083/jcb.201109112; Regier DS, 2005, P NATL ACAD SCI USA, V102, P7595, DOI 10.1073/pnas.0500663102; Rincon E, 2007, MOL CELL PROTEOMICS, V6, P1073, DOI 10.1074/mcp.M700047-MCP200; Royle SJ, 2005, J CELL SCI, V118, P3073, DOI 10.1242/jcs.02451; Tabellini G, 2003, EXP CELL RES, V287, P143, DOI 10.1016/S0014-4827(03)00115-0; Topham MK, 2009, BBA-GEN SUBJECTS, V1790, P416, DOI 10.1016/j.bbagen.2009.01.010; Tu-Sekine B, 2007, BIOCHEMISTRY-US, V46, P924, DOI 10.1021/bi061170c; Tu-Sekine B, 2011, CRIT REV BIOCHEM MOL, V46, P353, DOI 10.3109/10409238.2011.577761; van Baal J, 2005, J BIOL CHEM, V280, P9870, DOI 10.1074/jbc.M409301200; Walker AJ, 2001, BIOCHEM J, V353, P129, DOI 10.1042/bj3530129; Watanabe H, 2010, J NEUROSCI, V30, P655, DOI 10.1523/JNEUROSCI.3214-09.2010; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Yang J, 2011, EMBO J, V30, P165, DOI 10.1038/emboj.2010.286; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394	33	10	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41619	41627		10.1074/jbc.M112.404855	http://dx.doi.org/10.1074/jbc.M112.404855			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23091060	Green Published, hybrid			2022-12-28	WOS:000312103000006
J	Fan, CD; Lum, MA; Xu, C; Black, JD; Wang, XJ				Fan, Chuan-Dong; Lum, Michelle A.; Xu, Chao; Black, Jennifer D.; Wang, Xinjiang			Ubiquitin-dependent Regulation of Phospho-AKT Dynamics by the Ubiquitin E3 Ligase, NEDD4-1, in the Insulin-like Growth Factor-1 Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; PTEN; DEGRADATION; STABILITY; COMPLEX; PHOSPHORYLATION; PROTOONCOGENE; SENSITIVITY; ACTIVATION; MUTATION	AKT is a critical effector kinase downstream of the PI3K pathway that regulates a plethora of cellular processes including cell growth, death, differentiation, and migration. Mechanisms underlying activated phospho-AKT (pAKT) translocation to its action sites remain unclear. Here we show that NEDD4-1 is a novel E3 ligase that specifically regulates ubiquitin-dependent trafficking of pAKT in insulin-like growth factor (IGF)-1 signaling. NEDD4-1 physically interacts with AKT and promotes HECT domain-dependent ubiquitination of exogenous and endogenous AKT. NEDD4-1 catalyzes K63-type polyubiquitin chain formation on AKT in vitro. Plasma membrane binding is the key step for AKT ubiquitination by NEDD4-1 in vivo. Ubiquitinated pAKT translocates to perinuclear regions, where it is released into the cytoplasm, imported into the nucleus, or coupled with proteasomal degradation. IGF-1 signaling specifically stimulates NEDD4-1-mediated ubiquitination of pAKT, without altering total AKT ubiquitination. A cancer-derived plasma membrane-philic mutant AKT(E17K) is more effectively ubiquitinated by NEDD4-1 and more efficiently trafficked into the nucleus compared with wild type AKT. This study reveals a novel mechanism by which a specific E3 ligase is required for ubiquitin-dependent control of pAKT dynamics in a ligand-specific manner.	[Fan, Chuan-Dong; Lum, Michelle A.; Xu, Chao; Black, Jennifer D.; Wang, Xinjiang] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Wang, XJ (corresponding author), Elm & Carlton St, Buffalo, NY 14263 USA.	xinjiang.wang@roswellpark.org			National Institutes of Health [DK54909, DK60632]; Roswell Park Cancer Institute; American Cancer Society [02-197-04]; Roswell Park Core Grant [CA16056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060632, R56DK060632, R01DK054909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roswell Park Cancer Institute; American Cancer Society(American Cancer Society); Roswell Park Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54909 and DK60632 (to J. B.), start-up funds from Roswell Park Cancer Institute (to X. W.), American Cancer Society Institutional Research Grant 02-197-04 (to X. W.), and Roswell Park Core Grant CA16056.	Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Drinjakovic J, 2010, NEURON, V65, P341, DOI 10.1016/j.neuron.2010.01.017; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Lee JRE, 2009, J BIOL CHEM, V284, P32126, DOI 10.1074/jbc.M109.048629; Maccario H, 2010, J BIOL CHEM, V285, P12620, DOI 10.1074/jbc.M109.072280; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meier R, 1997, J BIOL CHEM, V272, P30491, DOI 10.1074/jbc.272.48.30491; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Suizu F, 2009, DEV CELL, V17, P800, DOI 10.1016/j.devcel.2009.09.007; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wu YT, 2011, J BIOL CHEM, V286, P14190, DOI 10.1074/jbc.M111.219923; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012	32	75	77	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1674	1684		10.1074/jbc.M112.416339	http://dx.doi.org/10.1074/jbc.M112.416339			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23195959	Green Published, hybrid			2022-12-28	WOS:000313751400023
J	Makkonen, M; Bertling, E; Chebotareva, NA; Baum, J; Lappalainen, P				Makkonen, Maarit; Bertling, Enni; Chebotareva, Natalia A.; Baum, Jake; Lappalainen, Pekka			Mammalian and Malaria Parasite Cyclase-associated Proteins Catalyze Nucleotide Exchange on G-actin through a Conserved Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPOLYMERIZING FACTOR; FILAMENT TURNOVER; SRV2/CAP COMPLEX; REGULATES ACTIN; CELL POLARITY; ATP-ACTIN; ADP-ACTIN; COFILIN; PROFILIN; CAP	Cyclase-associated proteins (CAPs) are among the most highly conserved regulators of actin dynamics, being present in organisms from mammals to apicomplexan parasites. Yeast, plant, and mammalian CAPs are large multidomain proteins, which catalyze nucleotide exchange on actin monomers from ADP to ATP and recycle actin monomers from actin-depolymerizing factor (ADF)/cofilin for new rounds of filament assembly. However, the mechanism by which CAPs promote nucleotide exchange is not known. Furthermore, how apicomplexan CAPs, which lack many domains present in yeast and mammalian CAPs, contribute to actin dynamics is not understood. We show that, like yeast Srv2/CAP, mouse CAP1 interacts with ADF/cofilin and ADP-G-actin through its N-terminal alpha-helical and C-terminal beta-strand domains, respectively. However, in the variation to yeast Srv2/CAP, mouse CAP1 has two adjacent profilin-binding sites, and it interacts with ATP-actin monomers with high affinity through its WH2 domain. Importantly, we revealed that the C-terminal beta-sheet domain of mouse CAP1 is essential and sufficient for catalyzing nucleotide exchange on actin monomers, although the adjacent WH2 domain is not required for this function. Supporting these data, we show that the malaria parasite Plasmodium falciparum CAP, which is entirely composed of the beta-sheet domain, efficiently promotes nucleotide exchange on actin monomers. Collectively, this study provides evidence that catalyzing nucleotide exchange on actin monomers via the beta-sheet domain is the most highly conserved function of CAPs from mammals to apicomplexan parasites. Other functions, including interactions with profilin and ADF/cofilin, evolved in more complex organisms to adjust the specific role of CAPs in actin dynamics.	[Makkonen, Maarit; Bertling, Enni; Lappalainen, Pekka] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland; [Chebotareva, Natalia A.] Russian Acad Sci, Bach Inst Biochem, Moscow 11907, Russia; [Baum, Jake] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Baum, Jake] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	University of Helsinki; Research Center of Biotechnology RAS; Russian Academy of Sciences; Walter & Eliza Hall Institute; University of Melbourne	Lappalainen, P (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland.	pekka.lappalainen@helsinki.fi	; Chebotareva, Natalia/X-6019-2018	Baum, Jake/0000-0002-0275-352X; Lappalainen, Pekka/0000-0001-6227-0354; Chebotareva, Natalia/0000-0002-3505-8777	Academy of Finland; Sigrid Juselius Foundation; Biocentrum Helsinki; Helsinki Graduate Program in Biotechnology and Molecular Biology; program "Molecular and Cell Biology" from the Russian Academy of Sciences; Australian Research Council Future Fellowship [FT100100112]; Human Frontier Science Organization Grant [RGY0071/2011]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsinki; Helsinki Graduate Program in Biotechnology and Molecular Biology; program "Molecular and Cell Biology" from the Russian Academy of Sciences; Australian Research Council Future Fellowship(Australian Research Council); Human Frontier Science Organization Grant(Human Frontier Science Program)	This work was supported in part by grants from the Academy of Finland, the Sigrid Juselius Foundation, and Biocentrum Helsinki (to P. L.).; Funded by a fellowship from the Helsinki Graduate Program in Biotechnology and Molecular Biology.; Supported by the program "Molecular and Cell Biology" from the Russian Academy of Sciences.; Supported by Australian Research Council Future Fellowship FT100100112 and by Human Frontier Science Organization Grant RGY0071/2011.	Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Barrero RA, 2002, PLANT CELL, V14, P149, DOI 10.1105/tpc.010301; Baum B, 2000, CURR BIOL, V10, P964, DOI 10.1016/S0960-9822(00)00640-0; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Benlali A, 2000, CELL, V101, P271, DOI 10.1016/S0092-8674(00)80837-5; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Bertling E, 2007, J CELL SCI, V120, P1225, DOI 10.1242/jcs.000158; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chaudhry F., 2012, MOL BIOL CE IN PRESS; Chaudhry F, 2007, MOL BIOL CELL, V18, P3002, DOI 10.1091/mbc.E06-11-1041; Chaudhry F, 2010, CYTOSKELETON, V67, P120, DOI 10.1002/cm.20429; DiNubile MJ, 1999, CELL MOTIL CYTOSKEL, V43, P10, DOI 10.1002/(SICI)1097-0169(1999)43:1<10::AID-CM2>3.3.CO;2-M; Dodatko T, 2004, BIOCHEMISTRY-US, V43, P10628, DOI 10.1021/bi049071r; Dominguez R, 2007, ANN NY ACAD SCI, V1112, P86, DOI 10.1196/annals.1415.011; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Eads JC, 1998, BIOCHEMISTRY-US, V37, P11171, DOI 10.1021/bi9720033; Effendi K, 2013, EXP CELL RES, V319, P35, DOI 10.1016/j.yexcr.2012.09.013; FEDORCHAIKEN M, 1990, CELL, V61, P329, DOI 10.1016/0092-8674(90)90813-T; FIELD J, 1990, CELL, V61, P319, DOI 10.1016/0092-8674(90)90812-S; FREEMAN NL, 1995, J BIOL CHEM, V270, P5680, DOI 10.1074/jbc.270.10.5680; Frenal K, 2009, CELL HOST MICROBE, V5, P602, DOI 10.1016/j.chom.2009.05.013; GERST JE, 1991, MOL CELL BIOL, V11, P1248, DOI 10.1128/MCB.11.3.1248; Helfer E, 2006, EMBO J, V25, P1184, DOI 10.1038/sj.emboj.7601019; Hliscs M, 2010, J BIOL CHEM, V285, P11572, DOI 10.1074/jbc.M109.054916; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; Kardos R, 2009, BIOPHYS J, V96, P2335, DOI 10.1016/j.bpj.2008.12.3906; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Mattila PK, 2004, MOL BIOL CELL, V15, P5158, DOI 10.1091/mbc.E04-06-0444; Mattila PK, 2003, J BIOL CHEM, V278, P8452, DOI 10.1074/jbc.M212113200; Michelot A, 2011, CURR BIOL, V21, pR560, DOI 10.1016/j.cub.2011.06.019; Moriyama K, 2002, J CELL SCI, V115, P1591; Noegel AA, 2004, MOL BIOL CELL, V15, P934, DOI 10.1091/mbc.E03-05-0269; Nomura K, 2012, J CELL SCI, V125, P4077, DOI 10.1242/jcs.104950; Normoyle KPM, 2012, J BIOL CHEM, V287, P35722, DOI 10.1074/jbc.M112.396051; Ojala PJ, 2002, MOL BIOL CELL, V13, P3811, DOI 10.1091/mbc.E02-03-0157; Olshina MA, 2012, IUBMB LIFE, V64, P370, DOI 10.1002/iub.1014; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Peche V. S., 2012, CELL MOL LI IN PRESS; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Quintero-Monzon O, 2009, J BIOL CHEM, V284, P10923, DOI 10.1074/jbc.M808760200; Schuler H, 2005, MOL BIOL CELL, V16, P4013, DOI 10.1091/mbc.E05-02-0086; Singh BK, 2011, J BIOL CHEM, V286, P28256, DOI 10.1074/jbc.M111.211730; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Turunen SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034910; Wen KK, 2008, J BIOL CHEM, V283, P9444, DOI 10.1074/jbc.M709806200; Wong W, 2011, P NATL ACAD SCI USA, V108, P9869, DOI 10.1073/pnas.1018927108; Yusof AM, 2005, PROTEINS, V58, P255, DOI 10.1002/prot.20314	54	47	50	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					984	994		10.1074/jbc.M112.435719	http://dx.doi.org/10.1074/jbc.M112.435719			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184938	hybrid, Green Published			2022-12-28	WOS:000313570300023
J	Shimamura, S; Sasaki, K; Tanaka, M				Shimamura, Shintaro; Sasaki, Kazuki; Tanaka, Masamitsu			The Src Substrate SKAP2 Regulates Actin Assembly by Interacting with WAVE2 and Cortactin Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; ARP2/3 COMPLEX; CELL MOTILITY; ADAPTER; WASP; CYTOSKELETON; ADHESION; HOM; PHOSPHORYLATION; POLYMERIZATION	In our attempt to screen for substrates of Src family kinases in glioblastoma, Src kinase-associated phosphoprotein 2 (SKAP2) was identified. Although SKAP2 has been suggested to be associated with integrin-mediated adhesion of hematopoietic cells, little is known about its molecular function and the effects in other types of cells and tumors. Here, we demonstrate that SKAP2 physically associates with actin assembly factors WAVE2 and cortactin and inhibits their interaction. Cortactin is required for the membrane localization of WAVE2, and SKAP2 suppresses actin polymerization mediated by WAVE2 and cortactin in vitro. Knockdown of SKAP2 in NIH3T3 accelerated cell migration and enhanced translocation of WAVE2 to the cell membrane, and those effects of SKAP2 depend on the binding activity of SKAP2 to WAVE2. Furthermore, reduction of SKAP2 in the glioblastoma promoted tumor invasion both in ex vivo organotypic rat brain slices and immune-deficient mouse brains. These results suggest that SKAP2 negatively regulates cell migration and tumor invasion in fibroblasts and glioblastoma cells by suppressing actin assembly induced by the WAVE2-cortactin complex, indicating that SKAP2 may be a novel candidate for the suppressor of tumor progression.	[Shimamura, Shintaro; Tanaka, Masamitsu] Akita Univ, Grad Sch Med, Dept Mol Med & Biochem, Akita 0108543, Japan; [Sasaki, Kazuki] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Mol Pharmacol, Suita, Osaka 5658565, Japan	Akita University; National Cerebral & Cardiovascular Center - Japan	Tanaka, M (corresponding author), Akita Univ, Grad Sch Med, Dept Mol Med & Biochem, 1-1-1 Hondo, Akita 0108543, Japan.	mastanak@med.akita-u.ac.jp			Japan Society for the Promotion of Science [22300324, 23650590, 24700364]; National Cancer Center Research and Development Fund [23-A-9]; Uehara Memorial Foundation; Naito Foundation; Yasuda Medical Foundation; Grants-in-Aid for Scientific Research [23650590] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Yasuda Medical Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science Grants 22300324 and 23650590 (to M. T.) and 24700364 (to S. S.), National Cancer Center Research and Development Fund Grant 23-A-9 (to M. T.), the Uehara Memorial Foundation, the Naito Foundation, and the Yasuda Medical Foundation.	Black DS, 2000, CELL MICROBIOL, V2, P401, DOI 10.1046/j.1462-5822.2000.00061.x; Bourette RP, 2005, CELL SIGNAL, V17, P941, DOI 10.1016/j.cellsig.2004.11.009; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cavalcanti BN, 2011, BRAZ ORAL RES, V25, P13, DOI 10.1590/S1806-83242011000100003; Coppolino MG, 2001, J CELL SCI, V114, P4307; Curtis DJ, 2000, EXP HEMATOL, V28, P1250, DOI 10.1016/S0301-472X(00)00537-3; Derivery E, 2010, BIOESSAYS, V32, P119, DOI 10.1002/bies.200900123; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Kang HR, 2010, BIOCHEM BIOPH RES CO, V400, P661, DOI 10.1016/j.bbrc.2010.08.123; Kouroku Y, 1998, BIOCHEM BIOPH RES CO, V252, P738, DOI 10.1006/bbrc.1998.9637; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Liu J, 1998, P NATL ACAD SCI USA, V95, P8779, DOI 10.1073/pnas.95.15.8779; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Marie-Cardine A, 1998, FEBS LETT, V435, P55, DOI 10.1016/S0014-5793(98)01040-0; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Reinhold A, 2009, J LEUKOCYTE BIOL, V86, P61, DOI [10.1189/JLB.0608344, 10.1189/jlb.0608344]; Ren G, 2009, CELL MOTIL CYTOSKEL, V66, P865, DOI 10.1002/cm.20380; Swanson KD, 2008, MOL CELL, V32, P564, DOI 10.1016/j.molcel.2008.09.022; Takenawa T, 2001, J CELL SCI, V114, P1801; Tanaka M, 2005, J BIOL CHEM, V280, P42375, DOI 10.1074/jbc.M503786200; Tanaka M, 2007, J CELL SCI, V120, P2179, DOI 10.1242/jcs.008607; Tanaka M, 2009, MOL CELL BIOL, V29, P402, DOI 10.1128/MCB.01035-08; Togni M, 2005, MOL CELL BIOL, V25, P8052, DOI 10.1128/MCB.25.18.8052-8063.2005; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; Wang HY, 2008, TRENDS CELL BIOL, V18, P486, DOI 10.1016/j.tcb.2008.07.005; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Yagi R, 2011, ONCOGENE, V30, P1413, DOI 10.1038/onc.2010.522; Zhou L, 2011, J CELL MOL MED, V15, P783, DOI 10.1111/j.1582-4934.2010.01048.x	31	17	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1171	1183		10.1074/jbc.M112.386722	http://dx.doi.org/10.1074/jbc.M112.386722			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23161539	Green Published, hybrid			2022-12-28	WOS:000313570300039
J	Fernandez, PV; Quintana, I; Cerezo, AS; Caramelo, JJ; Pol-Fachin, L; Verli, H; Estevez, JM; Ciancia, M				Fernandez, Paula V.; Quintana, Irene; Cerezo, Alberto S.; Caramelo, Julio J.; Pol-Fachin, Laercio; Verli, Hugo; Estevez, Jose M.; Ciancia, Marina			Anticoagulant Activity of a Unique Sulfated Pyranosic (1 -> 3)-beta-L-Arabinan through Direct Interaction with Thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARINE GREEN-ALGA; CODIUM-FRAGILE; CRYSTAL-STRUCTURE; POLYSACCHARIDES; GALACTAN; HEPARIN; PROTEOGLYCAN; CARRAGEENAN; INHIBITORS; SEAWEEDS	A highly sulfated 3-linked beta-arabinan (Ab1) with arabinose in the pyranose form was obtained from green seaweed Codium vermilara (Bryopsidales). It comprised major amounts of units sulfated on C-2 and C-4 and constitutes the first polysaccharide of this type isolated in the pure form and fully characterized. Ab1 showed anticoagulant activity by global coagulation tests. Less sulfated arabinans obtained from the same seaweed have less or no activity. Ab1 exerts its activity through direct and indirect (antithrombin-and heparin cofactor II-mediated) inhibition of thrombin. Direct thrombin inhibition was studied in detail. By native PAGE, it was possible to detect formation of a complex between Ab1 and human thrombin (HT). Ab1 binding to HT was measured by fluorescence spectroscopy. CD spectra of the Ab1 complex suggested that ligand binding induced a small conformational change on HT. Ab1-thrombin interactions were studied by molecular dynamic simulations using the persulfated octasaccharide as model compound. Most carbohydrate-protein contacts would occur by interaction of sulfate groups with basic amino acid residues on the surface of the enzyme, more than 60% of them being performed by the exosite 2-composing residues. In these interactions, the sulfate groups on C-2 were shown to interact more intensely with the thrombin structure. In contrast, the disulfated oligosaccharide does not promote major conformational modifications at the catalytic site when complexed to exosite 1. These results show that this novel pyranosic sulfated arabinan Ab1 exerts its anticoagulant activity by a mechanism different from those found previously for other sulfated polysaccharides and glycosaminoglycans.	[Fernandez, Paula V.; Ciancia, Marina] Univ Buenos Aires, Fac Agron, Catedra Quim Biomol, Dept Biol Aplicada & Alimentos, RA-1417 Buenos Aires, DF, Argentina; [Quintana, Irene] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Hemostasia & Trombosis, RA-1417 Buenos Aires, DF, Argentina; [Cerezo, Alberto S.; Ciancia, Marina] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Organ, Ctr Invest Hidratos Carbono CIHIDEC,Consejo Nacl, RA-1417 Buenos Aires, DF, Argentina; [Caramelo, Julio J.] Consejo Nacl Invest Cient & Tecn, IIBBA, RA-1405 Buenos Aires, DF, Argentina; [Pol-Fachin, Laercio; Verli, Hugo] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Programa Posgrad Biol Celular & Mol, BR-90610000 Porto Alegre, RS, Brazil; [Verli, Hugo] Univ Fed Rio Grande do Sul, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil; [Estevez, Jose M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias IFIByNE, CONICET, RA-1417 Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Ciancia, M (corresponding author), Univ Buenos Aires, Fac Agron, Catedra Quim Biomol, Dept Biol Aplicada & Alimentos, Av San Martin 4453, RA-1417 Buenos Aires, DF, Argentina.	ciancia@agro.uba.ar	Estevez, Jose Manuel/C-2915-2018; Verli, Hugo/G-8703-2012; Verli, Hugo/AAZ-2148-2021; Estevez, Jose Manuel/AAZ-9261-2020	Estevez, Jose Manuel/0000-0001-6332-7738; Verli, Hugo/0000-0002-4796-8620; Estevez, Jose Manuel/0000-0001-6332-7738	National Research Council of Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 559/2010]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) [PICT 2008-0500]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	National Research Council of Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from the National Research Council of Argentina, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Grant PIP 559/2010, and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) Grant PICT 2008-0500 (to M. C.) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (to H. V.).	ASPINALL GO, 1982, POLYSACCHARIDES, V1, P19; Becker CF, 2007, J MOL GRAPH MODEL, V26, P391, DOI 10.1016/j.jmgm.2007.01.008; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bilan MI, 2007, CARBOHYD RES, V342, P586, DOI 10.1016/j.carres.2006.11.008; BOCK K, 1983, ADV CARBOHYD CHEM BI, V41, P27, DOI 10.1016/S0065-2318(08)60055-4; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Boraso de Zaixso A., 2004, HIST NAT, V3, P95; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Carroll WE, 1999, AM J CLIN PATHOL, V111, P565; Ciancia M, 2010, CURR MED CHEM, V17, P2503, DOI 10.2174/092986710791556069; Ciancia M, 2007, INT J BIOL MACROMOL, V41, P641, DOI 10.1016/j.ijbiomac.2007.08.007; Cinelli LP, 2010, GLYCOBIOLOGY, V20, P702, DOI 10.1093/glycob/cwq017; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; CLARKE AE, 1979, PHYTOCHEMISTRY, V18, P521, DOI 10.1016/S0031-9422(00)84255-7; COLLIEC S, 1991, THROMB RES, V64, P143, DOI 10.1016/0049-3848(91)90114-C; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Di Nisio M, 2005, NEW ENGL J MED, V353, P1028, DOI 10.1056/NEJMra044440; DODGSON KS, 1962, BIOCHEM J, V84, P106, DOI 10.1042/bj0840106; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Estevez JM, 2009, GLYCOBIOLOGY, V19, P212, DOI 10.1093/glycob/cwn101; Farias EHC, 2008, GLYCOBIOLOGY, V18, P250, DOI 10.1093/glycob/cwm139; Fernandes CL, 2010, CARBOHYD RES, V345, P663, DOI 10.1016/j.carres.2009.12.018; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; Hayakawa Y, 2000, BBA-PROTEIN STRUCT M, V1543, P86, DOI 10.1016/S0167-4838(00)00193-X; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Ishii T, 2005, PHYTOCHEMISTRY, V66, P2418, DOI 10.1016/j.phytochem.2005.08.007; JURD KM, 1995, J APPL PHYCOL, V7, P339, DOI 10.1007/BF00003790; Kam PCA, 2005, ANAESTHESIA, V60, P565, DOI 10.1111/j.1365-2044.2005.04192.x; Kelton JG, 2008, BLOOD, V112, P2607, DOI 10.1182/blood-2008-02-078014; KNUTSEN SH, 1987, BOT MAR, V30, P497, DOI 10.1515/botm.1987.30.6.497; Laffan M.A., 1995, PRACTICAL HAEMATOLOG, P297; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; LOVE J, 1964, J CHEM SOC, P3338, DOI 10.1039/jr9640003338; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao WJ, 2006, J APPL PHYCOL, V18, P9, DOI 10.1007/s10811-005-9008-4; Matsubara K, 2000, J APPL PHYCOL, V12, P9, DOI 10.1023/A:1008174115350; Matsubara K, 2001, INT J BIOL MACROMOL, V28, P395, DOI 10.1016/S0141-8130(01)00137-4; Melo FR, 2004, J BIOL CHEM, V279, P20824, DOI 10.1074/jbc.M308688200; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Navarro DA, 2007, CARBOHYD POLYM, V69, P742, DOI 10.1016/j.carbpol.2007.02.009; NILSSON S, 1991, MACROMOLECULES, V24, P3804, DOI 10.1021/ma00013a010; NOSEDA MD, 1993, INT J BIOL MACROMOL, V15, P177, DOI 10.1016/0141-8130(93)90020-M; ODONMAZIG P, 1994, CARBOHYD RES, V252, P317, DOI 10.1016/0008-6215(94)90028-0; Ohta Y, 2009, BIOL PHARM BULL, V32, P892, DOI 10.1248/bpb.32.892; PARK JT, 1949, J BIOL CHEM, V181, P149; Pereira MS, 2002, CARBOHYD RES, V337, P2231, DOI 10.1016/S0008-6215(02)00215-X; Pol-Fachin L, 2010, CARBOHYD RES, V345, P1922, DOI 10.1016/j.carres.2010.06.010; Prado Fernandez J., 2003, ANAL CHIM ACTA, V480, P23; ROBINSON G, 1980, J CHEM SOC CHEM COMM, P152, DOI 10.1039/c39800000152; Salvagnini C, 2005, ORG BIOMOL CHEM, V3, P4209, DOI 10.1039/b510239a; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; SHASHKOV AS, 1988, MAGN RESON CHEM, V26, P735, DOI 10.1002/mrc.1260260904; SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518; Siddhanta AK, 1999, INT J BIOL MACROMOL, V26, P151, DOI 10.1016/S0141-8130(99)00079-3; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Sommer-Knudsen J, 1998, PHYTOCHEMISTRY, V47, P483, DOI 10.1016/S0031-9422(97)00724-3; Spedding H., 1962, METHODS CARBOHYDRATE, VI, P539; STEVENSON TT, 1991, CARBOHYD RES, V210, P277, DOI 10.1016/0008-6215(91)80129-B; STORTZ CA, 1992, CARBOHYD POLYM, V18, P237, DOI 10.1016/0144-8617(92)90088-8; Tryfona T, 2010, CARBOHYD RES, V345, P2648, DOI 10.1016/j.carres.2010.09.018; UEHARA T, 1992, CARBOHYD RES, V235, P309, DOI 10.1016/0008-6215(92)80100-F; VANDELOCHT A, 1995, EMBO J, V14, P5149, DOI 10.1002/j.1460-2075.1995.tb00199.x; Fernandez PV, 2012, CARBOHYD POLYM, V87, P916, DOI 10.1016/j.carbpol.2011.06.063; Zhuo KL, 2008, CARBOHYD RES, V343, P2428, DOI 10.1016/j.carres.2008.07.015	65	37	39	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					223	+		10.1074/jbc.M112.386441	http://dx.doi.org/10.1074/jbc.M112.386441			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23161548	Green Published, hybrid			2022-12-28	WOS:000313197200022
J	Wang, Q; Dai, XQ; Li, Q; Tuli, J; Liang, GQ; Li, SS; Chen, XZ				Wang, Qian; Dai, Xiao-Qing; Li, Qiang; Tuli, Jagdeep; Liang, Gengqing; Li, Shayla S.; Chen, Xing-Zhen			Filamin Interacts with Epithelial Sodium Channel and Inhibits Its Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; ALPHA-SUBUNIT; CELL-VOLUME; ACTIN; EXPRESSION; MEMBRANE; BINDS; ENAC; POLYCYSTIN-2; ORGANIZATION	Epithelial sodium channel (ENaC) in the kidneys is critical for Na+ balance, extracellular volume, and blood pressure. Altered ENaC function is associated with respiratory disorders, pseudo-hypoaldosteronism type 1, and Liddle syndrome. ENaC is known to interact with components of the cytoskeleton, but the functional roles remain largely unclear. Here, we examined the interaction between ENaC and filamins, important actin filament components. We first discovered by yeast two-hybrid screening that the C termini of ENaC alpha and beta subunits bind filamin A, B, and C, and we then confirmed the binding by in vitro biochemical assays. We demonstrated by co-immunoprecipitation that ENaC, either over-expressed in HEK, HeLa, and melanoma A7 cells or natively expressed in LLC-PK1 and IMCD cells, is in the same complex with native filamin. Furthermore, the biotinylation and co-immunoprecipitation combined assays showed the ENaC-filamin interaction on the cell surface. Using Xenopus oocyte expression and two-electrode voltage clamp electrophysiology, we found that co-expression of an ENaC-binding domain of filamin substantially reduces ENaC channel function. Western blot and immunohistochemistry experiments revealed that the filamin A C terminus(FLNAC) modestly reduces the expression of the ENaC alpha subunit in oocytes and A7 cells. After normalizing the current by plasma membrane expression, we found that FLNAC results in similar to 50% reduction in the ENaC channel activity. The inhibitory effect of FLNAC was confirmed by lipid bilayer electrophysiology experiments using purified ENaC and FLNAC proteins, which showed that FLNAC substantially reduces ENaC single channel open probability. Taken together, our study demonstrated that filamin reduces ENaC channel function through direct interaction on the cell surface.	[Wang, Qian; Dai, Xiao-Qing; Li, Qiang; Tuli, Jagdeep; Liang, Gengqing; Li, Shayla S.; Chen, Xing-Zhen] Univ Alberta, Fac Med & Dent, Dept Physiol, Membrane Prot Dis Res Grp, Edmonton, AB T6G 2H7, Canada	University of Alberta		xzchen@ualberta.ca			Canadian Institutes of Health Research; Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC); Alberta Innovates [201200922] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates	This work was supported in part by the Canadian Institutes of Health Research and the Kidney Foundation of Canada (to X.Z.C.).; Recipient of a studentship from the Natural Sciences and Engineering Research Council of Canada (NSERC), Collaborative Research and Training Experience.	Awayda MS, 1998, J GEN PHYSIOL, V112, P97, DOI 10.1085/jgp.112.2.97; Barbry P, 1997, AM J PHYSIOL-GASTR L, V273, pG571, DOI 10.1152/ajpgi.1997.273.3.G571; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Cantiello HF, 1997, J EXP ZOOL, V279, P425, DOI 10.1002/(SICI)1097-010X(19971201)279:5<425::AID-JEZ4>3.0.CO;2-Q; CANTIELLO HF, 1991, AM J PHYSIOL, V261, pC882, DOI 10.1152/ajpcell.1991.261.5.C882; CANTIELLO HF, 1993, J BIOL CHEM, V268, P4596; Chasan B, 2002, EUR BIOPHYS J BIOPHY, V30, P617, DOI 10.1007/s00249-001-0188-9; Chen XZ, 1999, NATURE, V401, P383, DOI 10.1038/43907; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Gormley K, 2003, BIOCHEM J, V371, P1, DOI 10.1042/BJ20021375; Ismailov II, 1996, J BIOL CHEM, V271, P807, DOI 10.1074/jbc.271.2.807; Jovov B, 1999, J BIOL CHEM, V274, P37845, DOI 10.1074/jbc.274.53.37845; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Khurana S, 2000, J MEMBRANE BIOL, V178, P73, DOI 10.1007/s002320010016; Kizer N, 1997, P NATL ACAD SCI USA, V94, P1013, DOI 10.1073/pnas.94.3.1013; Li Q, 2005, HUM MOL GENET, V14, P1587, DOI 10.1093/hmg/ddi167; Li Q, 2004, FEBS LETT, V576, P231, DOI 10.1016/j.febslet.2004.09.017; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; Mazzochi C, 2006, J BIOL CHEM, V281, P6528, DOI 10.1074/jbc.M509386200; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; Nakhoul NL, 2001, AM J PHYSIOL-RENAL, V281, pF493, DOI 10.1152/ajprenal.2001.281.3.F493; Noda Y, 2004, BIOCHEM BIOPH RES CO, V322, P740, DOI 10.1016/j.bbrc.2004.07.195; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takafuta T, 2003, J BIOL CHEM, V278, P12175, DOI 10.1074/jbc.M209339200; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040448; Weisz OA, 2000, J BIOL CHEM, V275, P39886, DOI 10.1074/jbc.M003822200; Yang J, 2012, J BIOL CHEM, V287, P6551, DOI 10.1074/jbc.M111.305854; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001; Zuckerman JB, 1999, J BIOL CHEM, V274, P23286, DOI 10.1074/jbc.274.33.23286	36	13	14	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					264	273		10.1074/jbc.M112.396408	http://dx.doi.org/10.1074/jbc.M112.396408			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23161538	Green Published, hybrid			2022-12-28	WOS:000313197200026
J	Goulet, A; Behnke-Parks, WM; Sindelar, CV; Major, J; Rosenfeld, SS; Moores, CA				Goulet, Adeline; Behnke-Parks, William M.; Sindelar, Charles V.; Major, Jennifer; Rosenfeld, Steven S.; Moores, Carolyn A.			The Structural Basis of Force Generation by the Mitotic Motor Kinesin-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECK-LINKER; ALLOSTERIC INHIBITION; MONASTROL INHIBITION; ELECTRON-MICROSCOPY; SMALL-MOLECULE; EG5; PROTEIN; MICROTUBULES; MECHANISM; MODEL	Kinesin-5 is required for forming the bipolar spindle during mitosis. Its motor domain, which contains nucleotide and microtubule binding sites and mechanical elements to generate force, has evolved distinct properties for its spindle-based functions. In this study, we report subnanometer resolution cryoelectron microscopy reconstructions of microtubule-bound human kinesin-5 before and after nucleotide binding and combine this information with studies of the kinetics of nucleotide-induced neck linker and cover strand movement. These studies reveal coupled, nucleotide-dependent conformational changes that explain many of this motor's properties. We find that ATP binding induces a ratchet-like docking of the neck linker and simultaneous, parallel docking of the N-terminal cover strand. Loop L5, the binding site for allosteric inhibitors of kinesin-5, also undergoes a dramatic reorientation when ATP binds, suggesting that it is directly involved in controlling nucleotide binding. Our structures indicate that allosteric inhibitors of human kinesin-5, which are being developed as anti-cancer therapeutics, bind to a motor conformation that occurs in the course of normal function. However, due to evolutionarily defined sequence variations in L5, this conformation is not adopted by invertebrate kinesin-5s, explaining their resistance to drug inhibition. Together, our data reveal the precision with which the molecular mechanism of kinesin-5 motors has evolved for force generation.	[Goulet, Adeline; Moores, Carolyn A.] Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England; [Behnke-Parks, William M.] Columbia Univ, Dept Biol, New York, NY 10035 USA; [Sindelar, Charles V.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Major, Jennifer; Rosenfeld, Steven S.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA	University of London; Birkbeck University London; Columbia University; Yale University; Cleveland Clinic Foundation	Moores, CA (corresponding author), Birkbeck Coll, Inst Struct & Mol Biol, Malet St, London WC1E 7HX, England.	c.moores@mail.cryst.bbk.ac.uk		Goulet, Adeline/0000-0002-5971-9488	National Institutes of Health [GM102875]; Biotechnology and Biological Sciences Research Council [BB/H005137/1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102875] Funding Source: NIH RePORTER; BBSRC [BB/H005137/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant GM102875. This work was also supported by Biotechnology and Biological Sciences Research Council Grant BB/H005137/1	Behnke-Parks WM, 2011, J BIOL CHEM, V286, P5242, DOI 10.1074/jbc.M110.192930; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; DALE RE, 1979, BIOPHYS J, V26, P161, DOI 10.1016/S0006-3495(79)85243-1; Duselder A, 2012, J MOL BIOL, V423, P159, DOI 10.1016/j.jmb.2012.06.043; Ferenz NP, 2010, SEMIN CELL DEV BIOL, V21, P255, DOI 10.1016/j.semcdb.2010.01.019; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Geoghegan KF, 2000, BIOCONJUGATE CHEM, V11, P71, DOI 10.1021/bc9900845; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Harrington TD, 2011, J THEOR BIOL, V289, P107, DOI 10.1016/j.jtbi.2011.08.017; Hirose K, 2000, EMBO J, V19, P5308, DOI 10.1093/emboj/19.20.5308; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Kaan HYK, 2010, BIOCHEM J, V425, P55, DOI 10.1042/BJ20091207; Kalchishkova N, 2008, J MOL BIOL, V382, P127, DOI 10.1016/j.jmb.2008.06.092; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Khalil AS, 2008, P NATL ACAD SCI USA, V105, P19247, DOI 10.1073/pnas.0805147105; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Kikkawa M, 2008, TRENDS CELL BIOL, V18, P128, DOI 10.1016/j.tcb.2008.01.002; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Kim ED, 2010, J BIOL CHEM, V285, P18650, DOI 10.1074/jbc.M109.092072; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Kwok BH, 2006, NAT CHEM BIOL, V2, P480, DOI 10.1038/nchembio812; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; Li MH, 2012, BIOCHEMISTRY-US, V51, P5022, DOI 10.1021/bi300362a; Liu LQ, 2011, J BIOL CHEM, V286, P6201, DOI 10.1074/jbc.M110.154989; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maliga Zoltan, 2006, BMC Chemical Biology, V6, P2, DOI 10.1186/1472-6769-6-2; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; MCINTOSH JR, 1969, NATURE, V224, P659, DOI 10.1038/224659a0; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pandurangan AP, 2012, J STRUCT BIOL, V177, P520, DOI 10.1016/j.jsb.2011.10.011; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pylypenko O, 2011, J BIOL CHEM, V286, P11716, DOI 10.1074/jbc.M110.200626; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 1996, J BIOL CHEM, V271, P9473, DOI 10.1074/jbc.271.16.9473; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Safer D, 1999, J STRUCT BIOL, V127, P101, DOI 10.1006/jsbi.1999.4110; Sarli V, 2008, CLIN CANCER RES, V14, P7583, DOI 10.1158/1078-0432.CCR-08-0120; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; Sheth PR, 2009, BIOCHEMISTRY-US, V48, P11045, DOI 10.1021/bi900946r; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Sindelar Charles V, 2011, Biophys Rev, V3, P85, DOI 10.1007/s12551-011-0049-4; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Sindelar CV, 2002, NAT STRUCT BIOL, V9, P844, DOI 10.1038/nsb852; Sousa D, 2007, J STRUCT BIOL, V157, P201, DOI 10.1016/j.jsb.2006.08.003; Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016; Toprak E, 2009, P NATL ACAD SCI USA, V106, P12717, DOI 10.1073/pnas.0808396106; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Waitzman JS, 2011, BIOPHYS J, V101, P2760, DOI 10.1016/j.bpj.2011.10.032; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074; Zhao YC, 2010, J BIOL CHEM, V285, P25213, DOI 10.1074/jbc.M110.123067	63	58	60	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44654	44666		10.1074/jbc.M112.404228	http://dx.doi.org/10.1074/jbc.M112.404228			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23135273	Green Published, hybrid			2022-12-28	WOS:000312938600061
J	De La Vega-Beltran, JL; Sanchez-Cardenas, C; Krapf, D; Hernandez-Gonzalez, EO; Wertheimer, E; Trevino, CL; Visconti, PE; Darszon, A				Luis De La Vega-Beltran, Jose; Sanchez-Cardenas, Claudia; Krapf, Dario; Hernandez-Gonzalez, Enrique O.; Wertheimer, Eva; Trevino, Claudia L.; Visconti, Pablo E.; Darszon, Alberto			Mouse Sperm Membrane Potential Hyperpolarization Is Necessary and Sufficient to Prepare Sperm for the Acrosome Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN-TYROSINE PHOSPHORYLATION; SPERMATOGENIC CELLS; CA2+ CHANNELS; ZONA-PELLUCIDA; CALCIUM-CHANNELS; MAMMALIAN SPERM; MALE-FERTILITY; K+ CURRENT; CAPACITATION	Mammalian sperm are unable to fertilize the egg immediately after ejaculation; they acquire this capacity during migration in the female reproductive tract. This maturational process is called capacitation and in mouse sperm it involves a plasma membrane reorganization, extensive changes in the state of protein phosphorylation, increases in intracellular pH (pH(i)) and Ca2+ ([Ca2+](i)), and the appearance of hyperactivated motility. In addition, mouse sperm capacitation is associated with the hyperpolarization of the cell membrane potential. However, the functional role of this process is not known. In this work, to dissect the role of this membrane potential change, hyperpolarization was induced in noncapacitated sperm using either the ENaC inhibitor amiloride, the CFTR agonist genistein or the K+ ionophore valinomycin. In this experimental setting, other capacitation-associated processes such as activation of a cAMP-dependent pathway and the consequent increase in protein tyrosine phosphorylation were not observed. However, hyperpolarization was sufficient to prepare sperm for the acrosome reaction induced either by depolarization with high K+ or by addition of solubilized zona pellucida (sZP). Moreover, K+ and sZP were also able to increase [Ca2+](i) in non-capacitated sperm treated with these hyperpolarizing agents but not in untreated cells. On the other hand, in conditions that support capacitation-associated processes blocking hyperpolarization by adding valinomycin and increasing K+ concentrations inhibited the agonist-induced acrosome reaction as well as the increase in [Ca2+](i). Altogether, these results suggest that sperm hyperpolarization by itself is key to enabling mice sperm to undergo the acrosome reaction.	[Luis De La Vega-Beltran, Jose; Sanchez-Cardenas, Claudia; Trevino, Claudia L.; Darszon, Alberto] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62210, Morelos, Mexico; [Krapf, Dario] Univ Nacl Rosario, CONICET, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina; [Hernandez-Gonzalez, Enrique O.] CINVESTAV, IPN, Dept Biol Celular, Mexico City 07360, DF, Mexico; [Wertheimer, Eva; Visconti, Pablo E.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	Universidad Nacional Autonoma de Mexico; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; University of Massachusetts System; University of Massachusetts Amherst	Visconti, PE (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	pvisconti@vasci.umass.edu; darszon@ibt.unam.mx	Hernández-González, Enrique/AAU-8526-2020	Trevino, Claudia L/0000-0002-7281-0534; Krapf, Dario/0000-0001-7607-1954; Darszon, Alberto/0000-0002-2502-0505	National Institutes of Health [R01 HD44044, HD038082]; CONACyT-Mexico [49113, 128566, 47011, 99333]; DGAPA/UNAM [IN211809, IN225406, IN204109, IN202212-3]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044044, R01HD038082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA/UNAM(Universidad Nacional Autonoma de Mexico); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HD44044 and HD038082 (to P. E. V.), CONACyT-Mexico, (49113 and 128566, to A. D., 47011 and 99333, to C. T.), DGAPA/UNAM (IN211809 and IN225406, to A. D., IN204109 and IN202212-3, to C. T.).	Acevedo JJ, 2006, DEV BIOL, V289, P395, DOI 10.1016/j.ydbio.2005.11.002; Arnoult C, 1999, P NATL ACAD SCI USA, V96, P6757, DOI 10.1073/pnas.96.12.6757; Arnoult C, 1996, P NATL ACAD SCI USA, V93, P13004, DOI 10.1073/pnas.93.23.13004; Arnoult C, 1998, MOL PHARMACOL, V53, P1104; Bello OD, 2012, EXP CELL RES, V318, P478, DOI 10.1016/j.yexcr.2012.01.002; Bennett JC, 2010, J BIOL CHEM, V285, P26269, DOI 10.1074/jbc.M109.095752; Chang HX, 2010, BIOL REPROD, V83, P507, DOI 10.1095/biolreprod.109.083113; Chavez JC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094037; Chen JH, 2009, J BIOL CHEM, V284, P35495, DOI 10.1074/jbc.M109.072678; Chen WY, 2009, BIOL REPROD, V80, P115, DOI 10.1095/biolreprod.108.068528; Darszon A, 2006, CELL CALCIUM, V40, P241, DOI 10.1016/j.ceca.2006.04.028; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; Escoffier J, 2007, J CELL PHYSIOL, V212, P753, DOI 10.1002/jcp.21075; Escoffier J, 2012, J CELL SCI, V125, P473, DOI 10.1242/jcs.093344; ESPINOSA F, 1995, FEBS LETT, V372, P119, DOI 10.1016/0014-5793(95)00962-9; Espinosa F, 1998, FEBS LETT, V426, P47, DOI 10.1016/S0014-5793(98)00305-6; Fierro D. F., 2012, J CELL PHYS IN PRESS; FLORMAN HM, 1992, DEV BIOL, V152, P304, DOI 10.1016/0012-1606(92)90137-6; Florman HM, 1998, BIOL REPROD, V59, P12, DOI 10.1095/biolreprod59.1.12; Hernandez-Gonzalez EO, 2007, J BIOL CHEM, V282, P24397, DOI 10.1074/jbc.M701603200; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Lievano A, 1996, FEBS LETT, V388, P150, DOI 10.1016/0014-5793(96)00515-7; Lishko PV, 2012, ANNU REV PHYSIOL, V74, P453, DOI 10.1146/annurev-physiol-020911-153258; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Lopez-Gonzalez I, 2001, DEV BIOL, V236, P210, DOI 10.1006/dbio.2001.0314; Luke T, 2012, AM J PHYSIOL-LUNG C, V302, pL1128, DOI 10.1152/ajplung.00396.2011; Martinez-Lopez P, 2009, BIOCHEM BIOPH RES CO, V381, P204, DOI 10.1016/j.bbrc.2009.02.008; Mayorga LS, 2007, IUBMB LIFE, V59, P286, DOI 10.1080/15216540701222872; McPartlin LA, 2011, BIOL REPROD, V85, P179, DOI 10.1095/biolreprod.110.085555; MOORE GD, 1994, DEVELOPMENT, V120, P3313; Munoz-Garay C, 2001, DEV BIOL, V234, P261, DOI 10.1006/dbio.2001.0196; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Nisihigaki T., 2006, BIOTECHNIQUES, V41, P191; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Reddy MM, 2009, J MEMBRANE BIOL, V231, P65, DOI 10.1007/s00232-009-9205-1; Ren DJ, 2010, PHYSIOLOGY, V25, P165, DOI 10.1152/physiol.00049.2009; Rode B, 2012, HUM MOL GENET, V21, P1287, DOI 10.1093/hmg/ddr558; Samak G, 2011, J BIOL CHEM, V286, P30232, DOI 10.1074/jbc.M111.240358; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Santi CM, 1996, AM J PHYSIOL-CELL PH, V271, pC1583, DOI 10.1152/ajpcell.1996.271.5.C1583; Saponara S, 2011, BRIT J PHARMACOL, V164, P1684, DOI 10.1111/j.1476-5381.2011.01476.x; Schaefer AT, 2003, BIOPHYS J, V84, P3508, DOI 10.1016/S0006-3495(03)75086-3; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Trevino CL, 2004, FEBS LETT, V563, P87, DOI 10.1016/S0014-5793(04)00257-1; Trevino CL, 2001, FEBS LETT, V509, P119, DOI 10.1016/S0014-5793(01)03134-9; Visconti PE, 2011, ASIAN J ANDROL, V13, P395, DOI 10.1038/aja.2010.69; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; WARD CR, 1992, J BIOL CHEM, V267, P14061; Xia JS, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-119; Xia JS, 2009, BIOL REPROD, V80, P1092, DOI 10.1095/biolreprod.108.074039; Xu WM, 2007, P NATL ACAD SCI USA, V104, P9816, DOI 10.1073/pnas.0609253104; Zeng XH, 2011, P NATL ACAD SCI USA, V108, P5879, DOI 10.1073/pnas.1100240108; ZENG Y, 1995, DEV BIOL, V171, P554, DOI 10.1006/dbio.1995.1304	60	65	67	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44384	44393		10.1074/jbc.M112.393488	http://dx.doi.org/10.1074/jbc.M112.393488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23095755	Green Published, hybrid			2022-12-28	WOS:000312938600035
J	Yates, LA; Lumb, CN; Brahme, NN; Zalyte, R; Bird, LE; De Colibus, L; Owens, RJ; Calderwood, DA; Sansom, MSP; Gilbert, RJC				Yates, Luke A.; Lumb, Craig N.; Brahme, Nina N.; Zalyte, Ruta; Bird, Louise E.; De Colibus, Luigi; Owens, Raymond J.; Calderwood, David A.; Sansom, Mark S. P.; Gilbert, Robert J. C.			Structural and Functional Characterization of the Kindlin-1 Pleckstrin Homology Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; INTEGRIN ACTIVATION; CRYSTAL-STRUCTURE; FORCE-FIELD; PH DOMAIN; PHOSPHOINOSITIDE-BINDING; SPECIFICITY DETERMINANTS; RESOLUTION STRUCTURE; INOSITOL PHOSPHATES; LEUKOCYTE ADHESION	Inside-out activation of integrins is mediated via the binding of talin and kindlin to integrin beta-subunit cytoplasmic tails. The kindlin FERM domain is interrupted by a pleckstrin homology (PH) domain within its F2 subdomain. Here, we present data confirming the importance of the kindlin-1 PH domain for integrin activation and its x-ray crystal structure at a resolution of 2.1 angstrom revealing a C-terminal second alpha-helix integral to the domain but found only in the kindlin protein family. An isoform-specific salt bridge occludes the canonical phosphoinositide binding site, but molecular dynamics simulations display transient switching to an alternative open conformer. Molecular docking reveals that the opening of the pocket would enable potential ligands to bind within it. Although lipid overlay assays suggested the PH domain binds inositol monophosphates, surface plasmon resonance demonstrated weak affinities for inositol 3,4,5-triphosphate (Ins(3,4,5)P-3; K-D similar to 100 mu M) and no monophosphate binding. Removing the salt bridge by site-directed mutagenesis increases the PH domain affinity for Ins(3,4,5)P-3 as measured by surface plasmon resonance and enables it to bind PtdIns(3,5)P-2 on a dot-blot. Structural comparison with other PH domains suggests that the phosphate binding pocket in the kindlin-1 PH domain is more occluded than in kindlins-2 and -3 due to its salt bridge. In addition, the apparent affinity for Ins(3,4,5)P-3 is affected by the presence of PO4 ions in the buffer. We suggest the physiological ligand of the kindlin-1 PH domain is most likely not an inositol phosphate but another phosphorylated species.	[Yates, Luke A.; Zalyte, Ruta; Bird, Louise E.; De Colibus, Luigi; Owens, Raymond J.; Gilbert, Robert J. C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; [Lumb, Craig N.; Sansom, Mark S. P.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Brahme, Nina N.; Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Brahme, Nina N.; Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Bird, Louise E.; Owens, Raymond J.] Oxford Prot Prod Facil United Kingdom, Rutherford Appleton Lab, Didcot OX11 0FA, Oxon, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Yale University; Yale University; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Gilbert, RJC (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England.	gilbert@strubi.ox.ac.uk	Sansom, Mark S.P./C-5157-2009; Calderwood, David A/AAC-6954-2019	Sansom, Mark S.P./0000-0001-6360-7959; Calderwood, David A/0000-0002-0791-4142; Bird, Louise/0000-0002-9846-5716; Yates, Luke/0000-0002-5023-0803; Gilbert, Robert/0000-0001-9336-5604; Owens, Ray/0000-0002-3705-2993	National Institutes of Health [R01GM088240, R01 GM068600, T32 GM007223]; Biotechnology and Biological Sciences Research Council (United Kingdom); Wellcome Trust; Medical Research Council (UK); Oxford Division of Structural Biology is part of the Wellcome Trust Centre for Human Genetics, Wellcome Trust [090532/Z/09/Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088240, T32GM007223, R01GM068600] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BEP17032, BBS/B/16011, B19456, BB/I019855/1, BB/H000267/1] Funding Source: researchfish; Medical Research Council [G1100525, G0701506] Funding Source: researchfish; BBSRC [BB/H000267/1, BB/I019855/1] Funding Source: UKRI; MRC [G0701506] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Division of Structural Biology is part of the Wellcome Trust Centre for Human Genetics, Wellcome Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM088240, R01 GM068600, and T32 GM007223 (to D. A. C. and N. N. B.). This work was also supported by the Biotechnology and Biological Sciences Research Council (United Kingdom) and the Wellcome Trust (to M. S. P. S.).; Supported by the Medical Research Council (UK) for financial support.; The Oxford Division of Structural Biology is part of the Wellcome Trust Centre for Human Genetics, Wellcome Trust Core Award Grant number 090532/Z/09/Z. We gratefully acknowledge the technical support of David Staunton and Marcus Bridge and the use of the SPR equipment in the Biophysical Facility of the Department of Biochemistry, University of Oxford, and the Sir William Dunn School of Pathology, University of Oxford.	Anthis NJ, 2010, STRUCTURE, V18, P1654, DOI 10.1016/j.str.2010.09.018; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baraldi E, 1999, STRUCTURE, V7, P449, DOI 10.1016/S0969-2126(99)80057-4; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Begley MJ, 2006, P NATL ACAD SCI USA, V103, P927, DOI 10.1073/pnas.0510006103; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Ceccarelli DFJ, 2007, J BIOL CHEM, V282, P13864, DOI 10.1074/jbc.M700505200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Dowling JJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-36; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Feng C, 2012, J BIOL CHEM, V287, P10714, DOI 10.1074/jbc.M111.299594; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Has C, 2009, AM J PATHOL, V175, P1442, DOI 10.2353/ajpath.2009.090203; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kern J S, 2007, J Pathol, V213, P462, DOI 10.1002/path.2253; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Lai-Cheong JE, 2008, J INVEST DERMATOL, V128, P2156, DOI 10.1038/jid.2008.58; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li CL, 2004, J MED CHEM, V47, P6681, DOI 10.1021/jm049504o; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Liu Y, 2012, PROTEIN CELL, V3, P434, DOI 10.1007/s13238-012-2046-1; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Miller GJ, 2005, MOL CELL, V18, P201, DOI 10.1016/j.molcel.2005.03.016; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Riffel N, 2002, STRUCTURE, V10, P1627, DOI 10.1016/S0969-2126(02)00896-1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmidt S, 2011, J CELL BIOL, V192, P883, DOI 10.1083/jcb.201007141; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Terawaki S, 2010, EMBO J, V29, P236, DOI 10.1038/emboj.2009.323; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsujishita Y, 2001, CELL, V105, P379, DOI 10.1016/S0092-8674(01)00326-9; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Worthylake DK, 2004, STRUCTURE, V12, P1079, DOI 10.1016/j.str.2004.03.021; Wu CY, 2005, J CELL SCI, V118, P659, DOI 10.1242/jcs.01639	82	23	23	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43246	43261		10.1074/jbc.M112.422089	http://dx.doi.org/10.1074/jbc.M112.422089			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23132860	Green Published, hybrid			2022-12-28	WOS:000312940800006
J	Banerjee, A; Qian, PX; Wu, ZS; Ren, XG; Steiner, M; Bougen, NM; Liu, SL; Liu, DX; Zhu, T; Lobie, PE				Banerjee, Arindam; Qian, PengXu; Wu, Zheng-Sheng; Ren, Xiaoge; Steiner, Michael; Bougen, Nicola M.; Liu, Suling; Liu, Dong-Xu; Zhu, Tao; Lobie, Peter E.			Artemin Stimulates Radio- and Chemo-resistance by Promoting TWIST1-BCL-2-dependent Cancer Stem Cell-like Behavior in Mammary Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; GENE-EXPRESSION; ALDEHYDE DEHYDROGENASE; THERAPEUTIC TARGET; ESTROGEN-RECEPTOR; UP-REGULATION; GDNF FAMILY; CLAUDIN-LOW; BCL-2	Artemin (ARTN) has been reported to promote a TWIST1-dependent epithelial to mesenchymal transition of estrogen receptor negative mammary carcinoma (ER-MC) cells associated with metastasis and poor survival outcome. We therefore examined a potential role of ARTN in the promotion of the cancer stem cell (CSC)-like phenotype in mammary carcinoma cells. Acquired resistance of ER-MC cells to either ionizing radiation (IR) or paclitaxel was accompanied by increased ARTN expression. Small interfering RNA (siRNA)-mediated depletion of ARTN in either IR- or paclitaxel-resistant ER-MC cells restored cell sensitivity to IR or paclitaxel. Expression of ARTN was enriched in ER-MC cells grown in mammospheric compared with monolayer culture and was also enriched along with BMI1, TWIST1, and DVL1 in mammospheric and ALDH1+ populations. ARTN promoted mammospheric growth and self-renewal of ER-MC cells and increased the ALDH1+ population, whereas siRNA-mediated depletion of ARTN diminished these CSC-like cell behaviors. Furthermore, increased ARTN expression was significantly correlated with ALDH1 expression in a cohort of ER-MC patients. Forced expression of ARTN also dramatically enhanced tumor initiating capacity of ER-MC cells in xenograft models at low inoculum. ARTN promotion of the CSC-like cell phenotype was mediated by TWIST1 regulation of BCL-2 expression. ARTN also enhanced mammosphere formation and the ALDH1 + population in estrogen receptor-positive mammary carcinoma (ER + MC) cells. Increased expression of ARTN and the functional consequences thereof may be one common adaptive mechanism used by mammary carcinoma cells to promote cell survival and renewal in hostile tumor microenvironments.	[Qian, PengXu; Wu, Zheng-Sheng; Liu, Suling; Zhu, Tao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Qian, PengXu; Wu, Zheng-Sheng; Liu, Suling; Zhu, Tao] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Banerjee, Arindam; Ren, Xiaoge; Steiner, Michael; Liu, Dong-Xu; Lobie, Peter E.] Univ Auckland, Liggins Inst, Auckland 1023, New Zealand; [Wu, Zheng-Sheng] Anhui Med Univ, Dept Pathol, Hefei, Anhui, Peoples R China; [Wu, Zheng-Sheng] Fudan Univ, Shanghai Med Coll, Dept Pathol, Shanghai 200433, Peoples R China; [Bougen, Nicola M.; Lobie, Peter E.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Bougen, Nicola M.; Lobie, Peter E.] Natl Univ Singapore, Dept Pharmacol, Singapore 117599, Singapore	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Auckland; Anhui Medical University; Fudan University; National University of Singapore; National University of Singapore	Zhu, T (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	zhut@ustc.edu.cn; csipel@nus.edu.sg	Liu, Suling/N-2796-2013; liu, suling/AAF-5249-2019; Qian, Pengxu/B-9376-2016	Liu, Suling/0000-0002-0475-0242; liu, suling/0000-0002-0475-0242; Qian, Pengxu/0000-0001-5636-6704; Bougen-Zhukov, Nicola/0000-0001-9535-1150	Breast Cancer Research Trust (New Zealand); Dick Roberts Trust (New Zealand); Cancer Science Institute (Singapore); National Key Scientific Programme of China [2012CB934002, 2010CB912804]; Chinese Academy of Sciences [XDA1040410]; National Natural Science Foundation of China [30971492, 81101597]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists [2010T2S03]; Saratan Therapeutics Ltd.	Breast Cancer Research Trust (New Zealand); Dick Roberts Trust (New Zealand); Cancer Science Institute (Singapore); National Key Scientific Programme of China; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Visiting Professorship for Senior International Scientists; Saratan Therapeutics Ltd.	This work was funded by the Breast Cancer Research Trust (New Zealand), The Dick Roberts Trust (New Zealand), Cancer Science Institute (Singapore), The National Key Scientific Programme of China (2012CB934002 and 2010CB912804), Chinese Academy of Sciences (XDA1040410), National Natural Science Foundation of China (30971492 and 81101597), and the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists (2010T2S03). D.-X. L. and P. E. L. are inventors of PCT/NZ2008/000152 and derivatives thereof. P. E. L. is an inventor of PCT/NZ2010/000207 and derivatives thereof. Z. T. and P. E. L. received consultancies from Saratan Therapeutics Ltd (a biotech company formed around the potential to use Artemin as a target for breast cancer). Salaries of D.-X. L. and A. B. were supported in part by Saratan Therapeutics Ltd.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Ansieau S, 2010, ONCOGENE, V29, P3173, DOI 10.1038/onc.2010.92; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Baloh RH, 1998, P NATL ACAD SCI USA, V95, P5801, DOI 10.1073/pnas.95.10.5801; Banerjee A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3054; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Bespalov MM, 2007, TRENDS PHARMACOL SCI, V28, P68, DOI 10.1016/j.tips.2006.12.005; Bespalov MM, 2011, J CELL BIOL, V192, P153, DOI 10.1083/jcb.201009136; Bjorklund A, 2010, PROG BRAIN RES, V184, P237, DOI 10.1016/S0079-6123(10)84013-0; Boulay A, 2008, CANCER RES, V68, P3743, DOI 10.1158/0008-5472.CAN-07-5100; Bratton MR, 2010, INT J ONCOL, V37, P541, DOI 10.3892/ijo_00000703; Chen JQ, 2009, BBA-REV CANCER, V1796, P162, DOI 10.1016/j.bbcan.2009.06.003; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; Dawson SJ, 2010, BRIT J CANCER, V103, P668, DOI 10.1038/sj.bjc.6605736; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deans AJ, 2006, CANCER RES, V66, P8219, DOI 10.1158/0008-5472.CAN-05-3945; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Gazitt Y, 1998, INT J ONCOL, V13, P839; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hofmann MC, 2008, MOL CELL ENDOCRINOL, V288, P95, DOI 10.1016/j.mce.2008.04.012; Jameel JKA, 2004, BREAST, V13, P452, DOI 10.1016/j.breast.2004.08.004; Kallergi G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2896; Kang J, 2010, ONCOGENE, V29, P3228, DOI 10.1038/onc.2010.71; Kang J, 2009, ONCOGENE, V28, P2034, DOI 10.1038/onc.2009.66; Karimi-Busheri F, 2010, CRYOBIOLOGY, V60, P308, DOI 10.1016/j.cryobiol.2010.02.005; Kerr Daniel Alan II, 2011, Hormones & Cancer, V2, P261, DOI 10.1007/s12672-011-0080-8; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Lang JY, 2011, CANCER CELL, V20, P341, DOI 10.1016/j.ccr.2011.07.017; Liu DX, 2007, CELL DEATH DIFFER, V14, P1893, DOI 10.1038/sj.cdd.4402209; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Morimoto K, 2009, CANCER SCI, V100, P1062, DOI 10.1111/j.1349-7006.2009.01151.x; Morrison R, 2011, J ONCOL, V2011, DOI 10.1155/2011/941876; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pandey V, 2010, TRANSL ONCOL, V3, P218, DOI 10.1593/tlo.09325; Patel N, 2010, P NATL ACAD SCI USA, V107, P2503, DOI 10.1073/pnas.0910649107; Pearce AG, 2001, RADIAT RES, V156, P739, DOI 10.1667/0033-7587(2001)156[0739:TGACOA]2.0.CO;2; Pidgeon GP, 2001, BRIT J CANCER, V85, P273, DOI 10.1054/bjoc.2001.1876; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Samuel S, 2010, MOL THER, V18, P2094, DOI 10.1038/mt.2010.188; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Song J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011456; Spinnler K, 2010, HUM REPROD, V25, P2181, DOI 10.1093/humrep/deq170; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Tang JZ, 2010, MOL CANCER THER, V9, P1697, DOI 10.1158/1535-7163.MCT-09-1077; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tawfik K, 2012, HUM PATHOL, V43, P23, DOI 10.1016/j.humpath.2011.04.011; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yang QF, 2009, BREAST CANCER RES TR, V115, P343, DOI 10.1007/s10549-008-0068-4; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	62	39	43	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42502	42515		10.1074/jbc.M112.365163	http://dx.doi.org/10.1074/jbc.M112.365163			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095743	Green Published, hybrid			2022-12-28	WOS:000312501600012
J	Hayashi, T; Hayashi, E; Fujimoto, M; Sprong, H; Su, TP				Hayashi, Teruo; Hayashi, Eri; Fujimoto, Michiko; Sprong, Hein; Su, Tsung-Ping			The Lifetime of UDP-galactose: Ceramide Galactosyltransferase Is Controlled by a Distinct Endoplasmic Reticulum-associated Degradation (ERAD) Regulated by Sigma-1 Receptor Chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGODENDROCYTE DIFFERENTIATION; BINDING-SITE; PROTEIN; EXPRESSION; CELLS; MICE; GLYCOSPHINGOLIPIDS; GALACTOSYLCERAMIDE; IDENTIFICATION; PURIFICATION	The glycosphingolipid biosynthesis is initiated by monoglycosylation of ceramides, the action of which is catalyzed either by UDP-glucose: ceramide glucosyltransferase or by UDP-galactose: ceramide galactosyltransferase (CGalT). CGalT is expressed predominantly at the endoplasmic reticulum (ER) of oligodendrocytes and is responsible for synthesizing galactosylceramides (GalCer) that play an important role in regulation of axon conductance. However, despite the importance of ceramide monoglycosylation enzymes in a spectrum of cellular functions, the mechanism that fine tunes activities of those enzymes is largely unknown. In the present study, we demonstrated that the sigma-1 receptor (Sig-1R) chaperone, the mammalian homologue of a yeast C8-C7 sterol isomerase, controls the protein level and activity of the CGalT enzyme via a distinct ER-associated degradation system involving Insig. The Sig-1R forms a complex with Insig via its transmembrane domain partly in a sterol-dependent manner and associates with CGalT at the ER. The knockdown of Sig-1Rs dramatically prolonged the lifetime of CGalT without affecting the trimming of N-linked oligosaccharides at CGalT. The increased lifetime leads to the up-regulation of CGalT protein as well as elevated enzymatic activity in CHO cells stably expressing CGalT. Knockdown of Sig-1Rs also decreased CGalT degradation endogenously expressed in D6P2T-schwannoma cells. Our data suggest that Sig-1Rs negatively regulate the activity of GalCer synthesis under physiological conditions by enhancing the degradation of CGalT through regulation of the dynamics of Insig in the lipid-activated ER-associated degradation system. The GalCer synthesis may thus be influenced by sterols at the ER.	[Hayashi, Teruo; Hayashi, Eri; Fujimoto, Michiko] NIDA, Cellular Stress Signaling Unit, NIH, Baltimore, MD 21224 USA; [Su, Tsung-Ping] NIDA, Cellular Pathobiol Sect, Integrat Neurosci Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Sprong, Hein] Natl Inst Publ Hlth & Environm, Lab Zoonoses & Environm Microbiol, NL-3720 BA Bilthoven, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Netherlands National Institute for Public Health & the Environment	Hayashi, T (corresponding author), Seiwakai Nishikawa Hosp, 293-2 Minato Machi, Hamada, Shimane 6970052, Japan.	thayashi2r@gmail.com; tsu@intra.nida.nih.gov		Sprong, Hein/0000-0002-0218-4320	National Institutes of Health, NIDA, Intramural Research Program; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000206] Funding Source: NIH RePORTER	National Institutes of Health, NIDA, Intramural Research Program; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by the National Institutes of Health, NIDA, Intramural Research Program.	Bansal R, 1999, J NEUROSCI, V19, P7913; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Bernasconi R, 2011, CURR OPIN CELL BIOL, V23, P176, DOI 10.1016/j.ceb.2010.10.002; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boggs JA, 2008, BBA-GEN SUBJECTS, V1780, P445, DOI 10.1016/j.bbagen.2007.10.015; Bowen W D, 2000, Pharm Acta Helv, V74, P211; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Fewou SN, 2005, J NEUROCHEM, V94, P469, DOI 10.1111/j.1471-4159.2005.03221.x; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hashimoto Kenji, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P197; Hayashi T, 2004, P NATL ACAD SCI USA, V101, P14949, DOI 10.1073/pnas.0402890101; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2011, EXPERT OPIN THER TAR, V15, P557, DOI 10.1517/14728222.2011.560837; Hayashi T, 2010, MOL PHARMACOL, V77, P517, DOI 10.1124/mol.109.062539; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Iyanagi T, 2007, INT REV CYTOL, V260, P35, DOI 10.1016/S0074-7696(06)60002-8; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kim FJ, 2010, MOL PHARMACOL, V77, P695, DOI 10.1124/mol.109.057083; Kohyama-Koganeya A, 2004, J BIOL CHEM, V279, P35995, DOI 10.1074/jbc.M400444200; Lopez PHH, 2009, CURR OPIN STRUC BIOL, V19, P549, DOI 10.1016/j.sbi.2009.06.001; Matsumoto RR, 2002, NEUROPHARMACOLOGY, V42, P1043, DOI 10.1016/S0028-3908(02)00056-4; Maurice T, 1998, NEUROSCIENCE, V83, P413, DOI 10.1016/S0306-4522(97)00405-3; Meunier J, 2006, BRIT J PHARMACOL, V149, P998, DOI 10.1038/sj.bjp.0706927; Meunier J, 2010, J PHARMACOL EXP THER, V332, P388, DOI 10.1124/jpet.109.160960; Nuwayhid SJ, 2003, J PHARMACOL EXP THER, V304, P364, DOI 10.1124/jpet.102.043398; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; Palacios G, 2003, BRAIN RES, V961, P92, DOI 10.1016/S0006-8993(02)03892-1; Ramachandran S, 2009, EUR J PHARMACOL, V609, P19, DOI 10.1016/j.ejphar.2009.03.003; Sabino V, 2009, NEUROPSYCHOPHARMACOL, V34, P1482, DOI 10.1038/npp.2008.192; SCHULTE S, 1993, P NATL ACAD SCI USA, V90, P10265, DOI 10.1073/pnas.90.21.10265; Sever N, 2004, J BIOL CHEM, V279, P43136, DOI 10.1074/jbc.M406406200; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Sot J, 2005, BIOPHYS J, V88, P3368, DOI 10.1529/biophysj.104.057851; Sprong H, 2003, MOL BIOL CELL, V14, DOI 10.1091/mbc.E03-03-0130; Sprong H, 1998, J BIOL CHEM, V273, P25880, DOI 10.1074/jbc.273.40.25880; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Sprong H, 2001, J CELL BIOL, V155, P369, DOI 10.1083/jcb.200106104; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; van Meer G, 2000, BBA-MOL CELL BIOL L, V1486, P145, DOI 10.1016/S1388-1981(00)00054-8; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386	52	37	38	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43156	43169		10.1074/jbc.M112.380444	http://dx.doi.org/10.1074/jbc.M112.380444			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105111	hybrid, Green Published			2022-12-28	WOS:000312501600070
J	Hirano, Y; Hizume, K; Kimura, H; Takeyasu, K; Haraguchi, T; Hiraoka, Y				Hirano, Yasuhiro; Hizume, Kohji; Kimura, Hiroshi; Takeyasu, Kunio; Haraguchi, Tokuko; Hiraoka, Yasushi			Lamin B Receptor Recognizes Specific Modifications of Histone H4 in Heterochromatin Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PROTEIN LBR; ENVELOPE INNER MEMBRANE; NUCLEAR-ENVELOPE; CHROMODOMAIN PROTEINS; INTEGRAL PROTEIN; TUDOR DOMAIN; DNA-DAMAGE; CHROMATIN; BINDING; METHYLATION	Inner nuclear membrane proteins provide a structural framework for chromatin, modulating transcription beneath the nuclear envelope. Lamin B receptor (LBR) is a classical inner nuclear membrane protein that associates with heterochromatin, and its mutations are known to cause Pelger-Huet anomaly in humans. However, the mechanisms by which LBR organizes heterochromatin remain to be elucidated. Here, we show that LBR represses transcription by binding to chromatin regions that are marked by specific histone modifications. The tudor domain (residues 1-62) of LBR primarily recognizes histone H4 lysine 20 dimethylation and is essential for chromatin compaction, whereas the whole nucleoplasmic region (residues 1-211) is required for transcriptional repression. We propose a model in which the nucleoplasmic domain of LBR tethers epigenetically marked chromatin to the nuclear envelope and transcriptional repressors are loaded onto the chromatin through their interaction with LBR.	[Hirano, Yasuhiro; Kimura, Hiroshi; Haraguchi, Tokuko; Hiraoka, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Hizume, Kohji] Natl Inst Genet, Div Microbial Genet, Mishima, Shizuoka 4118540, Japan; [Takeyasu, Kunio] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; [Haraguchi, Tokuko; Hiraoka, Yasushi] Natl Inst Informat & Communicat Technol, Adv ICT Res Inst Kobe, Kobe, Hyogo 6512492, Japan	Osaka University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kyoto University; National Institute of Information & Communications Technology (NICT) - Japan	Hiraoka, Y (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Yamadaoka 1-3, Suita, Osaka 5650871, Japan.	hiraoka@fbs.osaka-u.ac.jp	Hizume, Kohji/L-6661-2019; Hiraoka, Yasushi/B-5111-2009; Kimura, Hiroshi/B-9524-2015; Hirano, Yasuhiro/AAN-4617-2021	Hiraoka, Yasushi/0000-0001-9407-8228; Kimura, Hiroshi/0000-0003-0854-083X; Kimura, Hiroshi/0000-0002-4968-7144; Hizume, Kohji/0000-0001-9091-9173; Hirano, Yasuhiro/0000-0001-7339-4053	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [24770157] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research on innovative areas (to Y. Hiraoka, H. K., and T. H.) and a grant-in-aid for scientific research on priority areas (to K. T.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and a grant-in-aid for research activity start-up (to Y. Hirano) from the Japan Society for the Promotion of Science.	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bock I, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-48; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Duband-Goulet I, 2000, BIOCHEMISTRY-US, V39, P6483, DOI 10.1021/bi992908b; Greeson NT, 2008, J BIOL CHEM, V283, P33168, DOI 10.1074/jbc.M806857200; Guarda A, 2009, EXP CELL RES, V315, P1895, DOI 10.1016/j.yexcr.2009.01.019; Haraguchi T, 2000, J CELL SCI, V113, P779; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; Hirano Y, 2008, PFLUG ARCH EUR J PHY, V456, P139, DOI 10.1007/s00424-007-0431-z; Hirano Y, 2009, GENES CELLS, V14, P155, DOI 10.1111/j.1365-2443.2008.01262.x; Hizume K, 2005, BIOCHEMISTRY-US, V44, P12978, DOI 10.1021/bi050623v; Hizume K, 2007, NUCLEIC ACIDS RES, V35, P2787, DOI 10.1093/nar/gkm116; Hoffmann K, 2002, NAT GENET, V31, P410, DOI 10.1038/ng925; Hoffmann K, 2007, CHROMOSOMA, V116, P227, DOI 10.1007/s00412-007-0094-8; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P109, DOI 10.1038/nsmb1326; Liokatis S, 2012, J BIOL CHEM, V287, P1032, DOI 10.1074/jbc.M111.281303; Ma Y, 2007, J CELL SCI, V120, P520, DOI 10.1242/jcs.03355; Makatsori D, 2004, J BIOL CHEM, V279, P25567, DOI 10.1074/jbc.M313606200; Martins SB, 2000, J CELL SCI, V113, P3703; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Ohniwa RL, 2007, GENES CELLS, V12, P1141, DOI 10.1111/j.1365-2443.2007.01125.x; Ostlund C, 2006, BIOCHEMISTRY-US, V45, P1374, DOI 10.1021/bi052156n; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Polioudaki H, 2001, EMBO REP, V2, P920, DOI 10.1093/embo-reports/kve199; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Takano M, 2002, EUR J BIOCHEM, V269, P943, DOI 10.1046/j.0014-2956.2001.02730.x; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; Tsuchiya M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025694; WORMAN HJ, 1988, P NATL ACAD SCI USA, V85, P8531, DOI 10.1073/pnas.85.22.8531; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; YE Q, 1994, J BIOL CHEM, V269, P11306; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983; Zwerger M, 2008, EXP HEMATOL, V36, P977, DOI 10.1016/j.exphem.2008.03.003	42	81	84	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42654	42663		10.1074/jbc.M112.397950	http://dx.doi.org/10.1074/jbc.M112.397950			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23100253	Green Published, hybrid			2022-12-28	WOS:000312501600026
J	Ding, WX; Li, M; Biazik, JM; Morgan, DG; Guo, FL; Ni, HM; Goheen, M; Eskelinen, EL; Yin, XM				Ding, Wen-Xing; Li, Min; Biazik, Joanna M.; Morgan, David G.; Guo, Fengli; Ni, Hong-Min; Goheen, Michael; Eskelinen, Eeva-Liisa; Yin, Xiao-Ming			Electron Microscopic Analysis of a Spherical Mitochondrial Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; MITOPHAGY; PARKIN; AUTOPHAGY; MEMBRANE; DISEASE; STRESS; FUSION; PINK1	Mitochondria undergo dynamic structural alterations to meet changing needs and to maintain homeostasis. We report here a novel mitochondrial structure. Conventional transmission electron microscopic examination of murine embryonic fibroblasts treated with carbonyl cyanide m-chlorophenylhydrazone (CCCP), a mitochondrial uncoupler, found that more than half of the mitochondria presented a ring-shaped or C-shaped morphology. Many of these mitochondria seemed to have engulfed various cytosolic components. Serial sections through individual mitochondria indicated that they formed a ball-like structure with an internal lumen surrounded by the membranes and containing cytosolic materials. Notably, the lumen was connected to the external cytoplasm through a small opening. Electron tomographic reconstruction of the mitochondrial spheroids demonstrated the membrane topology and confirmed the vesicular configuration of this mitochondrial structure. The outside periphery and the lumen were defined by the outer membranes, which were lined with the inner membranes. Matrix and cristae were retained but distributed unevenly with less being kept near the luminal opening. Mitochondrial spheroids seem to form in response to oxidative mitochondrial damage independently of mitophagy. The structural features of the mitochondrial spheroids thus represent a novel mitochondrial dynamics.	[Ding, Wen-Xing; Ni, Hong-Min] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Li, Min; Goheen, Michael; Yin, Xiao-Ming] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Biazik, Joanna M.; Eskelinen, Eeva-Liisa] Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, FIN-00014 Helsinki, Finland; [Morgan, David G.] Indiana Univ, Cryotransmiss Electron Microscopy Facil, Bloomington, IN 47405 USA; [Guo, Fengli] Stowers Inst Med Res, Kansas City, MO 64110 USA	University of Kansas; University of Kansas Medical Center; Indiana University System; Indiana University Bloomington; University of Helsinki; Indiana University System; Indiana University Bloomington; Stowers Institute for Medical Research	Ding, WX (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, MS 1018,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	wxding@kumc.edu; xmyin@iupui.edu	Li, Min/B-1281-2011; Eskelinen, Eeva-Liisa/AAF-3496-2019; Morgan, David Gene/W-3429-2019	Eskelinen, Eeva-Liisa/0000-0003-0006-7785; Biazik-Richmond, Joanna/0000-0002-5855-0457	National Institutes of Health [R01 AA020518-01, R21AA017421, P20 RR021940, P20 RR016475, R01CA111456, R01CA83817]; NATIONAL CANCER INSTITUTE [R01CA083817, R01CA111456] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475, P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA017421, R37AA020518, R01AA020518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AA020518-01, R21AA017421, P20 RR021940, and P20 RR016475 (to W.-X. D.) and R01CA111456 and R01CA83817 (to X.-M.Y.).	Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; CHRISTENSEN AK, 1959, EXP CELL RES, V18, P576, DOI 10.1016/0014-4827(59)90323-4; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; Ding WX, 2012, J BIOL CHEM, V287, P42379, DOI 10.1074/jbc.M112.413682; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; KIESSLING KH, 1964, EXP CELL RES, V33, P350, DOI 10.1016/S0014-4827(64)81040-5; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; LAUBER JK, 1983, CURR EYE RES, V2, P855, DOI 10.3109/02713688209020022; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Messerschmitt M, 2003, J CELL BIOL, V160, P553, DOI 10.1083/jcb.200211113; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Ricci JE, 2003, CELL DEATH DIFFER, V10, P488, DOI 10.1038/sj.cdd.4401225; Scheffler I.E., 1999, MITOCHONDRIA, p[15, 145]; SETOGUTI T, 1977, AM J ANAT, V148, P65, DOI 10.1002/aja.1001480107; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	26	72	72	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42373	42378		10.1074/jbc.M112.413674	http://dx.doi.org/10.1074/jbc.M112.413674			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23093403	Green Published, hybrid			2022-12-28	WOS:000312103000072
J	Gangalum, RK; Horwitz, J; Kohan, SA; Bhat, SP				Gangalum, Rajendra K.; Horwitz, Joseph; Kohan, Sirus A.; Bhat, Suraj P.			alpha A-Crystallin and alpha B-Crystallin Reside in Separate Subcellular Compartments in the Developing Ocular Lens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; ENDOPLASMIC-RETICULUM; NONOCULAR TISSUES; MEMBRANE; EXPRESSION; COMPLEX; CELL; BINDING; LIPIDS; PHOSPHORYLATION	alpha A-Crystallin (alpha A) and alpha B-crystallin (alpha B), the two prominent members of the small heat shock family of proteins are considered to be two subunits of one multimeric protein, alpha-crystallin, within the ocular lens. Outside of the ocular lens, however, alpha A and alpha B are known to be two independent proteins, with mutually exclusive expression in many tissues. This dichotomous view is buoyed by the high expression of alpha A and alpha B in the lens and their co-fractionation from lens extracts as one multimeric entity, alpha-crystallin. To understand the biological function(s) of each of these two proteins, it is important to investigate the biological basis of this perceived dichotomy; in this report, we address the question whether alpha A and alpha B exist as independent proteins in the ocular lens. Discontinuous sucrose density gradient fractionation and immunoconfocal localization reveal that in early developing rat lens alpha A is a membrane-associated small heat shock protein similar to alpha B but with remarkable differences. Employing an established protocol, we demonstrate that alpha B predominantly sediments with rough endoplasmic reticulum, whereas alpha A fractionates with smooth membranes. These biochemical observations were corroborated with immunogold labeling and transmission electron microscopy. Importantly, in the rat heart also, which does not contain alpha A, alpha B fractionates with rough endoplasmic reticulum, suggesting that alpha A has no influence on the distribution of alpha B. These data demonstrate presence of alpha A and alpha B in two separate subcellular membrane compartments, pointing to their independent existence in the developing ocular lens.	[Gangalum, Rajendra K.; Horwitz, Joseph; Bhat, Suraj P.] Univ Calif Los Angeles, Jules Stein Eye Inst, Geffen Sch Med, Los Angeles, CA 90095 USA; [Bhat, Suraj P.] Univ Calif Los Angeles, Inst Mol Biol, Geffen Sch Med, Los Angeles, CA 90095 USA; [Kohan, Sirus A.; Bhat, Suraj P.] Univ Calif Los Angeles, Brain Res Inst, Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bhat, SP (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, Geffen Sch Med, 100 Stein Plaza,BH623, Los Angeles, CA 90095 USA.	bhat@jsei.ucla.edu	Gangalum, Rajendra K/H-1369-2013	Gangalum, Rajendra K/0000-0002-8746-0266; Bhat, Suraj P/0000-0003-4707-5870	NEI, National Institutes of Health [1R01EY006044]; NATIONAL EYE INSTITUTE [R01EY006044] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NEI, National Institutes of Health grant to S. P. B. (1R01EY006044).	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Bassnett S, 2002, EXP EYE RES, V74, P1, DOI 10.1006/exer.2001.1111; BENEDETTI EL, 1968, BIOCHEM J, V108, P765, DOI 10.1042/bj1080765; Bhat SP, 2004, EXP EYE RES, V79, P809, DOI 10.1016/j.exer.2004.08.020; Bhat SP, 2003, PROG DRUG RES, V60, P205; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; BHAT SP, 1991, EUR J BIOCHEM, V202, P775, DOI 10.1111/j.1432-1033.1991.tb16432.x; Bloemendal H, 1974, Methods Enzymol, V30, P313; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; BRAHMA SK, 1987, CURR EYE RES, V6, P1291, DOI 10.3109/02713688708997554; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; CENEDELLA RJ, 1993, CURR EYE RES, V12, P1025, DOI 10.3109/02713689309029230; Chanoux RA, 2012, J BIOL CHEM, V287, P19255, DOI 10.1074/jbc.M112.357756; CHIESA R, 1989, CURR EYE RES, V8, P151, DOI 10.3109/02713688908995186; Cobb BA, 2000, J BIOL CHEM, V275, P6664, DOI 10.1074/jbc.275.9.6664; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Gangalum RK, 2011, J BIOL CHEM, V286, P3261, DOI 10.1074/jbc.M110.160135; Gangalum RK, 2009, INVEST OPHTH VIS SCI, V50, P3283, DOI 10.1167/iovs.08-3052; Gangalum RK, 2004, J BIOL CHEM, V279, P43374, DOI 10.1074/jbc.C400371200; GROENEN PJTA, 1994, EUR J BIOCHEM, V225, P1, DOI 10.1111/j.1432-1033.1994.00001.x; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; HORWITZ J, 1993, INVEST OPHTH VIS SCI, V34, P10; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; IFEANYI F, 1990, CURR EYE RES, V9, P259, DOI 10.3109/02713689009044521; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; KATO K, 1991, BIOCHIM BIOPHYS ACTA, V1074, P201, DOI 10.1016/0304-4165(91)90062-L; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; KIBBELAAR MA, 1979, EXP EYE RES, V29, P679, DOI 10.1016/0014-4835(79)90024-1; Persson S, 2009, J NEUROSCI METH, V184, P42, DOI 10.1016/j.jneumeth.2009.07.017; Rao NA, 2008, INVEST OPHTH VIS SCI, V49, P1161, DOI 10.1167/iovs.07-1259; Robenek MJ, 2004, FASEB J, V18, P866, DOI 10.1096/fj.03-0782fje; Robinson ML, 1996, INVEST OPHTH VIS SCI, V37, P2276; Saint-Geniez M, 2009, INVEST OPHTH VIS SCI, V50, P311, DOI 10.1167/iovs.08-2461; SILBERSTEIN S, 1992, J BIOL CHEM, V267, P23658; SRINIVASAN AN, 1992, J BIOL CHEM, V267, P23337; Suetsugu S, 2010, SEMIN CELL DEV BIOL, V21, P340, DOI 10.1016/j.semcdb.2009.12.002; TAKIGUCHI M, 1985, J BIOCHEM, V97, P1447, DOI 10.1093/oxfordjournals.jbchem.a135199; VOORTER CEM, 1989, FEBS LETT, V259, P50; WAGNER M, 1994, J CELL SCI, V107, P933; ZELENKA PS, 1984, CURR EYE RES, V3, P1337, DOI 10.3109/02713688409007421; ZIGMAN S, 1984, CURR EYE RES, V3, P887, DOI 10.3109/02713688409167206	43	17	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42407	42416		10.1074/jbc.M112.414854	http://dx.doi.org/10.1074/jbc.M112.414854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23071119	hybrid, Green Published			2022-12-28	WOS:000312103000076
J	Ginkel, C; Hartmann, D; vom Dorp, K; Zlomuzica, A; Farwanah, H; Eckhardt, M; Sandhoff, R; Degen, J; Rabionet, M; Dere, E; Dormann, P; Sandhoff, K; Willecke, K				Ginkel, Christina; Hartmann, Dieter; vom Dorp, Katharina; Zlomuzica, Armin; Farwanah, Hany; Eckhardt, Matthias; Sandhoff, Roger; Degen, Joachim; Rabionet, Mariona; Dere, Ekrem; Doermann, Peter; Sandhoff, Konrad; Willecke, Klaus			Ablation of Neuronal Ceramide Synthase 1 in Mice Decreases Ganglioside Levels and Expression of Myelin-associated Glycoprotein in Oligodendrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							(DIHYDRO)CERAMIDE SYNTHASE; SUBSTRATE-SPECIFICITY; COMPLEX GANGLIOSIDES; METABOLIC-PATHWAYS; MOUSE; SPHINGOLIPIDS; DEFICIENT; DISEASE; MOTOR; ROLES	Ceramide synthase 1 (CerS1) catalyzes the synthesis of C18 ceramide and is mainly expressed in the brain. Custom-made antibodies to a peptide from the C-terminal region of the mouse CerS1 protein yielded specific immunosignals in neurons but no other cell types of wild type brain, but the CerS1 protein was not detected in CerS1-deficient mouse brains. To elucidate the biological function of CerS1-derived sphingolipids in the brain, we generated CerS1-deficient mice by introducing a targeted mutation into the coding region of the cers1 gene. General deficiency of CerS1 in mice caused a foliation defect, progressive shrinkage, and neuronal apoptosis in the cerebellum. Mass spectrometric analyses revealed up to 60% decreased levels of ganglio-sides in cerebellum and forebrain. Expression of myelin-associated glycoprotein was also decreased by about 60% in cerebellum and forebrain, suggesting that interaction and stabilization of oligodendrocytic myelin-associated glycoprotein by neuronal gangliosides is due to the C18 acyl membrane anchor of CerS1-derived precursor ceramides. A behavioral analysis of CerS1-deficient mice yielded functional deficits including impaired exploration of novel objects, locomotion, and motor coordination. Our results reveal an essential function of CerS1-derived ceramide in the regulation of cerebellar development and neurodevelopmentally regulated behavior.	[Ginkel, Christina; Farwanah, Hany; Degen, Joachim; Sandhoff, Konrad; Willecke, Klaus] Univ Bonn, Life & Med Sci Inst, D-53115 Bonn, Germany; [Hartmann, Dieter] Univ Bonn, Inst Anat, Div Neuroanat, D-53115 Bonn, Germany; [vom Dorp, Katharina; Doermann, Peter] Univ Bonn, Inst Mol Physiol & Biotechnol Plants, D-53115 Bonn, Germany; [Eckhardt, Matthias] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [Zlomuzica, Armin] Ruhr Univ Bochum, Dept Clin Psychol & Psychotherapy, D-44780 Bochum, Germany; [Sandhoff, Roger; Rabionet, Mariona] German Canc Res Ctr, Lipid Pathobiochem Grp Cellular & Mol Pathol, D-69120 Heidelberg, Germany; [Dere, Ekrem] Univ Paris 06, Unite Format & Rech Sci Vie, F-75005 Paris, France	University of Bonn; University of Bonn; University of Bonn; University of Bonn; Ruhr University Bochum; Helmholtz Association; German Cancer Research Center (DKFZ); UDICE-French Research Universities; Sorbonne Universite	Willecke, K (corresponding author), Univ Bonn, Life & Med Sci Inst, Carl Troll Str 31, D-53115 Bonn, Germany.	k.willecke@uni-bonn.de	Dere, Ekrem/F-3879-2018; Dere, Ekrem/Y-3872-2019	Dere, Ekrem/0000-0001-7823-7778; 	German Research Foundation through Collaborative Research Center Grant [SFB645, B2, B8, B5];  [DE1149/5-1]	German Research Foundation through Collaborative Research Center Grant; 	This work was supported by the German Research Foundation through Collaborative Research Center Grant SFB645, project B2 (to K. W.), project B8 (to P. D.), and project B5 (to M. E.), and through Grant DE1149/5-1 (to E. D.).	Becker I, 2008, HISTOCHEM CELL BIOL, V129, P233, DOI 10.1007/s00418-007-0344-0; Bevins RA, 2005, NEUROSCI BIOBEHAV R, V29, P707, DOI 10.1016/j.neubiorev.2005.03.013; Blank MC, 2011, DEVELOPMENT, V138, P1207, DOI 10.1242/dev.054114; Blatter K, 2006, EXP BRAIN RES, V168, P541, DOI 10.1007/s00221-005-0114-y; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Chiavegatto S, 2000, EXP NEUROL, V166, P227, DOI 10.1006/exnr.2000.7504; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Dere E, 2003, EUR J NEUROSCI, V18, P629, DOI 10.1046/j.1460-9568.2003.02784.x; Di Pardo A, 2012, P NATL ACAD SCI USA, V109, P3528, DOI 10.1073/pnas.1114502109; HANAUER A, 1984, EMBO J, V3, P2627, DOI 10.1002/j.1460-2075.1984.tb02185.x; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Jennemann R, 2007, J BIOL CHEM, V282, P3083, DOI 10.1074/jbc.M610304200; Kim YS, 2010, CEREBELLUM, V9, P310, DOI 10.1007/s12311-010-0163-z; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Kolter T, 1999, ANGEW CHEM INT EDIT, V38, P1532, DOI 10.1002/(SICI)1521-3773(19990601)38:11<1532::AID-ANIE1532>3.0.CO;2-U; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu B, 1997, SEMIN CELL DEV BIOL, V8, P311, DOI 10.1006/scdb.1997.0153; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Maxeiner S, 2005, J NEUROSCI, V25, P566, DOI 10.1523/JNEUROSCI.3232-04.2005; Mencarelli C., 2012, CELL MOL LI IN PRESS; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; MERRILL AH, 1983, BIOCHIM BIOPHYS ACTA, V754, P284, DOI 10.1016/0005-2760(83)90144-3; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; MOMOI T, 1976, BIOCHIM BIOPHYS ACTA, V441, P488; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; NAGY A, 2003, MANIPULATING MOUSE E, P476; Niimi K, 2011, BIOCHEM BIOPH RES CO, V406, P524, DOI 10.1016/j.bbrc.2011.02.071; Ogretmen B, 2001, DRUG RESIST UPDATE, V4, P368, DOI 10.1054/drup.2001.0225; Ohmi Y, 2011, J NEUROCHEM, V116, P926, DOI 10.1111/j.1471-4159.2010.07067.x; Pan BH, 2005, EXP NEUROL, V195, P208, DOI 10.1016/j.expneurol.2005.04.017; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Rankin CT, 2000, NAT GENET, V24, P262, DOI 10.1038/73472; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Russell D. W, 2001, MOL CLONING LAB MANU, P34; Sandhoff R, 2005, J BIOL CHEM, V280, P27310, DOI 10.1074/jbc.M502775200; Sandhoff R, 2002, J BIOL CHEM, V277, P20386, DOI 10.1074/jbc.M110641200; Sandhoff R, 2010, FEBS LETT, V584, P1907, DOI 10.1016/j.febslet.2009.12.032; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Sudarov A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-26; Sun J, 2004, GLYCOBIOLOGY, V14, P851, DOI 10.1093/glycob/cwh107; Tajima O, 2009, BEHAV BRAIN RES, V198, P74, DOI 10.1016/j.bbr.2008.10.024; Teigler A, 2009, HUM MOL GENET, V18, P1897, DOI 10.1093/hmg/ddp110; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Wang BH, 2007, DNA SEQUENCE, V18, P92, DOI 10.1080/10425170601060947; Watanabe S, 2010, GLIA, V58, P1197, DOI 10.1002/glia.20999; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wewer V, 2011, J LIPID RES, V52, P1039, DOI 10.1194/jlr.D013987; WILLIAMS MA, 1980, J NEUROCHEM, V35, P266, DOI 10.1111/j.1471-4159.1980.tb12515.x; Yang LJS, 1996, P NATL ACAD SCI USA, V93, P814, DOI 10.1073/pnas.93.2.814; Yu RK, 2012, NEUROCHEM RES, V37, P1230, DOI 10.1007/s11064-012-0744-y; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009; Zheng-Fischhofer Q, 2007, EUR J CELL BIOL, V86, P683, DOI 10.1016/j.ejcb.2007.01.005; Zlomuzica A, 2008, EUR J NEUROSCI, V27, P1461, DOI 10.1111/j.1460-9568.2008.06115.x; Zlomuzica A, 2012, DEV NEUROSCI-BASEL, V34, P277, DOI 10.1159/000339305	59	87	90	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41888	41902		10.1074/jbc.M112.413500	http://dx.doi.org/10.1074/jbc.M112.413500			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23074226	Green Published, hybrid			2022-12-28	WOS:000312103000029
J	Raj, N; Zhang, L; Wei, YL; Arnosti, DN; Henry, RW				Raj, Nitin; Zhang, Liang; Wei, Yiliang; Arnosti, David N.; Henry, R. William			Ubiquitination of Retinoblastoma Family Protein 1 Potentiates Gene-specific Repression Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; ECTOPIC EXPRESSION; ACTIVATION DOMAIN; E2F; BINDING; RB; PHOSPHORYLATION; TRANSCRIPTION; MECHANISM; PRB	The retinoblastoma (RB) tumor suppressor family functions as a regulatory node governing cell cycle progression, differentiation, and apoptosis. Post-translational modifications play a critical role in modulating RB activity, but additional levels of control, including protein turnover, are also essential for proper function. The Drosophila RB homolog Rbf1 is subjected to developmentally cued proteolysis mediated by an instability element (IE) present in the C terminus of this protein. Paradoxically, instability mediated by the IE is also linked to Rbf1 repression potency, suggesting that proteolytic machinery may also be directly involved in transcriptional repression. We show that the Rbf1 IE is an autonomous degron that stimulates both Rbf1 ubiquitination and repression potency. Importantly, Rbf1 IE function is promoter-specific, contributing to repression of cell cycle responsive genes but not to repression of cell signaling genes. The multifunctional IE domain thus provides Rbf1 flexibility for discrimination between target genes embedded in divergent cellular processes.	[Wei, Yiliang; Arnosti, David N.; Henry, R. William] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Raj, Nitin] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Zhang, Liang] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Arnosti, DN (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	arnosti@msu.edu; henryrw@msu.edu	Wei, Yiliang/S-7723-2018	Wei, Yiliang/0000-0001-8956-2955; Raj, Nitin/0000-0001-7678-3855	National Institutes of Health [1R01GM079098, 1R01CA142644]; Michigan State University Gene Expression in Development and Disease Group; NATIONAL CANCER INSTITUTE [R01CA142644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan State University Gene Expression in Development and Disease Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01GM079098 (to R.W.H. and D.N.A.) and 1R01CA142644 (to J.J. Tepe and R.W.H.). This work was also supported by the Michigan State University Gene Expression in Development and Disease Group.	Acharya P., 2012, GENES GENOM IN PRESS; Acharya P, 2010, MOL BIOL CELL, V21, P3890, DOI 10.1091/mbc.E10-06-0520; Barbash O, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-2; Bech-Otschir D, 2002, J CELL SCI, V115, P467; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Chamovitz DA, 2002, CURR BIOL, V12, pR232, DOI 10.1016/S0960-9822(02)00775-3; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Delston RB, 2011, ONCOGENE, V30, P588, DOI 10.1038/onc.2010.442; Delston RB, 2006, CURR MOL MED, V6, P713; Deroo BJ, 2002, J BIOL CHEM, V277, P20120, DOI 10.1074/jbc.C200173200; Du W, 1996, EMBO J, V15, P3684, DOI 10.1002/j.1460-2075.1996.tb00738.x; Du W, 1999, EMBO J, V18, P916, DOI 10.1093/emboj/18.4.916; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Genovese C, 2006, ONCOGENE, V25, P5201, DOI 10.1038/sj.onc.1209652; Hammond-Martel I, 2012, CELL SIGNAL, V24, P410, DOI 10.1016/j.cellsig.2011.10.009; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Horwitz AA, 2007, P NATL ACAD SCI USA, V104, P6614, DOI 10.1073/pnas.0610481104; KATO J, 1993, GENE DEV, V7, P331; Keller SA, 2005, GENE EXPR PATTERNS, V5, P411, DOI 10.1016/j.modgep.2004.09.005; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Korenjak M, 2012, MOL CELL BIOL, V32, P4375, DOI 10.1128/MCB.00536-12; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; LIN BTY, 1992, CIBA F SYMP, V170, P227; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Nguyen DX, 2005, J CELL BIOCHEM, V94, P870, DOI 10.1002/jcb.20375; Raj N, 2012, CELL CYCLE, V11, P3731, DOI 10.4161/cc.21665; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Ryu JR, 2003, NUCLEIC ACIDS RES, V31, P4654, DOI 10.1093/nar/gkg491; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Skapek SX, 2006, ONCOGENE, V25, P5268, DOI 10.1038/sj.onc.1209710; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Ullah Z, 2007, MOL BIOL CELL, V18, P1179, DOI 10.1091/mbc.E06-09-0790; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Wells J, 2003, ONCOGENE, V22, P1445, DOI 10.1038/sj.onc.1206264; Wikenheiser-Brokamp KA, 2006, CELL MOL LIFE SCI, V63, P767, DOI 10.1007/s00018-005-5487-3; Ying HQ, 2006, CELL CYCLE, V5, P506, DOI 10.4161/cc.5.5.2515	42	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41835	41843		10.1074/jbc.M112.422428	http://dx.doi.org/10.1074/jbc.M112.422428			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086928	Green Published, hybrid			2022-12-28	WOS:000312103000024
J	Mogami, H; Kishore, AH; Shi, H; Keller, PW; Akgul, Y; Word, RA				Mogami, Haruta; Kishore, Annavarapu Hari; Shi, Haolin; Keller, Patrick W.; Akgul, Yucel; Word, R. Ann			Fetal Fibronectin Signaling Induces Matrix Metalloproteases and Cyclooxygenase-2 (COX-2) in Amnion Cells and Preterm Birth in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTOR-4; PREMATURE RUPTURE; HUMAN-PLASMA; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; BINDING DOMAIN; HUMAN PLACENTA; MOUSE VAGINA; EXTRA DOMAIN	Fetal fibronectin (fFN) in cervical and vaginal secretions has been used as a predictor of preterm delivery. Here, we clarified the pathological function of fFN on cell type-specific matrix metalloproteinases (MMPs) and prostaglandin synthesis in fetal membranes. Treatment of amnion mesenchymal cells with fFN resulted in dramatic increases in MMP-1 and MMP-9 mRNA and enzymatic activity as well as COX-2 mRNA and prostaglandin E-2 synthesis, activating both NF kappa B and ERK1/2 signaling. Fetal FN-induced increases in MMPs and COX-2 were mediated through its extra domain A and Toll-like receptor 4 expressed in mesenchymal cells. Lipopolysaccharide and TNF-alpha increased the release of free FN in medium of amnion epithelial cells in culture. Finally, injection of fFN in pregnant mice resulted in preterm birth. Collectively, these results indicate that fFN is not only a marker of preterm delivery but also plays a significant role in the pathogenesis of preterm labor and premature rupture of fetal membranes.	[Word, R. Ann] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Cecil H & Ida Green Ctr Reprod Biol Sci, Div Reprod Endocrinol & Urogynecol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Word, RA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Cecil H & Ida Green Ctr Reprod Biol Sci, Div Reprod Endocrinol & Urogynecol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	ruth.word@utsouthwestern.edu	Akgul, Yucel/M-1745-2013	akgul, yucel/0000-0001-8880-9821	National Institutes of Health [HD11149]; SUMITOMO Life Social Welfare Service Foundation; Human Tissue and Biologic Fluid Core Laboratory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD011149] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD011149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SUMITOMO Life Social Welfare Service Foundation; Human Tissue and Biologic Fluid Core Laboratory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD11149. This work was also supported by a fellowship from the SUMITOMO Life Social Welfare Service Foundation and the Human Tissue and Biologic Fluid Core Laboratory.	Athayde N, 1998, AM J OBSTET GYNECOL, V179, P1248, DOI 10.1016/S0002-9378(98)70141-3; Becher N, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-45; Casey ML, 1996, BIOL REPROD, V55, P1253, DOI 10.1095/biolreprod55.6.1253; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Challis JRG, 2002, REPRODUCTION, V124, P1; DRAPER D, 1995, AM J OBSTET GYNECOL, V173, P1506, DOI 10.1016/0002-9378(95)90640-1; Drewes PG, 2007, AM J PATHOL, V170, P578, DOI 10.2353/ajpath.2007.060662; DUCHESNE MJ, 1978, PROSTAG OTH LIPID M, V15, P19, DOI 10.1016/S0090-6980(78)80003-3; Dudley DJ, 1996, BIOL REPROD, V55, P992, DOI 10.1095/biolreprod55.5.992; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Filipovich Y, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.038; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; HARGER JH, 1990, AM J OBSTET GYNECOL, V163, P130, DOI 10.1016/S0002-9378(11)90686-3; Hirsch E, 1999, AM J OBSTET GYNECOL, V180, P429, DOI 10.1016/S0002-9378(99)70227-9; Jackson GM, 1996, J SOC GYNECOL INVEST, V3, P85, DOI 10.1016/1071-5576(95)00050-X; Kim YS, 1998, J BIOL CHEM, V273, P27686, DOI 10.1074/jbc.273.42.27686; KORNBLIHTT AR, 1984, EMBO J, V3, P221, DOI 10.1002/j.1460-2075.1984.tb01787.x; Leon CG, 2008, PHARM RES-DORDR, V25, P1751, DOI 10.1007/s11095-008-9571-x; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li W, 2007, BIOL REPROD, V76, P654, DOI 10.1095/biolreprod.106.057034; LOCKWOOD CJ, 1991, NEW ENGL J MED, V325, P669, DOI 10.1056/NEJM199109053251001; Maurer LM, 2012, J BIOL CHEM, V287, P13303, DOI 10.1074/jbc.M111.294041; Maymon E, 2000, AM J OBSTET GYNECOL, V183, P914, DOI 10.1067/mob.2000.108879; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MOSESSON MW, 1970, J BIOL CHEM, V245, P5728; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; OYAMA F, 1989, BIOCHEMISTRY-US, V28, P1428, DOI 10.1021/bi00429a072; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Pressman EK, 2002, AM J OBSTET GYNECOL, V187, P672, DOI 10.1067/mob.2002.125742; QUADE BJ, 1988, J BIOL CHEM, V263, P19602; Rahn DD, 2009, AM J PATHOL, V174, P206, DOI 10.2353/ajpath.2009.080212; Retta SF, 1999, METH MOL B, V96, P119; Romer LH, 1995, BIOCHEM CELL BIOL, V73, P515, DOI 10.1139/o95-057; ROMERO R, 1987, AM J OBSTET GYNECOL, V157, P1461, DOI 10.1016/S0002-9378(87)80245-4; Saito S, 1999, J BIOL CHEM, V274, P30756, DOI 10.1074/jbc.274.43.30756; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; SALAFIA CM, 1995, AM J OBSTET GYNECOL, V173, P1065, DOI 10.1016/0002-9378(95)91327-0; Sanchez-Ramos L, 2009, OBSTET GYNECOL, V114, P631, DOI 10.1097/AOG.0b013e3181b47217; Sil H, 2011, ONCOL RES, V19, P335, DOI 10.3727/096504011X13079697132925; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Strakova Z, 1998, AM J PHYSIOL-ENDOC M, V274, pE634, DOI 10.1152/ajpendo.1998.274.4.E634; THERRIEN M, 1993, MOL CELL BIOL, V13, P2342, DOI 10.1128/MCB.13.4.2342; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; VADILLOORTEGA F, 1995, AM J PATHOL, V146, P148; Weiss A, 2007, FRONT BIOSCI-LANDMRK, V12, P649, DOI 10.2741/2089; Wieslander CK, 2008, BIOL REPROD, V78, P521, DOI 10.1095/biolreprod.107.063024; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yoshimura K, 2005, J SOC GYNECOL INVEST, V12, P533, DOI 10.1016/j.jsgi.2005.06.006; Zakar T, 1998, BBA-LIPID LIPID MET, V1391, P37, DOI 10.1016/S0005-2760(97)00195-1; ZHU BCR, 1984, J BIOL CHEM, V259, P3962	56	37	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1953	1966		10.1074/jbc.M112.424366	http://dx.doi.org/10.1074/jbc.M112.424366			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184961	hybrid, Green Published			2022-12-28	WOS:000313751400048
J	BasuRay, S; Mukherjee, S; Romero, EG; Seaman, MNJ; Wandinger-Ness, A				BasuRay, Soumik; Mukherjee, Sanchita; Romero, Elsa G.; Seaman, Matthew N. J.; Wandinger-Ness, Angela			Rab7 Mutants Associated with Charcot-Marie-Tooth Disease Cause Delayed Growth Factor Receptor Transport and Altered Endosomal and Nuclear Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCYTIC TRAFFICKING; MUTATIONS; MOTOR; NEUROPATHIES; LOCALIZATION; RECRUITMENT; REGULATORS; SURVIVAL; SUBUNIT; PATHWAY	Rab7 belongs to the Ras superfamily of small GTPases and is a master regulator of early to late endocytic membrane transport. Four missense mutations in the late endosomal Rab7 GTPase (L129F, K157N, N161T, and V162M) cause the autosomal dominant peripheral neuropathy Charcot-Marie-Tooth type 2B (CMT2B) disease. As yet, the pathological mechanisms connecting mutant Rab7 protein expression to altered neuronal function are undefined. Here, we analyze the effects of Rab7 CMT2B mutants on epidermal growth factor (EGF)-dependent intracellular signaling and trafficking. Three different cell lines expressing Rab7 CMT2B mutants and stimulated with EGF exhibited delayed trafficking of EGF to LAMP1-positive late endosomes and lysosomes and slowed EGF receptor (EGFR) degradation. Expression of all Rab7 CMT2B mutants altered the Rab7 activation cycle, leading to enhanced and prolonged EGFR signaling as well as variable increases in p38 and ERK1/2 activation. However, due to reduced nuclear translocation of p38 and ERK1/2, the downstream nuclear activation of Elk-1 was decreased along with the expression of immediate early genes like c-fos and Egr-1 by the disease mutants. In conclusion, our results demonstrate that Rab7 CMT2B mutants impair growth factor receptor trafficking and, in turn, alter p38 and ERK1/2 signaling from perinuclear, clustered signaling endosomes. The resulting down-regulation of EGFR-dependent nuclear transcription that is crucial for normal axon outgrowth and peripheral innervation offers a crucial new mechanistic insight into disease pathogenesis that is relevant to other neurodegenerative diseases.	[BasuRay, Soumik; Mukherjee, Sanchita; Romero, Elsa G.; Wandinger-Ness, Angela] Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; [BasuRay, Soumik; Mukherjee, Sanchita; Romero, Elsa G.; Wandinger-Ness, Angela] Univ New Mexico, Hlth Sci Ctr, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Seaman, Matthew N. J.] Univ Cambridge, Cambridge Inst Med Res, Dept Clin Biochem, Cambridge CB2 0XY, England	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of Cambridge	Wandinger-Ness, A (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Pathol, HSC MSC08-4640,2325 Camino Salud NE,CRF225, Albuquerque, NM 87131 USA.	wness@unm.edu	Wandinger-Ness, Angela/J-9104-2012	Wandinger-Ness, Angela/0000-0003-0613-3157	University of New Mexico; Cancer Center Fluorescence Microscopy Shared Resource; National Science Foundation [425 (MCB0956027)]; Medical Research Council [G0701444]; MRC [G0701444] Funding Source: UKRI	University of New Mexico; Cancer Center Fluorescence Microscopy Shared Resource; National Science Foundation(National Science Foundation (NSF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Images in this paper were generated in the University of New Mexico and Cancer Center Fluorescence Microscopy Shared Resource (funded as detailed on the Web site). We thank Dr. Edward Bedrick for helpful discussions regarding the statistical analyses. We thank the University of New Mexico flow cytometry facility for the selection of GFP-Rab7-expressing stable PC12 cell lines. We are grateful to Jamie Padilla and Genevieve Phillips for excellent technical support and Janet Kelly and Lauren Thal for outstanding administrative support.; This work was supported by National Science Foundation Grant 425 (MCB0956027) (to A. W. N.) and Medical Research Council Grant G0701444 (to M. N. J. S.).	Agola JO, 2011, CLIN GENET, V80, P305, DOI 10.1111/j.1399-0004.2011.01724.x; Ascano M, 2012, TRENDS CELL BIOL, V22, P266, DOI 10.1016/j.tcb.2012.02.005; Barisic N, 2008, ANN HUM GENET, V72, P416, DOI 10.1111/j.1469-1809.2007.00412.x; BasuRay S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015351; Bienfait HME, 2007, NEUROLOGY, V68, P1658, DOI 10.1212/01.wnl.0000263479.97552.94; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Ceresa BP, 2006, J BIOL CHEM, V281, P1099, DOI 10.1074/jbc.M504175200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Cogli L, 2010, ACTA NEUROPATHOL, V120, P491, DOI 10.1007/s00401-010-0696-8; Cogli L, 2009, BIOCHEM SOC T, V37, P1027, DOI 10.1042/BST0371027; Daniele T, 2011, TRAFFIC, V12, P902, DOI 10.1111/j.1600-0854.2011.01194.x; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Demir O, 2011, BBA-MOL BASIS DIS, V1812, P652, DOI 10.1016/j.bbadis.2011.02.012; Dong JB, 2004, J BIOL CHEM, V279, P21334, DOI 10.1074/jbc.M401022200; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Gama Lucio, 2002, Methods Mol Biol, V182, P77; Germain M, 2011, EMBO J, V30, P395, DOI 10.1038/emboj.2010.327; Golding JP, 2000, NAT CELL BIOL, V2, P103, DOI 10.1038/35000058; Houlden H, 2004, ANN NEUROL, V56, P586, DOI 10.1002/ana.20281; Jian XY, 2010, TRAFFIC, V11, P732, DOI 10.1111/j.1600-0854.2010.01054.x; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Makhortova NR, 2011, NAT CHEM BIOL, V7, P544, DOI [10.1038/NCHEMBIO.595, 10.1038/nchembio.595]; Maklad A, 2009, J INVEST DERMATOL, V129, P690, DOI 10.1038/jid.2008.281; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCray BA, 2010, HUM MOL GENET, V19, P1033, DOI 10.1093/hmg/ddp567; Meggouh F, 2006, NEUROLOGY, V67, P1476, DOI 10.1212/01.wnl.0000240068.21499.f5; Mukherjee S, 2005, METHOD ENZYMOL, V403, P650, DOI 10.1016/S0076-6879(05)03056-9; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Odrowaz Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002694; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Saxena S, 2005, J NEUROSCI, V25, P10930, DOI 10.1523/JNEUROSCI.2029-05.2005; Schroeder B, 2010, EMBO J, V29, P3039, DOI 10.1038/emboj.2010.190; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Shy ME, 2002, LANCET NEUROL, V1, P110, DOI 10.1016/S1474-4422(02)00042-X; Snider MD, 2003, MOL CELL, V12, P796, DOI 10.1016/S1097-2765(03)00401-5; Sokolova I P, 1998, Tsitologiia, V40, P862; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Taub N, 2007, MOL BIOL CELL, V18, P4698, DOI 10.1091/mbc.E07-02-0098; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Vardarajan BN, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.04.020; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Young P, 2003, CELL MOL LIFE SCI, V60, P2547, DOI 10.1007/s00018-003-3133-5	49	32	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1135	1149		10.1074/jbc.M112.417766	http://dx.doi.org/10.1074/jbc.M112.417766			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23188822	hybrid, Green Published			2022-12-28	WOS:000313570300036
J	Radzyukevich, TL; Neumann, JC; Rindler, TN; Oshiro, N; Goldhamer, DJ; Lingrel, JB; Heiny, JA				Radzyukevich, Tatiana L.; Neumann, Jonathon C.; Rindler, Tara N.; Oshiro, Naomi; Goldhamer, David J.; Lingrel, Jerry B.; Heiny, Judith A.			Tissue-specific Role of the Na,K-ATPase alpha 2 Isozyme in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-ATPASE; NICOTINIC ACETYLCHOLINE-RECEPTOR; BLOOD-PRESSURE; BINDING-SITE; ISOFORM; PUMP; POTASSIUM; SUBUNIT; TRANSPORT; MOUSE	The Na,K-ATPase alpha 2 isozyme is the major Na, K-ATPase of mammalian skeletal muscle. This distribution is unique compared with most other cells, which express mainly the Na, K-ATPase alpha 1 isoform, but its functional significance is not known. We developed a gene-targeted mouse (sk alpha 2(-/-)) in which the alpha 2 gene (Atp1a2) is knocked out in the skeletal muscles, and examined the consequences for exercise performance, membrane potentials, contractility, and muscle fatigue. Targeted knockout was confirmed by genotyping, Western blot, and immunohistochemistry. Skeletal muscle cells of sk alpha 2(-/-) mice completely lack alpha 2 protein and have no alpha 2 in the transverse tubules, where its expression is normally enhanced. The alpha 1 isoform, which is normally enhanced on the outer sarcolemma, is up-regulated 2.5-fold without change in subcellular targeting. sk alpha 2(-/-) mice are apparently normal under basal conditions but show significantly reduced exercise capacity when challenged to run. Their skeletal muscles produce less force, are unable to increase force to match demand, and show significantly increased susceptibility to fatigue. The impairments affect both fast and slow muscle types. The subcellular targeting of alpha 2 to the transverse tubules is important for this role. Increasing Na, K-ATPase alpha 1 content cannot fully compensate for the loss of alpha 2. The increased fatigability of sk alpha 2(-/-) muscles is reproduced in control extensor digitorum longus muscles by selectively inhibiting alpha 2 enzyme activity with ouabain. These results demonstrate that the Na, K-ATPase alpha 2 isoform performs an acute, isoform-specific role in skeletal muscle. Its activity is regulated by muscle use and enables working muscles to maintain contraction and resist fatigue.	[Radzyukevich, Tatiana L.; Heiny, Judith A.] Univ Cincinnati, Dept Mol & Cellular Physiol, Coll Med, Cincinnati, OH 45267 USA; [Neumann, Jonathon C.; Rindler, Tara N.; Oshiro, Naomi; Lingrel, Jerry B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Goldhamer, David J.] Univ Connecticut, Stem Cell Inst, Dept Mol & Cell Biol, Ctr Regenerat Biol, Storrs, CT 06269 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Connecticut	Heiny, JA (corresponding author), Univ Cincinnati, Dept Mol Physiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	heinyja@ucmail.uc.edu			National Institutes of Health, NHLBI [5RO1HL28573]; National Institutes of Health, NIAMS [R01AR052777]; University of Cincinnati; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052777] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Cincinnati; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grant 5RO1HL28573 and National Institutes of Health, NIAMS, Grant R01AR052777. This work was also supported by the Physiology Research Fund of the University of Cincinnati.	ALMERS W, 1980, FED PROC, V39, P1527; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Chibalin AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033719; Clausen T, 2003, ANN NY ACAD SCI, V986, P595, DOI 10.1111/j.1749-6632.2003.tb07258.x; Clausen T, 2003, PHYSIOL REV, V83, P1269, DOI 10.1152/physrev.00011.2003; Clausen T, 1998, ACTA PHYSIOL SCAND, V162, P183, DOI 10.1046/j.1365-201X.1998.0295e.x; CLAUSEN T, 1987, J PHYSIOL-LONDON, V388, P163, DOI 10.1113/jphysiol.1987.sp016608; Clausen T, 2008, J GEN PHYSIOL, V131, P473, DOI 10.1085/jgp.200809971; Clausen T, 2007, J PHYSIOL-LONDON, V584, P295, DOI 10.1113/jphysiol.2007.136044; Cougnon MH, 2002, PFLUG ARCH EUR J PHY, V445, P123, DOI 10.1007/s00424-002-0898-6; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; He SW, 2001, AM J PHYSIOL-REG I, V281, pR917, DOI 10.1152/ajpregu.2001.281.3.R917; Heiny JA, 2010, J BIOL CHEM, V285, P28614, DOI 10.1074/jbc.M110.150961; Ikeda K, 2003, J NEUROSCI, V23, P4667; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Krivoi II, 2006, PFLUG ARCH EUR J PHY, V452, P756, DOI 10.1007/s00424-006-0081-6; Lavoie L, 1997, BIOCHEMISTRY-US, V36, P7726, DOI 10.1021/bi970109s; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; LUFF AR, 1971, J CELL BIOL, V51, P369, DOI 10.1083/jcb.51.2.369; MOERLAND TS, 1994, AM J PHYSIOL, V267, pC127, DOI 10.1152/ajpcell.1994.267.1.C127; Moseley AE, 2003, J BIOL CHEM, V278, P5317, DOI 10.1074/jbc.M211315200; ORLOWSKI J, 1988, J BIOL CHEM, V263, P10436; Oshiro N, 2010, AM J HYPERTENS, V23, P1279, DOI 10.1038/ajh.2010.195; PRESSLEY TA, 1992, AM J PHYSIOL, V262, pC743, DOI 10.1152/ajpcell.1992.262.3.C743; Pritchard TJ, 2007, AM J PHYSIOL-HEART C, V293, pH1172, DOI 10.1152/ajpheart.00279.2007; Radzyukevich TL, 2009, P NATL ACAD SCI USA, V106, P2565, DOI 10.1073/pnas.0804150106; Radzyukevich TL, 2004, AM J PHYSIOL-CELL PH, V287, pC1300, DOI 10.1152/ajpcell.00231.2004; Rindler TN, 2011, AM J PHYSIOL-HEART C, V301, pH1396, DOI 10.1152/ajpheart.00121.2011; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sejersted OM, 2000, PHYSIOL REV, V80, P1411, DOI 10.1152/physrev.2000.80.4.1411; Song H, 2006, J BIOL CHEM, V281, P12929, DOI 10.1074/jbc.M507450200; TAKEYASU K, 1988, J BIOL CHEM, V263, P4347; Williams MW, 2001, J CELL SCI, V114, P751	37	64	66	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1226	1237		10.1074/jbc.M112.424663	http://dx.doi.org/10.1074/jbc.M112.424663			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23192345	Green Published, hybrid			2022-12-28	WOS:000313570300043
J	Maciejewska, AM; Poznanski, J; Kaczmarska, Z; Krowisz, B; Nieminuszczy, J; Polkowska-Nowakowska, A; Grzesiuk, E; Kusmierek, JT				Maciejewska, Agnieszka M.; Poznanski, Jaroslaw; Kaczmarska, Zuzanna; Krowisz, Beata; Nieminuszczy, Jadwiga; Polkowska-Nowakowska, Agnieszka; Grzesiuk, Elzbieta; Kusmierek, Jaroslaw T.			AlkB Dioxygenase Preferentially Repairs Protonated Substrates SPECIFICITY AGAINST EXOCYCLIC ADDUCTS AND MOLECULAR MECHANISM OF ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URACIL-DNA GLYCOSYLASE; ESCHERICHIA-COLI; OXIDATIVE DEMETHYLATION; ALKYLATION DAMAGE; ADAPTIVE RESPONSE; IN-VIVO; PROTEINS; BACTERIAL; MISMATCH; 1,N-6-ETHENOADENINE	Efficient repair by Escherichia coli AlkB dioxygenase of exo-cyclic DNA adducts 3, N-4-ethenocytosine, 1, N-6-ethenoadenine, 3, N-4-alpha-hydroxyethanocytosine, and reported here for the first time 3, N-4-alpha-hydroxypropanocytosine requires higher Fe(II) concentration than the reference 3-methylcytosine. The pH optimum for the repair follows the order of pK(a) values for protonation of the adduct, suggesting that positively charged substrates favorably interact with the negatively charged carboxylic group of Asp-135 side chain in the enzyme active center. This interaction is supported by molecular modeling, indicating that 1, N-6-ethenoadenine and 3, N-4-ethenocytosine are bound to AlkB more favorably in their protonated cationic forms. An analysis of the pattern of intermolecular interactions that stabilize the location of the ligand points to a role of Asp-135 in recognition of the adduct in its protonated form. Moreover, ab initio calculations also underline the role of substrate protonation in lowering the free energy barrier of the transition state of epoxidation of the etheno adducts studied. The observed time courses of repair of mixtures of stereoisomers of 3, N-4-alpha-hydroxyethanocytosine or 3, N-4-alpha-hydroxypropanocytosine are unequivocally two-exponential curves, indicating that the respective isomers are repaired by AlkB with different efficiencies. Molecular modeling of these adducts bound by AlkB allowed evaluation of the participation of their possible conformational states in the enzymatic reaction.	[Maciejewska, Agnieszka M.; Poznanski, Jaroslaw; Kaczmarska, Zuzanna; Krowisz, Beata; Nieminuszczy, Jadwiga; Polkowska-Nowakowska, Agnieszka; Grzesiuk, Elzbieta; Kusmierek, Jaroslaw T.] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Maciejewska, AM (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Pawinskiego 5A St, PL-02106 Warsaw, Poland.	agniesza@ibb.waw.pl	poznanski, jarek/G-7064-2013; Maciejewska, Agnieszka M/B-2287-2012; Poznanski, Jaroslaw/F-7705-2014	Poznanski, Jaroslaw/0000-0003-2684-1775; Grzesiuk, Elzbieta/0000-0002-7833-7602; Kaczmarska, Zuzanna/0000-0002-7668-1442; Maciejewska, Agnieszka M./0000-0002-1268-2606	Polish-Norwegian Research Fund [PNRF-143-AI-1/07]; National Science Centre [UMO-2012/04/M/NZ1/00068]; International Centre for Genetic Engineering and Biotechnology, Trieste, Italy [CRP/08/011]	Polish-Norwegian Research Fund; National Science Centre(National Science Centre, Poland); International Centre for Genetic Engineering and Biotechnology, Trieste, Italy	This work was supported by Polish-Norwegian Research Fund Grant PNRF-143-AI-1/07 and partially by National Science Centre Grant UMO-2012/04/M/NZ1/00068. Molecular modeling performed by J. P. was partially supported by International Centre for Genetic Engineering and Biotechnology, Trieste, Italy Grant CRP/08/011.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; ARAVIND L, 2001, GENOME BIOL, V2; Bartsch H, 1999, IARC SCI PUBL, P1; BORYS E, 1994, MUTAGENESIS, V9, P407, DOI 10.1093/mutage/9.5.407; Borys-Brzywczy E, 2005, ACTA BIOCHIM POL, V52, P149; Chen H, 2006, CHEM BIOL, V13, P849, DOI 10.1016/j.chembiol.2006.06.009; CHENNA A, 1993, CHEM RES TOXICOL, V6, P261, DOI 10.1021/tx00033a003; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P3456, DOI 10.1093/nar/gkh655; FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267; Frick LE, 2007, P NATL ACAD SCI USA, V104, P755, DOI 10.1073/pnas.0607377104; Gozdek A, 2008, ACTA BIOCHIM POL, V55, P57, DOI 10.18388/abp.2008_3201; Hang B, 2004, BIOESSAYS, V26, P1195, DOI 10.1002/bies.20130; Hertwig RH, 1997, CHEM PHYS LETT, V268, P345, DOI 10.1016/S0009-2614(97)00207-8; Ho RYN, 2001, J AM CHEM SOC, V123, P5022, DOI 10.1021/ja0041775; Jurado J, 2004, DNA REPAIR, V3, P1579, DOI 10.1016/j.dnarep.2004.06.012; Kim MY, 2007, CHEM RES TOXICOL, V20, P1075, DOI 10.1021/tx700167v; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Koivisto P, 2003, J BIOL CHEM, V278, P44348, DOI 10.1074/jbc.M307361200; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Krwawicz J, 2007, ACTA BIOCHIM POL, V54, P413, DOI 10.18388/abp.2007_3219; KUSMIEREK JT, 1982, BIOCHEMISTRY-US, V21, P5717, DOI 10.1021/bi00265a050; Leiros I, 2007, EMBO J, V26, P2206, DOI 10.1038/sj.emboj.7601662; LEONARD NJ, 1984, CRC CR REV BIOCH MOL, V15, P125, DOI 10.3109/10409238409102299; Maciejewska AM, 2011, MUTAGENESIS, V26, P401, DOI 10.1093/mutage/geq107; Maciejewska AM, 2010, MUTAT RES-FUND MOL M, V684, P24, DOI 10.1016/j.mrfmmm.2009.11.005; Mishina Y, 2005, J AM CHEM SOC, V127, P14594, DOI 10.1021/ja055957m; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nair U, 2007, FREE RADICAL BIO MED, V43, P1109, DOI 10.1016/j.freeradbiomed.2007.07.012; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; NILGES M, 1991, NATO ADV SCI I A-LIF, V225, P451; O'Neill RJ, 2003, J BIOL CHEM, V278, P20526, DOI 10.1074/jbc.M210860200; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Poznanski J, 2004, THERMOCHIM ACTA, V409, P25, DOI 10.1016/S0040-6031(03)00329-0; Poznanski J, 2007, J PHYS CHEM A, V111, P6501, DOI 10.1021/jp071611h; Ringvoll J, 2008, CANCER RES, V68, P4142, DOI 10.1158/0008-5472.CAN-08-0796; Saparbaev M, 1998, P NATL ACAD SCI USA, V95, P8508, DOI 10.1073/pnas.95.15.8508; SAPARBAEV M, 1995, NUCLEIC ACIDS RES, V23, P3750, DOI 10.1093/nar/23.18.3750; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; SMITH RA, 1989, CHEM RES TOXICOL, V2, P267, DOI 10.1021/tx00010a009; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Wasik R, 2010, J PHYS CHEM B, V114, P10601, DOI 10.1021/jp102848y; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Wiewi?rowski M, 1979, POL J CHEM, V53, P243; Yi CQ, 2010, NATURE, V468, P330, DOI 10.1038/nature09497; Yu B, 2009, P NATL ACAD SCI USA, V106, P14315, DOI 10.1073/pnas.0812938106; Zielenkiewicz W, 2005, J MOL LIQ, V121, P8, DOI 10.1016/j.molliq.2004.08.031	52	28	28	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					432	441		10.1074/jbc.M112.353342	http://dx.doi.org/10.1074/jbc.M112.353342			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23148216	Green Published, hybrid			2022-12-28	WOS:000313197200044
J	Bruel, N; Castanie-Cornet, MP; Cirinesi, AM; Koningstein, G; Georgopoulos, C; Luirink, J; Genevaux, P				Bruel, Nicolas; Castanie-Cornet, Marie-Pierre; Cirinesi, Anne-Marie; Koningstein, Gregory; Georgopoulos, Costa; Luirink, Joen; Genevaux, Pierre			Hsp33 Controls Elongation Factor-Tu Stability and Allows Escherichia coli Growth in the Absence of the Major DnaK and Trigger Factor Chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK GENES; MULTIDRUG TOLERANCE; QUALITY-CONTROL; PROTEIN; IDENTIFICATION; DEGRADATION; RECOGNITION; SECB; ACTIVATION; DISSECTION	Intracellular de novo protein folding is assisted by cellular networks of molecular chaperones. In Escherichia coli, cooperation between the chaperones trigger factor (TF) and DnaK is central to this process. Accordingly, the simultaneous deletion of both chaperone-encoding genes leads to severe growth and protein folding defects. Herein, we took advantage of such defective phenotypes to further elucidate the interactions of chaperone networks in vivo. We show that disruption of the TF/DnaK chaperone pathway is efficiently rescued by overexpression of the redox-regulated chaperone Hsp33. Consistent with this observation, the deletion of hslO, the Hsp33 structural gene, is no longer tolerated in the absence of the TF/DnaK pathway. However, in contrast with other chaperones like GroEL or SecB, suppression by Hsp33 was not attributed to its potential overlapping general chaperone function(s). Instead, we show that overexpressed Hsp33 specifically binds to elongation factor-Tu (EF-Tu) and targets it for degradation by the protease Lon. This synergistic action of Hsp33 and Lon was responsible for the rescue of bacterial growth in the absence of TF and DnaK, by presumably restoring the coupling between translation and the downstream folding capacity of the cell. In support of this hypothesis, we show that overexpression of the stress-responsive toxin HipA, which inhibits EF-Tu, also rescues bacterial growth and protein folding in the absence of TF and DnaK. The relevance for such a convergence of networks of chaperones and proteases acting directly on EF-Tu to modulate the intracellular rate of protein synthesis in response to protein aggregation is discussed.	[Bruel, Nicolas; Castanie-Cornet, Marie-Pierre; Cirinesi, Anne-Marie; Genevaux, Pierre] CNRS, LMGM, F-31062 Toulouse 9, France; [Bruel, Nicolas; Castanie-Cornet, Marie-Pierre; Cirinesi, Anne-Marie; Genevaux, Pierre] Univ Toulouse 3, F-31062 Toulouse, France; [Koningstein, Gregory; Luirink, Joen] Vrije Univ Amsterdam, Dept Mol Microbiol, Amsterdam, Netherlands; [Georgopoulos, Costa] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Vrije Universiteit Amsterdam; Utah System of Higher Education; University of Utah	Genevaux, P (corresponding author), CNRS, LMGM, 118 Route Narbonne, F-31062 Toulouse 9, France.	pierre.genevaux@ibcg.biotoul.fr	Luirink, Joen/AAB-8658-2021; Castanie-Cornet, Marie-Pierre/AAC-6857-2022; Genevaux, Pierre/A-4851-2015	Luirink, J./0000-0001-8431-0804; Castanie-Cornet, Marie-Pierre/0000-0001-9889-1101; GENEVAUX, Pierre/0000-0001-7539-3126	National Institutes of Health [5R01GM088207]; CNRS-ATIP Microbiology program; joint Region Midi-Pyrenees/CNRS grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS-ATIP Microbiology program; joint Region Midi-Pyrenees/CNRS grant(Region Occitanie); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM088207 (to C.G.), a grant from the CNRS-ATIP Microbiology program (to P.G), and a joint Region Midi-Pyrenees/CNRS grant (to N.B.).	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Akhtar MW, 2004, J BIOL CHEM, V279, P55760, DOI 10.1074/jbc.M406333200; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; BUKAU B, 1989, J BACTERIOL, V171, P6030, DOI 10.1128/jb.171.11.6030-6038.1989; BUKAU B, 1990, EMBO J, V9, P4027, DOI 10.1002/j.1460-2075.1990.tb07624.x; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chi SW, 2011, FEBS LETT, V585, P664, DOI 10.1016/j.febslet.2011.01.029; CHUANG SE, 1993, J BACTERIOL, V175, P5242, DOI 10.1128/JB.175.16.5242-5252.1993; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Cremers CM, 2010, J BIOL CHEM, V285, P11243, DOI 10.1074/jbc.M109.084350; CROOKE E, 1987, P NATL ACAD SCI USA, V84, P5216, DOI 10.1073/pnas.84.15.5216; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Genevaux P, 2002, GENETICS, V162, P1045; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Graf PCF, 2004, J BIOL CHEM, V279, P20529, DOI 10.1074/jbc.M401764200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hansen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039185; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hoffmann A, 2012, MOL CELL, V48, P63, DOI 10.1016/j.molcel.2012.07.018; Hoffmann JH, 2004, EMBO J, V23, P160, DOI 10.1038/sj.emboj.7600016; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Jong WSP, 2004, EUR J BIOCHEM, V271, P4779, DOI 10.1111/j.1432-1033.2004.04442.x; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kim SJ, 2001, NAT STRUCT BIOL, V8, P459, DOI 10.1038/87639; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kumsta C, 2009, BIOCHEMISTRY-US, V48, P4666, DOI 10.1021/bi9003556; Lakshmipathy SK, 2007, J BIOL CHEM, V282, P12186, DOI 10.1074/jbc.M609871200; LUIRINK J, 1992, NATURE, V359, P741, DOI 10.1038/359741a0; MAURIZI MR, 1990, J BIOL CHEM, V265, P12536; Meriin AB, 2012, J BIOL CHEM, V287, P34264, DOI 10.1074/jbc.M112.397307; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Moll I, 2012, TRENDS BIOCHEM SCI, V37, P493, DOI 10.1016/j.tibs.2012.07.007; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Sakr S, 2010, J BIOL CHEM, V285, P23504, DOI 10.1074/jbc.M110.133058; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; THOMPSON RC, 1986, J BIOL CHEM, V261, P4868; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Tomoyasu T, 2001, J BACTERIOL, V183, P5911, DOI 10.1128/JB.183.20.5911-5917.2001; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; Ullers RS, 2004, P NATL ACAD SCI USA, V101, P7583, DOI 10.1073/pnas.0402398101; Ullers RS, 2003, J CELL BIOL, V161, P679, DOI 10.1083/jcb.200302130; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Vorderwulbecke S, 2004, FEBS LETT, V559, P181, DOI 10.1016/S0014-5793(04)00052-3; Wholey WY, 2012, MOL MICROBIOL, V83, P981, DOI 10.1111/j.1365-2958.2012.07982.x; Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412; Yamaguchi Y, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-16; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412	65	24	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44435	44446		10.1074/jbc.M112.418525	http://dx.doi.org/10.1074/jbc.M112.418525			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23148222	Green Published, hybrid			2022-12-28	WOS:000312938600040
J	Lee, YJ; Kim, KJ; Kang, HY; Kim, HR; Maeng, PJ				Lee, Yong Joo; Kim, Kyung Jin; Kang, Hong Yong; Kim, Hye-Rim; Maeng, Pil Jae			Involvement of GDH3-encoded NADP(+)-dependent Glutamate Dehydrogenase in Yeast Cell Resistance to Stress-induced Apoptosis in Stationary Phase Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; INSULIN-RELEASE; GLUTATHIONE; GENE; METABOLISM; EXPRESSION; BIOSYNTHESIS; PURIFICATION; SUPEROXIDE	Glutamate metabolism is linked to a number of fundamental metabolic pathways such as amino acid metabolism, the TCA cycle, and glutathione (GSH) synthesis. In the yeast Saccharomyces cerevisiae, glutamate is synthesized from alpha-ketoglutarate by two NADP(+)-dependent glutamate dehydrogenases (NADP-GDH) encoded by GDH1 and GDH3. Here, we report the relationship between the function of the NADP-GDH and stress-induced apoptosis. Gdh3-null cells showed accelerated chronological aging and hypersusceptibility to thermal and oxidative stress during stationary phase. Upon exposure to oxidative stress, Gdh3-null strains displayed a rapid loss in viability associated with typical apoptotic hallmarks, i.e. reactive oxygen species accumulation, nuclear fragmentation, DNA breakage, and phosphatidylserine translocation. In addition, Gdh3-null cells, but not Gdh1-null cells, had a higher tendency toward GSHdepletion and subsequent reactive oxygen species accumulation than did WT cells. GSH depletion was rescued by exogenous GSH or glutamate. The hypersusceptibility of stationary phase Gdh3-null cells to stress-induced apoptosis was suppressed by deletion of GDH2. Promoter swapping and site-directed mutagenesis of GDH1 and GDH3 indicated that the necessity of GDH3 for the resistance to stress-induced apoptosis and chronological aging is due to the stationary phase-specific expression of GDH3 and concurrent degradation of Gdh1 in which the Lys-426 residue plays an essential role.	[Lee, Yong Joo; Kim, Kyung Jin; Kang, Hong Yong; Kim, Hye-Rim; Maeng, Pil Jae] Chungnam Natl Univ, Dept Microbiol & Mol Biol, Taejon 305764, South Korea	Chungnam National University	Maeng, PJ (corresponding author), Chungnam Natl Univ, Dept Microbiol & Mol Biol, Taejon 305764, South Korea.	pjmaeng@cnu.ac.kr		Maeng, Pil Jae/0000-0002-7677-3208	National Research Foundation of Korea [2009-0077095]; Ministry of Education, Science, and Technology (MEST)	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Grant 2009-0077095 from the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (MEST).	ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Armstrong JS, 2002, CELL DEATH DIFFER, V9, P252, DOI 10.1038/sj.cdd.4400959; Avendano A, 2005, MOL MICROBIOL, V57, P291, DOI 10.1111/j.1365-2958.2005.04689.x; Avendano A, 1997, J BACTERIOL, V179, P5594, DOI 10.1128/jb.179.17.5594-5597.1997; Avery AM, 2001, J BIOL CHEM, V276, P33730, DOI 10.1074/jbc.M105672200; BENJAMIN PM, 1989, MOL GEN GENET, V217, P370, DOI 10.1007/BF02464906; BERMINGHAMMCDONOGH O, 1988, P NATL ACAD SCI USA, V85, P4789, DOI 10.1073/pnas.85.13.4789; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; COGONI C, 1995, J BACTERIOL, V177, P792, DOI 10.1128/jb.177.3.792-798.1995; COOPER AJL, 1987, PHYSIOL REV, V67, P440, DOI 10.1152/physrev.1987.67.2.440; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; DeLuna A, 2001, J BIOL CHEM, V276, P43775, DOI 10.1074/jbc.M107986200; Doherty D., 1970, METHODS ENZYMOLOGY A, V17, P850; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; FAHIEN LA, 1988, J BIOL CHEM, V263, P13610; Filetici P, 1996, YEAST, V12, P1359, DOI 10.1002/(SICI)1097-0061(199610)12:13<1359::AID-YEA3>3.0.CO;2-5; GALIAZZO F, 1987, BIOCHEM BIOPH RES CO, V147, P1200, DOI 10.1016/S0006-291X(87)80197-3; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Herman PK, 2002, CURR OPIN MICROBIOL, V5, P602, DOI 10.1016/S1369-5274(02)00377-6; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Lauber K, 2001, J BIOL CHEM, V276, P29772, DOI 10.1074/jbc.M101524200; Lee YJ, 2007, MOL BIOL CELL, V18, P3556, DOI 10.1091/mbc.E07-02-0118; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Mates JM, 2002, INT J BIOCHEM CELL B, V34, P439, DOI 10.1016/S1357-2725(01)00143-1; MAVROTHALASSITIS G, 1988, P NATL ACAD SCI USA, V85, P3494, DOI 10.1073/pnas.85.10.3494; Mayor T, 2005, METHOD ENZYMOL, V399, P385, DOI 10.1016/S0076-6879(05)99026-5; Mayor T, 2005, MOL CELL PROTEOMICS, V4, P741, DOI 10.1074/mcp.M400220-MCP200; MAZON MJ, 1979, J BACTERIOL, V139, P686; McKenna MC, 1996, J NEUROCHEM, V66, P386; MILLER SM, 1990, J BACTERIOL, V172, P4927, DOI 10.1128/jb.172.9.4927-4935.1990; Paz I, 2001, J BACTERIOL, V183, P4477, DOI 10.1128/JB.183.15.4477-4483.2001; Plaitakis A, 2000, J NEUROCHEM, V75, P1862, DOI 10.1046/j.1471-4159.2000.0751862.x; Plaitakis A, 2001, J NEUROSCI RES, V66, P899, DOI 10.1002/jnr.10054; Plaitakis A, 2011, NEUROCHEM INT, V59, P495, DOI 10.1016/j.neuint.2011.03.015; Riego L, 2002, BIOCHEM BIOPH RES CO, V293, P79, DOI 10.1016/S0006-291X(02)00174-2; Savolainen KM, 1995, TOXICOL LETT, V82-3, P399; SENER A, 1981, P NATL ACAD SCI-BIOL, V78, P5460, DOI 10.1073/pnas.78.9.5460; Shashidharan P, 1997, J NEUROCHEM, V68, P1804; SHASHIDHARAN P, 1994, J BIOL CHEM, V269, P16971; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Wang XF, 2000, J NEUROCHEM, V74, P1434, DOI 10.1046/j.1471-4159.2000.0741434.x; WernerWashburne M, 1996, MOL MICROBIOL, V19, P1159, DOI 10.1111/j.1365-2958.1996.tb02461.x; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; Zaganas I, 2009, NEUROCHEM INT, V55, P52, DOI 10.1016/j.neuint.2009.03.001	51	20	20	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44221	44233		10.1074/jbc.M112.375360	http://dx.doi.org/10.1074/jbc.M112.375360			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23105103	Green Published, hybrid			2022-12-28	WOS:000312938600021
J	Shih, HH; Tu, C; Cao, W; Klein, A; Ramsey, R; Fennell, BJ; Lambert, M; Shuilleabhain, DN; Autin, B; Kouranova, E; Laxmanan, S; Braithwaite, S; Wu, L; Ait-Zahra, M; Milici, AJ; Dumin, JA; LaVallie, ER; Arai, M; Corcoran, C; Paulsen, JE; Gill, D; Cunningham, O; Bard, J; Mosyak, L; Finlay, WJJ				Shih, Heather H.; Tu, Chao; Cao, Wei; Klein, Anne; Ramsey, Renee; Fennell, Brian J.; Lambert, Matthew; Shuilleabhain, Deirdre Ni; Autin, Benedicte; Kouranova, Eugenia; Laxmanan, Sri; Braithwaite, Steven; Wu, Leeying; Ait-Zahra, Mostafa; Milici, Anthony J.; Dumin, Jo Ann; LaVallie, Edward R.; Arai, Maya; Corcoran, Christopher; Paulsen, Janet E.; Gill, Davinder; Cunningham, Orla; Bard, Joel; Mosyak, Lydia; Finlay, William J. J.			An Ultra-specific Avian Antibody to Phosphorylated Tau Protein Reveals a Unique Mechanism for Phosphoepitope Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; V-H REPERTOIRE; ABNORMAL PHOSPHORYLATION; HIGH-AFFINITY; PHAGE-DISPLAY; IN-VITRO; RECOMBINANT ANTIBODIES; CHICKEN; GENERATION; CHAIN	Highly specific antibodies to phosphoepitopes are valuable tools to study phosphorylation in disease states, but their discovery is largely empirical, and the molecular mechanisms mediating phosphospecific binding are poorly understood. Here, we report the generation and characterization of extremely specific recombinant chicken antibodies to three phosphoepitopes on the Alzheimer disease-associated protein tau. Each antibody shows full specificity for a single phosphopeptide. The chimeric IgG pT231/pS235_1 exhibits a K-D of 0.35 nM in 1:1 binding to its cognate phosphopeptide. This IgG is murine ortholog-cross-reactive, specifically recognizing the pathological form of tau in brain samples from Alzheimer patients and a mouse model of tauopathy. To better understand the underlying binding mechanisms allowing such remarkable specificity, we determined the structure of pT231/pS235_1 Fab in complex with its cognate phosphopeptide at 1.9 angstrom resolution. The Fab fragment exhibits novel complementarity determining region (CDR) structures with a "bowl-like" conformation in CDR-H2 that tightly and specifically interacts with the phospho-Thr-231 phosphate group, as well as a long, disulfide-constrained CDR-H3 that mediates peptide recognition. This binding mechanism differs distinctly from either peptide-or hapten-specific antibodies described to date. Surface plasmon resonance analyses showed that pT231/pS235_1 binds a truly compound epitope, as neither phosphorylated Ser-235 nor free peptide shows any measurable binding affinity.	[Shih, Heather H.; Tu, Chao; Cao, Wei; Ramsey, Renee; Laxmanan, Sri; Wu, Leeying; Ait-Zahra, Mostafa; LaVallie, Edward R.; Arai, Maya; Corcoran, Christopher; Paulsen, Janet E.; Gill, Davinder; Bard, Joel; Mosyak, Lydia] Pfizer Global Res & Dev, Global Biotherapeut Technol, Cambridge, MA 02140 USA; [Fennell, Brian J.; Lambert, Matthew; Shuilleabhain, Deirdre Ni; Autin, Benedicte; Cunningham, Orla; Finlay, William J. J.] Pfizer Global Res & Dev, Global Biotherapeut Technol, Dublin D22, Ireland; [Klein, Anne; Kouranova, Eugenia; Braithwaite, Steven; Milici, Anthony J.; Dumin, Jo Ann] Pfizer Global Res & Dev, Neurosci Res Unit, Groton, CT 06340 USA	Pfizer; Pfizer; Pfizer	Finlay, WJJ (corresponding author), Pfizer R&D, Global Biotherapeut Technol, Grange Castle Business Pk, Dublin D22, Ireland.	william.finlay@pfizer.com			Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank John Dunlop for support and encouragement on this project. Use of Industrial Macromolecular Crystallography Association Collaborative Access Team beamline 17-ID (or 17-BM) at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with the Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Abraha A, 2000, J CELL SCI, V113, P3737; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Almagro JC, 2004, J MOL RECOGNIT, V17, P132, DOI 10.1002/jmr.659; Almagro JC, 2006, J MOL RECOGNIT, V19, P413, DOI 10.1002/jmr.796; Almagro JC, 2012, J MOL RECOGNIT, V25, P125, DOI 10.1002/jmr.1168; Alonso AD, 2001, J BIOL CHEM, V276, P37967; Andreeva A, 2007, NUCLEIC ACIDS RES, V35, pD253, DOI 10.1093/nar/gkl746; Andris-Widhopf J, 2000, J IMMUNOL METHODS, V242, P159, DOI 10.1016/S0022-1759(00)00221-0; Blanc E., 2011, BUSTER VERSION 2 11; BRION JP, 1991, BIOCHEM J, V273, P127, DOI 10.1042/bj2730127; Brumbaugh K, 2011, METHODS MOL BIOL, V717, P3, DOI 10.1007/978-1-61779-024-9_1; Chailyan A, 2011, PROTEINS, V79, P1513, DOI 10.1002/prot.22979; Cobaugh CW, 2008, J MOL BIOL, V378, P622, DOI 10.1016/j.jmb.2008.02.037; Cummins E, 2008, J IMMUNOL METHODS, V339, P38, DOI 10.1016/j.jim.2008.07.016; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fennell BJ, 2010, J MOL BIOL, V400, P155, DOI 10.1016/j.jmb.2010.04.061; Finlay WJ, 2009, J MOL BIOL, V388, P541, DOI 10.1016/j.jmb.2009.03.019; Finlay WJJ, 2006, APPL ENVIRON MICROB, V72, P3343, DOI 10.1128/AEM.72.5.3343-3349.2006; Finlay WJJ, 2011, METHODS MOL BIOL, V681, P87, DOI 10.1007/978-1-60761-913-0_6; Finlay WJJ, 2011, METHODS MOL BIOL, V681, P383, DOI 10.1007/978-1-60761-913-0_21; Finlay WJJ, 2005, CLIN EXP ALLERGY, V35, P1040, DOI 10.1111/j.1365-2222.2005.02307.x; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Govaert J, 2012, J BIOL CHEM, V287, P1970, DOI 10.1074/jbc.M111.242818; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Hampel H, 2010, EXP GERONTOL, V45, P30, DOI 10.1016/j.exger.2009.10.010; Hanger DP, 2009, EXPERT REV NEUROTHER, V9, P1647, DOI 10.1586/ERN.09.104; Hof D, 2008, CLIN EXP IMMUNOL, V151, P367, DOI 10.1111/j.1365-2249.2007.03569.x; Iwamoto S, 2009, MABS-AUSTIN, V1, P357, DOI 10.4161/mabs.1.4.8919; Kabat EA, 1991, SEQUENCES PROTEINS I; KENESSEY A, 1993, BRAIN RES, V629, P40, DOI 10.1016/0006-8993(93)90478-6; KOPKE E, 1993, J BIOL CHEM, V268, P24374; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KSIEZAKREDING H, 1992, BRAIN RES, V597, P209, DOI 10.1016/0006-8993(92)91476-U; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Liu F, 2007, EUR J NEUROSCI, V26, P3429, DOI 10.1111/j.1460-9568.2007.05955.x; Lu PJ, 1999, NATURE, V399, P784; MacCallum RM, 1996, J MOL BIOL, V262, P732, DOI 10.1006/jmbi.1996.0548; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NAIRN AC, 1982, NATURE, V299, P734, DOI 10.1038/299734a0; Nishibori N, 2006, MOL IMMUNOL, V43, P634, DOI 10.1016/j.molimm.2005.04.002; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARVARI R, 1990, P NATL ACAD SCI USA, V87, P3072, DOI 10.1073/pnas.87.8.3072; Persson H, 2006, J MOL BIOL, V357, P607, DOI 10.1016/j.jmb.2006.01.004; REYNAUD CA, 1991, EUR J IMMUNOL, V21, P2661, DOI 10.1002/eji.1830211104; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; ROSS AH, 1981, NATURE, V294, P654, DOI 10.1038/294654a0; RUFFJAMISON S, 1991, J BIOL CHEM, V266, P6607; RUFFJAMISON S, 1993, J IMMUNOL, V150, P3389; RUFFJAMISON S, 1993, PROTEIN ENG, V6, P661, DOI 10.1093/protein/6.6.661; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schroeder HW, 2006, DEV COMP IMMUNOL, V30, P119, DOI 10.1016/j.dci.2005.06.006; SCHROEDER HW, 1990, INT IMMUNOL, V2, P41, DOI 10.1093/intimm/2.1.41; Tan CSH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002093; Tars K, 2012, J MOL BIOL, V415, P118, DOI 10.1016/j.jmb.2011.10.042; Valler MJ, 2000, DRUG DISCOV TODAY, V5, P286, DOI 10.1016/S1359-6446(00)01517-8; Vielemeyer O, 2009, J BIOL CHEM, V284, P20791, DOI 10.1074/jbc.M109.008730; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; WEILL JC, 1992, CURR OPIN IMMUNOL, V4, P177, DOI 10.1016/0952-7915(92)90009-4; Wu LY, 2012, J IMMUNOL, V188, P322, DOI 10.4049/jimmunol.1102466; Yamanaka HI, 1996, J IMMUNOL, V157, P1156; Zahnd C, 2004, J BIOL CHEM, V279, P18870, DOI 10.1074/jbc.M309169200; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007	69	44	47	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44425	44434		10.1074/jbc.M112.415935	http://dx.doi.org/10.1074/jbc.M112.415935			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23148212	hybrid, Green Published			2022-12-28	WOS:000312938600039
J	Fowler, AK; Hewetson, A; Agrawal, RG; Dagda, M; Dagda, R; Moaddel, R; Balbo, S; Sanghvi, M; Chen, YK; Hogue, RJ; Bergeson, SE; Henderson, GI; Kruman, II				Fowler, Anna-Kate; Hewetson, Aveline; Agrawal, Rajiv G.; Dagda, Marisela; Dagda, Raul; Moaddel, Ruin; Balbo, Silvia; Sanghvi, Mitesh; Chen, Yukun; Hogue, Ryan J.; Bergeson, Susan E.; Henderson, George I.; Kruman, Inna I.			Alcohol-induced One-carbon Metabolism Impairment Promotes Dysfunction of DNA Base Excision Repair in Adult Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE; GENOMIC INSTABILITY; CELL-DEATH; DAMAGE; APOPTOSIS; FOLATE; MECHANISMS; CANCER; ACETALDEHYDE; DEFICIENCY	The brain is one of the major targets of chronic alcohol abuse. Yet the fundamental mechanisms underlying alcohol-mediated brain damage remain unclear. The products of alcohol metabolism cause DNA damage, which in conditions of DNA repair dysfunction leads to genomic instability and neural death. We propose that one-carbon metabolism (OCM) impairment associated with long term chronic ethanol intake is a key factor in ethanol-induced neurotoxicity, because OCM provides cells with DNA precursors for DNA repair and methyl groups for DNA methylation, both critical for genomic stability. Using histological (immunohistochemistry and stereological counting) and biochemical assays, we show that 3-week chronic exposure of adult mice to 5% ethanol (Lieber-Decarli diet) results in increased DNA damage, reduced DNA repair, and neuronal death in the brain. These were concomitant with compromised OCM, as evidenced by elevated homocysteine, a marker of OCM dysfunction. We conclude that OCM dysfunction plays a causal role in alcohol-induced genomic instability in the brain because OCM status determines the alcohol effect on DNA damage/repair and genomic stability. Short ethanol exposure, which did not disturb OCM, also did not affect the response to DNA damage, whereas additional OCM disturbance induced by deficiency in a key OCM enzyme, methylenetetrahydrofolate reductase (MTHFR) in Mthfr(+/-) mice, exaggerated the ethanol effect on DNA repair. Thus, the impact of long term ethanol exposure on DNA repair and genomic stability in the brain results from OCM dysfunction, and MTHFR mutations such as Mthfr 677C -> T, common in human population, may exaggerate the adverse effects of ethanol on the brain.	[Fowler, Anna-Kate; Hewetson, Aveline; Agrawal, Rajiv G.; Dagda, Marisela; Chen, Yukun; Hogue, Ryan J.; Bergeson, Susan E.; Henderson, George I.; Kruman, Inna I.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA; [Dagda, Raul] Texas Tech Univ, Hlth Sci Ctr, Dept Pathol, Lubbock, TX 79430 USA; [Moaddel, Ruin; Sanghvi, Mitesh] NIA, Clin Invest Lab, NIH, Baltimore, MD 21224 USA; [Balbo, Silvia] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Minnesota System; University of Minnesota Twin Cities	Kruman, II (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA.	inna.kruman@ttuhsc.edu	Chen, Yu/Y-3292-2019; Moaddel, Ruin/AAE-3378-2020; Chen, Yi/HIR-2608-2022; Sanghvi, Mitesh/C-6740-2013	Moaddel, Ruin/0000-0002-6812-0127; Balbo, Silvia/0000-0002-7686-0504	Foundation for Alcohol Research; South Plains Alcohol and Addiction Research Center; National Institute of Health Intramural Research Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010114] Funding Source: NIH RePORTER	Foundation for Alcohol Research; South Plains Alcohol and Addiction Research Center; National Institute of Health Intramural Research Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Foundation for Alcohol Research (to I. I. K.), the South Plains Alcohol and Addiction Research Center and in part, by National Institute of Health Intramural Research Program (to R.M.).	Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Andrabi SA, 2004, BRAIN RES, V1017, P98, DOI 10.1016/j.brainres.2004.05.038; Aras R, 2012, BRAIN RES, V1450, P102, DOI 10.1016/j.brainres.2012.02.056; Bailey LB, 2003, J NUTR, V133, p3748S, DOI 10.1093/jn/133.11.3748S; Balbo S, 2008, CANCER EPIDEM BIOMAR, V17, P3026, DOI 10.1158/1055-9965.EPI-08-0117; Benassi-Evans B, 2011, MUTAGENESIS, V26, P421, DOI 10.1093/mutage/geq110; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Brooks PJ, 2008, DNA REPAIR, V7, P834, DOI 10.1016/j.dnarep.2008.01.017; Cabelof DC, 2003, CANCER RES, V63, P5799; Celtikci B, 2009, ANTI-CANCER DRUG, V20, P787, DOI 10.1097/CAD.0b013e32832f4aa8; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Domazet-Damjanov D., 2009, OPEN BIOL J, V2, P149; Duthie SJ, 2000, NUTR CANCER, V37, P245, DOI 10.1207/S15327914NC372_18; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; FANG JL, 1995, CARCINOGENESIS, V16, P2177, DOI 10.1093/carcin/16.9.2177; Fang JL, 1997, CARCINOGENESIS, V18, P627, DOI 10.1093/carcin/18.4.627; Fenech M, 2010, MECH AGEING DEV, V131, P236, DOI 10.1016/j.mad.2010.02.004; Finckbone V, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.003.2009; Fishel ML, 2007, MUTAT RES-FUND MOL M, V614, P24, DOI 10.1016/j.mrfmmm.2006.06.007; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Halsted CH, 2002, J NUTR, V132, p2367S, DOI 10.1093/jn/132.8.2367S; Hamid A, 2009, FEBS J, V276, P2175, DOI 10.1111/j.1742-4658.2009.06959.x; Harper C, 2009, ALCOHOL ALCOHOLISM, V44, P136, DOI 10.1093/alcalc/agn102; Hirano T, 2011, INT J ENV RES PUB HE, V8, P2895, DOI 10.3390/ijerph8072895; Jefford CE, 2006, CRIT REV ONCOL HEMAT, V59, P1, DOI 10.1016/j.critrevonc.2006.02.005; Jeppesen DK, 2011, PROG NEUROBIOL, V94, P166, DOI 10.1016/j.pneurobio.2011.04.013; Job MO, 2007, BIOL PSYCHIAT, V62, P627, DOI 10.1016/j.biopsych.2006.11.016; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Kanoh M, 1999, CIRCULATION, V99, P2757, DOI 10.1161/01.CIR.99.21.2757; Kastan MB, 1997, CURR TOP MICROBIOL, V221, P1; KEANE B, 1989, ALCOHOL ALCOHOLISM, V24, P299, DOI 10.1093/oxfordjournals.alcalc.a044916; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kulkarni A, 2008, AM J HUM GENET, V82, P539, DOI 10.1016/j.ajhg.2008.01.009; Ljungman M, 2005, MUTAT RES-FUND MOL M, V577, P203, DOI 10.1016/j.mrfmmm.2005.02.014; Loo DT, 2011, METHODS MOL BIOL, V682, P3, DOI 10.1007/978-1-60327-409-8_1; Martin SA, 2010, J PATHOL, V220, P281, DOI 10.1002/path.2631; Mayor-Olea A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-104; McKillop IH, 2009, SEMIN LIVER DIS, V29, P222, DOI 10.1055/s-0029-1214377; McMurray CT, 2005, MUTAT RES-FUND MOL M, V577, P260, DOI 10.1016/j.mrfmmm.2005.03.006; Miller AM, 2010, ALCOHOL CLIN EXP RES, V34, P719, DOI 10.1111/j.1530-0277.2009.01141.x; Narciso L, 2007, P NATL ACAD SCI USA, V104, P17010, DOI 10.1073/pnas.0701743104; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nelson BC, 2003, ANAL CHEM, V75, P775, DOI 10.1021/ac0204799; Oomman S, 2005, DEV BRAIN RES, V160, P130, DOI 10.1016/j.devbrainres.2005.07.010; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Rao KS, 2007, NAT CLIN PRACT NEURO, V3, P162, DOI 10.1038/ncpneuro0448; Sairanen T, 2009, ACTA NEUROPATHOL, V118, P541, DOI 10.1007/s00401-009-0559-3; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Stover PJ, 2009, J NUTR, V139, P2402, DOI 10.3945/jn.109.113670; Sun AY, 2001, J BIOMED SCI, V8, P37, DOI 10.1007/BF02255969; Wang MY, 2006, CHEM RES TOXICOL, V19, P319, DOI 10.1021/tx0502948; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Zhang HH, 2010, DNA REPAIR, V9, P898, DOI 10.1016/j.dnarep.2010.06.003	55	19	19	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43533	43542		10.1074/jbc.M112.401497	http://dx.doi.org/10.1074/jbc.M112.401497			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118224	hybrid, Green Published			2022-12-28	WOS:000312940800034
J	Gokirmak, T; Campanale, JP; Shipp, LE; Moy, GW; Tao, HC; Hamdoun, A				Goekirmak, Tufan; Campanale, Joseph P.; Shipp, Lauren E.; Moy, Gary W.; Tao, Houchao; Hamdoun, Amro			Localization and Substrate Selectivity of Sea Urchin Multidrug (MDR) Efflux Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-GLYCOPROTEIN; STRONGYLOCENTROTUS-PURPURATUS; CAENORHABDITIS-ELEGANS; RESISTANCE PROTEINS; BINDING; GENE; EXPRESSION; FAMILY; ABCG2; ABCB1	In this study, we cloned, expressed and functionally characterized Stronglycentrotus purpuratus (Sp) ATP-binding cassette (ABC) transporters. This screen identified three multidrug resistance (MDR) transporters with functional homology to the major types of MDR transporters found in humans. When overexpressed in embryos, the apical transporters Sp-ABCB1a, ABCB4a, and ABCG2a can account for as much as 87% of the observed efflux activity, providing a robust assay for their substrate selectivity. Using this assay, we found that sea urchin MDR transporters export canonical MDR susbtrates such as calcein-AM, bodipy-verapamil, bodipy-vinblastine, and mitoxantrone. In addition, we characterized the impact of nonconservative substitutions in the primary sequences of drug binding domains of sea urchin versus murine ABCB1 by mutation of Sp-ABCB1a and treatment of embryos with stereoisomeric cyclic peptide inhibitors (QZ59 compounds). The results indicated that two substitutions in transmembrane helix 6 reverse stereoselectivity of Sp-ABCB1a for QZ59 enantiomers compared with mouse ABCB1a. This suggests that subtle changes in the primary sequence of transporter drug binding domains could fine-tune substrate specificity through evolution.	[Goekirmak, Tufan; Campanale, Joseph P.; Shipp, Lauren E.; Moy, Gary W.; Hamdoun, Amro] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; [Tao, Houchao] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Scripps Research Institute	Hamdoun, A (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, 9500 Gilman Dr 0202, La Jolla, CA 92093 USA.	hamdoun@ucsd.edu	Campanale, Joseph/A-9409-2011; Tao, Houchao/N-7042-2013; Tao, Houchao/E-7436-2013; Hamdoun, Amro/AAE-1905-2021	Hamdoun, Amro/0000-0003-2568-048X; Campanale, Joseph/0000-0003-1902-7708	National Institutes of Health Grant [HD058070]; Krinsk Research Advancement Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K99HD058070, R00HD058070] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Krinsk Research Advancement Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD058070 (to A. H.). This work was also supported by Krinsk Research Advancement Initiative (to A. H.).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Bosnjak I, 2009, ENVIRON SCI TECHNOL, V43, P8374, DOI 10.1021/es901677r; Broeks A, 1996, EMBO J, V15, P6132, DOI 10.1002/j.1460-2075.1996.tb01001.x; Caminada D, 2008, AQUAT TOXICOL, V90, P214, DOI 10.1016/j.aquatox.2008.08.013; Campanale JP, 2012, DEVELOPMENT, V139, P783, DOI 10.1242/dev.076752; Cheers MS, 2004, METHOD CELL BIOL, V74, P287; Chen ZS, 2011, FEBS J, V278, P3226, DOI 10.1111/j.1742-4658.2011.08235.x; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Crivellato E, 2002, J HISTOCHEM CYTOCHEM, V50, P731, DOI 10.1177/002215540205000514; Croce JC, 2006, DEV BIOL, V300, P121, DOI 10.1016/j.ydbio.2006.08.045; Dean M, 2001, J LIPID RES, V42, P1007; DEPABLO F, 1988, DEV BIOL, V130, P304, DOI 10.1016/0012-1606(88)90436-8; Essodaigui M, 1998, BIOCHEMISTRY-US, V37, P2243, DOI 10.1021/bi9718043; Geng XH, 2003, DIABETES, V52, P767, DOI 10.2337/diabetes.52.3.767; Goldstone JV, 2006, DEV BIOL, V300, P366, DOI 10.1016/j.ydbio.2006.08.066; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Hamdoun AM, 2004, DEV BIOL, V276, P452, DOI 10.1016/j.ydbio.2004.09.013; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kimchi-Sarfaty C, 2002, MOL PHARMACOL, V62, P1, DOI 10.1124/mol.62.1.1; Klepsch F, 2010, MOL INFORM, V29, P276, DOI 10.1002/minf.201000017; Lepesheva GI, 2011, BBA-PROTEINS PROTEOM, V1814, P88, DOI 10.1016/j.bbapap.2010.06.006; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Litman T, 2000, J CELL SCI, V113, P2011; Luckenbach T, 2008, AM J PHYSIOL-REG I, V294, pR1919, DOI 10.1152/ajpregu.00563.2007; Nies AT, 2004, NEUROSCIENCE, V129, P349, DOI 10.1016/j.neuroscience.2004.07.051; Orban TI, 2008, BIOCHEM BIOPH RES CO, V367, P667, DOI 10.1016/j.bbrc.2007.12.172; Pajeva IK, 2009, FEBS J, V276, P7016, DOI 10.1111/j.1742-4658.2009.07415.x; Prasad KVSK, 2012, SCIENCE, V337, P1081, DOI 10.1126/science.1221636; RAYMOND M, 1992, SCIENCE, V256, P232, DOI 10.1126/science.1348873; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; Shipp LE, 2012, DEV DYNAM, V241, P1111, DOI 10.1002/dvdy.23786; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Tao HC, 2011, CHEMBIOCHEM, V12, P868, DOI 10.1002/cbic.201100048; Tarnay JN, 2004, INSECT MOL BIOL, V13, P539, DOI 10.1111/j.0962-1075.2004.00512.x; Tommasini R, 1996, P NATL ACAD SCI USA, V93, P6743, DOI 10.1073/pnas.93.13.6743; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Vache C, 2007, ENVIRON TOXICOL CHEM, V26, P1418, DOI 10.1897/06-552R.1; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; Whalen K, 2012, MOL BIOL CELL, V23, P3663, DOI 10.1091/mbc.E12-06-0438; Wirgin I, 2011, SCIENCE, V331, P1322, DOI 10.1126/science.1197296; Zaja R, 2008, AQUAT TOXICOL, V90, P322, DOI 10.1016/j.aquatox.2008.09.012	43	46	46	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43876	43883		10.1074/jbc.M112.424879	http://dx.doi.org/10.1074/jbc.M112.424879			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23124201	hybrid, Green Published			2022-12-28	WOS:000312940800064
J	Paci, A; Liu, XH; Huang, H; Lim, A; Houry, WA; Zhao, RM				Paci, Alexandr; Liu, Xiao Hu; Huang, Hao; Lim, Abelyn; Houry, Walid A.; Zhao, Rongmin			The Stability of the Small Nucleolar Ribonucleoprotein (snoRNP) Assembly Protein Pih1 in Saccharomyces cerevisiae Is Modulated by Its C Terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; SECONDARY STRUCTURE; HSP90 CHAPERONE; 20S PROTEASOME; R2TP COMPLEX; SEQUENCES; COCHAPERONE; PREDICTION; HELICASES; BINDING	Pih1 is an unstable protein and a subunit of the R2TP complex that, in yeast Saccharomyces cerevisiae, also contains the helicases Rvb1, Rvb2, and the Hsp90 cofactor Tah1. Pih1 and the R2TP complex are required for the box C/D small nucleolar ribonucleoprotein (snoRNP) assembly and ribosomal RNA processing. Purified Pih1 tends to aggregate in vitro. Molecular chaperone Hsp90 and its cochaperone Tah1 are required for the stability of Pih1 in vivo. We had shown earlier that the C terminus of Pih1 destabilizes the protein and that the C terminus of Tah1 binds to the Pih1 C terminus to form a stable complex. Here, we analyzed the secondary structure of the Pih1 C terminus and identified two intrinsically disordered regions and five hydrophobic clusters. Site-directed mutagenesis indicated that one predicted intrinsically disordered region IDR2 is involved in Tah1 binding, and that the C terminus of Pih1 contains multiple destabilization or degron elements. Additionally, the Pih1 N-terminal domain, Pih1(1-230), was found to be able to complement the physiological role of full-length Pih1 at 37 degrees C. Pih1(1-230) as well as a shorter Pih1 N-terminal fragment Pih1(1-195) is able to bind Rvb1/Rvb2 heterocomplex. However, the sequence between the two disordered regions in Pih1 significantly enhances the Pih1 N-terminal domain binding to Rvb1/Rvb2. Based on these data, a model of protein-protein interactions within the R2TP complex is proposed.	[Paci, Alexandr; Liu, Xiao Hu; Huang, Hao; Lim, Abelyn; Zhao, Rongmin] Univ Toronto Scarborough, Dept Biol Sci, Scarborough, ON M1C 1A4, Canada; [Houry, Walid A.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Scarborough; University of Toronto	Zhao, RM (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, 1265 Mil Trail, Scarborough, ON M1C 1A4, Canada.	r.zhao@utsc.utoronto.ca		Zhao, Rongmin/0000-0003-1300-5882; Huang, Hao/0000-0002-1188-9760	University of Toronto Connaught New Stuff Matching-Fund [487199]; NSERC Discovery Grant [371789-2009]; Canadian Institutes of Health Research [MOP-93778]; Canadian Institutes of Health Research Strategic Training Program in Protein Folding and Interaction Dynamics [TGF-53910]; NSERC Undergraduate Student Research Award	University of Toronto Connaught New Stuff Matching-Fund; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Strategic Training Program in Protein Folding and Interaction Dynamics(Canadian Institutes of Health Research (CIHR)); NSERC Undergraduate Student Research Award(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a University of Toronto Connaught New Stuff Matching-Fund (487199) and NSERC Discovery Grant 371789-2009 (to R. Z.) and by Grant MOP-93778 from the Canadian Institutes of Health Research (to W. A. H.).; Supported by the Canadian Institutes of Health Research Strategic Training Program in Protein Folding and Interaction Dynamics (TGF-53910).; Supported by an NSERC Undergraduate Student Research Award.	Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eckert K, 2010, J BIOL CHEM, V285, P31304, DOI 10.1074/jbc.M110.138263; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Gribun A, 2008, J MOL BIOL, V376, P1320, DOI 10.1016/j.jmb.2007.12.049; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Huen J, 2010, BIOCHEM CELL BIOL, V88, P29, DOI [10.1139/o09-122, 10.1139/O09-122]; Inoue M, 2010, BIOCHEM BIOPH RES CO, V403, P340, DOI 10.1016/j.bbrc.2010.11.031; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Jimenez B, 2012, J BIOL CHEM, V287, P5698, DOI 10.1074/jbc.M111.287458; Kakihara Y., BIOCH BIOPHYS ACTA, V1823, P101; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lijnzaad P, 1997, PROTEINS, V28, P333; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Meszaros B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035003; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Ni L, 2009, J CELL BIOCHEM, V106, P920, DOI 10.1002/jcb.22073; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Shen XT, 2004, METHOD ENZYMOL, V377, P401; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsvetkov P, 2008, PROTEINS, V70, P1357, DOI 10.1002/prot.21614; Tsvetkov P, 2012, MOL BIOSYST, V8, P368, DOI 10.1039/c1mb05283g; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zhai N., J MOL CELL BIOL; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061	36	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43205	43214		10.1074/jbc.M112.408849	http://dx.doi.org/10.1074/jbc.M112.408849			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23139418	Green Published, hybrid			2022-12-28	WOS:000312940800002
J	Wenk, M; Ba, QR; Erichsen, V; MacInnes, K; Wiese, H; Warscheid, B; Koch, HG				Wenk, Meike; Ba, Qiaorui; Erichsen, Veronika; MacInnes, Katherine; Wiese, Heike; Warscheid, Bettina; Koch, Hans-Georg			A Universally Conserved ATPase Regulates the Oxidative Stress Response in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYR TRANSCRIPTION FACTOR; TRANSFER-RNA HYDROLASE; GTP-BINDING PROTEINS; OBG-LIKE ATPASE; HYDROGEN-PEROXIDE; DNA-BINDING; OXIDASE ACTIVITY; CATALASE; IRON; IDENTIFICATION	YchF is an evolutionarily conserved ATPase of unknown function. In humans, the YchF homologue hOla1 appears to influence cell proliferation and was found to be up-regulated in many tumors. A possible involvement in regulating the oxidative stress response was also suggested, but details on the underlying mechanism are lacking. For gaining insight into YchF function, we used Escherichia coli as a model organism and found that YchF overexpression resulted in H2O2 hypersensitivity. This was not caused by transcriptional or translational down-regulation of H2O2-scavenging enzymes. Instead, we observed YchF-dependent inhibition of catalase activity and a direct interaction with the major E. coli catalase KatG. KatG inhibition was dependent on the ATPase activity of YchF and was regulated by post-translational modifications, most likely including an H2O2-dependent dephosphorylation. We furthermore showed that YchF expression is repressed by the transcription factor OxyR and further post-translationally modified in response to H2O2. In summary, our data show that YchF functions as a novel negative regulator of the oxidative stress response in E. coli. Considering the available data on hOla1, YchF/Ola1 most likely execute similar functions in bacteria and humans, and their up-regulation inhibits the ability of the cells to scavenge damaging reactive oxygen species.	[Koch, Hans-Georg] ZBMZ, Fac Med, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Warscheid, Bettina] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Wenk, Meike; Ba, Qiaorui; Wiese, Heike; Warscheid, Bettina] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Koch, HG (corresponding author), ZBMZ, Fac Med, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany.	Hans-Georg.Koch@biochemie.uni-freiburg.de		Wiese, Heike/0000-0002-8941-3762; Warscheid, Bettina/0000-0001-5096-1975	Deutsche Forschungsgemeinschaft [DFG-FOR 967, IRTG1478, FOR1352]; Excellence Initiative of the German Federal Government [GSC-4]; Excellence Initiative of the German State Government [GSC-4]; China Scholarship Council;  [EXC 294 BIOSS]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government; China Scholarship Council(China Scholarship Council); 	This work was supported in part by Deutsche Forschungsgemeinschaft Grants DFG-FOR 967 and IRTG1478 (to H. G. K.) and FOR1352 (to B. W.) and the Excellence Initiative of the German Federal and State Governments (Grant GSC-4, Spemann Graduate School for Biology and Medicine (to H. G. K.) and Grant EXC 294 BIOSS (to B. W.)).; Supported by a China Scholarship Council Ph.D. scholarship.	ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Arigoni F, 1998, NAT BIOTECHNOL, V16, P851, DOI 10.1038/nbt0998-851; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; ATHERLY AG, 1972, NATURE-NEW BIOL, V240, P245, DOI 10.1038/newbio240245a0; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Chen YC, 2011, INT J MED MICROBIOL, V301, P469, DOI 10.1016/j.ijmm.2011.02.002; Cheung MY, 2010, J BIOL CHEM, V285, P37359, DOI 10.1074/jbc.M110.172080; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; CHRISTMAN MF, 1985, CELL, V41, P753, DOI 10.1016/S0092-8674(85)80056-8; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CUZIN F, 1967, P NATL ACAD SCI USA, V58, P2079, DOI 10.1073/pnas.58.5.2079; Danese I, 2004, INFECT IMMUN, V72, P5783, DOI 10.1128/IAI.72.10.5783-5790.2004; Das G, 2006, MICROBIOL-SGM, V152, P2191, DOI 10.1099/mic.0.29024-0; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Fernebro J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-65; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gradia DF, 2009, INT J PARASITOL, V39, P49, DOI 10.1016/j.ijpara.2008.05.019; Guerrero C, 2006, MOL CELL PROTEOMICS, V5, P366, DOI 10.1074/mcp.M500303-MCP200; Ilari A, 2002, J BIOL CHEM, V277, P37619, DOI 10.1074/jbc.M206186200; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaller M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010462; Kira Y, 2008, CELL MOL BIOL LETT, V13, P570, DOI 10.2478/s11658-008-0023-8; Koch HG, 2003, REV PHYSIOL BIOCH P, V146, P55, DOI 10.1007/s10254-002-0002-9; Koller-Eichhorn R, 2007, J BIOL CHEM, V282, P19928, DOI 10.1074/jbc.M700541200; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Morimoto T, 2002, MICROBIOL-SGM, V148, P3539, DOI 10.1099/00221287-148-11-3539; MULVEY MR, 1990, J BACTERIOL, V172, P6713, DOI 10.1128/jb.172.12.6713-6720.1990; Nabilsi NH, 2009, ONCOGENE, V28, P2046, DOI 10.1038/onc.2009.62; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; RADI R, 1991, J BIOL CHEM, V266, P22028; Robichon C, 2011, APPL ENVIRON MICROB, V77, P4634, DOI 10.1128/AEM.00119-11; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Salvi M, 2007, J BIOL CHEM, V282, P24407, DOI 10.1074/jbc.M701589200; Sartoretto JL, 2011, P NATL ACAD SCI USA, V108, P15792, DOI 10.1073/pnas.1111331108; Schembri MA, 2003, J BACTERIOL, V185, P2236, DOI 10.1128/JB.185.7.2236-2242.2003; Sen CK, 2008, BBA-GEN SUBJECTS, V1780, P1348, DOI 10.1016/j.bbagen.2008.01.006; Singh R, 2004, J BIOL CHEM, V279, P43098, DOI 10.1074/jbc.M406374200; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; Sun H, 2010, MOL CANCER RES, V8, P57, DOI 10.1158/1541-7786.MCR-09-0278; Teplyakov A, 2003, J BACTERIOL, V185, P4031, DOI 10.1128/JB.185.14.4031-4037.2003; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Tomar SK, 2011, BIOCHEM BIOPH RES CO, V408, P459, DOI 10.1016/j.bbrc.2011.04.052; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Verstraeten N, 2011, MICROBIOL MOL BIOL R, V75, P507, DOI 10.1128/MMBR.00009-11; Vetrano AM, 2005, J BIOL CHEM, V280, P35372, DOI 10.1074/jbc.M503991200; Wallecha A, 2003, J BACTERIOL, V185, P2203, DOI 10.1128/JB.185.7.2203-2209.2003; Wei Q, 2012, NUCLEIC ACIDS RES, V40, P4320, DOI 10.1093/nar/gks017; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046; Zhang JW, 2009, J ZHEJIANG UNIV-SC B, V10, P796, DOI 10.1631/jzus.B0910009; Zhang J, 2009, P NATL ACAD SCI USA, V106, P15356, DOI 10.1073/pnas.0907213106; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	59	23	23	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43585	43598		10.1074/jbc.M112.413070	http://dx.doi.org/10.1074/jbc.M112.413070			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23139412	Green Published, hybrid			2022-12-28	WOS:000312940800039
J	Wranik, BJ; Christensen, EL; Schaefer, G; Jackman, JK; Vendel, AC; Eaton, D				Wranik, Bernd J.; Christensen, Erin L.; Schaefer, Gabriele; Jackman, Janet K.; Vendel, Andrew C.; Eaton, Dan			LUZ-Y, a Novel Platform for the Mammalian Cell Production of Full-length IgG-bispecific Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; MONOCLONAL-ANTIBODY; HER2; RECEPTORS; MOLECULES; VARIANTS; SITES	The ability of bispecific antibodies to simultaneously bind two unique antigens has great clinical potential. However, most approaches utilized to generate bispecific antibodies yield antibody-like structures that diverge significantly from the structure of archetype human IgG, and those that do approach structural similarity to native antibodies are often challenging to engineer and manufacture. Here, we present a novel platform for the mammalian cell production of bispecific antibodies that differ from their parental mAbs by only a single point mutation per heavy chain. Central to this platform is the addition of a leucine zipper to the C terminus of the C(H)3 domain of the antibody that is sufficient to drive the heterodimeric assembly of antibody heavy chains and can be readily removed post-purification. Using this approach, we developed various antibody constructs including one-armed Abs, bispecific antibodies that utilize a common light chain, and bispecific antibodies that pair light chains to their cognate heavy chains via peptide tethers. We have applied this technology to various antibody pairings and will demonstrate the engineering, purification, and biological activity of these antibodies herein.	[Wranik, Bernd J.; Christensen, Erin L.; Vendel, Andrew C.; Eaton, Dan] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Schaefer, Gabriele] Genentech Inc, Dept Res Oncol, San Francisco, CA USA; [Jackman, Janet K.] Genentech Inc, Dept Discovery Immunol, San Francisco, CA USA; [Vendel, Andrew C.] Lilly Biotechnol Ctr San Diego, San Diego, CA 92121 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Eaton, D (corresponding author), Genentech Inc, Dept Prot Chem, 1 DNA Way MS63, San Francisco, CA 94080 USA.	dle@gene.com		Schaefer, Gabriele/0000-0001-9727-3555				Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Davis JH, 2010, PROTEIN ENG DES SEL, V23, P195, DOI 10.1093/protein/gzp094; deKruif J, 1996, J BIOL CHEM, V271, P7630, DOI 10.1074/jbc.271.13.7630; Fischer N, 2007, PATHOBIOLOGY, V74, P3, DOI 10.1159/000101046; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; HARRIS RJ, 1995, J CHROMATOGR A, V705, P129, DOI 10.1016/0021-9673(94)01255-D; Hollander N, 2009, IMMUNOTHERAPY-UK, V1, P211, DOI 10.2217/1750743X.1.2.211; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; Jackman J, 2010, J BIOL CHEM, V285, P20850, DOI 10.1074/jbc.M110.113910; Kontermann RE, 2010, CURR OPIN MOL THER, V12, P176; KOSTELNY SA, 1992, J IMMUNOL, V148, P1547; Krysan DJ, 1999, J BIOL CHEM, V274, P23229, DOI 10.1074/jbc.274.33.23229; Kuwada SK, 2004, INT J CANCER, V109, P291, DOI 10.1002/ijc.11686; Li JSS, 2005, J BIOL CHEM, V280, P38513, DOI 10.1074/jbc.M508449200; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; PRUSS RM, 1978, NATURE, V274, P272, DOI 10.1038/274272a0; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Schaefer G, 2007, CANCER RES, V67, P1228, DOI 10.1158/0008-5472.CAN-06-3493; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; STAERZ UD, 1985, NATURE, V314, P628, DOI 10.1038/314628a0; STAERZ UD, 1986, P NATL ACAD SCI USA, V83, P1453, DOI 10.1073/pnas.83.5.1453; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Wines BD, 2000, J IMMUNOL, V164, P5313, DOI 10.4049/jimmunol.164.10.5313	25	27	50	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43331	43339		10.1074/jbc.M112.397869	http://dx.doi.org/10.1074/jbc.M112.397869			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118228	Green Published, hybrid			2022-12-28	WOS:000312940800014
J	Perez-Gonzalez, R; Gauthier, SA; Kumar, A; Levy, E				Perez-Gonzalez, Rocio; Gauthier, Sebastien A.; Kumar, Asok; Levy, Efrat			The Exosome Secretory Pathway Transports Amyloid Precursor Protein Carboxyl-terminal Fragments from the Cell into the Brain Extracellular Space	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; MEMORY DEFICITS; MULTIVESICULAR BODIES; TRANSGENIC MICE; BETA PEPTIDE; MOUSE MODEL; ASSOCIATION; INHIBITION; VESICLES; BIOGENESIS	In vitro studies have shown that neuronal cell cultures secrete exosomes containing amyloid-beta precursor protein (APP) and the APP-processing products, C-terminal fragments (CTFs) and amyloid-beta (A beta). We investigated the secretion of full-length APP (flAPP) and APP CTFs via the exosome secretory pathway in vivo. To this end, we developed a novel protocol designed to isolate exosomes secreted into mouse brain extracellular space. Exosomes with typical morphology were isolated from freshly removed mouse brains and from frozen mouse and human brain tissues, demonstrating that exosomes can be isolated from postmortem tissue frozen for long periods of time. flAPP, APPCTFs, and enzymes that cleave both flAPP and APP CTFs were identified in brain exosomes. Although higher levels of both flAPP and APP CTFs were observed in exosomes isolated from the brains of transgenic mice overexpressing human APP (Tg2576) compared with wild-type control mice, there was no difference in the number of secreted brain exosomes. These data indicate that the levels of flAPP and APP CTFs associated with exosomes mirror the cellular levels of flAPP and APP CTFs. Interestingly, exosomes isolated from the brains of both Tg2576 and wild-type mice are enriched with APP CTFs relative to flAPP. Thus, we hypothesize that the exosome secretory pathway plays a pleiotropic role in the brain: exosome secretion is beneficial to the cell, acting as a specific releasing system of neurotoxic APP CTFs and A beta, but the secretion of exosomes enriched with APP CTFs, neurotoxic proteins that are also a source of secreted A beta, is harmful to the brain.	[Perez-Gonzalez, Rocio; Gauthier, Sebastien A.; Kumar, Asok; Levy, Efrat] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; [Perez-Gonzalez, Rocio] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA; [Levy, Efrat] NYU, Dept Psychiat, Langone Med Ctr, New York, NY 10016 USA; [Levy, Efrat] NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, New York, NY 10016 USA	Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Levy, E (corresponding author), Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, 140 Old Orangeburg Rd, Orangeburg, NY 10962 USA.	elevy@nki.rfmh.org	Perez-Gonzalez, Rocio/GQH-7068-2022	Perez-Gonzalez, Rocio/0000-0002-0641-2001; Gauthier, Sebastien/0000-0002-5692-9260	National Institutes of Health [AG017617]; Alzheimer's Association [ZEN-10-172559]; NATIONAL INSTITUTE ON AGING [P01AG017617] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG017617. This work was also supported by Alzheimer's Association Grant ZEN-10-172559.	Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Clayton A., 2006, CURR PROTOC CELL BIO; Deyts C, 2012, J NEUROSCI, V32, P1714, DOI 10.1523/JNEUROSCI.5433-11.2012; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Escrevente C, 2008, BBA-GEN SUBJECTS, V1780, P905, DOI 10.1016/j.bbagen.2008.03.004; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Grant R, 2011, J IMMUNOL METHODS, V371, P143, DOI 10.1016/j.jim.2011.06.024; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harrington MG, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-10; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Izquierdo-Useros N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000740; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Langui D, 2004, AM J PATHOL, V165, P1465, DOI 10.1016/S0002-9440(10)63405-0; Mathews PM, 2002, J BIOL CHEM, V277, P36415, DOI 10.1074/jbc.M205208200; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Savina A, 2002, J CELL SCI, V115, P2505; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Smalheiser NR, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-35; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; Tasaki M, 2010, BIOCHEM BIOPH RES CO, V400, P559, DOI 10.1016/j.bbrc.2010.08.101; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tizon B, 2010, J ALZHEIMERS DIS, V19, P885, DOI 10.3233/JAD-2010-1291; Vella LJ, 2008, VET IMMUNOL IMMUNOP, V124, P385, DOI 10.1016/j.vetimm.2008.04.002; Vella LJ, 2008, EUR BIOPHYS J BIOPHY, V37, P323, DOI 10.1007/s00249-007-0246-z; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yamazaki T, 1996, J CELL SCI, V109, P999; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273	51	255	260	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43108	43115		10.1074/jbc.M112.404467	http://dx.doi.org/10.1074/jbc.M112.404467			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23129776	hybrid, Green Published			2022-12-28	WOS:000312501600066
J	Yang, CX; Cao, ML; Liu, H; He, YQ; Xu, J; Du, Y; Liu, YW; Wang, WJ; Cui, L; Hu, JJ; Gao, F				Yang, Cuixia; Cao, Manlin; Liu, Hua; He, Yiqing; Xu, Jing; Du, Yan; Liu, Yiwen; Wang, Wenjuan; Cui, Lian; Hu, Jiajie; Gao, Feng			The High and Low Molecular Weight Forms of Hyaluronan Have Distinct Effects on CD44 Clustering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-MEDIATED MOTILITY; T-CELLS; PERICELLULAR MATRIX; SIGNALING PATHWAYS; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; VASCULAR-DISEASE; RECEPTOR FAMILY; BINDING DOMAIN; TISSUE-INJURY	CD44 is a major cell surface receptor for the glycosaminoglycan hyaluronan (HA). Native high molecular weight hyaluronan (nHA) and oligosaccharides of hyaluronan (oHA) provoke distinct biological effects upon binding to CD44. Despite the importance of such interactions, however, the feature of binding with CD44 at the cell surface and the molecular basis for functional distinction between different sizes of HA is still unclear. In this study we investigated the effects of high and low molecular weight hyaluronan on CD44 clustering. For the first time, we provided direct evidence for a strong relationship between HA size and CD44 clustering in vivo. In CD44-transfected COS-7 cells, we showed that exogenous nHA stimulated CD44 clustering, which was disrupted by oHA. Moreover, naturally expressed CD44 was distributed into clusters due to abundantly expressed nHA in HK-2 cells (human renal proximal tubule cells) and BT549 cells (human breast cancer cell line) without exogenous stimulation. Our results suggest that native HA binding to CD44 selectively induces CD44 clustering, which could be inhibited by oHA. Finally, we demonstrated that HA regulates cell adhesion in a manner specifically dependent on its size. oHA promoted cell adhesion while nHA showed no effects. Our results might elucidate a molecular- and/or cellular-based mechanism for the diverse biological activities of nHA and oHA.	[Yang, Cuixia; He, Yiqing; Du, Yan; Liu, Yiwen; Cui, Lian; Hu, Jiajie; Gao, Feng] Shanghai Jiao Tong Univ, Dept Mol Biol Lab, Sch Med, Shanghai 200233, Peoples R China; [Cao, Manlin] Shanghai Jiao Tong Univ, Dept Rehabil Med, Sch Med, Shanghai 200233, Peoples R China; [Liu, Hua; Xu, Jing; Wang, Wenjuan] Shanghai Jiao Tong Univ, Dept Clin Lab, Sch Med, Shanghai 200233, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, F (corresponding author), Shanghai Jiao Tong Univ, Dept Mol Biol Lab, Shanghai Peoples Hosp 6, Sch Med, 600 Yishan Rd, Shanghai 200233, Peoples R China.	gao3507@126.com	liu, yi/GXE-9662-2022		Science and Technology Commission of Shanghai Municipality [08411952700]; National Natural Science Foundation of China [81071814, 81172027, 81272479]; Program of Shanghai Subject Chief Scientist [11XD1404000]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist	This work was supported by the Science and Technology Commission of Shanghai Municipality (Key Technology Support Programme, 08411952700), the National Natural Science Foundation of China (81071814, 81172027, 81272479), and the Program of Shanghai Subject Chief Scientist (11XD1404000).	A-Ayoubi A, 2008, J CELL BIOCHEM, V105, P875, DOI 10.1002/jcb.21889; Banerji S, 2010, J BIOL CHEM, V285, P10724, DOI 10.1074/jbc.M109.047647; Bollyky PL, 2007, J IMMUNOL, V179, P744, DOI 10.4049/jimmunol.179.2.744; Bollyky PL, 2009, J LEUKOCYTE BIOL, V86, P567, DOI 10.1189/jlb.0109001; Bollyky PL, 2009, J IMMUNOL, V183, P2232, DOI 10.4049/jimmunol.0900191; Boraldi F, 2003, TISSUE CELL, V35, P37, DOI 10.1016/S0040-8166(02)00101-5; Brenner B, 1996, P NATL ACAD SCI USA, V93, P15376, DOI 10.1073/pnas.93.26.15376; Camenisch TD, 2000, AM J RESP CELL MOL, V23, P431, DOI 10.1165/ajrcmb.23.4.f201; Chalkiadaki G, 2011, CANCER LETT, V312, P235, DOI 10.1016/j.canlet.2011.08.016; Estess P, 1998, J CLIN INVEST, V102, P1173, DOI 10.1172/JCI4235; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Ezzell RM, 1997, EXP CELL RES, V231, P14, DOI 10.1006/excr.1996.3451; Fanning A, 2005, INT IMMUNOL, V17, P449, DOI 10.1093/intimm/dxh225; Felber LM, 2004, BIOTECHNIQUES, V36, P878, DOI 10.2144/04365PT04; Gao F, 2008, CLIN INVEST MED, V31, pE106, DOI 10.25011/cim.v31i3.3467; Gao F, 2006, J BIOMED MATER RES B, V78B, P385, DOI 10.1002/jbm.b.30499; Gao F, 2010, MATRIX BIOL, V29, P107, DOI 10.1016/j.matbio.2009.11.002; Gares SL, 1998, J LEUKOCYTE BIOL, V64, P781, DOI 10.1002/jlb.64.6.781; Gares SL, 1999, SCAND J IMMUNOL, V50, P626; Gribbon P, 2000, BIOCHEM J, V350, P329, DOI 10.1042/0264-6021:3500329; HALL CL, 1994, J CELL BIOL, V126, P575, DOI 10.1083/jcb.126.2.575; HALL CL, 1995, CELL, V82, P19, DOI 10.1016/0092-8674(95)90048-9; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang H, 2002, J BIOL CHEM, V277, P10531, DOI 10.1074/jbc.M108654200; KATOH S, 1995, J EXP MED, V182, P419, DOI 10.1084/jem.182.2.419; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; Kothapalli D, 2008, J BIOL CHEM, V283, P31823, DOI 10.1074/jbc.M802934200; Kothapalli D, 2007, J CELL BIOL, V176, P535, DOI 10.1083/jcb.200611058; Kouvidi K, 2011, J BIOL CHEM, V286, P38509, DOI 10.1074/jbc.M111.275875; Lesley J, 2000, J BIOL CHEM, V275, P26967; Lesley J, 1997, GLYCOCONJUGATE J, V14, P611, DOI 10.1023/A:1018540610858; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Liu Dacai, 1998, Frontiers in Bioscience, V3, pD631; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Nagy JI, 1996, CELL GROWTH DIFFER, V7, P745; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200; SHIMIZU Y, 1989, J IMMUNOL, V143, P2457; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Slomiany MG, 2009, CANCER RES, V69, P4992, DOI 10.1158/0008-5472.CAN-09-0143; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Spessotto P, 2002, J CELL BIOL, V158, P1133, DOI 10.1083/jcb.200202120; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Thiagarajan P, 1996, CELL ADHES COMMUN, V4, P317, DOI 10.3109/15419069609010775; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; Wang YZ, 2011, EXP BIOL MED, V236, P84, DOI 10.1258/ebm.2010.010206; Wolny PM, 2010, J BIOL CHEM, V285, P30170, DOI 10.1074/jbc.M110.137562; Wong NKY, 2008, J IMMUNOL, V181, P7033, DOI 10.4049/jimmunol.181.10.7033; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467	63	188	194	3	75	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43094	43107		10.1074/jbc.M112.349209	http://dx.doi.org/10.1074/jbc.M112.349209			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23118219	Green Published, hybrid			2022-12-28	WOS:000312501600065
J	Han, D; Ybanez, MD; Johnson, HS; McDonald, JN; Mesropyan, L; Sancheti, H; Martin, G; Martin, A; Lim, AM; Dara, L; Cadenas, E; Tsukamoto, H; Kaplowitz, N				Han, Derick; Ybanez, Maria D.; Johnson, Heather S.; McDonald, Jeniece N.; Mesropyan, Lusine; Sancheti, Harsh; Martin, Gary; Martin, Alanna; Lim, Atalie M.; Dara, Lily; Cadenas, Enrique; Tsukamoto, Hidekazu; Kaplowitz, Neil			Dynamic Adaptation of Liver Mitochondria to Chronic Alcohol Feeding in Mice BIOGENESIS, REMODELING, AND FUNCTIONAL ALTERATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE MITOCHONDRIA; CHRONIC ETHANOL TREATMENT; RAT-LIVER; ENERGY-METABOLISM; SUPEROXIDE ANION; SWIFT INCREASE; NECROSIS; EXERCISE; PROTEIN; STRESS	Liver mitochondria undergo dynamic alterations following chronic alcohol feeding to mice. Intragastric alcohol feeding to mice resulted in 1) increased state III respiration (109% compared with control) in isolated liver mitochondria, probably due to increased levels of complexes I, IV, and V being incorporated into the respiratory chain; 2) increased mitochondrial NAD(+) and NADH levels (similar to 2-fold), with no change in the redox status; 3) alteration in mitochondrial morphology, with increased numbers of elongated mitochondria; and 4) enhanced mitochondrial biogenesis in the liver, which corresponded with an up-regulation of PGC-1 alpha (peroxisome proliferator-activated receptor gamma coactivator-1 alpha). Oral alcohol feeding to mice, which is associated with less liver injury and steatosis, slightly enhanced respiration in isolated liver mitochondria (30.8% compared with control), lower than the striking increase caused by intragastric alcohol feeding. Mitochondrial respiration increased with both oral and intragastric alcohol feeding despite extensive N-acetylation of mitochondrial proteins. The alcohol-induced mitochondrial alterations are probably an adaptive response to enhance alcohol metabolism in the liver. Isolated liver mitochondria from alcohol-treated mice had a greater rate of acetaldehyde metabolism and respiration when treated with acetaldehyde than control. Aldehyde dehydrogenase-2 levels were unaltered in response to alcohol, suggesting that the greater acetaldehyde metabolism by isolated mitochondria from alcohol-treated mice was due to increased mitochondrial respiration that regenerated NAD(+), the rate-limiting substrate in alcohol/acetaldehyde metabolism. Overall, our work suggests that mitochondrial plasticity in the liver may be an important adaptive response to the metabolic stress caused by alcohol intake and could potentially play a role in many other vital functions performed by the liver.	[Han, Derick; Lim, Atalie M.; Dara, Lily; Kaplowitz, Neil] Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, Los Angeles, CA 90089 USA; [Lim, Atalie M.; Dara, Lily; Kaplowitz, Neil] Univ So Calif, Keck Sch Med, So Calif Res Ctr Alcohol Liver & Pancreat Dis, Los Angeles, CA 90089 USA; [Sancheti, Harsh; Cadenas, Enrique] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Martin, Gary; Martin, Alanna] Occidental Coll, Dept Biol, Los Angeles, CA 90041 USA; [Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, So Calif Res Ctr Alcohol Liver & Pancreat Dis & C, Los Angeles, CA 90089 USA; [Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90089 USA; [Tsukamoto, Hidekazu] Greater Los Angeles Vet Affairs Healthcare Syst, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California; Occidental College; University of Southern California; University of Southern California; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Han, D (corresponding author), Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, 2011 Zonal Ave,HMR 101, Los Angeles, CA 90089 USA.	derickh@usc.edu	Dara, Lily/S-2444-2019	Dara, Lily/0000-0002-0121-7186; Sancheti, Harsh/0000-0001-8084-4550	National Institutes of Health Grant [AA016911, AA14428, P50AA11999]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999, K01AA016911, R01AA014428] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant AA016911 (to D. H.), AA14428 (to N. K.), and P50AA11999 (to H. T.).	Adhihetty PJ, 2003, EXP PHYSIOL, V88, P99, DOI 10.1113/eph8802505; Arteel GE, 2010, DIGEST DIS, V28, P729, DOI 10.1159/000324280; Arteel GE, 2003, GASTROENTEROLOGY, V124, P778, DOI 10.1053/gast.2003.50087; Arteel GE, 1997, HEPATOLOGY, V25, P920, DOI 10.1002/hep.510250422; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bailey SM, 2002, FREE RADICAL BIO MED, V32, P11, DOI 10.1016/S0891-5849(01)00769-9; BARAONA E, 1977, J CLIN INVEST, V60, P546, DOI 10.1172/JCI108806; BARAONA E, 1982, ANNU REV MED, V33, P281, DOI 10.1146/annurev.me.33.020182.001433; BERNSTEIN JD, 1978, BIOCHEM PHARMACOL, V27, P2337, DOI 10.1016/0006-2952(78)90141-7; Bradford BU, 2005, ALCOHOL, V35, P13, DOI 10.1016/j.alcohol.2004.12.001; Campian JL, 2007, J BIOL CHEM, V282, P12430, DOI 10.1074/jbc.M604547200; CEDERBAUM AI, 1974, ARCH BIOCHEM BIOPHYS, V165, P560, DOI 10.1016/0003-9861(74)90283-5; CUNNINGHAM CC, 1990, ALCOHOL ALCOHOLISM, V25, P127, DOI 10.1093/oxfordjournals.alcalc.a044987; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; FRENCH SW, 1984, HEPATOLOGY, V4, P912, DOI 10.1002/hep.1840040521; Fritz KS, 2012, J PROTEOME RES, V11, P1633, DOI 10.1021/pr2008384; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; HASUMURA Y, 1976, J BIOL CHEM, V251, P4908; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; Hoppeler H, 2003, MED SCI SPORT EXER, V35, P95, DOI 10.1097/00005768-200301000-00016; ISRAEL Y, 1975, P NATL ACAD SCI USA, V72, P1137, DOI 10.1073/pnas.72.3.1137; Israel Y, 1984, Recent Dev Alcohol, V2, P119; ITURRIAGA H, 1980, EUR J CLIN INVEST, V10, P211, DOI 10.1111/j.1365-2362.1980.tb00022.x; Ji C, 2006, J HEPATOL, V45, P717, DOI 10.1016/j.jhep.2006.05.009; JI SC, 1982, P NATL ACAD SCI-BIOL, V79, P5415, DOI 10.1073/pnas.79.17.5415; KLAIDMAN LK, 1995, ANAL BIOCHEM, V228, P312, DOI 10.1006/abio.1995.1356; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; MOLE PA, 1971, J CLIN INVEST, V50, P2323, DOI 10.1172/JCI106730; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Oliva J, 2008, EXP MOL PATHOL, V85, P155, DOI 10.1016/j.yexmp.2008.08.002; Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002; Picklo MJ, 2008, BIOCHEM BIOPH RES CO, V376, P615, DOI 10.1016/j.bbrc.2008.09.039; Reddy PH, 2011, BRAIN RES REV, V67, P103, DOI 10.1016/j.brainresrev.2010.11.004; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schagger H, 2001, J BIOL CHEM, V276, P37861; Shinohara M, 2010, HEPATOLOGY, V51, P796, DOI 10.1002/hep.23391; SPACH PI, 1987, BIOCHIM BIOPHYS ACTA, V894, P460, DOI 10.1016/0005-2728(87)90125-3; THURMAN RG, 1982, J PHARMACOL EXP THER, V223, P45; TOBON F, 1971, J LAB CLIN MED, V77, P110; TSUKAMOTO H, 1985, HEPATOLOGY, V5, P224, DOI 10.1002/hep.1840050212; TSUKAMOTO H, 1986, HEPATOLOGY, V6, P814, DOI 10.1002/hep.1840060503; Venkatraman A, 2004, HEPATOLOGY, V40, P565, DOI 10.1002/hep.20326; Venkatraman A, 2004, J BIOL CHEM, V279, P22092, DOI 10.1074/jbc.M402245200; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; VIDELA L, 1970, BIOCHEM J, V118, P275, DOI 10.1042/bj1180275; VIDELA L, 1973, BIOCHEM J, V134, P507, DOI 10.1042/bj1340507; Vinogradov AD, 2008, BBA-BIOENERGETICS, V1777, P729, DOI 10.1016/j.bbabio.2008.04.014; Yap LP, 2009, ADV DRUG DELIVER REV, V61, P1283, DOI 10.1016/j.addr.2009.07.015; Zhang XY, 2010, HEPATOLOGY, V52, P2137, DOI 10.1002/hep.23909	57	52	53	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42165	42179		10.1074/jbc.M112.377374	http://dx.doi.org/10.1074/jbc.M112.377374			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086958	hybrid, Green Published			2022-12-28	WOS:000312103000054
J	Pusapati, GV; Luchetti, G; Pfeffer, SR				Pusapati, Ganesh V.; Luchetti, Giovanni; Pfeffer, Suzanne R.			Ric1-Rgp1 Complex Is a Guanine Nucleotide Exchange Factor for the Late Golgi Rab6A GTPase and an Effector of the Medial Golgi Rab33B GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI; LOCALIZATION; TRAFFICKING; MAINTENANCE; ENDOSOMES; PROTEINS; VESICLES; PATHWAY; CASCADE; GCC185	Rab GTPases are master regulators of membrane trafficking events and template the directionality of protein transport through the secretory and endocytic pathways. Certain Rabs recruit the guanine nucleotide exchange factor (GEF) that activates a subsequent acting Rab protein in a given pathway; this process has been termed a Rab cascade. We show here that the medial Golgi-localized Rab33B GTPase has the potential to link functionally to the late Golgi, Rab6 GTPase, by its capacity for association with Ric1 and Rgp1 proteins. In yeast, Ric1p and Rgp1p form a complex that catalyzes guanine nucleotide exchange by Ypt6p, the Rab6 homolog. Human Ric1 and Rgp1 both bind Rab6A with preference for the GDP-bound conformation, characteristic of a GEF. Nevertheless, both Ric1 and Rgp1 proteins are needed to catalyze nucleotide exchange on Rab6A protein. Ric1 and Rgp1 form a complex, but unlike their yeast counterparts, most of the subunits are not associated, and most of the proteins are cytosolic. Loss of Ric1 or Rgp1 leads to destabilization of Rab6, concomitant with a block in Rab6-dependent retrograde transport of mannose 6-phosphate receptors to the Golgi. The C terminus of Ric1 protein contains a distinct binding site for Rab33B-GTP, supporting the existence of a Rab cascade between the medial and trans Golgi. This study thus identifies a GEF for Rab6A in human cells.	[Pusapati, Ganesh V.; Luchetti, Giovanni; Pfeffer, Suzanne R.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University	Pfeffer, SR (corresponding author), Stanford Univ, Dept Biochem, Sch Med, 279 Campus Dr B400, Stanford, CA 94305 USA.	pfeffer@stanford.edu		Pusapati, Ganesh/0000-0002-1406-2566	National Institutes of Health Grant [DK37332]; National Institutes of Health Training Grant [GM007276]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037332, R56DK037332, R37DK037332] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK37332 (to S.R.P.).; Supported by National Institutes of Health Training Grant GM007276.	Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; Akiyama M, 2005, BIOCHEM BIOPH RES CO, V335, P1264, DOI 10.1016/j.bbrc.2005.08.019; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Barr FA, 2009, SEMIN CELL DEV BIOL, V20, P780, DOI 10.1016/j.semcdb.2009.03.007; Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Bensen ES, 2001, MOL BIOL CELL, V12, P13, DOI 10.1091/mbc.12.1.13; Brown FC, 2011, J CELL BIOL, V194, P779, DOI 10.1083/jcb.201104019; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; Diaz E., 1997, J CELL BIOL, V138, P283; DIRACSVEJSTRUP AB, 1994, J BIOL CHEM, V269, P15427; Field MC, 2011, J CELL BIOL, V193, P963, DOI 10.1083/jcb.201102042; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Nottingham RM, 2011, J BIOL CHEM, V286, P33213, DOI 10.1074/jbc.M111.261115; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Pfeffer SR, 2010, P NATL ACAD SCI USA, V107, P19614, DOI 10.1073/pnas.1011016107; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rivera-Molina FE, 2009, P NATL ACAD SCI USA, V106, P14408, DOI 10.1073/pnas.0906536106; Siniossoglou S, 2000, EMBO J, V19, P4885, DOI 10.1093/emboj/19.18.4885; Starr T, 2010, TRAFFIC, V11, P626, DOI 10.1111/j.1600-0854.2010.01051.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Storrie B, 2012, TRAFFIC, V13, P727, DOI 10.1111/j.1600-0854.2012.01343.x	25	39	42	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42129	42137		10.1074/jbc.M112.414565	http://dx.doi.org/10.1074/jbc.M112.414565			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23091056	Green Published, hybrid			2022-12-28	WOS:000312103000051
J	Ragnarsson, L; Wang, CIA; Andersson, A; Fajarningsih, D; Monks, T; Brust, A; Rosengren, KJ; Lewis, RJ				Ragnarsson, Lotten; Wang, Ching-I Anderson; Andersson, Asa; Fajarningsih, Dewi; Monks, Thea; Brust, Andreas; Rosengren, K. Johan; Lewis, Richard J.			Conopeptide rho-TIA Defines a New Allosteric Site on the Extracellular Surface of the alpha(1B)-Adrenoceptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MUSCARINIC ACETYLCHOLINE-RECEPTORS; PHASE PEPTIDE-SYNTHESIS; CRYSTAL-STRUCTURE; DISULFIDE BOND; CYSTEINE RESIDUE-110; ANTAGONIST BINDING; HORMONE RECEPTOR; LIGAND-BINDING; RHODOPSIN; PROTEINS	The G protein-coupled receptor (GPCR) superfamily is an important drug target that includes over 1000 membrane receptors that functionally couple extracellular stimuli to intracellular effectors. Despite the potential of extracellular surface (ECS) residues in GPCRs to interact with subtype-specific allosteric modulators, few ECS pharmacophores for class A receptors have been identified. Using the turkey beta(1)-adrenergic receptor crystal structure, we modeled the alpha(1B)-adrenoceptor (alpha(1B)-AR) to help identify the allosteric site for rho-conopeptide TIA, an inverse agonist at this receptor. Combining mutational radioligand binding and inositol 1-phosphate signaling studies, together with molecular docking simulations using a refined NMR structure of rho-TIA, we identified 14 residues on the ECS of the alpha(1B)-AR that influenced rho-TIA binding. Double mutant cycle analysis and docking confirmed that rho-TIA binding was dominated by a salt bridge and cation-pi between Arg-4-rho-TIA and Asp-327 and Phe-330, respectively, and a T-stacking-pi interaction between Trp-3-rho-TIA and Phe-330. Water-bridging hydrogen bonds between Asn-2-rho-TIA and Val-197, Trp-3-rho-TIA and Ser-318, and the positively charged N terminus and Glu-186, were also identified. These interactions reveal that peptide binding to the ECS on transmembrane helix 6 (TMH6) and TMH7 at the base of extracellular loop 3 (ECL3) is sufficient to allosterically inhibit agonist signaling at a GPCR. The ligand-accessible ECS residues identified provide the first view of an allosteric inhibitor pharmacophore for alpha(1)-adrenoceptors and mechanistic insight and a new set of structural constraints for the design of allosteric antagonists at related GPCRs.	[Ragnarsson, Lotten; Wang, Ching-I Anderson; Andersson, Asa; Fajarningsih, Dewi; Monks, Thea; Brust, Andreas; Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Rosengren, K. Johan] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	r.lewis@imb.uq.edu.au	Lewis, Richard/T-8763-2019; Ragnarsson, Lotten/A-8632-2012; Lewis, Richard J/E-8674-2013; Rosengren, K. Johan/P-4450-2016	Lewis, Richard/0000-0003-3470-923X; Ragnarsson, Lotten/0000-0002-7137-1656; Lewis, Richard J/0000-0003-3470-923X; Rosengren, K. Johan/0000-0002-5007-8434; Brust, Andreas/0000-0003-4238-5706; Fajarningsih, Nurrahmi Dewi/0000-0002-9111-9036	National Health and Medical Research Council [011246, 351446]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council Project Grants 011246 and 351446 and a National Health and Medical Research Council Principal Research Fellowship (to R. J. L.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andersson HS, 2012, AMINO ACIDS, V43, P1471, DOI 10.1007/s00726-012-1220-3; Asher WB, 2007, J CHEM INF MODEL, V47, P1906, DOI 10.1021/ci700026v; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brust A, 2009, J MED CHEM, V52, P6991, DOI 10.1021/jm9003413; BUCK MA, 1989, ANAL BIOCHEM, V182, P295, DOI 10.1016/0003-2697(89)90597-6; Chen SH, 1999, J BIOL CHEM, V274, P16320, DOI 10.1074/jbc.274.23.16320; Chen ZJ, 2004, J BIOL CHEM, V279, P35326, DOI 10.1074/jbc.M403703200; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Cook JVF, 1997, ENDOCRINOLOGY, V138, P2800, DOI 10.1210/en.138.7.2800; Correa SAA, 2006, REGUL PEPTIDES, V134, P132, DOI 10.1016/j.regpep.2006.02.008; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DOHLMAN HG, 1990, BIOCHEMISTRY-US, V29, P2335, DOI 10.1021/bi00461a018; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; FRASER CM, 1989, J BIOL CHEM, V264, P9266; Greasley PJ, 2002, MOL PHARMACOL, V61, P1025, DOI 10.1124/mol.61.5.1025; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Huang XP, 2005, MOL PHARMACOL, V68, P769, DOI 10.1124/mol.105.014043; Ilyin VA, 2004, PROTEIN SCI, V13, P1865, DOI 10.1110/ps.04672604; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; KARNIK SS, 1990, J BIOL CHEM, V265, P17520; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; KURTENBACH E, 1990, J BIOL CHEM, V265, P13702; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; Marquer C, 2011, J BIOL CHEM, V286, P31661, DOI 10.1074/jbc.M111.261404; McCune DF, 2000, MOL PHARMACOL, V57, P659, DOI 10.1124/mol.57.4.659; Michelotti GA, 2000, PHARMACOL THERAPEUT, V88, P281, DOI 10.1016/S0163-7258(00)00092-9; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; PERLMAN JH, 1995, J BIOL CHEM, V270, P24682, DOI 10.1074/jbc.270.42.24682; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SARIN VK, 1981, ANAL BIOCHEM, V117, P147, DOI 10.1016/0003-2697(81)90704-1; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Sharpe IA, 2003, J BIOL CHEM, V278, P34451, DOI 10.1074/jbc.M305410200; Sharpe IA, 2001, NAT NEUROSCI, V4, P902, DOI 10.1038/nn0901-902; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; Wang C. I., 2012, BIOCH PHARM IN PRESS; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Waugh DJJ, 2001, J BIOL CHEM, V276, P25366, DOI 10.1074/jbc.M103152200; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zhong HY, 1999, EUR J PHARMACOL, V375, P261, DOI 10.1016/S0014-2999(99)00222-8; Zhou HP, 2000, ARCH BIOCHEM BIOPHYS, V373, P211, DOI 10.1006/abbi.1999.1555	56	22	23	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1814	1827		10.1074/jbc.M112.430785	http://dx.doi.org/10.1074/jbc.M112.430785			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184947	hybrid, Green Published			2022-12-28	WOS:000313751400037
J	Suzuki, K; Harada, N; Yamane, S; Nakamura, Y; Sasaki, K; Nasteska, D; Joo, E; Shibue, K; Harada, T; Hamasaki, A; Toyoda, K; Nagashima, K; Inagaki, N				Suzuki, Kazuyo; Harada, Norio; Yamane, Shunsuke; Nakamura, Yasuhiko; Sasaki, Kazuki; Nasteska, Daniela; Joo, Erina; Shibue, Kimitaka; Harada, Takanari; Hamasaki, Akihiro; Toyoda, Kentaro; Nagashima, Kazuaki; Inagaki, Nobuya			Transcriptional Regulatory Factor X6 (Rfx6) Increases Gastric Inhibitory Polypeptide (GIP) Expression in Enteroendocrine K-cells and Is Involved in GIP Hypersecretion in High Fat Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT-INSULINOTROPIC POLYPEPTIDE; BINDING-PROTEIN; GLUCOSE; ENDOCRINE; RECEPTOR; CARBOHYDRATE; HYPERPLASIA; METABOLISM; DEFECT; GLP-1	Gastric inhibitory polypeptide (GIP) is an incretin released from enteroendocrine K-cells in response to nutrient ingestion. GIP potentiates glucose-stimulated insulin secretion and induces energy accumulation into adipose tissue, resulting in obesity. Plasma GIP levels are reported to be increased in the obese state. However, the molecular mechanisms of GIP secretion and high fat diet (HFD)-induced GIP hypersecretion remain unclear, primarily due to difficulties in separating K-cells from other intestinal epithelial cells in vivo. In this study, GIP-GFP knock-in mice that enable us to visualize K-cells by enhanced GFP were established. Microarray analysis of isolated K-cells from these mice revealed that transcriptional regulatory factor X6 (Rfx6) is expressed exclusively in K-cells. In vitro experiments using the mouse intestinal cell line STC-1 showed that knockdown of Rfx6 decreased mRNA expression, cellular content, and secretion of GIP. Rfx6 bound to the region in the gip promoter that regulates gip promoter activity, and overexpression of Rfx6 increased GIP mRNA expression. HFD induced obesity and GIP hypersecretion in GIP-GFP heterozygous mice in vivo. Immunohistochemical and flow cytometry analysis showed no significant difference in K-cell number between control fat diet-fed (CFD) and HFD-fed mice. However, GIP content in the upper small intestine and GIP mRNA expression in K-cells were significantly increased in HFD-fed mice compared with those in CFD-fed mice. Furthermore, expression levels of Rfx6 mRNA were increased in K-cells of HFD-fed mice. These results suggest that Rfx6 increases GIP expression and content in K-cells and is involved in GIP hypersecretion in HFD-induced obesity.	[Suzuki, Kazuyo; Harada, Norio; Yamane, Shunsuke; Nakamura, Yasuhiko; Sasaki, Kazuki; Nasteska, Daniela; Joo, Erina; Shibue, Kimitaka; Harada, Takanari; Hamasaki, Akihiro; Toyoda, Kentaro; Nagashima, Kazuaki; Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University	Inagaki, N (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	inagaki@metab.kuhp.kyoto-u.ac.jp		Nasteska, Daniela/0000-0002-8996-5102; Inagaki, Nobuya/0000-0001-8261-2593; Suzuki, Kazuyo/0000-0001-5716-5242; HARADA, NORIO/0000-0001-8720-1013	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor, and Welfare, Japan; Japan Diabetes Foundation; Grants-in-Aid for Scientific Research [22590975] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Diabetes Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by scientific research grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, the Ministry of Health, Labor, and Welfare, Japan, and scientific research grants from the Japan Diabetes Foundation.	Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Ait-Lounis A, 2007, DIABETES, V56, P950, DOI 10.2337/db06-1187; Ait-Lounis A, 2010, DIABETES, V59, P1674, DOI 10.2337/db09-0986; BAILEY CJ, 1986, ACTA ENDOCRINOL-COP, V112, P224, DOI 10.1530/acta.0.1120224; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; Brown J C, 1975, Recent Prog Horm Res, V31, P487; CREUTZFELDT W, 1978, DIABETOLOGIA, V14, P15, DOI 10.1007/BF00429703; Dockray JH., 1994, GUT PEPTIDES BIOCH P, P217; Drucker DJ, 1998, DIABETES, V47, P159, DOI 10.2337/diabetes.47.2.159; FALKO JM, 1975, J CLIN ENDOCR METAB, V41, P260, DOI 10.1210/jcem-41-2-260; FLATT PR, 1983, DIABETES, V32, P433, DOI 10.2337/diabetes.32.5.433; Fujita Y, 2008, AM J PHYSIOL-ENDOC M, V295, pE648, DOI 10.1152/ajpendo.90440.2008; Gniuli D, 2010, DIABETOLOGIA, V53, P2233, DOI 10.1007/s00125-010-1830-9; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; Harada N, 2008, AM J PHYSIOL-ENDOC M, V294, pE61, DOI 10.1152/ajpendo.00358.2007; Harada N, 2011, J DIABETES INVEST, V2, P193, DOI 10.1111/j.2040-1124.2010.00078.x; HAUNER H, 1988, ANN NUTR METAB, V32, P282, DOI 10.1159/000177467; Jepeal LI, 2005, ENDOCRINOLOGY, V146, P383, DOI 10.1210/en.2004-0223; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Katan-Khaykovich Y, 1998, J BIOL CHEM, V273, P24504, DOI 10.1074/jbc.273.38.24504; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Parker HE, 2009, DIABETOLOGIA, V52, P289, DOI 10.1007/s00125-008-1202-x; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; REITH W, 1989, P NATL ACAD SCI USA, V86, P4200, DOI 10.1073/pnas.86.11.4200; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Seino Y, 2010, J DIABETES INVEST, V1, P8, DOI 10.1111/j.2040-1124.2010.00022.x; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Song DH, 2007, GASTROENTEROLOGY, V133, P1796, DOI 10.1053/j.gastro.2007.09.005; Soyer J, 2010, DEVELOPMENT, V137, P203, DOI 10.1242/dev.041673; Tsukiyama K, 2006, MOL ENDOCRINOL, V20, P1644, DOI 10.1210/me.2005-0187; USDIN TB, 1993, ENDOCRINOLOGY, V133, P2861, DOI 10.1210/en.133.6.2861; Vollmer K, 2008, DIABETES, V57, P678, DOI 10.2337/db07-1124; Yamane S, 2012, J DIABETES INVEST, V3, P80, DOI 10.1111/j.2040-1124.2011.00143.x; Yoder SM, 2010, AM J PHYSIOL-GASTR L, V299, pG476, DOI 10.1152/ajpgi.00432.2009	38	65	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1929	1938		10.1074/jbc.M112.423137	http://dx.doi.org/10.1074/jbc.M112.423137			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23192339	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000313751400046
J	Cicchillitti, L; Di Stefano, V; Isaia, E; Crimaldi, L; Fasanaro, P; Ambrosino, V; Antonini, A; Capogrossi, MC; Gaetano, C; Piaggio, G; Martelli, F				Cicchillitti, Lucia; Di Stefano, Valeria; Isaia, Eleonora; Crimaldi, Luca; Fasanaro, Pasquale; Ambrosino, Valeria; Antonini, Annalisa; Capogrossi, Maurizio C.; Gaetano, Carlo; Piaggio, Giulia; Martelli, Fabio			Hypoxia-inducible Factor 1-alpha Induces miR-210 in Normoxic Differentiating Myoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; IN-VITRO; MUSCLE REGENERATION; ENDOTHELIAL-CELLS; GENE-EXPRESSION; UP-REGULATION; STEM-CELLS; MICRORNA-210; ANGIOGENESIS; MITOCHONDRIA	MicroRNA-210 (miR-210) induction is a virtually constant feature of the hypoxic response in both normal and transformed cells, regulating several key aspects of cardiovascular diseases and cancer. We found that miR-210 was induced in normoxic myoblasts upon myogenic differentiation both in vitro and in vivo. miR-210 transcription was activated in an hypoxia-inducible factor 1-alpha (Hif1a)-dependent manner, and chromatin immunoprecipitation experiments show that Hif1a bound to the miR-210 promoter only in differentiated myotubes. Accordingly, luciferase reporter assays demonstrated the functional relevance of the Hif1a binding site for miR-210 promoter activation in differentiating myoblasts. To investigate the functional relevance of increased miR-210 levels in differentiated myofibers, we blocked miR-210 with complementary locked nucleic acid oligonucleotides (anti-miR-210). We found that C2C12 myoblast cell line differentiation was largely unaffected by anti-miR-210. Likewise, miR-210 inhibition did not affect skeletal muscle regeneration following cardiotoxin damage. However, we found that miR-210 blockade greatly increased myotube sensitivity to oxidative stress and mitochondrial dysfunction. In conclusion, miR-210 is induced in normoxic myofibers, playing a cytoprotective role.	[Martelli, Fabio] IRCCS Policlin San Donato, Mol Cardiol Lab, I-20097 Milan, Italy; [Di Stefano, Valeria; Fasanaro, Pasquale; Antonini, Annalisa; Capogrossi, Maurizio C.] IRCCS, Ist Dermopat Immacolata, I-00167 Rome, Italy; [Ambrosino, Valeria; Piaggio, Giulia] Ist Nazl Tumori Regina Elena, I-00158 Rome, Italy; [Gaetano, Carlo] Uniklinikum Goethe Univ, D-60590 Frankfurt, Germany	IRCCS Policlinico San Donato; IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Martelli, F (corresponding author), IRCCS Policlin San Donato, Mol Cardiol Lab, Via Morandi 30, I-20097 Milan, Italy.	fabio.martelli@grupposandonato.it	Gaetano, Carlo/P-9997-2019; Martelli, Fabio/AAL-3788-2020; Piaggio, Giulia/AAD-7336-2022; Piaggio, Giulia/J-7214-2018	Gaetano, Carlo/0000-0002-5238-1832; Martelli, Fabio/0000-0002-8624-7738; Piaggio, Giulia/0000-0003-2114-1892	Ministero della Salute and Associazione Italiana per la Ricerca sul Cancro Grant [AIRC IG-11436]	Ministero della Salute and Associazione Italiana per la Ricerca sul Cancro Grant(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by Ministero della Salute and Associazione Italiana per la Ricerca sul Cancro Grant AIRC IG-11436.	Alaiti MA, 2012, J CELL MOL MED, V16, P2413, DOI 10.1111/j.1582-4934.2012.01557.x; Bianchi N, 2009, BMB REP, V42, P493, DOI 10.5483/BMBRep.2009.42.8.493; Bloomer RJ, 2004, CAN J APPL PHYSIOL, V29, P245, DOI 10.1139/h04-017; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chan YC, 2012, MICROCIRCULATION, V19, P215, DOI 10.1111/j.1549-8719.2011.00154.x; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; Devlin C, 2011, IUBMB LIFE, V63, P94, DOI [10.1002/iub.00427, 10.1002/iub.427]; Du YT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-249; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fasanaro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044651; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Gou DM, 2012, AM J PHYSIOL-LUNG C, V303, pL682, DOI 10.1152/ajplung.00344.2011; Greco S, 2012, DIABETES, V61, P1633, DOI 10.2337/db11-0952; Gurtner C, 2002, ELECTROPHORESIS, V23, P1543, DOI 10.1002/1522-2683(200205)23:10<1543::AID-ELPS1543>3.0.CO;2-#; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Hildebrand J, 2011, J INVEST DERMATOL, V131, P20, DOI 10.1038/jid.2010.268; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Huang X, 2010, TRENDS MOL MED, V16, P230, DOI 10.1016/j.molmed.2010.03.004; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Kane NM, 2010, ARTERIOSCL THROM VAS, V30, P1389, DOI 10.1161/ATVBAHA.110.204800; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Kon M, 2007, APPL PHYSIOL NUTR ME, V32, P273, DOI 10.1139/H06-115; Kosaka N, 2008, BRIT J HAEMATOL, V142, P293, DOI 10.1111/j.1365-2141.2008.07151.x; Liu F, 2012, KIDNEY BLOOD PRESS R, V35, P182, DOI 10.1159/000331054; Lou YL, 2012, MOL CELL BIOCHEM, V370, P45, DOI 10.1007/s11010-012-1396-6; MARTELLI F, 1994, ONCOGENE, V9, P3579; Mason SD, 2004, PLOS BIOL, V2, P1540, DOI 10.1371/journal.pbio.0020288; Milkiewicz M, 2004, J PHYSIOL-LONDON, V560, P21, DOI 10.1113/jphysiol.2004.069757; Mizuno Y, 2009, FEBS LETT, V583, P2263, DOI 10.1016/j.febslet.2009.06.006; Musaro A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101; Musaro A, 2010, CURR OPIN CLIN NUTR, V13, P236, DOI 10.1097/MCO.0b013e3283368188; Mutharasan RK, 2011, AM J PHYSIOL-HEART C, V301, pH1519, DOI 10.1152/ajpheart.01080.2010; Ono Y, 2006, J CELL BIOCHEM, V98, P642, DOI 10.1002/jcb.20804; Pisani DF, 2005, J GEN PHYSIOL, V126, P173, DOI 10.1085/jgp.200509265; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Qin LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-320; Quero L, 2011, RADIOTHER ONCOL, V101, P203, DOI 10.1016/j.radonc.2011.05.063; Scatena R, 2012, ADV EXP MED BIOL, V942, P329, DOI 10.1007/978-94-007-2869-1_15; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Travaglione S, 2005, CELL DEATH DIFFER, V12, P78, DOI 10.1038/sj.cdd.4401522; Tsuchiya S, 2009, NUCLEIC ACIDS RES, V37, P3821, DOI 10.1093/nar/gkp255; Voellenkle C, 2012, RNA, V18, P472, DOI 10.1261/rna.027615.111; Yang W, 2012, EXP CELL RES, V318, P944, DOI 10.1016/j.yexcr.2012.02.010; Yoshioka Y, 2012, J BIOL CHEM, V287, P34110, DOI 10.1074/jbc.M112.356717; Zaccagnini G, 2007, J BIOL CHEM, V282, P31453, DOI 10.1074/jbc.M702511200; Zhang Y, 2012, J CELL MOL MED, V16, P249, DOI 10.1111/j.1582-4934.2011.01291.x; Zhang Z, 2009, CELL CYCLE, V8, P2756, DOI 10.4161/cc.8.17.9387	53	78	83	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44761	44771		10.1074/jbc.M112.421255	http://dx.doi.org/10.1074/jbc.M112.421255			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23148210	hybrid, Green Published			2022-12-28	WOS:000312938600070
J	Mishra, AK; Alves, JE; Krumbach, K; Nigou, J; Castro, AG; Geurtsen, J; Eggeling, L; Saraiva, M; Besra, GS				Mishra, Arun K.; Alves, Joana E.; Krumbach, Karin; Nigou, Jerome; Castro, Antonio G.; Geurtsen, Jeroen; Eggeling, Lothar; Saraiva, Margarida; Besra, Gurdyal S.			Differential Arabinan Capping of Lipoarabinomannan Modulates Innate Immune Responses and Impacts T Helper Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CORYNEBACTERIUM-GLUTAMICUM; BIOSYNTHESIS; IDENTIFICATION; INFECTION; TLR2; RECOGNITION; LIPOMANNANS; LIPOGLYCANS; MICE	Toll-like receptors (TLRs) recognize pathogens by interacting with pathogen-associated molecular patterns, such as the phosphatidylinositol-based lipoglycans, lipomannan (LM) and lipoarabinomannan (LAM). Such structures are present in several pathogens, including Mycobacterium tuberculosis, being important for the initiation of immune responses. It is well established that the interaction of LM and LAM with TLR2 is a process dependent on the structure of the ligands. However, the implications of structural variations on TLR2 ligands for the development of T helper (Th) cell responses or in the context of in vivo responses are less studied. Herein, we used Corynebacterium glutamicum as a source of lipoglycan intermediates for host interaction studies. In this study, we have deleted a putative glycosyltransferase, NCgl2096, from C. glutamicum and found that it encodes for a novel alpha(1 -> 2) arabinofuranosyltransferase, AftE. Biochemical analysis of the lipoglycans obtained in the presence (wild type) or absence of NCgl2096 showed that AftE is involved in the biosynthesis of singular arabinans of LAM. In its absence, the resulting molecule is a hypermannosylated (hLM) form of LAM. Both LAM and hLM were recognized by dendritic cells, mainly via TLR2, and triggered the production of several cytokines. hLM was a stronger stimulus for in vitro cytokine production and, as a result, a more potent inducer of Th17 responses. In vivo data confirmed hLM as a stronger inducer of cytokine responses and suggested the involvement of pattern recognition receptors other than TLR2 as sensors for lipoglycans.	[Mishra, Arun K.; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Alves, Joana E.; Castro, Antonio G.; Saraiva, Margarida; Besra, Gurdyal S.] Univ Minho, Life & Hlth & Sci Res Inst, P-4710057 Braga, Portugal; [Alves, Joana E.; Castro, Antonio G.; Saraiva, Margarida; Besra, Gurdyal S.] ICVS 3Bs PT Govt Associate Lab, P-4710057 Braga, Portugal; [Krumbach, Karin; Eggeling, Lothar] Res Ctr Juelich, Inst Biotechnol 1, D-52425 Julich, Germany; [Nigou, Jerome] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Nigou, Jerome] Univ Toulouse 3, Univ Toulouse, Inst Pharmacol & Biol Struct, F-31062 Toulouse, France; [Geurtsen, Jeroen] VU, Med Ctr, Dept Med Microbiol & Infect Control, NL-1081 BT Amsterdam, Netherlands	University of Birmingham; Universidade do Minho; Helmholtz Association; Research Center Julich; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Vrije Universiteit Amsterdam	Saraiva, M (corresponding author), Univ Minho, Life & Hlth & Sci Res Inst, P-4710057 Braga, Portugal.	msaraiva@ecsaude.uminho.pt; g.besra@bham.ac.uk	Castro, Gil/T-7584-2018; Alves, Joana EV/J-6866-2013; Nigou, Jérôme/D-6802-2019; Saraiva, Margarida/E-8781-2011	Castro, Gil/0000-0002-4684-4183; Alves, Joana EV/0000-0003-3131-9834; Nigou, Jérôme/0000-0002-6233-2487; Besra, Gurdyal/0000-0002-5605-0395; Saraiva, Margarida/0000-0002-8180-1293	Fundacao para a Ciencia e Tecnologia (FCT), Portugal [PTDC/SAU-MII/101977/2008, PTDC/BIA-BCM/102776/2008]; Netherlands Organization for Scientific Research (NWO) [016.101.001]; Personal Research Chair from James Bardrick; Royal Society Wolfson Research Merit Award; Lister Institute-Jenner research fellowship; Medical Research Council; Wellcome Trust Grant [081569/Z/06/Z]; Medical Research Council [G0901690] Funding Source: researchfish; MRC [G0901690] Funding Source: UKRI	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Personal Research Chair from James Bardrick; Royal Society Wolfson Research Merit Award(Royal Society of London); Lister Institute-Jenner research fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Grant(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by Fundacao para a Ciencia e Tecnologia (FCT), Portugal, Personal Grant PTDC/SAU-MII/101977/2008.; Supported by the Netherlands Organization for Scientific Research (NWO) through a VENI research grant (016.101.001).; Supported by FCT, Portugal, Project Grant PTDC/BIA-BCM/102776/2008. A Ciencia 2007 fellow.; Supported by a Personal Research Chair from James Bardrick, a Royal Society Wolfson Research Merit Award, a Lister Institute-Jenner research fellowship, the Medical Research Council, and Wellcome Trust Grant 081569/Z/06/Z.	Alderwick LJ, 2007, BIOCHEM SOC T, V35, P1325, DOI 10.1042/BST0351325; Alderwick LJ, 2006, GLYCOBIOLOGY, V16, P1073, DOI 10.1093/glycob/cwl030; Alderwick LJ, 2006, J BIOL CHEM, V281, P15653, DOI 10.1074/jbc.M600045200; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Birch HL, 2010, P NATL ACAD SCI USA, V107, P2634, DOI 10.1073/pnas.0915082107; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200; Geurtsen J, 2009, J IMMUNOL, V183, P5221, DOI 10.4049/jimmunol.0900768; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Holscher C, 2008, EUR J IMMUNOL, V38, P680, DOI 10.1002/eji.200736458; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Jang S, 2004, J IMMUNOL, V173, P3392, DOI 10.4049/jimmunol.173.5.3392; Jankute M, 2012, FUTURE MICROBIOL, V7, P129, DOI [10.2217/fmb.11.123, 10.2217/FMB.11.123]; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kaur D, 2008, P NATL ACAD SCI USA, V105, P17973, DOI 10.1073/pnas.0807761105; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kirschner DE, 2010, CURR OPIN BIOTECH, V21, P524, DOI 10.1016/j.copbio.2010.06.002; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Krishna S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028476; Mazzoni A, 2004, J LEUKOCYTE BIOL, V75, P721, DOI 10.1189/jlb.1003482; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mishra AK, 2008, MOL MICROBIOL, V68, P1595, DOI 10.1111/j.1365-2958.2008.06265.x; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Mishra AK, 2011, MOL MICROBIOL, V80, P1241, DOI 10.1111/j.1365-2958.2011.07640.x; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Mishra AK, 2009, J BACTERIOL, V191, P4465, DOI 10.1128/JB.01729-08; Nigou J, 2003, BIOCHIMIE, V85, P153, DOI 10.1016/S0300-9084(03)00048-8; Nigou J, 2008, J IMMUNOL, V180, P6696, DOI 10.4049/jimmunol.180.10.6696; O'Garra A, 2004, ADV IMMUNOL, V83, P133; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Pitarque S, 2008, TUBERCULOSIS, V88, P560, DOI 10.1016/j.tube.2008.04.002; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Seidel M, 2007, GLYCOBIOLOGY, V17, P210, DOI 10.1093/glycob/cwl066; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Sugawara I, 2003, MICROBIOL IMMUNOL, V47, P327, DOI 10.1111/j.1348-0421.2003.tb03404.x; Tatituri RVV, 2007, J BIOL CHEM, V282, P4561, DOI 10.1074/jbc.M608695200; Tatituri RVV, 2007, MICROBIOL-SGM, V153, P2621, DOI 10.1099/mic.0.2007/008078-0; Teixeira-Coelho M, 2011, INT IMMUNOL, V23, P89, DOI 10.1093/intimm/dxq459; Torrelles JB, 2008, J BIOL CHEM, V283, P31417, DOI 10.1074/jbc.M806350200; Torrelles JB, 2011, J BIOL CHEM, V286, P35438, DOI 10.1074/jbc.M111.232587; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Vignal C, 2003, J IMMUNOL, V171, P2014, DOI 10.4049/jimmunol.171.4.2014	53	14	14	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44173	44183		10.1074/jbc.M112.402396	http://dx.doi.org/10.1074/jbc.M112.402396			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144457	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000312938600016
J	Sukumaran, P; Lof, C; Kemppainen, K; Kankaanpaa, P; Pulli, I; Nasman, J; Viitanen, T; Tornquist, K				Sukumaran, Pramod; Lof, Christoffer; Kemppainen, Kati; Kankaanpaa, Pasi; Pulli, Ilari; Nasman, Johnny; Viitanen, Tero; Tornquist, Kid			Canonical Transient Receptor Potential Channel 2 (TRPC2) as a Major Regulator of Calcium Homeostasis in Rat Thyroid FRTL-5 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CATION CHANNEL; PATCH-CLAMP; CA2+ ENTRY; STIM1; THYROTROPIN; MECHANISM; STIMULATION; RETICULUM; BINDING	Mammalian non-selective transient receptor potential cation channels (TRPCs) are important in the regulation of cellular calcium homeostasis. In thyroid cells, including rat thyroid FRTL-5 cells, calcium regulates a multitude of processes. RT-PCR screening of FRTL-5 cells revealed the presence of TRPC2 channels only. Knockdown of TRPC2 using shRNA (shTRPC2) resulted in decreased ATP-evoked calcium peak amplitude and inward current. In calcium-free buffer, there was no difference in the ATP-evoked calcium peak amplitude between control cells and shTRPC2 cells. Store-operated calcium entry was indistinguishable between the two cell lines. Basal calcium entry was enhanced in shTRPC2 cells, whereas the level of PKC beta 1 andPKC delta, the activity of sarco/endoplasmic reticulum Ca2+-ATPase, and the calcium content in the endoplasmic reticulum were decreased. Stromal interaction molecule (STIM) 2, but not STIM1, was arranged in puncta in resting shTRPC2 cells but not in control cells. Phosphorylation site Orai1 S27A/S30A mutant and non-functional Orai1 R91W attenuated basal calcium entry in shTRPC2 cells. Knockdown of PKC delta with siRNA increased STIM2 punctum formation and enhanced basal calcium entry but decreased sarco/endoplasmic reticulum Ca2+-ATPase activity in wild-type cells. Transfection of a truncated, non-conducting mutant of TRPC2 evoked similar results. Thus, TRPC2 functions as a major regulator of calcium homeostasis in rat thyroid cells.	[Sukumaran, Pramod; Lof, Christoffer; Kemppainen, Kati; Pulli, Ilari; Nasman, Johnny; Tornquist, Kid] Abo Akad Univ, Dept Biosci, FIN-20520 Turku, Finland; [Lof, Christoffer] Turku Doctoral Programme Biomed Sci, Turku 20520, Finland; [Kankaanpaa, Pasi] Univ Turku, Dept Biochem & Food Chem, FI-20014 Turku, Finland; [Viitanen, Tero] Univ Helsinki, Inst Biomed Physiol, FIN-00014 Helsinki, Finland; [Viitanen, Tero; Tornquist, Kid] Biomedicum Helsinki, Minerva Fdn Inst Med Res, Helsinki 00270, Finland	Abo Akademi University; University of Turku; University of Helsinki; University of Helsinki	Tornquist, K (corresponding author), Abo Akad Univ, Dept Biosci, Tykistokatu 6A, FIN-20520 Turku, Finland.	ktornqvi@abo.fi		Pulli, Ilari/0000-0002-4785-8253; Sukumaran, Pramod/0000-0002-4781-3389; Lof, Christoffer/0000-0002-7149-5528; Kemppainen, Kati/0000-0003-3785-2269	Academy of Finland; Sigrid Juselius Foundation; Centre of Excellence in Cell Stress and Molecular Ageing (Abo Akademi University); Magnus Ehrnrooth Foundation; Receptor Research Program (Abo Akademi University and University of Turku)	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Centre of Excellence in Cell Stress and Molecular Ageing (Abo Akademi University); Magnus Ehrnrooth Foundation; Receptor Research Program (Abo Akademi University and University of Turku)	This work was supported by the Academy of Finland, the Sigrid Juselius Foundation, the Centre of Excellence in Cell Stress and Molecular Ageing (Abo Akademi University), the Magnus Ehrnrooth Foundation, and the Receptor Research Program (Abo Akademi University and University of Turku).	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Alvarez J, 2008, AM J PHYSIOL-HEART C, V295, pH21, DOI 10.1152/ajpheart.00135.2008; Arruda AP, 2007, BBA-BIOMEMBRANES, V1768, P1498, DOI 10.1016/j.bbamem.2007.03.016; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; BERMAN MI, 1987, MOL CELL ENDOCRINOL, V54, P151, DOI 10.1016/0303-7207(87)90152-3; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chu X, 2005, CELL CALCIUM, V37, P173, DOI 10.1016/j.ceca.2004.08.005; Chu X, 2002, J BIOL CHEM, V277, P34375, DOI 10.1074/jbc.M205541200; Churchill EN, 2009, TRENDS ENDOCRIN MET, V20, P25, DOI 10.1016/j.tem.2008.10.002; CORDA D, 1985, J BIOL CHEM, V260, P9230; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Di Jeso B, 1998, EUR J BIOCHEM, V252, P583, DOI 10.1046/j.1432-1327.1998.2520583.x; Dietrich A, 2005, N-S ARCH PHARMACOL, V371, P257, DOI 10.1007/s00210-005-1052-8; Ekokoski E, 2001, J CELL PHYSIOL, V187, P166, DOI 10.1002/jcp.1070; Grasberger H, 2007, J CLIN ENDOCR METAB, V92, P2816, DOI 10.1210/jc.2007-0366; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Kawasaki T, 2010, J BIOL CHEM, V285, P25720, DOI 10.1074/jbc.M109.022996; Larsen AH, 2001, BMC BIOCHEM, V2; Larsson KP, 2005, J BIOL CHEM, V280, P1771, DOI 10.1074/jbc.M406073200; Liman ER, 2003, J PHYSIOL-LONDON, V548, P777, DOI 10.1113/jphysiol.2002.037119; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XB, 2000, J BIOL CHEM, V275, P3403, DOI 10.1074/jbc.275.5.3403; Lof C, 2008, J CELL PHYSIOL, V216, P245, DOI 10.1002/jcp.21396; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; Mast TG, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-61; McCollum AT, 2004, J NEUROSCI RES, V76, P104, DOI 10.1002/jnr.20059; OKAJIMA F, 1987, J BIOL CHEM, V262, P13483; Okajima F, 1997, ENDOCRINOLOGY, V138, P220, DOI 10.1210/en.138.1.220; Pozo-Guisado E, 2010, J CELL SCI, V123, P3084, DOI 10.1242/jcs.067215; RASPE E, 1991, MOL CELL ENDOCRINOL, V81, P175, DOI 10.1016/0303-7207(91)90216-F; Rivas M, 2004, J BIOL CHEM, V279, P33114, DOI 10.1074/jbc.M403526200; SAJI M, 1991, BIOCHEM BIOPH RES CO, V176, P94, DOI 10.1016/0006-291X(91)90894-D; Salido GM, 2009, BBA-MOL CELL RES, V1793, P223, DOI 10.1016/j.bbamcr.2008.11.001; SHO K, 1991, J BIOL CHEM, V266, P12180; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stiber JA, 2008, MOL CELL BIOL, V28, P2637, DOI 10.1128/MCB.01601-07; Sukumaran P., 2012, MOL ENDOCRI IN PRESS; Sutton KA, 2004, DEV BIOL, V274, P426, DOI 10.1016/j.ydbio.2004.07.031; Tong Q, 2004, AM J PHYSIOL-CELL PH, V287, pC1667, DOI 10.1152/ajpcell.00265.2004; TORNQUIST K, 1993, BIOCHEM J, V290, P443; Tornquist K, 1997, ENDOCRINOLOGY, V138, P4049, DOI 10.1210/en.138.10.4049; Tornquist K, 1996, J CELL PHYSIOL, V166, P241; TORNQUIST K, 1992, J CELL PHYSIOL, V150, P90, DOI 10.1002/jcp.1041500113; Villereal ML, 2006, SEMIN CELL DEV BIOL, V17, P618, DOI 10.1016/j.semcdb.2006.10.010; Wang L, 2011, MOL CANCER THER, V10, P461, DOI 10.1158/1535-7163.MCT-10-0812; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; Yildirim E, 2003, P NATL ACAD SCI USA, V100, P2220, DOI 10.1073/pnas.0438036100; Yildirim E., 2007, V179, P53; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200	59	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44345	44360		10.1074/jbc.M112.374348	http://dx.doi.org/10.1074/jbc.M112.374348			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144458	Green Published, hybrid			2022-12-28	WOS:000312938600032
J	Muller, JR; Waldmann, TA; Kruhlak, MJ; Dubois, S				Mueller, Juergen R.; Waldmann, Thomas A.; Kruhlak, Michael J.; Dubois, Sigrid			Paracrine and Transpresentation Functions of IL-15 Are Mediated by Diverse Splice Versions of IL-15R alpha in Human Monocytes and Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ALPHA-CHAIN; NATURAL-KILLER; CUTTING EDGE; T-CELLS; EXPRESSION; INTERLEUKIN-15; GLYCOSYLATION; TRANS; NK; PROLIFERATION	Species-specific differences of post-translational modifications suggested the existence of human IL-15R alpha isoforms. We identified eight new isoforms that are predicted to modify the intracellular C termini of IL-15R alpha, and another N-terminal exon "Ex2A" that was consistently present in all but one of the C-terminal isoforms. Ex2A encodes a 49-amino acid domain that allowed the transfer of IL-15/IL-15R alpha complex to the cell surface but prevented its cleavage from cell membranes and its secretion thus facilitating the transpresentation of IL-15 as part of the immunological synapse. The Ex2A domain also affected the O-glycosylation of IL-15R alpha that explained the species-specific differences. The Ex2A domain appeared to be removed from major IL-15R alpha species during protein maturation, but both Ex2A and IL-15R alpha appeared on the surface of monocytic cells upon activation. The membrane-associated form of the only C-terminal isoform that lacked Ex2A (IC3) was retained inside the cell, but soluble IL-15/IL-15R alpha complexes were readily released from cells that expressed IL-15/IL-15R alpha-IC3 thus limiting this IL-15/IL-15R alpha isoform to act as a secreted molecule. These data suggest that splice versions of IL-15R alpha determine the range of IL-15 activities.	[Mueller, Juergen R.; Waldmann, Thomas A.; Dubois, Sigrid] NCI, Metab Branch, NIH, Bethesda, MD 20892 USA; [Kruhlak, Michael J.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dubois, S (corresponding author), NCI, Metab Branch, NIH, Bldg 10,Rm 4B47,10 Ctr Dr, Bethesda, MD 20892 USA.	duboiss@mail.nih.gov	Waldmann, Thomas/AAT-5972-2021	Waldmann, Thomas/0000-0003-4500-6660; Dubois, Sigrid/0000-0002-4543-5222	NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIASC004002, ZICBC010915] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural research program of the NCI, National Institutes of Health.	ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; Baum LG, 2002, IMMUNITY, V16, P5, DOI 10.1016/S1074-7613(02)00265-0; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Burkett PR, 2003, P NATL ACAD SCI USA, V100, P4724, DOI 10.1073/pnas.0737048100; Dubois S, 1999, J BIOL CHEM, V274, P26978, DOI 10.1074/jbc.274.38.26978; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; Dubois SP, 2005, P NATL ACAD SCI USA, V102, P8662, DOI 10.1073/pnas.0503360102; Freeze H H, 2001, Curr Protoc Cell Biol, VChapter 15, DOI 10.1002/0471143030.cb1502s03; Horng T, 2007, NAT IMMUNOL, V8, P1345, DOI 10.1038/ni1524; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Koka R, 2004, J IMMUNOL, V173, P3594, DOI 10.4049/jimmunol.173.6.3594; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Mariner JM, 2002, J IMMUNOL, V168, P5667, DOI 10.4049/jimmunol.168.11.5667; Mariner JM, 2001, J IMMUNOL, V166, P2602, DOI 10.4049/jimmunol.166.4.2602; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Mortier E, 2004, J IMMUNOL, V173, P1681, DOI 10.4049/jimmunol.173.3.1681; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Mortier E, 2009, IMMUNITY, V31, P811, DOI 10.1016/j.immuni.2009.09.017; Orinska Z, 2007, NAT MED, V13, P927, DOI 10.1038/nm1615; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Sandau MM, 2004, J IMMUNOL, V173, P6537, DOI 10.4049/jimmunol.173.11.6537; Schluns KS, 2004, BLOOD, V103, P988, DOI 10.1182/blood-2003-08-2814; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Yokoyama Wayne M, 2006, Curr Protoc Immunol, VChapter 2, DOI 10.1002/0471142735.im0205s74	35	16	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40328	40338		10.1074/jbc.M112.378612	http://dx.doi.org/10.1074/jbc.M112.378612			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23074221	Green Published, hybrid			2022-12-28	WOS:000311448800024
J	Tong, XJ; Xia, ZD; Zu, Y; Telfer, H; Hu, J; Yu, JY; Liu, H; Zhang, Q; Sodmergen; Lin, S; Zhang, B				Tong, Xiangjun; Xia, Zhidan; Zu, Yao; Telfer, Helena; Hu, Jing; Yu, Jingyi; Liu, Huan; Zhang, Quan; Sodmergen; Lin, Shuo; Zhang, Bo			ngs (Notochord Granular Surface) Gene Encodes a Novel Type of Intermediate Filament Family Protein Essential for Notochord Maintenance in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; MUTATIONS; DISEASE; EMBRYO; CELLS; GFAP	The notochord is an important organ involved in embryonic patterning and locomotion. In zebrafish, the mature notochord consists of a single stack of fully differentiated, large vacuolated cells called chordocytes, surrounded by a single layer of less differentiated notochordal epithelial cells called chordoblasts. Through genetic analysis of zebrafish lines carrying pseudo-typed retroviral insertions, a mutant exhibiting a defective notochord with a granular appearance was isolated, and the corresponding gene was identified as ngs (notochord granular surface), which was specifically expressed in the notochord. In the mutants, the notochord started to degenerate from 32 hours post-fertilization, and the chordocytes were then gradually replaced by smaller cells derived from chordoblasts. The granular notochord phenotype was alleviated by anesthetizing the mutant embryos with tricaine to prevent muscle contraction and locomotion. Phylogenetic analysis showed that ngs encodes a new type of intermediate filament (IF) family protein, which we named chordostatin based on its function. Under the transmission electron microcopy, bundles of 10-nm-thick IF-like filaments were enriched in the chordocytes of wild-type zebrafish embryos, whereas the chordocytes in ngs mutants lacked IF-like structures. Furthermore, chordostatin-enhanced GFP (EGFP) fusion protein assembled into a filamentous network specifically in chordocytes. Taken together, our work demonstrates that ngs encodes a novel type of IF protein and functions to maintain notochord integrity for larval development and locomotion. Our work sheds light on the mechanisms of notochord structural maintenance, as well as the evolution and biological function of IF family proteins.	[Tong, Xiangjun; Xia, Zhidan; Zu, Yao; Hu, Jing; Yu, Jingyi; Liu, Huan; Zhang, Quan; Sodmergen; Zhang, Bo] Peking Univ, Coll Life Sci, Ctr Dev Biol & Genet, Minist Educ,Key Lab Cell Proliferat & Differentia, Beijing 100871, Peoples R China; [Zu, Yao] Hebei Univ, Coll Life Sci, Baoding 071002, Hebei Province, Peoples R China; [Telfer, Helena] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	Peking University; Hebei University; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles	Zhang, B (corresponding author), Peking Univ, Coll Life Sci, Ctr Dev Biol & Genet, Minist Educ,Key Lab Cell Proliferat & Differentia, Yiheyuan Rd 5, Beijing 100871, Peoples R China.	bzhang@pku.edu.cn		Zu, Yao/0000-0001-8081-9136	National Natural Science Foundation of China [30871418, 31110103904, 30730056]; 973 Program [2012CB945101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30871418, 31110103904, and 30730056 and 973 Program Grant 2012CB945101.	ADAMS DS, 1990, DEVELOPMENT, V110, P115; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; Bartels H, 1998, J ELECTRON MICROSC, V47, P627, DOI 10.1093/oxfordjournals.jmicro.a023636; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Cao TY, 2001, J CELL BIOL, V152, P651, DOI 10.1083/jcb.152.3.651; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; Coutinho P, 2004, DEV CELL, V7, P547, DOI 10.1016/j.devcel.2004.07.020; Erber A, 1998, J MOL EVOL, V47, P751, DOI 10.1007/PL00006434; Fouquet B, 1997, DEV BIOL, V183, P37, DOI 10.1006/dbio.1996.8495; Glickman NS, 2003, DEVELOPMENT, V130, P873, DOI 10.1242/dev.00314; Goldstein AM, 1998, DEV BIOL, V201, P247, DOI 10.1006/dbio.1998.8976; GOTZ W, 1995, CELL TISSUE RES, V280, P455; Grotmol S, 2005, J ANAT, V206, P427, DOI 10.1111/j.1469-7580.2005.00408.x; Grotmol S, 2006, J ANAT, V209, P339, DOI 10.1111/j.1469-7580.2006.00618.x; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; Li R, 2002, INT J DEV NEUROSCI, V20, P259, DOI 10.1016/S0736-5748(02)00019-9; McGowan KM, 2002, GENE DEV, V16, P1412, DOI 10.1101/gad.979502; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL, P7; Odenthal J, 1996, DEVELOPMENT, V123, P103; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Parsons MJ, 2002, DEVELOPMENT, V129, P3137; Platz F, 2006, ANN ANAT, V188, P289, DOI 10.1016/j.aanat.2006.01.009; Schmitz RJ, 1998, J MORPHOL, V236, P105, DOI 10.1002/(SICI)1097-4687(199805)236:2<105::AID-JMOR2>3.0.CO;2-4; Schmitz RJ, 1998, J MORPHOL, V236, P75, DOI 10.1002/(SICI)1097-4687(199805)236:2<75::AID-JMOR1>3.0.CO;2-N; Stehr CM, 2006, TOXICOL SCI, V92, P270, DOI 10.1093/toxsci/kfj185; Stemple DL, 2004, CURR BIOL, V14, pR873, DOI 10.1016/j.cub.2004.09.065; Stemple DL, 1996, DEVELOPMENT, V123, P117; Tada M, 2005, CURR BIOL, V15, pR14, DOI 10.1016/j.cub.2004.12.011; VENETIANER A, 1983, NATURE, V305, P730, DOI 10.1038/305730a0; Wang DW, 2007, P NATL ACAD SCI USA, V104, P12428, DOI 10.1073/pnas.0705502104; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE	36	5	5	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2711	2720		10.1074/jbc.M112.379172	http://dx.doi.org/10.1074/jbc.M112.379172			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23132861	Green Published, hybrid			2022-12-28	WOS:000314211500055
J	Luo, SL; Zhangsun, DT; Wu, Y; Zhu, XP; Hu, YY; McIntyre, M; Christensen, S; Akcan, M; Craik, DJ; McIntosh, JM				Luo, Sulan; Zhangsun, Dongting; Wu, Yong; Zhu, Xiaopeng; Hu, Yuanyan; McIntyre, Melissa; Christensen, Sean; Akcan, Muharrem; Craik, David J.; McIntosh, J. Michael			Characterization of a Novel alpha-Conotoxin from Conus textile That Selectively Targets alpha 6/alpha 3 beta 2 beta 3 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENTRAL TEGMENTAL AREA; SUBUNIT COMPOSITION; PEPTIDE; BLOCKS; MII; STIMULATION; INHIBITION; EXPRESSION; SUBTYPES	alpha 6 beta 2 Nicotinic acetylcholine receptors (nAChRs) expressed by dopaminergic neurons in the CNS are potential therapeutic targets for the treatment of several neuropsychiatric diseases, including nicotine addiction and Parkinson disease. However, recent studies indicate that the alpha 6 subunit can also associate with the beta 4 subunit to form alpha 6 beta 4 nAChRs that are difficult to pharmacologically distinguish from alpha 6 beta 2, alpha 3 beta 4, and alpha 3 beta 2 subtypes. The current study characterized a novel 16-amino acid alpha-conotoxin (alpha-CTx) TxIB from Conus textile whose sequence is GCCSDPPCRNKHPDLC-amide as deduced from gene cloning. The peptide and an analog with an additional C-terminal glycine were chemically synthesized and tested on rat nAChRs heterologously expressed in Xenopus laevis oocytes. alpha-CTx TxIB blocked alpha 6/alpha 3 beta 2 beta 3 nAChR with an IC50 of 28 nM. In contrast, the peptide showed little or no block of other tested subtypes at concentrations up to 10 mu M. The three-dimensional solution structure of alpha-CTx TxIB was determined using NMR spectroscopy. alpha-CTx TxIB represents a uniquely selective ligand for probing the structure and function of alpha 6 beta 2 nAChRs.	[Luo, Sulan; Zhangsun, Dongting; Wu, Yong; Zhu, Xiaopeng; Hu, Yuanyan] Hainan Univ, Minist Educ, Key Lab Trop Biol Resources, Key Lab Marine Drug Haikou, Haikou Hainan 570228, Peoples R China; [McIntyre, Melissa; Christensen, Sean; McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [McIntyre, Melissa; Christensen, Sean; McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA; [Akcan, Muharrem; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Hainan University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Queensland	Luo, SL (corresponding author), Hainan Univ, Minist Educ, Key Lab Trop Biol Resources, Key Lab Marine Drug Haikou, Haikou Hainan 570228, Peoples R China.	luosulan2003@163.com	Craik, David/B-1695-2010; Akcan, Muharrem/GRX-8850-2022; Akcan, Muharrem/F-8799-2013	Craik, David/0000-0003-0007-6796; Akcan, Muharrem/0000-0002-5208-9575; 	Program for International Science & Technology Cooperation Program of China [2011DFR31210]; National Natural Science Foundation of China [81160503]; State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China [2012AA021706]; Changjiang Scholars and Innovative Research Team in University Grant PCSIRT [IRT1123]; National Institutes of Health [GM103801, GM48677]; Australian Research Council [1093115]; National Health & Medical Research Council Professorial Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677, R01GM103801] Funding Source: NIH RePORTER	Program for International Science & Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China; Changjiang Scholars and Innovative Research Team in University Grant PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); National Health & Medical Research Council Professorial Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the Program for International Science & Technology Cooperation Program of China Grant 2011DFR31210, National Natural Science Foundation of China Grant 81160503, State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China Grant 2012AA021706, Changjiang Scholars and Innovative Research Team in University Grant PCSIRT, IRT1123. This work was also supported by National Institutes of Health Grants GM103801 and GM48677, and Australian Research Council Grant 1093115. D.J.C. acknowledges the support of a National Health & Medical Research Council Professorial Fellowship. Apreliminary account of some of this work was presented in the patent literature (51).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Azam L, 2005, J BIOL CHEM, V280, P80, DOI 10.1074/jbc.M406281200; Azam L, 2002, J COMP NEUROL, V444, P260, DOI 10.1002/cne.10138; Azam L, 2010, FASEB J, V24, P5113, DOI 10.1096/fj.10-166272; Azam L, 2009, ACTA PHARMACOL SIN, V30, P771, DOI 10.1038/aps.2009.47; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunzell DH, 2010, NEUROPSYCHOPHARMACOL, V35, P665, DOI 10.1038/npp.2009.171; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dowell C, 2003, J NEUROSCI, V23, P8445; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Ellison M, 2006, BIOCHEMISTRY-US, V45, P1511, DOI 10.1021/bi0520129; Exley R, 2008, NEUROPSYCHOPHARMACOL, V33, P2158, DOI 10.1038/sj.npp.1301617; FAINZILBER M, 1994, BIOCHEMISTRY-US, V33, P9523, DOI 10.1021/bi00198a018; Gehrmann J, 1998, J MOL BIOL, V278, P401, DOI 10.1006/jmbi.1998.1701; Grady SR, 2007, BIOCHEM PHARMACOL, V74, P1235, DOI 10.1016/j.bcp.2007.07.032; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Harvey SC, 1997, MOL PHARMACOL, V51, P336, DOI 10.1124/mol.51.2.336; Hone AJ, 2012, FASEB J, V26, P917, DOI 10.1096/fj.11-195883; Jackson KJ, 2009, J PHARMACOL EXP THER, V331, P547, DOI 10.1124/jpet.109.155457; Kaiser SA, 1998, J NEUROCHEM, V70, P1069; Klimis H, 2011, PAIN, V152, P259, DOI 10.1016/j.pain.2010.09.007; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Korn D., 1995, MANUAL LIVING CONIDA, P308; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Liu J, 2009, INVEST OPHTH VIS SCI, V50, P1408, DOI 10.1167/iovs.08-2398; Lof E, 2007, PSYCHOPHARMACOLOGY, V195, P333, DOI 10.1007/s00213-007-0899-4; Lopez-Vera E, 2007, FEBS J, V274, P3972, DOI 10.1111/j.1742-4658.2007.05931.x; Luo S., 2012, Chinese patent literature, Patent No. [CN(201210277619.8)-A, 2012102776198]; Luo SQ, 1998, J NEUROSCI, V18, P8571; Luo SL, 2010, J BIOL CHEM, V285, P12355, DOI 10.1074/jbc.M109.079012; Mackey EDW, 2012, J NEUROSCI, V32, P10226, DOI 10.1523/JNEUROSCI.0007-12.2012; Marritt AM, 2005, MOL PHARMACOL, V68, P1656, DOI 10.1124/mol.105.012380; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; McIntosh JM, 2002, J BIOL CHEM, V277, P33610, DOI 10.1074/jbc.M205102200; MCINTOSH M, 1982, ARCH BIOCHEM BIOPHYS, V218, P329, DOI 10.1016/0003-9861(82)90351-4; Muttenthaler M, 2011, CURR PHARM DESIGN, V17, P4226, DOI 10.2174/138161211798999384; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Papke RL, 2008, NEUROPHARMACOLOGY, V54, P1189, DOI 10.1016/j.neuropharm.2008.03.010; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Quik M, 2011, BIOCHEM PHARMACOL, V82, P873, DOI 10.1016/j.bcp.2011.06.001; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; Vailati S, 1999, MOL PHARMACOL, V56, P11, DOI 10.1124/mol.56.1.11; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yang KC, 2009, ACTA PHARMACOL SIN, V30, P740, DOI 10.1038/aps.2009.63; [郑晓冬 ZHENG Xiaodong], 2011, [生物技术, Biotechnology], V21, P40	49	46	56	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					894	902		10.1074/jbc.M112.427898	http://dx.doi.org/10.1074/jbc.M112.427898			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184959	Green Published, hybrid			2022-12-28	WOS:000313570300014
J	Xie, FQ; Wu, CG; Weiland, E; Lohman, TM				Xie, Fuqian; Wu, Colin G.; Weiland, Elizabeth; Lohman, Timothy M.			Asymmetric Regulation of Bipolar Single-stranded DNA Translocation by the Two Motors within Escherichia coli RecBCD Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; SITE-DIRECTED MUTAGENESIS; RECOMBINATION HOTSPOT CHI; CONSERVED LYSINE RESIDUE; RECA PROTEIN; HOMOLOGOUS RECOMBINATION; TURNOVER KINETICS; LOOP FORMATION; STEP-SIZE; ENZYME	Repair of double-stranded DNA breaks in Escherichia coli is initiated by the RecBCD helicase that possesses two superfamily-1 motors, RecB (3' to 5' translocase) and RecD (5' to 3' translocase), that operate on the complementary DNA strands to unwind duplex DNA. However, it is not known whether the RecB and RecD motors act independently or are functionally coupled. Here we show by directly monitoring ATP-driven single-stranded DNA translocation of RecBCD that the 5' to 3' rate is always faster than the 3' to 5' rate on DNA without a crossover hotspot instigator site and that the translocation rates are coupled asymmetrically. That is, RecB regulates both 3' to 5' and 5' to 3' translocation, whereas RecD only regulates 5' to 3' translocation. We show that the recently identified RecBC secondary translocase activity functions within RecBCD and that this contributes to the coupling. This coupling has implications for how RecBCD activity is regulated after it recognizes a crossover hotspot instigator sequence during DNA unwinding.	[Xie, Fuqian; Weiland, Elizabeth; Lohman, Timothy M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Wu, Colin G.] Univ Iowa, Dept Biochem, Iowa City, IA 52240 USA	Washington University (WUSTL); University of Iowa	Lohman, TM (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 S Euclid Ave,Box 8231, St Louis, MO 63110 USA.	lohman@biochem.wustl.edu			National Institutes of Health [GM045948]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM045948 (to T. M. L.).	AMUNDSEN SK, 1990, GENETICS, V126, P25; Amundsen SK, 2007, GENE DEV, V21, P3296, DOI 10.1101/gad.1605807; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENES CELLS, V2, P117, DOI 10.1046/j.1365-2443.1997.1130311.x; Arnold DA, 2000, J BIOL CHEM, V275, P12261, DOI 10.1074/jbc.275.16.12261; Bianco PR, 1997, P NATL ACAD SCI USA, V94, P6706, DOI 10.1073/pnas.94.13.6706; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dillingham MS, 2005, J BIOL CHEM, V280, P37069, DOI 10.1074/jbc.M505520200; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Farah JA, 1997, J MOL BIOL, V272, P699, DOI 10.1006/jmbi.1997.1259; FINCH PW, 1986, NUCLEIC ACIDS RES, V14, P8583, DOI 10.1093/nar/14.21.8583; FINCH PW, 1986, NUCLEIC ACIDS RES, V14, P8573, DOI 10.1093/nar/14.21.8573; Handa N, 2005, MOL CELL, V17, P745, DOI 10.1016/j.molcel.2005.02.011; HSIEH S, 1992, NUCLEIC ACIDS RES, V20, P5647, DOI 10.1093/nar/20.21.5647; KORANGY F, 1992, J BIOL CHEM, V267, P1727; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Lucius AL, 2004, J MOL BIOL, V339, P751, DOI 10.1016/j.jmb.2004.04.010; Lucius AL, 2004, J MOL BIOL, V339, P731, DOI 10.1016/j.jmb.2004.04.009; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; MASCOTTI DP, 1995, BIOCHEMISTRY-US, V34, P2908, DOI 10.1021/bi00009a022; Rigden DJ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-9; Saikrishnan K, 2008, EMBO J, V27, P2222, DOI 10.1038/emboj.2008.144; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Smith GR, 2012, MICROBIOL MOL BIOL R, V76, P217, DOI 10.1128/MMBR.05026-11; SMITH GR, 1989, GENOME, V31, P520, DOI 10.1139/g89-100; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Spies M, 2005, J BIOL CHEM, V280, P37078, DOI 10.1074/jbc.M505521200; Spies M, 2007, CELL, V131, P694, DOI 10.1016/j.cell.2007.09.023; TAYLOR AF, 1995, J BIOL CHEM, V270, P24451, DOI 10.1074/jbc.270.41.24451; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; Tomko EJ, 2010, METHODS, V51, P269, DOI 10.1016/j.ymeth.2010.03.010; Williams DJ, 2000, METHOD ENZYMOL, V321, P330; Wong CJ, 2008, J MOL BIOL, V378, P761, DOI 10.1016/j.jmb.2008.03.023; Wong CJ, 2006, J MOL BIOL, V362, P26, DOI 10.1016/j.jmb.2006.07.016; Wong CJ, 2005, J MOL BIOL, V352, P765, DOI 10.1016/j.jmb.2005.07.056; Wu CG, 2008, J MOL BIOL, V382, P312, DOI 10.1016/j.jmb.2008.07.012; Wu CG, 2012, J MOL BIOL, V423, P303, DOI 10.1016/j.jmb.2012.07.009; Wu CG, 2010, NAT STRUCT MOL BIOL, V17, P1210, DOI 10.1038/nsmb.1901; Yu M, 1998, J MOL BIOL, V283, P797, DOI 10.1006/jmbi.1998.2127	41	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1055	1064		10.1074/jbc.M112.423384	http://dx.doi.org/10.1074/jbc.M112.423384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23192341	hybrid, Green Published			2022-12-28	WOS:000313570300029
J	Besteiro, MAG; Ulm, R				Besteiro, Marina A. Gonzalez; Ulm, Roman			Phosphorylation and Stabilization of Arabidopsis MAP Kinase Phosphatase 1 in Response to UV-B Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIFICITY PROTEIN PHOSPHATASE; SALICYLIC-ACID; PHOSPHOPROTEOMIC ANALYSIS; GENE-EXPRESSION; THALIANA; ACTIVATION; CALMODULIN; YEAST; IDENTIFICATION; TRANSCRIPTION	MAP kinase phosphatases (MKPs) are important regulators of the activation levels and kinetics of MAP kinases. This is crucial for a large number of physiological processes during development and growth, as well as interactions with the environment, including the response to ultraviolet-B (UV-B) stress. Arabidopsis MKP1 is a key regulator of MAP kinases MPK3 and MPK6 in response to UV-B stress. However, virtually nothing is presently known about the post-translational regulation of plant MKPs in vivo. Here, we provide evidence that MKP1 is a phosphoprotein in vivo and that MKP1 accumulates in response to UV-B stress. Moreover, proteasome inhibitor experiments suggest that MKP1 is constantly turned-over under non-stress conditions and that MKP1 is stabilized upon stress treatment. Stress-responsive phosphorylation and stabilization of MKP1 demonstrate the post-translational regulation of a plant MKP in vivo, adding an additional regulatory layer to MAP kinase signaling in plants.	[Besteiro, Marina A. Gonzalez; Ulm, Roman] Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva 4, Switzerland; [Besteiro, Marina A. Gonzalez] Univ Freiburg, Inst Biol 2, Fac Biol, D-79104 Freiburg, Germany; [Besteiro, Marina A. Gonzalez] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany	University of Geneva; University of Freiburg; University of Freiburg	Ulm, R (corresponding author), Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva 4, Switzerland.	roman.ulm@unige.ch		Gonzalez Besteiro, Marina Alejandra/0000-0002-9269-792X	Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School); Emmy Noether Programme; Swiss National Science Foundation	Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School); Emmy Noether Programme(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School), the Emmy Noether Programme, and the Swiss National Science Foundation.	Anderson JR, 2011, PSYCHOL REV, V118, P1, DOI 10.1037/a0022225; Bartels S, 2010, TRENDS PLANT SCI, V15, P322, DOI 10.1016/j.tplants.2010.04.003; Bartels S, 2009, PLANT CELL, V21, P2884, DOI 10.1105/tpc.109.067678; Besteiro MAG, 2011, PLANT J, V68, P727, DOI 10.1111/j.1365-313X.2011.04725.x; Bethke G, 2012, MOL PLANT MICROBE IN, V25, P471, DOI 10.1094/MPMI-11-11-0281; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Durek P, 2010, NUCLEIC ACIDS RES, V38, pD828, DOI 10.1093/nar/gkp810; Flandez M, 2004, J BIOL CHEM, V279, P11027, DOI 10.1074/jbc.M306412200; Heazlewood JL, 2008, NUCLEIC ACIDS RES, V36, pD1015, DOI 10.1093/nar/gkm812; Jones AME, 2009, J PROTEOMICS, V72, P439, DOI 10.1016/j.jprot.2009.02.004; Kalbina I, 2006, PLANT CELL ENVIRON, V29, P1783, DOI 10.1111/j.1365-3040.2006.01555.x; Katou S, 2005, J BIOL CHEM, V280, P39569, DOI 10.1074/jbc.M508115200; Katou S, 2007, PLANT CELL PHYSIOL, V48, P332, DOI 10.1093/pcp/pcm007; Lee K, 2008, J BIOL CHEM, V283, P23581, DOI 10.1074/jbc.M801549200; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; Li H, 2009, PROTEOMICS, V9, P1646, DOI 10.1002/pmic.200800420; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Park HC, 2011, PLANT CELL REP, V30, P1523, DOI 10.1007/s00299-011-1064-4; Peck SC, 2006, PLANT J, V45, P512, DOI 10.1111/j.1365-313X.2005.02613.x; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Safrany J, 2008, PLANT J, V54, P402, DOI 10.1111/j.1365-313X.2008.03435.x; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sohaskey ML, 2002, MOL BIOL CELL, V13, P454, DOI 10.1091/mbc.01-11-0553; Sorensson C, 2012, BIOCHEM J, V446, P271, DOI 10.1042/BJ20111809; Ulm R, 2004, P NATL ACAD SCI USA, V101, P1397, DOI 10.1073/pnas.0308044100; Ulm R, 2002, EMBO J, V21, P6483, DOI 10.1093/emboj/cdf646; Ulm R, 2001, GENE DEV, V15, P699, DOI 10.1101/gad.192601; Wang HC, 2008, PLANT CELL, V20, P602, DOI 10.1105/tpc.108.058032; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yamakawa H, 2004, J BIOL CHEM, V279, P928, DOI 10.1074/jbc.M310277200; Yoo JH, 2004, J BIOL CHEM, V279, P848, DOI 10.1074/jbc.M310709200; Zaidi I, 2010, PLANT MOL BIOL, V73, P325, DOI 10.1007/s11103-010-9617-4	43	34	35	2	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					480	486		10.1074/jbc.M112.434654	http://dx.doi.org/10.1074/jbc.M112.434654			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23188831	hybrid, Green Published			2022-12-28	WOS:000313197200048
J	Cai, R; Yu, TT; Huang, C; Xia, XF; Liu, XB; Gu, JM; Xue, S; Yeh, ETH; Cheng, JK				Cai, Rong; Yu, Tingting; Huang, Chao; Xia, Xuefeng; Liu, Xiaobing; Gu, Jianmin; Xue, Song; Yeh, Edward T. H.; Cheng, Jinke			SUMO-specific Protease 1 Regulates Mitochondrial Biogenesis through PGC-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL CONTROL; SKELETAL-MUSCLE; COACTIVATOR PGC-1-BETA; RECEPTOR-ALPHA; ERR-ALPHA; PHOSPHORYLATION; HOMEOSTASIS; SENP5; AMPK	Peroxisome proliferator-activated receptor gamma (PPAR gamma) coactivator 1 alpha (PGC-1 alpha) is a master regulator of mitochondrial biogenesis in response to changes in the cellular environment, physiological or pathological status of mammals. PGC-1 alpha is known to be modified by SUMO (Small Ubiquitin-like Modifier). However, it is not known whether SUMOylation could affect the function of PGC-1 alpha in mitochondrial biogenesis and that how PGC-1 alpha SUMOylation is regulated. In this study, we have identified the role of Sentrin/SUMO-specific protease 1 (SENP1) as a specific SUMO protease to regulate SUMOylation status of PGC-1 alpha. More importantly, we have also found that SENP1 promotes PGC-1 alpha transcription activity, which is essential for the expression of mitochondrial genes and subsequently mitochondrial biogenesis. Thus, we reveal that the SUMOylation of PGC-1 alpha controlled by SENP1 plays an important role in mitochondrial biogenesis and function.	[Cai, Rong; Yu, Tingting; Huang, Chao; Cheng, Jinke] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200025, Peoples R China; [Liu, Xiaobing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp Affiliated 9, Shanghai 200011, Peoples R China; [Cheng, Jinke] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200438, Peoples R China; [Gu, Jianmin; Xue, Song] Shanghai Jiao Tong Univ, Sch Med, Shanghai RenJi Hosp Affiliated, Shanghai 200001, Peoples R China; [Xia, Xuefeng] Methodist Hosp, Res Inst, Weill Cornell Sch Med, Houston, TX 77030 USA; [Yeh, Edward T. H.] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA; [Huang, Chao; Liu, Xiaobing; Yeh, Edward T. H.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; UTMD Anderson Cancer Center; Saint Lukes Episcopal Hospital; Texas Heart Institute	Cheng, JK (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, 280 Chongqing S Rd, Shanghai 200025, Peoples R China.	jkcheng@shsmu.edu.cn	yu, tingting/HGA-4783-2022	huang, chao/0000-0002-4913-921X	National Natural Science Foundation of China [91019021]; National Basic Research Program of China (973 Program) [2010CB912104]; Shanghai Committee of Science and Technology [11XD1403200, 11DZ2260200]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Natural Science Foundation of China (91019021 to J. C.), National Basic Research Program of China (973 Program) (No. 2010CB912104 to J. C.), and Shanghai Committee of Science and Technology (11XD1403200 to J. C., 11DZ2260200).	Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kelly TJ, 2009, J BIOL CHEM, V284, P19945, DOI 10.1074/jbc.M109.015164; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Lustig Y, 2011, GENE DEV, V25, P1232, DOI 10.1101/gad.2054711; Michel S, 2012, J CELL PHYSIOL, V227, P2297, DOI 10.1002/jcp.23021; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Rytinki MM, 2009, J BIOL CHEM, V284, P26184, DOI 10.1074/jbc.M109.038943; Sakai M, 2012, NAT MED, V18, P612, DOI 10.1038/nm.2691; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Nguyen TV, 2012, MOL CELL, V45, P210, DOI 10.1016/j.molcel.2011.12.026; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003; Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418; Zunino R, 2009, J BIOL CHEM, V284, P17783, DOI 10.1074/jbc.M901902200	34	30	33	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44464	44470		10.1074/jbc.M112.422626	http://dx.doi.org/10.1074/jbc.M112.422626			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23152500	hybrid, Green Published			2022-12-28	WOS:000312938600042
J	Margadant, C; van den Bout, I; van Boxtel, AL; Thijssen, VL; Sonnenberg, A				Margadant, Coert; van den Bout, Iman; van Boxtel, Antonius L.; Thijssen, Victor L.; Sonnenberg, Arnoud			Epigenetic Regulation of Galectin-3 Expression by beta 1 Integrins Promotes Cell Adhesion and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEINS; DNA METHYLATION; BREAST-CARCINOMA; BINDING-PROTEIN; GENE-EXPRESSION; INTEGRINS; FIBRONECTIN; BETA-1; REEPITHILIALIZATION; ALPHA-5-BETA-1	Introduction of the integrin beta 1- but not the beta 3-subunit in GE11 cells induces an epithelial-to-mesenchymal-transition (EMT)-like phenomenon that is characterized by the loss of cell-cell contacts, cell scattering, increased cell migration and RhoA activity, and fibronectin fibrillogenesis. Because galactosebinding lectins (galectins) have been implicated in these phenomena, we investigated whether galectins are involved in the beta-induced phenotype. We examined 9 galectins and, intriguingly, found that the expression of galectin-3 (Gal-3) is specifically induced by beta 1 but not by beta 3. Using beta 1-beta 3 chimeric integrins, we show that the induction of Gal-3 expression requires the hypervariable region in the extracellular domain of beta 1, but not its cytoplasmic tail. Furthermore, Gal-3 expression does not depend on RhoA signaling, serum factors, or any of the major signal transduction pathways involving protein kinase C (PKC), p38 mitogen-activated protein kinase (p38MAPK), extracellular signal-regulated kinase-1/-2 (ERK-1/2), phosphatidylinositol3- OH kinase (PI3-K), or Src kinases. Instead, Gal-3 expression is controlled in an epigenetic manner. Whereas DNA methylation of the Lgals3 promoter maintains Gal-3 silencing in GE11 cells, expression of beta 1 causes its demethylation, leading to transcriptional activation of the Lgals3 gene. In turn, Gal-3 expression enhances beta 1 integrin-mediated cell adhesion to fibronectin (FN) and laminin (LN), as well as cell migration. Gal-3 also promotes beta 1-mediated cell adhesion to LN and Collagen-1 (Col)-1 in cells that endogenously express Gal-3 and beta 1 integrins. In conclusion, we identify a functional feedback-loop between beta 1 integrins and Gal-3 that involves the epigenetic induction of Gal-3 expression during integrin-induced EMT and cell scattering.	[Margadant, Coert; van den Bout, Iman; Sonnenberg, Arnoud] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [van Boxtel, Antonius L.] Vrije Univ Amsterdam, Inst Environm Studies IVM, NL-1081 HV Amsterdam, Netherlands; [Thijssen, Victor L.] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, NL-1081 HV Amsterdam, Netherlands; [Thijssen, Victor L.] Vrije Univ Amsterdam Med Ctr, Dept Radiat Oncol, NL-1081 HV Amsterdam, Netherlands	Netherlands Cancer Institute; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van den Bout, I (corresponding author), Paterson Inst Canc Res, Inositide Lab, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	ivbout@picr.man.ac.uk; a.sonnenberg@nki.nl	Thijssen, Victor LJL/B-2792-2009	Thijssen, Victor LJL/0000-0002-6146-1842; van den Bout, Iman/0000-0001-6333-1470	Dutch Cancer Society [NKI 2001-2488]; Netherlands Organization for Scientific Research [864.09.005]	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Dutch Cancer Society (NKI 2001-2488) and in part by the Netherlands Organization for Scientific Research (864.09.005, to A.L.v.B.).	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Benvenuto G, 1996, MOL CELL BIOL, V16, P2736; CAMPBELL ID, 2011, CSH PERSPECT BIOL, V3, DOI DOI 10.1101/cshperspect.a004994; Cao ZY, 2002, J BIOL CHEM, V277, P42299, DOI 10.1074/jbc.M200981200; Chen M, 2009, J BIOL CHEM, V284, P1484, DOI 10.1074/jbc.M803997200; Chiariotti L, 2002, GLYCOCONJUGATE J, V19, P441, DOI 10.1023/B:GLYC.0000014073.23096.3a; Danen EHJ, 2005, J CELL BIOL, V169, P515, DOI 10.1083/jcb.200412081; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Friedrichs J, 2008, J BIOL CHEM, V283, P32264, DOI 10.1074/jbc.M803634200; Friedrichs J, 2007, J BIOL CHEM, V282, P29375, DOI 10.1074/jbc.M701867200; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Gimond C, 1999, J CELL BIOL, V147, P1325, DOI 10.1083/jcb.147.6.1325; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Hughes RC, 2001, BIOCHIMIE, V83, P667; Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Kariya Y, 2010, J BIOL CHEM, V285, P3330, DOI 10.1074/jbc.M109.038836; Kuwabara I, 1996, J IMMUNOL, V156, P3939; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Levy Y, 2001, J BIOL CHEM, V276, P31285, DOI 10.1074/jbc.M100340200; Levy Y, 2003, J BIOL CHEM, V278, P14533, DOI 10.1074/jbc.M207380200; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Margadant C, 2009, J CELL SCI, V122, P278, DOI 10.1242/jcs.029108; Matarrese P, 2000, INT J CANCER, V85, P545, DOI 10.1002/(SICI)1097-0215(20000215)85:4<545::AID-IJC17>3.3.CO;2-E; Miao H, 2002, J CELL SCI, V115, P2199; Moiseeva EP, 2003, BIOCHEM BIOPH RES CO, V310, P1010, DOI 10.1016/j.bbrc.2003.09.112; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Nishi N, 2003, GLYCOBIOLOGY, V13, P755, DOI 10.1093/glycob/cwg102; Ochieng J, 1998, BIOCHEM BIOPH RES CO, V246, P788, DOI 10.1006/bbrc.1998.8708; Pacienza N, 2008, FASEB J, V22, P1113, DOI 10.1096/fj.07-9524com; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Ramasamy S, 2007, MOL CELL, V27, P992, DOI 10.1016/j.molcel.2007.07.031; Rao SP, 2007, J IMMUNOL, V179, P7800, DOI 10.4049/jimmunol.179.11.7800; Rozhon W, 2008, ANAL BIOCHEM, V375, P354, DOI 10.1016/j.ab.2008.01.001; Ruebel KH, 2005, CANCER RES, V65, P1136, DOI 10.1158/0008-5472.CAN-04-3578; Saravanan C, 2009, J CELL SCI, V122, P3684, DOI 10.1242/jcs.045674; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Thijssen VLJL, 2004, EXP CELL RES, V299, P286, DOI 10.1016/j.yexcr.2004.06.014; Warfield PR, 1997, INVAS METAST, V17, P101; WOO HJ, 1990, J BIOL CHEM, V265, P7097	48	38	40	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44684	44693		10.1074/jbc.M112.426445	http://dx.doi.org/10.1074/jbc.M112.426445			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23118221	Green Published, hybrid			2022-12-28	WOS:000312938600064
J	Moreno, JL; Muguruza, C; Umali, A; Mortillo, S; Holloway, T; Pilar-Cuellar, F; Mocci, G; Seto, J; Callado, LF; Neve, RL; Milligan, G; Sealfon, SC; Lopez-Gimenez, JF; Meana, JJ; Benson, DL; Gonzalez-Maeso, J				Moreno, Jose L.; Muguruza, Carolina; Umali, Adrienne; Mortillo, Steven; Holloway, Terrell; Pilar-Cuellar, Fuencisla; Mocci, Giuseppe; Seto, Jeremy; Callado, Luis F.; Neve, Rachael L.; Milligan, Graeme; Sealfon, Stuart C.; Lopez-Gimenez, Juan F.; Javier Meana, J.; Benson, Deanna L.; Gonzalez-Maeso, Javier			Identification of Three Residues Essential for 5-Hydroxytryptamine 2A-Metabotropic Glutamate 2 (5-HT2A.mGlu2) Receptor Heteromerization and Its Psychoactive Behavioral Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; CLASS-A; GPCR; RHODOPSIN; COMPLEX; MODELS; OLIGOMERIZATION; ORGANIZATION; PHARMACOLOGY	Serotonin and glutamate G protein-coupled receptor (GPCR) neurotransmission affects cognition and perception in humans and rodents. GPCRs are capable of forming heteromeric complexes that differentially alter cell signaling, but the role of this structural arrangement in modulating behavior remains unknown. Here, we identified three residues located at the intracellular end of transmembrane domain four that are necessary for the metabotropic glutamate 2 (mGlu2) receptor to be assembled as a GPCR heteromer with the serotonin 5-hydroxytryptamine 2A (5-HT2A) receptor in the mouse frontal cortex. Substitution of these residues (Ala-677(4.40), Ala-681(4.44), and Ala-685(4.48)) leads to absence of 5-HT2A.mGlu2 receptor complex formation, an effect that is associated with a decrease in their heteromeric ligand binding interaction. Disruption of heteromeric expression with mGlu2 attenuates the psychosis-like effects induced in mice by hallucinogenic 5-HT2A agonists. Furthermore, the ligand binding interaction between the components of the 5-HT2A.mGlu2 receptor heterocomplex is up-regulated in the frontal cortex of schizophrenic subjects as compared with controls. Together, these findings provide structural evidence for the unique behavioral function of a GPCR heteromer.	[Moreno, Jose L.; Umali, Adrienne; Holloway, Terrell; Pilar-Cuellar, Fuencisla; Mocci, Giuseppe; Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Seto, Jeremy; Sealfon, Stuart C.; Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Mortillo, Steven; Sealfon, Stuart C.; Benson, Deanna L.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Sealfon, Stuart C.] Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY 10029 USA; [Sealfon, Stuart C.; Benson, Deanna L.; Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA; [Muguruza, Carolina; Callado, Luis F.; Javier Meana, J.] Univ Pais Vasco Euskal Herriko Unibertsitatea, Univ Basque Country, Dept Pharmacol, E-48490 Leioa, Bizkaia, Spain; [Umali, Adrienne; Callado, Luis F.; Javier Meana, J.] Univ Pais Vasco Euskal Herriko Unibertsitatea, Univ Basque Country, Ctr Invest Biomed Red Salud Mental, E-48490 Leioa, Bizkaia, Spain; [Lopez-Gimenez, Juan F.] Fac Med, Inst Biomed Biotecnol Cantabria, E-39011 Santander, Spain; [Milligan, Graeme; Lopez-Gimenez, Juan F.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); University of Glasgow; Massachusetts Institute of Technology (MIT)	Gonzalez-Maeso, J (corresponding author), Mt Sinai Sch Med, Dept Psychiat, 1425 Madison Ave,Box 1229, New York, NY 10029 USA.	Javier.Maeso@mssm.edu	Pilar-Cuellar, Fuencisla/L-2983-2014; Callado, Luis F./A-7024-2008; Lopez-Gimenez, Juan/K-5823-2014; Milligan, Graeme/F-9426-2011; Moreno, Jose L/L-8981-2017; Muguruza, Carolina/B-8986-2013	Pilar-Cuellar, Fuencisla/0000-0003-1229-001X; Callado, Luis F./0000-0001-9941-012X; Lopez-Gimenez, Juan/0000-0003-3021-6200; Milligan, Graeme/0000-0002-6946-3519; Muguruza, Carolina/0000-0002-0477-5757; Benson, Deanna/0000-0001-7037-1147; MEANA, JOSE JAVIER/0000-0002-7913-6714; SEALFON, Stuart/0000-0001-5791-1217; CALLADO HERNANDO, LUIS FELIPE/0000-0002-5564-3447	National Institutes of Health [R01 MH084894, R01 NS37731, P01 DA12923]; Dainippon Sumi-tomo Pharma; National Alliance for Research on Schizophrenia and Depression; Mortimer D. Sackler Foundation; Ministerio de Ciencia e Innovacion Grant [SAF2009-084609]; Basque Government [IT-199-07]; Consejo Superior de Investigaciones Cientificas Grants [PA1003176, 200980I110]; Medical Research Council United Kingdom [G0900050]; University of the Basque Country, Spain; Fundacion Alicia Koplowitz, Spain; Consejo Superior de Investigaciones Cientificas, Spain; Medical Research Council [G0900050] Funding Source: researchfish; MRC [G0900050] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dainippon Sumi-tomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); National Alliance for Research on Schizophrenia and Depression(NARSAD); Mortimer D. Sackler Foundation; Ministerio de Ciencia e Innovacion Grant(Spanish Government); Basque Government(Basque Government); Consejo Superior de Investigaciones Cientificas Grants; Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of the Basque Country, Spain; Fundacion Alicia Koplowitz, Spain; Consejo Superior de Investigaciones Cientificas, Spain; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 MH084894 (to J. G. M.), R01 NS37731 (to D. L. B.), and P01 DA12923 (to S. C. S.). This work was also supported by Dainippon Sumi-tomo Pharma (to J. G. M.), National Alliance for Research on Schizophrenia and Depression (to J. G. M.), The Mortimer D. Sackler Foundation (to J. G. M.), Ministerio de Ciencia e Innovacion Grant SAF2009-084609 (to J. J. M.), Basque Government Grant IT-199-07 (to J. J. M.), Consejo Superior de Investigaciones Cientificas Grants PA1003176 and 200980I110 (to J. F. L.-G.), and Medical Research Council United Kingdom Grant G0900050 (to G. M.).; Recipient of a predoctoral fellowship from University of the Basque Country, Spain.; Recipient of a postdoctoral fellowship from Fundacion Alicia Koplowitz, Spain.; Recipient of a predoctoral fellowship from Consejo Superior de Investigaciones Cientificas, Spain.	Aghajanian GK, 2009, PSYCHOPHARMACOLOGY, V206, P575, DOI 10.1007/s00213-009-1484-9; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; Beique JC, 2007, P NATL ACAD SCI USA, V104, P9870, DOI 10.1073/pnas.0700436104; Belichenko P. V., 2000, COMP CYTOARCHITECTON, P129; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Carhart-Harris RL, 2012, P NATL ACAD SCI USA, V109, P2138, DOI 10.1073/pnas.1119598109; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Celada P, 2008, BIOL PSYCHIAT, V64, P392, DOI 10.1016/j.biopsych.2008.03.013; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; DeLano W.L, PYMOL MOL GRAPHICS S; Filizola M, 2005, CURR OPIN DRUG DISC, V8, P577; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Garcia-Sevilla JA, 2010, EUR NEUROPSYCHOPHARM, V20, P721, DOI 10.1016/j.euroneuro.2010.04.008; Gonzalez-Maeso J, 2003, J NEUROSCI, V23, P8836; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Gonzalez-Maeso J, 2009, TRENDS NEUROSCI, V32, P225, DOI 10.1016/j.tins.2008.12.005; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jakab RL, 1998, P NATL ACAD SCI USA, V95, P735, DOI 10.1073/pnas.95.2.735; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kurita M, 2012, NAT NEUROSCI, V15, P1245, DOI 10.1038/nn.3181; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Marek GJ, 2000, J PHARMACOL EXP THER, V292, P76; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Moreno JL, 2011, NEUROSCI LETT, V493, P76, DOI 10.1016/j.neulet.2011.01.046; Mortillo S, 2012, J COMP NEUROL, V520, P2041, DOI 10.1002/cne.23027; Muguruza C., 2012, EUR NEUROPS IN PRESS; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Ohishi H, 1998, NEUROSCI RES, V30, P65, DOI 10.1016/S0168-0102(97)00120-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Perez DM, 2003, MOL PHARMACOL, V63, P1202, DOI 10.1124/mol.63.6.1202; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Prezeau L, 2010, CURR OPIN PHARMACOL, V10, P6, DOI 10.1016/j.coph.2009.10.009; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rovira X, 2010, TRENDS PHARMACOL SCI, V31, P15, DOI 10.1016/j.tips.2009.10.008; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; Tsuji Y, 2000, J BIOL CHEM, V275, P28144; Urizar E, 2011, NAT CHEM BIOL, V7, P624, DOI [10.1038/NCHEMBIO.623, 10.1038/nchembio.623]; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vollenweider FX, 1997, NEUROPSYCHOPHARMACOL, V16, P357, DOI 10.1016/S0893-133X(96)00246-1; Vollenweider FX, 1998, NEUROREPORT, V9, P3897, DOI 10.1097/00001756-199812010-00024; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wright R. A., 2012, NEUROPHARMACOLOGY; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645	63	86	89	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44301	44319		10.1074/jbc.M112.413161	http://dx.doi.org/10.1074/jbc.M112.413161			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23129762	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000312938600028
J	Reynald, RL; Sansen, S; Stout, CD; Johnson, EF				Reynald, R. Leila; Sansen, Stefaan; Stout, C. David; Johnson, Eric F.			Structural Characterization of Human Cytochrome P450 2C19 ACTIVE SITE DIFFERENCES BETWEEN P450s 2C8, 2C9, AND 2C19	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; SUBSTRATE-SPECIFICITY; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; HIGH-AFFINITY; CLOPIDOGREL; IDENTIFICATION; CYP2C19; BINDING; DETERMINANTS	To identify the structural features underlying the distinct substrate and inhibitor profiles of P450 2C19 relative to the closely related human enzymes, P450s 2C8 and 2C9, the atomic structure (Protein Data Bank code 4GQS) of cytochrome P450 2C19 complexed with the inhibitor (2-methyl-1-benzo furan-3-yl)-(4-hydroxy- 3,5-dimethylphenyl) methanone (Protein Data Bank chemical component 0XV) was determined to 2.87 angstrom resolution by x-ray crystallography. The conformation of the peptide back-bone of P450 2C19 is most similar to that of P450 2C8, but the substrate-binding cavity of P450 2C8 is much larger than that of P450 2C19 due to differences in the amino acid residues that form the substrate-binding cavities of the two enzymes. In contrast, the substrate-binding cavity of P450 2C19 is much more similar in size to that of the structure of the P450 2C9 flurbiprofen complex than to that of a modified P450 2C9 or that of P450 2C8. The cavities of the P450 2C19 0XV complex and the P450 2C9 flurbiprofen complex differ, however, because the helix B-C loops of the two enzymes are dissimilar. These conformational differences reflect the effects of adjacent structural elements that interact with the B-C loops and that differ between the two enzymes. The availability of a structure for 2C19 will facilitate computational approaches for predictions of substrate and inhibitor binding to this enzyme.	[Reynald, R. Leila; Sansen, Stefaan; Johnson, Eric F.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Stout, C. David] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Stout, CD (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,MB8, La Jolla, CA 92037 USA.	dave@scripps.edu; johnson@scripps.edu			National Institutes of Health from NIGMS [R01GM031001]; Department of Energy Office of Biological and Environmental Research; National Institute of Health from NIGMS [P41GM103393]; National Institutes of Health from NCRR [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031001, P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of Health from NIGMS; National Institutes of Health from NCRR; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM031001 from NIGMS (to E.F.J.).; We thank Jeffrey Jones (Washington State University) for synthesizing and providing 0XV for this study and Mei Hsu for determination of the Ki value for 0XV inhibition of 3-methoxyfluorescein O-demethylation catalyzed by P450 2C19. The help of the support staff of the Stanford Synchrotron Radiation Lightsource for data collection and Qiping Zhao for excellent technical support is gratefully acknowledged. Portions of this work were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of the SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by National Institutes of Health Grant P41GM103393 from NIGMS and Grant P41RR001209 from NCRR.	Alessi M. C., 2012, HUM GENET, V5, P693; Blaisdell J, 2002, PHARMACOGENETICS, V12, P703, DOI 10.1097/00008571-200212000-00004; Boulenc X, 2012, DRUG METAB DISPOS, V40, P187, DOI 10.1124/dmd.111.040394; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cosme J, 2000, J BIOL CHEM, V275, P2545, DOI 10.1074/jbc.275.4.2545; Dansette PM, 2012, CHEM RES TOXICOL, V25, P348, DOI 10.1021/tx2004085; Dansette PM, 2009, CHEM RES TOXICOL, V22, P369, DOI 10.1021/tx8004828; Dickmann LJ, 2004, MOL PHARMACOL, V65, P842, DOI 10.1124/mol.65.4.842; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GOLDSTEIN JA, 1994, BIOCHEMISTRY-US, V33, P1743, DOI 10.1021/bi00173a017; Ibeanu GC, 1996, J BIOL CHEM, V271, P12496, DOI 10.1074/jbc.271.21.12496; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Ingelman-Sundberg M, 2010, BIOCHEM BIOPH RES CO, V396, P90, DOI 10.1016/j.bbrc.2010.02.162; Jung F, 1998, BIOCHEMISTRY-US, V37, P16270, DOI 10.1021/bi981704c; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Klose TS, 1998, ARCH BIOCHEM BIOPHYS, V357, P240, DOI 10.1006/abbi.1998.0826; Locuson CW, 2004, J MED CHEM, V47, P6768, DOI 10.1021/jm049605m; Locuson CW, 2003, DRUG METAB DISPOS, V31, P967, DOI 10.1124/dmd.31.7.967; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mosher CM, 2009, J PHARMACOL EXP THER, V329, P938, DOI 10.1124/jpet.109.150706; Nishiya Y, 2009, XENOBIOTICA, V39, P836, DOI 10.3109/00498250903191427; OMURA T, 1964, J BIOL CHEM, V239, P2379; RICHARDSON TH, 1995, ARCH BIOCHEM BIOPHYS, V323, P87, DOI 10.1006/abbi.1995.0013; Ridderstrom M, 2000, BIOCHEM BIOPH RES CO, V270, P983, DOI 10.1006/bbrc.2000.2538; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; Schoch GA, 2008, J BIOL CHEM, V283, P17227, DOI 10.1074/jbc.M802180200; Shi SJ, 2008, EUR J CLIN PHARMACOL, V64, P935, DOI 10.1007/s00228-008-0538-y; Sibbing D, 2010, CIRCULATION, V121, P512, DOI 10.1161/CIRCULATIONAHA.109.885194; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Spina E, 2008, CLIN THER, V30, P1206, DOI 10.1016/S0149-2918(08)80047-1; Tiroch KA, 2010, AM HEART J, V160, P506, DOI 10.1016/j.ahj.2010.06.039; Tsao CC, 2001, BIOCHEMISTRY-US, V40, P1937, DOI 10.1021/bi001678u; Wada Y, 2008, J BIOCHEM, V144, P323, DOI 10.1093/jb/mvn070; Wang A, 2012, J BIOL CHEM, V287, P10834, DOI 10.1074/jbc.M111.307918; Wang HJ, 2011, DRUG METAB DISPOS, V39, P830, DOI 10.1124/dmd.110.037549; Wester MR, 2004, J BIOL CHEM, V279, P35630, DOI 10.1074/jbc.M405427200; Wester MR, 2003, BIOCHEMISTRY-US, V42, P9335, DOI 10.1021/bi034556l; Wester MR, 2003, BIOCHEMISTRY-US, V42, P6370, DOI 10.1021/bi0273922; Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862; Zanger UM, 2008, ANAL BIOANAL CHEM, V392, P1093, DOI 10.1007/s00216-008-2291-6; Zvyaga T, 2012, DRUG METAB DISPOS, V40, P1698, DOI 10.1124/dmd.112.045575	45	74	77	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44581	44591		10.1074/jbc.M112.424895	http://dx.doi.org/10.1074/jbc.M112.424895			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23118231	Green Published, hybrid			2022-12-28	WOS:000312938600055
J	Jevnikar, Z; Rojnik, M; Jamnik, P; Doljak, B; Fonovic, UP; Kos, J				Jevnikar, Zala; Rojnik, Matija; Jamnik, Polona; Doljak, Bojan; Fonovic, Ursa Pecar; Kos, Janko			Cathepsin H Mediates the Processing of Talin and Regulates Migration of Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-LIKE DOMAIN; INTEGRIN ACTIVATION; CYSTEINE CATHEPSINS; STRUCTURAL BASIS; EXPRESSION; ENZYME; HEAD; INHIBITORS; INVASION; REVEALS	The cytoskeletal protein talin, an actin-and beta-integrin tail-binding protein, plays an important role in cell migration by promoting integrin activation and focal adhesion formation. Here, we show that talin is a substrate for cathepsin H (CtsH), a lysosomal cysteine protease with a strong aminopeptidase activity. Purified active CtsH sequentially cleaved a synthetic peptide representing the N terminus of the talin F0 head domain. The processing of talin by CtsH was determined also in the metastatic PC-3 prostate cancer cell line, which exhibits increased expression of CtsH. The attenuation of CtsH aminopeptidase activity by a specific inhibitor or siRNA-mediated silencing significantly reduced the migration of PC-3 cells on fibronectin and invasion through Matrigel. We found that in migrating PC-3 cells, CtsH was co-localized with talin in the focal adhesions. Furthermore, specific inhibition of CtsH increased the activation of alpha(v)beta(3)-integrin on PC-3 cells. We propose that CtsH-mediated processing of talin might promote cancer cell progression by affecting integrin activation and adhesion strength.	[Jevnikar, Zala; Rojnik, Matija; Doljak, Bojan; Fonovic, Ursa Pecar; Kos, Janko] Univ Ljubljana, Fac Pharm, Dept Pharmaceut Biol, SI-1000 Ljubljana, Slovenia; [Jamnik, Polona] Univ Ljubljana, Biotech Fac, SI-1000 Ljubljana, Slovenia; [Kos, Janko] Jozef Stefan Inst, Dept Biotechnol, SI-1000 Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Jevnikar, Z (corresponding author), Univ Ljubljana, Fac Pharm, Dept Pharmaceut Biol, Askerceva 7, SI-1000 Ljubljana, Slovenia.	zala.jevnikar@ffa.uni-lj.si			Slovenian Research Agency [P4 0127, J4 4123]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency Grants P4 0127 and J4 4123 (to J. K.).	ANGLIKER H, 1989, BIOCHEM J, V262, P63, DOI 10.1042/bj2620063; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Claus V, 1998, J BIOL CHEM, V273, P9842, DOI 10.1074/jbc.273.16.9842; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; del Re EC, 2000, BRIT J CANCER, V82, P1317; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Friedrich B, 1999, EUR J CANCER, V35, P138, DOI 10.1016/S0959-8049(98)00273-1; GABRIJELCIC D, 1992, EUR J CLIN CHEM CLIN, V30, P69; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Gopal P, 2006, ONCOL REP, V16, P313; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Jevnikar Z, 2009, CELL MOTIL CYTOSKEL, V66, P1030, DOI 10.1002/cm.20413; KAIGHN ME, 1979, INVEST UROL, V17, P16; KOGA H, 1992, CHEM PHARM BULL, V40, P965; Kos J, 1997, CLIN CANCER RES, V3, P1815; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; McCabe NP, 2007, ONCOGENE, V26, P6238, DOI 10.1038/sj.onc.1210429; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Podgorski I, 2005, NEOPLASIA, V7, P207, DOI 10.1593/neo.04349; Premzl A, 2003, EXP CELL RES, V283, P206, DOI 10.1016/S0014-4827(02)00055-1; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; Riou P, 2006, FASEB J, V20, P2291, DOI 10.1096/fj.06-6085com; Roberts Gordon C. K., 2009, Biophysical Reviews, V1, P61, DOI 10.1007/s12551-009-0009-4; Rojnik M, 2012, EUR J CELL BIOL, V91, P757, DOI 10.1016/j.ejcb.2012.05.004; Rojnik M, 2011, RADIOL ONCOL, V45, P259, DOI 10.2478/v10019-011-0034-3; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Schweiger A, 1997, J IMMUNOL METHODS, V201, P165, DOI 10.1016/S0022-1759(96)00218-9; Sivaparvathi M, 1996, CANCER LETT, V104, P121, DOI 10.1016/0304-3835(96)04242-5; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TAKAHASHI T, 1988, J BIOL CHEM, V263, P10952; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; TSUSHIMA H, 1991, INT J CANCER, V48, P726, DOI 10.1002/ijc.2910480516; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Waghray A, 2002, J BIOL CHEM, V277, P11533, DOI 10.1074/jbc.M109557200; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Zako T, 2009, BIOCHEM BIOPH RES CO, V381, P54, DOI 10.1016/j.bbrc.2009.02.004; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zheng DQ, 1999, CANCER RES, V59, P1655	52	33	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2201	2209		10.1074/jbc.M112.436394	http://dx.doi.org/10.1074/jbc.M112.436394			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23204516	Green Published, hybrid			2022-12-28	WOS:000314211500011
J	Shimizu, A; Nakayama, H; Wang, P; Konig, C; Akino, T; Sandlund, J; Coma, S; Italiano, JE; Mammoto, A; Bielenberg, DR; Klagsbrun, M				Shimizu, Akio; Nakayama, Hironao; Wang, Priscilla; Koenig, Courtney; Akino, Tomoshige; Sandlund, Johanna; Coma, Silvia; Italiano, Joseph E., Jr.; Mammoto, Akiko; Bielenberg, Diane R.; Klagsbrun, Michael			Netrin-1 Promotes Glioblastoma Cell Invasiveness and Angiogenesis by Multiple Pathways Including Activation of RhoA, Cathepsin B, and cAMP-response Element-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; UNC5B RECEPTOR; TUMOR; EXPRESSION; GROWTH; SURFACE; PHOSPHORYLATION; NEUROPILIN-1; MECHANISMS; COLLAPSE	Glioblastomas are very difficult tumors to treat because they are highly invasive and disseminate within the normal brain, resulting in newly growing tumors. We have identified netrin-1 as a molecule that promotes glioblastoma invasiveness. As evidence, netrin-1 stimulates glioblastoma cell invasion directly through Matrigel-coated transwells, promotes tumor cell sprouting and enhances metastasis to lymph nodes in vivo. Furthermore, netrin-1 regulates angiogenesis as shown in specific angiogenesis assays such as enhanced capillary endothelial cells (EC) sprouting and by increased EC infiltration into Matrigel plugs in vivo, as does VEGF-A. This netrin-1 signaling pathway in glioblastoma cells includes activation of RhoA and cyclic AMP response element-binding protein (CREB). A novel finding is that netrin-1-induced glioblastoma invasiveness and angiogenesis are mediated by activated cathepsin B (CatB), a cysteine protease that translocates to the cell surface as an active enzyme and co-localizes with cell surface annexin A2 (ANXA2). The specific CatB inhibitor CA-074Me inhibits netrin-1-induced cell invasion, sprouting, and Matrigel plug angiogenesis. Silencing of CREB suppresses netrin-1-induced glioblastoma cell invasion, sprouting, and CatB expression. It is concluded that netrin-1 plays an important dual role in glioblastoma progression by promoting both glioblastoma cell invasiveness and angiogenesis in a RhoA-, CREB-, and CatB-dependent manner. Targeting netrin-1 pathways may be a promising strategy for brain cancer therapy.	[Shimizu, Akio; Nakayama, Hironao; Wang, Priscilla; Koenig, Courtney; Akino, Tomoshige; Sandlund, Johanna; Coma, Silvia; Italiano, Joseph E., Jr.; Mammoto, Akiko; Bielenberg, Diane R.; Klagsbrun, Michael] Harvard Univ, Sch Med, Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Shimizu, Akio; Nakayama, Hironao; Akino, Tomoshige; Coma, Silvia; Mammoto, Akiko; Bielenberg, Diane R.; Klagsbrun, Michael] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Klagsbrun, Michael] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Italiano, Joseph E., Jr.] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Nakayama, Hironao] Ehime Univ, Grad Sch Med, Toon, Ehime 7910295, Japan; [Nakayama, Hironao] Ehime Univ, Proteomed Res Ctr, Toon, Ehime 7910295, Japan	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Ehime University; Ehime University	Klagsbrun, M (corresponding author), Karp Family Res Labs 12-210,1 Blackfan Circle, Boston, MA 02115 USA.	michael.klagsbrun@childrens.harvard.edu	Wang, Priscilla/GXV-9402-2022	Wang, Priscilla/0000-0002-7314-7092	National Institutes of Health from the NCI [CA37392, CA45548]; Japan Society for the Promotion of Science, Japan [S2207]; NATIONAL CANCER INSTITUTE [R37CA037392, R01CA037392, P01CA045548, R56CA037392] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA37392 and CA45548 from the NCI (to M. K.). H. N. is supported by the Strategic Young Researcher Overseas Visiting Program for Accelerating Brain Circulation (No. S2207 to Dr. Shigeki Higashiyama, Ehime University Proteo-Medicine Research Center), Japan Society for the Promotion of Science, Japan.	Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bielenberg DR, 2008, METHOD ENZYMOL, V443, P299, DOI 10.1016/S0076-6879(08)02015-6; Bielenberg DR, 2004, J CLIN INVEST, V114, P1260, DOI 10.1172/JCI200421378; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Cavallo-Medved D, 2003, NEOPLASIA, V5, P507, DOI 10.1016/S1476-5586(03)80035-0; Cavallo-Medved D, 2003, CURR TOP DEV BIOL, V54, P313, DOI 10.1016/S0070-2153(03)54013-3; Coma S, 2011, CELL ADHES MIGR, V5, P266, DOI 10.4161/cam.5.3.16294; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Dumartin L, 2010, GASTROENTEROLOGY, V138, P1595, DOI 10.1053/j.gastro.2009.12.061; Eveno C, 2011, AM J PATHOL, V178, P1861, DOI 10.1016/j.ajpath.2010.12.019; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Fitamant J, 2008, P NATL ACAD SCI USA, V105, P4850, DOI 10.1073/pnas.0709810105; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerszten RE, 2012, NEW ENGL J MED, V366, P1734, DOI 10.1056/NEJMcibr1200164; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Jarjour AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025408; Kaufmann S, 2009, CELL ONCOL, V31, P415, DOI 10.3233/CLO-2009-0491; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Lambert E, 2012, J BIOL CHEM, V287, P3987, DOI 10.1074/jbc.M111.289371; Larrivee B, 2007, GENE DEV, V21, P2433, DOI 10.1101/gad.437807; Lejmi E, 2008, P NATL ACAD SCI USA, V105, P12491, DOI 10.1073/pnas.0804008105; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Mantamadiotis T, 2012, BIOESSAYS, V34, P293, DOI 10.1002/bies.201100133; Mayo LD, 2001, J BIOL CHEM, V276, P25184, DOI 10.1074/jbc.M102932200; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mehlen P, 2005, CELL MOL LIFE SCI, V62, P2599, DOI 10.1007/s00018-005-5191-3; Mehlen P, 2011, NAT REV CANCER, V11, P188, DOI 10.1038/nrc3005; Melnikova VO, 2006, J BIOL CHEM, V281, P2911, DOI 10.1074/jbc.M508683200; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nakayama H, 2012, MOL BIOL CELL, V23, P1964, DOI 10.1091/mbc.E11-08-0683; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Ramesh G, 2011, BIOMARKERS, V16, P172, DOI 10.3109/1354750X.2010.541564; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; ReyesMugica M, 1997, CANCER RES, V57, P382; Rodrigues S, 2007, ONCOGENE, V26, P5615, DOI 10.1038/sj.onc.1210347; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757; Shi Y, 2011, INT J BIOCHEM CELL B, V43, P682, DOI 10.1016/j.biocel.2011.01.016; Shimizu A, 2008, J BIOL CHEM, V283, P27230, DOI 10.1074/jbc.M804520200; Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; Uciechowski P, 2000, BRIT J CANCER, V83, P1664, DOI 10.1054/bjoc.2000.1501; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704	50	70	74	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2210	2222		10.1074/jbc.M112.397398	http://dx.doi.org/10.1074/jbc.M112.397398			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23195957	hybrid, Green Published			2022-12-28	WOS:000314211500012
J	Bauer, EM; Shapiro, R; Billiar, TR; Bauer, PM				Bauer, Eileen M.; Shapiro, Richard; Billiar, Timothy R.; Bauer, Philip M.			High Mobility Group Box 1 Inhibits Human Pulmonary Artery Endothelial Cell Migration via a Toll-like Receptor 4- and Interferon Response Factor 3-dependent Mechanism(s)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR HMGB1; ACUTE LUNG INJURY; GENE-EXPRESSION; LIVER ISCHEMIA; HYPOXIA; ANGIOGENESIS; PROTEIN; IMMUNE; OVEREXPRESSION; HYPERTENSION	In pulmonary hypertension the loss of precapillary arterioles results from vascular injury causing endothelial dysfunction. Endothelial cell migration and proliferation are critical for vascular regeneration. This study focused on the effect of high mobility group box 1 protein (HMGB1) on these critical processes. HMGB1 had no effect on human pulmonary artery endothelial cell (HPAEC) proliferation. In contrast, treatment of HPAECs with HMGB1 dose-dependently inhibited VEGF-stimulated HPAEC migration. The effect of HMGB1 on HPAEC migration was TLR4-dependent because it was reversed by TLR4 siRNA or TLR4-neutralizing antibody. Exposure of HPAECs to hypoxia caused translocation and release of HMGB1 and inhibition of HPAEC migration. The effect of hypoxia on HPAEC migration was mediated by HMGB1 because HMGB1-neutralizing antibody but not control IgG restored HPAEC migration. Likewise, TLR4 siRNA but not control siRNA reversed the inhibitory effect of hypoxia in HPAECs. The canonical TLR4 signaling pathway requires the adaptor protein MyD88 and leads to downstream NF kappa B activation. Interestingly, HMGB1 failed to stimulate NF kappa B translocation to the nucleus, but instead activated an alternative pathway characterized by activation of interferon response factor 3 (IRF3). This was in contrast to human umbilical vein endothelial cells in which HMGB1 stimulated nuclear translocation of NF kappa B but not IRF3. IRF3 siRNA, but not MyD88 siRNA, reversed the inhibitory effect of HMGB1 on HPAEC migration. These data demonstrate that HMGB1 inhibits HPAEC migration, a critical process for vascular regeneration, via TLR4- and IRF3-dependent mechanisms.	[Bauer, Eileen M.; Shapiro, Richard; Billiar, Timothy R.; Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bauer, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, 200 Lothrop St,Starzl Biomed Sci,Tower W1147, Pittsburgh, PA 15261 USA.	bauerpm@upmc.edu			National Institutes of Health [R01-HL085134, R03-HL110794, P50-GM53789, T32-098036]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085134, R03HL110794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL085134 and R03-HL110794 (to P. M. B.), P50-GM53789 (to T. R. B.), and T32-098036 (to E. M. B.).	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Angus DC, 2007, CRIT CARE MED, V35, P1061, DOI 10.1097/01.CCM.0000259534.68873.2A; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Chavakis E, 2007, CIRC RES, V100, P204, DOI 10.1161/01.RES.0000257774.55970.f4; Chen JL, 2011, KIDNEY INT, V80, P504, DOI 10.1038/ki.2011.140; DeFilippis VR, 2006, J VIROL, V80, P1032, DOI 10.1128/JVI.80.2.1032-1037.2006; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Evankovich J, 2010, J BIOL CHEM, V285, P39888, DOI 10.1074/jbc.M110.128348; Fitzgerald KA, 2006, CELL, V125, P834, DOI 10.1016/j.cell.2006.05.014; Gong Q, 2009, SCAND J IMMUNOL, V69, P29, DOI 10.1111/j.1365-3083.2008.02194.x; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Huang WC, 2010, CYTOKINE, V51, P119, DOI 10.1016/j.cyto.2010.02.021; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Levy RM, 2007, AM J PHYSIOL-REG I, V293, pR1538, DOI 10.1152/ajpregu.00272.2007; Lin Q, 2011, ARTERIOSCL THROM VAS, V31, P1024, DOI 10.1161/ATVBAHA.111.224048; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Mittal D, 2010, EMBO J, V29, P2242, DOI 10.1038/emboj.2010.94; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Ngamkitidechakul C, 2002, BIOTECHNIQUES, V33, P1296, DOI 10.2144/02336pt02; Ogawa EN, 2006, AM J RESP CRIT CARE, V174, P400, DOI 10.1164/rccm.200605-699OC; Ohmori H, 2011, EXPERT OPIN THER TAR, V15, P183, DOI 10.1517/14728222.2011.546785; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Partovian C, 2000, AM J RESP CELL MOL, V23, P762, DOI 10.1165/ajrcmb.23.6.4106; Pascaud MA, 2003, AM J RESP CELL MOL, V29, P449, DOI 10.1165/rcmb.2002-0120OC; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Reiss LK, 2012, EUR J CELL BIOL, V91, P590, DOI 10.1016/j.ejcb.2011.11.004; Sachdev U, 2012, J VASC SURG, V55, P180, DOI 10.1016/j.jvs.2011.07.072; Schlueter C, 2005, PATHOL RES PRACT, V201, P101, DOI 10.1016/j.prp.2004.11.010; Schlueter C, 2005, AM J PATHOL, V166, P1259, DOI 10.1016/S0002-9440(10)62344-9; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Tsai TH, 2011, SHOCK, V35, P92, DOI 10.1097/SHK.0b013e3181ea45ca; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Ueno H, 2004, AM J RESP CRIT CARE, V170, P1310, DOI 10.1164/rccm.200402-188OC; van Beijnum JR, 2013, ONCOGENE, V32, P363, DOI 10.1038/onc.2012.49; van Beijnum JR, 2006, BLOOD, V108, P2339, DOI 10.1182/blood-2006-02-004291; Wang E, 2011, ANESTHESIOLOGY, V114, P603, DOI 10.1097/ALN.0b013e31820a4d5b; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Young KC, 2010, EXP LUNG RES, V36, P111, DOI 10.3109/01902140903171610; Zhu XY, 2008, LIFE SCI, V83, P801, DOI 10.1016/j.lfs.2008.09.029	48	43	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1365	1373		10.1074/jbc.M112.434142	http://dx.doi.org/10.1074/jbc.M112.434142			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23148224	hybrid, Green Published			2022-12-28	WOS:000313570300057
J	El-Shazly, AE; Begon, DY; Kustermans, G; Arafa, M; Dortu, E; Henket, M; Lefebvre, PP; Louis, R; Delvenne, P				El-Shazly, Amr E.; Begon, Dominique Y.; Kustermans, Gaelle; Arafa, Mohammad; Dortu, Estelle; Henket, Monique; Lefebvre, Philippe P.; Louis, Renaud; Delvenne, Philippe			Novel Association between Vasoactive Intestinal Peptide and CRTH2 Receptor in Recruiting Eosinophils A POSSIBLE BIOCHEMICAL MECHANISM FOR ALLERGIC EOSINOPHILIC INFLAMMATION OF THE AIRWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTANCE-P; 2B4 CD244; CHEMOTAXIS; CELLS; EXPRESSION; MIGRATION; MOLECULE; KINASE	We explored the relation between vasoactive intestinal peptide (VIP), CRTH2, and eosinophil recruitment. It is shown that CRTH2 expression by eosinophils from allergic rhinitis (AR) patients and eosinophil cell line (Eol-1 cells) was up-regulated by VIP treatment. This was functional and resulted in exaggerated migratory response of cells against PGD2. Nasal challenge of AR patients resulted in a significant increase of VIP contents in nasal secretion (ELISA), and the immunohistochemical studies of allergic nasal tissues showed significant expression of VIP in association with intense eosinophil recruitment. Biochemical assays showed that VIP-induced eosinophil chemotaxis from AR patients and Eol-1 cells was mediated through the CRTH2 receptor. Cell migration against VIP was sensitive to protein kinaseC(PKC) and protein kinaseA(PKA) inhibition but not to tyrosine kinase or p38 MAPK inhibition or calcium chelation. Western blot demonstrated a novel CRTH2-mediated cytosol-to-membrane translocation of PKC-epsilon, PKC-delta, and PKA-alpha, -gamma, and -II alpha reg in Eol-1 cells upon stimulation with VIP. Confocal images and FACS demonstrated a strong association and co-localization between VIP peptide and CRTH2 molecules. Further, VIP induced PGD2 secretion from eosinophils. Our results demonstrate the first evidence of association between VIP and CRTH2 in recruiting eosinophils.	[El-Shazly, Amr E.] Liege Univ Hosp, Rhinol Unit, Dept Otorhinolaryngol & Head & Neck Surg, CHU, B-4000 Liege, Belgium; [Henket, Monique; Louis, Renaud] Liege Univ Hosp, CHU, Dept Pulmonol, GIGA Res, B-4000 Liege, Belgium; [Begon, Dominique Y.; Kustermans, Gaelle; Arafa, Mohammad; Dortu, Estelle; Delvenne, Philippe] Univ Liege, Lab Expt Pathol, Dept Pathol, GIGA Canc, B-4000 Liege, Belgium	University of Liege; University of Liege; University of Liege	El-Shazly, AE (corresponding author), Liege Univ Hosp, Rhinol Unit, Dept Otorhinolaryngol & Head & Neck Surg, CHU, B-4000 Liege, Belgium.	amrel_shazly@hotmail.com			Centre Hospitalier Universitaire de Liege [4717]	Centre Hospitalier Universitaire de Liege	This work is supported by Centre Hospitalier Universitaire de Liege Grant 4717.	Bacon KB, 1996, J EXP MED, V184, P873, DOI 10.1084/jem.184.3.873; BARANIUK JN, 1990, J CLIN INVEST, V86, P825, DOI 10.1172/JCI114780; BOKOCH GM, 1995, BLOOD, V86, P1649, DOI 10.1182/blood.V86.5.1649.bloodjournal8651649; DOWNEY GP, 1994, CURR OPIN IMMUNOL, V6, P113, DOI 10.1016/0952-7915(94)90042-6; Dunzendorfer S, 1998, J LEUKOCYTE BIOL, V64, P828, DOI 10.1002/jlb.64.6.828; El-Shazly A, 2006, J IMMUNOL, V176, P1860, DOI 10.4049/jimmunol.176.3.1860; El-Shazly A, 1998, INT ARCH ALLERGY IMM, V117, P10, DOI 10.1159/000053563; El-Shazly AE, 2011, INT J IMMUNOPATH PH, V24, P949, DOI 10.1177/039463201102400413; El-Shazly AE, 2011, INT IMMUNOPHARMACOL, V11, P1864, DOI 10.1016/j.intimp.2011.07.017; El-Shazly Amr, 2000, Allergology International, V49, P19, DOI 10.1046/j.1440-1592.2000.00154.x; ElShazly AE, 1996, IMMUNOL INVEST, V25, P191, DOI 10.3109/08820139609059302; Fischer A, 2005, J OCCUP ENVIRON MED, V47, P20, DOI 10.1097/01.jom.0000150238.77663.49; GHATEI MA, 1982, ENDOCRINOLOGY, V111, P1248, DOI 10.1210/endo-111-4-1248; Harmar AJ, 1998, PHARMACOL REV, V50, P265; Heppt W, 2004, CLIN EXP ALLERGY, V34, P1105, DOI 10.1111/j.1365-2222.2004.01990.x; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Ishihara K, 2007, LIFE SCI, V80, P1213, DOI 10.1016/j.lfs.2006.12.016; Knall C, 1997, P NATL ACAD SCI USA, V94, P3052, DOI 10.1073/pnas.94.7.3052; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; Marchese A, 1999, GENOMICS, V56, P12, DOI 10.1006/geno.1998.5655; METWALI A, 1994, J NEUROIMMUNOL, V52, P69, DOI 10.1016/0165-5728(94)90164-3; Munitz A, 2005, J IMMUNOL, V174, P110, DOI 10.4049/jimmunol.174.1.110; Munitz A, 2007, AM J RESP CRIT CARE, V175, P911, DOI 10.1164/rccm.200605-695OC; Munitz A, 2006, J IMMUNOL, V177, P77, DOI 10.4049/jimmunol.177.1.77; Nagata K, 2003, PROSTAG LEUKOTR ESS, V69, P169, DOI 10.1016/S0952-3278(03)00078-4; Nagata K, 1999, J IMMUNOL, V162, P1278; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nomiya R, 2008, J IMMUNOL, V180, P5680, DOI 10.4049/jimmunol.180.8.5680; NUMAO T, 1992, J IMMUNOL, V149, P3309; Okano M, 2006, AM J RHINOL, V20, P342, DOI 10.2500/ajr.2006.20.2865; Royer JF, 2007, ALLERGY, V62, P1401, DOI 10.1111/j.1398-9995.2007.01452.x; Shiraishi Y, 2005, J PHARMACOL EXP THER, V312, P954, DOI 10.1124/jpet.104.078212; SNYDERMAN R, 1984, ANNU REV IMMUNOL, V2, P257, DOI 10.1146/annurev.immunol.2.1.257; Uller L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-16	34	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1374	1384		10.1074/jbc.M112.422675	http://dx.doi.org/10.1074/jbc.M112.422675			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23168411	Green Published, hybrid			2022-12-28	WOS:000313570300058
J	Haglund, L; Tillgren, V; Onnerfjord, P; Heinegard, D				Haglund, Lisbet; Tillgren, Viveka; Onnerfjord, Patrik; Heinegard, Dick			The C-terminal Peptide of Chondroadherin Modulates Cellular Activity by Selectively Binding to Heparan Sulfate Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; CARTILAGE; COLLAGEN; ADHESION; DOMAIN; RECEPTOR; DECORIN; PROTEOGLYCANS; FIBRONECTIN; INTEGRINS	Chondroadherin, a leucine-rich repeat family member, contains a very C-terminal sequence CKFPTKRSKKAGRH(359), now shown to bind to heparin with a K-D of 13 mu M. This observation led us to investigate whether chondroadherin interacts via this C-terminal heparin-binding domain with glycosaminoglycan chains of proteoglycans at the cell surface. Cells were shown to bind this heparin-binding peptide in FACS analysis, and the interaction was shown to be with glycosaminoglycans because it was abolished when sulfation was inhibited by chlorate treatment of the cells. In separate experiments, heparin and heparan sulfate inhibited the peptide interaction in a dose-dependent manner. Using a human chondrosarcoma and a murine osteoblast cell line, heparan sulfate proteoglycans were identified as the cell surface receptors involved in the binding. Different binding syndecans were identified in the two different cell lines, indicating that the same protein core of a proteoglycan may have structural and functional differences in the attached heparan sulfate chains. Upon binding to coated peptide, cells spread, demonstrating engagement of the cytoskeleton, but no focal adhesion complex was formed. The number of cells adhering via their beta(1) integrin receptor to collagen type II or chondroadherin was profoundly and rapidly enhanced by the addition of the heparin-binding peptide. The peptide added to the cells caused ERK phosphorylation, showing that it triggered intracellular signaling. The results show that heparan sulfate chains differ between various members of the proteoglycan families on a given cell, but also differ between the same proteoglycan on different cells with a potential for differential regulation of cellular activities.	[Haglund, Lisbet; Tillgren, Viveka; Onnerfjord, Patrik; Heinegard, Dick] Lund Univ, Dept Clin Sci, Rheumatol Sect, Biomed Ctr C12, SE-22184 Lund, Sweden	Lund University	Heinegard, D (corresponding author), Lund Univ, Dept Clin Sci, Rheumatol Sect, Biomed Ctr C12, BMC Plan C12, SE-22184 Lund, Sweden.	dick.heinegard@med.lu.se	Haglund, Lisbet/N-3095-2013; Onnerfjord, Patrik/R-3131-2019	Haglund, Lisbet/0000-0002-1288-2149; Onnerfjord, Patrik/0000-0002-2345-2937	Swedish Research Council; King Gustaf V:s 80-year Fund; Osterlund Foundation; Kock Foundation; European Commission 7th Framework Program for Research; NanoDiaRa; Anamar Medical	Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustaf V:s 80-year Fund; Osterlund Foundation; Kock Foundation; European Commission 7th Framework Program for Research; NanoDiaRa; Anamar Medical	This work was supported by funding from The Swedish Research Council, the King Gustaf V:s 80-year Fund, the Osterlund Foundation, the Kock Foundation, the European Commission 7th Framework Program for Research, NanoDiaRa, and Anamar Medical.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Couchman JR, 2001, INT REV CYTOL, V207, P113; DANILOV YN, 1989, J CELL BIOL, V108, P1925, DOI 10.1083/jcb.108.5.1925; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7; EYRE DR, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P119; Franzke CW, 2005, J BIOL CHEM, V280, P4005, DOI 10.1074/jbc.R400034200; Haglund L, 2011, J BIOL CHEM, V286, P3925, DOI 10.1074/jbc.M110.161141; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; HEINEGARD DK, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P95; Humphries Martin J, 2005, Novartis Found Symp, V269, P178; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Iba K, 2000, J CELL BIOL, V149, P1143, DOI 10.1083/jcb.149.5.1143; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; LARSSON T, 1991, J BIOL CHEM, V266, P20428; Latvanlehto A, 2003, J BIOL CHEM, V278, P37590, DOI 10.1074/jbc.M305974200; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Mansson B, 2001, J BIOL CHEM, V276, P32883, DOI 10.1074/jbc.M101680200; MILLER EJ, 1972, BIOCHEMISTRY-US, V11, P4903, DOI 10.1021/bi00776a005; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; NEAME PJ, 1994, J BIOL CHEM, V269, P21547; Rapraeger AC, 2000, J CELL BIOL, V149, P995, DOI 10.1083/jcb.149.5.995; RECKLIES AD, 1992, ARTHRITIS RHEUM, V35, P1510, DOI 10.1002/art.1780351215; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; Sandell L. J., 2007, OSTEOARTHRITIS DIAGN, P73; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; SOMMARIN Y, 1989, EXP CELL RES, V184, P181, DOI 10.1016/0014-4827(89)90376-5; SOMMARIN Y, 1983, BIOCHEM J, V214, P777, DOI 10.1042/bj2140777; Thodeti CK, 2003, J BIOL CHEM, V278, P9576, DOI 10.1074/jbc.M208937200; Tillgren V, 2009, J BIOL CHEM, V284, P28543, DOI 10.1074/jbc.M109.047076; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Wilcox-Adelman SA, 2002, J BIOL CHEM, V277, P32970, DOI 10.1074/jbc.M201283200; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607; Woods A, 1998, MATRIX BIOL, V17, P477, DOI 10.1016/S0945-053X(98)90095-6; YONEDA J, 1995, EXP CELL RES, V217, P169, DOI 10.1006/excr.1995.1076; Zako M, 2003, J BIOL CHEM, V278, P13561, DOI 10.1074/jbc.M209658200	42	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					995	1008		10.1074/jbc.M112.430512	http://dx.doi.org/10.1074/jbc.M112.430512			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23172228	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000313570300024
J	Madhuprakash, J; Tanneeru, K; Purushotham, P; Guruprasad, L; Podile, AR				Madhuprakash, Jogi; Tanneeru, Karunakar; Purushotham, Pallinti; Guruprasad, Lalitha; Podile, Appa Rao			Transglycosylation by Chitinase D from Serratia proteamaculans Improved through Altered Substrate Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY 18 CHITINASES; BINDING CLEFT; RESIDUES; CHITOOLIGOSACCHARIDES; LIGNIFICATION; MUTAGENESIS; ACTIVATION; ELICITOR; MUTATION; SITE	We describe the improvement of transglycosylation (TG) by chitinase D from Serratia proteamaculans (SpChiD). The SpChiD produced a smaller quantity of TG products for up to 90 min with 2 mM chitotetraose as the substrate and subsequently produced only hydrolytic products. Of the five residues targeted at the catalytic center, E159D resulted in substantial loss of both hydrolytic and TG activities. Y160A resulted in a product profile similar to SpChiD and a rapid turnover of substrate with slightly increased TG activity. The rest of the three mutants, M226A, Y228A, and R284A, displayed improved TG and decreased hydrolytic ability. Four of the five amino acid substitutions, F64W, F125A, G119S, and S116G, at the catalytic groove increased TG activity, whereas W120A completely lost the TG activity with a concomitant increase in hydrolysis. Mutation of Trp-247 at the solvent-accessible region significantly reduced the hydrolytic activity with increased TG activity. The mutants M226A, Y228A, F125A, S116G, F64W, G119S, R284A, and W247A accumulated approximately double the concentration of TG products like chitopentaose and chitohexaose, compared with SpChiD. The double mutant E159D/F64W regained the activity with accumulation of 6.0% chitopentaose at 6 h, similar to SpChiD at 30 min. Loss of chitobiase activity was unique to Y228A. Substitution of amino acids at the catalytic center and/or groove substantially improved the TG activity of SpChiD, both in terms of the quantity of TG products produced and the extended duration of TG activity.	[Madhuprakash, Jogi; Purushotham, Pallinti; Podile, Appa Rao] Univ Hyderabad, Dept Plant Sci, Sch Life Sci, Hyderabad 500046, Andhra Pradesh, India; [Tanneeru, Karunakar; Guruprasad, Lalitha] Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India	University of Hyderabad; University of Hyderabad	Podile, AR (corresponding author), Univ Hyderabad, Dept Plant Sci, Sch Life Sci, Hyderabad 500046, Andhra Pradesh, India.	arpsl@uohyd.ernet.in	Jogi, Madhuprakash/AAU-9958-2021; Tanneeru, Karunakar/C-8946-2016; Tanneeru, Karunakar/C-8200-2019; Podile, Appa Rao/W-5077-2018	Tanneeru, PhD, FICS, Dr. Karunakar/0000-0002-9250-6476; Podile, Appa Rao/0000-0003-3208-765X; Pallinti, Purushotham Naidu/0000-0002-5565-1762	University Grants Commission in the form of Centre for Advanced Studies in Life Sciences and Department Biotechnology, Government of India; Centre for Research and Education in Biology and Biotechnology to the School of Life Sciences; Department of Science and Technology-Funds for Infrastructure in Science and Technology Level II; University Grants Commission-Centre for Advanced Studies in Chemistry; International Research and Training Group-Molecular and Cellular Glycosciences, Deutsche Forschungsgemeinschaft (Germany); University Grants Commission, India	University Grants Commission in the form of Centre for Advanced Studies in Life Sciences and Department Biotechnology, Government of India; Centre for Research and Education in Biology and Biotechnology to the School of Life Sciences; Department of Science and Technology-Funds for Infrastructure in Science and Technology Level II; University Grants Commission-Centre for Advanced Studies in Chemistry; International Research and Training Group-Molecular and Cellular Glycosciences, Deutsche Forschungsgemeinschaft (Germany); University Grants Commission, India(University Grants Commission, India)	We thank the Department of Science and Technology, Government of India, Funds for Infrastructure in Science and Technology, Level II support to the Department of Plant Sciences. We gratefully acknowledge the support from University Grants Commission in the form of Centre for Advanced Studies in Life Sciences, and Department Biotechnology, Government of India, Centre for Research and Education in Biology and Biotechnology to the School of Life Sciences. We also thank the support given under Department of Science and Technology-Funds for Infrastructure in Science and Technology Level II and University Grants Commission-Centre for Advanced Studies in Chemistry to the School of Chemistry, and University Grants Commission-supported University with Potential for Excellence (Phase II) to the University of Hyderabad for the infrastructural support. We thank Prof. B. M. Moerschbacher and Dr. Nour Eddine El Gueddari for suggestions during revision of the manuscript.; Supported in part by International Research and Training Group-Molecular and Cellular Glycosciences, Deutsche Forschungsgemeinschaft (Germany), and University Grants Commission, India.	Aronson NN, 2006, BIOSCI BIOTECH BIOCH, V70, P243, DOI 10.1271/bbb.70.243; BARBER MS, 1989, PHYSIOL MOL PLANT P, V34, P3, DOI 10.1016/0885-5765(89)90012-X; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Cabrera JC, 2006, PHYSIOL PLANTARUM, V127, P44, DOI 10.1111/j.1399-3054.2006.00677.x; Fan SQ, 2012, J BIOL CHEM, V287, P11272, DOI 10.1074/jbc.M112.340497; FUKAMIZO T, 1989, AGR BIOL CHEM TOKYO, V53, P2641, DOI 10.1080/00021369.1989.10869717; GARDNER KH, 1975, BIOPOLYMERS, V14, P1581, DOI 10.1002/bip.1975.360140804; GOTTHARDT U, 1992, J PLANT PHYSIOL, V139, P659, DOI 10.1016/S0176-1617(11)81707-4; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Jitonnom J, 2011, BIOCHEMISTRY-US, V50, P4697, DOI 10.1021/bi101362g; Ke SH, 1997, NUCLEIC ACIDS RES, V25, P3371, DOI 10.1093/nar/25.16.3371; KENDRA DF, 1984, EXP MYCOL, V8, P276, DOI 10.1016/0147-5975(84)90013-6; Kim SK, 2005, CARBOHYD POLYM, V62, P357, DOI 10.1016/j.carbpol.2005.08.012; Krokeide IM, 2007, ANAL BIOCHEM, V363, P128, DOI 10.1016/j.ab.2006.12.044; Li CS, 2008, BIOORGAN MED CHEM, V16, P8366, DOI 10.1016/j.bmc.2008.08.042; Liu TT, 2012, SCIENCE, V336, P1160, DOI 10.1126/science.1218867; Lu Y, 2009, GLYCOCONJUGATE J, V26, P525, DOI 10.1007/s10719-008-9203-z; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Ly HD, 1999, ANNU REV BIOCHEM, V68, P487, DOI 10.1146/annurev.biochem.68.1.487; Makino A, 2006, BIOMACROMOLECULES, V7, P950, DOI 10.1021/bm050895d; MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3; MOERSCHBACHER B, 1986, Z NATURFORSCH C, V41, P830; Neeraja C, 2010, BIORESOURCE TECHNOL, V101, P3635, DOI 10.1016/j.biortech.2009.12.118; Norberg AL, 2011, FEBS LETT, V585, P2339, DOI 10.1016/j.febslet.2011.06.002; Purushotham P, 2012, J BACTERIOL, V194, P4260, DOI 10.1128/JB.06473-11; Purushotham P, 2012, BIORESOURCE TECHNOL, V112, P261, DOI 10.1016/j.biortech.2012.02.062; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Sakai K., 1990, DENPUN KAGAKU, V37, P79; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sashidhar B, 2010, J MOL MICROB BIOTECH, V18, P109, DOI 10.1159/000293819; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Synstad B, 2004, EUR J BIOCHEM, V271, P253, DOI 10.1046/j.1432-1033.2003.03923.x; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; Taira T, 2010, BBA-PROTEINS PROTEOM, V1804, P668, DOI 10.1016/j.bbapap.2009.10.015; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; Vander P, 1998, PLANT PHYSIOL, V118, P1353, DOI 10.1104/pp.118.4.1353; WATANABE T, 1993, J BIOL CHEM, V268, P18567; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; Williams SJ, 2000, CARBOHYD RES, V327, P27, DOI 10.1016/S0008-6215(00)00041-0; Zakariassen H, 2011, BIOCHEMISTRY-US, V50, P5693, DOI 10.1021/bi2002532; Zakariassen H, 2010, CARBOHYD POLYM, V81, P14, DOI 10.1016/j.carbpol.2010.01.048	41	38	38	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44619	44627		10.1074/jbc.M112.400879	http://dx.doi.org/10.1074/jbc.M112.400879			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23115231	hybrid, Green Published			2022-12-28	WOS:000312938600058
J	Ge, YJ; Chen, J				Ge, Yejing; Chen, Jie			Mammalian Target of Rapamycin (mTOR) Signaling Network in Skeletal Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NF-KAPPA-B; FIBER-TYPE SPECIFICATION; PROTEIN-KINASE B; P70 S6 KINASE; PHOSPHOLIPASE-D; MYOBLAST DIFFERENTIATION; MUSCLE-CELLS; C2C12 MYOBLASTS; IN-VIVO; PHOSPHATIDYLINOSITOL 3-KINASE	Mammalian (or mechanistic) target of rapamycin (mTOR) regulates a wide range of cellular and developmental processes by coordinating signaling responses to mitogens, nutrients, and various stresses. Over the last decade, mTOR has emerged as a master regulator of skeletal myogenesis, controlling multiple stages of the myofiber formation process. In this minireview, we present an emerging view of the signaling network underlying mTOR regulation of myogenesis, which contrasts with the well established mechanisms in the regulation of cell and muscle growth. Current questions for future studies are also highlighted.	[Ge, Yejing; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Chen, J (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA.	jiechen@illinois.edu		Chen, Jie/0000-0002-7887-3747	National Institutes of Health [AR048914, GM089771]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR048914 and GM089771 (to J.C.).	Amthor H, 2004, DEV BIOL, V270, P19, DOI 10.1016/j.ydbio.2004.01.046; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Blattler SM, 2012, CELL METAB, V15, P505, DOI 10.1016/j.cmet.2012.03.008; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Canicio J, 1998, ENDOCRINOLOGY, V139, P5042, DOI 10.1210/en.139.12.5042; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chen JF, 2009, J CELL SCI, V122, P13, DOI 10.1242/jcs.041723; Conejo R, 2001, J CELL PHYSIOL, V186, P82, DOI 10.1002/1097-4652(200101)186:1<82::AID-JCP1001>3.0.CO;2-R; Conejo R, 2002, ONCOGENE, V21, P3739, DOI 10.1038/sj.onc.1205469; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Ge YJ, 2011, J BIOL CHEM, V286, P35675, DOI 10.1074/jbc.M111.262881; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df; Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Hornberger TA, 2011, INT J BIOCHEM CELL B, V43, P1267, DOI 10.1016/j.biocel.2011.05.007; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Jaafar R, 2011, J BIOL CHEM, V286, P22609, DOI 10.1074/jbc.M110.203885; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jansen Katie M., 2008, V475, P115, DOI 10.1007/978-1-59745-250-2_7; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kaliman P, 1998, MOL ENDOCRINOL, V12, P66, DOI 10.1210/mend.12.1.0047; Kantidakis T, 2010, P NATL ACAD SCI USA, V107, P11823, DOI 10.1073/pnas.1005188107; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Liu GH, 2009, MOL CELL BIOL, V29, P5800, DOI 10.1128/MCB.00684-09; Liu QS, 2012, J BIOL CHEM, V287, P9742, DOI 10.1074/jbc.M111.304485; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Mebarek S, 2007, J CELL SCI, V120, P407, DOI 10.1242/jcs.03331; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Nicole S, 2003, J CELL BIOL, V161, P571, DOI 10.1083/jcb.200210117; Nishiyama T, 2004, J BIOL CHEM, V279, P47311, DOI 10.1074/jbc.M403546200; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Park IH, 2005, EXP CELL RES, V309, P211, DOI 10.1016/j.yexcr.2005.05.017; Park IH, 2005, J BIOL CHEM, V280, P32009, DOI 10.1074/jbc.M506120200; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pisconti A, 2006, J CELL BIOL, V172, P233, DOI 10.1083/jcb.200507083; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sarker KP, 2004, ONCOGENE, V23, P6064, DOI 10.1038/sj.onc.1207819; Schneyer AL, 2008, ENDOCRINOLOGY, V149, P4589, DOI 10.1210/en.2008-0259; Shu LL, 2009, MOL CELL BIOL, V29, P4691, DOI 10.1128/MCB.00764-09; Shu LL, 2002, J BIOL CHEM, V277, P16726, DOI 10.1074/jbc.M112285200; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Tsang CK, 2010, CELL CYCLE, V9, P953, DOI 10.4161/cc.9.5.10876; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wiczer BM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003019; Wu AL, 2008, ENDOCRINOLOGY, V149, P1407, DOI 10.1210/en.2007-1470; Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	98	76	79	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43928	43935		10.1074/jbc.R112.406942	http://dx.doi.org/10.1074/jbc.R112.406942			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115234	Green Published, hybrid			2022-12-28	WOS:000312940800068
J	Liu, L; Alonso, V; Guo, L; Tourkova, I; Henderson, SE; Almarza, AJ; Friedman, PA; Blair, HC				Liu, Li; Alonso, Veronica; Guo, Lida; Tourkova, Irina; Henderson, Sarah E.; Almarza, Alejandro J.; Friedman, Peter A.; Blair, Harry C.			Na+/H+ Exchanger Regulatory Factor 1 (NHERF1) Directly Regulates Osteogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; PROTEIN-COUPLED-RECEPTORS; PARATHYROID-HORMONE; BONE; MOUSE; PHOSPHORYLATION; COTRANSPORTERS; DETERIORATION; ASSOCIATION; INHIBITION	Bone formation requires synthesis, secretion, and mineralization of matrix. Deficiencies in these processes produce bone defects. The absence of the PDZ domain protein Na+/H+ exchange regulatory factor 1 (NHERF1) in mice, or its mutation in humans, causes osteomalacia believed to reflect renal phosphate wasting. We show that NHERF1 is expressed by mineralizing osteoblasts and organizes Na+/H+ exchangers (NHEs) and thePTHreceptor. NHERF1-null mice display reduced bone formation and wide mineralizing fronts despite elimination of phosphate wasting by dietary supplementation. Bone mass was normal, reflecting coordinated reduction of bone resorption and formation. NHERF1-null bone had decreased strength, consistent with compromised matrix quality. Mesenchymal stem cells from NHERF1-null mice showed limited osteoblast differentiation but enhanced adipocyte differentiation. PTH signaling and Na+/H+ exchange were dysregulated in these cells. Osteoclast differentiation from monocytes was unaffected. Thus, NHERF1 is required for normal osteoblast differentiation and matrix synthesis. In its absence, compensatory mechanisms maintain bone mass, but bone strength is reduced.	[Liu, Li; Guo, Lida; Tourkova, Irina; Blair, Harry C.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; [Liu, Li; Guo, Lida; Tourkova, Irina; Blair, Harry C.] Univ Pittsburgh, Sch Med, Dept Physiol & Cell Biol, Pittsburgh, PA 15261 USA; [Alonso, Veronica; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Henderson, Sarah E.; Almarza, Alejandro J.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol & Bioengn, Pittsburgh, PA 15261 USA; [Henderson, Sarah E.; Almarza, Alejandro J.] Univ Pittsburgh, Sch Engn, Dept Oral Biol & Bioengn, Pittsburgh, PA 15261 USA; [Blair, Harry C.] Pittsburgh Vet Affairs Med Ctr, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Blair, HC (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, S705 Scaife Hall, Pittsburgh, PA 15261 USA.	hcblair@imap.pitt.edu	RODRIGUEZ, VERONICA ALONSO/F-3364-2017	Alonso, Veronica/0000-0002-2813-3257	National Institutes of Health [AR053976, DK069998, AR055208]; Department of Veteran's Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053976, R01AR055208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran's Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AR053976, DK069998, and AR055208. This work was also supported by the Department of Veteran's Affairs.	Ardura JA, 2011, J BIOL CHEM, V286, P35020, DOI 10.1074/jbc.M111.264978; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Blair HC, 2011, BIOFACTORS, V37, P159, DOI 10.1002/biof.143; Brownstein CA, 2010, ENDOCRINOLOGY, V151, P492, DOI 10.1210/en.2009-0564; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Fratzl-Zelman N, 2004, J CLIN ENDOCR METAB, V89, P1538, DOI 10.1210/jc.2003-031055; Fratzl-Zelman N, 2011, CALCIFIED TISSUE INT, V88, P378, DOI 10.1007/s00223-011-9466-4; Gupta A, 2001, BONE, V29, P467, DOI 10.1016/S8756-3282(01)00601-9; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Hasegawa K, 2008, J BONE MINER METAB, V26, P394, DOI 10.1007/s00774-007-0827-z; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Hosogane N, 2010, INT J BIOCHEM CELL B, V42, P1132, DOI 10.1016/j.biocel.2010.03.020; Jamsa T, 1998, BONE, V23, P155, DOI 10.1016/S8756-3282(98)00076-3; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Khadeer MA, 2003, AM J PHYSIOL-CELL PH, V284, pC1633, DOI 10.1152/ajpcell.00580.2002; Li BZ, 2007, STEM CELLS DEV, V16, P921, DOI 10.1089/scd.2007.0074; Liu L, 2011, J CELL PHYSIOL, V226, P1702, DOI 10.1002/jcp.22501; Mannstadt M, 1999, AM J PHYSIOL-RENAL, V277, pF665, DOI 10.1152/ajprenal.1999.277.5.F665; Manoharan R, 1996, SPECTROCHIM ACTA A, V52, P215, DOI 10.1016/0584-8539(95)01573-6; Mistry PK, 2010, P NATL ACAD SCI USA, V107, P19473, DOI 10.1073/pnas.1003308107; Murrills RJ, 2009, J CELL BIOCHEM, V106, P887, DOI 10.1002/jcb.22057; Prie D, 2004, CURR OPIN NEPHROL HY, V13, P675, DOI 10.1097/00041552-200411000-00015; ROBERTS S, 1993, J ORTHOP RES, V11, P747, DOI 10.1002/jor.1100110517; Romero G, 2010, J BIOL CHEM, V285, P14756, DOI 10.1074/jbc.M110.102970; Saeed H, 2011, J BONE MINER RES, V26, P1494, DOI 10.1002/jbmr.349; Saito M, 2006, CALCIFIED TISSUE INT, V79, P160, DOI 10.1007/s00223-006-0035-1; Seeman E, 2010, J BONE MINER RES, V25, P1886, DOI 10.1002/jbmr.81; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Tobimatsu T, 2006, ENDOCRINOLOGY, V147, P2583, DOI 10.1210/en.2005-1627; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; WEINMAN EJ, 1993, J CLIN INVEST, V92, P1781, DOI 10.1172/JCI116767; Weinstein RS, 2010, ENDOCRINOLOGY, V151, P2641, DOI 10.1210/en.2009-1488; Wheeler DS, 2011, ONCOGENE, V30, P32, DOI 10.1038/onc.2010.389; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]	44	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43312	43321		10.1074/jbc.M112.422766	http://dx.doi.org/10.1074/jbc.M112.422766			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23109343	hybrid, Green Published			2022-12-28	WOS:000312940800012
J	Valentin-Hansen, L; Holst, B; Frimurer, TM; Schwartz, TW				Valentin-Hansen, Louise; Holst, Birgitte; Frimurer, Thomas M.; Schwartz, Thue W.			PheVI:09 (Phe6.44) as a Sliding Microswitch in Seven-transmembrane (7TM) G Protein-coupled Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BINDING-SITES; GLYCINE 121; DRY MOTIF; SWITCH; RHODOPSIN; IDENTIFICATION; MECHANISM; RESIDUES; TMVI	In seven-transmembrane (7TM), G protein-coupled receptors, highly conserved residues function as microswitches, which alternate between different conformations and interaction partners in an extended allosteric interface between the transmembrane segments performing the large scale conformational changes upon receptor activation. Computational analysis using x-ray structures of the beta(2)-adrenergic receptor demonstrated that PheVI:09 (6.44), which in the inactive state is locked between the backbone and two hydrophobic residues in transmembrane (TM)-III, upon activation slides similar to 2 angstrom toward TM-V into a tight pocket generated by five hydrophobic residues protruding from TM-III and TM-V. Of these, the residue in position III:16 (3.40) (often an Ile or Val) appears to function as a barrier or gate for the transition between inactive and active conformation. Mutational analysis showed that PheVI:09 is essential for the constitutive and/or agonist-induced signaling of the ghrelin receptor, GPR119, the beta(2)-adrenergic receptor, and the neurokinin-1 receptor. Substitution of the residues constituting the hydrophobic pocket between TM-III and TM-V in the ghrelin receptor in four of five positions impaired receptor signaling. In GPR39, representing the 12% of 7TM receptors lacking an aromatic residue at position VI:09, unchanged agonist-induced signaling was observed upon Ala substitution of LeuVI:09 despite reduced cell surface expression of the mutant receptor. It is concluded that PheVI:09 constitutes an aromatic microswitch that stabilizes the active, outward tilted conformation of TM-VI relative to TM-III by sliding into a tight hydrophobic pocket between TM-III and TM-V and that the hydrophobic residue in position III:16 constitutes a gate for this transition.	[Valentin-Hansen, Louise; Holst, Birgitte; Schwartz, Thue W.] Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, Panum Inst, DK-2200 Copenhagen, Denmark; [Valentin-Hansen, Louise; Holst, Birgitte; Frimurer, Thomas M.; Schwartz, Thue W.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Frimurer, Thomas M.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Schwartz, TW (corresponding author), Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, Panum Inst, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	tws@sund.ku.dk		Holst, Birgitte/0000-0001-7432-097X; Frimruer, Thomas/0000-0002-9682-8245; Schwartz, Thue W./0000-0002-0261-6904	Novo Nordisk Foundation; Faculty of Health Sciences at the University of Copenhagen	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Faculty of Health Sciences at the University of Copenhagen	The Novo Nordisk Foundation Center for Basic Metabolic Research is supported by an unconditional grant from the Novo Nordisk Foundation to the Faculty of Health Sciences at the University of Copenhagen.; Recipient of a Ph.D. scholarship from the Faculty of Health Sciences at the University of Copenhagen.	Alexandrov V, 2005, PROTEIN SCI, V14, P633, DOI 10.1110/ps.04882105; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Baranski TJ, 1999, J BIOL CHEM, V274, P15757, DOI 10.1074/jbc.274.22.15757; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen SH, 2002, BIOCHEMISTRY-US, V41, P6045, DOI 10.1021/bi012189c; Chen SH, 2002, BIOCHEMISTRY-US, V41, P588, DOI 10.1021/bi011868k; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Crocker E, 2006, J MOL BIOL, V357, P163, DOI 10.1016/j.jmb.2005.12.046; Echols N, 2003, NUCLEIC ACIDS RES, V31, P478, DOI 10.1093/nar/gkg104; Govaerts C, 2001, J BIOL CHEM, V276, P22991, DOI 10.1074/jbc.M102244200; Han M, 1996, J BIOL CHEM, V271, P32330, DOI 10.1074/jbc.271.50.32330; Han M, 1996, J BIOL CHEM, V271, P32337, DOI 10.1074/jbc.271.50.32337; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Holst B, 2007, J BIOL CHEM, V282, P15799, DOI 10.1074/jbc.M609796200; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Holst B, 2009, MOL PHARMACOL, V75, P44, DOI 10.1124/mol.108.049189; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jagerschmidt A, 1998, MOL PHARMACOL, V53, P878; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seibold A, 1998, RECEPTOR CHANNEL, V5, P375; Spalding TA, 1998, J BIOL CHEM, V273, P21563, DOI 10.1074/jbc.273.34.21563; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; Valentin-Hansen L, 2012, J BIOL CHEM, V287, P31973, DOI 10.1074/jbc.M112.348565; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	34	27	27	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43516	43526		10.1074/jbc.M112.395137	http://dx.doi.org/10.1074/jbc.M112.395137			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23135271	Green Published, hybrid			2022-12-28	WOS:000312940800032
J	Denu, JM; Gottesfeld, JM				Denu, John M.; Gottesfeld, Joel M.			Minireview Series on Sirtuins: From Biochemistry to Health and Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							METABOLISM		[Denu, John M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Wisconsin Inst Discovery, Madison, WI 53715 USA; [Gottesfeld, Joel M.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of Wisconsin System; University of Wisconsin Madison; Scripps Research Institute	Denu, JM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Wisconsin Inst Discovery, Madison, WI 53715 USA.	jmdenu@wisc.edu		Gottesfeld, Joel/0000-0002-4643-5777	NIGMS NIH HHS [R37 GM059785, R01 GM065386] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059785, R01GM065386] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Guarente L, 2000, GENE DEV, V14, P1021; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; SHORE D, 1984, EMBO J, V3, P2817, DOI 10.1002/j.1460-2075.1984.tb02214.x; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697	4	9	10	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42417	42418		10.1074/jbc.R112.428862	http://dx.doi.org/10.1074/jbc.R112.428862			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23086946	hybrid, Green Published			2022-12-28	WOS:000312501600001
J	Rainczuk, AK; Yamaryo-Botte, Y; Brammananth, R; Stinear, TP; Seemann, T; Coppel, RL; McConville, MJ; Crellin, PK				Rainczuk, Arek K.; Yamaryo-Botte, Yoshiki; Brammananth, Rajini; Stinear, Timothy P.; Seemann, Torsten; Coppel, Ross L.; McConville, Malcolm J.; Crellin, Paul K.			The Lipoprotein LpqW Is Essential for the Mannosylation of Periplasmic Glycolipids in Corynebacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WALL ARABINAN BIOSYNTHESIS; MYCOBACTERIUM-TUBERCULOSIS; PHOSPHATIDYLINOSITOL MANNOSIDES; LIPOARABINOMANNAN BIOSYNTHESIS; MONOPHOSPHOMANNOSE SYNTHASE; DEFICIENT MUTANT; CLONING VECTORS; CONSERVED GENE; MYCOLIC ACIDS; EMB PROTEINS	Phosphatidylinositol mannosides (PIM), lipomannan (LM), and lipoarabinomannan (LAM) are essential components of the cell wall and plasma membrane of mycobacteria, including the human pathogen Mycobacterium tuberculosis, as well as the related Corynebacterineae. We have previously shown that the lipoprotein, LpqW, regulates PIM and LM/LAM biosynthesis in mycobacteria. Here, we provide direct evidence that LpqW regulates the activity of key mannosyltransferases in the periplasmic leaflet of the cell membrane. Inactivation of the Corynebacterium glutamicum lpqW ortholog, NCgl1054, resulted in a slow growth phenotype and a global defect in lipoglycan biosynthesis. The NCgl1054 mutant lacked LAMs and was defective in the elongation of the major PIM species, AcPIM2, as well as a second glycolipid, termed Gl-X (mannose-alpha 1-4-glucuronic acid-alpha 1-diacylglycerol), which function as membrane anchors for LM-A and LM-B, respectively. Elongation of AcPIM2 and Gl-X was found to be dependent on expression of polyprenol phosphomannose (ppMan) synthase. However, the Delta NCgl1054 mutant synthesized normal levels of ppMan, indicating that LpqW is not required for synthesis of this donor. A spontaneous suppressor strain was isolated in which lipoglycan synthesis in the Delta NCgl1054 mutant was partially restored. Genome-wide sequencing indicated that a single amino acid substitution within the ppMan-dependent mannosyltransferase MptB could bypass the need for LpqW. Further evidence of an interaction is provided by the observation that MptB activity in cell-free extracts was significantly reduced in the absence of LpqW. Collectively, our results suggest that LpqW may directly activate MptB, highlighting the role of lipoproteins in regulating key cell wall biosynthetic pathways in these bacteria.	[Rainczuk, Arek K.; Brammananth, Rajini; Coppel, Ross L.; Crellin, Paul K.] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Rainczuk, Arek K.; Brammananth, Rajini; Seemann, Torsten; Coppel, Ross L.; Crellin, Paul K.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Yamaryo-Botte, Yoshiki; McConville, Malcolm J.] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Stinear, Timothy P.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Seemann, Torsten; Coppel, Ross L.] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic 3800, Australia	Monash University; Monash University; University of Melbourne; University of Melbourne; Monash University	Crellin, PK (corresponding author), Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia.	paul.crellin@monash.edu	Coppel, Ross L/A-6626-2008; Seemann, Torsten/B-2318-2010	Coppel, Ross L/0000-0002-4476-9124; Seemann, Torsten/0000-0001-6046-610X; Crellin, Paul K/0000-0002-2017-4935; Yamaryo-Botte, Yoshiki/0000-0002-9349-4411; Stinear, Timothy/0000-0003-0150-123X	Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics [COE562063]; National Health and Medical Research Council of Australia [ID1007676]	Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics (COE562063) and the National Health and Medical Research Council of Australia (Project Grant ID1007676).	Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Alderwick LJ, 2006, J BIOL CHEM, V281, P15653, DOI 10.1074/jbc.M600045200; Alderwick LJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001299; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; Bansal-Mutalik R, 2011, P NATL ACAD SCI USA, V108, P15360, DOI 10.1073/pnas.1112572108; BARKSDALE L, 1970, Bacteriological Reviews, V34, P378; Barry CE, 1996, TRENDS MICROBIOL, V4, P275, DOI 10.1016/0966-842X(96)10031-7; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; Birch HL, 2008, MOL MICROBIOL, V69, P1191, DOI 10.1111/j.1365-2958.2008.06354.x; Chatterjee D, 1998, GLYCOBIOLOGY, V8, P113, DOI 10.1093/glycob/8.2.113; Crellin PK, 2008, J BACTERIOL, V190, P3690, DOI 10.1128/JB.00200-08; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200; Gibson KJC, 2003, J BIOL CHEM, V278, P40842, DOI 10.1074/jbc.M307988200; Guerin ME, 2009, J BIOL CHEM, V284, P25687, DOI 10.1074/jbc.M109.030593; Gurcha SS, 2002, BIOCHEM J, V365, P441, DOI 10.1042/BJ20020107; Haites RE, 2005, J BIOL CHEM, V280, P10981, DOI 10.1074/jbc.M413443200; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Kalscheuer R, 2010, P NATL ACAD SCI USA, V107, P21761, DOI 10.1073/pnas.1014642108; Kaur D, 2007, J BIOL CHEM, V282, P27133, DOI 10.1074/jbc.M703389200; Kaur D, 2006, P NATL ACAD SCI USA, V103, P13664, DOI 10.1073/pnas.0603049103; Kaur D, 2008, P NATL ACAD SCI USA, V105, P17973, DOI 10.1073/pnas.0807761105; Kordulakova J, 2003, J BIOL CHEM, V278, P36285, DOI 10.1074/jbc.M303639200; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kovacevic S, 2006, J BIOL CHEM, V281, P9011, DOI 10.1074/jbc.M511709200; Lea-Smith DJ, 2008, J BIOL CHEM, V283, P6773, DOI 10.1074/jbc.M707139200; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; Marland Z, 2006, J MOL BIOL, V359, P983, DOI 10.1016/j.jmb.2006.04.012; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P7385; McKean S, 2005, MICROBES INFECT, V7, P1352, DOI 10.1016/j.micinf.2005.05.002; Mishra AK, 2008, MOL MICROBIOL, V68, P1595, DOI 10.1111/j.1365-2958.2008.06265.x; Mishra AK, 2008, ANTON LEEUW INT J G, V94, P277, DOI 10.1007/s10482-008-9243-1; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Mishra AK, 2009, J BACTERIOL, V191, P4465, DOI 10.1128/JB.01729-08; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Morita YS, 2005, J BIOL CHEM, V280, P21645, DOI 10.1074/jbc.m414181200; Morita YS, 2004, BIOCHEM J, V378, P589, DOI 10.1042/BJ20031372; Newton GL, 2006, PROTEIN EXPRES PURIF, V47, P542, DOI 10.1016/j.pep.2006.03.003; Nigou J, 2002, MICROBES INFECT, V4, P945, DOI 10.1016/S1286-4579(02)01621-0; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Reyrat JM, 2001, TRENDS MICROBIOL, V9, P472, DOI 10.1016/S0966-842X(01)02168-0; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Seidel M, 2007, J BIOL CHEM, V282, P14729, DOI 10.1074/jbc.M700271200; Seidel M, 2007, GLYCOBIOLOGY, V17, P210, DOI 10.1093/glycob/cwl066; Sena CBC, 2010, J BIOL CHEM, V285, P13326, DOI 10.1074/jbc.M109.077297; Skovierova H, 2009, GLYCOBIOLOGY, V19, P1235, DOI 10.1093/glycob/cwp116; Strohmeier GR, 1999, MICROBES INFECT, V1, P709, DOI 10.1016/S1286-4579(99)80072-0; Tatituri RVV, 2007, J BIOL CHEM, V282, P4561, DOI 10.1074/jbc.M608695200; Thanky NR, 2007, TUBERCULOSIS, V87, P231, DOI 10.1016/j.tube.2006.10.004; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; Vercellone A, 1998, FRONT BIOSCI-LANDMRK, V3, pE149; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang N, 2003, MOL MICROBIOL, V50, P69, DOI 10.1046/j.1365-2958.2003.03681.x	59	17	17	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42726	42738		10.1074/jbc.M112.373415	http://dx.doi.org/10.1074/jbc.M112.373415			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23091062	Green Published, hybrid			2022-12-28	WOS:000312501600032
J	Wang, W; Guo, MX; Hu, L; Cai, JY; Zeng, Y; Luo, J; Shu, ZQ; Li, WX; Huang, Z				Wang, Wei; Guo, Mingxiong; Hu, Li; Cai, Jinyang; Zeng, Yan; Luo, Jun; Shu, Zhiqiang; Li, Wenxin; Huang, Zan			The Zinc Finger Protein ZNF268 Is Overexpressed in Human Cervical Cancer and Contributes to Tumorigenesis via Enhancing NF-kappa B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; CELL-CYCLE; HUMAN-PAPILLOMAVIRUS; SPLICE VARIANTS; MESSENGER-RNA; UP-REGULATION; GENE ZNF268; TRANSCRIPTION; EXPRESSION; IDENTIFICATION	Cervical cancer is one of the most common tumors affecting women's health worldwide. Although human papillomavirus can be detected in nearly all cases, the mechanism of cervical carcinogenesis remains to be further addressed. Here, we demonstrated that ZNF268, a Kruppel-associated box-containing zinc finger protein, might contribute to the development of cervical cancer. We found that ZNF268b2, an isoform of ZNF268, was overexpressed in human squamous cervical cancer specimens. Knockdown of ZNF268 in cervical cancer cells caused cell cycle arrest at the G(0)/G(1) phase, reduced colony formation, and increased sensitivity to TNF alpha-induced apoptosis. In addition, HeLa cell growth in xenograft nude mice was suppressed by ZNF268 knockdown, with increased apoptosis. Furthermore, ZNF268b2 was shown to increase NF-kappa B signaling in vitro and in vivo. Reconstitution of NF-kappa B activity restored proliferation in ZNF268 knockdown HeLa cells. Of note, we observed a high frequency of NF-kappa B activation in ZNF268-overexpressing cervical cancer tissues, suggesting a pathological coincidence of ZNF268b2 overexpression and NF-kappa B activation. Taken together, our results reveal a novel role of ZNF268b2 that contributes to cervical carcinogenesis in part through enhancing NF-kappa B signaling.	[Wang, Wei; Guo, Mingxiong; Hu, Li; Cai, Jinyang; Zeng, Yan; Shu, Zhiqiang; Li, Wenxin] Wuhan Univ, Zhongnan Hosp, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Wang, Wei; Guo, Mingxiong; Hu, Li; Cai, Jinyang; Zeng, Yan; Shu, Zhiqiang; Li, Wenxin; Huang, Zan] Wuhan Univ, Zhongnan Hosp, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Luo, Jun] Wuhan Univ, Zhongnan Hosp, Dept Pathol, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Li, WX (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	liwxlab@whu.edu.cn; z-huang@whu.edu.cn	Cai, Jinyang/HCH-0290-2022	Huang, Zan/0000-0001-5623-6950; Wang, Wei/0000-0001-7429-1013; Cai, Jinyang/0000-0002-7385-8281; Wang, Wei/0000-0002-6179-4188	National High Technology Research and Development Program of China (863 Program) [2006AA02A306]; National Natural Science Foundation of China [30871245, 31271511, 30700412, 81070406]; Specialized Research Fund for the Doctoral Program of Higher Education of China [200804861004]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National High Technology Research and Development Program of China (863 Program) Grant 2006AA02A306 (to W. L.), National Natural Science Foundation of China Grants 30871245 and 31271511 (to M. G.) and 30700412 and 81070406 (to Z. H.), and Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 200804861004 (to M. G.).	BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Branca M, 2006, DIAGN CYTOPATHOL, V34, P555, DOI 10.1002/dc.20514; Brinkman BMN, 2004, CLIN BIOCHEM, V37, P584, DOI 10.1016/j.clinbiochem.2004.05.015; Chen C, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/9/095101; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chun JN, 2008, MOL CELLS, V26, P175; Engelmark MT, 2006, HUM MOL GENET, V15, P3351, DOI 10.1093/hmg/ddl411; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Gou DM, 2001, BBA-GENE STRUCT EXPR, V1518, P306, DOI 10.1016/S0167-4781(01)00194-4; Guo MX, 2006, J BIOL CHEM, V281, P24623, DOI 10.1074/jbc.M602753200; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Krackhardt AM, 2002, BLOOD, V100, P2123, DOI 10.1182/blood-2002-02-0513; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Magnusson PKE, 2000, INT J CANCER, V88, P698, DOI 10.1002/1097-0215(20001201)88:5<698::AID-IJC3>3.0.CO;2-J; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Nair A, 2003, ONCOGENE, V22, P50, DOI 10.1038/sj.onc.1206043; Philip M, 2004, SEMIN CANCER BIOL, V14, P433, DOI 10.1016/j.semcancer.2004.06.006; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; Rosenberger S, 2010, P NATL ACAD SCI USA, V107, P7006, DOI 10.1073/pnas.1002620107; Shao HJ, 2006, INT J MOL MED, V18, P457; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Suganuma M, 1999, CANCER RES, V59, P4516; Sun Y, 2004, INT J MOL MED, V14, P971; Sun Y, 2003, IUBMB LIFE, V55, P127, DOI 10.1080/1521654031000110208; Tjiong MY, 2001, CYTOKINE, V14, P357, DOI 10.1006/cyto.2001.0909; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Vieira KBL, 1996, CANCER RES, V56, P2452; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang D, 2008, J BIOL CHEM, V283, P16299, DOI 10.1074/jbc.M706426200; Wang SC, 2005, ANN NY ACAD SCI, V1059, P11, DOI 10.1196/annals.1339.002; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wilting SM, 2008, GENE CHROMOSOME CANC, V47, P890, DOI 10.1002/gcc.20590; Woerner SM, 1995, CLIN CANCER RES, V1, P1125; Zeng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029518	41	25	31	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42856	42866		10.1074/jbc.M112.399923	http://dx.doi.org/10.1074/jbc.M112.399923			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23091055	Green Published, hybrid			2022-12-28	WOS:000312501600044
J	Zhang, WS; Prakash, C; Sum, C; Gong, Y; Li, YH; Kwok, JJT; Thiessen, N; Pettersson, S; Jones, SJM; Knapp, S; Yang, H; Chin, KC				Zhang, Weishi; Prakash, Celine; Sum, Calvin; Gong, Yue; Li, Yinghui; Kwok, Jeffrey J. T.; Thiessen, Nina; Pettersson, Sven; Jones, Steven J. M.; Knapp, Stefan; Yang, Henry; Chin, Keh-Chuang			Bromodomain-containing Protein 4 (BRD4) Regulates RNA Polymerase II Serine 2 Phosphorylation in Human CD4+T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; NF-KAPPA-B; GENE-EXPRESSION; HUMAN GENOME; TRANSCRIPTIONAL ELONGATION; P-TEFB; TERMINAL DOMAIN; C-MYC; CHROMATIN; ENHANCERS	Transcriptional elongation by RNA polymerase II (Pol II) is regulated by positive transcription elongation factor b (P-TEFb) in association with bromodomain-containing protein 4 (BRD4). We used genome-wide chromatin immunoprecipitation sequencing in primary human CD4+ T cells to reveal that BRD4 co-localizes with Ser-2-phosphorylated Pol II (Pol II Ser-2) at both enhancers and promoters of active genes. Disruption of bromodomain-histone acetylation interactions by JQ1, a small-molecule bromodomain inhibitor, resulted in decreased BRD4 binding, reduced Pol II Ser-2, and reduced expression of lineage-specific genes in primary human CD4+ T cells. A large number of JQ1-disrupted BRD4 binding regions exhibited diacetylated H4 (lysine 5 and -8) and H3K27 acetylation (H3K27ac), which correlated with the presence of histone acetyltransferases and deacetylases. Genes associated with BRD4/H3K27ac co-occupancy exhibited significantly higher activity than those associated with H3K27ac or BRD4 binding alone. Comparison of BRD4 binding in T cells and in human embryonic stem cells revealed that enhancer BRD4 binding sites were predominantly lineage-specific. Our findings suggest that BRD4-driven Pol II phosphorylation at serine 2 plays an important role in regulating lineage-specific gene transcription in human CD4+ T cells.	[Zhang, Weishi; Prakash, Celine; Sum, Calvin; Gong, Yue; Li, Yinghui; Kwok, Jeffrey J. T.; Chin, Keh-Chuang] ASTAR, Lab Gene Regulat & Inflammat, Singapore Immunol Network SIgN, Biopolis, Singapore 138648, Singapore; [Pettersson, Sven] Karolinska Inst, Dept Microbiol Cell & Tumor Biol, S-17177 Stockholm, Sweden; [Thiessen, Nina; Jones, Steven J. M.] Canadas Michael Smith Genome Sci Ctr, Bioinformat Lab, Vancouver, BC V5Z 1L3, Canada; [Knapp, Stefan] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Yang, Henry] ASTAR, Bioinformat Grp, Singapore Immunol Network SIgN, Biopolis, Singapore 138648, Singapore; [Chin, Keh-Chuang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117573, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Karolinska Institutet; University of Oxford; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore	Chin, KC (corresponding author), ASTAR, Lab Gene Regulat & Inflammat, Singapore Immunol Network SIgN, Biopolis, Immunos 04-00,8A Biomed Grove, Singapore 138648, Singapore.	kehchuang_chin@immunol.a-star.edu.sg	Li, Yinghui/K-8253-2018; Knapp, Stefan/AAG-2347-2019; Pettersson, Sven/F-9511-2015; Jones, Steven J/C-3621-2009	Knapp, Stefan/0000-0001-5995-6494; Jones, Steven J/0000-0003-3394-2208; Li, Yinghui/0000-0002-9023-9466; Sum, Calvin/0000-0002-7713-2752; Prakash, Celine/0000-0002-3905-5768	SIgN (A*STAR, Singapore)	SIgN (A*STAR, Singapore)	This work was supported by SIgN (A*STAR, Singapore).	Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Devaiah BN, 2012, P NATL ACAD SCI USA, V109, P6927, DOI 10.1073/pnas.1120422109; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Hochheimer A, 2003, GENE DEV, V17, P1309, DOI 10.1101/gad.1099903; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Johnson KD, 2003, MOL CELL BIOL, V23, P6484, DOI 10.1128/MCB.23.18.6484-6493.2003; Johnson KD, 2001, MOL CELL, V8, P465, DOI 10.1016/S1097-2765(01)00309-4; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Lian Z, 2008, GENOME RES, V18, P1224, DOI 10.1101/gr.075804.107; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Louie MC, 2003, P NATL ACAD SCI USA, V100, P2226, DOI 10.1073/pnas.0437824100; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Szutorisz H, 2005, TRENDS BIOCHEM SCI, V30, P593, DOI 10.1016/j.tibs.2005.08.006; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	44	128	162	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43137	43155		10.1074/jbc.M112.413047	http://dx.doi.org/10.1074/jbc.M112.413047			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23086925	hybrid, Green Published			2022-12-28	WOS:000312501600069
J	Mehne, FMP; Gunka, K; Eilers, H; Herzberg, C; Kaever, V; Stulke, J				Mehne, Felix M. P.; Gunka, Katrin; Eilers, Hinnerk; Herzberg, Christina; Kaever, Volkhard; Stuelke, Joerg			Cyclic Di-AMP Homeostasis in Bacillus subtilis BOTH LACK AND HIGH LEVEL ACCUMULATION OF THE NUCLEOTIDE ARE DETRIMENTAL FOR CELL GROWTH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHECKPOINT PROTEIN; TRANSCRIPTION; RNA; GMP; IDENTIFICATION; STRESS; BACTERIA; REVEALS; OPERON; GENES	The genome of the Gram-positive soil bacterium Bacillus subtilis encodes three potential diadenylate cyclases that may synthesize the signaling nucleotide cyclic di-AMP (c-di-AMP). These enzymes are expressed under different conditions in different cell compartments, and they localize to distinct positions in the cell. Here we demonstrate the diadenylate cyclase activity of the so far uncharacterized enzymes CdaA (previously known as YbbP) and CdaS (YojJ). Our work confirms that c-di-AMP is essential for the growth of B. subtilis and shows that an excess of the molecule is also harmful for the bacteria. Several lines of evidence suggest that the diadenylate cyclase CdaA is part of the conserved essential cda-glm module involved in cell wall metabolism. In contrast, the CdaS enzyme seems to provide c-di-AMP for spores. Accumulation of large amounts of c-di-AMP impairs the growth of B. subtilis and results in the formation of aberrant curly cells. This phenotype can be partially suppressed by elevated concentrations of magnesium. These observations suggest that c-di-AMP interferes with the peptidoglycan synthesis machinery. The activity of the diadenylate cyclases is controlled by distinct molecular mechanisms. CdaA is stimulated by a regulatory interaction with the CdaR (YbbR) protein. In contrast, the activity of CdaS seems to be intrinsically restricted, and a single amino acid substitution is sufficient to drastically increase the activity of the enzyme. Taken together, our results support the idea of an important role for c-di-AMP in B. subtilis and suggest that the levels of the nucleotide have to be tightly controlled.	[Mehne, Felix M. P.; Gunka, Katrin; Eilers, Hinnerk; Herzberg, Christina; Stuelke, Joerg] Univ Gottingen, Dept Gen Microbiol, Inst Microbiol & Genet, D-37077 Gottingen, Germany; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Mass Spectrometry Metab, D-30625 Hannover, Germany; [Kaever, Volkhard] Hannover Med Sch, Inst Pharmacol, D-30625 Hannover, Germany	University of Gottingen; Hannover Medical School; Hannover Medical School	Stulke, J (corresponding author), Univ Gottingen, Dept Gen Microbiol, Inst Microbiol & Genet, Grisebachstr 8, D-37077 Gottingen, Germany.	jstuelk@gwdg.de	Kaever, Volkhard/G-3280-2013; Stülke, Jörg/AAD-1600-2021	Stulke, Jorg/0000-0001-5881-5390	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to J. S.).	Barb AW, 2011, PROTEIN SCI, V20, P396, DOI 10.1002/pro.571; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Cannon W, 1999, GENE DEV, V13, P357, DOI 10.1101/gad.13.3.357; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chen Y, 2012, J BACTERIOL, V194, P5080, DOI 10.1128/JB.01092-12; Collins JA, 2007, GENE DEV, V21, P3356, DOI 10.1101/gad.1605307; Commichau FM, 2007, MOL MICROBIOL, V65, P642, DOI 10.1111/j.1365-2958.2007.05816.x; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; DAHL MK, 1994, J MOL BIOL, V243, P413, DOI 10.1006/jmbi.1994.1669; Diethmaier C, 2011, J BACTERIOL, V193, P5997, DOI 10.1128/JB.05360-11; Formstone A, 2005, MOL MICROBIOL, V55, P1646, DOI 10.1111/j.1365-2958.2005.04506.x; Gardan R, 1997, MOL MICROBIOL, V24, P825, DOI 10.1046/j.1365-2958.1997.3881754.x; GARTNER D, 1992, MOL GEN GENET, V232, P415; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; Gongadze GM, 1999, FEBS LETT, V451, P51, DOI 10.1016/S0014-5793(99)00538-4; Gorke B, 2005, MICROBIOL-SGM, V151, P3777, DOI 10.1099/mic.0.28172-0; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Hahne H, 2008, PROTEOMICS, V8, P4123, DOI 10.1002/pmic.200800258; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Herzberg C, 2007, PROTEOMICS, V7, P4032, DOI 10.1002/pmic.200700491; Jervis AJ, 2007, J BACTERIOL, V189, P4534, DOI 10.1128/JB.00130-07; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kawai Y, 2009, MOL MICROBIOL, V71, P1131, DOI 10.1111/j.1365-2958.2009.06601.x; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Krasny L, 2008, MOL MICROBIOL, V69, P42, DOI 10.1111/j.1365-2958.2008.06256.x; Kriel A, 2012, MOL CELL, V48, P231, DOI 10.1016/j.molcel.2012.08.009; Kruger E, 1996, MOL MICROBIOL, V20, P713, DOI 10.1111/j.1365-2958.1996.tb02511.x; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Lehnik-Habrink M, 2011, MOL MICROBIOL, V81, P1459, DOI 10.1111/j.1365-2958.2011.07777.x; Lehnik-Habrink M, 2010, MOL MICROBIOL, V77, P958, DOI 10.1111/j.1365-2958.2010.07264.x; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Mader U, 2012, NUCLEIC ACIDS RES, V40, pD1278, DOI 10.1093/nar/gkr923; Murray T, 1998, J BACTERIOL, V180, P4555, DOI 10.1128/JB.180.17.4555-4563.1998; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Petsko G., 2004, PROTEIN STRUCTURE FU, P86; Pottathil M, 2003, FRONT BIOSCI-LANDMRK, V8, pD32, DOI 10.2741/913; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Sambrook J., 2001, MOL CLONING LAB MANU; Schilling O, 2007, APPL ENVIRON MICROB, V73, P499, DOI 10.1128/AEM.02084-06; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmalisch M, 2002, J MOL MICROB BIOTECH, V4, P495; Seshasayee ASN, 2010, NUCLEIC ACIDS RES, V38, P5970, DOI 10.1093/nar/gkq382; Song JH, 2005, MOL CELLS, V19, P365; Spangler C, 2010, J MICROBIOL METH, V81, P226, DOI 10.1016/j.mimet.2010.03.020; Stulke J, 1997, MOL MICROBIOL, V25, P65, DOI 10.1046/j.1365-2958.1997.4351797.x; Thoendel M, 2010, ADV APPL MICROBIOL, V71, P91, DOI 10.1016/S0065-2164(10)71004-2; Tojo S, 2010, J BACTERIOL, V192, P1573, DOI 10.1128/JB.01394-09; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801	54	142	156	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2004	2017		10.1074/jbc.M112.395491	http://dx.doi.org/10.1074/jbc.M112.395491			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23192352	hybrid, Green Published			2022-12-28	WOS:000313751400052
J	Naura, AS; Kim, H; Ju, JH; Rodriguez, PC; Jordan, J; Catling, AD; Rezk, BM; Abd Elmageed, ZY; Pyakurel, K; Tarhuni, AF; Abughazleh, MQ; Errami, Y; Zerfaoui, M; Ochoa, AC; Boulares, AH				Naura, Amarjit S.; Kim, Hogyoung; Ju, Jihang; Rodriguez, Paulo C.; Jordan, Joaquin; Catling, Andrew D.; Rezk, Bashir M.; Abd Elmageed, Zakaria Y.; Pyakurel, Kusma; Tarhuni, Abdelmetalab F.; Abughazleh, Mohammad Q.; Errami, Youssef; Zerfaoui, Mourad; Ochoa, Augusto C.; Boulares, A. Hamid			Minocycline Blocks Asthma-associated Inflammation in Part by Interfering with the T Cell Receptor-Nuclear Factor kappa B-GATA-3-IL-4 Axis without a Prominent Effect on Poly(ADP-ribose) Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLERGIC AIRWAY INFLAMMATION; FACTOR-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; MURINE MODEL; PROTEIN-KINASE; TH2 CYTOKINES; IGE RESPONSES; ACTIVATION; INHIBITION; PREVENTS	Minocycline protects against asthma independently of its antibiotic function and was recently reported as a potent poly(ADP-ribose) polymerase (PARP) inhibitor. In an animal model of asthma, a single administration of minocycline conferred excellent protection against ovalbumin-induced airway eosinophilia, mucus hypersecretion, and Th2 cytokine production (IL-4/IL-5/IL-12(p70)/IL-13/GM-CSF) and a partial protection against airway hyperresponsiveness. These effects correlated with pronounced reduction in lung and sera allergen-specific IgE. A reduction in poly(ADP-ribose) immunoreactivity in the lungs of minocycline-treated/ovalbumin-challenged mice correlated with decreased oxidative DNA damage. The effect of minocycline on PARP may be indirect, as the drug failed to efficiently block direct PARP activation in lungs of N-methyl-N'-nitro-N-nitroso-guanidine-treated mice or H2O2-treated cells. Minocycline blocked allergen-specific IgE production in B cells potentially by modulating T cell receptor (TCR)-linked IL-4 production at the mRNA level but not through a modulation of the IL-4-JAK-STAT-6 axis, IL-2 production, or NFAT1 activation. Restoration of IL-4, ex vivo, rescued IgE production by minocycline-treated/ovalbumin-stimulated B cells. IL-4 blockade correlated with a preferential inhibition of the NF-kappa B activation arm of TCR but not GSK3, Src, p38 MAPK, or ERK1/2. Interestingly, the drug promoted a slightly higher Src and ERK1/2 phosphorylation. Inhibition of NF-kappa B was linked to a complete blockade of TCR-stimulated GATA-3 expression, a pivotal transcription factor for IL-4 expression. Minocycline also reduced TNF-alpha-mediated NF-kappa B activation and expression of dependent genes. These results show a potentially broad effect of minocycline but that it may block IgE production in part by modulating TCR function, particularly by inhibiting the signaling pathway, leading to NF-kappa B activation, GATA-3 expression, and subsequent IL-4 production.	[Naura, Amarjit S.; Kim, Hogyoung; Ju, Jihang; Rodriguez, Paulo C.; Catling, Andrew D.; Abd Elmageed, Zakaria Y.; Pyakurel, Kusma; Tarhuni, Abdelmetalab F.; Abughazleh, Mohammad Q.; Errami, Youssef; Zerfaoui, Mourad; Ochoa, Augusto C.; Boulares, A. Hamid] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; [Kim, Hogyoung; Ju, Jihang; Catling, Andrew D.; Pyakurel, Kusma; Tarhuni, Abdelmetalab F.; Errami, Youssef; Zerfaoui, Mourad; Boulares, A. Hamid] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Naura, Amarjit S.] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70112 USA; [Jordan, Joaquin] Univ Castilla La Mancha, Dpto Ciencias Med, Fac Med, Albacete 02006, Spain; [Rezk, Bashir M.] So Univ New Orleans, Dept Nat Sci, New Orleans, LA 70126 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Universidad de Castilla-La Mancha; Southern University System; Southern University New Orleans	Naura, AS (corresponding author), 533 Bolivar St 701 509, New Orleans, LA 70112 USA.	anaura@lsuhsc.edu; hboulr@lsuhsc.edu	Elmageed, Zakaria Y Abd/O-3456-2018; Rodríguez, Paulo/HDM-9539-2022	Elmageed, Zakaria Y Abd/0000-0003-4031-0348; Rodriguez, Paulo/0000-0001-7480-6566; jordan, joaquin/0000-0002-6809-3384; Errami, Youssef/0000-0002-0432-4331	National Institutes of Health [HL072889]; American Cancer Society [RSG-116608]; National Institutes of Health/COBRE [P20GM103501]; NATIONAL CANCER INSTITUTE [R21CA162133, R01CA107974] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Institutes of Health/COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grant HL072889 from National Institutes of Health and grant RSG-116608 from the American Cancer Society (to A. H. B.). This work was also supported by grant National Institutes of Health/COBRE P20GM103501 (to A. S. N., with A. C. O. as overall Program Director).	Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Adcock IM, 2008, LANCET, V372, P1073, DOI 10.1016/S0140-6736(08)61449-X; Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; ALVAREZGONZALEZ R, 1989, MUTAT RES, V218, P67, DOI 10.1016/0921-8777(89)90012-8; Avila PC, 2007, ANNU REV MED, V58, P185, DOI 10.1146/annurev.med.58.061705.145252; Ba XQ, 2011, AM J PATHOL, V178, P946, DOI 10.1016/j.ajpath.2010.12.004; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Barnes PJ, 2006, TRENDS MOL MED, V12, P515, DOI 10.1016/j.molmed.2006.09.006; Barnes PJ, 2006, LAB INVEST, V86, P867, DOI 10.1038/labinvest.3700456; Boulares AH, 2003, AM J RESP CELL MOL, V28, P322, DOI 10.1165/rcmb.2001-0015OC; Busse PJ, 2007, CLIN EXP ALLERGY, V37, P1392, DOI 10.1111/j.1365-2222.2007.02775.x; Cohausz O, 2008, CELL MOL LIFE SCI, V65, P644, DOI 10.1007/s00018-008-7516-5; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Daoud A, 2008, ALLERGY ASTHMA PROC, V29, P286, DOI 10.2500/aap.2008.29.3121; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Fernandes A, 2009, CURR PHARM DESIGN, V15, P2915, DOI 10.2174/138161209789058165; Gagliardo R, 2003, AM J RESP CRIT CARE, V168, P1190, DOI 10.1164/rccm.200205-479OC; Gagliardo R, 2011, J ALLERGY CLIN IMMUN, V128, P635, DOI 10.1016/j.jaci.2011.03.045; Hamelmann Eckard, 2008, Clin Allergy Immunol, V21, P415; Hart LA, 1998, AM J RESP CRIT CARE, V158, P1585, DOI 10.1164/ajrccm.158.5.9706116; Huang TY, 2009, BIOCHEM BIOPH RES CO, V389, P634, DOI 10.1016/j.bbrc.2009.09.041; Huang TY, 2009, TOXICOL APPL PHARM, V237, P69, DOI 10.1016/j.taap.2009.02.026; Hutchison S, 2008, CLIN EXP IMMUNOL, V151, P114, DOI 10.1111/j.1365-2249.2007.03509.x; Joks R, 2011, PHARMACOL RES, V64, P602, DOI 10.1016/j.phrs.2011.04.001; Joks R, 2010, INT IMMUNOL, V22, P281, DOI 10.1093/intimm/dxq004; Jordan J., 2007, Current Drug Delivery, V4, P225; Ju JH, 2010, J BIOL CHEM, V285, P41152, DOI 10.1074/jbc.M110.158352; Kuang XH, 2009, BRAIN RES, V1286, P174, DOI 10.1016/j.brainres.2009.06.007; Kuzin II, 2001, INT IMMUNOL, V13, P921, DOI 10.1093/intimm/13.7.921; Le Saux CJ, 2008, J BIOL CHEM, V283, P5760, DOI 10.1074/jbc.M701572200; Lee KS, 2004, J ALLERGY CLIN IMMUN, V113, P902, DOI 10.1016/j.jaci.2004.03.008; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Garcia-Martinez EM, 2010, BIOCHEM PHARMACOL, V79, P239, DOI 10.1016/j.bcp.2009.07.028; Matera MG, 2010, PULM PHARMACOL THER, V23, P121, DOI 10.1016/j.pupt.2009.10.007; Mustapha O, 2006, J IMMUNOL, V177, P6489, DOI 10.4049/jimmunol.177.9.6489; Naura AS, 2008, CLIN EXP ALLERGY, V38, P839, DOI 10.1111/j.1365-2222.2008.02943.x; Naura AS, 2009, EUR RESPIR J, V33, P252, DOI 10.1183/09031936.00089008; Naura AS, 2010, J IMMUNOL, V185, P3076, DOI 10.4049/jimmunol.0904214; Nikodemova M, 2006, J NEUROCHEM, V96, P314, DOI 10.1111/j.1471-4159.2005.03520.x; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Padi SSV, 2008, EUR J PHARMACOL, V601, P79, DOI 10.1016/j.ejphar.2008.10.018; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Sandler C, 2005, INFLAMM RES, V54, P304, DOI 10.1007/s00011-005-1358-5; Smith-Norowitz TA, 2002, ANN ALLERG ASTHMA IM, V89, P172, DOI 10.1016/S1081-1206(10)61934-5; Steinke JW, 2001, RESP RES, V2, P66, DOI 10.1186/rr40; Suzuki Y, 2004, J PHARMACOL EXP THER, V311, P1241, DOI 10.1124/jpet.104.072546; Szeto GL, 2011, J BIOL CHEM, V286, P11275, DOI 10.1074/jbc.M110.210518; Tao R, 2010, J CARDIOVASC PHARM, V56, P659, DOI 10.1097/FJC.0b013e3181faeaf0; Yamashita N, 2006, AM J PHYSIOL-LUNG C, V290, pL1045, DOI 10.1152/ajplung.00195.2005; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P4766, DOI 10.1167/iovs.06-0871	50	19	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1458	1468		10.1074/jbc.M112.419580	http://dx.doi.org/10.1074/jbc.M112.419580			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184953	hybrid, Green Published			2022-12-28	WOS:000313751400004
J	Hayner, JN; Bloom, LB				Hayner, Jaclyn N.; Bloom, Linda B.			The beta Sliding Clamp Closes around DNA prior to Release by the Escherichia coli Clamp Loader gamma Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-III HOLOENZYME; CHROMOSOMAL REPLICATION MACHINE; ATP HYDROLYSIS; CRYSTAL-STRUCTURE; BINDING PROTEIN; SUBUNIT; MECHANISM; DELTA; PURIFICATION; DYNAMICS	Escherichia coli gamma complex clamp loader functions to load the beta sliding clamp onto sites of DNA replication and repair. The clamp loader uses the energy of ATP binding and hydrolysis to drive conformational changes allowing for beta binding and opening, DNA binding, and then release of the beta center dot DNA complex. Although much work has been done studying the sliding clamp and clamp loader mechanism, kinetic analysis of the events following beta center dot gamma complex center dot DNA formation is not complete. Using fluorescent clamp closing and release assays, we show that beta closing is faster than beta release, indicating that gamma complex closes beta before releasing it around DNA. Using a fluorescent ATP hydrolysis assay, we show that there is a burst of ATP hydrolysis before beta closing and that beta release may be the rate-limiting step in the overall clamp loading reaction. The combined use of these fluorescent assays provides a unique perspective into the E. coli clamp loader by providing a measure of the relative timing of different events in the clamp loading reaction, helping to elucidate the complicated clamp loading mechanism.	[Hayner, Jaclyn N.; Bloom, Linda B.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Bloom, LB (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	lbloom@ufl.edu	Bloom, Linda B/F-3684-2014		National Institutes of Health [R01 GM082849]; Training Grant in Cancer Biology Grant [5 T32 CA009126-32]; NATIONAL CANCER INSTITUTE [T32CA009126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Grant in Cancer Biology Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM082849 (to L. B. B.) and the Training Grant in Cancer Biology Grant 5 T32 CA009126-32 (to J. N. H.).	Anderson SG, 2009, BIOCHEMISTRY-US, V48, P8516, DOI 10.1021/bi900912a; Bertram JG, 2000, J BIOL CHEM, V275, P28413, DOI 10.1074/jbc.M910441199; Bertram JG, 1998, J BIOL CHEM, V273, P24564, DOI 10.1074/jbc.273.38.24564; Bloom LB, 1996, J BIOL CHEM, V271, P30699, DOI 10.1074/jbc.271.48.30699; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Chen S, 2008, NUCLEIC ACIDS RES, V36, P3274, DOI 10.1093/nar/gkn157; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; de Saro FL, 2004, PHILOS T R SOC B, V359, P25, DOI 10.1098/rstb.2003.1361; DONG ZM, 1993, J BIOL CHEM, V268, P11758; Downey CD, 2011, J MOL BIOL, V412, P340, DOI 10.1016/j.jmb.2011.07.051; Downey CD, 2010, MOL CELL, V37, P481, DOI 10.1016/j.molcel.2010.01.013; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fang J, 2011, BIOCHEMISTRY-US, V50, P5958, DOI 10.1021/bi200580b; Georgescu RE, 2008, P NATL ACAD SCI USA, V105, P11116, DOI 10.1073/pnas.0804754105; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Hingorani MM, 1999, EMBO J, V18, P5131, DOI 10.1093/emboj/18.18.5131; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Johnson A, 2003, J BIOL CHEM, V278, P14406, DOI 10.1074/jbc.M212708200; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Leu FP, 2001, J BIOL CHEM, V276, P47185, DOI 10.1074/jbc.M106780200; MAKI S, 1988, J BIOL CHEM, V263, P6547; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; Oakley AJ, 2003, ACTA CRYSTALLOGR D, V59, P1192, DOI 10.1107/S0907444903009958; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; Paschall CO, 2011, J BIOL CHEM, V286, P42704, DOI 10.1074/jbc.M111.268169; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Tainer JA, 2010, J AM CHEM SOC, V132, P7372, DOI 10.1021/ja100365x; Thompson JA, 2009, J BIOL CHEM, V284, P32147, DOI 10.1074/jbc.M109.045997; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Wieczorek A, 2010, J BIOL CHEM, V285, P29049, DOI 10.1074/jbc.C110.165076; Williams CR, 2004, J BIOL CHEM, V279, P4376, DOI 10.1074/jbc.M310429200; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x	49	12	12	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1162	1170		10.1074/jbc.M112.406231	http://dx.doi.org/10.1074/jbc.M112.406231			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23161545	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000313570300038
J	Trickey, M; Fujimitsu, K; Yamano, H				Trickey, Michelle; Fujimitsu, Kazuyuki; Yamano, Hiroyuki			Anaphase-promoting Complex/Cyclosome-mediated Proteolysis of Ams2 in the G(1) Phase Ensures the Coupling of Histone Gene Expression to DNA Replication in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; S-PHASE; TRANSCRIPTION FACTOR; CHROMOSOME SEGREGATION; LYSINE-56 ACETYLATION; UBIQUITIN LIGASE; MEIOSIS; APC/C; DESTRUCTION; CHECKPOINT	Histone transcription and deposition are tightly regulated with the DNA replication cycle to maintain genetic integrity. Ams2 is a GATA-containing transcription factor responsible for core histone gene expression and for CENP-A loading at centromeres in fission yeast. Ams2 levels are cell cycle-regulated, and after the S phase Ams2 is degraded by the SCFpof3 ubiquitin ligase; however, the regulation of Ams2 in G(1) or meiosis is poorly understood. Here we show that another ubiquitin ligase, the anaphase-promoting complex/cyclosome (APC/C) targets Ams2 for destruction in G(1). Ubiquitylation and destruction of Ams2 is dependent upon a coactivator Cdh1/Ste9 and the KEN box in the C terminus of Ams2. We also find that stabilization of Ams2 sensitizes cells to the anti-microtubule drug thiabendazole and the histone deacetylase inhibitor tricostatin A when a histone deacetylase gene hst4 is deleted, suggesting that histone acetylation together with Ams2 stability ensures the coupling of mitosis to DNA replication. Furthermore, in meiosis, the failure of the APC/C-mediated destruction of Ams2 is deleterious, and pre-meiotic DNA replication is barely completed. These data suggest that Ams2 destruction via both the APC/C and the SCF ubiquitin ligases underlies the coordination of histone expression and DNA replication.	[Trickey, Michelle; Fujimitsu, Kazuyuki; Yamano, Hiroyuki] UCL, Cell Cycle Control Grp, UCL Canc Inst, London WC1E 6BT, England	University of London; University College London	Yamano, H (corresponding author), UCL, Cell Cycle Control Grp, UCL Canc Inst, Mortimer St, London WC1E 6BT, England.	h.yamano@ucl.ac.uk			Marie Curie Cancer Care; Association for International Cancer Research; Cancer Research UK; Cancer Research UK [13586] Funding Source: researchfish; Worldwide Cancer Research [09-0658] Funding Source: researchfish	Marie Curie Cancer Care; Association for International Cancer Research; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	This work was supported by Marie Curie Cancer Care, the Association for International Cancer Research and Cancer Research UK.	Beckerman R, 2009, GENE DEV, V23, P1364, DOI 10.1101/gad.1795709; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Blackwell C, 2004, MOL CELL BIOL, V24, P4309, DOI 10.1128/MCB.24.10.4309-4320.2004; Borgne A, 2002, MOL BIOL CELL, V13, P2080, DOI 10.1091/mbc.01-10-0507; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; de Bruin RAM, 2009, CELL CYCLE, V8, P214, DOI 10.4161/cc.8.2.7412; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Fillingham J, 2009, MOL CELL, V35, P340, DOI 10.1016/j.molcel.2009.06.023; Grewal SIS, 1998, GENETICS, V150, P563; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Haldar D, 2008, EUKARYOT CELL, V7, P800, DOI 10.1128/EC.00379-07; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Izawa D, 2005, NATURE, V434, P529, DOI 10.1038/nature03406; Kawamura T, 2005, J BIOL CHEM, V280, P19682, DOI 10.1074/jbc.M412428200; Kimata Y, 2008, DEV CELL, V14, P446, DOI 10.1016/j.devcel.2007.12.010; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Koseoglu MM, 2010, CELL CYCLE, V9, P3857, DOI 10.4161/cc.9.19.13300; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Mallory MJ, 2007, MOL CELL, V27, P951, DOI 10.1016/j.molcel.2007.08.019; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murakami H, 1999, GENE DEV, V13, P2581, DOI 10.1101/gad.13.19.2581; Murakami-Tonami Y, 2007, P NATL ACAD SCI USA, V104, P14688, DOI 10.1073/pnas.0702906104; MURRAY AW, 1989, J CELL SCI, P65; Ors A, 2009, J BIOL CHEM, V284, P23989, DOI 10.1074/jbc.M109.018309; Park HJ, 2008, MOL CELL BIOL, V28, P5162, DOI 10.1128/MCB.00387-08; Perkins G, 2001, EMBO J, V20, P4836, DOI 10.1093/emboj/20.17.4836; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Takayama Y, 2007, NUCLEIC ACIDS RES, V35, P3223, DOI 10.1093/nar/gkm213; Takayama Y, 2010, DEV CELL, V18, P385, DOI 10.1016/j.devcel.2009.12.024; Thaminy S, 2007, J BIOL CHEM, V282, P37805, DOI 10.1074/jbc.M706384200; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Trickey M, 2008, MOL CELL BIOL, V28, P3905, DOI 10.1128/MCB.02116-07; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Wurtele H, 2012, MOL CELL BIOL, V32, P154, DOI 10.1128/MCB.05415-11; Xhemalce B, 2007, J BIOL CHEM, V282, P15040, DOI 10.1074/jbc.M701197200; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yamano H, 2004, J BIOL CHEM, V279, P18974, DOI 10.1074/jbc.M311060200; Yamano H, 1998, EMBO J, V17, P5670, DOI 10.1093/emboj/17.19.5670; Yamano H, 2000, MOL CELL, V6, P1377, DOI 10.1016/S1097-2765(00)00135-0	58	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					928	937		10.1074/jbc.M112.410241	http://dx.doi.org/10.1074/jbc.M112.410241			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23195958	Green Published, hybrid			2022-12-28	WOS:000313570300017
J	Benoit, ME; Hernandez, MX; Dinh, ML; Benavente, F; Vasquez, O; Tenner, AJ				Benoit, Marie E.; Hernandez, Michael X.; Dinh, Minhan L.; Benavente, Francisca; Vasquez, Osvaldo; Tenner, Andrea J.			C1q-induced LRP1B and GPR6 Proteins Expressed Early in Alzheimer Disease Mouse Models, Are Essential for the C1q-mediated Protection against Amyloid-beta Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; ELEMENT-BINDING PROTEIN; A-BETA; PRECURSOR PROTEIN; FIBRILLAR OLIGOMERS; COUPLED RECEPTORS; COMMON MECHANISM; CELL-SURFACE; COMPLEMENT; C1Q	Complement protein C1q is induced in the brain in response to a variety of neuronal injuries, including Alzheimer disease (AD), and blocks fibrillar amyloid-beta (fA beta) neurotoxicity in vitro. Here, we show that C1q protects immature and mature primary neurons against fA beta toxicity, and we report for the first time that C1q prevents toxicity induced by oligomeric forms of amyloid-beta (A beta). Gene expression analysis reveals C1q-activated phosphorylated cAMP-response element-binding protein and AP-1, two transcription factors associated with neuronal survival and neurite outgrowth, and increased LRP1B and G protein-coupled receptor 6(GPR6) expression in fA beta-injured neurons. Silencing of cAMP-response element-binding protein, LRP1B or GPR6 expression inhibited C1q-mediated neuroprotection from fA beta-induced injury. In addition, C1q altered the association of oligomeric A beta and fA beta with neurons. In vivo, increased hippocampal expression of C1q, LRP1B, and GPR6 is observed as early as 2 months of age in the 3 x Tg mouse model of AD, whereas no such induction of LRP1B and GPR6 was seen in C1q-deficient AD mice. In contrast, expression of C1r and C1s, proteases required to activate the classical complement pathway, and C3 showed a significant age-dependent increase only after 10-13 months of age when A beta plaques start to accumulate in this AD model. Thus, our results identify pathways by which C1q, up-regulated in vivo early in response to injury without the coordinate induction of other complement components, can induce a program of gene expression that promotes neuroprotection and thus may provide protection against A beta in preclinical stages of AD and other neurodegenerative processes.	[Benoit, Marie E.; Vasquez, Osvaldo; Tenner, Andrea J.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Hernandez, Michael X.; Tenner, Andrea J.] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA; [Dinh, Minhan L.; Benavente, Francisca; Tenner, Andrea J.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Tenner, Andrea J.] Univ Calif Irvine, Inst Memory Impairment & Neurol Disorders, Irvine, CA 92697 USA; [Tenner, Andrea J.] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Tenner, AJ (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, 3205 McGaugh Hall, Irvine, CA 92697 USA.	atenner@uci.edu		Benavente, Francisca/0000-0001-8245-2673	National Institutes of Health [AI 41090, NS35144, AG 00538]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG000538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 41090, NS35144, and AG 00538.	Alexander JJ, 2008, J NEUROCHEM, V107, P1169, DOI 10.1111/j.1471-4159.2008.05668.x; Benoit ME, 2012, J IMMUNOL, V188, P5682, DOI 10.4049/jimmunol.1103760; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; Bohlson SS, 2007, MOL IMMUNOL, V44, P33, DOI 10.1016/j.molimm.2006.06.021; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Bowden GT, 2004, NAT REV CANCER, V4, P23, DOI 10.1038/nrc1253; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; Caccamo A, 2010, P NATL ACAD SCI USA, V107, P22687, DOI 10.1073/pnas.1012851108; Cam JA, 2005, J BIOL CHEM, V280, P15464, DOI 10.1074/jbc.M500613200; Cam JA, 2004, J BIOL CHEM, V279, P29639, DOI 10.1074/jbc.M313893200; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cheng JS, 2009, NAT NEUROSCI, V12, P119, DOI 10.1038/nn.2240; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Fan R, 2004, EXP NEUROL, V185, P241, DOI 10.1016/j.expneurol.2003.09.023; Fan R, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-1; Fonseca MI, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-4; Fonseca MI, 2004, J NEUROSCI, V24, P6457, DOI 10.1523/JNEUROSCI.0901-04.2004; Fonseca MI, 2004, NEUROBIOL DIS, V15, P40, DOI 10.1016/j.nbd.2003.09.004; Fraser DA, 2007, J BIOL CHEM, V282, P7360, DOI 10.1074/jbc.M605741200; Fraser DA, 2010, J NEUROCHEM, V112, P733, DOI 10.1111/j.1471-4159.2009.06494.x; Fuentealba RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011884; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Harris JA, 2008, J NEUROSCI, V28, P10990, DOI 10.1523/JNEUROSCI.2697-08.2008; HEIBER M, 1995, DNA CELL BIOL, V14, P25, DOI 10.1089/dna.1995.14.25; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaeger S, 2008, CURR ALZHEIMER RES, V5, P15; Josselyn Sheena A., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P481, DOI 10.2174/156800705774322058; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Khoury MK, 2010, ANAL BIOCHEM, V397, P129, DOI 10.1016/j.ab.2009.09.041; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Kokubo M, 2009, J NEUROSCI, V29, P8901, DOI 10.1523/JNEUROSCI.0040-09.2009; Lee B, 2009, J NEUROCHEM, V108, P1251, DOI 10.1111/j.1471-4159.2008.05864.x; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; Liu CX, 2001, J BIOL CHEM, V276, P28889, DOI 10.1074/jbc.M102727200; Marschang P, 2004, MOL CELL BIOL, V24, P3782, DOI 10.1128/MCB.24.9.3782-3793.2004; McCauslin CS, 2006, J BIOL CHEM, V281, P17681, DOI 10.1074/jbc.M600207200; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Melchior B, 2010, ASN NEURO, V2, P157, DOI 10.1042/AN20100010; Nakagawa S, 2002, J NEUROSCI, V22, P9868; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ojha J, 2011, MOL CELL BIOL, V31, P3146, DOI 10.1128/MCB.01187-10; Pisalyaput K, 2008, J NEUROCHEM, V104, P696, DOI 10.1111/j.1471-4159.2007.05012.x; Poduslo SE, 2010, AM J MED GENET B, V153B, P114, DOI 10.1002/ajmg.b.30963; Reichwald J, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-35; Sanyal S, 2002, NATURE, V416, P870, DOI 10.1038/416870a; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; Supnet C, 2006, J BIOL CHEM, V281, P38440, DOI 10.1074/jbc.M606736200; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; Tchantchou F, 2009, J ALZHEIMERS DIS, V18, P787, DOI 10.3233/JAD-2009-1189; TENNER AJ, 1981, J IMMUNOL, V127, P648; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Vadigepalli Rajanikanth, 2003, OMICS A Journal of Integrative Biology, V7, P235, DOI 10.1089/153623103322452378; Webster S, 1996, J NEUROSCI RES, V46, P58, DOI 10.1002/(SICI)1097-4547(19961001)46:1<58::AID-JNR8>3.0.CO;2-E; WEBSTER S, 1994, J NEUROSCI RES, V39, P448, DOI 10.1002/jnr.490390412; YOUNG KR, 1991, J IMMUNOL, V146, P3356	64	85	87	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					654	665		10.1074/jbc.M112.400168	http://dx.doi.org/10.1074/jbc.M112.400168			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23150673	Green Published, hybrid			2022-12-28	WOS:000313197200066
J	Tirtom, NE; Okuno, D; Nakano, M; Yokoyama, K; Noji, H				Tirtom, Naciye Esma; Okuno, Daichi; Nakano, Masahiro; Yokoyama, Ken; Noji, Hiroyuki			Mechanical Modulation of ATP-binding Affinity of V-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMUS-THERMOPHILUS; F-1 MOTOR; V-ATPASE; ROTATION; HYDROLYSIS; SUBUNIT; STALK	V-1-ATPase is a rotary motor protein that rotates the central shaft in a counterclockwise direction hydrolyzing ATP. Although the ATP-binding process is suggested to be the most critical reaction step for torque generation in F-1-ATPase (the closest relative of V-1-ATPase evolutionarily), the role of ATP binding for V-1-ATPase in torque generation has remained unclear. In the present study, we performed single-molecule manipulation experiments on V-1-ATPase from Thermus thermophilus to investigate how the ATP-binding process is modulated upon rotation of the rotary shaft. When V-1-ATPase showed an ATP-waiting pause, it was stalled at a target angle and then released. Based on the response of the V-1-ATPase released, the ATP-binding probability was determined at individual stall angles. It was observed that the rate constant of ATP binding (k(on)) was exponentially accelerated with forward rotation, whereas the rate constant of ATP release (k(off)) was exponentially reduced. The angle dependence of the k(off) of V-1-ATPase was significantly smaller than that of F-1-ATPase, suggesting that the ATP-binding process is not the major torque-generating step in V-1-ATPase. When V-1-ATPase was stalled at the mean binding angle to restrict rotary Brownian motion, k(on) was evidently slower than that determined from free rotation, showing the reaction rate enhancement by conformational fluctuation. It was also suggested that shaft of V-1-ATPase should be rotated at least 277 degrees in a clockwise direction for efficient release of ATP under ATP-synthesis conditions.	[Tirtom, Naciye Esma; Noji, Hiroyuki] Univ Tokyo, Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan; [Okuno, Daichi] RIKEN, Quantitat Biol Ctr, Suita, Osaka 5650874, Japan; [Nakano, Masahiro] Inst Ind & Sci Res, Osaka 5650874, Japan; [Yokoyama, Ken] Kyoto Sangyo Univ, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan	University of Tokyo; RIKEN; Kyoto Sangyo University	Noji, H (corresponding author), Univ Tokyo, Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan.	hnoji@appchem.t.u-tokyo.ac.jp	Yokoyama, Ken/AAJ-3582-2020	Yokoyama, Ken/0000-0002-6813-1096; Tirtom, Naciye Esma/0000-0003-4637-8466	Ministry of Education, Culture, Sports, Science, and Technology, Japan [18074005]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research 18074005 (to H. N.) and by a Special Education and Research Expenses grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to H. N.).	Cherepanov DA, 2001, BIOPHYS J, V81, P1234, DOI 10.1016/S0006-3495(01)75781-5; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Furuike S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1215; Hayashi K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218103; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Nakano M, 2008, J BIOL CHEM, V283, P20789, DOI 10.1074/jbc.M801276200; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Okuno D, 2010, EUR BIOPHYS J BIOPHY, V39, P1589, DOI 10.1007/s00249-010-0616-9; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Uner NE, 2012, J BIOL CHEM, V287, P28327, DOI 10.1074/jbc.M112.381194; Watanabe R, 2012, NAT CHEM BIOL, V8, P86, DOI 10.1038/nchembio.715; Yokoyama K, 2005, J BIOENERG BIOMEMBR, V37, P405, DOI 10.1007/s10863-005-9480-1; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	19	5	5	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					619	623		10.1074/jbc.M112.420729	http://dx.doi.org/10.1074/jbc.M112.420729			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23155048	Green Published, hybrid			2022-12-28	WOS:000313197200062
J	Villar, VM; Jones, JE; Armando, I; Asico, LD; Escano, CS; Lee, H; Wang, XY; Yang, Y; Pascua-Crusan, AM; Palmes-Saloma, CP; Felder, RA; Jose, PA				Villar, Van Anthony M.; Jones, John Edward; Armando, Ines; Asico, Laureano D.; Escano, Crisanto S., Jr.; Lee, Hewang; Wang, Xiaoyan; Yang, Yu; Pascua-Crusan, Annabelle M.; Palmes-Saloma, Cynthia P.; Felder, Robin A.; Jose, Pedro A.			Sorting Nexin 1 Loss Results in D-5 Dopamine Receptor Dysfunction in Human Renal Proximal Tubule Cells and Hypertension in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAFFICKING PROPERTIES; TYPE-1 RECEPTOR; BLOOD-PRESSURE; NADPH OXIDASE; KNOCKOUT MICE; II TYPE-1; DEGRADATION; MEMBRANE; KIDNEY; RATS	The peripheral dopaminergic system plays a crucial role in blood pressure regulation through its actions on renal hemodynamics and epithelial ion transport. The dopamine D5 receptor (D5R) interacts with sorting nexin 1 (SNX1), a protein involved in receptor retrieval from the trans-Golgi network. In this report, we elucidated the spatial, temporal, and functional significance of this interaction in human renal proximal tubule cells and HEK293 cells stably expressing human D5R and in mice. Silencing of SNX1 expression via RNAi resulted in the failure of D5R to internalize and bind GTP, blunting of the agonist-induced increase in cAMP production and decrease in sodium transport, and up-regulation of angiotensin II receptor expression, of which expression was previously shown to be negatively regulated by D5R. Moreover, siRNA-mediated depletion of renal SNX1 in C57BL/6J and BALB/cJ mice resulted in increased blood pressure and blunted natriuretic response to agonist in salt-loaded BALB/cJ mice. These data demonstrate a crucial role for SNX1 in D5R trafficking and that SNX1 depletion results in D5R dysfunction and thus may represent a novel mechanism for the pathogenesis of essential hypertension.	[Villar, Van Anthony M.; Jones, John Edward; Armando, Ines; Asico, Laureano D.; Escano, Crisanto S., Jr.; Lee, Hewang; Wang, Xiaoyan; Yang, Yu; Pascua-Crusan, Annabelle M.; Jose, Pedro A.] Childrens Natl Med Ctr, Childrens Res Inst, Ctr Mol Physiol Res, Washington, DC 20010 USA; [Palmes-Saloma, Cynthia P.] Univ Philippines, Natl Inst Mol Biol & Biotechnol, Quezon City 1101, Philippines; [Felder, Robin A.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA	Children's National Health System; University of the Philippines System; University of the Philippines Diliman; University of Virginia	Villar, VM (corresponding author), Univ Maryland, Sch Med, Div Nephrol, Dept Med, 20 Penn St,Suite S003C, Baltimore, MD 21201 USA.	vvillar@medicine.umaryland.edu	Wang, Xiaoyan/GOK-1663-2022; Asico, Laureano/AAM-6321-2020	Wang, Xiaoyan/0000-0001-7406-5008; Lee, Hewang/0000-0003-1338-2573	National Institutes of Health (National Institutes of Health National Center for Research Resources) [HL68686, HL23081, HL074940, HL092196, DK39308, UL1RR031988, KL2 RR031987]; Lombardi Comprehensive Cancer Center Microscopy and Imaging Shared Resource; United States Public Health Service Grant [2P30-CA-51008, 1S10 RR15768-01]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031988, S10RR015768, KL2RR031987] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068686, R01HL023081, P01HL074940, R37HL023081, R01HL092196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090918, R01DK039308] Funding Source: NIH RePORTER	National Institutes of Health (National Institutes of Health National Center for Research Resources); Lombardi Comprehensive Cancer Center Microscopy and Imaging Shared Resource; United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL68686, HL23081, HL074940, HL092196, and DK39308 and awards UL1RR031988 and KL2 RR031987 (National Institutes of Health National Center for Research Resources). This work was also supported by the Lombardi Comprehensive Cancer Center Microscopy and Imaging Shared Resource and United States Public Health Service Grants 2P30-CA-51008 and 1S10 RR15768-01.	Banday AA, 2008, CURR HYPERTENS REP, V10, P268, DOI 10.1007/s11906-008-0051-9; Brismar H, 1998, P NATL ACAD SCI USA, V95, P5573, DOI 10.1073/pnas.95.10.5573; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Carey RM, 2001, HYPERTENSION, V38, P297, DOI 10.1161/hy0901.096422; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Chen Y., 2005, MOL IMAGING FRET MIC, P126; CHRISTIE MI, 1992, BRIT J PHARMACOL, V107, P1008, DOI 10.1111/j.1476-5381.1992.tb13399.x; Clague MJ, 2001, J CELL SCI, V114, P3075; Crowley SD, 2007, CURR HYPERTENS REP, V9, P148, DOI 10.1007/s11906-007-0026-2; Escano CS, 2009, AM J PHYSIOL-REG I, V297, pR1660, DOI 10.1152/ajpregu.00147.2009; Felder RA, 2002, P NATL ACAD SCI USA, V99, P3872, DOI 10.1073/pnas.062694599; FELDER RA, 1990, HYPERTENSION, V15, P560, DOI 10.1161/01.HYP.15.6.560; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Gildea JJ, 2008, HYPERTENSION, V51, P360, DOI 10.1161/HYPERTENSIONAHA.107.100099; Guo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029204; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; HAYASHI M, 1991, AM J PHYSIOL, V260, pE675, DOI 10.1152/ajpendo.1991.260.5.E675; He Y, 2009, NEUROSCI BULL, V25, P43, DOI 10.1007/s12264-009-0107-0; Heydorn A, 2004, FEBS LETT, V556, P276, DOI 10.1016/S0014-5793(03)01431-5; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Hollon TR, 2002, J NEUROSCI, V22, P10801, DOI 10.1523/jneurosci.22-24-10801.2002; Jose PA, 1998, PHARMACOL THERAPEUT, V80, P149, DOI 10.1016/S0163-7258(98)00027-8; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Li HW, 2008, J CLIN INVEST, V118, P2180, DOI 10.1172/JCI33637; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Nisar S, 2010, TRAFFIC, V11, P508, DOI 10.1111/j.1600-0854.2010.01035.x; Pons V, 2003, J BIOL CHEM, V278, P21155, DOI 10.1074/jbc.M211008200; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Prosser DC, 2010, TRAFFIC, V11, P1347, DOI 10.1111/j.1600-0854.2010.01100.x; Rosskopf D, 2007, N-S ARCH PHARMACOL, V374, P429, DOI 10.1007/s00210-007-0133-2; Schwarz DG, 2002, MOL BIOL CELL, V13, P3588, DOI 10.1091/mbc.E02-03-0145; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; SIRAGY HM, 1989, AM J PHYSIOL, V257, pF469, DOI 10.1152/ajprenal.1989.257.3.F469; Thompson D, 2011, TRAFFIC, V12, P644, DOI 10.1111/j.1600-0854.2011.01179.x; TIBERI M, 1994, J BIOL CHEM, V269, P27925; Vieira-Coelho MA, 2000, BRIT J PHARMACOL, V129, P573, DOI 10.1038/sj.bjp.0703065; Wang XY, 2008, PEDIATR NEPHROL, V23, P2131, DOI 10.1007/s00467-008-0901-3; Wang YJ, 2002, MOL BIOL CELL, V13, P1965, DOI 10.1091/mbc.E01-11-0131; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Yang ZW, 2006, AM J PHYSIOL-REG I, V290, pR96, DOI 10.1152/ajpregu.00434.2005; Yang ZW, 2004, J RECEPT SIG TRANSD, V24, P149, DOI 10.1081/LRST-200029971; Yao LP, 1998, HYPERTENSION, V32, P1049, DOI 10.1161/01.HYP.32.6.1049; Yu P, 2006, KIDNEY INT, V70, P1072, DOI 10.1038/sj.ki.5001708; Yu PY, 2000, HYPERTENSION, V36, P1053, DOI 10.1161/01.HYP.36.6.1053; Zeng CY, 2005, HYPERTENSION, V45, P804, DOI 10.1161/01.HYP.0000155212.33212.99; Zeng CY, 2004, PHYSIOL GENOMICS, V19, P233, DOI 10.1152/physiolgenomics.00127.2004	50	25	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					152	163		10.1074/jbc.M112.428458	http://dx.doi.org/10.1074/jbc.M112.428458			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23152498	Green Published, hybrid			2022-12-28	WOS:000313197200015
J	Chauviac, FX; Bommer, M; Yan, J; Parkin, G; Daviter, T; Lowden, P; Raven, EL; Thalassinos, K; Keep, NH				Chauviac, Francois-Xavier; Bommer, Martin; Yan, Jun; Parkin, Gary; Daviter, Tina; Lowden, Philip; Raven, Emma L.; Thalassinos, Konstantinos; Keep, Nicholas H.			Crystal Structure of Reduced MsAcg, a Putative Nitroreductase from Mycobacterium smegmatis and a Close Homologue of Mycobacterium tuberculosis Acg	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIC RESPONSE; REDOX PROPERTIES; PROTEIN; FLAVIN; REDUCTION; GENE; VALIDATION; DELETION; SYSTEM; GROWTH	This paper presents the structure of MsAcg (MSMEG_5246), a Mycobacterium smegmatis homologue of Mycobacterium tuberculosis Acg (Rv2032) in its reduced form at 1.6 angstrom resolution using x-ray crystallography. Rv2032 is one of the most induced genes under the hypoxic model of tuberculosis dormancy. The Acg family turns out to be unusual flavin mononucleotide (FMN)-binding proteins that have probably arisen by gene duplication and fusion from a classical homodimeric nitroreductase such that the monomeric protein resembles a classical nitroreductase dimer but with one active site deleted and the other active site covered by a unique lid. The FMN cofactor is not reduced by either NADH or NADPH, but the chemically reduced enzyme is capable of reduction of nitro substrates, albeit at no kinetic advantage over free FMN. The reduced enzyme is rapidly oxidized by oxygen but without any evidence for a radical state commonly seen in oxygen-sensitive nitroreductases. The presence of the unique lid domain, the lack of reduction by NAD(P)H, and the slow rate of reaction of the chemically reduced protein raises a possible alternative function of Acg proteins in FMN storage or sequestration from other biochemical pathways as part of the bacteria's adaptation to a dormancy state.	[Bommer, Martin] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Bommer, Martin] Helmholtz Zentrum Berlin Mat & Energie, Inst Soft Matter & Funct Mat, Macromol Crystallog Grp, D-12489 Berlin, Germany; [Yan, Jun; Thalassinos, Konstantinos] UCL, Div Biosci, Inst Struct & Mol Biol, London WC1E 6BT, England; [Parkin, Gary; Raven, Emma L.] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; [Daviter, Tina; Keep, Nicholas H.] Univ London, Dept Biol Sci, Inst Struct & Mol Biol, Ctr Biophys, London WC1E 7HX, England	Humboldt University of Berlin; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); University of London; Birkbeck University London; University College London; University of Leicester; University of London; Birkbeck University London	Keep, NH (corresponding author), Univ London, Dept Biol Sci, Inst Struct & Mol Biol, Ctr Biophys, Malet St, London WC1E 7HX, England.	n.keep@mail.cryst.bbk.ac.uk	Keep, N/C-2759-2008; Keep, Nicholas/R-3493-2019	Keep, N/0000-0002-5042-1837; Keep, Nicholas/0000-0002-5042-1837; Thalassinos, Konstantinos/0000-0001-5072-8428; Frederiksen, Jun/0000-0003-0764-1831; Raven, Emma/0000-0002-1643-8694	Bloomsbury Colleges Studentship; Biotechnology and Biological Sciences Research Council [BB/F011148/1] Funding Source: researchfish; BBSRC [BB/F011148/1] Funding Source: UKRI	Bloomsbury Colleges Studentship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Sponsored by a Bloomsbury Colleges Studentship. Present address: Virology Dept., Structural Virology Unit, Institut Pasteur, 28 rue du docteur Roux, 75724 Paris cedex 15, France.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Basran J, 2008, BIOCHEMISTRY-US, V47, P4752, DOI 10.1021/bi702393b; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark W. M., 1972, OXIDATION REDUCTION; Roldan M, 2008, FEMS MICROBIOL REV, V32, P474, DOI 10.1111/j.1574-6976.2008.00107.x; Efimov I, 2004, BIOCHEMISTRY-US, V43, P10532, DOI 10.1021/bi049375d; Efimov I, 2007, BIOCHEMISTRY-US, V46, P8017, DOI 10.1021/bi7006492; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Hao Q, 2004, J APPL CRYSTALLOGR, V37, P498, DOI 10.1107/S0021889804008696; Haynes CA, 2002, J BIOL CHEM, V277, P11513, DOI 10.1074/jbc.M111334200; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Hu Y., 2003, DORMANCY LOW GROWTH, P181; Hu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020958; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Kennaway CK, 2005, J BIOL CHEM, V280, P33419, DOI 10.1074/jbc.M504263200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Lederer F, 1999, METH MOL B, V131, P149; Lennon BW, 1999, PROTEIN SCI, V8, P2366; Long QX, 2010, CHEM BIOL DRUG DES, V75, P339, DOI 10.1111/j.1747-0285.2010.00946.x; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; Manina G, 2010, MOL MICROBIOL, V77, P1172, DOI 10.1111/j.1365-2958.2010.07277.x; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; Mayhew SG, 1999, EUR J BIOCHEM, V265, P698, DOI 10.1046/j.1432-1327.1999.00767.x; MCCALLA DR, 1970, J BACTERIOL, V104, P1126, DOI 10.1128/JB.104.3.1126-1134.1970; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nivinskas H, 2001, ARCH BIOCHEM BIOPHYS, V385, P170, DOI 10.1006/abbi.2000.2127; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Pringle SD, 2007, INT J MASS SPECTROM, V261, P1, DOI 10.1016/j.ijms.2006.07.021; Purkayastha A, 2002, INFECT IMMUN, V70, P1518, DOI 10.1128/IAI.70.3.1518-1529.2002; Rohr AK, 2010, ANGEW CHEM INT EDIT, V49, P2324, DOI 10.1002/anie.200907143; Sandegren L, 2008, J ANTIMICROB CHEMOTH, V62, P495, DOI 10.1093/jac/dkn222; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick G.M, 2001, International Tables for Macromolecular Crystallography, P333; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Tito MA, 2000, J AM CHEM SOC, V122, P3550, DOI 10.1021/ja993740k; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; WHO, 2011, 2011 2012 TUB GLOB F; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578; Yuan Y., 1996, J BACTERIOL, V178, P4484, DOI DOI 10.1128/JB.178.15.4484-4492.1996	62	16	16	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44372	44383		10.1074/jbc.M112.406264	http://dx.doi.org/10.1074/jbc.M112.406264			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23148223	Green Published, hybrid			2022-12-28	WOS:000312938600034
J	Ninkina, N; Peters, OM; Connor-Robson, N; Lytkina, O; Sharfeddin, E; Buchman, VL				Ninkina, Natalia; Peters, Owen M.; Connor-Robson, Natalie; Lytkina, Olga; Sharfeddin, Essam; Buchman, Vladimir L.			Contrasting Effects of alpha-Synuclein and gamma-Synuclein on the Phenotype of Cysteine String Protein alpha (CSP alpha) Null Mutant Mice Suggest Distinct Function of these Proteins in Neuronal Synapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE; EXPRESSION; BINDING; SNARE; NEURODEGENERATION; IDENTIFICATION; CHAPERONE; DYNAMICS; GLAUCOMA; PATTERN	In neuronal synapses, neurotransmitter-loaded vesicles fuse with presynaptic plasma membrane in a complex sequence of tightly regulated events. The assembly of specialized SNARE complexes plays a pivotal role in this process. The function of the chaperone cysteine string protein alpha (CSP alpha) is important for synaptic SNARE complex formation, and mice lacking this protein develop severe synaptic dysfunction and neurodegeneration that lead to their death within 3 months after birth. Another presynaptic protein, alpha-synuclein, also potentiates SNARE complex formation, and its overexpression rescues the phenotype of CSP alpha null mutant mice, although these two proteins use different mechanisms to achieve this effect. alpha-synuclein is a member of a family of three related proteins whose structural similarity suggests functional redundancy. Here, we assessed whether gamma-synuclein shares the ability of alpha-synuclein to bind synaptic vesicles and ameliorate neurodegeneration caused by CSP alpha deficiency in vivo. Although the N-terminal lipid-binding domains of the two synucleins showed similar affinity for purified synaptic vesicles, the C-terminal domain of gamma-synuclein was not able to interact with synaptobrevin-2/VAMP2. Consequently, overexpression of gamma-synuclein did not have any noticeable effect on the phenotype of CSP alpha null mutant mice. Our data suggest that the functions of alpha- and gamma-synucleins in presynaptic terminals are not fully redundant.	[Ninkina, Natalia; Peters, Owen M.; Connor-Robson, Natalie; Sharfeddin, Essam; Buchman, Vladimir L.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Lytkina, Olga] Russian Acad Sci, Inst Physiologically Act Cpds, Chernogolovka 142432, Moscow Region, Russia	Cardiff University; Russian Academy of Sciences; Institute of Physiologically Active Compounds of the Russian Academy of Sciences	Buchman, VL (corresponding author), Cardiff Univ, Sch Biosci, Museum Ave, Cardiff CF10 3AX, S Glam, Wales.	buchmanvl@cf.ac.uk	Lytkina, Olga/H-3118-2014; Ninkina, Natalia N/A-1732-2011; Buchman, Vladimir L/A-4814-2010	Lytkina, Olga/0000-0003-3015-6447; Buchman, Vladimir L/0000-0002-7631-8352; Peters, Owen/0000-0002-6824-0663; Connor-Robson, Natalie/0000-0001-8350-6928	Parkinson's UK [G-1006]; Wellcome Trust [075615/Z/04/z]; ERA.Net RUS [STProjects-065]; Parkinson&quot;s UK [G-1006] Funding Source: researchfish	Parkinson's UK(Parkinson's UK); Wellcome Trust(Wellcome TrustEuropean Commission); ERA.Net RUS; Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was supported by Parkinson's UK Grant G-1006 and Programme Grant 075615/Z/04/z from The Wellcome Trust (to V. L. B.) and STProjects-065 (ERA.Net RUS) (to N. N.).	Anwar S, 2011, J NEUROSCI, V31, P7264, DOI 10.1523/JNEUROSCI.6194-10.2011; Buchman VL, 1998, J NEUROSCI, V18, P9335; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Lavedan C, 1998, GENOME RES, V8, P871, DOI 10.1101/gr.8.9.871; Rozas JL, 2012, NEURON, V74, P151, DOI 10.1016/j.neuron.2012.02.019; Narayanan V, 2001, BIOCHEMISTRY-US, V40, P9927, DOI 10.1021/bi002952n; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Ninkina N., 2012, P NATL ACAD IN PRESS; Ninkina N, 2009, HUM MOL GENET, V18, P1779, DOI 10.1093/hmg/ddp090; Ninkina NN, 1998, HUM MOL GENET, V7, P1417, DOI 10.1093/hmg/7.9.1417; Oort PJ, 2008, J NUTR, V138, P841, DOI 10.1093/jn/138.5.841; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Peters OM, 2012, NEUROBIOL DIS, V48, P124, DOI 10.1016/j.nbd.2012.06.016; Robertson DC, 2004, J NEUROCHEM, V89, P1126, DOI 10.1111/j.1471-4159.2004.02378.x; Senior SL, 2008, EUR J NEUROSCI, V27, P947, DOI 10.1111/j.1460-9568.2008.06055.x; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sung YH, 2006, PROTEIN SCI, V15, P1162, DOI 10.1110/ps.051803606; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; Surgucheva I, 2002, J NEUROSCI RES, V68, P97, DOI 10.1002/jnr.10198; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; TOLL L, 1978, BIOCHEMISTRY-US, V17, P2517, DOI 10.1021/bi00606a010; Zhang YQ, 2012, NEURON, V74, P136, DOI 10.1016/j.neuron.2012.01.029	37	19	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44471	44477		10.1074/jbc.M112.422402	http://dx.doi.org/10.1074/jbc.M112.422402			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23129765	hybrid, Green Published			2022-12-28	WOS:000312938600043
J	Tanabe, C; Maeda, T; Zou, K; Liu, JJ; Liu, SY; Nakajima, T; Komano, H				Tanabe, Chiaki; Maeda, Tomoji; Zou, Kun; Liu, Junjun; Liu, Shuyu; Nakajima, Toshihiro; Komano, Hiroto			The Ubiquitin Ligase Synoviolin Up-regulates Amyloid beta Production by Targeting a Negative Regulator of gamma-Secretase, Rer1, for Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED-DEGRADATION; ER-ASSOCIATED DEGRADATION; MEMBRANE-PROTEINS; RETRIEVAL RECEPTOR; ALZHEIMERS-DISEASE; GOLGI-APPARATUS; NICASTRIN; COMPLEX; TRAFFICKING; MATURATION	Alzheimer's disease is characterized by the deposition of A beta, which is generated from the amyloid precursor protein through its cleavage by beta- and gamma-secretases. The gamma-secretase complex component nicastrin (NCT) plays significant roles in the assembly and proper trafficking of the gamma-secretase complex and in the recognition of amyloid precursor protein. NCT is incorporated into the gamma-secretase complex in the endoplasmic reticulum (ER) and glycosylated in the Golgi. In contrast, unassembled NCT is retrieved or retained in the ER by the protein Retention in endoplasmic reticulum 1 (Rer1). We reported previously that synoviolin (Syvn), an E3 ubiquitin ligase, degrades NCT and affects the generation of A beta. Here, we examined in more detail the effect of Syvn on the generation of A beta. We found that overexpression of a dominant negative form of Syvn (C307A mutant) and a Syvn-RNAi decreased the generation of A beta. These results indicate that the ubiquitin ligase activity of Syvn up-regulates the generation of A beta. We hypothesized, therefore, that Syvn regulates the assembly or localization of the gamma-secretase complex by ubiquitinating Rer1, resulting in its subsequent degradation. Our findings that the level of Rer1 was increased in Syvn knockout fibroblasts because of inhibition of its degradation support this hypothesis. Moreover, we found that Rer1 interacts with Syvn in the ER, is ubiquitinated by Syvn, and is then degraded via the proteasome or lysosomal pathways. Finally, we showed that localization of mature NCT to the plasma membrane as well as gamma-secretase complex levels are decreased in fibroblasts of Syvn knockout mice. Thus, it is likely that Syvn regulates the assembly of the gamma-secretase complex via the degradation of Rer1, which results in the generation of A beta.	[Tanabe, Chiaki; Maeda, Tomoji; Zou, Kun; Liu, Junjun; Liu, Shuyu; Komano, Hiroto] Iwate Med Univ, Sch Pharm, Dept Neurosci, Shiwa, Iwate 0283694, Japan; [Nakajima, Toshihiro] Tokyo Med Univ, Inst Med Sci, Tokyo 1608402, Japan	Iwate Medical University; Tokyo Medical University	Maeda, T (corresponding author), Iwate Med Univ, Sch Pharm, Dept Neurosci, 2-1-1 Nishitokuta, Shiwa, Iwate 0283694, Japan.	maedato@iwate-med.ac.jp; hkomano@iwate-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation;  [23700425];  [23590110]; Grants-in-Aid for Scientific Research [23590110, 24700383, 23659176] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Young Scientists (B) 23700425 (to C.T.); Grant-in-Aid for Scientific Research (C) 23590110 (to T.M.); by a Grant-in-Aid for Strategic Medical Science Research Center (The MIAST Project) (to H.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and a grant from the Takeda Science Foundation (to T.M.).	Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Capell A, 2003, J BIOL CHEM, V278, P52519, DOI 10.1074/jbc.C300435200; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Fullekrug J, 1997, EUR J CELL BIOL, V74, P31; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kaminskyy V, 2012, BBA-PROTEINS PROTEOM, V1824, P44, DOI 10.1016/j.bbapap.2011.05.013; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kimberly WT, 2002, J BIOL CHEM, V277, P35113, DOI 10.1074/jbc.M204446200; Komano H, 2002, J BIOL CHEM, V277, P39627, DOI 10.1074/jbc.M205255200; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Maeda T, 2009, FEBS J, V276, P5832, DOI 10.1111/j.1742-4658.2009.07264.x; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Sato K, 2003, MOL BIOL CELL, V14, P3605, DOI 10.1091/mbc.E02-12-0777; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Schwappach B, 2008, MOL MEMBR BIOL, V25, P270, DOI 10.1080/09687680801960998; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Spasic D, 2008, J CELL SCI, V121, P413, DOI 10.1242/jcs.015255; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Tomita T, 2002, FEBS LETT, V520, P117, DOI 10.1016/S0014-5793(02)02802-8; Valkova C, 2011, P NATL ACAD SCI USA, V108, P621, DOI 10.1073/pnas.1001624108; Yagishita N, 2005, J BIOL CHEM, V280, P7909, DOI 10.1074/jbc.M410863200; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490; Zou K, 2008, BIOCHEMISTRY-US, V47, P3370, DOI 10.1021/bi7014508	31	16	16	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44203	44211		10.1074/jbc.M112.365296	http://dx.doi.org/10.1074/jbc.M112.365296			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23129766	hybrid, Green Published			2022-12-28	WOS:000312938600019
J	Flach, K; Hilbrich, I; Schiffmann, A; Gartner, U; Kruger, M; Leonhardt, M; Waschipky, H; Wick, L; Arendt, T; Holzer, M				Flach, Katharina; Hilbrich, Isabel; Schiffmann, Andrea; Gaertner, Ulrich; Krueger, Martin; Leonhardt, Marion; Waschipky, Hanka; Wick, Lukas; Arendt, Thomas; Holzer, Max			Tau Oligomers Impair Artificial Membrane Integrity and Cellular Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOFIBRILLAR ALPHA-SYNUCLEIN; PROTEIN MISFOLDING DISEASES; SOLUBLE AMYLOID OLIGOMERS; PAIRED HELICAL FILAMENTS; BETA-SHEET STRUCTURE; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; IN-VITRO; NEURODEGENERATIVE DISEASES; VESICLE PERMEABILIZATION	The microtubule-associated protein Tau is mainly expressed in neurons, where it binds and stabilizes microtubules. In Alzheimer disease and other tauopathies, Tau protein has a reduced affinity toward microtubules. As a consequence, Tau protein detaches from microtubules and eventually aggregates into beta-sheet-containing filaments. The fibrillization of monomeric Tau to filaments is a multistep process that involves the formation of various aggregates, including spherical and protofibrillar oligomers. Previous concepts, primarily developed for A beta and alpha-synuclein, propose these oligomeric intermediates as the primary cytotoxic species mediating their deleterious effects through membrane permeabilization. In the present study, we thus analyzed whether this concept can also be applied to Tau protein. To this end, viability and membrane integrity were assessed on SH-SY5Y neuroblastoma cells and artificial phospholipid vesicles, treated with Tau monomers, Tau aggregation intermediates, or Tau fibrils. Our findings suggest that oligomeric Tau aggregation intermediates are the most toxic compounds of Tau fibrillogenesis, which effectively decrease cell viability and increase phospholipid vesicle leakage. Our data integrate Tau protein into the class of amyloidogenic proteins and enforce the hypothesis of a common toxicity-mediating mechanism for amyloidogenic proteins.	[Flach, Katharina; Hilbrich, Isabel; Schiffmann, Andrea; Gaertner, Ulrich; Leonhardt, Marion; Arendt, Thomas; Holzer, Max] Univ Leipzig, Fac Med, Dept Mol & Cellular Mech Neurodegenerat, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Krueger, Martin] Inst Anat, D-04103 Leipzig, Germany; [Waschipky, Hanka] Inst Med Phys & Biophys, D-04107 Leipzig, Germany; [Wick, Lukas] Helmholtz Ctr Environm Res, Dept Environm Microbiol, D-04318 Leipzig, Germany	Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Holzer, M (corresponding author), Univ Leipzig, Fac Med, Dept Mol & Cellular Mech Neurodegenerat, Paul Flechsig Inst Brain Res, Jahnallee 59, D-04109 Leipzig, Germany.	holm@medizin.uni-leipzig.de	Holzer, Max/A-1729-2008; Arendt, Thomas/C-8747-2012; Wick, Lukas Y/AAH-3221-2020	Holzer, Max/0000-0003-1754-9932; Wick, Lukas Y/0000-0001-7296-865X; Arendt, Thomas/0000-0003-4553-1625	Deutsche Forschungsgemeinschaft Grant [HO2368-4/1]; Alzheimer Forschung Initiative Project [06825]	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Alzheimer Forschung Initiative Project	This work was supported, in part, by Deutsche Forschungsgemeinschaft Grant HO2368-4/1 and by Alzheimer Forschung Initiative Project 06825.	Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; ARISPE N, 1994, MOL CELL BIOCHEM, V140, P119, DOI 10.1007/BF00926750; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Bibow S, 2011, ANGEW CHEM INT EDIT, V50, P11520, DOI 10.1002/anie.201105493; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Bodles AM, 2000, EUR J BIOCHEM, V267, P2186, DOI 10.1046/j.1432-1327.2000.01219.x; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BRANDT R, 1993, J BIOL CHEM, V268, P3414; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; Goedert M, 1999, PHILOS T ROY SOC B, V354, P1101, DOI 10.1098/rstb.1999.0466; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; HOLZER M, 1994, NEUROSCIENCE, V63, P499, DOI 10.1016/0306-4522(94)90546-0; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; IHARA Y, 1988, BRAIN RES, V459, P138, DOI 10.1016/0006-8993(88)90293-4; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim HY, 2009, J AM CHEM SOC, V131, P17482, DOI 10.1021/ja9077599; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; Kourie JI, 2001, J NEUROSCI RES, V66, P214, DOI 10.1002/jnr.1213; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Monoi H, 2000, BIOPHYS J, V78, P2892, DOI 10.1016/S0006-3495(00)76830-5; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pountney DL, 2005, NEUROTOX RES, V7, P59, DOI 10.1007/BF03033776; PRICE DL, 1987, CIBA F SYMP, V126, P30; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wong PC, 2002, NAT NEUROSCI, V5, P633, DOI 10.1038/nn0702-633; Yoshida H, 2002, BIOCHEMISTRY-US, V41, P15203, DOI 10.1021/bi026464m; Zschornig O, 2005, COLLOID SURFACE B, V42, P69, DOI 10.1016/j.colsurfb.2005.01.008	70	131	131	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43223	43233		10.1074/jbc.M112.396176	http://dx.doi.org/10.1074/jbc.M112.396176			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129775	Green Published, hybrid			2022-12-28	WOS:000312940800004
J	Saavedra, YGL; Day, R; Seidah, NG				Saavedra, Yascara Grisel Luna; Day, Robert; Seidah, Nabil G.			The M2 Module of the Cys-His-rich Domain (CHRD) of PCSK9 Protein Is Needed for the Extracellular Low-density Lipoprotein Receptor (LDLR) Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; PROPROTEIN CONVERTASE PCSK9; FAMILIAL HYPERCHOLESTEROLEMIA; LIVER-REGENERATION; MOUSE-LIVER; CHOLESTEROL; MUTATIONS; MICE; ANTIBODY; MUTANTS	PCSK9 enhances the cellular degradation of the LDL receptor (LDLR), leading to increased plasma LDL cholesterol. This multidomain protein contains a prosegment, a catalytic domain, a hinge region, and a cysteine-histidine rich domain (CHRD) composed of three tightly packed modules named M1, M2, and M3. The CHRD is required for the activity of PCSK9, but the mechanism behind this remains obscure. To define the contribution of each module to the function of PCSK9, we dissected the CHRD structure. Six PCSK9 deletants were generated by mutagenesis, corresponding to the deletion of only one (Delta M1, Delta M2, Delta M3) or two (Delta M12, Delta M13, Delta M23) modules. Transfection of HEK293 cells showed that all deletants were well processed and expressed compared with the parent PCSK9 but that only those lacking the M2 module were secreted. HepG2 cells lacking endogenous PCSK9 (HepG2/shPCSK9) were used for the functional analysis of the extracellular or intracellular activity of PCSK9 and its deletants. To analyze the ability of the deletants to enhance the LDLR degradation by the intracellular pathway, cellular expressions revealed that only the Delta M2 deletant retains a comparable total LDLR-degrading activity to full-length PCSK9. To probe the extracellular pathway, HepG2/shPCSK9 cells were incubated with conditioned media from transfected HEK293 or HepG2/shPCSK9 cells, and cell surface LDLR levels were analyzed by FACS. The results showed no activity of any secreted deletant compared with PCSK9. Thus, although M2 is dispensable for secretion, its presence is required for the extracellular activity of PCSK9 on cell surface LDLR.	[Saavedra, Yascara Grisel Luna; Seidah, Nabil G.] Univ Montreal, IRCM, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Day, Robert] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Sherbrooke	Seidah, NG (corresponding author), Univ Montreal, IRCM, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342	Canadian Institute of Health Research [MOP-102741, CTP 82946]; Bristol-Myers Squibb; Strauss Foundation; Canada Chair [216684]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Bristol-Myers Squibb(Bristol-Myers Squibb); Strauss Foundation; Canada Chair	This research was supported by Canadian Institute of Health Research Grants MOP-102741 and CTP 82946, a Bristol-Myers Squibb collaborative agreement grant, a Strauss Foundation grant, and Canada Chair no. 216684.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Cariou B, 2011, ATHEROSCLEROSIS, V216, P258, DOI 10.1016/j.atherosclerosis.2011.04.018; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; David J.-P, 2007, Proceedings of the 8th European Conference on Radiation and its Effects on Components and Systems, P1; Davignon J, 2010, CURR ATHEROSCLER REP, V12, P308, DOI 10.1007/s11883-010-0123-6; Denis M, 2012, CIRCULATION, V125, P894, DOI 10.1161/CIRCULATIONAHA.111.057406; Du F, 2011, J BIOL CHEM, V286, P43054, DOI 10.1074/jbc.M111.273474; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Holla OL, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-9; Holla OL, 2011, J LIPID RES, V52, P1787, DOI 10.1194/jlr.M018093; Holla OL, 2011, BIOCHEM BIOPH RES CO, V406, P234, DOI 10.1016/j.bbrc.2011.02.023; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Marduel M, 2013, HUM MUTAT, V34, P83, DOI 10.1002/humu.22215; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Sikka P, 2011, J POSTGRAD MED, V57, P321, DOI 10.4103/0022-3859.90085; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Strom TB, 2010, MOL GENET METAB, V101, P76, DOI 10.1016/j.ymgme.2010.05.003; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	42	48	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43492	43501		10.1074/jbc.M112.394023	http://dx.doi.org/10.1074/jbc.M112.394023			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23105118	hybrid, Green Published			2022-12-28	WOS:000312940800030
J	Smith, KE; Wilkie, SE; Tebbs-Warner, JT; Jarvis, BJ; Gallasch, L; Stocker, M; Hunt, DM				Smith, Katie E.; Wilkie, Susan E.; Tebbs-Warner, Joseph T.; Jarvis, Bradley J.; Gallasch, Linn; Stocker, Martin; Hunt, David M.			Functional Analysis of Missense Mutations in Kv8.2 Causing Cone Dystrophy with Supernormal Rod Electroretinogram	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL SUBUNIT; K+ CHANNEL; ALPHA-SUBUNITS; N-TERMINUS; KV2.1; DOMAIN; GENE; SHAB; TETRAMERIZATION	Mutations in KCNV2 have been proposed as the molecular basis for cone dystrophy with supernormal rod electroretinogram. KCNV2 codes for the modulatory voltage-gated potassium channel alpha-subunit, Kv8.2, which is incapable of forming functional channels on its own. Functional heteromeric channels are however formed with Kv2.1 in heterologous expression systems, with both alpha-subunit genes expressed in rod and cone photoreceptors. Of the 30 mutations identified in the KCNV2 gene, we have selected three missense mutations localized in the potassium channel pore and two missense mutations localized in the tetramerization domain for analysis. We characterized the differences between homomeric Kv2.1 and heteromeric Kv2.1/Kv8.2 channels and investigated the influence of the selected mutations on the function of heteromeric channels. We found that two pore mutations (W467G and G478R) led to the formation of nonconducting heteromeric Kv2.1/Kv8.2 channels, whereas the mutations localized in the tetramerization domain prevented heteromer generation and resulted in the formation of homomeric Kv2.1 channels only. Consequently, our study suggests the existence of two distinct molecular mechanisms involved in the disease pathology.	[Smith, Katie E.; Tebbs-Warner, Joseph T.; Jarvis, Bradley J.; Gallasch, Linn; Stocker, Martin] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Smith, Katie E.; Wilkie, Susan E.; Hunt, David M.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Hunt, David M.] Univ Western Australia, Sch Anim Biol, Oceans Inst, Perth, WA 6009, Australia; [Hunt, David M.] Univ Western Australia, Lions Eye Inst, Perth, WA 6009, Australia	University of London; University College London; University of London; University College London; University of Western Australia; Lions Eye Institute; University of Western Australia	Stocker, M (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Mortimer St, London WC1E 6BT, England.	M.Stocker@ucl.ac.uk; david.hunt@uwa.edu.au	Stocker, Martin/C-1844-2008; Smith, Katie Elizabeth/GXH-2114-2022; Hunt, David M/K-6024-2012	Hunt, David M/0000-0002-9264-3948; Smith, Katie E./0000-0002-6302-0274	United Kingdom Biotechnology and Biological Sciences Research Council [BB/E023142/1]; Australian National Health and Medical Research Council [AP102740]; Biotechnology and Biological Sciences Research Council [BB/D526961/1]; BBSRC [BB/E023142/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E023142/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by United Kingdom Biotechnology and Biological Sciences Research Council Grant BB/E023142/1 (to D. M. H. and M. S.) and Australian National Health and Medical Research Council Grant AP102740 (to D. M. H.).; Supported by Biotechnology and Biological Sciences Research Council Doctoral Training Grant Studentship BB/D526961/1.	BEECH DJ, 1989, NEURON, V3, P573, DOI 10.1016/0896-6273(89)90267-5; Ben Salah S, 2008, AM J OPHTHALMOL, V145, P1099, DOI 10.1016/j.ajo.2008.02.004; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Bocksteins E, 2012, PHYSIOLOGY, V27, P73, DOI 10.1152/physiol.00023.2011; Bocksteins E, 2009, J BIOL CHEM, V284, P31625, DOI 10.1074/jbc.M109.039479; Castellano A, 1997, J NEUROSCI, V17, P4652; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chiara MD, 1999, J NEUROSCI, V19, P6865, DOI 10.1523/JNEUROSCI.19-16-06865.1999; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; Czirjak G, 2007, J NEUROPHYSIOL, V98, P1213, DOI 10.1152/jn.00493.2007; Demontis GC, 1999, J PHYSIOL-LONDON, V515, P813, DOI 10.1111/j.1469-7793.1999.813ab.x; Es-Salah-Lamoureux Z, 2011, BIOPHYS J, V101, P662, DOI 10.1016/j.bpj.2011.06.028; Frings S, 1998, J GEN PHYSIOL, V111, P583, DOI 10.1085/jgp.111.4.583; GOURAS P, 1983, ARCH OPHTHALMOL-CHIC, V101, P718, DOI 10.1001/archopht.1983.01040010718003; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hejtmancik JF, 2008, AM J HUM GENET, V82, P174, DOI 10.1016/j.ajhg.2007.08.002; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hugnot JP, 1996, EMBO J, V15, P3322, DOI 10.1002/j.1460-2075.1996.tb00697.x; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Jentsch TJ, 2004, NAT CELL BIOL, V6, P1039, DOI 10.1038/ncb1104-1039; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Kerschensteiner D, 1999, BIOPHYS J, V77, P248, DOI 10.1016/S0006-3495(99)76886-4; Khan AO, 2012, BRIT J OPHTHALMOL, V96, P422, DOI 10.1136/bjophthalmol-2011-300271; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Kramer JW, 1998, AM J PHYSIOL-CELL PH, V274, pC1501, DOI 10.1152/ajpcell.1998.274.6.C1501; Kullmann DM, 2010, ANNU REV NEUROSCI, V33, P151, DOI 10.1146/annurev-neuro-060909-153122; LEE TE, 1994, BIOPHYS J, V66, P667, DOI 10.1016/S0006-3495(94)80840-9; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P5943, DOI 10.1167/iovs.10-5797; Schnitzler MMY, 2009, J BIOL CHEM, V284, P4695, DOI 10.1074/jbc.M808786200; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; Park Kang-Sik, 2007, Channels (Austin), V1, P59; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Patel AJ, 1999, ANN NY ACAD SCI, V868, P438, DOI 10.1111/j.1749-6632.1999.tb11309.x; Post MA, 1996, FEBS LETT, V399, P177, DOI 10.1016/S0014-5793(96)01316-6; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Robson AG, 2010, RETINA-J RET VIT DIS, V30, P51, DOI 10.1097/IAE.0b013e3181bfe24e; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; Salinas M, 1997, J BIOL CHEM, V272, P24371, DOI 10.1074/jbc.272.39.24371; Salinas M, 1997, J BIOL CHEM, V272, P8774, DOI 10.1074/jbc.272.13.8774; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Sergouniotis PI, 2012, BRIT J OPHTHALMOL, V96, P213, DOI 10.1136/bjo.2011.203638; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; Stocker M, 1999, J NEUROCHEM, V72, P1725, DOI 10.1046/j.1471-4159.1999.721725.x; Thiagalingam S, 2007, OPHTHALMIC GENET, V28, P135, DOI 10.1080/13816810701503681; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; WERBLIN FS, 1979, J PHYSIOL-LONDON, V294, P613, DOI 10.1113/jphysiol.1979.sp012949; Wissinger B, 2008, INVEST OPHTH VIS SCI, V49, P751, DOI 10.1167/iovs.07-0471; Wissinger B, 2011, HUM MUTAT, V32, P1398, DOI 10.1002/humu.21580; Wu HM, 2006, AM J HUM GENET, V79, P574, DOI 10.1086/507568; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; YAGI T, 1994, J NEUROPHYSIOL, V71, P656, DOI 10.1152/jn.1994.71.2.656; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhu XR, 1999, RECEPTOR CHANNEL, V6, P337	57	14	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43972	43983		10.1074/jbc.M112.388033	http://dx.doi.org/10.1074/jbc.M112.388033			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115240	Green Published, hybrid			2022-12-28	WOS:000312940800072
J	Botelho, HM; Leal, SS; Cardoso, I; Yanamandra, K; Morozova-Roche, LA; Fritz, G; Gomes, CM				Botelho, Hugo M.; Leal, Sonia S.; Cardoso, Isabel; Yanamandra, Kiran; Morozova-Roche, Ludmilla A.; Fritz, Guenter; Gomes, Claudio M.			S100A6 Amyloid Fibril Formation Is Calcium-modulated and Enhances Superoxide Dismutase-1 (SOD1) Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; CELLULAR PRION PROTEIN; P-COMPONENT; MUTANT P53; A-BETA; ALZHEIMERS-DISEASE; BINDING-PROTEIN; METAL-IONS; MICE; RECEPTOR	S100A6 is a small EF-hand calcium- and zinc-binding protein involved in the regulation of cell proliferation and cytoskeletal dynamics. It is overexpressed in neurodegenerative disorders and a proposed marker for Amyotrophic Lateral Sclerosis (ALS). Following recent reports of amyloid formation by S100 proteins, we investigated the aggregation properties of S100A6. Computational analysis using aggregation predictors Waltz and Zyggregator revealed increased propensity within S100A6 helices HI and HIV. Subsequent analysis of Thioflavin-T binding kinetics under acidic conditions elicited a very fast process with no lag phase and extensive formation of aggregates and stacked fibrils as observed by electron microscopy. Ca2+ exerted an inhibitory effect on the aggregation kinetics, which could be reverted upon chelation. An FT-IR investigation of the early conformational changes occurring under these conditions showed that Ca2+ promotes anti-parallel beta-sheet conformations that repress fibrillation. At pH 7, Ca2+ rendered the fibril formation kinetics slower: time-resolved imaging showed that fibril formation is highly suppressed, with aggregates forming instead. In the absence of metals an extensive network of fibrils is formed. S100A6 oligomers, but not fibrils, were found to be cytotoxic, decreasing cell viability by up to 40%. This effect was not observed when the aggregates were formed in the presence of Ca2+. Interestingly, native S1006 seeds SOD1 aggregation, shortening its nucleation process. This suggests a cross-talk between these two proteins involved in ALS. Overall, these results put forward novel roles for S100 proteins, whose metalmodulated aggregation propensity may be a key aspect in their physiology and function.	[Botelho, Hugo M.; Leal, Sonia S.; Gomes, Claudio M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal; [Cardoso, Isabel] Inst Biol Mol & Celular, Mol Neurobiol Unit, P-4150180 Oporto, Portugal; [Cardoso, Isabel] Inst Politecn Porto, Escola Super Tecnol Saude Porto, P-4400330 Vila Nova De Gaia, Portugal; [Yanamandra, Kiran; Morozova-Roche, Ludmilla A.] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Fritz, Guenter] Univ Freiburg, Dept Neuropathol, D-79106 Freiburg, Germany	Universidade Nova de Lisboa; Universidade do Porto; Polytechnic Institute of Porto; Umea University; University of Freiburg	Gomes, CM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Av Republ 127, P-2780756 Oeiras, Portugal.	gomes@itqb.unl.pt	Morozova-Roche, Ludmilla/AAV-9983-2021; Cardoso, Isabel/K-3903-2013; Morozova-Roche, Ludmilla A./AAU-9044-2021; Yanamandra, Kiran/M-4037-2014; Gomes, Cláudio M./A-8152-2008; Fritz, Guenter/E-2933-2013; Leal, Sónia/F-1129-2015; Botelho, Hugo M/B-3092-2008	Morozova-Roche, Ludmilla/0000-0001-5886-2023; Cardoso, Isabel/0000-0003-2472-7055; Yanamandra, Kiran/0000-0002-4908-5848; Gomes, Cláudio M./0000-0003-4662-6933; Fritz, Guenter/0000-0002-4571-8812; Leal, Sónia/0000-0001-8445-0065; Botelho, Hugo M/0000-0002-4208-1086	Fundacao para a Ciencia e Tecnologia (FCT/MCTES, Portugal) [PTDC/QUI/70101, PTDC/EBB-BIO/117793/2010, PTDC/QUI-BIQ/117789/2010]; Swedish Medical Research Council; Kempe Foundation; Brain Foundation; Insamlingsstiftelsen Sweden; Deutsche Forschungsgemeinschaft (DFG) [FR 1488/3-2, FR 1488/5-2]; CRUP/DAAD collaborative grant [A-15/08];  [SFRH/BPD/47477/2008];  [SFRH/BD/31126/2006];  [PEst-OE/EQB/LA0004/2011]	Fundacao para a Ciencia e Tecnologia (FCT/MCTES, Portugal)(Portuguese Foundation for Science and Technology); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Kempe Foundation; Brain Foundation; Insamlingsstiftelsen Sweden; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); CRUP/DAAD collaborative grant; ; ; 	This work was supported in part by the Fundacao para a Ciencia e Tecnologia (FCT/MCTES, Portugal) through research grants PTDC/QUI/70101, PTDC/EBB-BIO/117793/2010, and PTDC/QUI-BIQ/117789/2010 (to C. M. G.), doctoral and post-doctoral fellowships (SFRH/BPD/47477/2008 (to S. S. L.) and SFRH/BD/31126/2006 (to H. M. B.)), the strategic Grant PEst-OE/EQB/LA0004/2011 (to the ITQB Laboratorio Associado), and by the Swedish Medical Research Council, Kempe Foundation, Brain Foundation, and Insamlingsstiftelsen Sweden (to L. M. R.). This work was also funded in part by Grants FR 1488/3-2 and FR 1488/5-2 from the Deutsche Forschungsgemeinschaft (DFG) (to G. F.) and a CRUP/DAAD collaborative grant A-15/08 (to C. M. G. and G. F.).	Ahl IM, 2004, PROTEIN EXPRES PURIF, V37, P311, DOI 10.1016/j.pep.2004.06.006; Amadoro G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.001; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Andreetto E, 2011, CHEMBIOCHEM, V12, P1313, DOI 10.1002/cbic.201100192; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Barbato C, 2005, NEUROBIOL DIS, V18, P399, DOI 10.1016/j.nbd.2004.10.011; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Berridge M.V., 1996, BIOCHEMICA, V4, P14, DOI DOI 10.1155/2013/420601; Bodin K, 2010, NATURE, V468, P93, DOI 10.1038/nature09494; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Boom A, 2004, BBA-MOL CELL RES, V1742, P161, DOI 10.1016/j.bbamcr.2004.09.011; Botelho HM, 2012, METHODS MOL BIOL, V849, P373, DOI 10.1007/978-1-61779-551-0_25; Botelho HM, 2009, FEBS J, V276, P1776, DOI 10.1111/j.1742-4658.2009.06912.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P49; Fritz G., 2004, HDB METALLOPROTEINS; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Fritz G, 2010, FEBS J, V277, P4578, DOI 10.1111/j.1742-4658.2010.07887.x; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Green JD, 2004, J BIOL CHEM, V279, P12206, DOI 10.1074/jbc.M312452200; Hoyaux D, 2000, BRAIN RES, V867, P280, DOI 10.1016/S0006-8993(00)02393-3; Hoyaux D, 2002, J NEUROPATH EXP NEUR, V61, P736, DOI 10.1093/jnen/61.8.736; Hoyaux D, 2000, BBA-MOL CELL RES, V1498, P264, DOI 10.1016/S0167-4889(00)00101-4; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Inoue S, 1998, AMYLOID, V5, P99, DOI 10.3109/13506129808995287; Inoue S, 2005, AMYLOID, V12, P157, DOI 10.1080/13506120500232010; Inoue S, 1996, LAB INVEST, V74, P670; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kogel D, 2004, NEUROSCIENCE, V127, P913, DOI 10.1016/j.neuroscience.2004.06.013; Kovacs GG, 2002, NEUROSCI LETT, V329, P269, DOI 10.1016/S0304-3940(02)00668-7; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leal SS, 2012, COORDIN CHEM REV, V256, P2253, DOI 10.1016/j.ccr.2012.04.004; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Lesniak W, 2009, BIOCHEM BIOPH RES CO, V390, P1087, DOI 10.1016/j.bbrc.2009.10.150; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Miklossy J, 2010, NEUROBIOL AGING, V31, P1503, DOI 10.1016/j.neurobiolaging.2008.08.019; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; MOSS J, 1994, HISTOPATHOLOGY, V24, P427, DOI 10.1111/j.1365-2559.1994.tb00551.x; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nicolls MR, 2004, CURR ALZHEIMER RES, V1, P47, DOI 10.2174/1567205043480555; Nielsen EH, 2000, SCAND J IMMUNOL, V52, P110; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Otterbein LR, 2002, STRUCTURE, V10, P557, DOI 10.1016/S0969-2126(02)00740-2; Pepys MB, 1997, AMYLOID, V4, P274, DOI 10.3109/13506129709003838; Pflanzner T, 2012, J CEREBR BLOOD F MET, V32, P628, DOI 10.1038/jcbfm.2012.7; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Rezaei-Ghaleh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020289; Roltsch E, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-78; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Seeliger J, 2012, ANGEW CHEM INT EDIT, V51, P679, DOI 10.1002/anie.201105877; Shi J, 2002, J NUCL MED, V43, P1044; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Togashi S, 1997, LAB INVEST, V77, P525; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Yan LM, 2007, ANGEW CHEM INT EDIT, V46, P1246, DOI 10.1002/anie.200604056; Yanamandra K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005562; Zhang XA, 2010, PROG MOL BIOL TRANSL, V93, P309, DOI 10.1016/S1877-1173(10)93013-5; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297; Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356	75	30	30	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42233	42242		10.1074/jbc.M112.396416	http://dx.doi.org/10.1074/jbc.M112.396416			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23076148	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000312103000059
J	Bauer, I; Grozio, A; Lasiglie, D; Basile, G; Sturla, L; Magnone, M; Sociali, G; Soncini, D; Caffa, I; Poggi, A; Zoppoli, G; Cea, M; Feldmann, G; Mostoslavsky, R; Ballestrero, A; Patrone, F; Bruzzone, S; Nencioni, A				Bauer, Inga; Grozio, Alessia; Lasiglie, Denise; Basile, Giovanna; Sturla, Laura; Magnone, Mirko; Sociali, Giovanna; Soncini, Debora; Caffa, Irene; Poggi, Alessandro; Zoppoli, Gabriele; Cea, Michele; Feldmann, Georg; Mostoslavsky, Raul; Ballestrero, Alberto; Patrone, Franco; Bruzzone, Santina; Nencioni, Alessio			The NAD(+)-dependent Histone Deacetylase SIRT6 Promotes Cytokine Production and Migration in Pancreatic Cancer Cells by Regulating Ca2+ Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; GENE-EXPRESSION; TRANSCRIPTION FACTOR; PROTEIN-SYNTHESIS; CALCIUM; INFLAMMATION; CARCINOMA; MECHANISM; CHANNEL; NAD(+)	Cytokine secretion by cancer cells contributes to cancer-induced symptoms and angiogenesis. Studies show that the sirtuin SIRT6 promotes inflammation by enhancing TNF expression. Here, we aimed to determine whether SIRT6 is involved in conferring an inflammatory phenotype to cancer cells and to define the mechanisms linking SIRT6 to inflammation. We show that SIRT6 enhances the expression of pro-inflammatory cyto-/chemokines, such as IL8 and TNF, and promotes cell migration in pancreatic cancer cells by enhancing Ca2+ responses. Via its enzymatic activity, SIRT6 increases the intracellular levels of ADP-ribose, an activator of the Ca2+ channel TRPM2. In turn, TRPM2 and Ca2+ are shown to be involved in SIRT6-induced TNF and IL8 expression. SIRT6 increases the nuclear levels of the Ca2+-dependent transcription factor, nuclear factor of activated T cells (NFAT), and cyclosporin A, a calcineurin inhibitor that reduces NFAT activity, reduces TNF and IL8 expression in SIRT6-overexpressing cells. These results implicate a role for SIRT6 in the synthesis of Ca2+-mobilizing second messengers, in the regulation of Ca2+-dependent transcription factors, and in the expression of pro-inflammatory, pro-angiogenic, and chemotactic cytokines. SIRT6 inhibition may help combat cancer-induced inflammation, angiogenesis, and metastasis.	[Grozio, Alessia; Basile, Giovanna; Sturla, Laura; Magnone, Mirko; Sociali, Giovanna; Bruzzone, Santina] Univ Genoa, Dept Expt Med, Biochem Sect, I-16132 Genoa, Italy; [Bauer, Inga; Lasiglie, Denise; Soncini, Debora; Caffa, Irene; Zoppoli, Gabriele; Cea, Michele; Ballestrero, Alberto; Patrone, Franco; Nencioni, Alessio] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy; [Grozio, Alessia; Basile, Giovanna; Sturla, Laura; Magnone, Mirko; Sociali, Giovanna; Bruzzone, Santina] Univ Genoa, CEBR, I-16132 Genoa, Italy; [Poggi, Alessandro] IRCCS Azienda Osped Univ San Martino IST Natl Ins, Unit Mol Oncol & Angiogenesis, I-16132 Genoa, Italy; [Cea, Michele] Harvard Univ, Sch Med, LeBow Inst Myeloma Therapeut, Dana Farber Canc Inst 02215, Boston, MA USA; [Cea, Michele] Harvard Univ, Sch Med, Jerome Lipper Ctr Multiple Myeloma Res, Dana Farber Canc Inst 02215, Boston, MA USA; [Feldmann, Georg] Univ Bonn, Dept Internal Med 3, Ctr Integrated Oncol Cologne Bonn, D-53127 Bonn, Germany; [Mostoslavsky, Raul] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA	University of Genoa; University of Genoa; University of Genoa; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Bonn; Harvard University; Harvard Medical School; Massachusetts General Hospital	Bruzzone, S (corresponding author), Univ Genoa, Dept Expt Med, Biochem Sect, Viale Benedetto 15,1, I-16132 Genoa, Italy.	santina.bruzzone@unige.it	Ballestrero, Alberto/K-7546-2016; Bruzzone, Santina/A-4264-2015; Poggi, Alessandro/K-6664-2016; Soncini, Debora/AAB-2230-2019; Nencioni, Alessio/K-3692-2018; cea, Michele/K-3863-2018; Zoppoli, Gabriele/B-6935-2016; Caffa, Irene/J-9835-2016; Zoppoli, Gabriele/B-6935-2016	Ballestrero, Alberto/0000-0002-2601-7711; Bruzzone, Santina/0000-0003-2034-3716; Poggi, Alessandro/0000-0002-1860-430X; Soncini, Debora/0000-0001-5156-498X; cea, Michele/0000-0002-1530-6729; Zoppoli, Gabriele/0000-0003-3890-5588; Caffa, Irene/0000-0003-1111-9915; NENCIONI, ALESSIO/0000-0001-5068-8884; Zoppoli, Gabriele/0000-0002-1619-1708	Associazione Italiana per la Ricerca sul Cancro (AIRC) [6108]; European Seventh Framework Program [256986]; Ministero della Salute [GR-2008-1135635]; Fondazione CARIGE; Compagnia di San Paolo; University of Genoa	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Seventh Framework Program; Ministero della Salute(Ministry of Health, Italy); Fondazione CARIGE(Fondazione Carige); Compagnia di San Paolo(Compagnia di San Paolo); University of Genoa	This work was supported in part by the Associazione Italiana per la Ricerca sul Cancro (AIRC, Code 6108) (to A. N.), by the European Seventh Framework Program (Project 256986, PANACREAS) (to A. N.), by Ministero della Salute Grant GR-2008-1135635 (to A. N.), by the Fondazione CARIGE, by the Compagnia di San Paolo, and by the University of Genoa.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Argiles Josep M, 2009, Curr Opin Support Palliat Care, V3, P263, DOI 10.1097/SPC.0b013e3283311d09; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Basile G, 2005, P NATL ACAD SCI USA, V102, P14509, DOI 10.1073/pnas.0503691102; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Egberts JH, 2008, CANCER RES, V68, P1443, DOI 10.1158/0008-5472.CAN-07-5704; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Grahnert A, 2011, INNATE IMMUN-LONDON, V17, P212, DOI 10.1177/1753425910361989; Grubisha O, 2006, J BIOL CHEM, V281, P14057, DOI 10.1074/jbc.M513741200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hasmann M, 2003, CANCER RES, V63, P7436; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ishikawa M, 2005, CANCER SCI, V96, P387, DOI 10.1111/j.1349-7006.2005.00064.x; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kiefer F, 2011, CELL MOL LIFE SCI, V68, P2811, DOI 10.1007/s00018-011-0677-7; Knowles H, 2011, P NATL ACAD SCI USA, V108, P11578, DOI 10.1073/pnas.1010678108; Kurzrock R, 2001, CANCER, V92, P1684, DOI 10.1002/1097-0142(20010915)92:6+<1684::AID-CNCR1497>3.0.CO;2-Z; Lee HC, 2011, SCI CHINA LIFE SCI, V54, P699, DOI 10.1007/s11427-011-4197-3; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Lund FE, 2006, MOL MED, V12, P328, DOI 10.2119/2006-00099.Lund; Magnone M, 2012, J BIOL CHEM, V287, P21067, DOI 10.1074/jbc.M111.324269; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Montecucco F., 2012, ANTIOXID RE IN PRESS; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; MUKAIDA N, 1989, J IMMUNOL, V143, P1366; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Peterson FC, 2011, J BIOL CHEM, V286, P35955, DOI 10.1074/jbc.M111.276238; PREISS J, 1958, J BIOL CHEM, V233, P493; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Robert F, 2012, CANCER RES, V72, P747, DOI 10.1158/0008-5472.CAN-11-2739; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Shi Q, 1999, CLIN CANCER RES, V5, P3711; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Slade D, 2011, NATURE, V477, P616, DOI 10.1038/nature10404; STEFFAN NM, 1995, J IMMUNOL, V155, P4685; SUNG SSJ, 1991, J IMMUNOL, V147, P2047; Suzuki YJ, 2011, CELL SIGNAL, V23, P1094, DOI 10.1016/j.cellsig.2011.02.007; Tennen RI, 2010, MECH AGEING DEV, V131, P185, DOI 10.1016/j.mad.2010.01.006; Tong L, 2010, BBA-PROTEINS PROTEOM, V1804, P1617, DOI 10.1016/j.bbapap.2010.02.007; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]	62	129	134	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40924	40937		10.1074/jbc.M112.405837	http://dx.doi.org/10.1074/jbc.M112.405837			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23086953	Green Published, hybrid			2022-12-28	WOS:000311887600012
J	Abdulrahman, BA; Abu Khweek, A; Akhter, A; Caution, K; Tazi, M; Hassan, H; Zhang, YC; Rowland, PD; Malhotra, S; Aeffner, F; Davis, IC; Valvano, MA; Amer, AO				Abdulrahman, Basant A.; Abu Khweek, Arwa; Akhter, Anwari; Caution, Kyle; Tazi, Mia; Hassan, Hoda; Zhang, Yucheng; Rowland, Patrick D.; Malhotra, Sankalp; Aeffner, Famke; Davis, Ian C.; Valvano, Miguel A.; Amer, Amal O.			Depletion of the Ubiquitin-binding Adaptor Molecule SQSTM1/p62 from Macrophages Harboring cftr Delta F508 Mutation Improves the Delivery of Burkholderia cenocepacia to the Autophagic Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE AUTOPHAGY; LUNG INFLAMMATION; CYSTIC-FIBROSIS; P62; INFECTION; NBR1; INTERNALIZATION; FRANCISELLA; SALMONELLA; EXPRESSION	Cystic fibrosis is the most common inherited lethal disease in Caucasians. It is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), of which the cftr Delta F508 mutation is the most common. Delta F508 macrophages are intrinsically defective in autophagy because of the sequestration of essential autophagy molecules within unprocessed CFTR aggregates. Defective autophagy allows Burkholderia cenocepacia (B. cepacia) to survive and replicate in Delta F508 macrophages. Infection by B. cepacia poses a great risk to cystic fibrosis patients because it causes accelerated lung inflammation and, in some cases, a lethal necrotizing pneumonia. Autophagy is a cell survival mechanism whereby an autophagosome engulfs nonfunctional organelles and delivers them to the lysosome for degradation. The ubiquitin binding adaptor protein SQSTM1/p62 is required for the delivery of several ubiquitinated cargos to the autophagosome. In WT macrophages, p62 depletion and overexpression lead to increased and decreased bacterial intracellular survival, respectively. In contrast, depletion of p62 in Delta F508 macrophages results in decreased bacterial survival, whereas overexpression of p62 leads to increased B. cepacia intracellular growth. Interestingly, the depletion of p62 from Delta F508 macrophages results in the release of the autophagy molecule beclin1 (BECN1) from the mutant CFTR aggregates and allows its redistribution and recruitment to the B. cepacia vacuole, mediating the acquisition of the autophagy marker LC3 and bacterial clearance via autophagy. These data demonstrate that p62 differentially dictates the fate of B. cepacia infection in WT and Delta F508 macrophages.	[Abdulrahman, Basant A.; Abu Khweek, Arwa; Akhter, Anwari; Caution, Kyle; Tazi, Mia; Hassan, Hoda; Zhang, Yucheng; Rowland, Patrick D.; Amer, Amal O.] Ohio State Univ, Dept Microbial Infect & Immun, Dept Internal Med, Columbus, OH 43210 USA; [Abdulrahman, Basant A.; Abu Khweek, Arwa; Akhter, Anwari; Caution, Kyle; Tazi, Mia; Hassan, Hoda; Zhang, Yucheng; Rowland, Patrick D.; Amer, Amal O.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Abdulrahman, Basant A.] Helwan Univ, Dept Biochem & Mol Biol, Fac Pharm, Cairo, Egypt; [Malhotra, Sankalp] Ohio State Univ, Med Scientist Training Program, Columbus, OH 43210 USA; [Aeffner, Famke; Davis, Ian C.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Valvano, Miguel A.] Univ Western Ontario, Ctr Human Immunol, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Valvano, Miguel A.] Queens Univ Belfast, Ctr Infect & Immun, Belfast BT9 7BL, Antrim, North Ireland	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Egyptian Knowledge Bank (EKB); Helwan University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Western University (University of Western Ontario); Queens University Belfast	Amer, AO (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Dept Internal Med, Biol Res Tower,460 W 12th Ave,Room 1014, Columbus, OH 43210 USA.	amal.amer@osumc.edu	Amer, Amal/E-2643-2011; Valvano, Miguel A/G-8759-2012	Valvano, Miguel A/0000-0001-8229-3641; Abdulrahman, Basant/0000-0002-4970-6835; Aeffner, Famke/0000-0002-1405-9228	Egyptian Bureau of Education; National Institutes of Health [R01HL094586]; Cystic Fibrosis Canada grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER	Egyptian Bureau of Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Canada grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a doctoral fellowship from the Egyptian Bureau of Education (to B. A. A.). This work was supported, in whole or in part, by the National Institutes of Health (Grant R01HL094586 (to A. O. A.)) and a Cystic Fibrosis Canada grant (to M. A. V).	Abdulrahman BA, 2011, AUTOPHAGY, V7, P1359, DOI 10.4161/auto.7.11.17660; Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Amer AO, 2005, AUTOPHAGY, V1, P53, DOI 10.4161/auto.1.1.1589; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; Devenish RJ, 2011, AUTOPHAGY, V7, P1269, DOI 10.4161/auto.7.11.17941; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Fahy RJ, 2008, AM J RESP CRIT CARE, V177, P983, DOI 10.1164/rccm.200703-418OC; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Hamad MA, 2010, APPL ENVIRON MICROB, V76, P3170, DOI 10.1128/AEM.03024-09; Hocking LJ, 2002, HUM MOL GENET, V11, P2735, DOI 10.1093/hmg/11.22.2735; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kirkin V, 2009, AUTOPHAGY, V5, P732, DOI 10.4161/auto.5.5.8566; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Knorre A, 2002, BIOL CHEM, V383, P271, DOI 10.1515/BC.2002.029; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kotrange S, 2011, J LEUKOCYTE BIOL, V89, P481, DOI 10.1189/jlb.0910513; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Loutet SA, 2010, INFECT IMMUN, V78, P4088, DOI 10.1128/IAI.00212-10; Luciani A, 2012, AUTOPHAGY, V8, P1657, DOI 10.4161/auto.21483; Luciani A, 2011, AUTOPHAGY, V7, P104, DOI 10.4161/auto.7.1.13987; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; McCloskey M, 2001, IRISH J MED SCI, V170, P28, DOI 10.1007/BF03167716; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Nezis IP, 2008, METHOD ENZYMOL, V451, P669, DOI 10.1016/S0076-6879(08)03237-0; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Rosales-Reyes R, 2012, CELL MICROBIOL, V14, P255, DOI 10.1111/j.1462-5822.2011.01716.x; Saldias MS, 2009, MICROBIOL-SGM, V155, P2809, DOI 10.1099/mic.0.031344-0; Tolman JS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-63; Vergne I, 2010, FEBS LETT, V584, P1313, DOI 10.1016/j.febslet.2010.02.054; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Witko-Sarsat V, 1999, MEDIAT INFLAMM, V8, P7, DOI 10.1080/09629359990658; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	49	49	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2049	2058		10.1074/jbc.M112.411728	http://dx.doi.org/10.1074/jbc.M112.411728			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23148214	hybrid, Green Published			2022-12-28	WOS:000313751400056
J	Mochizuki, Y; Ohashi, R; Kawamura, T; Iwanari, H; Kodama, T; Naito, M; Hamakubo, T				Mochizuki, Yasuhiro; Ohashi, Riuko; Kawamura, Takeshi; Iwanari, Hiroko; Kodama, Tatsuhiko; Naito, Makoto; Hamakubo, Takao			Phosphatidylinositol 3-Phosphatase Myotubularin-related Protein 6 (MTMR6) Is Regulated by Small GTPase Rab1B in the Early Secretory and Autophagic Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; MICE DEFICIENT; GRAM DOMAIN; PHOSPHATASE; MEMBRANE; GENE; PSEUDOPHOSPHATASE; 3,5-BISPHOSPHATE; IDENTIFICATION; ASSOCIATION	A large family of myotubularin phosphatases dephosphorylates phosphatidylinositol 3-phosphate and phosphatidylinositol 3,5-bisphosphate, which are known to play important roles in vesicular trafficking and autophagy. The family is composed of 16 members, and understanding their regulatory mechanisms is important to understand their functions and related genetic diseases. We prepared anti-myotubularin-related protein 6 (MTMR6) monoclonal antibody and used it to study the regulatory mechanism of MTMR6. Endogenous MTMR6 was present in the cytoplasm and was condensed in the perinuclear region in a microtubule-dependent manner. MTMR6 preferentially interacted with GDP-bound Rab1B via the GRAM domain and partly overlapped with Rab1B in the pericentrosomal and peri-Golgi regions in normal rat kidney cells. Overexpression of GDP-bound Rab1B and the reduction of Rab1B disrupted the localization of MTMR6, suggesting that Rab1B regulates the localization of MTMR6. The reduction of MTMR6 accelerated the transport of vesicular stomatitis virus glycoprotein in which Rab1B is involved. Furthermore, reduction of MTMR6 or Rab1B inhibited the formation of the tubular omegasome that is induced by overexpression of DFCP1 in autophagy. Our results indicate that the cellular localization of MTMR6 is regulated by Rab1B in the early secretory and autophagic pathways. We propose a new regulatory mechanism of myotubularin phosphatase by the small GTPase Rab1B.	[Mochizuki, Yasuhiro] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Mol Biol & Med, Meguro Ku, Tokyo 1538904, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Syst Biol & Med, Tokyo 1538904, Japan; [Ohashi, Riuko; Naito, Makoto] Niigata Univ, Grad Sch Med & Dent Sci, Div Cellular & Mol Pathol, Dept Cellular Funct, Niigata 9518510, Japan	University of Tokyo; University of Tokyo; Niigata University	Mochizuki, Y (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Mol Biol & Med, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	mochizuki@lsbm.org	Ohashi, Riuko/AAH-1415-2019	Ohashi, Riuko/0000-0001-5820-7870	development of New Functional Antibody Technologies of the New Energy and Industrial Technology Development Organization (NEDO); Funding Program for World-Leading Innovative R&D on Science and Technology (First Program); Ministry of Education, Culture, Sports, Science and Technology [20221010]	development of New Functional Antibody Technologies of the New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Funding Program for World-Leading Innovative R&D on Science and Technology (First Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the development of New Functional Antibody Technologies of the New Energy and Industrial Technology Development Organization (NEDO), the Funding Program for World-Leading Innovative R&D on Science and Technology (First Program), and Ministry of Education, Culture, Sports, Science and Technology Grant-in-aid for Scientific Research 20221010.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alvarez C, 2003, SYNTHESE, V134, P1; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Berger P, 2006, HUM MOL GENET, V15, P569, DOI 10.1093/hmg/ddi473; Berger P, 2003, P NATL ACAD SCI USA, V100, P12177, DOI 10.1073/pnas.2132732100; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Choudhury P, 2006, J BIOL CHEM, V281, P31762, DOI 10.1074/jbc.M606344200; Clague MJ, 2009, EXP CELL RES, V315, P1627, DOI 10.1016/j.yexcr.2008.10.005; Daigo K, 2011, J BIOL CHEM, V286, P674, DOI 10.1074/jbc.M110.154732; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; de Lartigue J, 2009, TRAFFIC, V10, P883, DOI 10.1111/j.1600-0854.2009.00915.x; Domin J, 2000, J BIOL CHEM, V275, P11943, DOI 10.1074/jbc.275.16.11943; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; Firestein R, 2002, J CLIN INVEST, V109, P1165, DOI [10.1172/JCI200212589, 10.1172/JCI0212589]; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Hotta K, 2011, J HUM GENET, V56, P647, DOI 10.1038/jhg.2011.74; Huang J, 2011, AUTOPHAGY, V7, P17, DOI 10.4161/auto.7.1.13840; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; Jones DR, 1999, J BIOL CHEM, V274, P18407, DOI 10.1074/jbc.274.26.18407; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim SA, 2003, P NATL ACAD SCI USA, V100, P4492, DOI 10.1073/pnas.0431052100; Kong AM, 2006, MOL CELL BIOL, V26, P6065, DOI 10.1128/MCB.00203-06; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lorenzo O, 2005, J CELL SCI, V118, P2005, DOI 10.1242/jcs.02325; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; Marie M, 2009, MOL BIOL CELL, V20, P4458, DOI 10.1091/mbc.E08-12-1229; Zoppino FCM, 2010, TRAFFIC, V11, P1246, DOI 10.1111/j.1600-0854.2010.01086.x; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Mochizuki Y, 2003, P NATL ACAD SCI USA, V100, P9768, DOI 10.1073/pnas.1333958100; Nandurkar HH, 2003, P NATL ACAD SCI USA, V100, P8660, DOI 10.1073/pnas.1033097100; Robinson FL, 2005, J BIOL CHEM, V280, P31699, DOI 10.1074/jbc.M505159200; Robinson FL, 2006, TRENDS CELL BIOL, V16, P403, DOI 10.1016/j.tcb.2006.06.001; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Saitoh R, 2007, J IMMUNOL METHODS, V322, P104, DOI 10.1016/j.jim.2007.02.005; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; Seaman MNJ, 2008, CELL MOL LIFE SCI, V65, P2842, DOI 10.1007/s00018-008-8354-1; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; Shen JH, 2009, NAT CELL BIOL, V11, P769, DOI 10.1038/ncb1884; Silhankova M, 2010, EMBO J, V29, P4094, DOI 10.1038/emboj.2010.278; Srivastava S, 2005, MOL CELL BIOL, V25, P3630, DOI 10.1128/MCB.25.9.3630-3638.2005; Taguchi-Atarashi N, 2010, TRAFFIC, V11, P468, DOI 10.1111/j.1600-0854.2010.01034.x; Tanaka Toshiya, 2002, J Atheroscler Thromb, V9, P233; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Tosch V, 2006, HUM MOL GENET, V15, P3098, DOI 10.1093/hmg/ddl250; Tsujita K, 2004, J BIOL CHEM, V279, P13817, DOI 10.1074/jbc.M312294200; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Yanagiya T, 2007, HUM MOL GENET, V16, P3017, DOI 10.1093/hmg/ddm260; Yoshimori T, 2008, CURR OPIN CELL BIOL, V20, P401, DOI 10.1016/j.ceb.2008.03.010; Zou J, 2012, P NATL ACAD SCI USA, V109, P9539, DOI 10.1073/pnas.1207021109; Zou J, 2009, J BIOL CHEM, V284, P2064, DOI 10.1074/jbc.M804292200	60	31	33	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1009	1021		10.1074/jbc.M112.395087	http://dx.doi.org/10.1074/jbc.M112.395087			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23188820	Green Published, hybrid			2022-12-28	WOS:000313570300025
J	Hochrainer, K; Racchumi, G; Anrather, J				Hochrainer, Karin; Racchumi, Gianfranco; Anrather, Josef			Site-specific Phosphorylation of the p65 Protein Subunit Mediates Selective Gene Expression by Differential NF-kappa B and RNA Polymerase II Promoter Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; TRANSCRIPTION FACTOR; PROINFLAMMATORY CYTOKINES; ENDOTHELIAL-CELLS; RESPONSE ELEMENT; IKK-EPSILON; ACTIVATION; KINASE; PROTEOLYSIS; SEQUENCE	Phosphorylation of NF-kappa B plays an important role in modulating transcriptional activity of NF-kappa B independently of inhibitor of kappa B (I kappa B) proteins. For the p65 subunit, multiple phosphorylation sites have been mapped in and adjacent to both the N-terminal Rel homology domain and the C-terminal transactivation domain. Their impact on NF-kappa B-dependent transcription, however, has never been assessed at a broader level. In this study, we evaluate the importance of differential p65 phosphorylation on four serine acceptor sites in the Rel homology domain for the expression of an array of NF-kappa B-dependent genes in endothelial cells. We find that inhibition of p65 phosphorylation on these serine residues targets NF-kappa B activity to distinctive gene subsets in a kappa B enhancer element-specific context. We show that the phosphorylation-dependent alterations in gene and protein expression are reflective of the amount of p65 and phosphorylated RNA polymerase II (p-RNAP II) bound to respective gene promoter regions. Depending on the gene subset, impaired gene expression was either a result of decreased p65 promoter recruitment or of a failure of bound p65 to recruit p-RNAP II. In conclusion, our findings demonstrate that site-specific p65 phosphorylation targets NF-kappa B activity to particular gene subsets on a global level by influencing p65 and p-RNAP II promoter recruitment.	[Hochrainer, Karin; Racchumi, Gianfranco; Anrather, Josef] Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, New York, NY 10065 USA	Cornell University	Anrather, J (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, 407 E 61st St,RR 409, New York, NY 10065 USA.	joa2006@med.cornell.edu	Hochrainer, Karin/AAN-6145-2020	Hochrainer, Karin/0000-0001-5147-0633	National Institutes of Health [HL077308]; American Heart Association [10SDG2600298]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL077308 (to J. A.). This work was also supported by American Heart Association Scientist Development Grant 10SDG2600298 (to K.H.).	Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Anrather J, 1999, J BIOL CHEM, V274, P13594, DOI 10.1074/jbc.274.19.13594; Anrather J, 2005, J BIOL CHEM, V280, P244, DOI 10.1074/jbc.M409344200; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BALDWIN AS, 1988, P NATL ACAD SCI USA, V85, P723, DOI 10.1073/pnas.85.3.723; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dong J, 2008, GENE DEV, V22, P1159, DOI 10.1101/gad.1657408; Drier EA, 1999, GENE DEV, V13, P556, DOI 10.1101/gad.13.5.556; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Ghosh CC, 2010, J IMMUNOL, V185, P3685, DOI 10.4049/jimmunol.0902230; Harant H, 2001, FEBS LETT, V509, P439, DOI 10.1016/S0014-5793(01)03138-6; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Hochrainer K, 2007, FEBS LETT, V581, P5493, DOI 10.1016/j.febslet.2007.10.056; Hochrainer K, 2012, CELL MOL LIFE SCI, V69, P2057, DOI 10.1007/s00018-011-0912-2; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Moreno R, 2010, NUCLEIC ACIDS RES, V38, P6029, DOI 10.1093/nar/gkq439; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; O'Shea JM, 2010, BIOCHEM J, V426, P345, DOI 10.1042/BJ20091630; OBRIEN T, 1994, NATURE, V370, P75, DOI 10.1038/370075a0; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Pan JL, 1998, J BIOL CHEM, V273, P10068, DOI 10.1074/jbc.273.16.10068; Rocha S, 2005, EMBO J, V24, P1157, DOI 10.1038/sj.emboj.7600608; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Sabatel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038246; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Tanaka Y, 1996, J VIROL, V70, P8508, DOI 10.1128/JVI.70.12.8508-8517.1996; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; WIDMER U, 1993, J IMMUNOL, V150, P4996; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	46	54	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					285	293		10.1074/jbc.M112.385625	http://dx.doi.org/10.1074/jbc.M112.385625			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23100252	Green Published, hybrid			2022-12-28	WOS:000313197200028
J	Lauer, ME; Glant, TT; Mikecz, K; DeAngelis, PL; Haller, FM; Husni, ME; Hascall, VC; Calabro, A				Lauer, Mark E.; Glant, Tibor T.; Mikecz, Katalin; DeAngelis, Paul L.; Haller, F. Michael; Husni, M. Elaine; Hascall, Vincent C.; Calabro, Anthony			Irreversible Heavy Chain Transfer to Hyaluronan Oligosaccharides by Tumor Necrosis Factor-stimulated Gene-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TRYPSIN INHIBITOR; INDUCED ARTHRITIS; ACID; FAMILY; FLUID; TSG-6; SHAP; MICE	The covalent transfer of heavy chains (HCs) from inter-alpha-inhibitor (I alpha I) to hyaluronan (HA) via the protein product of tumor necrosis factor-stimulated gene-6 (TSG-6) forms the HC-HA complex, a pathological form of HA that promotes the adhesion of leukocytes to HA matrices. The transfer of HCs to high molecular weight (HMW) HA is a reversible event whereby TSG-6 can shuffle HCs from one HA molecule to another. Therefore, HMW HA can serve as both an HC acceptor and an HC donor. In the present study, we show that transfer of HCs to low molecular weight HA oligosaccharides is an irreversible event where subsequent shuffling does not occur, i.e. HA oligosaccharides from 8 to 21 monosaccharide units in length can serve as HC acceptors, but are unable to function as HC donors. We show that the HC-HA complex is present in the synovial fluid of mice subjected to systemic and monoarticular mouse models of rheumatoid arthritis. Furthermore, we demonstrate that HA oligosaccharides can be used, with TSG-6, to irreversibly shuffle HCs from pathological, HMW HC-HA to HA oligosaccharides, thereby restoring HC-HA matrices from the inflamed joint to their normal state, unmodified with HCs. This process was also effective for HC-HA in the synovial fluid of human rheumatoid arthritis patients (in vitro).	[Lauer, Mark E.; Hascall, Vincent C.; Calabro, Anthony] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Husni, M. Elaine] Cleveland Clin, Orthoped & Rheumatol Inst, Cleveland, OH 44195 USA; [Glant, Tibor T.; Mikecz, Katalin] Rush Univ, Med Ctr, Sect Mol Med, Chicago, IL 60612 USA; [DeAngelis, Paul L.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73126 USA; [Haller, F. Michael] Hyalose LLC, Oklahoma City, OK 73104 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Rush University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Lauer, ME (corresponding author), Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA.	lauerm1@ccf.org		Mikecz, Katalin/0000-0003-1506-4296	National Institutes of Health from the NHLBI [P11HL081064, P01HL107147]; Oklahoma Center for Advancement of Science and Technology Oklahoma Applied Research Support (OARS) program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064, P01HL107147] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Oklahoma Center for Advancement of Science and Technology Oklahoma Applied Research Support (OARS) program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P11HL081064 and P01HL107147 from the NHLBI. This work was also supported by the Oklahoma Center for Advancement of Science and Technology Oklahoma Applied Research Support (OARS) program.	Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; DECKER B, 1959, CLIN CHEM, V5, P465; FRASER JRE, 1981, BIOCHEM J, V200, P415, DOI 10.1042/bj2000415; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Giant TT, 2004, METH MOLEC MED, V102, P313; GLANT TT, 1987, ARTHRITIS RHEUM-US, V30, P201, DOI 10.1002/art.1780300211; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; NISHIMURA H, 1995, FEBS LETT, V357, P207; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Salier JP, 1996, BIOCHEM J, V315, P1, DOI 10.1042/bj3150001; SALIER JP, 1992, MAMM GENOME, V2, P233, DOI 10.1007/BF00355432; Sandson J, 1965, Trans Assoc Am Physicians, V78, P304; Sanggaard KW, 2010, J BIOL CHEM, V285, P21988, DOI 10.1074/jbc.M109.041046; Szanto S, 2004, J IMMUNOL, V172, P6723, DOI 10.4049/jimmunol.172.11.6723; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	18	38	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					205	214		10.1074/jbc.M112.403998	http://dx.doi.org/10.1074/jbc.M112.403998			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23166324	Green Published, hybrid			2022-12-28	WOS:000313197200020
J	Li, L; Guan, KL				Li, Li; Guan, Kun-Liang			Microtubule-associated Protein/Microtubule Affinity-regulating Kinase 4 (MARK4) Is a Negative Regulator of the Mammalian Target of Rapamycin Complex 1 (mTORC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACIDS; RAG GTPASES; DROSOPHILA; AMPK; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; AUTOPHAGY; GROWTH; PRAS40	The mammalian target of rapamycin (mTOR) is a central cell growth regulator. It resides in two protein complexes, which in mammals are referred to as mTORC1 and mTORC2. mTORC1, which is directly inhibited by rapamycin, promotes cell growth by stimulating protein synthesis and inhibiting autophagy. A wide range of extra and intracellular signals, including growth factors, nutrients, energy levels, and various stress conditions, regulates mTORC1. Dysregulation of mTORC1 contributes to many human diseases, including cancer, cardiovascular disease, autoimmunity, and metabolic disorder. In this study, we identified MARK4, an AMP-activated kinase-related kinase, as a negative regulator of mTORC1. In Drosophila S2 cells and mammalian cells, knockdown of MARK family member increased mTORC1 activity, whereas overexpression of MARK4 in mammalian cells significantly inhibited mTORC1 activity. Interestingly, MARK4 selectively inhibits mTORC1 activation by Rag GTPases, which are involved in amino acid signaling, but does not inhibit the effect of Rheb, which directly binds to and activates mTORC1. In addition, we found that MARK4 phosphorylates Raptor, a key component of mTORC1, and this phosphorylation may interfere with Raptor-Rag interaction. Our data demonstrate MARK4 as a new negative regulator of mTORC1.	[Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022		National Institutes of Health [R01GM51586, R01CA108941]; NATIONAL CANCER INSTITUTE [R01CA108941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM51586 and R01CA108941 (to K. L. G.).	Bright NJ, 2009, ACTA PHYSIOL, V196, P15, DOI 10.1111/j.1748-1716.2009.01971.x; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Tassan JP, 2004, BIOL CELL, V96, P193, DOI 10.1016/j.biolcel.2003.10.009; Tomancak P, 2000, NAT CELL BIOL, V2, P458, DOI 10.1038/35017101; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64	24	50	52	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					703	708		10.1074/jbc.C112.396903	http://dx.doi.org/10.1074/jbc.C112.396903			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23184942	hybrid, Green Published			2022-12-28	WOS:000313197200070
J	Vatine, GD; Zada, D; Lerer-Goldshtein, T; Tovin, A; Malkinson, G; Yaniv, K; Appelbaum, L				Vatine, Gad David; Zada, David; Lerer-Goldshtein, Tali; Tovin, Adi; Malkinson, Guy; Yaniv, Karina; Appelbaum, Lior			Zebrafish as a Model for Monocarboxyl Transporter 8-Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE TRANSPORTER; ORGANIC ANION TRANSPORTER; AMINO-ACID TRANSPORTER; BLOOD-BRAIN; FUNCTIONAL-CHARACTERIZATION; IODOTHYRONINE DEIODINASE; EMBRYONIC-DEVELOPMENT; TRANSGENIC ZEBRAFISH; EXPRESSION; IDENTIFICATION	Allan-Herndon-Dudley syndrome (AHDS) is a severe psychomotor retardation characterized by neurological impairment and abnormal thyroid hormone (TH) levels. Mutations in the TH transporter, monocarboxylate transporter 8 (MCT8), are associated with AHDS. MCT8 knock-out mice exhibit impaired TH levels; however, they lack neurological defects. Here, the zebrafish mct8 gene and promoter were isolated, and mct8 promoter-driven transgenic lines were used to show that, similar to humans, mct8 is primarily expressed in the nervous and vascular systems. Morpholino-based knockdown and rescue experiments revealed that MCT8 is strictly required for neural development in the brain and spinal cord. This study shows thatMCT8is a crucial regulator during embryonic development and establishes the first vertebrate model for MCT8 deficiency that exhibits a neurological phenotype.	[Vatine, Gad David; Zada, David; Lerer-Goldshtein, Tali; Tovin, Adi; Appelbaum, Lior] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Vatine, Gad David; Zada, David; Lerer-Goldshtein, Tali; Tovin, Adi; Appelbaum, Lior] Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, IL-52900 Ramat Gan, Israel; [Malkinson, Guy; Yaniv, Karina] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Bar Ilan University; Bar Ilan University; Weizmann Institute of Science	Appelbaum, L (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	lior.appelbaum@biu.ac.il	Vatine, Gad/ABF-3907-2021	Malkinson, Guy/0000-0001-7339-3659; Vatine, Gad/0000-0003-3674-1671	SMILE Foundation; Sherman family; Israel Science Foundation [1705/11]; Marie Curie Actions-International Reintegration Grant [FP7-PEOPLE-2010-RG 274333]; Lymphatic Research Foundation; Israeli Cancer Research Foundation	SMILE Foundation; Sherman family; Israel Science Foundation(Israel Science Foundation); Marie Curie Actions-International Reintegration Grant; Lymphatic Research Foundation; Israeli Cancer Research Foundation	This work was supported by the SMILE Foundation, Sherman family, and Israel Science Foundation Grant 1705/11 (to L. A.). L. A. is also supported in part by the Marie Curie Actions-International Reintegration Grants FP7-PEOPLE-2010-RG 274333. G. M. is supported by the Lymphatic Research Foundation and the Israeli Cancer Research Foundation. K. Y. is the incumbent of the Louis and Ida Rich Career Development Chair and is supported in part by the Marie Curie Actions-International Reintegration Grants FP7-PEOPLE-2009-RG 256393.	Abe S, 2012, ENDOCRINOLOGY, V153, P4049, DOI 10.1210/en.2011-1713; Appelbaum L, 2007, BRAIN RES, V1174, P66, DOI 10.1016/j.brainres.2007.06.103; Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; Arjona FJ, 2011, ENDOCRINOLOGY, V152, P5065, DOI 10.1210/en.2011-1166; Ben-Moshe Z, 2010, CHRONOBIOL INT, V27, P1509, DOI 10.3109/07420528.2010.510229; BERNAL J, 1995, EUR J ENDOCRINOL, V133, P390, DOI 10.1530/eje.0.1330390; Bernardos RL, 2006, GENE EXPR PATTERNS, V6, P1007, DOI 10.1016/j.modgep.2006.04.006; Bouzaffour M, 2010, GEN COMP ENDOCR, V168, P88, DOI 10.1016/j.ygcen.2010.04.006; Braun D, 2011, GLIA, V59, P463, DOI 10.1002/glia.21116; Brockmann K, 2005, J NEUROL, V252, P663, DOI 10.1007/s00415-005-0713-3; Chan YC, 2012, ARTERIOSCL THROM VAS, V32, P1372, DOI 10.1161/ATVBAHA.112.248583; Darras VM, 2012, J ENDOCRINOL, V215, P189, DOI 10.1530/JOE-12-0204; Dumitrescu AM, 2006, ENDOCRINOLOGY, V147, P4036, DOI 10.1210/en.2006-0390; Dutton K, 2009, DIS MODEL MECH, V2, P68, DOI 10.1242/dmm.001164; Elbaz I, 2012, J NEUROSCI, V32, P12961, DOI 10.1523/JNEUROSCI.1284-12.2012; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Friesema ECH, 2008, MOL ENDOCRINOL, V22, P1357, DOI 10.1210/me.2007-0112; Garcia-Lecea M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003090; Geysens S, 2012, NEUROSCIENCE, V221, P69, DOI 10.1016/j.neuroscience.2012.06.057; Heuer H, 2005, ENDOCRINOLOGY, V146, P1701, DOI 10.1210/en.2004-1179; Heuer H., 2012, BIOCH BIOPH IN PRESS; Heuer H, 2009, ENDOCRINOLOGY, V150, P1078, DOI 10.1210/en.2008-1518; Ji C, 2012, TOXICOL APPL PHARM, V262, P149, DOI 10.1016/j.taap.2012.04.029; Kaufman CK, 2009, NAT PROTOC, V4, P1422, DOI 10.1038/nprot.2009.144; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Khalili K, 2003, MOL CELL BIOL, V23, P6857, DOI 10.1128/MCB.23.19.6857-6875.2003; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Kim DK, 2001, J BIOL CHEM, V276, P17221, DOI 10.1074/jbc.M009462200; Kinne A, 2011, THYROID RES, V4, DOI 10.1186/1756-6614-4-S1-S7; Kinne A, 2010, J BIOL CHEM, V285, P28054, DOI 10.1074/jbc.M110.129577; Kogai T, 2010, J BIOL CHEM, V285, P27279, DOI 10.1074/jbc.M110.123158; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Lister JA, 1999, DEVELOPMENT, V126, P3757; Mayerl S, 2012, ENDOCRINOLOGY, V153, P1528, DOI 10.1210/en.2011-1633; Nishimura M, 2008, DRUG METAB PHARMACOK, V23, P22, DOI 10.2133/dmpk.23.22; Popovic M, 2010, COMP BIOCHEM PHYS A, V155, P327, DOI 10.1016/j.cbpa.2009.11.011; Porazzi P, 2009, MOL CELL ENDOCRINOL, V312, P14, DOI 10.1016/j.mce.2009.05.011; Ramadan T, 2006, J CELL PHYSIOL, V206, P771, DOI 10.1002/jcp.20531; Roberts LM, 2008, ENDOCRINOLOGY, V149, P6251, DOI 10.1210/en.2008-0378; Stiebel-Kalish H, 2012, EUR J HUM GENET, V20, P884, DOI 10.1038/ejhg.2012.10; Sugiyama D, 2003, J BIOL CHEM, V278, P43489, DOI 10.1074/jbc.M306933200; Takada N, 2010, DEV DYNAM, V239, P2041, DOI 10.1002/dvdy.22338; Tanaka K, 2004, J BIOL CHEM, V279, P7275, DOI 10.1074/jbc.M310726200; TATSUMI K, 1988, GENE, V73, P489; Tohyama K, 2004, ENDOCRINOLOGY, V145, P4384, DOI 10.1210/en.2004-0058; Tonduti D., 2012, J CHILD NEU IN PRESS; Trajkovic M, 2007, J CLIN INVEST, V117, P627, DOI 10.1172/JCI28253; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Van Herck SLJ, 2012, MOL CELL ENDOCRINOL, V349, P289, DOI 10.1016/j.mce.2011.11.012; Vatine G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000223; Visser WE, 2010, HUM MOL GENET, V19, P4189, DOI 10.1093/hmg/ddq337; Walpita CN, 2007, GEN COMP ENDOCR, V152, P206, DOI 10.1016/j.ygcen.2007.02.020; Walpita CN, 2009, ENDOCRINOLOGY, V150, P530, DOI 10.1210/en.2008-0457; Weinberg ES, 1996, DEVELOPMENT, V122, P271; WONDISFORD FE, 1988, J BIOL CHEM, V263, P12538; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76; Yan W, 2012, CHEMOSPHERE, V87, P1301, DOI 10.1016/j.chemosphere.2012.01.041; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097	60	54	54	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					169	180		10.1074/jbc.M112.413831	http://dx.doi.org/10.1074/jbc.M112.413831			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23161551	Green Published, hybrid			2022-12-28	WOS:000313197200017
J	Shi, S; Carattino, MD; Kleyman, TR				Shi, Shujie; Carattino, Marcelo D.; Kleyman, Thomas R.			Role of the Wrist Domain in the Response of the Epithelial Sodium Channel to External Stimuli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; POTASSIUM SECRETION; K+ SECRETION; FLOW-RATE; ENAC; INHIBITION; TRANSPORT; FINGER; TUBULE; FLUID	The epithelial Na+ channel (ENaC) is regulated by a variety of external factors that alter channel activity by inducing conformational changes within its large extracellular region that are transmitted to the gate. The wrist domain consists of small linkers connecting the extracellular region to the transmembrane domains, where the channel pore and gate reside. We employed site-directed mutagenesis combined with two-electrode voltage clamp to investigate the role of the wrist domain in channel gating in response to extracellular factors. Channel inhibition by external Na+ was reduced by selected mutations within the wrist domain of the alpha subunit, likely reflecting an increase in channel open probability. The most robust changes were observed when Cys was introduced at alpha Pro-138 and alpha Ser-568, sites immediately adjacent to the palm domain. In addition, one of these Cys mutants exhibited an enhanced response to shear stress. In the context of channels that have a low open probability due to retention of an inhibitory tract, the response to external Na+ was reduced by Cys substitutions at both alpha Pro-138 and alpha Ser-568. We observed a significant correlation between changes in channel inhibition by external Na+ and the relative response to shear stress for the alpha subunit mutants that were examined. Mutants that exhibited reduced inhibition by external Na+ also showed an enhanced response to shear stress. Together, our data suggest that the wrist domain has a role in modulating the channel's response to external stimuli.	[Shi, Shujie; Carattino, Marcelo D.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, A919 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu	Shi, Shujie/D-4999-2012		National Institutes of Health [R37 DK051391, R01 DK084060, P30 DK079307]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, R01DK051391, R37DK051391, R01DK084060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part by National Institutes of Health Grants R37 DK051391, R01 DK084060, and P30 DK079307.; Supported by a postdoctoral fellowship award from the American Heart Association.	Althaus M, 2007, FASEB J, V21, P2389, DOI 10.1096/fj.06-7694com; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; ENGBRETSON BG, 1987, AM J PHYSIOL, V253, pF896, DOI 10.1152/ajprenal.1987.253.5.F896; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; GOOD DW, 1979, AM J PHYSIOL, V236, pF192, DOI 10.1152/ajprenal.1979.236.2.F192; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2012, J BIOL CHEM, V287, P20720, DOI 10.1074/jbc.M112.358218; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; KHURI RN, 1975, AM J PHYSIOL, V228, P1249, DOI 10.1152/ajplegacy.1975.228.4.1249; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; KUNAU RT, 1974, J CLIN INVEST, V54, P1488, DOI 10.1172/JCI107897; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; MALNIC G, 1989, AM J PHYSIOL, V256, pF932, DOI 10.1152/ajprenal.1989.256.5.F932; Morimoto T, 2006, AM J PHYSIOL-RENAL, V291, pF663, DOI 10.1152/ajprenal.00514.2005; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Satlin LM, 2006, AM J PHYSIOL-RENAL, V291, pF923, DOI 10.1152/ajprenal.00192.2006; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Shi SJ, 2012, J BIOL CHEM, V287, P15439, DOI 10.1074/jbc.M112.346551; Shi SJ, 2011, J BIOL CHEM, V286, P14753, DOI 10.1074/jbc.M110.191734; Tolino LA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202366; Woda CB, 2001, AM J PHYSIOL-RENAL, V280, pF786, DOI 10.1152/ajprenal.2001.280.5.F786	31	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44027	44035		10.1074/jbc.M112.421743	http://dx.doi.org/10.1074/jbc.M112.421743			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144453	hybrid, Green Published			2022-12-28	WOS:000312938600002
J	Santolla, MF; Lappano, R; De Marco, P; Pupo, M; Vivacqua, A; Sisci, D; Abonante, S; Iacopetta, D; Cappello, AR; Dolce, V; Maggiolini, M				Santolla, Maria Francesca; Lappano, Rosamaria; De Marco, Paola; Pupo, Marco; Vivacqua, Adele; Sisci, Diego; Abonante, Sergio; Iacopetta, Domenico; Cappello, Anna Rita; Dolce, Vincenza; Maggiolini, Marcello			G Protein-coupled Estrogen Receptor Mediates the Up-regulation of Fatty Acid Synthase Induced by 17 beta-Estradiol in Cancer Cells and Cancer-associated Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION CHANGES; STROMAL FIBROBLASTS; PROSTATE-CANCER; COLON-CANCER; TUMOR MICROENVIRONMENT; HORMONE-RECEPTORS; BREAST; GPR30; GROWTH; PROLIFERATION	Activation of lipid metabolism is an early event in carcinogenesis and a central hallmark of many tumors. Fatty acid synthase (FASN) is a key lipogenic enzyme catalyzing the terminal steps in the de novo biogenesis of fatty acids. In cancer cells, FASN may act as a metabolic oncogene, given that it confers growth and survival advantages to these cells, whereas its inhibition effectively and selectively kills tumor cells. Hormones such as estrogens and growth factors contribute to the transcriptional regulation of FASN expression also through the activation of downstream signaling and a cross-talk among diverse transduction pathways. In this study, we demonstrate for the first time that 17 beta-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts. In addition, the proliferative effects induced by E2 and G-1 in these cells involved FASN as the inhibitor of its activity, named cerulenin, abolished the growth response to both ligands. Our data suggest that GPER may be included among the transduction mediators involved by estrogens in regulating FASN expression and activity in cancer cells and cancer-associated fibroblasts that strongly contribute to cancer progression.	[Santolla, Maria Francesca; Lappano, Rosamaria; De Marco, Paola; Pupo, Marco; Vivacqua, Adele; Sisci, Diego; Iacopetta, Domenico; Cappello, Anna Rita; Dolce, Vincenza; Maggiolini, Marcello] Univ Calabria, Dept Pharmacobiol, I-87030 Arcavacata Di Rende, CS, Italy; [Abonante, Sergio] Reg Hosp, I-87100 Cosenza, Italy	University of Calabria	Maggiolini, M (corresponding author), Univ Calabria, Dept Pharmacobiol, I-87030 Arcavacata Di Rende, CS, Italy.	marcellomaggiolini@yahoo.it	Lappano, Rosamaria/Z-4857-2019; Iacopetta, Domenico/H-4242-2014; Cappello, Anna Rita/AAE-2766-2020; vivacqua, adele/I-2771-2015; Maggiolini, Marcello/Z-4729-2019; /AAD-9701-2019; Santolla, Maria Francesca/AAH-5481-2020	Iacopetta, Domenico/0000-0001-5179-7118; vivacqua, adele/0000-0001-5333-8396; /0000-0001-6577-1541; Maggiolini, Marcello/0000-0002-7485-854X; Dolce, Vincenza/0000-0003-2966-4866; Abonante, Sergio/0000-0003-4686-6961; Santolla, Maria Francesca/0000-0002-4838-5953; cappello, anna rita/0000-0001-7824-3561; Lappano, Rosamaria/0000-0002-9374-9701	Associazione Italiana per la Ricerca sul Cancro [12849/2012]; Associazione Italiana per la Ricerca sul Cancro Project Calabria; Fondazione Cassa di Risparmio di Calabria e Lucania	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro Project Calabria(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Calabria e Lucania	This work was supported by Associazione Italiana per la Ricerca sul Cancro (Project 12849/2012), Associazione Italiana per la Ricerca sul Cancro Project Calabria 2011, and Fondazione Cassa di Risparmio di Calabria e Lucania.	Abramson HN, 2011, J MED CHEM, V54, P5615, DOI 10.1021/jm2005805; Albanito L, 2008, ENDOCRINOLOGY, V149, P3799, DOI 10.1210/en.2008-0117; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Chimento A, 2010, MOL CELL ENDOCRINOL, V320, P136, DOI 10.1016/j.mce.2010.01.035; De Marco P, 2013, ONCOGENE, V32, P678, DOI 10.1038/onc.2012.97; DIMANCHEBOITREL MT, 1994, INT J CANCER, V56, P512, DOI 10.1002/ijc.2910560410; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filice E, 2009, J PHYSIOL PHARMACOL, V60, P3; Gerdes MJ, 2006, CANCER RES, V66, P7578, DOI 10.1158/0008-5472.CAN-06-1247; IKUTA K, 1986, VIROLOGY, V154, P207, DOI 10.1016/0042-6822(86)90442-3; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; Kumar-Sinha C, 2003, CANCER RES, V63, P132; Lacasa D, 2001, J BIOL CHEM, V276, P11512, DOI 10.1074/jbc.M008556200; Lafkas D, 2008, INT J CANCER, V123, P967, DOI 10.1002/ijc.23546; Lappano R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3096; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lappano R, 2010, MOL CELL ENDOCRINOL, V320, P162, DOI 10.1016/j.mce.2010.02.006; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Lupu R, 2006, ENDOCRINOLOGY, V147, P4056, DOI 10.1210/en.2006-0486; Madeo A, 2010, ONCOGENE, V29, P978, DOI 10.1038/onc.2009.400; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; Maggiolini M, 1999, BIOL CHEM, V380, P695, DOI 10.1515/BC.1999.086; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; Menendez JA, 2005, INT J ONCOL, V26, P1507; Menendez JA, 2005, MED HYPOTHESES, V64, P997, DOI 10.1016/j.mehy.2004.09.027; Menendez JA, 2005, MED HYPOTHESES, V64, P342, DOI 10.1016/j.mehy.2004.07.022; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Murata S, 2010, CANCER SCI, V101, P1861, DOI 10.1111/j.1349-7006.2010.01596.x; Ollila S, 2007, J PHYS CHEM B, V111, P3139, DOI 10.1021/jp065424f; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Panno ML, 1996, J CANCER RES CLIN, V122, P745, DOI 10.1007/BF01209122; Picard N, 2008, MOL ENDOCRINOL, V22, P317, DOI 10.1210/me.2007-0281; Pizer ES, 1998, CANCER-AM CANCER SOC, V83, P528, DOI 10.1002/(SICI)1097-0142(19980801)83:3<528::AID-CNCR22>3.0.CO;2-X; Pizer ES, 1996, CANCER RES, V56, P2745; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; Pupo M, 2012, ENVIRON HEALTH PERSP, V120, P1177, DOI 10.1289/ehp.1104526; Recchia AG, 2011, J BIOL CHEM, V286, P10773, DOI 10.1074/jbc.M110.172247; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; Sirianni R, 2008, ENDOCRINOLOGY, V149, P5043, DOI 10.1210/en.2007-1593; Swinnen JV, 1997, P NATL ACAD SCI USA, V94, P12975, DOI 10.1073/pnas.94.24.12975; Swinnen JV, 1997, CANCER RES, V57, P1086; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; TSAI SY, 1989, CELL, V57, P443, DOI 10.1016/0092-8674(89)90919-7; Van de Sande T, 2002, CANCER RES, V62, P642; VANCE D, 1972, BIOCHEM BIOPH RES CO, V48, P649, DOI 10.1016/0006-291X(72)90397-X; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344; Vivacqua A, 2009, MOL ENDOCRINOL, V23, P1815, DOI 10.1210/me.2009-0120; Wang Young Y, 2004, J Exp Ther Oncol, V4, P101; Wortman MD, 2003, NAT MED, V9, P483, DOI 10.1038/nm0503-483; Xing F, 2010, FRONT BIOSCI-LANDMRK, V15, P166, DOI 10.2741/3613; Yamaguchi Y, 2009, ENDOCR J, V56, P1, DOI 10.1507/endocrj.K08E-099; Yoon S, 2007, J BIOL CHEM, V282, P26122, DOI 10.1074/jbc.M702854200; Zhan Y, 2008, CLIN CANCER RES, V14, P5735, DOI 10.1158/1078-0432.CCR-07-5074	64	76	77	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43234	43245		10.1074/jbc.M112.417303	http://dx.doi.org/10.1074/jbc.M112.417303			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23135268	Green Published, hybrid			2022-12-28	WOS:000312940800005
J	Yang, ZZ; Vild, C; Ju, JY; Zhang, X; Liu, JP; Shen, J; Zhao, B; Lan, WX; Gong, FC; Liu, ML; Cao, CY; Xu, ZH				Yang, Zhongzheng; Vild, Cody; Ju, Jiaying; Zhang, Xu; Liu, Jianping; Shen, Jie; Zhao, Bin; Lan, Wenxian; Gong, Fuchun; Liu, Maili; Cao, Chunyang; Xu, Zhaohui			Structural Basis of Molecular Recognition between ESCRT-III-like Protein Vps60 and AAA-ATPase Regulator Vta1 in the Multivesicular Body Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE ASSOCIATION; CHEMICAL-SHIFT; MACHINERY; NMR; BIOGENESIS; COMPLEXES; VPS4P; CYTOKINESIS; BODIES; SYSTEM	The AAA-ATPase Vps4 is critical for function of the multivesicular body sorting pathway, which impacts cellular phenomena ranging from receptor down-regulation to viral budding to cytokinesis. Vps4 activity is stimulated by the interaction between Vta1 and Vps60, but the structural basis for this interaction is unclear. The fragment Vps60(128-186) was reported to display the full activity of Vps60. Vta1 interacts with Vps60 using its N-terminal domain (Vta1NTD). In this work, the structure of Vps60(128-186) in complex with Vta1NTD was determined using NMR techniques, demonstrating a novel recognition mode of the microtubule-interacting and transport (MIT) domain in which Vps60(128-186) interacts with Vta1NTD through helices alpha 4' and alpha 5', extending over Vta1NTD MIT2 domain helices 1-3. The Vps60 binding does not result in Vta1 conformational changes, further revealing the fact that Vps4 ATPase is enhanced by the interaction between Vta1 and Vps60 in an unanticipated manner.	[Yang, Zhongzheng; Ju, Jiaying; Liu, Jianping; Shen, Jie; Zhao, Bin; Lan, Wenxian; Cao, Chunyang] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Vild, Cody; Xu, Zhaohui] Univ Michigan, Sch Med, Inst Life Sci, Ann Arbor, MI 48109 USA; [Vild, Cody; Xu, Zhaohui] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Zhang, Xu; Liu, Maili] Chinese Acad Sci, Wuhan Inst Phys & Math, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan 430071, Peoples R China; [Liu, Jianping; Gong, Fuchun] Changsha Univ Sci & Technol, Inst Chem & Biochem Engn, Changsha 410076, Hunan, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Changsha University of Science & Technology	Cao, CY (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China.	ccao@mail.sioc.ac.cn; zhaohui@umich.edu	Liu, Maili/A-8543-2011; Zhang, Xu/B-4753-2015	Liu, Maili/0000-0002-9359-915X; 	National Basic Research Program of China [2009CB918600, 2011CB966300]; National Science Foundation of China [30970595, 20921091]; International Cooperation Foundation from the Science and Technology Commission of Shanghai Municipality [09540703800]; Ministry of Health of China [2011ZX09506]; State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan Center for Magnetic Resonance, Wuhan Institute of Physics and Mathematics, Chinese Academy of Sciences [T151102]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095769] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Foundation from the Science and Technology Commission of Shanghai Municipality; Ministry of Health of China; State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan Center for Magnetic Resonance, Wuhan Institute of Physics and Mathematics, Chinese Academy of Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Basic Research Program of China Grants 2009CB918600 and 2011CB966300, National Science Foundation of China Grants 30970595 and 20921091, International Cooperation Foundation Grant 09540703800 from the Science and Technology Commission of Shanghai Municipality, National New Drug Design Program Grant 2011ZX09506 from the Ministry of Health of China, and Grant T151102 from the State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan Center for Magnetic Resonance, Wuhan Institute of Physics and Mathematics, Chinese Academy of Sciences.	Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Babst M, 2011, TRAFFIC, V12, P1298, DOI 10.1111/j.1600-0854.2011.01230.x; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Goddard T. D., 2001, SPARKY 3; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Hurley JH, 2008, DEV CELL, V14, P6, DOI 10.1016/j.devcel.2007.12.013; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kieffer CC, 2008, PSYCHOANAL INQ, V28, P1, DOI 10.1080/07351690701787077; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lottridge JM, 2006, P NATL ACAD SCI USA, V103, P6202, DOI 10.1073/pnas.0601712103; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Saksena S, 2009, BIOCHEM SOC T, V37, P167, DOI 10.1042/BST0370167; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Solomons J, 2011, STRUCTURE, V19, P1149, DOI 10.1016/j.str.2011.05.011; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Wang CK, 2011, CELL RES, V21, P1379, DOI 10.1038/cr.2011.123; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Winter V, 2006, TRENDS PLANT SCI, V11, P115, DOI 10.1016/j.tplants.2006.01.008; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Xiao JY, 2008, DEV CELL, V14, P37, DOI 10.1016/j.devcel.2007.10.013; Xiao JY, 2007, J MOL BIOL, V374, P655, DOI 10.1016/j.jmb.2007.09.067; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Yang D, 2010, STRUCTURE, V18, P976, DOI 10.1016/j.str.2010.04.014; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Yu ZH, 2008, J MOL BIOL, V377, P364, DOI 10.1016/j.jmb.2008.01.009	45	32	32	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43899	43908		10.1074/jbc.M112.390724	http://dx.doi.org/10.1074/jbc.M112.390724			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23105107	Green Published, hybrid			2022-12-28	WOS:000312940800066
J	Molnar, E; Swamy, M; Holzer, M; Beck-Garcia, K; Worch, R; Thiele, C; Guigas, G; Boye, K; Luescher, IF; Schwille, P; Schubert, R; Schamel, WWA				Molnar, Eszter; Swamy, Mahima; Holzer, Martin; Beck-Garcia, Katharina; Worch, Remigiusz; Thiele, Christoph; Guigas, Gernot; Boye, Kristian; Luescher, Immanuel F.; Schwille, Petra; Schubert, Rolf; Schamel, Wolfgang W. A.			Cholesterol and Sphingomyelin Drive Ligand-independent T-cell Antigen Receptor Nanoclustering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE MICRODOMAINS; MULTIVALENT STRUCTURE; CRYSTAL-STRUCTURE; PROTEINS; BINDING; STOICHIOMETRY; ACTIVATION; RAFTS; ORGANIZATION; RECOGNITION	The T-cell antigen receptor (TCR) exists in monomeric and nanoclustered forms independently of antigen binding. Although the clustering is involved in the regulation of T-cell sensitivity, it is unknown how the TCR nanoclusters form. We show that cholesterol is required for TCR nanoclustering in T cells and that this clustering enhances the avidity but not the affinity of the TCR-antigen interaction. Investigating the mechanism of the nanoclustering, we found that radioactive photocholesterol specifically binds to the TCR beta chain in vivo. In order to reduce the complexity of cellular membranes, we used a synthetic biology approach and reconstituted the TCR in liposomes of defined lipid composition. Both cholesterol and sphingomyelin were required for the formation of TCR dimers in phosphatidylcholine-containing large unilamellar vesicles. Further, the TCR was localized in the liquid disordered phase in giant unilamellar vesicles. We propose a model in which cholesterol and sphingomyelin binding to the TCR beta chain causes TCR dimerization. The lipid-induced TCR nanoclustering enhances the avidity to antigen and thus might be involved in enhanced sensitivity of memory compared with naive T cells. Our work contributes to the understanding of the function of specific non-annular lipid-membrane protein interactions.	[Molnar, Eszter; Swamy, Mahima; Beck-Garcia, Katharina; Schamel, Wolfgang W. A.] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Molnar, Eszter; Swamy, Mahima; Holzer, Martin; Beck-Garcia, Katharina; Schubert, Rolf; Schamel, Wolfgang W. A.] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany; [Molnar, Eszter; Beck-Garcia, Katharina; Schamel, Wolfgang W. A.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Holzer, Martin; Schubert, Rolf] Univ Freiburg, Dept Pharmaceut Technol & Biopharm, Inst Pharmaceut Sci, D-79104 Freiburg, Germany; [Beck-Garcia, Katharina] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany; [Worch, Remigiusz; Schwille, Petra] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany; [Thiele, Christoph] Life & Med Sci Inst LIMES, D-53115 Bonn, Germany; [Guigas, Gernot] Univ Bayreuth, D-95447 Bayreuth, Germany; [Boye, Kristian] German Canc Res Ctr, Cellular Biophys Grp, D-69120 Heidelberg, Germany; [Luescher, Immanuel F.] Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; [Schamel, Wolfgang W. A.] Univ Clin, CCI, D-79106 Freiburg, Germany	Max Planck Society; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Technische Universitat Dresden; University of Bonn; University of Bayreuth; Helmholtz Association; German Cancer Research Center (DKFZ); Ludwig Institute for Cancer Research; University of Freiburg	Schamel, WWA (corresponding author), Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany.	wolfgang.schamel@biologie.uni-freiburg.de	Swamy, Mahima/J-7046-2019; Schwille, Petra/A-4983-2010	Swamy, Mahima/0000-0003-3977-3425; Boye, Kristian/0000-0002-7135-9577; Worch, Remigiusz/0000-0002-3222-4821; Holzer, Martin/0000-0002-2602-8293	Deutsche Forschungsgemeinschaft [EXC294, SFB620, SCHA 976/2-1]; European Union	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grants EXC294, SFB620, and SCHA 976/2-1 and by the European Union through Grant FP7/2007-2013 (SYBILLA).	Alarcon B, 2006, EMBO REP, V7, P490, DOI 10.1038/sj.embor.7400682; Bjorkbom A, 2011, BBA-BIOMEMBRANES, V1808, P1179, DOI 10.1016/j.bbamem.2011.01.009; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Charrin S, 2003, EUR J IMMUNOL, V33, P2479, DOI 10.1002/eji.200323884; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Contreras FX, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004705; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DEMEL RA, 1977, BIOCHIM BIOPHYS ACTA, V465, P1, DOI 10.1016/0005-2736(77)90350-9; Drake DR, 2001, J IMMUNOL, V166, P7009, DOI 10.4049/jimmunol.166.12.7009; Dubey C, 1996, J IMMUNOL, V157, P3280; Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673; EXLEY M, 1995, MOL IMMUNOL, V32, P829, DOI 10.1016/0161-5890(95)00046-H; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Horejsi V, 2003, IMMUNOL REV, V191, P148, DOI 10.1034/j.1600-065X.2003.00001.x; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Hunte C, 2005, BIOCHEM SOC T, V33, P938, DOI 10.1042/BST0330938; James JR, 2007, P NATL ACAD SCI USA, V104, P17662, DOI 10.1073/pnas.0700411104; James JR, 2011, J BIOL CHEM, V286, P31993, DOI 10.1074/jbc.M111.219212; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kumar R, 2011, IMMUNITY, V35, P375, DOI 10.1016/j.immuni.2011.08.010; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Malissen B, 2003, IMMUNOL REV, V191, P7, DOI 10.1034/j.1600-065X.2003.00016.x; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Rouquette-Jazdanian AK, 2006, CELL SIGNAL, V18, P105, DOI 10.1016/j.cellsig.2005.03.024; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Sezgin E, 2012, BBA-BIOMEMBRANES, V1818, P1777, DOI 10.1016/j.bbamem.2012.03.007; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Swamy M., 2006, SCI STKE, V2006, pl4, DOI DOI 10.1126/STKE.3452006PL4.PMID:16868305; Swamy M, 2007, J IMMUNOL METHODS, V324, P74, DOI 10.1016/j.jim.2007.05.003; Swamy M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-5; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Torchilin V., 2003, LIPOSOMES PRACTICAL; Veiga MP, 2001, BIOCHEMISTRY-US, V40, P2614, DOI 10.1021/bi0019803; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	50	99	100	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42664	42674		10.1074/jbc.M112.386045	http://dx.doi.org/10.1074/jbc.M112.386045			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23091059	Green Published, hybrid			2022-12-28	WOS:000312501600027
J	Sebastian, C; Satterstrom, FK; Haigis, MC; Mostoslavsky, R				Sebastian, Carlos; Satterstrom, F. Kyle; Haigis, Marcia C.; Mostoslavsky, Raul			From Sirtuin Biology to Human Diseases: An Update	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FATTY-ACID OXIDATION; DEPENDENT GENE-EXPRESSION; HISTONE DEACETYLASE SIRT6; LIFE-SPAN; CALORIE RESTRICTION; CARDIAC-HYPERTROPHY; ENERGY-EXPENDITURE; NAD(+) DEPLETION; TUMOR-SUPPRESSOR; CELL-SURVIVAL	Originally rising to notoriety for their role in the regulation of aging, sirtuins are a family of NAD(+)-dependent enzymes that have been connected to a steadily growing set of biological processes. In addition to regulating aging, sirtuins play key roles in the maintenance of organismal metabolic homeostasis. These enzymes also have primarily protective functions in the development of many age-related diseases, including cancer, neurodegeneration, and cardiovascular disease. In this minireview, we provide an update on the known roles for each of the seven mammalian sirtuins in these areas.	[Satterstrom, F. Kyle; Haigis, Marcia C.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Sebastian, Carlos; Mostoslavsky, Raul] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA; [Satterstrom, F. Kyle] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Haigis, MC (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	marcia_haigis@hms.harvard.edu; rmostoslavsky@mgh.harvard.edu	Sebastian, Carlos/CAG-6271-2022; Sebastian, Carlos/H-8014-2018	Sebastian, Carlos/0000-0001-6623-8028; Satterstrom, Frederick/0000-0001-6187-7680	National Institutes of Health [AG032375, DK088190, GM093072, T32 DK007260]; Beatriu de Pinos postdoctoral fellowship; Paul F. Glenn Foundation for Medical Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007260, R01DK088190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beatriu de Pinos postdoctoral fellowship; Paul F. Glenn Foundation for Medical Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG032375 (to M. C. H.), Grants DK088190 and GM093072 (to R. M.), and Training Grant T32 DK007260 (to F. K. S.). This is the fourth article in the Thematic Minireview Series on Sirtuins: From Biochemistry to Health and Disease.; Recipient of a Beatriu de Pinos postdoctoral fellowship.; Supported by the Paul F. Glenn Foundation for Medical Research. To whom correspondence may be addressed. E-mail: marcia_haigis@hms.harvard.edu.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Arima K, 1998, BRAIN RES, V808, P93, DOI 10.1016/S0006-8993(98)00734-3; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Beirowski B, 2011, P NATL ACAD SCI USA, V108, pE952, DOI 10.1073/pnas.1104969108; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Cai Y, 2012, FEBS LETT, V586, P866, DOI 10.1016/j.febslet.2012.02.014; Canto C, 2009, TRENDS ENDOCRIN MET, V20, P325, DOI 10.1016/j.tem.2009.03.008; Chakrabarti P, 2011, J LIPID RES, V52, P1693, DOI 10.1194/jlr.M014647; Chen J, 2011, CANCER RES, V71, P4138, DOI 10.1158/0008-5472.CAN-10-4274; Choi HN, 2011, ONCOL REP, V26, P503, DOI 10.3892/or.2011.1301; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Cosentino F, 2008, ARTERIOSCL THROM VAS, V28, P622, DOI 10.1161/ATVBAHA.107.156059; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Elangovan S, 2011, CANCER RES, V71, P6654, DOI 10.1158/0008-5472.CAN-11-1446; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Gillum MP, 2011, DIABETES, V60, P3235, DOI 10.2337/db11-0616; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Guo WJ, 2011, J NEUROSCI RES, V89, P1723, DOI 10.1002/jnr.22725; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Ji SP, 2011, J MOL CELL BIOL, V3, P351, DOI 10.1093/jmcb/mjr009; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kawahara TLA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002153; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kawashima T, 2011, J MOL CELL CARDIOL, V51, P1026, DOI 10.1016/j.yjmcc.2011.09.013; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim SH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014731, 10.1371/journal.pone.0026214]; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Lang D, 2002, HEART, V87, P316, DOI 10.1136/heart.87.4.316; Leong HS, 2003, COMP BIOCHEM PHYS A, V135, P499, DOI 10.1016/S1095-6433(03)00007-2; Li P, 2012, NUCLEIC ACIDS RES, V40, P1609, DOI 10.1093/nar/gkr984; Li WB, 2007, J NEUROSCI, V27, P2606, DOI 10.1523/JNEUROSCI.4181-06.2007; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Liu XZ, 2007, J PATHOL, V211, P188, DOI 10.1002/path.2102; Lombard DB, 2012, NATURE, V483, P166, DOI 10.1038/nature10950; Luthi-Carter R, 2010, P NATL ACAD SCI USA, V107, P7927, DOI 10.1073/pnas.1002924107; Marshall GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002135; Martinez-Pastor B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00022; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Montecucco F, 2013, ANTIOXID REDOX SIGN, V18, P630, DOI 10.1089/ars.2011.4487; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nasrin N, 2010, J BIOL CHEM, V285, P31995, DOI 10.1074/jbc.M110.124164; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Planavila A, 2011, CARDIOVASC RES, V90, P276, DOI 10.1093/cvr/cvq376; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Purushotham A, 2012, FASEB J, V26, P656, DOI 10.1096/fj.11-195172; Qiang L, 2011, CELL METAB, V14, P758, DOI 10.1016/j.cmet.2011.10.007; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Sack MN, 2011, AM J PHYSIOL-HEART C, V301, pH2191, DOI 10.1152/ajpheart.00199.2011; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Schwer B, 2010, P NATL ACAD SCI USA, V107, P21790, DOI 10.1073/pnas.1016306107; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Van Meter M, 2011, CELL CYCLE, V10, P3153, DOI 10.4161/cc.10.18.17435; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Viswanathan M, 2011, NATURE, V477, pE1, DOI 10.1038/nature10440; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Weiss EP, 2011, AM J PHYSIOL-HEART C, V301, pH1205, DOI 10.1152/ajpheart.00685.2011; Wu DS, 2011, ANN OPER RES, V185, P1, DOI 10.1007/s10479-010-0822-y; Wu Z, 2012, BLOOD, V119, P2422, DOI 10.1182/blood-2011-04-350413; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yu SS, 2013, BRIT J PHARMACOL, V168, P117, DOI 10.1111/j.1476-5381.2012.01903.x; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167; Zhang ZY, 2010, J BIOL CHEM, V285, P41391, DOI 10.1074/jbc.M110.174482; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhou S, 2011, CIRC RES, V109, P639, DOI 10.1161/CIRCRESAHA.111.243592	105	162	168	0	37	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42444	42452		10.1074/jbc.R112.402768	http://dx.doi.org/10.1074/jbc.R112.402768			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23086954	Green Published, hybrid			2022-12-28	WOS:000312501600005
J	Ungaro, P; Mirra, P; Oriente, F; Nigro, C; Ciccarelli, M; Vastolo, V; Longo, M; Perruolo, G; Spinelli, R; Formisano, P; Miele, C; Beguinot, F				Ungaro, Paola; Mirra, Paola; Oriente, Francesco; Nigro, Cecilia; Ciccarelli, Marco; Vastolo, Viviana; Longo, Michele; Perruolo, Giuseppe; Spinelli, Rosa; Formisano, Pietro; Miele, Claudia; Beguinot, Francesco			Peroxisome Proliferator-activated Receptor-gamma Activation Enhances Insulin-stimulated Glucose Disposal by Reducing ped/pea-15 Gene Expression in Skeletal Muscle Cells EVIDENCE FOR INVOLVEMENT OF ACTIVATOR PROTEIN-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PPAR-GAMMA; RESISTANCE; METABOLISM; MECHANISMS; DISEASE; ACID; FAT; DIFFERENTIATION; TROGLITAZONE	The gene network responsible for inflammation-induced insulin resistance remains enigmatic. In this study, we show that, in L6 cells, rosiglitazone-as well as pioglitazone-dependent activation of peroxisome proliferator-activated receptor-gamma (PPAR gamma) represses transcription of the ped/pea-15 gene, whose increased activity impairs glucose tolerance in mice and humans. Rosiglitazone enhanced insulin-induced glucose uptake in L6 cells expressing the endogenous ped/pea-15 gene but not in cells expressing ped/pea-15 under the control of an exogenous promoter. The ability of PPAR gamma to affect ped/pea-15 expression was also lost in cells and in C57BL/6J transgenic mice expressing ped/pea-15 under the control of an exogenous promoter, suggesting that ped/pea-15 repression may contribute to rosiglitazone action on glucose disposal. Indeed, high fat diet mice showed insulin resistance and increased ped/pea-15 levels, although these effects were reduced by rosiglitazone treatment. Both supershift and ChIP assays revealed the presence of the AP-1 component c-JUN at the PED/PEA-15 promoter upon 12-O-tetradecanoylphorbol-13-acetate stimulation of the cells. In these experiments, rosiglitazone treatment reduced c-JUN presence at the PED/PEA-15 promoter. This effect was not associated with a decrease in c-JUN expression. In addition, c-jun silencing in L6 cells lowered ped/pea-15 expression and caused nonresponsiveness to rosiglitazone, although c-jun overexpression enhanced the binding to the ped/pea-15 promoter and blocked the rosiglitazone effect. These results indicate that PPAR gamma regulates ped/pea-15 transcription by inhibiting c-JUN binding at the ped/pea-15 promoter. Thus, ped/pea-15 is downstream of a major PPAR gamma-regulated inflammatory network. Repression of ped/pea-15 transcription might contribute to the PPAR gamma regulation of muscle sensitivity to insulin.	[Ungaro, Paola; Mirra, Paola; Nigro, Cecilia; Vastolo, Viviana; Longo, Michele; Perruolo, Giuseppe; Miele, Claudia; Beguinot, Francesco] Univ Naples Federico II, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, Consiglio Nazl Ric, I-80131 Naples, Italy; [Oriente, Francesco; Ciccarelli, Marco; Vastolo, Viviana; Spinelli, Rosa; Formisano, Pietro; Beguinot, Francesco] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Naples Federico II	Ungaro, P (corresponding author), Univ Naples Federico II, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, Consiglio Nazl Ric, I-80131 Naples, Italy.	pungaro@ieos.cnr.it	LONGO, Michele/AAB-9188-2019; NIGRO, Cecilia/AAB-9189-2019; Nigro, Cecilia/K-7338-2016; giuseppe, perruolo/AAW-3869-2021; Longo, Michele/AAB-5972-2020; Formisano, Pietro/J-4237-2018; ORIENTE, Francesco/J-6652-2018	LONGO, Michele/0000-0003-4798-0504; NIGRO, Cecilia/0000-0001-8924-9731; Spinelli, Rosa/0000-0001-7308-4119; ORIENTE, Francesco/0000-0003-4375-4526; Formisano, Pietro/0000-0001-7020-6870; Perruolo, Giuseppe/0000-0003-0479-8729	European Community [201681]; European Foundation for the Study of Diabetes; Associazione Italiana per la Ricerca sul Cancro; Ministero dell'Universita e della Ricerca Scientifica; Fondazione Telethon Funding Source: Custom	European Community(European Commission); European Foundation for the Study of Diabetes; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR)); Fondazione Telethon(Fondazione Telethon)	This study was supported in part by European Community FP6 PREPOBEDIA Grant 201681, the European Foundation for the Study of Diabetes, the Associazione Italiana per la Ricerca sul Cancro, and by Ministero dell'Universita e della Ricerca Scientifica Grants PRIN and FIRB-MERIT.	Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Blanquart C, 2003, J STEROID BIOCHEM, V85, P267, DOI 10.1016/S0960-0760(03)00214-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Condorelli G, 2001, DIABETES, V50, P1244, DOI 10.2337/diabetes.50.6.1244; Condorelli G, 1998, EMBO J, V17, P3858, DOI 10.1093/emboj/17.14.3858; Condorelli G, 2002, J BIOL CHEM, V277, P11013, DOI 10.1074/jbc.M110934200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; DuBois RN, 1998, CARCINOGENESIS, V19, P49, DOI 10.1093/carcin/19.1.49; Fiory F, 2009, AM J PHYSIOL-ENDOC M, V297, pE592, DOI 10.1152/ajpendo.00228.2009; Frias JP, 2000, DIABETES CARE, V23, P64, DOI 10.2337/diacare.23.1.64; Gurnell M, 2004, ESSAYS BIOCHEM, V40, P169, DOI 10.1042/bse0400169; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Kintscher U, 2005, AM J PHYSIOL-ENDOC M, V288, pE287, DOI 10.1152/ajpendo.00440.2004; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEDCALF RL, 1990, J BIOL CHEM, V265, P14618; Miele C, 2007, DIABETES, V56, P622, DOI 10.2337/db06-1260; Miyazaki Y, 2001, DIABETES CARE, V24, P710, DOI 10.2337/diacare.24.4.710; NOLAN JJ, 1994, NEW ENGL J MED, V331, P1188, DOI 10.1056/NEJM199411033311803; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Perfetti A, 2007, J BIOL CHEM, V282, P8648, DOI 10.1074/jbc.M608359200; Raskin P, 2000, DIABETOLOGIA, V43, P278, DOI 10.1007/s001250050045; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; SCHLINGENSIEPEN KH, 1993, DEV GENET, V14, P305, DOI 10.1002/dvg.1020140408; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Ungaro P, 2010, DIABETOLOGIA, V53, P1482, DOI 10.1007/s00125-010-1732-x; Ungaro P, 2008, J BIOL CHEM, V283, P30970, DOI 10.1074/jbc.M803895200; Valentino R, 2006, DIABETOLOGIA, V49, P3058, DOI 10.1007/s00125-006-0455-5; Vigliotta G, 2004, MOL CELL BIOL, V24, P5005, DOI 10.1128/MCB.24.11.5005-5015.2004; Viparelli F, 2008, J BIOL CHEM, V283, P21769, DOI 10.1074/jbc.M803771200; Way JM, 2001, ENDOCRINOLOGY, V142, P1269, DOI 10.1210/en.142.3.1269; Wheatley KE, 2011, J OBES, V2011, DOI 10.1155/2011/265417; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Zierath JR, 1998, ENDOCRINOLOGY, V139, P5034, DOI 10.1210/en.139.12.5034	44	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42951	42961		10.1074/jbc.M112.406637	http://dx.doi.org/10.1074/jbc.M112.406637			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105093	hybrid, Green Published			2022-12-28	WOS:000312501600052
J	Ahn, SW; Gang, GT; Tadi, S; Nedumaran, B; Kim, YD; Park, JH; Kweon, GR; Koo, SH; Lee, K; Ahn, RS; Yim, YH; Lee, CH; Harris, RA; Choi, HS				Ahn, Seung Won; Gang, Gil-Tae; Tadi, Surendar; Nedumaran, Balachandar; Kim, Yong Deuk; Park, Ji Hoon; Kweon, Gi Ryang; Koo, Seung-Hoi; Lee, Keesook; Ahn, Ryun-Sup; Yim, Yong-Hyeon; Lee, Chul-Ho; Harris, Robert A.; Choi, Hueng-Sik			Phosphoenolpyruvate Carboxykinase and Glucose-6-phosphatase Are Required for Steroidogenesis in Testicular Leydig Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE REGULATORY PROTEIN; NUCLEAR RECEPTOR NUR77; HEPATIC GLUCONEOGENESIS; TUMOR-CELLS; RAT TESTIS; TRANSCRIPTIONAL COREPRESSOR; LUTEINIZING-HORMONE; GENE-EXPRESSION; CYCLIC-AMP; KINASE-A	Cyclic AMP (cAMP) induces steroidogenic enzyme gene expression and stimulates testosterone production in Leydig cells. Phosphoenolpyruvate carboxykinase (PEPCK) is expressed in Leydig cells, but its role has not been defined. In this study, we found that PEPCK and glucose-6-phosphatase (Glc-6-Pase) are increased significantly following cAMP treatment of mouse Leydig cells. Moreover, cAMP treatment increased recruitment of the cAMP-response element-binding transcription factor and decreased recruitment of the corepressor DAX-1 on the pepck promoter. Furthermore, cAMP induced an increase in ATP that correlated with a decrease in phospho-AMP- activated protein kinase (AMPK). In contrast, knockdown or inhibition of PEPCK decreased ATP and increased phospho-AMPK. Treatment with an AMPK activator or overexpression of the constitutively active form of AMPK inhibited cAMP-induced steroidogenic enzyme promoter activities and gene expression. Liver receptor homolog-1 (LRH-1) was involved in cAMP-induced steroidogenic enzyme gene expression but was inhibited by AMPK activation in Leydig cells. Additionally, inhibition or knockdown of PEPCK and Glc-6-Pase decreased cAMP-mediated induction of steroidogenic enzyme gene expression and steroidogenesis. Finally, pubertal mouse (8-week-old) testes and human chorionic gonadotropin-induced prepubertal mouse testes showed increased PEPCK and Glc-6-Pase gene expression. Taken together, these results suggest that induction of PEPCK and Glc-6-Pase by cAMP plays an important role in Leydig cell steroidogenesis.	[Ahn, Seung Won; Nedumaran, Balachandar; Kim, Yong Deuk; Lee, Keesook; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea; [Ahn, Seung Won; Nedumaran, Balachandar; Kim, Yong Deuk; Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Kwangju 500757, South Korea; [Gang, Gil-Tae; Lee, Chul-Ho] Chungnam Natl Univ, Sch Med, Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Tadi, Surendar] Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon 305806, South Korea; [Park, Ji Hoon; Kweon, Gi Ryang] Chungnam Natl Univ, Sch Med, Dept Biochem, Taejon 305806, South Korea; [Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, South Korea; [Ahn, Ryun-Sup] CHA Med Univ, Grad Sch Integrat Med, Seoul 135913, South Korea; [Yim, Yong-Hyeon] Korea Res Inst Stand & Sci, Taejon 305806, South Korea; [Harris, Robert A.] Indiana Univ Sch Med, Richard Roudebush Vet Affairs Med Ctr, World Class Univ Program, Indianapolis, IN 46202 USA; [Harris, Robert A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Res Inst Med Sci, Kwangju 501746, South Korea	Chonnam National University; Chonnam National University; Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Chungnam National University; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Korea Research Institute of Standards & Science (KRISS); Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University Bloomington; Chonnam National University	Choi, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Koo, Seung-Hoi/E-2763-2015; Nedumaran, Balachandar/V-9958-2019; Ahn, Ryun S./D-1218-2011	Koo, Seung-Hoi/0000-0001-8769-2879; 	National Creative Research Initiatives Grant from the Korean Ministry of Education, Science, and Technology [2011-0018305]; Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea; Ministry of Education, Science, and Technology Grant [20100019512]	National Creative Research Initiatives Grant from the Korean Ministry of Education, Science, and Technology; Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea; Ministry of Education, Science, and Technology Grant	This work was supported by National Creative Research Initiatives Grant 2011-0018305 from the Korean Ministry of Education, Science, and Technology and the Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology Grant 20100019512.	Ahn SW, 2008, MOL CELLS, V26, P74; AMROLIA P, 1988, BIOCHEM J, V249, P925, DOI 10.1042/bj2490925; Arion WJ, 1998, ARCH BIOCHEM BIOPHYS, V351, P279, DOI 10.1006/abbi.1997.0563; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Caron KM, 1997, MOL ENDOCRINOL, V11, P138, DOI 10.1210/me.11.2.138; Chakravarty K, 2001, J BIOL CHEM, V276, P34816, DOI 10.1074/jbc.M103310200; Chanda D, 2010, NUCLEIC ACIDS RES, V38, P4607, DOI 10.1093/nar/gkq227; Chanda D, 2009, J BIOL CHEM, V284, P28510, DOI 10.1074/jbc.M109.022244; Chen Y, 2003, J ENDOCRINOL, V179, P63, DOI 10.1677/joe.0.1790063; Clark BJ, 2001, MOL CELL ENDOCRINOL, V173, P183, DOI 10.1016/S0303-7207(00)00410-X; Clem BF, 2005, ENDOCRINOLOGY, V146, P1348, DOI 10.1210/en.2004-0761; Doege H, 2000, J BIOL CHEM, V275, P16275, DOI 10.1074/jbc.275.21.16275; FREEMAN DA, 1992, J LIPID RES, V33, P1139; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hanson RW, 2003, BIOCHIMIE, V85, P1199, DOI 10.1016/j.biochi.2003.10.022; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hong CY, 2004, MOL CELL BIOL, V24, P2593, DOI 10.1128/MCB.24.7.2593-2604.2004; Inoue Y, 2008, J CONTROL RELEASE, V126, P59, DOI 10.1016/j.jconrel.2007.10.022; Kim GS, 2008, BIOCHEM BIOPH RES CO, V370, P264, DOI 10.1016/j.bbrc.2008.03.098; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lalli E, 2010, EXPERT OPIN THER TAR, V14, P169, DOI 10.1517/14728220903531454; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; LEIDERMA.B, 1969, ENDOCRINOLOGY, V85, P607, DOI 10.1210/endo-85-3-607; LIANG T, 1976, J PROTOZOOL, V23, P473, DOI 10.1111/j.1550-7408.1976.tb03816.x; Lin XZ, 2001, MOL ENDOCRINOL, V15, P1264, DOI 10.1210/me.15.8.1264; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MOYLE WR, 1970, STEROIDS, V15, P681, DOI 10.1016/S0039-128X(70)80073-3; Nedumaran B, 2009, J BIOL CHEM, V284, P27511, DOI 10.1074/jbc.M109.034660; Nehar D, 1998, BIOL REPROD, V59, P1425, DOI 10.1095/biolreprod59.6.1425; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; QUINN PG, 1988, MOL CELL BIOL, V8, P3467, DOI 10.1128/MCB.8.8.3467; ROMMERTS FF, 1973, FEBS LETT, V33, P114, DOI 10.1016/0014-5793(73)80172-3; ROMMERTS FFG, 1982, J REPROD FERTIL, V65, P289, DOI 10.1530/jrf.0.0650289; Sewer MB, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290163; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; Song KH, 2001, ENDOCRINOLOGY, V142, P5116, DOI 10.1210/en.142.12.5116; Song KH, 2004, MOL ENDOCRINOL, V18, P1929, DOI 10.1210/me.2004-0043; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532; Stocco DM, 2001, MOL CELL ENDOCRINOL, V177, P55, DOI 10.1016/S0303-7207(01)00423-3; Tosca L, 2007, BIOL REPROD, V76, P368, DOI 10.1095/biolreprod.106.055749; WICKS WD, 1972, BIOCHEM BIOPH RES CO, V48, P205, DOI 10.1016/0006-291X(72)90364-6; Yanez AJ, 2003, J CELL PHYSIOL, V197, P189, DOI 10.1002/jcp.10337; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543	46	21	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41875	41887		10.1074/jbc.M112.421552	http://dx.doi.org/10.1074/jbc.M112.421552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23074219	hybrid, Green Published			2022-12-28	WOS:000312103000028
J	Kormendi, V; Szyk, A; Piszczek, G; Roll-Mecak, A				Kormendi, Vasilisa; Szyk, Agnieszka; Piszczek, Grzegorz; Roll-Mecak, Antonina			Crystal Structures of Tubulin Acetyltransferase Reveal a Conserved Catalytic Core and the Plasticity of the Essential N Terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS ALPHA-TUBULIN; ACETYLATION; FLAGELLA; MEC-17; SYSTEM; FORM	Tubulin acetyltransferase (TAT) acetylates Lys-40 of alpha-tubulin in the microtubule lumen. TAT is inefficient, and its activity is enhanced when tubulin is incorporated in microtubules. Acetylation is associated with stable microtubules and regulates the binding of microtubule motors and associated proteins. TAT is important in neuronal polarity and mechanosensation, and decreased tubulin acetylation levels are associated with axonal transport defects and neurodegeneration. We present the first structure of TAT in complex with acetyl-CoA (Ac-CoA) at 2.7 angstrom resolution. The structure reveals a conserved stable catalytic core shared with other GCN5 superfamily acetyltransferases consisting of a central beta-sheet flanked by alpha-helices and a C-terminal beta-hairpin unique to TAT. Structure-guided mutagenesis establishes the molecular determinants for Ac-CoA and tubulin substrate recognition. The wild-type TAT construct is a monomer in solution. We identify a metastable interface between the conserved core and N-terminal domain that modulates the oligomerization of TAT in solution and is essential for activity. The 2.45 angstrom resolution structure of an inactive TAT construct with an active site point mutation near this interface reveals a domain-swapped dimer in which the functionally essential N terminus shows evidence of marked structural plasticity. The sequence segment corresponding to this structurally plastic region in TAT has been implicated in substrate recognition in other GCN5 superfamily acetyltransferases. Our structures provide a rational platform for the mechanistic dissection of TAT activity and the design of TAT inhibitors with therapeutic potential in neuronal regeneration.	[Roll-Mecak, Antonina] NINDS, Cell Biol & Biophys Unit, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA; [Piszczek, Grzegorz; Roll-Mecak, Antonina] NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Roll-Mecak, A (corresponding author), NINDS, Cell Biol & Biophys Unit, Porter Neurosci Res Ctr, NIH, Bldg 35,Rm 3B-203,35 Convent Dr,MSC 3700, Bethesda, MD 20892 USA.	Antonina@mail.nih.gov	Piszczek, Grzegorz/GYU-2029-2022	Roll-Mecak, Antonina/0000-0003-2621-7307	National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL000338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the intramural program of the National Institutes of Health (to A. R. M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen L, 2012, EMBO J, V31, P3033, DOI 10.1038/emboj.2012.175; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Cueva JG, 2012, CURR BIOL, V22, P1066, DOI 10.1016/j.cub.2012.05.012; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; GAERTIG J, 1995, J CELL BIOL, V129, P1301, DOI 10.1083/jcb.129.5.1301; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Kolonko EM, 2010, P NATL ACAD SCI USA, V107, P20275, DOI 10.1073/pnas.1009860107; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LHERNAULT SW, 1983, J CELL BIOL, V97, P258, DOI 10.1083/jcb.97.1.258; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Santander VS, 2006, MOL CELL BIOCHEM, V291, P167, DOI 10.1007/s11010-006-9212-9; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Steczkiewicz K, 2006, CELL CYCLE, V5, P2927, DOI 10.4161/cc.5.24.3572; Szyk A, 2011, NAT STRUCT MOL BIOL, V18, P1250, DOI 10.1038/nsmb.2148; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Topalidou I, 2012, CURR BIOL, V22, P1057, DOI 10.1016/j.cub.2012.03.066; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727	31	24	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41569	41575		10.1074/jbc.C112.421222	http://dx.doi.org/10.1074/jbc.C112.421222			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23105108	Green Published, hybrid			2022-12-28	WOS:000312103000001
J	Nietzel, T; Dudkina, NV; Haase, C; Denolf, P; Semchonok, DA; Boekema, EJ; Braun, HP; Sunderhaus, S				Nietzel, Thomas; Dudkina, Natalya V.; Haase, Christin; Denolf, Peter; Semchonok, Dmitry A.; Boekema, Egbert J.; Braun, Hans-Peter; Sunderhaus, Stephanie			The Native Structure and Composition of the Cruciferin Complex in Brassica napus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEED STORAGE PROTEINS; POLYACRYLAMIDE GELS; CRYSTAL-STRUCTURE; 11S GLOBULIN; BLUE DYES; ARABIDOPSIS; RAPESEED; POLYPEPTIDES; PROTEASES; VACUOLES	Globulins are an important group of seed storage proteins in dicotyledonous plants. They are synthesized during seed development, assembled into very compact protein complexes, and finally stored in protein storage vacuoles (PSVs). Here, we report a proteomic investigation on the native composition and structure of cruciferin, the 12 S globulin of Brassica napus. PSVs were directly purified from mature seeds by differential centrifugations. Upon analyses by blue native (BN) PAGE, two major types of cruciferin complexes of similar to 300-390 kDa and of similar to 470 kDa are resolved. Analyses by two-dimensional BN/SDS-PAGE revealed that both types of complexes are composed of several copies of the cruciferin alpha and beta polypeptide chains, which are present in various isoforms. Protein analyses by two-dimensional isoelectric focusing (IEF)/SDS-PAGE not only revealed different alpha and beta isoforms but also several further versions of the two polypeptide chains that most likely differ with respect to posttranslational modifications. Overall, more than 30 distinct forms of cruciferin were identified by mass spectrometry. To obtain insights into the structure of the cruciferin holocomplex, a native PSV fraction was analyzed by single particle electron microscopy. More than 20,000 images were collected, classified, and used for the calculation of detailed projection maps of the complex. In contrast to previous reports on globulin structure in other plant species, the cruciferin complex of Brassica napus has an octameric barrel-like structure, which represents a very compact building block optimized for maximal storage of amino acids within minimal space.	[Nietzel, Thomas; Haase, Christin; Braun, Hans-Peter; Sunderhaus, Stephanie] Leibniz Univ Hannover, Dept Plant Prote, Inst Plant Genet, Fac Nat Sci, D-30419 Hannover, Germany; [Dudkina, Natalya V.; Semchonok, Dmitry A.; Boekema, Egbert J.] Univ Groningen, Electron Microscopy Grp, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Denolf, Peter] Bayer CropSci NV, Oilseeds Res, BioSci, B-9052 Zwijnaarde, Belgium	Leibniz University Hannover; University of Groningen; Bayer AG; Bayer CropScience	Braun, HP (corresponding author), Leibniz Univ Hannover, Dept Plant Prote, Inst Plant Genet, Fac Nat Sci, Herrenhauser Str 2, D-30419 Hannover, Germany.	braun@genetik.uni-hannover.de	Braun, Hans-Peter/E-7149-2011; Semchonok, Dmitry/E-1461-2017	Braun, Hans-Peter/0000-0002-4459-9727; Nietzel, Thomas/0000-0002-1934-1732; Semchonok, Dmitry A./0000-0003-1622-9443	HARVEST Marie Curie Research Training Network Grant [PITN-GA-2009-238017]	HARVEST Marie Curie Research Training Network Grant	Supported by HARVEST Marie Curie Research Training Network Grant PITN-GA-2009-238017.	Adachi M, 2003, P NATL ACAD SCI USA, V100, P7395, DOI 10.1073/pnas.0832158100; Adachi M, 2001, J MOL BIOL, V305, P291, DOI 10.1006/jmbi.2000.4310; Agrawal GK, 2006, MOL CELL PROTEOMICS, V5, P2044, DOI 10.1074/mcp.M600084-MCP200; BADLEY RA, 1975, BIOCHIM BIOPHYS ACTA, V412, P214, DOI 10.1016/0005-2795(75)90036-7; BHATTY RS, 1968, CAN J BIOCHEM CELL B, V46, P1191, DOI 10.1139/o68-178; BREEN JP, 1992, PLANT MOL BIOL, V19, P1049, DOI 10.1007/BF00040536; CHRISPEELS MJ, 1982, J CELL BIOL, V93, P306, DOI 10.1083/jcb.93.2.306; CROUCH ML, 1981, PLANTA, V153, P64, DOI 10.1007/BF00385319; DICKINSON CD, 1989, PLANT CELL, V1, P459, DOI 10.1105/tpc.1.4.459; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; EREKENTUMER N, 1982, J BIOL CHEM, V257, P4016; Huang AHC, 1996, PLANT PHYSIOL, V110, P1055, DOI 10.1104/pp.110.4.1055; INQUELLO V, 1993, EUR J BIOCHEM, V217, P891, DOI 10.1111/j.1432-1033.1993.tb18318.x; Jiang LW, 2000, J CELL BIOL, V150, P755, DOI 10.1083/jcb.150.4.755; Jung R, 1998, PLANT CELL, V10, P343, DOI 10.1105/tpc.10.3.343; Kruft V, 2001, PLANT PHYSIOL, V127, P1694, DOI 10.1104/pp.010474; LAWRENCE MC, 1990, EMBO J, V9, P9, DOI 10.1002/j.1460-2075.1990.tb08074.x; MARCONE MF, 1994, J AGR FOOD CHEM, V42, P2675, DOI 10.1021/jf00048a005; Meyer LJ, 2012, PLANT PHYSIOL, V159, P517, DOI 10.1104/pp.111.191700; MOREIRA MA, 1979, J BIOL CHEM, V254, P9921; Muntz K, 1996, J EXP BOT, V47, P605, DOI 10.1093/jxb/47.5.605; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; NEUHOFF V, 1990, ELECTROPHORESIS, V11, P101, DOI 10.1002/elps.1150110202; Ondzighi CA, 2008, PLANT CELL, V20, P2205, DOI 10.1105/tpc.108.058339; Otegui MS, 2006, PLANT CELL, V18, P2567, DOI 10.1105/tpc.106.040931; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PLIETZ P, 1983, EUR J BIOCHEM, V130, P315, DOI 10.1111/j.1432-1033.1983.tb07154.x; Quillin ML, 2000, ACTA CRYSTALLOGR D, V56, P791, DOI 10.1107/S090744490000679X; RODIN J, 1990, J BIOL CHEM, V265, P2720; RODIN J, 1992, PLANT MOL BIOL, V20, P559, DOI 10.1007/BF00040615; Rossmann MG, 2000, ACTA CRYSTALLOGR D, V56, P1341, DOI 10.1107/S0907444900009562; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schagger H., 2003, MEMBRANE PROTEIN PUR, P105; SCHWENKE KD, 1983, NAHRUNG, V27, P165, DOI 10.1002/food.19830270208; SENGUPTA C, 1981, Plant Molecular Biology, V1, P19, DOI 10.1007/BF00023011; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; SJODAHL S, 1991, EUR J BIOCHEM, V196, P617, DOI 10.1111/j.1432-1033.1991.tb15857.x; Sunderhaus S, 2010, PLANT PHYSIOL BIOCH, V48, P265, DOI 10.1016/j.plaphy.2010.01.010; Tandang MRG, 2004, BIOTECHNOL LETT, V26, P385, DOI 10.1023/B:BILE.0000018256.90457.ee; Tandang-Silvas MRG, 2010, BBA-PROTEINS PROTEOM, V1804, P1432, DOI 10.1016/j.bbapap.2010.02.016; Vitale A, 2005, TRENDS PLANT SCI, V10, P316, DOI 10.1016/j.tplants.2005.05.001; Wan LL, 2007, BIOCHEM J, V404, P247, DOI 10.1042/BJ20061569; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	44	15	16	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2238	2245		10.1074/jbc.M112.356089	http://dx.doi.org/10.1074/jbc.M112.356089			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23192340	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000314211500014
J	Hashimoto, S; Imaoka, S				Hashimoto, Shoko; Imaoka, Susumu			Protein-disulfide Isomerase Regulates the Thyroid Hormone Receptor-mediated Gene Expression via Redox Factor-1 through Thiol Reduction-Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; TISSUE FACTOR; BISPHENOL-A; ENDOPLASMIC-RETICULUM; CHOLERA-TOXIN; THIOREDOXIN; ACTIVATION; HYPOXIA; DOMAIN; CELLS	Protein-disulfide isomerase (PDI) is a dithiol/disulfide oxidoreductase that regulates the redox state of proteins. We previously found that overexpression of PDI in rat pituitary tumor (GH3) cells suppresses 3,3',5-triiodothyronine (T-3)-stimulated growth hormone (GH) expression, suggesting the contribution of PDI to the T-3-mediated gene expression via thyroid hormone receptor (TR). In the present study, we have clarified the mechanism of regulation by which TR function is regulated by PDI. Overexpression of wild-type but not redox-inactive mutant PDI suppressed the T-3-induced GH expression, suggesting that the redox activity of PDI contributes to the suppression of GH. We considered that PDI regulates the redox state of the TR and focused on redox factor-1 (Ref-1) as a mediator of the redox regulation of TR by PDI. Interaction between Ref-1 and TR beta 1 was detected. Overexpression of wild-type but not C64S Ref-1 facilitated the GH expression, suggesting that redox activity of Cys-64 in Ref-1 is involved in the TR-mediated gene expression. Moreover, PDI interacted with Ref-1 and changed the redox state of Ref-1, suggesting that PDI controls the redox state of Ref-1. Our studies suggested that Ref-1 contributes to TR-mediated gene expression and that the redox state of Ref-1 is regulated by PDI. Redox regulation of PDI via Ref-1 is a new aspect of PDI function.	[Imaoka, Susumu] Kwansei Gakuin Univ, Sch Sci & Technol, Res Ctr Environm Biosci, Sanda, Hyogo 6691337, Japan; Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, Sanda, Hyogo 6691337, Japan	Kwansei Gakuin University; Kwansei Gakuin University	Imaoka, S (corresponding author), Kwansei Gakuin Univ, Sch Sci & Technol, Res Ctr Environm Biosci, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan.	imaoka@kwansei.ac.jp			Japan Society for the Promotion of Science; Hyogo Science and Technology Association; Kwansei Gakuin University; Support Project to Assist Private Universities in Developing Bases for Research by the Ministry of Education, Culture, Sports, Science and Technology	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hyogo Science and Technology Association; Kwansei Gakuin University(Kwansei Gakuin University); Support Project to Assist Private Universities in Developing Bases for Research by the Ministry of Education, Culture, Sports, Science and Technology	This work was supported in part by a grant-in-aid for scientific research (B) from the Japan Society for the Promotion of Science, a grant-in-aid from the Hyogo Science and Technology Association, and a grant-in-aid from Kwansei Gakuin University and by the Support Project to Assist Private Universities in Developing Bases for Research by the Ministry of Education, Culture, Sports, Science and Technology.	Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Alanen HI, 2003, ANTIOXID REDOX SIGN, V5, P367, DOI 10.1089/152308603768295096; Ando K, 2008, NUCLEIC ACIDS RES, V36, P4327, DOI 10.1093/nar/gkn416; Barbouche R, 2003, J BIOL CHEM, V278, P3131, DOI 10.1074/jbc.M205467200; Burrows HL, 1998, J CLIN INVEST, V101, P1439, DOI 10.1172/JCI1963; Curbo S, 2009, BIOCHEM BIOPH RES CO, V390, P1272, DOI 10.1016/j.bbrc.2009.10.134; Curtis CD, 2009, MOL ENDOCRINOL, V23, P1346, DOI 10.1210/me.2009-0093; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Fu XM, 2009, J STEROID BIOCHEM, V115, P20, DOI 10.1016/j.jsbmb.2009.02.008; Grillo C, 2006, FREE RADICAL BIO MED, V41, P1113, DOI 10.1016/j.freeradbiomed.2006.06.016; Hashimoto S, 2008, J BIOCHEM, V144, P335, DOI 10.1093/jb/mvn075; Hashimoto S, 2012, CHEM RES TOXICOL, V25, P656, DOI 10.1021/tx200374s; Hashimoto S, 2012, J BIOCHEM, V151, P35, DOI 10.1093/jb/mvr122; Hiroi T, 2006, ENDOCRINOLOGY, V147, P2773, DOI 10.1210/en.2005-1235; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Hohenwarter O, 1996, ANAL BIOCHEM, V234, P56, DOI 10.1006/abio.1996.0049; HOLMGREN A, 1978, BIOCHEMISTRY-US, V17, P4071, DOI 10.1021/bi00612a031; Janiszewski M, 2005, J BIOL CHEM, V280, P40813, DOI 10.1074/jbc.M509255200; Kang K, 2009, ANTIOXID REDOX SIGN, V11, P2553, DOI [10.1089/ars.2009.2465, 10.1089/ARS.2009.2465]; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Klappa P, 2001, BIOCHEM J, V354, P553, DOI 10.1042/0264-6021:3540553; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Manukyan D, 2008, THROMB RES, V122, pS19, DOI 10.1016/S0049-3848(08)70013-6; OBATA T, 1988, J BIOL CHEM, V263, P782; Okada K, 2007, MOL CELL ENDOCRINOL, V278, P44, DOI 10.1016/j.mce.2007.08.005; Okada Kazushi, 2005, Osaka City Medical Journal, V51, P51; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Paes AMD, 2011, J LEUKOCYTE BIOL, V90, P799, DOI 10.1189/jlb.0610324; Primm TP, 2001, J BIOL CHEM, V276, P281, DOI 10.1074/jbc.M007670200; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; Schulman S, 2010, P NATL ACAD SCI USA, V107, P15027, DOI 10.1073/pnas.1009972107; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; Tell G, 2002, J BIOL CHEM, V277, P14564, DOI 10.1074/jbc.M200582200; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; TSIBRIS JCM, 1989, J BIOL CHEM, V264, P13967; Ueno M, 1999, J BIOL CHEM, V274, P35809, DOI 10.1074/jbc.274.50.35809; Vascotto C, 2011, MOL BIOL CELL, V22, P3887, DOI 10.1091/mbc.E11-05-0391; Versteeg HH, 2007, J BIOL CHEM, V282, P25416, DOI 10.1074/jbc.M702410200; Wajih N, 2007, J BIOL CHEM, V282, P2626, DOI 10.1074/jbc.M608954200; Ziel KA, 2004, FASEB J, V18, P986, DOI 10.1096/fj.03-1160fje	42	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1706	1716		10.1074/jbc.M112.365239	http://dx.doi.org/10.1074/jbc.M112.365239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23148211	Green Published, hybrid			2022-12-28	WOS:000313751400027
J	Jiang, WY; Napoli, JL				Jiang, Weiya; Napoli, Joseph L.			The Retinol Dehydrogenase Rdh10 Localizes to Lipid Droplets during Acyl Ester Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; POLYPOSIS-COLI CONTROL; SMOOTH-MUSCLE-CELLS; ALL-TRANS-RETINOL; BINDING-PROTEIN; RAT-LIVER; ACID BIOSYNTHESIS; FATTY-ACIDS; MOLECULAR CHARACTERIZATION; PROMOTES PROLIFERATION	Rdh10 catalyzes the first step of all-trans-retinoic acid biogenesis physiologically, conversion of retinol into retinal. We show that Rdh10 associates predominantly with mitochondria/mitochondrial-associated membrane (MAM) in the absence of lipid droplet biosynthesis, but also locates with lipid droplets during acyl ester biosynthesis. Targeting to lipid droplets requires the 32 N-terminal residues, which include a hydrophobic region followed by a net positive charge. Targeting to mitochondria/MAM and/or the stability of Rdh10 require both the N-terminal and the 48 C-terminal hydrophobic residues. Rdh10 behaves similarly to cellular retinol-binding protein, type 1, which also localizes to mitochondria/MAM before lipid droplet synthesis, and associates with lipid droplets during acyl ester synthesis (Jiang, W., and Napoli, J. L. (2012) Biochem. Biophys. Acta 1820, 859-8692). LRAT, an ER protein, also associates with lipid droplets upon acyl ester biosynthesis. Colocalization of Rdh10, Crbp1, and LRAT on lipid droplets suggests a metabolon that mediates retinol homeostasis.	[Jiang, Weiya; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Grad Program Metab Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Napoli, JL (corresponding author), 119 Morgan Hall,MC 3104, Berkeley, CA 94720 USA.	jna@berkeley.edu			National Institutes of Health [RO1 AA017927, DK090522]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AA017927 and DK090522 (to J. L. N.).	Ashique AM, 2012, GENESIS, V50, P415, DOI 10.1002/dvg.22002; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Belyaeva OV, 2006, GENOMICS, V88, P820, DOI 10.1016/j.ygeno.2006.06.004; Belyaeva OV, 2012, J BIOL CHEM, V287, P9061, DOI 10.1074/jbc.M111.336727; Belyaeva OV, 2003, BIOCHEMISTRY-US, V42, P14838, DOI 10.1021/bi035288u; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; BOERMAN MHEM, 1995, BIOCHEMISTRY-US, V34, P7027, DOI 10.1021/bi00021a014; BOERMAN MHEM, 1991, J BIOL CHEM, V266, P22273; Boerman MHEM, 1996, J BIOL CHEM, V271, P5610, DOI 10.1074/jbc.271.10.5610; Bouchoux J, 2011, BIOL CELL, V103, P499, DOI 10.1042/BC20110024; Bozidis Petros, 2007, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0327s37; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Cammas L, 2007, DEV DYNAM, V236, P2899, DOI 10.1002/dvdy.21312; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Deisenroth C, 2011, J BIOL CHEM, V286, P28343, DOI 10.1074/jbc.M111.254227; Digel M, 2010, FEBS LETT, V584, P2168, DOI 10.1016/j.febslet.2010.03.035; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Farjo KM, 2011, DEV BIOL, V357, P347, DOI 10.1016/j.ydbio.2011.07.011; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; Hardy S, 2000, CANCER RES, V60, P6353; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; HERR FM, 1992, BIOCHEMISTRY-US, V31, P6748, DOI 10.1021/bi00144a014; Hess D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011394; Huang DY, 1997, BBA-PROTEIN STRUCT M, V1338, P47, DOI 10.1016/S0167-4838(96)00183-5; Jiang WY, 2012, BBA-GEN SUBJECTS, V1820, P859, DOI 10.1016/j.bbagen.2012.03.016; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; KASAYAMA S, 1994, CANCER RES, V54, P6441; Lee SA, 2011, J BIOL CHEM, V286, P13550, DOI 10.1074/jbc.M110.181065; Listenberger LL, 2008, CURR BIOL, V18, pR237, DOI 10.1016/j.cub.2008.01.010; Listenberger LL, 2007, CURR PROTOC CELL BIO, DOI [DOI 10.1002/0471143030.CB2402S35, 10.1002/0471143030.cb2402s35]; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; MACDONALD PN, 1988, BIOCHEM BIOPH RES CO, V156, P157, DOI 10.1016/S0006-291X(88)80818-0; Magdalon J, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-218; MALPELI G, 1995, EUR J BIOCHEM, V229, P486, DOI 10.1111/j.1432-1033.1995.0486k.x; Nadauld LD, 2004, J BIOL CHEM, V279, P51581, DOI 10.1074/jbc.M408830200; Nadauld LD, 2006, J BIOL CHEM, V281, P37828, DOI 10.1074/jbc.M602119200; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; Napoli JL, 1996, CLIN IMMUNOL IMMUNOP, V80, pS52, DOI 10.1006/clin.1996.0142; NAPOLI JL, 1990, METHOD ENZYMOL, V189, P470; Napoli JL, 1998, METH MOL B, V89, P29; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; ONG DE, 1988, J BIOL CHEM, V263, P5789; OPAS M, 1991, J CELL PHYSIOL, V149, P160, DOI 10.1002/jcp.1041490120; OTTONELLO S, 1993, J BIOL CHEM, V268, P27133; Penzes P, 1999, BIOCHEMISTRY-US, V38, P2088, DOI 10.1021/bi982228t; POSCH KC, 1991, BIOCHEMISTRY-US, V30, P6224, DOI 10.1021/bi00239a021; Renard CB, 2003, DIABETOLOGIA, V46, P1676, DOI 10.1007/s00125-003-1247-9; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; SALEMME FR, 1977, ANNU REV BIOCHEM, V46, P299, DOI 10.1146/annurev.bi.46.070177.001503; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Southgate J, 1996, BRIT J CANCER, V74, P728, DOI 10.1038/bjc.1996.429; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Tajima S, 2001, COMP BIOCHEM PHYS B, V128, P425, DOI 10.1016/S1096-4959(00)00347-X; Wang C, 2011, J BIOL CHEM, V286, P6542, DOI 10.1074/jbc.M110.198382; Wang J, 2001, BIOCHEMISTRY-US, V40, P12533, DOI 10.1021/bi011396+; Wolf G, 1996, NUTR REV, V54, P182, DOI 10.1111/j.1753-4887.1996.tb03928.x; Wu BX, 2002, INVEST OPHTH VIS SCI, V43, P3365; YAMADA K, 1990, AGR BIOL CHEM TOKYO, V54, P1867, DOI 10.1080/00021369.1990.10870205; YOST RW, 1988, J BIOL CHEM, V263, P18693; Zhai Y, 1997, J CELL PHYSIOL, V173, P36, DOI 10.1002/(SICI)1097-4652(199710)173:1<36::AID-JCP5>3.0.CO;2-K; Zhang M, 2004, J BIOL CHEM, V279, P51482, DOI 10.1074/jbc.M409051200; Zhang M, 2001, J BIOL CHEM, V276, P44083, DOI 10.1074/jbc.M105748200; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com; Zhang Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001137	68	36	36	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					589	597		10.1074/jbc.M112.402883	http://dx.doi.org/10.1074/jbc.M112.402883			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23155051	Green Published, hybrid			2022-12-28	WOS:000313197200059
J	Padilla-Benavides, T; McCann, CJ; Arguello, JM				Padilla-Benavides, Teresita; McCann, Courtney J.; Argueello, Jose M.			The Mechanism of Cu+ Transport ATPases INTERACTION WITH CU+ CHAPERONES AND THE ROLE OF TRANSIENT METAL-BINDING SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATX1 METALLOCHAPERONE; CRYSTAL-STRUCTURE; COPPER PUMP; PROTEIN; IDENTIFICATION; P-1B-ATPASES; DELIVERY; DOMAINS	Cu+-ATPases are membrane proteins that couple the hydrolysis of ATP to the efflux of cytoplasmic Cu+. In cells, soluble chaperone proteins bind and distribute cytoplasmic Cu+, delivering the ion to the transmembrane metal-binding sites in the ATPase. The structure of Legionella pneumophila Cu+-ATPase (Gourdon, P., Liu, X. Y., Skjorringe, T., Morth, J. P., Moller, L. B., Pedersen, B. P., and Nissen, P. (2011) Nature 475, 59-64) shows that a kinked transmembrane segment forms a "platform" exposed to the cytoplasm. In addition, neighboring invariant Met, Asp, and Glu are located at the "entrance" of the ion path. Mutations of amino acids in these regions of the Archaeoglobus fulgidus Cu+-ATPase CopA do not affect ATPase activity in the presence of Cu+ free in solution. However, Cu+ bound to the corresponding chaperone (CopZ) could not activate the mutated ATPases, and in parallel experiments, CopZ was unable to transfer Cu+ to CopA. Furthermore, mutation of a specific electronegative patch on the CopZ surface abolishes the ATPase activation and Cu+ transference, indicating that the region is required for the CopZ-CopA interaction. Moreover, the data suggest that the interaction is driven by the complementation of the electropositive platform in the ATPase and the electronegative Cu+ chaperone. This docking likely places the Cu+ proximal to the conserved carboxyl and thiol groups in the entrance site that induce metal release from the chaperone via ligand exchange. The initial interaction of Cu+ with the pump is transient because Cu+ is transferred from the entrance site to transmembrane metal-binding sites involved in transmembrane translocation.	[Padilla-Benavides, Teresita; McCann, Courtney J.; Argueello, Jose M.] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Arguello, JM (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	arguello@wpi.edu	Johnson, Michael D. L./B-4352-2012; Padilla-Benavides, Teresita/K-1968-2012; Arguello, Jose/D-1997-2012	Padilla-Benavides, Teresita/0000-0002-4624-0822; Arguello, Jose/0000-0003-3940-6297	National Science Foundation [MCB-0743901]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0743901 (to J. M. A.).	Arguello JM, 2012, J BIOL CHEM, V287, P13510, DOI 10.1074/jbc.R111.319343; Arguello JM, 2011, BIOCHEMISTRY-US, V50, P9940, DOI 10.1021/bi201418k; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Banci L, 2010, CELL MOL LIFE SCI, V67, P2563, DOI 10.1007/s00018-010-0330-x; Banci L, 2010, NAT PROD REP, V27, P695, DOI 10.1039/b906678k; Barry AN, 2010, J BIOL INORG CHEM, V15, P47, DOI 10.1007/s00775-009-0595-4; Boal AK, 2009, CHEM REV, V109, P4760, DOI 10.1021/cr900104z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER AJ, 1995, ANAL BIOCHEM, V226, P80, DOI 10.1006/abio.1995.1194; Fan B, 2002, J BIOL CHEM, V277, P46987, DOI 10.1074/jbc.M208490200; Frausto da Silva J, 2001, BIOL CHEM ELEMENTS, P418; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gonzalez-Guerrero M, 2009, J BIOL CHEM, V284, P20804, DOI 10.1074/jbc.M109.016329; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Gupta A, 2009, FORM METHOD SYST DES, V35, P1, DOI 10.1007/s10703-009-0072-2; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Mandal AK, 2004, J BIOL CHEM, V279, P54802, DOI 10.1074/jbc.M410854200; Mandal AK, 2003, BIOCHEMISTRY-US, V42, P11040, DOI 10.1021/bi034806y; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Portnoy ME, 1999, J BIOL CHEM, V274, P15041, DOI 10.1074/jbc.274.21.15041; Raimunda D, 2011, BIOMETALS, V24, P467, DOI 10.1007/s10534-010-9404-3; Rice WJ, 2006, BIOCHEM BIOPH RES CO, V348, P124, DOI 10.1016/j.bbrc.2006.07.012; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Rosenzweig AC, 1999, STRUCTURE, V7, P605, DOI 10.1016/S0969-2126(99)80082-3; Rosenzweig AC, 2001, ACCOUNTS CHEM RES, V34, P119, DOI 10.1021/ar000012p; Sazinsky MH, 2007, J BIOL CHEM, V282, P25950, DOI 10.1074/jbc.M703311200; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025	44	56	56	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					69	78		10.1074/jbc.M112.420810	http://dx.doi.org/10.1074/jbc.M112.420810			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23184962	hybrid, Green Published			2022-12-28	WOS:000313197200007
J	Yang, SY; Huang, FK; Huang, JY; Chen, S; Jakoncic, J; Leo-Macias, A; Diaz-Avalos, R; Chen, L; Zhang, JJ; Huang, XY				Yang, Shengyu; Huang, Fang-Ke; Huang, Jianyun; Chen, Shuai; Jakoncic, Jean; Leo-Macias, Alejandra; Diaz-Avalos, Ruben; Chen, Lin; Zhang, J. Jillian; Huang, Xin-Yun			Molecular Mechanism of Fascin Function in Filopodial Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE BREAST-CANCER; CROSS-LINKING PROTEIN; ACTIN-BINDING; IN-VIVO; EXPRESSION; MOTILITY; TOMOGRAPHY; CARCINOMA; ROLES; METASTASIS	Filopodia are cell surface protrusions that are essential for cell migration. This finger-like structure is supported by rigid tightly bundled actin filaments. The protein responsible for actin bundling in filopodia is fascin. However, the mechanism by which fascin functions in filopodial formation is not clear. Here we provide biochemical, cryo-electron tomographic, and x-ray crystal structural data demonstrating the unique structural characteristics of fascin. Systematic mutagenesis studies on 100 mutants of fascin indicate that there are two major actin-binding sites on fascin. Crystal structures of four fascin mutants reveal concerted conformational changes in fascin from inactive to active states in the process of actin bundling. Mutations in any one of the actin-binding sites impair the cellular function of fascin in filopodial formation. Altogether, our data reveal the molecular mechanism of fascin function in filopodial formation.	[Yang, Shengyu; Huang, Fang-Ke; Huang, Jianyun; Chen, Shuai; Chen, Lin; Zhang, J. Jillian; Huang, Xin-Yun] Cornell Univ, Dept Physiol, Weill Med Coll, New York, NY 10065 USA; [Jakoncic, Jean] Brookhaven Natl Lab, Upton, NY 11973 USA; [Leo-Macias, Alejandra] NYU, Skirball Inst Biomol Med, Sch Med, New York, NY 10016 USA; [Diaz-Avalos, Ruben] New York Struct Biol Ctr, New York, NY 10027 USA	Cornell University; United States Department of Energy (DOE); Brookhaven National Laboratory; New York University	Huang, XY (corresponding author), Cornell Univ, Dept Physiol, Weill Med Coll, New York, NY 10065 USA.	xyhuang@med.cornell.edu	Yang, Shengyu/I-9531-2012; Leo-Macias, Alejandra/B-3159-2017	Yang, Shengyu/0000-0002-7933-6118; Leo-Macias, Alejandra/0000-0002-7579-9764	National Institutes of Health [CA136837]; NATIONAL CANCER INSTITUTE [R01CA136837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA136837.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Aratyn YS, 2007, MOL BIOL CELL, V18, P3928, DOI 10.1091/mbc.E07-04-0346; BRYAN J, 1978, J MOL BIOL, V125, P207, DOI 10.1016/0022-2836(78)90345-5; Cant K, 1996, GENETICS, V143, P249; Cao DF, 2005, INT J GYNECOL PATHOL, V24, P67, DOI 10.1097/01.pgp.0000139648.17750.35; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Claessens MMAE, 2006, NAT MATER, V5, P748, DOI 10.1038/nmat1718; DEROSIER D, 1977, J MOL BIOL, V113, P679, DOI 10.1016/0022-2836(77)90230-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102; Grothey A, 2000, BRIT J CANCER, V83, P870, DOI 10.1054/bjoc.2000.1395; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Hashimoto Y, 2004, ONCOLOGY-BASEL, V67, P262, DOI 10.1159/000081327; Jansen S, 2011, J BIOL CHEM, V286, P30087, DOI 10.1074/jbc.M111.251439; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Lee K, 2010, SCIENCE, V329, P1341, DOI 10.1126/science.1191710; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Maitra A, 2002, AM J CLIN PATHOL, V118, P52; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006; Ono S, 1997, J BIOL CHEM, V272, P2527; OTTO JJ, 1979, CELL, V17, P285, DOI 10.1016/0092-8674(79)90154-5; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pelosi G, 2003, LUNG CANCER-J IASLC, V42, P203, DOI 10.1016/S0169-5002(03)00294-0; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Sedeh RS, 2010, J MOL BIOL, V400, P589, DOI 10.1016/j.jmb.2010.04.043; Shin JB, 2010, J NEUROSCI, V30, P9683, DOI 10.1523/JNEUROSCI.1541-10.2010; SPUDICH JA, 1979, J MOL BIOL, V129, P319, DOI 10.1016/0022-2836(79)90285-7; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tilney LG, 1998, J CELL BIOL, V143, P121, DOI 10.1083/jcb.143.1.121; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Yamakita Y, 1996, J BIOL CHEM, V271, P12632, DOI 10.1074/jbc.271.21.12632; YAMASHIROMATSUMURA S, 1985, J BIOL CHEM, V260, P5087; Yoder BJ, 2005, CLIN CANCER RES, V11, P186; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921; Zigeuner R, 2006, UROLOGY, V68, P518, DOI 10.1016/j.urology.2006.03.032	45	81	81	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					274	284		10.1074/jbc.M112.427971	http://dx.doi.org/10.1074/jbc.M112.427971			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23184945	hybrid, Green Published			2022-12-28	WOS:000313197200027
J	Ziarek, JJ; Veldkamp, CT; Zhang, FM; Murray, NJ; Kartz, GA; Liang, XL; Su, JD; Baker, JE; Linhardt, RJ; Volkman, BF				Ziarek, Joshua J.; Veldkamp, Christopher T.; Zhang, Fuming; Murray, Nathan J.; Kartz, Gabriella A.; Liang, Xinle; Su, Jidong; Baker, John E.; Linhardt, Robert J.; Volkman, Brian F.			Heparin Oligosaccharides Inhibit Chemokine (CXC Motif) Ligand 12 (CXCL12) Cardioprotection by Binding Orthogonal to the Dimerization Interface, Promoting Oligomerization, and Competing with the Chemokine (CXC Motif) Receptor 4 (CXCR4) N Terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DERIVED FACTOR-1-ALPHA; FACTOR-I; VENTRICULAR-FUNCTION; STRUCTURAL BASIS; STEM; RECRUITMENT; PROGENITOR; HEART; GLYCOSAMINOGLYCANS; SULFOTYROSINE	The ability to interact with cell surface glycosaminoglycans (GAGs) is essential to the cell migration properties of chemokines, but association with soluble GAGs induces the oligomerization of most chemokines including CXCL12. Monomeric CXCL12, but not dimeric CXCL12, is cardioprotective in a number of experimental models of cardiac ischemia. We found that co-administration of heparin, a common treatment for myocardial infarction, abrogated the protective effect of CXCL12 in an ex vivo rat heart model for myocardial infarction. The interaction between CXCL12 and heparin oligosaccharides has previously been analyzed through mutagenesis, in vitro binding assays, and molecular modeling. However, complications from heparin-induced CXCL12 oligomerization and studies using very short oligosaccharides have led to inconsistent conclusions as to the residues involved, the orientation of the binding site, and whether it overlaps with the CXCR4 N-terminal site. We used a constitutively dimeric variant to simplify the NMR analysis of CXCL12-binding heparin oligosaccharides of varying length. Biophysical and mutagenic analyses reveal a CXCL12/heparin interaction surface that lies perpendicular to the dimer interface, does not involve the chemokine N terminus, and partially overlaps with the CXCR4-binding site. We further demonstrate that heparin-mediated enzymatic protection results from the promotion of dimerization rather than direct heparin binding to the CXCL12 N terminus. These results clarify the structural basis for GAG recognition by CXCL12 and lend insight into the development of CXCL12-based therapeutics.	[Ziarek, Joshua J.; Murray, Nathan J.; Su, Jidong; Baker, John E.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Kartz, Gabriella A.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Veldkamp, Christopher T.] Univ Wisconsin, Dept Chem, Whitewater, WI 53190 USA; [Zhang, Fuming; Liang, Xinle; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Zhang, Fuming; Liang, Xinle; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Zhang, Fuming; Liang, Xinle; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Zhang, Fuming; Liang, Xinle; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Zhang, Fuming; Liang, Xinle; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Medical College of Wisconsin; Medical College of Wisconsin; University of Wisconsin System; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Volkman, BF (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	bvolkman@mcw.edu	Volkman, Brian F./ABE-7306-2020; Baker, John/V-8897-2019; Volkman, Brian F./ABE-7312-2020	Volkman, Brian F./0000-0002-6681-5179; Baker, John/0000-0001-7899-3266; Volkman, Brian F./0000-0002-6681-5179; Ziarek, Joshua/0000-0002-3740-9999	National Institutes of Health [AI058072, GM097381, AI063325, 1-R15CA159202-01, GM38060, HL62244, HL54075, AI080363]; Medical College of Wisconsin Cancer Center; American Heart Association; NATIONAL CANCER INSTITUTE [R15CA159202] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062244, R01HL054075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080363, R56AI063325, R01AI063325, R01AI058072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097381, R01GM038060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical College of Wisconsin Cancer Center; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058072, GM097381, and AI063325 (to B. F. V.); 1-R15CA159202-01 (to C. T. V.); GM38060 and HL62244 (to F. Z. and R. J. L.); and HL54075 and AI080363 (to J. E. B.). This work was also supported by a postdoctoral fellowship from the Medical College of Wisconsin Cancer Center (to J. J. Z.) and a predoctoral fellowship from the American Heart Association (to G. A. K.).	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; Baker JE, 1997, CIRCULATION, V95, P1278; Baker JE, 2000, AM J PHYSIOL-HEART C, V278, pH1395, DOI 10.1152/ajpheart.2000.278.4.H1395; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Chien CH, 2004, J BIOL CHEM, V279, P52338, DOI 10.1074/jbc.M406185200; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Delgado MB, 2001, EUR J IMMUNOL, V31, P699, DOI 10.1002/1521-4141(200103)31:3<699::AID-IMMU699>3.0.CO;2-6; Fermas S, 2008, GLYCOBIOLOGY, V18, P1054, DOI 10.1093/glycob/cwn088; Fuster V., 2004, HURSTS HEART; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Keller R., 2004, COMPUTER AIDED RESON, V1; Koch KC, 2006, BASIC RES CARDIOL, V101, P69, DOI 10.1007/s00395-005-0570-3; Laguri C, 2011, J AM CHEM SOC, V133, P9642, DOI 10.1021/ja201753e; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Penn MS, 2004, INT J CARDIOL, V95, pS23, DOI 10.1016/S0167-5273(04)90007-1; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Proulx C, 2007, PFLUG ARCH EUR J PHY, V455, P241, DOI 10.1007/s00424-007-0284-5; ROSENBERG RD, 1973, J BIOL CHEM, V248, P6490; Sadir R, 2004, J BIOL CHEM, V279, P43854, DOI 10.1074/jbc.M405392200; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Sasaki T, 2007, PEDIATR INT, V49, P966, DOI 10.1111/j.1442-200X.2007.02491.x; Saxena A, 2008, CIRCULATION, V117, P2224, DOI 10.1161/CIRCULATIONAHA.107.694992; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; Seibert C, 2008, BIOCHEMISTRY-US, V47, P11251, DOI 10.1021/bi800965m; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Takekoshi T, 2012, MOL CANCER THER, V11, P2516, DOI 10.1158/1535-7163.MCT-12-0494; Thoma R, 2003, STRUCTURE, V11, P947, DOI 10.1016/S0969-2126(03)00160-6; Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Veldkamp CT, 2009, PROTEIN SCI, V18, P1359, DOI 10.1002/pro.167; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Zhang FM, 2011, ANAL BIOANAL CHEM, V401, P2793, DOI 10.1007/s00216-011-5367-7; Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	46	68	70	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					737	746		10.1074/jbc.M112.394064	http://dx.doi.org/10.1074/jbc.M112.394064			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23148226	Green Published, hybrid			2022-12-28	WOS:000313197200073
J	Bonacci, G; Baker, PRS; Salvatore, SR; Shores, D; Khoo, NKH; Koenitzer, JR; Vitturi, DA; Woodcock, SR; Golin-Bisello, F; Cole, MP; Watkins, S; Croix, CS; Batthyany, CI; Freeman, BA; Schopfer, FJ				Bonacci, Gustavo; Baker, Paul R. S.; Salvatore, Sonia R.; Shores, Darla; Khoo, Nicholas K. H.; Koenitzer, Jeffrey R.; Vitturi, Dario A.; Woodcock, Steven R.; Golin-Bisello, Franca; Cole, Marsha P.; Watkins, Simon; Croix, Claudette St.; Batthyany, Carlos I.; Freeman, Bruce A.; Schopfer, Francisco J.			Conjugated Linoleic Acid Is a Preferential Substrate for Fatty Acid Nitration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; NITROGEN-DIOXIDE; HUMAN BLOOD; ISCHEMIA; INFLAMMATION; NITROALKENE; GENERATION; MYELOPEROXIDASE; PEROXYNITRITE; REPERFUSION	The oxidation and nitration of unsaturated fatty acids by oxides of nitrogen yield electrophilic derivatives that can modulate protein function via post-translational protein modifications. The biological mechanisms accounting for fatty acid nitration and the specific structural characteristics of products remain to be defined. Herein, conjugated linoleic acid (CLA) is identified as the primary endogenous substrate for fatty acid nitration in vitro and in vivo, yielding up to 10(5) greater extent of nitration products as compared with bis-allylic linoleic acid. Multiple enzymatic and cellular mechanisms account for CLA nitration, including reactions catalyzed by mitochondria, activated macrophages, and gastric acidification. Nitroalkene derivatives of CLA and their metabolites are detected in the plasma of healthy humans and are increased in tissues undergoing episodes of ischemia reperfusion. Dietary CLA and nitrite supplementation in rodents elevates NO2-CLA levels in plasma, urine, and tissues, which in turn induces heme oxygenase-1 (HO-1) expression in the colonic epithelium. These results affirm that metabolic and inflammatory reactions yield electrophilic products that can modulate adaptive cell signaling mechanisms.	[Bonacci, Gustavo; Baker, Paul R. S.; Salvatore, Sonia R.; Khoo, Nicholas K. H.; Koenitzer, Jeffrey R.; Vitturi, Dario A.; Woodcock, Steven R.; Golin-Bisello, Franca; Cole, Marsha P.; Freeman, Bruce A.; Schopfer, Francisco J.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Shores, Darla] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15261 USA; [Watkins, Simon; Croix, Claudette St.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Batthyany, Carlos I.] Inst Pasteur, Montevideo 11400, Uruguay	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Freeman, BA (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Thomas E Starzl Biomed Sci Tower E1340,200 Lothro, Pittsburgh, PA 15213 USA.	freerad@pitt.edu; fjs2@pitt.edu	Woodcock, Steven/AAE-9199-2020; Schopfer, Francisco Jose/AAE-8125-2020; Watkins, Simon/ABG-2590-2021; Vitturi, Dario/Z-3469-2019; Schopfer, Francisco/AAW-6505-2021; Shores, Darla/GXH-2652-2022	Schopfer, Francisco Jose/0000-0001-9526-695X; Watkins, Simon/0000-0003-4092-1552; Batthyany, Carlos/0000-0002-0627-1982; Vitturi, Dario/0000-0003-0354-4567; Bonacci, Gustavo/0000-0002-9830-1850; Salvatore, Sonia/0000-0002-9942-3905	National Institutes of Health [R01-HL058115, R01-HL64937, P30-DK072506, P01-HL103455, R01 AT006822-01]; National Center for Complementary & Integrative Health [R01AT006822] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058115, P01HL103455, R00HL095769, R01HL064937, K99HL095769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL058115, R01-HL64937, P30-DK072506, P01-HL103455 (to B.A.F.), and R01 AT006822-01 (to F.J.S.). B.A.F. and F.J.S. acknowledge financial interest in Complexa, Inc.	Adkins Y, 2010, J NUTR BIOCHEM, V21, P781, DOI 10.1016/j.jnutbio.2009.12.004; ATKINSON R, 1984, INT J CHEM KINET, V16, P697, DOI 10.1002/kin.550160607; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Baldus S, 2001, J CLIN INVEST, V108, P1759; Bates DJP, 2011, BIOCHEMISTRY-US, V50, P7765, DOI 10.1021/bi2005784; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; Bonacci G, 2011, J AM SOC MASS SPECTR, V22, P1534, DOI 10.1007/s13361-011-0185-x; Borniquel S, 2010, FREE RADICAL BIO MED, V48, P499, DOI 10.1016/j.freeradbiomed.2009.11.014; Claridge RP, 1998, J CHEM SOC PERK T 1, P3523, DOI 10.1039/a806451b; Cole MP, 2009, CIRC RES, V105, P965, DOI 10.1161/CIRCRESAHA.109.199075; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Dejam A, 2007, CIRCULATION, V116, P1821, DOI 10.1161/CIRCULATIONAHA.107.712133; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V333, P49, DOI 10.1006/abbi.1996.0363; DENNIS SC, 1991, J MOL CELL CARDIOL, V23, P1077, DOI 10.1016/0022-2828(91)91642-5; Dezfulian C, 2009, CIRCULATION, V120, P897, DOI 10.1161/CIRCULATIONAHA.109.853267; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Evans NP, 2010, J NUTR, V140, P515, DOI 10.3945/jn.109.115642; Ferreira AM, 2009, BIOCHEM J, V417, P223, DOI 10.1042/BJ20080701; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; GIAMALVA DH, 1987, J AM CHEM SOC, V109, P7059, DOI 10.1021/ja00257a025; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; HUYSER ES, 1966, J ORG CHEM, V31, P2437, DOI 10.1021/jo01346a002; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Kansanen E, 2009, J BIOL CHEM, V284, P33233, DOI 10.1074/jbc.M109.064873; Lima ES, 2002, BIOCHEMISTRY-US, V41, P10717, DOI 10.1021/bi025504j; LINDSAY T, 1988, AM J PHYSIOL, V254, pH578, DOI 10.1152/ajpheart.1988.254.3.H578; Liu HY, 2008, AM J PHYSIOL-RENAL, V295, pF942, DOI 10.1152/ajprenal.90236.2008; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Lundberg JO, 2011, CARDIOVASC RES, V89, P525, DOI 10.1093/cvr/cvq325; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Nadtochiy SM, 2009, CARDIOVASC RES, V82, P333, DOI 10.1093/cvr/cvn323; Napolitano A, 2002, TETRAHEDRON, V58, P5061, DOI 10.1016/S0040-4020(02)00460-X; Napolitano A, 2000, J ORG CHEM, V65, P4853, DOI 10.1021/jo000090q; Nishida M, 2012, NAT CHEM BIOL, V8, P714, DOI [10.1038/NCHEMBIO.1018, 10.1038/nchembio.1018]; O'Donnell VB, 1999, CHEM RES TOXICOL, V12, P83, DOI 10.1021/tx980207u; Pannala AS, 2006, FREE RADICAL BIO MED, V41, P896, DOI 10.1016/j.freeradbiomed.2006.05.010; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Reynolds CM, 2010, PROSTAG LEUKOTR ESS, V82, P199, DOI 10.1016/j.plefa.2010.02.021; Rudolph TK, 2010, ARTERIOSCL THROM VAS, V30, P938, DOI 10.1161/ATVBAHA.109.201582; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Rudolph V, 2009, CIRC RES, V105, P511, DOI 10.1161/CIRCRESAHA.109.202077; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Shiva S, 2009, BASIC RES CARDIOL, V104, P113, DOI 10.1007/s00395-009-0009-3; Trostchansky A, 2007, BIOCHEMISTRY-US, V46, P4645, DOI 10.1021/bi602652j; Turpeinen AM, 2002, AM J CLIN NUTR, V76, P504, DOI 10.1093/ajcn/76.3.504; Wright MM, 2009, BIOCHEM J, V422, P353, DOI 10.1042/BJ20090339; Zlatanos SN, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-34; Zulet MA, 2005, J PHYSIOL BIOCHEM, V61, P483, DOI 10.1007/BF03168454	55	103	107	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44071	44082		10.1074/jbc.M112.401356	http://dx.doi.org/10.1074/jbc.M112.401356			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144452	Green Published, hybrid			2022-12-28	WOS:000312938600006
J	Gorjestani, S; Darnay, BG; Lin, X				Gorjestani, Sara; Darnay, Bryant G.; Lin, Xin			Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and TGF beta-activated Kinase 1 (TAK1) Play Essential Roles in the C-type Lectin Receptor Signaling in Response to Candida albicans Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PHOSPHOLIPASE C-GAMMA-2 PLC-GAMMA-2; PATTERN-RECOGNITION RECEPTOR; INNATE IMMUNE; ADAPTER PROTEIN; TAB2; CARD9; UBIQUITIN; DECTIN-2; INTERLEUKIN-1	Tumor necrosis factor receptor-associated factor 6 (TRAF6) and TGF beta-activated kinase 1 (TAK1) are considered as key intermediates in Toll-like receptor (TLR) signaling. However, the role of TRAF6 and TAK1 in C-type lectin receptors (CLRs) in response to fungal infection has not been studied. In this study, we have utilized macrophages derived from TRAF6 knock-out mice and myeloid-specific TAK1-deficient mice and determined the role of TRAF6 and TAK1 in CLR-induced signal transduction events. We demonstrate that TRAF6 and TAK1 are required for NF-kappa B and JNK activation, and expression of proinflammatory cytokines in response to Candida albicans infection. Our results highlight TRAF6 and TAK1 as key components in the signaling cascade downstream of C-type lectin receptors and as critical mediators of the anti-fungal immune response. Therefore, our studies provide a mechanistic understanding of the host immune response to C. albicans, which has a significant impact for the development of anti-fungal therapeutics and in understanding risk-factors and determining susceptibility to C. albicans infection.	[Gorjestani, Sara; Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Gorjestani, Sara; Lin, Xin] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Darnay, Bryant G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Lin, X (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd,Unit 108, Houston, TX 77030 USA.	xllin@mdanderson.org			National Institutes of Health [RO1AI050848, RO1GM065899]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants RO1AI050848 and RO1GM065899 (to X.L.).	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Bi LK, 2010, J BIOL CHEM, V285, P25969, DOI 10.1074/jbc.M110.131300; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Eftychi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031550; Gorjestani S, 2011, J BIOL CHEM, V286, P43651, DOI 10.1074/jbc.M111.307389; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hara H, 2009, TRENDS IMMUNOL, V30, P234, DOI 10.1016/j.it.2009.03.002; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; Kingeter LM, 2012, CELL MOL IMMUNOL, V9, P105, DOI 10.1038/cmi.2011.58; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; McCully RR, 2008, MOL CELL BIOL, V28, P5668, DOI 10.1128/MCB.00418-08; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Tassi I, 2009, EUR J IMMUNOL, V39, P1369, DOI 10.1002/eji.200839313; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	45	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44143	44150		10.1074/jbc.M112.414276	http://dx.doi.org/10.1074/jbc.M112.414276			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23148225	hybrid, Green Published			2022-12-28	WOS:000312938600013
J	Herzog, G; Joerger, AC; Shmueli, MD; Fersht, AR; Gazit, E; Segal, D				Herzog, Gal; Joerger, Andreas C.; Shmueli, Merav D.; Fersht, Alan R.; Gazit, Ehud; Segal, Daniel			Evaluating Drosophila p53 as a Model System for Studying Cancer Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; MUTANT P53; STRUCTURAL BASIS; CORE DOMAIN; CRYSTAL-STRUCTURE; WILD-TYPE; RESCUE; MECHANISM; STABILITY; AGGREGATION	The transcription factor p53 is a key tumor suppressor protein. In about half of human cancers, p53 is inactivated directly through mutation in its sequence-specific DNA-binding domain. Drosophila p53 (Dmp53) has similar apoptotic functions as its human homolog and is therefore an attractive model system for studying cancer pathways. To probe the structure and function of Dmp53, we studied the effect of point mutations, corresponding to cancer hot spot mutations in human p53 (Hp53), on the stability and DNA binding affinity of the full-length protein. Despite low sequence conservation, the Hp53 and Dmp53 proteins had a similar melting temperature and generally showed a similar energetic and functional response to cancer-associated mutations. We also found a correlation between the thermodynamic stability of the mutant proteins and their rate of aggregation. The effects of the mutations were rationalized based on homology modeling of the Dmp53 DNA-binding domain, suggesting that the drastically different effects of a cancer mutation in the loop-sheet-helix motif (R282W in Hp53 and R268W in Dmp53) on stability and DNA binding affinity of the two proteins are related to conformational differences in the L1 loop adjacent to the mutation site. On the basis of these data, we discuss the advantages and limitations of using Dmp53 as a model system for studying p53 function and testing p53 rescue drugs.	[Herzog, Gal; Shmueli, Merav D.; Gazit, Ehud; Segal, Daniel] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Ramat Aviv, Israel; [Joerger, Andreas C.; Fersht, Alan R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Tel Aviv University; MRC Laboratory Molecular Biology	Segal, D (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Ramat Aviv, Israel.	dsegal@post.tau.ac.il	Gazit, Ehud/C-3715-2011; Gazit, Ehud/M-8026-2019; Shmueli, Merav/HDM-9859-2022; Gazit, Ehud/AHE-9332-2022; Fersht, Alan R/B-2189-2008	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Shmueli, Merav/0000-0002-9196-7633; Segal, Daniel/0000-0002-6777-505X; Joerger, Andreas/0000-0002-1232-0138	Israel Science Foundation; United States Department of Defense (Congressionally Directed Medical Research Programs (CDMRP)); MRC Programme [G0901534]; Short Term European Molecular Biology Organization (EMBO) fellowship; Medical Research Council [MC_UP_A024_1010, MC_EX_G0901534] Funding Source: researchfish; MRC [MC_UP_A024_1010, MC_EX_G0901534] Funding Source: UKRI	Israel Science Foundation(Israel Science Foundation); United States Department of Defense (Congressionally Directed Medical Research Programs (CDMRP)); MRC Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Short Term European Molecular Biology Organization (EMBO) fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported in part by grants from the Israel Science Foundation and United States Department of Defense (Congressionally Directed Medical Research Programs (CDMRP)) and by MRC Programme Grant G0901534.; The recipient of a Short Term European Molecular Biology Organization (EMBO) fellowship.	Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Brandt T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-628; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Dearth LR, 2007, CARCINOGENESIS, V28, P289, DOI 10.1093/carcin/bgl132; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Friedler A, 2003, J BIOL CHEM, V278, P24108, DOI 10.1074/jbc.M302458200; Giacomotto J, 2010, BRIT J PHARMACOL, V160, P204, DOI 10.1111/j.1476-5381.2010.00725.x; Hamroun D, 2006, HUM MUTAT, V27, P14, DOI 10.1002/humu.20269; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Joerger AC, 2005, J BIOL CHEM, V280, P16030, DOI 10.1074/jbc.M500179200; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Joerger AC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000919; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; Natan E, 2011, J MOL BIOL, V409, P358, DOI 10.1016/j.jmb.2011.03.047; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Ou HD, 2007, EMBO J, V26, P3463, DOI 10.1038/sj.emboj.7601764; Palecek E, 2011, J AM CHEM SOC, V133, P7190, DOI 10.1021/ja201006s; PARKER TG, 1977, BIOPOLYMERS, V16, P2533, DOI 10.1002/bip.1977.360161115; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rudrapatna VA, 2012, DEV DYNAM, V241, P107, DOI 10.1002/dvdy.22771; Rutkowski R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001131; Scherzer-Attali R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011101; Shaltiel-Karyo R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013863; Suad O, 2009, J MOL BIOL, V385, P249, DOI 10.1016/j.jmb.2008.10.063; Vidal M, 2006, CURR OPIN GENET DEV, V16, P10, DOI 10.1016/j.gde.2005.12.004; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang GZ, 2012, P NATL ACAD SCI USA, V109, P13590, DOI 10.1073/pnas.1211557109; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; Weinberg RL, 2004, J MOL BIOL, V342, P801, DOI 10.1016/j.jmb.2004.07.042; Wilcken R, 2012, P NATL ACAD SCI USA, V109, P13584, DOI 10.1073/pnas.1211550109; Wilcken R, 2012, J AM CHEM SOC, V134, P6810, DOI 10.1021/ja301056a; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546	45	11	11	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44330	44337		10.1074/jbc.M112.417980	http://dx.doi.org/10.1074/jbc.M112.417980			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23135266	hybrid, Green Published			2022-12-28	WOS:000312938600030
J	Kabil, O; Banerjee, R				Kabil, Omer; Banerjee, Ruma			Characterization of Patient Mutations in Human Persulfide Dioxygenase (ETHE1) Involved in H2S Catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYOXALASE-II; HYDROGEN-SULFIDE; OXIDATION; ENCEPHALOPATHY; BINDING; GENE; ZINC	Hydrogen sulfide (H2S) is a recently described endogenously produced gaseous signaling molecule that influences various cellular processes in the central nervous system, cardiovascular system, and gastrointestinal tract. The biogenesis of H2S involves the cytoplasmic transsulfuration enzymes, cystathionine beta-synthase and gamma-cystathionase, whereas its catabolism occurs in the mitochondrion and couples to the energy-yielding electron transfer chain. Low steady-state levels of H2S appear to be controlled primarily by efficient oxygen-dependent catabolism via sulfide quinone oxidoreductase, persulfide dioxygenase (ETHE1), rhodanese, and sulfite oxidase. Mutations in the persulfide dioxgenase, i.e. ETHE1, result in ethylmalonic encephalopathy, an inborn error of metabolism. In this study, we report the biochemical characterization and kinetic properties of human persulfide dioxygenase and describe the biochemical penalties associated with two patient mutations, T152I and D196N. Steady-state kinetic analysis reveals that the T152I mutation results in a 3-fold lower activity, which is correlated with a 3-fold lower iron content compared with the wild-type enzyme. The D196N mutation results in a 2-fold higher K-m for the substrate, glutathione persulfide.	[Kabil, Omer; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 3320B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Kabil, Omer/AAJ-1435-2020		National Institutes of Health [HL58984]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL58984.	Bouillaud F, 2011, ANTIOXID REDOX SIGN, V15, P379, DOI 10.1089/ars.2010.3678; BURLINA AB, 1991, LANCET, V338, P1522, DOI 10.1016/0140-6736(91)92338-3; Cameron AD, 1999, STRUCTURE, V7, P1067, DOI 10.1016/S0969-2126(99)80174-9; Crowder MW, 1997, FEBS LETT, V418, P351, DOI 10.1016/S0014-5793(97)01416-6; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; GARCIASILVA MT, 1994, J PEDIATR-US, V125, P843, DOI 10.1016/S0022-3476(94)70093-1; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Holdorf MM, 2008, J INORG BIOCHEM, V102, P1825, DOI 10.1016/j.jinorgbio.2008.06.003; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; KOJ A, 1967, BIOCHEM J, V103, P791, DOI 10.1042/bj1030791; Leschelle X, 2005, BBA-GEN SUBJECTS, V1725, P201, DOI 10.1016/j.bbagen.2005.06.002; Levitt MD, 2011, ANTIOXID REDOX SIGN, V15, P373, DOI 10.1089/ars.2010.3525; Marasinghe GPK, 2005, J BIOL CHEM, V280, P40668, DOI 10.1074/jbc.M509748200; McCoy JG, 2006, ACTA CRYSTALLOGR D, V62, P964, DOI 10.1107/S0907444906020592; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; Mineri R, 2008, J MED GENET, V45, P473, DOI 10.1136/jmg.2008.058271; Olson KR, 2006, J EXP BIOL, V209, P4011, DOI 10.1242/jeb.02480; Olson KR, 2010, ANTIOXID REDOX SIGN, V12, P1219, DOI 10.1089/ars.2009.2921; SHAW L, 1987, BIOCHIM BIOPHYS ACTA, V919, P171, DOI 10.1016/0005-2760(87)90204-9; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Wenzel NF, 2004, J BIOL INORG CHEM, V9, P429, DOI 10.1007/s00775-004-0535-2; WILLIAMSON G, 1982, J BIOL CHEM, V257, P4314; WOOD JL, 1987, METHOD ENZYMOL, V143, P25; Zang TM, 2001, J BIOL CHEM, V276, P4788, DOI 10.1074/jbc.M005090200	28	92	95	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44561	44567		10.1074/jbc.M112.407411	http://dx.doi.org/10.1074/jbc.M112.407411			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144459	Green Published, hybrid			2022-12-28	WOS:000312938600052
J	Rodriguez, F; Zanetti, MN; Mayorga, LS; Tomes, CN				Rodriguez, Facundo; Natalia Zanetti, M.; Mayorga, Luis S.; Tomes, Claudia N.			Munc18-1 Controls SNARE Protein Complex Assembly during Human Sperm Acrosomal Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE DOCKING; REGULATES NEUROTRANSMITTER RELEASE; GTP-BINDING PROTEIN; SYNAPTOTAGMIN-VI; ALPHA-SNAP; MAMMALIAN SPERM; RAB3A TRIGGERS; SEC1 HOMOLOG; SYNTAXIN; FUSION	The spermatozoon is a very specialized cell capable of carrying out a limited set of functions with high efficiency. Sperm are then excellent model cells to dissect fundamental processes such as regulated exocytosis. The secretion of the single densecore granule of mammalian spermatozoa relies on the same highly conserved molecules and goes through the same stages as exocytosis in other types of cells. In this study, we describe the presence of Munc18-1 in human sperm and show that this protein has an essential role in acrosomal exocytosis. We observed that inactivation of endogenous Munc18-1 with a specific antibody precluded the stabilization of trans-SNARE complexes and inhibited acrosomal exocytosis. Addition of recombinant Munc18-1 blocked secretion by sequestering monomeric syntaxin, an effect that was rescued by alpha-soluble NSF attachment protein. By electron microscopy, we observed that both the anti-Munc18-1 antibody and recombinant Munc18-1 inhibited the docking of the acrosome to the plasma membrane. In conclusion, our results indicate that Munc18-1 plays a key role in the dynamics of trans-SNARE complex assembly and/or stabilization, a process that is necessary for the docking of the outer acrosomal membrane to the plasma membrane and subsequent fusion pore opening.	[Rodriguez, Facundo; Natalia Zanetti, M.; Mayorga, Luis S.; Tomes, Claudia N.] Univ Nacl Cuyo, Lab Biol & Celular Mol, Inst Histol & Embriol, Consejo Nacl Invest Cient & Tecn,Fac Ciencias Med, RA-5500 Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Mayorga, LS (corresponding author), Univ Nacl Cuyo, Lab Biol & Celular Mol, Inst Histol & Embriol, Consejo Nacl Invest Cient & Tecn,Fac Ciencias Med, RA-5500 Mendoza, Argentina.	lmayorga@fcm.uncu.edu.ar		Mayorga, Luis S/0000-0002-5995-0671; Rodriguez Ayala, Juan Facundo/0000-0003-3165-2186	National University of Cuyo, Argentina [06/J388, 06/J353 SeCTyP]; CONICET, Argentina [PIP 112-200801-02277]; ANPCyT, Argentina [PICT-2008-1114, PICT-2011-2310, PICT-2006-01036]	National University of Cuyo, Argentina; CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT, Argentina(ANPCyT)	This work was supported by Grants 06/J388 and 06/J353 SeCTyP from National University of Cuyo, Argentina, Grant PIP 112-200801-02277 from CONICET, Argentina, and Grants PICT-2008-1114, PICT-2011-2310, and PICT-2006-01036 from ANPCyT, Argentina.	Alpadi K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001243; Alvarez L, 2012, J CELL BIOL, V196, P653, DOI 10.1083/jcb.201106096; [Anonymous], MOL BIOL CELL, V22, P4150; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; BARROS C, 1967, J CELL BIOL, V34, pC1, DOI 10.1083/jcb.34.3.C1; Bello OD, 2012, EXP CELL RES, V318, P478, DOI 10.1016/j.yexcr.2012.01.002; Berruti Giovanna, 2011, Spermatogenesis, V1, P95; Blengini CS, 2011, ASIAN J ANDROL, V13, P769, DOI 10.1038/aja.2011.27; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; BURGOS MH, 1955, J BIOPHYS BIOCHEM CY, V1, P287, DOI 10.1083/jcb.1.4.287; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Bustos MA, 2012, P NATL ACAD SCI USA, V109, pE2057, DOI 10.1073/pnas.1121173109; Christie MP, 2012, P NATL ACAD SCI USA, V109, P9816, DOI 10.1073/pnas.1116975109; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; Dresbach T, 1998, J NEUROSCI, V18, P2923; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Graham ME, 2004, J BIOL CHEM, V279, P32751, DOI 10.1074/jbc.M400827200; Guerrero A, 2010, DEV BIOL, V344, P52, DOI 10.1016/j.ydbio.2010.04.013; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Han GYA, 2011, MOL BIOL CELL, V22, P4134, DOI 10.1091/mbc.E11-02-0135; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Hutt DM, 2005, J BIOL CHEM, V280, P20197, DOI 10.1074/jbc.M412920200; Iida H, 1999, DEV BIOL, V211, P144, DOI 10.1006/dbio.1999.9302; Jorgacevski J, 2011, J NEUROSCI, V31, P9055, DOI 10.1523/JNEUROSCI.0185-11.2011; Lang Thorsten, 2008, V184, P107; Lesich KA, 2008, BIOPHYS J, V95, P472, DOI 10.1529/biophysj.107.127951; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; May AP, 2001, J BIOL CHEM, V276, P21991, DOI 10.1074/jbc.R100013200; Mayorga LS, 2007, IUBMB LIFE, V59, P286, DOI 10.1080/15216540701222872; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Meijer M, 2012, EMBO J, V31, P2156, DOI 10.1038/emboj.2012.72; MENDOZA C, 1992, J REPROD FERTIL, V95, P755; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Michaut M, 2001, DEV BIOL, V235, P521, DOI 10.1006/dbio.2001.0316; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Ramalho-Santos J, 2000, DEV BIOL, V223, P54, DOI 10.1006/dbio.2000.9745; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rodriguez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021925; Roggero CM, 2007, J BIOL CHEM, V282, P26335, DOI 10.1074/jbc.M700854200; Roggero CM, 2005, DEV BIOL, V285, P422, DOI 10.1016/j.ydbio.2005.07.007; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tomes C., 2007, MOL MECH EXOCYTOSIS, P117; Tomes CN, 2005, MOL HUM REPROD, V11, P43, DOI 10.1093/molehr/gah126; Tomes CN, 2002, DEV BIOL, V243, P326, DOI 10.1006/dbio.2002.0567; Tsai PSJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032603; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Ward CR, 1999, MOL REPROD DEV, V53, P413, DOI 10.1002/(SICI)1098-2795(199908)53:4&lt;413::AID-MRD7&gt;3.0.CO;2-W; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2005, CURR TOP DEV BIOL, V65, P83; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Xia T, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-19; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97; Yanagimachi R., 1994, P189; Yunes R, 2000, BIOL REPROD, V62, P1084, DOI 10.1095/biolreprod62.4.1084; Zanetti N, 2009, BIOL REPROD, V81, P396, DOI 10.1095/biolreprod.109.076166; Zarelli VEP, 2009, J BIOL CHEM, V284, P10491, DOI 10.1074/jbc.M807614200; Zhao L, 2007, DEV BIOL, V309, P236, DOI 10.1016/j.ydbio.2007.07.009	76	14	15	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43825	43839		10.1074/jbc.M112.409649	http://dx.doi.org/10.1074/jbc.M112.409649			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23091057	Green Published, hybrid			2022-12-28	WOS:000312940800060
J	Tamura, Y; Onguka, O; Itoh, K; Endo, T; Iijima, M; Claypool, SM; Sesaki, H				Tamura, Yasushi; Onguka, Ouma; Itoh, Kie; Endo, Toshiya; Iijima, Miho; Claypool, Steven M.; Sesaki, Hiromi			Phosphatidylethanolamine Biosynthesis in Mitochondria PHOSPHATIDYLSERINE (PS) TRAFFICKING IS INDEPENDENT OF A PS DECARBOXYLASE AND INTERMEMBRANE SPACE PROTEINS UPS1P AND UPS2P	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CARDIOLIPIN BIOSYNTHESIS; ENDOPLASMIC-RETICULUM; INNER MEMBRANE; YEAST; GENE; MAINTENANCE; COMPLEX; FUSION; IDENTIFICATION	Phosphatidylethanolamine (PE) plays important roles for the structure and function of mitochondria and other intracellular organelles. In yeast, the majority of PE is produced from phosphatidylserine (PS) by a mitochondrion-located PS decarboxylase, Psd1p. Because PS is synthesized in the endoplasmic reticulum (ER), PS is transported from the ER to mitochondria and converted to PE. After its synthesis, a portion of PE moves back to the ER. Two mitochondrial proteins located in the intermembrane space, Ups1p and Ups2p, have been shown to regulate PE metabolism by controlling the export of PE. It remains to be determined where PS is decarboxylated in mitochondria and whether decarboxylation is coupled to trafficking of PS. Here, using fluorescent PS as a substrate in an in vitro assay for Psd1p-dependent PE production in isolated mitochondria, we show that PS is transferred from the mitochondrial outer membrane to the inner membrane independently of Psd1p, Ups1p, and Ups2p and decarboxylated to PE by Psd1p in the inner membrane. Interestingly, Ups1p is required for the maintenance of Psd1p and therefore PE production. Restoration of Psd1p levels rescued PE production defects in ups1 Delta mitochondria. Our data provide novel mechanistic insight into PE biogenesis in mitochondria.	[Tamura, Yasushi; Itoh, Kie; Iijima, Miho; Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Onguka, Ouma; Claypool, Steven M.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Endo, Toshiya] Nagoya Univ, Grad Sch Sci, Dept Chem, Nagoya, Aichi 4648602, Japan	Johns Hopkins University; Johns Hopkins University; Nagoya University	Tamura, Y (corresponding author), Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648602, Japan.	tamura@chem.nagoya-u.ac.jp; sclaypo1@jhmi.edu; hsesaki@jhmi.edu	Yasushi, TAMURA/I-7122-2014; Tamura, Yasushi/H-8270-2017; Tamura, Yasushi/A-9997-2013	Tamura, Yasushi/0000-0002-8462-0607; Claypool, Steven/0000-0001-5316-1623	National Institutes of Health [GM084015, GM089853]; Japan Society for the Promotion of Science	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported, in whole or in part, by National Institutes of Health Grants GM084015 (to M. I.) and GM089853 (to H. S.). This work was also supported by a postdoctoral fellowship for research abroad from the Japan Society for the Promotion of Science (to Y. T.).	ACHLEITNER G, 1995, J BIOL CHEM, V270, P29836; Achleitner G, 1999, EUR J BIOCHEM, V264, P545, DOI 10.1046/j.1432-1327.1999.00658.x; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Brachmann CB, 1998, YEAST, V14, P115; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Choi JY, 2005, ANAL BIOCHEM, V347, P165, DOI 10.1016/j.ab.2005.03.017; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; de Kroon AIPM, 1999, MOL MEMBR BIOL, V16, P205; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Dimmer KS, 2005, J CELL BIOL, V168, P103, DOI 10.1083/jcb.200410030; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Federovitch CM, 2008, MOL BIOL CELL, V19, P4506, DOI 10.1091/mbc.E07-11-1188; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Harada Y, 2010, BIOCHEM BIOPH RES CO, V392, P228, DOI 10.1016/j.bbrc.2010.01.024; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; KODAKI T, 1987, J BIOL CHEM, V262, P15428; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; LETTS VA, 1983, P NATL ACAD SCI-BIOL, V80, P7279, DOI 10.1073/pnas.80.23.7279; Li GL, 2007, BBA-MOL CELL BIOL L, V1771, P432, DOI 10.1016/j.bbalip.2006.06.007; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P929, DOI 10.1038/cdd.2008.9; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Potting C, 2010, EMBO J, V29, P2888, DOI 10.1038/emboj.2010.169; Rujiviphat J, 2009, J BIOL CHEM, V284, P28682, DOI 10.1074/jbc.M109.044933; Sani MA, 2009, BBA-BIOMEMBRANES, V1788, P623, DOI 10.1016/j.bbamem.2008.12.014; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; Sesaki H, 2004, J BIOL CHEM, V279, P28298, DOI 10.1074/jbc.M401363200; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; SIMBENI R, 1993, BIOCHIM BIOPHYS ACTA, V1145, P1, DOI 10.1016/0005-2736(93)90374-9; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Tamura Y, 2006, J CELL BIOL, V174, P631, DOI 10.1083/jcb.200603087; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tamura Y, 2011, CELL, V145, DOI 10.1016/j.cell.2011.06.018; Tamura Y, 2010, EMBO J, V29, P2875, DOI 10.1038/emboj.2010.149; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; VOELKER DR, 1989, J BIOL CHEM, V264, P8019; VOELKER DR, 1989, P NATL ACAD SCI USA, V86, P9921, DOI 10.1073/pnas.86.24.9921; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wu WI, 2004, J BIOL CHEM, V279, P6635, DOI 10.1074/jbc.M311570200; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057	58	33	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43961	43971		10.1074/jbc.M112.390997	http://dx.doi.org/10.1074/jbc.M112.390997			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23124206	Green Published, hybrid			2022-12-28	WOS:000312940800071
J	Guo, DX; Shi, XL; Arledge, KC; Song, DK; Jiang, LW; Fu, LL; Gong, XQ; Zhang, SY; Wang, XQ; Zhang, LQ				Guo, Dongxing; Shi, Xuanling; Arledge, Kelly C.; Song, Dingka; Jiang, Liwei; Fu, Lili; Gong, Xinqi; Zhang, Senyan; Wang, Xinquan; Zhang, Linqi			A Single Residue within the V5 Region of HIV-1 Envelope Facilitates Viral Escape from the Broadly Neutralizing Monoclonal Antibody VRC01	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD4 BINDING-SITE; CD4-BINDING SITE; STRUCTURAL BASIS; CELL RESPONSES; POTENT; GP120; GLYCOPROTEIN; RECEPTOR; IMMUNOGENS; COFACTOR	VRC01, a broadly neutralizing monoclonal antibody, is capable of neutralizing a diverse array of HIV-1 isolates by mimicking CD4 binding with the envelope glycoprotein gp120. Nonetheless, resistant strains have been identified. Here, we examined two genetically related and two unrelated envelope clones, derived from CRF08_BC-infected patients, with distinct VRC01 neutralization profiles. A total of 22 chimeric envelope clones was generated by interchanging the loop D and/or V5 regions between the original envelopes or by single alanine substitutions within each region. Analysis of pseudoviruses built from these mutant envelopes showed that interchanging the V5 region between the genetically related or unrelated clones completely swapped their VRC01 sensitivity profiles. Mutagenesis analysis revealed that the asparagine residue at position 460 (Asn-460), a potential N-linked glycosylation site in the V5 region, is a key factor for observed resistance in these strains, which is further supported by our structural modeling. Moreover, changes in resistance were found to positively correlate with deviations in VRC01 binding affinity. Overall, our study indicates that Asn-460 in the V5 region is a critical determinant of sensitivity to VRC01 specifically in these viral strains. The long side chain of Asn-460, and potential glycosylation, may create steric hindrance that lowers binding affinity, thereby increasing resistance to VRC01 neutralization.	[Shi, Xuanling; Arledge, Kelly C.; Song, Dingka; Jiang, Liwei; Fu, Lili; Zhang, Linqi] Tsinghua Univ, Comprehens AIDS Res Ctr, Sch Med, Beijing 100084, Peoples R China; [Shi, Xuanling; Arledge, Kelly C.; Song, Dingka; Jiang, Liwei; Fu, Lili; Zhang, Linqi] Tsinghua Univ, Res Ctr Publ Hlth, Sch Med, Beijing 100084, Peoples R China; [Gong, Xinqi; Zhang, Senyan; Wang, Xinquan] Tsinghua Univ, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Guo, Dongxing; Zhang, Linqi] Peking Union Med Coll, Beijing 100730, Peoples R China; [Guo, Dongxing; Zhang, Linqi] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, AIDS Res Ctr, Beijing 100730, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS	Zhang, LQ (corresponding author), Tsinghua Univ, Comprehens AIDS Res Ctr, Sch Med, Beijing 100084, Peoples R China.	zhanglinqi@tsinghua.edu.cn	ZHANG, LIN/GYD-9123-2022; zhang, sen/GXH-3513-2022	Song, Dingka/0000-0002-8481-9309	National Science and Technology Major Projects [2012ZX10001-006, 2012ZX10001-009]; National Outstanding Youth Award [30825035]; National Natural Science Funds [U0832604, 81101236]; Tsinghua University Initiative Scientific Research Program; Tsinghua Yue-Yuen Medical Sciences Fund	National Science and Technology Major Projects; National Outstanding Youth Award; National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Scientific Research Program; Tsinghua Yue-Yuen Medical Sciences Fund	This work was supported by National Science and Technology Major Projects 2012ZX10001-006 and 2012ZX10001-009, National Outstanding Youth Award 30825035, National Natural Science Funds U0832604 and 81101236, the Tsinghua University Initiative Scientific Research Program, and the Tsinghua Yue-Yuen Medical Sciences Fund.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P10164, DOI 10.1073/pnas.89.21.10164; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Douagi I, 2010, J VIROL, V84, P1683, DOI 10.1128/JVI.01896-09; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Falkowska E, 2012, J VIROL, V86, P4394, DOI 10.1128/JVI.06973-11; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Feng Y, 2012, J BIOL CHEM, V287, P5673, DOI 10.1074/jbc.M111.317776; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Pancera M, 2005, J VIROL, V79, P9954, DOI 10.1128/JVI.79.15.9954-9969.2005; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Saha P, 2012, BIOCHEMISTRY-US, V51, P1836, DOI 10.1021/bi300003v; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shang H, 2011, J BIOL CHEM, V286, P14531, DOI 10.1074/jbc.M111.224527; Song RJ, 2010, J VIROL, V84, P6935, DOI 10.1128/JVI.00453-10; Toma J, 2011, J VIROL, V85, P3872, DOI 10.1128/JVI.02237-10; Visciano ML, 2008, VIROLOGY, V372, P409, DOI 10.1016/j.virol.2007.10.044; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wu XL, 2012, J VIROL, V86, P5844, DOI 10.1128/JVI.07139-11; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2009, J VIROL, V83, P10892, DOI 10.1128/JVI.01142-09; Zhang LQ, 1996, NATURE, V383, P768, DOI 10.1038/383768a0; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	40	25	26	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43170	43179		10.1074/jbc.M112.399402	http://dx.doi.org/10.1074/jbc.M112.399402			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23100255	hybrid, Green Published			2022-12-28	WOS:000312501600071
J	Okuda, T; Osawa, C; Yamada, H; Hayashi, K; Nishikawa, S; Ushio, T; Kubo, Y; Satou, M; Ogawa, H; Haga, T				Okuda, Takashi; Osawa, Chieko; Yamada, Haruhiko; Hayashi, Kengo; Nishikawa, Shizue; Ushio, Tomoko; Kubo, Yuji; Satou, Motoyasu; Ogawa, Haruo; Haga, Tatsuya			Transmembrane Topology and Oligomeric Structure of the High-affinity Choline Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLES; RADIATION-INACTIVATION; MEMBRANE TOPOLOGY; FUNCTIONAL UNIT; COTRANSPORTER; GLUCOSE; MODEL; IDENTIFICATION; LOCALIZATION; ENDOCYTOSIS	The high-affinity choline transporter CHT1 mediates choline uptake essential for acetylcholine synthesis in cholinergic nerve terminals. CHT1 belongs to the Na+/glucose cotransporter family (SLC5), which is postulated to have a common 13-transmembrane domain core; however, no direct experimental evidence for CHT1 transmembrane topology has yet been reported. We examined the transmembrane topology of human CHT1 using cysteine-scanning analysis. Single cysteine residues were introduced into the putative extra- and intracellular loops and probed for external accessibility for labeling with a membrane-impermeable, sulfhydryl-specific biotinylating reagent in intact cells expressing these mutants. The results provide experimental evidence for a topological model of a 13-transmembrane domain protein with an extracellular amino terminus and an intracellular carboxyl terminus. We also constructed a three-dimensional homology model of CHT1 based on the crystal structure of the bacterial Na+/galactose cotransporter, which supports our conclusion of CHT1 transmembrane topology. Furthermore, we examined whether CHT1 exists as a monomer or oligomer. Chemical cross-linking induces the formation of a higher molecular weight form of CHT1 on the cell surface in HEK293 cells. Two different epitope-tagged CHT1 proteins expressed in the same cells can be co-immunoprecipitated. Moreover, co-expression of an inactive mutant I89A with the wild type induces a dominant-negative effect on the overall choline uptake activity. These results indicate that CHT1 forms a homo-oligomer on the cell surface in cultured cells.	[Okuda, Takashi] Keio Univ, Fac Pharm, Dept Pharmacol, Minato Ku, Tokyo 1058512, Japan; [Okuda, Takashi; Osawa, Chieko; Yamada, Haruhiko; Hayashi, Kengo; Nishikawa, Shizue; Ushio, Tomoko; Kubo, Yuji; Satou, Motoyasu; Haga, Tatsuya] Gakushuin Univ, Fac Sci, Dept Life Sci, Toshima Ku, Tokyo 1718588, Japan; [Ogawa, Haruo] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Keio University; Gakushuin University; University of Tokyo	Okuda, T (corresponding author), Keio Univ, Fac Pharm, Dept Pharmacol, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	okuda-tk@pha.keio.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	BELIVEAU R, 1988, BIOCHEM J, V252, P807, DOI 10.1042/bj2520807; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; English BA, 2009, J NEURODEV DISORD, V1, P252, DOI 10.1007/s11689-009-9033-8; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Ferguson SM, 2004, MOL INTERV, V4, P22, DOI 10.1124/mi.4.1.22; Ferguson SM, 2003, J NEUROSCI, V23, P9697; Hahn MK, 2008, GENES BRAIN BEHAV, V7, P487, DOI 10.1111/j.1601-183X.2007.00384.x; Hahn MK, 2003, J NEUROSCI, V23, P4470; Hou ZJ, 2010, J BIOL CHEM, V285, P4732, DOI 10.1074/jbc.M109.086033; Iwamoto H, 2006, J NEUROSCI, V26, P9851, DOI 10.1523/JNEUROSCI.1862-06.2006; Jette M, 1997, BBA-BIOMEMBRANES, V1327, P242, DOI 10.1016/S0005-2736(97)00069-2; Jung H, 1998, J BIOL CHEM, V273, P26400, DOI 10.1074/jbc.273.41.26400; KOEPSELL H, 1994, J MEMBRANE BIOL, V138, P1; Kohler K, 2000, J BIOL CHEM, V275, P26113, DOI 10.1074/jbc.M003564200; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Levy O, 1998, J BIOL CHEM, V273, P22657, DOI 10.1074/jbc.273.35.22657; LIN JT, 1984, BIOCHIM BIOPHYS ACTA, V777, P201, DOI 10.1016/0005-2736(84)90421-8; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; Nakata K, 2004, SYNAPSE, V53, P53, DOI 10.1002/syn.20029; Okuda T, 2000, FEBS LETT, V484, P92, DOI 10.1016/S0014-5793(00)02134-7; Okuda T, 2000, NAT NEUROSCI, V3, P120, DOI 10.1038/72059; Okuda T, 2003, NEUROCHEM RES, V28, P483, DOI 10.1023/A:1022809003997; Okuda T, 2002, J BIOL CHEM, V277, P45315, DOI 10.1074/jbc.M207742200; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Okuda T, 2011, J NEUROSCI, V31, P14989, DOI 10.1523/JNEUROSCI.2983-11.2011; Ribeiro FM, 2006, J NEUROCHEM, V97, P1, DOI 10.1111/j.1471-4159.2006.03695.x; Ribeiro FM, 2005, J NEUROCHEM, V94, P86, DOI 10.1111/j.1471-4159.2005.03171.x; Ribeiro FM, 2003, J NEUROCHEM, V87, P136, DOI 10.1046/j.1471-4159.2003.01974.x; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sarter M, 2005, NAT REV NEUROSCI, V6, P48, DOI 10.1038/nrn1588; STEVENS BR, 1990, P NATL ACAD SCI USA, V87, P1456, DOI 10.1073/pnas.87.4.1456; TAKAHASHI M, 1985, J BIOL CHEM, V260, P551; Trotti D, 2001, J BIOL CHEM, V276, P576, DOI 10.1074/jbc.M003779200; Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200; Turk E, 1997, J MEMBRANE BIOL, V159, P1, DOI 10.1007/s002329900264; Turk E, 1996, J BIOL CHEM, V271, P1925, DOI 10.1074/jbc.271.4.1925; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6	41	22	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42826	42834		10.1074/jbc.M112.405027	http://dx.doi.org/10.1074/jbc.M112.405027			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23132865	Green Published, hybrid			2022-12-28	WOS:000312501600041
J	Terrasse, R; Tacnet-Delorme, P; Moriscot, C; Perard, J; Schoehn, G; Vernet, T; Thielens, NM; Di Guilmi, AM; Frachet, P				Terrasse, Remi; Tacnet-Delorme, Pascale; Moriscot, Christine; Perard, Julien; Schoehn, Guy; Vernet, Thierry; Thielens, Nicole M.; Di Guilmi, Anne Marie; Frachet, Philippe			Human and Pneumococcal Cell Surface Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Proteins Are Both Ligands of Human C1q Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-BINDING-PROTEIN; STREPTOCOCCUS-PNEUMONIAE; MOONLIGHTING PROTEINS; EXTRACELLULAR-MATRIX; BACTERIAL ADHERENCE; COMPLEMENT PATHWAY; RECOGNITION; VIRULENCE; RECEPTOR; TRANSMIGRATION	C1q, a key component of the classical complement pathway, is a major player in the response to microbial infection and has been shown to detect noxious altered-self substances such as apoptotic cells. In this work, using complementary experimental approaches, we identified the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a C1q partner when exposed at the surface of human pathogenic bacteria Streptococcus pneumoniae and human apoptotic cells. The membrane-associated GAPDH on HeLa cells bound the globular regions of C1q as demonstrated by pulldown and cell surface co-localization experiments. Pneumococcal strains deficient in surface-exposed GAPDH harbored a decreased level of C1q recognition when compared with the wild-type strains. Both recombinant human and pneumococcal GAPDHs interacted avidly with C1q as measured by surface plasmon resonance experiments (K-D = 0.34-2.17 nM). In addition, GAPDH-C1q complexes were observed by transmission electron microscopy after cross-linking. The purified pneumococcal GAPDH protein activated C1 in an in vitro assay unlike the human form. Deposition of C1q, C3b, and C4b from human serum at the surface of pneumococcal cells was dependent on the presence of surface-exposed GAPDH. This ability of C1q to sense both human and bacterial GAPDHs sheds new insights on the role of this important defense collagen molecule in modulating the immune response.	[Di Guilmi, Anne Marie] Univ Grenoble 1, PG, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble 1, France; [Frachet, Philippe] Univ Grenoble 1, IRPAS Grp, ASP Team, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble 1, France; [Moriscot, Christine; Schoehn, Guy] Univ Grenoble 1, MEM Grp, F-38027 Grenoble 1, France; [Terrasse, Remi; Tacnet-Delorme, Pascale; Moriscot, Christine; Perard, Julien; Schoehn, Guy; Vernet, Thierry; Thielens, Nicole M.; Di Guilmi, Anne Marie; Frachet, Philippe] CNRS, F-38027 Grenoble, France; [Terrasse, Remi; Tacnet-Delorme, Pascale; Moriscot, Christine; Schoehn, Guy; Vernet, Thierry; Thielens, Nicole M.; Di Guilmi, Anne Marie; Frachet, Philippe] Commissariat Energie Atom, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble, France; [Perard, Julien] Univ Grenoble 1, Unit Virus Host Cell Interact, CNRS, European Mol Biol Lab,UJF,UMI 3265, F-38042 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Di Guilmi, AM (corresponding author), Univ Grenoble 1, PG, Inst Biol Struct Jean Pierre Ebel, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.	anne-marie.di-guilmi@ibs.fr; philippe.frachet@ibs.fr	Thielens, Nicole M/F-2512-2013; Vernet, Thierry/G-1118-2012; frachet, philippe/Q-2869-2019; Frachet, philippe/C-3797-2018	Thielens, Nicole M/0000-0002-7354-0302; frachet, philippe/0000-0002-1658-3859; Frachet, philippe/0000-0002-1658-3859; MORISCOT, Christine/0000-0001-5707-0999; Di Guilmi, Anne Marie/0000-0001-7335-3470; Schoehn, Guy/0000-0002-1459-3201	European Commission [LSHM-CT-2004-512138]; Agence Nationale de la Recherche [PneumoPG, ANR-09-PIRIbio]; University Joseph Fourier-Grenoble	European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de la Recherche(French National Research Agency (ANR)); University Joseph Fourier-Grenoble	This work was supported in part by European Commission Grant LSHM-CT-2004-512138, Agence Nationale de la Recherche Grants PneumoPG and ANR-09-PIRIbio, and a grant from University Joseph Fourier-Grenoble (to P. F.).	Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Attali C, 2008, INFECT IMMUN, V76, P466, DOI 10.1128/IAI.01261-07; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Biro A, 2007, MOL IMMUNOL, V44, P1169, DOI 10.1016/j.molimm.2006.06.013; Biro A, 2010, BIOCHEMISTRY-US, V49, P2167, DOI 10.1021/bi9021022; Blanquet-Grossard F, 2005, BIOCHEMISTRY-US, V44, P4349, DOI 10.1021/bi047370a; Boel G, 2005, INFECT IMMUN, V73, P6237, DOI 10.1128/IAI.73.10.6237-6248.2005; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; Castellano G, 2007, EUR J IMMUNOL, V37, P2803, DOI 10.1002/eji.200636845; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Egea L, 2007, INT J BIOCHEM CELL B, V39, P1190, DOI 10.1016/j.biocel.2007.03.008; Elward K, 2005, J BIOL CHEM, V280, P36342, DOI 10.1074/jbc.M506579200; Ferreira-da-Silva F, 2006, J BIOL CHEM, V281, P33433, DOI 10.1074/jbc.M605267200; Fraser DA, 2010, J NEUROCHEM, V112, P733, DOI 10.1111/j.1471-4159.2009.06494.x; Fraser DA, 2009, J IMMUNOL, V183, P6175, DOI 10.4049/jimmunol.0902232; Henderson B., 2012, CURR TOP MI IN PRESS; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Jia BL, 2011, EXTREMOPHILES, V15, P337, DOI 10.1007/s00792-011-0365-4; Jin H, 2005, J MOL BIOL, V350, P27, DOI 10.1016/j.jmb.2005.04.063; Jin H, 2011, MBIO, V2, DOI 10.1128/mBio.00068-11; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Kojouharova M, 2010, MOL IMMUNOL, V47, P2154, DOI 10.1016/j.molimm.2010.05.011; Korb LC, 1997, J IMMUNOL, V158, P4525; Laschet JJ, 2004, J NEUROSCI, V24, P7614, DOI 10.1523/JNEUROSCI.0868-04.2004; Lu L, 2008, J IMMUNOL, V181, P7138, DOI 10.4049/jimmunol.181.10.7138; Madureira P, 2007, J IMMUNOL, V178, P1379, DOI 10.4049/jimmunol.178.3.1379; Martin M, 2012, J BIOL CHEM, V287, P33733, DOI 10.1074/jbc.M112.341339; Matta SK, 2010, BBA-PROTEINS PROTEOM, V1804, P2111, DOI 10.1016/j.bbapap.2010.08.004; Mouche F, 2002, J BIOL CHEM, V277, P6743, DOI 10.1074/jbc.M106401200; Navratil JS, 2001, J IMMUNOL, V166, P3231, DOI 10.4049/jimmunol.166.5.3231; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Paidassi H, 2008, FEBS LETT, V582, P3111, DOI 10.1016/j.febslet.2008.08.001; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Paidassi H, 2007, MOL IMMUNOL, V44, P225, DOI 10.1016/j.molimm.2006.07.183; Paidassi H, 2011, J MOL BIOL, V408, P277, DOI 10.1016/j.jmb.2011.02.029; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Raje CI, 2007, J BIOL CHEM, V282, P3252, DOI 10.1074/jbc.M608328200; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Sirover MA, 1997, J CELL BIOCHEM, V66, P133, DOI 10.1002/(SICI)1097-4644(19970801)66:2<133::AID-JCB1>3.3.CO;2-V; Smith BL, 2000, J INFECT DIS, V182, P497, DOI 10.1086/315722; Tacnet-Delorme P, 2001, J IMMUNOL, V167, P6374, DOI 10.4049/jimmunol.167.11.6374; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; Ucker DS, 2012, J BIOL CHEM, V287, P10325, DOI 10.1074/jbc.M111.314971; VELLIEUX FMD, 1995, ACTA CRYSTALLOGR D, V51, P575, DOI 10.1107/S0907444995003015; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120; Yuste J, 2008, INFECT IMMUN, V76, P3761, DOI 10.1128/IAI.00291-08	55	42	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42620	42633		10.1074/jbc.M112.423731	http://dx.doi.org/10.1074/jbc.M112.423731			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23086952	Green Published, hybrid			2022-12-28	WOS:000312501600023
J	Zhang, J; Wang, SH; Yuan, L; Yang, YX; Zhang, BW; Liu, QB; Chen, L; Yue, W; Li, YH; Pei, XT				Zhang, Jing; Wang, Sihan; Yuan, Lin; Yang, Yinxiang; Zhang, Bowen; Liu, Qingbin; Chen, Lin; Yue, Wen; Li, Yanhua; Pei, Xuetao			Neuron-restrictive Silencer Factor (NRSF) Represses Cocaine- and Amphetamine-regulated Transcript (CART) Transcription and Antagonizes cAMP-response Element-binding Protein Signaling through a Dual NRSE Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; RAT NUCLEUS-ACCUMBENS; GENE-EXPRESSION; MESSENGER-RNA; GH3 CELLS; PEPTIDE; BRAIN; ACTIVATION; PROMOTER; REST	Cocaine- and amphetamine-regulated transcript (CART) peptide plays a pivotal role in neuroprotection against stroke-related brain injury. However, the regulatory mechanism on CART transcription, especially the repression mechanism, is not fully understood. Here, we show that the transcriptional repressor neuron-restrictive silencer elements (NRSF, also known as REST) represses CART expression through direct binding to two NRSF-binding elements (NRSEs) in the CART promoter and intron 1 (named pNRSE and iNRSE, respectively). EMSA show that NRSF binds to pNRSE and iNRSE directly in vitro. ChIP assays show that NRSF recruits differential co-repressor complexes including CoREST and HDAC1 to these NRSEs. The presence of both NRSEs is required for efficient repression of CART transcription as indicated by reporter gene assays. NRSF overexpression antagonizes forskolin-mediated up-regulation of CART mRNA and protein. Ischemia insult triggered by oxygen-glucose deprivation (OGD) enhances NRSF mRNA levels and then NRSF antagonizes the CREB signaling on CART activation, leading to augmented cell death. Depletion of NRSF in combination with forskolin treatment increases neuronal survival after ischemic insult. These findings reveal a novel dual NRSE mechanism by which NRSF represses CART expression and suggest that NRSF may serve as a therapeutic target for stroke treatment.	[Zhang, Jing; Wang, Sihan; Yang, Yinxiang; Zhang, Bowen; Liu, Qingbin; Chen, Lin; Yue, Wen; Li, Yanhua; Pei, Xuetao] Beijing Inst Transfus Med, Stem Cell & Regenerat Med Lab, Beijing 100850, Peoples R China; [Yuan, Lin] Beijing Inst Radiat Med, State Key Lab Prote, Beijing 100850, Peoples R China	Academy of Military Medical Sciences - China	Pei, XT (corresponding author), Beijing Inst Transfus Med, Stem Cell & Regenerat Med Lab, Beijing 100850, Peoples R China.	peixt@nic.bmi.ac.cn		YUAN, LIN/0000-0001-5449-3435	National High Technology Research and Development Program of China [2006AA02A107]; National Basic Research Program of China [2010CB945500]; Chinese National Natural Science Foundation [81070618]; Beijing Natural Science Foundation [5102036]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National High Technology Research and Development Program of China Grant 2006AA02A107, the National Basic Research Program of China Grant 2010CB945500, Chinese National Natural Science Foundation Grant 81070618, and Beijing Natural Science Foundation Grant 5102036.	Ahima RS, 2000, REGUL PEPTIDES, V92, P1, DOI 10.1016/S0167-0115(00)00142-7; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Balkan B, 2012, BRAIN RES, V1432, P56, DOI 10.1016/j.brainres.2011.11.006; Barrett P, 2002, OBES RES, V10, P1291, DOI 10.1038/oby.2002.175; Bech P, 2008, J CLIN ENDOCR METAB, V93, P1246, DOI 10.1210/jc.2007-1946; Brennan DJ, 2012, ONCOGENE, V31, P3483, DOI 10.1038/onc.2011.519; Broberger C, 1999, P NATL ACAD SCI USA, V96, P13506, DOI 10.1073/pnas.96.23.13506; Chang LL, 2011, BRAIN BEHAV IMMUN, V25, P260, DOI 10.1016/j.bbi.2010.09.017; de Lartigue G, 2007, J NEUROSCI, V27, P2876, DOI 10.1523/JNEUROSCI.5508-06.2007; Dominguez G, 2002, J NEUROCHEM, V80, P885, DOI 10.1046/j.0022-3042.2002.00775.x; Dominguez G, 2006, PEPTIDES, V27, P1913, DOI 10.1016/j.peptides.2006.01.025; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Gao ZL, 2011, J NEUROSCI, V31, P9772, DOI 10.1523/JNEUROSCI.1604-11.2011; Greco SJ, 2007, J BIOL CHEM, V282, P30039, DOI 10.1074/jbc.M703026200; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Hunter RG, 2006, NEUROPHARMACOLOGY, V50, P858, DOI 10.1016/j.neuropharm.2005.12.007; Jia J, 2008, NEUROPEPTIDES, V42, P653, DOI 10.1016/j.npep.2008.05.006; Jones DC, 2009, NEUROSCIENCE, V160, P339, DOI 10.1016/j.neuroscience.2009.02.051; Jones DC, 2006, J PHARMACOL EXP THER, V317, P454, DOI 10.1124/jpet.105.096123; Kasacka I, 2012, ACTA HISTOCHEM, V114, P695, DOI 10.1016/j.acthis.2011.12.004; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Kuhar MJ, 1999, TRENDS NEUROSCI, V22, P316, DOI 10.1016/S0166-2236(98)01377-0; Kuriyama G, 2004, ENDOCRINOLOGY, V145, P2542, DOI 10.1210/en.2003-0845; Lakatos A, 2002, MOL BRAIN RES, V104, P81, DOI 10.1016/S0169-328X(02)00321-2; Li BW, 2011, STEM CELLS DEV, V20, P1223, DOI 10.1089/scd.2010.0195; Li YH, 2008, J NEUROCHEM, V106, P1314, DOI 10.1111/j.1471-4159.2008.05487.x; Ling F, 2011, DNA CELL BIOL, V30, P91, DOI 10.1089/dna.2010.1101; Liu L, 2012, COMP BIOCHEM PHYS B, V162, P81, DOI 10.1016/j.cbpb.2012.04.005; Liu Z, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-67; Mao PZ, 2007, EUR J NEUROSCI, V26, P624, DOI 10.1111/j.1460-9568.2007.05691.x; Mao PZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029343; Martin D, 2003, J BIOL CHEM, V278, P53082, DOI 10.1074/jbc.M306861200; Rodrigues BC, 2011, NEUROSCIENCE, V195, P201, DOI 10.1016/j.neuroscience.2011.08.036; Rogge GA, 2010, BRAIN RES, V1344, P1, DOI 10.1016/j.brainres.2010.04.069; Sarvari M, 2010, ENDOCRINOLOGY, V151, P1161, DOI 10.1210/en.2009-0911; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Upadhya MA, 2012, NEUROPHARMACOLOGY, V62, P1823, DOI 10.1016/j.neuropharm.2011.12.004; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Vicentic A, 2004, ENDOCRINOLOGY, V145, P4119, DOI 10.1210/en.2003-1648; Vrang N, 1999, BRAIN RES, V818, P499, DOI 10.1016/S0006-8993(98)01349-3; Wu B, 2006, BIOCHEM BIOPH RES CO, V347, P656, DOI 10.1016/j.bbrc.2006.06.117; Xu Y, 2006, P NATL ACAD SCI USA, V103, P14489, DOI 10.1073/pnas.0602932103; Yang YX, 2008, EXP CELL RES, V314, P2257, DOI 10.1016/j.yexcr.2008.04.008; Yu HB, 2011, GENOME RES, V21, P1284, DOI 10.1101/gr.114488.110; Yuan L, 2012, EMBO REP, V13, P363, DOI 10.1038/embor.2012.10	46	11	12	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42574	42587		10.1074/jbc.M112.376590	http://dx.doi.org/10.1074/jbc.M112.376590			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23086924	hybrid, Green Published			2022-12-28	WOS:000312501600019
J	Huang, YF; Yang, CH; Huang, CC; Hsu, KS				Huang, Yu-Fei; Yang, Chih-Hao; Huang, Chiung-Chun; Hsu, Kuei-Sen			Vascular Endothelial Growth Factor-dependent Spinogenesis Underlies Antidepressant-like Effects of Enriched Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR DEPRESSIVE DISORDER; MEDIATED ANTAGOMIR EXPRESSION; UNPREDICTABLE MILD STRESS; D-ASPARTATE ANTAGONIST; NEUROTROPHIC FACTOR; HIPPOCAMPAL NEUROGENESIS; RAT-BRAIN; LEARNED HELPLESSNESS; BEHAVIORAL ACTIONS; GENE-EXPRESSION	Current antidepressant treatments remain limited by poor efficacy and a slow onset of action. Increasing evidence demonstrates that enriched environment (EE) treatment can promote structural and behavioral plasticity in the brain and dampen stress-induced alterations of neuroplasticity. Here, we have examined whether short term exposure to EE is able to produce antidepressant-like effects. Our results show that housing adult mice in an EE cage for 7 days led to antidepressant-like behavioral profiles and a significant increase in the number of dendritic spines in hippocampal CA1 pyramidal neurons. These EE-induced antidepressant-like effects are primarily attributed to increased vascular endothelial growth factor (VEGF) expression through a hypoxia-inducible factor-1 alpha (HIF-1 alpha)-mediated transcriptional mechanism. Blockade of HIF-1 alpha synthesis by lentiviral infection with HIF-1 alpha small hairpin RNAs completely blocked the increase in expression of VEGF and the antidepressant-like effects induced by EE. Moreover, no significant antidepressant-like effects were observed with EE treatment in VEGF receptor 2 (Flk-1) knock-out mice. The increase in HIF-1 alpha expression in the hippocampus induced by EE was associated with a decrease in endogenous levels of microRNA-107 (miR-107). Overexpression of miR-107 in the hippocampus completely blocked EE-induced HIF-1 alpha expression and the antidepressant-like effects. These results support a model in which the down-regulation of miR-107, acting through HIF-1 alpha, mediates VEGF-dependent spinogenesis to underlie the EE-induced antidepressant-like effects.	[Huang, Yu-Fei; Yang, Chih-Hao; Huang, Chiung-Chun; Hsu, Kuei-Sen] Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, Tainan 701, Taiwan; [Huang, Yu-Fei; Hsu, Kuei-Sen] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University	Hsu, KS (corresponding author), Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, Tainan 701, Taiwan.	richard@mail.ncku.edu.tw	Hsu, Kuei-Sen/AAV-8386-2021		National Health Research Institute Research Grant [NHRI-EX101-9618NI]; National Science Council, Taiwan [NSC99-2321-B-006-001]	National Health Research Institute Research Grant; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Health Research Institute Research Grant NHRI-EX101-9618NI and by National Science Council Grant NSC99-2321-B-006-001, Taiwan.	Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Balkowiec A, 2002, J NEUROSCI, V22, P10399; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berchtold NC, 2002, J NEUROSCI RES, V68, P511, DOI 10.1002/jnr.10256; Bindu B, 2007, NEUROSCIENCE, V144, P412, DOI 10.1016/j.neuroscience.2006.09.057; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Cooper DC, 2006, BEHAV BRAIN RES, V174, P225, DOI 10.1016/j.bbr.2006.05.036; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cryan JF, 2010, SCIENCE, V329, P913, DOI 10.1126/science.1194313; Dalvi A, 1999, PSYCHOPHARMACOLOGY, V147, P14, DOI 10.1007/s002130051131; De Foubert G, 2004, NEUROSCIENCE, V128, P597, DOI 10.1016/j.neuroscience.2004.06.054; de la Pena FA, 2011, J BIOL CHEM, V286, P20778, DOI 10.1074/jbc.M110.198069; Diazgranados N, 2010, ARCH GEN PSYCHIAT, V67, P793, DOI 10.1001/archgenpsychiatry.2010.90; Dolt KS, 2007, GENE, V386, P73, DOI 10.1016/j.gene.2006.08.004; Duman CH, 2008, BRAIN RES, V1199, P148, DOI 10.1016/j.brainres.2007.12.047; During Matthew J., 2006, Current Alzheimer Research, V3, P29, DOI 10.2174/156720506775697133; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Fournier NM, 2012, BEHAV BRAIN RES, V227, P440, DOI 10.1016/j.bbr.2011.04.022; Franklin B.J, 2008, MOUSE BRAIN STEREOTA; Frodl T, 2004, J CLIN PSYCHIAT, V65, P492; Gallassi R, 2006, J AFFECT DISORDERS, V91, P243, DOI 10.1016/j.jad.2006.01.018; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Greene J, 2009, NEUROPSYCHOPHARMACOL, V34, P2459, DOI 10.1038/npp.2009.68; Greenwood BN, 2008, NEUROMOL MED, V10, P81, DOI 10.1007/s12017-008-8029-y; Greenwood BN, 2003, J NEUROSCI, V23, P2889; Hajszan T, 2010, BIOL PSYCHIAT, V67, P168, DOI 10.1016/j.biopsych.2009.08.017; Hajszan T, 2009, BIOL PSYCHIAT, V65, P392, DOI 10.1016/j.biopsych.2008.09.031; Hattori S, 2007, BEHAV BRAIN RES, V180, P69, DOI 10.1016/j.bbr.2007.02.036; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang YF, 2010, J NEUROSCI, V30, P6080, DOI 10.1523/JNEUROSCI.5493-09.2010; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Knierim JJ, 2006, HIPPOCAMPUS, V16, P755, DOI 10.1002/hipo.20203; Koh S, 2005, J CHILD NEUROL, V20, P796, DOI 10.1177/08830738050200100301; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Kuzumaki N, 2011, HIPPOCAMPUS, V21, P127, DOI 10.1002/hipo.20775; Law AJ, 2004, AM J PSYCHIAT, V161, P1848, DOI 10.1176/appi.ajp.161.10.1848; Lee JS, 2009, J NEUROSCI, V29, P8493, DOI 10.1523/JNEUROSCI.1321-09.2009; Lei Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007629; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Llorens-Martin MV, 2007, NEUROSCIENCE, V147, P631, DOI 10.1016/j.neuroscience.2007.04.054; Malykhin NV, 2010, J PSYCHIATR NEUROSCI, V35, P337, DOI 10.1503/jpn.100002; Marlatt MW, 2012, DEV NEUROBIOL, V72, P943, DOI 10.1002/dneu.22009; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McEwen BS, 2002, NEUROBIOL AGING, V23, P921, DOI 10.1016/S0197-4580(02)00027-1; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Moreau J L, 1992, Eur Neuropsychopharmacol, V2, P43; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; O'Brien JT, 2004, AM J PSYCHIAT, V161, P2081, DOI 10.1176/appi.ajp.161.11.2081; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; Scherr M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm971; Schloesser RJ, 2010, MOL PSYCHIATR, V15, P1152, DOI 10.1038/mp.2010.34; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; Surdziel E, 2010, METHODS MOL BIOL, V667, P237, DOI 10.1007/978-1-60761-811-9_16; Sutter CH, 2000, P NATL ACAD SCI USA, V97, P4748, DOI 10.1073/pnas.080072497; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Trivedi MH, 2006, CLIN TRIALS, V3, P291, DOI 10.1191/1740774506cn151oa; Veena J, 2009, J NEUROSCI RES, V87, P831, DOI 10.1002/jnr.21907; Warner-Schmidt JL, 2007, P NATL ACAD SCI USA, V104, P4647, DOI 10.1073/pnas.0610282104; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Winter C, 2007, BEHAV BRAIN RES, V184, P133, DOI 10.1016/j.bbr.2007.07.002; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566; Wright RL, 2008, BEHAV BRAIN RES, V187, P41, DOI 10.1016/j.bbr.2007.08.025; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	87	24	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40938	40955		10.1074/jbc.M112.392076	http://dx.doi.org/10.1074/jbc.M112.392076			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23074224	Green Published, hybrid			2022-12-28	WOS:000311887600013
J	Yakubenko, VP; Hsi, LC; Cathcart, MK; Bhattacharjee, A				Yakubenko, Valentin P.; Hsi, Linda C.; Cathcart, Martha K.; Bhattacharjee, Ashish			From Macrophage Interleukin-13 Receptor to Foam Cell Formation MECHANISMS FOR alpha(M)beta(2) INTEGRIN INTERFERENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ALTERNATIVE ACTIVATION; GENE-EXPRESSION; HUMAN MONOCYTES; 15-LIPOXYGENASE; CD36; INDUCTION; PHOSPHORYLATION; ATHEROSCLEROSIS; LIPOXYGENASES	IL-13 is a potent stimulator of alternative monocyte/macrophage activation. During alternative activation, the expression of several proteins is induced including 15-lipoxygenase (15-LO), a lipid-peroxidating enzyme and the scavenger receptor CD36. We previously reported that alpha(M)beta(2) integrin activation or clustering suppresses the expression of both 15-LO and CD36. In this study we focused on exploring the molecular mechanisms that down-regulate CD36 expression and CD36-mediated foam cell formation in IL-13-stimulated monocytes/macrophages after alpha(M)beta(2) activation. Our studies reveal that alpha(M)beta(2) integrin activation inhibits the IL-13 activation of several critical pathways that are required for macrophage alternative activation; namely, blocking Jak2 and Tyk2 phosphorylation, which bind to the cytoplasmic tails of the IL-4R alpha/IL-13R alpha 1 complex. This leads to the inhibition of tyrosine phosphorylation of Stats (Stat1, Stat3, and Stat6) and prevents the formation of a signaling complex (containing p38MAPK, PKC delta, and Stat3) that are critical for the expression of both 15-LO and CD36. Jak2-mediated Hck activation is also inhibited, thereby preventing Stats serine phosphorylation, which is essential for downstream Stat-dependent gene transcription. Moreover, inhibition of Jak2, Tyk2, or their downstream target 15-LO with antisense oligonucleotides profoundly inhibits IL-13-induced CD36 expression and CD36-dependent foam cell formation, whereas13(S) Hydroperoxyoctadecadienoic acid (HPODE), a 15-LO product and peroxisome proliferator-activated receptor-gamma ligand, completely restores CD36 expression in monocytes treated with 15-LO antisense. alpha(M)beta(2) integrin activation controls CD36 expression and foam cell formation in alternatively activated monocyte/macrophages by blocking Tyk2/Jak2 phosphorylation via a 15-LO-dependent pathway. The discovery of this mechanism helps our understanding of the potential role of alternatively activated macrophages in atherogenesis and highlights the impact of integrin alpha(M)beta(2) on this process.	[Bhattacharjee, Ashish] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Bhattacharjee, A (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	bhattaa@ccf.org			National Institutes of Health [HL051068, HL087018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087018, R01HL051068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL051068 and HL087018 (to M. K. C.).	Berry A, 2007, EUR J IMMUNOL, V37, P1642, DOI 10.1002/eji.200636625; Bhattacharjee A, 2006, J IMMUNOL, V177, P3771, DOI 10.4049/jimmunol.177.6.3771; Bhattacharjee A, 2011, J BIOL CHEM, V286, P36709, DOI 10.1074/jbc.M111.291492; Cabodi S, 2010, ADV EXP MED BIOL, V674, P43; Cathcart MK, 2000, FREE RADICAL BIO MED, V28, P1726, DOI 10.1016/S0891-5849(00)00230-6; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Feng JW, 2000, J LIPID RES, V41, P688; FOLCIK VA, 1995, J CLIN INVEST, V96, P504, DOI 10.1172/JCI118062; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Huang JS, 1999, BIOCHEM J, V342, P231, DOI 10.1042/0264-6021:3420231; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; KUHN H, 1994, J EXP MED, V179, P1903, DOI 10.1084/jem.179.6.1903; NASSAR GM, 1994, J BIOL CHEM, V269, P27631; PATARROYO M, 1994, IMMUNOBIOLOGY, V191, P474, DOI 10.1016/S0171-2985(11)80453-5; Pluskota E., 2010, ATVB POSTER; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Roy B, 1998, J BIOL CHEM, V273, P32023, DOI 10.1074/jbc.273.48.32023; Roy B, 2002, J LEUKOCYTE BIOL, V72, P580; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Wang LH, 2000, BLOOD, V95, P1249, DOI 10.1182/blood.V95.4.1249.004k39_1249_1257; Wittwer J, 2007, PROSTAG LEUKOTR ESS, V77, P67, DOI 10.1016/j.plefa.2007.08.001; Xu B, 2003, MOL CELL BIOL, V23, P3918, DOI 10.1128/MCB.23.11.3918-3928.2003; Yakubenko VP, 2011, CIRC RES, V108, P544, DOI 10.1161/CIRCRESAHA.110.231803; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9	32	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2778	2788		10.1074/jbc.M112.381343	http://dx.doi.org/10.1074/jbc.M112.381343			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23184931	Green Published, hybrid			2022-12-28	WOS:000314211500061
J	Baldzizhar, R; Fedorchuk, C; Jha, M; Rathinam, C; Henegariu, O; Czyzyk, J				Baldzizhar, Raman; Fedorchuk, Christine; Jha, Mithilesh; Rathinam, Chozhavendan; Henegariu, Octavian; Czyzyk, Jan			Anti-serpin Antibody-mediated Regulation of Proteases in Autoimmune Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATHEPSIN-L; EXPRESSION; ONSET; AUTOANTIBODY; INHIBITION; PREVENTION; MELLITUS; IMMUNITY; HEADPIN; EMBRYO	Secretion of anti-serpin B13 autoantibodies in young diabetes-prone nonobese diabetic mice is associated with reduced inflammation in pancreatic islets and a slower progression to autoimmune diabetes. Injection of these mice with a monoclonal antibody (mAb) against serpin B13 also leads to fewer inflammatory cells in the islets and more rapid recovery from recent-onset diabetes. The exact mechanism by which anti-serpin activity is protective remains unclear. We found that serpin B13 is expressed in the exocrine component of the mouse pancreas, including the ductal cells. We also found that anti-serpin B13 mAb blocked the inhibitory activity of serpin B13, thereby allowing partial preservation of the function of its target protease. Consistent with the hypothesis that anti-clade B serpin activity blocks the serpin from binding, exposure to exogenous anti-serpin B13 mAb or endogenous anti-serpin B13 autoantibodies resulted in cleavage of the surface molecules CD4 and CD19 in lymphocytes that accumulated in the pancreatic islets and pancreatic lymph nodes but not in the inguinal lymph nodes. This cleavage was inhibited by an E64 protease inhibitor. Consequently, T cells with the truncated form of CD4 secreted reduced levels of interferon-gamma. We conclude that anti-serpin antibodies prevent serpin B13 from neutralizing proteases, thereby impairing leukocyte function and reducing the severity of autoimmune inflammation.	[Baldzizhar, Raman; Fedorchuk, Christine; Czyzyk, Jan] Univ Rochester, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Jha, Mithilesh] Trudeau Inst Inc, Saranac Lake, NY 12983 USA; [Rathinam, Chozhavendan] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Henegariu, Octavian] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	University of Rochester; Trudeau Institute; Columbia University; Yale University	Czyzyk, J (corresponding author), Univ Rochester, Dept Pathol & Lab Med, 601 Elmwood Ave, Rochester, NY 14692 USA.	jan_czyzyk@URMC.rochester.edu			Diabetes Endocrinology Research Center; Yale University	Diabetes Endocrinology Research Center; Yale University	This work was supported by a Diabetes Endocrinology Research Center grant (to J. C.) and a Translational and Interdisciplinary Research pilot grant from Yale University (to J. C. and O. H.).	Afonso S, 1997, DEVELOPMENT, V124, P3415; ALSENZ J, 1987, NEW ENGL J MED, V316, P1360, DOI 10.1056/NEJM198705283162202; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Boyce BF, 2006, ANN NY ACAD SCI, V1068, P447, DOI 10.1196/annals.1346.042; Buhling F, 1999, AM J RESP CELL MOL, V20, P612; Casciola-Rosen L, 1999, J EXP MED, V190, P815, DOI 10.1084/jem.190.6.815; Czyzyk J, 2012, J IMMUNOL, V188, P6319, DOI 10.4049/jimmunol.1200467; Dickinson DP, 2002, CRIT REV ORAL BIOL M, V13, P238, DOI 10.1177/154411130201300304; Fu WX, 2012, NAT IMMUNOL, V13, P361, DOI 10.1038/ni.2233; GAWRYL MS, 1982, BLOOD, V60, P1103; Haeckel C, 1999, DEV DYNAM, V216, P89, DOI 10.1002/(SICI)1097-0177(199910)216:2<89::AID-DVDY1>3.0.CO;2-9; Higgins WJ, 2010, J BIOL CHEM, V285, P3722, DOI 10.1074/jbc.M109.037358; Hsing LC, 2010, J AUTOIMMUN, V34, P96, DOI 10.1016/j.jaut.2009.07.003; Hugues S, 2002, IMMUNITY, V16, P169, DOI 10.1016/S1074-7613(02)00273-X; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Ishimaru N, 2004, ADV ENZYME REGUL, V44, P309, DOI 10.1016/j.advenzreg.2003.11.004; JACKSON J, 1986, NATURE, V323, P722, DOI 10.1038/323722a0; Jayakumar A, 2003, ARCH BIOCHEM BIOPHYS, V409, P367, DOI 10.1016/S0003-9861(02)00635-5; Koczwara K, 2004, DIABETES, V53, P1; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; Lazarski CA, 2008, IMMUNITY, V29, P511, DOI 10.1016/j.immuni.2008.09.012; Lu YQ, 2006, HUM GENE THER, V17, P625, DOI 10.1089/hum.2006.17.625; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; Maehr R, 2005, J CLIN INVEST, V115, P2934, DOI 10.1172/JCI25485; Menard V, 1999, PHARMACEUT RES, V16, P1059, DOI 10.1023/A:1018939900961; Miralles F, 1998, J CELL BIOL, V143, P827, DOI 10.1083/jcb.143.3.827; Nakashima T, 2000, BBA-GENE STRUCT EXPR, V1492, P441, DOI 10.1016/S0167-4781(00)00100-7; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Reinhold D, 2008, FRONT BIOSCI-LANDMRK, V13, P2356, DOI 10.2741/2849; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Robker RL, 2000, P NATL ACAD SCI USA, V97, P4689, DOI 10.1073/pnas.080073497; Roep BO, 2002, DIABETOLOGIA, V45, P686, DOI 10.1007/s00125-002-0797-6; SARVETNICK N, 1988, CELL, V52, P773, DOI 10.1016/0092-8674(88)90414-X; She JX, 1999, P NATL ACAD SCI USA, V96, P8116, DOI 10.1073/pnas.96.14.8116; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Solomon M, 2004, ADV IMMUNOL, V84, P239, DOI 10.1016/S0065-2776(04)84007-0; SPITZER RE, 1969, SCIENCE, V164, P436, DOI 10.1126/science.164.3878.436; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Targoni OS, 1999, J AUTOIMMUN, V12, P191, DOI 10.1006/jaut.1999.0271; Welss T, 2003, BIOCHEMISTRY-US, V42, P7381, DOI 10.1021/bi027307q; Wiest-Ladenburger U, 1997, INT J IMMUNOTHER, V13, P75; Yamada A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012894; Yoshifuji H, 2005, INT IMMUNOL, V17, P1327, DOI 10.1093/intimm/dxh311	44	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1612	1619		10.1074/jbc.M112.409664	http://dx.doi.org/10.1074/jbc.M112.409664			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23195956	Green Published, hybrid			2022-12-28	WOS:000313751400017
J	Kubli, DA; Zhang, XX; Lee, Y; Hanna, RA; Quinsay, MN; Nguyen, CK; Jimenez, R; Petrosyan, S; Murphy, AN; Gustafsson, AB				Kubli, Dieter A.; Zhang, Xiaoxue; Lee, Youngil; Hanna, Rita A.; Quinsay, Melissa N.; Nguyen, Christine K.; Jimenez, Rebecca; Petrosyan, Susanna; Murphy, Anne N.; Gustafsson, Asa B.			Parkin Protein Deficiency Exacerbates Cardiac Injury and Reduces Survival following Myocardial Infarction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; AUTOPHAGY; BNIP3; MICE; CARDIOMYOPATHY; DEGRADATION; P62/SQSTM1; MUTATIONS; MITOPHAGY	It is known that loss-of-function mutations in the gene encoding Parkin lead to development of Parkinson disease. Recently, Parkin was found to play an important role in the removal of dysfunctional mitochondria via autophagy in neurons. Although Parkin is expressed in the heart, its functional role in this tissue is largely unexplored. In this study, we have investigated the role of Parkin in the myocardium under normal physiological conditions and in response to myocardial infarction. We found that Parkin-deficient (Parkin(-/-)) mice had normal cardiac function for up to 12 months of age as determined by echocardiographic analysis. Although ultrastructural analysis revealed that Parkin-deficient hearts had disorganized mitochondrial networks and significantly smaller mitochondria, mitochondrial function was unaffected. However, Parkin(-/-) mice were much more sensitive to myocardial infarction when compared with wild type mice. Parkin(-/-) mice had reduced survival and developed larger infarcts when compared with wild type mice after the infarction. Interestingly, Parkin protein levels and mitochondrial autophagy (mitophagy) were rapidly increased in the border zone of the infarct in wild type mice. In contrast, Parkin(-/-) myocytes had reduced mitophagy and accumulated swollen, dysfunctional mitochondria after the infarction. Overexpression of Parkin in isolated cardiac myocytes also protected against hypoxia-mediated cell death, whereas nonfunctional Parkinson disease-associated mutants ParkinR42P and ParkinG430D had no effect. Our results suggest that Parkin plays a critical role in adapting to stress in the myocardium by promoting removal of damaged mitochondria.	[Kubli, Dieter A.; Zhang, Xiaoxue; Lee, Youngil; Hanna, Rita A.; Quinsay, Melissa N.; Nguyen, Christine K.; Jimenez, Rebecca; Gustafsson, Asa B.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Petrosyan, Susanna; Murphy, Anne N.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Gustafsson, AB (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	asag@ucsd.edu	Lee, Youngil/AAX-2787-2021; Murphy, Anne N/H-3217-2016	Lee, Youngil/0000-0003-3819-2469; Murphy, Anne N/0000-0002-5222-9902	National Institutes of Health [R01HL087023, R01HL101217]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087023, R01HL101217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL087023 and R01HL101217 (to A. B. G.).	Aviv Y, 2011, ANTIOXID REDOX SIGN, V14, P2245, DOI 10.1089/ars.2010.3479; Bennett DA, 1996, NEW ENGL J MED, V334, P71, DOI 10.1056/NEJM199601113340202; BENSHLOMO Y, 1995, J NEUROL NEUROSUR PS, V58, P293, DOI 10.1136/jnnp.58.3.293; Billia F, 2011, P NATL ACAD SCI USA, V108, P9572, DOI 10.1073/pnas.1106291108; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Gottlieb RA, 2011, BBA-MOL CELL RES, V1813, P1295, DOI 10.1016/j.bbamcr.2010.11.017; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Huang CQ, 2010, CIRCULATION, V121, P675, DOI 10.1161/CIRCULATIONAHA.109.902221; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanamori H, 2009, AM J PATHOL, V174, P1705, DOI 10.2353/ajpath.2009.080875; Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kubli DA, 2008, AM J PHYSIOL-HEART C, V295, pH2025, DOI 10.1152/ajpheart.00552.2008; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lee Y, 2011, AM J PHYSIOL-HEART C, V301, pH1924, DOI 10.1152/ajpheart.00368.2011; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Sayen MR, 2003, AM J PHYSIOL-CELL PH, V284, pC562, DOI 10.1152/ajpcell.00336.2002; Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tang DL, 2011, CELL METAB, V13, P701, DOI 10.1016/j.cmet.2011.04.008; Van Humbeeck C, 2011, J NEUROSCI, V31, P10249, DOI 10.1523/JNEUROSCI.1917-11.2011; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	44	321	334	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					915	926		10.1074/jbc.M112.411363	http://dx.doi.org/10.1074/jbc.M112.411363			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23152496	hybrid, Green Published			2022-12-28	WOS:000313570300016
J	Lancaster, DL; Dobson, CM; Rachubinski, RA				Lancaster, David L.; Dobson, C. Melissa; Rachubinski, Richard A.			Chaperone Proteins Select and Maintain [PIN+] Prion Conformations in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO APPEARANCE; STRAIN VARIATION; ATPASE ACTIVITY; PSI+ PRION; HEAT-SHOCK; YEAST; HSP90; HSP104; PROPAGATION; SCRAPIE	Prions are proteins that can adopt different infectious conformations known as "strains" or "variants," each with a distinct, epigenetically inheritable phenotype. Mechanisms by which prion variants are determined remain unclear. Here we use the Saccharomyces cerevisiae prion Rnq1p/[PIN+] as a model to investigate the effects of chaperone proteins upon prion variant determination. We show that deletion of specific chaperone genes alters [PIN+] variant phenotypes, including [PSI+] induction efficiency, Rnq1p aggregate morphology/size and variant dominance. Mating assays demonstrate that gene deletion-induced phenotypic changes are stably inherited in a non-Mendelian manner even after restoration of the deleted gene, confirming that they are due to a bona fide change in the [PIN+] variant. Together, our results demonstrate a role for chaperones in regulating the prion variant complement of a cell.	[Lancaster, David L.; Dobson, C. Melissa; Rachubinski, Richard A.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta	Lancaster, DL (corresponding author), Univ Alberta, Dept Cell Biol, Med Sci Bldg 5-14, Edmonton, AB T6G 2H7, Canada.	dll1@ualberta.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Recipient of a Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award from the Canadian Institutes of Health Research. To whom correspondence should be addressed: Dept. of Cell Biology, University of Alberta, Medical Sciences Building 5-14, Edmonton, Alberta T6G 2H7, Canada. Tel.: 780-492-7407; Fax: 780-492-0450; E-mail: dll1@ualberta.ca.	Abbas-Terki T, 2001, MOL CELL BIOL, V21, P7569, DOI 10.1128/MCB.21.22.7569-7575.2001; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Bagriantsev S, 2004, J BIOL CHEM, V279, P51042, DOI 10.1074/jbc.M410611200; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Borchsenius AS, 2006, CURR GENET, V49, P21, DOI 10.1007/s00294-005-0035-0; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Bradley ME, 2003, GENETICS, V165, P1675; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Brown K, 2010, J GERIATR PSYCH NEUR, V23, P277, DOI 10.1177/0891988710383576; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Derdowski A, 2010, SCIENCE, V330, P680, DOI 10.1126/science.1197785; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; Fan Q, 2007, GENETICS, V177, P1583, DOI 10.1534/genetics.107.077982; FEILOTTER HE, 1994, NUCLEIC ACIDS RES, V22, P1502, DOI 10.1093/nar/22.8.1502; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kurahashi H, 2008, MOL CELL BIOL, V28, P3313, DOI 10.1128/MCB.01900-07; Kushnirov VV, 2000, CURR BIOL, V10, P1443, DOI 10.1016/S0960-9822(00)00802-2; Liebman SW, 2006, METHODS, V39, P23, DOI 10.1016/j.ymeth.2006.04.010; Mackay RG, 2008, BIOCHEMISTRY-US, V47, P1918, DOI 10.1021/bi701714s; Masison DC, 2009, PRION, V3, P65, DOI 10.4161/pri.3.2.9134; Mayr C, 2000, J BIOL CHEM, V275, P34140, DOI 10.1074/jbc.M005251200; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Park KW, 2006, GENETICS, V173, P35, DOI 10.1534/genetics.105.054221; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Reidy M, 2010, MOL CELL BIOL, V30, P3542, DOI 10.1128/MCB.01292-09; Romanova NV, 2009, PROTEIN PEPTIDE LETT, V16, P598, DOI 10.2174/092986609788490078; Rose MD., 1990, METHODS YEAST GENETI; Schlumpberger M, 2001, MOL CELL BIOL, V21, P7035, DOI 10.1128/MCB.21.20.7035-7046.2001; Scholz O, 2000, EUR J BIOCHEM, V267, P1565, DOI 10.1046/j.1432-1327.2000.01170.x; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Sharma J, 2012, MOL MICROBIOL, V86, P866, DOI 10.1111/mmi.12024; Sindi SS, 2009, CURR OPIN MICROBIOL, V12, P623, DOI 10.1016/j.mib.2009.09.003; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; Summers DW, 2009, PRION, V3, P59, DOI 10.4161/pri.3.2.9062; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	60	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1266	1276		10.1074/jbc.M112.377564	http://dx.doi.org/10.1074/jbc.M112.377564			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23148221	hybrid, Green Published			2022-12-28	WOS:000313570300046
J	Wu, GS; Zhang, LY; Li, TT; Zuniga, A; Lopaschuk, GD; Li, L; Jacobs, RL; Vance, DE				Wu, Gengshu; Zhang, Liyan; Li, Tete; Zuniga, Azeret; Lopaschuk, Gary D.; Li, Liang; Jacobs, Rene L.; Vance, Dennis E.			Choline Supplementation Promotes Hepatic Insulin Resistance in Phosphatidylethanolamine N-Methyltransferase-deficient Mice via Increased Glucagon Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID-METABOLISM; CDP-CHOLINE; RECEPTOR; GLUCOSE; LIVER; RAT; PHOSPHATIDYLCHOLINE; PHOSPHOCHOLINE; METHYLATION; INVOLVEMENT	Biosynthesis of hepatic choline via phosphatidylethanolamine N-methyltransferase (PEMT) plays an important role in the development of type 2 diabetes and obesity. We investigated the mechanism(s) by which choline modulates insulin sensitivity. PEMT wild-type (Pemt(+/+)) and knock-out (Pemt(-/-)) mice received either a high fat diet (HF; 60% kcal of fat) or a high fat, high choline diet(HFHC; 4 g of choline/kg of HF diet) for 1 week. Hepatic insulin signaling and glucose and lipid homeostasis were investigated. Glucose and insulin intolerance occurred in Pemt(-/-) mice fed the HFHC diet, but not in their Pemt(-/-) littermates fed the HF diet. Plasma glucagon was elevated in Pemt(-/-) mice fed the HFHC diet compared with Pemt(-/-) mice fed the HF diet, concomitant with increased hepatic expression of glucagon receptor, phosphorylated AMP-activated protein kinase (AMPK), and phosphorylated insulin receptor substrate 1 at serine 307 (IRS1-s307). Gluconeogenesis and mitochondrial oxidative stress were markedly enhanced, whereas glucose oxidation and triacylglycerol biosynthesis were diminished in Pemt(-/-) mice fed the HFHC diet. A glucagon receptor antagonist (2-aminobenzimidazole) attenuated choline-induced hyperglycemia and insulin intolerance and blunted up-regulation of phosphorylated AMPK and IRS1-s307. Choline induces glucose and insulin intolerance in Pemt(-/-) mice through modulating plasma glucagon and its action in liver.	[Wu, Gengshu; Li, Tete; Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Wu, Gengshu; Li, Tete; Jacobs, Rene L.; Vance, Dennis E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Zhang, Liyan; Lopaschuk, Gary D.] Univ Alberta, Cardiovasc Res Ctr, Mazankowski Alberta Heart Inst, Edmonton, AB T6G 2S2, Canada; [Jacobs, Rene L.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2S2, Canada; [Zuniga, Azeret; Li, Liang] Univ Alberta, Dept Chem, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Vance, DE (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada.	dennis.vance@ualberta.ca	Li, Liang/D-1822-2011; Zhang, Li/GWM-7501-2022	Jacobs, Rene/0000-0002-5525-1355	Canadian Institutes of Health Research [MOP 89793]; Genome Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada)	This research was supported Canadian Institutes of Health Research Grant MOP 89793 and Genome Canada.	Albright CD, 1999, DEV BRAIN RES, V113, P13, DOI 10.1016/S0165-3806(98)00183-7; Best CH, 1932, J PHYSIOL-LONDON, V75, P405, DOI 10.1113/jphysiol.1932.sp002899; Cansev M., 2008, Autonomic & Autacoid Pharmacology, V28, P41, DOI 10.1111/j.1474-8673.2007.00416.x; Cansev M, 2008, EUR J PHARMACOL, V589, P315, DOI 10.1016/j.ejphar.2008.05.017; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; DOBBS R, 1975, SCIENCE, V187, P544, DOI 10.1126/science.1089999; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; GLASER M, 1974, P NATL ACAD SCI USA, V71, P4072, DOI 10.1073/pnas.71.10.4072; Gronbaek Henning, 2008, Expert Rev Gastroenterol Hepatol, V2, P705, DOI 10.1586/17474124.2.5.705; Gu W, 2010, AM J PHYSIOL-ENDOC M, V299, pE624, DOI 10.1152/ajpendo.00102.2010; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Ilcol YO, 2008, NEUROSCI LETT, V431, P71, DOI 10.1016/j.neulet.2007.11.024; Ilcol YO, 2002, HORM METAB RES, V34, P341, DOI 10.1055/s-2002-33264; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Koek GH, 2011, CLIN CHIM ACTA, V412, P1297, DOI 10.1016/j.cca.2011.04.013; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Ling J, 2012, HEPATOLOGY, V55, P1094, DOI 10.1002/hep.24782; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Mang Y, 2004, DIABETES, V53, P410; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Petersen KF, 2001, DIABETOLOGIA, V44, P2018, DOI 10.1007/s001250100006; PRIPBUUS C, 1990, BIOCHEM J, V269, P409, DOI 10.1042/bj2690409; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Saito S, 2001, J HUM GENET, V46, P529, DOI 10.1007/s100380170035; SILVIUS JR, 1986, BIOCHEMISTRY-US, V25, P4249, DOI 10.1021/bi00363a012; SUNDLER R, 1975, BIOCHEM J, V146, P309, DOI 10.1042/bj1460309; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; Waite KA, 2004, BBA-MOL CELL BIOL L, V1636, P175, DOI 10.1016/j.bbalip.2003.10.014; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Watkins SM, 2003, J NUTR, V133, P3386, DOI 10.1093/jn/133.11.3386; Wu GS, 2009, BBA-MOL CELL BIOL L, V1791, P347, DOI 10.1016/j.bbalip.2009.02.006; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Zhang LY, 2011, CARDIOVASC RES, V89, P148, DOI 10.1093/cvr/cvq266; Zhu XN, 2003, BIOCHEM J, V370, P987, DOI 10.1042/BJ20021523	45	17	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					837	847		10.1074/jbc.M112.415117	http://dx.doi.org/10.1074/jbc.M112.415117			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23179947	hybrid, Green Published			2022-12-28	WOS:000313570300009
J	Deng, ZQ; Du, WW; Fang, L; Shan, SW; Qian, J; Lin, J; Qian, W; Ma, JC; Rutnam, ZJ; Yang, BB				Deng, Zhaoqun; Du, William W.; Fang, Ling; Shan, Sze Wan; Qian, Jun; Lin, Jiang; Qian, Wei; Ma, Jichun; Rutnam, Zina Jeyapalan; Yang, Burton B.			The Intermediate Filament Vimentin Mediates MicroRNA miR-378 Function in Cellular Self-renewal by Regulating the Expression of the Sox2 Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; PROMOTES TUMOR-GROWTH; NUCLEAR EXPORT; HUMAN CANCER; PROLIFERATION; BINDING; OCT4; ANGIOGENESIS; MULTIPOTENT; GENERATION	MicroRNAs are short noncoding RNAs that are implicated in cell self-renewal and cancer development. We show that miR-378 is up-regulated in human cancers and found that tumor cells transfected with miR-378 acquired properties of tumor stem cells, including cell self-renewal. Overexpression of miR-378 enhanced cell survival and colony formation. Isolated from a single-cell colony, the miR-378-expressing cells formed tumors in nude mice at low cell densities. These cells expressed higher levels of miR-378 and formed more and larger spheres and colonies. We found that the miR-378-expressing cells contained a large number of side population cells and could undergo differentiation. Cells transfected with miR-378 expressed increased levels of Sox2. Expression of miR-378 and Sox2 was found correlated significantly in cancer cell lines and in cancer patient specimens. We also observed opposite levels of vimentin in the cancer cell lines and human breast carcinoma specimens. We further demonstrated that vimentin is a target of miR-378, and ectopic transfection of vimentin inhibited Sox2 expression, resulting in decreased cell survival. Silencing vimentin promoted Sox2 expression and cell survival. Our study demonstrates that miR-378 is a regulator of stem cell marker Sox2 by targeting vimentin, which may serve as a new tool in studying the role of stem cells in tumorigenesis.	[Deng, Zhaoqun; Du, William W.; Fang, Ling; Shan, Sze Wan; Rutnam, Zina Jeyapalan; Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Qian, Jun; Lin, Jiang; Qian, Wei; Ma, Jichun] Jiangsu Univ, Affiliated Peoples Hosp, Zhenjiang City 212000, Peoples R China; [Deng, Zhaoqun; Du, William W.; Fang, Ling; Shan, Sze Wan; Rutnam, Zina Jeyapalan; Yang, Burton B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Jiangsu University; University of Toronto	Yang, BB (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	byang@sri.utoronto.ca		SHAN, SW/0000-0001-6876-9914	Canadian Institutes of Health Research [MOP-102635, MOP-111171]; Heart and Stroke Foundation of Ontario [CI 7418]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by grants from Canadian Institutes of Health Research (MOP-102635, MOP-111171) to B. B. Y., who is the recipient of a Career Investigator Award (CI 7418) from the Heart and Stroke Foundation of Ontario.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chellappan P, 2005, P NATL ACAD SCI USA, V102, P10381, DOI 10.1073/pnas.0504439102; Collins RE, 2005, FEBS LETT, V579, P5841, DOI 10.1016/j.febslet.2005.07.072; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Fang L., 2012, CELL CYCLE, V30, P23; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Feng M, 2011, ONCOGENE, V30, P2242, DOI 10.1038/onc.2010.602; Ferletta M, 2011, INT J CANCER, V129, P45, DOI 10.1002/ijc.25647; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Giorgetti A, 2010, NAT PROTOC, V5, P811, DOI 10.1038/nprot.2010.16; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Laguette MJ, 2011, MATRIX BIOL, V30, P338, DOI 10.1016/j.matbio.2011.05.001; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liber D, 2010, CELL STEM CELL, V7, P114, DOI 10.1016/j.stem.2010.05.020; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Mello CC, 2004, NAT MED, V10, P1297, DOI 10.1038/nm1204-1297; Mergui X, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-473; Nakajima N, 2006, BIOCHEM BIOPH RES CO, V350, P1006, DOI 10.1016/j.bbrc.2006.09.153; Negrini M, 2007, J CELL SCI, V120, P1833, DOI 10.1242/jcs.03450; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rutnam ZJ, 2012, HISTOL HISTOPATHOL, V27, P1263, DOI 10.14670/HH-27.1263; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Shatseva T, 2011, J CELL SCI, V124, P2826, DOI 10.1242/jcs.077529; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; Tanaka Y, 2000, INT J ONCOL, V16, P725; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yang Weining, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P140; Yang XL, 2012, CELL CYCLE, V11, P3097, DOI 10.4161/cc.21503; Ye G, 2011, J CELL SCI, V124, P359, DOI 10.1242/jcs.072223; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje	54	41	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					319	331		10.1074/jbc.M112.418830	http://dx.doi.org/10.1074/jbc.M112.418830			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23135265	Green Published, hybrid			2022-12-28	WOS:000313197200034
J	Herrmann, S; Ninkovic, M; Kohl, T; Lorinczi, EV; Pardo, LA				Herrmann, Solveig; Ninkovic, Milena; Kohl, Tobias; Loerinczi, Eva; Pardo, Luis A.			Cortactin Controls Surface Expression of the Voltage-gated Potassium Channel K(V)10.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GO-GO; HUMAN ETHER; FUNCTIONAL EXPRESSION; ACTIN CYTOSKELETON; CELL-CYCLE; HUMAN EAG1; PHOSPHORYLATION; ADHESION; IDENTIFICATION; ACTIVATION	K(V)10.1 is a voltage-gated potassium channel aberrantly expressed in many cases of cancer, and participates in cancer initiation and tumor progression. Its action as an oncoprotein can be inhibited by a functional monoclonal antibody, indicating a role for channels located at the plasma membrane, accessible to the antibody. Cortactin is an actin-interacting protein implicated in cytoskeletal architecture and often amplified in several types of cancer. In this study, we describe a physical and functional interaction between cortactin and K(V)10.1. Binding of these two proteins occurs between the Cterminus of K(V)10.1 and the proline-rich domain of cortactin, regions targeted by many post-translational modifications. This interaction is specific for K(V)10.1 and does not occur with K(V)10.2. Cortactin controls the abundance of K(V)10.1 at the plasma membrane and is required for functional expression of K(V)10.1 channels.	[Ninkovic, Milena; Kohl, Tobias; Loerinczi, Eva] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, D-37975 Gottingen, Germany; [Herrmann, Solveig; Pardo, Luis A.] Max Planck Inst Expt Med, Oncophysiol Grp, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society	Pardo, LA (corresponding author), Max Planck Inst Expt Med, AG Onkophysiol, Hermann Rein Str 3, D-37975 Gottingen, Germany.	pardo@em.mpg.de	Pardo, Luis/C-5066-2013	Pardo, Luis/0000-0003-1375-4349				Agarwal JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-18; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Arcangeli A, 2004, BIOCHEM SOC T, V32, P826, DOI 10.1042/BST0320826; Borowiec AS, 2007, J CELL PHYSIOL, V212, P690, DOI 10.1002/jcp.21065; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Camacho J, 2000, PFLUG ARCH EUR J PHY, V441, P167, DOI 10.1007/s004240000420; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Chen IH, 2011, J BIOL CHEM, V286, P27183, DOI 10.1074/jbc.M111.233825; Chen L, 2006, ACTA BIOCH BIOPH SIN, V38, P95, DOI 10.1111/j.1745-7270.2006.00141.x; Cherubini A, 2005, MOL BIOL CELL, V16, P2972, DOI 10.1091/mbc.E04-10-0940; Downie BR, 2008, J BIOL CHEM, V283, P36234, DOI 10.1074/jbc.M801830200; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; Hattan D, 2002, J BIOL CHEM, V277, P38596, DOI 10.1074/jbc.M205005200; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Hofmann G, 2001, J BIOL CHEM, V276, P4923, DOI 10.1074/jbc.M005682200; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Ju M, 2002, FEBS LETT, V524, P204, DOI 10.1016/S0014-5793(02)03055-7; Kohl T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026329; Lin HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020362; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; Ludwig J, 2000, MOL CELL NEUROSCI, V16, P59, DOI 10.1006/mcne.2000.0851; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 1998, J CELL BIOL, V143, P767, DOI 10.1083/jcb.143.3.767; Phartiyal P, 2007, J BIOL CHEM, V282, P9874, DOI 10.1074/jbc.M610875200; Schonherr R, 2002, FEBS LETT, V514, P204, DOI 10.1016/S0014-5793(02)02365-7; SCHUURING E, 1992, ONCOGENE, V7, P355; Stuhmer W, 1998, METHOD ENZYMOL, V293, P280; Tian L, 2008, J BIOL CHEM, V283, P3067, DOI 10.1074/jbc.M706826200; Tian LJ, 2006, FASEB J, V20, P2588, DOI 10.1096/fj.06-6152fje; Toral C, 2007, LIFE SCI, V81, P255, DOI 10.1016/j.lfs.2007.05.014; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weber C, 2006, J BIOL CHEM, V281, P13030, DOI 10.1074/jbc.M600883200; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Williams MR, 2007, P NATL ACAD SCI USA, V104, P17412, DOI 10.1073/pnas.0703865104; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Zahradka P, 2009, CAN J PHYSIOL PHARM, V87, P805, DOI 10.1139/Y09-052	44	23	27	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44151	44163		10.1074/jbc.M112.372540	http://dx.doi.org/10.1074/jbc.M112.372540			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144454	Green Published, hybrid			2022-12-28	WOS:000312938600014
J	Rosnoblet, C; Fritzinger, B; Legrand, D; Launay, H; Wieruszeski, JM; Lippens, G; Hanoulle, X				Rosnoblet, Claire; Fritzinger, Bernd; Legrand, Dominique; Launay, Helene; Wieruszeski, Jean-Michel; Lippens, Guy; Hanoulle, Xavier			Hepatitis C Virus NS5B and Host Cyclophilin A Share a Common Binding Site on NS5A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; NONSTRUCTURAL PROTEIN 5A; CRYSTAL-STRUCTURE; MEMBRANE ASSOCIATION; ISOMERASE ACTIVITY; ANTIVIRAL THERAPY; CYCLOSPORINE-A; DOMAIN-II; REPLICATION; INHIBITORS	Nonstructural protein 5B (NS5B) is essential for hepatitis C virus (HCV) replication as it carries the viral RNA-dependent RNA polymerase enzymatic activity. HCV replication occurs in a membrane-associated multiprotein complex in which HCV NS5A and host cyclophilin A (CypA) have been shown to be present together with the viral polymerase. We used NMR spectroscopy to perform a per residue level characterization of the molecular interactions between the unfolded domains 2 and 3 of NS5A (NS5A-D2 and NS5A-D3), CypA, and NS5B(Delta 21). We show that three regions of NS5A-D2 (residues 250-262 (region A), 274-287 (region B), and 306-333 (region C)) interact with NS5B(Delta 21), whereas NS5A-D3 does not. We show that both NS5B(Delta 21) and CypA share a common binding site on NS5A that contains residues Pro-306 to Glu-323. No direct molecular interaction has been detected by NMR spectroscopy between HCV NS5B(Delta 21) and host CypA. We show that cyclosporine A added to a sample containing NS5B(Delta 21), NS5A-D2, and CypA specifically inhibits the interaction between CypA and NS5A-D2 without altering the one between NS5A-D2 and NS5B(Delta 21). A high quality heteronuclear NMR spectrum of HCV NS5B(Delta 21) has been obtained and was used to characterize the binding site on the polymerase of NS5A-D2. Moreover these data highlight the potential of using NMR of NS5B(Delta 21) as a powerful tool to characterize in solution the interactions of the HCV polymerase with all kinds of molecules (proteins, inhibitors, RNA). This work brings new insights into the comprehension of the molecular interplay between NS5B, NS5A, and CypA, three essentials proteins for HCV replication.	[Hanoulle, Xavier] Univ Lille Nord France, F-59000 Lille, France; CNRS, UMR 8576, F-59655 Villeneuve Dascq, France; Univ Sci & Technol Lille, Unite Glycobiol Struct & Fonct, IFR 147, F-59655 Villeneuve Dascq, France	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Hanoulle, X (corresponding author), Univ Lille Nord France, F-59000 Lille, France.	xavier.hanoulle@univ-lille1.fr	HANOULLE, Xavier/HHN-4815-2022; Legrand, Dominique/AAT-5715-2021; Rosnoblet, Claire/AAD-3462-2020; Hanoulle, Xavier/AAK-7236-2021	Rosnoblet, Claire/0000-0002-1906-0922; Hanoulle, Xavier/0000-0002-3755-2680; Launay, Helene/0000-0003-0639-2642; LEGRAND, Dominique/0000-0002-0814-221X; Lippens, Guy/0000-0002-8236-0901	CNR Sand University of Lille; French National Agency for Research on AIDS and Viral Hepatitis; French National Agency for Research (ANR JCJC StruFunc5A5B); Region Nord-Pas de Calais (France); University of Lille 1; Institut Pasteur de Lille; University of Lille 2; CNRS	CNR Sand University of Lille; French National Agency for Research on AIDS and Viral Hepatitis(ANRS); French National Agency for Research (ANR JCJC StruFunc5A5B)(French National Research Agency (ANR)); Region Nord-Pas de Calais (France)(Region Hauts-de-France); University of Lille 1; Institut Pasteur de Lille; University of Lille 2; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the CNR Sand University of Lille and grants from the French National Agency for Research on AIDS and Viral Hepatitis and the French National Agency for Research (ANR JCJC StruFunc5A5B).; We gratefully acknowledge Drs. S. Bressanelli and D. Harrus (Laboratoire de Virologie Moleculaire et Structurale, CNRS UPR 3296, Gif-sur-Yvette, France) for providing the pET21-NS5B <INF>Delta 21</INF> plasmid and Drs. J. Neyts and L. Coelmont (Rega Institute for Medical Research, University of Leuven (KU Leuven), Leuven, Belgium) for providing the TCA-based inhibitor. The NMR facility used in this study was funded by the Region Nord-Pas de Calais (France), the CNRS, the Universities of Lille 1 and Lille 2, and the Institut Pasteur de Lille.	Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Biswal BK, 2006, J MOL BIOL, V361, P33, DOI 10.1016/j.jmb.2006.05.074; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Buhler S, 2012, LIVER INT, V32, P9, DOI 10.1111/j.1478-3231.2011.02701.x; Carroll SS, 2000, BIOCHEMISTRY-US, V39, P8243, DOI 10.1021/bi991992s; Chatterji U, 2010, J GEN VIROL, V91, P1189, DOI 10.1099/vir.0.018531-0; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; Chinnaswamy S, 2010, J VIROL, V84, P5923, DOI 10.1128/JVI.02446-09; Ciesek S, 2011, NAT REV GASTRO HEPAT, V8, P69, DOI 10.1038/nrgastro.2010.219; Coelmont L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013687; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Delang L, 2010, VIRUSES-BASEL, V2, P826, DOI 10.3390/v2040826; Di Marco S, 2005, J BIOL CHEM, V280, P29765, DOI 10.1074/jbc.M505423200; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Fernandes F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009815; Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Gravitz L, 2011, NATURE, V474, pS2, DOI 10.1038/474S2a; Grise H, 2012, J VIROL, V86, P4811, DOI 10.1128/JVI.06641-11; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Hanoulle X, 2012, WILEY SER PROTEIN P, P409; Hanoulle X, 2010, PROTEIN PEPTIDE LETT, V17, P1012, DOI 10.2174/092986610791498920; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Hanoulle X, 2009, BIOCHEM BIOPH RES CO, V381, P634, DOI 10.1016/j.bbrc.2009.02.108; Heck JA, 2009, BIOCHEM PHARMACOL, V77, P1173, DOI 10.1016/j.bcp.2008.12.019; Hopkins S, 2010, ANTIMICROB AGENTS CH, V54, P660, DOI 10.1128/AAC.00660-09; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; Ivashkina N, 2002, J VIROL, V76, P13088, DOI 10.1128/JVI.76.24.13088-13093.2002; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; LaPlante SR, 2010, J AM CHEM SOC, V132, P15204, DOI 10.1021/ja101358s; Le Pogam S, 2006, J VIROL, V80, P6146, DOI 10.1128/JVI.02628-05; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Liang Y, 2007, BIOCHEMISTRY-US, V46, P11550, DOI 10.1021/bi700776e; Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Moradpour D, 2004, J VIROL, V78, P13278, DOI 10.1128/JVI.78.23.13278-13284.2004; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nakagawa M, 2005, GASTROENTEROLOGY, V129, P1031, DOI 10.1053/j.gastro.2005.06.031; Nietlispach D, 2005, J BIOMOL NMR, V31, P161, DOI 10.1007/s10858-004-8195-7; Paeshuyse J, 2006, HEPATOLOGY, V43, P761, DOI 10.1002/hep.21102; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Puyang XL, 2010, ANTIMICROB AGENTS CH, V54, P1981, DOI 10.1128/AAC.01236-09; Qin WP, 2001, HEPATOLOGY, V33, P728, DOI 10.1053/jhep.2001.22765; Quezada Elizabeth M, 2009, Open Biochem J, V3, P39, DOI 10.2174/1874091X00903010039; Ranjith-Kumar CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022575; Rigat K, 2010, ANTIVIR RES, V88, P197, DOI 10.1016/j.antiviral.2010.08.014; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; Schlutter J, 2011, NATURE, V474, pS5, DOI 10.1038/474S5a; Schmidt-Mende J, 2001, J BIOL CHEM, V276, P44052, DOI 10.1074/jbc.M103358200; Shimakami T, 2004, J VIROL, V78, P2738, DOI 10.1128/JVI.78.6.2738-2748.2004; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Simister P, 2009, J VIROL, V83, P11926, DOI 10.1128/JVI.01008-09; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Verdegem D, 2011, J BIOL CHEM, V286, P20441, DOI 10.1074/jbc.M110.182436; Wang MT, 2003, J BIOL CHEM, V278, P9489, DOI 10.1074/jbc.M209397200; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Yamashita T, 1998, J BIOL CHEM, V273, P15479, DOI 10.1074/jbc.273.25.15479; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07	75	29	29	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44249	44260		10.1074/jbc.M112.392209	http://dx.doi.org/10.1074/jbc.M112.392209			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23152499	Green Published, hybrid			2022-12-28	WOS:000312938600023
J	Schulz, EM; Correll, RN; Sheikh, HN; Lofrano-Alves, MS; Engel, PL; Newman, G; Schultz, JE; Molkentin, JD; Wolska, BM; Solaro, RJ; Wieczorek, DF				Schulz, Emily M.; Correll, Richard N.; Sheikh, Hajer N.; Lofrano-Alves, Marco S.; Engel, Patti L.; Newman, Gilbert; Schultz, Jo El J.; Molkentin, Jeffery D.; Wolska, Beata M.; Solaro, R. John; Wieczorek, David F.			Tropomyosin Dephosphorylation Results in Compensated Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ALPHA-ALPHA-TROPOMYOSIN; GENE-EXPRESSION; CARDIOMYOCYTE HYPERTROPHY; BETA-TROPOMYOSIN; RABBIT SKELETAL; PHOSPHORYLATION; EPSILON; BINDING; CA2+	Phosphorylation of tropomyosin (Tm) has been shown to vary in mouse models of cardiac hypertrophy. Little is known about the in vivo role of Tm phosphorylation. This study examines the consequences of Tm dephosphorylation in the murine heart. Transgenic (TG) mice were generated with cardiac specific expression of alpha-Tm with serine 283, the phosphorylation site of Tm, mutated to alanine. Echocardiographic analysis and cardiomyocyte cross-sectional area measurements show that alpha-Tm S283A TG mice exhibit a hypertrophic phenotype at basal levels. Interestingly, there are no alterations in cardiac function, myofilament calcium (Ca2+) sensitivity, cooperativity, or response to beta-adrenergic stimulus. Studies of Ca2+ handling proteins show significant increases in sarcoplasmic reticulum ATPase (SERCA2a) protein expression and an increase in phospholamban phosphorylation at serine 16, similar to hearts under exercise training. Compared with controls, the decrease in phosphorylation of alpha-Tm results in greater functional defects in TG animals stressed by transaortic constriction to induce pressure overload-hypertrophy. This is the first study to investigate the in vivo role of Tm dephosphorylation under both normal and cardiac stress conditions, documenting a role for Tm dephosphorylation in the maintenance of a compensated or physiological phenotype. Collectively, these results suggest that modification of the Tm phosphorylation status in the heart, depending upon the cardiac state/condition, may modulate the development of cardiac hypertrophy.	[Schulz, Emily M.; Sheikh, Hajer N.; Wieczorek, David F.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Correll, Richard N.; Molkentin, Jeffery D.] Univ Cincinnati, Coll Med, Dept Pediat, Howard Hughes Med Inst, Cincinnati, OH 45267 USA; [Newman, Gilbert; Schultz, Jo El J.] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; [Lofrano-Alves, Marco S.; Wolska, Beata M.] Univ Illinois, Ctr Cardiovasc Res, Dept Med, Chicago, IL 60612 USA; [Engel, Patti L.; Wolska, Beata M.; Solaro, R. John] Univ Illinois, Ctr Cardiovasc Res, Dept Physiol & Biophys, Chicago, IL 60612 USA	University System of Ohio; University of Cincinnati; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wieczorek, DF (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	David.Wieczorek@uc.edu	Alves, Marco/H-5924-2013	LOFRANO-ALVES, MARCO/0000-0003-0794-7339; Sheikh, Hajer/0000-0002-6411-5259; Molkentin, Jeffery/0000-0002-3558-6529	National Institutes of Health [RO1 HL-081680, RO1 HL-064035, PO1 HL062427, T32 HL-07382, F32HL097551, T32 HL-07692]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064035, T32HL007692, R01HL081680, T32HL007382, R01HL062427, F32HL097551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL-081680 (to D. F. W.), RO1 HL-064035 (to R. J. S. and B. M. W.), PO1 HL062427 (to R. J. S.), T32 HL-07382 (to E. M. S.), F32HL097551 (to R. N. C.), and T32 HL-07692 (to P. L. E.).	ARAI M, 1994, CIRC RES, V74, P555, DOI 10.1161/01.RES.74.4.555; BALL KL, 1994, J MOL CELL CARDIOL, V26, P519, DOI 10.1006/jmcc.1994.1062; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; DEBELLE I, 1987, BIOCHIM BIOPHYS ACTA, V925, P17, DOI 10.1016/0304-4165(87)90143-7; del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308; Donaldson C, 2009, CIRC RES, V104, P265, DOI 10.1161/CIRCRESAHA.108.190397; Fidzianska A, 2010, J ELECTRON MICROSC, V59, P181, DOI 10.1093/jmicro/dfp048; Flashman E, 2004, CIRC RES, V94, P1279, DOI 10.1161/01.RES.0000127175.21818.C2; Gaffin RD, 2004, J PHYSIOL-LONDON, V561, P777, DOI 10.1113/jphysiol.2004.070631; Gaffin RD, 2011, J MOL CELL CARDIOL, V51, P812, DOI 10.1016/j.yjmcc.2011.07.026; Gardner JD, 2008, AM J PHYSIOL-HEART C, V294, pH198, DOI 10.1152/ajpheart.00281.2007; Greenfield NJ, 2006, J MOL BIOL, V364, P80, DOI 10.1016/j.jmb.2006.08.033; GU X, 1994, CIRC RES, V75, P926, DOI 10.1161/01.RES.75.5.926; Haines CD, 2012, ENDOCRINOLOGY, V153, P4480, DOI 10.1210/en.2012-1353; Hamilton M, 2001, J BIOL CHEM, V276, P29079, DOI 10.1074/jbc.M102001200; HEELEY DA, 1982, FEBS LETT, V146, P115, DOI 10.1016/0014-5793(82)80716-3; HEELEY DH, 1989, J BIOL CHEM, V264, P2424; HEELEY DH, 1994, EUR J BIOCHEM, V221, P129, DOI 10.1111/j.1432-1033.1994.tb18721.x; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hilioti Z, 2003, BIOCHEM BIOPH RES CO, V311, P1089, DOI 10.1016/S0006-291X(03)01515-8; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Jiao QB, 2009, AM J PHYSIOL-HEART C, V297, pH576, DOI 10.1152/ajpheart.00946.2008; Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014; Kemi OJ, 2007, J MOL CELL CARDIOL, V43, P354, DOI 10.1016/j.yjmcc.2007.06.013; Khoynezhad A, 2007, TEX HEART I J, V34, P352; Liao SY, 2007, J MOL CELL CARDIOL, V42, P106, DOI 10.1016/j.yjmcc.2006.10.005; Lu L, 2002, J APPL PHYSIOL, V92, P1524, DOI 10.1152/japplphysiol.00405.2001; Lu QW, 2010, J BIOL CHEM, V285, P11810, DOI 10.1074/jbc.M109.055657; Luo WS, 1996, CIRC RES, V78, P839, DOI 10.1161/01.RES.78.5.839; MAK A, 1978, P NATL ACAD SCI USA, V75, P3588, DOI 10.1073/pnas.75.8.3588; Mattiazzi A, 2006, BRAZ J MED BIOL RES, V39, P563, DOI 10.1590/S0100-879X2006000500001; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; MONTGOMERY K, 1984, J BIOL CHEM, V259, P5555; Moraczewska J, 1999, BIOCHEMISTRY-US, V38, P15885, DOI 10.1021/bi991816j; Moss RL, 2006, CIRC RES, V99, P225, DOI 10.1161/01.RES.0000236793.88131.dc; Muthuchamy M, 1999, CIRC RES, V85, P47; Muthuchamy M, 1995, J BIOL CHEM, V270, P30593, DOI 10.1074/jbc.270.51.30593; Nakayama H, 2009, J CLIN INVEST, V119, P3787, DOI 10.1172/JCI39724; ONEILL L, 1991, CARDIOSCIENCE, V2, P1; Pena JR, 2010, J MOL CELL CARDIOL, V49, P993, DOI 10.1016/j.yjmcc.2010.09.010; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinz I, 2011, J BIOL CHEM, V286, P10163, DOI 10.1074/jbc.M110.210757; Prabhakar R, 2001, J MOL CELL CARDIOL, V33, P1815, DOI 10.1006/jmcc.2001.1445; Prekeris R, 1998, J BIOL CHEM, V273, P26790, DOI 10.1074/jbc.273.41.26790; Rajan S, 2007, CIRC RES, V101, P205, DOI 10.1161/CIRCRESAHA.107.148379; Rajan S, 2010, CIRCULATION, V121, P410, DOI 10.1161/CIRCULATIONAHA.109.889725; REDDY YS, 1973, J MOL CELL CARDIOL, V5, P461, DOI 10.1016/0022-2828(73)90016-3; Robia SL, 2001, BIOPHYS J, V80, P2140, DOI 10.1016/S0006-3495(01)76187-5; Rolim NPL, 2007, PHYSIOL GENOMICS, V29, P246, DOI 10.1152/physiolgenomics.00188.2006; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sanna B, 2006, P NATL ACAD SCI USA, V103, P7327, DOI 10.1073/pnas.0509340103; Schmidt U, 1999, AM J PHYSIOL-HEART C, V277, pH474, DOI 10.1152/ajpheart.1999.277.2.H474; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; van Deel ED, 2011, J MOL CELL CARDIOL, V50, P1017, DOI 10.1016/j.yjmcc.2011.01.016; van der Velden J, 2006, CARDIOVASC RES, V69, P876, DOI 10.1016/j.cardiores.2005.11.021; Warren CM, 2008, PROTEOMICS, V8, P100, DOI 10.1002/pmic.200700772; WATSON MH, 1988, BIOCHEMISTRY-US, V27, P4506, DOI 10.1021/bi00412a043; Wisloff U, 2002, CARDIOVASC RES, V54, P162, DOI 10.1016/S0008-6363(01)00565-X; Wolska BM, 1999, CIRC RES, V84, P745; Wu GY, 2000, J BIOL CHEM, V275, P29927, DOI 10.1074/jbc.C000380200; Wu SC, 2007, J BIOL CHEM, V282, P30691, DOI 10.1074/jbc.M703670200; Xuan YT, 2005, CIRCULATION, V112, P1971, DOI 10.1161/CIRCULATIONAHA.105.561522; Yuan C, 2008, AM J PHYSIOL-HEART C, V295, pH647, DOI 10.1152/ajpheart.00357.2008	66	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44478	44489		10.1074/jbc.M112.402040	http://dx.doi.org/10.1074/jbc.M112.402040			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23148217	Green Published, hybrid			2022-12-28	WOS:000312938600044
J	Bower, NI; de la Serrana, DG; Cole, NJ; Hollway, GE; Lee, HT; Assinder, S; Johnston, IA				Bower, Neil I.; de la Serrana, Daniel Garcia; Cole, Nicholas J.; Hollway, Georgina E.; Lee, Hung-Tai; Assinder, Stephen; Johnston, Ian A.			Stac3 Is Required for Myotube Formation and Myogenic Differentiation in Vertebrate Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; PROTEIN; GENES; SLOW; EXPRESSION; HEDGEHOG; IDENTIFICATION; PATHWAY; GROWTH; PHOSPHORYLATION	Stac3 was identified as a nutritionally regulated gene from an Atlantic salmon subtractive hybridization library with highest expression in skeletal muscle. Salmon Stac3 mRNA was highly correlated with myogenin and myoD1a expression during differentiation of a salmon primary myogenic culture and was regulated by amino acid availability. In zebrafish embryos, stac3 was initially expressed in myotomal adaxial cells and in fast muscle fibers post-segmentation. Morpholino knockdown resulted in defects in myofibrillar protein assembly, particularly in slow muscle fibers, and decreased levels of the hedgehog receptor patched. The function of Stac3 was further characterized in vitro using the mammalian C2C12 myogenic cell line. Stac3 mRNA expression increased during the differentiation of the C2C12 myogenic cell line. Knock-down of Stac3 by RNAi inhibited myotube formation, and microarray analysis revealed that transcripts involved in cell cycle, focal adhesion, cytoskeleton, and the pro-myogenic factors Igfbp-5 and Igf2 were down-regulated. RNAi-treated cells had suppressed Akt signaling and exogenous insulin-like growth factor (Igf) 2 was unable to rescue the phenotype, however, Igf/Akt signaling was not blocked. Overexpression of Stac3, which results in increased levels of Igfbp-5 mRNA, did not lead to increased differentiation. In synchronized cells, Stac3 mRNA was most abundant during the G(1) phase of the cell cycle. RNAi-treated cells were smaller, had higher proliferation rates and a decreased proportion of cells in G(1) phase when compared with controls, suggesting a role in the G(1) phase checkpoint. These results identify Stac3 as a new gene required for myogenic differentiation and myofibrillar protein assembly in vertebrates.	[Bower, Neil I.; de la Serrana, Daniel Garcia; Lee, Hung-Tai; Johnston, Ian A.] Univ St Andrews, Sch Biol, Scottish Oceans Inst, St Andrews KY16 8LB, Fife, Scotland; [Cole, Nicholas J.; Assinder, Stephen] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Hollway, Georgina E.] Garvan Inst Med Res, Sydney, NSW, Australia	University of St Andrews; University of Sydney; Garvan Institute of Medical Research	de la Serrana, DG (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	n.bower@uq.edu.au; iaj@st-andrews.ac.uk	cole, nicholas/M-7010-2016; Johnston, Ian A./AAE-2044-2019; Garcia de la serrana, Daniel/R-9956-2018; Hollway, Georgina E/E-6764-2010; Johnston, Ian A/D-6592-2013; Bower, Neil/K-1478-2014	Garcia de la serrana, Daniel/0000-0001-6630-3379; Johnston, Ian A/0000-0002-7796-5754; Bower, Neil/0000-0002-6764-6063; Cole, Nicholas/0000-0003-1006-2662; Lee, Hung-Tai/0000-0003-2362-3182	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; European Community [222719-LIFECYCLE]	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; European Community(European Commission)	This work was supported in part by the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) supported by Scottish Funding Council Grant HR09011.; Supported by the European Community's Seventh Framework Programme FP7/2007-2013 under Grant 222719-LIFECYCLE.	Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Barresi MJF, 2001, CURR BIOL, V11, P1432, DOI 10.1016/S0960-9822(01)00428-6; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bower NI, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq816; Bower NI, 2010, PHYSIOL GENOMICS, V42A, P114, DOI 10.1152/physiolgenomics.00065.2010; Bower NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011100; Bower NI, 2010, AM J PHYSIOL-REG I, V298, pR1615, DOI 10.1152/ajpregu.00114.2010; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cabane C, 2004, CELL SIGNAL, V16, P1405, DOI 10.1016/j.cellsig.2004.05.003; Cole NJ, 2003, CURR BIOL, V13, pR951, DOI 10.1016/S0960-9822(03)00881-9; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Elworthy S, 2008, DEVELOPMENT, V135, P2115, DOI 10.1242/dev.015719; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Hardy K, 2005, MOL BIOL CELL, V16, P943, DOI 10.1091/mbc.E04-05-0392; Henry CA, 2004, DEV CELL, V7, P917, DOI 10.1016/j.devcel.2004.09.017; Kitzmann M, 1999, MOL CELL BIOL, V19, P3167; Koshimizu E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017688; Legha W, 2010, GENE EXPR PATTERNS, V10, P368, DOI 10.1016/j.gep.2010.08.003; Lewis KE, 1999, DEV BIOL, V216, P469, DOI 10.1006/dbio.1999.9519; Lim CS, 2001, J BIOL CHEM, V276, P12871, DOI 10.1074/jbc.M009411200; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Raharjo WH, 2001, J CELL SCI, V114, P4447; Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sarbassov DD, 1997, MOL ENDOCRINOL, V11, P2038, DOI 10.1210/me.11.13.2038; Satoh J, 2006, J NEUROSCI METH, V152, P278, DOI 10.1016/j.jneumeth.2005.09.015; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Suzuki H, 1996, BIOCHEM BIOPH RES CO, V229, P902, DOI 10.1006/bbrc.1996.1900; Tanaka K, 2011, MUSCLE NERVE, V44, P968, DOI 10.1002/mus.22224; Thalappilly S, 2008, PROTEOMICS, V8, P3071, DOI 10.1002/pmic.200701157; Tiffin N, 2004, ENDOCRINOLOGY, V145, P4991, DOI 10.1210/en.2004-0101; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Williams RJ, 2011, BIOMATERIALS, V32, P5304, DOI 10.1016/j.biomaterials.2011.03.078; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Yi JS, 2002, J BIOL CHEM, V277, P9580, DOI 10.1074/jbc.M106922200	41	30	30	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43936	43949		10.1074/jbc.M112.361311	http://dx.doi.org/10.1074/jbc.M112.361311			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23076145	hybrid, Green Published			2022-12-28	WOS:000312940800069
J	Burgers, PP; Ma, YL; Margarucci, L; Mackey, M; van der Heyden, MAG; Ellisman, M; Scholten, A; Taylor, SS; Heck, AJR				Burgers, Pepijn P.; Ma, Yuliang; Margarucci, Luigi; Mackey, Mason; van der Heyden, Marcel A. G.; Ellisman, Mark; Scholten, Arjen; Taylor, Susan S.; Heck, Albert J. R.			A Small Novel A-Kinase Anchoring Protein (AKAP) That Localizes Specifically Protein Kinase A-Regulatory Subunit I (PKA-RI) to the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING COMPLEXES; HEART-TISSUE; PALMITOYLATION; ISOFORMS; ACTIVATION; DYNAMICS; BINDING; CELLS	Protein kinase A-anchoring proteins (AKAPs) provide spatio-temporal specificity for the omnipotent cAMP-dependent protein kinase (PKA) via high affinity interactions with PKA regulatory subunits (PKA-RI, RII). Many PKA-RII-AKAP complexes are heavily tethered to cellular substructures, whereas PKA-RI-AKAP complexes have remained largely undiscovered. Here, using a cAMP affinity-based chemical proteomics strategy in human heart and platelets, we uncovered a novel, ubiquitously expressed AKAP, termed small membrane (sm) AKAP due to its specific localization at the plasma membrane via potential myristoylation/palmitoylation anchors. In vitro binding studies revealed specificity of smAKAP for PKA-RI (K-d = 7 nM) over PKA-RII (K-d = 53 nM) subunits, co-expression of smAKAP with the four PKA R subunits revealed an even more exclusive specificity of smAKAP for PKA-RI alpha/beta in the cellular context. Applying the singlet oxygen-generating electron microscopy probe miniSOG indicated that smAKAP is tethered to the plasma membrane and is particularly dense at cell-cell junctions and within filopodia. Our preliminary functional characterization of smAKAP provides evidence that, like PKA-RII, PKA-RI can be tightly tethered by a novel repertoire of AKAPs, providing a new perspective on spatio-temporal control of cAMP signaling.	[Scholten, Arjen] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Burgers, Pepijn P.; Margarucci, Luigi; Scholten, Arjen; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Burgers, Pepijn P.; Margarucci, Luigi; Scholten, Arjen; Heck, Albert J. R.] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands; [Ma, Yuliang] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Margarucci, Luigi] Univ Salerno, Dipartimento Sci Farmaceut & Biomed, I-84084 Fisciano, Italy; [Mackey, Mason; Ellisman, Mark] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [van der Heyden, Marcel A. G.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Med Physiol, NL-3584 CM Utrecht, Netherlands; [Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	Utrecht University; Utrecht University; University of California System; University of California San Diego; University of Salerno; University of California System; University of California San Diego; Utrecht University; Utrecht University Medical Center; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Scholten, A (corresponding author), Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	a.scholten@uu.nl	Margarucci, Luigi/F-6110-2011; Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404; van der Heyden, Marcel/0000-0002-4225-7942	PRIME-XS Project [262067]; European Union Seventh Framework Program; National Institutes of Health [DK54441]; Netherlands Proteomics Centre, embedded in The Netherlands Genomics Initiative; Centre for Biomedical Genetics; Utrecht University Focus and Massa program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	PRIME-XS Project; European Union Seventh Framework Program(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Proteomics Centre, embedded in The Netherlands Genomics Initiative; Centre for Biomedical Genetics; Utrecht University Focus and Massa program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the PRIME-XS Project, Grant Agreement 262067, funded by the European Union Seventh Framework Program and by National Institutes of Health Grant DK54441 (to S. S. T.). This work was also supported by The Netherlands Proteomics Centre, embedded in The Netherlands Genomics Initiative (to A. S. and A. J. R. H.) and the Centre for Biomedical Genetics (to A. J. R. H.).; Supported by the Utrecht University Focus and Massa program.	Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Angelo R, 1998, J BIOL CHEM, V273, P14633, DOI 10.1074/jbc.273.23.14633; Aye TT, 2012, J MOL CELL CARDIOL, V52, P511, DOI 10.1016/j.yjmcc.2011.06.003; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Brown SHJ, 2009, J MOL BIOL, V393, P1070, DOI 10.1016/j.jmb.2009.09.014; BRUNTON LL, 1981, ADV CYCL NUCL RES<D>, V14, P391; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; Burns-Hamuro LL, 2005, PROTEIN SCI, V14, P2982, DOI 10.1110/ps.051687305; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; CARR DW, 1991, J BIOL CHEM, V266, P14188; CORBIN JD, 1978, J BIOL CHEM, V253, P3997; CORBIN JD, 1977, J BIOL CHEM, V252, P3854; Day ME, 2011, J CELL BIOL, V193, P347, DOI 10.1083/jcb.201010034; de Jong Rob N., 2006, Journal of Structural and Functional Genomics, V7, P109, DOI 10.1007/s10969-006-9014-z; Delint-Ramirez I, 2011, J BIOL CHEM, V286, P32962, DOI 10.1074/jbc.M111.243899; Di Benedetto G, 2008, CIRC RES, V103, P836, DOI 10.1161/CIRCRESAHA.108.174813; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kovanich D, 2012, METHODS MOL BIOL, V803, P167, DOI 10.1007/978-1-61779-364-6_12; Kovanich D, 2010, CHEMBIOCHEM, V11, P963, DOI 10.1002/cbic.201000058; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; LOHMANN SM, 1984, P NATL ACAD SCI-BIOL, V81, P6723, DOI 10.1073/pnas.81.21.6723; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Malbon CC, 2004, BIOCHEM J, V379, P1, DOI 10.1042/BJ20031648; Margarucci L, 2011, MOL BIOSYST, V7, P2311, DOI 10.1039/c1mb05145h; Martin BR, 2007, CHEM BIOL, V14, P1031, DOI 10.1016/j.chembiol.2007.07.017; Means CK, 2011, P NATL ACAD SCI USA, V108, pE1227, DOI 10.1073/pnas.1107182108; Montoliu C, 2007, AM J PHYSIOL-GASTR L, V292, pG305, DOI 10.1152/ajpgi.00100.2006; Mosenden R, 2011, J IMMUNOL, V186, P5119, DOI 10.4049/jimmunol.1100003; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Pidoux G, 2011, EMBO J, V30, P4371, DOI 10.1038/emboj.2011.365; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; ROBBINS SM, 1995, MOL CELL BIOL, V15, P3507; RUBIN CS, 1972, J BIOL CHEM, V247, P6135; Sarma GN, 2010, STRUCTURE, V18, P155, DOI 10.1016/j.str.2009.12.012; Scholten A, 2008, MASS SPECTROM REV, V27, P331, DOI 10.1002/mas.20166; Scholten A, 2007, J PROTEOME RES, V6, P1705, DOI 10.1021/pr060601a; Scholten A, 2006, J PROTEOME RES, V5, P1435, DOI 10.1021/pr0600529; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Trotter KW, 1999, J CELL BIOL, V147, P1481, DOI 10.1083/jcb.147.7.1481; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wright Megan H, 2010, J Chem Biol, V3, P19, DOI 10.1007/s12154-009-0032-8	49	58	64	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43789	43797		10.1074/jbc.M112.395970	http://dx.doi.org/10.1074/jbc.M112.395970			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115245	Green Published, hybrid			2022-12-28	WOS:000312940800057
J	Gawecka, JE; Young-Robbins, SS; Sulzmaier, FJ; Caliva, MJ; Heikkila, MM; Matter, ML; Ramos, JW				Gawecka, Joanna E.; Young-Robbins, Shirley S.; Sulzmaier, Florian J.; Caliva, Maisel J.; Heikkilae, Minna M.; Matter, Michelle L.; Ramos, Joe W.			RSK2 Protein Suppresses Integrin Activation and Fibronectin Matrix Assembly and Promotes Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL S6 KINASE; TYROSINE PHOSPHORYLATION; CYTOPLASMIC DOMAIN; FILAMIN BINDING; MEK/ERK PATHWAY; TALIN BINDING; MAP KINASE; CANCER; RAS; PEA-15	Modulation of integrin activation is important in many cellular functions including adhesion, migration, and assembly of the extracellular matrix. RSK2 functions downstream of Ras/Raf and promotes tumor cell motility and metastasis. We therefore investigated whether RSK2 affects integrin function. We report that RSK2 mediates Ras/Raf inactivation of integrins. As a result, we find that RSK2 impairs cell adhesion and integrin-mediated matrix assembly and promotes cell motility. Active RSK2 appears to affect integrins by reducing actin stress fibers and disrupting focal adhesions. Moreover, RSK2 co-localizes with the integrin activator talin and is present at integrin cytoplasmic tails. It is thereby in a position to modulate integrin activation and integrin-mediated migration. Activation of RSK2 promotes filamin phosphorylation and binding to integrins. We also find that RSK2 is activated in response to integrin ligation to fibronectin. Thus, RSK2 could participate in a feedback loop controlling integrin function. These results reveal RSK2 as a key regulator of integrin activity and provide a novel mechanism by which it may promote cell migration and cancer metastasis.	[Gawecka, Joanna E.; Young-Robbins, Shirley S.; Sulzmaier, Florian J.; Caliva, Maisel J.; Heikkilae, Minna M.; Ramos, Joe W.] Univ Hawaii Manoa, Univ Hawaii Canc Ctr, Canc Biol Program, Honolulu, HI 96813 USA; [Matter, Michelle L.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA; [Sulzmaier, Florian J.; Ramos, Joe W.] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA	Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Ramos, JW (corresponding author), Univ Hawaii Manoa, Univ Hawaii Canc Ctr, Canc Biol Program, 651 Ilalo St, Honolulu, HI 96813 USA.	jramos@cc.hawaii.edu	Matter, Michelle/GSN-9703-2022; Ramos, Joe/G-4074-2010	Ramos, Joe/0000-0002-9708-2115; Matter, Michelle/0000-0002-5988-9663	National Institutes of Health [R01-CA093849, R01-GM088266]; Robert C. Perry Fund of the Hawai'i Community Foundation [20061496]; Department of Defense [05245002]; National Center for Research Resources [P20-RR016453]; NATIONAL CANCER INSTITUTE [R01CA093849] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert C. Perry Fund of the Hawai'i Community Foundation; Department of Defense(United States Department of Defense); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA093849 and R01-GM088266 (to J. W. R.). This work was also supported by Grant 20061496 from the Robert C. Perry Fund of the Hawai'i Community Foundation (to J. W. R.) and Department of Defense Grant 05245002 (to J. W. R.).; Supported by National Center for Research Resources Grant P20-RR016453.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; BECKERLE MC, 1989, J CELL BIOL, V109, P3333, DOI 10.1083/jcb.109.6.3333; Belkin AM, 1997, J CELL BIOL, V139, P1583, DOI 10.1083/jcb.139.6.1583; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; BERTAGNOLLI ME, 1993, J CELL SCI, V106, P1189; Bignone PA, 2007, ONCOGENE, V26, P683, DOI 10.1038/sj.onc.1209827; Brenner KA, 2000, ONCOGENE, V19, P3156, DOI 10.1038/sj.onc.1203626; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Chou FL, 2003, J BIOL CHEM, V278, P52587, DOI 10.1074/jbc.M309322200; Clark DE, 2005, CANCER RES, V65, P3108; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Glading A, 2007, CANCER RES, V67, P1536, DOI 10.1158/0008-5472.CAN-06-1378; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Hughes PE, 2002, MOL BIOL CELL, V13, P2256, DOI 10.1091/mbc.01-10-0480; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379; Kang S, 2008, J BIOL CHEM, V283, P4652, DOI 10.1074/jbc.M709673200; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; Kato-Stankiewicz J, 2002, P NATL ACAD SCI USA, V99, P14398, DOI 10.1073/pnas.222222699; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Lad Y, 2007, METHOD ENZYMOL, V426, P69, DOI 10.1016/S0076-6879(07)26004-5; Lara R, 2011, ONCOGENE, V30, P3513, DOI 10.1038/onc.2011.61; Liu SC, 2000, J CELL SCI, V113, P3563; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Ohta Y, 1996, J BIOL CHEM, V271, P11858, DOI 10.1074/jbc.271.20.11858; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Pearson G, 2000, J BIOL CHEM, V275, P37303, DOI 10.1074/jbc.C000570200; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Ramos JW, 1998, J BIOL CHEM, V273, P33897, DOI 10.1074/jbc.273.51.33897; Renault-Mihara F, 2006, MOL BIOL CELL, V17, P5141, DOI 10.1091/mbc.E05-11-1072; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; SMITH DB, 1993, NUCLEIC ACIDS RES, V21, P359, DOI 10.1093/nar/21.2.359; Smith DB, 2001, CURRENT PROTOCOLS MO, V28; Smith JA, 2005, CANCER RES, V65, P1027; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Vaidyanathan H, 2003, J BIOL CHEM, V278, P32367, DOI 10.1074/jbc.M303988200; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X	56	40	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43424	43437		10.1074/jbc.M112.423046	http://dx.doi.org/10.1074/jbc.M112.423046			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118220	Green Published, hybrid			2022-12-28	WOS:000312940800024
J	Schofield, AV; Steel, R; Bernard, O				Schofield, Alice V.; Steel, Rohan; Bernard, Ora			Rho-associated Coiled-coil Kinase (ROCK) Protein Controls Microtubule Dynamics in a Novel Signaling Pathway That Regulates Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TUBULIN; LIM-KINASE; PHOSPHORYLATION; ACETYLATION; DEACETYLASE; ACTIVATION; RECEPTOR; HDAC6; ACETYLTRANSFERASE; IDENTIFICATION	The two members of the Rho-associated coiled-coil kinase (ROCK1 and 2) family are established regulators of actin dynamics that are involved in the regulation of the cell cycle as well as cell motility and invasion. Here, we discovered a novel signaling pathway whereby ROCK regulates microtubule (MT) acetylation via phosphorylation of the tubulin polymerization promoting protein 1 (TPPP1/p25). We show that ROCK phosphorylation of TPPP1 inhibits the interaction between TPPP1 and histone deacetylase 6 (HDAC6), which in turn results in increased HDAC6 activity followed by a decrease in MT acetylation. As a consequence, we show that TPPP1 phosphorylation by ROCK increases cell migration and invasion via modulation of cellular acetyl MT levels. We establish here that the ROCK-TPPP1-HDAC6 signaling pathway is important for the regulation of cell migration and invasion.	[Schofield, Alice V.; Bernard, Ora] St Vincents Inst Med Res, Cytoskeleton & Canc Unit, Fitzroy, Vic 3065, Australia; [Schofield, Alice V.; Bernard, Ora] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Steel, Rohan] Univ Melbourne, Prot Chem & Metab Unit, Fitzroy, Vic 3065, Australia	St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; University of Melbourne	Bernard, O (corresponding author), St Vincents Inst Med Res, Cytoskeleton & Canc Unit, 9 Princes St, Fitzroy, Vic 3065, Australia.	obernard@svi.edu.au		/0000-0002-0423-6120	National Health and Medical Research Council (NHMRC); Australian Research Council (ARC); Cancer Council of Victoria; Victorian Government Operational Infrastructure Support Program; NHMRC; Australian Postgraduate Award; St. Vincent's Institute Foundation Top-up Scholarship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Victorian Government Operational Infrastructure Support Program; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); St. Vincent's Institute Foundation Top-up Scholarship	This research was supported by grants from the National Health and Medical Research Council (NHMRC), the Australian Research Council (ARC), the Cancer Council of Victoria, and in part by the Victorian Government Operational Infrastructure Support Program. This work was also supported by a fellowship from the NHMRC (to O.B.) and by an Australian Postgraduate Award and St. Vincent's Institute Foundation Top-up Scholarship (to A.V.S.).	Acevedo K, 2007, EXP CELL RES, V313, P4091, DOI 10.1016/j.yexcr.2007.08.012; Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Belletti B, 2010, MOL CELL BIOL, V30, P2229, DOI 10.1128/MCB.00723-09; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Harrison BA, 2009, J MED CHEM, V52, P6515, DOI 10.1021/jm901226j; Heng YW, 2012, J CELL SCI, V125, P1579, DOI 10.1242/jcs.096818; Hlavanda E, 2002, BIOCHEMISTRY-US, V41, P8657, DOI 10.1021/bi020140g; Hlavanda E, 2007, J BIOL CHEM, V282, P29531, DOI 10.1074/jbc.M703466200; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ikegami T, 2005, EUR J NEUROSCI, V22, P3036, DOI 10.1111/j.1460-9568.2005.04492.x; Inada H, 1998, BIOCHEM BIOPH RES CO, V253, P21, DOI 10.1006/bbrc.1998.9732; Kadir S, 2011, J CELL SCI, V124, P2642, DOI 10.1242/jcs.087965; Kang JH, 2007, BIOCHIMIE, V89, P39, DOI 10.1016/j.biochi.2006.08.003; Kang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022699; Katoh K, 2001, AM J PHYSIOL-CELL PH, V280, pC1669, DOI 10.1152/ajpcell.2001.280.6.C1669; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kruger JS, 2003, MOL CANCER RES, V1, P801; Lafarga V, 2012, EMBO J, V31, P856, DOI 10.1038/emboj.2011.466; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Matsuzawa K, 1997, BIOCHEM BIOPH RES CO, V234, P621, DOI 10.1006/bbrc.1997.6669; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; O'Reilly LA, 1998, BIOTECHNIQUES, V25, P824, DOI 10.2144/98255st03; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Saji S, 2005, ONCOGENE, V24, P4531, DOI 10.1038/sj.onc.1208646; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Tokesi N, 2010, J BIOL CHEM, V285, P17896, DOI 10.1074/jbc.M109.096578; Vincze O, 2006, BIOCHEMISTRY-US, V45, P13818, DOI 10.1021/bi061305e; Wu Y, 2010, J BIOL CHEM, V285, P3554, DOI 10.1074/jbc.M109.063354; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	40	54	56	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43620	43629		10.1074/jbc.M112.394965	http://dx.doi.org/10.1074/jbc.M112.394965			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23093407	Green Published, hybrid			2022-12-28	WOS:000312940800042
J	Skalicky, JJ; Arii, J; Wenzel, DM; Stubblefield, WMB; Katsuyama, A; Uter, NT; Bajorek, M; Myszka, DG; Sundquist, WI				Skalicky, Jack J.; Arii, Jun; Wenzel, Dawn M.; Stubblefield, William-May B.; Katsuyama, Angela; Uter, Nathan T.; Bajorek, Monika; Myszka, David G.; Sundquist, Wesley I.			Interactions of the Human LIP5 Regulatory Protein with Endosomal Sorting Complexes Required for Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA-ATPASE VPS4; ESCRT-III COMPLEX; STRUCTURAL BASIS; MULTIVESICULAR BODY; MIT DOMAIN; MEMBRANE ASSOCIATION; CYTOKINESIS; AUTOINHIBITION; MACHINERY; DYNAMICS	The endosomal sorting complex required for transport (ESCRT) pathway remodels membranes during multivesicular body biogenesis, the abscission stage of cytokinesis, and enveloped virus budding. The ESCRT-III and VPS4 ATPase complexes catalyze the membrane fission events associated with these processes, and the LIP5 protein helps regulate their interactions by binding directly to a subset of ESCRT-III proteins and to VPS4. We have investigated the biochemical and structural basis for different LIP5-ligand interactions and show that the first microtubule-interacting and trafficking (MIT) module of the tandem LIP5 MIT domain binds CHMP1B (and other ESCRT-III proteins) through canonical type 1 MIT-interacting motif (MIM1) interactions. In contrast, the second LIP5 MIT module binds with unusually high affinity to a novel MIM element within the ESCRT-III protein CHMP5. A solution structure of the relevant LIP5-CHMP5 complex reveals that CHMP5 helices 5 and 6 and adjacent linkers form an amphipathic "leucine collar" that wraps almost completely around the second LIP5 MIT module but makes only limited contacts with the first MIT module. LIP5 binds MIM1-containing ESCRT-III proteins and CHMP5 and VPS4 ligands independently in vitro, but these interactions are coupled within cells because formation of stable VPS4 complexes with both LIP5 and CHMP5 requires LIP5 to bind both a MIM1-containing ESCRT-III protein and CHMP5. Our studies thus reveal how the tandem MIT domain of LIP5 binds different types of ESCRT-III proteins, promoting assembly of active VPS4 enzymes on the polymeric ESCRT-III substrate.	[Skalicky, Jack J.; Arii, Jun; Wenzel, Dawn M.; Stubblefield, William-May B.; Katsuyama, Angela; Uter, Nathan T.; Bajorek, Monika; Myszka, David G.; Sundquist, Wesley I.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Sundquist, WI (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	wes@biochem.utah.edu		Bajorek, Monika/0000-0002-0160-4709	National Institutes of Health [AI051174, GM082545]; Japan Herpesvirus Infections Forum; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051174, R37AI051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Herpesvirus Infections Forum; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI051174 and GM082545 (to W.I.S.).; Supported by a research fellowship from Japan Herpesvirus Infections Forum and Japan Society for the Promotion of Science.	Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Boura E, 2012, STRUCTURE, V20, P874, DOI 10.1016/j.str.2012.03.008; Caballe A, 2011, TRAFFIC, V12, P1318, DOI 10.1111/j.1600-0854.2011.01244.x; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davies BA, 2010, MOL BIOL CELL, V21, P3396, DOI 10.1091/mbc.E10-06-0512; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Elia N, 2012, BIOPHYS J, V102, P2309, DOI 10.1016/j.bpj.2012.04.007; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Fujita H, 2004, J CELL SCI, V117, P2997, DOI 10.1242/jcs.01170; Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Goddard T. D., 2001, SPARKY 3; Gonciarz MD, 2008, J MOL BIOL, V384, P878, DOI 10.1016/j.jmb.2008.09.066; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Guizetti J, 2012, TRENDS CELL BIOL, V22, P133, DOI 10.1016/j.tcb.2011.11.007; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Haas TJ, 2007, PLANT CELL, V19, P1295, DOI 10.1105/tpc.106.049346; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Hartmann C, 2008, J MOL BIOL, V377, P352, DOI 10.1016/j.jmb.2008.01.010; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hill CP, 2012, BBA-MOL CELL RES, V1823, P172, DOI 10.1016/j.bbamcr.2011.08.017; Hurley JH, 2008, DEV CELL, V14, P6, DOI 10.1016/j.devcel.2007.12.013; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jouvenet N, 2011, J MOL BIOL, V410, P501, DOI 10.1016/j.jmb.2011.04.062; Jouvenet N, 2011, NAT CELL BIOL, V13, P394, DOI 10.1038/ncb2207; Kieffer CC, 2008, PSYCHOANAL INQ, V28, P1, DOI 10.1080/07351690701787077; Kuang ZZ, 2011, J VIROL, V85, P7153, DOI 10.1128/JVI.02610-10; Landsberg MJ, 2009, STRUCTURE, V17, P427, DOI 10.1016/j.str.2008.12.020; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Lata S, 2009, BIOCHEM SOC T, V37, P156, DOI 10.1042/BST0370156; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Lottridge JM, 2006, P NATL ACAD SCI USA, V103, P6202, DOI 10.1073/pnas.0601712103; McCullough J., 2012, ANN REV BIO IN PRESS; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Mu RL, 2012, STRUCTURE, V20, P887, DOI 10.1016/j.str.2012.03.001; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Nickerson DP, 2010, MOL BIOL CELL, V21, P1023, DOI 10.1091/mbc.E09-09-0776; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Pincetic A, 2010, J VIROL, V84, P4725, DOI 10.1128/JVI.02478-09; Popov S, 2009, J VIROL, V83, P7185, DOI 10.1128/JVI.00198-09; Rigden DJ, 2009, FEBS LETT, V583, P872, DOI 10.1016/j.febslet.2009.02.012; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Rusten TE, 2012, NAT CELL BIOL, V14, P38, DOI 10.1038/ncb2381; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shiflett SL, 2004, J BIOL CHEM, V279, P10982, DOI 10.1074/jbc.M312669200; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Solomons J, 2011, STRUCTURE, V19, P1149, DOI 10.1016/j.str.2011.05.011; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takasu H, 2005, BIOCHEM BIOPH RES CO, V334, P460, DOI 10.1016/j.bbrc.2005.06.110; Tsang HTH, 2006, GENOMICS, V88, P333, DOI 10.1016/j.ygeno.2006.04.003; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Weiss ER, 2011, J MOL BIOL, V410, P525, DOI 10.1016/j.jmb.2011.04.055; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xiao JY, 2008, DEV CELL, V14, P37, DOI 10.1016/j.devcel.2007.10.013; Xiao JY, 2007, J MOL BIOL, V374, P655, DOI 10.1016/j.jmb.2007.09.067; Xiao JY, 2009, MOL BIOL CELL, V20, P3514, DOI 10.1091/mbc.E09-05-0403; Yang D, 2010, STRUCTURE, V18, P976, DOI 10.1016/j.str.2010.04.014; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Zimmerman DE, 1997, J MOL BIOL, V269, P592, DOI 10.1006/jmbi.1997.1052	79	35	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43910	43926		10.1074/jbc.M112.417899	http://dx.doi.org/10.1074/jbc.M112.417899			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23105106	Green Published, hybrid			2022-12-28	WOS:000312940800067
J	Santos, JS; Asmar-Rovira, GA; Han, GW; Liu, W; Syeda, R; Cherezov, V; Baker, KA; Stevens, RC; Montal, M				Santos, Jose S.; Asmar-Rovira, Guillermo A.; Han, Gye Won; Liu, Wei; Syeda, Ruhma; Cherezov, Vadim; Baker, Kent A.; Stevens, Raymond C.; Montal, Mauricio			Crystal Structure of a Voltage-gated K+ Channel Pore Module in a Closed State in Lipid Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM-CHANNEL; SELECTIVITY FILTER; PROTEINS; RECEPTOR; MESOPHASES; RESOLUTION; SOFTWARE; COMPLEX; DESIGN; SYSTEM	Voltage-gated K+ channels underlie the electrical excitability of cells. Each subunit of the functional tetramer consists of the tandem fusion of two modules, an N-terminal voltage-sensor and a C-terminal pore. To investigate how sensor coupling to the pore generates voltage-dependent channel opening, we solved the crystal structure and characterized the function of a voltage-gated K+ channel pore in a lipid membrane. The structure of a functional channel in a membrane environment at 3.1 angstrom resolution establishes an unprecedented connection between channel structure and function. The structure is unique in delineating an ion-occupied ready to conduct selectivity filter, a confined aqueous cavity, and a closed activation gate, embodying a dynamic entity trapped in an unstable closed state.	[Santos, Jose S.; Syeda, Ruhma; Montal, Mauricio] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Asmar-Rovira, Guillermo A.; Han, Gye Won; Liu, Wei; Cherezov, Vadim; Baker, Kent A.; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Scripps Research Institute	Montal, M (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mmontal@ucsd.edu	Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8724-2022; Cherezov, Vadim/L-9812-2013; Stevens, Raymond/K-7272-2015; Han, Gye Won/GLQ-8673-2022	Han, Gye Won/0000-0003-4107-835X; Cherezov, Vadim/0000-0002-5265-3914; Stevens, Raymond/0000-0002-4522-8725; 	National Institutes of Health [GM-073197, GM-49711]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049711, P50GM073197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-073197 and GM-49711. This work was also supported by National Cancer Institute Grant Y1-CO-1020 and National Institute of General Medical Sciences Grant Y1-GM-1104.	Armstrong CM, 2001, BIOPHYS J, V81, P895, DOI 10.1016/S0006-3495(01)75749-9; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; Bayley H, 2008, MOL BIOSYST, V4, P1191, DOI 10.1039/b808893d; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; Jogini V, 2005, J MOL BIOL, V354, P272, DOI 10.1016/j.jmb.2005.09.031; Lange A, 2006, NATURE, V440, P959, DOI 10.1038/nature04649; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONTAL M, 1990, FASEB J, V4, P2623, DOI 10.1096/fasebj.4.9.1693348; MONTAL M, 1995, ANNU REV BIOPH BIOM, V24, P31, DOI 10.1146/annurev.bb.24.060195.000335; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pauling L., 1960, NATURE CHEMICAL BOND, P513; Petrek M, 2007, STRUCTURE, V15, P1357, DOI 10.1016/j.str.2007.10.007; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Santos JS, 2008, J GEN PHYSIOL, V132, P651, DOI 10.1085/jgp.200810077; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	38	20	21	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43063	43070		10.1074/jbc.M112.415091	http://dx.doi.org/10.1074/jbc.M112.415091			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095758	Green Published, hybrid			2022-12-28	WOS:000312501600062
J	Calamaras, TD; Lee, C; Lan, F; Ido, Y; Siwik, DA; Colucci, WS				Calamaras, Timothy D.; Lee, Charlie; Lan, Fan; Ido, Yasuo; Siwik, Deborah A.; Colucci, Wilson S.			Post-translational Modification of Serine/Threonine Kinase LKB1 via Adduction of the Reactive Lipid Species 4-Hydroxy-trans-2-nonenal (HNE) at Lysine Residue 97 Directly Inhibits Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; 4-HYDROXYNONENAL HNE; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; RAT-HEART; C-ZETA; PHOSPHORYLATION; ACETYLATION; PRODUCT; MUSCLE	Oxidative stress is pathogenic in a variety of diseases, but the mechanism by which cellular signaling is affected by oxidative species has yet to be fully characterized. Lipid peroxidation, a secondary process that occurs during instances of free radical production, may play an important role in modulating cellular signaling under conditions of oxidative stress. 4-Hydroxy-trans-2-nonenal (HNE) is an electrophilic aldehyde produced during lipid peroxidation that forms covalent adducts on proteins, altering their activity and function. One such target, LKB1, has been reported to be inhibited by HNE adduction. We tested the hypothesis that HNE inhibits LKB1 activity through adduct formation on a specific reactive residue of the protein. To elucidate the mechanism of the inhibitory effect, HEK293T cells expressing LKB1 were treated with HNE (10 mu M for 1 h) and assayed for HNE-LKB1 adduct formation and changes in LKB1 kinase activity. HNE treatment resulted in the formation of HNE-LKB1 adducts and decreased LKB1 kinase activity by 31 +/- 9% (S.E.) but had no effect on the association of LKB1 with its adaptor proteins sterile-20-related adaptor and mouse protein 25. Mutation of LKB1 lysine residue 97 reduced HNE adduct formation and attenuated the effect of HNE on LKB1 activity. Taken together, our results suggest that adduction of LKB1 Lys-97 mediates the inhibitory effect of HNE.	[Calamaras, Timothy D.; Lee, Charlie; Siwik, Deborah A.; Colucci, Wilson S.] Boston Univ, Dept Med, Myocardial Biol Unit, Sch Med, Boston, MA 02118 USA; [Lan, Fan; Ido, Yasuo] Boston Univ, Sch Med, Dept Med, Diabet & Metab Res Unit,Sect Endocrinol, Boston, MA 02118 USA	Boston University; Boston University	Colucci, WS (corresponding author), Boston Univ, Dept Med, Myocardial Biol Unit, Sch Med, 88 E Newton St, Boston, MA 02118 USA.	wilson.colucci@bmc.org		Colucci, Wilson/0000-0002-0576-9420; /0000-0002-7166-327X; Ido, Yasuo/0000-0002-3036-9971	National Institutes of Health [HL-061639, HL-064750]; NHLBI-sponsored Boston University Cardiovascular Proteomics Center [N01-HV-28178]; T32 Cardiovascular Predoctoral Training Grant [HL-007969]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064750, R01HL061639, T32HL007969, R01HL028178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI-sponsored Boston University Cardiovascular Proteomics Center; T32 Cardiovascular Predoctoral Training Grant; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-061639 (to W.S.C.) and HL-064750 (to W.S.C.), the NHLBI-sponsored Boston University Cardiovascular Proteomics Center (Contract N01-HV-28178 to W.S.C.), and T32 Cardiovascular Predoctoral Training Grant HL-007969 (to T.D.C.).	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Backos DS, 2011, FREE RADICAL BIO MED, V50, P14, DOI 10.1016/j.freeradbiomed.2010.10.694; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Carbone DL, 2004, FREE RADICAL BIO MED, V37, P1430, DOI 10.1016/j.freeradbiomed.2004.07.016; Chen JJ, 2001, J MOL CELL CARDIOL, V33, P1919, DOI 10.1006/jmcc.2001.1454; Denison FC, 2009, J BIOL CHEM, V284, P67, DOI 10.1074/jbc.M806153200; Dolinsky VW, 2009, CIRCULATION, V119, P1643, DOI 10.1161/CIRCULATIONAHA.108.787440; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Eaton P, 1999, AM J PHYSIOL-HEART C, V276, pH935, DOI 10.1152/ajpheart.1999.276.3.H935; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fogarty S, 2009, J BIOL CHEM, V284, P77, DOI 10.1074/jbc.M806152200; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hill BG, 2008, BIOCHEM J, V410, P525, DOI 10.1042/BJ20071063; Hurst D, 2005, AM J PHYSIOL-ENDOC M, V289, pE710, DOI 10.1152/ajpendo.00155.2005; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Ji B, 2002, FREE RADICAL BIO MED, V33, P370, DOI 10.1016/S0891-5849(02)00906-1; Ji C, 2001, J BIOL CHEM, V276, P18223, DOI 10.1074/jbc.M101266200; Kimura H, 2005, FREE RADICAL RES, V39, P845, DOI 10.1080/10715760500161546; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lu ZP, 2009, CIRC RES, V105, P830, DOI 10.1161/CIRCRESAHA.109.204974; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Montine KS, 1997, AM J PATHOL, V150, P437; Nakamura K, 2009, J CARD FAIL, V15, P709, DOI 10.1016/j.cardfail.2009.04.008; Pamplona R, 2008, BBA-BIOENERGETICS, V1777, P1249, DOI 10.1016/j.bbabio.2008.07.003; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117; Qin FZ, 2012, CIRCULATION, V125, P1757, DOI 10.1161/CIRCULATIONAHA.111.067801; Sampey BP, 2007, MOL PHARMACOL, V71, P871, DOI 10.1124/mol.106.029686; Schaur R. J., 2003, Molecular Aspects of Medicine, V24, P149, DOI 10.1016/S0098-2997(03)00009-8; STROHMAIER H, 1995, J LIPID MEDIAT CELL, V11, P51, DOI 10.1016/0929-7855(94)00027-A; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Vladykovskaya E, 2012, J BIOL CHEM, V287, P11398, DOI 10.1074/jbc.M111.320416; Wagner TM, 2006, J BIOL CHEM, V281, P2598, DOI 10.1074/jbc.M509723200; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang ZG, 2012, MOL CELL ENDOCRINOL, V349, P222, DOI 10.1016/j.mce.2011.10.027; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	40	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42400	42406		10.1074/jbc.M112.385831	http://dx.doi.org/10.1074/jbc.M112.385831			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086944	Green Published, hybrid			2022-12-28	WOS:000312103000075
J	Panigrahi, GB; Slean, MM; Simard, JP; Pearson, CE				Panigrahi, Gagan B.; Slean, Meghan M.; Simard, Jodie P.; Pearson, Christopher E.			Human Mismatch Repair Protein hMutL alpha Is Required to Repair Short Slipped-DNAs of Trinucleotide Repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC POLYMORPHISMS; FUNCTIONAL-ANALYSIS; MYOTONIC-DYSTROPHY; NUCLEAR EXTRACTS; MLH1 MUTATIONS; HMLH1 GENE; CAG REPEAT; CANCER; INSTABILITY; EXPRESSION	Mismatch repair (MMR) is required for proper maintenance of the genome by protecting against mutations. The mismatch repair system has also been implicated as a driver of certain mutations, including disease-associated trinucleotide repeat instability. We recently revealed a requirement of hMutS beta in the repair of short slip-outs containing a single CTG repeat unit (1). The involvement of other MMR proteins in short trinucleotide repeat slip-out repair is unknown. Here we show that hMutL alpha is required for the highly efficient in vitro repair of single CTG repeat slip-outs, to the same degree as hMutS beta. HEK293T cell extracts, deficient in hMLH1, are unable to process single-repeat slip-outs, but are functional when complemented with hMutL alpha. The MMR-deficient hMLH1 mutant, T117M, which has a point mutation proximal to the ATP-binding domain, is defective in slip-out repair, further supporting a requirement for hMLH1 in the processing of short slip-outs and possibly the involvement of hMHL1 ATPase activity. Extracts of hPMS2-deficient HEC-1-A cells, which express hMLH1, hMLH3, and hPMS1, are only functional when complemented with hMutL alpha, indicating that neither hMutL beta nor hMutL gamma is sufficient to repair short slip-outs. The resolution of clustered short slip-outs, which are poorly repaired, was partially dependent upon a functional hMutL alpha. The joint involvement of hMutS beta and hMutL alpha suggests that repeat instability may be the result of aberrant outcomes of repair attempts.	[Panigrahi, Gagan B.; Slean, Meghan M.; Simard, Jodie P.; Pearson, Christopher E.] Hosp Sick Children, Dept Genet & Genome Biol, Toronto, ON M5G 1L7, Canada; [Slean, Meghan M.; Pearson, Christopher E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Pearson, CE (corresponding author), TMDT Bldg,101 Coll St,15th Floor,E Tower, Toronto, ON M5G 1L7, Canada.	cepearson.sickkids@gmail.com		Pearson, Christopher/0000-0001-9545-4205	Canadian Institutes of Health Research (CIHR) [MOP-97896]; Muscular Dystrophy Association Canada (Rachel Fund); Tribute Communities; Paul Wellstone Muscular Dystrophy Cooperative Research Center, National Institutes of Health [U54NS48843]; Hospital for Sick Children Research Training Competition; CIHR Collaborative Graduate Training Program in Molecular Medicine; Ontario Graduate Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS048843] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Association Canada (Rachel Fund); Tribute Communities; Paul Wellstone Muscular Dystrophy Cooperative Research Center, National Institutes of Health; Hospital for Sick Children Research Training Competition; CIHR Collaborative Graduate Training Program in Molecular Medicine(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the Canadian Institutes of Health Research (CIHR, MOP-97896), the Muscular Dystrophy Association Canada (Rachel Fund), generous support from Tribute Communities, and the Paul Wellstone Muscular Dystrophy Cooperative Research Center, National Institutes of Health Grant U54NS48843. M.M.S. was supported by studentships from The Hospital for Sick Children Research Training Competition and the CIHR Collaborative Graduate Training Program in Molecular Medicine and by an Ontario Graduate Scholarship.	An Y, 2008, LUNG CANCER, V59, P164, DOI 10.1016/j.lungcan.2007.08.003; Burmester JK, 2004, HUM HERED, V57, P172, DOI 10.1159/000081443; Cannavo E, 2005, CANCER RES, V65, P10759, DOI 10.1158/0008-5472.CAN-05-2528; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Chen PC, 2005, CANCER RES, V65, P8662, DOI 10.1158/0008-5472.CAN-05-0742; Damaraju S, 2006, CLIN CANCER RES, V12, P2545, DOI 10.1158/1078-0432.CCR-05-2703; Dieumegard B, 2000, BRIT J CANCER, V82, P871, DOI 10.1054/bjoc.1999.1014; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Glaab WE, 1998, J BIOL CHEM, V273, P26662, DOI 10.1074/jbc.273.41.26662; Gomes-Pereira M, 2004, HUM MOL GENET, V13, P1815, DOI 10.1093/hmg/ddh186; Harfe BD, 2000, CURR BIOL, V10, P145, DOI 10.1016/S0960-9822(00)00314-6; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Jager AC, 2001, ONCOGENE, V20, P3590, DOI 10.1038/sj.onc.1204467; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kondo E, 2003, CANCER RES, V63, P3302; Lee KM, 2005, CLIN CANCER RES, V11, P4620, DOI 10.1158/1078-0432.CCR-04-2534; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; Lin YF, 2009, DNA REPAIR, V8, P878, DOI 10.1016/j.dnarep.2009.04.024; LIU B, 1995, NAT GENET, V9, P48, DOI 10.1038/ng0195-48; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Mann A, 2008, EUR J CANCER, V44, P2259, DOI 10.1016/j.ejca.2008.07.010; Mathonnet G, 2003, BRIT J HAEMATOL, V123, P45, DOI 10.1046/j.1365-2141.2003.04551.x; Miret JJ, 1998, P NATL ACAD SCI USA, V95, P12438, DOI 10.1073/pnas.95.21.12438; Miret JJ, 1997, MOL CELL BIOL, V17, P3382, DOI 10.1128/MCB.17.6.3382; Moslein G, 1996, HUM MOL GENET, V5, P1245, DOI 10.1093/hmg/5.9.1245; Panariello L, 1998, Hum Mutat, V12, P216; Panigrahi GB, 2010, P NATL ACAD SCI USA, V107, P12593, DOI 10.1073/pnas.0909087107; Panigrahi GB, 2005, NAT STRUCT MOL BIOL, V12, P654, DOI 10.1038/nsmb959; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Pearson CE, 1998, NUCLEIC ACIDS RES, V26, P816, DOI 10.1093/nar/26.3.816; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; Pelletier R, 2005, NUCLEIC ACIDS RES, V33, P5667, DOI 10.1093/nar/gki880; Raschle M, 1999, J BIOL CHEM, V274, P32368, DOI 10.1074/jbc.274.45.32368; Richard GF, 1999, MOL GEN GENET, V261, P871, DOI 10.1007/s004380050031; RISINGER JI, 1995, J BIOL CHEM, V270, P18183, DOI 10.1074/jbc.270.31.18183; Risinger JI, 1998, CANCER RES, V58, P2978; Rolfsmeier ML, 2000, MOL CELL, V6, P1501, DOI 10.1016/S1097-2765(00)00146-5; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Shimodaira H, 1998, NAT GENET, V19, P384, DOI 10.1038/1277; Slean MM, 2008, DNA REPAIR, V7, P1135, DOI 10.1016/j.dnarep.2008.03.014; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Takahashi M, 2007, CANCER RES, V67, P4595, DOI 10.1158/0008-5472.CAN-06-3509; TANNERGARD P, 1995, CANCER RES, V55, P6092; Tome S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000482; Tomer G, 2002, J BIOL CHEM, V277, P21801, DOI 10.1074/jbc.M111342200; Trojan J, 2002, GASTROENTEROLOGY, V122, P211, DOI 10.1053/gast.2002.30296; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; Vietri MT, 2009, GENET TEST MOL BIOMA, V13, P193, DOI 10.1089/gtmb.2008.0088; Ward R, 2002, J CANCER RES CLIN, V128, P403, DOI 10.1007/s00432-002-0361-2; Wheeler VC, 2003, HUM MOL GENET, V12, P273, DOI 10.1093/hmg/ddg056; Wu Y, 1997, GENE CHROMOSOME CANC, V18, P269, DOI 10.1002/(SICI)1098-2264(199704)18:4<269::AID-GCC4>3.0.CO;2-Z	53	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41844	41850		10.1074/jbc.M112.420398	http://dx.doi.org/10.1074/jbc.M112.420398			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086927	Green Published, hybrid			2022-12-28	WOS:000312103000025
J	Patil, VA; Fox, JL; Gohil, VM; Winge, DR; Greenberg, ML				Patil, Vinay A.; Fox, Jennifer L.; Gohil, Vishal M.; Winge, Dennis R.; Greenberg, Miriam L.			Loss of Cardiolipin Leads to Perturbation of Mitochondrial and Cellular Iron Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR PROTEIN BIOGENESIS; OXIDATIVE STRESS-RESPONSE; CLUSTER SCAFFOLD PROTEIN; ABC TRANSPORTER ATM1P; SACCHAROMYCES-CEREVISIAE; YEAST FRATAXIN; RESPIRATORY-CHAIN; METHIONINE BIOSYNTHESIS; SUCCINATE-DEHYDROGENASE; ACONITASE DEFICIENCY	Cardiolipin (CL) is the signature phospholipid of mitochondrial membranes, where it is synthesized locally and plays a critical role in mitochondrial bioenergetic functions. The importance of CL in human health is underscored by the observation that perturbation of CL biosynthesis causes the severe genetic disorder Barth syndrome. To fully understand the cellular response to the loss of CL, we carried out genome-wide expression profiling of the yeast CL mutant crd1 Delta. Our results show that the loss of CL in this mutant leads to increased expression of iron uptake genes accompanied by elevated levels of mitochondrial iron and increased sensitivity to iron and hydrogen peroxide. Previous studies have shown that increased mitochondrial iron levels result from perturbations in iron-sulfur (Fe-S) cluster biogenesis. Consistent with an Fe-S defect, deletion of ISU1, one of two ISU genes that encode the mitochondrial Fe-S scaffolding protein essential for the synthesis of Fe-S clusters, led to synthetic growth defects with the crd1 Delta mutant. We further show that crd1 Delta cells have reduced activities of mitochondrial Fe-S enzymes (aconitase, succinate dehydrogenase, and ubiquinol-cytochrome c oxidoreductase), as well as cytosolic Fe-S enzymes (sulfite reductase and isopropylmalate isomerase). Increased expression of ATM1 or YAP1 did not rescue the Fe-S defects in crd1 Delta. These findings show for the first time that CL is required for Fe-S biogenesis to maintain mitochondrial and cellular iron homeostasis.	[Patil, Vinay A.; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Fox, Jennifer L.; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Fox, Jennifer L.; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA; [Gohil, Vishal M.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Wayne State University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Texas A&M University System; Texas A&M University College Station	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	mlgreen@sun.science.wayne.edu		Gohil, Vishal/0000-0002-9920-2563	National Institutes of Health from NIEHS [R21 HL 084218, R01 ES03817]; National Institutes of Health [T32 HL007576-25]; Barth Syndrome Foundation; Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL084218, T32HL007576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003817] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barth Syndrome Foundation; Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 HL 084218 (to M. L. G.), R01 ES03817 from NIEHS (to D. R. W.), and T32 HL007576-25 (to J. L. F.). This work was also supported by the Barth Syndrome Foundation (to M. L. G.) and graduate enhancement research funds from Wayne State University (to V. A. P.).	Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Andrew AJ, 2008, MOL BIOL CELL, V19, P5259, DOI 10.1091/mbc.E08-06-0622; Atkinson A, 2011, MOL CELL BIOL, V31, P3988, DOI 10.1128/MCB.05673-11; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Barros MH, 1999, GENE, V233, P197, DOI 10.1016/S0378-1119(99)00137-7; Barth PG, 1999, J INHERIT METAB DIS, V22, P555, DOI 10.1023/A:1005568609936; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Bleyl SB, 1997, AM J HUM GENET, V61, P868, DOI 10.1086/514879; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Burri L, 2004, J BIOL CHEM, V279, P50243, DOI 10.1074/jbc.M409194200; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Crane BR, 1997, BIOCHEMISTRY-US, V36, P12101, DOI 10.1021/bi971065q; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Davis-Kaplan SR, 2004, J BIOL CHEM, V279, P4322, DOI 10.1074/jbc.M310680200; de la Loza MDD, 2011, NUCLEIC ACIDS RES, V39, P6002, DOI 10.1093/nar/gkr193; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Foury F, 1999, FEBS LETT, V456, P281, DOI 10.1016/S0014-5793(99)00961-8; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; FRY M, 1980, BIOCHEM BIOPH RES CO, V93, P1238, DOI 10.1016/0006-291X(80)90622-1; Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882; HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422; Hausmann A, 2008, J BIOL CHEM, V283, P8318, DOI 10.1074/jbc.M705570200; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HSU YP, 1984, J BIOL CHEM, V259, P3714; Inoue Y, 1999, J BIOL CHEM, V274, P27002, DOI 10.1074/jbc.274.38.27002; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; Kaplan J, 2006, BBA-MOL CELL RES, V1763, P646, DOI 10.1016/j.bbamcr.2006.03.008; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Knight SAB, 1998, J BIOL CHEM, V273, P18389, DOI 10.1074/jbc.273.29.18389; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Leidgens S, 2010, HUM MOL GENET, V19, P276, DOI 10.1093/hmg/ddp495; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Li J, 2001, J BIOL CHEM, V276, P1503, DOI 10.1074/jbc.M007198200; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Lucau-Danila A, 2005, MOL CELL BIOL, V25, P1860, DOI 10.1128/MCB.25.5.1860-1868.2005; Ma LN, 2004, J BIOL CHEM, V279, P44394, DOI 10.1074/jbc.M405479200; Manzella L, 1998, YEAST, V14, P839, DOI 10.1002/(SICI)1097-0061(19980630)14:9<839::AID-YEA283>3.0.CO;2-A; MASSELOT M, 1975, MOL GEN GENET, V139, P121, DOI 10.1007/BF00264692; MASSELOT M, 1977, MOL GEN GENET, V154, P23, DOI 10.1007/BF00265572; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Morales JG, 2010, BIOCHEMISTRY-US, V49, P5436, DOI 10.1021/bi100558z; Moreno-Cermeno A, 2010, J BIOL CHEM, V285, P41653, DOI 10.1074/jbc.M110.149443; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; *R DEV COR TEAM, 2005, R LANG ENV STAT COMP; Radisky DC, 1997, P NATL ACAD SCI USA, V94, P5662, DOI 10.1073/pnas.94.11.5662; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Rissler M, 2005, J MOL BIOL, V353, P485, DOI 10.1016/j.jmb.2005.08.051; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; ROBINSON NC, 1993, J BIOENERG BIOMEMBR, V25, P153, DOI 10.1007/BF00762857; Runkoa AP, 2008, FEBS LETT, V582, P715, DOI 10.1016/j.febslet.2008.01.046; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schulz TJ, 2010, AGING-US, V2, P843, DOI 10.18632/aging.100234; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; SKALA J, 1991, YEAST, V7, P281, DOI 10.1002/yea.320070310; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sugiyama K, 2000, J BIOL CHEM, V275, P15535, DOI 10.1074/jbc.275.20.15535; Szklarz LKS, 2005, J MOL BIOL, V351, P206, DOI 10.1016/j.jmb.2005.05.068; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Vanoni MA, 1999, CELL MOL LIFE SCI, V55, P617, DOI 10.1007/s000180050319; Vasquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064; WEMMIE JA, 1994, J BIOL CHEM, V269, P32592; Wemmie JA, 1997, J BIOL CHEM, V272, P7908, DOI 10.1074/jbc.272.12.7908; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Yamamoto H, 2005, FEBS LETT, V579, P507, DOI 10.1016/j.febslet.2004.12.018; YOSHIMOTO A, 1968, BIOCHIM BIOPHYS ACTA, V153, P555, DOI 10.1016/0005-2728(68)90185-0; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200; Zhang Y, 2006, J BIOL CHEM, V281, P22493, DOI 10.1074/jbc.M604246200; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200	112	58	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1696	1705		10.1074/jbc.M112.428938	http://dx.doi.org/10.1074/jbc.M112.428938			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23192348	hybrid, Green Published			2022-12-28	WOS:000313751400026
J	von Schwarzenberg, K; Wiedmann, RM; Oak, P; Schulz, S; Zischka, H; Wanner, G; Efferth, T; Trauner, D; Vollmar, AM				von Schwarzenberg, Karin; Wiedmann, Romina M.; Oak, Prajakta; Schulz, Sabine; Zischka, Hans; Wanner, Gerhard; Efferth, Thomas; Trauner, Dirk; Vollmar, Angelika M.			Mode of Cell Death Induction by Pharmacological Vacuolar H+-ATPase (V-ATPase) Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON PUMP; PH HOMEOSTASIS; BAFILOMYCIN A1; IN-VITRO; HYPOXIA; APOPTOSIS; AUTOPHAGY; BNIP3; EXPRESSION; SUBUNIT	The vacuolar H+-ATPase (V-ATPase), a multisubunit proton pump, has come into focus as an attractive target in cancer invasion. However, little is known about the role of V-ATPase in cell death, and especially the underlying mechanisms remain mostly unknown. We used the myxobacterial macrolide archazolid B, a potent inhibitor of the V-ATPase, as an experimental drug as well as a chemical tool to decipher V-ATPase-related cell death signaling. We found that archazolid induced apoptosis in highly invasive tumor cells at nanomolar concentrations which was executed by the mitochondrial pathway. Prior to apoptosis induction archazolid led to the activation of a cellular stress response including activation of the hypoxia-inducible factor-1 alpha (HIF1 alpha) and autophagy. Autophagy, which was demonstrated by degradation of p62 or fusion of autophagosomes with lysosomes, was induced at low concentrations of archazolid that not yet increase pH in lysosomes. HIF1 alpha was induced due to energy stress shown by a decline of the ATP level and followed by a shutdown of energy-consuming processes. As silencing HIF1 alpha increases apoptosis, the cellular stress response was suggested to be a survival mechanism. We conclude that archazolid leads to energy stress which activates adaptive mechanisms like autophagy mediated by HIF1 alpha and finally leads to apoptosis. We propose V-ATPase as a promising drugable target in cancer therapy caught up at the interplay of apoptosis, autophagy, and cellular/metabolic stress.	[von Schwarzenberg, Karin; Wiedmann, Romina M.; Oak, Prajakta; Vollmar, Angelika M.] Univ Munich, Dept Pharm, D-81377 Munich, Germany; [Schulz, Sabine; Zischka, Hans] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Toxicol, D-80539 Neuherberg, Germany; [Wanner, Gerhard] Univ Munich, Dept Biol 1, D-81377 Munich, Germany; [Efferth, Thomas] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Dept Pharmaceut Biol, D-55099 Mainz, Germany; [Trauner, Dirk] Univ Munich, Dept Chem, D-81377 Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Johannes Gutenberg University of Mainz; University of Munich	von Schwarzenberg, K (corresponding author), Ludwig Maximilians Univ Munchen, Dept Pharm, Butenandtstr 5-13, D-81377 Munich, Germany.	karin.von.schwarzenberg@cup.uni-muenchen.de	Zischka, Hans/M-1490-2017	Zischka, Hans/0000-0002-4047-1566; Efferth, Thomas/0000-0002-3096-3292	Deutsche Forschungsgemeinschaft [FOR 1406 Vo 376/15-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grant FOR 1406 Vo 376/15-1.	Amelio I, 2011, BIOCHEM BIOPH RES CO, V414, P277, DOI 10.1016/j.bbrc.2011.09.080; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bockelmann S, 2010, J BIOL CHEM, V285, P38304, DOI 10.1074/jbc.M110.137539; Burton TR, 2009, CELL DEATH DIFFER, V16, P515, DOI 10.1038/cdd.2008.185; Cosse JP, 2010, BIOCHEM PHARMACOL, V80, P1160, DOI 10.1016/j.bcp.2010.07.009; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; Dirsch VM, 2001, CANCER RES, V61, P5817; Drose S, 1997, J EXP BIOL, V200, P1; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Huss M, 2011, EUR J CELL BIOL, V90, P688, DOI 10.1016/j.ejcb.2011.04.009; Huss Markus, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-13; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; Lebreton S, 2008, BIOORG MED CHEM LETT, V18, P5879, DOI 10.1016/j.bmcl.2008.07.003; Lim JH, 2007, MOL PHARMACOL, V71, P942, DOI 10.1124/mol.106.030296; Lopez-Anton N, 2007, APOPTOSIS, V12, P141, DOI 10.1007/s10495-006-0331-2; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mellor HR, 2007, CANCER METAST REV, V26, P553, DOI 10.1007/s10555-007-9080-0; Menche D, 2007, J AM CHEM SOC, V129, P6100, DOI 10.1021/ja071461o; Morimura T, 2008, PEDIATR SURG INT, V24, P1087, DOI 10.1007/s00383-008-2229-2; Mousavi SA, 2001, BBA-BIOMEMBRANES, V1510, P243, DOI 10.1016/S0005-2736(00)00354-0; Nakashima S, 2003, J BIOCHEM, V134, P359, DOI 10.1093/jb/mvg153; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Ohta T, 1996, BRIT J CANCER, V73, P1511, DOI 10.1038/bjc.1996.285; Petit PX, 1998, FEBS LETT, V426, P111, DOI 10.1016/S0014-5793(98)00318-4; Roethle PA, 2007, J AM CHEM SOC, V129, P8960, DOI 10.1021/ja0733033; Schneiders UM, 2009, MOL CANCER THER, V8, P2914, DOI 10.1158/1535-7163.MCT-08-1179; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Supino R, 2008, J PHARMACOL EXP THER, V324, P15, DOI 10.1124/jpet.107.128587; Teplova VV, 2007, J BIOENERG BIOMEMBR, V39, P321, DOI 10.1007/s10863-007-9095-9; Tschan MP, 2010, J INTERN MED, V268, P410, DOI 10.1111/j.1365-2796.2010.02266.x; Wang YR, 2005, J BIOL CHEM, V280, P40481, DOI 10.1074/jbc.M509106200; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wu YC, 2009, BIOCHEM BIOPH RES CO, V382, P451, DOI 10.1016/j.bbrc.2009.03.051; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Zamzami N, 2000, METHOD ENZYMOL, V322, P208; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	48	74	75	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1385	1396		10.1074/jbc.M112.412007	http://dx.doi.org/10.1074/jbc.M112.412007			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23168408	Green Published, hybrid			2022-12-28	WOS:000313570300059
J	Castro-Nunez, L; Bloem, E; Boon-Spijker, MG; van der Zwaan, C; van den Biggelaar, M; Mertens, K; Meijer, AB				Castro-Nunez, Lydia; Bloem, Esther; Boon-Spijker, Mariette G.; van der Zwaan, Carmen; van den Biggelaar, Maartje; Mertens, Koen; Meijer, Alexander B.			Distinct Roles of Ser-764 and Lys-773 at the N Terminus of von Willebrand Factor in Complex Assembly with Coagulation Factor VIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VONWILLEBRAND-FACTOR; LIGHT-CHAIN; BINDING-SITE; FACTOR IXA; FACTOR-X; DOMAIN; RESIDUES; ACTIVATION; DISEASE; ANTIBODIES	Complex formation between coagulation factor VIII (FVIII) and von Willebrand factor (VWF) is of critical importance to protect FVIII from rapid in vivo clearance and degradation. We have now employed a chemical footprinting approach to identify regions on VWF involved in FVIII binding. To this end, lysine amino acid residues of VWF were chemically modified in the presence of FVIII or activated FVIII, which does not bind VWF. Nano-LC-MS analysis showed that the lysine residues of almost all identified VWF peptides were not differentially modified upon incubation of VWF with FVIII or activated FVIII. However, Lys-773 of peptide Ser-766-Leu-774 was protected from chemical modification in the presence of FVIII. In addition, peptide Ser-764-Arg-782, which comprises the first 19 amino acid residues of matureVWF, showed a differential modification of both Lys-773 and the alpha-amino group of Ser-764. To verify the role of Lys-773 and the N-terminal Ser-764 in FVIII binding, we employed VWF variants in which either Lys-773 or Ser-764 was replaced with Ala. Surface plasmon resonance analysis and competition studies revealed that VWF(K773A) exhibited reduced binding to FVIII and the FVIII light chain, which harbors the VWF-binding site. In contrast, VWF(S764A) revealed more effective binding to FVIII and the FVIII light chain compared with WTVWF. The results of our study show that the N terminus of VWF is critical for the interaction with FVIII and that Ser-764 and Lys-773 have opposite roles in the binding mechanism.	[Castro-Nunez, Lydia; Bloem, Esther; Boon-Spijker, Mariette G.; van der Zwaan, Carmen; van den Biggelaar, Maartje; Mertens, Koen; Meijer, Alexander B.] Sanquin Res, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands; [Mertens, Koen; Meijer, Alexander B.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut Sci, NL-3584 CG Utrecht, Netherlands	Utrecht University	Meijer, AB (corresponding author), Sanquin Res, Dept Plasma Prot, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	s.meijer@sanquin.nl			Landsteiner Stichting voor Bloedtransfusieresearch [LSBR-0730]	Landsteiner Stichting voor Bloedtransfusieresearch	This work was supported by Landsteiner Stichting voor Bloedtransfusieresearch Grant LSBR-0730 (to A.B.M.).	Bendetowicz AV, 1998, BLOOD, V92, P529, DOI 10.1182/blood.V92.2.529.414k31_529_538; Bloem E, 2012, J BIOL CHEM, V287, P5775, DOI 10.1074/jbc.M111.308627; BRINKHOUS KM, 1985, P NATL ACAD SCI USA, V82, P8752, DOI 10.1073/pnas.82.24.8752; BRINKMAN HJM, 1994, BRIT J HAEMATOL, V87, P332, DOI 10.1111/j.1365-2141.1994.tb04918.x; Cierpicki T, 2000, PROTEIN SCI, V9, P976, DOI 10.1110/ps.9.5.976; Dayon L, 2010, J PROTEOMICS, V73, P769, DOI 10.1016/j.jprot.2009.10.015; DONG ZG, 1994, J BIOL CHEM, V269, P6753; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fay PJ, 2006, INT J HEMATOL, V83, P103, DOI 10.1532/IJH97.05113; FOSTER PA, 1987, J BIOL CHEM, V262, P8443; FOSTER PA, 1988, J BIOL CHEM, V263, P5230; HILLEUBANKS DC, 1990, J BIOL CHEM, V265, P17854; Jacquemin M, 2009, ACTA HAEMATOL-BASEL, V121, P102, DOI 10.1159/000214849; KOEDAM JA, 1990, EUR J BIOCHEM, V189, P229, DOI 10.1111/j.1432-1033.1990.tb15481.x; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; LEYTE A, 1991, J BIOL CHEM, V266, P740; LEYTE A, 1991, BIOCHEM J, V274, P257, DOI 10.1042/bj2740257; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; Lu JH, 2011, BLOOD, V117, P3181, DOI 10.1182/blood-2010-08-301663; Meems H, 2011, INT J BIOCHEM CELL B, V43, P1114, DOI 10.1016/j.biocel.2011.03.014; Meems H, 2009, BLOOD, V114, P3938, DOI 10.1182/blood-2009-01-197707; MERTENS K, 1985, THROMB HAEMOSTASIS, V54, P654; MORFINI M, 1993, THROMB HAEMOSTASIS, V70, P270; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Sadler JE, 2009, J THROMB HAEMOST, V7, P24, DOI 10.1111/j.1538-7836.2009.03375.x; Saenko EL, 1997, J BIOL CHEM, V272, P18007, DOI 10.1074/jbc.272.29.18007; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Schneppenheim R, 2011, J THROMB HAEMOST, V9, P209, DOI 10.1111/j.1538-7836.2011.04324.x; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; STEL HV, 1984, BLOOD, V63, P1408; TAKAHASHI Y, 1987, BLOOD, V70, P1679; van den Biggelaar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024163; van den Biggelaar M, 2009, BLOOD, V113, P3102, DOI 10.1182/blood-2008-05-159699; van Haren SD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002246; Zhou YF, 2012, BLOOD, V120, P449, DOI 10.1182/blood-2012-01-405134	36	12	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					393	400		10.1074/jbc.M112.400572	http://dx.doi.org/10.1074/jbc.M112.400572			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23168412	Green Published, hybrid			2022-12-28	WOS:000313197200040
J	Hong, TJ; Kim, S; Wi, AR; Lee, P; Kang, M; Jeong, JH; Hahn, JS				Hong, Tae-Joon; Kim, Sangkyu; Wi, Ah Ram; Lee, Peter; Kang, Miae; Jeong, Jae-Hoon; Hahn, Ji-Sook			Dynamic Nucleotide-dependent Interactions of Cysteine- and Histidine-rich Domain (CHORD)-containing Hsp90 Cochaperones Chp-1 and Melusin with Cochaperones PP5 and Sgt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE-5; DISEASE RESISTANCE; INNATE IMMUNITY; CHAPERONE MACHINERY; ATP CONCENTRATION; CO-CHAPERONE; COMPLEXES; PROTEIN-PHOSPHATASE-5; DEPHOSPHORYLATION; ACTIVATION	Mammals have two cysteine-and histidine-rich domain (CHORD)-containing Hsp90 cochaperones, Chp-1 and melusin, which are homologs of plant Rar1. It has been shown previously that Rar1 CHORD directly interacts with ADP bound to the nucleotide pocket of Hsp90. Here, we report that ADP and ATP can bind to Hsp90 cochaperones Chp-1 and PP5, inducing their conformational changes. Furthermore, we demonstrate that Chp-1 and melusin can interact with cochaperones PP5 and Sgt1 and with each other in an ATP-dependent manner. Based on the known structure of the Rar1-Hsp90 complex, His-186 has been identified as an important residue of Chp-1 for ADP/ATP binding. His-186 is necessary for the nucleotide-dependent interaction of Chp-1 not only with Hsp90 but also with Sgt1. In addition, Ca2+, which is known to bind to melusin, enhances the interactions of melusin with Hsp90 and Sgt1. Furthermore, melusin acquires the ADP preference for Hsp90 binding in the presence of Ca2+. Our newly discovered nucleotide-dependent interactions between cochaperones might provide additional complexity to the dynamics of the Hsp90 chaperone system, also suggesting potential Hsp90-independent roles for these cochaperones.	[Hong, Tae-Joon; Kim, Sangkyu; Wi, Ah Ram; Lee, Peter; Hahn, Ji-Sook] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 151744, South Korea; [Kang, Miae; Jeong, Jae-Hoon] Korea Inst Radiol & Med Sci, Res Ctr Radiotherapy, Seoul 139706, South Korea	Seoul National University (SNU); Korea Institute of Radiological & Medical Sciences	Hahn, JS (corresponding author), Seoul Natl Univ, Sch Chem & Biol Engn, 1 Gwanak Ro, Seoul 151744, South Korea.	hahnjs@snu.ac.kr	Rho, Hyunji/R-6242-2016	Rho, Hyunji/0000-0001-7650-8933; Hong, Tae-Joon/0000-0003-4636-6131	Priority Research Centers Program Grant from the National Research Foundation of Korea (NRF) [2011-0031388]; Ministry of Education, Science and Technology	Priority Research Centers Program Grant from the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Priority Research Centers Program Grant 2011-0031388 from the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology.	Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Bansal PK, 2009, J BIOL CHEM, V284, P3586, DOI 10.1074/jbc.M806281200; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; Brancaccio M, 1999, J BIOL CHEM, V274, P29282, DOI 10.1074/jbc.274.41.29282; Brancaccio M, 2003, FEBS LETT, V551, P47, DOI 10.1016/S0014-5793(03)00892-5; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; Chen MX, 1997, FEBS LETT, V400, P136, DOI 10.1016/S0014-5793(96)01427-5; Chua CS, 2010, CELL MOL LIFE SCI, V67, P1675, DOI 10.1007/s00018-010-0275-0; Conde R, 2005, J BIOL CHEM, V280, P28989, DOI 10.1074/jbc.M503594200; Correia JD, 2007, P NATL ACAD SCI USA, V104, P6764, DOI 10.1073/pnas.0610926104; Davies AE, 2010, J CELL BIOL, V189, P261, DOI 10.1083/jcb.200910036; Eckert K, 2010, J BIOL CHEM, V285, P31304, DOI 10.1074/jbc.M110.138263; Ferretti R, 2010, DEV CELL, V18, P486, DOI 10.1016/j.devcel.2009.12.020; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Gong CX, 2004, J NEUROCHEM, V88, P298, DOI 10.1046/j.1471-4159.2003.02147.x; Hahn JS, 2009, BMB REP, V42, P623, DOI 10.5483/BMBRep.2009.42.10.623; Hahn JS, 2005, FEBS LETT, V579, P4513, DOI 10.1016/j.febslet.2005.07.024; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Kadota Y, 2008, EMBO REP, V9, P1209, DOI 10.1038/embor.2008.185; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Liu F, 2005, J BIOL CHEM, V280, P1790, DOI 10.1074/jbc.M410775200; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Marcussen M, 1996, CELL MOTIL CYTOSKEL, V35, P94, DOI 10.1002/(SICI)1097-0169(1996)35:2<94::AID-CM2>3.0.CO;2-I; Martins T, 2009, EMBO J, V28, P234, DOI 10.1038/emboj.2008.283; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Michowski W, 2010, BBA-MOL CELL RES, V1803, P1043, DOI 10.1016/j.bbamcr.2010.05.005; Picard D, 2008, EMBO REP, V9, P1193, DOI 10.1038/embor.2008.208; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Ramsey AJ, 2002, BIOCHEMISTRY-US, V41, P5625, DOI 10.1021/bi016090h; Rodrigo-Brenni MC, 2004, MOL BIOL CELL, V15, P3366, DOI 10.1091/mbc.E03-12-0887; Sbroggio M, 2008, FEBS LETT, V582, P1788, DOI 10.1016/j.febslet.2008.04.058; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Tretter L, 1997, J NEUROCHEM, V69, P2529; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wandinger SK, 2006, EMBO J, V25, P367, DOI 10.1038/sj.emboj.7600930; Wang YL, 2008, MOL PLANT MICROBE IN, V21, P294, DOI 10.1094/MPMI-21-3-0294; Wang Z, 2007, MOL ENDOCRINOL, V21, P625, DOI 10.1210/me.2005-0338; Wu JC, 2005, FEBS LETT, V579, P421, DOI 10.1016/j.febslet.2004.12.005; Zhang MH, 2010, MOL CELL, V39, P269, DOI 10.1016/j.molcel.2010.05.010	43	14	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					215	222		10.1074/jbc.M112.398636	http://dx.doi.org/10.1074/jbc.M112.398636			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23184943	Green Published, hybrid			2022-12-28	WOS:000313197200021
J	Lin-Moshier, Y; Sebastian, PJ; Higgins, L; Sampson, ND; Hewitt, JE; Marchant, JS				Lin-Moshier, Yaping; Sebastian, Peter J.; Higgins, LeeAnn; Sampson, Natalie D.; Hewitt, Jane E.; Marchant, Jonathan S.			Re-evaluation of the Role of Calcium Homeostasis Endoplasmic Reticulum Protein (CHERP) in Cellular Calcium Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICING FACTOR; SUBNUCLEAR LOCALIZATION; CA2+ MOBILIZATION; RS DOMAIN; PROLIFERATION; EXPRESSION; KINETICS; RELEASE; NUCLEUS; BINDING	Changes in cytoplasmic Ca2+ concentration, resulting from activation of intracellular Ca2+ channels within the endoplasmic reticulum, regulate several aspects of cellular growth and differentiation. Ca2+ homeostasis endoplasmic reticulum protein (CHERP) is a ubiquitously expressed protein that has been proposed as a regulator of both major families of endoplasmic reticulum Ca2+ channels, inositol 1,4,5-trisphosphate receptors (IP(3)Rs) and ryanodine receptors (RyRs), with resulting effects on mitotic cycling. However, the manner by which CHERP regulates intracellular Ca2+ channels to impact cellular growth is unknown. Here, we challenge previous findings that CHERP acts as a direct cytoplasmic regulator of IP(3)Rs and RyRs and propose that CHERP acts in the nucleus to impact cellular proliferation by regulating the function of the U2 snRNA spliceosomal complex. The previously reported effects of CHERP on cellular growth therefore are likely indirect effects of altered spliceosomal function, consistent with prior data showing that loss of function of U2 snRNP components can interfere with cell growth and induce cell cycle arrest.	[Lin-Moshier, Yaping; Sebastian, Peter J.; Marchant, Jonathan S.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Higgins, LeeAnn] Univ Minnesota, Sch Med, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Sampson, Natalie D.; Hewitt, Jane E.] Univ Nottingham, Sch Biol, Queens Med Ctr, Nottingham NG7 2UH, England	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Nottingham	Marchant, JS (corresponding author), 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	march029@umn.edu	Marchant, Jonathan/Q-5484-2019; MARCHANT, Jonathan/B-8051-2009	Marchant, Jonathan/0000-0001-6592-0877; MARCHANT, Jonathan/0000-0001-6592-0877; Sampson, Natalie/0000-0001-9326-8177	National Science Foundation [NSF-DBI-0215759, 9871237]; National Institutes of Health [GM088790]; Biotechnology and Biological Sciences Research Council, UK; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088790] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Thompson and Metzger laboratories at the University of Minnesota for preparation of skeletal muscle slices and cardiac myocytes. We are also grateful for technical support from the Center for Mass Spectrometry and Proteomics at the University of Minnesota and the various supporting agencies of this facility, including National Science Foundation Major Research Instrumentation Grants NSF-DBI-0215759 and 9871237 used to purchase the core instruments used in this study.; This work was supported, in whole or in part, by National Institutes of Health Grant GM088790 (to J.S.M.).; Supported by a Ph.D. studentship from the Biotechnology and Biological Sciences Research Council, UK.	Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P342, DOI 10.1016/S0968-0004(99)01437-1; Benkusky NA, 2004, BIOCHEM BIOPH RES CO, V322, P1280, DOI 10.1016/j.bbrc.2004.08.033; Bickmore WA, 2002, EMBO J, V21, P1248, DOI 10.1093/emboj/21.6.1248; Boucher L, 2001, RNA, V7, P1693; Boulware MJ, 2008, CURR BIOL, V18, pR769, DOI 10.1016/j.cub.2008.07.018; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Chaurasia G, 2009, NUCLEIC ACIDS RES, V37, pD657, DOI 10.1093/nar/gkn841; CHOE CU, 2006, SCI STKE, pRE15; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; HEDLEY ML, 1995, P NATL ACAD SCI USA, V92, P11524, DOI 10.1073/pnas.92.25.11524; Hofmann JC, 2010, NUCLEUS-PHILA, V1, P447, DOI 10.4161/nucl.1.6.13328; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kostal V, 2011, ANAL BIOANAL CHEM, V400, P213, DOI 10.1007/s00216-011-4725-9; Kuwasako K, 2006, STRUCTURE, V14, P1677, DOI 10.1016/j.str.2006.09.009; LaPlante JM, 2000, BIOCHEM J, V348, P189, DOI 10.1042/0264-6021:3480189; Lipskaia L, 2004, BIOL CELL, V96, P55, DOI 10.1016/j.biolcel.2003.11.001; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Missiaen L, 2000, CELL CALCIUM, V28, P1, DOI 10.1054/ceca.2000.0131; Noble CG, 2005, NAT STRUCT MOL BIOL, V12, P144, DOI 10.1038/nsmb887; O'Rourke FA, 2003, BIOCHEM J, V373, P133, DOI 10.1042/BJ20030013; OROURKE F, 1994, BIOCHEM J, V300, P673, DOI 10.1042/bj3000673; Patturajan M, 1998, MOL CELL BIOL, V18, P2406, DOI 10.1128/MCB.18.4.2406; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rodenbaugh DW, 2007, AM J PHYSIOL-HEART C, V293, pH1705, DOI 10.1152/ajpheart.00232.2007; Ryan T, 2011, J BIOL CHEM, V286, P17060, DOI 10.1074/jbc.M110.197186; Rymond B, 2007, NAT CHEM BIOL, V3, P533, DOI 10.1038/nchembio0907-533; Sampson ND, 2003, GENE, V305, P91, DOI 10.1016/S0378-1119(02)01230-1; Shikata H, 2012, PLANT J, V70, P727, DOI 10.1111/j.1365-313X.2012.04937.x; SPECTOR DL, 1993, ANNU REV CELL BIOL, V9, P265, DOI 10.1146/annurev.cellbio.9.1.265; Spector DL, 2011, COLD SPRING HARBOR P, P3; Takenaka K, 2004, BIOCHEM J, V382, P223, DOI 10.1042/BJ20040521; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480	38	70	71	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					355	367		10.1074/jbc.M112.405761	http://dx.doi.org/10.1074/jbc.M112.405761			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23148228	hybrid, Green Published			2022-12-28	WOS:000313197200037
J	Liu, SL; May, JR; Helgeson, LA; Nolen, BJ				Liu, Su-Ling; May, Jordan R.; Helgeson, Luke A.; Nolen, Brad J.			Insertions within the Actin Core of Actin-related Protein 3 (Arp3) Modulate Branching Nucleation by Arp2/3 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; MOLECULAR-DYNAMICS SIMULATIONS; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; STRUCTURAL BASIS; CONFORMATIONAL-CHANGES; SACCHAROMYCES-CEREVISIAE; FILAMENT NUCLEATION; PROMOTING FACTORS; POINTED END	The Arp2/3 (actin-related protein 2/3) complex nucleates branched actin filaments involved in multiple cellular functions, including endocytosis and cellular motility. Two subunits (Arp2 and Arp3) in this seven-subunit assembly are closely related to actin and upon activation of the complex form a "cryptic dimer" that stably mimics an actin dimer to nucleate a new filament. Both Arps contain a shared actin core structure, and each Arp contains multiple insertions of unknown function at conserved positions within the core. Here we characterize three key insertions within the actin core of Arp3 and show that each one plays a distinct role in modulating Arp2/3 function. The beta 4/beta 5 insert mediates interactions of Arp2/3 complex with actin filaments and "dampers" the nucleation activity of the complex. The Arp3 hydrophobic plug plays an important role in maintaining the integrity of the complex but is not absolutely required for formation of the daughter filament nucleus. Deletion of the alpha K/beta 15 insert did not constitutively activate the complex, as previously hypothesized. Instead, it abolished in vitro nucleation activity and caused defects in endocytic actin patch assembly in fission yeast, indicating a role for the alpha K/beta 15 insert in the activated state of the complex. Biochemical characterization of each mutant revealed steps in the nucleation pathway influenced by each Arp3-specific insert to provide new insights into the structural basis of activation of the complex.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Oregon, Dept Chem, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Nolen, BJ (corresponding author), 1229 Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	bnolen@uoregon.edu		Nolen, Brad/0000-0002-0224-9980	National Institutes of Health [GM092917]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759, R01GM092917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM092917 (to B.J.N).	Achard V, 2010, CURR BIOL, V20, P423, DOI 10.1016/j.cub.2009.12.056; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beltzner CC, 2004, J MOL BIOL, V336, P551, DOI 10.1016/j.jmb.2003.12.017; Beltzner CC, 2008, J BIOL CHEM, V283, P7135, DOI 10.1074/jbc.M705894200; Berro J, 2010, MOL BIOL CELL, V21, P2905, DOI 10.1091/mbc.E10-06-0494; Cabrera R, 2011, YEAST, V28, P495, DOI 10.1002/yea.1853; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; D'Agostino JL, 2005, GENETICS, V171, P35, DOI 10.1534/genetics.105.040634; Dalhaimer P, 2008, J MOL BIOL, V376, P166, DOI 10.1016/j.jmb.2007.11.068; Dalhaimer P, 2010, BIOPHYS J, V99, P2568, DOI 10.1016/j.bpj.2010.08.027; Daugherty KM, 2008, J BIOL CHEM, V283, P16950, DOI 10.1074/jbc.M800783200; Dayel MJ, 2001, P NATL ACAD SCI USA, V98, P14871, DOI 10.1073/pnas.261419298; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Fenn S, 2011, EMBO J, V30, P2153, DOI 10.1038/emboj.2011.118; Firat-Karalar EN, 2011, CURR OPIN CELL BIOL, V23, P4, DOI 10.1016/j.ceb.2010.10.007; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Goley ED, 2010, P NATL ACAD SCI USA, V107, P8159, DOI 10.1073/pnas.0911668107; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Irobi E, 2004, EMBO J, V23, P3599, DOI 10.1038/sj.emboj.7600372; Ishiguro J, 1996, FEBS LETT, V392, P237, DOI 10.1016/0014-5793(96)00819-8; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; KEENEY JB, 1994, GENETICS, V136, P849; Kreishman-Deitrick M, 2005, BIOCHEMISTRY-US, V44, P15247, DOI 10.1021/bi051065n; Kuang B, 1997, J BIOL CHEM, V272, P1237, DOI 10.1074/jbc.272.2.1237; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Liu SL, 2011, J BIOL CHEM, V286, P17039, DOI 10.1074/jbc.M111.219964; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Miki H, 1998, BIOCHEM BIOPH RES CO, V243, P73, DOI 10.1006/bbrc.1997.8064; Moreau V, 1996, J CELL BIOL, V134, P117, DOI 10.1083/jcb.134.1.117; Muller J, 2005, MOL BIOL CELL, V16, P5736, DOI 10.1091/mbc.E05-06-0508; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; Narita A, 2011, EMBO J, V30, P1230, DOI 10.1038/emboj.2011.48; Nolen BJ, 2004, P NATL ACAD SCI USA, V101, P15627, DOI 10.1073/pnas.0407149101; Nolen BJ, 2008, J BIOL CHEM, V283, P26490, DOI 10.1074/jbc.M802607200; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Pfaendtner J, 2012, J MOL BIOL, V416, P148, DOI 10.1016/j.jmb.2011.12.025; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Shvetsov A, 2008, J MOL BIOL, V375, P793, DOI 10.1016/j.jmb.2007.10.076; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Takeda T, 2005, CURR BIOL, V15, P1331, DOI 10.1016/j.cub.2005.07.009; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Winter D, 1997, CURR BIOL, V7, P519, DOI 10.1016/S0960-9822(06)00223-5; Xu XP, 2012, EMBO J, V31, P236, DOI 10.1038/emboj.2011.343; YU FX, 1991, J BIOL CHEM, V266, P19269; Zalevsky J, 2001, J BIOL CHEM, V276, P3468, DOI 10.1074/jbc.M006407200	60	16	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					487	497		10.1074/jbc.M112.406744	http://dx.doi.org/10.1074/jbc.M112.406744			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23148219	Green Published, hybrid			2022-12-28	WOS:000313197200049
J	Rather, MI; Nagashri, MN; Swamy, SS; Gopinath, KS; Kumar, A				Rather, Mohammad Iqbal; Nagashri, Mathighatta N.; Swamy, Shivananda S.; Gopinath, Kodaganur S.; Kumar, Arun			Oncogenic MicroRNA-155 Down-regulates Tumor Suppressor CDC73 and Promotes Oral Squamous Cell Carcinoma Cell Proliferation IMPLICATIONS FOR CANCER THERAPEUTICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HRPT2 GENE; PRIMARY HYPERPARATHYROIDISM; ENCODING PARAFIBROMIN; PARATHYROID CARCINOMA; TRANSGENIC MICE; PAF1 COMPLEX; EXPRESSION; MIR-155; RNA; METHYLATION	The CDC73 gene is mutationally inactivated in hereditary and sporadic parathyroid tumors. It negatively regulates beta-catenin, cyclin D1, and c-MYC. Down-regulation of CDC73 has been reported in breast, renal, and gastric carcinomas. However, the reports regarding the role of CDC73 in oral squamous cell carcinoma (OSCC) are lacking. In this study we show that CDC73 is down-regulated in a majority of OSCC samples. We further show that oncogenic microRNA-155 (miR-155) negatively regulates CDC73 expression. Our experiments show that the dramatic up-regulation of miR-155 is an exclusive mechanism for down-regulation of CDC73 in a panel of human cell lines and a subset of OSCC patient samples in the absence of loss of heterozygosity, mutations, and promoter methylation. Ectopic expression of miR-155 in HEK293 cells dramatically reduced CDC73 levels, enhanced cell viability, and decreased apoptosis. Conversely, the delivery of a miR-155 antagonist (antagomir-155) to KB cells overexpressing miR-155 resulted in increased CDC73 levels, decreased cell viability, increased apoptosis, and marked regression of xenografts in nude mice. Cotransfection of miR-155 with CDC73 in HEK293 cells abrogated its pro-oncogenic effect. Reduced cell proliferation and increased apoptosis of KB cells were dependent on the presence or absence of the 3'-UTR in CDC73. In summary, knockdown of CDC73 expression due to overexpression of miR-155 not only adds a novelty to the list of mechanisms responsible for its down-regulation in different tumors, but the restoration of CDC73 levels by the use of antagomir-155 may also have an important role in therapeutic intervention of cancers, including OSCC.	[Rather, Mohammad Iqbal; Nagashri, Mathighatta N.; Kumar, Arun] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Swamy, Shivananda S.; Gopinath, Kodaganur S.] Bangalore Inst Oncol, Dept Surg Oncol, Bangalore 560027, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Kumar, A (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	karun@mrdg.iisc.ernet.in	Kumar, Arun/C-9149-2009	Kumar, Arun/0000-0001-8422-0219	University Grants Commission (New Delhi)	University Grants Commission (New Delhi)(University Grants Commission, India)	This work was supported by the University Grants Commission (New Delhi).	Aldred MJ, 2006, ORAL SURG ORAL MED O, V101, P214, DOI 10.1016/j.tripleo.2005.06.01; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bradley KJ, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032201; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Cetani F, 2004, J CLIN ENDOCR METAB, V89, P5583, DOI 10.1210/jc.2004-0294; Chakraborty S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-163; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Daskalova E, 2006, EVOL BIOINFORM, V2, P103; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Hahn MA, 2010, ENDOCR-RELAT CANCER, V17, P273, DOI 10.1677/ERC-09-0291; Hewitt KM, 2007, ANN OTO RHINOL LARYN, V116, P928, DOI 10.1177/000348940711601210; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; James RG, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000230; Jiang L, 2011, HUM GENET, V129, P189, DOI 10.1007/s00439-010-0915-3; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mehrotra R, 2006, Indian J Cancer, V43, P60; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Pimenta FJ, 2006, ORAL ONCOL, V42, P735, DOI 10.1016/j.oraloncology.2005.11.019; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Sharbati-Tehrani S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-34; Shattuck TM, 2003, NEW ENGL J MED, V349, P1722, DOI 10.1056/NEJMoa031237; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang PF, 2005, HORM METAB RES, V37, P380, DOI 10.1055/s-2005-870150; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wu S, 2012, ONCOGENE, V31, P3866, DOI 10.1038/onc.2011.551; Xiqiang L., 2009, COMP FUNCT GENOMICS; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; Zhang C, 2006, BIOCHEM BIOPH RES CO, V350, P17, DOI 10.1016/j.bbrc.2006.08.169; Zhang WY, 2007, AM J PATHOL, V171, P728, DOI 10.2353/ajpath.2007.070070; Zheng LA, 2010, BIOCHEM BIOPH RES CO, V400, P483, DOI 10.1016/j.bbrc.2010.08.067	46	85	88	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					608	618		10.1074/jbc.M112.425736	http://dx.doi.org/10.1074/jbc.M112.425736			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23166327	Green Published, hybrid			2022-12-28	WOS:000313197200061
J	Gottschalk, AJ; Trivedi, RD; Conaway, JW; Conaway, RC				Gottschalk, Aaron J.; Trivedi, Rushi D.; Conaway, Joan W.; Conaway, Ronald C.			Activation of the SNF2 Family ATPase ALC1 by Poly(ADP-ribose) in a Stable ALC1.PARP1.Nucleosome Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; CHROMATIN; CHD1L; GLYCOHYDROLASE; RIBOSE); PARP-1	The human ALC1/CHD1L oncogene encodes an SNF2 family ATPase with a macrodomain that binds poly(ADP-ribose) (PAR). We and others previously showed that ALC1 possesses a cryptic ATP-dependent nucleosome remodeling activity that is potently activated in the presence of PARP1 and NAD(+), its substrate for PAR synthesis. In this work, we dissected the mechanism by which PARP1 and NAD(+) activate ALC1 nucleosome remodeling. We demonstrate that ALC1 activation depends on the formation of a stable ALC1.PARylated PARP1.nucleosome intermediate. In addition, by exploiting a novel PAR footprinting assay, we obtained evidence that the ALC1 macrodomain remains stably associated with PAR on autoPARylated PARP1 during the course of nucleosome remodeling reactions. Taken together, our findings are consistent with the model that PAR present on PARylated PARP1 acts as an allosteric effector of ALC1 nucleosome remodeling activity.	[Gottschalk, Aaron J.; Trivedi, Rushi D.; Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Trivedi, Rushi D.; Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Conaway, JW (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlc@stowers.org; rcc@stowers.org		Conaway, Joan/0000-0002-2786-0663	National Institutes of Health Grant from NIGMS [GM41628]; Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041628, R37GM041628] Funding Source: NIH RePORTER	National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM41628 from NIGMS (to J. W. C. and R. C. C.). This work was also supported by a grant to the Stowers Institute from the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Brockschmidt A, 2012, NEPHROL DIAL TRANSPL, V27, P2355, DOI 10.1093/ndt/gfr649; Chen LL, 2010, J CLIN INVEST, V120, P1178, DOI 10.1172/JCI40665; Chen MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006727; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Gutierrez JL, 2007, EMBO J, V26, P730, DOI 10.1038/sj.emboj.7601524; Kim IK, 2012, NAT STRUCT MOL BIOL, V19, P653, DOI 10.1038/nsmb.2305; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; MIWA M, 1974, J BIOL CHEM, V249, P3475; Owen-Hughes T, 1999, METH MOL B, V119, P319; PURNELL MR, 1980, BIOCHEM J, V185, P775, DOI 10.1042/bj1850775; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664	15	44	44	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43527	43532		10.1074/jbc.M112.401141	http://dx.doi.org/10.1074/jbc.M112.401141			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23132853	Green Published, hybrid			2022-12-28	WOS:000312940800033
J	Oberg, EA; Nifoussi, SK; Gingras, AC; Strack, S				Oberg, Elizabeth A.; Nifoussi, Shanna K.; Gingras, Anne-Claude; Strack, Stefan			Selective Proteasomal Degradation of the B 'beta Subunit of Protein Phosphatase 2A by the E3 Ubiquitin Ligase Adaptor Kelch-like 15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE PHOSPHATASES; SUBSTRATE ADAPTER; TYROSINE-HYDROXYLASE; REGULATORY SUBUNITS; CRYSTAL-STRUCTURE; CORE ENZYME; HUMAN-CELLS; HOLOENZYME; PP2A; PATHWAY	Protein phosphatase 2A (PP2A), a ubiquitous and pleiotropic regulator of intracellular signaling, is composed of a core dimer (AC) bound to a variable (B) regulatory subunit. PP2A is an enzyme family of dozens of heterotrimers with different subcellular locations and cellular substrates dictated by the B subunit. B'beta is a brain-specific PP2A regulatory subunit that mediates dephosphorylation of Ca2+/calmodulin-dependent protein kinase II and tyrosine hydroxylase. Unbiased proteomic screens for B'beta interactors identified Cullin3 (Cul3), a scaffolding component of E3 ubiquitin ligase complexes, and the previously uncharacterized Kelch-like 15 (KLHL15). KLHL15 is one of similar to 40 Kelch-like proteins, many of which have been identified as adaptors for the recruitment of substrates to Cul3-based E3 ubiquitin ligases. Here, we report that KLHL15-Cul3 specifically targets B'beta to promote turnover of the PP2A subunit by ubiquitylation and proteasomal degradation. Comparison of KLHL15 and B'beta tissue expression profiles suggests that the E3 ligase adaptor contributes to selective expression of the PP2A/B'beta holoenzyme in the brain. We mapped KLHL15 residues critical for homodimerization as well as interaction with Cul3 and B'beta. Explaining PP2A subunit selectivity, the divergent N terminus of B'beta was found necessary and sufficient for KLHL15-mediated degradation, with Tyr-52 having an obligatory role. Although KLHL15 can interact with the PP2A/B'beta heterotrimer, it only degrades B'beta, thus promoting exchange with other regulatory subunits. E3 ligase adaptor-mediated control of PP2A holoenzyme composition thereby adds another layer of regulation to cellular dephosphorylation events.	[Oberg, Elizabeth A.; Nifoussi, Shanna K.; Strack, Stefan] Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; [Gingras, Anne-Claude] Univ Toronto, Samuel Lunenfeld Inst, Toronto, ON M5G 1X5, Canada	University of Iowa; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Strack, S (corresponding author), Univ Iowa, Carver Coll Med, Dept Pharmacol, 51 Newton Rd,2-432 BSB, Iowa City, IA 52242 USA.	stefan-strack@uiowa.edu	Gingras, Anne-Claude/E-9982-2010; Gingras, Anne-Claude/ABA-8341-2020	Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Strack, Stefan/0000-0002-6175-7280	National Institutes of Health [NS043254, NS056244, NS057714]; Canadian Institutes of Health Research [MOP-84314]; American Heart Association Predoctoral Fellowship [0715634Z]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057714, R01NS056244, R56NS056244, R01NS043254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS043254, NS056244, and NS057714 (to S. S.). This work was also supported by the Canadian Institutes of Health Research Grant MOP-84314 (to A.-C. G.) and American Heart Association Predoctoral Fellowship 0715634Z (to S. K. N.).	Allen E, 2005, NATURE, V438, P224, DOI 10.1038/nature04256; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen GI, 2007, METHODS, V42, P298, DOI 10.1016/j.ymeth.2007.02.018; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dunham WH, 2011, PROTEOMICS, V11, P2603, DOI 10.1002/pmic.201000571; Fukunaga K, 2000, J NEUROCHEM, V74, P807, DOI 10.1046/j.1471-4159.2000.740807.x; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kigoshi Y, 2011, J BIOL CHEM, V286, P33613, DOI 10.1074/jbc.M111.245126; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Laezza F, 2008, NEUROPHARMACOLOGY, V55, P1131, DOI 10.1016/j.neuropharm.2008.07.021; Li XC, 2004, J BIOL CHEM, V279, P54750, DOI 10.1074/jbc.M410073200; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Nam S, 2009, J BIOL CHEM, V284, P8192, DOI 10.1074/jbc.M808230200; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; Rondou P, 2008, J BIOL CHEM, V283, P11083, DOI 10.1074/jbc.M708473200; Ruediger R, 1999, J VIROL, V73, P839, DOI 10.1128/JVI.73.1.839-842.1999; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; Saraf A, 2007, J BIOL CHEM, V282, P573, DOI 10.1074/jbc.M607407200; Saraf A, 2010, BIOCHEMISTRY-US, V49, P986, DOI 10.1021/bi902160t; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Sumara I, 2007, CELL CYCLE, V6, P3004, DOI 10.4161/cc.6.24.5068; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; van den Heuvel S, 2004, CURR BIOL, V14, pR59, DOI 10.1016/j.cub.2003.12.044; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yang J, 2010, LIFE SCI, V87, P659, DOI 10.1016/j.lfs.2010.10.003; Yatsenko AN, 2006, HUM MOL GENET, V15, P3411, DOI 10.1093/hmg/ddl417; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	45	24	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43378	43389		10.1074/jbc.M112.420281	http://dx.doi.org/10.1074/jbc.M112.420281			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23135275	hybrid, Green Published			2022-12-28	WOS:000312940800019
J	Sayed, N; Nonin-Lecomte, S; Rety, S; Felden, B				Sayed, Nour; Nonin-Lecomte, Sylvie; Rety, Stephane; Felden, Brice			Functional and Structural Insights of a Staphylococcus aureus Apoptotic-like Membrane Peptide from a Toxin-Antitoxin Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIA; DYNAMICS; SYSTEMS; RNAS; DISCOVERY; PROTEINS; MODEL	We report a functional type I toxin-antitoxin (TA) module expressed by a human pathogen, Staphylococcus aureus. TA-systems consist of stable toxins and labile antitoxins encoded within small genetic modules widespread in eubacteria and archaea. TA genes provide stress adaptation and protection against DNA loss or invasion. The genes encoding the SprA1 toxic peptide (PepA1) and the SprA1(AS) RNA antitoxin are within a pathogenicity island on opposite strands and possess a 3' overlap. To prevent peptide toxicity during S. aureus growth, PepA1 expression from stable (half-life > 3 h) SprA1 is repressed by elevated amounts of unstable (half-life = similar to 10 mn) SprA1(AS). In vivo, PepA1 localizes at the bacterial membrane and triggers S. aureus death. Based on NMR and CD data, its solution structure was solved and is a long bent, interrupted helix. Molecular dynamics simulations indicate that PepA1 compaction and helical content fluctuate in accordance with its cytoplasm or membrane location. When inserted into the S. aureus membrane, the PepA1 conformation switches to a similar to 7-nm-long continuous helix, presumably forming pores to alter membrane integrity. PepA1 expression is induced upon acidic and oxidative stresses by reducing SprA1(AS) levels. As an altruistic behavior during infection, some cells may induce the expression of that toxin that would facilitate departure from the host immune cells for spreading.	[Nonin-Lecomte, Sylvie; Rety, Stephane] CNRS, UMR 8015, Lab Cristallog & RMN Biol, F-75270 Paris 06, France; [Sayed, Nour; Felden, Brice] Univ Rennes 1, INSERM U835, Upres EA2311, F-35043 Rennes, France; [Nonin-Lecomte, Sylvie; Rety, Stephane] Univ Paris 05, Fac Pharm, F-75270 Paris 06, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; UDICE-French Research Universities; Universite Paris Cite	Nonin-Lecomte, S (corresponding author), CNRS, UMR 8015, Lab Cristallog & RMN Biol, F-75270 Paris 06, France.	snonin@parisdescartes.fr; bfelden@univ-rennes1.fr	Rety, Stephane/L-9870-2019; felden, brice/L-4825-2015	Rety, Stephane/0000-0002-2089-6727; Nonin-Lecomte, Sylvie/0000-0001-5155-8088	Agence Nationale pour la Recherche [ANR-09-MIEN-030-01]; INSERM; CNRS; Brittany; Fondation pour la Recherche Medicale; French Department of Research and Education	Agence Nationale pour la Recherche(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Brittany; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Department of Research and Education	This work was supported by Grant ANR-09-MIEN-030-01 from the Agence Nationale pour la Recherche (to B. F. and S. N.-L.), funds from the INSERM and the CNRS, a doctoral grant from Brittany (to N. S.), a grant from the Fondation pour la Recherche Medicale (to N. S.), and funds from the French Department of Research and Education.	Alix E, 2009, MOL MICROBIOL, V72, P5, DOI 10.1111/j.1365-2958.2009.06626.x; Beaume M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010725; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bohn C, 2010, NUCLEIC ACIDS RES, V38, P6620, DOI 10.1093/nar/gkq462; Burkhart BM, 1999, BIOPOLYMERS, V51, P129, DOI 10.1002/(SICI)1097-0282(1999)51:2<129::AID-BIP3>3.0.CO;2-Y; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Felden B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002006; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Fischer J, 1996, J CHROMATOGR B, V681, P3, DOI 10.1016/0378-4347(95)00538-2; Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; Gobl C, 2010, BIOCHEMISTRY-US, V49, P6567, DOI 10.1021/bi1005128; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Kandasamy SK, 2006, BIOPHYS J, V90, P2326, DOI 10.1529/biophysj.105.073395; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Nilges M, 2008, STRUCTURE, V16, P1305, DOI 10.1016/j.str.2008.07.008; Pashkov VS, 1999, FEBS LETT, V457, P117, DOI 10.1016/S0014-5793(99)01023-6; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Romilly C, 2012, RNA BIOL, V9, P402, DOI 10.4161/rna.20103; Sayed N, 2012, NAT STRUCT MOL BIOL, V19, P105, DOI 10.1038/nsmb.2193; Standberg E., 2004, CONCEPTS MAGN REAS A, V23A, P89; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang G., 2008, OPEN MAGN RESON J, V1, P9; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412	27	54	55	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43454	43463		10.1074/jbc.M112.402693	http://dx.doi.org/10.1074/jbc.M112.402693			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129767	hybrid, Green Published			2022-12-28	WOS:000312940800026
J	Skeldal, S; Sykes, AM; Glerup, S; Matusica, D; Palstra, N; Autio, H; Boskovic, Z; Madsen, P; Castren, E; Nykjaer, A; Coulson, EJ				Skeldal, Sune; Sykes, Alex M.; Glerup, Simon; Matusica, Dusan; Palstra, Nickless; Autio, Henri; Boskovic, Zoran; Madsen, Peder; Castren, Eero; Nykjaer, Anders; Coulson, Elizabeth J.			Mapping of the Interaction Site between Sortilin and the p75 Neurotrophin Receptor Reveals a Regulatory Role for the Sortilin Intracellular Domain in p75 Neurotrophin Receptor Shedding and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; ACTIVATION; DEATH; LIGAND; PRONGF; PRONEUROTROPHIN-3; TRANSPORT; P75(NTR); CLEAVAGE; SURVIVAL	Neurotrophins comprise a group of neuronal growth factors that are essential for the development and maintenance of the nervous system. However, the immature pro-neurotrophins promote apoptosis by engaging in a complex with sortilin and the p75 neurotrophin receptor (p75(NTR)). To identify the interaction site between sortilin and p75(NTR), we analyzed binding between chimeric receptor constructs and truncated p75(NTR) variants by co-immunoprecipitation experiments, surface plasmon resonance analysis, and FRET. We found that complex formation between sortilin and p75(NTR) relies on contact points in the extracellular domains of the receptors. We also determined that the interaction critically depends on an extracellular juxtamembrane 23-amino acid sequence of p75(NTR). Functional studies further revealed an important regulatory function of the sortilin intracellular domain in p75(NTR)-regulated intramembrane proteolysis and apoptosis. Thus, although the intracellular domain of sortilin does not contribute to p75(NTR) binding, it does regulate the rates of p75(NTR) cleavage, which is required to mediate pro-neurotrophin-stimulated cell death.	[Skeldal, Sune; Glerup, Simon; Madsen, Peder; Nykjaer, Anders; Coulson, Elizabeth J.] Univ Aarhus, Dept Biomed, Lundbeck Fdn Res Ctr MIND, DK-8000 Aarhus C, Denmark; [Skeldal, Sune; Sykes, Alex M.; Matusica, Dusan; Palstra, Nickless; Boskovic, Zoran; Coulson, Elizabeth J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Autio, Henri; Castren, Eero] Univ Helsinki, Neurosci Ctr, FIN-00014 Helsinki, Finland	Aarhus University; Lundbeckfonden; University of Queensland; University of Helsinki	Coulson, EJ (corresponding author), Univ Aarhus, Dept Biomed, Lundbeck Fdn Res Ctr MIND, DK-8000 Aarhus C, Denmark.	an@biokemi.au.dk	Matusica, Dusan/G-8138-2011; Boskovic, Zoran/Y-2764-2018; Coulson, Elizabeth J./C-8766-2009	Matusica, Dusan/0000-0001-6472-7653; Boskovic, Zoran/0000-0002-9867-1827; Coulson, Elizabeth J./0000-0003-3783-6197; Skeldal, Sune/0000-0002-3268-289X; Castren, Eero/0000-0002-1402-2791; Nykjaer, Anders/0000-0001-6422-6736; Sykes, Alex/0000-0001-8981-6652; Madsen, Peder Sondergaard/0000-0002-8845-4802	Lundbeck Foundation; National Health and Medical Research Council of Australia; Finnish Graduate School of Neuroscience; Sigrid Juselius Foundation; Academy of Finland Center of Excellence program	Lundbeck Foundation(Lundbeckfonden); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Finnish Graduate School of Neuroscience; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland Center of Excellence program(Academy of Finland)	This work was supported by the by the Lundbeck Foundation, the National Health and Medical Research Council of Australia, the Finnish Graduate School of Neuroscience, the Sigrid Juselius Foundation, and Academy of Finland Center of Excellence program.	Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Bronfman FC, 2007, DEV NEUROBIOL, V67, P1183, DOI 10.1002/dneu.20513; Ceni C, 2010, J CELL SCI, V123, P2299, DOI 10.1242/jcs.062612; Coulson EJ, 2000, J BIOL CHEM, V275, P30537, DOI 10.1074/jbc.M005214200; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Frade JM, 1998, BIOESSAYS, V20, P137, DOI 10.1002/(SICI)1521-1878(199802)20:2<137::AID-BIES6>3.0.CO;2-Q; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hauburger A, 2007, FEBS LETT, V581, P4159, DOI 10.1016/j.febslet.2007.07.063; Hermey G, 2006, BIOCHEM J, V395, P285, DOI 10.1042/BJ20051364; Jacobsen L, 2001, J BIOL CHEM, V276, P22788, DOI 10.1074/jbc.M100857200; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kenchappa RS, 2010, J BIOL CHEM, V285, P20358, DOI 10.1074/jbc.M109.082834; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kommaddi RP, 2011, FASEB J, V25, P2061, DOI 10.1096/fj.10-173740; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Mohler WA, 1996, P NATL ACAD SCI USA, V93, P12423, DOI 10.1073/pnas.93.22.12423; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Nykjaer A, 2012, TRENDS NEUROSCI, V35, P261, DOI 10.1016/j.tins.2012.01.003; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Schlondorff J, 1999, J CELL SCI, V112, P3603; Skeldal S, 2011, BIOESSAYS, V33, P614, DOI 10.1002/bies.201100036; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Sykes AM, 2012, J BIOL CHEM, V287, P43810, DOI 10.1074/jbc.M112.382903; Tauris J, 2011, EUR J NEUROSCI, V33, P622, DOI 10.1111/j.1460-9568.2010.07556.x; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Urra S, 2007, J BIOL CHEM, V282, P7606, DOI 10.1074/jbc.M610458200; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Yano H, 2009, J NEUROSCI, V29, P14790, DOI 10.1523/JNEUROSCI.2059-09.2009; Zareen N, 2009, JOVE-J VIS EXP, V23, pe988	34	35	40	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43798	43809		10.1074/jbc.M112.374710	http://dx.doi.org/10.1074/jbc.M112.374710			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23105113	Green Published, hybrid			2022-12-28	WOS:000312940800058
J	Hayes, SD; Liu, H; MacDonald, E; Sanderson, CM; Coulson, JM; Clague, MJ; Urbe, S				Hayes, Sebastian D.; Liu, Han; MacDonald, Ewan; Sanderson, Christopher M.; Coulson, Judy M.; Clague, Michael J.; Urbe, Sylvie			Direct and Indirect Control of Mitogen-activated Protein Kinase Pathway-associated Components, BRAP/IMP E3 Ubiquitin Ligase and CRAF/RAF1 Kinase, by the Deubiquitylating Enzyme USP15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYMES; SIGNALING COMPLEXES; T-CELLS; DOMAIN; DEGRADATION; SENSITIVITY; INHIBITORS; KSR1; BRAF; P21	The opposing regulators of ubiquitylation status, E3 ligases and deubiquitylases, are often found to be associated in complexes. Here we report on a novel interaction between the E3 ligase BRAP (also referred to as IMP), a negative regulator of the MAPK scaffold protein KSR, and two closely related deubiquitylases, USP15 and USP4. We map the interaction to the N-terminal DUSP-UBL domain of USP15 and the coiled coil region of BRAP. USP15 as well as USP4 oppose the autoubiquitylation of BRAP, whereas BRAP promotes the ubiquitylation of USP15. Importantly, USP15 but not USP4 depletion destabilizes BRAP by promoting its proteasomal degradation, and BRAP-protein levels can be rescued by reintroducing catalytically active but not inactive mutant USP15. Unexpectedly, USP15 depletion results in a decrease in amplitude of MAPK signaling in response to EGF and PDGF. We provide evidence for a model in which the dominant effect of prolonged USP15 depletion upon signal amplitude is due to a decrease in CRAF levels while allowing for the possibility that USP15 may also function to dampen MAPK signaling through direct stabilization of a negative regulator, the E3 ligase BRAP.	[Hayes, Sebastian D.; Liu, Han; MacDonald, Ewan; Sanderson, Christopher M.; Coulson, Judy M.; Clague, Michael J.; Urbe, Sylvie] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Clague, MJ (corresponding author), Univ Liverpool, Inst Translat Med, Crown St, Liverpool L69 3BX, Merseyside, England.	clague@liv.ac.uk; urbe@liv.ac.uk	Clague, Michael J/A-7199-2008; Urbe, Sylvie/S-1433-2018	Clague, Michael J/0000-0003-3355-9479; Urbe, Sylvie/0000-0003-4735-9814; Liu, Han/0000-0002-0014-4675; MacDonald, Ewan/0000-0001-7594-6552; HAYES, SEBASTIAN/0000-0002-2383-9461; Coulson, Judy/0000-0003-2191-2001	Cancer Research United Kingdom; Wellcome Trust; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom	Cancer Research United Kingdom(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Cancer Research United Kingdom Senior Fellowship.; Recipient of a Wellcome Trust Prize studentship. Present address: Dept. of Cell Biology, Harvard Medical School, Boston, MA 02115.; Recipient of a Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom research studentship.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Asada M, 2004, MOL CELL BIOL, V24, P8236, DOI 10.1128/MCB.24.18.8236-8243.2004; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BECK TW, 1990, MOL CELL BIOL, V10, P3325, DOI 10.1128/MCB.10.7.3325; Brooks CL, 2007, ONCOGENE, V26, P7262, DOI 10.1038/sj.onc.1210531; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Chiu YH, 2009, CHEM REV, V109, P1549, DOI 10.1021/cr800554j; Czyzyk J, 2008, J BIOL CHEM, V283, P23004, DOI 10.1074/jbc.M804084200; de Jong RN, 2006, J BIOL CHEM, V281, P5026, DOI 10.1074/jbc.M510993200; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Elliott PR, 2011, FEBS LETT, V585, P3385, DOI 10.1016/j.febslet.2011.09.040; Faronato M., 2010, USP15 UBIQUITIN SPEC; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Inui M, 2011, NAT CELL BIOL, V13, P1368, DOI 10.1038/ncb2346; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; Lin J, 2009, MOL CELL BIOL, V29, P2082, DOI 10.1128/MCB.01634-08; Liu H, 2012, SEMIN CELL DEV BIOL, V23, P509, DOI 10.1016/j.semcdb.2012.01.014; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Matheny SA, 2006, METHOD ENZYMOL, V407, P237, DOI 10.1016/S0076-6879(05)07020-5; Matheny SA, 2009, J BIOL CHEM, V284, P11007, DOI 10.1074/jbc.R800082200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Smith FD, 2002, CURR BIOL, V12, pR32, DOI 10.1016/S0960-9822(01)00646-7; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Winters BS, 2006, MOL BIOL CELL, V17, P3386, DOI 10.1091/mbc.E05-09-0849; Xu LZ, 2010, CURR BIOL, V20, P1372, DOI 10.1016/j.cub.2010.06.051; Ye Y, 2009, MOL BIOSYST, V5, P1797, DOI 10.1039/b907669g; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	42	37	39	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43007	43018		10.1074/jbc.M112.386938	http://dx.doi.org/10.1074/jbc.M112.386938			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105109	Green Published, hybrid			2022-12-28	WOS:000312501600057
J	Berger, G; Turpin, J; Cordeil, S; Tartour, K; Nguyen, XN; Mahieux, R; Cimarelli, A				Berger, Gregory; Turpin, Jocelyn; Cordeil, Stephanie; Tartour, Kevin; Nguyen, Xuan-Nhi; Mahieux, Renaud; Cimarelli, Andrea			Functional Analysis of the Relationship between Vpx and the Restriction Factor SAMHD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DENDRITIC CELLS; MACROPHAGE INFECTION; NUCLEAR-LOCALIZATION; ACCESSORY PROTEINS; UBIQUITIN LIGASE; HIV-1; RNA; TRANSDUCTION; MUTATIONS	SAMHD1 is a newly identified restriction factor that targets lentiviruses in myeloid cells and is countered by the SIVSM/HIV-2 Vpx protein. By analyzing a large panel of Vpx mutants, we identify several residues throughout the 3-helix bundle predicted for Vpx that impair both its functionality and its ability to degrade SAMHD1. We determine that SAMHD1 is a strictly non-shuttling nuclear protein and that as expected WT Vpx localizes with it in the nucleus. However, we also identify a functional Vpx mutant with predominant cytoplasmic distribution that colocalizes with SAMHD1 in this location, suggesting that Vpx may also retain SAMHD1 in the cell cytoplasm, prior to its entry into the nucleus. Several mutations in Vpx were shown to affect the stability of Vpx, as well as Vpx: Vpx interactions. However, no strict correlation was observed between these parameters and the functionality of Vpx, implying that neither properties is absolutely required for this function and indicating that even unstable Vpx mutants may be very efficient in inducing SAMHD1 degradation. Overall, our analysis identifies several Vpx residues required for SAMHD1 degradation and points to a very efficient and plastic mechanism through which Vpx depletes this restriction factor.	[Berger, Gregory; Turpin, Jocelyn; Cordeil, Stephanie; Tartour, Kevin; Nguyen, Xuan-Nhi; Mahieux, Renaud; Cimarelli, Andrea] Univ Lyon 1, Dept Human Virol, ENS L, INSERM,U758, F-69364 Lyon, France; [Berger, Gregory; Turpin, Jocelyn; Cordeil, Stephanie; Tartour, Kevin; Nguyen, Xuan-Nhi; Mahieux, Renaud; Cimarelli, Andrea] US8, UMS3444, F-69364 Lyon, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Cimarelli, A (corresponding author), Univ Lyon 1, Dept Human Virol, ENS L, INSERM,U758, 46 Allee Italie, F-69364 Lyon, France.	acimarel@ens-lyon.fr		Turpin, Jocelyn/0000-0001-5177-2471; CIMARELLI, Andrea/0000-0003-0892-0488; mahieux, renaud/0000-0002-5129-6804	ANRS; ENS-L; FRM; InCa; Sidaction; Cluster 10 Region Rhone-Alpes; ENS-Lyon	ANRS(ANRSFrench National Research Agency (ANR)); ENS-L; FRM(Fondation pour la Recherche Medicale); InCa(Institut National du Cancer (INCA) France); Sidaction; Cluster 10 Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); ENS-Lyon	This work was supported by the ANRS, the ENS-L, the FRM, the InCa, and Sidaction.; A PhD student financed by the Cluster 10 Region Rhone-Alpes.; A PhD student financed by the ANRS.; Supported by the ENS-Lyon.	Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Arfi V, 2009, J VIROL, V83, P7524, DOI 10.1128/JVI.00429-09; Ayinde D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-35; Baldauf H. M., 2012, NAT MED IN PRESS; Belshan M, 2006, VIROLOGY, V346, P118, DOI 10.1016/j.virol.2005.10.036; Belshan M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-32; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Berger A, 2010, J BIOL CHEM, V285, P12248, DOI 10.1074/jbc.M109.090977; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Boyd MT, 2011, J CELL BIOL, V194, P689, DOI 10.1083/jcb.201105143; Brandariz-Nunez A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-49; Cimarelli A, 2000, J VIROL, V74, P3046, DOI 10.1128/JVI.74.7.3046-3057.2000; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Goncalves A, 2012, HUM MUTAT, V33, P1116, DOI 10.1002/humu.22087; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08; Hiriart E, 2003, J BIOL CHEM, V278, P335, DOI 10.1074/jbc.M208656200; Hofmann H., 2012, J VIROL IN PRESS; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Kewalramani VN, 1996, VIROLOGY, V218, P159, DOI 10.1006/viro.1996.0176; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Kumar PR, 2005, J BIOL CHEM, V280, P8553, DOI 10.1074/jbc.M407863200; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; OBRIEN WA, 1994, J VIROL, V68, P1258, DOI 10.1128/JVI.68.2.1258-1263.1994; Pertel T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-49; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Triques K, 2004, J VIROL, V78, P5523, DOI 10.1128/JVI.78.10.5523-5527.2004	38	26	27	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41210	41217		10.1074/jbc.M112.403816	http://dx.doi.org/10.1074/jbc.M112.403816			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23076149	Green Published, hybrid			2022-12-28	WOS:000311887600036
J	Lu, YZ; Li, JZ; Cheng, DM; Parameswaran, B; Zhang, SH; Jiang, ZF; Yew, PR; Peng, JM; Ye, QN; Hu, YF				Lu, Yunzhe; Li, Jiezhi; Cheng, Dongmei; Parameswaran, Balaji; Zhang, Shaohua; Jiang, Zefei; Yew, P. Renee; Peng, Junmin; Ye, Qinong; Hu, Yanfen			The F-box Protein FBXO44 Mediates BRCA1 Ubiquitination and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORADIC BREAST; OVARIAN-CANCER; BRCA1/BARD1 HETERODIMER; POLYUBIQUITIN CHAINS; TUMOR-SUPPRESSOR; FREQUENT LOSS; E3 LIGASE; EXPRESSION; IDENTIFICATION; COMPLEX	BRCA1 mutations account for a significant proportion of familial breast and ovarian cancers. In addition, reduced BRCA1 protein is associated with sporadic cancer cases in these tissues. At the cellular level, BRCA1 plays a critical role in multiple cellular functions such as DNA repair and cell cycle checkpoint control. Its protein level is regulated in a cell cycle-dependent manner. However, regulation of BRCA1 protein stability is not fully understood. Our earlier study showed that the amino terminus of BRCA1 harbors a degron sequence that is sufficient and necessary for conferring BRCA1 degradation. In the current study, we used mass spectrometry to identify Skp1 that regulates BRCA1 protein stability. Small interfering RNA screening that targets all human F-box proteins uncovered FBXO44 as an important protein that influences BRCA1 protein level. The Skp1-Cul1-F-box-protein44 (SCFFBXO44) complex ubiquitinates full-length BRCA1 in vitro. Furthermore, the N terminus of BRCA1 mediates the interaction between BRCA1 and FBXO44. Overexpression of SCFFBXO44 reduces BRCA1 protein level. Taken together, our work strongly suggests that SCFFBXO44 is an E3 ubiquitin ligase responsible for BRCA1 degradation. In addition, FBXO44 expression pattern in breast carcinomas suggests that SCFFBXO44-mediated BRCA1 degradation might contribute to sporadic breast tumor development.	[Li, Jiezhi; Ye, Qinong] Beijing Inst Biotechnol, Dept Mol Oncol, Beijing 100850, Peoples R China; [Lu, Yunzhe; Parameswaran, Balaji; Yew, P. Renee; Hu, Yanfen] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, Inst Biotechnol, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Li, Jiezhi; Peng, Junmin] Emory Univ, Sch Med, Dept Human Genet, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Zhang, Shaohua; Jiang, Zefei] Acad Mil Med Sci, Hosp 307, Dept Breast Canc, Beijing 100071, Peoples R China	Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Emory University; Academy of Military Medical Sciences - China	Ye, QN (corresponding author), Beijing Inst Biotechnol, Dept Mol Oncol, Beijing 100850, Peoples R China.	yeqn66@yahoo.com; huy3@uthscsa.edu	Peng, Junmin/N-2614-2018; zhang, shaohua/GXA-1772-2022	Peng, Junmin/0000-0003-0472-7648; Lu, Yunzhe/0000-0001-7542-6848; Parameswaran, Balaji/0000-0002-1665-4872	National Institutes of Health [R01CA118578]; cancer center support grant from the American Cancer Society [P30CA054174]; American Cancer Society [RSG-09-181-01]; Major State Basic Research Development Program [2011CB504202]; National Natural Science Foundation [81072173]; NATIONAL CANCER INSTITUTE [R01CA118578, P30CA054174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); cancer center support grant from the American Cancer Society; American Cancer Society(American Cancer Society); Major State Basic Research Development Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by National Institutes of Health Grant (to Y. H.) R01CA118578 and the cancer center support grant P30CA054174, a Research Scholar Grant RSG-09-181-01 from the American Cancer Society (to J. P.) and Major State Basic Research Development Program 2011CB504202 and National Natural Science Foundation 81072173 (to Q. Y.).	Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Catteau A, 1999, ONCOGENE, V18, P1957, DOI 10.1038/sj.onc.1202509; Chan KYK, 2002, CANCER RES, V62, P4151; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Glenn KA, 2008, J BIOL CHEM, V283, P12717, DOI 10.1074/jbc.M709508200; Horwitz AA, 2007, P NATL ACAD SCI USA, V104, P6614, DOI 10.1073/pnas.0610481104; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Ilyin GP, 2002, GENE, V296, P11, DOI 10.1016/S0378-1119(02)00867-3; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Lambie H, 2003, J PATHOL, V200, P207, DOI 10.1002/path.1348; Lu YZ, 2007, MOL ENDOCRINOL, V21, P651, DOI 10.1210/me.2006-0188; MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; Ohta T, 2004, ONCOGENE, V23, P2079, DOI 10.1038/sj.onc.1207371; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Russell PA, 2000, INT J CANCER, V87, P317, DOI 10.1002/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Wu WW, 2010, CANCER RES, V70, P6384, DOI 10.1158/0008-5472.CAN-10-1304; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yoshikawa K, 1999, CLIN CANCER RES, V5, P1249; Yoshikawa K, 2000, INT J CANCER, V88, P28, DOI 10.1002/1097-0215(20001001)88:1<28::AID-IJC5>3.0.CO;2-4; Zhang H, 2005, J BIOL CHEM, V280, P43188, DOI 10.1074/jbc.M506598200	30	35	35	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41014	41022		10.1074/jbc.M112.407106	http://dx.doi.org/10.1074/jbc.M112.407106			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23086937	Green Published, hybrid			2022-12-28	WOS:000311887600019
J	Yun, J; Nagai, T; Furukawa-Hibi, Y; Kuroda, K; Kaibuchi, K; Greenberg, ME; Yamada, K				Yun, Jaesuk; Nagai, Taku; Furukawa-Hibi, Yoko; Kuroda, Keisuke; Kaibuchi, Kozo; Greenberg, Michael E.; Yamada, Kiyofumi			Neuronal Per Arnt Sim (PAS) Domain Protein 4 (NPAS4) Regulates Neurite Outgrowth and Phosphorylation of Synapsin I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL NEUROGENESIS; TRANSCRIPTION; KINASE; DIFFERENTIATION; MEMORY; GENE; SPECIFICATION; ACTIVATION; PLASTICITY; CDK5	Neuronal Per Arnt Sim domain protein 4 (NPAS4), a brain-specific basic helix-loop-helix transcription factor, has recently been shown to regulate the development of the GABAergic inhibitory synapses and transcription program for contextual memory formation in the hippocampus. We previously reported that chronic social isolation or restriction stress in mice resulted in an impairment in memory and emotional behavior, which was associated with a decrease in Npas4 mRNA levels. In this study, we investigated the role of NPAS4 in neuronal function in vitro and in vivo. Differentiation medium-induced neurite outgrowth was inhibited in Npas4 knockdown Neuro2a cells, whereas overexpression of NPAS4 accelerated the neurite outgrowth in Neuro2a cells. Furthermore, depolarization-induced neurite outgrowth was abolished in Npas4 KO hippocampal neurons. NPAS4 overexpression increased cyclin-dependent kinase 5 (CDK5)-dependent synapsin I phosphorylation in Neuro2a cells and primary cultured hippocampal neurons. A CDK5 inhibitor, roscovitine, inhibited the neurite outgrowth and the increase in phosphorylated synapsin I (p-SYN I) levels in Npas4-overexpressed Neuro2a cells. Interaction of NPAS4 with promoters of Cdk5 and NeuN genes was demonstrated by a chromatin immunoprecipitation assay. In an in vivo study, pentylenetetrazole-induced convulsions in mice resulted in an increase in NPAS4 and p-SYN I levels in the prefrontal cortex of wild-type mice, although no changes in p-SYN I levels were observed in Npas4 knock-out mice. These results suggest that NPAS4 plays an important role in the structural and functional plasticity of neurons.	[Yun, Jaesuk; Nagai, Taku; Furukawa-Hibi, Yoko; Yamada, Kiyofumi] Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Nagoya, Aichi 4668560, Japan; [Kuroda, Keisuke; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi 4668560, Japan; [Greenberg, Michael E.] Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp, Boston, MA 02115 USA; [Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Nagoya University; Nagoya University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Yamada, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Nagoya, Aichi 4668560, Japan.	kyamada@med.nagoya-u.ac.jp	Sokabe, Masahiro/I-1565-2012; Kuroda, Keisuke/K-5255-2013; Yamada, Kiyofumi/I-7487-2014; Kaibuchi, Kozo/M-4887-2014; Nagai, Taku/I-7507-2014	Kuroda, Keisuke/0000-0002-6715-5125; Yamada, Kiyofumi/0000-0002-5280-5180; Kaibuchi, Kozo/0000-0003-0714-1992; Nagai, Taku/0000-0001-5050-7748	Japan Society for the Promotion of Science [22390046, 23659135, 23790081]; Ministry of Education, Culture, Sports, Science and Technology; Global-Center of Excellence Program from the Ministry of Education, Culture, Sports, Science and Technology; CREST from Japan Science and Technology Agency; Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry [24-12]; Agriculture, Forestry and Fisheries Research Council Project; Nobiletin Research and Development Consortium; Smoking Research Foundation Grant for Biomedical Research; Uehara Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global-Center of Excellence Program from the Ministry of Education, Culture, Sports, Science and Technology; CREST from Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry; Agriculture, Forestry and Fisheries Research Council Project; Nobiletin Research and Development Consortium; Smoking Research Foundation Grant for Biomedical Research; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported in part by Grants-in-aid for Scientific Research 22390046, 23659135, and 23790081, Exploratory Research from Japan Society for the Promotion of Science, "Integrated Research on Neuropsychiatric Disorders" and "Bioinformatics for Brain Sciences" carried out under the Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science and Technology, the Global-Center of Excellence Program from the Ministry of Education, Culture, Sports, Science and Technology, CREST from Japan Science and Technology Agency, Intramural Research Grant 24-12 for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry, Agriculture, Forestry and Fisheries Research Council Project, Nobiletin Research and Development Consortium, Smoking Research Foundation Grant for Biomedical Research, and The Uehara Memorial Foundation.	BECKER A, 1995, PHARMACOL BIOCHEM BE, V52, P765, DOI 10.1016/0091-3057(95)00175-V; Bonanomi D, 2005, J NEUROSCI, V25, P7299, DOI 10.1523/JNEUROSCI.1573-05.2005; Brunskill EW, 1999, MECH DEVELOP, V88, P237, DOI 10.1016/S0925-4773(99)00182-3; Bykhovskaia M, 2011, SEMIN CELL DEV BIOL, V22, P387, DOI 10.1016/j.semcdb.2011.07.003; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Cheung Zelda H., 2007, Biotechnology Journal, V2, P949, DOI 10.1002/biot.200700056; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; Erbel-Sieler C, 2004, P NATL ACAD SCI USA, V101, P13648, DOI 10.1073/pnas.0405310101; Evangelopoulos ME, 2009, J NEUROSCI RES, V87, P2138, DOI 10.1002/jnr.22025; Evangelopoulos ME, 2005, ONCOGENE, V24, P3309, DOI 10.1038/sj.onc.1208494; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Flood WD, 2004, EUR J NEUROSCI, V20, P1819, DOI 10.1111/j.1460-9568.2004.03646.x; Fornasiero EF, 2010, CELL MOL LIFE SCI, V67, P1383, DOI 10.1007/s00018-009-0227-8; Garcia-Perez J, 1999, J NEUROSCI RES, V57, P261, DOI 10.1002/(SICI)1097-4547(19990715)57:2<261::AID-JNR12>3.0.CO;2-4; Havrda MC, 2008, J NEUROSCI, V28, P14074, DOI 10.1523/JNEUROSCI.3188-08.2008; Ibi D, 2008, J NEUROCHEM, V105, P921, DOI 10.1111/j.1471-4159.2007.05207.x; Ide M, 2005, HUM GENET, V117, P520, DOI 10.1007/s00439-005-1342-8; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Le Be JV, 2006, P NATL ACAD SCI USA, V103, P13214, DOI 10.1073/pnas.0604691103; Lee S, 2009, NEURON, V62, P641, DOI 10.1016/j.neuron.2009.04.025; Levy M, 2003, J BIOL CHEM, V278, P17727, DOI 10.1074/jbc.M212878200; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; Moser M, 2004, MOL BRAIN RES, V128, P141, DOI 10.1016/j.molbrainres.2004.06.023; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Ooe N, 2009, J BIOL CHEM, V284, P1057, DOI 10.1074/jbc.M805196200; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Pautot S, 2008, NAT METHODS, V5, P735, DOI 10.1038/nmeth.1236; Pickard BS, 2009, MOL PSYCHIATR, V14, P874, DOI 10.1038/mp.2008.24; Pickard BS, 2006, ANN MED, V38, P439, DOI 10.1080/07853890600946500; Pieper AA, 2005, P NATL ACAD SCI USA, V102, P14052, DOI 10.1073/pnas.0506713102; Ploski JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023760; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Russo SJ, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.059; SCHRODER H, 1993, J NEUROCHEM, V60, P1007, DOI 10.1111/j.1471-4159.1993.tb03248.x; Shamloo M, 2006, EUR J NEUROSCI, V24, P2705, DOI 10.1111/j.1460-9568.2006.05172.x; Shimizu N, 2009, BIOL PHARM BULL, V32, P999, DOI 10.1248/bpb.32.999; Shupliakov O, 2011, SEMIN CELL DEV BIOL, V22, P393, DOI 10.1016/j.semcdb.2011.07.006; Soylemezoglu F, 2003, PATHOL RES PRACT, V199, P463, DOI 10.1078/0344-0338-00446; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Yun J, 2010, J NEUROCHEM, V114, P1840, DOI 10.1111/j.1471-4159.2010.06893.x; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	47	29	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2655	2664		10.1074/jbc.M112.413310	http://dx.doi.org/10.1074/jbc.M112.413310			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23172225	Green Published, hybrid			2022-12-28	WOS:000314211500050
J	Park, K; Botelho, SC; Hong, J; Osterberg, M; Kim, H				Park, Kwangjin; Botelho, Salome Calado; Hong, Joonki; Osterberg, Marie; Kim, Hyun			Dissecting Stop Transfer versus Conservative Sorting Pathways for Mitochondrial Inner Membrane Proteins in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M-AAA PROTEASE; CYTOCHROME BC(1) COMPLEX; SACCHAROMYCES-CEREVISIAE; INTERMEMBRANE SPACE; SUCCINATE-DEHYDROGENASE; IMPORT MOTOR; TRANSMEMBRANE DOMAINS; PRECURSOR PROTEINS; YEAST; SUBUNIT	Mitochondrial inner membrane proteins that carry an N-terminal presequence are sorted by one of two pathways: stop transfer or conservative sorting. However, the sorting pathway is known for only a small number of proteins, in part due to the lack of robust experimental tools with which to study. Here we present an approach that facilitates determination of inner membrane protein sorting pathways in vivo by fusing a mitochondrial inner membrane protein to the C-terminal part of Mgm1p containing the rhomboid cleavage region. We validated the Mgm1 fusion approach using a set of proteins for which the sorting pathway is known, and determined sorting pathways of inner membrane proteins for which the sorting mode was previously uncharacterized. For Sdh4p, a multispanning membrane protein, our results suggest that both conservative sorting and stop transfer mechanisms are required for insertion. Furthermore, the sorting process of Mgm1 fusion proteins was analyzed under different growth conditions and yeast mutant strains that were defective in the import motor or the m-AAA protease function. Our results show that the sorting of mitochondrial proteins carrying moderately hydrophobic transmembrane segments is sensitive to cellular conditions, implying that mitochondrial import and membrane sorting in the physiological environment may be dynamically tuned.	[Park, Kwangjin; Hong, Joonki; Kim, Hyun] Seoul Natl Univ, Sch Biol Sci, Seoul 151747, South Korea; [Botelho, Salome Calado; Osterberg, Marie] Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Seoul National University (SNU); Stockholm University	Kim, H (corresponding author), Seoul Natl Univ, Sch Biol Sci, Bldg 504-421, Seoul 151747, South Korea.	joy@snu.ac.kr		Osterberg, Marie/0000-0002-7439-3754	National Research Foundation of Korea [2012-0001935, C00048]; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/36107/2007]	National Research Foundation of Korea(National Research Foundation of Korea); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Basic Research Grant 2012-0001935 and Global Research Network Grant C00048 from the National Research Foundation of Korea (to H. K.).; Recipient of Graduate Student Fellowship SFRH/BD/36107/2007 from Fundacao para a Ciencia e a Tecnologia, Portugal.	Arnold I, 1998, J BIOL CHEM, V273, P1469, DOI 10.1074/jbc.273.3.1469; Baumann F, 2002, J BIOL CHEM, V277, P21405, DOI 10.1074/jbc.M201670200; BEASLEY EM, 1993, EMBO J, V12, P2303, DOI 10.1002/j.1460-2075.1993.tb05884.x; Bohnert M, 2010, CURR BIOL, V20, P1227, DOI 10.1016/j.cub.2010.05.058; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Bonn F, 2011, EMBO J, V30, P2545, DOI 10.1038/emboj.2011.169; Botelho SC, 2011, EMBO J, V30, P1003, DOI 10.1038/emboj.2011.29; BRANDT U, 1994, J BIOL CHEM, V269, P12947; BUCHWALD P, 1991, MOL GEN GENET, V229, P413, DOI 10.1007/BF00267464; BULLIS BL, 1994, J BIOL CHEM, V269, P6543; Carlson CG, 2003, J BIOL CHEM, V278, P3770, DOI 10.1074/jbc.M209893200; Cui TZ, 2012, MOL CELL BIOL, V32, P4400, DOI 10.1128/MCB.00441-12; CUMSKY MG, 1987, MOL CELL BIOL, V7, P3511, DOI 10.1128/MCB.7.10.3511; Dibrov E, 1998, J BIOL CHEM, V273, P32042, DOI 10.1074/jbc.273.48.32042; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Frazier AE, 2003, MOL CELL BIOL, V23, P7818, DOI 10.1128/MCB.23.21.7818-7828.2003; Funes S, 2004, FEBS LETT, V569, P89, DOI 10.1016/j.febslet.2004.05.055; Gaume B, 1998, EMBO J, V17, P6497, DOI 10.1093/emboj/17.22.6497; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Graef M, 2007, MOL CELL BIOL, V27, P2476, DOI 10.1128/MCB.01721-06; Hanekamp T, 1996, MOL CELL BIOL, V16, P2764; Harner M, 2011, EMBO J, V30, P3232, DOI 10.1038/emboj.2011.235; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Herrmann JM, 2003, IUBMB LIFE, V55, P219, DOI 10.1080/1521654031000123349; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; Herrmann JM, 1997, EMBO J, V16, P2217, DOI 10.1093/emboj/16.9.2217; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Klanner C, 2000, FEBS LETT, V470, P365, DOI 10.1016/S0014-5793(00)01322-3; Korbel D, 2004, EMBO REP, V5, P698, DOI 10.1038/sj.embor.7400186; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Lemaire C, 2004, J BIOL CHEM, V279, P47464, DOI 10.1074/jbc.M404861200; Leonhard K, 1996, EMBO J, V15, P4218, DOI 10.1002/j.1460-2075.1996.tb00796.x; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Lode A, 2002, YEAST, V19, P909, DOI 10.1002/yea.883; MAARSE AC, 1987, EUR J BIOCHEM, V165, P419, DOI 10.1111/j.1432-1033.1987.tb11455.x; Meier S, 2005, J CELL BIOL, V170, P881, DOI 10.1083/jcb.200505126; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Messerschmitt M, 2003, J CELL BIOL, V160, P553, DOI 10.1083/jcb.200211113; MILLER BR, 1993, J CELL BIOL, V121, P1021, DOI 10.1083/jcb.121.5.1021; Mokranjac D, 2009, MOL BIOL CELL, V20, P1400, DOI 10.1091/mbc.E08-09-0934; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; ONO H, 1995, J BIOL CHEM, V270, P16932, DOI 10.1074/jbc.270.28.16932; Oyedotun KS, 1997, J BIOL CHEM, V272, P31382, DOI 10.1074/jbc.272.50.31382; Preuss M, 2001, J CELL BIOL, V153, P1085, DOI 10.1083/jcb.153.5.1085; Rojo EE, 1998, J BIOL CHEM, V273, P8040, DOI 10.1074/jbc.273.14.8040; Saracco SA, 2002, MOL BIOL CELL, V13, P1122, DOI 10.1091/mbc.01-12-0580; Schilke BA, 2012, GENETICS, V190, P1341, DOI 10.1534/genetics.112.138743; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; SCHWARZ E, 1993, EMBO J, V12, P2295, DOI 10.1002/j.1460-2075.1993.tb05883.x; Smith PM, 2012, BBA-BIOENERGETICS, V1817, P276, DOI 10.1016/j.bbabio.2011.11.009; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; van der Laan M, 2010, BBA-MOL CELL RES, V1803, P732, DOI 10.1016/j.bbamcr.2010.01.013; VANLOON APGM, 1987, EMBO J, V6, P2433, DOI 10.1002/j.1460-2075.1987.tb02522.x; VANLOON APGM, 1986, CELL, V44, P801, DOI 10.1016/0092-8674(86)90846-9; Wegener N, 2011, MOL CELL, V44, P191, DOI 10.1016/j.molcel.2011.07.036; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013	60	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1521	1532		10.1074/jbc.M112.409748	http://dx.doi.org/10.1074/jbc.M112.409748			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184936	Green Published, hybrid			2022-12-28	WOS:000313751400010
J	Silverstein, N; Crisman, TJ; Forrest, LR; Kanner, BI				Silverstein, Nechama; Crisman, Thomas J.; Forrest, Lucy R.; Kanner, Baruch I.			Cysteine Scanning Mutagenesis of Transmembrane Helix 3 of a Brain Glutamate Transporter Reveals Two Conformationally Sensitive Positions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC-ACID TRANSPORTER; CONTROLS CATION INTERACTIONS; RAT-BRAIN; SUBSTRATE INTERACTIONS; MEMBRANE-VESICLES; BINDING; GLT-1; RESIDUE; SODIUM; MUTATION	Glutamate transporters in the brain remove the neurotransmitter from the synapse by cotransport with three sodium ions into the surrounding cells. Recent structural work on an archaeal homolog suggests that, during substrate translocation, the transport domain, including the peripheral transmembrane helix 3 (TM3), moves relative to the trimerization domain in an elevator-like process. Moreover, two TM3 residues have been proposed to form part of a transient Na3' site, and another, Tyr-124, appears close to both Na3' and Na1. To obtain independent evidence for the role of TM3 in glutamate transport, each of its 31 amino acid residues from the glial GLT-1 transporter was individually mutated to cysteine. Except for six mutants, substantial transport activity was detected. Aqueous accessibility of the introduced cysteines was probed with membrane-permeant and membrane-impermeant sulfhydryl reagents under a variety of conditions. Transport of six single cysteine mutants, all located on the intracellular side of TM3, was affected by membrane-permeant sulfhydryl reagents. However, only at two positions could ligands modulate the reactivity. A120C reactivity was diminished under conditions expected to favor the outward-facing conformation of the transporter. Sulfhydryl modification of Y124C by 2-aminoethyl methanethiosulfonate, but not by N-ethylmaleimide, was fully protected in the presence of sodium. Our data are consistent with the idea that TM3 moves during transport. Moreover, computational modeling indicated that electrostatic repulsion between the positive charge introduced at position 124 and the sodium ions bound at Na3' and Na1 underlies the protection by sodium.	[Silverstein, Nechama; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel; [Crisman, Thomas J.; Forrest, Lucy R.] Max Planck Inst Biophys, Computat Struct Biol Grp, D-60438 Frankfurt, Germany	Hebrew University of Jerusalem; Max Planck Society	Forrest, LR (corresponding author), Max Planck Inst Biophys, Computat Struct Biol Grp, Max von Laue Str 3, D-60438 Frankfurt, Germany.	lucy.forrest@biophys.mpg.de; baruch.kanner@mail.huji.ac.il	Forrest, Lucy/E-8113-2016	Forrest, Lucy/0000-0003-1855-7985; Crisman, Thomas/0000-0001-6235-8110	National Institutes of Health from NINDS [NS16708]; United States-Israel Binational Science Foundation [2007051]; German Research Council (DFG) Collaborative Research Group 807 "Transport and Communication across Membranes"; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016708, R56NS016708] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); German Research Council (DFG) Collaborative Research Group 807 "Transport and Communication across Membranes"(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS16708 from NINDS (to B. I. K). This work was also supported by United States-Israel Binational Science Foundation Grant 2007051 (to B. I. K.) and by German Research Council (DFG) Collaborative Research Group 807 "Transport and Communication across Membranes" (to L. R. F.).	Bastug T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033058; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; Forrest LR, 2005, PROTEINS, V61, P296, DOI 10.1002/prot.20601; Frisch M. J., 2009, GAUSSIAN 09 REVISION; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; GRUNEWALD M, 1995, J BIOL CHEM, V270, P17017, DOI 10.1074/jbc.270.28.17017; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Holley DC, 2009, PHILOS T R SOC B, V364, P155, DOI 10.1098/rstb.2008.0246; Huang ZJ, 2010, BIOPHYS J, V99, P1416, DOI 10.1016/j.bpj.2010.06.052; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Menaker D, 2006, J NEUROCHEM, V99, P20, DOI 10.1111/j.1471-4159.2006.04003.x; NELSON PJ, 1983, BIOCHEMISTRY-US, V22, P5459, DOI 10.1021/bi00292a030; Nina M, 1997, J PHYS CHEM B, V101, P5239, DOI 10.1021/jp970736r; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Rosental N, 2011, J BIOL CHEM, V286, P41381, DOI 10.1074/jbc.M111.291021; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2012, J BIOL CHEM, V287, P17198, DOI 10.1074/jbc.M112.355040; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	54	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					964	973		10.1074/jbc.M112.403576	http://dx.doi.org/10.1074/jbc.M112.403576			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23188832	Green Published, hybrid			2022-12-28	WOS:000313570300021
J	Schellekens, H; van Oeffelen, WEPA; Dinan, TG; Cryan, JF				Schellekens, Harriet; van Oeffelen, Wesley E. P. A.; Dinan, Timothy G.; Cryan, John F.			Promiscuous Dimerization of the Growth Hormone Secretagogue Receptor (GHS-R1a) Attenuates Ghrelin-mediated Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; GENE-TRANSFER; HIGH-AFFINITY; CROSS-TALK; SEROTONIN; PROTEIN; REWARD; BRAIN; SYSTEM; FOOD	G protein-coupled receptors (GPCRs), such as the ghrelin receptor (GHS-R1a), the melanocortin 3 receptor (MC3), and the serotonin 2C receptor (5-HT2C), are well known for their key role in the homeostatic control of food intake and energy balance. Ghrelin is the only known gut peptide exerting an orexigenic effect and has thus received much attention as an antiobesity drug target. In addition, recent data have revealed a critical role for ghrelin in dopaminergic mesolimbic circuits involved in food reward signaling. This study investigates the downstream signaling consequences and ligand-mediated co-internalization following heterodimerization of the GHS-R1a receptor with the dopamine 1 receptor, as well as that of the GHS-R1a-MC3 heterodimer. In addition, a novel heterodimer between the GHS-R1a receptor and the 5-HT2C receptor was identified. Interestingly, dimerization of the GHS-R1a receptor with the unedited 5-HT2C-INI receptor, but not with the partially edited 5-HT2C-VSV isoform, significantly reduced GHS-R1a agonist-mediated calcium influx, which was completely restored following pharmacological blockade of the 5-HT2C receptor. These results combined suggest a potential novel mechanism for fine-tuning GHS-R1a receptor-mediated activity via promiscuous dimerization of the GHS-R1a receptor with other G protein-coupled receptors involved in appetite regulation and food reward. These findings may uncover novel mechanisms of significant relevance for the future pharmacological targeting of the GHS-R1a receptor in the homeostatic regulation of energy balance and in hedonic appetite signaling, both of which play a significant role in the development of obesity.	[Cryan, John F.] Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Food Hlth Ireland, Cork, Ireland; [Dinan, Timothy G.; Cryan, John F.] Natl Univ Ireland Univ Coll Cork, Lab Neurogastroenterol, Alimentary Pharmabiot Ctr, Cork, Ireland; [Dinan, Timothy G.] Natl Univ Ireland Univ Coll Cork, Dept Psychiat, Cork, Ireland; [Schellekens, Harriet; van Oeffelen, Wesley E. P. A.] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland	Teagasc; University College Cork; University College Cork; University College Cork; University College Cork	Cryan, JF (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Food Hlth Ireland, 386 Western Gateway Bldg, Cork, Ireland.	j.cryan@ucc.ie	Cryan, John F./A-6950-2013; Dinan, Timothy/ABA-8284-2020	Cryan, John F./0000-0001-5887-2723; Dinan, Timothy/0000-0002-2316-7220; Schellekens, Harriet/0000-0002-6065-3797	Enterprise Ireland [CC20080001]; Science Foundation Ireland [02/CE/B124, 07/CE/B1368]; Science Foundation Ireland through the Irish Government; European Community [201714]	Enterprise Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Science Foundation Ireland through the Irish Government(Science Foundation Ireland); European Community(European Commission)	The work was supported by Enterprise Ireland under Grant CC20080001 and by Science Foundation Ireland Grants 02/CE/B124 and 07/CE/B1368.; Supported in part by Science Foundation Ireland in the form of a grant to the Alimentary Pharmabiotic Centre through the Irish Government's National Development Plan.; Supported by the European Community's Seventh Framework Programme Grant FP7/2007-2013, Grant Agreement 201714.	Adan RAH, 2006, BRIT J PHARMACOL, V149, P815, DOI 10.1038/sj.bjp.0706929; Alex KD, 2007, PHARMACOL THERAPEUT, V113, P296, DOI 10.1016/j.pharmthera.2006.08.004; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Berg KA, 2008, NEUROPHARMACOLOGY, V55, P969, DOI 10.1016/j.neuropharm.2008.06.014; Bonhaus DW, 1997, NEUROPHARMACOLOGY, V36, P621, DOI 10.1016/S0028-3908(97)00049-X; Bonhaus DW, 1998, ANN NY ACAD SCI, V861, P269, DOI 10.1111/j.1749-6632.1998.tb10218.x; Brunetti L, 2002, EUR J PHARMACOL, V454, P189, DOI 10.1016/S0014-2999(02)02552-9; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Castaneda TR, 2010, FRONT NEUROENDOCRIN, V31, P44, DOI 10.1016/j.yfrne.2009.10.008; Chollet C, 2009, J PEPT SCI, V15, P711, DOI 10.1002/psc.1177; Clemett DA, 2000, NEUROPHARMACOLOGY, V39, P123, DOI 10.1016/S0028-3908(99)00086-6; Clifton P. G., 2006, CNS & Neurological Disorders-Drug Targets, V5, P293, DOI 10.2174/187152706777452254; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Currie PJ, 2010, PHARMACOL BIOCHEM BE, V97, P152, DOI 10.1016/j.pbb.2010.05.027; da Silva UBO, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/neuro.23.001.2010; Davenport AP, 2005, PHARMACOL REV, V57, P541, DOI 10.1124/pr.57.4.1; Delgado M, 2008, BRAIN BEHAV IMMUN, V22, P1146, DOI 10.1016/j.bbi.2008.06.001; Delille HK, 2012, NEUROPHARMACOLOGY, V62, P2184, DOI 10.1016/j.neuropharm.2012.01.010; Derangeon M, 2010, J MOL CELL CARDIOL, V48, P220, DOI 10.1016/j.yjmcc.2009.07.005; Dezaki K, 2007, DIABETES, V56, P2319, DOI 10.2337/db07-0345; Dickson SL, 2011, MOL CELL ENDOCRINOL, V340, P80, DOI 10.1016/j.mce.2011.02.017; Dutton A. C., 2006, DRUG DISCOV TODAY, V3, P577, DOI DOI 10.1016/J.DDSTR.2006.11.005; Egecioglu E, 2011, REV ENDOCR METAB DIS, V12, P141, DOI 10.1007/s11154-011-9166-4; Els S, 2010, METHOD ENZYMOL, V485, P103, DOI [10.1016/S0076-6879(10)85006-2, 10.1016/B978-0-12-381296-4.00006-3]; Follenzi A, 2002, METHOD ENZYMOL, V346, P454; Follenzi Antonia, 2002, Methods Mol Med, V69, P259; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Garfield AS, 2009, J PHYSIOL-LONDON, V587, P49, DOI 10.1113/jphysiol.2008.164152; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Gonzalez-Maeso J, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-20; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Halford JCG, 2007, DRUGS, V67, P27, DOI 10.2165/00003495-200767010-00004; Higgins GA, 2003, EUR J PHARMACOL, V480, P151, DOI 10.1016/j.ejphar.2003.08.102; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Jiang H, 2006, MOL ENDOCRINOL, V20, P1772, DOI 10.1210/me.2005-0084; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Kent T, 2007, CURR OPIN DRUG DISC, V10, P580; Kern A, 2012, NEURON, V73, P317, DOI 10.1016/j.neuron.2011.10.038; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Kohno D, 2003, DIABETES, V52, P948, DOI 10.2337/diabetes.52.4.948; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lam DD, 2008, ENDOCRINOLOGY, V149, P1323, DOI 10.1210/en.2007-1321; Lam Daniel D., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000245; Leysen JE, 2004, CNS NEUROL DISORD-DR, V3, P11, DOI 10.2174/1568007043482598; Liu G, 2007, J PHARMACOL EXP THER, V322, P1036, DOI 10.1124/jpet.107.123141; Lukasiewicz S, 2010, BBA-MOL CELL RES, V1803, P1347, DOI 10.1016/j.bbamcr.2010.08.010; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; Miller KJ, 2005, MOL INTERV, V5, P282, DOI 10.1124/mi.5.5.8; Muccioli G, 2002, EUR J PHARMACOL, V440, P235, DOI 10.1016/S0014-2999(02)01432-2; Muccioli G, 2007, NEUROENDOCRINOLOGY, V86, P147, DOI 10.1159/000105141; Naldini L, 1998, CURR OPIN BIOTECH, V9, P457, DOI 10.1016/S0958-1669(98)80029-3; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Nonogaki K, 2006, BIOCHEM BIOPH RES CO, V341, P703, DOI 10.1016/j.bbrc.2006.01.021; Panetta R, 2008, DRUG DISCOV TODAY, V13, P1059, DOI 10.1016/j.drudis.2008.09.002; Perello M, 2012, BIOL PSYCHIAT, V72, P347, DOI 10.1016/j.biopsych.2012.02.016; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Rediger A, 2011, J BIOL CHEM, V286, P39623, DOI 10.1074/jbc.M111.287607; Rediger A, 2009, OBESITY FACTS, V2, P80, DOI 10.1159/000209862; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Schellekens H, 2012, PHARMACOL THERAPEUT, V135, P316, DOI 10.1016/j.pharmthera.2012.06.004; Schellekens H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032266; Schellekens H, 2010, NEUROPHARMACOLOGY, V58, P2, DOI 10.1016/j.neuropharm.2009.06.024; Skibicka KP, 2011, PEPTIDES, V32, P2265, DOI 10.1016/j.peptides.2011.05.016; Skibicka KP, 2012, ADDICT BIOL, V17, P95, DOI 10.1111/j.1369-1600.2010.00294.x; Soares JB, 2008, EXPERT OPIN THER TAR, V12, P1177, DOI [10.1517/14728222.12.9.1177, 10.1517/14728222.12.9.1177 ]; Somerville EM, 2007, EUR J NEUROSCI, V25, P3115, DOI 10.1111/j.1460-9568.2007.05567.x; Vigna E, 2000, J GENE MED, V2, P308; Yang YK, 2011, EUR J PHARMACOL, V660, P125, DOI 10.1016/j.ejphar.2010.12.020; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	75	105	108	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					181	191		10.1074/jbc.M112.382473	http://dx.doi.org/10.1074/jbc.M112.382473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23161547	Green Published, hybrid			2022-12-28	WOS:000313197200018
J	Schlattner, U; Tokarska-Schlattner, M; Ramirez, S; Tyurina, YY; Amoscato, AA; Mohammadyani, D; Huang, ZT; Jiang, JF; Yanamala, N; Seffouh, A; Boissan, M; Epand, RF; Epand, RM; Klein-Seetharaman, J; Lacombe, ML; Kagan, VE				Schlattner, Uwe; Tokarska-Schlattner, Malgorzata; Ramirez, Sacnicte; Tyurina, Yulia Y.; Amoscato, Andrew A.; Mohammadyani, Dariush; Huang, Zhentai; Jiang, Jianfei; Yanamala, Naveena; Seffouh, Amal; Boissan, Mathieu; Epand, Raquel F.; Epand, Richard M.; Klein-Seetharaman, Judith; Lacombe, Marie-Lise; Kagan, Valerian E.			Dual Function of Mitochondrial Nm23-H4 Protein in Phosphotransfer and Intermembrane Lipid Transfer A CARDIOLIPIN-DEPENDENT SWITCH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE-DIPHOSPHATE-KINASE; CREATINE-KINASE; OUTER MEMBRANES; OPTIC ATROPHY; CYTOCHROME-C; APOPTOSIS; INNER; RESPIRATION; DISEASE; HEALTH	The nucleoside diphosphate kinase Nm23-H4/NDPK-D forms symmetrical hexameric complexes in the mitochondrial intermembrane space with phosphotransfer activity using mitochondrial ATP to regenerate nucleoside triphosphates. We demonstrate the complex formation between Nm23-H4 and mitochondrial GTPase OPA1 in rat liver, suggesting its involvement in local and direct GTP delivery. Similar to OPA1, Nm23-H4 is further known to strongly bind in vitro to anionic phospholipids, mainly cardiolipin, and in vivo to the inner mitochondrial membrane. We show here that such protein-lipid complexes inhibit nucleoside diphosphate kinase activity but are necessary for another function of Nm23-H4, selective intermembrane lipid transfer. Mitochondrial lipid distribution was analyzed by liquid chromatography-mass spectrometry using HeLa cells expressing either wild-type Nm23-H4 or a membrane binding-deficient mutant at a site predicted based on molecular modeling to be crucial for cardiolipin binding and transfer mechanism. We found that wild type, but not the mutant enzyme, selectively increased the content of cardiolipin in the outer mitochondrial membrane, but the distribution of other more abundant phospholipids (e.g. phosphatidylcholine) remained unchanged. HeLa cells expressing the wild-type enzyme showed increased accumulation of Bax in mitochondria and were sensitized to rotenone-induced apoptosis as revealed by stimulated release of cytochrome c into the cytosol, elevated caspase 3/7 activity, and increased annexin V binding. Based on these data and molecular modeling, we propose that Nm23-H4 acts as a lipid-dependent mitochondrial switch with dual function in phosphotransfer serving local GTP supply and cardiolipin transfer for apoptotic signaling and putative other functions.	[Schlattner, Uwe; Tokarska-Schlattner, Malgorzata; Ramirez, Sacnicte; Seffouh, Amal] Univ Grenoble 1, Lab Fundamental & Appl Bioenerget, INSERM, U1055, F-38041 Grenoble 9, France; [Tyurina, Yulia Y.; Amoscato, Andrew A.; Huang, Zhentai; Jiang, Jianfei; Yanamala, Naveena; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Ctr Free Radical & Antioxidant Hlth, Pittsburgh, PA 15219 USA; [Mohammadyani, Dariush; Yanamala, Naveena; Klein-Seetharaman, Judith] Univ Pittsburgh, Dept Biol Struct, Sch Med, Pittsburgh, PA 15219 USA; [Boissan, Mathieu; Lacombe, Marie-Lise] INSERM, UMR S938, F-75012 Paris, France; [Boissan, Mathieu; Lacombe, Marie-Lise] Univ Paris 06, F-75012 Paris, France; [Boissan, Mathieu] Hop Tenon, AP HP, Serv Biochim & Hormonol, F-75020 Paris, France; [Epand, Raquel F.; Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; McMaster University	Schlattner, U (corresponding author), Univ Grenoble 1, Lab Fundamental & Appl Bioenerget, INSERM, U1055, BP 53, F-38041 Grenoble 9, France.	uwe.schlattner@ujf-grenoble.fr; kagan@pitt.edu	Yanamala, Naveena/AAA-6729-2022; , Richard/R-2316-2019; Schlattner, Uwe/D-1267-2009; Huang, Zhentai/C-6926-2012	, Richard/0000-0002-9602-9558; Schlattner, Uwe/0000-0003-1159-5911; Huang, Zhentai/0000-0002-8102-464X; Tyurina, Yulia/0000-0003-0287-2091; Amoscato, Andrew/0000-0002-1340-9150; Tokarska-Schlattner, Malgorzata/0000-0003-4401-7050; Kagan, Valerian E./0000-0002-7245-1885; Yanamala, Naveena/0000-0002-4454-4240	National Institutes of Health [U19AIO68021, HL70755, NS076511, ES020693, ES021068, R01 LM007994-07]; French "Agence Nationale de Recherche" "Chaire d'Excellence"; National Institute for Occupational Safety and Health [OH008282]; National Science Foundation [CCF-1144281]; Groupement des Entreprises Francaises Contre le Cancer; Canadian Natural Sciences and Engineering Research Council [9848]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020693, R21ES021068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076511] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French "Agence Nationale de Recherche" "Chaire d'Excellence"(French National Research Agency (ANR)); National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); National Science Foundation(National Science Foundation (NSF)); Groupement des Entreprises Francaises Contre le Cancer; Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported, in whole or in part, by National Institutes of Health Grants U19AIO68021, HL70755, NS076511, ES020693, and ES021068 (to V. K.) and Grant R01 LM007994-07 (to J. K. S.). This work was also supported by the French "Agence Nationale de Recherche" "Chaire d'Excellence" (to U. S.), National Institute for Occupational Safety and Health Grant OH008282 (to V. K.), National Science Foundation Grant CCF-1144281 (to J. K. S.), a grant from the "Groupement des Entreprises Francaises Contre le Cancer" (to M. L. L. and M. B.), and in part by the Canadian Natural Sciences and Engineering Research Council Grant 9848 (to R. M. E.).	Agarwal R P, 1978, Methods Enzymol, V51, P376; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; Bayir H, 2006, BBA-BIOENERGETICS, V1757, P648, DOI 10.1016/j.bbabio.2006.03.002; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Brahimi-Horn MC, 2012, CANCER RES, V72, P2140, DOI 10.1158/0008-5472.CAN-11-3940; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; DUMAS C, 1992, EMBO J, V11, P3203, DOI 10.1002/j.1460-2075.1992.tb05397.x; Epand RF, 2007, BIOPHYS J, V92, P126, DOI 10.1529/biophysj.106.092353; Epand RF, 2003, BIOCHEMISTRY-US, V42, P14576, DOI 10.1021/bi035348w; Esposti MD, 2001, MOL CELL BIOL, V21, P7268, DOI 10.1128/MCB.21.21.7268-7276.2001; Fang HY, 2012, HUM PATHOL, V43, P105, DOI 10.1016/j.humpath.2011.04.012; FOLCH J, 1957, J BIOL CHEM, V226, P497; Galluzzi L, 2012, EMBO REP, V13, P322, DOI 10.1038/embor.2012.19; GARCES E, 1969, BIOCHEMISTRY-US, V8, P633, DOI 10.1021/bi00830a026; Gilquin B, 2010, MOL CELL BIOL, V30, P1984, DOI 10.1128/MCB.00007-10; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P614, DOI 10.1038/sj.cdd.4401571; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Isin Basak, 2012, Methods Mol Biol, V914, P285, DOI 10.1007/978-1-62703-023-6_17; Kagan VE, 2006, CHEM-BIOL INTERACT, V163, P15, DOI 10.1016/j.cbi.2006.04.019; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kapralov AA, 2011, BBA-BIOMEMBRANES, V1808, P2147, DOI 10.1016/j.bbamem.2011.04.009; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lacombe ML, 2009, BIOCHIMIE, V91, P779, DOI 10.1016/j.biochi.2009.02.006; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; Landes T, 2010, EMBO REP, V11, P459, DOI 10.1038/embor.2010.50; Landeta O, 2011, J BIOL CHEM, V286, P8213, DOI 10.1074/jbc.M110.165852; Li SJ, 2012, J BIOENERG BIOMEMBR, V44, P189, DOI 10.1007/s10863-012-9424-5; Liu JH, 2003, MOL CANCER RES, V1, P892; Milon L, 2000, J BIOL CHEM, V275, P14264, DOI 10.1074/jbc.275.19.14264; Milon L, 1997, HUM GENET, V99, P550, DOI 10.1007/s004390050405; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schlattner U, 2009, BBA-BIOMEMBRANES, V1788, P2032, DOI 10.1016/j.bbamem.2009.04.018; Sorice M, 2004, CELL DEATH DIFFER, V11, P1133, DOI 10.1038/sj.cdd.4401457; Sorice M, 2009, FEBS LETT, V583, P2447, DOI 10.1016/j.febslet.2009.07.018; Stachowiak O, 1998, MOL CELL BIOCHEM, V184, P141, DOI 10.1023/A:1006803431821; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tokarska-Schlattner M, 2008, J BIOL CHEM, V283, P26198, DOI 10.1074/jbc.M803132200; Tokarska-Schlattner M, 2007, BBA-BIOENERGETICS, V1767, P1276, DOI 10.1016/j.bbabio.2007.08.006; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tyurina YY, 2011, ACS NANO, V5, P7342, DOI 10.1021/nn202201j; Walzel B, 2002, J BIOL CHEM, V277, P37503, DOI 10.1074/jbc.M201168200	49	76	77	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					111	121		10.1074/jbc.M112.408633	http://dx.doi.org/10.1074/jbc.M112.408633			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23150663	Green Published, hybrid			2022-12-28	WOS:000313197200011
J	Hershko, K; Simhadri, VL; Blaisdell, A; Hunt, RC; Newell, J; Tseng, SC; Hershko, AY; Choi, JW; Sauna, ZE; Wu, A; Bram, RJ; Komar, AA; Kimchi-Sarfaty, C				Hershko, Klilah; Simhadri, Vijaya L.; Blaisdell, Adam; Hunt, Ryan C.; Newell, Jordan; Tseng, Sandra C.; Hershko, Alon Y.; Choi, Jae Won; Sauna, Zuben E.; Wu, Andrew; Bram, Richard J.; Komar, Anton A.; Kimchi-Sarfaty, Chava			Cyclosporin A Impairs the Secretion and Activity of ADAMTS13 (A Disintegrin and Metalloprotease with Thrombospondin Type 1 Repeat)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOTIC THROMBOCYTOPENIC PURPURA; VON-WILLEBRAND-FACTOR; HEMOLYTIC-UREMIC SYNDROME; FACTOR-CLEAVING PROTEASE; PLASMA-EXCHANGE; SURFACE EXPRESSION; CYCLOPHILIN-B; IN-VIVO; TRANSPLANTATION; ISOMERASES	The protease ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat) cleaves multimers of von Willebrand factor, thus regulating platelet aggregation. ADAMTS13 deficiency leads to the fatal disorder thrombotic thrombocytopenic purpura (TTP). It has been observed that cyclosporin A (CsA) treatment, particularly in transplant patients, may sometimes be linked to the development of TTP. Until now, the reason for such a link was unclear. Here we provide evidence demonstrating that cyclophilin B (CypB) activity plays an important role in the secretion of active ADAMTS13. We found that CsA, an inhibitor of CypB, reduces the secretion of ADAMTS13 and leads to conformational changes in the protein resulting in diminished ADAMTS13 proteolytic activity. A direct, functional interaction between CypB (which possesses peptidyl-prolyl cis-trans isomerase (PPIase) and chaperone functions) and ADAMTS13 is demonstrated using immunoprecipitation and siRNA knockdown of CypB. Finally, CypB knockout mice were found to have reduced ADAMTS13 levels. Taken together, our findings indicate that cyclophilin-mediated activity is an important factor affecting secretion and activity of ADAMTS13. The large number of proline residues in ADAMTS13 is consistent with the important role of cis-trans isomerization in the proper folding of this protein. These results altogether provide a novel mechanistic explanation for CsA-induced TTP in transplant patients.	[Hershko, Klilah; Simhadri, Vijaya L.; Blaisdell, Adam; Hunt, Ryan C.; Newell, Jordan; Tseng, Sandra C.; Sauna, Zuben E.; Wu, Andrew; Kimchi-Sarfaty, Chava] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20982 USA; [Choi, Jae Won; Bram, Richard J.] Mayo Clin, Dept Pediat Hematol Oncol, Rochester, MN 55905 USA; [Hershko, Alon Y.] Meir Med Ctr, Dept Med, IL-44281 Kefar Sava, Israel; [Komar, Anton A.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA	US Food & Drug Administration (FDA); Mayo Clinic; Tel Aviv University; Sackler Faculty of Medicine; University System of Ohio; Cleveland State University	Kimchi-Sarfaty, C (corresponding author), 29 Lincoln Dr, Bethesda, MD 20892 USA.	Chava.kimchi-sarfaty@fda.hhs.gov	Sauna, Zuben E./AAA-7149-2019	Kimchi-Sarfaty, Chava/0000-0002-9355-8585; Komar, Anton/0000-0003-4188-0633	United States Food and Drug Administration; National American Heart Association [0730120N]	United States Food and Drug Administration; National American Heart Association(American Heart Association)	This work was supported by the United States Food and Drug Administration and National American Heart Association Grant 0730120N (to A. A. K.).	Allford SL, 2002, LEUKEMIA LYMPHOMA, V43, P1921, DOI 10.1080/1042819021000015862; Arai S, 2001, Hematol J, V2, P292, DOI 10.1038/sj.thj.6200127; Batts ED, 2007, BONE MARROW TRANSPL, V40, P709, DOI 10.1038/sj.bmt.1705758; BONSER RS, 1984, LANCET, V2, P1337; Brooks DJ, 2002, MOL BIOL EVOL, V19, P1645, DOI 10.1093/oxfordjournals.molbev.a003988; Cataland SR, 2007, BRIT J HAEMATOL, V139, P486, DOI 10.1111/j.1365-2141.2007.06819.x; Cataland SR, 2007, BRIT J HAEMATOL, V136, P146, DOI 10.1111/j.1365-2141.2006.06384.x; Cataland SR, 2008, AM J HEMATOL, V83, P911, DOI 10.1002/ajh.21281; Cataland SR, 2006, J THROMB HAEMOST, V4, P1162, DOI 10.1111/j.1538-7836.2006.01909.x; Cattaneo D, 2004, TRANSPL P, V36, p234S, DOI 10.1016/j.transproceed.2004.01.011; Chen H, 1998, FEBS LETT, V422, P307, DOI 10.1016/S0014-5793(98)00028-3; Choi JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000750; Claus RA, 2005, THROMB HAEMOSTASIS, V94, P41; Donadelli R, 2006, THROMB HAEMOSTASIS, V96, P454, DOI 10.1160/TH06-05-0236; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Dugave C, 2003, CHEM REV, V103, P2475, DOI 10.1021/cr0104375; Elliott MA, 2003, MAYO CLIN PROC, V78, P421, DOI 10.4065/78.4.421; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Geetha S, 2009, CYTOM PART A, V75A, P675, DOI 10.1002/cyto.a.20748; George JN, 2004, TRANSFUSION, V44, P1384, DOI 10.1111/j.1537-2995.2004.03412.x; George JN, 2004, TRANSFUSION, V44, P294, DOI 10.1111/j.1537-2995.2004.00700.x; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Hachem RR, 2006, TRANSPLANTATION, V81, P57, DOI 10.1097/01.tp.0000188140.50673.63; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hommais A, 2007, THROMB HAEMOSTASIS, V98, P593, DOI 10.1160/TH07-01-0059; Horowitz DS, 2002, EMBO J, V21, P470, DOI 10.1093/emboj/21.3.470; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Hunter T, 1998, CELL, V92, P141, DOI 10.1016/S0092-8674(00)80906-X; Ivery MTG, 2000, MED RES REV, V20, P452, DOI 10.1002/1098-1128(200011)20:6<452::AID-MED2>3.0.CO;2-6; Kahan BD, 2009, TRANSPL P, V41, P3011, DOI 10.1016/j.transproceed.2009.07.104; Kentouche K, 2006, SEMIN THROMB HEMOST, V32, P98, DOI 10.1055/s-2006-939765; Kimchi-Sarfaty C, 2002, J BIOL CHEM, V277, P2505, DOI 10.1074/jbc.M109154200; Kokame K, 2002, P NATL ACAD SCI USA, V99, P11902, DOI 10.1073/pnas.172277399; Lane-Guermonprez L, 2005, J NEUROCHEM, V93, P1401, DOI 10.1111/j.1471-4159.2005.03125.x; Lee CH, 2008, TRANSPL P, V40, P2554, DOI 10.1016/j.transproceed.2008.07.011; Levy G A, 2002, Gastroenterol Hepatol, V25, P289; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; Luban J, 1996, CELL, V87, P1157, DOI 10.1016/S0092-8674(00)81811-5; Manea M, 2009, PEDIATR NEPHROL, V24, P447, DOI 10.1007/s00467-008-0986-8; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Peyvandi F, 2006, BRIT J HAEMATOL, V134, P187, DOI 10.1111/j.1365-2141.2006.06126.x; Pimanda JE, 2004, BLOOD, V103, P627, DOI 10.1182/blood-2003-04-1346; PRICE ER, 1994, P NATL ACAD SCI USA, V91, P3931, DOI 10.1073/pnas.91.9.3931; Rahamimoff H, 2007, ANN NY ACAD SCI, V1099, P204, DOI 10.1196/annals.1387.046; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sauna ZE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006506; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shitrit D, 2003, TRANSPLANT P, V35, P627, DOI 10.1016/S0041-1345(03)00015-0; Soejima K, 2006, J BIOCHEM, V139, P147, DOI 10.1093/jb/mvj013; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; Sternberg MJE, 1999, CURR OPIN STRUC BIOL, V9, P368, DOI 10.1016/S0959-440X(99)80050-5; Stevens FJ, 1999, SEMIN CELL DEV BIOL, V10, P443, DOI 10.1006/scdb.1999.0315; Tran TT, 2000, J BIOL CHEM, V275, P35708, DOI 10.1074/jbc.M005636200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai HM, 2006, ANNU REV MED, V57, P419, DOI 10.1146/annurev.med.57.061804.084505; van der Plas RM, 1999, BLOOD, V93, P3798, DOI 10.1182/blood.V93.11.3798.411k07_3798_3802; VANDUYNE GD, 1991, SCIENCE, V252, P839, DOI 10.1126/science.1709302; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vesely SK, 2003, BLOOD, V102, P60, DOI 10.1182/blood-2003-01-0193; WAINBERG MA, 1988, BLOOD, V72, P1904; WALSH CT, 1992, J BIOL CHEM, V267, P13115; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Zhou HY, 2010, ANTI-CANCER AGENT ME, V10, P571, DOI 10.2174/187152010793498663; Zhou WH, 2009, BLOOD, V113, P929, DOI 10.1182/blood-2008-07-167775	67	8	8	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44361	44371		10.1074/jbc.M112.383968	http://dx.doi.org/10.1074/jbc.M112.383968			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144461	hybrid, Green Published			2022-12-28	WOS:000312938600033
J	Pilla, E; Moller, U; Sauer, G; Mattiroli, F; Melchior, F; Geiss-Friedlander, R				Pilla, Esther; Moeller, Ulrike; Sauer, Guido; Mattiroli, Francesca; Melchior, Frauke; Geiss-Friedlander, Ruth			A Novel SUMO1-specific Interacting Motif in Dipeptidyl Peptidase 9 (DPP9) That Is Important for Enzymatic Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO-BINDING-MOTIF; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; UBIQUITIN; COMPLEX; IV; SUMOYLATION; REVEALS; LOCALIZATION; INHIBITORS	Sumoylation affects many cellular processes by regulating the interactions of modified targets with downstream effectors. Here we identified the cytosolic dipeptidyl peptidase 9 (DPP9) as a SUMO1 interacting protein. Surprisingly, DPP9 binds to SUMO1 independent of the well known SUMO interacting motif, but instead interacts with a loop involving Glu(67) of SUMO1. Intriguingly, DPP9 selectively associates with SUMO1 and not SUMO2, due to a more positive charge in the SUMO1-loop. We mapped the SUMO-binding site of DPP9 to an extended arm structure, predicted to directly flank the substrate entry site. Importantly, whereas mutants in the SUMO1-binding arm are less active compared with wild-type DPP9, SUMO1 stimulates DPP9 activity. Consistent with this, silencing of SUMO1 leads to a reduced cytosolic prolyl-peptidase activity. Taken together, these results suggest that SUMO1, or more likely, a sumoylated protein, acts as an allosteric regulator of DPP9.	[Pilla, Esther; Moeller, Ulrike; Sauer, Guido; Geiss-Friedlander, Ruth] Univ Goettingen, Dept Biochem 1, Fac Med, D-37073 Gottingen, Germany; [Mattiroli, Francesca] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Melchior, Frauke] Heidelberg Univ, DKFZ ZMBH Alliance, Zentrum Mol Biol, D-69120 Heidelberg, Germany	University of Gottingen; Netherlands Cancer Institute; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Geiss-Friedlander, R (corresponding author), Univ Goettingen, Dept Biochem 1, Fac Med, Humboldtallee 23, D-37073 Gottingen, Germany.	rgeiss@gwdg.de	Geiss-Friedlander, Ruth/AAT-8768-2020; Melchior, Frauke/E-2014-2014; Geiss-Friedlander, Ruth/G-3569-2013; Mattiroli, Francesca/AAT-1489-2020	Geiss-Friedlander, Ruth/0000-0002-1720-3440; Melchior, Frauke/0000-0001-9546-8797; Geiss-Friedlander, Ruth/0000-0002-1720-3440; Mattiroli, Francesca/0000-0002-1574-7217	Deutsche Forschungsgemeinschaft [2234/1-1]; European Union NoE Rubicon	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union NoE Rubicon	This work was supported by Deutsche Forschungsgemeinschaft Grant 2234/1-1 and the European Union NoE Rubicon (until 2011).	Abbott CA, 2000, ADV EXP MED BIOL, V477, P103; Aertgeerts K, 2005, J BIOL CHEM, V280, P19441, DOI 10.1074/jbc.C500092200; Aertgeerts K, 2004, PROTEIN SCI, V13, P412, DOI 10.1110/ps.03460604; Ajami K, 2004, BBA-GENE STRUCT EXPR, V1679, P18, DOI 10.1016/j.bbaexp.2004.03.010; Alegre KO, 2011, J BIOL CHEM, V286, P36142, DOI 10.1074/jbc.M111.268847; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Cho G, 2009, J BIOL CHEM, V284, P19592, DOI 10.1074/jbc.M109.010181; Connolly BA, 2008, J MED CHEM, V51, P6005, DOI 10.1021/jm800390n; Ding HS, 2005, BIOCHEMISTRY-US, V44, P2790, DOI 10.1021/bi0477586; Dou H, 2011, FEBS LETT, V585, P2891, DOI 10.1016/j.febslet.2011.04.002; Dubois V, 2009, J HISTOCHEM CYTOCHEM, V57, P531, DOI 10.1369/jhc.2009.952739; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Geiss-Friedlander R, 2009, J BIOL CHEM, V284, P27211, DOI 10.1074/jbc.M109.041871; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Kotackova L, 2009, FOLIA BIOL-PRAGUE, V55, P77; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lu CY, 2011, J BIOL CHEM, V286, P27494, DOI 10.1074/jbc.M111.224089; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; McIntosh CHS, 2005, REGUL PEPTIDES, V128, P159, DOI 10.1016/j.regpep.2004.06.001; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Park J., 2008, OPEN ENZYM INHIB J, V1, P52, DOI [10.2174/1874940200801010052, DOI 10.2174/1874940200801010052]; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Rummey C, 2007, PROTEINS, V66, P160, DOI 10.1002/prot.21138; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Schade J, 2008, J HISTOCHEM CYTOCHEM, V56, P147, DOI 10.1369/jhc.7A7319.2007; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Tang HK, 2011, FEBS LETT, V585, P3409, DOI 10.1016/j.febslet.2011.10.009; Tang HK, 2009, ARCH BIOCHEM BIOPHYS, V485, P120, DOI 10.1016/j.abb.2009.02.015; Tatham MH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001484; Thoma R, 2003, STRUCTURE, V11, P947, DOI 10.1016/S0969-2126(03)00160-6; Van Goethem S, 2011, J MED CHEM, V54, P5737, DOI 10.1021/jm200383j; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Weihofen WA, 2004, J BIOL CHEM, V279, P43330, DOI 10.1074/jbc.M405001200; Yao TW, 2011, MOL CANCER RES, V9, P948, DOI 10.1158/1541-7786.MCR-10-0272; Yu DMT, 2006, FEBS J, V273, P2447, DOI 10.1111/j.1742-4658.2006.05253.x; Yu DMT, 2009, J HISTOCHEM CYTOCHEM, V57, P1025, DOI 10.1369/jhc.2009.953760; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	62	45	48	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44320	44329		10.1074/jbc.M112.397224	http://dx.doi.org/10.1074/jbc.M112.397224			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23152501	Green Published, hybrid			2022-12-28	WOS:000312938600029
J	Ganguly, A; Yang, HL; Sharma, R; Patel, KD; Cabral, F				Ganguly, Anutosh; Yang, Hailing; Sharma, Ritu; Patel, Kamala D.; Cabral, Fernando			The Role of Microtubules and Their Dynamics in Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; BETA-TUBULIN; LIVING CELLS; ALPHA-TUBULIN; MOTILITY; VINBLASTINE; PACLITAXEL; RESISTANCE; DRUGS; NOCODAZOLE	Although microtubules have long been implicated in cell locomotion, the mechanism of their involvement remains controversial. Most studies have concluded that microtubules play a positive role by regulating actin polymerization, transporting membrane vesicles to the leading edge, and/or facilitating the turnover of adhesion plaques. Here we used wild-type and mutant CHO cell lines with alterations in tubulin to demonstrate that microtubules can also act to restrain cell motility. Tubulin mutations or low concentrations of drugs that suppress microtubule dynamics without affecting the amount of microtubule polymer inhibited the rate of migration by preventing microtubule reorganization in the trailing portion of the cells where the more dynamic microtubules are normally found. Under these conditions, cells along the edge of a wound still extended lamellipodia and elongated toward the wound but were inhibited in their ability to retract their tails, thus retarding forward progress. The idea that microtubules normally act to restrain cell locomotion was confirmed by treating cells with high concentrations of nocodazole to depolymerize the microtubule network. In the absence of microtubules, wild-type CHO and HeLa cells could still move at near normal speeds, but the movement became more random. We conclude that microtubules act both to restrain cell movement and to establish directionality.	[Ganguly, Anutosh; Cabral, Fernando] Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Ganguly, Anutosh; Sharma, Ritu; Patel, Kamala D.] Univ Calgary, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Yang, Hailing] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Calgary; University of Texas System; UTMD Anderson Cancer Center	Cabral, F (corresponding author), Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	fernando.r.cabral@uth.tmc.edu	Patel, Kamala D/AAX-1245-2021	Ganguly, Anutosh/0000-0002-7228-7827	National Institutes of Health [CA 85935]; Canadian Institute for Health Research [MOP-14180]; NATIONAL CANCER INSTITUTE [R01CA085935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA 85935 (to F. C.) and Canadian Institute for Health Research Grant MOP-14180 (to K. P.).	BARLOW S, 1994, J CELL BIOL, V126, P1017, DOI 10.1083/jcb.126.4.1017; Belotti D, 1996, CLIN CANCER RES, V2, P1843; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Brown RA, 1996, J CELL PHYSIOL, V169, P439, DOI 10.1002/(SICI)1097-4652(199612)169:3<439::AID-JCP4>3.0.CO;2-P; CABRAL F, 1980, CELL, V20, P29, DOI 10.1016/0092-8674(80)90231-7; Cabral F., 2000, DRUG RESIST UPDATE, V3, P1; Cheng G, 2008, AM J PHYSIOL-HEART C, V294, pH2231, DOI 10.1152/ajpheart.91515.2007; DZIEZANOWSKI MA, 1980, J CELL SCI, V42, P379; EDELSON PJ, 1973, INFECT IMMUN, V8, P127, DOI 10.1128/IAI.8.1.127-129.1973; EUTENEUER U, 1984, NATURE, V310, P58, DOI 10.1038/310058a0; Ganguly A, 2011, CELL CYCLE, V10, P2614, DOI 10.4161/cc.10.16.16593; Ganguly A, 2011, ONCOTARGET, V2, P368, DOI 10.18632/oncotarget.250; Ganguly A, 2010, MOL CANCER THER, V9, P2914, DOI 10.1158/1535-7163.MCT-10-0552; GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752; Hari M, 2003, MOL CANCER THER, V2, P597; Huzil JT, 2007, CANCER INFORM, V3, P159; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Jordan MA, 1998, METHOD ENZYMOL, V298, P252, DOI 10.1016/S0076-6879(98)98024-7; Kadir S, 2011, J CELL SCI, V124, P2642, DOI 10.1242/jcs.087965; Kaverina I, 2011, SEMIN CELL DEV BIOL, V22, P968, DOI 10.1016/j.semcdb.2011.09.017; KELLER HU, 1984, EXP CELL RES, V153, P173, DOI 10.1016/0014-4827(84)90459-2; LIAO GJ, 1995, J CELL SCI, V108, P3473; Mikhailov A, 1998, CELL MOTIL CYTOSKEL, V41, P325, DOI 10.1002/(SICI)1097-0169(1998)41:4<325::AID-CM5>3.0.CO;2-D; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; OLSON KR, 1995, J CELL BIOL, V130, P639, DOI 10.1083/jcb.130.3.639; Palmer TD, 2011, ADV DRUG DELIVER REV, V63, P568, DOI 10.1016/j.addr.2011.04.008; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Salaycik KJ, 2005, J CELL SCI, V118, P4113, DOI 10.1242/jcs.02531; Samant RS, 2011, ONCOTARGET, V2, P122; SCHIBLER MJ, 1989, FASEB J, V3, P163, DOI 10.1096/fasebj.3.2.2563346; SCHIBLER MJ, 1986, J CELL BIOL, V102, P1522, DOI 10.1083/jcb.102.4.1522; Schwartz EL, 2009, CLIN CANCER RES, V15, P2594, DOI 10.1158/1078-0432.CCR-08-2710; Small JV, 2002, NAT REV MOL CELL BIO, V3, P957, DOI 10.1038/nrm971; SPOONER BS, 1971, J CELL BIOL, V49, P595, DOI 10.1083/jcb.49.3.595; Ueda M, 1997, P NATL ACAD SCI USA, V94, P9674, DOI 10.1073/pnas.94.18.9674; Vacca A, 1999, BLOOD, V94, P4143, DOI 10.1182/blood.V94.12.4143.424k26_4143_4155; VASILIEV JM, 1970, J EMBRYOL EXP MORPH, V24, P625; Wang XM, 1996, J CELL BIOL, V132, P345, DOI 10.1083/jcb.132.3.345; Yang HL, 2010, J BIOL CHEM, V285, P32242, DOI 10.1074/jbc.M110.160820; Yin SH, 2012, PHARM RES-DORDR, V29, P2994, DOI 10.1007/s11095-012-0794-5; Zhang DH, 2000, J MUSCLE RES CELL M, V21, P293, DOI 10.1023/A:1005600118157	41	91	91	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43359	43369		10.1074/jbc.M112.423905	http://dx.doi.org/10.1074/jbc.M112.423905			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23135278	hybrid, Green Published			2022-12-28	WOS:000312940800017
J	Lu, CS; Truong, LN; Aslanian, A; Shi, LDZ; Li, YJ; Hwang, PYH; Koh, KH; Hunter, T; Yates, JR; Berns, MW; Wu, XH				Lu, Chi-Sheng; Truong, Lan N.; Aslanian, Aaron; Shi, Linda Z.; Li, Yongjiang; Hwang, Patty Yi-Hwa; Koh, Kwi Hye; Hunter, Tony; Yates, John R., III; Berns, Michael W.; Wu, Xiaohua			The RING Finger Protein RNF8 Ubiquitinates Nbs1 to Promote DNA Double-strand Break Repair by Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE CHECKPOINT; DAMAGE RESPONSE; ATM ACTIVATION; MRE11-RAD50-NBS1 COMPLEX; POLYUBIQUITIN CHAINS; CHROMATIN RETENTION; GENOMIC STABILITY; MRE11 COMPLEX; HISTONE H2AX; MRN COMPLEX	Ubiquitination plays an important role in the DNA damage response. We identified a novel interaction of the E3 ubiquitin ligase RNF8 with Nbs1, a key regulator of DNA double-strand break (DSB) repair. We found that Nbs1 is ubiquitinated both before and after DNA damage and is a direct ubiquitination substrate of RNF8. We also identified key residues on Nbs1 that are ubiquitinated by RNF8. By using laser microirradiation and live-cell imaging, we observed that RNF8 and its ubiquitination activity are important for promoting optimal binding of Nbs1 to DSB-containing chromatin. We also demonstrated that RNF8-mediated ubiquitination of Nbs1 contributes to the efficient and stable binding of Nbs1 to DSBs and is important for HR-mediated DSB repair. Taken together, these studies suggest that Nbs1 is one important target of RNF8 to regulate DNA DSB repair.	[Lu, Chi-Sheng; Truong, Lan N.; Li, Yongjiang; Hwang, Patty Yi-Hwa; Koh, Kwi Hye; Wu, Xiaohua] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Aslanian, Aaron; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Aslanian, Aaron; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Shi, Linda Z.; Berns, Michael W.] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA	Scripps Research Institute; Scripps Research Institute; Salk Institute; University of California System; University of California San Diego	Wu, XH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	xiaohwu@scripps.edu		Berns, Michael/0000-0002-9640-2885	National Institutes of Health [CA102361, GM080677, CA140972, CA102361-07S1, CA80100, P41 RR011823]; Beckman Laser Institute Inc. Foundation; NATIONAL CANCER INSTITUTE [R01CA080100, R01CA102361, R01CA140972] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080677, P41GM103533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Laser Institute Inc. Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA102361, GM080677, CA140972, and CA102361-07S1 (to X. W.); CA80100 (to T. H.); and P41 RR011823 (to J. R. Y.). This work was also supported by the Beckman Laser Institute Inc. Foundation (to M. W. B.).	Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Al-Hakim A, 2010, DNA REPAIR, V9, P1229, DOI 10.1016/j.dnarep.2010.09.011; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Botvinick EL, 2005, MICROSC RES TECHNIQ, V68, P65, DOI 10.1002/jemt.20216; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Harper JW, 2006, CELL, V124, P1133, DOI 10.1016/j.cell.2006.03.009; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Ito K, 2001, EUR J BIOCHEM, V268, P2725, DOI 10.1046/j.1432-1327.2001.02169.x; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lok GTM, 2012, NUCLEIC ACIDS RES, V40, P196, DOI 10.1093/nar/gkr655; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; Nussenzweig A, 2007, CELL, V131, P223, DOI 10.1016/j.cell.2007.10.005; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Olson E, 2007, J BIOL CHEM, V282, P22939, DOI 10.1074/jbc.M702162200; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang HL, 2012, J BIOL CHEM, V287, P21471, DOI 10.1074/jbc.M112.355354; Wu J, 2012, MOL CELL, V46, P351, DOI 10.1016/j.molcel.2012.02.018; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; Wu XH, 2004, GENE DEV, V18, P1305, DOI 10.1101/gad.1182804; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Zhang SF, 2008, CELL CYCLE, V7, P3399, DOI 10.4161/cc.7.21.6949	61	40	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43984	43994		10.1074/jbc.M112.421545	http://dx.doi.org/10.1074/jbc.M112.421545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115235	Green Published, hybrid			2022-12-28	WOS:000312940800073
J	Sorensen, L; Andersen, J; Thomsen, M; Hansen, SMR; Zhao, XB; Sandelin, A; Stromgaard, K; Kristensen, AS				Sorensen, Lena; Andersen, Jacob; Thomsen, Mette; Hansen, Stinna M. R.; Zhao, Xiaobei; Sandelin, Albin; Stromgaard, Kristian; Kristensen, Anders S.			Interaction of Antidepressants with the Serotonin and Norepinephrine Transporters MUTATIONAL STUDIES OF THE S1 SUBSTRATE BINDING POCKET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY RECOGNITION; DOPAMINE TRANSPORTER; BINDING-SITE; NEUROTRANSMITTER TRANSPORTERS; BACTERIAL HOMOLOG; SELECTIVE RECOGNITION; SUBSTRATE; COCAINE; INHIBITION; LEUT	The serotonin transporter (SERT) and the norepinephrine transporter (NET) are sodium-dependent neurotransmitter transporters responsible for reuptake of released serotonin and norepinephrine, respectively, into nerve terminals in the brain. A wide range of inhibitors of SERT and NET are used as treatment of depression and anxiety disorders or as psychostimulant drugs of abuse. Despite their clinical importance, the molecular mechanisms by which various types of antidepressant drugs bind and inhibit SERT and NET are still elusive for the majority of the inhibitors, including the molecular basis for SERT/NET selectivity. Mutational analyses have suggested that a central substrate binding site (denoted the S1 pocket) also harbors an inhibitor binding site. In this study, we determine the effect of mutating six key S1 residues in human SERT (hSERT) and NET (hNET) on the potency of 15 prototypical SERT/NET inhibitors belonging to different drug classes. Analysis of the resulting drug sensitivity profiles provides novel information on drug binding modes in hSERT and hNET and identifies specific S1 residues as important molecular determinants for inhibitor potency and hSERT/hNET selectivity.	[Stromgaard, Kristian; Kristensen, Anders S.] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark; [Zhao, Xiaobei; Sandelin, Albin] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2100 Copenhagen, Denmark; [Sandelin, Albin] Univ Copenhagen, Bioinformat Ctr, Dept Biol, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Kristensen, AS (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark.	ask@sund.ku.dk	Andersen, Jacob/B-7768-2016; Sandelin, Albin/G-2881-2011; Kristensen, Anders Skov/B-4414-2009; Zhao, Xiaobei/G-3567-2014	Andersen, Jacob/0000-0002-8067-3074; Sandelin, Albin/0000-0002-7109-7378; Kristensen, Anders Skov/0000-0001-8955-6790; Zhao, Xiaobei/0000-0002-5277-0846; Stromgaard, Kristian/0000-0003-2206-4737	Faculty of Pharmaceutical Sciences, University of Copenhagen; H. Lundbeck A/S; Brodrene Hartmanns Foundation; Torben Frimodt and Alice Frimodt Foundation; Lundbeck Foundation; Novo Nordisk Foundation	Faculty of Pharmaceutical Sciences, University of Copenhagen; H. Lundbeck A/S; Brodrene Hartmanns Foundation; Torben Frimodt and Alice Frimodt Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by the Faculty of Pharmaceutical Sciences, University of Copenhagen (Ph.D. stipend to L. S.), H. Lundbeck A/S, Brodrene Hartmanns Foundation, Torben Frimodt and Alice Frimodt Foundation, the Lundbeck Foundation (X. Z. and A. S.) and the Novo Nordisk Foundation (X. Z. and A. S.).	Andersen J, 2011, P NATL ACAD SCI USA, V108, P12137, DOI 10.1073/pnas.1103060108; Andersen J, 2010, J BIOL CHEM, V285, P2051, DOI 10.1074/jbc.M109.072587; Andersen J, 2009, CHEM COMMUN, P3677, DOI 10.1039/b903035m; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Apparsundaram S, 2008, J PHARMACOL EXP THER, V327, P982, DOI 10.1124/jpet.108.142315; Barker EL, 1999, J NEUROSCI, V19, P4705; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Bisgaard H, 2011, NEUROPHARMACOLOGY, V60, P182, DOI 10.1016/j.neuropharm.2010.08.021; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Combs S, 2011, ACS CHEM NEUROSCI, V2, P75, DOI 10.1021/cn100066p; Dar DE, 2005, BIOCHEM PHARMACOL, V70, P461, DOI 10.1016/j.bcp.2005.04.032; Gabrielsen M, 2012, EUR J MED CHEM, V47, P24, DOI 10.1016/j.ejmech.2011.09.056; Gundertofte K., 2007, COMPUTER ASSISTED LE, P443; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Hill ER, 2011, NEUROPHARMACOLOGY, V61, P112, DOI 10.1016/j.neuropharm.2011.03.014; Indarte M, 2008, PROTEINS, V70, P1033, DOI 10.1002/prot.21598; Jorgensen AM, 2007, CHEMMEDCHEM, V2, P815, DOI 10.1002/cmdc.200600242; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; Koldso H, 2010, J AM CHEM SOC, V132, P1311, DOI 10.1021/ja906923j; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kristensen AS, 2004, EUR J NEUROSCI, V19, P1513, DOI 10.1111/j.1460-9568.2004.03202.x; Mason JN, 2007, J PHARMACOL EXP THER, V323, P720, DOI 10.1124/jpet.107.125716; Masson J, 1999, PHARMACOL REV, V51, P439; Nencetti S, 2011, EUR J MED CHEM, V46, P825, DOI 10.1016/j.ejmech.2010.12.018; Paczkowski FA, 2007, J BIOL CHEM, V282, P17837, DOI 10.1074/jbc.M610813200; Poulsen A, 2002, J COMPUT AID MOL DES, V16, P273, DOI 10.1023/A:1020220306702; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Rupp A, 1994, Pharm Acta Helv, V68, P235, DOI 10.1016/0031-6865(94)90054-X; Sarker S, 2010, MOL PHARMACOL, V78, P1026, DOI 10.1124/mol.110.067538; Schlessinger A, 2011, P NATL ACAD SCI USA, V108, P15810, DOI 10.1073/pnas.1106030108; Shan JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016350; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; Team R.D.C, 2010, R LANG ENV STAT COMP; Tsuruda PR, 2010, J PHARMACOL TOXICOL, V61, P192, DOI 10.1016/j.vascn.2009.12.003; Ukairo OT, 2005, J PHARMACOL EXP THER, V314, P575, DOI 10.1124/jpet.105.085829; Walline CC, 2008, J PHARMACOL EXP THER, V325, P791, DOI 10.1124/jpet.108.136200; Wang WF, 2003, MOL PHARMACOL, V64, P430, DOI 10.1124/mol.64.2.430; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhou FC, 1998, BRAIN RES, V805, P241, DOI 10.1016/S0006-8993(98)00691-X; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	56	62	63	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43694	43707		10.1074/jbc.M112.342212	http://dx.doi.org/10.1074/jbc.M112.342212			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23086945	Green Published, hybrid			2022-12-28	WOS:000312940800049
J	Sugiura, N; Shioiri, T; Chiba, M; Sato, T; Narimatsu, H; Kimata, K; Watanabe, H				Sugiura, Nobuo; Shioiri, Tatsumasa; Chiba, Mie; Sato, Takashi; Narimatsu, Hisashi; Kimata, Koji; Watanabe, Hideto			Construction of a Chondroitin Sulfate Library with Defined Structures and Analysis of Molecular Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLGALACTOSAMINE 4-SULFATE 6-O-SULFOTRANSFERASE; MONOCLONAL-ANTIBODY; ESCHERICHIA-COLI; POLYMERIZING FACTOR; CLONING; EXPRESSION; BINDING; 6-SULFOTRANSFERASE; POLYMERASE; TISSUES	Chondroitin sulfate (CS) is a linear acidic polysaccharide, composed of repeating disaccharide units of glucuronic acid and N-acetyl-D-galactosamine and modified with sulfate residues at different positions, which plays various roles in development and disease. Here, we chemo-enzymatically synthesized various CS species with defined lengths and defined sulfate compositions, from chondroitin hexasaccharide conjugated with hexamethylenediamine at the reducing ends, using bacterial chondroitin polymerase and recombinant CS sulfotransferases, including chondroitin-4-sulfotransferase 1 (C4ST-1), chondroitin-6-sulfotransferase 1 (C6ST-1), N-acetylgalactosamine 4-sulfate 6-sulfotransferase (GalNAc4S-6ST), and uronosyl 2-sulfotransferase (UA2ST). Sequential modifications of CS with a series of CS sulfotransferases revealed their distinct features, including their substrate specificities. Reactions with chondroitin polymerase generated non-sulfated chondroitin, and those with C4ST-1 and C6ST-1 generated uniformly sulfated CS containing >95% 4S and 6S units, respectively. GalNAc4S-6ST and UA2ST generated highly sulfated CS possessing similar to 90% corresponding disulfated disaccharide units. Sequential reactions with UA2ST and GalNAc4S-6ST generated further highly sulfated CS containing a mixed structure of disulfated units. Surprisingly, sequential reactions with GalNAc4S-6ST and UA2ST generated a novel CS molecule containing similar to 29% trisulfated disaccharide units. Enzyme-linked immunosorbent assay and surface plasmon resonance analysis using the CS library and natural CS products modified with biotin at the reducing ends, revealed details of the interactions of CS species with anti-CS antibodies, and with CS-binding molecules such as midkine and pleiotrophin. Chemo-enzymatic synthesis enables the generation of CS chains of the desired lengths, compositions, and distinct structures, and the resulting library will be a useful tool for studies of CS functions.	[Sugiura, Nobuo; Shioiri, Tatsumasa; Chiba, Mie; Watanabe, Hideto] Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 4801195, Japan; [Sato, Takashi; Narimatsu, Hisashi] Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058568, Japan	Aichi Medical University; National Institute of Advanced Industrial Science & Technology (AIST)	Sugiura, N (corresponding author), Aichi Med Univ, Inst Mol Sci Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	nsugiura@aichi-med-u.ac.jp	Narimatsu, Hisashi/M-4757-2018; Sato, Takashi/M-2577-2018	Narimatsu, Hisashi/0000-0002-8402-133X; Sato, Takashi/0000-0002-9973-8923; Watanabe, Hideto/0000-0001-5291-0696	New Energy and Industrial Technology Development Organization (NEDO); Ministry of Education, Culture, Sports, Science, and technology in Japan (MEXT) [S1101027]; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [23570176] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science, and technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the New Energy and Industrial Technology Development Organization (NEDO), a Ministry of Education, Culture, Sports, Science, and technology in Japan (MEXT)-supported Program for the Strategic Research Foundation at Private Universities 2011-2015 (S1101027), and grants-in-aid for scientific research (to N. S. and H. W.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; AVNUR Z, 1984, CELL, V38, P811, DOI 10.1016/0092-8674(84)90276-9; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Fukuta M, 1998, BBA-GENE STRUCT EXPR, V1399, P57, DOI 10.1016/S0167-4781(98)00089-X; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; HABUCHI O, 1993, J BIOL CHEM, V268, P21968; Jing W, 2004, J BIOL CHEM, V279, P42345, DOI 10.1074/jbc.M402744200; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Maeda N, 2006, J BIOL CHEM, V281, P4894, DOI 10.1074/jbc.M507750200; Mascellani G, 1996, THROMB RES, V84, P21, DOI 10.1016/0049-3848(96)00158-2; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Myette JR, 2002, BIOCHEM BIOPH RES CO, V290, P1206, DOI 10.1006/bbrc.2001.6268; NAGASAWA K, 1977, CARBOHYD RES, V58, P47, DOI 10.1016/S0008-6215(00)83402-3; Ninomiya T, 2002, J BIOL CHEM, V277, P21567, DOI 10.1074/jbc.M201719200; Numakura M, 2010, GLYCOCONJUGATE J, V27, P479, DOI 10.1007/s10719-010-9293-2; Ogawa H, 2010, J BIOL CHEM, V285, P34155, DOI 10.1074/jbc.M110.109553; Ohtake S, 2005, J BIOL CHEM, V280, P39115, DOI 10.1074/jbc.M508816200; Ohtake S, 2003, J BIOL CHEM, V278, P38443, DOI 10.1074/jbc.M306132200; Ohtake S, 2001, J BIOL CHEM, V276, P43894, DOI 10.1074/jbc.M104922200; Okuda T, 2000, J BIOCHEM, V128, P763, DOI 10.1093/oxfordjournals.jbchem.a022813; OOHIRA A, 1994, NEUROSCIENCE, V60, P145, DOI 10.1016/0306-4522(94)90210-0; Osawa T, 2009, BIOCHEM BIOPH RES CO, V378, P10, DOI 10.1016/j.bbrc.2008.08.121; Pothacharoen P, 2007, J BIOL CHEM, V282, P35232, DOI 10.1074/jbc.M702255200; Sueyoshi T, 1998, FEBS LETT, V433, P211, DOI 10.1016/S0014-5793(98)00913-2; SUGIURA N, 1993, J BIOL CHEM, V268, P15779; Sugiura N, 2008, GLYCOCONJUGATE J, V25, P521, DOI 10.1007/s10719-008-9105-0; Sugiura N, 2007, ANAL BIOCHEM, V365, P62, DOI 10.1016/j.ab.2007.02.023; Sugiura N, 2011, J BIOL CHEM, V286, P29026, DOI 10.1074/jbc.M111.251157; TOYODA H, 1988, ANAL SCI, V4, P381, DOI 10.2116/analsci.4.381; UENO Y, 1988, CHEM PHARM BULL, V36, P4971; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; Xu D, 2007, J BIOL CHEM, V282, P8356, DOI 10.1074/jbc.M608062200; YADA T, 1992, J BIOL CHEM, V267, P9391; YAMAGATA M, 1987, J BIOL CHEM, V262, P4146	37	42	43	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43390	43400		10.1074/jbc.M112.412676	http://dx.doi.org/10.1074/jbc.M112.412676			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129769	hybrid, Green Published			2022-12-28	WOS:000312940800020
J	van Wietmarschen, N; Moradian, A; Morin, GB; Lansdorp, PM; Uringa, EJ				van Wietmarschen, Niek; Moradian, Annie; Morin, Gregg B.; Lansdorp, Peter M.; Uringa, Evert-Jan			The Mammalian Proteins MMS19, MIP18, and ANT2 Are Involved in Cytoplasmic Iron-Sulfur Cluster Protein Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; TRANSCRIPTION; BIOGENESIS; REPAIR; IDENTIFICATION; METABOLISM; MATURATION; COMPONENT; COMPLEX	Iron-sulfur (Fe-S) clusters are essential cofactors of proteins with a wide range of biological functions. A dedicated cytosolic Fe-S cluster assembly (CIA) system is required to assemble Fe-S clusters into cytosolic and nuclear proteins. Here, we show that the mammalian nucleotide excision repair protein homolog MMS19 can simultaneously bind probable cytosolic iron-sulfur protein assembly protein CIAO1 and Fe-S proteins, confirming that MMS19 is a central protein of the CIA machinery that brings Fe-S cluster donor proteins and the receiving apoproteins into proximity. In addition, we show that mitotic spindle-associated MMXD complex subunit MIP18 also interacts with both CIAO1 and Fe-S proteins. Specifically, it binds the Fe-S cluster coordinating regions in Fe-S proteins. Furthermore, we show that ADP/ATP translocase 2 (ANT2) interacts with Fe-S apoproteins and MMS19 in the CIA complex but not with the individual proteins. Together, these results elucidate the composition and interactions within the late CIA complex.	[van Wietmarschen, Niek; Lansdorp, Peter M.; Uringa, Evert-Jan] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, NL-9713 AV Groningen, Netherlands; [Moradian, Annie; Morin, Gregg B.] British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Morin, Gregg B.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 4E3, Canada; [Lansdorp, Peter M.; Uringa, Evert-Jan] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Lansdorp, Peter M.] Univ British Columbia, Dept Med, Div Hematol, Vancouver, BC V5Z 4E3, Canada	University of Groningen; British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Uringa, EJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	e.j.uringa@umcg.nl	Morin, Gregg B/E-9123-2012; van Wietmarschen, Niek/ABE-8269-2020	Morin, Gregg B/0000-0001-8949-4374; Lansdorp, Peter/0000-0001-7435-1071; van Wietmarschen, Niek/0000-0001-6136-5757	Terry Fox Foundation Program Project [018006]; Canadian Cancer Society [105265]	Terry Fox Foundation Program Project; Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by Grant 018006 awarded by the Terry Fox Foundation Program Project and Grant 105265 from the Canadian Cancer Society.	ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hatfield MD, 2006, DNA REPAIR, V5, P914, DOI 10.1016/j.dnarep.2006.05.007; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito S, 2010, MOL CELL, V39, P632, DOI 10.1016/j.molcel.2010.07.029; Jin FL, 2006, NAT METHODS, V3, P183, DOI 10.1038/nmeth859; Lauder S, 1996, MOL CELL BIOL, V16, P6783; Li F, 2011, NATURE, V475, P244, DOI 10.1038/nature10161; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lombaerts M, 1997, NUCLEIC ACIDS RES, V25, P3974, DOI 10.1093/nar/25.20.3974; Mead CLR, 2010, J NEUROCHEM, V113, P1491, DOI 10.1111/j.1471-4159.2010.06690.x; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Srinivasan V, 2007, STRUCTURE, V15, P1246, DOI 10.1016/j.str.2007.08.009; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Uringa EJ, 2012, MOL BIOL CELL, V23, P2782, DOI 10.1091/mbc.E12-03-0179; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Wu Y, 2009, CELL MOL LIFE SCI, V66, P1209, DOI 10.1007/s00018-008-8580-6; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	23	32	32	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43351	43358		10.1074/jbc.M112.431270	http://dx.doi.org/10.1074/jbc.M112.431270			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23150669	Green Published, hybrid			2022-12-28	WOS:000312940800016
J	Li, YM; Xiao, HJ; de Renty, C; Jaramillo-Lambert, A; Han, ZY; DePamphilis, ML; Brown, KJ; Zhu, WG				Li, Yongming; Xiao, Haijie; de Renty, Christelle; Jaramillo-Lambert, Aimee; Han, Zhiyong; DePamphilis, Melvin L.; Brown, Kristy J.; Zhu, Wenge			The Involvement of Acidic Nucleoplasmic DNA-binding Protein (And-1) in the Regulation of Prereplicative Complex (pre-RC) Assembly in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-ALPHA; REPLICATION; HELICASE; DOMAIN; CTF4; G1; IDENTIFICATION; ACETYLATION; CTF4/AND-1; INITIATION	DNA replication in all eukaryotes starts with the process of loading the replicative helicase MCM2-7 onto chromatin during late mitosis of the cell cycle. MCM2-7 is a key component of the prereplicative complex (pre-RC), which is loaded onto chromatin by the concerted action of origin recognition complex, Cdc6, and Cdt1. Here, we demonstrate that And-1 is assembled onto chromatin in late mitosis and early G(1) phase before the assembly of pre-RC in human cells. And-1 forms complexes with MCM2-7 to facilitate the assembly of MCM2-7 onto chromatin at replication origins in late mitosis and G(1) phase. We also present data to show that depletion of And-1 significantly reduces the interaction between Cdt1 and MCM7 in G(1) phase cells. Thus, human And-1 facilitates loading of the MCM2-7 helicase onto chromatin during the assembly of pre-RC.	[Li, Yongming; Xiao, Haijie; Jaramillo-Lambert, Aimee; Han, Zhiyong; Zhu, Wenge] George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [de Renty, Christelle; DePamphilis, Melvin L.] NICHHD, Bethesda, MD 20892 USA; [Brown, Kristy J.] George Washington Univ, Sch Med, Childrens Natl Med Ctr, Dept Integrat Syst Biol,Ctr Genet Med, Washington, DC 20010 USA	George Washington University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Children's National Health System; George Washington University	Zhu, WG (corresponding author), George Washington Univ, Sch Med, Dept Biochem & Mol Biol, 2300 Eye St NW, Washington, DC 20037 USA.	wz6812@gwu.edu	li, yong/HDN-3885-2022	Brown, Kristy/0000-0002-1047-4328; Jaramillo-Lambert, Aimee/0000-0001-7697-8580	National Institutes of Health [CA136555]; National Institutes of Health National Center for Medical Rehabilitation Research/NINDS [2R24HD050846-06]; Intellectual and Developmental Disabilities Research Center [5P30HD040677-10]; National Center for Medical Rehabilitation [UL1RR031988]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Center for Medical Rehabilitation Research/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intellectual and Developmental Disabilities Research Center; National Center for Medical Rehabilitation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health Grant CA136555 (to W. Z.). This work was also supported in part by National Institutes of Health National Center for Medical Rehabilitation Research/NINDS Core Grants 2R24HD050846-06 (National Center for Medical Rehabilitation Research) and Intellectual and Developmental Disabilities Research Center Grant 5P30HD040677-10 and by National Center for Medical Rehabilitation Research Grant UL1RR031988 (George Washington University, Children's National Medical Center, Clinical and Translational Science Institute).	Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bermudez VP, 2010, J BIOL CHEM, V285, P9493, DOI 10.1074/jbc.M109.093609; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Chadha GS, 2010, MOL CELL, V37, P5, DOI 10.1016/j.molcel.2009.12.028; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Errico A, 2009, EMBO J, V28, P3681, DOI 10.1038/emboj.2009.304; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Fujita M, 1996, J BIOL CHEM, V271, P4349; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Grienenberger A, 2002, CURR BIOL, V12, P762, DOI 10.1016/S0960-9822(02)00814-X; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; Guilbaud G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002322; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Herrick J, 2000, P NATL ACAD SCI USA, V97, P222, DOI 10.1073/pnas.97.1.222; Holm M, 2001, EMBO J, V20, P118, DOI 10.1093/emboj/20.1.118; Iizuka M, 2006, MOL CELL BIOL, V26, P1098, DOI 10.1128/MCB.26.3.1098-1108.2006; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Jensen ON, 1999, METH MOL B, V112, P513; Kouprina E. K., 1992, MOL CELL BIOL, V12; LALANDE M, 1990, EXP CELL RES, V186, P332, DOI 10.1016/0014-4827(90)90313-Y; Li Y, 2012, ONCOGENE, V31, P643, DOI 10.1038/onc.2011.261; Li YM, 2011, J BIOL CHEM, V286, P41344, DOI 10.1074/jbc.M111.290767; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Maiorano D, 2005, CELL, V120, P315, DOI 10.1016/j.cell.2004.12.010; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Miotto B, 2010, MOL CELL, V37, P57, DOI 10.1016/j.molcel.2009.12.012; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Sanjuan R, 2001, MOL BIOL EVOL, V18, P330, DOI 10.1093/oxfordjournals.molbev.a003809; Schwob Etienne, 2009, V521, P673, DOI 10.1007/978-1-60327-817-5_36; Sclafani RA, 2000, J CELL SCI, V113, P2111; Sibani S, 2005, BIOCHEMISTRY-US, V44, P7885, DOI 10.1021/bi047327n; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Tsutsui Y, 2005, CURR GENET, V48, P34, DOI 10.1007/s00294-005-0584-2; Volkening M, 2005, MOL CELL BIOL, V25, P1560, DOI 10.1128/MCB.25.4.1560-1568.2005; Wang G, 2000, EXP CELL RES, V254, P64, DOI 10.1006/excr.1999.4743; Williams DR, 2002, EUKARYOT CELL, V1, P758, DOI 10.1128/EC.1.5.758-773.2002; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yoshizawa-Sugata N, 2009, J BIOL CHEM, V284, P20718, DOI 10.1074/jbc.M806711200; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607; Zhu WG, 2006, MOL CELL BIOL, V26, P4601, DOI 10.1128/MCB.02141-05; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	46	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42469	42479		10.1074/jbc.M112.404277	http://dx.doi.org/10.1074/jbc.M112.404277			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23093411	Green Published, hybrid			2022-12-28	WOS:000312501600009
J	Martins, M; Custodio, R; Camejo, A; Almeida, MT; Cabanes, D; Sousa, S				Martins, Mariana; Custodio, Rafael; Camejo, Ana; Almeida, Maria Teresa; Cabanes, Didier; Sousa, Sandra			Listeria monocytogenes Triggers the Cell Surface Expression of Gp96 Protein and Interacts with Its N Terminus to Support Cellular Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K1; MICROVASCULAR ENDOTHELIAL-CELLS; FOCAL ADHESION KINASE; ENDOPLASMIC-RETICULUM; A RECEPTOR; BINDING-PROTEIN; QUALITY-CONTROL; INVASION; VIRULENCE; GRP94	Listeria monocytogenes is an intracellular food-borne pathogen causing listeriosis in humans. This bacterium deploys an arsenal of virulence factors that act in concert to promote cellular infection. Bacterial surface proteins are of primary importance in the process of host cell invasion. They interact with host cellular receptors, inducing/modulating specific cellular responses. We previously identified Vip, a Listeria surface protein covalently attached to the bacterial cell wall acting as a key virulence factor. We have shown that Vip interacts with Gp96 localized at the surface of host cells during invasion and that this interaction is critical for a successful infection in vivo. To better understand the importance of Vip-Gp96 interaction during infection, we aimed to characterize this interaction at the molecular level. Here we demonstrate that, during infection, L. monocytogenes triggers the cellular redistribution of Gp96, inducing its exposure at the cell surface. Upon infection, Gp96 N-terminal domain is exposed to the extracellular milieu in L2071 fibroblasts and interacts with Vip expressed by Listeria. We identified Gp96 (Asp(1)-Leu(170)) as sufficient to interact with Vip; however, we also showed that the region Tyr(179)-Leu(390) of Gp96 is important for the interaction. Our findings unravel the Listeria-induced surface expression of Gp96 and the topology of its insertion on the plasma membrane and improve our knowledge on the Vip-Gp96 interaction during Listeria infection.	[Martins, Mariana; Custodio, Rafael; Camejo, Ana; Almeida, Maria Teresa; Cabanes, Didier; Sousa, Sandra] Univ Porto, Inst Biol Mol & Celular, Grp Mol Microbiol, P-4150180 Oporto, Portugal	Universidade do Porto	Cabanes, D (corresponding author), Univ Porto, Inst Biol Mol & Celular, Grp Mol Microbiol, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	didier@ibmc.up.pt; srsousa@ibmc.up.pt	Cabanes, Didier/P-3052-2019; Sousa, Sandra/K-3934-2013; Cabanes, Didier/K-3917-2013; Sousa, Sandra/P-2133-2019; Martins, M. Cristina/J-8284-2013	Cabanes, Didier/0000-0002-4001-1332; Sousa, Sandra/0000-0001-8578-0461; Cabanes, Didier/0000-0002-4001-1332; Sousa, Sandra/0000-0001-8578-0461; Martins, M. Cristina/0000-0002-6574-4794; Martins, Mariana/0000-0002-5677-7068	Fundo Europeu de Desenvolvimento Regional (FEDER)-Programa Operacional Factores de Competitividade (COMPETE); Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/SAU-MII/65407/2006, FCOMP-01-0124-FEDER-007512, ERA-PTG/0003/2010, PTDC/SAU-MIC/111581/2009FCOMP-01-0124-FEDER-015844]; FCT [BD/29314/2006, BD/43352/2008]; Ciencia Program (COMPETE); Ciencia Program (Programa Operacional Potencial Humano); Ciencia Program (FCT)	Fundo Europeu de Desenvolvimento Regional (FEDER)-Programa Operacional Factores de Competitividade (COMPETE); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Ciencia Program (COMPETE); Ciencia Program (Programa Operacional Potencial Humano); Ciencia Program (FCT)	This work was supported in part by Fundo Europeu de Desenvolvimento Regional (FEDER)-Programa Operacional Factores de Competitividade (COMPETE) and Fundacao para a Ciencia e a Tecnologia (FCT) Grants PTDC/SAU-MII/65407/2006, FCOMP-01-0124-FEDER-007512, ERA-PTG/0003/2010, and PTDC/SAU-MIC/111581/2009FCOMP-01-0124-FEDER-015844.; Supported by FCT Doctoral Fellowships BD/29314/2006 and BD/43352/2008.; Supported by the Ciencia 2008 Program (COMPETE, Programa Operacional Potencial Humano, and FCT). To whom correspondence may be addressed: Group of Molecular Microbiology, Inst. de Biologia Molecular e Celular, Rua do Campo Alegre 823, 4150-180 Porto, Portugal. Tel.: 351226074907; Fax: 351-226099157; E-mail: srsousa@ibmc.up.pt.	Altmeyer A, 1996, INT J CANCER, V69, P340, DOI 10.1002/(SICI)1097-0215(19960822)69:4<340::AID-IJC18>3.0.CO;2-9; Argon Y, 1999, SEMIN CELL DEV BIOL, V10, P495, DOI 10.1006/scdb.1999.0320; Aubry C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033299; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; Burkholder KM, 2010, INFECT IMMUN, V78, P5062, DOI 10.1128/IAI.00516-10; Cabanes D, 2005, EMBO J, V24, P2827, DOI 10.1038/sj.emboj.7600750; Camejo A, 2011, VIRULENCE, V2, P379, DOI 10.4161/viru.2.5.17703; Cho NH, 2004, MICROBIOL IMMUNOL, V48, P297, DOI 10.1111/j.1348-0421.2004.tb03510.x; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076; Hilf N, 2002, INT J HYPERTHER, V18, P521, DOI 10.1080/02656730210166177; Hilf N, 2002, BLOOD, V99, P3676, DOI 10.1182/blood.V99.10.3676; Kim G, 2010, BIOCHEM BIOPH RES CO, V397, P100, DOI 10.1016/j.bbrc.2010.05.075; Krishnan S., 2012, CELL MICROB IN PRESS; Krishnan S, 2012, CELL MICROBIOL, V14, P1415, DOI 10.1111/j.1462-5822.2012.01805.x; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Liu YP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002305; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machata S, 2008, J IMMUNOL, V181, P2028, DOI 10.4049/jimmunol.181.3.2028; Maruvada R, 2008, CELL MICROBIOL, V10, P2326, DOI 10.1111/j.1462-5822.2008.01214.x; Maruvada R, 2008, IMMUNOLOGY, V124, P265, DOI 10.1111/j.1365-2567.2007.02764.x; Marzec M, 2012, BBA-MOL CELL RES, V1823, P774, DOI 10.1016/j.bbamcr.2011.10.013; Mittal R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1554; Mittal R, 2010, CELL MICROBIOL, V12, P67, DOI 10.1111/j.1462-5822.2009.01379.x; Na X, 2008, INFECT IMMUN, V76, P2862, DOI 10.1128/IAI.00326-08; Prasadarao NV, 2003, INFECT IMMUN, V71, P1680, DOI 10.1128/IAI.71.4.1680-1688.2003; Prasadarao NV, 2002, J IMMUNOL, V169, P6352, DOI 10.4049/jimmunol.169.11.6352; Prasadarao NV, 2002, INFECT IMMUN, V70, P4556, DOI 10.1128/IAI.70.8.4556-4563.2002; Radsak MP, 2003, BLOOD, V101, P2810, DOI 10.1182/blood-2002-07-2261; Rechner C, 2007, CELL HOST MICROBE, V2, P393, DOI 10.1016/j.chom.2007.11.002; Reddy MA, 2000, INFECT IMMUN, V68, P6423, DOI 10.1128/IAI.68.11.6423-6430.2000; Reddy MA, 2000, J BIOL CHEM, V275, P36769, DOI 10.1074/jbc.M007382200; Reis O, 2010, J INFECT DIS, V202, P551, DOI 10.1086/654880; Rolhion N, 2010, GUT, V59, P1355, DOI 10.1136/gut.2010.207456; Soldano KL, 2003, J BIOL CHEM, V278, P48330, DOI 10.1074/jbc.M308661200; Sousa S, 2005, CURR OPIN CELL BIOL, V17, P489, DOI 10.1016/j.ceb.2005.08.013; Stavru F, 2011, IMMUNOL REV, V240, P160, DOI 10.1111/j.1600-065X.2010.00993.x; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Valle J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002843; Wampler JL, 2004, INFECT IMMUN, V72, P931, DOI 10.1128/IAI.72.2.931-936.2004; Xu AM, 1998, J VIROL, V72, P9865, DOI 10.1128/JVI.72.12.9865-9872.1998; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	45	21	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43083	43093		10.1074/jbc.M112.422568	http://dx.doi.org/10.1074/jbc.M112.422568			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23109341	Green Published, hybrid			2022-12-28	WOS:000312501600064
J	Yermolenko, IS; Gorkun, OV; Fuhrmann, A; Podolnikova, NP; Lishko, VK; Oshkadyerov, SP; Lord, ST; Ros, R; Ugarova, TP				Yermolenko, Ivan S.; Gorkun, Oleg V.; Fuhrmann, Alexander; Podolnikova, Nataly P.; Lishko, Valeryi K.; Oshkadyerov, Stanislav P.; Lord, Susan T.; Ros, Robert; Ugarova, Tatiana P.			The Assembly of Nonadhesive Fibrinogen Matrices Depends on the alpha C Regions of the Fibrinogen Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; NEUTROPHIL ADHESION; ADSORBED FIBRINOGEN; FLOW CONDITIONS; FRAGMENT-X; HETEROGENEITY; PLATELET; DOMAIN; PLASMINOGEN; PLASMA	Adsorption of fibrinogen on fibrin clots and other surfaces strongly reduces integrin-mediated adhesion of platelets and leukocytes with implications for the surface-mediated control of thrombus growth and blood compatibility of biomaterials. The underlying mechanism of this process is surface-induced aggregation of fibrinogen, resulting in the assembly of a nanoscale multilayered matrix. The matrix is extensible, which makes it incapable of transducing strong mechanical forces via cellular integrins, resulting in insufficient intracellular signaling and weak cell adhesion. To determine the mechanism of the multilayer formation, the physical and adhesive properties of fibrinogen matrices prepared from human plasma fibrinogen (hFg), recombinant normal (rFg), and fibrinogen with the truncated alpha C regions (FgA alpha 251) were compared. Using atomic force microscopy and force spectroscopy, we show that whereas hFg and rFg generated the matrices with a thickness of similar to 8 nm consisting of 7-8 molecular layers, the deposition of FgA alpha 251 was terminated at two layers, indicating that the alpha C regions are essential for the multilayer formation. The extensibility of the matrix prepared from FgA alpha 251 was 2-fold lower than that formed from hFg and rFg. In agreement with previous findings that cell adhesion inversely correlates with the extensibility of the fibrinogen matrix, the less extensible FgA alpha 251 matrix and matrices generated from human fibrinogen variants lacking the alpha C regions supported sustained adhesion of leukocytes and platelets. The persistent adhesiveness of matrices formed from fibrinogen derivatives without the alpha C regions may have implications for conditions in which elevated levels of these molecules are found, including vascular pathologies, diabetes, thrombolytic therapy, and dysfibrinogenemia.	[Yermolenko, Ivan S.; Podolnikova, Nataly P.; Lishko, Valeryi K.; Ugarova, Tatiana P.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Ros, Robert] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Gorkun, Oleg V.; Lord, Susan T.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Fuhrmann, Alexander] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Yermolenko, Ivan S.; Oshkadyerov, Stanislav P.] Natl Acad Sci Ukraine, Inst Met Phys, UA-03680 Kiev, Ukraine	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; National Academy of Sciences Ukraine	Ugarova, TP (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Tatiana.Ugarova@asu.edu	Ros, Robert/G-2154-2012; Ros, Robert/X-3030-2019	Ros, Robert/0000-0001-9271-4091; GORKUN, OLEG/0000-0002-3068-3389	National Institutes of Health [HL107539]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063199, R01HL107539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL107539 (to T.P.U. and R.R.). This work was also supported by a Predoctoral Fellowship from the American Heart Association (to Y.I.S).	Burton RA, 2006, BIOCHEMISTRY-US, V45, P2257, DOI 10.1021/bi052380c; Cooley BC, 2011, ARTERIOSCL THROM VAS, V31, P1351, DOI 10.1161/ATVBAHA.111.225334; de Maat MPM, 2005, CURR OPIN HEMATOL, V12, P377, DOI 10.1097/01.moh.0000169287.51594.3b; DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211; Endenburg SC, 1996, ARTERIOSCL THROM VAS, V16, P633, DOI 10.1161/01.ATV.16.5.633; Evans-Nguyen KM, 2006, LANGMUIR, V22, P5115, DOI 10.1021/la053070y; GOLLWITZER R, 1983, THROMB RES, P41; Gorkun OV, 2006, BIOCHEMISTRY-US, V45, P14843, DOI 10.1021/bi061430q; GORKUN OV, 1994, BIOCHEMISTRY-US, V33, P6986, DOI 10.1021/bi00188a031; Gorkun OV, 1998, BIOCHEMISTRY-US, V37, P15434, DOI 10.1021/bi981551t; GROVES HM, 1982, LAB INVEST, V46, P605; GUREWICH V, 1981, THROMB RES, V22, P535, DOI 10.1016/0049-3848(81)90051-7; Hanss M, 2001, ANN NY ACAD SCI, V936, P89; Hayes T, 2002, ARCH PATHOL LAB MED, V126, P1387; HOLM B, 1984, THROMB RES, V35, P279, DOI 10.1016/0049-3848(84)90359-1; HOLM B, 1985, THROMB RES, V37, P165, DOI 10.1016/0049-3848(85)90043-X; Kamocka MM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3322676; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; Koo J, 2010, J THROMB HAEMOST, V8, P2727, DOI 10.1111/j.1538-7836.2010.04072.x; Kuijper PHM, 1997, BLOOD, V89, P166, DOI 10.1182/blood.V89.1.166.166_166_175; Kuijper PHM, 1997, BLOOD, V89, P2131, DOI 10.1182/blood.V89.6.2131; LIPINSKA I, 1976, AM J CLIN PATHOL, V66, P958; LIPINSKI B, 1977, J LAB CLIN MED, V90, P187; Lishko VK, 2010, J THROMB HAEMOST, V8, P799, DOI 10.1111/j.1538-7836.2010.03778.x; Lishko VK, 2007, BLOOD, V109, P1541, DOI 10.1182/blood-2006-05-022764; Lishko VK, 2002, BIOCHEMISTRY-US, V41, P12942, DOI 10.1021/bi026324c; Litvinov RI, 2007, BIOCHEMISTRY-US, V46, P9133, DOI 10.1021/bi700944j; MILLS D, 1971, BIOCHIM BIOPHYS ACTA, V251, P121, DOI 10.1016/0005-2795(71)90069-9; OWEN J, 1987, J CLIN INVEST, V79, P1642, DOI 10.1172/JCI113001; Podolnikova NP, 2010, BIOCHEMISTRY-US, V49, P68, DOI 10.1021/bi9016022; RUDEE ML, 1981, ULTRAMICROSCOPY, V7, P193, DOI 10.1016/0304-3991(81)90010-3; SCHIELEN WJG, 1989, P NATL ACAD SCI USA, V86, P8951, DOI 10.1073/pnas.86.22.8951; Tsurupa G, 2002, BIOCHEMISTRY-US, V41, P6449, DOI 10.1021/bi025584r; Tsurupa G, 2010, BIOCHEMISTRY-US, V49, P7643, DOI 10.1021/bi1010317; Tsurupa G, 2009, BIOCHEMISTRY-US, V48, P12191, DOI 10.1021/bi901640e; UGAROVA TP, 1993, J BIOL CHEM, V268, P21080; van Ryn J, 2003, THROMB HAEMOSTASIS, V90, P1179, DOI 10.1160/TH03-05-0305; VANAKEN PJ, 1982, ARTERY, V11, P156; VEKLICH YI, 1993, J BIOL CHEM, V268, P13577; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Weisel JW, 2001, ANN NY ACAD SCI, V936, P312; WIGREN R, 1991, FEBS LETT, V280, P225, DOI 10.1016/0014-5793(91)80298-H; WRIGHT SD, 1988, P NATL ACAD SCI USA, V85, P7734, DOI 10.1073/pnas.85.20.7734; Yakovlev S, 2000, BIOCHEMISTRY-US, V39, P15730, DOI 10.1021/bi001847a; Yang Z, 2000, P NATL ACAD SCI USA, V97, P14156, DOI 10.1073/pnas.97.26.14156; Yermolenko IS, 2011, BIOMACROMOLECULES, V12, P370, DOI 10.1021/bm101122g; Yermolenko IS, 2010, LANGMUIR, V26, P17269, DOI 10.1021/la101791r; ZAMARRON C, 1990, THROMB HAEMOSTASIS, V64, P41; Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017	49	17	17	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41979	41990		10.1074/jbc.M112.410696	http://dx.doi.org/10.1074/jbc.M112.410696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086938	Green Published, hybrid			2022-12-28	WOS:000312103000037
